Psyllid ID: psy14889
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 443 | 2.2.26 [Sep-21-2011] | |||||||
| Q28041 | 509 | Activin receptor type-1 O | yes | N/A | 0.916 | 0.797 | 0.589 | 1e-146 | |
| Q04771 | 509 | Activin receptor type-1 O | yes | N/A | 0.916 | 0.797 | 0.589 | 1e-146 | |
| P37172 | 509 | Activin receptor type-1 O | yes | N/A | 0.916 | 0.797 | 0.589 | 1e-146 | |
| Q90ZK6 | 504 | Activin receptor type-1 O | yes | N/A | 0.920 | 0.809 | 0.605 | 1e-145 | |
| P80201 | 509 | Activin receptor type-1 O | yes | N/A | 0.916 | 0.797 | 0.587 | 1e-145 | |
| Q61288 | 502 | Serine/threonine-protein | no | N/A | 0.914 | 0.806 | 0.572 | 1e-136 | |
| P80203 | 504 | Serine/threonine-protein | no | N/A | 0.914 | 0.803 | 0.572 | 1e-133 | |
| Q5RAN0 | 503 | Serine/threonine-protein | no | N/A | 0.905 | 0.797 | 0.574 | 1e-133 | |
| P37023 | 503 | Serine/threonine-protein | no | N/A | 0.905 | 0.797 | 0.574 | 1e-133 | |
| Q5CD18 | 503 | TGF-beta receptor type-1 | no | N/A | 0.911 | 0.803 | 0.527 | 1e-123 |
| >sp|Q28041|ACVR1_BOVIN Activin receptor type-1 OS=Bos taurus GN=ACVR1 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 517 bits (1332), Expect = e-146, Method: Compositional matrix adjust.
Identities = 246/417 (58%), Positives = 315/417 (75%), Gaps = 11/417 (2%)
Query: 14 IQCCDGDFCNNGSFPILPPSYRELPEYAQRYDYILKLSMAILGPVIVLGMLAAVIVLFMR 73
++CC GD+CN LP + P ++ L++ + IL V + +LA ++ + +R
Sbjct: 91 VECCQGDWCNRNITAQLPTKGKSFPGTQ---NFHLEVGLIILSVVFAVCLLACLLGVALR 147
Query: 74 RNHRK--KLLAARAIQSDPDCFLADADLLRATAAGDSTLREYLDASLTSGSGSGLPLLIQ 131
+ R+ + L R ++ + L T GDSTL + LD S TSGSGSGLP L+Q
Sbjct: 148 KFKRRNQERLNPRDVE------YGTIEGLITTNVGDSTLADLLDHSCTSGSGSGLPFLVQ 201
Query: 132 RTLAKQISLSECIGKGRYGEVWRGVWHGENVAVKIFFSRDEASWSRETEIYSTVLLRHEN 191
RT+A+QI+L EC+GKGRYGEVWRG W GENVAVKIF SRDE SW RETE+Y+TV+LRHEN
Sbjct: 202 RTVARQITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHEN 261
Query: 192 ILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHT 251
ILG+I SDMTSR+S TQLWL+THYH GSLYD+L TTL+ ++I LSI +GL HLH
Sbjct: 262 ILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHI 321
Query: 252 EIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRY 311
EIFGTQGKPAIAHRD+KSKNILVK NG C IAD GLAV +SQ +N++D+ NPRVGTKRY
Sbjct: 322 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 381
Query: 312 MSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSF 371
M+PE+LDE+I +DCF+S+K+ DI+A GLVLWEV RR +NGI E+YK P++D+VP DPSF
Sbjct: 382 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSF 441
Query: 372 DDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKL 428
+DMRKV+C+DQQRP +PNRW SD TL ++ K+MKECW+QN + RL+ALR+KKTL K+
Sbjct: 442 EDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 498
|
On ligand binding, forms a receptor complex consisting of two type II and two type I transmembrane serine/threonine kinases. Type II receptors phosphorylate and activate type I receptors which autophosphorylate, then bind and activate SMAD transcriptional regulators. Receptor for TGF-beta. May also bind activin. Bos taurus (taxid: 9913) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 3EC: 0 |
| >sp|Q04771|ACVR1_HUMAN Activin receptor type-1 OS=Homo sapiens GN=ACVR1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 517 bits (1331), Expect = e-146, Method: Compositional matrix adjust.
Identities = 246/417 (58%), Positives = 315/417 (75%), Gaps = 11/417 (2%)
Query: 14 IQCCDGDFCNNGSFPILPPSYRELPEYAQRYDYILKLSMAILGPVIVLGMLAAVIVLFMR 73
++CC GD+CN LP + P ++ L++ + IL V + +LA ++ + +R
Sbjct: 91 VECCQGDWCNRNITAQLPTKGKSFPGTQ---NFHLEVGLIILSVVFAVCLLACLLGVALR 147
Query: 74 RNHRK--KLLAARAIQSDPDCFLADADLLRATAAGDSTLREYLDASLTSGSGSGLPLLIQ 131
+ R+ + L R ++ + L T GDSTL + LD S TSGSGSGLP L+Q
Sbjct: 148 KFKRRNQERLNPRDVE------YGTIEGLITTNVGDSTLADLLDHSCTSGSGSGLPFLVQ 201
Query: 132 RTLAKQISLSECIGKGRYGEVWRGVWHGENVAVKIFFSRDEASWSRETEIYSTVLLRHEN 191
RT+A+QI+L EC+GKGRYGEVWRG W GENVAVKIF SRDE SW RETE+Y+TV+LRHEN
Sbjct: 202 RTVARQITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHEN 261
Query: 192 ILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHT 251
ILG+I SDMTSR+S TQLWL+THYH GSLYD+L TTL+ ++I LSI +GL HLH
Sbjct: 262 ILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHI 321
Query: 252 EIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRY 311
EIFGTQGKPAIAHRD+KSKNILVK NG C IAD GLAV +SQ +N++D+ NPRVGTKRY
Sbjct: 322 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 381
Query: 312 MSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSF 371
M+PE+LDE+I +DCF+S+K+ DI+A GLVLWEV RR +NGI E+YK P++D+VP DPSF
Sbjct: 382 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSF 441
Query: 372 DDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKL 428
+DMRKV+C+DQQRP +PNRW SD TL ++ K+MKECW+QN + RL+ALR+KKTL K+
Sbjct: 442 EDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 498
|
On ligand binding, forms a receptor complex consisting of two type II and two type I transmembrane serine/threonine kinases. Type II receptors phosphorylate and activate type I receptors which autophosphorylate, then bind and activate SMAD transcriptional regulators. Receptor for activin. May be involved for left-right pattern formation during embryogenesis. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 3 EC: 0 |
| >sp|P37172|ACVR1_MOUSE Activin receptor type-1 OS=Mus musculus GN=Acvr1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 516 bits (1330), Expect = e-146, Method: Compositional matrix adjust.
Identities = 246/417 (58%), Positives = 314/417 (75%), Gaps = 11/417 (2%)
Query: 14 IQCCDGDFCNNGSFPILPPSYRELPEYAQRYDYILKLSMAILGPVIVLGMLAAVIVLFMR 73
++CC GD+CN LP + P ++ L++ + IL V + +LA ++ + +R
Sbjct: 91 VECCQGDWCNRNITAQLPTKGKSFPGTQ---NFHLEVGLIILSVVFAVCLLACILGVALR 147
Query: 74 RNHRK--KLLAARAIQSDPDCFLADADLLRATAAGDSTLREYLDASLTSGSGSGLPLLIQ 131
+ R+ + L R ++ + L T GDSTL E LD S TSGSGSGLP L+Q
Sbjct: 148 KFKRRNQERLNPRDVE------YGTIEGLITTNVGDSTLAELLDHSCTSGSGSGLPFLVQ 201
Query: 132 RTLAKQISLSECIGKGRYGEVWRGVWHGENVAVKIFFSRDEASWSRETEIYSTVLLRHEN 191
RT+A+QI+L EC+GKGRYGEVWRG W GENVAVKIF SRDE SW RETE+Y+TV+LRHEN
Sbjct: 202 RTVARQITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHEN 261
Query: 192 ILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHT 251
ILG+I SDMTSR+S TQLWL+THYH GSLYD+L TTL+ ++I LSI +GL HLH
Sbjct: 262 ILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHI 321
Query: 252 EIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRY 311
EIFGTQGK AIAHRD+KSKNILVK NG C IAD GLAV +SQ +N++D+ NPRVGTKRY
Sbjct: 322 EIFGTQGKSAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 381
Query: 312 MSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSF 371
M+PE+LDE+I +DCF+S+K+ DI+A GLVLWEV RR +NGI E+YK P++D+VP DPSF
Sbjct: 382 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSF 441
Query: 372 DDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKL 428
+DMRKV+C+DQQRP +PNRW SD TL ++ K+MKECW+QN + RL+ALR+KKTL K+
Sbjct: 442 EDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 498
|
On ligand binding, forms a receptor complex consisting of two type II and two type I transmembrane serine/threonine kinases. Type II receptors phosphorylate and activate type I receptors which autophosphorylate, then bind and activate SMAD transcriptional regulators. Receptor for activin. May be involved in left-right pattern formation during embryogenesis. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 3 EC: 0 |
| >sp|Q90ZK6|ACVR1_CHICK Activin receptor type-1 OS=Gallus gallus GN=ACVR1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 516 bits (1329), Expect = e-145, Method: Compositional matrix adjust.
Identities = 253/418 (60%), Positives = 313/418 (74%), Gaps = 10/418 (2%)
Query: 14 IQCCDGDFCNNGSFPILPPSYRELPEYAQRYDYILKLSMAILGPVIVLGMLAAVIVLFMR 73
++CC G CN LP S + + + L + IL PV+VL + + V VL +R
Sbjct: 83 VECCQGYLCNMNITAKLPSSKGQTLQGEAAGYSMETLIIVILAPVVVLVIFSVVAVLIIR 142
Query: 74 R---NHRKKLLAARAIQSDPDCFLADADLLRATAAGDSTLREYLDASLTSGSGSGLPLLI 130
R NH ++L + D + L A+ GDSTL + LD S TSGSGSGLP L+
Sbjct: 143 RIQKNHMERL-------NSRDAEYGTIEGLIASNVGDSTLADLLDHSCTSGSGSGLPFLV 195
Query: 131 QRTLAKQISLSECIGKGRYGEVWRGVWHGENVAVKIFFSRDEASWSRETEIYSTVLLRHE 190
QRT+A+QI+L EC+GKGRYGEVWRG W GENVAVKIF SRDE SW RETE+Y+TVLLRHE
Sbjct: 196 QRTVARQITLVECVGKGRYGEVWRGQWQGENVAVKIFSSRDEKSWFRETELYNTVLLRHE 255
Query: 191 NILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLH 250
NILG+I SDMTSRNS TQLWL+THYH GSLYD+L TTL+ ++I LSI +GL HLH
Sbjct: 256 NILGFIASDMTSRNSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLH 315
Query: 251 TEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKR 310
EIFGTQGKPAI+HRD+KSKNILVK NG C IAD GLAV +SQ +N++D+ NPRVGTKR
Sbjct: 316 IEIFGTQGKPAISHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKR 375
Query: 311 YMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPS 370
YM+PE+LDE+I DCF+S+K+ DI+A GLVLWEV RR +NGI E+YK P++DLVP DPS
Sbjct: 376 YMAPEVLDETIQADCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDLVPNDPS 435
Query: 371 FDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKL 428
F+DMRKV+C+DQQRP +PNRW SD TL ++ K+MKECW+QN + RL+ALR+KKTL K+
Sbjct: 436 FEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 493
|
On ligand binding, forms a receptor complex consisting of two type II and two type I transmembrane serine/threonine kinases. Type II receptors phosphorylate and activate type I receptors which autophosphorylate, then bind and activate SMAD transcriptional regulators. Receptor for activin. Gallus gallus (taxid: 9031) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 3 EC: 0 |
| >sp|P80201|ACVR1_RAT Activin receptor type-1 OS=Rattus norvegicus GN=Acvr1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 516 bits (1328), Expect = e-145, Method: Compositional matrix adjust.
Identities = 245/417 (58%), Positives = 313/417 (75%), Gaps = 11/417 (2%)
Query: 14 IQCCDGDFCNNGSFPILPPSYRELPEYAQRYDYILKLSMAILGPVIVLGMLAAVIVLFMR 73
++CC GD+CN LP + P ++ L++ + IL V + + A ++ + +R
Sbjct: 91 VECCQGDWCNRNVTARLPTKGKSFP---GSQNFHLEVGLIILSVVFAVCLFACILGVALR 147
Query: 74 RNHRK--KLLAARAIQSDPDCFLADADLLRATAAGDSTLREYLDASLTSGSGSGLPLLIQ 131
+ R+ + L R ++ + L T GDSTL E LD S TSGSGSGLP L+Q
Sbjct: 148 KFKRRNQERLNPRDVE------YGTIEGLITTNVGDSTLAELLDHSCTSGSGSGLPFLVQ 201
Query: 132 RTLAKQISLSECIGKGRYGEVWRGVWHGENVAVKIFFSRDEASWSRETEIYSTVLLRHEN 191
RT+A+QI+L EC+GKGRYGEVWRG W GENVAVKIF SRDE SW RETE+Y+TV+LRHEN
Sbjct: 202 RTVARQITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHEN 261
Query: 192 ILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHT 251
ILG+I SDMTSR+S TQLWL+THYH GSLYD+L TTL+ ++I LSI +GL HLH
Sbjct: 262 ILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHI 321
Query: 252 EIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRY 311
EIFGTQGK AIAHRD+KSKNILVK NG C IAD GLAV +SQ +N++D+ NPRVGTKRY
Sbjct: 322 EIFGTQGKSAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 381
Query: 312 MSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSF 371
M+PE+LDE+I +DCF+S+K+ DI+A GLVLWEV RR +NGI E+YK P++D+VP DPSF
Sbjct: 382 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSF 441
Query: 372 DDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKL 428
+DMRKV+C+DQQRP +PNRW SD TL ++ K+MKECW+QN + RL+ALR+KKTL K+
Sbjct: 442 EDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 498
|
On ligand binding, forms a receptor complex consisting of two type II and two type I transmembrane serine/threonine kinases. Type II receptors phosphorylate and activate type I receptors which autophosphorylate, then bind and activate SMAD transcriptional regulators. Receptor for activin. May be involved for left-right pattern formation during embryogenesis. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 3 EC: 0 |
| >sp|Q61288|ACVL1_MOUSE Serine/threonine-protein kinase receptor R3 OS=Mus musculus GN=Acvrl1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 486 bits (1250), Expect = e-136, Method: Compositional matrix adjust.
Identities = 238/416 (57%), Positives = 305/416 (73%), Gaps = 11/416 (2%)
Query: 15 QCCDGDFCNNGSFPILPPSYRELPEYAQRYDYILKLSMAILGPVIVLGMLAAVIVLFMRR 74
CC FCN+ +L + + P D L L ILGPV+ L +L A+ L + R
Sbjct: 87 HCCYRSFCNHNVSLMLEAT--QTPSEEPEVDAHLPL---ILGPVLALPVLVALGALGLWR 141
Query: 75 NHRKKLLAARAIQSDPDCFLADADL-LRATAAGDSTLREYLDASLTSGSGSGLPLLIQRT 133
R++ R + SD L ++ L L+A+ DS L ++LD+ T+GSGSGLP L+QRT
Sbjct: 142 VRRRQE-KQRDLHSD----LGESSLILKASEQADSMLGDFLDSDCTTGSGSGLPFLVQRT 196
Query: 134 LAKQISLSECIGKGRYGEVWRGVWHGENVAVKIFFSRDEASWSRETEIYSTVLLRHENIL 193
+A+Q++L EC+GKGRYGEVWRG WHGE+VAVKIF SRDE SW RETEIY+TVLLRH+NIL
Sbjct: 197 VARQVALVECVGKGRYGEVWRGSWHGESVAVKIFSSRDEQSWFRETEIYNTVLLRHDNIL 256
Query: 194 GYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEI 253
G+I SDMTSRNS TQLWL+THYH GSLYD L R TL +++ +S GL HLH EI
Sbjct: 257 GFIASDMTSRNSSTQLWLITHYHEHGSLYDFLQRQTLEPQLALRLAVSAACGLAHLHVEI 316
Query: 254 FGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMS 313
FGTQGKPAIAHRD+KS+N+LVK+N C IAD GLAV +SQ S+ +DI NPRVGTKRYM+
Sbjct: 317 FGTQGKPAIAHRDLKSRNVLVKSNLQCCIADLGLAVMHSQSSDYLDIGNNPRVGTKRYMA 376
Query: 314 PEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFDD 373
PE+LDE I DCFES+K DI+A GLVLWE+ RRT NGI E+Y+ P++D+VP DPSF+D
Sbjct: 377 PEVLDEHIRTDCFESYKWTDIWAFGLVLWEIARRTIINGIVEDYRPPFYDMVPNDPSFED 436
Query: 374 MRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLA 429
M+KV+C+DQQ P +PNR +D L+ + ++M+ECW+ N + RL+ALR+KKTL KL+
Sbjct: 437 MKKVVCVDQQTPTIPNRLAADPVLSGLAQMMRECWYPNPSARLTALRIKKTLQKLS 492
|
On ligand binding, forms a receptor complex consisting of two type II and two type I transmembrane serine/threonine kinases. Type II receptors phosphorylate and activate type I receptors which autophosphorylate, then bind and activate SMAD transcriptional regulators. Receptor for TGF-beta. May bind activin as well. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 3 EC: 0 |
| >sp|P80203|ACVL1_RAT Serine/threonine-protein kinase receptor R3 OS=Rattus norvegicus GN=Acvrl1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 475 bits (1223), Expect = e-133, Method: Compositional matrix adjust.
Identities = 238/416 (57%), Positives = 305/416 (73%), Gaps = 11/416 (2%)
Query: 15 QCCDGDFCNNGSFPILPPSYRELPEYAQRYDYILKLSMAILGPVIVLGMLAAVIVLFMRR 74
CC FCN+ +L + + P D L L ILGPV+ L +L A+ L + R
Sbjct: 89 HCCYRSFCNHNVSLMLEAT--QTPSEEPEVDAHLPL---ILGPVLALLVLVALGTLGLWR 143
Query: 75 NHRKKLLAARAIQSDPDCFLADADL-LRATAAGDSTLREYLDASLTSGSGSGLPLLIQRT 133
R++ R + SD L ++ L L+A+ GDS L ++L + T+GSGSGLP L+QRT
Sbjct: 144 VRRRQE-KQRGLHSD----LGESSLILKASEQGDSMLGDFLVSDCTTGSGSGLPFLVQRT 198
Query: 134 LAKQISLSECIGKGRYGEVWRGVWHGENVAVKIFFSRDEASWSRETEIYSTVLLRHENIL 193
+A+Q++L EC+GKGRYGEVWRG WHGE+VAVKIF SRDE SW RETEIY+TVLLRH+NIL
Sbjct: 199 VARQVALVECVGKGRYGEVWRGSWHGESVAVKIFSSRDEQSWFRETEIYNTVLLRHDNIL 258
Query: 194 GYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEI 253
G+I SDMTSRNS TQLWL+THYH GSLYD L R TL +++ +S GL HLH EI
Sbjct: 259 GFIASDMTSRNSSTQLWLITHYHEHGSLYDFLQRQTLEPQLALRLAVSAACGLAHLHVEI 318
Query: 254 FGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMS 313
FGTQGKPAIAHRD+KS+N+LVK+N C IAD GLAV +SQ S+ +DI NPRVGTKRYM+
Sbjct: 319 FGTQGKPAIAHRDLKSRNVLVKSNLQCCIADLGLAVMHSQSSDYLDIGNNPRVGTKRYMA 378
Query: 314 PEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFDD 373
PE+LDE I DCFES+K DI+A GLVLWE+ RRT NGI E+Y+ P++D+VP DPSF+D
Sbjct: 379 PEVLDEQIRTDCFESYKWTDIWAFGLVLWEIARRTIINGIVEDYRPPFYDMVPNDPSFED 438
Query: 374 MRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLA 429
M+KV+C+DQQ P +PNR +D L+ + ++M+ECW+ N + RL+ALR+KKTL KL+
Sbjct: 439 MKKVVCVDQQTPTIPNRLAADPVLSGLAQMMRECWYPNPSARLTALRIKKTLQKLS 494
|
On ligand binding, forms a receptor complex consisting of two type II and two type I transmembrane serine/threonine kinases. Type II receptors phosphorylate and activate type I receptors which autophosphorylate, then bind and activate SMAD transcriptional regulators. Receptor for TGF-beta. May bind activin as well. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 3 EC: 0 |
| >sp|Q5RAN0|ACVL1_PONAB Serine/threonine-protein kinase receptor R3 OS=Pongo abelii GN=ACVRL1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 474 bits (1220), Expect = e-133, Method: Compositional matrix adjust.
Identities = 240/418 (57%), Positives = 306/418 (73%), Gaps = 17/418 (4%)
Query: 16 CCDGDFCNNGSFPILPPSYRELPEYAQRYDYILKLSMAILGPVIVLGMLAAVIVL---FM 72
CCD CN+ +L + + P D L L ILGPV+ L L A+ VL +
Sbjct: 89 CCDSHLCNHNVSLVLEAT--QSPSEQPGTDGQLAL---ILGPVLALLALVALGVLGLWHV 143
Query: 73 RRNHRKKLLAARAIQSDPDCFLADADL-LRATAAGDSTLREYLDASLTSGSGSGLPLLIQ 131
RR K+ R + S+ L ++ L L+A+ GDS L + LD+ T+GSGSGLP L+Q
Sbjct: 144 RRRQEKQ----RGLHSE----LGESSLILKASEQGDSMLGDLLDSDCTTGSGSGLPFLVQ 195
Query: 132 RTLAKQISLSECIGKGRYGEVWRGVWHGENVAVKIFFSRDEASWSRETEIYSTVLLRHEN 191
RT+A+Q++L EC+GKGRYGEVWRG+WHGE+VAVKIF SRDE SW RETEIY+TVLLRH+N
Sbjct: 196 RTVARQVALVECVGKGRYGEVWRGLWHGESVAVKIFSSRDEQSWFRETEIYNTVLLRHDN 255
Query: 192 ILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHT 251
ILG+I SDMTSRNS TQLWL+THYH GSLYD L R TL H +++ +S GL HLH
Sbjct: 256 ILGFIASDMTSRNSSTQLWLITHYHEHGSLYDFLQRQTLEPHLALRLTVSAACGLAHLHV 315
Query: 252 EIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRY 311
EIFGTQGKPAIAHRD KS+N+LVK+N C IAD GLAV +SQ S+ +DI NPRVGTKRY
Sbjct: 316 EIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRY 375
Query: 312 MSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSF 371
M+PE+LDE I DCFES+K DI+A GLVLWE+ RRT NGI E+Y+ P++D+VP DPSF
Sbjct: 376 MAPEVLDEQIRTDCFESYKWTDIWAFGLVLWEIARRTIVNGIVEDYRPPFYDVVPNDPSF 435
Query: 372 DDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLA 429
+DM+KV+C+DQQ P +PNR +D L+ + ++M+ECW+ N + RL+ALR+KKTL K++
Sbjct: 436 EDMKKVVCVDQQTPTIPNRLAADPVLSGLAQMMRECWYPNPSARLTALRIKKTLQKIS 493
|
On ligand binding, forms a receptor complex consisting of two type II and two type I transmembrane serine/threonine kinases. Type II receptors phosphorylate and activate type I receptors which autophosphorylate, then bind and activate SMAD transcriptional regulators. Receptor for TGF-beta. May bind activin as well. Pongo abelii (taxid: 9601) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 3 EC: 0 |
| >sp|P37023|ACVL1_HUMAN Serine/threonine-protein kinase receptor R3 OS=Homo sapiens GN=ACVRL1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 474 bits (1219), Expect = e-133, Method: Compositional matrix adjust.
Identities = 240/418 (57%), Positives = 306/418 (73%), Gaps = 17/418 (4%)
Query: 16 CCDGDFCNNGSFPILPPSYRELPEYAQRYDYILKLSMAILGPVIVLGMLAAVIVL---FM 72
CCD CN+ +L + + P D L L ILGPV+ L L A+ VL +
Sbjct: 89 CCDSHLCNHNVSLVLEAT--QPPSEQPGTDGQLAL---ILGPVLALLALVALGVLGLWHV 143
Query: 73 RRNHRKKLLAARAIQSDPDCFLADADL-LRATAAGDSTLREYLDASLTSGSGSGLPLLIQ 131
RR K+ R + S+ L ++ L L+A+ GDS L + LD+ T+GSGSGLP L+Q
Sbjct: 144 RRRQEKQ----RGLHSE----LGESSLILKASEQGDSMLGDLLDSDCTTGSGSGLPFLVQ 195
Query: 132 RTLAKQISLSECIGKGRYGEVWRGVWHGENVAVKIFFSRDEASWSRETEIYSTVLLRHEN 191
RT+A+Q++L EC+GKGRYGEVWRG+WHGE+VAVKIF SRDE SW RETEIY+TVLLRH+N
Sbjct: 196 RTVARQVALVECVGKGRYGEVWRGLWHGESVAVKIFSSRDEQSWFRETEIYNTVLLRHDN 255
Query: 192 ILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHT 251
ILG+I SDMTSRNS TQLWL+THYH GSLYD L R TL H +++ +S GL HLH
Sbjct: 256 ILGFIASDMTSRNSSTQLWLITHYHEHGSLYDFLQRQTLEPHLALRLAVSAACGLAHLHV 315
Query: 252 EIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRY 311
EIFGTQGKPAIAHRD KS+N+LVK+N C IAD GLAV +SQ S+ +DI NPRVGTKRY
Sbjct: 316 EIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRY 375
Query: 312 MSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSF 371
M+PE+LDE I DCFES+K DI+A GLVLWE+ RRT NGI E+Y+ P++D+VP DPSF
Sbjct: 376 MAPEVLDEQIRTDCFESYKWTDIWAFGLVLWEIARRTIVNGIVEDYRPPFYDVVPNDPSF 435
Query: 372 DDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLA 429
+DM+KV+C+DQQ P +PNR +D L+ + ++M+ECW+ N + RL+ALR+KKTL K++
Sbjct: 436 EDMKKVVCVDQQTPTIPNRLAADPVLSGLAQMMRECWYPNPSARLTALRIKKTLQKIS 493
|
On ligand binding, forms a receptor complex consisting of two type II and two type I transmembrane serine/threonine kinases. Type II receptors phosphorylate and activate type I receptors which autophosphorylate, then bind and activate SMAD transcriptional regulators. Receptor for TGF-beta. May bind activin as well. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 3 EC: 0 |
| >sp|Q5CD18|TGFR1_PIG TGF-beta receptor type-1 OS=Sus scrofa GN=TGFBR1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 441 bits (1134), Expect = e-123, Method: Compositional matrix adjust.
Identities = 220/417 (52%), Positives = 280/417 (67%), Gaps = 13/417 (3%)
Query: 13 TIQCCDGDFCNNGSFPILPPSYRELPEYAQRYDYILKLSMAILGPVIVLGMLAAVIVLFM 72
T CC+ D CN P + P P ++L+ I GPV + + ++V
Sbjct: 93 TTYCCNQDHCNKIELPTVGP----FPGKPPSGLGPVELAAVIAGPVCFVCISLMLMVYIC 148
Query: 73 RRNHRKKLLAARAIQSDPDCFLADADLLRATAAGDSTLREYLDASLTSGSGSGLPLLIQR 132
H + ++ R + D L R + +TL++ + TSGSGSGLPLL+QR
Sbjct: 149 ---HNRTVIHHRVPNEE------DPSLDRPFISEGTTLKDLIYDMTTSGSGSGLPLLVQR 199
Query: 133 TLAKQISLSECIGKGRYGEVWRGVWHGENVAVKIFFSRDEASWSRETEIYSTVLLRHENI 192
T+A+ I L E IGKGR+GEVWRG W GE VAVKIF SR+E SW RE EIY TV+LRHENI
Sbjct: 200 TIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENI 259
Query: 193 LGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTE 252
LG+I +D + TQLWLV+ YH GSL+D+LNR T+ M+K+ LS +GL HLH E
Sbjct: 260 LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHME 319
Query: 253 IFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYM 312
I GTQGKPAIAHRD+KSKNILVK NGTC IAD GLAV + ++ +DI PN RVGTKRYM
Sbjct: 320 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 379
Query: 313 SPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFD 372
+PE+LD+SINM FESFK+ADIYA+GLV WE+ RR GI E+Y+ PY+DLVP DPS +
Sbjct: 380 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 439
Query: 373 DMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLA 429
+MRKV+C + RP +PNRW S L M K+M+ECW+ N RL+ALR+KKTL +L+
Sbjct: 440 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 496
|
Transmembrane serine/threonine kinase forming with the TGF-beta type II serine/threonine kinase receptor, TGFBR2, the non-promiscuous receptor for the TGF-beta cytokines TGFB1, TGFB2 and TGFB3. Transduces the TGFB1, TGFB2 and TGFB3 signal from the cell surface to the cytoplasm and is thus regulating a plethora of physiological and pathological processes including cell cycle arrest in epithelial and hematopoietic cells, control of mesenchymal cell proliferation and differentiation, wound healing, extracellular matrix production, immunosuppression and carcinogenesis. The formation of the receptor complex composed of 2 TGFBR1 and 2 TGFBR2 molecules symmetrically bound to the cytokine dimer results in the phosphorylation and the activation of TGFBR1 by the constitutively active TGFBR2. Activated TGFBR1 phosphorylates SMAD2 which dissociates from the receptor and interacts with SMAD4. The SMAD2-SMAD4 complex is subsequently translocated to the nucleus where it modulates the transcription of the TGF-beta-regulated genes. This constitutes the canonical SMAD-dependent TGF-beta signaling cascade. Also involved in non-canonical, SMAD-independent TGF-beta signaling pathways. For instance, TGFBR1 induces TRAF6 autoubiquitination which in turn results in MAP3K7 ubiquitination and activation to trigger apoptosis. Also regulates epithelial to mesenchymal transition through a SMAD-independent signaling pathway through PARD6A phosphorylation and activation. Sus scrofa (taxid: 9823) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 3 EC: 0 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 443 | ||||||
| 270011128 | 553 | saxophone [Tribolium castaneum] | 0.966 | 0.773 | 0.703 | 0.0 | |
| 282158073 | 569 | saxophone precursor [Tribolium castaneum | 0.966 | 0.752 | 0.703 | 0.0 | |
| 242022850 | 589 | SAX, putative [Pediculus humanus corpori | 0.961 | 0.723 | 0.703 | 0.0 | |
| 157131637 | 509 | activin receptor type I, putative [Aedes | 0.975 | 0.848 | 0.678 | 1e-179 | |
| 195436440 | 573 | GK22220 [Drosophila willistoni] gi|19416 | 0.963 | 0.745 | 0.672 | 1e-177 | |
| 195149654 | 566 | GL10841 [Drosophila persimilis] gi|19410 | 0.963 | 0.754 | 0.671 | 1e-177 | |
| 125807251 | 566 | GA15112 [Drosophila pseudoobscura pseudo | 0.963 | 0.754 | 0.671 | 1e-177 | |
| 195474498 | 570 | GE19150 [Drosophila yakuba] gi|194175629 | 0.963 | 0.749 | 0.669 | 1e-176 | |
| 194757441 | 566 | GF13635 [Drosophila ananassae] gi|190622 | 0.950 | 0.743 | 0.680 | 1e-176 | |
| 194863702 | 570 | GG23304 [Drosophila erecta] gi|190662438 | 0.957 | 0.743 | 0.669 | 1e-176 |
| >gi|270011128|gb|EFA07576.1| saxophone [Tribolium castaneum] | Back alignment and taxonomy information |
|---|
Score = 657 bits (1695), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 303/431 (70%), Positives = 362/431 (83%), Gaps = 3/431 (0%)
Query: 10 GQFTIQCCDGDFCNNGSFPILPPSY-RELPEYAQRYDYILKLSMAILGPVIVLGMLAAVI 68
GQF + CC GDFCN G FP LP + + + ++ DY LK++ AILGPV+V+G L A++
Sbjct: 119 GQFQVDCCTGDFCNKGDFPELPILFTKNMTMHSDSVDYALKMTAAILGPVVVIGTLGAIV 178
Query: 69 VLFMRRNHRKKLLAARAIQSDPDCFLADADLLRATAAGDSTLREYLDASLTSGSGSGLPL 128
+ MRR H+++L + DPD + A DLLRATAAGDSTLREYL+ SLTSGSGSGLPL
Sbjct: 179 LYLMRRIHQRRLCLESRL--DPDTYYASDDLLRATAAGDSTLREYLENSLTSGSGSGLPL 236
Query: 129 LIQRTLAKQISLSECIGKGRYGEVWRGVWHGENVAVKIFFSRDEASWSRETEIYSTVLLR 188
LIQRT+AKQISL+ECIGKGRYGEVWRG+W GENVAVKIFFSRDEASW+RETEIYST+LLR
Sbjct: 237 LIQRTMAKQISLAECIGKGRYGEVWRGIWFGENVAVKIFFSRDEASWNRETEIYSTILLR 296
Query: 189 HENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVH 248
HENILGYIGSDMTSRNSCTQLWL+THYH GSLYDHLNRTTL H Q++++CLSI NGLVH
Sbjct: 297 HENILGYIGSDMTSRNSCTQLWLITHYHPLGSLYDHLNRTTLTHQQLLRLCLSIANGLVH 356
Query: 249 LHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGT 308
LHTEIFGT+GKPAIAHRDIKSKNILVK NGTC IADFGLAV++ Q ++++DI NP+VGT
Sbjct: 357 LHTEIFGTEGKPAIAHRDIKSKNILVKNNGTCCIADFGLAVTHQQATDQLDIGSNPKVGT 416
Query: 309 KRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMD 368
KRYM+PE+LDE+I MD F+SF++ADIYALGLVLWE+CRRT +NGI E+YK P++D+VP D
Sbjct: 417 KRYMAPEVLDETIRMDYFDSFRRADIYALGLVLWELCRRTVSNGIAEDYKPPFYDVVPND 476
Query: 369 PSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKL 428
PSF+DMRKV+C+DQQRP L NRW SD L+ M K+M+ECWH N NVRL ALR+KKT++KL
Sbjct: 477 PSFEDMRKVVCVDQQRPSLLNRWASDPILSVMAKLMRECWHHNPNVRLPALRIKKTILKL 536
Query: 429 ACADMYIHCSD 439
D I+ D
Sbjct: 537 CSGDNLINLDD 547
|
Source: Tribolium castaneum Species: Tribolium castaneum Genus: Tribolium Family: Tenebrionidae Order: Coleoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|282158073|ref|NP_001164080.1| saxophone precursor [Tribolium castaneum] | Back alignment and taxonomy information |
|---|
Score = 656 bits (1693), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 303/431 (70%), Positives = 362/431 (83%), Gaps = 3/431 (0%)
Query: 10 GQFTIQCCDGDFCNNGSFPILPPSY-RELPEYAQRYDYILKLSMAILGPVIVLGMLAAVI 68
GQF + CC GDFCN G FP LP + + + ++ DY LK++ AILGPV+V+G L A++
Sbjct: 135 GQFQVDCCTGDFCNKGDFPELPILFTKNMTMHSDSVDYALKMTAAILGPVVVIGTLGAIV 194
Query: 69 VLFMRRNHRKKLLAARAIQSDPDCFLADADLLRATAAGDSTLREYLDASLTSGSGSGLPL 128
+ MRR H+++L + DPD + A DLLRATAAGDSTLREYL+ SLTSGSGSGLPL
Sbjct: 195 LYLMRRIHQRRLCLESRL--DPDTYYASDDLLRATAAGDSTLREYLENSLTSGSGSGLPL 252
Query: 129 LIQRTLAKQISLSECIGKGRYGEVWRGVWHGENVAVKIFFSRDEASWSRETEIYSTVLLR 188
LIQRT+AKQISL+ECIGKGRYGEVWRG+W GENVAVKIFFSRDEASW+RETEIYST+LLR
Sbjct: 253 LIQRTMAKQISLAECIGKGRYGEVWRGIWFGENVAVKIFFSRDEASWNRETEIYSTILLR 312
Query: 189 HENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVH 248
HENILGYIGSDMTSRNSCTQLWL+THYH GSLYDHLNRTTL H Q++++CLSI NGLVH
Sbjct: 313 HENILGYIGSDMTSRNSCTQLWLITHYHPLGSLYDHLNRTTLTHQQLLRLCLSIANGLVH 372
Query: 249 LHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGT 308
LHTEIFGT+GKPAIAHRDIKSKNILVK NGTC IADFGLAV++ Q ++++DI NP+VGT
Sbjct: 373 LHTEIFGTEGKPAIAHRDIKSKNILVKNNGTCCIADFGLAVTHQQATDQLDIGSNPKVGT 432
Query: 309 KRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMD 368
KRYM+PE+LDE+I MD F+SF++ADIYALGLVLWE+CRRT +NGI E+YK P++D+VP D
Sbjct: 433 KRYMAPEVLDETIRMDYFDSFRRADIYALGLVLWELCRRTVSNGIAEDYKPPFYDVVPND 492
Query: 369 PSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKL 428
PSF+DMRKV+C+DQQRP L NRW SD L+ M K+M+ECWH N NVRL ALR+KKT++KL
Sbjct: 493 PSFEDMRKVVCVDQQRPSLLNRWASDPILSVMAKLMRECWHHNPNVRLPALRIKKTILKL 552
Query: 429 ACADMYIHCSD 439
D I+ D
Sbjct: 553 CSGDNLINLDD 563
|
Source: Tribolium castaneum Species: Tribolium castaneum Genus: Tribolium Family: Tenebrionidae Order: Coleoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|242022850|ref|XP_002431851.1| SAX, putative [Pediculus humanus corporis] gi|212517183|gb|EEB19113.1| SAX, putative [Pediculus humanus corporis] | Back alignment and taxonomy information |
|---|
Score = 656 bits (1692), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 308/438 (70%), Positives = 367/438 (83%), Gaps = 12/438 (2%)
Query: 10 GQFTIQCCDGDFCNNGSFPILPPS--YRELPE-YAQRYDYILKLSMAILGPVIVLGMLAA 66
GQ+ + CC+ D+CNNGSFP LP + ++ Y + YILKL++AILGPV+ LG+L
Sbjct: 148 GQYEVICCEEDYCNNGSFPSLPEVTFHDDVSSIYPDKNIYILKLTLAILGPVVGLGVLGT 207
Query: 67 VIVLFMRRNHRKKLLAARAIQS--------DPDCFLADADLLRATAAGDSTLREYLDASL 118
+++L MRR H+K+L + S D D + D +L+ TA GDSTLRE+++ SL
Sbjct: 208 IVLLLMRRTHKKRLERQSGLWSKERQNGILDSDAYYTD-ELVHVTAPGDSTLREFMEHSL 266
Query: 119 TSGSGSGLPLLIQRTLAKQISLSECIGKGRYGEVWRGVWHGENVAVKIFFSRDEASWSRE 178
TSGSGSGLPLLIQRTLAKQISLSECIGKGRYG+VWRGVWHGEN+AVKIFFSRDEASW+RE
Sbjct: 267 TSGSGSGLPLLIQRTLAKQISLSECIGKGRYGQVWRGVWHGENIAVKIFFSRDEASWNRE 326
Query: 179 TEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKI 238
TEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVTHYH GSLYDHLNRT+L HHQMMKI
Sbjct: 327 TEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVTHYHPLGSLYDHLNRTSLTHHQMMKI 386
Query: 239 CLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKM 298
CL+IV+GLVHLH+EIFGTQGKPAIAHRD+K+KNIL++ NG+CVIADFGLAV++ Q + +M
Sbjct: 387 CLTIVSGLVHLHSEIFGTQGKPAIAHRDLKTKNILIRMNGSCVIADFGLAVTHVQATGQM 446
Query: 299 DIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYK 358
DI NPRVGTKRYM+PE+L+E++ DCFES+++AD+YALGLVLWEVC +T +NGI +EYK
Sbjct: 447 DIADNPRVGTKRYMAPEVLEETMKTDCFESYRRADMYALGLVLWEVCTKTLSNGIADEYK 506
Query: 359 APYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSA 418
PYHD+VP DPSF+DMRKV+C+D QRP+L NRW SD TLN M K+MKECWHQN NVRL A
Sbjct: 507 PPYHDVVPNDPSFEDMRKVVCVDGQRPILSNRWSSDPTLNGMGKLMKECWHQNPNVRLPA 566
Query: 419 LRVKKTLIKLACADMYIH 436
LR+KKTLIKLA AD IH
Sbjct: 567 LRIKKTLIKLASADPLIH 584
|
Source: Pediculus humanus corporis Species: Pediculus humanus Genus: Pediculus Family: Pediculidae Order: Phthiraptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|157131637|ref|XP_001662289.1| activin receptor type I, putative [Aedes aegypti] gi|108871473|gb|EAT35698.1| AAEL012152-PA, partial [Aedes aegypti] | Back alignment and taxonomy information |
|---|
Score = 635 bits (1637), Expect = e-179, Method: Compositional matrix adjust.
Identities = 295/435 (67%), Positives = 362/435 (83%), Gaps = 3/435 (0%)
Query: 10 GQFTIQCCDGDFCNNGSFPILPP-SYRELPEYAQRYDYILKLSMAILGPVIVLGMLAAVI 68
G + I+CC GD+CNNG+FP LPP Y + Y LK++ AILGPV +L + A ++
Sbjct: 74 GTYNIECCTGDYCNNGTFPALPPVEYGNEVMKLESSTYALKMTGAILGPVTMLIVGATIV 133
Query: 69 VLFMRRNHRKKLLAARAIQSDPDCFLADADLLRATAAGDSTLREYLDASLTSGSGSGLPL 128
FMRR+H K+L+A+R+ + DP+ + A ++LRAT+AGDSTLREYL S+TSGSGSGLPL
Sbjct: 134 WYFMRRSHHKRLMASRS-KHDPETYYASDEILRATSAGDSTLREYLQHSVTSGSGSGLPL 192
Query: 129 LIQRTLAKQISLSECIGKGRYGEVWRGVWHGENVAVKIFFSRDEASWSRETEIYSTVLLR 188
LIQRTLA+Q+SL ECIG+GRYGEVWRG+WHGE+VAVKIFFSRDE SW RETEIYSTVLLR
Sbjct: 193 LIQRTLARQVSLCECIGRGRYGEVWRGIWHGESVAVKIFFSRDEDSWKRETEIYSTVLLR 252
Query: 189 HENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVH 248
HENILGYIGSDMTSRNSCTQLWL+THY+ GSL+DHLNRT L+HHQM ICLSI NGLVH
Sbjct: 253 HENILGYIGSDMTSRNSCTQLWLITHYYPLGSLFDHLNRTALSHHQMATICLSIANGLVH 312
Query: 249 LHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGT 308
LHTEIFGT+GKPAIAHRD+K+KNILV+ NG+CVIADFGLAV++SQ +NK+D+ RVGT
Sbjct: 313 LHTEIFGTEGKPAIAHRDLKTKNILVRINGSCVIADFGLAVTHSQTTNKIDMGNTARVGT 372
Query: 309 KRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMD 368
KRYM+PE+LDESINM+CFES +KADIYA+GL+ WE+CRRT +NGI E+YK P++D V D
Sbjct: 373 KRYMAPEVLDESINMECFESLRKADIYAIGLMFWEICRRTLSNGIAEDYKVPFYDCVTSD 432
Query: 369 PSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKL 428
PSF++MRKV+C D RP +PNRWVSD L+ M K+M+ECWH N+NVRL ALR+KKTL+KL
Sbjct: 433 PSFEEMRKVVCGDNYRPSIPNRWVSDPLLSGMAKLMRECWHANSNVRLPALRIKKTLLKL 492
Query: 429 ACADMYIHCS-DGDM 442
A D + + DG++
Sbjct: 493 ASLDETVKLNYDGEI 507
|
Source: Aedes aegypti Species: Aedes aegypti Genus: Aedes Family: Culicidae Order: Diptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|195436440|ref|XP_002066176.1| GK22220 [Drosophila willistoni] gi|194162261|gb|EDW77162.1| GK22220 [Drosophila willistoni] | Back alignment and taxonomy information |
|---|
Score = 628 bits (1620), Expect = e-177, Method: Compositional matrix adjust.
Identities = 289/430 (67%), Positives = 358/430 (83%), Gaps = 3/430 (0%)
Query: 8 NVGQF-TIQCCDGDFCNNGSFPILPPSY-RELPEYAQRYDYILKLSMAILGPVIVLGMLA 65
N F ++CC GDFCN+G FP LPP ++ + K+++AILGP +V+ ++
Sbjct: 136 NTANFVNVECCTGDFCNSGEFPELPPFMGNDVTVITADSSNMSKMALAILGPFLVITLMG 195
Query: 66 AVIVLFMRRNHRKKLLAARAIQSDPDCFLADADLLRATAAGDSTLREYLDASLTSGSGSG 125
AV + FMRR+HRK+L A+R I+ DP+ +L + +LLRAT+AGDSTLREYL S+TSGSGSG
Sbjct: 196 AVAIFFMRRSHRKRLAASR-IKQDPESYLVNDELLRATSAGDSTLREYLQHSVTSGSGSG 254
Query: 126 LPLLIQRTLAKQISLSECIGKGRYGEVWRGVWHGENVAVKIFFSRDEASWSRETEIYSTV 185
LPLL+QRTLAKQ++L ECIG+G+YGEVWRG WHGE++AVKIFFSRDE SW RETEIYSTV
Sbjct: 255 LPLLVQRTLAKQVTLLECIGRGKYGEVWRGHWHGESIAVKIFFSRDEESWKRETEIYSTV 314
Query: 186 LLRHENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNG 245
LLRHENILG+IGSDMTSRNSCTQLWL+THY+ GSL+DHLNR L+H+ M+ ICLSI NG
Sbjct: 315 LLRHENILGFIGSDMTSRNSCTQLWLMTHYYPLGSLFDHLNRNPLSHNDMICICLSIANG 374
Query: 246 LVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPR 305
LVHLHTEIFGT+GKPA+AHRD+KSKNILV +NGTCVIADFGLAV++S ++ ++D+ NP+
Sbjct: 375 LVHLHTEIFGTEGKPAMAHRDLKSKNILVTSNGTCVIADFGLAVTHSHVTGQLDMGNNPK 434
Query: 306 VGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLV 365
VGTKRYM+PE+LDESI+++CFE+ ++ DIYA GLVLWEVCRRT + GI EEYK P++D+V
Sbjct: 435 VGTKRYMAPEVLDESIDLECFEALRRTDIYAFGLVLWEVCRRTISCGIAEEYKVPFYDVV 494
Query: 366 PMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTL 425
PMDPSF+DMRKV+CID RP +PNRW SDS L M+K+MKECWHQN NVRL ALR+KKT+
Sbjct: 495 PMDPSFEDMRKVVCIDNYRPSIPNRWSSDSLLAGMSKLMKECWHQNPNVRLPALRIKKTI 554
Query: 426 IKLACADMYI 435
KLA D I
Sbjct: 555 HKLAATDEKI 564
|
Source: Drosophila willistoni Species: Drosophila willistoni Genus: Drosophila Family: Drosophilidae Order: Diptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|195149654|ref|XP_002015771.1| GL10841 [Drosophila persimilis] gi|194109618|gb|EDW31661.1| GL10841 [Drosophila persimilis] | Back alignment and taxonomy information |
|---|
Score = 626 bits (1614), Expect = e-177, Method: Compositional matrix adjust.
Identities = 288/429 (67%), Positives = 356/429 (82%), Gaps = 2/429 (0%)
Query: 8 NVGQFTIQCCDGDFCNNGSFPILPPSYR-ELPEYAQRYDYILKLSMAILGPVIVLGMLAA 66
N ++ + CC GDFCN+G FP LPP ++ I K+S AILGP +++ +L A
Sbjct: 130 NAAKYNVACCTGDFCNSGDFPELPPIVSGDVTVITADTSNISKMSAAILGPFLIITLLGA 189
Query: 67 VIVLFMRRNHRKKLLAARAIQSDPDCFLADADLLRATAAGDSTLREYLDASLTSGSGSGL 126
V + ++RR+HRK+L A+R Q DP+ +L + +LLRAT+AGDSTLREYL S+TSGSGSGL
Sbjct: 190 VAIYYIRRSHRKRLAASRTKQ-DPESYLVNDELLRATSAGDSTLREYLQHSVTSGSGSGL 248
Query: 127 PLLIQRTLAKQISLSECIGKGRYGEVWRGVWHGENVAVKIFFSRDEASWSRETEIYSTVL 186
PLL+QRTLAKQ++L ECIG+G+YGEVWRG WHGE++AVKIFFSRDE SW RETEIYSTVL
Sbjct: 249 PLLVQRTLAKQVTLIECIGRGKYGEVWRGHWHGESIAVKIFFSRDEESWKRETEIYSTVL 308
Query: 187 LRHENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGL 246
LRHENILG+IGSDMTSRNSCTQLWL+THY+ GSL+DHLNR L+H+ M+ ICLSI NGL
Sbjct: 309 LRHENILGFIGSDMTSRNSCTQLWLMTHYYPLGSLFDHLNRNALSHNDMIWICLSIANGL 368
Query: 247 VHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRV 306
VHLHTEIFGT+GKPA+AHRD+KSKNILV +NGTCVIADFGLAV++S ++ ++D+ NP+V
Sbjct: 369 VHLHTEIFGTEGKPAMAHRDLKSKNILVTSNGTCVIADFGLAVTHSHVTGQLDLGHNPKV 428
Query: 307 GTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVP 366
GTKRYM+PE+LDESI+++CFE+ ++ DIYA GLVLWEVCRRT + GI EEYK P++D+VP
Sbjct: 429 GTKRYMAPEVLDESIDLECFEALRRTDIYAFGLVLWEVCRRTISCGIAEEYKVPFYDVVP 488
Query: 367 MDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLI 426
MDPSF+DMRKV+C D RP +PNRW SDS L M+K+MKECWHQN NVRL ALR+KKT+
Sbjct: 489 MDPSFEDMRKVVCTDNYRPSIPNRWSSDSLLAGMSKLMKECWHQNPNVRLPALRIKKTIH 548
Query: 427 KLACADMYI 435
KLA AD I
Sbjct: 549 KLASADEKI 557
|
Source: Drosophila persimilis Species: Drosophila persimilis Genus: Drosophila Family: Drosophilidae Order: Diptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|125807251|ref|XP_001360323.1| GA15112 [Drosophila pseudoobscura pseudoobscura] gi|54635495|gb|EAL24898.1| GA15112 [Drosophila pseudoobscura pseudoobscura] | Back alignment and taxonomy information |
|---|
Score = 626 bits (1614), Expect = e-177, Method: Compositional matrix adjust.
Identities = 288/429 (67%), Positives = 356/429 (82%), Gaps = 2/429 (0%)
Query: 8 NVGQFTIQCCDGDFCNNGSFPILPPSYR-ELPEYAQRYDYILKLSMAILGPVIVLGMLAA 66
N ++ + CC GDFCN+G FP LPP ++ I K+S AILGP +++ +L A
Sbjct: 130 NAAKYNVACCTGDFCNSGDFPELPPIVSGDVTVITADTSNISKMSAAILGPFLIITLLGA 189
Query: 67 VIVLFMRRNHRKKLLAARAIQSDPDCFLADADLLRATAAGDSTLREYLDASLTSGSGSGL 126
V + ++RR+HRK+L A+R Q DP+ +L + +LLRAT+AGDSTLREYL S+TSGSGSGL
Sbjct: 190 VAIYYIRRSHRKRLAASRTKQ-DPESYLVNDELLRATSAGDSTLREYLQHSVTSGSGSGL 248
Query: 127 PLLIQRTLAKQISLSECIGKGRYGEVWRGVWHGENVAVKIFFSRDEASWSRETEIYSTVL 186
PLL+QRTLAKQ++L ECIG+G+YGEVWRG WHGE++AVKIFFSRDE SW RETEIYSTVL
Sbjct: 249 PLLVQRTLAKQVTLIECIGRGKYGEVWRGHWHGESIAVKIFFSRDEESWKRETEIYSTVL 308
Query: 187 LRHENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGL 246
LRHENILG+IGSDMTSRNSCTQLWL+THY+ GSL+DHLNR L+H+ M+ ICLSI NGL
Sbjct: 309 LRHENILGFIGSDMTSRNSCTQLWLMTHYYPLGSLFDHLNRNALSHNDMIWICLSIANGL 368
Query: 247 VHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRV 306
VHLHTEIFGT+GKPA+AHRD+KSKNILV +NGTCVIADFGLAV++S ++ ++D+ NP+V
Sbjct: 369 VHLHTEIFGTEGKPAMAHRDLKSKNILVTSNGTCVIADFGLAVTHSHVTGQLDLGHNPKV 428
Query: 307 GTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVP 366
GTKRYM+PE+LDESI+++CFE+ ++ DIYA GLVLWEVCRRT + GI EEYK P++D+VP
Sbjct: 429 GTKRYMAPEVLDESIDLECFEALRRTDIYAFGLVLWEVCRRTISCGIAEEYKVPFYDVVP 488
Query: 367 MDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLI 426
MDPSF+DMRKV+C D RP +PNRW SDS L M+K+MKECWHQN NVRL ALR+KKT+
Sbjct: 489 MDPSFEDMRKVVCTDNYRPSIPNRWSSDSLLAGMSKLMKECWHQNPNVRLPALRIKKTIH 548
Query: 427 KLACADMYI 435
KLA AD I
Sbjct: 549 KLASADEKI 557
|
Source: Drosophila pseudoobscura pseudoobscura Species: Drosophila pseudoobscura Genus: Drosophila Family: Drosophilidae Order: Diptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|195474498|ref|XP_002089528.1| GE19150 [Drosophila yakuba] gi|194175629|gb|EDW89240.1| GE19150 [Drosophila yakuba] | Back alignment and taxonomy information |
|---|
Score = 624 bits (1608), Expect = e-176, Method: Compositional matrix adjust.
Identities = 288/430 (66%), Positives = 357/430 (83%), Gaps = 3/430 (0%)
Query: 8 NVGQF-TIQCCDGDFCNNGSFP-ILPPSYRELPEYAQRYDYILKLSMAILGPVIVLGMLA 65
N G+F + CC GD+CN G FP +LP ++ I K+S+AILGP +V+ +L
Sbjct: 133 NTGKFVNVVCCAGDYCNEGDFPELLPFDSNDVTVITADTSSISKMSVAILGPFLVIALLG 192
Query: 66 AVIVLFMRRNHRKKLLAARAIQSDPDCFLADADLLRATAAGDSTLREYLDASLTSGSGSG 125
AV + F+RR+HRK+L A+R Q DP+ +L + +LLRAT+AGDSTLREYL S+TSGSGSG
Sbjct: 193 AVTIFFIRRSHRKRLAASRTKQ-DPEAYLVNDELLRATSAGDSTLREYLQHSVTSGSGSG 251
Query: 126 LPLLIQRTLAKQISLSECIGKGRYGEVWRGVWHGENVAVKIFFSRDEASWSRETEIYSTV 185
LPLL+QRTLAKQ++L ECIG+G+YGEVWRG WHGE++AVKIFFSRDE SW RETEIYST+
Sbjct: 252 LPLLVQRTLAKQVTLIECIGRGKYGEVWRGHWHGESIAVKIFFSRDEESWKRETEIYSTI 311
Query: 186 LLRHENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNG 245
LLRHENILG+IGSDMTSRNSCTQLWL+THY+ GSL+DHLNR L+H+ M+ ICLSI NG
Sbjct: 312 LLRHENILGFIGSDMTSRNSCTQLWLMTHYYPLGSLFDHLNRNALSHNDMVWICLSIANG 371
Query: 246 LVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPR 305
LVHLHTEIFG QGKPA+AHRD+KSKNILV +NG+CVIADFGLAV++S ++ ++D+ NP+
Sbjct: 372 LVHLHTEIFGKQGKPAMAHRDLKSKNILVTSNGSCVIADFGLAVTHSHVTGQLDLGNNPK 431
Query: 306 VGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLV 365
VGTKRYM+PE+LDESI+++CFE+ ++ DIYA GLVLWEVCRRT + GI EEYK P++D+V
Sbjct: 432 VGTKRYMAPEVLDESIDLECFEALRRTDIYAFGLVLWEVCRRTISCGIAEEYKVPFYDVV 491
Query: 366 PMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTL 425
PMDPSF+DMRKV+CID RP +PNRW SDS L M+K+M+ECWHQN NVRL ALR+KKT+
Sbjct: 492 PMDPSFEDMRKVVCIDNYRPSIPNRWSSDSLLAGMSKLMRECWHQNPNVRLPALRIKKTI 551
Query: 426 IKLACADMYI 435
KLA AD I
Sbjct: 552 HKLASADEKI 561
|
Source: Drosophila yakuba Species: Drosophila yakuba Genus: Drosophila Family: Drosophilidae Order: Diptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|194757441|ref|XP_001960973.1| GF13635 [Drosophila ananassae] gi|190622271|gb|EDV37795.1| GF13635 [Drosophila ananassae] | Back alignment and taxonomy information |
|---|
Score = 624 bits (1608), Expect = e-176, Method: Compositional matrix adjust.
Identities = 288/423 (68%), Positives = 351/423 (82%), Gaps = 2/423 (0%)
Query: 14 IQCCDGDFCNNGSFPILPPSY-RELPEYAQRYDYILKLSMAILGPVIVLGMLAAVIVLFM 72
++CC GD+CN G FP LPP ++ I K+S AILGP +V+ +L AV + F+
Sbjct: 136 VECCTGDYCNKGDFPELPPMISNDVTVITADTSNISKMSAAILGPFLVITLLGAVAIYFI 195
Query: 73 RRNHRKKLLAARAIQSDPDCFLADADLLRATAAGDSTLREYLDASLTSGSGSGLPLLIQR 132
RR+HRK+L A+R Q DP+ +L + +LLRAT+AGDSTLREYL S+TSGSGSGLPLL+QR
Sbjct: 196 RRSHRKRLAASRTKQ-DPESYLVNDELLRATSAGDSTLREYLQHSVTSGSGSGLPLLVQR 254
Query: 133 TLAKQISLSECIGKGRYGEVWRGVWHGENVAVKIFFSRDEASWSRETEIYSTVLLRHENI 192
TLAKQ++L ECIG+G+YGEVWRG WHGE++AVKIFFSRDE SW RETEIYSTVLLRHENI
Sbjct: 255 TLAKQVTLIECIGRGKYGEVWRGHWHGESIAVKIFFSRDEESWKRETEIYSTVLLRHENI 314
Query: 193 LGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTE 252
LG+IGSDMTSRNSCTQLWL+THY+ GSL+DHLNR L+H+ M+ ICLSI NGLVHLHTE
Sbjct: 315 LGFIGSDMTSRNSCTQLWLMTHYYPLGSLFDHLNRNALSHNDMIWICLSIANGLVHLHTE 374
Query: 253 IFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYM 312
IFG QGKPA+AHRD+KSKNILV NG+CVIADFGLAV++S ++ ++D+ NP+VGTKRYM
Sbjct: 375 IFGKQGKPAMAHRDLKSKNILVTANGSCVIADFGLAVTHSHVTGQLDLGNNPKVGTKRYM 434
Query: 313 SPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFD 372
+PE+LDESIN++CFE+ ++ DIYA GLVLWEVCRRT + GI EEYK P++D+VPMDPSF+
Sbjct: 435 APEVLDESINLECFEALRRTDIYAFGLVLWEVCRRTISCGIAEEYKVPFYDVVPMDPSFE 494
Query: 373 DMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLACAD 432
DMRKV+C D RP +PNRW SDS L M+K+MKECWHQN NVRL ALR+KKT+ KLA AD
Sbjct: 495 DMRKVVCTDNYRPSIPNRWTSDSLLAGMSKLMKECWHQNPNVRLPALRIKKTIHKLASAD 554
Query: 433 MYI 435
I
Sbjct: 555 EKI 557
|
Source: Drosophila ananassae Species: Drosophila ananassae Genus: Drosophila Family: Drosophilidae Order: Diptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|194863702|ref|XP_001970571.1| GG23304 [Drosophila erecta] gi|190662438|gb|EDV59630.1| GG23304 [Drosophila erecta] | Back alignment and taxonomy information |
|---|
Score = 623 bits (1607), Expect = e-176, Method: Compositional matrix adjust.
Identities = 286/427 (66%), Positives = 357/427 (83%), Gaps = 3/427 (0%)
Query: 8 NVGQF-TIQCCDGDFCNNGSFP-ILPPSYRELPEYAQRYDYILKLSMAILGPVIVLGMLA 65
N G+F + CC GD+CN G FP +LP ++ I K+S+AILGP++V+ +L
Sbjct: 133 NTGKFVNVVCCTGDYCNEGDFPELLPFDSNDVTVITADTSSISKMSVAILGPILVIALLG 192
Query: 66 AVIVLFMRRNHRKKLLAARAIQSDPDCFLADADLLRATAAGDSTLREYLDASLTSGSGSG 125
A+ + F+RR+HRK+L A+R + DP+ +L + +LLRAT+AGDSTLREYL S+TSGSGSG
Sbjct: 193 AMTIFFIRRSHRKRLAASRT-KHDPEAYLVNDELLRATSAGDSTLREYLQHSVTSGSGSG 251
Query: 126 LPLLIQRTLAKQISLSECIGKGRYGEVWRGVWHGENVAVKIFFSRDEASWSRETEIYSTV 185
LPLL+QRTLAKQ++L ECIG+G+YGEVWRG WHGE++AVKIFFSRDE SW RETEIYST+
Sbjct: 252 LPLLVQRTLAKQVTLIECIGRGKYGEVWRGHWHGESIAVKIFFSRDEESWKRETEIYSTI 311
Query: 186 LLRHENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNG 245
LLRHENILG+IGSDMTSRNSCTQLWL+THY+ GSL+DHLNR L+H+ M+ ICLSI NG
Sbjct: 312 LLRHENILGFIGSDMTSRNSCTQLWLMTHYYPLGSLFDHLNRNALSHNDMVWICLSIANG 371
Query: 246 LVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPR 305
LVHLHTEIFG QGKPA+AHRD+KSKNILV +NG+CVIADFGLAV++S ++ ++D+ NP+
Sbjct: 372 LVHLHTEIFGKQGKPAMAHRDLKSKNILVTSNGSCVIADFGLAVTHSHVTGQLDLGNNPK 431
Query: 306 VGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLV 365
VGTKRYM+PE+LDESI+++CFE+ ++ DIYA GLVLWEVCRRT + GI EEYK P++D+V
Sbjct: 432 VGTKRYMAPEVLDESIDLECFEALRRTDIYAFGLVLWEVCRRTISCGIAEEYKVPFYDVV 491
Query: 366 PMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTL 425
PMDPSF+DMRKV+CID RP +PNRW SDS L M+K+MKECWHQN NVRL ALR+KKT+
Sbjct: 492 PMDPSFEDMRKVVCIDNYRPSIPNRWSSDSLLAGMSKLMKECWHQNPNVRLPALRIKKTI 551
Query: 426 IKLACAD 432
KLA AD
Sbjct: 552 HKLASAD 558
|
Source: Drosophila erecta Species: Drosophila erecta Genus: Drosophila Family: Drosophilidae Order: Diptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 443 | ||||||
| FB|FBgn0003317 | 570 | sax "saxophone" [Drosophila me | 0.957 | 0.743 | 0.615 | 2.7e-148 | |
| UNIPROTKB|Q90ZK6 | 504 | ACVR1 "Activin receptor type-1 | 0.918 | 0.807 | 0.570 | 2.3e-126 | |
| UNIPROTKB|E2RKJ3 | 469 | ACVR1 "Uncharacterized protein | 0.927 | 0.876 | 0.560 | 9.9e-126 | |
| UNIPROTKB|A2VDM5 | 509 | ACVR1 "Activin A receptor, typ | 0.927 | 0.807 | 0.558 | 5.5e-125 | |
| UNIPROTKB|Q28041 | 509 | ACVR1 "Activin receptor type-1 | 0.927 | 0.807 | 0.558 | 5.5e-125 | |
| UNIPROTKB|Q04771 | 509 | ACVR1 "Activin receptor type-1 | 0.927 | 0.807 | 0.558 | 5.5e-125 | |
| UNIPROTKB|E9M2M1 | 509 | ACVR1 "Uncharacterized protein | 0.927 | 0.807 | 0.558 | 5.5e-125 | |
| MGI|MGI:87911 | 509 | Acvr1 "activin A receptor, typ | 0.927 | 0.807 | 0.558 | 1.1e-124 | |
| ZFIN|ZDB-GENE-990415-9 | 506 | acvr1l "activin A receptor, ty | 0.952 | 0.833 | 0.549 | 1.1e-124 | |
| RGD|620200 | 509 | Acvr1 "activin A receptor, typ | 0.927 | 0.807 | 0.556 | 2.4e-124 |
| FB|FBgn0003317 sax "saxophone" [Drosophila melanogaster (taxid:7227)] | Back alignment and assigned GO terms |
|---|
Score = 1448 (514.8 bits), Expect = 2.7e-148, P = 2.7e-148
Identities = 263/427 (61%), Positives = 330/427 (77%)
Query: 8 NVGQFT-IQCCDGDFCNNGSFP-ILPPSYRELPEYAQRYDYILKLSMAILGPVIVLGMLA 65
N G+F + CC GD+CN G FP +LP ++ I K+ +A+LGP +V+ +L
Sbjct: 133 NTGKFVNVVCCAGDYCNEGDFPELLPFDSNDVTVITADTSSISKMLVAVLGPFLVIALLG 192
Query: 66 AVIVLFMRRNHRKKLLAARAIQSDPDCFXXXXXXXXXXXXXXSTLREYLDAXXXXXXXXX 125
AV + F+RR+HRK+L A+R Q DP+ + STLREYL
Sbjct: 193 AVTIFFIRRSHRKRLAASRTKQ-DPEAYLVNDELLRATSAGDSTLREYLQHSVTSGSGSG 251
Query: 126 XXXXIQRTLAKQISLSECIGKGRYGEVWRGVWHGENVAVKIFFSRDEASWSRETEIYSTV 185
+QRTLAKQ++L ECIG+G+YGEVWRG WHGE++AVKIFFSRDE SW RETEIYST+
Sbjct: 252 LPLLVQRTLAKQVTLIECIGRGKYGEVWRGHWHGESIAVKIFFSRDEESWKRETEIYSTI 311
Query: 186 LLRHENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNG 245
LLRHENILG+IGSDMTSRNSCTQLWL+THY+ GSL+DHLNR L+H+ M+ ICLSI NG
Sbjct: 312 LLRHENILGFIGSDMTSRNSCTQLWLMTHYYPLGSLFDHLNRNALSHNDMVWICLSIANG 371
Query: 246 LVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPR 305
LVHLHTEIFG QGKPA+AHRD+KSKNILV +NG+CVIADFGLAV++S ++ ++D+ NP+
Sbjct: 372 LVHLHTEIFGKQGKPAMAHRDLKSKNILVTSNGSCVIADFGLAVTHSHVTGQLDLGNNPK 431
Query: 306 VGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLV 365
VGTKRYM+PE+LDESI+++CFE+ ++ DIYA GLVLWEVCRRT + GI EEYK P++D+V
Sbjct: 432 VGTKRYMAPEVLDESIDLECFEALRRTDIYAFGLVLWEVCRRTISCGIAEEYKVPFYDVV 491
Query: 366 PMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTL 425
PMDPSF+DMRKV+CID RP +PNRW SDS + M+K+MKECWHQN +VRL ALR+KKT+
Sbjct: 492 PMDPSFEDMRKVVCIDNYRPSIPNRWSSDSLMTGMSKLMKECWHQNPDVRLPALRIKKTI 551
Query: 426 IKLACAD 432
KLA AD
Sbjct: 552 HKLASAD 558
|
|
| UNIPROTKB|Q90ZK6 ACVR1 "Activin receptor type-1" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 1241 (441.9 bits), Expect = 2.3e-126, P = 2.3e-126
Identities = 239/419 (57%), Positives = 299/419 (71%)
Query: 14 IQCCDGDFCNNGSFPILPPSYRELPEYAQRYDYILK-LSMAILGPVIVLGMLAAVIVLFM 72
++CC G CN LP S + + + Y ++ L + IL PV+VL + + V VL +
Sbjct: 83 VECCQGYLCNMNITAKLPSSKGQTLQ-GEAAGYSMETLIIVILAPVVVLVIFSVVAVLII 141
Query: 73 RR---NHRKKLLAARAIQSDPDCFXXXXXXXXXXXXXXSTLREYLDAXXXXXXXXXXXXX 129
RR NH ++L + D STL + LD
Sbjct: 142 RRIQKNHMERL-------NSRDAEYGTIEGLIASNVGDSTLADLLDHSCTSGSGSGLPFL 194
Query: 130 IQRTLAKQISLSECIGKGRYGEVWRGVWHGENVAVKIFFSRDEASWSRETEIYSTVLLRH 189
+QRT+A+QI+L EC+GKGRYGEVWRG W GENVAVKIF SRDE SW RETE+Y+TVLLRH
Sbjct: 195 VQRTVARQITLVECVGKGRYGEVWRGQWQGENVAVKIFSSRDEKSWFRETELYNTVLLRH 254
Query: 190 ENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHL 249
ENILG+I SDMTSRNS TQLWL+THYH GSLYD+L TTL+ ++I LSI +GL HL
Sbjct: 255 ENILGFIASDMTSRNSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHL 314
Query: 250 HTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTK 309
H EIFGTQGKPAI+HRD+KSKNILVK NG C IAD GLAV +SQ +N++D+ NPRVGTK
Sbjct: 315 HIEIFGTQGKPAISHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTK 374
Query: 310 RYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDP 369
RYM+PE+LDE+I DCF+S+K+ DI+A GLVLWEV RR +NGI E+YK P++DLVP DP
Sbjct: 375 RYMAPEVLDETIQADCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDLVPNDP 434
Query: 370 SFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKL 428
SF+DMRKV+C+DQQRP +PNRW SD TL ++ K+MKECW+QN + RL+ALR+KKTL K+
Sbjct: 435 SFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 493
|
|
| UNIPROTKB|E2RKJ3 ACVR1 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 1235 (439.8 bits), Expect = 9.9e-126, P = 9.9e-126
Identities = 235/419 (56%), Positives = 300/419 (71%)
Query: 10 GQFTIQCCDGDFCNNGSFPILPPSYRELPEYAQRYDYILKLSMAILGPVIVLGMLAAVIV 69
GQ ++CC GD+CN LP + PE Q + L++ + IL V + +LA ++
Sbjct: 48 GQ-AVECCQGDWCNRNITAQLPTKGKSFPE-TQNFH--LEVGLIILSVVFAVCLLACLLG 103
Query: 70 LFMRRNHRKKLLAARAIQSDPDCFXXXXXXXXXXXXXXSTLREYLDAXXXXXXXXXXXXX 129
+ +R+ R+ R D + STL + LD
Sbjct: 104 VALRKFKRRN--QERLNPRDVE--YGTIEGLITTNVGDSTLADLLDHSCTSGSGSGLPFL 159
Query: 130 IQRTLAKQISLSECIGKGRYGEVWRGVWHGENVAVKIFFSRDEASWSRETEIYSTVLLRH 189
+QRT+A+QI+L EC+GKGRYGEVWRG W GENVAVKIF SRDE SW RETE+Y+TV+LRH
Sbjct: 160 VQRTVARQITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRH 219
Query: 190 ENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHL 249
ENILG+I SDMTSR+S TQLWL+THYH GSLYD+L TTL+ ++I LSI +GL HL
Sbjct: 220 ENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHL 279
Query: 250 HTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTK 309
H EIFGTQGKPAIAHRD+KSKNILVK NG C IAD GLAV +SQ +N++D+ NPRVGTK
Sbjct: 280 HIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTK 339
Query: 310 RYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDP 369
RYM+PE+LDE+I +DCF+S+K+ DI+A GLVLWEV RR +NGI E+YK P++D+VP DP
Sbjct: 340 RYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDP 399
Query: 370 SFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKL 428
SF+DMRKV+C+DQQRP +PNRW SD TL ++ K+MKECW+QN + RL+ALR+KKTL K+
Sbjct: 400 SFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 458
|
|
| UNIPROTKB|A2VDM5 ACVR1 "Activin A receptor, type I" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 1228 (437.3 bits), Expect = 5.5e-125, P = 5.5e-125
Identities = 234/419 (55%), Positives = 299/419 (71%)
Query: 10 GQFTIQCCDGDFCNNGSFPILPPSYRELPEYAQRYDYILKLSMAILGPVIVLGMLAAVIV 69
GQ ++CC GD+CN LP + P Q + L++ + IL V + +LA ++
Sbjct: 88 GQ-AVECCQGDWCNRNITAQLPTKGKSFPG-TQNFH--LEVGLIILSVVFAVCLLACLLG 143
Query: 70 LFMRRNHRKKLLAARAIQSDPDCFXXXXXXXXXXXXXXSTLREYLDAXXXXXXXXXXXXX 129
+ +R+ R+ R D + STL + LD
Sbjct: 144 VALRKFKRRN--QERLNPRDVE--YGTIEGLITTNVGDSTLADLLDHSCTSGSGSGLPFL 199
Query: 130 IQRTLAKQISLSECIGKGRYGEVWRGVWHGENVAVKIFFSRDEASWSRETEIYSTVLLRH 189
+QRT+A+QI+L EC+GKGRYGEVWRG W GENVAVKIF SRDE SW RETE+Y+TV+LRH
Sbjct: 200 VQRTVARQITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRH 259
Query: 190 ENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHL 249
ENILG+I SDMTSR+S TQLWL+THYH GSLYD+L TTL+ ++I LSI +GL HL
Sbjct: 260 ENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHL 319
Query: 250 HTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTK 309
H EIFGTQGKPAIAHRD+KSKNILVK NG C IAD GLAV +SQ +N++D+ NPRVGTK
Sbjct: 320 HIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTK 379
Query: 310 RYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDP 369
RYM+PE+LDE+I +DCF+S+K+ DI+A GLVLWEV RR +NGI E+YK P++D+VP DP
Sbjct: 380 RYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDP 439
Query: 370 SFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKL 428
SF+DMRKV+C+DQQRP +PNRW SD TL ++ K+MKECW+QN + RL+ALR+KKTL K+
Sbjct: 440 SFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 498
|
|
| UNIPROTKB|Q28041 ACVR1 "Activin receptor type-1" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 1228 (437.3 bits), Expect = 5.5e-125, P = 5.5e-125
Identities = 234/419 (55%), Positives = 299/419 (71%)
Query: 10 GQFTIQCCDGDFCNNGSFPILPPSYRELPEYAQRYDYILKLSMAILGPVIVLGMLAAVIV 69
GQ ++CC GD+CN LP + P Q + L++ + IL V + +LA ++
Sbjct: 88 GQ-AVECCQGDWCNRNITAQLPTKGKSFPG-TQNFH--LEVGLIILSVVFAVCLLACLLG 143
Query: 70 LFMRRNHRKKLLAARAIQSDPDCFXXXXXXXXXXXXXXSTLREYLDAXXXXXXXXXXXXX 129
+ +R+ R+ R D + STL + LD
Sbjct: 144 VALRKFKRRN--QERLNPRDVE--YGTIEGLITTNVGDSTLADLLDHSCTSGSGSGLPFL 199
Query: 130 IQRTLAKQISLSECIGKGRYGEVWRGVWHGENVAVKIFFSRDEASWSRETEIYSTVLLRH 189
+QRT+A+QI+L EC+GKGRYGEVWRG W GENVAVKIF SRDE SW RETE+Y+TV+LRH
Sbjct: 200 VQRTVARQITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRH 259
Query: 190 ENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHL 249
ENILG+I SDMTSR+S TQLWL+THYH GSLYD+L TTL+ ++I LSI +GL HL
Sbjct: 260 ENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHL 319
Query: 250 HTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTK 309
H EIFGTQGKPAIAHRD+KSKNILVK NG C IAD GLAV +SQ +N++D+ NPRVGTK
Sbjct: 320 HIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTK 379
Query: 310 RYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDP 369
RYM+PE+LDE+I +DCF+S+K+ DI+A GLVLWEV RR +NGI E+YK P++D+VP DP
Sbjct: 380 RYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDP 439
Query: 370 SFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKL 428
SF+DMRKV+C+DQQRP +PNRW SD TL ++ K+MKECW+QN + RL+ALR+KKTL K+
Sbjct: 440 SFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 498
|
|
| UNIPROTKB|Q04771 ACVR1 "Activin receptor type-1" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 1228 (437.3 bits), Expect = 5.5e-125, P = 5.5e-125
Identities = 234/419 (55%), Positives = 299/419 (71%)
Query: 10 GQFTIQCCDGDFCNNGSFPILPPSYRELPEYAQRYDYILKLSMAILGPVIVLGMLAAVIV 69
GQ ++CC GD+CN LP + P Q + L++ + IL V + +LA ++
Sbjct: 88 GQ-AVECCQGDWCNRNITAQLPTKGKSFPG-TQNFH--LEVGLIILSVVFAVCLLACLLG 143
Query: 70 LFMRRNHRKKLLAARAIQSDPDCFXXXXXXXXXXXXXXSTLREYLDAXXXXXXXXXXXXX 129
+ +R+ R+ R D + STL + LD
Sbjct: 144 VALRKFKRRN--QERLNPRDVE--YGTIEGLITTNVGDSTLADLLDHSCTSGSGSGLPFL 199
Query: 130 IQRTLAKQISLSECIGKGRYGEVWRGVWHGENVAVKIFFSRDEASWSRETEIYSTVLLRH 189
+QRT+A+QI+L EC+GKGRYGEVWRG W GENVAVKIF SRDE SW RETE+Y+TV+LRH
Sbjct: 200 VQRTVARQITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRH 259
Query: 190 ENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHL 249
ENILG+I SDMTSR+S TQLWL+THYH GSLYD+L TTL+ ++I LSI +GL HL
Sbjct: 260 ENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHL 319
Query: 250 HTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTK 309
H EIFGTQGKPAIAHRD+KSKNILVK NG C IAD GLAV +SQ +N++D+ NPRVGTK
Sbjct: 320 HIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTK 379
Query: 310 RYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDP 369
RYM+PE+LDE+I +DCF+S+K+ DI+A GLVLWEV RR +NGI E+YK P++D+VP DP
Sbjct: 380 RYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDP 439
Query: 370 SFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKL 428
SF+DMRKV+C+DQQRP +PNRW SD TL ++ K+MKECW+QN + RL+ALR+KKTL K+
Sbjct: 440 SFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 498
|
|
| UNIPROTKB|E9M2M1 ACVR1 "Uncharacterized protein" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
Score = 1228 (437.3 bits), Expect = 5.5e-125, P = 5.5e-125
Identities = 234/419 (55%), Positives = 299/419 (71%)
Query: 10 GQFTIQCCDGDFCNNGSFPILPPSYRELPEYAQRYDYILKLSMAILGPVIVLGMLAAVIV 69
GQ ++CC GD+CN LP + P Q + L++ + IL V + +LA ++
Sbjct: 88 GQ-AVECCQGDWCNRNITAQLPTKGKSFPG-TQNFH--LEVGLIILSVVFAVCLLACLLG 143
Query: 70 LFMRRNHRKKLLAARAIQSDPDCFXXXXXXXXXXXXXXSTLREYLDAXXXXXXXXXXXXX 129
+ +R+ R+ R D + STL + LD
Sbjct: 144 VALRKFKRRN--QERLNPRDVE--YGTIEGLITTNVGDSTLADLLDHSCTSGSGSGLPFL 199
Query: 130 IQRTLAKQISLSECIGKGRYGEVWRGVWHGENVAVKIFFSRDEASWSRETEIYSTVLLRH 189
+QRT+A+QI+L EC+GKGRYGEVWRG W GENVAVKIF SRDE SW RETE+Y+TV+LRH
Sbjct: 200 VQRTVARQITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRH 259
Query: 190 ENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHL 249
ENILG+I SDMTSR+S TQLWL+THYH GSLYD+L TTL+ ++I LSI +GL HL
Sbjct: 260 ENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHL 319
Query: 250 HTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTK 309
H EIFGTQGKPAIAHRD+KSKNILVK NG C IAD GLAV +SQ +N++D+ NPRVGTK
Sbjct: 320 HIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTK 379
Query: 310 RYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDP 369
RYM+PE+LDE+I +DCF+S+K+ DI+A GLVLWEV RR +NGI E+YK P++D+VP DP
Sbjct: 380 RYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDP 439
Query: 370 SFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKL 428
SF+DMRKV+C+DQQRP +PNRW SD TL ++ K+MKECW+QN + RL+ALR+KKTL K+
Sbjct: 440 SFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 498
|
|
| MGI|MGI:87911 Acvr1 "activin A receptor, type 1" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 1225 (436.3 bits), Expect = 1.1e-124, P = 1.1e-124
Identities = 234/419 (55%), Positives = 298/419 (71%)
Query: 10 GQFTIQCCDGDFCNNGSFPILPPSYRELPEYAQRYDYILKLSMAILGPVIVLGMLAAVIV 69
GQ ++CC GD+CN LP + P Q + L++ + IL V + +LA ++
Sbjct: 88 GQ-AVECCQGDWCNRNITAQLPTKGKSFPG-TQNFH--LEVGLIILSVVFAVCLLACILG 143
Query: 70 LFMRRNHRKKLLAARAIQSDPDCFXXXXXXXXXXXXXXSTLREYLDAXXXXXXXXXXXXX 129
+ +R+ R+ R D + STL E LD
Sbjct: 144 VALRKFKRRN--QERLNPRDVE--YGTIEGLITTNVGDSTLAELLDHSCTSGSGSGLPFL 199
Query: 130 IQRTLAKQISLSECIGKGRYGEVWRGVWHGENVAVKIFFSRDEASWSRETEIYSTVLLRH 189
+QRT+A+QI+L EC+GKGRYGEVWRG W GENVAVKIF SRDE SW RETE+Y+TV+LRH
Sbjct: 200 VQRTVARQITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRH 259
Query: 190 ENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHL 249
ENILG+I SDMTSR+S TQLWL+THYH GSLYD+L TTL+ ++I LSI +GL HL
Sbjct: 260 ENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHL 319
Query: 250 HTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTK 309
H EIFGTQGK AIAHRD+KSKNILVK NG C IAD GLAV +SQ +N++D+ NPRVGTK
Sbjct: 320 HIEIFGTQGKSAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTK 379
Query: 310 RYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDP 369
RYM+PE+LDE+I +DCF+S+K+ DI+A GLVLWEV RR +NGI E+YK P++D+VP DP
Sbjct: 380 RYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDP 439
Query: 370 SFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKL 428
SF+DMRKV+C+DQQRP +PNRW SD TL ++ K+MKECW+QN + RL+ALR+KKTL K+
Sbjct: 440 SFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 498
|
|
| ZFIN|ZDB-GENE-990415-9 acvr1l "activin A receptor, type I like" [Danio rerio (taxid:7955)] | Back alignment and assigned GO terms |
|---|
Score = 1225 (436.3 bits), Expect = 1.1e-124, P = 1.1e-124
Identities = 235/428 (54%), Positives = 301/428 (70%)
Query: 3 SCHSVNVGQFTIQCCDGDFCN-NGSFPILPPSYRELPEYAQRYDYILK-LSMAILGPVIV 60
+C + ++CC CN N S L PE + Y ++ L + +LGP +V
Sbjct: 72 TCSATASASHVVECCSQHMCNANVSKETLLRLLLTSPEEEKSVHYRVEMLVLFVLGPFVV 131
Query: 61 LGMLAAVIVLFMRRNHRKKLLAARAIQSDPDCFXXXXXXXXXXXXXXSTLREYLDAXXXX 120
LG+L+ + +L RR H +L R + D + STL + +D
Sbjct: 132 LGLLSFLALLVCRRLHHGRL--ERLHEFDTE--QGAIDGLIASNVGDSTLADLMDHSCTS 187
Query: 121 XXXXXXXXXIQRTLAKQISLSECIGKGRYGEVWRGVWHGENVAVKIFFSRDEASWSRETE 180
+QRT+A+QISL EC+GKGRYGEVWRG W GENVAVKIF SRDE SW RETE
Sbjct: 188 GSGSGLPFLVQRTVARQISLVECVGKGRYGEVWRGQWQGENVAVKIFSSRDEKSWFRETE 247
Query: 181 IYSTVLLRHENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICL 240
IY+TVLLRHENILG++ SDMTSRNS TQLWL+THYH GSLYD+L R + + +
Sbjct: 248 IYNTVLLRHENILGFMASDMTSRNSSTQLWLITHYHENGSLYDYLQRVAVEMADGLHMAA 307
Query: 241 SIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDI 300
SI +GLVHLHTEIFGT+GKPAIAHRD+KSKNILVK + C IAD GLAV+++Q N++D+
Sbjct: 308 SIASGLVHLHTEIFGTEGKPAIAHRDLKSKNILVKKDLQCCIADLGLAVTHTQSDNQLDV 367
Query: 301 PPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAP 360
NP+VGTKRYM+PE+LDE+I DCF+++K+ DI+A GLVLWE+ RRT +NGI EEYK P
Sbjct: 368 GNNPKVGTKRYMAPEVLDETIQTDCFDAYKRVDIWAFGLVLWEIARRTISNGIVEEYKPP 427
Query: 361 YHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALR 420
++DLVP DPSFDDMRKV+C++QQRP +PNRW SD TL+A+ K+MKECW+QN + RL+ALR
Sbjct: 428 FYDLVPNDPSFDDMRKVVCVEQQRPFIPNRWFSDPTLSALVKLMKECWYQNPSARLTALR 487
Query: 421 VKKTLIKL 428
+KKTL K+
Sbjct: 488 IKKTLDKI 495
|
|
| RGD|620200 Acvr1 "activin A receptor, type I" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 1222 (435.2 bits), Expect = 2.4e-124, P = 2.4e-124
Identities = 233/419 (55%), Positives = 298/419 (71%)
Query: 10 GQFTIQCCDGDFCNNGSFPILPPSYRELPEYAQRYDYILKLSMAILGPVIVLGMLAAVIV 69
GQ ++CC GD+CN LP + P +Q + L++ + IL V + + A ++
Sbjct: 88 GQ-AVECCQGDWCNRNVTARLPTKGKSFPG-SQNFH--LEVGLIILSVVFAVCLFACILG 143
Query: 70 LFMRRNHRKKLLAARAIQSDPDCFXXXXXXXXXXXXXXSTLREYLDAXXXXXXXXXXXXX 129
+ +R+ R+ R D + STL E LD
Sbjct: 144 VALRKFKRRN--QERLNPRDVE--YGTIEGLITTNVGDSTLAELLDHSCTSGSGSGLPFL 199
Query: 130 IQRTLAKQISLSECIGKGRYGEVWRGVWHGENVAVKIFFSRDEASWSRETEIYSTVLLRH 189
+QRT+A+QI+L EC+GKGRYGEVWRG W GENVAVKIF SRDE SW RETE+Y+TV+LRH
Sbjct: 200 VQRTVARQITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRH 259
Query: 190 ENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHL 249
ENILG+I SDMTSR+S TQLWL+THYH GSLYD+L TTL+ ++I LSI +GL HL
Sbjct: 260 ENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHL 319
Query: 250 HTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTK 309
H EIFGTQGK AIAHRD+KSKNILVK NG C IAD GLAV +SQ +N++D+ NPRVGTK
Sbjct: 320 HIEIFGTQGKSAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTK 379
Query: 310 RYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDP 369
RYM+PE+LDE+I +DCF+S+K+ DI+A GLVLWEV RR +NGI E+YK P++D+VP DP
Sbjct: 380 RYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDP 439
Query: 370 SFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKL 428
SF+DMRKV+C+DQQRP +PNRW SD TL ++ K+MKECW+QN + RL+ALR+KKTL K+
Sbjct: 440 SFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 498
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
ID ![]() | Name ![]() | Annotated EC number ![]() | Identity ![]() | Query coverage ![]() | Hit coverage ![]() | RBH(Q2H) ![]() | RBH(H2Q) ![]() |
| Q5CD18 | TGFR1_PIG | 2, ., 7, ., 1, 1, ., 3, 0 | 0.5275 | 0.9119 | 0.8031 | no | N/A |
| P70539 | ACV1C_RAT | 2, ., 7, ., 1, 1, ., 3, 0 | 0.5152 | 0.9277 | 0.8336 | no | N/A |
| Q09488 | SMA6_CAEEL | 2, ., 7, ., 1, 1, ., 3, 0 | 0.3353 | 0.8939 | 0.6226 | yes | N/A |
| Q28041 | ACVR1_BOVIN | 2, ., 7, ., 1, 1, ., 3, 0 | 0.5899 | 0.9164 | 0.7976 | yes | N/A |
| Q61288 | ACVL1_MOUSE | 2, ., 7, ., 1, 1, ., 3, 0 | 0.5721 | 0.9142 | 0.8067 | no | N/A |
| Q05438 | BMR1B_CHICK | 2, ., 7, ., 1, 1, ., 3, 0 | 0.5322 | 0.9074 | 0.8007 | no | N/A |
| Q8K348 | ACV1C_MOUSE | 2, ., 7, ., 1, 1, ., 3, 0 | 0.5152 | 0.9277 | 0.8336 | no | N/A |
| P37172 | ACVR1_MOUSE | 2, ., 7, ., 1, 1, ., 3, 0 | 0.5899 | 0.9164 | 0.7976 | yes | N/A |
| P80204 | TGFR1_RAT | 2, ., 7, ., 1, 1, ., 3, 0 | 0.5289 | 0.9051 | 0.8003 | no | N/A |
| Q61271 | ACV1B_MOUSE | 2, ., 7, ., 1, 1, ., 3, 0 | 0.5143 | 0.9209 | 0.8079 | no | N/A |
| P80201 | ACVR1_RAT | 2, ., 7, ., 1, 1, ., 3, 0 | 0.5875 | 0.9164 | 0.7976 | yes | N/A |
| P80202 | ACV1B_RAT | 2, ., 7, ., 1, 1, ., 3, 0 | 0.5191 | 0.9209 | 0.8079 | no | N/A |
| P80203 | ACVL1_RAT | 2, ., 7, ., 1, 1, ., 3, 0 | 0.5721 | 0.9142 | 0.8035 | no | N/A |
| Q90ZK6 | ACVR1_CHICK | 2, ., 7, ., 1, 1, ., 3, 0 | 0.6052 | 0.9209 | 0.8095 | yes | N/A |
| Q04771 | ACVR1_HUMAN | 2, ., 7, ., 1, 1, ., 3, 0 | 0.5899 | 0.9164 | 0.7976 | yes | N/A |
| Q64729 | TGFR1_MOUSE | 2, ., 7, ., 1, 1, ., 3, 0 | 0.5275 | 0.9119 | 0.8031 | no | N/A |
| Q8NER5 | ACV1C_HUMAN | 2, ., 7, ., 1, 1, ., 3, 0 | 0.5186 | 0.9209 | 0.8275 | no | N/A |
| P36896 | ACV1B_HUMAN | 2, ., 7, ., 1, 1, ., 3, 0 | 0.5167 | 0.9209 | 0.8079 | no | N/A |
Prediction of Functionally Associated Proteins
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 443 | |||
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 9e-57 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 8e-44 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 8e-37 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 9e-35 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 6e-34 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 8e-34 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-32 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 7e-32 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-31 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 8e-31 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 9e-30 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-28 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-26 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-25 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 4e-24 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 4e-23 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 6e-23 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-22 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 7e-22 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-21 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-20 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-20 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-20 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 4e-20 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 7e-20 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-19 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-19 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 4e-19 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-18 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-18 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-18 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-18 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-17 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-17 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-17 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-17 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 5e-17 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-16 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-16 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-16 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-16 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-16 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 4e-16 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 5e-16 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 7e-16 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-15 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-15 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-15 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-15 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-15 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-15 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 4e-15 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 6e-15 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 9e-15 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 9e-15 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-14 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-14 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-14 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-14 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-14 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-14 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-14 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-14 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-14 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-14 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 7e-14 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-13 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-13 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-13 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-13 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-13 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-13 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-13 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-13 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-13 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 7e-13 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 9e-13 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-12 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-12 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-12 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-12 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-12 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-12 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-12 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-12 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 3e-12 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-12 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-12 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-12 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 5e-12 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 5e-12 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 5e-12 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 7e-12 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 7e-12 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 7e-12 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 9e-12 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-11 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-11 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-11 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-11 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-11 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-11 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-11 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-11 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 5e-11 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 5e-11 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-10 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-10 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-10 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-10 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-10 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-10 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-10 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-10 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 4e-10 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 4e-10 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 4e-10 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 4e-10 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 5e-10 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 5e-10 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 9e-10 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 9e-10 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-09 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-09 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-09 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-09 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-09 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-09 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-09 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-09 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-09 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-09 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-09 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-09 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-09 | |
| pfam08515 | 29 | pfam08515, TGF_beta_GS, Transforming growth factor | 3e-09 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-09 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 4e-09 | |
| smart00467 | 30 | smart00467, GS, GS motif | 4e-09 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 4e-09 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 4e-09 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 4e-09 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 5e-09 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 5e-09 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 6e-09 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 7e-09 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 9e-09 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 9e-09 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-08 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-08 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-08 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-08 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-08 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-08 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-08 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-08 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-08 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-08 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-08 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-08 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-08 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-08 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-08 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-08 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 4e-08 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 4e-08 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 4e-08 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-08 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 4e-08 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 5e-08 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 5e-08 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 5e-08 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 6e-08 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 8e-08 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 9e-08 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-07 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-07 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-07 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-07 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-07 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-07 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-07 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-07 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-07 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-07 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-07 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-07 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-07 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-07 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 4e-07 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 4e-07 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-07 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 4e-07 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 4e-07 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 5e-07 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 5e-07 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 5e-07 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 6e-07 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 6e-07 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 7e-07 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 7e-07 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 8e-07 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 8e-07 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 9e-07 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-06 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-06 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-06 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-06 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-06 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-06 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-06 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-06 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-06 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-06 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-06 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-06 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-06 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 4e-06 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-06 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-06 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 4e-06 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 4e-06 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 9e-06 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 9e-06 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-05 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-05 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-05 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-05 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-05 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-05 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-05 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-05 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-05 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 2e-05 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-05 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-05 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-05 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-05 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-05 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-05 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-05 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-05 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 4e-05 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 4e-05 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 6e-05 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 6e-05 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 6e-05 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 8e-05 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-04 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-04 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-04 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-04 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-04 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-04 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-04 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-04 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-04 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-04 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-04 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-04 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 4e-04 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 4e-04 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 4e-04 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 5e-04 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 5e-04 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 5e-04 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 7e-04 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 9e-04 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 0.001 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 0.001 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 0.001 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 0.001 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 0.001 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 0.002 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 0.002 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 0.002 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 0.003 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 0.004 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 0.004 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 0.004 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 187 bits (478), Expect = 9e-57
Identities = 82/292 (28%), Positives = 131/292 (44%), Gaps = 42/292 (14%)
Query: 138 ISLSECIGKGRYGEVWRGVWHGEN--VAVKIFFSRDEASWSRET---EIYSTVLLRHENI 192
L +G G +G V++ G VAVKI R E S +T EI L H NI
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 193 LGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHT 251
+ I + + L+LV Y G L+D+L+R L+ + KI L I+ GL +LH+
Sbjct: 61 VRLIDAFEDKDH----LYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHS 116
Query: 252 EIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRY 311
I HRD+K +NIL+ NG IADFGLA + S+ + VGT Y
Sbjct: 117 N--------GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSL----TTFVGTPWY 164
Query: 312 MSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSF 371
M+PE+L + K D+++LG++L+E+ K P+ +
Sbjct: 165 MAPEVL-----LGGNGYGPKVDVWSLGVILYELLTG----------KPPF-----SGENI 204
Query: 372 DDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423
D ++I P+ + S ++K+C +++ + R +A + +
Sbjct: 205 LDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 152 bits (386), Expect = 8e-44
Identities = 66/207 (31%), Positives = 100/207 (48%), Gaps = 28/207 (13%)
Query: 144 IGKGRYGEVWRGVWHGEN--VAVKIFFSRDEASWSRET--EIYSTVLLRHENILGYIGSD 199
+G+G +G V+ VA+KI D +S E EI L H NI+ G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 200 MTSRNSCTQLWLVTHYHSFGSLYDHL--NRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQ 257
+ L+LV Y GSL D L N L+ ++++I L I+ GL +LH+
Sbjct: 61 EDENH----LYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSN----- 111
Query: 258 GKPAIAHRDIKSKNILV-KTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEI 316
I HRD+K +NIL+ NG +ADFGL+ + + + VGT YM+PE+
Sbjct: 112 ---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLL----KTIVGTPAYMAPEV 164
Query: 317 LDESINMDCFESFKKADIYALGLVLWE 343
L +K+DI++LG++L+E
Sbjct: 165 LLGKGYYS-----EKSDIWSLGVILYE 186
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 134 bits (341), Expect = 8e-37
Identities = 75/290 (25%), Positives = 123/290 (42%), Gaps = 52/290 (17%)
Query: 142 ECIGKGRYGEVWRGVWH--GENVAVKI----FFSRDEASWSRETEIYSTVLLRHENILGY 195
E +G+G +G+V+ G+ VA+K+ +D RE +I L+H NI+
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKK--LKHPNIVRL 62
Query: 196 IGSDMTSRNSCTQLWLVTHYHSFGSLYDHL-NRTTLNHHQMMKICLSIVNGLVHLHTEIF 254
L+LV Y G L+D L R L+ + I++ L +LH+
Sbjct: 63 YDVFEDEDK----LYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHS--- 115
Query: 255 GTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSP 314
+G I HRD+K +NIL+ +G +ADFGLA QL + VGT YM+P
Sbjct: 116 --KG---IVHRDLKPENILLDEDGHVKLADFGLA---RQLDPGEKL--TTFVGTPEYMAP 165
Query: 315 EILDESINMDCFESF-KKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFDD 373
E+L + + K DI++LG++L+E+ K P+ D +
Sbjct: 166 EVLLG-------KGYGKAVDIWSLGVILYELLTG----------KPPFPG----DDQLLE 204
Query: 374 MRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423
+ K I + P +S + + K ++ RL+A +
Sbjct: 205 LFKKIGKPKPPFPPPEWDISPEAKDLIRK----LLVKDPEKRLTAEEALQ 250
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 9e-35
Identities = 73/300 (24%), Positives = 129/300 (43%), Gaps = 70/300 (23%)
Query: 138 ISLSECIGKGRYGEVWRGVWHGEN------VAVKIFF----SRDEASWSRETEIYSTVLL 187
+ L + +G+G +GEV++G G+ VAVK + + E I L
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKK--L 58
Query: 188 RHENILGYIGSDMTSRNSCTQ---LWLVTHYHSFGSLYDHL--NRTTLNHHQMMKICLSI 242
H NI+ +G CTQ L++VT Y G L D L + L ++++ L I
Sbjct: 59 SHPNIVRLLGV-------CTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQI 111
Query: 243 VNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA-----VSYSQLSNK 297
G+ +L + K + HRD+ ++N LV N I+DFGL+ Y +
Sbjct: 112 AKGMEYLES-------KNFV-HRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGG 163
Query: 298 MDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEY 357
+P ++M+PE L + F S K+D+++ G++LWE IF
Sbjct: 164 GKLPI-------KWMAPESLKDGK----FTS--KSDVWSFGVLLWE---------IFTLG 201
Query: 358 KAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLS 417
+ PY + + + +++ D R P ++ + + ++M +CW + R +
Sbjct: 202 EQPYPGMSNEE-----VLELL-EDGYRLPRP-----ENCPDELYELMLQCWAYDPEDRPT 250
|
Length = 258 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 6e-34
Identities = 72/239 (30%), Positives = 110/239 (46%), Gaps = 43/239 (17%)
Query: 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEASWSRETEIYSTVLL---RHE 190
+ + E +G+G YG V++ + G+ VA+K +E EI +L
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIK-VVPVEEDLQEIIKEI---SILKQCDSP 58
Query: 191 NILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRT--TLNHHQMMKICLSIVNGLVH 248
I+ Y GS + T LW+V Y GS+ D + T TL ++ I + GL +
Sbjct: 59 YIVKYYGSYFKN----TDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEY 114
Query: 249 LHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGT 308
LH HRDIK+ NIL+ G +ADFG++ QL++ M N +GT
Sbjct: 115 LH--------SNKKIHRDIKAGNILLNEEGQAKLADFGVS---GQLTDTMA-KRNTVIGT 162
Query: 309 KRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPM 367
+M+PE++ E I + KADI++LG+ E+ E K PY D+ PM
Sbjct: 163 PFWMAPEVIQE-IGYNN-----KADIWSLGITAIEMA----------EGKPPYSDIHPM 205
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 126 bits (320), Expect = 8e-34
Identities = 79/234 (33%), Positives = 116/234 (49%), Gaps = 44/234 (18%)
Query: 142 ECIGKGRYGEVWRGVWH---GENVAVKIF---FSRDEASWSRETEIYSTVLLRHENILGY 195
E IGKG +GEV++ H G+ VA+K+ + E +I +H NI+ Y
Sbjct: 6 EKIGKGGFGEVYK-ARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKK--CKHPNIVKY 62
Query: 196 IGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRT--TLNHHQMMKICLSIVNGLVHLHTEI 253
GS + +LW+V + S GSL D L T TL Q+ +C ++ GL +LH+
Sbjct: 63 YGSYLKK----DELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN- 117
Query: 254 FGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMS 313
I HRDIK+ NIL+ ++G + DFGL+ QLS+ N VGT +M+
Sbjct: 118 -------GIIHRDIKAANILLTSDGEVKLIDFGLSA---QLSDTK--ARNTMVGTPYWMA 165
Query: 314 PEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPM 367
PE+++ D KADI++LG+ E+ A G K PY +L PM
Sbjct: 166 PEVING-KPYDY-----KADIWSLGITAIEL-----AEG-----KPPYSELPPM 203
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 3e-32
Identities = 79/290 (27%), Positives = 125/290 (43%), Gaps = 47/290 (16%)
Query: 137 QISLSECIGKGRYGEVWRGVWH--GENVAVK-IFFSRDEASWS----RETEIYSTVLLRH 189
+ + E +G+G +G V+ + GE +AVK + S D RE I S+ L+H
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSS--LQH 58
Query: 190 ENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVH 248
NI+ Y GS+ + L + Y S GSL L + L + K I+ GL +
Sbjct: 59 PNIVRYYGSERDEEKNT--LNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAY 116
Query: 249 LHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGT 308
LH+ G I HRDIK NILV ++G +ADFG A + GT
Sbjct: 117 LHS-----NG---IVHRDIKGANILVDSDGVVKLADFGCAKRLG--DIETGEGTGSVRGT 166
Query: 309 KRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMD 368
+M+PE++ E + ADI++LG + E+ A G K P+ +L
Sbjct: 167 PYWMAPEVIRGE------EYGRAADIWSLGCTVIEM-----ATG-----KPPWSEL---G 207
Query: 369 PSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSA 418
+ K+ + P +P +S+ + + K C ++ R +A
Sbjct: 208 NPMAALYKIGSSG-EPPEIPE-HLSEEAKDFLRK----CLRRDPKKRPTA 251
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (307), Expect = 7e-32
Identities = 72/303 (23%), Positives = 126/303 (41%), Gaps = 81/303 (26%)
Query: 142 ECIGKGRYGEVWRGVWHGEN-----VAVKIFFSRDEASWS------RETEIYSTVLLRHE 190
+ +G+G +GEV++G G++ VAVK +++AS +E + L H
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKT--LKEDASEEERKDFLKEARVMKK--LGHP 56
Query: 191 NILGYIGSDMTSRNSCTQ---LWLVTHYHSFGSLYDHL----------NRTTLNHHQMMK 237
N++ +G CT+ L+LV Y G L D+L ++TL+ ++
Sbjct: 57 NVVRLLGV-------CTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLS 109
Query: 238 ICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNK 297
+ I G+ +L HRD+ ++N LV + I+DFGL+
Sbjct: 110 FAIQIAKGMEYLA--------SKKFVHRDLAARNCLVGEDLVVKISDFGLSR-------D 154
Query: 298 MDIPPNPRVGTK-----RYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANG 352
+ R T R+M+PE L + I F S K+D+++ G++LWE+ G
Sbjct: 155 VYDDDYYRKKTGGKLPIRWMAPESLKDGI----FTS--KSDVWSFGVLLWEIF----TLG 204
Query: 353 IFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNA 412
PY L S +++ + + R P + D + ++M CW +
Sbjct: 205 -----ATPYPGL-----SNEEVLEYL-RKGYRLPKP-EYCPD----ELYELMLSCWQLDP 248
Query: 413 NVR 415
R
Sbjct: 249 EDR 251
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 1e-31
Identities = 77/311 (24%), Positives = 134/311 (43%), Gaps = 77/311 (24%)
Query: 138 ISLSECIGKGRYGEVWRGVW------HGENVAVKIFFSRDEAS------WSRETEIYSTV 185
++L + +G+G +GEV++G VAVK +++AS + RE I
Sbjct: 1 LTLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKT--LKEDASEQQIEEFLREARIMRK- 57
Query: 186 LLRHENILGYIGSDMTSRNSCTQ---LWLVTHYHSFGSLYDHL--NRTTLNHHQMMKICL 240
L H N++ +G CT+ L++V Y G L +L NR L+ ++ L
Sbjct: 58 -LDHPNVVKLLGV-------CTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFAL 109
Query: 241 SIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA------VSYSQL 294
I G+ +L + K I HRD+ ++N LV N I+DFGL+ Y +
Sbjct: 110 QIARGMEYLES-------KNFI-HRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKR 161
Query: 295 SNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIF 354
K+ I R+M+PE L E F S K+D+++ G++LWE IF
Sbjct: 162 GGKLPI---------RWMAPESLKEGK----FTS--KSDVWSFGVLLWE---------IF 197
Query: 355 EEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANV 414
+ PY + +++ + + + LP + + +M +CW ++
Sbjct: 198 TLGEQPYPGMSN-----EEVLEYL---KNGYRLPQ---PPNCPPELYDLMLQCWAEDPED 246
Query: 415 RLSALRVKKTL 425
R + + + L
Sbjct: 247 RPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (299), Expect = 8e-31
Identities = 83/300 (27%), Positives = 131/300 (43%), Gaps = 59/300 (19%)
Query: 137 QISLSECIGKGRYGEVWRGV-WH-GENVAVK-----IFFSRDEASWSRETEIYSTVLLRH 189
L + IG+G +G V++G+ G+ VA+K S +E ++ L+H
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKN--LKH 58
Query: 190 ENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVH 248
NI+ YIGS TS L+++ Y GSL + + + ++ GL +
Sbjct: 59 PNIVKYIGSIETS----DSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAY 114
Query: 249 LHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGT 308
LH QG + HRDIK+ NIL +G +ADFG+A N + VGT
Sbjct: 115 LHE-----QG---VIHRDIKAANILTTKDGVVKLADFGVATK----LNDVSKDDASVVGT 162
Query: 309 KRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMD 368
+M+PE+ I M + +DI++LG + E+ T PY+DL PM
Sbjct: 163 PYWMAPEV----IEMS--GASTASDIWSLGCTVIELL--TG--------NPPYYDLNPMA 206
Query: 369 PSFDDMRKVICIDQ-QRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIK 427
F I Q P LP +S + + +C+ ++ N+R +A K L+K
Sbjct: 207 ALF-------RIVQDDHPPLPEG-ISP----ELKDFLMQCFQKDPNLRPTA----KQLLK 250
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 9e-30
Identities = 78/312 (25%), Positives = 131/312 (41%), Gaps = 78/312 (25%)
Query: 138 ISLSECIGKGRYGEVWRGVW------HGENVAVKIFFSRDEASWS------RETEIYSTV 185
++L + +G+G +GEV++G VAVK +++AS RE I
Sbjct: 1 LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKT--LKEDASEQQIEEFLREARIMRK- 57
Query: 186 LLRHENILGYIGSDMTSRNSCTQ---LWLVTHYHSFGSLYDHL---NRTTLNHHQMMKIC 239
L H NI+ +G CT+ L +V Y G L D+L L+ ++
Sbjct: 58 -LDHPNIVKLLGV-------CTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFA 109
Query: 240 LSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA------VSYSQ 293
L I G+ +L + K I HRD+ ++N LV N I+DFGL+ Y
Sbjct: 110 LQIARGMEYLES-------KNFI-HRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKV 161
Query: 294 LSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGI 353
K+ I R+M+PE L E F S K+D+++ G++LWE I
Sbjct: 162 KGGKLPI---------RWMAPESLKEGK----FTS--KSDVWSFGVLLWE---------I 197
Query: 354 FEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNAN 413
F + PY + ++ + + ++ LP + + K+M +CW ++
Sbjct: 198 FTLGEEPYPGMSN-----AEVLEYL---KKGYRLPKP---PNCPPELYKLMLQCWAEDPE 246
Query: 414 VRLSALRVKKTL 425
R + + + L
Sbjct: 247 DRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 2e-28
Identities = 80/299 (26%), Positives = 139/299 (46%), Gaps = 60/299 (20%)
Query: 136 KQISLSECIGKGRYGEVWRGVWHGENVAVKIFFSRDEASWSR----ETEIYSTVLLRHEN 191
K++ L IGKG +G+V G + G+ VAVK +D+++ ++ E + +T LRH N
Sbjct: 6 KELKLGATIGKGEFGDVMLGDYRGQKVAVKC--LKDDSTAAQAFLAEASVMTT--LRHPN 61
Query: 192 ILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHL---NRTTLNHHQMMKICLSIVNGLVH 248
++ +G + L++VT Y + GSL D+L R + Q + L + G+ +
Sbjct: 62 LVQLLGVVLQGNP----LYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEY 117
Query: 249 LHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA--VSYSQLSNKMDIPPNPRV 306
L + F HRD+ ++N+LV + ++DFGLA S Q S K+ +
Sbjct: 118 LEEKNF--------VHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPV------ 163
Query: 307 GTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVP 366
++ +PE L E F + K+D+++ G++LWE I+ + PY P
Sbjct: 164 ---KWTAPEALREKK----FST--KSDVWSFGILLWE---------IYSFGRVPY----P 201
Query: 367 MDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTL 425
P D + V R P + + KVMK+CW + R + ++++ L
Sbjct: 202 RIPLKDVVPHV--EKGYRMEAP-----EGCPPEVYKVMKDCWELDPAKRPTFKQLREQL 253
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 3e-26
Identities = 65/209 (31%), Positives = 100/209 (47%), Gaps = 32/209 (15%)
Query: 144 IGKGRYGEVWRG--VWHGENVAVK--IFFSRDEASWSRETEIYSTVLLRHENILGYIGSD 199
IG+G GEV++ G+ VA+K +++ E I +H NI+ Y S
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKD--CKHPNIVDYYDSY 84
Query: 200 MTSRNSCTQLWLVTHYHSFGSLYDHL--NRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQ 257
+ LW+V Y GSL D + N +N Q+ +C ++ GL +LH+ Q
Sbjct: 85 LV--GDE--LWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHS-----Q 135
Query: 258 GKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPE-I 316
+ HRDIKS NIL+ +G+ +ADFG A QL+ + N VGT +M+PE I
Sbjct: 136 N---VIHRDIKSDNILLSKDGSVKLADFGFAA---QLTKEKS-KRNSVVGTPYWMAPEVI 188
Query: 317 LDESINMDCFESFKKADIYALGLVLWEVC 345
+ K DI++LG++ E+
Sbjct: 189 KRKDYGP-------KVDIWSLGIMCIEMA 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 2e-25
Identities = 89/302 (29%), Positives = 134/302 (44%), Gaps = 62/302 (20%)
Query: 136 KQISLSECIGKGRYGEVWRGVWHGEN--VAVKIFFSRDEASWSRET---EIYSTVLLRHE 190
+ +L ECIGKG +GEV++ + N VA+K+ +EA E EI R
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVI-DLEEAEDEIEDIQQEIQFLSQCRSP 59
Query: 191 NILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLH 250
I Y GS + ++LW++ Y GS D L L+ + I ++ GL +LH
Sbjct: 60 YITKYYGSFLKG----SKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLH 115
Query: 251 TEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKR 310
+GK HRDIK+ NIL+ G +ADFG++ + +K N VGT
Sbjct: 116 E-----EGK---IHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKR----NTFVGTPF 163
Query: 311 YMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPS 370
+M+PE++ +S D +KADI++LG+ E+ A G + P DL P
Sbjct: 164 WMAPEVIKQS-GYD-----EKADIWSLGITAIEL-----AKG-----EPPLSDLHP---- 203
Query: 371 FDDMRKVICIDQQR-PVLPNRWVSDSTLNAMTKVMKE----CWHQNANVRLSALRVKKTL 425
MR + I + P L S K+ C +++ R SA K L
Sbjct: 204 ---MRVLFLIPKNNPPSLEGNKFSKP--------FKDFVSLCLNKDPKERPSA----KEL 248
Query: 426 IK 427
+K
Sbjct: 249 LK 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 4e-24
Identities = 61/217 (28%), Positives = 97/217 (44%), Gaps = 38/217 (17%)
Query: 142 ECIGKGRYGEVW--RGVWHGENVAVKI----FFSRDEASWS-RETEIYSTVLLRHENILG 194
+ IGKG +G+V+ R G+ +K S E + E +I L H NI+
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKK--LNHPNIIK 63
Query: 195 YIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNH-----HQMMKICLSIVNGLVHL 249
Y S C +V Y G L + + Q++ + + L +L
Sbjct: 64 YYESFEEKGKLC----IVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYL 119
Query: 250 HTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTK 309
H+ I HRDIK +NI + +NG + DFG++ LS+ +D+ VGT
Sbjct: 120 HSR--------KILHRDIKPQNIFLTSNGLVKLGDFGIS---KVLSSTVDL-AKTVVGTP 167
Query: 310 RYMSPEIL-DESINMDCFESFKKADIYALGLVLWEVC 345
Y+SPE+ ++ N K+DI++LG VL+E+C
Sbjct: 168 YYLSPELCQNKPYN-------YKSDIWSLGCVLYELC 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 4e-23
Identities = 79/295 (26%), Positives = 134/295 (45%), Gaps = 52/295 (17%)
Query: 136 KQISLSECIGKGRYGEVWRGVWHGENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGY 195
K++ L + IGKG +G+V G + G VAVK D + + E LRH N++
Sbjct: 6 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKC-IKNDATAQAFLAEASVMTQLRHSNLVQL 64
Query: 196 IGSDMTSRNSCTQLWLVTHYHSFGSLYDHL---NRTTLNHHQMMKICLSIVNGLVHLHTE 252
+G + + L++VT Y + GSL D+L R+ L ++K L + + +L
Sbjct: 65 LGVIVEEKGG---LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN 121
Query: 253 IFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYM 312
F HRD+ ++N+LV + ++DFGL S + +P ++
Sbjct: 122 NF--------VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP-------VKWT 166
Query: 313 SPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMD--PS 370
+PE L E F + K+D+++ G++LWE I+ + PY + D P
Sbjct: 167 APEALREKK----FST--KSDVWSFGILLWE---------IYSFGRVPYPRIPLKDVVPR 211
Query: 371 FDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTL 425
+ K+ D PV+ + VMK+CWH +A R S L++++ L
Sbjct: 212 VEKGYKMDAPDGCPPVVYD-------------VMKQCWHLDAATRPSFLQLREQL 253
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.3 bits (243), Expect = 6e-23
Identities = 70/245 (28%), Positives = 111/245 (45%), Gaps = 45/245 (18%)
Query: 139 SLSECIGKGRYGEVWRGVWH---GENVAVKIFFSRDEASWSRETEIYSTV-LLR----HE 190
L E IG+G YG+V++ H G+ VA+KI + E EI +LR H
Sbjct: 9 ELVEVIGEGTYGKVYKAR-HKKTGQLVAIKIM----DIIEDEEEEIKEEYNILRKYSNHP 63
Query: 191 NILGYIGSDMTSRNSCT--QLWLVTHYHSFGSLYDHLNRTTLNHHQMMK------ICLSI 242
NI + G+ + QLWLV GS+ D L + + +K I
Sbjct: 64 NIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTD-LVKGLRKKGKRLKEEWIAYILRET 122
Query: 243 VNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPP 302
+ GL +LH + + HRDIK +NIL+ N + DFG++ +QL + +
Sbjct: 123 LRGLAYLH--------ENKVIHRDIKGQNILLTKNAEVKLVDFGVS---AQLDSTLG-RR 170
Query: 303 NPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYH 362
N +GT +M+PE++ D ++D+++LG+ E+ A+G K P
Sbjct: 171 NTFIGTPYWMAPEVIACDEQPDASYDA-RSDVWSLGITAIEL-----ADG-----KPPLC 219
Query: 363 DLVPM 367
D+ PM
Sbjct: 220 DMHPM 224
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.2 bits (240), Expect = 1e-22
Identities = 80/286 (27%), Positives = 123/286 (43%), Gaps = 53/286 (18%)
Query: 144 IGKGRYGEVW--RGVWHGENVAVKIF-FSRDEASWSRETEIYSTVLLRHENILGYIGSDM 200
IG G YG+V+ R + GE VA+K+ + + EI RH NI+ Y GS +
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70
Query: 201 TSRNSCTQLWLVTHYHSFGSLYD--HLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQG 258
R +LW+V Y GSL D + R L+ Q+ +C + GL +LH G
Sbjct: 71 --RRD--KLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHE-----TG 121
Query: 259 KPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILD 318
K HRDIK NIL+ +G +ADFG++ +QL+ + +GT +M+PE+
Sbjct: 122 K---IHRDIKGANILLTEDGDVKLADFGVS---AQLTATIA-KRKSFIGTPYWMAPEVAA 174
Query: 319 ESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFDDMRKVI 378
K DI+ALG+ E+ E + P DL PM + +
Sbjct: 175 VERKGGYDG---KCDIWALGITAIELA----------ELQPPMFDLHPM--------RAL 213
Query: 379 CI----DQQRPVL--PNRWVSDSTLNAMTKVMKECWHQNANVRLSA 418
+ + P L +W +K+C ++ R +A
Sbjct: 214 FLISKSNFPPPKLKDKEKWSPV-----FHDFIKKCLTKDPKKRPTA 254
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 96.3 bits (238), Expect = 7e-22
Identities = 60/217 (27%), Positives = 103/217 (47%), Gaps = 30/217 (13%)
Query: 140 LSECIGKGRYGEVWRGVWHGENVAVKIF------FSRDEASWSRETEIYSTVLLRHENIL 193
+ +G+G +GEV+ + VA+K+ S++ + RE +I ++ L NI+
Sbjct: 4 ILRKLGEGSFGEVYLAR-DRKLVALKVLAKKLESKSKEVERFLREIQILAS-LNHPPNIV 61
Query: 194 GYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLN----RTTLNHHQMMKICLSIVNGLVHL 249
L+LV Y GSL D L + L+ + + I I++ L +L
Sbjct: 62 KLYDFFQDEG----SLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117
Query: 250 HTEIFGTQGKPAIAHRDIKSKNILVKTNGT-CVIADFGLAVSY--SQLSNKMDIPPNPRV 306
H++ I HRDIK +NIL+ +G + DFGLA ++ + P+ V
Sbjct: 118 HSK--------GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSV 169
Query: 307 GTKRYMSPEILDESINMDCFESFKKADIYALGLVLWE 343
GT YM+PE+L + + + +DI++LG+ L+E
Sbjct: 170 GTPGYMAPEVL---LGLSLAYASSSSDIWSLGITLYE 203
|
Length = 384 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 92.0 bits (229), Expect = 4e-21
Identities = 72/247 (29%), Positives = 105/247 (42%), Gaps = 49/247 (19%)
Query: 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIF------FSRDEASWSRETEIYSTVLL 187
L E IG G V+ + + E VA+K S DE +E + S
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELR--KEVQAMSQ--C 56
Query: 188 RHENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYD---HLNRTTLNHHQMMKICL-SIV 243
H N++ Y S + +LWLV Y S GSL D ++ L ++
Sbjct: 57 NHPNVVKYYTSFVVGD----ELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVL 112
Query: 244 NGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPN 303
GL +LH HRDIK+ NIL+ +G+ IADFG++ S L++ D
Sbjct: 113 KGLEYLH--------SNGQIHRDIKAGNILLGEDGSVKIADFGVSAS---LADGGDRTRK 161
Query: 304 PR---VGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAP 360
R VGT +M+PE++++ D KADI++ G+ E+ A G AP
Sbjct: 162 VRKTFVGTPCWMAPEVMEQVHGYD-----FKADIWSFGITAIEL-----ATG-----AAP 206
Query: 361 YHDLVPM 367
Y PM
Sbjct: 207 YSKYPPM 213
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 2e-20
Identities = 73/234 (31%), Positives = 118/234 (50%), Gaps = 36/234 (15%)
Query: 142 ECIGKGRYGEVWRGVWHGEN--VAVKIFFSRDEASWSRETEIYSTVLLRHEN--ILGYIG 197
E IGKG +GEV++G+ + VA+KI + + + TVL + ++ + Y G
Sbjct: 10 EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 198 SDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQ 257
S + T+LW++ Y GS D L L+ Q+ I I+ GL +LH+E
Sbjct: 70 SYLKD----TKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSE----- 120
Query: 258 GKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEIL 317
HRDIK+ N+L+ +G +ADFG+A QL++ I N VGT +M+PE++
Sbjct: 121 ---KKIHRDIKAANVLLSEHGEVKLADFGVA---GQLTD-TQIKRNTFVGTPFWMAPEVI 173
Query: 318 DESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSF 371
+S ++S KADI++LG+ E+ + + P+ +L PM F
Sbjct: 174 KQS----AYDS--KADIWSLGITAIELAKG----------EPPHSELHPMKVLF 211
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 2e-20
Identities = 86/298 (28%), Positives = 132/298 (44%), Gaps = 64/298 (21%)
Query: 142 ECIGKGRYGEVWRG--VWHGENVAVKIFF----SRDEASWSRETEIYSTVLLRH---ENI 192
E IG+G YG V+RG V G VA+KI D + RE + S LR NI
Sbjct: 7 ELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQ--LRQSQPPNI 64
Query: 193 LGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIV-----NGLV 247
Y GS + +LW++ Y GS+ RT + + + +S++ L
Sbjct: 65 TKYYGSYLKG----PRLWIIMEYAEGGSV-----RTLMKAGPIAEKYISVIIREVLVALK 115
Query: 248 HLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVG 307
++H K + HRDIK+ NILV G + DFG+A +Q S+K + VG
Sbjct: 116 YIH--------KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKR----STFVG 163
Query: 308 TKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPM 367
T +M+PE++ E D KADI++LG+ ++E+ A G PY D+
Sbjct: 164 TPYWMAPEVITEGKYYD-----TKADIWSLGITIYEM-----ATG-----NPPYSDV--- 205
Query: 368 DPSFDDMRKVICI-DQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKT 424
D R ++ I + P L + S + + + C + RLSA + K+
Sbjct: 206 ----DAFRAMMLIPKSKPPRLEDNGYSKL----LREFVAACLDEEPKERLSAEELLKS 255
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 89.6 bits (223), Expect = 3e-20
Identities = 84/282 (29%), Positives = 123/282 (43%), Gaps = 45/282 (15%)
Query: 143 CIGKGRYGEVWRGV--WHGENVAVK-IFFSRDEASWSR-ETEIYSTVLLRHENILGYIGS 198
+G+G G V++ G+ A+K I DE + E+ + ++ G+
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67
Query: 199 DMTSRNSCTQLWLVTHYHSFGSLYDHLNRT-TLNHHQMMKICLSIVNGLVHLHTEIFGTQ 257
++ +V Y GSL D L + + + I I+ GL +LHT
Sbjct: 68 FYKEG----EISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHT------ 117
Query: 258 GKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEIL 317
K I HRDIK N+L+ + G IADFG++ L N +D N VGT YMSPE +
Sbjct: 118 -KRHIIHRDIKPSNLLINSKGEVKIADFGIS---KVLENTLD-QCNTFVGTVTYMSPERI 172
Query: 318 D-ESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFDDMRK 376
ES + ADI++LGL L E C A G F P+ L P PSF ++ +
Sbjct: 173 QGESYSYA-------ADIWSLGLTLLE-C----ALGKF-----PF--LPPGQPSFFELMQ 213
Query: 377 VICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSA 418
IC D P LP S + ++ C ++ R SA
Sbjct: 214 AIC-DGPPPSLPAEEFSPEFRDFISA----CLQKDPKKRPSA 250
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 4e-20
Identities = 71/257 (27%), Positives = 110/257 (42%), Gaps = 50/257 (19%)
Query: 144 IGKGRYGEVW--RGVWHGENVAVK-IFFSRDEASWS---RETEIYSTVLLRHENILGYIG 197
+G G G V G+ +AVK I +EA RE +I I+G+ G
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKC--NSPYIVGFYG 66
Query: 198 SDMTSRNSCTQLWLVTHYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFG 255
+ + + + Y GSL L + + KI ++++ GL +LH
Sbjct: 67 AFYNN----GDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHE---- 118
Query: 256 TQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPE 315
K I HRD+K NILV + G + DFG VS QL N + VGT YM+PE
Sbjct: 119 ---KHKIIHRDVKPSNILVNSRGQIKLCDFG--VS-GQLVNSL---AKTFVGTSSYMAPE 169
Query: 316 ILDE---SINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFD 372
+ S+ K+DI++LGL L E+ A G + P + P F+
Sbjct: 170 RIQGNDYSV---------KSDIWSLGLSLIEL-----ATG---RFPYPPENDPPDGI-FE 211
Query: 373 DMRKVICIDQQRPVLPN 389
++ + +++ P LP+
Sbjct: 212 LLQYI--VNEPPPRLPS 226
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 89.0 bits (220), Expect = 7e-20
Identities = 76/230 (33%), Positives = 113/230 (49%), Gaps = 36/230 (15%)
Query: 142 ECIGKGRYGEVWRGVWH--GENVAVKIFFSRDEASWSRETEIYSTVLLRHEN--ILGYIG 197
E IGKG +GEV++G+ + E VA+KI + + + TVL + ++ I Y G
Sbjct: 10 ERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYG 69
Query: 198 SDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQ 257
S + T+LW++ Y GS D L L + I I+ GL +LH+E
Sbjct: 70 SYLKG----TKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSE----- 120
Query: 258 GKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEIL 317
HRDIK+ N+L+ G +ADFG+A QL++ I N VGT +M+PE++
Sbjct: 121 ---RKIHRDIKAANVLLSEQGDVKLADFGVA---GQLTD-TQIKRNTFVGTPFWMAPEVI 173
Query: 318 DESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPM 367
+S F KADI++LG+ E+ A G + P DL PM
Sbjct: 174 KQSA-----YDF-KADIWSLGITAIEL-----AKG-----EPPNSDLHPM 207
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 1e-19
Identities = 60/221 (27%), Positives = 102/221 (46%), Gaps = 41/221 (18%)
Query: 136 KQISLSECIGKGRYGEVWRGVWHGEN-VAVKIFF--SRDEASWSRETEIYSTVLLRHENI 192
I L +G G++GEVW G+W+ VAVK + D + E +I LRH +
Sbjct: 6 TSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKK--LRHPKL 63
Query: 193 LGYIGSDMTSRNSCTQ---LWLVTHYHSFGSLYDHLNR---TTLNHHQMMKICLSIVNGL 246
+ CT +++VT +GSL ++L L Q++ + + +G+
Sbjct: 64 IQLYAV-------CTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGM 116
Query: 247 VHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRV 306
+L + + HRD+ ++N+LV N C +ADFGLA K DI R
Sbjct: 117 AYLEAQNY--------IHRDLAARNVLVGENNICKVADFGLARVI-----KEDI-YEARE 162
Query: 307 GTK---RYMSPEILDESINMDCFESFKKADIYALGLVLWEV 344
G K ++ +P E+ + F K+D+++ G++L E+
Sbjct: 163 GAKFPIKWTAP----EAALYNRFSI--KSDVWSFGILLTEI 197
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 87.5 bits (216), Expect = 2e-19
Identities = 72/252 (28%), Positives = 111/252 (44%), Gaps = 39/252 (15%)
Query: 132 RTLAKQISLSECIGKGRYGEVWRG--VWHGENVAVKIFFSRDEASWSRETEIYSTVLL-- 187
R A L E +G G YG+V++G V G+ A+K+ + + E EI + +
Sbjct: 2 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM----DVTGDEEEEIKQEINMLK 57
Query: 188 ---RHENILGYIGSDMTSRNSCT--QLWLVTHYHSFGSLYDHLNRT---TLNHHQMMKIC 239
H NI Y G+ + QLWLV + GS+ D + T TL + IC
Sbjct: 58 KYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYIC 117
Query: 240 LSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMD 299
I+ GL HLH + HRDIK +N+L+ N + DFG++ + +
Sbjct: 118 REILRGLSHLHQH--------KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR- 168
Query: 300 IPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKA 359
N +GT +M+PE++ N D F K+D+++LG+ E+ E
Sbjct: 169 ---NTFIGTPYWMAPEVIACDENPDATYDF-KSDLWSLGITAIEMA----------EGAP 214
Query: 360 PYHDLVPMDPSF 371
P D+ PM F
Sbjct: 215 PLCDMHPMRALF 226
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 4e-19
Identities = 75/316 (23%), Positives = 117/316 (37%), Gaps = 81/316 (25%)
Query: 136 KQISLSECIGKGRYGEVWRGVW------HGENVAVKIF-------FSRDEASWSRETEIY 182
+ + + +G+G +G+V + GE VAVK D + RE EI
Sbjct: 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSD---FEREIEIL 60
Query: 183 STVLLRHENILGYIG-SDMTSRNSCTQLWLVTHYHSFGSLYDHL--NRTTLNHHQMMKIC 239
T L HENI+ Y G + S L L+ Y GSL D+L +R +N +++
Sbjct: 61 RT--LDHENIVKYKGVCEKPGGRS---LRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFS 115
Query: 240 LSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAV------SYSQ 293
I G+ +L ++ HRD+ ++NILV++ I+DFGLA Y
Sbjct: 116 SQICKGMDYLGSQ--------RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYY 167
Query: 294 LSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEV---CRRTKA 350
+ + P + +PE L S F S +D+++ G+ L+E+
Sbjct: 168 VKEPGESP-------IFWYAPECLRTSK----FSS--ASDVWSFGVTLYELFTYGD---- 210
Query: 351 NGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPV--LPNRWVSDSTLNAMTK------ 402
P F +R + Q V L L
Sbjct: 211 -----------PSQSPP-AEF--LRMIGIAQGQMIVTRLLELLKEGERLPRPPSCPDEVY 256
Query: 403 -VMKECWHQNANVRLS 417
+MK CW R S
Sbjct: 257 DLMKLCWEAEPQDRPS 272
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 1e-18
Identities = 68/233 (29%), Positives = 114/233 (48%), Gaps = 28/233 (12%)
Query: 142 ECIGKGRYGEVWRGVWHGEN--VAVKIFFSRDEASWSRETEIYSTVLLRHEN--ILGYIG 197
E IGKG +GEV++G+ + VA+KI + + + TVL + ++ + Y G
Sbjct: 10 ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 198 SDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQ 257
S + T+LW++ Y GS D L + Q+ + I+ GL +LH+E
Sbjct: 70 SYLKG----TKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSE----- 120
Query: 258 GKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEIL 317
HRDIK+ N+L+ G +ADFG+A QL++ I N VGT +M+PE++
Sbjct: 121 ---KKIHRDIKAANVLLSEQGDVKLADFGVA---GQLTD-TQIKRNTFVGTPFWMAPEVI 173
Query: 318 DESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPS 370
+S ++S KADI++LG+ E+ + N + + +P +
Sbjct: 174 QQS----AYDS--KADIWSLGITAIELAKGEPPNSDMHPMRVLFL--IPKNNP 218
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 2e-18
Identities = 75/251 (29%), Positives = 114/251 (45%), Gaps = 41/251 (16%)
Query: 129 LIQRTLAKQISLSECIGKGRYGEVW--RGVWHGENVAVKIFFSRDEASWSR-ETEIYSTV 185
+++R L + +G G YG+V+ R + GE AVKI +S + EI+
Sbjct: 2 ILRRNPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVK 61
Query: 186 LLRHENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRT-TLNHHQMMKICLSIVN 244
+H NI+ Y GS ++ +LW+ Y GSL D + T L+ Q+ +C +
Sbjct: 62 ECKHCNIVAYFGSYLSRE----KLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQ 117
Query: 245 GLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNP 304
GL +LH+ +GK HRDIK NIL+ NG +ADFG+A + K
Sbjct: 118 GLAYLHS-----KGK---MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKR----KS 165
Query: 305 RVGTKRYMSPEIL----DESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAP 360
+GT +M+PE+ + N C DI+A+G+ E+ E + P
Sbjct: 166 FIGTPYWMAPEVAAVEKNGGYNQLC-------DIWAVGITAIELA----------ELQPP 208
Query: 361 YHDLVPMDPSF 371
DL PM F
Sbjct: 209 MFDLHPMRALF 219
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 4e-18
Identities = 71/300 (23%), Positives = 124/300 (41%), Gaps = 76/300 (25%)
Query: 130 IQRTLAKQISLSECIGKGRYGEVWRGVWH---GENVAVKIFFSRDEASWSRETEIYSTVL 186
IQR I+L CIG+G++G+V++GV+ E +AV + ++ S S +
Sbjct: 3 IQRED---ITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAY 59
Query: 187 L----RHENILGYIG--SDMTSRNSCTQLWLVTHYHSFGSLYDHL--NRTTLNHHQMMKI 238
+ H +I+ IG ++ W+V G L +L N+ +L+ ++
Sbjct: 60 IMRQFDHPHIVKLIGVITENPV-------WIVMELAPLGELRSYLQVNKYSLDLASLILY 112
Query: 239 CLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA-----VSYSQ 293
+ L +L ++ F HRDI ++N+LV + + DFGL+ SY +
Sbjct: 113 SYQLSTALAYLESKRF--------VHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYK 164
Query: 294 LS-NKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKA-DIYALGLVLWEVCRRTKAN 351
S K+ I ++M+P ESIN F F A D++ G+ +WE
Sbjct: 165 ASKGKLPI---------KWMAP----ESIN---FRRFTSASDVWMFGVCMWE-------- 200
Query: 352 GIFEEYKAPYHDLVPMDPSFDDMRKVIC-IDQ-QRPVLPNRWVSDSTLNAMTKVMKECWH 409
I P+ + VI I+ +R +P + + +M +CW
Sbjct: 201 -ILMLGVKPFQGV--------KNNDVIGRIENGERLPMP-----PNCPPTLYSLMTKCWA 246
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 4e-18
Identities = 72/259 (27%), Positives = 112/259 (43%), Gaps = 39/259 (15%)
Query: 125 GLPLLIQRTLAKQISLSECIGKGRYGEVWRG--VWHGENVAVKIFFSRDEASWSRETEI- 181
+ L R A L E +G G YG+V++G V G+ A+K+ ++ + EI
Sbjct: 5 DIDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEIN 64
Query: 182 ----YSTVLLRHENILGYIGS--DMTSRNSCTQLWLVTHYHSFGSLYDHLNRT---TLNH 232
YS H NI Y G+ + QLWLV + GS+ D + T L
Sbjct: 65 MLKKYS----HHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKE 120
Query: 233 HQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYS 292
+ IC I+ GL HLH + HRDIK +N+L+ N + DFG++
Sbjct: 121 DWIAYICREILRGLAHLHAH--------KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 172
Query: 293 QLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANG 352
+ + N +GT +M+PE++ N D + ++DI++LG+ E+
Sbjct: 173 RTVGRR----NTFIGTPYWMAPEVIACDENPDATYDY-RSDIWSLGITAIEMA------- 220
Query: 353 IFEEYKAPYHDLVPMDPSF 371
E P D+ PM F
Sbjct: 221 ---EGAPPLCDMHPMRALF 236
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 81.9 bits (203), Expect = 1e-17
Identities = 58/222 (26%), Positives = 89/222 (40%), Gaps = 41/222 (18%)
Query: 142 ECIGKGRYGEVWRGVWH---GENVAVKIFFSRDEASWSRETE-----IYSTV----LLRH 189
E IGKG +G V R V G+ E + TE + S V L+H
Sbjct: 6 ETIGKGSFGTV-RKVRRKSDGK------ILVWKEIDYGNMTEKEKQQLVSEVNILRELKH 58
Query: 190 ENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNH-----HQMMKICLSIVN 244
NI+ Y + N L++V Y G L + + + +I ++
Sbjct: 59 PNIVRYYDRIIDRSN--QTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLL 116
Query: 245 GLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNP 304
L H + + HRD+K NI + N + DFGLA ++
Sbjct: 117 ALYECH---NRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLA----KILGHDSSFAKT 169
Query: 305 RVGTKRYMSPEIL-DESINMDCFESFKKADIYALGLVLWEVC 345
VGT YMSPE L S + +K+DI++LG +++E+C
Sbjct: 170 YVGTPYYMSPEQLNHMSYD-------EKSDIWSLGCLIYELC 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 2e-17
Identities = 76/290 (26%), Positives = 129/290 (44%), Gaps = 58/290 (20%)
Query: 136 KQISLSECIGKGRYGEVWRGVWHGE-NVAVKIFFSRDEASWSRE---TEIYSTVLLRHEN 191
K ++ + +G G++G V G W G+ +VA+K+ E S S + E + L HE
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI---KEGSMSEDEFIEEAKVMMKLSHEK 60
Query: 192 ILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNH---HQMMKICLSIVNGLVH 248
++ G R +++VT Y S G L ++L R Q++++C + G+ +
Sbjct: 61 LVQLYGVCTKQR----PIYIVTEYMSNGCLLNYL-REHGKRFQPSQLLEMCKDVCEGMAY 115
Query: 249 LHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGT 308
L ++ F HRD+ ++N LV G ++DFGL+ Y +D VG+
Sbjct: 116 LESKQF--------IHRDLAARNCLVDDQGCVKVSDFGLS-RYV-----LDDEYTSSVGS 161
Query: 309 K---RYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLV 365
K R+ PE+L S F S K+D++A G+++WEV + K PY
Sbjct: 162 KFPVRWSPPEVLLYSK----FSS--KSDVWAFGVLMWEV---------YSLGKMPYE--- 203
Query: 366 PMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVR 415
F++ V + Q + S+ + +M CWH+ A R
Sbjct: 204 ----RFNNSETVEKVSQGLRLYRPHLASEK----VYAIMYSCWHEKAEER 245
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 3e-17
Identities = 80/317 (25%), Positives = 131/317 (41%), Gaps = 90/317 (28%)
Query: 138 ISLSECIGKGRYGEVWRG-VWHGEN------VAVKIF--FSRDEA--SWSRETEIYSTVL 186
I L +G+G +G+V+ G +H E VAVK + ++A + RE E+ +
Sbjct: 7 IVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTN-- 64
Query: 187 LRHENILGYIGSDMTSRNSCTQ---LWLVTHYHSFGSLYDHLNR---------------T 228
+HENI+ + G CT+ +V Y G L L
Sbjct: 65 FQHENIVKFYGV-------CTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMG 117
Query: 229 TLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA 288
L Q+++I + I +G+V+L ++ F HRD+ ++N LV + I DFG++
Sbjct: 118 ELTLSQLLQIAVQIASGMVYLASQHF--------VHRDLATRNCLVGYDLVVKIGDFGMS 169
Query: 289 VSYSQLSNKMDIPPNP--RVGTK-----RYMSPEILDESINMDCFESFKKADIYALGLVL 341
D+ RVG R+M P ESI F + ++D+++ G+VL
Sbjct: 170 ---------RDVYTTDYYRVGGHTMLPIRWMPP----ESIMYRKFTT--ESDVWSFGVVL 214
Query: 342 WEVCRRTKANGIFEEYKAPYHDLVPMDPSFDDMRKVI-CIDQQRPVLPNRWVSDSTLNAM 400
WE IF K P++ L +VI CI Q R + R +
Sbjct: 215 WE---------IFTYGKQPWYGL--------SNEEVIECITQGRLLQRPRTCPSE----V 253
Query: 401 TKVMKECWHQNANVRLS 417
+M CW ++ R++
Sbjct: 254 YDIMLGCWKRDPQQRIN 270
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 3e-17
Identities = 62/230 (26%), Positives = 114/230 (49%), Gaps = 41/230 (17%)
Query: 136 KQISLSECIGKGRYGEVWRGVWHGENVAVKIFFSRDEA-SWSRETEIYSTVLLRHENILG 194
++++L E IG+G +G V +G + G+ VAVK A ++ ET + + L H+N++
Sbjct: 6 QKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDVTAQAFLEETAVMTK--LHHKNLVR 63
Query: 195 YIGSDMTSRNSCTQLWLVTHYHSFGSLYDHL---NRTTLNHHQMMKICLSIVNGLVHLHT 251
+G + + L++V S G+L + L R ++ Q+++ L + G+ +L +
Sbjct: 64 LLGVILHN-----GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES 118
Query: 252 EIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRY 311
+ + HRD+ ++NILV +G ++DFGLA S + +P ++
Sbjct: 119 K--------KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLP-------VKW 163
Query: 312 MSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPY 361
+PE L F S K+D+++ G++LWEV F +APY
Sbjct: 164 TAPEALKHKK----FSS--KSDVWSYGVLLWEV---------FSYGRAPY 198
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 5e-17
Identities = 64/235 (27%), Positives = 95/235 (40%), Gaps = 41/235 (17%)
Query: 142 ECIGKGRYGEVWRGV--WHGENVAVKIFFSRDEASWSRET------EIYSTVLLRHENIL 193
E +G G +G V+ G+ G+ AVK D+ +E EI L+H NI+
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65
Query: 194 GYIGSDMTSRNSCTQLWLVTH------YHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLV 247
Y+G++ N L LV +GS + + R L Q I+ GL
Sbjct: 66 QYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIR--LYTRQ-------ILLGLE 116
Query: 248 HLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVG 307
+LH HRDIK NILV TNG +ADFG+A + S G
Sbjct: 117 YLHDR--------NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSF-----KG 163
Query: 308 TKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYH 362
+ +M+PE++ + ADI++LG + E+ E A +
Sbjct: 164 SPYWMAPEVIAQQGGYGL-----AADIWSLGCTVLEMATGKPPWSQLEGVAAVFK 213
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 1e-16
Identities = 73/297 (24%), Positives = 125/297 (42%), Gaps = 70/297 (23%)
Query: 135 AKQISLSECIGKGRYGEVWRGVWHGE-NVAVKIFFSRDEASWSRETEIYSTVL---LRHE 190
+++ + +G G++G V G W G+ +VA+K+ E + S + I + L H
Sbjct: 3 PSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMI---REGAMSEDDFIEEAKVMMKLSHP 59
Query: 191 NILGYIGSDMTSRNSCTQ---LWLVTHYHSFGSLYDHL--NRTTLNHHQMMKICLSIVNG 245
N++ G CT+ +++VT Y + G L ++L + L ++ +C +
Sbjct: 60 NLVQLYGV-------CTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEA 112
Query: 246 LVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPR 305
+ +L + F HRD+ ++N LV + ++DFGLA Y +D
Sbjct: 113 MEYLESNGF--------IHRDLAARNCLVGEDNVVKVSDFGLA-RYV-----LDDQYTSS 158
Query: 306 VGTK---RYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYH 362
GTK ++ PE+ D S F S K+D+++ G+++WEV F E K PY
Sbjct: 159 QGTKFPVKWAPPEVFDYSR----FSS--KSDVWSFGVLMWEV---------FSEGKMPY- 202
Query: 363 DLVPMDPSFDDMRKVICIDQ----QRPVLPNRWVSDSTLNAMTKVMKECWHQNANVR 415
F + V + RP L V +M CWH+ R
Sbjct: 203 ------ERFSNSEVVESVSAGYRLYRPKLAPTEVYT--------IMYSCWHEKPEDR 245
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 1e-16
Identities = 63/220 (28%), Positives = 102/220 (46%), Gaps = 41/220 (18%)
Query: 137 QISLSECIGKGRYGEVWRGVWHGE-NVAVKIF--FSRDEASWSRETEIYSTVLLRHENIL 193
+ L +G G++GEVW G W+G VAVK + ++ +E +I LRH+ ++
Sbjct: 7 SLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKK--LRHDKLV 64
Query: 194 GYIGSDMTSRNSCTQ---LWLVTHYHSFGSLYDHLNRTT---LNHHQMMKICLSIVNGLV 247
C++ +++VT Y S GSL D L L Q++ + I G+
Sbjct: 65 QLYAV-------CSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMA 117
Query: 248 HLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVG 307
+L + + HRD+ ++NILV N C IADFGLA D R G
Sbjct: 118 YLESRNY--------IHRDLAARNILVGENLVCKIADFGLARLI------EDDEYTAREG 163
Query: 308 TK---RYMSPEILDESINMDCFESFKKADIYALGLVLWEV 344
K ++ +P E+ N F K+D+++ G++L E+
Sbjct: 164 AKFPIKWTAP----EAANYGRFT--IKSDVWSFGILLTEI 197
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 2e-16
Identities = 63/236 (26%), Positives = 109/236 (46%), Gaps = 49/236 (20%)
Query: 159 GENVAVKIFFSRDEASWSRETEIYSTVLLR---HENILGYIGSDMTSRNSCTQLWLVTHY 215
G+ VAVK R + RE V++R HEN++ S + +LW+V +
Sbjct: 47 GKQVAVKKMDLRKQQR--RELLFNEVVIMRDYHHENVVDMYNSYLVG----DELWVVMEF 100
Query: 216 HSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVK 275
G+L D + T +N Q+ +CLS++ L +LH + + HRDIKS +IL+
Sbjct: 101 LEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQ--------GVIHRDIKSDSILLT 152
Query: 276 TNGTCVIADFGLAVSYSQLSNKMDIPPNPR-VGTKRYMSPEILDESINMDCFESFKKADI 334
++G ++DFG S+ ++P VGT +M+PE++ + DI
Sbjct: 153 SDGRIKLSDFGFCAQVSK-----EVPKRKSLVGTPYWMAPEVISR------LPYGTEVDI 201
Query: 335 YALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNR 390
++LG+++ E+ + + PY + +P MR++ R LP R
Sbjct: 202 WSLGIMVIEMI----------DGEPPYFN----EPPLQAMRRI------RDNLPPR 237
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 3e-16
Identities = 57/211 (27%), Positives = 86/211 (40%), Gaps = 29/211 (13%)
Query: 144 IGKGRYGEVW--RGVWHGENVAVKIFFSRDEASWSRET---EIYSTVLLRHENILGYIGS 198
IG+G YG V+ R GE VA+K R E+ +T EI L H NI+ +
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLL-- 64
Query: 199 DMTSRNSCTQLWLVTHY--HSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGT 256
D+ L+LV + L + L + ++ GL H
Sbjct: 65 DVFRHKG--DLYLVFEFMDTDLYKLIKD-RQRGLPESLIKSYLYQLLQGLAFCH------ 115
Query: 257 QGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEI 316
I HRD+K +N+L+ T G +ADFGLA S+ V T+ Y +PE+
Sbjct: 116 --SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPY----THYVVTRWYRAPEL 169
Query: 317 LDESINMDCFESFKKADIYALGLVLWEVCRR 347
L + DI+++G + E+ R
Sbjct: 170 L-----LGDKGYSTPVDIWSVGCIFAELLSR 195
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 3e-16
Identities = 57/220 (25%), Positives = 101/220 (45%), Gaps = 49/220 (22%)
Query: 144 IGKGRYGEVWRGVW--HGEN----VAVKIFFSRDEASWSRETEI----YSTVLLRHENIL 193
+G G +G V++GVW GE VA+K+ R+E S EI Y + H +++
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVL--REETSPKANKEILDEAYVMASVDHPHVV 72
Query: 194 GYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHL--NRTTLNHHQMMKICLSIVNGLVHLHT 251
+G ++S Q+ L+T G L D++ ++ + ++ C+ I G+ +L
Sbjct: 73 RLLGICLSS-----QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEE 127
Query: 252 EIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA-------VSYSQLSNKMDIPPNP 304
+ + HRD+ ++N+LVKT I DFGLA Y K+ I
Sbjct: 128 K--------RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPI---- 175
Query: 305 RVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEV 344
++M+ ESI + K+D+++ G+ +WE+
Sbjct: 176 -----KWMAL----ESILHRIYTH--KSDVWSYGVTVWEL 204
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 4e-16
Identities = 73/251 (29%), Positives = 109/251 (43%), Gaps = 41/251 (16%)
Query: 129 LIQRTLAKQISLSECIGKGRYGEVW--RGVWHGENVAVKIF-FSRDEASWSRETEIYSTV 185
L +R + L + IG G YG+V+ R V GE A+K+ E + EI
Sbjct: 2 LSRRNPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMK 61
Query: 186 LLRHENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRT-TLNHHQMMKICLSIVN 244
+H NI+ Y GS + +LW+ + GSL D + T L+ Q+ + +
Sbjct: 62 DCKHSNIVAYFGSYLRR----DKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQ 117
Query: 245 GLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNP 304
GL +LH+ +GK HRDIK NIL+ NG +ADFG++ + K
Sbjct: 118 GLYYLHS-----KGK---MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKR----KS 165
Query: 305 RVGTKRYMSPEIL----DESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAP 360
+GT +M+PE+ N C DI+A+G+ E+ E + P
Sbjct: 166 FIGTPYWMAPEVAAVERKGGYNQLC-------DIWAVGITAIELA----------ELQPP 208
Query: 361 YHDLVPMDPSF 371
DL PM F
Sbjct: 209 MFDLHPMRALF 219
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 5e-16
Identities = 58/192 (30%), Positives = 97/192 (50%), Gaps = 35/192 (18%)
Query: 159 GENVAVKIFFSRDEASWSRETEIYSTVLLR---HENILGYIGSDMTSRNSCTQLWLVTHY 215
G VAVK R + RE V++R H NI+ S + +LW+V +
Sbjct: 44 GRQVAVKKMDLRKQQR--RELLFNEVVIMRDYQHPNIVEMYSSYLVG----DELWVVMEF 97
Query: 216 HSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVK 275
G+L D + T +N Q+ +CL+++ L LH QG + HRDIKS +IL+
Sbjct: 98 LEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHA-----QG---VIHRDIKSDSILLT 149
Query: 276 TNGTCVIADFGLAVSYSQLSNKMDIPPNPR----VGTKRYMSPEILDESINMDCFESFKK 331
++G ++DFG +Q+S ++ PR VGT +M+PE+ I+ + + +
Sbjct: 150 SDGRVKLSDFGFC---AQVSKEV-----PRRKSLVGTPYWMAPEV----ISRLPYGT--E 195
Query: 332 ADIYALGLVLWE 343
DI++LG+++ E
Sbjct: 196 VDIWSLGIMVIE 207
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 7e-16
Identities = 75/293 (25%), Positives = 114/293 (38%), Gaps = 56/293 (19%)
Query: 140 LSECIGKGRYGEVW--RGVWHGENVAVKIF-FSRDEASWSRET-----EIYSTVLLRHEN 191
+ +G+G +G V+ V G +AVK F D +E EI L+HE
Sbjct: 6 RGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHER 65
Query: 192 ILGYIGSDMTSRNSCTQ----LWLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGL 246
I+ Y G C + L + Y GS+ D L L K I+ G+
Sbjct: 66 IVQYYG--------CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGV 117
Query: 247 VHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRV 306
+LH+ + I HRDIK NIL + G + DFG + + +
Sbjct: 118 EYLHSNM--------IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG-TGMKSVT 168
Query: 307 GTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVP 366
GT +MSPE+ I+ + + +KAD++++G + E+ K P+ +
Sbjct: 169 GTPYWMSPEV----ISGEGYG--RKADVWSVGCTVVEMLTE----------KPPWAEFEA 212
Query: 367 MDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSAL 419
M F I P LP+ VS N + + E NA R SA
Sbjct: 213 MAAIFK-----IATQPTNPQLPSH-VSPDARNFLRRTFVE----NAKKRPSAE 255
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 1e-15
Identities = 59/207 (28%), Positives = 103/207 (49%), Gaps = 31/207 (14%)
Query: 144 IGKGRYGEVW--RGVWHGENVAVKIFFSRDEASWSRETEIYSTVLLR---HENILGYIGS 198
IG+G G V R G VAVK+ R + RE V++R H+N++ S
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQR--RELLFNEVVIMRDYQHQNVVEMYKS 86
Query: 199 DMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQG 258
+ +LW++ + G+L D +++T LN Q+ +C S++ L +LH++
Sbjct: 87 YLVGE----ELWVLMEFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQ------ 136
Query: 259 KPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPR-VGTKRYMSPEIL 317
+ HRDIKS +IL+ +G ++DFG S+ D+P VGT +M+PE++
Sbjct: 137 --GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISK-----DVPKRKSLVGTPYWMAPEVI 189
Query: 318 DESINMDCFESFKKADIYALGLVLWEV 344
+ + DI++LG+++ E+
Sbjct: 190 SRTPYG------TEVDIWSLGIMVIEM 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 2e-15
Identities = 59/208 (28%), Positives = 99/208 (47%), Gaps = 29/208 (13%)
Query: 142 ECIGKGRYGEVWRG--VWHGENVAVKIFFSRDEASWSRETEIYSTVLLR---HENILGYI 196
E IG+G G V+ V G+ VA+K + + +E I +++R H NI+ Y+
Sbjct: 25 EKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPK--KELIINEILVMRENKHPNIVNYL 82
Query: 197 GSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGT 256
S + +LW+V Y + GSL D + T ++ Q+ +C + L LH+
Sbjct: 83 DSYLV----GDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN---- 134
Query: 257 QGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEI 316
+ HRDIKS NIL+ +G+ + DFG + +K + VGT +M+PE+
Sbjct: 135 ----QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR----STMVGTPYWMAPEV 186
Query: 317 LDESINMDCFESFKKADIYALGLVLWEV 344
+ K DI++LG++ E+
Sbjct: 187 VTRK------AYGPKVDIWSLGIMAIEM 208
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 75.7 bits (187), Expect = 2e-15
Identities = 51/239 (21%), Positives = 89/239 (37%), Gaps = 70/239 (29%)
Query: 144 IGKGRYGEVWRGVWHGEN--VAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIGSDMT 201
IG+G + V N A+KI L E + Y+
Sbjct: 9 IGEGSFSTVVLAKEKETNKEYAIKI---------------LDKRQLIKEKKVKYV---KI 50
Query: 202 SRNSCTQL----WLVTHYHSF---------------GSLYDHLNR-TTLNHHQMMKICLS 241
+ T+L ++ Y++F G L ++ + +L+
Sbjct: 51 EKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAE 110
Query: 242 IVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYS--------- 292
I+ L +LH+ +G I HRD+K +NIL+ + I DFG A
Sbjct: 111 ILLALEYLHS-----KG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNK 162
Query: 293 QLSNKMDIPPNPR-------VGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEV 344
+ +D VGT Y+SPE+L+E + K +D++ALG +++++
Sbjct: 163 GDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKP------AGKSSDLWALGCIIYQM 215
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 2e-15
Identities = 65/207 (31%), Positives = 95/207 (45%), Gaps = 27/207 (13%)
Query: 144 IGKGRYGEVWRG--VWHGENVA---VKIFFSRDEASWSRETEIYSTVLLRHENILGYIGS 198
IG+G YG V+R GE VA V++ RD S EI + LRH NI+
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELK-- 72
Query: 199 DMTSRNSCTQLWLVTHY--HSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGT 256
++ ++LV Y SL D+ T + Q+ + L ++ GL +LH
Sbjct: 73 EVVVGKHLDSIFLVMEYCEQDLASLLDN-MPTPFSESQVKCLMLQLLRGLQYLHENF--- 128
Query: 257 QGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEI 316
I HRD+K N+L+ G IADFGLA +Y + M P+V T Y +PE+
Sbjct: 129 -----IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPM----TPKVVTLWYRAPEL 179
Query: 317 LDESINMDCFESFKKADIYALGLVLWE 343
L + C D++A+G +L E
Sbjct: 180 L-----LGCTTYTTAIDMWAVGCILAE 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 2e-15
Identities = 56/207 (27%), Positives = 88/207 (42%), Gaps = 28/207 (13%)
Query: 144 IGKGRYGEVW--RGVWHGENVAVKIFFSRDEASWSRET---EIYSTVLLRHENILGYIGS 198
+G+G YG V R GE VA+K F ++ ++T E+ LRHENI+ +
Sbjct: 9 VGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEA 68
Query: 199 DMTSRNSCTQLWLVTHY--HSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGT 256
+L+LV Y + L + + L + ++ + + H
Sbjct: 69 FRRKG----RLYLVFEYVERTLLELLE-ASPGGLPPDAVRSYIWQLLQAIAYCH------ 117
Query: 257 QGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEI 316
I HRDIK +NILV +G + DFG A L + P V T+ Y +PE+
Sbjct: 118 --SHNIIHRDIKPENILVSESGVLKLCDFGFA---RALRARPASPLTDYVATRWYRAPEL 172
Query: 317 LDESINMDCFESFKKADIYALGLVLWE 343
L N K D++A+G ++ E
Sbjct: 173 LVGDTNYG-----KPVDVWAIGCIMAE 194
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 3e-15
Identities = 63/208 (30%), Positives = 99/208 (47%), Gaps = 21/208 (10%)
Query: 144 IGKGRYGEVWRGVW--HGENVAVK-IFFSRDEASWSRETEIYSTVL--LRHENILGYIGS 198
IG G +G+V+ V GE +AVK I ++ +E VL L+H N++ Y G
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67
Query: 199 DMTSRNSCTQLWLVTHYHSFGSLYDHL-NRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQ 257
++ R ++++ Y S G+L + L + L+ H + L ++ GL +LH+
Sbjct: 68 EV-HRE---KVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHS-----H 118
Query: 258 GKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEIL 317
G I HRDIK NI + NG + DFG AV + M GT YM+PE++
Sbjct: 119 G---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVI 175
Query: 318 DESINMDCFESFKKADIYALGLVLWEVC 345
+ ADI++LG V+ E+
Sbjct: 176 TGG---KGKGHGRAADIWSLGCVVLEMA 200
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 4e-15
Identities = 76/306 (24%), Positives = 122/306 (39%), Gaps = 61/306 (19%)
Query: 131 QRTLAKQISLSECIGKGRYGEVWRGVWH------GENVAVKIFFS----RDEASWSRETE 180
+R L K L G+G +G+V + GE VAVK ++ + W +E
Sbjct: 3 KRYLKKIRVL----GEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEIN 58
Query: 181 IYSTVLLRHENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICL 240
I T L HENI+ Y G S L L+ Y GSL D+L + LN Q++
Sbjct: 59 ILKT--LYHENIVKYKGC--CSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQ 114
Query: 241 SIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVS------YSQL 294
I G+ +LH++ + HRD+ ++N+L+ + I DFGLA + Y ++
Sbjct: 115 QICEGMAYLHSQHY--------IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRV 166
Query: 295 SNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIF 354
D P + + E L E + +D+++ G+ L+E+
Sbjct: 167 REDGDSP-------VFWYAVECLKE------NKFSYASDVWSFGVTLYELLTHC------ 207
Query: 355 EEYKAPYHDLVPM-DPSFDDMRKVICID----QQRPVLPNRWVSDSTLNAMTKVMKECWH 409
+ ++P M P M V I+ R P + + +MK CW
Sbjct: 208 DSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQE-----VYILMKNCWE 262
Query: 410 QNANVR 415
A R
Sbjct: 263 TEAKFR 268
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 6e-15
Identities = 59/231 (25%), Positives = 111/231 (48%), Gaps = 51/231 (22%)
Query: 130 IQRTLAKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEASWSRETEIYSTVL- 186
++RT I++ +G G+YGEV+ GVW + VAVK +++ E + V+
Sbjct: 3 MERT---DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL--KEDTMEVEEFLKEAAVMK 57
Query: 187 -LRHENILGYIGSDMTSRNSCTQ---LWLVTHYHSFGSLYDHL---NRTTLNHHQMMKIC 239
++H N++ +G CT+ +++T + ++G+L D+L NR +N ++ +
Sbjct: 58 EIKHPNLVQLLGV-------CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMA 110
Query: 240 LSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA------VSYSQ 293
I + + +L + F HRD+ ++N LV N +ADFGL+ +
Sbjct: 111 TQISSAMEYLEKKNF--------IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 162
Query: 294 LSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEV 344
K I ++ +P ES+ + F K+D++A G++LWE+
Sbjct: 163 AGAKFPI---------KWTAP----ESLAYNKFSI--KSDVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 9e-15
Identities = 66/212 (31%), Positives = 96/212 (45%), Gaps = 32/212 (15%)
Query: 144 IGKGRYGEVW--RGVWHGENVAVKIFFSRDEASWSRETEIYSTV----LLRHENILGYIG 197
IG G +G V+ R V E VA+K + S + +I V LRH N + Y G
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82
Query: 198 SDMTSRNSCTQLWLVTHYHSFGSLYDHLN--RTTLNHHQMMKICLSIVNGLVHLHTEIFG 255
+ + WLV Y GS D L + L ++ IC + GL +LH+
Sbjct: 83 CYLREHTA----WLVMEY-CLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSH--- 134
Query: 256 TQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPE 315
HRDIK+ NIL+ GT +ADFG S + P N VGT +M+PE
Sbjct: 135 -----ERIHRDIKAGNILLTEPGTVKLADFG--------SASLVSPANSFVGTPYWMAPE 181
Query: 316 ILDESINMDCFESFKKADIYALGLVLWEVCRR 347
++ + MD + K D+++LG+ E+ R
Sbjct: 182 VI---LAMDEGQYDGKVDVWSLGITCIELAER 210
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 9e-15
Identities = 71/292 (24%), Positives = 125/292 (42%), Gaps = 65/292 (22%)
Query: 144 IGKGRYGEVWRGVWHGENV--AVKIFFSRDEAS---WSRETEIYSTVLLRHENILGYIGS 198
+G G +G+V++ + A KI E + E +I S +H NI+G +
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSEC--KHPNIVGLYEA 70
Query: 199 DMTSRNSCTQLWLVTHY---HSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFG 255
LW++ + + S+ L R L Q+ +C ++ L LH+
Sbjct: 71 YFYENK----LWILIEFCDGGALDSIMLELERG-LTEPQIRYVCRQMLEALNFLHSHK-- 123
Query: 256 TQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPE 315
+ HRD+K+ NIL+ +G +ADFG+ S + + +GT +M+PE
Sbjct: 124 ------VIHRDLKAGNILLTLDGDVKLADFGV----SAKNKSTLQKRDTFIGTPYWMAPE 173
Query: 316 ILDESINMDCFESFK------KADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDP 369
+ + C E+FK KADI++LG+ L E+ + + P+H+L P
Sbjct: 174 V------VAC-ETFKDNPYDYKADIWSLGITLIELAQM----------EPPHHELNP--- 213
Query: 370 SFDDMRKVICIDQQRP---VLPNRWVSDSTLNAMTKVMKECWHQNANVRLSA 418
MR ++ I + P P++W S +K C ++ + R +A
Sbjct: 214 ----MRVLLKILKSEPPTLDQPSKWSSS-----FNDFLKSCLVKDPDDRPTA 256
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 1e-14
Identities = 53/225 (23%), Positives = 90/225 (40%), Gaps = 44/225 (19%)
Query: 137 QISLSECIGKGRYGEVW--RGVWHGENVAVKIFFSRD-----EASWSRETEIYSTVLLRH 189
+ + IG+G +G V+ + GE VA+K R RE I + +H
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALRE--IKALQACQH 58
Query: 190 ENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLN--RTTLNHHQMMKICLSIVNGLV 247
++ + D+ S LV Y L + L L Q+ ++ G+
Sbjct: 59 PYVVKLL--DVFPHGSG--FVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRMLLKGVA 113
Query: 248 HLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVG 307
++H I HRD+K N+L+ +G IADFGLA + S + + +V
Sbjct: 114 YMHAN--------GIMHRDLKPANLLISADGVLKIADFGLARLF---SEEEPRLYSHQVA 162
Query: 308 TKRYMSPEIL------DESINMDCFESFKKADIYALGLVLWEVCR 346
T+ Y +PE+L D + D++A+G + E+
Sbjct: 163 TRWYRAPELLYGARKYDPGV-----------DLWAVGCIFAELLN 196
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 1e-14
Identities = 61/217 (28%), Positives = 96/217 (44%), Gaps = 34/217 (15%)
Query: 144 IGKGRYGE--VWRGVWHGENVAVK-IFFSRDEASWSR----ETEIYSTVLLRHENILGYI 196
+GKG +GE ++R V K + +R R E I S LL+H NI+ Y
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILS--LLQHPNIIAYY 65
Query: 197 GSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNH---HQMMKICLSIVNGLVHLHTEI 253
M L + Y + G+LYD + R ++ IV+ + ++H
Sbjct: 66 NHFMDD----NTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH--- 118
Query: 254 FGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMS 313
K I HRDIK+ NI + G + DFG++ L ++ + VGT YMS
Sbjct: 119 -----KAGILHRDIKTLNIFLTKAGLIKLGDFGIS---KILGSEYSMAETV-VGTPYYMS 169
Query: 314 PEILDESINMDCFESFKKADIYALGLVLWEVCRRTKA 350
PE+ + + + K+DI+ALG VL+E+ +
Sbjct: 170 PELC-QGVKYN-----FKSDIWALGCVLYELLTLKRT 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 1e-14
Identities = 60/217 (27%), Positives = 93/217 (42%), Gaps = 36/217 (16%)
Query: 140 LSECIGKGRYGEVWRG-------VWHGENVAVKIFFSRDEASWSRETEIYSTVLLRHENI 192
+ IGKG +G V++ V+ + + + R+ E + + L I
Sbjct: 4 ILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAK--LDSSYI 61
Query: 193 LGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNR---TTLNHHQMMKICLSIVNGLVHL 249
+ Y S + +L +V Y G L+ L L Q+ + + I+ GL HL
Sbjct: 62 IRYYESFLDKG----KLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHL 117
Query: 250 HTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTK 309
H I HRDIKS N+ + I D G+A S +N N VGT
Sbjct: 118 H--------SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF----ANTIVGTP 165
Query: 310 RYMSPEIL-DESINMDCFESFKKADIYALGLVLWEVC 345
Y+SPE+ D+ N +K+D++ALG+VL+E C
Sbjct: 166 YYLSPELCEDKPYN-------EKSDVWALGVVLYECC 195
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 1e-14
Identities = 70/239 (29%), Positives = 107/239 (44%), Gaps = 41/239 (17%)
Query: 117 SLTSGSGSGLPLLIQRTLAKQISLSEC-----IGKGRYGEVWRGVWH--GENVAVKIFFS 169
S +S S SG + SLSE IG G G V++ + G A+K+ +
Sbjct: 56 SSSSSSASG------SAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYG 109
Query: 170 RDEAS----WSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHL 225
E + RE EI V H N++ DM N Q+ L + GSL
Sbjct: 110 NHEDTVRRQICREIEILRDV--NHPNVVKC--HDMFDHNGEIQVLL--EFMDGGSL---- 159
Query: 226 NRTTLNH-HQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIAD 284
T + + + I++G+ +LH + I HRDIK N+L+ + IAD
Sbjct: 160 EGTHIADEQFLADVARQILSGIAYLH--------RRHIVHRDIKPSNLLINSAKNVKIAD 211
Query: 285 FGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWE 343
FG++ L+ MD P N VGT YMSPE ++ +N ++ + DI++LG+ + E
Sbjct: 212 FGVS---RILAQTMD-PCNSSVGTIAYMSPERINTDLNHGAYDGY-AGDIWSLGVSILE 265
|
Length = 353 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 2e-14
Identities = 60/218 (27%), Positives = 105/218 (48%), Gaps = 36/218 (16%)
Query: 144 IGKGRYGEVW--RGVWHGENVAVKIF----FSRDEASWSRETEIYSTVLLRHENILGYIG 197
+G+G +G V R + V +K ++DE + + E LL H NI+ Y
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERL-AAQNECQVLKLLSHPNIIEYYE 66
Query: 198 SDMTSRNSCTQLWLVTHYHSFGSLYDHLN---RTTLNHHQMMKICLSIVNGLVHLHTEIF 254
+ + + L +V Y G+L +++ + L+ ++ + I+ L H+HT++
Sbjct: 67 NFLEDK----ALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL- 121
Query: 255 GTQGKPAIAHRDIKSKNILVKTNGTCV-IADFGLAVSYSQLSNKMDIPPNPRVGTKRYMS 313
I HRD+K++NIL+ + V I DFG++ S S + VGT Y+S
Sbjct: 122 -------ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTV-----VGTPCYIS 169
Query: 314 PEILD-ESINMDCFESFKKADIYALGLVLWEVCRRTKA 350
PE+ + + N +K+DI+ALG VL+E+ +A
Sbjct: 170 PELCEGKPYN-------QKSDIWALGCVLYELASLKRA 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 3e-14
Identities = 72/312 (23%), Positives = 134/312 (42%), Gaps = 79/312 (25%)
Query: 137 QISLSECIGKGRYGEVWRGVWHG-------ENVAVKIFFS----RDEASWSRETEIYSTV 185
+++L + +G+G +G+V + G VAVK+ +D + E E+ +
Sbjct: 13 RLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMI 72
Query: 186 LLRHENILGYIGSDMTSRNSCTQ---LWLVTHYHSFGSLYDHLNRT-------------- 228
+H+NI+ +G CTQ L++V Y + G+L D L
Sbjct: 73 G-KHKNIINLLGV-------CTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRP 124
Query: 229 ---TLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADF 285
TL ++ + G+ L + K I HRD+ ++N+LV + IADF
Sbjct: 125 PEETLTQKDLVSFAYQVARGMEFLAS-------KKCI-HRDLAARNVLVTEDHVMKIADF 176
Query: 286 GLA--VSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWE 343
GLA + + K N R+ K +M+PE L + + +S D+++ G++LWE
Sbjct: 177 GLARDIHHIDYYRKTT---NGRLPVK-WMAPEALFD--RVYTHQS----DVWSFGVLLWE 226
Query: 344 VCRRTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKV 403
IF +PY +P++ F +++ ++ +P + + +
Sbjct: 227 ---------IFTLGGSPYPG-IPVEELFKLLKEGYRME--KPQ--------NCTQELYHL 266
Query: 404 MKECWHQNANVR 415
M++CWH+ + R
Sbjct: 267 MRDCWHEVPSQR 278
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 3e-14
Identities = 55/179 (30%), Positives = 88/179 (49%), Gaps = 29/179 (16%)
Query: 170 RDEASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNR-- 227
R+E+ +E + S ++H NI+ Y S + N L++V Y G LY +N
Sbjct: 43 REESR--KEVAVLSN--MKHPNIVQYQESFEENGN----LYIVMDYCEGGDLYKKINAQR 94
Query: 228 -TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFG 286
Q++ + I L H+H I HRDIKS+NI + +GT + DFG
Sbjct: 95 GVLFPEDQILDWFVQICLALKHVHDR--------KILHRDIKSQNIFLTKDGTIKLGDFG 146
Query: 287 LAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVC 345
+A L++ +++ +GT Y+SPEI + + K+DI+ALG VL+E+C
Sbjct: 147 IA---RVLNSTVEL-ARTCIGTPYYLSPEICENRPYNN------KSDIWALGCVLYEMC 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 3e-14
Identities = 58/214 (27%), Positives = 101/214 (47%), Gaps = 29/214 (13%)
Query: 136 KQISLSECIGKGRYGEVWRG--VWHGENVAVKIFFSRDEASWSRETEIYSTVLLRHE--- 190
K+ + E IG+G G V+ V G+ VA++ + + +E I +++R
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNP 77
Query: 191 NILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLH 250
NI+ Y+ S + +LW+V Y + GSL D + T ++ Q+ +C + L LH
Sbjct: 78 NIVNYLDSYLVG----DELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH 133
Query: 251 TEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKR 310
+ + HRDIKS NIL+ +G+ + DFG + +K + VGT
Sbjct: 134 SN--------QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR----STMVGTPY 181
Query: 311 YMSPEILDESINMDCFESFKKADIYALGLVLWEV 344
+M+PE++ K DI++LG++ E+
Sbjct: 182 WMAPEVVTRK------AYGPKVDIWSLGIMAIEM 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 3e-14
Identities = 58/214 (27%), Positives = 101/214 (47%), Gaps = 29/214 (13%)
Query: 136 KQISLSECIGKGRYGEVWRG--VWHGENVAVKIFFSRDEASWSRETEIYSTVLLRHE--- 190
K+ + E IG+G G V+ + G+ VA+K + + +E I +++R
Sbjct: 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPK--KELIINEILVMRENKNP 76
Query: 191 NILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLH 250
NI+ Y+ S + +LW+V Y + GSL D + T ++ Q+ +C + L LH
Sbjct: 77 NIVNYLDSYLVG----DELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLH 132
Query: 251 TEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKR 310
+ + HRDIKS NIL+ +G+ + DFG + +K + VGT
Sbjct: 133 SN--------QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR----STMVGTPY 180
Query: 311 YMSPEILDESINMDCFESFKKADIYALGLVLWEV 344
+M+PE++ K DI++LG++ E+
Sbjct: 181 WMAPEVVTRK------AYGPKVDIWSLGIMAIEM 208
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 4e-14
Identities = 72/304 (23%), Positives = 130/304 (42%), Gaps = 76/304 (25%)
Query: 138 ISLSECIGKGRYGEVWRGVWHGEN-------VAVKIFFSRDEAS------WSRETEIYST 184
+ E +G+G +G+V++G G N VA+K ++ A + +E E+ S
Sbjct: 7 VRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTL--KENAEPKVQQEFRQEAELMSD 64
Query: 185 VLLRHENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNR----------------- 227
L+H NI+ +G + +C ++ Y + G L++ L R
Sbjct: 65 --LQHPNIVCLLGVCTKEQPTC----MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVK 118
Query: 228 TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGL 287
++L+ + I + I G+ +L + F HRD+ ++N LV T I+DFGL
Sbjct: 119 SSLDCSDFLHIAIQIAAGMEYLSSHHF--------VHRDLAARNCLVGEGLTVKISDFGL 170
Query: 288 AVS-YSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR 346
+ YS ++ + + R+M P E+I F + ++DI++ G+VLWE
Sbjct: 171 SRDIYSADYYRV---QSKSLLPVRWMPP----EAILYGKFTT--ESDIWSFGVVLWE--- 218
Query: 347 RTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKE 406
IF PY+ + VI + + R +LP + + +M E
Sbjct: 219 ------IFSYGLQPYYGFSNQE--------VIEMIRSRQLLP---CPEDCPARVYALMIE 261
Query: 407 CWHQ 410
CW++
Sbjct: 262 CWNE 265
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 7e-14
Identities = 72/291 (24%), Positives = 118/291 (40%), Gaps = 69/291 (23%)
Query: 142 ECIGKGRYGEVWRGVWHGE-NVAVKI----FFSRDEASWSRETEIYSTVLLRHENILGYI 196
E IGKG +G+V++GV G VAVK + + +E EI H NI+ I
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQ--YDHPNIVKLI 58
Query: 197 GSDMTSRNSCTQ---LWLVTHYHSFGSLYDHL----NRTTLNHHQMMKICLSIVNGLVHL 249
G C Q +++V GSL L NR T+ +++++ L G+ +L
Sbjct: 59 GV-------CVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVK--KLLQMSLDAAAGMEYL 109
Query: 250 HTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVS-----YSQLSNKMDIPPNP 304
+ K I HRD+ ++N LV N I+DFG++ Y+ IP
Sbjct: 110 -------ESKNCI-HRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIP--- 158
Query: 305 RVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDL 364
++ +PE L N + S ++D+++ G++LWE F PY +
Sbjct: 159 ----IKWTAPEAL----NYGRYTS--ESDVWSYGILLWE---------TFSLGDTPYPGM 199
Query: 365 VPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVR 415
S R+ I + P + ++M +CW + R
Sbjct: 200 -----SNQQTRERIESGYRMP------APQLCPEEIYRLMLQCWAYDPENR 239
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 1e-13
Identities = 68/286 (23%), Positives = 128/286 (44%), Gaps = 53/286 (18%)
Query: 144 IGKGRYGEVWRGVWHGENV--AVKIFFSRDE---ASWSRETEIYSTVLLRHENILGYIGS 198
+G G +G+V++ V A K+ ++ E + E +I ++ H NI+ + +
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASC--DHPNIVKLLDA 70
Query: 199 DMTSRNSCTQLWLVTHYHSFGSL---YDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFG 255
N LW++ + + G++ L R L Q+ +C + L +LH
Sbjct: 71 FYYENN----LWILIEFCAGGAVDAVMLELERP-LTEPQIRVVCKQTLEALNYLHEN--- 122
Query: 256 TQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPE 315
I HRD+K+ NIL +G +ADFG++ ++ + D +GT +M+PE
Sbjct: 123 -----KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRD----SFIGTPYWMAPE 173
Query: 316 ILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFDDMR 375
++ + D + KAD+++LG+ L E+ + + P+H+L P MR
Sbjct: 174 VVMCETSKDRPYDY-KADVWSLGITLIEMA----------QIEPPHHELNP-------MR 215
Query: 376 KVICIDQQRP---VLPNRWVSDSTLNAMTKVMKECWHQNANVRLSA 418
++ I + P P+RW S+ +K+C +N + R +
Sbjct: 216 VLLKIAKSEPPTLAQPSRWSSE-----FKDFLKKCLEKNVDARWTT 256
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 2e-13
Identities = 53/220 (24%), Positives = 100/220 (45%), Gaps = 39/220 (17%)
Query: 136 KQISLSECIGKGRYGEVWRGVWHGE-NVAVKIFFSRDEASWSRE--TEIYSTVLLRHENI 192
++ +L +G G +GEVW G+W VA+KI D+ ++ E+ + LRH+++
Sbjct: 6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKIL-KSDDLLKQQDFQKEVQALKRLRHKHL 64
Query: 193 LGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRT---TLNHHQMMKICLSIVNGLVHL 249
+ + S ++++T GSL L L ++ + + G+ +L
Sbjct: 65 ISLFA--VCSVGE--PVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYL 120
Query: 250 HTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAV-----SYSQLSNKMDIPPNP 304
+ HRD+ ++NILV + C +ADFGLA Y K IP
Sbjct: 121 EEQ--------NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKK--IP--- 167
Query: 305 RVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEV 344
++ +P E+ + F + K+D+++ G++L+E+
Sbjct: 168 ----YKWTAP----EAASHGTFST--KSDVWSFGILLYEM 197
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 2e-13
Identities = 62/214 (28%), Positives = 102/214 (47%), Gaps = 37/214 (17%)
Query: 144 IGKGRYGEVWRGVWHGEN---VAVKIFFSR-----DEASWSRETEIYSTVLLRHENILGY 195
IG+G +G+++ ++ V +I ++ EAS + E+ ++H NI+ +
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEAS---KKEVILLAKMKHPNIVTF 64
Query: 196 IGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNR---TTLNHHQMMKICLSIVNGLVHLHTE 252
S + +L++V Y G L +NR + Q++ + I GL H+H
Sbjct: 65 FASFQEN----GRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR 120
Query: 253 IFGTQGKPAIAHRDIKSKNILVKTNGTCV-IADFGLAVSYSQLSNKMDIPPNPRVGTKRY 311
I HRDIKS+NI + NG + DFG+A QL++ M++ VGT Y
Sbjct: 121 --------KILHRDIKSQNIFLSKNGMVAKLGDFGIA---RQLNDSMELAYTC-VGTPYY 168
Query: 312 MSPEILDESINMDCFESFKKADIYALGLVLWEVC 345
+SPEI + K DI++LG VL+E+C
Sbjct: 169 LSPEICQNRPYNN------KTDIWSLGCVLYELC 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 3e-13
Identities = 53/190 (27%), Positives = 92/190 (48%), Gaps = 29/190 (15%)
Query: 159 GENVAVKIFFSRDEASWSRETEIYSTVLLR---HENILGYIGSDMTSRNSCTQLWLVTHY 215
G+ VAVK R + RE V++R HEN++ S + +LW+V +
Sbjct: 45 GKLVAVKKMDLRKQQR--RELLFNEVVIMRDYQHENVVEMYNSYLVG----DELWVVMEF 98
Query: 216 HSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVK 275
G+L D + T +N Q+ +CL+++ L LH + + HRDIKS +IL+
Sbjct: 99 LEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQ--------GVIHRDIKSDSILLT 150
Query: 276 TNGTCVIADFGLAVSYSQLSNKMDIPPNPR-VGTKRYMSPEILDESINMDCFESFKKADI 334
+G ++DFG S+ ++P VGT +M+PE++ + DI
Sbjct: 151 HDGRVKLSDFGFCAQVSK-----EVPRRKSLVGTPYWMAPELISR------LPYGPEVDI 199
Query: 335 YALGLVLWEV 344
++LG+++ E+
Sbjct: 200 WSLGIMVIEM 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 3e-13
Identities = 57/214 (26%), Positives = 96/214 (44%), Gaps = 39/214 (18%)
Query: 144 IGKGRYGEVWRGV--WHGENVA---VKIFFSRDEASWSRETEIYSTVLLR---HENILGY 195
IGKG++ V++ + G VA V+IF D + R+ + LL+ H N++ Y
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKA--RQDCLKEIDLLKQLDHPNVIKY 67
Query: 196 IGSDMTSRNSCTQLWLVTHYHSFGSL-----YDHLNRTTLNHHQMMKICLSIVNGLVHLH 250
+ S + + +L +V G L + + + + K + + + L H+H
Sbjct: 68 LASFIEN----NELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH 123
Query: 251 TEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKR 310
++ I HRDIK N+ + G + D GL S+K + VGT
Sbjct: 124 SK--------RIMHRDIKPANVFITATGVVKLGDLGLG---RFFSSKT-TAAHSLVGTPY 171
Query: 311 YMSPEILDES-INMDCFESFKKADIYALGLVLWE 343
YMSPE + E+ N K+DI++LG +L+E
Sbjct: 172 YMSPERIHENGYNF-------KSDIWSLGCLLYE 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 3e-13
Identities = 58/214 (27%), Positives = 93/214 (43%), Gaps = 36/214 (16%)
Query: 144 IGKGRYGEVWRGVWHGE-----NVAVKIF----FSRDEASWSRETEIYSTVLLRHENILG 194
+G G +G V RG W VAVK S + +E I + L HEN++
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHS--LDHENLIR 60
Query: 195 YIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNH---HQMMKICLSIVNGLVHLHT 251
G +T L +VT GSL D L + L H + + I NG+ +L +
Sbjct: 61 LYGVVLTH-----PLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLES 115
Query: 252 EIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRY 311
+ F HRD+ ++NIL+ ++ I DFGL + Q + + + +V +
Sbjct: 116 KRF--------IHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFA-W 166
Query: 312 MSPEILDESINMDCFESFKKA-DIYALGLVLWEV 344
+P ES+ +F A D++ G+ LWE+
Sbjct: 167 CAP----ESLR---TRTFSHASDVWMFGVTLWEM 193
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 3e-13
Identities = 64/216 (29%), Positives = 100/216 (46%), Gaps = 33/216 (15%)
Query: 144 IGKGRYGEVWRGV--WHGENVAVK--IFFSRDEASWSR--------ETEIYSTVLLRHEN 191
IG G +G V+ G+ GE +AVK S +S R EI L+HEN
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 192 ILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMK-ICLSIVNGLVHLH 250
I+ Y+GS + + L + Y GS+ LN +++ I+ GL +LH
Sbjct: 68 IVQYLGSSLDA----DHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLH 123
Query: 251 TEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA--VSYSQLSNKMDIPPNPRVGT 308
I HRDIK NILV G I+DFG++ + + LS K + G+
Sbjct: 124 NR--------GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGS 175
Query: 309 KRYMSPEILDESINMDCFESFKKADIYALGLVLWEV 344
+M+PE++ ++ +KADI++LG ++ E+
Sbjct: 176 VFWMAPEVVKQTSYT------RKADIWSLGCLVVEM 205
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.1 bits (170), Expect = 4e-13
Identities = 62/220 (28%), Positives = 95/220 (43%), Gaps = 49/220 (22%)
Query: 142 ECIGKGRYGEVWRGVWH--GENVAVKI----FFSRDEASWSRETEIYSTVLLR---HENI 192
+ +G G +G V+ GE VA+K F+S +E RE + L + H NI
Sbjct: 5 KQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVK----SLRKLNEHPNI 60
Query: 193 LG----YIGSDMTSRNSCTQLWLVTHYHSFGSLYD---HLNRTTLNHHQMMKICLSIVNG 245
+ + +D +L+ V Y G+LY + + I I+ G
Sbjct: 61 VKLKEVFREND--------ELYFVFEYME-GNLYQLMKDRKGKPFSESVIRSIIYQILQG 111
Query: 246 LVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPP-NP 304
L H+H F HRD+K +N+LV IADFGLA ++ ++ PP
Sbjct: 112 LAHIHKHGF--------FHRDLKPENLLVSGPEVVKIADFGLA---REIRSR---PPYTD 157
Query: 305 RVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEV 344
V T+ Y +PEIL S + DI+ALG ++ E+
Sbjct: 158 YVSTRWYRAPEILLRSTSYSS-----PVDIWALGCIMAEL 192
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.1 bits (170), Expect = 4e-13
Identities = 55/187 (29%), Positives = 82/187 (43%), Gaps = 33/187 (17%)
Query: 144 IGKGRYGEVWRG--VWHGENVAVK-IFFSRDEASWSRET--EIYSTVLLRHENILGYIGS 198
IG+G YG+V++ GE VA+K I ++ + EI LRH NI+
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEI 66
Query: 199 DMTSRNSCTQLWLVTHYHSF---GSLYDHLNRTTLNH-----HQMMKICLSIVNGLVHLH 250
+TS+ +++V Y G L + T + Q+++ GL +LH
Sbjct: 67 -VTSKGK-GSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLE-------GLQYLH 117
Query: 251 TEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKR 310
+ I HRDIK NIL+ +G +ADFGLA Y + + RV T
Sbjct: 118 SN--------GILHRDIKGSNILINNDGVLKLADFGLARPY---TKRNSADYTNRVITLW 166
Query: 311 YMSPEIL 317
Y PE+L
Sbjct: 167 YRPPELL 173
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 7e-13
Identities = 58/200 (29%), Positives = 87/200 (43%), Gaps = 43/200 (21%)
Query: 144 IGKGRYGEVWRGVWH--GENVAVK---IFFSRDEASWSRETEIYSTVLLRHENILGYIGS 198
+G+G +GEV++ G VA+K + +D + EI L+H N++ I
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLI-- 73
Query: 199 DMT------SRNSCTQLWLVTHY--HSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLH 250
DM S+ +++VT Y H L ++ L Q+ L ++ G+ +LH
Sbjct: 74 DMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLEN-PSVKLTESQIKCYMLQLLEGINYLH 132
Query: 251 TEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPR----- 305
+ I HRDIK+ NIL+ G IADFGLA Y PPNP+
Sbjct: 133 --------ENHILHRDIKAANILIDNQGILKIADFGLARPYD------GPPPNPKGGGGG 178
Query: 306 --------VGTKRYMSPEIL 317
V T+ Y PE+L
Sbjct: 179 GTRKYTNLVVTRWYRPPELL 198
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 9e-13
Identities = 65/227 (28%), Positives = 97/227 (42%), Gaps = 32/227 (14%)
Query: 144 IGKGRYGEVWRGVWHGEN--VAVKIFFSRDEASWSRETEIYSTV----LLRHENILGYIG 197
IG G +G V+ N VAVK + + + +I V L+H N + Y G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 198 SDMTSRNSCTQLWLVTHYHSFGSLYDHL--NRTTLNHHQMMKICLSIVNGLVHLHTEIFG 255
+ + WLV Y GS D L ++ L ++ I + GL +LH+
Sbjct: 89 CYLKEHTA----WLVMEY-CLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH--- 140
Query: 256 TQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPE 315
+ HRDIK+ NIL+ G +ADFG A S P N VGT +M+PE
Sbjct: 141 -----NMIHRDIKAGNILLTEPGQVKLADFGSASKSS--------PANSFVGTPYWMAPE 187
Query: 316 ILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYH 362
++ + MD + K D+++LG+ E+ R A YH
Sbjct: 188 VI---LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH 231
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 1e-12
Identities = 65/227 (28%), Positives = 99/227 (43%), Gaps = 32/227 (14%)
Query: 144 IGKGRYGEVW--RGVWHGENVAVKIFFSRDEASWSRETEIYSTV----LLRHENILGYIG 197
IG G +G V+ R V E VA+K + S + +I V ++H N + Y G
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92
Query: 198 SDMTSRNSCTQLWLVTHYHSFGSLYDHL--NRTTLNHHQMMKICLSIVNGLVHLHTEIFG 255
+ + WLV Y GS D L ++ L ++ I + GL +LH+
Sbjct: 93 CYLREHTA----WLVMEY-CLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH--- 144
Query: 256 TQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPE 315
+ HRDIK+ NIL+ G +ADFG S + P N VGT +M+PE
Sbjct: 145 -----NMIHRDIKAGNILLTEPGQVKLADFG--------SASIASPANSFVGTPYWMAPE 191
Query: 316 ILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYH 362
++ + MD + K D+++LG+ E+ R A YH
Sbjct: 192 VI---LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH 235
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 1e-12
Identities = 64/227 (28%), Positives = 99/227 (43%), Gaps = 32/227 (14%)
Query: 144 IGKGRYGEVW--RGVWHGENVAVKIFFSRDEASWSRETEIYSTVL----LRHENILGYIG 197
IG G +G V+ R V + E VA+K + S + +I V LRH N + Y G
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 198 SDMTSRNSCTQLWLVTHYHSFGSLYDHL--NRTTLNHHQMMKICLSIVNGLVHLHTEIFG 255
+ + WLV Y GS D L ++ L ++ + + GL +LH+
Sbjct: 83 CYLREHTA----WLVMEY-CLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH--- 134
Query: 256 TQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPE 315
+ HRD+K+ NIL+ G + DFG A + P N VGT +M+PE
Sbjct: 135 -----NMIHRDVKAGNILLSEPGLVKLGDFGSASIMA--------PANXFVGTPYWMAPE 181
Query: 316 ILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYH 362
++ + MD + K D+++LG+ E+ R A YH
Sbjct: 182 VI---LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH 225
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 1e-12
Identities = 68/235 (28%), Positives = 103/235 (43%), Gaps = 50/235 (21%)
Query: 144 IGKGRYGEVW--RGVWHGENVAVK---IFFSRDEASWSRETEIYSTVLLRHENILGYIGS 198
+GKG YG V+ R + +A+K SR E ++S L+H NI+ Y+GS
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSY--LKHRNIVQYLGS 73
Query: 199 DMTSRNSCTQLWLVTHYHSFGSLYDHLNRT----TLNHHQMMKICLSIVNGLVHLHTEIF 254
D S N ++++ GSL L N ++ I+ GL +LH
Sbjct: 74 D--SENGFFKIFM--EQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN-- 127
Query: 255 GTQGKPAIAHRDIKSKNILVKT-NGTCVIADFGLAVSYSQLSNKMDIPPNPRV----GTK 309
I HRDIK N+LV T +G I+DFG + + + NP GT
Sbjct: 128 ------QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI--------NPCTETFTGTL 173
Query: 310 RYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDL 364
+YM+PE++D+ ADI++LG + E+ A G K P+ +L
Sbjct: 174 QYMAPEVIDKGPR----GYGAPADIWSLGCTIVEM-----ATG-----KPPFIEL 214
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 2e-12
Identities = 57/212 (26%), Positives = 98/212 (46%), Gaps = 25/212 (11%)
Query: 136 KQISLSECIGKGRYGEVWRG--VWHGENVAVK-IFFSRDEASWSRETEIYSTVLLRHENI 192
K+ + E IG+G G V+ V G+ VA+K I + EI L++ NI
Sbjct: 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNI 78
Query: 193 LGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTE 252
+ ++ S + +L++V Y + GSL D + T ++ Q+ +C + L LH
Sbjct: 79 VNFLDSFLVG----DELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHAN 134
Query: 253 IFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYM 312
+ HRDIKS N+L+ +G+ + DFG + +K + VGT +M
Sbjct: 135 --------QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKR----STMVGTPYWM 182
Query: 313 SPEILDESINMDCFESFKKADIYALGLVLWEV 344
+PE++ K DI++LG++ E+
Sbjct: 183 APEVVTRK------AYGPKVDIWSLGIMAIEM 208
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 2e-12
Identities = 74/296 (25%), Positives = 122/296 (41%), Gaps = 61/296 (20%)
Query: 135 AKQISLSECIGKGRYGEVWRGVWH-----GENVAVKIFF--SRDEASWSRETEIYSTVLL 187
+++ + IG G +GEV RG +VA+K S D+ TE
Sbjct: 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQF 62
Query: 188 RHENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHL--NRTTLNHHQMMKICLSIVNG 245
H NI+ G SR + ++T Y GSL L N Q++ + I +G
Sbjct: 63 DHPNIIRLEGVVTKSR----PVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASG 118
Query: 246 LVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPR 305
+ +L + HRD+ ++NILV +N C ++DFGL+ +
Sbjct: 119 MKYLSEMNY--------VHRDLAARNILVNSNLVCKVSDFGLS--------RRLEDSEAT 162
Query: 306 VGTK------RYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKA 359
TK R+ +P E+I F S +D+++ G+V+WEV + E
Sbjct: 163 YTTKGGKIPIRWTAP----EAIAYRKFTS--ASDVWSFGIVMWEVMS-------YGE--R 207
Query: 360 PYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVR 415
PY D+ S D+ K + + P P +A+ ++M +CW ++ N R
Sbjct: 208 PYWDM-----SNQDVIKAVEDGYRLP--PPM----DCPSALYQLMLDCWQKDRNER 252
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 2e-12
Identities = 61/222 (27%), Positives = 97/222 (43%), Gaps = 42/222 (18%)
Query: 142 ECIGKGRYGEVWRG--VWHGENVAVK-------IFFSRDEASWSR----ETEIYSTVLLR 188
E IGKG YG V+ V GE +AVK I D +EI + L
Sbjct: 7 ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66
Query: 189 HENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLS-IVNGLV 247
H NI+ Y+G + + L + Y GS+ L Q+++ ++ GL
Sbjct: 67 HLNIVQYLGFE----TTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLA 122
Query: 248 HLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVS----YSQLSNKMDIPPN 303
+LH++ I HRD+K+ N+LV +G C I+DFG++ Y N
Sbjct: 123 YLHSK--------GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQN------M 168
Query: 304 PRVGTKRYMSPEILDESINMDCFESFK-KADIYALGLVLWEV 344
G+ +M+PE++ + + K DI++LG V+ E+
Sbjct: 169 SMQGSVFWMAPEVIHSY-----SQGYSAKVDIWSLGCVVLEM 205
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 3e-12
Identities = 51/189 (26%), Positives = 77/189 (40%), Gaps = 39/189 (20%)
Query: 237 KICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSN 296
KI ++++ GL +L + I HRD+K NILV + G + DFG VS QL +
Sbjct: 103 KISIAVLRGLTYLREKH-------KIMHRDVKPSNILVNSRGEIKLCDFG--VS-GQLID 152
Query: 297 KMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVC----------- 345
M N VGT+ YMSPE L + ++DI++LGL L E+
Sbjct: 153 SM---ANSFVGTRSYMSPERLQGT------HYTVQSDIWSLGLSLVEMAIGRYPIPPPDA 203
Query: 346 -RRTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICI--------DQQRPVLPNRWVSDST 396
G P+ D + + I ++ P LP+ SD
Sbjct: 204 KELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEF 263
Query: 397 LNAMTKVMK 405
+ + K +K
Sbjct: 264 QDFVDKCLK 272
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 3e-12
Identities = 60/191 (31%), Positives = 93/191 (48%), Gaps = 32/191 (16%)
Query: 144 IGKGRYGEVW--RGVWHGENVAVK-IFFSRDEASWS----RETEIYSTVLLRHENILGYI 196
IG+G +GEV+ R + VA+K + ++ + RE +I LL+HEN++ I
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQ--LLKHENVVNLI 77
Query: 197 ---GSDMTSRNSC-TQLWLVTHY--HSFGSLYDHLN-RTTLNH-HQMMKICLSIVNGLVH 248
+ T N +LV + H L + N + TL+ ++MK+ L NGL +
Sbjct: 78 EICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLL---NGLYY 134
Query: 249 LHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPP--NPRV 306
+H I HRD+K+ NIL+ +G +ADFGLA ++S +K P RV
Sbjct: 135 IHRN--------KILHRDMKAANILITKDGILKLADFGLARAFSL--SKNSKPNRYTNRV 184
Query: 307 GTKRYMSPEIL 317
T Y PE+L
Sbjct: 185 VTLWYRPPELL 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 3e-12
Identities = 59/236 (25%), Positives = 95/236 (40%), Gaps = 54/236 (22%)
Query: 136 KQISLSECIGKGRYGEVWRGVWHGEN-------VAVKIFFS----RDEASWSRETEIYST 184
I+L +G G +GEV+ G++ G + VAVK +DE+ + E I S
Sbjct: 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSK 65
Query: 185 VLLRHENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHL--NRTTLNH------HQMM 236
H+NI+ IG +++ + G L L NR ++
Sbjct: 66 --FNHQNIVRLIGVSFER----LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLL 119
Query: 237 KICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNG---TCVIADFGLA----- 288
+ G +L F HRDI ++N L+ G IADFG+A
Sbjct: 120 FCARDVAKGCKYLEENHF--------IHRDIAARNCLLTCKGPGRVAKIADFGMARDIYR 171
Query: 289 VSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEV 344
SY + + +P ++M PE + I F S K D+++ G++LWE+
Sbjct: 172 ASYYRKGGRAMLP-------IKWMPPEAFLDGI----FTS--KTDVWSFGVLLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 3e-12
Identities = 46/151 (30%), Positives = 76/151 (50%), Gaps = 21/151 (13%)
Query: 144 IGKGRYGEVWRGVWHGEN-VAVKIFF--SRDEASWSRETEIYSTVLLRHENILGYIGSDM 200
+G+G +GEVW G W+G VA+K + ++ +E ++ LRHE ++ +
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKK--LRHEKLV-----QL 66
Query: 201 TSRNSCTQLWLVTHYHSFGSLYDHLN---RTTLNHHQMMKICLSIVNGLVHLHTEIFGTQ 257
+ S +++VT Y S GSL D L L Q++ + I +G+ ++
Sbjct: 67 YAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE------- 119
Query: 258 GKPAIAHRDIKSKNILVKTNGTCVIADFGLA 288
+ HRD+++ NILV N C +ADFGLA
Sbjct: 120 -RMNYVHRDLRAANILVGENLVCKVADFGLA 149
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 3e-12
Identities = 59/240 (24%), Positives = 106/240 (44%), Gaps = 53/240 (22%)
Query: 137 QISLSECIGKGRYGEVWRGVWHGEN-VAVKI----FFSRDEASWSRETEIYSTVLLRHEN 191
+++L + IG G++G VW G W + VA+K S ++ + E ++ + L H
Sbjct: 5 ELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEED--FIEEAQV--MMKLSHPK 60
Query: 192 ILGYIGSDMTSRNSCTQ---LWLVTHYHSFGSLYDHL--NRTTLNHHQMMKICLSIVNGL 246
++ G CT+ + LV + G L D+L R + ++ +CL + G+
Sbjct: 61 LVQLYGV-------CTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGM 113
Query: 247 VHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRV 306
+L + HRD+ ++N LV N ++DFG+ +D
Sbjct: 114 AYLESSNV--------IHRDLAARNCLVGENQVVKVSDFGMTRFV------LDDQYTSST 159
Query: 307 GTK---RYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHD 363
GTK ++ SPE+ S + K+D+++ G+++WEV F E K PY +
Sbjct: 160 GTKFPVKWSSPEVFSFS------KYSSKSDVWSFGVLMWEV---------FSEGKTPYEN 204
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 3e-12
Identities = 65/285 (22%), Positives = 112/285 (39%), Gaps = 57/285 (20%)
Query: 144 IGKGRYGEVWRG--VWHGENVAVKIFFSRDEASWSRE---TEIYSTVLLRHENILGYIGS 198
+GKG YG V++ + + A+K + RE EI + H NI+ Y +
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEA 67
Query: 199 DMTSRNSCTQLWLVTHYHSFGSLYDHLN-----RTTLNHHQMMKICLSIVNGLVHLHTEI 253
+ C V Y FG L ++ R + ++ +I + ++ GL LH +
Sbjct: 68 FLDGNKLCI----VMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ- 122
Query: 254 FGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMS 313
I HRD+KS NIL+ N I D G++ L M ++GT YM+
Sbjct: 123 -------KILHRDLKSANILLVANDLVKIGDLGIS---KVLKKNM---AKTQIGTPHYMA 169
Query: 314 PEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDP-SFD 372
PE+ S+ K+DI++LG +L+E+ P + S
Sbjct: 170 PEVWK-----GRPYSY-KSDIWSLGCLLYEMATFA----------------PPFEARSMQ 207
Query: 373 DMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLS 417
D+R + + P +P + D + ++ +R +
Sbjct: 208 DLRYKVQ-RGKYPPIPPIYSQD-----LQNFIRSMLQVKPKLRPN 246
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.0 bits (162), Expect = 5e-12
Identities = 58/219 (26%), Positives = 93/219 (42%), Gaps = 39/219 (17%)
Query: 142 ECIGKGRYGEVWRG--VWHGENVAVK-IFFSRDEASWSRET--EIYSTVL--LRHENILG 194
E +G+G YG V++ GE VA+K I +E EI ++L L+H NI+
Sbjct: 5 EKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREI--SLLKELKHPNIVK 62
Query: 195 YIGSDMTSRNSCTQLWLVTHY--HSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTE 252
+ + + L+LV Y D L+ + + I ++ GL + H+
Sbjct: 63 LL-DVIHTERK---LYLVFEYCDMDLKKYLDK-RPGPLSPNLIKSIMYQLLRGLAYCHS- 116
Query: 253 IFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPN---PRVGTK 309
I HRD+K +NIL+ +G +ADFGLA ++ IP V T
Sbjct: 117 ----HR---ILHRDLKPQNILINRDGVLKLADFGLARAFG-------IPLRTYTHEVVTL 162
Query: 310 RYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRT 348
Y +PEIL + DI+++G + E+
Sbjct: 163 WYRAPEIL-----LGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 5e-12
Identities = 78/309 (25%), Positives = 126/309 (40%), Gaps = 83/309 (26%)
Query: 144 IGKGRYGEVWRGVWH------GENVAVKIFFSRDEAS---WSRETEIYSTVLLRHENILG 194
+GKG +G V + GE VAVK + RE EI + L+H+NI+
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKS--LQHDNIVK 69
Query: 195 YIGS--DMTSRNSCTQLWLVTHYHSFGSLYDHL--NRTTLNHHQMMKICLSIVNGLVHLH 250
Y G RN L LV Y +GSL D+L +R L+H +++ I G+ +L
Sbjct: 70 YKGVCYSAGRRN----LRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG 125
Query: 251 TEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKR 310
++ + HRD+ ++NILV++ I DFGL K+ +P + R
Sbjct: 126 SKRY--------VHRDLATRNILVESENRVKIGDFGLT--------KV-LPQDKEYYKVR 168
Query: 311 --------YMSPEILDESINMDCFESFKKA-DIYALGLVLWEV---CRRTKANGIFEEYK 358
+ +PE L ES F A D+++ G+VL+E+ ++ +
Sbjct: 169 EPGESPIFWYAPESLTESK-------FSVASDVWSFGVVLYELFTYSDKSCS-------- 213
Query: 359 APYHDLVPMDPSFDDMRKVICIDQQRPV-------LPNRW---VSDSTLNAMTKVMKECW 408
P + MR + Q + + L N + +MKECW
Sbjct: 214 ----------PPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECW 263
Query: 409 HQNANVRLS 417
+ + + R S
Sbjct: 264 NNDPSQRPS 272
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 5e-12
Identities = 63/213 (29%), Positives = 101/213 (47%), Gaps = 33/213 (15%)
Query: 144 IGKGRYGEVW--RGVWHGENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIGSDMT 201
IGKG +G+V+ R A+K+ S+ E + E+ T+ R NIL D +
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVL-SKKEIV--AKKEVAHTIGER--NILVRTLLDES 55
Query: 202 --------SRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLS-IVNGLVHLHTE 252
S + + L+LVT Y S G L+ HL + K ++ +V L HLH
Sbjct: 56 PFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLH-- 113
Query: 253 IFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYM 312
K I +RD+K +NIL+ G + DFGL S + L++ + N GT Y+
Sbjct: 114 ------KYDIVYRDLKPENILLDATGHIALCDFGL--SKANLTD--NKTTNTFCGTTEYL 163
Query: 313 SPEILDESINMDCFESFKKADIYALGLVLWEVC 345
+PE+L + K D ++LG++++E+C
Sbjct: 164 APEVLLDEKGYT-----KHVDFWSLGVLVFEMC 191
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (162), Expect = 7e-12
Identities = 62/235 (26%), Positives = 89/235 (37%), Gaps = 68/235 (28%)
Query: 144 IGKGRYGEVWRGV--WHGENVAVK----IFFSRDEASWS-RETEIYSTVLLRHENILGYI 196
IG G YG V V G VA+K +F +A RE ++ LRHENI+G
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLR--HLRHENIIG-- 63
Query: 197 GSDMTSRNSCTQLWLVTHYHSFGSLY--------DHLNR-------TTLNHHQ--MMKIC 239
+ F +Y D L++ T +H Q + +I
Sbjct: 64 ---------LLDILRPPSPEDFNDVYIVTELMETD-LHKVIKSPQPLTDDHIQYFLYQIL 113
Query: 240 LSIVNGLVHLHTEIFGTQGKPA-IAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKM 298
GL +LH+ A + HRD+K NILV +N I DFGLA
Sbjct: 114 R----GLKYLHS---------ANVIHRDLKPSNILVNSNCDLKICDFGLARGV------D 154
Query: 299 DIPPNPR-----VGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRT 348
V T+ Y +PE+L + K DI+++G + E+ R
Sbjct: 155 PDEDEKGFLTEYVVTRWYRAPELL-----LSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 65.3 bits (160), Expect = 7e-12
Identities = 68/295 (23%), Positives = 116/295 (39%), Gaps = 67/295 (22%)
Query: 144 IGKGRYGEVW--RGVWHGENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIGSDMT 201
I KG YG V+ + G+ A+K+ + + + + +L +IL S
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVI-KKADMIRKNQVD----QVLTERDILSQAQSPYV 55
Query: 202 SRNSCT-----QLWLVTHYHSFGSLYDHLNRTTLNHH------QMMKICLS-IVNGLVHL 249
+ + L+LV Y G L +L + + +I ++ IV L +L
Sbjct: 56 VKLYYSFQGKKNLYLVMEYLPGGDLA------SLLENVGSLDEDVARIYIAEIVLALEYL 109
Query: 250 HTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPR---- 305
H I HRD+K NIL+ +NG + DFGL S L + +
Sbjct: 110 H--------SNGIIHRDLKPDNILIDSNGHLKLTDFGL--SKVGLVRRQINLNDDEKEDK 159
Query: 306 --VGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHD 363
VGT Y++PE++ + K D ++LG +L+E GI P+H
Sbjct: 160 RIVGTPDYIAPEVI---LGQG---HSKTVDWWSLGCILYEFL-----VGI-----PPFHG 203
Query: 364 LVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSA 418
P + F ++ + P VSD ++ ++K++ + RL A
Sbjct: 204 ETPEE-IFQ---NILNGKIEWPEDVE--VSDEAIDLISKLL----VPDPEKRLGA 248
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 7e-12
Identities = 77/275 (28%), Positives = 119/275 (43%), Gaps = 58/275 (21%)
Query: 140 LSECIGKGRYGEVWR--GVWHGENVAVKIFFSRDEASWSRETEIYSTV--LLRHENILGY 195
+ E IGKG YG+V++ +G AVKI + E E Y+ + L H N++ +
Sbjct: 22 IIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAE-YNILKALSDHPNVVKF 80
Query: 196 IG----SDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMK------ICLSIVNG 245
G D+ + + QLWLV + GS+ D L + L + M+ I + G
Sbjct: 81 YGMYYKKDVKNGD---QLWLVLELCNGGSVTD-LVKGFLKRGERMEEPIIAYILHEALMG 136
Query: 246 LVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPR 305
L HLH HRD+K NIL+ T G + DFG++ +QL++ + N
Sbjct: 137 LQHLHVN--------KTIHRDVKGNNILLTTEGGVKLVDFGVS---AQLTSTR-LRRNTS 184
Query: 306 VGTKRYMSPEI------LDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKA 359
VGT +M+PE+ LD + + C D+++LG+ E+ +G
Sbjct: 185 VGTPFWMAPEVIACEQQLDSTYDARC-------DVWSLGITAIEL-----GDG-----DP 227
Query: 360 PYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSD 394
P DL PM F R Q P W ++
Sbjct: 228 PLADLHPMRALFKIPRNPPPTLHQ----PELWSNE 258
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 9e-12
Identities = 39/145 (26%), Positives = 58/145 (40%), Gaps = 27/145 (18%)
Query: 214 HYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNIL 273
YH +Y+ + + I+ GL HLH I +RD+K +N+L
Sbjct: 81 KYH----IYNV-GEPGFPEARAIFYAAQIICGLEHLHQR--------RIVYRDLKPENVL 127
Query: 274 VKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKAD 333
+ +G I+D GLAV R GT YM+PE+L + F D
Sbjct: 128 LDDHGNVRISDLGLAVELKGGK-----KIKGRAGTPGYMAPEVLQGEV-----YDF-SVD 176
Query: 334 IYALGLVLWEVCRRTKANGIFEEYK 358
+ALG L+E+ F + K
Sbjct: 177 WFALGCTLYEMIA---GRSPFRQRK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 1e-11
Identities = 60/219 (27%), Positives = 99/219 (45%), Gaps = 38/219 (17%)
Query: 136 KQISLSECIGKGRYGEVWRGVWHGEN-VAVKIFF--SRDEASWSRETEIYSTVLLRHENI 192
+ + L + +G G++GEVW G W+G VAVK + S+ E +I LRH+ +
Sbjct: 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKK--LRHDKL 63
Query: 193 LGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHL---NRTTLNHHQMMKICLSIVNGLVHL 249
+ + + S +++VT Y S GSL D L L ++ + + G+ ++
Sbjct: 64 V-----QLYAVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYI 118
Query: 250 HTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTK 309
+ HRD++S NILV C IADFGLA D R G K
Sbjct: 119 E--------RMNYIHRDLRSANILVGDGLVCKIADFGLARLIE------DNEYTARQGAK 164
Query: 310 ---RYMSPEILDESINMDCFESFK-KADIYALGLVLWEV 344
++ +PE + F K+D+++ G++L E+
Sbjct: 165 FPIKWTAPE-------AALYGRFTIKSDVWSFGILLTEL 196
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 1e-11
Identities = 77/303 (25%), Positives = 131/303 (43%), Gaps = 68/303 (22%)
Query: 142 ECIGKGRYGEVWRG-VWHGENVAVK--IFFSRDEASWSRE-----TEIYSTVLLRHENIL 193
E +GKG YG V+ G G+ +AVK + + + +E E+ L+H NI+
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 194 GYIGSDMTSRNSCTQLWLVTHYHSF---GSLYDHLNR-TTLNHHQMMKICLSIVNGLVHL 249
Y+G+ C ++ + F GS+ LNR L K I++G+ +L
Sbjct: 66 QYLGT-------CLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYL 118
Query: 250 HTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA---------VSYSQLSNKMDI 300
H + HRDIK N+++ NG + DFG A ++S + M
Sbjct: 119 HNN--------CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMH- 169
Query: 301 PPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAP 360
GT +M+PE+++ES +K+DI+++G ++E+ A G K P
Sbjct: 170 ------GTPYWMAPEVINES------GYGRKSDIWSIGCTVFEM-----ATG-----KPP 207
Query: 361 YHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALR 420
L MD + + I R ++P + DS A + C ++ + R SAL+
Sbjct: 208 ---LASMDR----LAAMFYIGAHRGLMPR--LPDSFSAAAIDFVTSCLTRDQHERPSALQ 258
Query: 421 VKK 423
+ +
Sbjct: 259 LLR 261
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 1e-11
Identities = 41/138 (29%), Positives = 73/138 (52%), Gaps = 23/138 (16%)
Query: 237 KICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSN 296
KI +SIV L +LH+++ ++ HRD+K N+L+ NG + DFG++ L +
Sbjct: 107 KIAVSIVKALEYLHSKL-------SVIHRDVKPSNVLINRNGQVKLCDFGIS---GYLVD 156
Query: 297 KMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIF-- 354
+ G K YM+PE ++ +N ++ K+D+++LG+ + E+ A G F
Sbjct: 157 SV--AKTIDAGCKPYMAPERINPELNQKGYDV--KSDVWSLGITMIEL-----ATGRFPY 207
Query: 355 EEYKAPYHDL--VPMDPS 370
+ +K P+ L V +PS
Sbjct: 208 DSWKTPFQQLKQVVEEPS 225
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 2e-11
Identities = 54/237 (22%), Positives = 102/237 (43%), Gaps = 35/237 (14%)
Query: 140 LSECIGKGRYGEVWRGVWHGENVAVKIFF--SRDEASWSR-ETEIYSTVLLRHENILGYI 196
+ +C + + VAVK S + + EI ++ L+H NIL Y+
Sbjct: 6 IGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYV 65
Query: 197 GSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICL---SIVNGLVHLHTEI 253
TS ++L++V+ ++GS D L + I ++N L ++H++
Sbjct: 66 ----TSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG 121
Query: 254 FGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSY---SQLSNKMDIPPNPRVGTKR 310
F HR +K+ +IL+ +G V++ +VS + + P V
Sbjct: 122 F--------IHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLP 173
Query: 311 YMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPM 367
++SPE+L + N+ + +K+DIY++G+ E+ ANG P+ D+
Sbjct: 174 WLSPEVLQQ--NLQGYN--EKSDIYSVGITACEL-----ANGH-----VPFKDMPAT 216
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 2e-11
Identities = 52/176 (29%), Positives = 78/176 (44%), Gaps = 35/176 (19%)
Query: 177 RETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVTHYHSFGSL---YDHL----NRTT 229
RE EI + + I+ Y G+ + S + + + Y GSL Y + R
Sbjct: 48 RELEINKSC--KSPYIVKYYGAFLD--ESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRI- 102
Query: 230 LNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAV 289
+ KI S++ GL +LH+ I HRDIK NIL+ G + DFG V
Sbjct: 103 -GEKVLGKIAESVLKGLSYLHSR--------KIIHRDIKPSNILLTRKGQVKLCDFG--V 151
Query: 290 SYSQLSNKMDIPPNPRVGTKRYMSPE-ILDESINMDCFESFKKADIYALGLVLWEV 344
S +L N + GT YM+PE I + ++ +D+++LGL L EV
Sbjct: 152 S-GELVNSLA---GTFTGTSFYMAPERIQGKPYSI-------TSDVWSLGLTLLEV 196
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 2e-11
Identities = 58/220 (26%), Positives = 100/220 (45%), Gaps = 49/220 (22%)
Query: 144 IGKGRYGEVWRGVWHGENVAVKIFFS----RDEASWSRETEIYSTVL----LRHENILGY 195
+G G +G V +G+W E ++KI + +D + EI +L L H I+
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 196 IGSDMTSRNSC--TQLWLVTHYHSFGSLYDHL--NRTTLNHHQMMKICLSIVNGLVHLHT 251
+G C L LVT GSL DH+ +R +L+ +++ C+ I G+ +L
Sbjct: 75 LGI-------CPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEE 127
Query: 252 EIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMD-IPPNPRVGTKR 310
+ HR++ ++NIL+K++ IADFG+A D + P+ K+
Sbjct: 128 H--------RMVHRNLAARNILLKSDSIVQIADFGVA----------DLLYPD----DKK 165
Query: 311 YMSPEILDESINMDCFES--FKK----ADIYALGLVLWEV 344
Y E I ES F + +D+++ G+ +WE+
Sbjct: 166 YFYSEH-KTPIKWMALESILFGRYTHQSDVWSYGVTVWEM 204
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.3 bits (155), Expect = 3e-11
Identities = 41/144 (28%), Positives = 64/144 (44%), Gaps = 35/144 (24%)
Query: 209 LWLVTHYHSFGSLYDHLNRTTLNHHQM----MKICLS-IVNGLVHLHTEIFGTQGKPAIA 263
L+LV Y G L+ HL++ + + + IV L +LH+ G I
Sbjct: 68 LYLVLEYAPGGELFSHLSK----EGRFSEERARFYAAEIVLALEYLHS-----LG---II 115
Query: 264 HRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPR----VGTKRYMSPEILDE 319
+RD+K +NIL+ +G + DFGLA K R GT Y++PE+L
Sbjct: 116 YRDLKPENILLDADGHIKLTDFGLA--------KELSSEGSRTNTFCGTPEYLAPEVLLG 167
Query: 320 SINMDCFESFKKADIYALGLVLWE 343
K D ++LG++L+E
Sbjct: 168 K------GYGKAVDWWSLGVLLYE 185
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 3e-11
Identities = 65/220 (29%), Positives = 100/220 (45%), Gaps = 38/220 (17%)
Query: 142 ECIGKGRYGEVWR--GVWHGENVAVKIFFSRDEASWSRETEIYSTV--LLRHENILGYIG 197
E IGKG YG+V++ G AVKI + E E Y+ + L H N++ + G
Sbjct: 28 ETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAE-YNILQSLPNHPNVVKFYG 86
Query: 198 SDMTSRN-SCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMK------ICLSIVNGLVHLH 250
+ QLWLV + GS+ + L + L Q + I + GL HLH
Sbjct: 87 MFYKADKLVGGQLWLVLELCNGGSVTE-LVKGLLICGQRLDEAMISYILYGALLGLQHLH 145
Query: 251 TEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKR 310
I HRD+K NIL+ T G + DFG++ +QL++ + N VGT
Sbjct: 146 NN--------RIIHRDVKGNNILLTTEGGVKLVDFGVS---AQLTSTR-LRRNTSVGTPF 193
Query: 311 YMSPEIL------DESINMDCFESFKKADIYALGLVLWEV 344
+M+PE++ D S + C D+++LG+ E+
Sbjct: 194 WMAPEVIACEQQYDYSYDARC-------DVWSLGITAIEL 226
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 5e-11
Identities = 56/241 (23%), Positives = 104/241 (43%), Gaps = 63/241 (26%)
Query: 136 KQISLSECIGKGRYGEVWRGVWHGE----NVAVKIF----FSRDEASWSRETEIYSTVLL 187
+ I + IG+G +G+V R + + N A+K+ D ++ E E+ L
Sbjct: 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCK-LG 60
Query: 188 RHENILGYIGSDMTSRNSCTQ---LWLVTHYHSFGSLYDHLNRT---------------- 228
H NI+ +G+ C L++ Y +G+L D L ++
Sbjct: 61 HHPNIINLLGA-------CENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTA 113
Query: 229 -TLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGL 287
TL Q+++ + G+ +L + F HRD+ ++N+LV N IADFGL
Sbjct: 114 STLTSQQLLQFASDVATGMQYLSEKQF--------IHRDLAARNVLVGENLASKIADFGL 165
Query: 288 A----VSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWE 343
+ V + ++ + R+M+ E L+ S+ K+D+++ G++LWE
Sbjct: 166 SRGEEVYVKKTMGRLPV---------RWMAIESLNYSVYT------TKSDVWSFGVLLWE 210
Query: 344 V 344
+
Sbjct: 211 I 211
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 5e-11
Identities = 76/291 (26%), Positives = 128/291 (43%), Gaps = 66/291 (22%)
Query: 138 ISLSECIGKGRYGEVWRGVWHG-------ENVAVKIFFSRDEASWSR----ETEIYSTVL 186
+S + +G G +G+V +G VAVK+ +S E +I S L
Sbjct: 37 LSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH-L 95
Query: 187 LRHENILGYIGSDMTSRNSCTQ---LWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIV 243
HENI+ +G+ CT + ++T Y +G L + L R + +
Sbjct: 96 GNHENIVNLLGA-------CTIGGPILVITEYCCYGDLLNFLRR---KRESFLTL----- 140
Query: 244 NGLVHLHTEIFGTQGKPAIA-----HRDIKSKNILVKTNGTCV-IADFGLAVSYSQLSNK 297
L+ ++ +G +A HRD+ ++N+L+ T+G V I DFGLA SN
Sbjct: 141 EDLLSFSYQV--AKGMAFLASKNCIHRDLAARNVLL-THGKIVKICDFGLARDIMNDSNY 197
Query: 298 MDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEY 357
+ + N R+ K +M+P ESI +C +F ++D+++ G++LWE IF
Sbjct: 198 V-VKGNARLPVK-WMAP----ESI-FNCVYTF-ESDVWSYGILLWE---------IFSLG 240
Query: 358 KAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECW 408
PY + P+D F + K + R P ++ + +MK CW
Sbjct: 241 SNPYPGM-PVDSKFYKLIK----EGYRMAQPEHAPAE-----IYDIMKTCW 281
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 1e-10
Identities = 44/151 (29%), Positives = 75/151 (49%), Gaps = 21/151 (13%)
Query: 144 IGKGRYGEVWRGVWHGEN-VAVKIFF--SRDEASWSRETEIYSTVLLRHENILGYIGSDM 200
+G+G +GEVW G W+G VA+K + ++ +E +I LRH+ ++ +
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKK--LRHDKLV-----PL 66
Query: 201 TSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNH---HQMMKICLSIVNGLVHLHTEIFGTQ 257
+ S +++VT + GSL D L + Q++ + I +G+ ++
Sbjct: 67 YAVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE------- 119
Query: 258 GKPAIAHRDIKSKNILVKTNGTCVIADFGLA 288
+ HRD+++ NILV N C IADFGLA
Sbjct: 120 -RMNYIHRDLRAANILVGDNLVCKIADFGLA 149
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 1e-10
Identities = 69/299 (23%), Positives = 121/299 (40%), Gaps = 70/299 (23%)
Query: 144 IGKGRYGEVWRGVWHGE-NVAVKIFFSRDEASWSRETEIYSTVL---LRHENILGYIGSD 199
+G G++G V G W + VA+K +E + S E I + L H ++ G
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAI---NEGAMSEEDFIEEAKVMMKLSHPKLVQLYGV- 67
Query: 200 MTSRNSCTQ---LWLVTHYHSFGSLYDHL--NRTTLNHHQMMKICLSIVNGLVHLHTEIF 254
CTQ L++VT + G L ++L + L+ ++ +C + G+ +L F
Sbjct: 68 ------CTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSF 121
Query: 255 GTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTK---RY 311
HRD+ ++N LV + G ++DFG+ +D G K ++
Sbjct: 122 --------IHRDLAARNCLVSSTGVVKVSDFGMT------RYVLDDEYTSSSGAKFPVKW 167
Query: 312 MSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSF 371
PE+ N + S K+D+++ G+++WEV F E K P+
Sbjct: 168 SPPEVF----NFSKYSS--KSDVWSFGVLMWEV---------FTEGKMPFE-------KK 205
Query: 372 DDMRKVICIDQ----QRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLI 426
+ V I + RP L + V +VM CWH+ R + + + +
Sbjct: 206 SNYEVVEMISRGFRLYRPKLASMTV--------YEVMYSCWHEKPEGRPTFAELLRAIT 256
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 1e-10
Identities = 50/168 (29%), Positives = 80/168 (47%), Gaps = 31/168 (18%)
Query: 222 YDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCV 281
Y+ L + + KI ++ V L +L E+ I HRD+K NIL+ NG
Sbjct: 97 YEVLKSV-IPEEILGKIAVATVKALNYLKEEL-------KIIHRDVKPSNILLDRNGNIK 148
Query: 282 IADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVL 341
+ DFG++ QL + I G + YM+PE +D S D ++ ++D+++LG+ L
Sbjct: 149 LCDFGIS---GQLVDS--IAKTRDAGCRPYMAPERIDPS-ARDGYDV--RSDVWSLGITL 200
Query: 342 WEVCRRTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPN 389
+EV A G F PY + FD + +V+ D P+L N
Sbjct: 201 YEV-----ATGKF-----PYPKW---NSVFDQLTQVVKGDP--PILSN 233
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 1e-10
Identities = 68/294 (23%), Positives = 123/294 (41%), Gaps = 53/294 (18%)
Query: 144 IGKGRYGEVW------RGVWHGENVAVKIFF--SRDEASWSRETEIYSTVLLRHENILGY 195
+G+G +G+V G GE VAVK S + EI L HENI+ Y
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 196 IGSDMTSRNSCTQLWLVTHYHSFGSLYDHL--NRTTLNHHQMMKICLSIVNGLVHLHTEI 253
G + + + + L+ + GSL ++L N+ +N Q +K + I G+ +L
Sbjct: 72 KG--ICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYL---- 125
Query: 254 FGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVS------YSQLSNKMDIPPNPRVG 307
G HRD+ ++N+LV++ I DFGL + Y + + +D P
Sbjct: 126 ----GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSP------ 175
Query: 308 TKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKAN----GIFEEYKAPYHD 363
+ +PE L +S + + +D+++ G+ L+E+ + +F + P H
Sbjct: 176 -VFWYAPECLIQS------KFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHG 228
Query: 364 LVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLS 417
+ + + +V+ ++ P PN + M K CW + R +
Sbjct: 229 QM----TVTRLVRVLEEGKRLPRPPN--CPEEVYQLMRK----CWEFQPSKRTT 272
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-10
Identities = 70/292 (23%), Positives = 119/292 (40%), Gaps = 61/292 (20%)
Query: 136 KQISLSECIGKGRYGEVWRGVWHGEN-VAVKIFFSRDEASWSRETEIYSTVLLRHENILG 194
+ I L + +G G++GEVW G ++ VAVK + + L N++
Sbjct: 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTL---------KPGTMSVQAFLEEANLMK 56
Query: 195 YIGSDMTSR-----NSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKI---CLSIVNGL 246
+ D R ++++T Y + GSL D L + K+ I G+
Sbjct: 57 TLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGM 116
Query: 247 VHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRV 306
++ + HRD+++ N+LV + C IADFGLA D R
Sbjct: 117 AYIE--------RKNYIHRDLRAANVLVSESLMCKIADFGLARVIE------DNEYTARE 162
Query: 307 GTK---RYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHD 363
G K ++ +P E+IN F K+D+++ G++L+E I K PY
Sbjct: 163 GAKFPIKWTAP----EAINFGSFTI--KSDVWSFGILLYE---------IVTYGKIPY-- 205
Query: 364 LVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVR 415
P + D M + Q+ +P ++ + + +MK CW + A R
Sbjct: 206 --PGMSNSDVMSAL----QRGYRMPR---MENCPDELYDIMKTCWKEKAEER 248
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 1e-10
Identities = 39/129 (30%), Positives = 66/129 (51%), Gaps = 20/129 (15%)
Query: 219 GSLYDHLNRTTLNHHQMMKICLS-IVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTN 277
G L+ HL++ + M+ + I+ GL H+H + +RD+K NIL+ +
Sbjct: 82 GDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRF--------VVYRDLKPANILLDEH 133
Query: 278 GTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYAL 337
G I+D GLA +S+ P+ VGT YM+PE+L + + D AD ++L
Sbjct: 134 GHVRISDLGLACDFSKKK------PHASVGTHGYMAPEVLQKGVAYD-----SSADWFSL 182
Query: 338 GLVLWEVCR 346
G +L+++ R
Sbjct: 183 GCMLFKLLR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 72/279 (25%), Positives = 116/279 (41%), Gaps = 48/279 (17%)
Query: 140 LSECIGKGRYGEVW--RGVWHGENVAVK-IFFSRDEASWSRET-----EIYSTVLLRHEN 191
L + +G+G +GEV+ G +AVK + F D S+E EI LRH+
Sbjct: 6 LGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDR 65
Query: 192 ILGYIG--SDMTSRNSCTQLWLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVH 248
I+ Y G D + +L + Y GS+ D L L + + I+ G+ +
Sbjct: 66 IVQYYGCLRDPEEK----KLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSY 121
Query: 249 LHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGT 308
LH+ + I HRDIK NIL + G + DFG A Q GT
Sbjct: 122 LHSNM--------IVHRDIKGANILRDSAGNVKLGDFG-ASKRIQTICMSGTGIKSVTGT 172
Query: 309 KRYMSPEILDESINMDCFESF-KKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPM 367
+MSPE++ E + +KAD++++ + E+ K P+ + M
Sbjct: 173 PYWMSPEVISG-------EGYGRKADVWSVACTVVEMLTE----------KPPWAEYEAM 215
Query: 368 DPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKE 406
F I +P+LP+ VSD+ + + ++ E
Sbjct: 216 AAIFK-----IATQPTKPMLPDG-VSDACRDFLKQIFVE 248
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 3e-10
Identities = 45/157 (28%), Positives = 75/157 (47%), Gaps = 27/157 (17%)
Query: 144 IGKGRYGEVWRGVW--HGEN----VAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIG 197
+G G +G V++G+W GEN VA+K+ R+ S EI L ++ +G
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVL--RENTSPKANKEI-----LDEAYVMAGVG 67
Query: 198 SDMTSR--NSC--TQLWLVTHYHSFGSLYDHL--NRTTLNHHQMMKICLSIVNGLVHLHT 251
S R C + + LVT +G L D++ N+ + ++ C+ I G+ +L
Sbjct: 68 SPYVCRLLGICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE- 126
Query: 252 EIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA 288
+ + HRD+ ++N+LVK+ I DFGLA
Sbjct: 127 -------EVRLVHRDLAARNVLVKSPNHVKITDFGLA 156
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 4e-10
Identities = 51/176 (28%), Positives = 85/176 (48%), Gaps = 33/176 (18%)
Query: 233 HQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYS 292
H + +I +++V GL +L + I HRD+K N+LV T G + DFG++ +
Sbjct: 95 HVLGRIAVAVVKGLTYLWSL--------KILHRDVKPSNMLVNTRGQVKLCDFGVS---T 143
Query: 293 QLSNKMDIPPNPRVGTKRYMSPE-ILDESINMDCFESFKKADIYALGLVLWEVCRRTKAN 351
QL N + VGT YM+PE I E + +D+++LG+ E+ A
Sbjct: 144 QLVNSI---AKTYVGTNAYMAPERISGEQYGI-------HSDVWSLGISFMEL-----AL 188
Query: 352 GIFEEYKAPYHDLVPMDPSFDDMRKVICI-DQQRPVLPNRWVSDSTLNAMTKVMKE 406
G F PY + S ++ + CI D+ PVLP S+ ++ +T+ M++
Sbjct: 189 GRF-----PYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFITQCMRK 239
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 4e-10
Identities = 59/232 (25%), Positives = 108/232 (46%), Gaps = 38/232 (16%)
Query: 144 IGKGRYGEVWRGVWH--GENVAVKIFFSRDE---ASWSRETEIYSTVLLRHENILGYIGS 198
+G G +G+V++ G A K+ ++ E + E EI +T H I+ +G+
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATC--NHPYIVKLLGA 77
Query: 199 DMTSRNSCTQLWLVTHYHSFGS---LYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFG 255
+LW++ + G+ + L+R L Q+ IC ++ L +LH+
Sbjct: 78 FYWD----GKLWIMIEFCPGGAVDAIMLELDRG-LTEPQIQVICRQMLEALQYLHSM--- 129
Query: 256 TQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPE 315
I HRD+K+ N+L+ +G +ADFG++ + + D +GT +M+PE
Sbjct: 130 -----KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRD----SFIGTPYWMAPE 180
Query: 316 ILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPM 367
++ D + KADI++LG+ L E+ + + P+H+L PM
Sbjct: 181 VVMCETMKDTPYDY-KADIWSLGITLIEMA----------QIEPPHHELNPM 221
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 4e-10
Identities = 58/210 (27%), Positives = 95/210 (45%), Gaps = 31/210 (14%)
Query: 144 IGKGRYGEV--WRGVWHGENVAVKIFFSRDEASWSR---ETEIYSTVLLRHENILGYIGS 198
+GKG YGEV R G+ +K R+ + R E E L+H NI+ Y S
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 199 DMTSRNSCTQLWLVTHYHSFGSLYDHLNRTT---LNHHQMMKICLSIVNGLVHLHTEIFG 255
L++V + G LY L L +Q+++ + I L +LH +
Sbjct: 68 ---WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK--- 121
Query: 256 TQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPE 315
I HRD+K++N+ + + D G+A L N+ D+ + +GT YMSPE
Sbjct: 122 -----HILHRDLKTQNVFLTRTNIIKVGDLGIA---RVLENQCDM-ASTLIGTPYYMSPE 172
Query: 316 IL-DESINMDCFESFKKADIYALGLVLWEV 344
+ ++ N K+D++ALG ++E+
Sbjct: 173 LFSNKPYNY-------KSDVWALGCCVYEM 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 4e-10
Identities = 66/305 (21%), Positives = 136/305 (44%), Gaps = 75/305 (24%)
Query: 137 QISLSECIGKGRYGEVWRGVWHG-------ENVAVKIFFSRDEASWSRETEIYSTVLL-- 187
+++L + +G+G +G+V G E V V + +D+A+ +++ S + +
Sbjct: 16 KLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMK 75
Query: 188 ---RHENILGYIGSDMTSRNSCTQ---LWLVTHYHSFGSLYDHL--------------NR 227
+H+NI+ +G+ CTQ L+++ Y S G+L ++L R
Sbjct: 76 MIGKHKNIINLLGA-------CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIAR 128
Query: 228 TT---LNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIAD 284
+ ++ + G+ +L ++ HRD+ ++N+LV N IAD
Sbjct: 129 VPDEQMTFKDLVSCTYQVARGMEYLASQ--------KCIHRDLAARNVLVTENNVMKIAD 180
Query: 285 FGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEV 344
FGLA + + + N R+ K +M+PE L + + ++D+++ G+++WE
Sbjct: 181 FGLARDVNNI-DYYKKTTNGRLPVK-WMAPEALFDRVYT------HQSDVWSFGVLMWE- 231
Query: 345 CRRTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVM 404
IF +PY +P++ F +++ +D +P + N + +M
Sbjct: 232 --------IFTLGGSPYPG-IPVEELFKLLKEGHRMD--KPA--------NCTNELYMMM 272
Query: 405 KECWH 409
++CWH
Sbjct: 273 RDCWH 277
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 5e-10
Identities = 54/235 (22%), Positives = 98/235 (41%), Gaps = 63/235 (26%)
Query: 142 ECIGKGRYGEVWRGVWHGE----NVAVKIF----FSRDEASWSRETEIYSTVLLRHENIL 193
+ IG+G +G+V + + + A+K D ++ E E+ L H NI+
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCK-LGHHPNII 59
Query: 194 GYIGSDMTSRNSCTQ---LWLVTHYHSFGSLYDHLNRT-----------------TLNHH 233
+G+ C L+L Y G+L D L ++ TL+
Sbjct: 60 NLLGA-------CEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 112
Query: 234 QMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA----V 289
Q++ + G+ +L + F HRD+ ++NILV N IADFGL+ V
Sbjct: 113 QLLHFAADVARGMDYLSQKQF--------IHRDLAARNILVGENYVAKIADFGLSRGQEV 164
Query: 290 SYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEV 344
+ ++ + R+M+ E L+ S+ +D+++ G++LWE+
Sbjct: 165 YVKKTMGRLPV---------RWMAIESLNYSVYT------TNSDVWSYGVLLWEI 204
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 5e-10
Identities = 48/160 (30%), Positives = 72/160 (45%), Gaps = 29/160 (18%)
Query: 204 NSCTQLWLVTHYHSFGSLYDHL---NRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKP 260
S T L LV + G L H+ L +++ I G++HLH+
Sbjct: 63 ESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSM-------- 114
Query: 261 AIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDES 320
I +RD+K +N+L+ G C ++D GLAV K R GT YM+PEIL E
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGLAVEL-----KDGKTITQRAGTNGYMAPEILKE- 168
Query: 321 INMDCFESFK-KADIYALGLVLWE-VCRRTKANGIFEEYK 358
E + D +A+G ++E V RT F+++K
Sbjct: 169 ------EPYSYPVDWFAMGCSIYEMVAGRTP----FKDHK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 9e-10
Identities = 39/129 (30%), Positives = 65/129 (50%), Gaps = 20/129 (15%)
Query: 219 GSLYDHLNRTTLNHHQMMKI-CLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTN 277
G L+ HL++ + + M+ I+ GL H+H + +RD+K NIL+ +
Sbjct: 82 GDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRF--------VVYRDLKPANILLDEH 133
Query: 278 GTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYAL 337
G I+D GLA +S+ P+ VGT YM+PE+L + D AD ++L
Sbjct: 134 GHVRISDLGLACDFSKKK------PHASVGTHGYMAPEVLQKGTAYD-----SSADWFSL 182
Query: 338 GLVLWEVCR 346
G +L+++ R
Sbjct: 183 GCMLFKLLR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.2 bits (144), Expect = 9e-10
Identities = 54/190 (28%), Positives = 80/190 (42%), Gaps = 34/190 (17%)
Query: 144 IGKGRYGEVWRG--VWHGENVAVK-IFFSRDEA----SWSRETEIYSTVLLR------HE 190
IG+G YG V++ + G VA+K + E S RE LL+ H
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIA-----LLKQLESFEHP 61
Query: 191 NILGYIGSDMTSRNS-CTQLWLV-THYHSFGSLY-DHLNRTTLNHHQMMKICLSIVNGLV 247
NI+ + R +L LV H + Y + L + + ++ G+
Sbjct: 62 NIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVD 121
Query: 248 HLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVG 307
LH+ I HRD+K +NILV ++G IADFGLA YS ++ V
Sbjct: 122 FLHSH--------RIVHRDLKPQNILVTSDGQVKIADFGLARIYS-----FEMALTSVVV 168
Query: 308 TKRYMSPEIL 317
T Y +PE+L
Sbjct: 169 TLWYRAPEVL 178
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 59.1 bits (144), Expect = 1e-09
Identities = 32/109 (29%), Positives = 52/109 (47%), Gaps = 17/109 (15%)
Query: 240 LSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMD 299
L + GL +LH I HRD+K N+L+ ++G +ADFGLA S+ + KM
Sbjct: 109 LMTLRGLEYLH--------SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKM- 159
Query: 300 IPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRT 348
+V T+ Y +PE+L D++++G + E+ R
Sbjct: 160 ---THQVVTRWYRAPELL-----FGARHYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 1e-09
Identities = 53/199 (26%), Positives = 77/199 (38%), Gaps = 55/199 (27%)
Query: 262 IAHRDIKSKNILVKTNGTCVIADFGLAVSYS-----QLSNKMDIP---------PNPRVG 307
+ HRD+K NIL+ G VI D+G A+ L +D P VG
Sbjct: 134 VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVG 193
Query: 308 TKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVC------RRTKANGI-------F 354
T YM+PE L + + DIYALG++L+++ RR K I
Sbjct: 194 TPDYMAPERLLGV------PASESTDIYALGVILYQMLTLSFPYRRKKGRKISYRDVILS 247
Query: 355 EEYKAPYHDLVPM-----------DP-----SFDDMRKVICIDQQRPVLPNRWVSDSTLN 398
APY ++ P DP S ++++ + + W +TL
Sbjct: 248 PIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDL---EPHLQGSPEWTVKATL- 303
Query: 399 AMTKVMKECWHQNANVRLS 417
MTK K CW + LS
Sbjct: 304 -MTK-KKSCWKFYEPILLS 320
|
Length = 932 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 1e-09
Identities = 46/171 (26%), Positives = 73/171 (42%), Gaps = 31/171 (18%)
Query: 209 LWLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDI 267
++LV G L HL++ + Q+ IV L +LH++ I HRDI
Sbjct: 75 MYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSK--------GIIHRDI 126
Query: 268 KSKNILVKTNGTCVIADFGLA--VSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDC 325
K NIL+ G I DF +A V+ L+ GT YM+PE+L C
Sbjct: 127 KPDNILLDEQGHVHITDFNIATKVTPDTLTTST-------SGTPGYMAPEVL-------C 172
Query: 326 FESFKKA-DIYALGLVLWEVCR-----RTKANGIFEEYKAPYHDLVPMDPS 370
+ + A D ++LG+ +E R R + I ++ +A + P+
Sbjct: 173 RQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPA 223
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 1e-09
Identities = 69/320 (21%), Positives = 122/320 (38%), Gaps = 92/320 (28%)
Query: 138 ISLSECIGKGRYGEVWRGVWHG-------ENVAVKIFFSRD----------EASWSRETE 180
I+L +G+G +G V+ G+ G VA+K EAS +E
Sbjct: 8 ITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFN 67
Query: 181 IYSTVLLRHENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHL-----------NRTT 229
+ V L LG + S T +V + G L +L
Sbjct: 68 CHHVVRL-----LGVV-----STGQPT--LVVMELMAKGDLKSYLRSRRPEAENNPGLGP 115
Query: 230 LNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA- 288
+ +++ I +G+ +L + F HRD+ ++N +V + T I DFG+
Sbjct: 116 PTLQKFIQMAAEIADGMAYLAAKKF--------VHRDLAARNCMVAEDLTVKIGDFGMTR 167
Query: 289 ----VSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEV 344
Y + K +P R+M+PE L + + F + K+D+++ G+VLWE+
Sbjct: 168 DIYETDYYRKGGKGLLP-------VRWMAPESLKDGV----FTT--KSDVWSFGVVLWEM 214
Query: 345 CRRTKANGIFEEYKAPYHDLVPMDPSFDDMRKVIC---IDQQRPVLPNRWVSDSTLNAMT 401
T A + PY L S +++ K + P++
Sbjct: 215 A--TLA-------EQPYQGL-----SNEEVLKFVIDGGHLDLPENCPDKL---------L 251
Query: 402 KVMKECWHQNANVRLSALRV 421
++M+ CW N +R + L +
Sbjct: 252 ELMRMCWQYNPKMRPTFLEI 271
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 1e-09
Identities = 57/219 (26%), Positives = 104/219 (47%), Gaps = 42/219 (19%)
Query: 138 ISLSECIGKGRYGEVWRGVWHG-ENVAVKIFFSRDEASWSRETEIYSTVL---LRHENIL 193
+ L + +G G++GEVW G ++G VA+K S + S S E + L L+H ++
Sbjct: 8 LKLVKKLGAGQFGEVWMGYYNGHTKVAIK---SLKQGSMSPEAFLAEANLMKQLQHPRLV 64
Query: 194 GYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTT---LNHHQMMKICLSIVNGLVHLH 250
+ + + ++++T Y GSL D L L ++++ + I G+ +
Sbjct: 65 -----RLYAVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE 119
Query: 251 TEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA--VSYSQLSNKMDIPPNPRVGT 308
+ + HRD+++ NILV C IADFGLA + ++ + R G
Sbjct: 120 RKNY--------IHRDLRAANILVSETLCCKIADFGLARLIEDNEYT--------AREGA 163
Query: 309 K---RYMSPEILDESINMDCFESFKKADIYALGLVLWEV 344
K ++ +P E+IN F K+D+++ G++L E+
Sbjct: 164 KFPIKWTAP----EAINYGTFTI--KSDVWSFGILLTEI 196
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 50/166 (30%), Positives = 76/166 (45%), Gaps = 33/166 (19%)
Query: 187 LRHENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDH--LNRTTLNHHQMM-----KIC 239
++H NI+ + S + L++V Y G L L R L + ++C
Sbjct: 55 MKHPNIVAF----KESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMC 110
Query: 240 LSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMD 299
L G+ H+H + + HRDIKSKNI + NG + DFG S L++
Sbjct: 111 L----GVQHIH--------EKRVLHRDIKSKNIFLTQNGKVKLGDFG---SARLLTSPGA 155
Query: 300 IPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVC 345
VGT Y+ PEI + NM K+DI++LG +L+E+C
Sbjct: 156 YACT-YVGTPYYVPPEIWE---NM---PYNNKSDIWSLGCILYELC 194
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 42/142 (29%), Positives = 69/142 (48%), Gaps = 22/142 (15%)
Query: 207 TQLWLVTHYHSFGSLYDHL-NRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHR 265
T+L L+ Y + G L+ HL R ++ IV L HLH K I +R
Sbjct: 78 TKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLH--------KLGIIYR 129
Query: 266 DIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEIL---DESIN 322
DIK +NIL+ +NG V+ DFGL+ + + + GT YM+P+I+ D +
Sbjct: 130 DIKLENILLDSNGHVVLTDFGLSKEFHEDEVER---AYSFCGTIEYMAPDIVRGGDGGHD 186
Query: 323 MDCFESFKKADIYALGLVLWEV 344
K D +++G++++E+
Sbjct: 187 -------KAVDWWSMGVLMYEL 201
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 57/212 (26%), Positives = 93/212 (43%), Gaps = 33/212 (15%)
Query: 144 IGKGRYGEVWRGVWHGEN--VAVK---IFFSRD-EASWSRETEIYSTVLLRHENILGYIG 197
IG+G++ EV+R + VA+K IF D +A EI L H N++ Y+
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69
Query: 198 SDMTSRNSCTQLWLVTHYHSFGSL-----YDHLNRTTLNHHQMMKICLSIVNGLVHLHTE 252
S + +L +V G L Y + + + K + + + + H+H+
Sbjct: 70 SFIED----NELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR 125
Query: 253 IFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYM 312
+ HRDIK N+ + G + D GL +S + + VGT YM
Sbjct: 126 --------RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA----AHSLVGTPYYM 173
Query: 313 SPEILDESINMDCFESFKKADIYALGLVLWEV 344
SPE + E N F K+DI++LG +L+E+
Sbjct: 174 SPERIHE--NGYNF----KSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 2e-09
Identities = 78/326 (23%), Positives = 132/326 (40%), Gaps = 82/326 (25%)
Query: 138 ISLSECIGKGRYGEVWRGVWHG-----ENVAVKIFFSRDEAS-----WSRETEIYSTVLL 187
I L +G+G +G+V+ + + + V + +D + + RE E+ + L
Sbjct: 7 IVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTN--L 64
Query: 188 RHENILGYIGSDMTSRNSCTQ---LWLVTHYHSFGSLYDHLNR--------------TTL 230
+HE+I+ + G C + L +V Y G L L L
Sbjct: 65 QHEHIVKFYGV-------CVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAEL 117
Query: 231 NHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGL--- 287
QM+ I I G+V+L ++ F HRD+ ++N LV N I DFG+
Sbjct: 118 TQSQMLHIAQQIAAGMVYLASQHF--------VHRDLATRNCLVGENLLVKIGDFGMSRD 169
Query: 288 --AVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVC 345
+ Y ++ +P R+M P ESI F + ++D+++LG+VLWE
Sbjct: 170 VYSTDYYRVGGHTMLP-------IRWMPP----ESIMYRKFTT--ESDVWSLGVVLWE-- 214
Query: 346 RRTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMK 405
IF K P++ L + + CI Q R + R + + +M
Sbjct: 215 -------IFTYGKQPWYQL-------SNNEVIECITQGRVLQRPR----TCPKEVYDLML 256
Query: 406 ECWHQNANVRLSALRVKKTLIKLACA 431
CW + ++RL+ + L LA A
Sbjct: 257 GCWQREPHMRLNIKEIHSLLQNLAKA 282
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 2e-09
Identities = 59/190 (31%), Positives = 83/190 (43%), Gaps = 31/190 (16%)
Query: 144 IGKGRYGEVWR-----GVWHGENVAVKIF-------FSRDEASWSRETEIYSTVLLRHEN 191
+GKG YG+V++ G G+ A+K+ +D A E I V +H
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAV--KHPF 61
Query: 192 ILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLS-IVNGLVHLH 250
I+ I + T +L+L+ Y S G L+ HL R + LS I L HLH
Sbjct: 62 IVDLIYAFQTG----GKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLH 117
Query: 251 TEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKR 310
QG I +RD+K +NIL+ G + DFGL + S + GT
Sbjct: 118 Q-----QG---IIYRDLKPENILLDAQGHVKLTDFGLC----KESIHEGTVTHTFCGTIE 165
Query: 311 YMSPEILDES 320
YM+PEIL S
Sbjct: 166 YMAPEILMRS 175
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 2e-09
Identities = 44/144 (30%), Positives = 72/144 (50%), Gaps = 16/144 (11%)
Query: 209 LWLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLS-IVNGLVHLHTEIFGTQGKPAIAHRD 266
L+LV Y G L LNR M + L+ +V + +H + HRD
Sbjct: 76 LYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGY--------VHRD 127
Query: 267 IKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCF 326
IK +N+L+ G +ADFG A + +NKM P VGT Y++PE+L ++N D
Sbjct: 128 IKPENVLIDRTGHIKLADFGSAARLT--ANKMVNSKLP-VGTPDYIAPEVL-TTMNGDGK 183
Query: 327 ESFK-KADIYALGLVLWE-VCRRT 348
++ + D ++LG++ +E + R+
Sbjct: 184 GTYGVECDWWSLGVIAYEMIYGRS 207
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 2e-09
Identities = 46/165 (27%), Positives = 74/165 (44%), Gaps = 29/165 (17%)
Query: 187 LRHENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHH-----QMMKICLS 241
LRH NI+ Y + + + +L++V L +H N ++ I +
Sbjct: 66 LRHPNIVRYYKTFLEN----DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQ 121
Query: 242 IVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIP 301
+V L +LH E I HRD+ NI++ + I DFGLA Q +K+
Sbjct: 122 MVLALRYLHKEKR-------IVHRDLTPNNIMLGEDDKVTITDFGLA-KQKQPESKL--- 170
Query: 302 PNPRVGTKRYMSPEILDESINMDCFESF-KKADIYALGLVLWEVC 345
VGT Y PEI+ E + +KAD++A G +L+++C
Sbjct: 171 -TSVVGTILYSCPEIVKN-------EPYGEKADVWAFGCILYQMC 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 3e-09
Identities = 74/304 (24%), Positives = 130/304 (42%), Gaps = 54/304 (17%)
Query: 138 ISLSECIGKGRYGEVWRG----VWHGEN-VAVKIFFSRDEASWSRETEIYSTVL--LRHE 190
+ + E IG G +GEV RG E VA+K S R+ ++++ H
Sbjct: 6 VKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHP 65
Query: 191 NILGYIGSDMTSRNSCTQLWLVTHYHSFGSL--YDHLNRTTLNHHQMMKICLSIVNGLVH 248
NI+ G SR + ++T + G+L + N Q++ + I G+ +
Sbjct: 66 NIIHLEGVVTKSR----PVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKY 121
Query: 249 LHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGT 308
L + HRD+ ++NILV +N C ++DFGL+ + + + D +G
Sbjct: 122 LSEMNY--------VHRDLAARNILVNSNLVCKVSDFGLS-RFLE-DDTSDPTYTSSLGG 171
Query: 309 K---RYMSPEILDESINMDCFESFKKA-DIYALGLVLWEVCRRTKANGIFEEYKAPYHDL 364
K R+ +PE + + F A D+++ G+V+WEV + E PY D+
Sbjct: 172 KIPIRWTAPEAI-------AYRKFTSASDVWSYGIVMWEVMS-------YGE--RPYWDM 215
Query: 365 VPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKT 424
S D+ I D + P + A+ ++M +CW ++ N R ++ T
Sbjct: 216 -----SNQDVINAIEQDYRLPPPMD------CPTALHQLMLDCWQKDRNARPKFGQIVST 264
Query: 425 LIKL 428
L K+
Sbjct: 265 LDKM 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|219878 pfam08515, TGF_beta_GS, Transforming growth factor beta type I GS-motif | Back alignment and domain information |
|---|
Score = 51.7 bits (125), Expect = 3e-09
Identities = 19/29 (65%), Positives = 25/29 (86%)
Query: 108 STLREYLDASLTSGSGSGLPLLIQRTLAK 136
TL++ L+ S TSGSGSGLPLL+QRT+A+
Sbjct: 1 KTLKDLLEDSTTSGSGSGLPLLVQRTIAR 29
|
This motif is found in the transforming growth factor beta (TGF-beta) type I which regulates cell growth and differentiation. The name of the GS motif comes from its highly conserved GSGSGLP signature in the cytoplasmic juxtamembrane region immediately preceding the protein's kinase domain. Point mutations in the GS motif modify the signaling ability of the type I receptor. Length = 29 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 4e-09
Identities = 71/306 (23%), Positives = 136/306 (44%), Gaps = 77/306 (25%)
Query: 137 QISLSECIGKGRYGEVWRGVWHGEN---------VAVKIF----FSRDEASWSRETEIYS 183
++ L + +G+G +G+V R +G + VAVK+ +D A E E+
Sbjct: 13 RLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMK 72
Query: 184 TVLLRHENILGYIGSDMTSRNSCTQ---LWLVTHYHSFGSLYDHL--------------- 225
++ +H+NI+ +G CTQ L+++ Y + G+L + L
Sbjct: 73 -LIGKHKNIINLLGV-------CTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDIT 124
Query: 226 --NRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIA 283
L+ ++ + G+ +L + + I HRD+ ++N+LV + IA
Sbjct: 125 KVPEEQLSFKDLVSCAYQVARGMEYL-------ESRRCI-HRDLAARNVLVTEDNVMKIA 176
Query: 284 DFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWE 343
DFGLA + + N R+ K +M+PE L + + ++D+++ G+++WE
Sbjct: 177 DFGLARGVHDI-DYYKKTSNGRLPVK-WMAPEALFDRVYT------HQSDVWSFGILMWE 228
Query: 344 VCRRTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKV 403
IF +PY +P++ F +R+ +D +P S+ T + + +
Sbjct: 229 ---------IFTLGGSPY-PGIPVEELFKLLREGHRMD--KP-------SNCT-HELYML 268
Query: 404 MKECWH 409
M+ECWH
Sbjct: 269 MRECWH 274
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 4e-09
Identities = 66/303 (21%), Positives = 118/303 (38%), Gaps = 79/303 (26%)
Query: 144 IGKGRYGEVWRGVWHGEN-------VAVKIFFSRDE----ASWSRETEIYSTVLLRHENI 192
+G+G +GEV+ G V VK + + + RE +++ L H+N+
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRK--LSHKNV 70
Query: 193 LGYIGSDMTSRNSCTQL---WLVTHYHSFGSLYDHLNRTT-----------LNHHQMMKI 238
+ +G C + +++ Y G L L R T L+ Q + +
Sbjct: 71 VRLLGL-------CREAEPHYMILEYTDLGDLKQFL-RATKSKDEKLKPPPLSTKQKVAL 122
Query: 239 CLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLS--- 295
C I G+ HL F HRD+ ++N LV + + VS LS
Sbjct: 123 CTQIALGMDHLSNARF--------VHRDLAARNCLVS-------SQREVKVSLLSLSKDV 167
Query: 296 -NKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIF 354
N + R+++PE + E D F + K+D+++ G+++WE +F
Sbjct: 168 YNSEYYKLRNALIPLRWLAPEAVQE----DDFST--KSDVWSFGVLMWE---------VF 212
Query: 355 EEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANV 414
+ + P++ L D + + + LP V + + + K+M CW N
Sbjct: 213 TQGELPFYGL-------SDEEVLNRLQAGKLELP---VPEGCPSRLYKLMTRCWAVNPKD 262
Query: 415 RLS 417
R S
Sbjct: 263 RPS 265
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|197743 smart00467, GS, GS motif | Back alignment and domain information |
|---|
Score = 51.4 bits (124), Expect = 4e-09
Identities = 20/31 (64%), Positives = 25/31 (80%), Gaps = 1/31 (3%)
Query: 108 STLREYLDASLTSGSGSGLPLLIQRTLAKQI 138
TL + L+ TSGSGSGLPLL+QRT+A+QI
Sbjct: 1 KTLSDLLE-DTTSGSGSGLPLLVQRTVARQI 30
|
Aa approx. 30 amino acid motif that precedes the kinase domain in types I and II TGF beta receptors. Mutation of two or more of the serines or threonines in the TTSGSGSG of TGF-beta type I receptor impairs phosphorylation and signaling activity. Length = 30 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 4e-09
Identities = 80/332 (24%), Positives = 131/332 (39%), Gaps = 87/332 (26%)
Query: 136 KQISLSECIGKGRYGEVWRGVWHGEN-------VAVKIFFSRDEAS---WSRETEIYSTV 185
+ I L +G+G +G+V+ + + VAVK A+ + RE E+ +
Sbjct: 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTN- 63
Query: 186 LLRHENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHL-----------------NRT 228
L+HE+I+ + G L +V Y G L L +
Sbjct: 64 -LQHEHIVKFYGVCGDG----DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKG 118
Query: 229 TLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGL- 287
L QM+ I I +G+V+L ++ F HRD+ ++N LV N I DFG+
Sbjct: 119 ELGLSQMLHIASQIASGMVYLASQHF--------VHRDLATRNCLVGANLLVKIGDFGMS 170
Query: 288 ----AVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWE 343
+ Y ++ +P R+M P ESI F + ++D+++ G++LWE
Sbjct: 171 RDVYSTDYYRVGGHTMLP-------IRWMPP----ESIMYRKFTT--ESDVWSFGVILWE 217
Query: 344 VCRRTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQ----QRPVLPNRWVSDSTLNA 399
IF K P+ L + + CI Q +RP + + V D
Sbjct: 218 ---------IFTYGKQPWFQLSNTE-------VIECITQGRVLERPRVCPKEVYD----- 256
Query: 400 MTKVMKECWHQNANVRLSALRVKKTLIKLACA 431
+M CW + RL+ + K L L A
Sbjct: 257 ---IMLGCWQREPQQRLNIKEIYKILHALGKA 285
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 4e-09
Identities = 77/322 (23%), Positives = 130/322 (40%), Gaps = 87/322 (27%)
Query: 130 IQRTLAKQISLSECIGKGRYGEVWRGVWHGEN-------VAVKIFFSRDEAS---WSRET 179
I+R + I L +G+G +G+V+ H VAVK E++ + RE
Sbjct: 2 IKR---RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREA 58
Query: 180 EIYSTVLLRHENILGYIGSDMTSRNSCTQ---LWLVTHYHSFGSLYDHLNRTTLNHH--- 233
E+ + +L+H++I+ + G CT+ L +V Y G L L +
Sbjct: 59 ELLT--VLQHQHIVRFYGV-------CTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILA 109
Query: 234 -------------QMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTC 280
QM+ I I +G+V+L + F HRD+ ++N LV
Sbjct: 110 GGEDVAPGQLTLGQMLAIASQIASGMVYLASLHF--------VHRDLATRNCLVGQGLVV 161
Query: 281 VIADFGL-----AVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIY 335
I DFG+ + Y ++ + +P R+M P ESI F + ++DI+
Sbjct: 162 KIGDFGMSRDIYSTDYYRVGGRTMLP-------IRWMPP----ESILYRKFTT--ESDIW 208
Query: 336 ALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDS 395
+ G+VLWE IF K P++ L + + CI Q R + R +
Sbjct: 209 SFGVVLWE---------IFTYGKQPWYQL-------SNTEAIECITQGRELERPR----T 248
Query: 396 TLNAMTKVMKECWHQNANVRLS 417
+ +M+ CW + R+
Sbjct: 249 CPPEVYAIMQGCWQREPQQRMV 270
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.6 bits (141), Expect = 4e-09
Identities = 65/251 (25%), Positives = 112/251 (44%), Gaps = 59/251 (23%)
Query: 144 IGKGRYGEVWRGVWHGENVAVKIFFSRDEASWS--RETEIYSTVL-------LRHENILG 194
IG GR+GEV+ V H + FF S+ +E E V+ L+H+NI+
Sbjct: 21 IGNGRFGEVFL-VKHKRT---QEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVR 76
Query: 195 YIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRT-----TLNHHQMMKICLSIVNGLVHL 249
YI + N +L+++ + G L ++ + + H ++ I +++ L +
Sbjct: 77 YIDRFLNKANQ--KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYC 134
Query: 250 HTEIFGTQGKPAIAHRDIKSKNILVKT---------------NGTCV--IADFGLAVSYS 292
H G G+ + HRD+K +NI + T NG + I DFGL+ +
Sbjct: 135 HNLKDGPNGE-RVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIG 193
Query: 293 QLSNKMDIPPNPRVGTKRYMSPEIL-DESINMDCFESFKKADIYALGLVLWEVCRRTKAN 351
++ + VGT Y SPE+L E+ + D K+D++ALG +++E+C
Sbjct: 194 -----IESMAHSCVGTPYYWSPELLLHETKSYD-----DKSDMWALGCIIYELCSG---- 239
Query: 352 GIFEEYKAPYH 362
K P+H
Sbjct: 240 ------KTPFH 244
|
Length = 1021 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 5e-09
Identities = 61/240 (25%), Positives = 99/240 (41%), Gaps = 66/240 (27%)
Query: 144 IGKGRYGEVWR----GVWHGEN---VAVKIFFSRDEASWSRETEIYSTVLLRHE----NI 192
IG+G +G V++ G+ E VAVK+ ++EAS + + L E NI
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKML--KEEASADMQADFQREAALMAEFDHPNI 70
Query: 193 LGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHL-----------------------NRTT 229
+ +G + C L+ Y ++G L + L N
Sbjct: 71 VKLLGVCAVGKPMC----LLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLP 126
Query: 230 LNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGL-- 287
L+ + + I + G+ +L F HRD+ ++N LV N IADFGL
Sbjct: 127 LSCTEQLCIAKQVAAGMAYLSERKF--------VHRDLATRNCLVGENMVVKIADFGLSR 178
Query: 288 ---AVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEV 344
+ Y + S IP R+M P ESI + + + ++D++A G+VLWE+
Sbjct: 179 NIYSADYYKASENDAIP-------IRWMPP----ESIFYNRYTT--ESDVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 5e-09
Identities = 71/311 (22%), Positives = 135/311 (43%), Gaps = 87/311 (27%)
Query: 137 QISLSECIGKGRYGEVWRGVWHG---------ENVAVKIFFS----RDEASWSRETEIYS 183
++ L + +G+G +G+V G VAVK+ S +D + E E+
Sbjct: 19 RLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMK 78
Query: 184 TVLLRHENILGYIGSDMTSRNSCTQ---LWLVTHYHSFGSLYDHLN-------------- 226
++ +H+NI+ +G+ CTQ L+++ Y S G+L ++L
Sbjct: 79 -MIGKHKNIINLLGA-------CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPT 130
Query: 227 ---RTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIA 283
L+ ++ + G+ +L + K I HRD+ ++N+LV + IA
Sbjct: 131 QVPEEQLSFKDLVSCAYQVARGMEYLAS-------KKCI-HRDLAARNVLVTEDNVMKIA 182
Query: 284 DFGLA-----VSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALG 338
DFGLA + Y + + +P ++M+PE L + I ++D+++ G
Sbjct: 183 DFGLARDIHHIDYYKKTTNGRLP-------VKWMAPEALFDRIYT------HQSDVWSFG 229
Query: 339 LVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLN 398
++LWE IF +PY VP++ F +++ +D +P + N
Sbjct: 230 VLLWE---------IFTLGGSPYPG-VPVEELFKLLKEGHRMD--KP--------SNCTN 269
Query: 399 AMTKVMKECWH 409
+ +M++CWH
Sbjct: 270 ELYMMMRDCWH 280
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 6e-09
Identities = 66/289 (22%), Positives = 115/289 (39%), Gaps = 60/289 (20%)
Query: 144 IGKGRYGEVWRG-VWHGENVA-VKIFFSRDEASWSRETEIYSTV----LLRHENILGYIG 197
IG G +G+V G G + A V + R A+ + V L H N+L +G
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 198 SDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMM-------KICLSIVNGLVHLH 250
+ S LV + G L ++L R+ M ++ + +GL+ LH
Sbjct: 63 QCIES----IPYLLVLEFCPLGDLKNYL-RSNRGMVAQMAQKDVLQRMACEVASGLLWLH 117
Query: 251 TEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKR 310
F H D+ +N + + + I D+GLA Q I + R
Sbjct: 118 QADF--------IHSDLALRNCQLTADLSVKIGDYGLA--LEQYPEDYYITKDCHAVPLR 167
Query: 311 YMSPEILDE-SINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDP 369
+++PE+++ ++ + KK++I++LG+ +WE +F PY DL
Sbjct: 168 WLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWE---------LFTAADQPYPDL----- 213
Query: 370 SFDDMRKVICIDQQ----RPVL----PNRWVSDSTLNAMTKVMKECWHQ 410
S + + K + +Q +P L +RW +VM+ CW
Sbjct: 214 SDEQVLKQVVREQDIKLPKPQLDLKYSDRWY---------EVMQFCWLD 253
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.5 bits (137), Expect = 7e-09
Identities = 54/200 (27%), Positives = 84/200 (42%), Gaps = 44/200 (22%)
Query: 143 CIGKGRYGEVWRGVWH----GENVAVKIFFSRDEASWSRETEIYST-----VLLR---HE 190
CIG+G YG V++ G+ A+K F + + T I + LLR HE
Sbjct: 7 CIGRGTYGRVYKAKRKNGKDGKEYAIKKF----KGDKEQYTGISQSACREIALLRELKHE 62
Query: 191 NILGYIGSDMTSRNSCTQLWLVTHY--HSFGSLYDHLNRTTLNHH---QMMK-ICLSIVN 244
N++ + + + ++L+ Y H + +R M+K + I+N
Sbjct: 63 NVVSLVEVFLEHADKS--VYLLFDYAEHDLWQIIKF-HRQAKRVSIPPSMVKSLLWQILN 119
Query: 245 GLVHLHTEIFGTQGKPAIAHRDIKSKNILV----KTNGTCVIADFGLAVSYSQLSNKMDI 300
G+ +LH+ + HRD+K NILV G I D GLA +L N
Sbjct: 120 GVHYLHSNW--------VLHRDLKPANILVMGEGPERGVVKIGDLGLA----RLFNAPLK 167
Query: 301 PP---NPRVGTKRYMSPEIL 317
P +P V T Y +PE+L
Sbjct: 168 PLADLDPVVVTIWYRAPELL 187
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 9e-09
Identities = 37/108 (34%), Positives = 57/108 (52%), Gaps = 19/108 (17%)
Query: 237 KICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSN 296
K+ ++++ GL +L K I HRD+K NILV + G + DFG++ QL +
Sbjct: 107 KVSIAVIKGLTYLRE-------KHKIMHRDVKPSNILVNSRGEIKLCDFGVS---GQLID 156
Query: 297 KMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEV 344
M N VGT+ YMSPE L + ++DI+++GL L E+
Sbjct: 157 SM---ANSFVGTRSYMSPERLQGT------HYSVQSDIWSMGLSLVEM 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 9e-09
Identities = 41/155 (26%), Positives = 72/155 (46%), Gaps = 23/155 (14%)
Query: 144 IGKGRYGEVWRGVW--HGEN----VAVKIFFSRDEASWSRET--EIYSTVLLRHENILGY 195
+G G +G V++G+W GE VA+K ++E E Y + + ++
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74
Query: 196 IGSDMTSRNSCTQLWLVTHYHSFGSLYDHL--NRTTLNHHQMMKICLSIVNGLVHLHTEI 253
+G +TS + L+T FG L D++ ++ + ++ C+ I G+ +L
Sbjct: 75 LGICLTS-----TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEER- 128
Query: 254 FGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA 288
+ HRD+ ++N+LVKT I DFGLA
Sbjct: 129 -------RLVHRDLAARNVLVKTPQHVKITDFGLA 156
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 1e-08
Identities = 72/283 (25%), Positives = 113/283 (39%), Gaps = 56/283 (19%)
Query: 140 LSECIGKGRYGEVW--RGVWHGENVAVK-IFFSRDEASWSRET-----EIYSTVLLRHEN 191
L + +G+G +G V+ G +AVK + F + S+E EI L HE
Sbjct: 6 LGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHER 65
Query: 192 ILGYIG--SDMTSRNSCTQLWLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVH 248
I+ Y G D R L + + GS+ D L L + K I+ G+ +
Sbjct: 66 IVQYYGCLRDPMERT----LSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSY 121
Query: 249 LHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQL----SNKMDIPPNP 304
LH+ + I HRDIK NIL + G + DFG + + + +
Sbjct: 122 LHSNM--------IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSV---- 169
Query: 305 RVGTKRYMSPEILDESINMDCFESF-KKADIYALGLVLWEVCRRTKANGIFEEYKAPYHD 363
GT +MSPE++ E + +KADI+++G + E+ K P+ +
Sbjct: 170 -TGTPYWMSPEVISG-------EGYGRKADIWSVGCTVVEMLTE----------KPPWAE 211
Query: 364 LVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKE 406
M F I PVLP VSD + + ++ E
Sbjct: 212 FEAMAAIFK-----IATQPTNPVLPPH-VSDHCRDFLKRIFVE 248
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 1e-08
Identities = 54/222 (24%), Positives = 92/222 (41%), Gaps = 43/222 (19%)
Query: 142 ECIGKGRYGEVW--RGVWHGENVAVK-IFFSRDEASWSRET------EIYSTVLLRHENI 192
+ +G G + + R V G +AVK + + R+ +S E EI L H +I
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 193 LGYIGSDMTSRNSCTQLWLVTHYHSF------GSLYDHL-NRTTLNHHQMMKICLSIVNG 245
+ +G+ T +S H++ F GS+ L ++ ++ G
Sbjct: 66 IRMLGA--TCEDS--------HFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRG 115
Query: 246 LVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCV-IADFGLAVSYSQLSNKMDIPPNP 304
L +LH I HRD+K N+L+ + G + IADFG A +
Sbjct: 116 LSYLHEN--------QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQ 167
Query: 305 RVGTKRYMSPEIL-DESINMDCFESFKKADIYALGLVLWEVC 345
+GT +M+PE+L E C D++++G V+ E+
Sbjct: 168 LLGTIAFMAPEVLRGEQYGRSC-------DVWSVGCVIIEMA 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 1e-08
Identities = 52/218 (23%), Positives = 92/218 (42%), Gaps = 40/218 (18%)
Query: 138 ISLSECIGKGRYGEVWRGVWHGEN-VAVKIFFSRDEASWSRETEIYSTVLLRHENILGYI 196
+ L + +G G++GEVW ++ VAVK + + L N++ +
Sbjct: 8 LKLEKKLGAGQFGEVWMATYNKHTKVAVKTM---------KPGSMSVEAFLAEANVMKTL 58
Query: 197 GSDMTSRNSCT----QLWLVTHYHSFGSLYDHLNRTTLNHHQMMKI---CLSIVNGLVHL 249
D + ++++T + + GSL D L + + K+ I G+ +
Sbjct: 59 QHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI 118
Query: 250 HTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTK 309
+ HRD+++ NILV + C IADFGLA D R G K
Sbjct: 119 EQRNY--------IHRDLRAANILVSASLVCKIADFGLARVIE------DNEYTAREGAK 164
Query: 310 ---RYMSPEILDESINMDCFESFKKADIYALGLVLWEV 344
++ +P E+IN F K+D+++ G++L E+
Sbjct: 165 FPIKWTAP----EAINFGSFTI--KSDVWSFGILLMEI 196
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 1e-08
Identities = 42/139 (30%), Positives = 67/139 (48%), Gaps = 16/139 (11%)
Query: 207 TQLWLVTHYHSFGSLYDHL-NRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHR 265
T+L L+ Y + G L+ HL R ++ IV L HLH + I +R
Sbjct: 78 TKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLH--------QLGIIYR 129
Query: 266 DIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDC 325
DIK +NIL+ + G V+ DFGL+ + L+ + + GT YM+PE+ I
Sbjct: 130 DIKLENILLDSEGHVVLTDFGLSKEF--LAEEEE-RAYSFCGTIEYMAPEV----IRGGS 182
Query: 326 FESFKKADIYALGLVLWEV 344
K D ++LG++ +E+
Sbjct: 183 GGHDKAVDWWSLGVLTFEL 201
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 2e-08
Identities = 53/200 (26%), Positives = 84/200 (42%), Gaps = 40/200 (20%)
Query: 142 ECIGKGRYGEVWRGVWH--GENVAVKIFFSRDEA-----SWSRETEIYSTVLLRHENILG 194
E IG+G YG V++ E VA+K D+ S RE + L+H+NI+
Sbjct: 6 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKE--LKHKNIVR 63
Query: 195 YIGSDMTSRNSCTQLWLVTHY--HSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTE 252
D+ + +L LV Y +D N ++ + ++ GL H+
Sbjct: 64 LY--DVLHSDK--KLTLVFEYCDQDLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCHSH 118
Query: 253 IFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPP---NPRVGTK 309
+ HRD+K +N+L+ NG +ADFGLA ++ IP + V T
Sbjct: 119 --------NVLHRDLKPQNLLINKNGELKLADFGLARAFG-------IPVRCYSAEVVTL 163
Query: 310 RYMSPEIL------DESINM 323
Y P++L SI+M
Sbjct: 164 WYRPPDVLFGAKLYSTSIDM 183
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 69/301 (22%), Positives = 128/301 (42%), Gaps = 60/301 (19%)
Query: 138 ISLSECIGKGRYGEVWRG------VWHGENVAVKIFFSRDEASWSRETEIYSTVL--LRH 189
+ E +G+ +G++++G + H + VA+K + E + ++++ L H
Sbjct: 7 VRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHH 66
Query: 190 ENILGYIGSDMTSRNSCTQLWLVTH--YHSF------------GSLYDHLNRTTLNHHQM 235
NI+ +G + C + H F S D +++L+H
Sbjct: 67 PNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDF 126
Query: 236 MKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVS-YSQL 294
+ I + I G+ +L + F H+D+ ++NIL+ I+D GL+ YS
Sbjct: 127 LHIAIQIAAGMEYLSSHFF--------VHKDLAARNILIGEQLHVKISDLGLSREIYS-- 176
Query: 295 SNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIF 354
++ + P + R+M PE +I F S +DI++ G+VLWE IF
Sbjct: 177 ADYYRVQPKSLLPI-RWMPPE----AIMYGKFSS--DSDIWSFGVVLWE---------IF 220
Query: 355 EEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANV 414
PY+ F + ++VI + ++R +LP S+ M +M ECW + +
Sbjct: 221 SFGLQPYY-------GFSN-QEVIEMVRKRQLLP---CSEDCPPRMYSLMTECWQEGPSR 269
Query: 415 R 415
R
Sbjct: 270 R 270
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 72/325 (22%), Positives = 123/325 (37%), Gaps = 90/325 (27%)
Query: 136 KQISLSECIGKGRYGEV----------------WRGVWHGENVAVKIFFSRDEAS----- 174
+ ++ E +G+G++GEV V V + R +AS
Sbjct: 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNARE 64
Query: 175 -WSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQ---LWLVTHYHSFGSLYDHL----- 225
+ +E +I S L NI +G CT L ++ Y G L L
Sbjct: 65 DFLKEVKILSR--LSDPNIARLLGV-------CTVDPPLCMIMEYMENGDLNQFLQKHVA 115
Query: 226 -------NRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNG 278
N +L+ ++ + I +G+ +L + F HRD+ ++N LV N
Sbjct: 116 ETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNF--------VHRDLATRNCLVGKNY 167
Query: 279 TCVIADFGL-----AVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKAD 333
T IADFG+ + Y ++ + P P R+M+ E S+ + F + K+D
Sbjct: 168 TIKIADFGMSRNLYSSDYYRVQGR---APLP----IRWMAWE----SVLLGKFTT--KSD 214
Query: 334 IYALGLVLWEV---CRRTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNR 390
++A G+ LWE+ CR PY L ++ D ++ LP
Sbjct: 215 VWAFGVTLWEILTLCREQ-----------PYEHL-TDQQVIENAGHFFRDDGRQIYLPRP 262
Query: 391 WVSDSTLNAMTKVMKECWHQNANVR 415
+ ++M ECW ++ R
Sbjct: 263 PNCPKDI---YELMLECWRRDEEDR 284
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 60/213 (28%), Positives = 91/213 (42%), Gaps = 38/213 (17%)
Query: 144 IGKGRYGEVWRGVWHGENV--AVKIFFSRDEASWSRETEIYS--TVLLR---HENILGYI 196
IGKG +G+V E AVK+ + E I S VLL+ H ++G
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 197 GSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKI-CLSIVNGLVHLHTEIFG 255
S T+ +L+ V Y + G L+ HL R + I + L +LH+
Sbjct: 63 FSFQTA----DKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSL--- 115
Query: 256 TQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRV----GTKRY 311
I +RD+K +NIL+ + G V+ DFGL K +I N GT Y
Sbjct: 116 -----NIVYRDLKPENILLDSQGHIVLTDFGLC--------KENIEHNGTTSTFCGTPEY 162
Query: 312 MSPEILDESINMDCFESFKKADIYALGLVLWEV 344
++PE+L + + D + LG VL+E+
Sbjct: 163 LAPEVLHKQ------PYDRTVDWWCLGAVLYEM 189
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 2e-08
Identities = 60/222 (27%), Positives = 95/222 (42%), Gaps = 45/222 (20%)
Query: 142 ECIGKGRYGEVWRGVWH--GENVAVKIFFSRDEASWSRETEIYSTVLL---RHENILGYI 196
E IG+G YG V++G G+ VA+K E T I LL +H NI+
Sbjct: 6 EKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQ 65
Query: 197 GSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICL------SIVNGLVHLH 250
M ++L+L+ + S L +L+ +L Q M L I+ G++ H
Sbjct: 66 DVLMQE----SRLYLIFEFLSM-DLKKYLD--SLPKGQYMDAELVKSYLYQILQGILFCH 118
Query: 251 TEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKR 310
+ + HRD+K +N+L+ G +ADFGLA ++ IP RV T
Sbjct: 119 SR--------RVLHRDLKPQNLLIDNKGVIKLADFGLARAFG-------IP--VRVYTHE 161
Query: 311 -----YMSPEILDESINMDCFESFKKADIYALGLVLWEVCRR 347
Y +PE+L S DI+++G + E+ +
Sbjct: 162 VVTLWYRAPEVLLGSPRYST-----PVDIWSIGTIFAEMATK 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 67/307 (21%), Positives = 135/307 (43%), Gaps = 79/307 (25%)
Query: 137 QISLSECIGKGRYGEVWRGVWHG---------ENVAVKIFFSRDEASWSRETEIYSTVLL 187
+++L + +G+G +G+V G VAVK+ +D+A+ +++ S + +
Sbjct: 13 RLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKML--KDDATDKDLSDLVSEMEM 70
Query: 188 -----RHENILGYIGSDMTSRNSCTQ---LWLVTHYHSFGSLYDHLN------------- 226
+H+NI+ +G+ CTQ L+++ Y S G+L ++L
Sbjct: 71 MKMIGKHKNIINLLGA-------CTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDT 123
Query: 227 ----RTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVI 282
L ++ + G+ +L ++ HRD+ ++N+LV + I
Sbjct: 124 CKLPEEQLTFKDLVSCAYQVARGMEYLASQ--------KCIHRDLAARNVLVTEDNVMKI 175
Query: 283 ADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLW 342
ADFGLA + + N R+ K +M+PE L + + ++D+++ G++LW
Sbjct: 176 ADFGLARDVHNI-DYYKKTTNGRLPVK-WMAPEALFDRVYT------HQSDVWSFGVLLW 227
Query: 343 EVCRRTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTK 402
E IF +PY +P++ F +++ +D +P + + +
Sbjct: 228 E---------IFTLGGSPYPG-IPVEELFKLLKEGHRMD--KPA--------NCTHELYM 267
Query: 403 VMKECWH 409
+M+ECWH
Sbjct: 268 IMRECWH 274
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 2e-08
Identities = 58/210 (27%), Positives = 100/210 (47%), Gaps = 35/210 (16%)
Query: 144 IGKGRYGEVW--RGVWHGENVAVKIFFSRDEASWSRET---EIYSTVLLRHENILGYIGS 198
+G+G YG V + G+ VA+K F ++ ++ EI LRHEN++ I
Sbjct: 9 VGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLI-- 66
Query: 199 DMTSRNSCTQLWLVTHY--HSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIF 254
++ R +L+LV + H+ + D L + L+ ++ K I+ G+ H+
Sbjct: 67 EVFRRKK--RLYLVFEFVDHT---VLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSH-- 119
Query: 255 GTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSP 314
I HRDIK +NILV +G + DFG A + L+ ++ + V T+ Y +P
Sbjct: 120 ------NIIHRDIKPENILVSQSGVVKLCDFGFART---LAAPGEVYTD-YVATRWYRAP 169
Query: 315 EILDESINMDCFESFKKA-DIYALGLVLWE 343
E+L + +A DI+A+G ++ E
Sbjct: 170 ELLVGDT------KYGRAVDIWAVGCLVTE 193
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 2e-08
Identities = 57/216 (26%), Positives = 102/216 (47%), Gaps = 27/216 (12%)
Query: 137 QISLSECIGKGRYGEVWRGVWH---GENVAVK-IFFSRDEASWSRETEIYSTVLLRHENI 192
+I + + +GKG YG V++ V H G +A+K I DE+ ++ +I + + H+ +
Sbjct: 2 EIEVLDELGKGNYGSVYK-VLHRPTGVTMAMKEIRLELDESKFN---QIIMELDILHKAV 57
Query: 193 LGYIGSDMTSRNSCTQLWLVTHYHSFGS---LYDHLNRTT-LNHHQMMKICLSIVNGLVH 248
YI + +++ Y GS LY T + + +I ++V GL
Sbjct: 58 SPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKF 117
Query: 249 LHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGT 308
L E I HRD+K N+LV NG + DFG++ + K +I G
Sbjct: 118 LKEEH-------NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI------GC 164
Query: 309 KRYMSPEILDESINMDCFESFK-KADIYALGLVLWE 343
+ YM+PE + +S + ++ ++D+++LGL + E
Sbjct: 165 QSYMAPERI-KSGGPNQNPTYTVQSDVWSLGLSILE 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 53/198 (26%), Positives = 91/198 (45%), Gaps = 28/198 (14%)
Query: 154 RGVWHGENVAVKIFFSRDE--ASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWL 211
RG E V K DE A+++R +E++ H I+ + D S + +L L
Sbjct: 88 RGSDPKEKVVAKFVMLNDERQAAYAR-SELHCLAACDHFGIVKHF-DDFKSDD---KLLL 142
Query: 212 VTHYHSFGSLYDHLNRTTLNH-----HQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRD 266
+ Y S G L + + H +++ + IV L +H+ + HRD
Sbjct: 143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR--------KMMHRD 194
Query: 267 IKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCF 326
+KS NI + G + DFG + YS S +D+ + GT Y++PE+ +
Sbjct: 195 LKSANIFLMPTGIIKLGDFGFSKQYSD-SVSLDV-ASSFCGTPYYLAPELWERK------ 246
Query: 327 ESFKKADIYALGLVLWEV 344
KKAD+++LG++L+E+
Sbjct: 247 RYSKKADMWSLGVILYEL 264
|
Length = 478 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 3e-08
Identities = 59/230 (25%), Positives = 103/230 (44%), Gaps = 36/230 (15%)
Query: 132 RTLAKQISLSECIGKGRYGEVW--RGVWHGENVAVKI-----FFSRDEASWSRETEI--- 181
+ AK+ +S +G G G V + V GE AVK+ D+ E
Sbjct: 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLN 87
Query: 182 --YSTVLLRHENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHL-NRTTLN----HHQ 234
+ +++ HE+ + D + + + LV Y + G L + +R N H+
Sbjct: 88 CDFFSIVKCHED---FAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHE 144
Query: 235 MMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQL 294
+ + ++ + H+H++ + HRDIKS NIL+ +NG + DFG + Y+
Sbjct: 145 AGLLFIQVLLAVHHVHSK--------HMIHRDIKSANILLCSNGLVKLGDFGFSKMYAAT 196
Query: 295 SNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEV 344
+ D GT Y++PEI S KKAD+++LG++L+E+
Sbjct: 197 VS--DDVGRTFCGTPYYVAPEIWRR-----KPYS-KKADMFSLGVLLYEL 238
|
Length = 496 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 3e-08
Identities = 30/102 (29%), Positives = 49/102 (48%), Gaps = 22/102 (21%)
Query: 242 IVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIP 301
+V G+ LH + I HRDIK +N+L+ G + DFGL+ + +
Sbjct: 106 VVLGVEDLH--------QRGIIHRDIKPENLLIDQTGHLKLTDFGLS--------RNGLE 149
Query: 302 PNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWE 343
VGT Y++PE + + D K +D ++LG V++E
Sbjct: 150 NKKFVGTPDYLAPETI-LGVGDD-----KMSDWWSLGCVIFE 185
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 4e-08
Identities = 37/108 (34%), Positives = 57/108 (52%), Gaps = 19/108 (17%)
Query: 237 KICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSN 296
K+ ++++ GL +L K I HRD+K NILV + G + DFG++ QL +
Sbjct: 107 KVSIAVLRGLAYLRE-------KHQIMHRDVKPSNILVNSRGEIKLCDFGVS---GQLID 156
Query: 297 KMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEV 344
M N VGT+ YMSPE L + ++DI+++GL L E+
Sbjct: 157 SM---ANSFVGTRSYMSPERLQGT------HYSVQSDIWSMGLSLVEL 195
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 4e-08
Identities = 71/289 (24%), Positives = 123/289 (42%), Gaps = 60/289 (20%)
Query: 144 IGKGRYGEVWRG-VWHGEN---VAVKIFFS----RDEASWSRETEIYSTVLLRHENILGY 195
IG G +G+V G V G V VK +++ + E + Y + L+H N+L
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRS--LQHSNLLQC 60
Query: 196 IGSDMTSRNSCTQL---WLVTHYHSFGSLYDHL------NRTTLNHHQMMKICLSIVNGL 246
+G CT++ LV + G L +L T + + ++ I GL
Sbjct: 61 LGQ-------CTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGL 113
Query: 247 VHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMD--IPPNP 304
+HLH F H D+ +N L+ + T I D+GL S K D + P+
Sbjct: 114 LHLHKNNF--------IHSDLALRNCLLTADLTVKIGDYGL----SHNKYKEDYYVTPDQ 161
Query: 305 RVGTKRYMSPEILDE-SINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHD 363
R+++PE++DE N+ + K++++++LG+ +WE +FE PY
Sbjct: 162 LWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWE---------LFELGSQPY-- 210
Query: 364 LVPMDPSFDDMRKVIC--IDQQRPVLPNRWVSDSTLNAMTKVMKECWHQ 410
D +V+ + +Q+ LP + + +VM+ CW Q
Sbjct: 211 -----RHLSD-EQVLTYTVREQQLKLPKPRLKLPLSDRWYEVMQFCWLQ 253
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 4e-08
Identities = 40/126 (31%), Positives = 67/126 (53%), Gaps = 22/126 (17%)
Query: 230 LNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAV 289
L+H +M + ++ G+ HLH+ I HRD+K NI+VK++ T I DFGLA
Sbjct: 120 LDHERMSYLLYQMLCGIKHLHS--------AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 171
Query: 290 SYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTK 349
+ +N M P V T+ Y +PE++ + M E+ DI+++G ++ E+ K
Sbjct: 172 TAC--TNFM---MTPYVVTRYYRAPEVI---LGMGYKEN---VDIWSVGCIMGEL---VK 217
Query: 350 ANGIFE 355
+ IF+
Sbjct: 218 GSVIFQ 223
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 4e-08
Identities = 36/109 (33%), Positives = 56/109 (51%), Gaps = 21/109 (19%)
Query: 237 KICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSN 296
KI +++V GL +L+ I HRDIK NILV + G + DFG++ +L N
Sbjct: 107 KIAVAVVEGLTYLYNVH-------RIMHRDIKPSNILVNSRGQIKLCDFGVS---GELIN 156
Query: 297 KMDIPPNPRVGTKRYMSPE-ILDESINMDCFESFKKADIYALGLVLWEV 344
+ + VGT YMSPE I + K+D+++LG+ + E+
Sbjct: 157 SI---ADTFVGTSTYMSPERIQGGKYTV-------KSDVWSLGISIIEL 195
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 4e-08
Identities = 54/189 (28%), Positives = 80/189 (42%), Gaps = 29/189 (15%)
Query: 144 IGKGRYGEVWRGVWH--GENVAVKIFFSRDEA-----SWSRETEIYSTVLLRHENI--LG 194
IG+G YG+V++ GE VA+K +E + RE +I L H NI L
Sbjct: 15 IGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQ--LNHRNIVNLK 72
Query: 195 YIGSD----MTSRNSCTQLWLVTHY--HSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVH 248
I +D + + +LV Y H L + + + ++ GL +
Sbjct: 73 EIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLES-GLVHFSEDHIKSFMKQLLEGLNY 131
Query: 249 LHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGT 308
H + F HRDIK NIL+ G +ADFGLA Y+ ++ P +V T
Sbjct: 132 CHKKNF--------LHRDIKCSNILLNNKGQIKLADFGLARLYNSEESR---PYTNKVIT 180
Query: 309 KRYMSPEIL 317
Y PE+L
Sbjct: 181 LWYRPPELL 189
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 4e-08
Identities = 68/262 (25%), Positives = 104/262 (39%), Gaps = 38/262 (14%)
Query: 144 IGKGRYGEVW--RGVWHGENVAVK-IFFSRDEASWSRET-----EIYSTVLLRHENILGY 195
+G+G +G V+ V G +A K + F + S+E EI L+HE I+ Y
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 196 IGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIF 254
G + R T L + Y GS+ D L L K I+ G+ +LH+ +
Sbjct: 70 YGC-LRDRAEKT-LTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM- 126
Query: 255 GTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSP 314
I HRDIK NIL + G + DFG A Q GT +MSP
Sbjct: 127 -------IVHRDIKGANILRDSAGNVKLGDFG-ASKRLQTICMSGTGIRSVTGTPYWMSP 178
Query: 315 EILDESINMDCFESF-KKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLV-PMDPSF- 371
E++ E + +KAD+++LG + E+ +E A + P +P
Sbjct: 179 EVISG-------EGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLP 231
Query: 372 --------DDMRKVICIDQQRP 385
D + + + RP
Sbjct: 232 SHISEHARDFLGCIFVEARHRP 253
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 5e-08
Identities = 56/209 (26%), Positives = 90/209 (43%), Gaps = 27/209 (12%)
Query: 144 IGKGRYGEVWRG--VWHGENVAVK---IFFSRD-EASWSRETEIYSTVLLRHENILGYIG 197
IG+G++ EV+R + G VA+K IF D +A EI L H N++ Y
Sbjct: 10 IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 69
Query: 198 SDMTSRNSCTQLWLVTHYHSFGSLYDHL--NRTTLNHHQMMKICLSIVNGLVHLHTEIFG 255
S N + + + H + + + K + + + L H+H+
Sbjct: 70 S-FIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR--- 125
Query: 256 TQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPE 315
+ HRDIK N+ + G + D GL +S + + VGT YMSPE
Sbjct: 126 -----RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA----AHSLVGTPYYMSPE 176
Query: 316 ILDESINMDCFESFKKADIYALGLVLWEV 344
+ E N F K+DI++LG +L+E+
Sbjct: 177 RIHE--NGYNF----KSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 5e-08
Identities = 40/139 (28%), Positives = 65/139 (46%), Gaps = 17/139 (12%)
Query: 207 TQLWLVTHYHSFGSLYDHL-NRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHR 265
+L L+ Y S G ++ HL R + ++ I+ L HLH K I +R
Sbjct: 78 AKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLH--------KLGIVYR 129
Query: 266 DIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDC 325
DIK +NIL+ + G V+ DFGL+ + + GT YM+PEI+
Sbjct: 130 DIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTY---SFCGTIEYMAPEIIRGKGGHG- 185
Query: 326 FESFKKADIYALGLVLWEV 344
K D ++LG++++E+
Sbjct: 186 ----KAVDWWSLGILIFEL 200
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 5e-08
Identities = 48/199 (24%), Positives = 84/199 (42%), Gaps = 25/199 (12%)
Query: 152 VWRGVWHGENVAVKIF--FSRDEASWSR--ETEIYSTVLLRHENILGYIGSDMTSRNSCT 207
+++G+++ + V ++ F F + E EI + + NIL G + +
Sbjct: 36 IYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLP 95
Query: 208 QLWLVTHYHSFGSLYDHL-NRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRD 266
+L L+ Y + G L + L L+ + + + GL +L+ KP +++
Sbjct: 96 RLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYT----NKP---YKN 148
Query: 267 IKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCF 326
+ S + LV N I GL + PP V Y S ++L D F
Sbjct: 149 LTSVSFLVTENYKLKIICHGL-------EKILSSPPFKNVNFMVYFSYKML-----NDIF 196
Query: 327 ESFK-KADIYALGLVLWEV 344
+ K DIY+LG+VLWE+
Sbjct: 197 SEYTIKDDIYSLGVVLWEI 215
|
Length = 283 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 53.4 bits (129), Expect = 6e-08
Identities = 54/189 (28%), Positives = 78/189 (41%), Gaps = 38/189 (20%)
Query: 144 IGKGRYGEVWRGV--WHGENVAVK--IFFSRDEA---SWSRETEIYSTVLLRHENILGY- 195
I +G YG V+R GE VA+K E + RE I L+H NI+
Sbjct: 13 IEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLK--LQHPNIVTVK 70
Query: 196 ---IGSDMTSRNSCTQLWLVTHY--HSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVH 248
+GS++ ++++V Y H SL + + + +M LS G+ H
Sbjct: 71 EVVVGSNLD------KIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLS---GVAH 121
Query: 249 LHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGT 308
LH I HRD+K+ N+L+ G I DFGLA Y V T
Sbjct: 122 LH--------DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY----TQLVVT 169
Query: 309 KRYMSPEIL 317
Y +PE+L
Sbjct: 170 LWYRAPELL 178
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 8e-08
Identities = 55/214 (25%), Positives = 91/214 (42%), Gaps = 41/214 (19%)
Query: 144 IGKGRYGEVWRGVWHGEN--VAVKIF-----FSRDEA-SWSRETEIYSTV-LLRHENILG 194
+G+G +G+V + A+K +RDE S E I+ T RH ++
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66
Query: 195 YIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIF 254
T + C V Y + G L H++ + + + +V GL +LH
Sbjct: 67 LFACFQTEDHVC----FVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLH---- 118
Query: 255 GTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRV----GTKR 310
+ I +RD+K N+L+ T G IADFGL K + R GT
Sbjct: 119 ----ENKIVYRDLKLDNLLLDTEGFVKIADFGLC--------KEGMGFGDRTSTFCGTPE 166
Query: 311 YMSPEILDESINMDCFESFKKA-DIYALGLVLWE 343
+++PE+L E S+ +A D + LG++++E
Sbjct: 167 FLAPEVLTE-------TSYTRAVDWWGLGVLIYE 193
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 9e-08
Identities = 35/106 (33%), Positives = 50/106 (47%), Gaps = 19/106 (17%)
Query: 242 IVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIP 301
+ GL LH I HRD+K +NILV + G +ADFGLA YS +
Sbjct: 117 FLRGLDFLHAN--------CIVHRDLKPENILVTSGGQVKLADFGLARIYS-----CQMA 163
Query: 302 PNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRR 347
P V T Y +PE+L +S D++++G + E+ RR
Sbjct: 164 LTPVVVTLWYRAPEVLLQSTYA------TPVDMWSVGCIFAEMFRR 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 67/228 (29%), Positives = 96/228 (42%), Gaps = 53/228 (23%)
Query: 140 LSECIGKGRYGEVWRGV--WHGENVAVK----IF-FSRDEASWSRETEIYSTVLLRHENI 192
+ E IGKG YG V + GE VA+K +F D RE ++ LLRH +I
Sbjct: 4 IQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLR--LLRHPDI 61
Query: 193 LGYIGSDM--TSRNSCTQLWLV-----THYHSFGSLYDHLNRTTLNHHQMMKICLSIVNG 245
+ I M SR +++V + H D L T HHQ ++
Sbjct: 62 V-EIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDL---TPEHHQFF--LYQLLRA 115
Query: 246 LVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA-VSYSQLSNKMDIPP-- 302
L ++HT + HRD+K KNIL + I DFGLA V+++ D P
Sbjct: 116 LKYIHTA--------NVFHRDLKPKNILANADCKLKICDFGLARVAFN------DTPTAI 161
Query: 303 --NPRVGTKRYMSPEILDESINMDCFESFKK----ADIYALGLVLWEV 344
V T+ Y +PE+ C F K DI+++G + EV
Sbjct: 162 FWTDYVATRWYRAPEL--------CGSFFSKYTPAIDIWSIGCIFAEV 201
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 1e-07
Identities = 41/155 (26%), Positives = 71/155 (45%), Gaps = 31/155 (20%)
Query: 237 KICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSN 296
K+ ++IV L +L K + HRD+K NIL+ +G + DFG++ +L +
Sbjct: 118 KMTVAIVKALHYLKE-------KHGVIHRDVKPSNILLDASGNVKLCDFGIS---GRLVD 167
Query: 297 KMDIPPNPR-VGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFE 355
R G YM+PE +D ++ +AD+++LG+ L E+ A G F
Sbjct: 168 SK---AKTRSAGCAAYMAPERIDPPDPNPKYDI--RADVWSLGISLVEL-----ATGQF- 216
Query: 356 EYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNR 390
PY + F+ + K+ + ++ P LP
Sbjct: 217 ----PYKN---CKTEFEVLTKI--LQEEPPSLPPN 242
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 1e-07
Identities = 46/145 (31%), Positives = 71/145 (48%), Gaps = 27/145 (18%)
Query: 264 HRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINM 323
HRD+ ++NIL+ I DFGLA SN + + N R+ K +M+P ESI
Sbjct: 237 HRDLAARNILLTHGRITKICDFGLARDIRNDSNYV-VKGNARLPVK-WMAP----ESI-F 289
Query: 324 DCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQ 383
+C +F ++D+++ G++LWE IF +PY + P+D F M K +
Sbjct: 290 NCVYTF-ESDVWSYGILLWE---------IFSLGSSPYPGM-PVDSKFYKMIK----EGY 334
Query: 384 RPVLPNRWVSDSTLNAMTKVMKECW 408
R + P S+ M +MK CW
Sbjct: 335 RMLSPECAPSE-----MYDIMKSCW 354
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 1e-07
Identities = 53/234 (22%), Positives = 105/234 (44%), Gaps = 50/234 (21%)
Query: 129 LIQRTLAKQISLSECIGKGRYGEVWRGVW--HGENV----AVKIF--FSRDEASWSRETE 180
+++ T K++ + +G G +G V++G+W GE V A+KI + +A+ E
Sbjct: 3 ILKETELKRVKV---LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDE 59
Query: 181 IYSTVLLRHENILGYIGSDMTSRNSCTQLWLVTHYHSFGSL--YDHLNRTTLNHHQMMKI 238
+ H +++ +G ++ + LVT G L Y H ++ + ++
Sbjct: 60 ALIMASMDHPHLVRLLGVCLSP-----TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNW 114
Query: 239 CLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA-------VSY 291
C+ I G+++L + HRD+ ++N+LVK+ I DFGLA Y
Sbjct: 115 CVQIAKGMMYLEER--------RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEY 166
Query: 292 SQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFK-KADIYALGLVLWEV 344
+ KM I ++M+ E + + F ++D+++ G+ +WE+
Sbjct: 167 NADGGKMPI---------KWMALECIH-------YRKFTHQSDVWSYGVTIWEL 204
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 45/160 (28%), Positives = 67/160 (41%), Gaps = 43/160 (26%)
Query: 264 HRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNP---RVGTKR----YMSPE- 315
HRD+ ++NIL+ N I DFGLA DI +P R G R +M+PE
Sbjct: 196 HRDLAARNILLSENNVVKICDFGLA---------RDIYKDPDYVRKGDARLPLKWMAPES 246
Query: 316 ILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFDDMR 375
I D+ ++D+++ G++LWE IF +PY V +D F
Sbjct: 247 IFDKVYTT-------QSDVWSFGVLLWE---------IFSLGASPYPG-VQIDEEFCRRL 289
Query: 376 KVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVR 415
K + R P + + +M +CWH N R
Sbjct: 290 K----EGTRMRAP-----EYATPEIYSIMLDCWHNNPEDR 320
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 2e-07
Identities = 74/297 (24%), Positives = 125/297 (42%), Gaps = 68/297 (22%)
Query: 138 ISLSECIGKGRYGEVWRGVWH---GENVAVKI------FFSRDEASWSRETEIYSTVLLR 188
I+ + IG G +GEV+RG+ + VAV I + + + E I
Sbjct: 7 ITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQ--FS 64
Query: 189 HENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHL--NRTTLNHHQMMKICLSIVNGL 246
H NI+ G + ++T Y G+L +L + + +Q++ + I G+
Sbjct: 65 HHNIIRLEGVVTKFKP----AMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGM 120
Query: 247 VHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA--------VSYSQLSNKM 298
+L + HRD+ ++NILV +N C ++DFGL+ +Y+ K+
Sbjct: 121 KYLSDMNY--------VHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKI 172
Query: 299 DIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYK 358
I R+ +P E+I F S +D+++ G+V+WEV F E
Sbjct: 173 PI---------RWTAP----EAIAYRKFTS--ASDVWSFGIVMWEVMS-------FGE-- 208
Query: 359 APYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVR 415
PY D+ S ++ K I D R P S A+ ++M +CW Q+ R
Sbjct: 209 RPYWDM-----SNHEVMKAIN-DGFRLPAPMDCPS-----AVYQLMLQCWQQDRARR 254
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 2e-07
Identities = 38/117 (32%), Positives = 63/117 (53%), Gaps = 19/117 (16%)
Query: 230 LNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAV 289
L+H +M + ++ G+ HLH+ I HRD+K NI+VK++ T I DFGLA
Sbjct: 116 LDHERMSYLLYQMLCGIKHLHS--------AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 167
Query: 290 SYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR 346
+ + S M P V T+ Y +PE++ + M E+ DI+++G ++ E+ R
Sbjct: 168 T-AGTSFMM----TPYVVTRYYRAPEVI---LGMGYKEN---VDIWSVGCIMGEMVR 213
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 2e-07
Identities = 56/236 (23%), Positives = 96/236 (40%), Gaps = 57/236 (24%)
Query: 138 ISLSECIGKGRYGEVWRGVWHGENVAVKIFFSR--------DEASWSRETEIYSTVLLRH 189
I + IG+G +G+V + + + + R D ++ E E+ L H
Sbjct: 9 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCK-LGHH 67
Query: 190 ENILGYIGSDMTSRNSCTQ---LWLVTHYHSFGSLYDHLNRT-----------------T 229
NI+ +G+ C L+L Y G+L D L ++ T
Sbjct: 68 PNIINLLGA-------CEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 120
Query: 230 LNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAV 289
L+ Q++ + G+ +L + F HRD+ ++NILV N IADFGL+
Sbjct: 121 LSSQQLLHFAADVARGMDYLSQKQF--------IHRDLAARNILVGENYVAKIADFGLSR 172
Query: 290 SYSQLSNK-MDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEV 344
K M P R+M+ E L+ S+ +D+++ G++LWE+
Sbjct: 173 GQEVYVKKTMGRLP------VRWMAIESLNYSVYT------TNSDVWSYGVLLWEI 216
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 2e-07
Identities = 56/233 (24%), Positives = 97/233 (41%), Gaps = 56/233 (24%)
Query: 135 AKQISLSECIGKGRYGEVWRG---VWHGENVAVKI------FFSRDEASWSRETEIYSTV 185
A I + + IG G +GEV G + + V I + + + E I
Sbjct: 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQ- 61
Query: 186 LLRHENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNR-----TTLNHHQMMKICL 240
H NI+ G + ++ + +VT Y GSL L + T + Q++ +
Sbjct: 62 -FDHPNIIHLEG--VVTK--SKPVMIVTEYMENGSLDAFLRKHDGQFTVI---QLVGMLR 113
Query: 241 SIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA--------VSYS 292
I +G+ +L HRD+ ++NILV +N C ++DFGL+ +Y+
Sbjct: 114 GIASGMKYL--------SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYT 165
Query: 293 QLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKA-DIYALGLVLWEV 344
K+ I R+ +PE + + F A D+++ G+V+WEV
Sbjct: 166 TRGGKIPI---------RWTAPEAI-------AYRKFTSASDVWSYGIVMWEV 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 2e-07
Identities = 33/104 (31%), Positives = 52/104 (50%), Gaps = 20/104 (19%)
Query: 242 IVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIP 301
I++GL HLH + I +RD+K +N+L+ +G I+D GLAV +K
Sbjct: 106 IISGLEHLH--------QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKT--- 154
Query: 302 PNPRVGTKRYMSPEIL-DESINMDCFESFKKADIYALGLVLWEV 344
GT +M+PE+L E + D +ALG+ L+E+
Sbjct: 155 -KGYAGTPGFMAPELLQGEEYDF-------SVDYFALGVTLYEM 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 3e-07
Identities = 84/334 (25%), Positives = 142/334 (42%), Gaps = 84/334 (25%)
Query: 136 KQISLSECIGKGRYGEVWRGVWHGEN------------------VAVKIFFSRDEAS--- 174
K+++ E +G+G++GEV G VAVK+ R++A+
Sbjct: 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKML--REDANKNA 62
Query: 175 ---WSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNR---- 227
+ +E +I S L+ NI+ + +TS C ++T Y G L L+R
Sbjct: 63 RNDFLKEIKIMSR--LKDPNIIRLLAVCITSDPLC----MITEYMENGDLNQFLSRHEPQ 116
Query: 228 --------TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGT 279
T+++ ++ + I +G+ +L + F HRD+ ++N LV N T
Sbjct: 117 EAAEKADVVTISYSTLIFMATQIASGMKYLSSLNF--------VHRDLATRNCLVGKNYT 168
Query: 280 CVIADFGLAVS-----YSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADI 334
IADFG++ + Y ++ + +P R+MS ESI + F + +D+
Sbjct: 169 IKIADFGMSRNLYSGDYYRIQGRAVLP-------IRWMSW----ESILLGKFTT--ASDV 215
Query: 335 YALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPV-LPNRWVS 393
+A G+ LWE+ K + PY L D + DQ R V LP +
Sbjct: 216 WAFGVTLWEILTLCK--------EQPYSQLS--DEQVIENTGEFFRDQGRQVYLPKPALC 265
Query: 394 DSTLNAMTKVMKECWHQNANVRLSALRVKKTLIK 427
+L K+M CW +NA R S + TL++
Sbjct: 266 PDSLY---KLMLSCWRRNAKERPSFQEIHATLLE 296
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 3e-07
Identities = 49/187 (26%), Positives = 78/187 (41%), Gaps = 36/187 (19%)
Query: 144 IGKGRYGEVW--RGVWHGENVAVKIFFSRDEASWSRET---EIYSTVLLRHENILGYIGS 198
IG+G YG V+ R G+ VA+K F ++ ++ EI L+H N++ I
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68
Query: 199 DMTSRNSCTQLWLVTHYHSFGSLYDHLNRTT--LNHHQMMKICLSIVNGL--VHLHTEIF 254
R +L LV Y ++ + L + + H + KI + + H H I
Sbjct: 69 FRRKR----KLHLVFEYCDH-TVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCI- 122
Query: 255 GTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPR----VGTKR 310
HRD+K +NIL+ G + DFG A ++ P V T+
Sbjct: 123 ---------HRDVKPENILITKQGQIKLCDFGFA--------RILTGPGDDYTDYVATRW 165
Query: 311 YMSPEIL 317
Y +PE+L
Sbjct: 166 YRAPELL 172
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 3e-07
Identities = 68/294 (23%), Positives = 121/294 (41%), Gaps = 68/294 (23%)
Query: 142 ECIGKGRYGEVWRGVWHGEN-----VAVKIFFSRDEASWSRETEIYST-------VLLR- 188
IGKG +G V+ G + AVK S +R T++ ++++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVK--------SLNRITDLEEVEQFLKEGIIMKD 52
Query: 189 --HENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNH--HQMMKICLSIVN 244
H N+L +G + S S +V Y G L + + T N ++ L +
Sbjct: 53 FSHPNVLSLLGICLPSEGSPL---VVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAK 109
Query: 245 GLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNP 304
G+ +L ++ F HRD+ ++N ++ + T +ADFGLA + +K +
Sbjct: 110 GMEYLASKKF--------VHRDLAARNCMLDESFTVKVADFGLA---RDIYDKEYYSVHN 158
Query: 305 RVGTK---RYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPY 361
G K ++M+ ES+ F + K+D+++ G++LWE+ R PY
Sbjct: 159 HTGAKLPVKWMAL----ESLQTQKFTT--KSDVWSFGVLLWELMTRG---------APPY 203
Query: 362 HDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVR 415
D+ D + + Q R +L + D + +VM CWH +R
Sbjct: 204 PDVDSFD-------ITVYLLQGRRLLQPEYCPDP----LYEVMLSCWHPKPEMR 246
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 3e-07
Identities = 53/213 (24%), Positives = 89/213 (41%), Gaps = 36/213 (16%)
Query: 144 IGKGRYGEVWRGVWHGEN-----VAVKIFFSRDEASWSRETEIYSTVL----LRHENILG 194
+G G +G V +GV+ ++ VAVK + E + + E L H I+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTL--KQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 195 YIGSDMTSRNSCT--QLWLVTHYHSFGSLYDHL-NRTTLNHHQMMKICLSIVNGLVHLHT 251
IG C L LV G L +L R + + ++ + G+ +L +
Sbjct: 61 LIGV-------CKGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLES 113
Query: 252 EIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRY 311
+ F HRD+ ++N+L+ I+DFG++ + S+ R K Y
Sbjct: 114 KHF--------VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWY 165
Query: 312 MSPEILDESINMDCFESFKKADIYALGLVLWEV 344
+P E IN F S K+D+++ G+ LWE
Sbjct: 166 -AP----ECINYGKFSS--KSDVWSYGVTLWEA 191
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 3e-07
Identities = 53/220 (24%), Positives = 87/220 (39%), Gaps = 42/220 (19%)
Query: 136 KQISLSECIGKGRYGEVW--RGVWHGENVAVKIF-----FSRDEASW-SRETEIYSTVLL 187
K + +G+G YG+V+ + GE VA+K F +E E +I +T
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTT-- 58
Query: 188 RHENI--LGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRT-TLNHHQMMKICLSIVN 244
+ E + L Y D L+L Y G LN L+ +
Sbjct: 59 KSEWLVKLLYAFQDDEY------LYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFE 112
Query: 245 GLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNP 304
+ LH + HRD+K +N L+ +G + DFGL+ +N +
Sbjct: 113 AVDALH--------ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSV------ 158
Query: 305 RVGTKRYMSPEIL-DESINMDCFESFKKADIYALGLVLWE 343
VG+ YM+PE+L + + D ++LG +L+E
Sbjct: 159 -VGSPDYMAPEVLRGKGYDFTV-------DYWSLGCMLYE 190
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 4e-07
Identities = 34/102 (33%), Positives = 44/102 (43%), Gaps = 18/102 (17%)
Query: 226 NRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADF 285
+ L Q+ I L I+NGL LH K HRD+ NI + + G C IADF
Sbjct: 112 RKIRLTESQVKCILLQILNGLNVLH--------KWYFMHRDLSPANIFINSKGICKIADF 163
Query: 286 GLAVSY------SQLSNKMDIPPN----PRVGTKRYMSPEIL 317
GLA Y LS + +V T Y +PE+L
Sbjct: 164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELL 205
|
Length = 335 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 4e-07
Identities = 37/115 (32%), Positives = 62/115 (53%), Gaps = 19/115 (16%)
Query: 230 LNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAV 289
L+H +M + ++ G+ HLH+ I HRD+K NI+VK++ T I DFGLA
Sbjct: 123 LDHERMSYLLYQMLCGIKHLHS--------AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 174
Query: 290 SYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEV 344
+ + S M P V T+ Y +PE++ + M E+ DI+++G ++ E+
Sbjct: 175 T-AGTSFMMT----PYVVTRYYRAPEVI---LGMGYKEN---VDIWSVGCIMGEM 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 4e-07
Identities = 52/189 (27%), Positives = 77/189 (40%), Gaps = 35/189 (18%)
Query: 142 ECIGKGRYGEVW--RGVWHGENVAVKIFFSRDEASWSRETEIYSTVLL---RHENI---L 193
E IG+G YG V+ R GE VA+K E T I LL H NI L
Sbjct: 5 EKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLL 64
Query: 194 GYIGSDMTSRNSCTQLWLVTHY--HSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHT 251
+ S+ +L+LV + D T L+ + ++ G+ + H+
Sbjct: 65 DVVHSE-------NKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS 117
Query: 252 EIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNP---RVGT 308
+ HRD+K +N+L+ G +ADFGLA ++ +P V T
Sbjct: 118 H--------RVLHRDLKPQNLLIDREGALKLADFGLARAFG-------VPVRTYTHEVVT 162
Query: 309 KRYMSPEIL 317
Y +PEIL
Sbjct: 163 LWYRAPEIL 171
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 4e-07
Identities = 76/318 (23%), Positives = 126/318 (39%), Gaps = 87/318 (27%)
Query: 137 QISLS-----ECIGKGRYGEVWRGVWHG-------ENVAVKIFFSRDEASWSRETEIYST 184
+I+LS E +G+ R+G+V++G G + VA+K +D+A E
Sbjct: 1 EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTL--KDKAEGPLREEFKHE 58
Query: 185 VLLR----HENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLN-------------- 226
++R H NI+ +G + L ++ Y S L++ L
Sbjct: 59 AMMRSRLQHPNIVCLLGVVTKEQ----PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDD 114
Query: 227 ---RTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIA 283
++TL + I I G+ L + + H+D+ ++N+LV I+
Sbjct: 115 KTVKSTLEPADFVHIVTQIAAGMEFLSSH--------HVVHKDLATRNVLVFDKLNVKIS 166
Query: 284 DFGL-----AVSYSQLSNKMDIPPNPRVGTKRYMSPE-ILDESINMDCFESFKKADIYAL 337
D GL A Y +L +P R+MSPE I+ ++D +DI++
Sbjct: 167 DLGLFREVYAADYYKLMGNSLLP-------IRWMSPEAIMYGKFSID-------SDIWSY 212
Query: 338 GLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTL 397
G+VLWEV F PY D VI + + R VLP D
Sbjct: 213 GVVLWEV---------FSYGLQPYCGYSNQD--------VIEMIRNRQVLP---CPDDCP 252
Query: 398 NAMTKVMKECWHQNANVR 415
+ +M ECW++ + R
Sbjct: 253 AWVYTLMLECWNEFPSRR 270
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 4e-07
Identities = 60/215 (27%), Positives = 101/215 (46%), Gaps = 36/215 (16%)
Query: 144 IGKGRYGEVW--RGVWHGENVAVKIF-----FSRDEASWSRETEIYSTVL--LRHENILG 194
+GKG +G+V R G+ A+KI ++DE + T S VL RH
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVA---HTLTESRVLKNTRHP---- 55
Query: 195 YIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKIC-LSIVNGLVHLHTEI 253
++ S S + +L V Y + G L+ HL+R + + IV+ L +LH+
Sbjct: 56 FLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHS-- 113
Query: 254 FGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMS 313
GK I +RD+K +N+++ +G I DFGL + M GT Y++
Sbjct: 114 ----GK--IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATM----KTFCGTPEYLA 163
Query: 314 PEILDESINMDCFESFKKADIYALGLVLWE-VCRR 347
PE+L+++ + + D + LG+V++E +C R
Sbjct: 164 PEVLEDN------DYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.1 bits (123), Expect = 5e-07
Identities = 51/185 (27%), Positives = 80/185 (43%), Gaps = 31/185 (16%)
Query: 144 IGKGRYGEVWRGV--WHGENVAVKI----FFSRDEASWS-RETEIYSTVLLRHENILGYI 196
+G G YG+V G VA+K F S A + RE + + HEN++G +
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLK--HMDHENVIGLL 80
Query: 197 GSDM----TSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTE 252
D+ +S ++LVTH L + + L+ + + I+ GL ++H+
Sbjct: 81 --DVFTPASSLEDFQDVYLVTHLMG-ADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHS- 136
Query: 253 IFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYM 312
I HRD+K NI V + I DFGLA ++M V T+ Y
Sbjct: 137 -------AGIIHRDLKPSNIAVNEDCELKILDFGLA---RHTDDEM----TGYVATRWYR 182
Query: 313 SPEIL 317
+PEI+
Sbjct: 183 APEIM 187
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 5e-07
Identities = 59/216 (27%), Positives = 95/216 (43%), Gaps = 44/216 (20%)
Query: 142 ECIGKGRYGEVWRGVWHGEN-VAVKIFFSRDEASWSRETEIYSTVLLR---HENILGYIG 197
E +GKG +GEV++G + VAVK D + + +L+ H NI+ IG
Sbjct: 1 ELLGKGNFGEVFKGTLKDKTPVAVKTC-KEDLPQELKIKFLSEARILKQYDHPNIVKLIG 59
Query: 198 SDMTSRNSCTQ---LWLVTHYHSFGSLYDHLNRTT--LNHHQMMKICLSIVNGLVHLHTE 252
CTQ +++V G L + L Q++K L G+ +L
Sbjct: 60 V-------CTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYL--- 109
Query: 253 IFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVS-----YSQLSNKMDIPPNPRVG 307
+ K I HRD+ ++N LV N I+DFG++ YS S IP
Sbjct: 110 ----ESKNCI-HRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSS-SGLKQIP------ 157
Query: 308 TKRYMSPEILDESINMDCFESFKKADIYALGLVLWE 343
++ +PE L N + S ++D+++ G++LWE
Sbjct: 158 -IKWTAPEAL----NYGRYSS--ESDVWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 51.0 bits (123), Expect = 5e-07
Identities = 32/85 (37%), Positives = 47/85 (55%), Gaps = 14/85 (16%)
Query: 264 HRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNP----RVGTKRYMSPEILDE 319
HRD+K NIL+ ++ +ADFGLA S S+L + P NP V T+ Y +PEIL
Sbjct: 130 HRDLKPSNILLNSDCRVKLADFGLARSLSELE---ENPENPVLTDYVATRWYRAPEILLG 186
Query: 320 SINMDCFESFKKA-DIYALGLVLWE 343
S + K D++++G +L E
Sbjct: 187 S------TRYTKGVDMWSVGCILGE 205
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 6e-07
Identities = 58/216 (26%), Positives = 88/216 (40%), Gaps = 34/216 (15%)
Query: 142 ECIGKGRYGEVW--RGVWHGENVAVKIFFSRDEASWSRETEIYSTVLLR---HENILGYI 196
E IG+G YG V+ R GE VA+K E T I LL+ H NI+ +
Sbjct: 6 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 65
Query: 197 GSDMTSRNSCTQLWLVTHY--HSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIF 254
T +L+LV + D + + + ++ GL H+
Sbjct: 66 DVIHTEN----KLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH-- 119
Query: 255 GTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNP---RVGTKRY 311
+ HRD+K +N+L+ T G +ADFGLA ++ +P V T Y
Sbjct: 120 ------RVLHRDLKPQNLLINTEGAIKLADFGLARAFG-------VPVRTYTHEVVTLWY 166
Query: 312 MSPEILDESINMDCFESFKKADIYALGLVLWEVCRR 347
+PEIL + C DI++LG + E+ R
Sbjct: 167 RAPEIL-----LGCKYYSTAVDIWSLGCIFAEMVTR 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 6e-07
Identities = 29/81 (35%), Positives = 44/81 (54%), Gaps = 7/81 (8%)
Query: 264 HRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINM 323
HRD+K N+LV + I DFGLA +S+ + V T+ Y +PEI M
Sbjct: 128 HRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEI------M 181
Query: 324 DCFESFKKA-DIYALGLVLWE 343
F+S+ KA D++++G +L E
Sbjct: 182 LSFQSYTKAIDVWSVGCILAE 202
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 7e-07
Identities = 47/164 (28%), Positives = 76/164 (46%), Gaps = 28/164 (17%)
Query: 187 LRHENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHL-----NRTTLNHHQMMKICLS 241
L H I+ + S + C ++T Y L L TL+ +Q+ + +
Sbjct: 59 LDHPAIVKFHASFLERDAFC----IITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQ 114
Query: 242 IVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIP 301
++ G+ ++H I HRD+K+KNI +K N I DFG++ L D+
Sbjct: 115 LLLGVHYMHQR--------RILHRDLKAKNIFLKNN-LLKIGDFGVS---RLLMGSCDL- 161
Query: 302 PNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVC 345
GT YMSPE L ++S K+DI++LG +L+E+C
Sbjct: 162 ATTFTGTPYYMSPEALKHQ----GYDS--KSDIWSLGCILYEMC 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 7e-07
Identities = 52/238 (21%), Positives = 98/238 (41%), Gaps = 45/238 (18%)
Query: 144 IGKGRYGEVWRG-VWHGENVAVKIF-------FSRDEASWSRETEIYSTVLLRHENILGY 195
IG G +G+V ++ VA + S+++ + ++ + Y +L+H NIL
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYR--ILQHPNILQC 60
Query: 196 IGSDMTSRNSCTQ---LWLVTHYHSFGSLYDHL-----NRTTLNHHQMMKICLSIVNGLV 247
+G C + LV Y G L +L +R + ++ I G+
Sbjct: 61 LGQ-------CVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVT 113
Query: 248 HLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVG 307
H+H F H D+ +N + ++ T + D+G + S+ + +
Sbjct: 114 HMHKHNF--------LHSDLALRNCFLTSDLTVKVGDYG--IGPSRYKEDYIETEDDKCV 163
Query: 308 TKRYMSPEILDE-SINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDL 364
R+++PE++ E + E K ++++ALG+ LWE +FE PY L
Sbjct: 164 PLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWE---------LFENAAQPYSHL 212
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 8e-07
Identities = 58/226 (25%), Positives = 96/226 (42%), Gaps = 53/226 (23%)
Query: 143 CIGKGRYGEVWRGV--WHGENVAVK----IFFSRDEASWSRET--EIYSTVLLRHENILG 194
IG+G YG V E VA+K F +R +A + T EI L HEN++
Sbjct: 12 PIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDA---KRTLREIKLLRHLDHENVIA 68
Query: 195 YIGSDM-TSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMK------------ICLS 241
R + +++V Y+ L T L HQ+++
Sbjct: 69 IKDIMPPPHREAFNDVYIV---------YE-LMDTDL--HQIIRSSQTLSDDHCQYFLYQ 116
Query: 242 IVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIP 301
++ GL ++H+ + HRD+K N+L+ N I DFGLA + S+ + M
Sbjct: 117 LLRGLKYIHS--------ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFM--- 165
Query: 302 PNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRR 347
V T+ Y +PE+L ++C E D++++G + E+ R
Sbjct: 166 -TEYVVTRWYRAPELL-----LNCSEYTTAIDVWSVGCIFAELLGR 205
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 8e-07
Identities = 48/190 (25%), Positives = 80/190 (42%), Gaps = 31/190 (16%)
Query: 142 ECIGKGRYGEVWRGV--WHGENVAVK-IFFSRDEASWSRET--EIYSTVLLRHENILGYI 196
E IG G YG V + G+ VA+K I + D + ++ T E+ +H+NI+
Sbjct: 11 ENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIR 70
Query: 197 GSDMTSRNSCTQLWLVT-------HY--HSFGSLYDHLNRTTLNHHQMMKICLSIVNGLV 247
+++V H+ HS L + R L +Q+++ GL
Sbjct: 71 DILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFL--YQLLR-------GLK 121
Query: 248 HLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVG 307
++H+ + HRD+K N+LV + I DFG+A S + V
Sbjct: 122 YIHSA--------NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVA 173
Query: 308 TKRYMSPEIL 317
T+ Y +PE+L
Sbjct: 174 TRWYRAPELL 183
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 9e-07
Identities = 44/160 (27%), Positives = 70/160 (43%), Gaps = 26/160 (16%)
Query: 187 LRHENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNR--TTLNHHQMMKICLSIVN 244
+ H +++ D + T + L HY S LY +L + L Q + I I+
Sbjct: 114 VNHPSVIRM--KDTLVSGAITCMVL-PHYSS--DLYTYLTKRSRPLPIDQALIIEKQILE 168
Query: 245 GLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNP 304
GL +LH + I HRD+K++NI + I D G A + +
Sbjct: 169 GLRYLHAQ--------RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGL---- 216
Query: 305 RVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEV 344
GT +PE+L D + S KADI++ G+VL+E+
Sbjct: 217 -AGTVETNAPEVLAR----DKYNS--KADIWSAGIVLFEM 249
|
Length = 357 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 67/259 (25%), Positives = 98/259 (37%), Gaps = 61/259 (23%)
Query: 144 IGKGRYGEVWRGV--WHGENVAVK----IFFSRDEASWSRE-TEIYSTVLLRHENILGYI 196
IG G +G VW G+ VA+K +F ++ S R E+ +H+N+L +
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVF--QNLVSCKRVFRELKMLCFFKHDNVLSAL 65
Query: 197 GSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLS--------------- 241
+ V T L + KI +S
Sbjct: 66 DILQPPHIDPFEEIYVV--------------TELMQSDLHKIIVSPQPLSSDHVKVFLYQ 111
Query: 242 IVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA-VSYSQLSNKMDI 300
I+ GL +LH+ I HRDIK N+LV +N I DFGLA V S M
Sbjct: 112 ILRGLKYLHS--------AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHM-- 161
Query: 301 PPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRT---KANGIFEEY 357
V T+ Y +PEIL M DI+++G + E+ R +A ++
Sbjct: 162 --TQEVVTQYYRAPEIL-----MGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQL 214
Query: 358 KAPYHDLVPMDPSFDDMRK 376
DL+ PS + MR
Sbjct: 215 DLIT-DLL-GTPSLEAMRS 231
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 1e-06
Identities = 35/108 (32%), Positives = 50/108 (46%), Gaps = 29/108 (26%)
Query: 242 IVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIP 301
I GL LH E I +RD+K +NIL+ G I+D GLAV +IP
Sbjct: 111 ITCGLEDLHRE--------RIVYRDLKPENILLDDYGHIRISDLGLAV---------EIP 153
Query: 302 PNP----RVGTKRYMSPEILDESINMDCFESFK-KADIYALGLVLWEV 344
RVGT YM+PE++ E + D + LG +++E+
Sbjct: 154 EGETIRGRVGTVGYMAPEVVKN-------ERYTFSPDWWGLGCLIYEM 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 1e-06
Identities = 55/229 (24%), Positives = 88/229 (38%), Gaps = 48/229 (20%)
Query: 142 ECIGKGRYGEVW--RGVWHGENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIGSD 199
E IG+G YG+V+ R G+ VA+K + + E LR ++L +
Sbjct: 7 EKIGEGTYGKVYKARDKNTGKLVALK------KTRLEMDEEGIPPTALREISLLQMLSES 60
Query: 200 -----------MTSRNSCTQLWLVTHY-----HSFGSLYDHLNRTTLNHHQMMKICLSIV 243
+ +N L+LV Y F L + ++
Sbjct: 61 IYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLL 120
Query: 244 NGLVHLHTEIFGTQGKPAIAHRDIKSKNILV-KTNGTCVIADFGLAVSYSQLSNKMDIPP 302
G+ H H K + HRD+K +N+LV K G IAD GL ++S IP
Sbjct: 121 KGVAHCH--------KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFS-------IPV 165
Query: 303 NP---RVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRT 348
+ T Y +PE+L S + DI+++G + E+ R+
Sbjct: 166 KSYTHEIVTLWYRAPEVLLGSTHYS-----TPVDIWSVGCIFAEMSRKQ 209
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 1e-06
Identities = 71/301 (23%), Positives = 122/301 (40%), Gaps = 66/301 (21%)
Query: 142 ECIGKGRYGEVWRGVWHGENVAVKIFFSRD------EASWSRETEIYSTVLLRHENILGY 195
E IG+G +GEV+ G +N V + R+ +A + +E I H NI+
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQ--YSHPNIVRL 58
Query: 196 IGSDMTSRNSCTQ---LWLVTHYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLH 250
IG CTQ +++V G L L +++++ + G+ +L
Sbjct: 59 IGV-------CTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYL- 110
Query: 251 TEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVS-----YSQLSNKMDIPPNPR 305
+ K I HRD+ ++N LV I+DFG++ Y+ IP
Sbjct: 111 ------ESKHCI-HRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIP---- 159
Query: 306 VGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLV 365
++ +PE L N + S ++D+++ G++LWE F PY +L
Sbjct: 160 ---VKWTAPEAL----NYGRYSS--ESDVWSFGILLWEA---------FSLGAVPYANL- 200
Query: 366 PMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTL 425
S R+ I +Q LP + +A+ ++M+ CW + R S V + L
Sbjct: 201 ----SNQQTREAI---EQGVRLP---CPELCPDAVYRLMERCWEYDPGQRPSFSTVHQEL 250
Query: 426 I 426
Sbjct: 251 Q 251
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 1e-06
Identities = 43/145 (29%), Positives = 68/145 (46%), Gaps = 27/145 (18%)
Query: 264 HRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINM 323
HRD+ ++N+L+ I DFGLA SN + + N R+ K +M+P ESI
Sbjct: 235 HRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV-VKGNARLPVK-WMAP----ESI-F 287
Query: 324 DCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQ 383
DC + ++D+++ G++LWE IF K+PY ++ ++ F M K
Sbjct: 288 DCVYTV-QSDVWSYGILLWE---------IFSLGKSPYPGIL-VNSKFYKMVKR-GYQMS 335
Query: 384 RPVLPNRWVSDSTLNAMTKVMKECW 408
RP D + +MK CW
Sbjct: 336 RP--------DFAPPEIYSIMKMCW 352
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 1e-06
Identities = 63/242 (26%), Positives = 110/242 (45%), Gaps = 55/242 (22%)
Query: 136 KQISLSECIGKGRYGEV----------WRGVWHGEN------VAVKIFFSRDEASWSRE- 178
+Q+ L E +G+G++GEV + G E VAVK+ + D +R
Sbjct: 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRA-DVTKTARND 63
Query: 179 --TEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLN----RTTLNH 232
EI L++ NI+ +G ++ C ++T Y G L L+ +T H
Sbjct: 64 FLKEIKIMSRLKNPNIIRLLGVCVSDDPLC----MITEYMENGDLNQFLSQREIESTFTH 119
Query: 233 HQMMKICLSIVNGLVHLHTEIFGTQGKPAIA-----HRDIKSKNILVKTNGTCVIADFGL 287
+ +SI N L+++ +I G +A HRD+ ++N LV + T IADFG+
Sbjct: 120 ANNIP-SVSIAN-LLYMAVQI--ASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGM 175
Query: 288 AVS-----YSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLW 342
+ + Y ++ + +P R+M+ ESI + F + +D++A G+ LW
Sbjct: 176 SRNLYSGDYYRIQGRAVLP-------IRWMAW----ESILLGKFTT--ASDVWAFGVTLW 222
Query: 343 EV 344
E+
Sbjct: 223 EM 224
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 2e-06
Identities = 56/215 (26%), Positives = 98/215 (45%), Gaps = 36/215 (16%)
Query: 144 IGKGRYGEVW--RGVWHGENVAVKIF-----FSRDEASWSRETEIYSTVL--LRHENILG 194
+GKG +G+V R G+ A+KI ++DE + T S VL RH
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVA---HTLTESRVLQNTRHP---- 55
Query: 195 YIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRT-TLNHHQMMKICLSIVNGLVHLHTEI 253
++ + S + +L V Y + G L+ HL+R + + IV+ L +LH+
Sbjct: 56 FLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSC- 114
Query: 254 FGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMS 313
+ +RD+K +N+++ +G I DFGL M GT Y++
Sbjct: 115 -------DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATM----KTFCGTPEYLA 163
Query: 314 PEILDESINMDCFESFKKADIYALGLVLWE-VCRR 347
PE+L+++ + + D + LG+V++E +C R
Sbjct: 164 PEVLEDN------DYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 2e-06
Identities = 68/313 (21%), Positives = 119/313 (38%), Gaps = 79/313 (25%)
Query: 144 IGKGRYGEVWRG-------VWHGE-NVAVKIFFSRDEASWSRETEIYSTVLL----RHEN 191
+G G +GEV+ G G VAVK R A+ + E L H N
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTL--RKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 192 ILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTT--------LNHHQMMKICLSIV 243
I+ +G + + +++ G L +L L +++ ICL +
Sbjct: 61 IVKLLGVCLLNE----PQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVA 116
Query: 244 NGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNG-----TCVIADFGLA-----VSYSQ 293
G V+L F HRD+ ++N LV G I DFGLA Y +
Sbjct: 117 KGCVYLEQMHF--------IHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYR 168
Query: 294 LSNKMDIPPNPRVGTKRYMSPE-ILDESINMDCFESFKKADIYALGLVLWEVCRRTKANG 352
+ +P R+M+PE +LD ++D+++ G+++WE
Sbjct: 169 KEGEGLLP-------VRWMAPESLLDGKFTT-------QSDVWSFGVLMWE--------- 205
Query: 353 IFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNA 412
I + PY P + + ++ V + + P + ++M CW Q+
Sbjct: 206 ILTLGQQPY----PALNNQEVLQHVTAGGRLQK--PENCPDK-----IYQLMTNCWAQDP 254
Query: 413 NVRLSALRVKKTL 425
+ R + R+++ L
Sbjct: 255 SERPTFDRIQEIL 267
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 2e-06
Identities = 38/142 (26%), Positives = 69/142 (48%), Gaps = 19/142 (13%)
Query: 208 QLWLVTHYHSFGSLYDHLNRTTLNHHQMMKIC-LSIVNGLVHLHTEIFGTQGKPAIAHRD 266
+L V Y + G L+ HL+R + + IV+ L +LH+E + +RD
Sbjct: 69 RLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE-------KNVVYRD 121
Query: 267 IKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCF 326
+K +N+++ +G I DFGL + M GT Y++PE+L+++
Sbjct: 122 LKLENLMLDKDGHIKITDFGLCKEGIKDGATM----KTFCGTPEYLAPEVLEDN------ 171
Query: 327 ESFKKADIYALGLVLWE-VCRR 347
+ + D + LG+V++E +C R
Sbjct: 172 DYGRAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 57/220 (25%), Positives = 89/220 (40%), Gaps = 54/220 (24%)
Query: 144 IGKGRYGEVWRGVWHGEN--VAVKIF-----FSRDEASWSR-ETEIYSTVLLRHENILGY 195
+GKG +G+V G + AVK+ D+ + E + + +H
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAG-KHPF---- 57
Query: 196 IGSDMTSRNSCTQ----LWLVTHYHSFGSLYDHLNRT---TLNHHQMMKICLSIVNGLVH 248
+T +SC Q L+ V Y + G L H+ R+ + IV GL
Sbjct: 58 ----LTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAE--IVLGLQF 111
Query: 249 LHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRV-- 306
LH + I +RD+K N+L+ + G IADFG+ K I
Sbjct: 112 LH--------ERGIIYRDLKLDNVLLDSEGHIKIADFGMC--------KEGILGGVTTST 155
Query: 307 --GTKRYMSPEILDESINMDCFESFKKA-DIYALGLVLWE 343
GT Y++PEIL + + A D +ALG++L+E
Sbjct: 156 FCGTPDYIAPEILSY-------QPYGPAVDWWALGVLLYE 188
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 3e-06
Identities = 65/313 (20%), Positives = 131/313 (41%), Gaps = 74/313 (23%)
Query: 136 KQISLSECIGKGRYGEVWRGVWHG-------ENVAVKIFFSRDEASWSRETEIYSTVLLR 188
++I++S +G+G +G V+ G+ G VA+K + AS E + +
Sbjct: 6 EKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTV--NEAASMRERIEFLNEASVM 63
Query: 189 HE----NILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLN--RTTLNHH--------- 233
E +++ +G + + + L+T G L +L R + ++
Sbjct: 64 KEFNCHHVVRLLGVVSQGQPTLVIMELMTR----GDLKSYLRSLRPEMENNPVQAPPSLK 119
Query: 234 QMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA----- 288
+M+++ I +G+ +L+ F HRD+ ++N +V + T I DFG+
Sbjct: 120 KMIQMAGEIADGMAYLNANKF--------VHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 171
Query: 289 VSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRT 348
Y + K +P R+MSPE L + + F ++ +D+++ G+VLWE+
Sbjct: 172 TDYYRKGGKGLLP-------VRWMSPESLKDGV----FTTY--SDVWSFGVVLWEIATLA 218
Query: 349 KANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECW 408
+ PY + +V+ + +L D+ + + ++M+ CW
Sbjct: 219 ---------EQPYQGM--------SNEQVLRFVMEGGLLDK---PDNCPDMLFELMRMCW 258
Query: 409 HQNANVRLSALRV 421
N +R S L +
Sbjct: 259 QYNPKMRPSFLEI 271
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 3e-06
Identities = 55/214 (25%), Positives = 92/214 (42%), Gaps = 40/214 (18%)
Query: 144 IGKGRYGEVWRGVWHGENV--AVKIFFSRDEASWSRETEIYS--TVLL---RHENILGYI 196
IGKG +G+V + AVK+ + + I + VLL +H ++G
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 197 GSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKI-CLSIVNGLVHLHTEIFG 255
S T+ +L+ V Y + G L+ HL R + + + + +LH+
Sbjct: 63 YSFQTAE----KLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSL--- 115
Query: 256 TQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRV----GTKRY 311
I +RD+K +NIL+ + G V+ DFGL K + P GT Y
Sbjct: 116 -----NIIYRDLKPENILLDSQGHVVLTDFGLC--------KEGVEPEETTSTFCGTPEY 162
Query: 312 MSPEILDESINMDCFESFKKA-DIYALGLVLWEV 344
++PE+L + E + + D + LG VL+E+
Sbjct: 163 LAPEVLRK-------EPYDRTVDWWCLGAVLYEM 189
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 3e-06
Identities = 56/214 (26%), Positives = 94/214 (43%), Gaps = 32/214 (14%)
Query: 137 QISLSECIGKGRYGEVWRGVWHGENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYI 196
Q ++ + G GEV+ HG+ K+ + EI + H I+ I
Sbjct: 93 QYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGKTPGREIDILKTISHRAIINLI 152
Query: 197 GSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTT-LNHHQMMKICLSIVNGLVHLHTEIFG 255
+ R T ++ Y L+ +++R+ L Q + I ++ L +LH
Sbjct: 153 HA---YRWKSTVCMVMPKYKC--DLFTYVDRSGPLPLEQAITIQRRLLEALAYLH----- 202
Query: 256 TQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPN-PR----VGTKR 310
G+ I HRD+K++NI + V+ DFG A K+D P+ P+ GT
Sbjct: 203 --GR-GIIHRDVKTENIFLDEPENAVLGDFGAAC-------KLDAHPDTPQCYGWSGTLE 252
Query: 311 YMSPEILDESINMDCFESFKKADIYALGLVLWEV 344
SPE+L +++ C K DI++ GLVL+E+
Sbjct: 253 TNSPELL--ALDPYC----AKTDIWSAGLVLFEM 280
|
Length = 392 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 3e-06
Identities = 39/119 (32%), Positives = 62/119 (52%), Gaps = 19/119 (15%)
Query: 230 LNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAV 289
L+H +M + ++ G+ HLH+ I HRD+K NI+VK++ T I DFGLA
Sbjct: 115 LDHERMSYLLYQMLCGIKHLHSA--------GIIHRDLKPSNIVVKSDCTLKILDFGLAR 166
Query: 290 SYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRT 348
+ S M P V T+ Y +PE++ + M E DI+++G ++ E+ R T
Sbjct: 167 TAGT-SFMM----TPYVVTRYYRAPEVI---LGMGYKE---NVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 4e-06
Identities = 55/216 (25%), Positives = 92/216 (42%), Gaps = 31/216 (14%)
Query: 144 IGKGRYGEVWRG---VWHGENVAVKIFFSRDEASWSRETEIYSTVLLR------HENILG 194
IG+G YG+V++ G VA+K + + I +LR H N++
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 195 YIGSDMTSR-NSCTQLWLVTHY--HSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHT 251
SR + T+L LV + + D + + + + ++ GL LH+
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS 128
Query: 252 EIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRY 311
+ HRD+K +NILV ++G +ADFGLA YS + V T Y
Sbjct: 129 H--------RVVHRDLKPQNILVTSSGQIKLADFGLARIYS-----FQMALTSVVVTLWY 175
Query: 312 MSPEILDESINMDCFESFKKADIYALGLVLWEVCRR 347
+PE+L +S D++++G + E+ RR
Sbjct: 176 RAPEVLLQS------SYATPVDLWSVGCIFAEMFRR 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 4e-06
Identities = 35/104 (33%), Positives = 50/104 (48%), Gaps = 21/104 (20%)
Query: 242 IVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIP 301
I GL LH E I +RD+K +NIL+ +G I+D GLAV +
Sbjct: 111 ICCGLEDLHQE--------RIVYRDLKPENILLDDHGHIRISDLGLAVHVPE-----GQT 157
Query: 302 PNPRVGTKRYMSPEILDESINMDCFESFK-KADIYALGLVLWEV 344
RVGT YM+PE++ E + D +ALG +L+E+
Sbjct: 158 IKGRVGTVGYMAPEVVKN-------ERYTFSPDWWALGCLLYEM 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 47.9 bits (115), Expect = 4e-06
Identities = 55/219 (25%), Positives = 88/219 (40%), Gaps = 56/219 (25%)
Query: 144 IGKGRYGEVWRGVWHGEN---VAVKIFFSRD------EASWSRETEIYSTVLLRHENILG 194
+G G +G V V H + A+KI E I ++ RH ++
Sbjct: 9 LGTGSFGRVML-VRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSI--RHPFLVN 65
Query: 195 YIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLS-IVNGLVHLHTEI 253
GS N L+LV Y G L+ HL ++ + + + +V L +LH+
Sbjct: 66 LYGSFQDDSN----LYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSL- 120
Query: 254 FGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRV------- 306
I +RD+K +N+L+ ++G I DFG A RV
Sbjct: 121 -------DIVYRDLKPENLLLDSDGYIKITDFGFAK---------------RVKGRTYTL 158
Query: 307 -GTKRYMSPE-ILDESINMDCFESFKKADIYALGLVLWE 343
GT Y++PE IL + K D +ALG++++E
Sbjct: 159 CGTPEYLAPEIILSKGYG-------KAVDWWALGILIYE 190
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 48.0 bits (115), Expect = 4e-06
Identities = 58/214 (27%), Positives = 93/214 (43%), Gaps = 41/214 (19%)
Query: 144 IGKGRYGEVWRG--VWHGENVAVK----IFFSRDEASWSRETEIYSTVLLR----HENIL 193
IG+G + EV + G+ A+K F S ++ + RE + LR H NIL
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQ-----ALRRLSPHPNIL 61
Query: 194 GYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLN--RTTLNHHQMMKICLSIVNGLVHLHT 251
I ++ +L LV +LY+ + + L ++ ++ L H+H
Sbjct: 62 RLI--EVLFDRKTGRLALVFELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH- 117
Query: 252 EIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVS-YSQLSNKMDIPPNPRVGTKR 310
+ I HRDIK +NIL+K + +ADFG YS+ P + T+
Sbjct: 118 -------RNGIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKP------PYTEYISTRW 163
Query: 311 YMSPEILDESINMDCFESFKKADIYALGLVLWEV 344
Y +PE L D + K DI+A+G V +E+
Sbjct: 164 YRAPECL----LTDGYYGP-KMDIWAVGCVFFEI 192
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 4e-06
Identities = 57/215 (26%), Positives = 98/215 (45%), Gaps = 36/215 (16%)
Query: 144 IGKGRYGEVW--RGVWHGENVAVKIF-----FSRDEASWSRETEIYSTVL--LRHENILG 194
+GKG +G+V R G A+KI ++DE + T S VL RH +
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVA---HTVTESRVLQNTRHPFLTA 59
Query: 195 YIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKIC-LSIVNGLVHLHTEI 253
+ T C V Y + G L+ HL+R + + + IV+ L +LH+
Sbjct: 60 LKYAFQTHDRLC----FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR- 114
Query: 254 FGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMS 313
+ +RDIK +N+++ +G I DFGL +S+ + GT Y++
Sbjct: 115 -------DVVYRDIKLENLMLDKDGHIKITDFGLC--KEGISDGATM--KTFCGTPEYLA 163
Query: 314 PEILDESINMDCFESFKKADIYALGLVLWE-VCRR 347
PE+L+++ + + D + LG+V++E +C R
Sbjct: 164 PEVLEDN------DYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 9e-06
Identities = 56/212 (26%), Positives = 91/212 (42%), Gaps = 36/212 (16%)
Query: 144 IGKGRYGEVWRG--VWHGENVAVKIFFSRDEASWSRETEIYSTVLL----RHENILGYIG 197
+G G YG V G VAVK SR S Y + L +HEN++G +
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 83
Query: 198 --SDMTSRNSCTQLWLVTHYHSFGSLYDHL---NRTTLNHHQMMKICLSIVNGLVHLHTE 252
+ S ++LVTH G+ +++ + T +H Q + I+ GL ++H+
Sbjct: 84 VFTPARSLEEFNDVYLVTHL--MGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIHS- 138
Query: 253 IFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYM 312
I HRD+K N+ V + I DFGLA D V T+ Y
Sbjct: 139 -------ADIIHRDLKPSNLAVNEDCELKILDFGLA-------RHTDDEMTGYVATRWYR 184
Query: 313 SPEILDESINMDCFESFKKADIYALGLVLWEV 344
+PEI+ ++ + DI+++G ++ E+
Sbjct: 185 APEIM-----LNWMHYNQTVDIWSVGCIMAEL 211
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 9e-06
Identities = 73/337 (21%), Positives = 132/337 (39%), Gaps = 96/337 (28%)
Query: 137 QISLSECIGKGRYGEVWRGVWHG-------ENVAVKIFFSRDEASWSRETEIYSTVLL-- 187
+ L + +G+G +G+V + VAVK+ ++ AS S ++ S L
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKML--KENASSSELRDLLSEFNLLK 58
Query: 188 --RHENILGYIGSDMTSRNSCTQ---LWLVTHYHSFGSLYDHL----------------- 225
H +++ G+ C+Q L L+ Y +GSL L
Sbjct: 59 QVNHPHVIKLYGA-------CSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNR 111
Query: 226 NRTTLNHHQM----MKICLS----IVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTN 277
N + L++ M +S I G+ +L + + HRD+ ++N+LV
Sbjct: 112 NSSYLDNPDERALTMGDLISFAWQISRGMQYL--------AEMKLVHRDLAARNVLVAEG 163
Query: 278 GTCVIADFGLAV------SYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKK 331
I+DFGL+ SY + S R+ K +M+ E L + I +
Sbjct: 164 RKMKISDFGLSRDVYEEDSYVKRSKG-------RIPVK-WMAIESLFDHIYT------TQ 209
Query: 332 ADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRW 391
+D+++ G++LWE I PY + P + F+ ++ ++ RP
Sbjct: 210 SDVWSFGVLLWE---------IVTLGGNPYPGIAP-ERLFNLLKTGYRME--RP------ 251
Query: 392 VSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKL 428
++ M +M CW Q + R + + K L K+
Sbjct: 252 --ENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM 286
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 43/160 (26%), Positives = 68/160 (42%), Gaps = 43/160 (26%)
Query: 264 HRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNP---RVGTKR----YMSPE- 315
HRD+ ++NIL+ N I DFGLA DI +P R G+ R +M+PE
Sbjct: 197 HRDLAARNILLSENNVVKICDFGLA---------RDIYKDPDYVRKGSARLPLKWMAPES 247
Query: 316 ILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFDDMR 375
I D+ ++D+++ G++LWE IF +PY V ++ F
Sbjct: 248 IFDKVYT-------TQSDVWSFGVLLWE---------IFSLGASPYPG-VQINEEFCQRL 290
Query: 376 KVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVR 415
K D R P ++ + ++M CW + R
Sbjct: 291 K----DGTRMRAP-----ENATPEIYRIMLACWQGDPKER 321
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 1e-05
Identities = 56/230 (24%), Positives = 94/230 (40%), Gaps = 72/230 (31%)
Query: 144 IGKGRYGEVWRGVWHGENVAVKIFFSRDEASWSRETEIYSTVLLRHENIL-----GYIGS 198
IGKG +G K+ ++ +A + + Y+ +L+ + IL +I
Sbjct: 3 IGKGSFG--------------KVLLAKHKA----DGKFYAVKVLQKKAILKKKEQKHI-- 42
Query: 199 DMTSRN----SCTQLWLVTHYHSFGS---LY---DHLNRTTLNHHQMMKICLS------- 241
M RN + +LV ++SF + LY D++N L H +
Sbjct: 43 -MAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFY 101
Query: 242 ---IVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKM 298
I + L +LH+ I +RD+K +NIL+ + G V+ DFGL K
Sbjct: 102 AAEIASALGYLHSL--------NIIYRDLKPENILLDSQGHVVLTDFGLC--------KE 145
Query: 299 DIPPNPRV----GTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEV 344
I + GT Y++PE+L + + D + LG VL+E+
Sbjct: 146 GIEHSKTTSTFCGTPEYLAPEVLRKQ------PYDRTVDWWCLGAVLYEM 189
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 1e-05
Identities = 47/204 (23%), Positives = 86/204 (42%), Gaps = 60/204 (29%)
Query: 234 QMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA----- 288
+M+++ I +G+ +L+ + F HRD+ ++N +V + T I DFG+
Sbjct: 120 EMIQMAAEIADGMAYLNAKKF--------VHRDLAARNCMVAHDFTVKIGDFGMTRDIYE 171
Query: 289 VSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRT 348
Y + K +P R+M+PE L + + F + +D+++ G+VLWE+
Sbjct: 172 TDYYRKGGKGLLP-------VRWMAPESLKDGV----FTTS--SDMWSFGVVLWEI---- 214
Query: 349 KANGIFEEYKAPYHDL-------VPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMT 401
+ E+ PY L MD + D +P D+ +T
Sbjct: 215 --TSLAEQ---PYQGLSNEQVLKFVMDGGYLD----------QP--------DNCPERVT 251
Query: 402 KVMKECWHQNANVRLSALRVKKTL 425
+M+ CW N +R + L + L
Sbjct: 252 DLMRMCWQFNPKMRPTFLEIVNLL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 1e-05
Identities = 34/108 (31%), Positives = 50/108 (46%), Gaps = 29/108 (26%)
Query: 242 IVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIP 301
I+ GL LH E +RD+K +NIL+ G I+D GLAV IP
Sbjct: 111 ILCGLEDLHRE--------NTVYRDLKPENILLDDYGHIRISDLGLAVK---------IP 153
Query: 302 PNP----RVGTKRYMSPEILDESINMDCFESFK-KADIYALGLVLWEV 344
RVGT YM+PE+L+ + + D + LG +++E+
Sbjct: 154 EGESIRGRVGTVGYMAPEVLNN-------QRYTLSPDYWGLGCLIYEM 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 1e-05
Identities = 47/160 (29%), Positives = 68/160 (42%), Gaps = 43/160 (26%)
Query: 264 HRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNP---RVGTKR----YMSPE- 315
HRD+ ++NIL+ N I DFGLA DI +P R G R +M+PE
Sbjct: 202 HRDLAARNILLSENNVVKICDFGLA---------RDIYKDPDYVRKGDARLPLKWMAPET 252
Query: 316 ILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFDDMR 375
I D + ++D+++ G++LWE IF +PY V +D F
Sbjct: 253 IFDRVYTI-------QSDVWSFGVLLWE---------IFSLGASPYPG-VKIDEEFCRRL 295
Query: 376 KVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVR 415
K + R P D T M + M +CWH + R
Sbjct: 296 K----EGTRMRAP-----DYTTPEMYQTMLDCWHGEPSQR 326
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 2e-05
Identities = 52/201 (25%), Positives = 81/201 (40%), Gaps = 62/201 (30%)
Query: 178 ETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMK 237
E EI +T L H + S T C LV Y G L+ L R Q K
Sbjct: 51 EQEILAT--LDHPFLPTLYASFQTETYLC----LVMDYCPGGELFRLLQR------QPGK 98
Query: 238 ICLS----------IVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGL 287
CLS ++ L +LH I +RD+K +NIL+ +G +++DF L
Sbjct: 99 -CLSEEVARFYAAEVLLALEYLHLL--------GIVYRDLKPENILLHESGHIMLSDFDL 149
Query: 288 AV-----------SYSQLSNKMDI----------PPNPR----VGTKRYMSPEILDESIN 322
+ + + S + + P+ R VGT+ Y++PE+ I+
Sbjct: 150 SKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEV----IS 205
Query: 323 MDCFESFKKADIYALGLVLWE 343
D S D + LG++L+E
Sbjct: 206 GDGHGS--AVDWWTLGILLYE 224
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 2e-05
Identities = 30/106 (28%), Positives = 45/106 (42%), Gaps = 33/106 (31%)
Query: 264 HRDIKSKNILVKTNGTCVIADFGLA---------VSYSQLSNKMDIPPNPR--------- 305
HRDIK NIL+ +G +ADFGL Y S+ + N
Sbjct: 124 HRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQR 183
Query: 306 -------VGTKRYMSPEIL-DESINMDCFESFKKADIYALGLVLWE 343
VGT Y++PE+L ++C D ++LG++L+E
Sbjct: 184 RVRANSTVGTPDYIAPEVLRGTPYGLEC-------DWWSLGVILYE 222
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.1 bits (110), Expect = 2e-05
Identities = 28/86 (32%), Positives = 40/86 (46%), Gaps = 18/86 (20%)
Query: 264 HRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPR-----VGTKRYMSPEILD 318
HRD+K N+L+ TN I DFGLA + V T+ Y +PEI
Sbjct: 129 HRDLKPSNLLLNTNCDLKICDFGLARIADPEH------DHTGFLTEYVATRWYRAPEI-- 180
Query: 319 ESINMDCFESFKKA-DIYALGLVLWE 343
M + + KA DI+++G +L E
Sbjct: 181 ----MLNSKGYTKAIDIWSVGCILAE 202
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 2e-05
Identities = 40/152 (26%), Positives = 69/152 (45%), Gaps = 27/152 (17%)
Query: 200 MTSRNSCTQ----LWLVTHYHSFGSLYDHLNRT-TLNHHQMMKICLSIVNGLVHLHTEIF 254
+T +SC Q L+ V Y + G L H+ + Q + I GL LH
Sbjct: 63 LTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLH---- 118
Query: 255 GTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMD-IPPNPRVGTKRYMS 313
+ I +RD+K N+++ + G IADFG+ + +D + GT Y++
Sbjct: 119 ----RRGIIYRDLKLDNVMLDSEGHIKIADFGMCK-----EHMVDGVTTRTFCGTPDYIA 169
Query: 314 PEILDESINMDCFESF-KKADIYALGLVLWEV 344
PEI+ ++ + K D +A G++L+E+
Sbjct: 170 PEII-------AYQPYGKSVDWWAYGVLLYEM 194
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 2e-05
Identities = 44/196 (22%), Positives = 90/196 (45%), Gaps = 38/196 (19%)
Query: 178 ETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYD----HLNRTTLNHH 233
+ E++ + L H NI+ Y + + +LW+VT + ++GS D H ++
Sbjct: 47 QGELHVSKLFNHPNIVPYRATFIAD----NELWVVTSFMAYGSAKDLICTHFM-DGMSEL 101
Query: 234 QMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQ 293
+ I ++ L ++H HR +K+ +IL+ +G ++ GL + S
Sbjct: 102 AIAYILQGVLKALDYIH--------HMGYVHRSVKASHILISVDGKVYLS--GLRSNLSM 151
Query: 294 LSNKMDIP-----PNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRT 348
+++ + P V ++SPE+L + N+ +++ K+DIY++G+ E+
Sbjct: 152 INHGQRLRVVHDFPKYSVKVLPWLSPEVLQQ--NLQGYDA--KSDIYSVGITACEL---- 203
Query: 349 KANGIFEEYKAPYHDL 364
ANG P+ D+
Sbjct: 204 -ANG-----HVPFKDM 213
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 45.3 bits (108), Expect = 2e-05
Identities = 29/110 (26%), Positives = 51/110 (46%), Gaps = 27/110 (24%)
Query: 238 ICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNK 297
+V +LH +G I +RD+K +N+L+ +NG + DFG A +L +
Sbjct: 98 YIACVVLAFEYLHN-----RG---IIYRDLKPENLLLDSNGYVKLVDFGFA---KKLKSG 146
Query: 298 MDIPPNPR----VGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWE 343
+ GT Y++PEI+ + D D ++LG++L+E
Sbjct: 147 ------QKTWTFCGTPEYVAPEII-LNKGYDFS-----VDYWSLGILLYE 184
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 53/211 (25%), Positives = 94/211 (44%), Gaps = 30/211 (14%)
Query: 144 IGKGRYGEVWRG--VWHGENVAVKIFFSRDEASWSRETEIYSTVLL----RHENILGYIG 197
+G G YG V + VAVK SR S Y + L +HEN++G +
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKL-SRPFQSLIHARRTYRELRLLKHMKHENVIGLLD 81
Query: 198 --SDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFG 255
+ TS + +++LVT+ L + + L+ + + ++ GL ++H+
Sbjct: 82 VFTPATSIENFNEVYLVTNLMG-ADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHS---- 136
Query: 256 TQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPE 315
I HRD+K N+ V + I DFGLA Q ++M V T+ Y +PE
Sbjct: 137 ----AGIIHRDLKPSNVAVNEDCELRILDFGLA---RQADDEM----TGYVATRWYRAPE 185
Query: 316 ILDESINMDCFESFKKADIYALGLVLWEVCR 346
I+ ++ + DI+++G ++ E+ +
Sbjct: 186 IM-----LNWMHYNQTVDIWSVGCIMAELLK 211
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 2e-05
Identities = 25/54 (46%), Positives = 31/54 (57%), Gaps = 3/54 (5%)
Query: 264 HRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEIL 317
HRDIK N+L+ NG +ADFG S +L + N VGT Y+SPEIL
Sbjct: 125 HRDIKPDNVLLDKNGHIRLADFG---SCLRLLADGTVQSNVAVGTPDYISPEIL 175
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 3e-05
Identities = 54/212 (25%), Positives = 94/212 (44%), Gaps = 36/212 (16%)
Query: 144 IGKGRYGEVW--RGVWHGENVAVKIFFSRDEASWSRETEIYS--TVLLR---HENILGYI 196
IGKG +G+V + G+ AVK+ + + + I + VLL+ H ++G
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 197 GSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRT-TLNHHQMMKICLSIVNGLVHLHTEIFG 255
S T+ +L+ V + + G L+ HL R + + I + L +LH+
Sbjct: 63 YSFQTTE----KLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHS---- 114
Query: 256 TQGKPAIAHRDIKSKNILVKTNGTCVIADFGL---AVSYSQLSNKMDIPPNPRVGTKRYM 312
I +RD+K +NIL+ + G V+ DFGL ++ S + GT Y+
Sbjct: 115 ----INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTF-------CGTPEYL 163
Query: 313 SPEILDESINMDCFESFKKADIYALGLVLWEV 344
+PE++ + D + LG VL+E+
Sbjct: 164 APEVIRKQ------PYDNTVDWWCLGAVLYEM 189
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 3e-05
Identities = 54/209 (25%), Positives = 90/209 (43%), Gaps = 31/209 (14%)
Query: 144 IGKGRYGEVWR-------GVWHGENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYI 196
IGKG +G+V + ++ + + SR E + T TVL + +I
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVT---HTLAERTVLAQVNC--PFI 55
Query: 197 GSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRT-TLNHHQMMKICLSIVNGLVHLHTEIFG 255
S S +L+LV + + G L+ HL R + + ++ L +LH
Sbjct: 56 VPLKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLH----- 110
Query: 256 TQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPE 315
K + +RD+K +NIL+ G + DFGL +L+ K D N GT Y++PE
Sbjct: 111 ---KFNVIYRDLKPENILLDYQGHIALCDFGLC----KLNMKDDDKTNTFCGTPEYLAPE 163
Query: 316 ILDESINMDCFESFKKADIYALGLVLWEV 344
+L D + LG++L+E+
Sbjct: 164 LLLGHGYTKA------VDWWTLGVLLYEM 186
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 3e-05
Identities = 52/226 (23%), Positives = 93/226 (41%), Gaps = 44/226 (19%)
Query: 135 AKQISLSECIGKGRYGEVWRGVWH---GENVAVKIFFSRDEASWSRETEIYSTVL----L 187
K I + +G GR+GE+ RG + V I R S + + L
Sbjct: 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQF 63
Query: 188 RHENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNG 245
H NI+ G +T N+ + +VT Y S G+L L + L Q+M + + +G
Sbjct: 64 DHSNIVRLEGV-ITRGNT---MMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASG 119
Query: 246 LVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFG------LAVSYSQLSNKMD 299
+ +L +E+ H+ + + +LV ++ C I+ F Y+ +S K
Sbjct: 120 MKYL-SEM-------GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSP 171
Query: 300 IPPNPRVGTKRYMSPEILDESINMDCFESFKKA-DIYALGLVLWEV 344
+ + +PE + + F A D+++ G+V+WEV
Sbjct: 172 V---------LWAAPEAIQ-------YHHFSSASDVWSFGIVMWEV 201
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 3e-05
Identities = 49/180 (27%), Positives = 75/180 (41%), Gaps = 26/180 (14%)
Query: 144 IGKGRYGEVW--RGVWHGENVAVKIF---FSRDEASWSRETEIYSTVLLRHENILGYIGS 198
+G G +G V R G+NVA+K FS + E+ LRHENI+
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDI 77
Query: 199 DMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQG 258
++ ++ VT L+ L L + I+ GL ++H+
Sbjct: 78 FISPL---EDIYFVTELLG-TDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHS------- 126
Query: 259 KPAIAHRDIKSKNILVKTNGTCVIADFGLA-VSYSQLSNKMDIPPNPRVGTKRYMSPEIL 317
+ HRD+K NIL+ N I DFGLA + Q++ V T+ Y +PEI+
Sbjct: 127 -AGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTG--------YVSTRYYRAPEIM 177
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 3e-05
Identities = 68/287 (23%), Positives = 114/287 (39%), Gaps = 72/287 (25%)
Query: 162 VAVKIFFSRDEAS------WSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVTHY 215
VAVKI R +A+ + +E +I S L+ NI+ +G + C ++T Y
Sbjct: 49 VAVKIL--RPDANKNARNDFLKEVKILSR--LKDPNIIRLLGVCVDEDPLC----MITEY 100
Query: 216 HSFGSLYDHLNR--------------------TTLNHHQMMKICLSIVNGLVHLHTEIFG 255
G L L+ +++ ++ + L I +G+ +L + F
Sbjct: 101 MENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNF- 159
Query: 256 TQGKPAIAHRDIKSKNILVKTNGTCVIADFGL-----AVSYSQLSNKMDIPPNPRVGTKR 310
HRD+ ++N LV N T IADFG+ A Y ++ + +P R
Sbjct: 160 -------VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLP-------IR 205
Query: 311 YMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPS 370
+M+ E I M F + +D++A G+ LWE+ K PY +L D
Sbjct: 206 WMAW----ECILMGKFTT--ASDVWAFGVTLWEILMLCKEQ--------PYGELT--DEQ 249
Query: 371 FDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLS 417
+ DQ R V R + ++M +CW ++ R S
Sbjct: 250 VIENAGEFFRDQGRQVYLFR--PPPCPQGLYELMLQCWSRDCRERPS 294
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 4e-05
Identities = 27/81 (33%), Positives = 47/81 (58%), Gaps = 4/81 (4%)
Query: 264 HRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINM 323
HRDIK N+L+ NG +ADFG S +++ + + VGT Y+SPEIL +++
Sbjct: 125 HRDIKPDNVLLDMNGHIRLADFG---SCLKMNQDGTVQSSVAVGTPDYISPEIL-QAMED 180
Query: 324 DCFESFKKADIYALGLVLWEV 344
+ + D ++LG+ ++E+
Sbjct: 181 GMGKYGPECDWWSLGVCMYEM 201
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 4e-05
Identities = 50/212 (23%), Positives = 97/212 (45%), Gaps = 34/212 (16%)
Query: 142 ECIGKGRYGEVWRGV--WHGENVAVKIFFSRDEA----SWSRETEIYSTVLLRHENILGY 195
E +G+G Y V++G+ +G+ VA+K+ + E + RE + L+H NI+
Sbjct: 11 EKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKG--LKHANIV-L 67
Query: 196 IGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFG 255
+ + ++ + T ++ + H+ + Y + L+ + + ++ GL ++H +
Sbjct: 68 LHDIIHTKETLT--FVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQ--- 122
Query: 256 TQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPP---NPRVGTKRYM 312
I HRD+K +N+L+ G +ADFGLA + S IP + V T Y
Sbjct: 123 -----HILHRDLKPQNLLISYLGELKLADFGLARAKS-------IPSQTYSSEVVTLWYR 170
Query: 313 SPEILDESINMDCFESFKKADIYALGLVLWEV 344
P++L + + DI+ G + E+
Sbjct: 171 PPDVL-----LGATDYSSALDIWGAGCIFIEM 197
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 6e-05
Identities = 46/208 (22%), Positives = 87/208 (41%), Gaps = 26/208 (12%)
Query: 140 LSECIGKGRYGEVWRGVWH---GENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYI 196
+ E +G G +G V R H GE A+K R+ + + + E +I
Sbjct: 22 MGETLGTGSFGRV-RIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFI 80
Query: 197 GSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKI-CLSIVNGLVHLHTEIFG 255
+ M S +++ + + G L+ HL + + + K +V +LH++
Sbjct: 81 VNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSK--- 137
Query: 256 TQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPE 315
I +RD+K +N+L+ G + DFG A + + GT Y++PE
Sbjct: 138 -----DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTL-------CGTPEYLAPE 185
Query: 316 ILDESINMDCFESFKKADIYALGLVLWE 343
++ +S K D + +G++L+E
Sbjct: 186 VI-QSKGHG-----KAVDWWTMGVLLYE 207
|
Length = 329 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 6e-05
Identities = 51/188 (27%), Positives = 81/188 (43%), Gaps = 32/188 (17%)
Query: 142 ECIGKGRYGEVWRGV--WHGENVAVKIFFSRDEASWSRETEIYSTVLL---RHENILGYI 196
E IG+G YG V++ E +A+K E T I LL +H NI+
Sbjct: 8 EKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRL- 66
Query: 197 GSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTT--LNHHQMMKICL-SIVNGLVHLHTEI 253
D+ L+LV Y L H++ + + +++K L I+ G+ + H+
Sbjct: 67 -QDVVHSEKR--LYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH- 121
Query: 254 FGTQGKPAIAHRDIKSKNILV-KTNGTCVIADFGLAVSYSQLSNKMDIPPNP---RVGTK 309
+ HRD+K +N+L+ + +ADFGLA ++ IP V T
Sbjct: 122 -------RVLHRDLKPQNLLIDRRTNALKLADFGLARAFG-------IPVRTFTHEVVTL 167
Query: 310 RYMSPEIL 317
Y +PEIL
Sbjct: 168 WYRAPEIL 175
|
Length = 294 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 6e-05
Identities = 28/87 (32%), Positives = 42/87 (48%), Gaps = 18/87 (20%)
Query: 262 IAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRV----GTKRYMSPEIL 317
+ +RD+K NIL+ G C +ADFG+ K I GT Y++PEIL
Sbjct: 117 VIYRDLKLDNILLDAEGHCKLADFGMC--------KEGILNGVTTTTFCGTPDYIAPEIL 168
Query: 318 DESINMDCFESFKKADIYALGLVLWEV 344
E E D +ALG++++E+
Sbjct: 169 QE------LEYGPSVDWWALGVLMYEM 189
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 8e-05
Identities = 59/260 (22%), Positives = 111/260 (42%), Gaps = 48/260 (18%)
Query: 144 IGKGRYGEVW--RGVWHGENVAVKIFFSRDEASWSRETEIYS--TVL--LRHENILGYIG 197
+G G +G V R A+K+ + +E +++ VL + H I+
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFW 68
Query: 198 SDMTSRNSCTQLWLVTHYHSFGSLYDHL-NRTTLNHHQMMKICLSIVNGLVHLHTEIFGT 256
++ R L+++ Y G L+ +L N ++ + IV L +LH++
Sbjct: 69 TEHDQRF----LYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK---- 120
Query: 257 QGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEI 316
I +RD+K +NIL+ G + DFG A + + GT Y++PE+
Sbjct: 121 ----EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTL-------CGTPEYLAPEV 169
Query: 317 LDESINMDCFESFKKADIYALGLVLWEVC------RRTKANGIFEEYKA-----PYHDLV 365
+ +S + K D +ALG++++E+ GI+E+ A P H
Sbjct: 170 I-QSKGHN-----KAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRH--- 220
Query: 366 PMDPSFDDM-RKVICIDQQR 384
+D D+ +K++ +D+ R
Sbjct: 221 -LDLYAKDLIKKLLVVDRTR 239
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 1e-04
Identities = 29/81 (35%), Positives = 46/81 (56%), Gaps = 4/81 (4%)
Query: 264 HRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINM 323
HRDIK NIL+ NG +ADFG S +L + + VGT Y+SPEIL +++
Sbjct: 125 HRDIKPDNILMDMNGHIRLADFG---SCLKLMEDGTVQSSVAVGTPDYISPEIL-QAMED 180
Query: 324 DCFESFKKADIYALGLVLWEV 344
+ + D ++LG+ ++E+
Sbjct: 181 GKGKYGPECDWWSLGVCMYEM 201
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 43/168 (25%), Positives = 73/168 (43%), Gaps = 35/168 (20%)
Query: 235 MMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQL 294
++ I S++ + +LH I HRDIK++NI + G + DFG A
Sbjct: 184 ILAIERSVLRAIQYLHEN--------RIIHRDIKAENIFINHPGDVCLGDFGAACF---- 231
Query: 295 SNKMDIPPNPR---VGTKRYMSPEILDESINMDCFESFKKA-DIYALGLVLWEVCRRTKA 350
+DI N GT +PE+L + + A DI++ G+VL+E+ T
Sbjct: 232 --PVDINANKYYGWAGTIATNAPELLAR-------DPYGPAVDIWSAGIVLFEMA--TCH 280
Query: 351 NGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLN 398
+ +FE+ +D D R++ I ++ PN + D+ N
Sbjct: 281 DSLFEKDG--------LDGDCDSDRQIKLIIRRSGTHPNEFPIDAQAN 320
|
Length = 391 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 1e-04
Identities = 47/209 (22%), Positives = 88/209 (42%), Gaps = 30/209 (14%)
Query: 144 IGKGRYGEVWRGVWH----GENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIGSD 199
+G G +G V +G++ + VAVKI + + ++ LLR N++ + +
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDE------LLREANVMQQLDNP 56
Query: 200 MTSRN----SCTQLWLVTHYHSFGSLYDHLNRTT-LNHHQMMKICLSIVNGLVHLHTEIF 254
R LV G L L + + + ++ + G+ +L F
Sbjct: 57 YIVRMIGICEAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNF 116
Query: 255 GTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSP 314
HRD+ ++N+L+ T I+DFGL+ + N + + K Y +P
Sbjct: 117 --------VHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWY-AP 167
Query: 315 EILDESINMDCFESFKKADIYALGLVLWE 343
E +N F S K+D+++ G+++WE
Sbjct: 168 ----ECMNYYKFSS--KSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 28/86 (32%), Positives = 42/86 (48%), Gaps = 9/86 (10%)
Query: 259 KPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILD 318
K I HRDIK +N+L+ N + DFG A LS + V T+ Y SPE+L
Sbjct: 118 KNDIVHRDIKPENLLISHNDVLKLCDFGFA---RNLSEGSNANYTEYVATRWYRSPELLL 174
Query: 319 ESINMDCFESFKKADIYALGLVLWEV 344
+ K D++++G +L E+
Sbjct: 175 GA------PYGKAVDMWSVGCILGEL 194
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 1e-04
Identities = 53/212 (25%), Positives = 91/212 (42%), Gaps = 36/212 (16%)
Query: 144 IGKGRYGEVWRGVWHG--ENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIGSD-- 199
+GKG +G+V G E A+KI +D + E + + +L G
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKIL-KKDVVIQDDDVE----CTMVEKRVLALSGKPPF 62
Query: 200 MTSRNSCTQ----LWLVTHYHSFGSLYDHLNRT-TLNHHQMMKICLSIVNGLVHLHTEIF 254
+T +SC Q L+ V Y + G L + + + I GL LH++
Sbjct: 63 LTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK-- 120
Query: 255 GTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMD-IPPNPRVGTKRYMS 313
I +RD+K N+++ + G IADFG+ N D + GT Y++
Sbjct: 121 ------GIIYRDLKLDNVMLDSEGHIKIADFGMCK-----ENMWDGVTTKTFCGTPDYIA 169
Query: 314 PEILDESINMDCFESFKKA-DIYALGLVLWEV 344
PEI+ ++ + K+ D +A G++L+E+
Sbjct: 170 PEII-------AYQPYGKSVDWWAFGVLLYEM 194
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 1e-04
Identities = 29/91 (31%), Positives = 45/91 (49%), Gaps = 21/91 (23%)
Query: 259 KPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNP----RVGTKRYMSP 314
+ I +RD+K +NIL+ G I+D GLAV IP RVGT YM+P
Sbjct: 120 RERIVYRDLKPENILLDDRGHIRISDLGLAV---------QIPEGETVRGRVGTVGYMAP 170
Query: 315 EILDESINMDCFESFK-KADIYALGLVLWEV 344
E+++ E + D + LG +++E+
Sbjct: 171 EVINN-------EKYTFSPDWWGLGCLIYEM 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 1e-04
Identities = 50/236 (21%), Positives = 97/236 (41%), Gaps = 51/236 (21%)
Query: 138 ISLSECIGKGRYGEVWRGVWHGEN-----VAVK-----IFFSRDEASWSRETEIYSTVLL 187
+ L + +G+G +G V G ++ VAVK I + + E
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKD--F 58
Query: 188 RHENILGYIGS--DMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNH-------HQMMKI 238
H N++ IG + +S + ++ + G L+ L + L ++K
Sbjct: 59 DHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKF 118
Query: 239 CLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVS------YS 292
+ I G+ +L F HRD+ ++N +++ + T +ADFGL+ Y
Sbjct: 119 MVDIALGMEYLSNRNF--------IHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYR 170
Query: 293 Q-LSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRR 347
Q KM + ++++ E L + + + S K+D++A G+ +WE+ R
Sbjct: 171 QGRIAKMPV---------KWIAIESLADRV----YTS--KSDVWAFGVTMWEIATR 211
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 54/188 (28%), Positives = 83/188 (44%), Gaps = 33/188 (17%)
Query: 142 ECIGKGRYGEVWRGV--WHGENVAVK-IFFSRDEASWSRETEIYSTVL---LRHENILGY 195
E +G+G Y V++G GE VA+K I +E + S T I L L+HENI+
Sbjct: 6 EKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPS--TAIREISLMKELKHENIVRL 63
Query: 196 IGSDMTSRNSCTQLWLVTHY--HSFGSLYD-HLNRTTLNHHQMMKICLSIVNGLVHLHTE 252
D+ + +L LV Y D H R L+ + + ++ G+ H
Sbjct: 64 --HDVIHTEN--KLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN 119
Query: 253 IFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNP---RVGTK 309
+ HRD+K +N+L+ G +ADFGLA ++ IP N V T
Sbjct: 120 --------RVLHRDLKPQNLLINKRGELKLADFGLARAFG-------IPVNTFSNEVVTL 164
Query: 310 RYMSPEIL 317
Y +P++L
Sbjct: 165 WYRAPDVL 172
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 25/76 (32%), Positives = 36/76 (47%), Gaps = 12/76 (15%)
Query: 242 IVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIP 301
I+ GL LH + I +RD+K N+L+ +G IADFG+ K
Sbjct: 105 IICGLQFLHKK--------GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK---- 152
Query: 302 PNPRVGTKRYMSPEIL 317
+ GT Y++PEIL
Sbjct: 153 ASTFCGTPDYIAPEIL 168
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 2e-04
Identities = 50/237 (21%), Positives = 102/237 (43%), Gaps = 60/237 (25%)
Query: 138 ISLSECIGKGRYGEVWRGVWH----GENVAVKIFFSRDEASWSRETEIYSTVL----LRH 189
++LS+ + +G +G ++ G+ G+ V + +D AS + T + L H
Sbjct: 8 VTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSH 67
Query: 190 ENILGYIGSDMTSRNSCTQL----WLVTHYHSFGSLYDHL---------NRTTLNHHQMM 236
+NIL + C + +++ Y ++G+L L N L+ Q++
Sbjct: 68 QNILPILHV-------CIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLV 120
Query: 237 KICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIAD-FGLAVSYSQLS 295
+ + I G+ +LH K + H+DI ++N CVI + + ++ + LS
Sbjct: 121 HMAIQIACGMSYLH--------KRGVIHKDIAARN--------CVIDEELQVKITDNALS 164
Query: 296 NKMDIPPNPR--VGTK-----RYMSPEILDESINMDCFESFKKADIYALGLVLWEVC 345
D+ P +G ++M+ E L + S +D+++ G++LWE+
Sbjct: 165 R--DLFPMDYHCLGDNENRPVKWMALESLVNKE----YSS--ASDVWSFGVLLWELM 213
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 28/85 (32%), Positives = 47/85 (55%), Gaps = 13/85 (15%)
Query: 264 HRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMD----IPPNPRVGTKRYMSPEILDE 319
HRD+K N+L+ +G +ADFG + KMD + + VGT Y+SPE+L +
Sbjct: 165 HRDVKPDNMLLDKSGHLKLADFGTCM-------KMDANGMVRCDTAVGTPDYISPEVL-K 216
Query: 320 SINMDCFESFKKADIYALGLVLWEV 344
S D ++ D +++G+ L+E+
Sbjct: 217 SQGGDG-YYGRECDWWSVGVFLYEM 240
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 41/152 (26%), Positives = 69/152 (45%), Gaps = 27/152 (17%)
Query: 264 HRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINM 323
HRD+ ++N+L+ I DFGLA + SN I ++M+P ESI
Sbjct: 262 HRDLAARNVLICEGKLVKICDFGLARDIMRDSNY--ISKGSTFLPLKWMAP----ESIFN 315
Query: 324 DCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQ 383
+ + + +D+++ G++LWE IF PY +L PM+ F + K
Sbjct: 316 NLYTTL--SDVWSFGILLWE---------IFTLGGTPYPEL-PMNEQFYNAIK----RGY 359
Query: 384 RPVLPNRWVSDSTLNAMTKVMKECWHQNANVR 415
R P SD + ++M++CW + +R
Sbjct: 360 RMAKPAH-ASDE----IYEIMQKCWEEKFEIR 386
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 3e-04
Identities = 54/213 (25%), Positives = 91/213 (42%), Gaps = 38/213 (17%)
Query: 144 IGKGRYGEVWRGVWHG--ENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIGSDMT 201
+GKG +G+V G E A+KI +D + E T++ + L +T
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKIL-KKDVIIQDDDVE--CTMVEKRVLALPGKPPFLT 64
Query: 202 SRNSCTQ----LWLVTHYHSFGSLYDHLNRT-TLNHHQMMKICLSIVNGLVHLHTEIFGT 256
+SC Q L+ V Y + G L H+ + + I GL LH++
Sbjct: 65 QLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSK---- 120
Query: 257 QGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRV----GTKRYM 312
I +RD+K N+++ G IADFG+ K +I GT Y+
Sbjct: 121 ----GIIYRDLKLDNVMLDAEGHIKIADFGMC--------KENIFGGKTTRTFCGTPDYI 168
Query: 313 SPEILDESINMDCFESFKKA-DIYALGLVLWEV 344
+PEI+ ++ + K+ D +A G++L+E+
Sbjct: 169 APEII-------AYQPYGKSVDWWAFGVLLYEM 194
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 3e-04
Identities = 57/231 (24%), Positives = 98/231 (42%), Gaps = 41/231 (17%)
Query: 138 ISLSECIGKGRYGEVWRGVWHGEN-----VAVK-----IFFSRDEASWSRETEIYSTVLL 187
+L +GKG +G V E+ VAVK IF S D + RE
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKE--F 58
Query: 188 RHENILGYIGSDMTSRNSCTQL---WLVTHYHSFGSLYDHL-------NRTTLNHHQMMK 237
H N++ IG + SR +L ++ + G L+ L TL +++
Sbjct: 59 DHPNVIKLIGVSLRSRAK-GRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVR 117
Query: 238 ICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNK 297
+ I +G+ +L ++ F HRD+ ++N ++ N T +ADFGL S K
Sbjct: 118 FMIDIASGMEYLSSKNF--------IHRDLAARNCMLNENMTVCVADFGL-------SKK 162
Query: 298 MDIPPNPRVGTKRYMSPEILD-ESINMDCFESFKKADIYALGLVLWEVCRR 347
+ R G + + L ES+ + + + +D++A G+ +WE+ R
Sbjct: 163 IYSGDYYRQGCASKLPVKWLALESLADNVYTT--HSDVWAFGVTMWEIMTR 211
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 4e-04
Identities = 53/187 (28%), Positives = 83/187 (44%), Gaps = 31/187 (16%)
Query: 144 IGKGRYGEVWRGVWH-GEN-VAVK-IFFSRDEASWS---RETEIYSTVLLRHENILGYIG 197
+G+G Y V++G EN VA+K I +E + RE + L+H NI+
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKN--LKHANIVTL-- 68
Query: 198 SDMTSRNSCTQLWLVTHYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFG 255
D+ C L LV Y L +L+ ++ H + ++ GL + H
Sbjct: 69 HDIIHTERC--LTLVFEYLD-SDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH----- 120
Query: 256 TQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA----VSYSQLSNKMDI----PPNPRVG 307
K I HRD+K +N+L+ G +ADFGLA V SN++ PP+ +G
Sbjct: 121 ---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLG 177
Query: 308 TKRYMSP 314
+ Y +P
Sbjct: 178 STEYSTP 184
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 41.4 bits (98), Expect = 4e-04
Identities = 37/128 (28%), Positives = 53/128 (41%), Gaps = 26/128 (20%)
Query: 219 GSLYDHL-NRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNIL-VKT 276
G L+D L L+ ++ KI +V L LH K I H DIK +N+L +
Sbjct: 94 GDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLH--------KHNIIHNDIKLENVLYDRA 145
Query: 277 NGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPE-ILDESINMDCFESFKKADIY 335
+ D+GL S D GT Y SPE I + SF D +
Sbjct: 146 KDRIYLCDYGLCKIIGTPS-CYD-------GTLDYFSPEKIKGH----NYDVSF---DWW 190
Query: 336 ALGLVLWE 343
A+G++ +E
Sbjct: 191 AVGVLTYE 198
|
Length = 267 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 4e-04
Identities = 46/227 (20%), Positives = 96/227 (42%), Gaps = 34/227 (14%)
Query: 138 ISLSECIGKGRYGEVWRGVWHGENVAVKIFFSRDEASWSRETE----IYSTVLLR---HE 190
++L + +G+G +G V G + ++ +K+ + + +E + V ++ H
Sbjct: 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHP 60
Query: 191 NILGYIGSDM--TSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNH-------HQMMKICLS 241
N++ IG + ++ + G L+ L + L ++K
Sbjct: 61 NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTD 120
Query: 242 IVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIP 301
I +G+ +L ++ F HRD+ ++N ++ N +ADFG LS K+
Sbjct: 121 IASGMEYLSSKSF--------IHRDLAARNCMLNENMNVCVADFG-------LSKKIYNG 165
Query: 302 PNPRVGTKRYMSPE-ILDESINMDCFESFKKADIYALGLVLWEVCRR 347
R G M + I ES+ + + K+D+++ G+ +WE+ R
Sbjct: 166 DYYRQGRIAKMPVKWIAIESLADRVYTT--KSDVWSFGVTMWEIATR 210
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 5e-04
Identities = 47/215 (21%), Positives = 94/215 (43%), Gaps = 21/215 (9%)
Query: 135 AKQISLSECIGKGRYGEVWRGVWHGENVAVKIFFSRDEASWSRETEIYSTVLLRHENILG 194
A+ + + IG+G +GEV + V H + K++ + + + S +I+
Sbjct: 42 AEDYDVVKVIGRGAFGEV-QLVRH--KSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMA 98
Query: 195 YIGSDMTSRNSCT-----QLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHL 249
+ S + C L++V Y G L + ++ + +V L +
Sbjct: 99 FANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAI 158
Query: 250 HTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTK 309
H+ + HRD+K N+L+ +G +ADFG + + + + VGT
Sbjct: 159 HSM--------GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGM---VRCDTAVGTP 207
Query: 310 RYMSPEILDESINMDCFESFKKADIYALGLVLWEV 344
Y+SPE+L +S D + ++ D +++G+ L+E+
Sbjct: 208 DYISPEVL-KSQGGDGYYG-RECDWWSVGVFLFEM 240
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 5e-04
Identities = 35/138 (25%), Positives = 68/138 (49%), Gaps = 19/138 (13%)
Query: 208 QLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLS-IVNGLVHLHTEIFGTQGKPAIAHRD 266
+L+L+ + G L+ L++ + + +K L+ + L HLH+ I +RD
Sbjct: 72 KLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL--------GIIYRD 123
Query: 267 IKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCF 326
+K +NIL+ G + DFGL S+ S + GT YM+PE+++ +
Sbjct: 124 LKPENILLDEEGHIKLTDFGL----SKESIDHEKKAYSFCGTVEYMAPEVVNRRGHT--- 176
Query: 327 ESFKKADIYALGLVLWEV 344
+ AD ++ G++++E+
Sbjct: 177 ---QSADWWSFGVLMFEM 191
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 5e-04
Identities = 46/177 (25%), Positives = 74/177 (41%), Gaps = 36/177 (20%)
Query: 178 ETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHL----NRTTLNH- 232
E EI + L HENIL I + S + + + + +YD +R L
Sbjct: 211 ENEILALGRLNHENILK-IEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQT 269
Query: 233 HQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYS 292
+MK L V ++H + + HRDIK +NI + +G V+ DFG A+ +
Sbjct: 270 RAIMKQLLCAVE---YIHDKK--------LIHRDIKLENIFLNCDGKIVLGDFGTAMPFE 318
Query: 293 QLSNKMDIPPNPR----VGTKRYMSPEILDESINMDCFESF-KKADIYALGLVLWEV 344
+ VGT SPEIL + + + DI++ GL+L ++
Sbjct: 319 K-------EREAFDYGWVGTVATNSPEILAG-------DGYCEITDIWSCGLILLDM 361
|
Length = 501 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 7e-04
Identities = 27/76 (35%), Positives = 39/76 (51%), Gaps = 12/76 (15%)
Query: 242 IVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIP 301
I+ GL LH++ I +RD+K NIL+ T+G IADFG+ + + D
Sbjct: 105 IICGLQFLHSK--------GIVYRDLKLDNILLDTDGHIKIADFGMC----KENMLGDAK 152
Query: 302 PNPRVGTKRYMSPEIL 317
GT Y++PEIL
Sbjct: 153 TCTFCGTPDYIAPEIL 168
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 9e-04
Identities = 30/103 (29%), Positives = 50/103 (48%), Gaps = 18/103 (17%)
Query: 242 IVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIP 301
I + L+ LH + I +RD+K N+L+ G C +ADFG+ + N
Sbjct: 105 ITSALMFLHDK--------GIIYRDLKLDNVLLDHEGHCKLADFGMC--KEGIFN--GKT 152
Query: 302 PNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEV 344
+ GT Y++PEIL E + D +A+G++L+E+
Sbjct: 153 TSTFCGTPDYIAPEILQEMLYG------PSVDWWAMGVLLYEM 189
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.001
Identities = 49/210 (23%), Positives = 90/210 (42%), Gaps = 32/210 (15%)
Query: 144 IGKGRYGEVWRGV--WHGENVAVKIF---FSRDEASWSRETEIYSTVLLRHENILGYIG- 197
+G G YG V + G VA+K F + + E+ ++HEN++G +
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82
Query: 198 -SDMTSRNSCTQLWLVTHYH--SFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIF 254
+ S + +LV + G L H L+ ++ + ++ GL ++H
Sbjct: 83 FTPDLSLDRFHDFYLVMPFMGTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHA--- 136
Query: 255 GTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSP 314
I HRD+K N+ V + I DFGLA Q ++M V T+ Y +P
Sbjct: 137 -----AGIIHRDLKPGNLAVNEDCELKILDFGLA---RQTDSEM----TGYVVTRWYRAP 184
Query: 315 EILDESINMDCFESFKKADIYALGLVLWEV 344
E++ ++ + DI+++G ++ E+
Sbjct: 185 EVI-----LNWMHYTQTVDIWSVGCIMAEM 209
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 25/81 (30%), Positives = 49/81 (60%), Gaps = 5/81 (6%)
Query: 264 HRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINM 323
HRD+K N+L+ +G +ADFG + +++ + + + VGT Y+SPE+L +S
Sbjct: 165 HRDVKPDNMLLDKSGHLKLADFGTCM---KMNKEGMVRCDTAVGTPDYISPEVL-KSQGG 220
Query: 324 DCFESFKKADIYALGLVLWEV 344
D + ++ D +++G+ L+E+
Sbjct: 221 DGYYG-RECDWWSVGVFLYEM 240
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 49/184 (26%), Positives = 86/184 (46%), Gaps = 27/184 (14%)
Query: 142 ECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEASWSRETEIYSTVLLR---HENILGYI 196
E +G+G Y V++G +G+ VA+K+ ++E + T I LL+ H NI+ +
Sbjct: 11 EKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEG-TPFTAIREASLLKGLKHANIV-LL 68
Query: 197 GSDMTSRNSCTQLWLVTHY-HSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFG 255
+ ++ + T LV Y H+ Y + L+ + ++ GL ++H
Sbjct: 69 HDIIHTKETLT---LVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY-- 123
Query: 256 TQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYS----QLSNKMDI----PPNPRVG 307
I HRD+K +N+L+ G +ADFGLA + S SN++ PP+ +G
Sbjct: 124 ------ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLG 177
Query: 308 TKRY 311
+ Y
Sbjct: 178 STEY 181
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.001
Identities = 51/217 (23%), Positives = 94/217 (43%), Gaps = 47/217 (21%)
Query: 144 IGKGRYGEVWRGV--WHGENVAVKIFFSRDEASWSRETEIYS-------TVL--LRHENI 192
+G G YG V + GE VA+K + S ++EI++ T+L ++HEN+
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIK------KLSRPFQSEIFAKRAYRELTLLKHMQHENV 76
Query: 193 LGYIG--SDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTT---LNHHQMMKICLSIVNGLV 247
+G + + S + +LV Y + L + L+ ++ + ++ GL
Sbjct: 77 IGLLDVFTSAVSGDEFQDFYLVMPY-----MQTDLQKIMGHPLSEDKVQYLVYQMLCGLK 131
Query: 248 HLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVG 307
++H I HRD+K N+ V + I DFGLA D V
Sbjct: 132 YIH--------SAGIIHRDLKPGNLAVNEDCELKILDFGLARH-------ADAEMTGYVV 176
Query: 308 TKRYMSPEILDESINMDCFESFKKADIYALGLVLWEV 344
T+ Y +PE++ ++ + DI+++G ++ E+
Sbjct: 177 TRWYRAPEVI-----LNWMHYNQTVDIWSVGCIMAEM 208
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.001
Identities = 45/196 (22%), Positives = 87/196 (44%), Gaps = 38/196 (19%)
Query: 178 ETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRT----TLNHH 233
+ E+ + RH NI+ T + + LW+++ + ++GS + L +T ++
Sbjct: 47 QNEVVLSHFFRHPNIMTS----WTVFTTGSWLWVISPFMAYGSA-NSLLKTYFPEGMSEA 101
Query: 234 QMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQ 293
+ I + GL +LH + HR+IK+ +IL+ +G ++ GL+ YS
Sbjct: 102 LIGNILFGALRGLNYLH--------QNGYIHRNIKASHILISGDGLVSLS--GLSHLYSL 151
Query: 294 LSNKMDIP-----PNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRT 348
+ N P ++SPE+L + D + K+DIY++G+ E+
Sbjct: 152 VRNGQKAKVVYDFPQFSTSVLPWLSPELLRQ----DLYGYNVKSDIYSVGITACEL---- 203
Query: 349 KANGIFEEYKAPYHDL 364
A G + P+ D+
Sbjct: 204 -ATG-----RVPFQDM 213
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.002
Identities = 53/201 (26%), Positives = 82/201 (40%), Gaps = 33/201 (16%)
Query: 159 GENVAVKIFFSRDEASWS---RETEIYSTVLLRHENI------LGYIGSDMTSRNS---- 205
+ VAVK D S RE +I L H+NI LG GSD+T
Sbjct: 30 DKRVAVKKIVLTDPQSVKHALREIKI--IRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTE 87
Query: 206 CTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHR 265
+++V Y L + L + L+ ++ GL ++H+ + HR
Sbjct: 88 LNSVYIVQEYME-TDLANVLEQGPLSEEHARLFMYQLLRGLKYIHS--------ANVLHR 138
Query: 266 DIKSKNILVKTNGTCV-IADFGLA-VSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINM 323
D+K N+ + T + I DFGLA + S+K + + TK Y SP +L N
Sbjct: 139 DLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEG--LVTKWYRSPRLLLSPNNY 196
Query: 324 DCFESFKKADIYALGLVLWEV 344
K D++A G + E+
Sbjct: 197 T-----KAIDMWAAGCIFAEM 212
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 31/118 (26%), Positives = 53/118 (44%), Gaps = 23/118 (19%)
Query: 230 LNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAV 289
+N H + ++ GL + H + + HRD+K +N+L+ G +ADFGLA
Sbjct: 101 INMHNVKLFLFQLLRGLNYCH--------RRKVLHRDLKPQNLLINERGELKLADFGLAR 152
Query: 290 SYSQLSNKMDIPPNP---RVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEV 344
+ S IP V T Y P+IL S + + D++ +G + +E+
Sbjct: 153 AKS-------IPTKTYSNEVVTLWYRPPDILLGSTDYS-----TQIDMWGVGCIFYEM 198
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 39.7 bits (92), Expect = 0.002
Identities = 66/266 (24%), Positives = 112/266 (42%), Gaps = 51/266 (19%)
Query: 144 IGKGRYGEVWR-----GVWHGENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIGS 198
+G+G YG V++ G E +I + S RE + L+H N++
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRE--LKHPNVIAL--Q 64
Query: 199 DMTSRNSCTQLWLVTHY--HSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGT 256
+ +S ++WL+ Y H + +R + + + M++ S+V L++ +
Sbjct: 65 KVFLSHSDRKVWLLFDYAEHDLWHIIK-FHRASKANKKPMQLPRSMVKSLLYQILDGIHY 123
Query: 257 QGKPAIAHRDIKSKNILV----KTNGTCVIADFGLAVSY-SQLSNKMDIPPNPRVGTKRY 311
+ HRD+K NILV G IAD G A + S L D+ +P V T Y
Sbjct: 124 LHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL--DPVVVTFWY 181
Query: 312 MSPEILDESINMDCFESFKKADIYALGLVLWEV--------CRRTKANGIFEEYKA--PY 361
+PE+L + K DI+A+G + E+ CR+ E+ K P+
Sbjct: 182 RAPELL-----LGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ-------EDIKTSNPF 229
Query: 362 H----DLV------PMDPSFDDMRKV 377
H D + P D ++D+RK+
Sbjct: 230 HHDQLDRIFSVMGFPADKDWEDIRKM 255
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.003
Identities = 29/115 (25%), Positives = 49/115 (42%), Gaps = 42/115 (36%)
Query: 264 HRDIKSKNILVKTNGTCVIADFGLA--------------VSYSQLSNKMDIPPNPR---- 305
HRDIK N+L+ G ++DFGL +S++ SN +D P
Sbjct: 124 HRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKR 183
Query: 306 ----------------VGTKRYMSPEILDES-INMDCFESFKKADIYALGLVLWE 343
VGT Y++PE+ ++ N +C D ++LG++++E
Sbjct: 184 KAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKEC-------DWWSLGVIMYE 231
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.004
Identities = 28/115 (24%), Positives = 53/115 (46%), Gaps = 17/115 (14%)
Query: 230 LNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAV 289
++ H + I+ GL + H + + HRD+K +N+L+ G +ADFGLA
Sbjct: 101 MSMHNVKIFLYQILRGLAYCH--------RRKVLHRDLKPQNLLINERGELKLADFGLAR 152
Query: 290 SYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEV 344
+ S + + V T Y P++L + E + D++ +G + +E+
Sbjct: 153 AKSVPTKTY----SNEVVTLWYRPPDVL-----LGSSEYSTQIDMWGVGCIFFEM 198
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.004
Identities = 26/83 (31%), Positives = 43/83 (51%), Gaps = 13/83 (15%)
Query: 262 IAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESI 321
I +RD+K +N+L+ +G + DFG A +D GT Y++PEIL +
Sbjct: 152 IVYRDLKPENLLLDKDGFIKMTDFGFA-------KVVDTRTYTLCGTPEYIAPEIL---L 201
Query: 322 NMDCFESFKKADIYALGLVLWEV 344
N+ K AD + LG+ ++E+
Sbjct: 202 NVG---HGKAADWWTLGIFIYEI 221
|
Length = 340 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 38.9 bits (90), Expect = 0.004
Identities = 40/165 (24%), Positives = 69/165 (41%), Gaps = 27/165 (16%)
Query: 264 HRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINM 323
HRD+ ++N+L+ I DFGLA SN + ++M+P ESI
Sbjct: 260 HRDLAARNVLLAQGKIVKICDFGLARDIMHDSNY--VSKGSTFLPVKWMAP----ESIFD 313
Query: 324 DCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQ 383
+ + + +D+++ G++LWE IF PY ++ +D +F + K
Sbjct: 314 NLYTTL--SDVWSYGILLWE---------IFSLGGTPYPGMI-VDSTFYNKIK----SGY 357
Query: 384 RPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKL 428
R P D + +M +CW+ R S L + + L
Sbjct: 358 RMAKP-----DHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL 397
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 443 | |||
| KOG2052|consensus | 513 | 100.0 | ||
| KOG3653|consensus | 534 | 100.0 | ||
| KOG0192|consensus | 362 | 100.0 | ||
| KOG0197|consensus | 468 | 100.0 | ||
| KOG1187|consensus | 361 | 100.0 | ||
| KOG0581|consensus | 364 | 100.0 | ||
| KOG1026|consensus | 774 | 100.0 | ||
| KOG0196|consensus | 996 | 100.0 | ||
| KOG0575|consensus | 592 | 100.0 | ||
| KOG0595|consensus | 429 | 100.0 | ||
| KOG0591|consensus | 375 | 100.0 | ||
| KOG0615|consensus | 475 | 100.0 | ||
| KOG4721|consensus | 904 | 100.0 | ||
| KOG0592|consensus | 604 | 100.0 | ||
| KOG1094|consensus | 807 | 100.0 | ||
| KOG0598|consensus | 357 | 100.0 | ||
| KOG0582|consensus | 516 | 100.0 | ||
| KOG0198|consensus | 313 | 100.0 | ||
| KOG0193|consensus | 678 | 100.0 | ||
| KOG1095|consensus | 1025 | 100.0 | ||
| KOG0593|consensus | 396 | 100.0 | ||
| KOG0578|consensus | 550 | 100.0 | ||
| KOG0659|consensus | 318 | 100.0 | ||
| KOG0600|consensus | 560 | 100.0 | ||
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0661|consensus | 538 | 100.0 | ||
| KOG0194|consensus | 474 | 100.0 | ||
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0663|consensus | 419 | 100.0 | ||
| KOG0201|consensus | 467 | 100.0 | ||
| KOG0583|consensus | 370 | 100.0 | ||
| KOG0694|consensus | 694 | 100.0 | ||
| KOG0585|consensus | 576 | 100.0 | ||
| KOG0588|consensus | 786 | 100.0 | ||
| KOG0616|consensus | 355 | 100.0 | ||
| KOG0597|consensus | 808 | 100.0 | ||
| KOG0605|consensus | 550 | 100.0 | ||
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0658|consensus | 364 | 100.0 | ||
| KOG0660|consensus | 359 | 100.0 | ||
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG1989|consensus | 738 | 100.0 | ||
| KOG4278|consensus | 1157 | 100.0 | ||
| KOG1025|consensus | 1177 | 100.0 | ||
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0594|consensus | 323 | 100.0 | ||
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG2345|consensus | 302 | 100.0 | ||
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0589|consensus | 426 | 100.0 | ||
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0033|consensus | 355 | 100.0 | ||
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG4257|consensus | 974 | 100.0 | ||
| KOG0611|consensus | 668 | 100.0 | ||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG0580|consensus | 281 | 100.0 | ||
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0599|consensus | 411 | 100.0 | ||
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0199|consensus | 1039 | 100.0 | ||
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0610|consensus | 459 | 100.0 | ||
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577|consensus | 948 | 100.0 | ||
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0667|consensus | 586 | 100.0 | ||
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG0574|consensus | 502 | 100.0 | ||
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4279|consensus | 1226 | 100.0 | ||
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG0032|consensus | 382 | 100.0 | ||
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| KOG4717|consensus | 864 | 100.0 | ||
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0200|consensus | 609 | 100.0 | ||
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0584|consensus | 632 | 100.0 | ||
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| KOG1024|consensus | 563 | 100.0 | ||
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579|consensus | 1187 | 100.0 | ||
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| KOG0983|consensus | 391 | 100.0 | ||
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| KOG4645|consensus | 1509 | 100.0 | ||
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| KOG1035|consensus | 1351 | 100.0 | ||
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0596|consensus | 677 | 100.0 | ||
| KOG0586|consensus | 596 | 100.0 | ||
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0604|consensus | 400 | 100.0 | ||
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| KOG4250|consensus | 732 | 100.0 | ||
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| KOG0986|consensus | 591 | 100.0 | ||
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0612|consensus | 1317 | 100.0 | ||
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0587|consensus | 953 | 100.0 | ||
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG0666|consensus | 438 | 100.0 | ||
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG0669|consensus | 376 | 100.0 | ||
| KOG0690|consensus | 516 | 100.0 | ||
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| KOG1006|consensus | 361 | 100.0 | ||
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0696|consensus | 683 | 100.0 | ||
| KOG0603|consensus | 612 | 100.0 | ||
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG1151|consensus | 775 | 100.0 | ||
| KOG0662|consensus | 292 | 100.0 | ||
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG4236|consensus | 888 | 100.0 | ||
| KOG1027|consensus | 903 | 100.0 | ||
| KOG0607|consensus | 463 | 100.0 | ||
| KOG0984|consensus | 282 | 100.0 | ||
| KOG0614|consensus | 732 | 100.0 | ||
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0695|consensus | 593 | 100.0 | ||
| KOG0671|consensus | 415 | 100.0 | ||
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0576|consensus | 829 | 99.98 | ||
| KOG0664|consensus | 449 | 99.97 | ||
| KOG0608|consensus | 1034 | 99.97 | ||
| KOG0668|consensus | 338 | 99.97 | ||
| KOG1290|consensus | 590 | 99.97 | ||
| KOG1152|consensus | 772 | 99.97 | ||
| KOG1345|consensus | 378 | 99.96 | ||
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG0665|consensus | 369 | 99.96 | ||
| KOG0670|consensus | 752 | 99.96 | ||
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| KOG0195|consensus | 448 | 99.95 | ||
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.95 | |
| KOG1167|consensus | 418 | 99.95 | ||
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.93 | |
| KOG1164|consensus | 322 | 99.91 | ||
| KOG1165|consensus | 449 | 99.91 | ||
| KOG1163|consensus | 341 | 99.91 | ||
| KOG0590|consensus | 601 | 99.91 | ||
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.9 | |
| KOG1023|consensus | 484 | 99.9 | ||
| KOG4158|consensus | 598 | 99.89 | ||
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.87 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.87 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.86 | |
| KOG0603|consensus | 612 | 99.85 | ||
| PRK10345 | 210 | hypothetical protein; Provisional | 99.84 | |
| KOG1240|consensus | 1431 | 99.83 | ||
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.83 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.82 | |
| KOG1166|consensus | 974 | 99.81 | ||
| smart00090 | 237 | RIO RIO-like kinase. | 99.78 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.77 | |
| KOG0606|consensus | 1205 | 99.77 | ||
| KOG1033|consensus | 516 | 99.76 | ||
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.75 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.75 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.74 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.68 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.68 | |
| KOG1266|consensus | 458 | 99.65 | ||
| KOG0590|consensus | 601 | 99.65 | ||
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.63 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.54 | |
| KOG0601|consensus | 524 | 99.45 | ||
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.44 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.37 | |
| KOG0601|consensus | 524 | 99.24 | ||
| KOG1243|consensus | 690 | 99.23 | ||
| KOG0606|consensus | 1205 | 99.23 | ||
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.23 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.16 | |
| KOG3741|consensus | 655 | 99.12 | ||
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.12 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.12 | |
| KOG3087|consensus | 229 | 99.02 | ||
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.0 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.86 | |
| KOG2137|consensus | 700 | 98.82 | ||
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.71 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.7 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.54 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.51 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.39 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.35 | |
| KOG1235|consensus | 538 | 98.23 | ||
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.22 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.18 | |
| KOG1035|consensus | 1351 | 98.18 | ||
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.15 | |
| KOG0576|consensus | 829 | 98.11 | ||
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.11 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.04 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.95 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.91 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.85 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.84 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.79 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.77 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.69 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.53 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.52 | |
| KOG1826|consensus | 2724 | 97.3 | ||
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.1 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.06 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.05 | |
| KOG2270|consensus | 520 | 97.01 | ||
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.91 | |
| PLN02236 | 344 | choline kinase | 96.88 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.75 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.32 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.18 | |
| KOG2268|consensus | 465 | 96.15 | ||
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.11 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.11 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.92 | |
| KOG1093|consensus | 725 | 95.7 | ||
| PF06697 | 278 | DUF1191: Protein of unknown function (DUF1191); In | 95.68 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.65 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 95.53 | |
| KOG4258|consensus | 1025 | 95.52 | ||
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 95.49 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 95.31 | |
| PF08693 | 40 | SKG6: Transmembrane alpha-helix domain; InterPro: | 95.08 | |
| KOG1236|consensus | 565 | 94.98 | ||
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 94.84 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 94.82 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 94.76 |
| >KOG2052|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-71 Score=520.22 Aligned_cols=416 Identities=60% Similarity=0.974 Sum_probs=351.3
Q ss_pred CeeEecCCCCCCCCCCCCCCCCCCCCCCccccccchhhhhhHHhHHHHHHHHHHHHHHHHHHHHhhhhhHHHhhhhcCCC
Q psy14889 11 QFTIQCCDGDFCNNGSFPILPPSYRELPEYAQRYDYILKLSMAILGPVIVLGMLAAVIVLFMRRNHRKKLLAARAIQSDP 90 (443)
Q Consensus 11 ~~~~~~~~~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 90 (443)
-...-||.+++||+...+.++|..... ..+... ....+...+++.++.+.+++.+.++.+++++++.....+....++
T Consensus 96 ~~~~~CC~~d~CN~~~i~~~~~~~~~~-~~~~~~-~~~~~~~ii~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~ 173 (513)
T KOG2052|consen 96 FRNIECCYGDYCNNILIPLLLPHPQKP-FTPGML-GPVELVAIILGPVVFLLLIAILTVLGCFYRKRRYHERQRPNREDP 173 (513)
T ss_pred ceEEEecCccccccccCCCCCCCCCCC-CCcccC-ChHHHHHHHHHHHHHHHHHHHHHHheeeeeeecchhhccccccCc
Confidence 467788889999998887766553322 111111 222233333333333333333332222222211111101001111
Q ss_pred cccchhhHHHhhhcCCCchhHHhhhhcccCCCCCCCchHHHhhhhccccccceeeeecCeEEEEEEECCceeEEEEeecc
Q psy14889 91 DCFLADADLLRATAAGDSTLREYLDASLTSGSGSGLPLLIQRTLAKQISLSECIGKGRYGEVWRGVWHGENVAVKIFFSR 170 (443)
Q Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~ 170 (443)
. ..+...+++++++.++...++++++++|++.++.+.+++++.+.||+|.||+||+|.|.|+.||||++...
T Consensus 174 ~--------~~~~~~~~stl~Dll~~~~tSGSGSGlplLVQRTiarqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~sr 245 (513)
T KOG2052|consen 174 S--------TEATLAGDSTLKDLLDDLETSGSGSGLPLLVQRTIARQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSR 245 (513)
T ss_pred c--------ccccccCCccHHHHHHhhccCCCCCCchhHhHHhhhheeEEEEEecCccccceeeccccCCceEEEEeccc
Confidence 1 01256778889999999999999999999999999999999999999999999999999999999999999
Q ss_pred CccchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEeeecccCcccHHHHhcccCCCHHHHHHHHHHHHHHHHHHH
Q psy14889 171 DEASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLH 250 (443)
Q Consensus 171 ~~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH 250 (443)
++..+.+|.||.....|+|+||+.|++.-..+.+...++|||++|.+.|||+|||.+..++.+..++++..+|.||+|||
T Consensus 246 dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r~tv~~~~ml~LalS~AsGLaHLH 325 (513)
T KOG2052|consen 246 DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNRNTVTTEGMLKLALSIASGLAHLH 325 (513)
T ss_pred chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhhccCCHHHHHHHHHHHhhhHHHHH
Confidence 99999999999999999999999999998888888899999999999999999999999999999999999999999999
Q ss_pred HchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCC
Q psy14889 251 TEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFK 330 (443)
Q Consensus 251 ~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~ 330 (443)
...+++|++|.|.|||||+.|||+..++.+.|+|+|||..........+.+.+..+||.+|||||++....+...++...
T Consensus 326 ~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk 405 (513)
T KOG2052|consen 326 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYK 405 (513)
T ss_pred HHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhh
Confidence 99999999999999999999999999999999999999988888788888889999999999999999888877777778
Q ss_pred ccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcC
Q psy14889 331 KADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQ 410 (443)
Q Consensus 331 ~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 410 (443)
.+||||||.|+||++.+..-.++.++++.||.++++.+++++++++.++.+..+|.+|++|.++++...+.++|+.||..
T Consensus 406 ~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~ 485 (513)
T KOG2052|consen 406 RADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYA 485 (513)
T ss_pred HHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcC
Confidence 89999999999999999888899999999999999999999999999999999999999999999999999999999999
Q ss_pred CcCCCCcHHHHHHHHHHHhhcccccc
Q psy14889 411 NANVRLSALRVKKTLIKLACADMYIH 436 (443)
Q Consensus 411 dP~~Rps~~evl~~L~~l~~~~~~~~ 436 (443)
||..|.|+--|.+.|.++.+.++..+
T Consensus 486 Np~aRltALriKKtl~~l~~~~ek~k 511 (513)
T KOG2052|consen 486 NPAARLTALRIKKTLAKLSNSDEKIK 511 (513)
T ss_pred CchhhhHHHHHHHHHHHHhcChhhhc
Confidence 99999999999999999998765543
|
|
| >KOG3653|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-62 Score=463.40 Aligned_cols=297 Identities=39% Similarity=0.715 Sum_probs=267.5
Q ss_pred ccccccceeeeecCeEEEEEEECCceeEEEEeeccCccchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEeeecc
Q psy14889 136 KQISLSECIGKGRYGEVWRGVWHGENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVTHY 215 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e~ 215 (443)
..+++.++||+|+||.||+|+++++.||||++...+.+.+..|++|+.+-.++|+||++|+++-........++|||+||
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~f 289 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLDNRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEF 289 (534)
T ss_pred CchhhHHHhhcCccceeehhhccCceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeee
Confidence 46778899999999999999999999999999988889999999999999999999999999876555444679999999
Q ss_pred cCcccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchh-cCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCccccccc
Q psy14889 216 HSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIF-GTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQL 294 (443)
Q Consensus 216 ~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~-~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~~~~ 294 (443)
.++|+|.+||+...++|....+|+..+++||+|||+... +.+.+|+|+|||||++||||.+|+++.|+|||+|..+...
T Consensus 290 h~kGsL~dyL~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~ 369 (534)
T KOG3653|consen 290 HPKGSLCDYLKANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPG 369 (534)
T ss_pred ccCCcHHHHHHhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecCC
Confidence 999999999999999999999999999999999998754 4778999999999999999999999999999999888754
Q ss_pred CCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCC--CcccccCCCCCCCCCCCCChH
Q psy14889 295 SNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKAN--GIFEEYKAPYHDLVPMDPSFD 372 (443)
Q Consensus 295 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~--~~~~~~~~P~~~~~~~~~~~~ 372 (443)
....+ ....+||.+|||||++.+..+........+.||||+|.|||||++++... +..+.++.||+.....++..+
T Consensus 370 ~~~~d--~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e 447 (534)
T KOG3653|consen 370 KPQGD--THGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLE 447 (534)
T ss_pred CCCcc--hhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHH
Confidence 43332 23479999999999999887664223446899999999999999999876 778889999999999999999
Q ss_pred HHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhhcccc
Q psy14889 373 DMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLACADMY 434 (443)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~~~~~ 434 (443)
+++..+..+..||.+|..|........+++.+..||+.||+.|.|+.-+.+++.++....+.
T Consensus 448 ~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~ 509 (534)
T KOG3653|consen 448 EMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWED 509 (534)
T ss_pred HHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCc
Confidence 99999999999999999999998999999999999999999999999999999999877654
|
|
| >KOG0192|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-52 Score=403.24 Aligned_cols=260 Identities=32% Similarity=0.542 Sum_probs=215.9
Q ss_pred ccccccceeeeecCeEEEEEEECCce-eEEEEeeccCcc---chHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEe
Q psy14889 136 KQISLSECIGKGRYGEVWRGVWHGEN-VAVKIFFSRDEA---SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWL 211 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~~~~~-vAvK~~~~~~~~---~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~l 211 (443)
..+.+.+.||+|+||+||+|.|.|+. ||||++...... ......|+..+.+++|||||+|+|++..... .+.+
T Consensus 41 ~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~---~~~i 117 (362)
T KOG0192|consen 41 DELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPG---SLCI 117 (362)
T ss_pred HHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC---ceEE
Confidence 45566777999999999999999998 999998764422 2234556666666999999999999988742 4789
Q ss_pred eecccCcccHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCC-eEEeCCCCCCEEEcCCC-cEEEEecC
Q psy14889 212 VTHYHSFGSLYDHLNR---TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPA-IAHRDIKSKNILVKTNG-TCVIADFG 286 (443)
Q Consensus 212 v~e~~~~gsL~~~l~~---~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~-iiHrDlk~~NiLl~~~~-~~kl~DfG 286 (443)
||||+++|+|.+++++ ..+++..++.++.|||+||.|||++ + ||||||||+|||++.++ ++||+|||
T Consensus 118 VtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~--------~~iIHrDLK~~NiLv~~~~~~~KI~DFG 189 (362)
T KOG0192|consen 118 VTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSE--------GPIIHRDLKSDNILVDLKGKTLKIADFG 189 (362)
T ss_pred EEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC--------CCeeecccChhhEEEcCCCCEEEECCCc
Confidence 9999999999999955 6899999999999999999999998 6 99999999999999998 99999999
Q ss_pred CcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCC
Q psy14889 287 LAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVP 366 (443)
Q Consensus 287 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~ 366 (443)
+++...... ...+...||+.|||||++.+. ...|+.|+||||||++||||+|| +.||.+..+
T Consensus 190 lsr~~~~~~----~~~~~~~GT~~wMAPEv~~~~----~~~~~~K~DvySFgIvlWEl~t~----------~~Pf~~~~~ 251 (362)
T KOG0192|consen 190 LSREKVISK----TSMTSVAGTYRWMAPEVLRGE----KSPYTEKSDVYSFGIVLWELLTG----------EIPFEDLAP 251 (362)
T ss_pred cceeecccc----ccccCCCCCccccChhhhcCC----CCcCCccchhhhHHHHHHHHHHC----------CCCCCCCCH
Confidence 997765422 112336899999999999953 11788999999999999999999 889988632
Q ss_pred CCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhhcccc
Q psy14889 367 MDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLACADMY 434 (443)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~~~~~ 434 (443)
......+.....++.+|. .+++.+..||.+||+.||++||++.+++..|+.+......
T Consensus 252 -----~~~~~~v~~~~~Rp~~p~-----~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~ 309 (362)
T KOG0192|consen 252 -----VQVASAVVVGGLRPPIPK-----ECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS 309 (362)
T ss_pred -----HHHHHHHHhcCCCCCCCc-----cCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence 344444555677777774 3778899999999999999999999999999988775443
|
|
| >KOG0197|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-52 Score=399.21 Aligned_cols=259 Identities=26% Similarity=0.456 Sum_probs=214.7
Q ss_pred hhhccccccceeeeecCeEEEEEEECCc-eeEEEEeeccCccchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEe
Q psy14889 133 TLAKQISLSECIGKGRYGEVWRGVWHGE-NVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWL 211 (443)
Q Consensus 133 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~-~vAvK~~~~~~~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~l 211 (443)
...+.+++.+.||+|.||+||.|.|++. .||+|.++........+..|+..+.+|+|+|||+++|+|....+ ++|
T Consensus 203 i~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~p----iyI 278 (468)
T KOG0197|consen 203 IPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEP----IYI 278 (468)
T ss_pred ecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCc----eEE
Confidence 3446688899999999999999999876 99999998755443444455566666999999999999988753 799
Q ss_pred eecccCcccHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCc
Q psy14889 212 VTHYHSFGSLYDHLNR---TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA 288 (443)
Q Consensus 212 v~e~~~~gsL~~~l~~---~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla 288 (443)
|||||+.|+|.+||+. ..+...+.+.++.|||+||+||+++ ++|||||.++||||+++..+||+|||||
T Consensus 279 VtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~--------~~IHRDLAARNiLV~~~~~vKIsDFGLA 350 (468)
T KOG0197|consen 279 VTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESK--------NYIHRDLAARNILVDEDLVVKISDFGLA 350 (468)
T ss_pred EEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhC--------CccchhhhhhheeeccCceEEEcccccc
Confidence 9999999999999975 5699999999999999999999999 9999999999999999999999999999
Q ss_pred ccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCC
Q psy14889 289 VSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMD 368 (443)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~ 368 (443)
+...+..... .....-...|.|||.+..+ .++.|||||||||+||||+|- ++.||.++
T Consensus 351 r~~~d~~Y~~---~~~~kfPIkWtAPEa~~~~------~FS~kSDVWSFGVlL~E~fT~---------G~~py~~m---- 408 (468)
T KOG0197|consen 351 RLIGDDEYTA---SEGGKFPIKWTAPEALNYG------KFSSKSDVWSFGVLLWELFTY---------GRVPYPGM---- 408 (468)
T ss_pred cccCCCceee---cCCCCCCceecCHHHHhhC------CcccccceeehhhhHHHHhcc---------CCCCCCCC----
Confidence 9554332221 1222345689999999988 788999999999999999986 47888876
Q ss_pred CChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhhcc
Q psy14889 369 PSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLACAD 432 (443)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~~~ 432 (443)
...++.+.+... .+.+-| +.||+++.++|+.||+.+|++|||++.+...|+.+....
T Consensus 409 -sn~ev~~~le~G-yRlp~P-----~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~ 465 (468)
T KOG0197|consen 409 -SNEEVLELLERG-YRLPRP-----EGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTST 465 (468)
T ss_pred -CHHHHHHHHhcc-CcCCCC-----CCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcc
Confidence 455666666443 333333 459999999999999999999999999999999887654
|
|
| >KOG1187|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-50 Score=389.31 Aligned_cols=282 Identities=28% Similarity=0.375 Sum_probs=214.8
Q ss_pred CCCCchHHHhhhhccccccceeeeecCeEEEEEEEC-CceeEEEEeeccCcc-chHHHHHHHHHHhccCCCceeeeeecc
Q psy14889 123 GSGLPLLIQRTLAKQISLSECIGKGRYGEVWRGVWH-GENVAVKIFFSRDEA-SWSRETEIYSTVLLRHENILGYIGSDM 200 (443)
Q Consensus 123 ~~~~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~~~~~~~~-~~~~e~ei~~~~~l~H~nIv~l~g~~~ 200 (443)
...+.......++++|...+.||+|+||.||+|... |..||||++...... ...+..|+..+.+++|||+|+|+|||.
T Consensus 62 ~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~ 141 (361)
T KOG1187|consen 62 LRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCL 141 (361)
T ss_pred cceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEe
Confidence 334566677788899999999999999999999994 589999988665443 333556666666699999999999999
Q ss_pred ccCCcccEEEeeecccCcccHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCC
Q psy14889 201 TSRNSCTQLWLVTHYHSFGSLYDHLNRT---TLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTN 277 (443)
Q Consensus 201 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~---~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~ 277 (443)
+... +..||+|||++|+|.++|+.. .++|.++++|+.++|+||+|||+.+ .|+||||||||+|||||++
T Consensus 142 e~~~---~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~-----~~~iiHrDiKssNILLD~~ 213 (361)
T KOG1187|consen 142 EGGE---HRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGC-----PPPIIHRDIKSSNILLDED 213 (361)
T ss_pred cCCc---eEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCC-----CCCEecCCCCHHHeeECCC
Confidence 8753 479999999999999999753 7899999999999999999999873 6689999999999999999
Q ss_pred CcEEEEecCCcccccc-cCCcCCCCCCCc-ccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCccc
Q psy14889 278 GTCVIADFGLAVSYSQ-LSNKMDIPPNPR-VGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFE 355 (443)
Q Consensus 278 ~~~kl~DfGla~~~~~-~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~ 355 (443)
+++||+|||+|+.... .... ... .||.+|+|||++..+ ..+.|+|||||||+|+||+||+++.+...
T Consensus 214 ~~aKlsDFGLa~~~~~~~~~~-----~~~~~gt~gY~~PEy~~~g------~lt~KsDVySFGVvllElitgr~~~d~~~ 282 (361)
T KOG1187|consen 214 FNAKLSDFGLAKLGPEGDTSV-----STTVMGTFGYLAPEYASTG------KLTEKSDVYSFGVVLLELITGRKAVDQSR 282 (361)
T ss_pred CCEEccCccCcccCCccccce-----eeecCCCCccCChhhhccC------CcCcccccccchHHHHHHHhCCcccCCCC
Confidence 9999999999965543 2111 112 799999999999876 77899999999999999999976543211
Q ss_pred ccCCCCCCCCCCCCChHHHHhhhhh----cCCCCCCCCCCCCc-hhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhh
Q psy14889 356 EYKAPYHDLVPMDPSFDDMRKVICI----DQQRPVLPNRWVSD-STLNAMTKVMKECWHQNANVRLSALRVKKTLIKLAC 430 (443)
Q Consensus 356 ~~~~P~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~-~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~ 430 (443)
|-.. ....+.....+.. +...+.+....... .....+..+..+|++.+|.+||+|.||++.|+.+..
T Consensus 283 ----~~~~----~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 283 ----PRGE----LSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred ----Cccc----ccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 1110 0011111112111 11223322111121 456678899999999999999999999999976654
Q ss_pred c
Q psy14889 431 A 431 (443)
Q Consensus 431 ~ 431 (443)
.
T Consensus 355 ~ 355 (361)
T KOG1187|consen 355 L 355 (361)
T ss_pred c
Confidence 4
|
|
| >KOG0581|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-50 Score=370.31 Aligned_cols=251 Identities=27% Similarity=0.384 Sum_probs=205.7
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccch--HHHHHHHHHHhccCCCceeeeeeccccCCcccEEEe
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEASW--SRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWL 211 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~--~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~l 211 (443)
.+++..+.||+|..|+||++++ +++.+|+|++....+... +-.+|+..+...+||+||.+||.|..... ++.+
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~---~isI 155 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE---EISI 155 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc---eEEe
Confidence 4677788999999999999998 588999999854433322 23456666666899999999999988742 5899
Q ss_pred eecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCccc
Q psy14889 212 VTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVS 290 (443)
Q Consensus 212 v~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~ 290 (443)
+||||.+|||++++.. +++++....+++.+|++||.|||..+ +||||||||+|||++..|.+||+|||.++.
T Consensus 156 ~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~-------~IIHRDIKPsNlLvNskGeVKicDFGVS~~ 228 (364)
T KOG0581|consen 156 CMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEER-------KIIHRDIKPSNLLVNSKGEVKICDFGVSGI 228 (364)
T ss_pred ehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcc-------CeeeccCCHHHeeeccCCCEEeccccccHH
Confidence 9999999999999975 77999999999999999999999632 999999999999999999999999999987
Q ss_pred ccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCC
Q psy14889 291 YSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPS 370 (443)
Q Consensus 291 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~ 370 (443)
+... ..++++||..|||||.+.+. .|+.++||||||++++|+++| ++||....+....
T Consensus 229 lvnS------~a~tfvGT~~YMsPERi~g~------~Ys~~sDIWSLGLsllE~a~G----------rfP~~~~~~~~~~ 286 (364)
T KOG0581|consen 229 LVNS------IANTFVGTSAYMSPERISGE------SYSVKSDIWSLGLSLLELAIG----------RFPYPPPNPPYLD 286 (364)
T ss_pred hhhh------hcccccccccccChhhhcCC------cCCcccceecccHHHHHHhhC----------CCCCCCcCCCCCC
Confidence 7643 24678999999999999998 788899999999999999999 6666553222223
Q ss_pred hHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 371 FDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
.-++...+. ....|.+|.. .++++++.++..||++||.+|||++|+++
T Consensus 287 ~~~Ll~~Iv-~~ppP~lP~~----~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 287 IFELLCAIV-DEPPPRLPEG----EFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred HHHHHHHHh-cCCCCCCCcc----cCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 333333332 3455666642 47788999999999999999999999886
|
|
| >KOG1026|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-50 Score=405.61 Aligned_cols=265 Identities=26% Similarity=0.368 Sum_probs=216.2
Q ss_pred HHhhhhccccccceeeeecCeEEEEEEEC-------CceeEEEEeeccCcc--chHHHHHHHHHHhccCCCceeeeeecc
Q psy14889 130 IQRTLAKQISLSECIGKGRYGEVWRGVWH-------GENVAVKIFFSRDEA--SWSRETEIYSTVLLRHENILGYIGSDM 200 (443)
Q Consensus 130 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~~--~~~~e~ei~~~~~l~H~nIv~l~g~~~ 200 (443)
..+..+.+..+.+.||+|.||+||+|+.. ...||||.++...+. ...+++|+..+..++|||||+|+|+|.
T Consensus 480 ~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~ 559 (774)
T KOG1026|consen 480 VLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCR 559 (774)
T ss_pred eeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEc
Confidence 34455678889999999999999999874 357999999776543 333445555555699999999999999
Q ss_pred ccCCcccEEEeeecccCcccHHHHhcc-----------c----CCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEe
Q psy14889 201 TSRNSCTQLWLVTHYHSFGSLYDHLNR-----------T----TLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHR 265 (443)
Q Consensus 201 ~~~~~~~~~~lv~e~~~~gsL~~~l~~-----------~----~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHr 265 (443)
.+++ ++||+|||..|||.+||+- . +|+..+.+.||.|||.||+||-++ .+|||
T Consensus 560 ~~~P----~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~--------~FVHR 627 (774)
T KOG1026|consen 560 EGDP----LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH--------HFVHR 627 (774)
T ss_pred cCCe----eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------ccccc
Confidence 9865 7999999999999999941 2 288999999999999999999999 78999
Q ss_pred CCCCCCEEEcCCCcEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHH
Q psy14889 266 DIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVC 345 (443)
Q Consensus 266 Dlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ell 345 (443)
||..+|+||.++..+||+||||++.+....... ......-.++|||||.+..+ ++|++||||||||+|||++
T Consensus 628 DLATRNCLVge~l~VKIsDfGLsRdiYssDYYk--~~~~t~lPIRWMppEsIly~------kFTteSDVWs~GVvLWEIF 699 (774)
T KOG1026|consen 628 DLATRNCLVGENLVVKISDFGLSRDIYSSDYYK--VRGNTLLPIRWMPPESILYG------KFTTESDVWSFGVVLWEIF 699 (774)
T ss_pred chhhhhceeccceEEEecccccchhhhhhhhhc--ccCCceeeeecCCHHHhhcC------cccchhhhhhhhhhhhhhh
Confidence 999999999999999999999998765432211 11223446799999999988 8889999999999999998
Q ss_pred hcccCCCcccccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHH
Q psy14889 346 RRTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTL 425 (443)
Q Consensus 346 tg~~~~~~~~~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 425 (443)
+- +..||.+. +.+++.+.+..... ++. ++.||.++++||..||+.+|++|||++||..+|
T Consensus 700 sy---------G~QPy~gl-----Sn~EVIe~i~~g~l---L~~---Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L 759 (774)
T KOG1026|consen 700 SY---------GKQPYYGL-----SNQEVIECIRAGQL---LSC---PENCPTEVYSLMLECWNENPKRRPSFKEIHSRL 759 (774)
T ss_pred cc---------ccCccccc-----chHHHHHHHHcCCc---ccC---CCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHH
Confidence 74 48899887 44666666643333 332 367999999999999999999999999999999
Q ss_pred HHHhhcccc
Q psy14889 426 IKLACADMY 434 (443)
Q Consensus 426 ~~l~~~~~~ 434 (443)
+...+..+.
T Consensus 760 ~~~~~~s~~ 768 (774)
T KOG1026|consen 760 QAWAQASPK 768 (774)
T ss_pred HHHHhcCcc
Confidence 999877554
|
|
| >KOG0196|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-49 Score=395.47 Aligned_cols=290 Identities=24% Similarity=0.356 Sum_probs=233.9
Q ss_pred hhHHhhhhcccCCCCCCCchHHHhhhhccccccceeeeecCeEEEEEEEC--C---ceeEEEEeeccCcc--chHHHHHH
Q psy14889 109 TLREYLDASLTSGSGSGLPLLIQRTLAKQISLSECIGKGRYGEVWRGVWH--G---ENVAVKIFFSRDEA--SWSRETEI 181 (443)
Q Consensus 109 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~--~---~~vAvK~~~~~~~~--~~~~e~ei 181 (443)
..+.++++....++......+..+.-...+.+.++||.|.||+|++|+++ | ..||||.++....+ +..+..|.
T Consensus 602 G~k~YiDP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EA 681 (996)
T KOG0196|consen 602 GTKTYIDPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEA 681 (996)
T ss_pred CceeecCCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhh
Confidence 35666666666655555555566666678889999999999999999983 3 57999999764332 22333445
Q ss_pred HHHHhccCCCceeeeeeccccCCcccEEEeeecccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCC
Q psy14889 182 YSTVLLRHENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGK 259 (443)
Q Consensus 182 ~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~ 259 (443)
-++.+++||||++|.|+.....+ ++||+|||+||+|+.||++ +.+++.++..++++||.||.||-+.
T Consensus 682 sIMGQFdHPNIIrLEGVVTks~P----vMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm------- 750 (996)
T KOG0196|consen 682 SIMGQFDHPNIIRLEGVVTKSKP----VMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDM------- 750 (996)
T ss_pred hhcccCCCCcEEEEEEEEecCce----eEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhc-------
Confidence 55555999999999999877744 7999999999999999964 6799999999999999999999988
Q ss_pred CCeEEeCCCCCCEEEcCCCcEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHH
Q psy14889 260 PAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGL 339 (443)
Q Consensus 260 ~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gv 339 (443)
++|||||.++|||++.+..+|++|||+++.+.++.... .....-.-..+|.|||.+... ++|.+||||||||
T Consensus 751 -~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~-ytt~GGKIPiRWTAPEAIa~R------KFTsASDVWSyGI 822 (996)
T KOG0196|consen 751 -NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAA-YTTLGGKIPIRWTAPEAIAYR------KFTSASDVWSYGI 822 (996)
T ss_pred -CchhhhhhhhheeeccceEEEeccccceeecccCCCcc-ccccCCccceeecChhHhhhc------ccCchhhccccce
Confidence 99999999999999999999999999999887655222 111222234689999999887 7889999999999
Q ss_pred HHHHHHhcccCCCcccccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHH
Q psy14889 340 VLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSAL 419 (443)
Q Consensus 340 vl~elltg~~~~~~~~~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ 419 (443)
+|||.++- ++.||+++ +.+++.+.+..+...|.. .+||..+.+||..||++|-.+||.+.
T Consensus 823 VmWEVmSy---------GERPYWdm-----SNQdVIkaIe~gyRLPpP------mDCP~aL~qLMldCWqkdR~~RP~F~ 882 (996)
T KOG0196|consen 823 VMWEVMSY---------GERPYWDM-----SNQDVIKAIEQGYRLPPP------MDCPAALYQLMLDCWQKDRNRRPKFA 882 (996)
T ss_pred EEEEeccc---------CCCccccc-----chHHHHHHHHhccCCCCC------CCCcHHHHHHHHHHHHHHhhcCCCHH
Confidence 99998863 38899987 556777777655444433 44999999999999999999999999
Q ss_pred HHHHHHHHHhhccccccC
Q psy14889 420 RVKKTLIKLACADMYIHC 437 (443)
Q Consensus 420 evl~~L~~l~~~~~~~~~ 437 (443)
+|+..|+++......++.
T Consensus 883 qiV~~lDklIrnP~SLk~ 900 (996)
T KOG0196|consen 883 QIVSTLDKLIRNPNSLKT 900 (996)
T ss_pred HHHHHHHHHhcCchhhcc
Confidence 999999999988776664
|
|
| >KOG0575|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-48 Score=379.78 Aligned_cols=243 Identities=26% Similarity=0.371 Sum_probs=204.6
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeecc----CccchHHHHHHHHHHhccCCCceeeeeeccccCCcccEE
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSR----DEASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQL 209 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~----~~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~ 209 (443)
..|...+.||+|||+.+|+++. +|+.||+|++.+. ......-..||.+.+.|+|||||+++++|.+.. .+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~----nV 93 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSN----NV 93 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCC----ce
Confidence 5799999999999999999987 6999999998652 233333346677777799999999999999985 48
Q ss_pred EeeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCc
Q psy14889 210 WLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA 288 (443)
Q Consensus 210 ~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla 288 (443)
|||.|+|.+|+|..++++ ..+++.++..++.||+.||.|||++ +|||||||..|++++++.++||+|||||
T Consensus 94 YivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~--------~IiHRDLKLGNlfL~~~~~VKIgDFGLA 165 (592)
T KOG0575|consen 94 YIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSL--------GIIHRDLKLGNLFLNENMNVKIGDFGLA 165 (592)
T ss_pred EEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhc--------CceecccchhheeecCcCcEEeccccee
Confidence 999999999999999974 6899999999999999999999999 9999999999999999999999999999
Q ss_pred ccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCC
Q psy14889 289 VSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMD 368 (443)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~ 368 (443)
..+...... ..+.+||+.|.|||++... ..+..+||||+||+||-|++| ++||+..
T Consensus 166 t~le~~~Er----k~TlCGTPNYIAPEVl~k~------gHsfEvDiWSlGcvmYtLL~G----------~PPFetk---- 221 (592)
T KOG0575|consen 166 TQLEYDGER----KKTLCGTPNYIAPEVLNKS------GHSFEVDIWSLGCVMYTLLVG----------RPPFETK---- 221 (592)
T ss_pred eeecCcccc----cceecCCCcccChhHhccC------CCCCchhhhhhhhHHHhhhhC----------CCCcccc----
Confidence 888754332 2457999999999999866 677899999999999999999 6777653
Q ss_pred CChHHH-HhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 369 PSFDDM-RKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 369 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
...+. .++...+. .+| ...+.+..+||.++|+.||.+|||+++|+.
T Consensus 222 -~vkety~~Ik~~~Y---~~P-----~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 222 -TVKETYNKIKLNEY---SMP-----SHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred -hHHHHHHHHHhcCc---ccc-----cccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 23333 33433332 233 236678999999999999999999999986
|
|
| >KOG0595|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-48 Score=364.67 Aligned_cols=244 Identities=25% Similarity=0.345 Sum_probs=198.5
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccc---hHHHHHHHHHHhccCCCceeeeeeccccCCcccEEE
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEAS---WSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLW 210 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~---~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~ 210 (443)
.+|.+.+.||+|+||+||+|++ ++..||||.+....... ...+.||..++.++|||||++++++.++ ..+|
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~----~~i~ 85 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDD----DFIY 85 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecC----CeEE
Confidence 6789999999999999999998 58999999886654222 2236788888889999999999999888 4689
Q ss_pred eeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCC------CcEEEE
Q psy14889 211 LVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTN------GTCVIA 283 (443)
Q Consensus 211 lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~------~~~kl~ 283 (443)
||||||.+|||.+|+++ +.+++..+..++.|+|.||++||++ +||||||||+||||+.. -.+||+
T Consensus 86 lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~--------~IiHRDLKPQNiLLs~~~~~~~~~~LKIA 157 (429)
T KOG0595|consen 86 LVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHEN--------NIIHRDLKPQNILLSTTARNDTSPVLKIA 157 (429)
T ss_pred EEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC--------CeeeccCCcceEEeccCCCCCCCceEEec
Confidence 99999999999999986 4899999999999999999999999 99999999999999875 468999
Q ss_pred ecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCC
Q psy14889 284 DFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHD 363 (443)
Q Consensus 284 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~ 363 (443)
|||+|+.+..... ..+.+|++.|||||++... .|+.|+|+||.|+++||+++| ..||..
T Consensus 158 DFGfAR~L~~~~~-----a~tlcGSplYMAPEV~~~~------~YdAKADLWSiG~Ilyq~l~g----------~~Pf~a 216 (429)
T KOG0595|consen 158 DFGFARFLQPGSM-----AETLCGSPLYMAPEVIMSQ------QYDAKADLWSIGTILYQCLTG----------KPPFDA 216 (429)
T ss_pred ccchhhhCCchhH-----HHHhhCCccccCHHHHHhc------cccchhhHHHHHHHHHHHHhC----------CCCccc
Confidence 9999998875332 2456999999999999876 788999999999999999999 667765
Q ss_pred CCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHH
Q psy14889 364 LVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRV 421 (443)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ev 421 (443)
. +..++...+.......+.++. .....+.+++...+..+|.+|.++.+-
T Consensus 217 ~-----t~~eL~~~~~k~~~~~~~~~~----~~s~~~~~Ll~~ll~~~~~~~~~~~~~ 265 (429)
T KOG0595|consen 217 E-----TPKELLLYIKKGNEIVPVLPA----ELSNPLRELLISLLQRNPKDRISFEDF 265 (429)
T ss_pred c-----CHHHHHHHHhccccccCchhh----hccCchhhhhhHHHhcCccccCchHHh
Confidence 3 345555544433333333322 233446678888888888888876653
|
|
| >KOG0591|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-49 Score=353.48 Aligned_cols=255 Identities=27% Similarity=0.409 Sum_probs=204.8
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccchHH---HHHHHHHHhccCCCceeeeeeccccCCcccEEE
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEASWSR---ETEIYSTVLLRHENILGYIGSDMTSRNSCTQLW 210 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~---e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~ 210 (443)
.+|++.+.||+|+||+||++.. +|..||.|.+.-...+...+ -.||..+++|+|||||++++.....++ ..++
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~--evln 96 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDN--EVLN 96 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccc--hhhH
Confidence 5799999999999999999986 89999999876433222222 367777888999999999995444332 2379
Q ss_pred eeecccCcccHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEec
Q psy14889 211 LVTHYHSFGSLYDHLNR-----TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADF 285 (443)
Q Consensus 211 lv~e~~~~gsL~~~l~~-----~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~Df 285 (443)
||||||..|||...++. +.+++..+++++.|+++||..+|+..- ..-|+||||||.||+|+.+|.+||+||
T Consensus 97 ivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~----r~~VmHRDIKPaNIFl~~~gvvKLGDf 172 (375)
T KOG0591|consen 97 IVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIP----RGTVMHRDIKPANIFLTANGVVKLGDF 172 (375)
T ss_pred HHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhcccc----ccceeeccCcchheEEcCCCceeeccc
Confidence 99999999999999853 569999999999999999999998421 113999999999999999999999999
Q ss_pred CCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCC
Q psy14889 286 GLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLV 365 (443)
Q Consensus 286 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~ 365 (443)
|+++.+...... ..+.+|||.||+||.+.+. .|+.||||||+||++|||+.- +.||.+.
T Consensus 173 GL~r~l~s~~tf----A~S~VGTPyYMSPE~i~~~------~Y~~kSDiWslGCllyEMcaL----------~~PF~g~- 231 (375)
T KOG0591|consen 173 GLGRFLSSKTTF----AHSLVGTPYYMSPERIHES------GYNFKSDIWSLGCLLYEMCAL----------QSPFYGD- 231 (375)
T ss_pred hhHhHhcchhHH----HHhhcCCCcccCHHHHhcC------CCCcchhHHHHHHHHHHHHhc----------CCCcccc-
Confidence 999988754332 3567999999999999988 888999999999999999987 8888874
Q ss_pred CCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHH
Q psy14889 366 PMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLI 426 (443)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 426 (443)
....+.+.+.. ...+++|. +..+..+.+|+..|+..||+.||+...++..+.
T Consensus 232 ----n~~~L~~KI~q-gd~~~~p~----~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 232 ----NLLSLCKKIEQ-GDYPPLPD----EHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred ----cHHHHHHHHHc-CCCCCCcH----HHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 44555555543 34455553 346678999999999999999998544444443
|
|
| >KOG0615|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-49 Score=365.15 Aligned_cols=255 Identities=24% Similarity=0.310 Sum_probs=202.7
Q ss_pred hhhhccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccc--------hHHHHHHHHHHhccCCCceeeeeeccc
Q psy14889 132 RTLAKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEAS--------WSRETEIYSTVLLRHENILGYIGSDMT 201 (443)
Q Consensus 132 ~~~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~--------~~~e~ei~~~~~l~H~nIv~l~g~~~~ 201 (443)
+.+.+.|.+.+.||+|+||.|-+|.. +|+.||||++.++.... ..-+.|+..+++|+|||||++++++..
T Consensus 168 ks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~ 247 (475)
T KOG0615|consen 168 KSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEV 247 (475)
T ss_pred chhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeec
Confidence 34567888999999999999999987 69999999986543211 122456666667999999999999988
Q ss_pred cCCcccEEEeeecccCcccHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCC---
Q psy14889 202 SRNSCTQLWLVTHYHSFGSLYDHLN-RTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTN--- 277 (443)
Q Consensus 202 ~~~~~~~~~lv~e~~~~gsL~~~l~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~--- 277 (443)
++. .||||||+++|+|.+.+- ++.+.+..-..++.|++.|+.|||+. ||+||||||+|||+..+
T Consensus 248 ~ds----~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~--------GI~HRDiKPeNILl~~~~e~ 315 (475)
T KOG0615|consen 248 PDS----SYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQ--------GIIHRDIKPENILLSNDAED 315 (475)
T ss_pred CCc----eEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHc--------CcccccCCcceEEeccCCcc
Confidence 854 699999999999999884 56788888899999999999999999 99999999999999877
Q ss_pred CcEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCccccc
Q psy14889 278 GTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEY 357 (443)
Q Consensus 278 ~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~ 357 (443)
..+||+|||+|+.....+ ...+++||+.|.|||++.+.... .+..++|+||+||+||-+++|
T Consensus 316 ~llKItDFGlAK~~g~~s-----fm~TlCGTpsYvAPEVl~~kg~~---~~~~kVDiWSlGcvLfvcLsG---------- 377 (475)
T KOG0615|consen 316 CLLKITDFGLAKVSGEGS-----FMKTLCGTPSYVAPEVLASKGVE---YYPSKVDIWSLGCVLFVCLSG---------- 377 (475)
T ss_pred eEEEecccchhhccccce-----ehhhhcCCccccChhheecCCee---cccchheeeeccceEEEEecc----------
Confidence 679999999998876422 23678999999999999865321 233589999999999999999
Q ss_pred CCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 358 KAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 358 ~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
..||.+...... +.+.+. .+...-.|..| ..++++..+||.+||..||++|||++|+++
T Consensus 378 ~pPFS~~~~~~s----l~eQI~-~G~y~f~p~~w--~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 378 YPPFSEEYTDPS----LKEQIL-KGRYAFGPLQW--DRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred CCCcccccCCcc----HHHHHh-cCcccccChhh--hhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 778877543211 222222 12223333333 457889999999999999999999999886
|
|
| >KOG4721|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-47 Score=367.84 Aligned_cols=245 Identities=28% Similarity=0.452 Sum_probs=207.9
Q ss_pred ccccccceeeeecCeEEEEEEECCceeEEEEeeccCccchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEeeecc
Q psy14889 136 KQISLSECIGKGRYGEVWRGVWHGENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVTHY 215 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e~ 215 (443)
+.+.-++-||+|+-|.||+|++.++.||||.+ ...+|.+|..+++|+||||+.|.|+|... ..++|||||
T Consensus 124 e~IsELeWlGSGaQGAVF~Grl~netVAVKKV------~elkETdIKHLRkLkH~NII~FkGVCtqs----PcyCIiMEf 193 (904)
T KOG4721|consen 124 EEISELEWLGSGAQGAVFLGRLHNETVAVKKV------RELKETDIKHLRKLKHPNIITFKGVCTQS----PCYCIIMEF 193 (904)
T ss_pred HHhhhhhhhccCcccceeeeeccCceehhHHH------hhhhhhhHHHHHhccCcceeeEeeeecCC----ceeEEeeec
Confidence 34455678999999999999999999999976 33568889999999999999999999877 468999999
Q ss_pred cCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCccccccc
Q psy14889 216 HSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQL 294 (443)
Q Consensus 216 ~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~~~~ 294 (443)
|..|-|+..|+. ..++......+..+||.||.|||.+ .|||||||.-||||+.+..+||+|||-++.+...
T Consensus 194 Ca~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~h--------KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~ 265 (904)
T KOG4721|consen 194 CAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLH--------KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK 265 (904)
T ss_pred cccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHh--------hHhhhccCCCceEeeccceEEeccccchHhhhhh
Confidence 999999999975 6789999999999999999999999 8999999999999999999999999999888765
Q ss_pred CCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCChHHH
Q psy14889 295 SNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFDDM 374 (443)
Q Consensus 295 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~~~~~ 374 (443)
++. ..+.||..|||||++... ..+.|+||||||||||||+|| ..||.+..... .+
T Consensus 266 STk-----MSFaGTVaWMAPEvIrne------PcsEKVDIwSfGVVLWEmLT~----------EiPYkdVdssA----II 320 (904)
T KOG4721|consen 266 STK-----MSFAGTVAWMAPEVIRNE------PCSEKVDIWSFGVVLWEMLTG----------EIPYKDVDSSA----II 320 (904)
T ss_pred hhh-----hhhhhhHhhhCHHHhhcC------CcccccceehhHHHHHHHHhc----------CCCccccchhe----eE
Confidence 443 357899999999999987 777999999999999999999 88998763321 11
Q ss_pred HhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHh
Q psy14889 375 RKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLA 429 (443)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~ 429 (443)
.. +-........ +..|++.++-||++||+..|.+|||+.+|+..|+-..
T Consensus 321 wG-VGsNsL~Lpv-----PstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~ 369 (904)
T KOG4721|consen 321 WG-VGSNSLHLPV-----PSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIAS 369 (904)
T ss_pred Ee-ccCCcccccC-----cccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcC
Confidence 11 1111122222 3568999999999999999999999999999998544
|
|
| >KOG0592|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-46 Score=359.36 Aligned_cols=247 Identities=24% Similarity=0.413 Sum_probs=206.0
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeecc------CccchHHHHHHHHHHhccCCCceeeeeeccccCCccc
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSR------DEASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCT 207 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~------~~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~ 207 (443)
++|.+++.||+|+|++|++|+. +++.+|||++.++ ...-...|++++.... .||.|++|+-.|.+..
T Consensus 73 ~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~-~hPgivkLy~TFQD~~---- 147 (604)
T KOG0592|consen 73 NDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLS-GHPGIVKLYFTFQDEE---- 147 (604)
T ss_pred hhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhh-CCCCeEEEEEEeeccc----
Confidence 6899999999999999999987 6899999987543 2333455777777632 9999999999998884
Q ss_pred EEEeeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecC
Q psy14889 208 QLWLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFG 286 (443)
Q Consensus 208 ~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfG 286 (443)
.+|+|+||+++|+|.+++++ +.|++.....++.+|+.||+|||++ |||||||||+|||||.++++||+|||
T Consensus 148 sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~--------GIIHRDlKPENILLd~dmhikITDFG 219 (604)
T KOG0592|consen 148 SLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSN--------GIIHRDLKPENILLDKDGHIKITDFG 219 (604)
T ss_pred ceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhc--------CceeccCChhheeEcCCCcEEEeecc
Confidence 48999999999999999976 7899999999999999999999999 99999999999999999999999999
Q ss_pred CcccccccCCc---------CCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCccccc
Q psy14889 287 LAVSYSQLSNK---------MDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEY 357 (443)
Q Consensus 287 la~~~~~~~~~---------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~ 357 (443)
.|+.+...... .......++||..|.+||++..+ ..++.+|+|+|||+||+|+.|
T Consensus 220 sAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~------~~~~~sDiWAlGCilyQmlaG---------- 283 (604)
T KOG0592|consen 220 SAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDS------PAGPSSDLWALGCILYQMLAG---------- 283 (604)
T ss_pred ccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCC------CCCcccchHHHHHHHHHHhcC----------
Confidence 99988754332 11112558999999999999988 667899999999999999999
Q ss_pred CCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 358 KAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 358 ~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
..||... ...-.+++++..+.. +| ...++.+.+|+++.|..||.+|+|..+|.+
T Consensus 284 ~PPFra~----NeyliFqkI~~l~y~---fp-----~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~ 337 (604)
T KOG0592|consen 284 QPPFRAA----NEYLIFQKIQALDYE---FP-----EGFPEDARDLIKKLLVRDPSDRLTSQQIKA 337 (604)
T ss_pred CCCCccc----cHHHHHHHHHHhccc---CC-----CCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence 7788764 233445555544332 33 235578999999999999999999988765
|
|
| >KOG1094|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-46 Score=361.25 Aligned_cols=267 Identities=25% Similarity=0.350 Sum_probs=209.9
Q ss_pred HhhhhccccccceeeeecCeEEEEEEECC-ceeEEEEeeccCccc--hHHHHHHHHHHhccCCCceeeeeeccccCCccc
Q psy14889 131 QRTLAKQISLSECIGKGRYGEVWRGVWHG-ENVAVKIFFSRDEAS--WSRETEIYSTVLLRHENILGYIGSDMTSRNSCT 207 (443)
Q Consensus 131 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~vAvK~~~~~~~~~--~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~ 207 (443)
++-.++...+.++||+|-||+|.+++..+ ..||||+++...... ..+..||..+.+++|||||+++|+|..+++
T Consensus 533 ~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DeP--- 609 (807)
T KOG1094|consen 533 VEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDP--- 609 (807)
T ss_pred hhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCc---
Confidence 34455678899999999999999999876 899999997655443 344577777888999999999999999876
Q ss_pred EEEeeecccCcccHHHHhcccC---CCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEe
Q psy14889 208 QLWLVTHYHSFGSLYDHLNRTT---LNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIAD 284 (443)
Q Consensus 208 ~~~lv~e~~~~gsL~~~l~~~~---l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~D 284 (443)
+++|+|||++|+|.+|+.... +......+|+.|||+||+||.+. ++|||||.++|||++.++++||+|
T Consensus 610 -icmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~--------nfVHrd~a~rNcLv~~e~~iKiad 680 (807)
T KOG1094|consen 610 -LCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESL--------NFVHRDLATRNCLVDGEFTIKIAD 680 (807)
T ss_pred -hHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhh--------chhhccccccceeecCcccEEecC
Confidence 689999999999999997642 35566788999999999999999 999999999999999999999999
Q ss_pred cCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCC
Q psy14889 285 FGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDL 364 (443)
Q Consensus 285 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~ 364 (443)
||+++.+...... ......+-.++|||||.+.-+ ++|++||||+||+++||+++-+. +.||.+.
T Consensus 681 fgmsR~lysg~yy--~vqgr~vlpiRwmawEsillg------kFttaSDvWafgvTlwE~~~~C~--------e~Py~~l 744 (807)
T KOG1094|consen 681 FGMSRNLYSGDYY--RVQGRAVLPIRWMAWESILLG------KFTTASDVWAFGVTLWEVFMLCR--------EQPYSQL 744 (807)
T ss_pred cccccccccCCce--eeecceeeeeeehhHHHHHhc------cccchhhhhhhHHHHHHHHHHHh--------hCchhhh
Confidence 9999865533221 122334566899999999887 88899999999999999987644 6788876
Q ss_pred CCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHh
Q psy14889 365 VPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLA 429 (443)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~ 429 (443)
...+ ..+.. ..+..++.+...+. .+.-|+..++++|.+||..|-++|||++++...|++..
T Consensus 745 t~e~-vven~-~~~~~~~~~~~~l~--~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~ 805 (807)
T KOG1094|consen 745 TDEQ-VVENA-GEFFRDQGRQVVLS--RPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA 805 (807)
T ss_pred hHHH-HHHhh-hhhcCCCCcceecc--CCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence 3211 01111 11222222222111 23558899999999999999999999999999998765
|
|
| >KOG0598|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-46 Score=346.02 Aligned_cols=236 Identities=28% Similarity=0.400 Sum_probs=193.5
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCc------cchHHHHHHHHHHhccCCCceeeeeeccccCCccc
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDE------ASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCT 207 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~------~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~ 207 (443)
++|++.++||+|+||+||.++. +++.+|+|++++..- .....|+.|+. .++||.||+++-.|++. .
T Consensus 25 ~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~--~v~hPFiv~l~ysFQt~----~ 98 (357)
T KOG0598|consen 25 DDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILS--KIKHPFIVKLIYSFQTE----E 98 (357)
T ss_pred hheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHH--hCCCCcEeeeEEecccC----C
Confidence 7899999999999999999987 689999998865422 22333445544 49999999999999888 4
Q ss_pred EEEeeecccCcccHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecC
Q psy14889 208 QLWLVTHYHSFGSLYDHLN-RTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFG 286 (443)
Q Consensus 208 ~~~lv~e~~~~gsL~~~l~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfG 286 (443)
.+|||+||+.||+|..+|+ ++.+++..+..++.+|+.||.|||+. +||||||||+|||||.+|+++|+|||
T Consensus 99 kLylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~--------gIiyRDlKPENILLd~~GHi~LtDFg 170 (357)
T KOG0598|consen 99 KLYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSK--------GIIYRDLKPENILLDEQGHIKLTDFG 170 (357)
T ss_pred eEEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhC--------CeeeccCCHHHeeecCCCcEEEeccc
Confidence 6899999999999999997 46799999999999999999999999 99999999999999999999999999
Q ss_pred CcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCC
Q psy14889 287 LAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVP 366 (443)
Q Consensus 287 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~ 366 (443)
+++..-.... ...+++||+.|||||++.+. .|+..+|+||+|+++|||++| ..||...
T Consensus 171 L~k~~~~~~~----~t~tfcGT~eYmAPEil~~~------gy~~~vDWWsLGillYeML~G----------~pPF~~~-- 228 (357)
T KOG0598|consen 171 LCKEDLKDGD----ATRTFCGTPEYMAPEILLGK------GYDKAVDWWSLGILLYEMLTG----------KPPFYAE-- 228 (357)
T ss_pred cchhcccCCC----ccccccCCccccChHHHhcC------CCCcccchHhHHHHHHHHhhC----------CCCCcCc--
Confidence 9975443322 23568999999999999987 788999999999999999999 7777764
Q ss_pred CCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCC
Q psy14889 367 MDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRL 416 (443)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp 416 (443)
+...+.+.+.... .+..|. -.+.+.++++++.|..||++|.
T Consensus 229 ---~~~~~~~~I~~~k-~~~~p~-----~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 229 ---DVKKMYDKILKGK-LPLPPG-----YLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred ---cHHHHHHHHhcCc-CCCCCc-----cCCHHHHHHHHHHhccCHHHhc
Confidence 3334444333221 122222 2446799999999999999996
|
|
| >KOG0582|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-46 Score=349.43 Aligned_cols=255 Identities=27% Similarity=0.394 Sum_probs=203.9
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccch--HHHHHHHHHHhccCCCceeeeeeccccCCcccEEEe
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEASW--SRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWL 211 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~--~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~l 211 (443)
+.|++.+.||.|.-++||+|++ .++.||||++........ ...+|+..+..++||||++++..|..+ ..+|+
T Consensus 26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~----~~LWv 101 (516)
T KOG0582|consen 26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVD----SELWV 101 (516)
T ss_pred cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEec----ceeEE
Confidence 7899999999999999999998 689999999965433222 223566666669999999999999887 45899
Q ss_pred eecccCcccHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCc
Q psy14889 212 VTHYHSFGSLYDHLNR---TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA 288 (443)
Q Consensus 212 v~e~~~~gsL~~~l~~---~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla 288 (443)
||.||.+||+.+.++. ..+++..+..|++++++||.|||.+ |.||||||+.||||+++|.+||+|||.+
T Consensus 102 VmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~--------G~IHRdvKAgnILi~~dG~VkLadFgvs 173 (516)
T KOG0582|consen 102 VMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQN--------GHIHRDVKAGNILIDSDGTVKLADFGVS 173 (516)
T ss_pred eehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhc--------CceecccccccEEEcCCCcEEEcCceee
Confidence 9999999999999964 5799999999999999999999999 9999999999999999999999999988
Q ss_pred ccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCC
Q psy14889 289 VSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMD 368 (443)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~ 368 (443)
..+.............++||+.|||||++..+.. .|+.|+||||||++..||++| ..||.+..+..
T Consensus 174 a~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~----GYdfKaDIwSfGITA~ELA~G----------~aPf~k~pPmk 239 (516)
T KOG0582|consen 174 ASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLH----GYDFKADIWSFGITACELAHG----------HAPFSKYPPMK 239 (516)
T ss_pred eeecccCceeeEeeccccCcccccChHHhhhccc----CccchhhhhhhhHHHHHHhcC----------CCCcccCChHH
Confidence 7665544332222267799999999999766543 788999999999999999999 88888865432
Q ss_pred CChHHHHhhhhhcCCCCCCCCC-C----CCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 369 PSFDDMRKVICIDQQRPVLPNR-W----VSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~-~----~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
. ....-+..|+.+.. . .....+..+++++..||+.||.+|||+.++++
T Consensus 240 v-------Ll~tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 240 V-------LLLTLQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred H-------HHHHhcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 1 11111222221111 0 11234567999999999999999999999886
|
|
| >KOG0198|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-46 Score=349.97 Aligned_cols=259 Identities=28% Similarity=0.413 Sum_probs=203.1
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc-chHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEee
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA-SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLV 212 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~-~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv 212 (443)
.++...+.||+|+||.||++.. +|...|||.+...+.. ....+.|+..+..++|||||+++|....... ..+++.
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~--~~~~i~ 94 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSREN--DEYNIF 94 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccC--eeeEee
Confidence 4678899999999999999998 3799999987554222 2234677777778999999999998555443 368999
Q ss_pred ecccCcccHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcC-CCcEEEEecCCcc
Q psy14889 213 THYHSFGSLYDHLNRT--TLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKT-NGTCVIADFGLAV 289 (443)
Q Consensus 213 ~e~~~~gsL~~~l~~~--~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~-~~~~kl~DfGla~ 289 (443)
|||+++|+|.+++.+. .+++..+..++.||++||+|||++ +||||||||+|||++. ++.+||+|||+++
T Consensus 95 mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~--------g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~ 166 (313)
T KOG0198|consen 95 MEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSK--------GIVHCDIKPANILLDPSNGDVKLADFGLAK 166 (313)
T ss_pred eeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC--------CEeccCcccceEEEeCCCCeEEeccCcccc
Confidence 9999999999999764 599999999999999999999999 9999999999999999 7999999999998
Q ss_pred cccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCC
Q psy14889 290 SYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDP 369 (443)
Q Consensus 290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~ 369 (443)
.... ............||+.|||||++..+. ....++|||||||++.||+|| ..||.+. ..
T Consensus 167 ~~~~-~~~~~~~~~~~~Gtp~~maPEvi~~g~-----~~~~~sDiWSlGCtVvEM~Tg----------~~PW~~~---~~ 227 (313)
T KOG0198|consen 167 KLES-KGTKSDSELSVQGTPNYMAPEVIRNGE-----VARRESDIWSLGCTVVEMLTG----------KPPWSEF---FE 227 (313)
T ss_pred cccc-ccccccccccccCCccccCchhhcCCC-----cCCccchhhhcCCEEEeccCC----------CCcchhh---cc
Confidence 7664 111122234568999999999998531 222589999999999999999 6677663 01
Q ss_pred ChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHh
Q psy14889 370 SFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLA 429 (443)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~ 429 (443)
....+..+. .....|.+| ...+.+.++++.+|+..||++||||.++++..-...
T Consensus 228 ~~~~~~~ig-~~~~~P~ip-----~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~ 281 (313)
T KOG0198|consen 228 EAEALLLIG-REDSLPEIP-----DSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQ 281 (313)
T ss_pred hHHHHHHHh-ccCCCCCCC-----cccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhc
Confidence 112222222 222334444 347788999999999999999999999998765443
|
|
| >KOG0193|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-46 Score=362.72 Aligned_cols=274 Identities=28% Similarity=0.427 Sum_probs=217.5
Q ss_pred HHHhhhhccccccceeeeecCeEEEEEEECCceeEEEEeeccCc---cchHHHHHHHHHHhccCCCceeeeeeccccCCc
Q psy14889 129 LIQRTLAKQISLSECIGKGRYGEVWRGVWHGENVAVKIFFSRDE---ASWSRETEIYSTVLLRHENILGYIGSDMTSRNS 205 (443)
Q Consensus 129 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~---~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~ 205 (443)
...++..+.+.+.+.||+|+||+||+|.|.| .||||++.-... +...+..|+..+++-+|.||+-|.|+|..+.
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~-- 461 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP-- 461 (678)
T ss_pred cccccCHHHhhccceeccccccceeeccccc-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc--
Confidence 3445566778899999999999999999987 589999865433 2334457888888899999999999998773
Q ss_pred ccEEEeeecccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEE
Q psy14889 206 CTQLWLVTHYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIA 283 (443)
Q Consensus 206 ~~~~~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~ 283 (443)
+.||+.+|++-+|+.+++. ..|...+...|+.|||+||.|||.+ +|||||||..||++.++++|||+
T Consensus 462 ---~AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK--------~IIHrDLKSnNIFl~~~~kVkIg 530 (678)
T KOG0193|consen 462 ---LAIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAK--------NIIHRDLKSNNIFLHEDLKVKIG 530 (678)
T ss_pred ---eeeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhh--------hhhhhhccccceEEccCCcEEEe
Confidence 3899999999999999974 5799999999999999999999999 99999999999999999999999
Q ss_pred ecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCC
Q psy14889 284 DFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHD 363 (443)
Q Consensus 284 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~ 363 (443)
|||++..-..-.... ......|...|||||+++... ..+|++.+||||||+|+|||+|| ..||..
T Consensus 531 DFGLatvk~~w~g~~--q~~qp~gsilwmAPEvIRmqd---~nPfS~qSDVYaFGiV~YELltg----------~lPysi 595 (678)
T KOG0193|consen 531 DFGLATVKTRWSGEQ--QLEQPHGSLLWMAPEVIRMQD---DNPFSFQSDVYAFGIVWYELLTG----------ELPYSI 595 (678)
T ss_pred cccceeeeeeecccc--ccCCCccchhhhcHHHHhhcc---cCCCCcccchhhhhHHHHHHHhC----------cCCcCC
Confidence 999985433221111 123346888999999998553 23899999999999999999999 888873
Q ss_pred CCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhhccccccCC
Q psy14889 364 LVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLACADMYIHCS 438 (443)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~~~~~~~~~ 438 (443)
.. .+.+.-.+......+.... ....+++++++|+..||..++++||.+.+|+..|+.+....+++.-+
T Consensus 596 ~~-----~dqIifmVGrG~l~pd~s~--~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~pki~RS 663 (678)
T KOG0193|consen 596 QN-----RDQIIFMVGRGYLMPDLSK--IRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSLPKINRS 663 (678)
T ss_pred CC-----hhheEEEecccccCccchh--hhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcccccccC
Confidence 21 1222222222222222221 23568999999999999999999999999999999999877776643
|
|
| >KOG1095|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-46 Score=387.07 Aligned_cols=263 Identities=23% Similarity=0.363 Sum_probs=208.9
Q ss_pred hhccccccceeeeecCeEEEEEEE---CCc----eeEEEEeeccC--ccchHHHHHHHHHHhccCCCceeeeeeccccCC
Q psy14889 134 LAKQISLSECIGKGRYGEVWRGVW---HGE----NVAVKIFFSRD--EASWSRETEIYSTVLLRHENILGYIGSDMTSRN 204 (443)
Q Consensus 134 ~~~~~~~~~~lG~G~fg~Vy~~~~---~~~----~vAvK~~~~~~--~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~ 204 (443)
..++.++.+.||+|.||.||+|.+ +|. .||||.+.... .+...+-.|...+..++|||||+++|++.+..+
T Consensus 690 ~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~ 769 (1025)
T KOG1095|consen 690 PRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGP 769 (1025)
T ss_pred ChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCC
Confidence 346788899999999999999998 243 48888876542 222333455666666999999999999998644
Q ss_pred cccEEEeeecccCcccHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcC
Q psy14889 205 SCTQLWLVTHYHSFGSLYDHLNRT--------TLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKT 276 (443)
Q Consensus 205 ~~~~~~lv~e~~~~gsL~~~l~~~--------~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~ 276 (443)
.+|++|||++|||..||++. .++..+.+.++.|||+|+.||+++ ++|||||.++||||+.
T Consensus 770 ----~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~--------~fvHRDLAaRNCLL~~ 837 (1025)
T KOG1095|consen 770 ----PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK--------HFVHRDLAARNCLLDE 837 (1025)
T ss_pred ----cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC--------CCcCcchhhhheeecc
Confidence 68999999999999999753 589999999999999999999999 8899999999999999
Q ss_pred CCcEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccc
Q psy14889 277 NGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEE 356 (443)
Q Consensus 277 ~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~ 356 (443)
...+||+|||+|+.+......... ....-...|||||.+..+ .+|.|+|||||||+|||++|.
T Consensus 838 ~r~VKIaDFGlArDiy~~~yyr~~--~~a~lPvkWm~PEsl~d~------iFtskSDvWsFGVllWEifsl--------- 900 (1025)
T KOG1095|consen 838 RRVVKIADFGLARDIYDKDYYRKH--GEAMLPVKWMPPESLKDG------IFTSKSDVWSFGVLLWEIFSL--------- 900 (1025)
T ss_pred cCcEEEcccchhHhhhhchheecc--CccccceecCCHHHHhhc------ccccccchhhhHHHHHHHHhC---------
Confidence 999999999999965543222111 111234689999999987 778999999999999999996
Q ss_pred cCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhhcccccc
Q psy14889 357 YKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLACADMYIH 436 (443)
Q Consensus 357 ~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~~~~~~~ 436 (443)
+..||.+.. ..++...+.... +...| ..|++.++++|.+||+.+|++||++..|++++..+.+.....+
T Consensus 901 G~~PY~~~~-----n~~v~~~~~~gg-RL~~P-----~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~~ 969 (1025)
T KOG1095|consen 901 GATPYPSRS-----NFEVLLDVLEGG-RLDPP-----SYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGTI 969 (1025)
T ss_pred CCCCCCCcc-----hHHHHHHHHhCC-ccCCC-----CCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccCc
Confidence 488988752 233333333333 44333 4589999999999999999999999999999999887665443
|
|
| >KOG0593|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-46 Score=334.14 Aligned_cols=252 Identities=25% Similarity=0.367 Sum_probs=195.9
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccchHH---HHHHHHHHhccCCCceeeeeeccccCCcccEEE
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEASWSR---ETEIYSTVLLRHENILGYIGSDMTSRNSCTQLW 210 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~---e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~ 210 (443)
+.|+...++|+|+||+||+++. +|+.||||++..+.++...+ .+||..+++++|+|+|.++.+|... ..++
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrk----rklh 77 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRK----RKLH 77 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhc----ceeE
Confidence 4677888999999999999987 69999999997766544333 4788888889999999999999877 5689
Q ss_pred eeecccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCc
Q psy14889 211 LVTHYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA 288 (443)
Q Consensus 211 lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla 288 (443)
||+|||+. ++.+-|.+ .+++.+.+..++.|++.|+.|+|++ ++|||||||+||||+.++.+||+|||+|
T Consensus 78 LVFE~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~--------n~IHRDIKPENILit~~gvvKLCDFGFA 148 (396)
T KOG0593|consen 78 LVFEYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKN--------NCIHRDIKPENILITQNGVVKLCDFGFA 148 (396)
T ss_pred EEeeecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhc--------CeecccCChhheEEecCCcEEeccchhh
Confidence 99999987 66666653 6799999999999999999999999 9999999999999999999999999999
Q ss_pred ccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCC
Q psy14889 289 VSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMD 368 (443)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~ 368 (443)
+.+....... +..+.|.+|+|||++.+.. +|++.+||||.||++.||++|.+ -|.+.
T Consensus 149 R~L~~pgd~Y----TDYVATRWYRaPELLvGDt-----qYG~pVDiWAiGCv~aEl~~G~p----------L~PG~---- 205 (396)
T KOG0593|consen 149 RTLSAPGDNY----TDYVATRWYRAPELLVGDT-----QYGKPVDIWAIGCVFAELLTGEP----------LWPGR---- 205 (396)
T ss_pred HhhcCCcchh----hhhhhhhhccChhhhcccC-----cCCCcccchhhhHHHHHHhcCCc----------CCCCc----
Confidence 9887533222 4458899999999999862 77799999999999999999943 33332
Q ss_pred CChHHHHhhhhhcC-----------CCC-----CCCC--CCC-----CchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 369 PSFDDMRKVICIDQ-----------QRP-----VLPN--RWV-----SDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 369 ~~~~~~~~~~~~~~-----------~~~-----~~~~--~~~-----~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
.+.+.+..+...-+ ..+ .+|. ... -...+..+.++++.||+.||.+|++.+|++.
T Consensus 206 SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 206 SDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred chHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 12222211111000 000 0110 000 0124457899999999999999999999874
|
|
| >KOG0578|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=356.05 Aligned_cols=248 Identities=29% Similarity=0.459 Sum_probs=208.2
Q ss_pred hccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccch-HHHHHHHHHHhccCCCceeeeeeccccCCcccEEEe
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEASW-SRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWL 211 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~-~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~l 211 (443)
...|..-++||+|+.|.||.|.. +++.||||++........ ..-.|+..++..+|+|||.+++.|... .++|+
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~----deLWV 347 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVG----DELWV 347 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhccc----ceeEE
Confidence 35688889999999999999986 688999999876554332 234677777779999999999998877 45899
Q ss_pred eecccCcccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcccc
Q psy14889 212 VTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSY 291 (443)
Q Consensus 212 v~e~~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~ 291 (443)
|||||++|+|.+.+....+++.++..|+++++.||+|||.+ +|+|||||.+|||++.+|.+||+|||++..+
T Consensus 348 VMEym~ggsLTDvVt~~~~~E~qIA~Icre~l~aL~fLH~~--------gIiHrDIKSDnILL~~~g~vKltDFGFcaqi 419 (550)
T KOG0578|consen 348 VMEYMEGGSLTDVVTKTRMTEGQIAAICREILQGLKFLHAR--------GIIHRDIKSDNILLTMDGSVKLTDFGFCAQI 419 (550)
T ss_pred EEeecCCCchhhhhhcccccHHHHHHHHHHHHHHHHHHHhc--------ceeeeccccceeEeccCCcEEEeeeeeeecc
Confidence 99999999999999988999999999999999999999999 9999999999999999999999999999887
Q ss_pred cccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCCh
Q psy14889 292 SQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSF 371 (443)
Q Consensus 292 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~~ 371 (443)
.....+ ..+.+||+.|||||++... .|++|.||||||++++||+-| +.||....+ .
T Consensus 420 ~~~~~K----R~TmVGTPYWMAPEVvtrk------~YG~KVDIWSLGIMaIEMveG----------EPPYlnE~P----l 475 (550)
T KOG0578|consen 420 SEEQSK----RSTMVGTPYWMAPEVVTRK------PYGPKVDIWSLGIMAIEMVEG----------EPPYLNENP----L 475 (550)
T ss_pred ccccCc----cccccCCCCccchhhhhhc------ccCccccchhhhhHHHHHhcC----------CCCccCCCh----H
Confidence 765443 3567999999999999887 788999999999999999999 778765221 1
Q ss_pred HHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 372 DDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
..+..+ .....|.+.. .+..+..+++++.+||+.|+++|+|+.|+|+
T Consensus 476 rAlyLI--a~ng~P~lk~---~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 476 RALYLI--ATNGTPKLKN---PEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred HHHHHH--hhcCCCCcCC---ccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 222222 2233444443 3567889999999999999999999999987
|
|
| >KOG0659|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-45 Score=321.75 Aligned_cols=263 Identities=26% Similarity=0.318 Sum_probs=206.5
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc---chHHHHHHHHHHhccCCCceeeeeeccccCCcccEEE
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA---SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLW 210 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~---~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~ 210 (443)
.+|...++||+|.||.||+|+. +|+.||||.++..+.. ....-+||..++.++|+||+.++++|-...+ +.
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~----l~ 77 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSN----LS 77 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCc----eE
Confidence 4688889999999999999998 6999999998765433 3444677888888999999999999987754 78
Q ss_pred eeecccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCc
Q psy14889 211 LVTHYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA 288 (443)
Q Consensus 211 lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla 288 (443)
||+|||+. ||...++. ..++..++..++.++++||+|||++ .|+||||||.|+|++++|.+||+|||+|
T Consensus 78 lVfEfm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~--------~IlHRDlKPnNLLis~~g~lKiADFGLA 148 (318)
T KOG0659|consen 78 LVFEFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSK--------WILHRDLKPNNLLISSDGQLKIADFGLA 148 (318)
T ss_pred EEEEeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhh--------hhhcccCCccceEEcCCCcEEeecccch
Confidence 99999996 99999976 4589999999999999999999999 8999999999999999999999999999
Q ss_pred ccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCC----------cccccC
Q psy14889 289 VSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANG----------IFEEYK 358 (443)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~----------~~~~~~ 358 (443)
+.+....... ...+-|.+|+|||++.+.. .|+...|+||.||++.||+.|.+.+- +|....
T Consensus 149 r~f~~p~~~~----~~~V~TRWYRAPELLfGsr-----~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LG 219 (318)
T KOG0659|consen 149 RFFGSPNRIQ----THQVVTRWYRAPELLFGSR-----QYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALG 219 (318)
T ss_pred hccCCCCccc----ccceeeeeccChHHhccch-----hcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcC
Confidence 9887644332 3337899999999999874 56689999999999999999876431 344455
Q ss_pred CCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHH
Q psy14889 359 APYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKT 424 (443)
Q Consensus 359 ~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 424 (443)
.|-.+.+++-....+..+.. ..|..+....-..+++.+.+|+.++|..||.+|+|+.|+++.
T Consensus 220 TP~~~~WP~~~~lpdY~~~~----~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 220 TPTPDQWPEMTSLPDYVKIQ----QFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred CCCcccCccccccccHHHHh----cCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 55555444332222222221 112212111113356678999999999999999999998864
|
|
| >KOG0600|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=352.34 Aligned_cols=263 Identities=26% Similarity=0.324 Sum_probs=202.5
Q ss_pred hccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc---chHHHHHHHHHHhccCCCceeeeeeccccCCcccEE
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA---SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQL 209 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~---~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~ 209 (443)
.+.|+.+++||+|+||.||+|+. +|+.||+|++....+. -...-+||.++++|+||||++|.+...+... ..+
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~--~si 193 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLS--GSI 193 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCC--ceE
Confidence 36789999999999999999998 7999999988654422 2333578888888999999999999877633 468
Q ss_pred EeeecccCcccHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCC
Q psy14889 210 WLVTHYHSFGSLYDHLNRT--TLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGL 287 (443)
Q Consensus 210 ~lv~e~~~~gsL~~~l~~~--~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGl 287 (443)
|||+|||+. ||..++... .|++.++..++.|++.||+|+|++ +|+|||||.+|||||.+|.+||+||||
T Consensus 194 YlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~--------gvlHRDIK~SNiLidn~G~LKiaDFGL 264 (560)
T KOG0600|consen 194 YLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSR--------GVLHRDIKGSNILIDNNGVLKIADFGL 264 (560)
T ss_pred EEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhc--------CeeeccccccceEEcCCCCEEeccccc
Confidence 999999997 999999764 799999999999999999999999 999999999999999999999999999
Q ss_pred cccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCC----------ccccc
Q psy14889 288 AVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANG----------IFEEY 357 (443)
Q Consensus 288 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~----------~~~~~ 357 (443)
|+++....... .+..+-|.+|.|||++.+.. .|+.+.|+||.||||.||++|++.+. +|...
T Consensus 265 Ar~y~~~~~~~---~T~rVvTLWYRpPELLLG~t-----~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklc 336 (560)
T KOG0600|consen 265 ARFYTPSGSAP---YTSRVVTLWYRPPELLLGAT-----SYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLC 336 (560)
T ss_pred eeeccCCCCcc---cccceEEeeccChHHhcCCc-----ccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHh
Confidence 99887654332 46678999999999999873 77799999999999999999976432 22222
Q ss_pred CCCCCCCCCCCCChHHHHhhhhhcCCCCCCC--CCC--CCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 358 KAPYHDLVPMDPSFDDMRKVICIDQQRPVLP--NRW--VSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 358 ~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~--~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
..|-.+.++.. ++-.....++..+ ... .-...+....+|+..+|..||.+|.|+.++++
T Consensus 337 GSP~e~~W~~~-------kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 337 GSPTEDYWPVS-------KLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred CCCChhccccc-------cCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 33322211100 0000000011110 000 01224567889999999999999999999875
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=343.74 Aligned_cols=251 Identities=21% Similarity=0.306 Sum_probs=200.8
Q ss_pred ceeeeecCeEEEEEEECCceeEEEEeeccCccc----hHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEeeecccC
Q psy14889 142 ECIGKGRYGEVWRGVWHGENVAVKIFFSRDEAS----WSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVTHYHS 217 (443)
Q Consensus 142 ~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~----~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e~~~ 217 (443)
..||+|++|.||+|.++|+.||||.+....... ...+.|+..+..++||||++++|++.+.......+++||||++
T Consensus 26 ~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~ 105 (283)
T PHA02988 26 VLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCT 105 (283)
T ss_pred eEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCC
Confidence 679999999999999999999999886543322 2334677777779999999999998763222246899999999
Q ss_pred cccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcccccccCC
Q psy14889 218 FGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSN 296 (443)
Q Consensus 218 ~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~~~~~~ 296 (443)
+|+|.+++.+ ..+++.....++.|++.||.|||+.. +++||||||+|||+++++.+||+|||+++......
T Consensus 106 ~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~-------~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~- 177 (283)
T PHA02988 106 RGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYT-------NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP- 177 (283)
T ss_pred CCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcC-------CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence 9999999965 56899999999999999999999741 77899999999999999999999999987654321
Q ss_pred cCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCChHHHHh
Q psy14889 297 KMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFDDMRK 376 (443)
Q Consensus 297 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~~~~~~~ 376 (443)
....||..|+|||++.+... .++.++|||||||++|||++| ..||... ....+..
T Consensus 178 ------~~~~~~~~y~aPE~~~~~~~----~~~~k~Di~SlGvil~el~~g----------~~Pf~~~-----~~~~~~~ 232 (283)
T PHA02988 178 ------FKNVNFMVYFSYKMLNDIFS----EYTIKDDIYSLGVVLWEIFTG----------KIPFENL-----TTKEIYD 232 (283)
T ss_pred ------ccccCcccccCHHHhhhccc----cccchhhhhHHHHHHHHHHHC----------CCCCCCC-----CHHHHHH
Confidence 23468899999999875211 677899999999999999999 7788654 2233333
Q ss_pred hhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhh
Q psy14889 377 VICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLAC 430 (443)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~ 430 (443)
.+.....++.++ ..++..+.+++.+||+.||++|||+.|+++.|+.+..
T Consensus 233 ~i~~~~~~~~~~-----~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 233 LIINKNNSLKLP-----LDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred HHHhcCCCCCCC-----CcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 333333344433 2367889999999999999999999999999998764
|
|
| >KOG0661|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-46 Score=351.09 Aligned_cols=264 Identities=23% Similarity=0.319 Sum_probs=204.6
Q ss_pred hhhccccccceeeeecCeEEEEEEE--CCceeEEEEeeccC--ccchHHHHHHHHHHhcc-CCCceeeeeeccccCCccc
Q psy14889 133 TLAKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRD--EASWSRETEIYSTVLLR-HENILGYIGSDMTSRNSCT 207 (443)
Q Consensus 133 ~~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~--~~~~~~e~ei~~~~~l~-H~nIv~l~g~~~~~~~~~~ 207 (443)
.+.++|.+.++||.|+||.||+|+. +|..||||.++.+- -++..+-+|+..+++++ |||||++.+++.+.+.
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~--- 83 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDR--- 83 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCc---
Confidence 3457899999999999999999987 68999999886543 33445568899999999 9999999999988753
Q ss_pred EEEeeecccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEec
Q psy14889 208 QLWLVTHYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADF 285 (443)
Q Consensus 208 ~~~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~Df 285 (443)
.+++|||||+. +|++++++ ..+++..+..|+.||++||+|+|.+ |+.|||+||+|||+..+..+||+||
T Consensus 84 ~L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~--------GfFHRDlKPENiLi~~~~~iKiaDF 154 (538)
T KOG0661|consen 84 ILYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKH--------GFFHRDLKPENILISGNDVIKIADF 154 (538)
T ss_pred eEeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhc--------CcccccCChhheEecccceeEeccc
Confidence 68999999986 99999964 5699999999999999999999999 9999999999999999999999999
Q ss_pred CCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCC----------ccc
Q psy14889 286 GLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANG----------IFE 355 (443)
Q Consensus 286 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~----------~~~ 355 (443)
|+|+.+.... +.+..+.|.+|+|||++.... .|+.+.|+||+|||++|+.+-++.+- +.+
T Consensus 155 GLARev~Skp-----PYTeYVSTRWYRAPEvLLrs~-----~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~ 224 (538)
T KOG0661|consen 155 GLAREVRSKP-----PYTEYVSTRWYRAPEVLLRSG-----YYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICE 224 (538)
T ss_pred ccccccccCC-----CcchhhhcccccchHHhhhcc-----ccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHH
Confidence 9998776432 335568999999999998763 66789999999999999999865431 111
Q ss_pred ccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCC----CCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHH
Q psy14889 356 EYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNR----WVSDSTLNAMTKVMKECWHQNANVRLSALRVKKT 424 (443)
Q Consensus 356 ~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 424 (443)
..+.|-.+..+.. ..+...+ ...-|..+.. .. ..++.++.+||.+|+.+||.+|||+.|+++.
T Consensus 225 VLGtP~~~~~~eg---~~La~~m--nf~~P~~~~~~l~~L~-p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 225 VLGTPDKDSWPEG---YNLASAM--NFRFPQVKPSPLKDLL-PNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HhCCCccccchhH---HHHHHHh--ccCCCcCCCCChHHhC-cccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 2233322211110 1111111 1111222111 11 2367889999999999999999999999873
|
|
| >KOG0194|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-45 Score=358.36 Aligned_cols=261 Identities=29% Similarity=0.441 Sum_probs=209.2
Q ss_pred hhhccccccceeeeecCeEEEEEEEC---C--ce-eEEEEeeccC----ccchHHHHHHHHHHhccCCCceeeeeecccc
Q psy14889 133 TLAKQISLSECIGKGRYGEVWRGVWH---G--EN-VAVKIFFSRD----EASWSRETEIYSTVLLRHENILGYIGSDMTS 202 (443)
Q Consensus 133 ~~~~~~~~~~~lG~G~fg~Vy~~~~~---~--~~-vAvK~~~~~~----~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~ 202 (443)
...++..+.++||+|+||.||+|.+. + .. ||||..+... .+....-.|...+.+++|||||+++|++...
T Consensus 154 l~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~ 233 (474)
T KOG0194|consen 154 LSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLE 233 (474)
T ss_pred EeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCC
Confidence 34467788899999999999999882 2 23 8999876422 1112222444455559999999999999888
Q ss_pred CCcccEEEeeecccCcccHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcE
Q psy14889 203 RNSCTQLWLVTHYHSFGSLYDHLNRT--TLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTC 280 (443)
Q Consensus 203 ~~~~~~~~lv~e~~~~gsL~~~l~~~--~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~ 280 (443)
.+ +++|||+|.+|+|.++|++. .++..+.+.++.++|.||+|||+. ++|||||.++|||++.++.+
T Consensus 234 ~P----l~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k--------~~IHRDIAARNcL~~~~~~v 301 (474)
T KOG0194|consen 234 EP----LMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSK--------NCIHRDIAARNCLYSKKGVV 301 (474)
T ss_pred Cc----cEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHC--------CCcchhHhHHHheecCCCeE
Confidence 55 79999999999999999864 499999999999999999999999 99999999999999999999
Q ss_pred EEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCC
Q psy14889 281 VIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAP 360 (443)
Q Consensus 281 kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P 360 (443)
||+|||+++.-...... .....-...|+|||.+... .+++++|||||||++||+++. +..|
T Consensus 302 KISDFGLs~~~~~~~~~----~~~~klPirWLAPEtl~~~------~~s~kTDV~sfGV~~~Eif~~---------g~~P 362 (474)
T KOG0194|consen 302 KISDFGLSRAGSQYVMK----KFLKKLPIRWLAPETLNTG------IFSFKTDVWSFGVLLWEIFEN---------GAEP 362 (474)
T ss_pred EeCccccccCCcceeec----cccccCcceecChhhhccC------ccccccchhheeeeEEeeecc---------CCCC
Confidence 99999998654311111 1111345789999999987 777999999999999999873 2668
Q ss_pred CCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhhcccc
Q psy14889 361 YHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLACADMY 434 (443)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~~~~~ 434 (443)
|.+. ...+++..+.....+...|. ..+.++..++.+||..||++||||.++.+.|+.+......
T Consensus 363 y~g~-----~~~~v~~kI~~~~~r~~~~~-----~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 363 YPGM-----KNYEVKAKIVKNGYRMPIPS-----KTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred CCCC-----CHHHHHHHHHhcCccCCCCC-----CCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 8886 44566666655566665553 4788899999999999999999999999999999887654
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=352.19 Aligned_cols=258 Identities=21% Similarity=0.398 Sum_probs=197.3
Q ss_pred hccccccceeeeecCeEEEEEEE-------CCceeEEEEeeccCcc--chHHHHHHHHHHhc-cCCCceeeeeeccccCC
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVW-------HGENVAVKIFFSRDEA--SWSRETEIYSTVLL-RHENILGYIGSDMTSRN 204 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~-------~~~~vAvK~~~~~~~~--~~~~e~ei~~~~~l-~H~nIv~l~g~~~~~~~ 204 (443)
.++|++.+.||+|+||.||+|.+ +++.||||++...... ......|+..+..+ +||||+++++++....
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~- 84 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN- 84 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC-
Confidence 36899999999999999999975 2467999988643221 12233455555556 8999999999886543
Q ss_pred cccEEEeeecccCcccHHHHhcc---------------------------------------------------------
Q psy14889 205 SCTQLWLVTHYHSFGSLYDHLNR--------------------------------------------------------- 227 (443)
Q Consensus 205 ~~~~~~lv~e~~~~gsL~~~l~~--------------------------------------------------------- 227 (443)
..+++||||+++|+|.+++..
T Consensus 85 --~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (338)
T cd05102 85 --GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQE 162 (338)
T ss_pred --CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchh
Confidence 347899999999999998853
Q ss_pred ------cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcccccccCCcCCCC
Q psy14889 228 ------TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIP 301 (443)
Q Consensus 228 ------~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~ 301 (443)
..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......... .
T Consensus 163 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~--------~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~--~ 232 (338)
T cd05102 163 TDDLWKSPLTMEDLICYSFQVARGMEFLASR--------KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV--R 232 (338)
T ss_pred ccccccCCCCHHHHHHHHHHHHHHHHHHHHC--------CEECCCCccceEEEcCCCcEEEeecccccccccCcchh--c
Confidence 2377888999999999999999998 99999999999999999999999999997654322111 1
Q ss_pred CCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh-cccCCCcccccCCCCCCCCCCCCChHHHHhhhhh
Q psy14889 302 PNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR-RTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICI 380 (443)
Q Consensus 302 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt-g~~~~~~~~~~~~P~~~~~~~~~~~~~~~~~~~~ 380 (443)
.....++..|+|||++.+. .++.++|||||||++|||++ | ..||.+... .+.+...+.
T Consensus 233 ~~~~~~~~~y~aPE~~~~~------~~~~~sDiwslG~il~el~~~g----------~~pf~~~~~----~~~~~~~~~- 291 (338)
T cd05102 233 KGSARLPLKWMAPESIFDK------VYTTQSDVWSFGVLLWEIFSLG----------ASPYPGVQI----NEEFCQRLK- 291 (338)
T ss_pred ccCCCCCccccCcHHhhcC------CCCcccCHHHHHHHHHHHHhCC----------CCCCCCCCc----cHHHHHHHh-
Confidence 1233567789999999766 67789999999999999997 7 667765321 122222221
Q ss_pred cCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhhc
Q psy14889 381 DQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLACA 431 (443)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~~ 431 (443)
....+..+ ..++..+.+|+.+||+.||++|||+.|+++.|+++...
T Consensus 292 ~~~~~~~~-----~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~~ 337 (338)
T cd05102 292 DGTRMRAP-----ENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQE 337 (338)
T ss_pred cCCCCCCC-----CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 12222222 33567899999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0663|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-45 Score=331.43 Aligned_cols=268 Identities=24% Similarity=0.308 Sum_probs=207.8
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc---chHHHHHHHHHHhccCCCceeeeeeccccCCcccEEE
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA---SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLW 210 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~---~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~ 210 (443)
+.|+..+.|++|+||.||+|+. +++.||+|+++-..+. ....-+||..+.+.+|||||.+..+.....- ..+|
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~--d~iy 153 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNM--DKIY 153 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccc--ceee
Confidence 6799999999999999999998 6899999998654332 2333567777777999999999988776544 4589
Q ss_pred eeecccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCc
Q psy14889 211 LVTHYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA 288 (443)
Q Consensus 211 lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla 288 (443)
||||||+. ||...+.. +++...++..++.|+++|++|||.+ .|+|||||++|+|++..|.+||+|||+|
T Consensus 154 ~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~--------wilHRDLK~SNLLm~~~G~lKiaDFGLA 224 (419)
T KOG0663|consen 154 IVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDN--------WILHRDLKTSNLLLSHKGILKIADFGLA 224 (419)
T ss_pred eeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhc--------eeEecccchhheeeccCCcEEecccchh
Confidence 99999997 99999974 6799999999999999999999999 8999999999999999999999999999
Q ss_pred ccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCC----------cccccC
Q psy14889 289 VSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANG----------IFEEYK 358 (443)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~----------~~~~~~ 358 (443)
+.+...... .+..+-|.+|+|||++.+.. .|+++.|+||+|||+.||+++++.+. +|....
T Consensus 225 R~ygsp~k~----~T~lVVTLWYRaPELLLG~~-----tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llG 295 (419)
T KOG0663|consen 225 REYGSPLKP----YTPLVVTLWYRAPELLLGAK-----TYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLG 295 (419)
T ss_pred hhhcCCccc----CcceEEEeeecCHHHhcCCc-----ccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhC
Confidence 988765433 35668899999999999874 67789999999999999999987542 444555
Q ss_pred CCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 359 APYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 359 ~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
.|-...++.-.......+.-........+...+.....++.-.+|+..+|.+||.+|.|+.|.++
T Consensus 296 tPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 296 TPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred CCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 66555544332222221111111111111111111224567899999999999999999999876
|
|
| >KOG0201|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-45 Score=344.22 Aligned_cols=245 Identities=30% Similarity=0.464 Sum_probs=203.1
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccc--hHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEe
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEAS--WSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWL 211 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~--~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~l 211 (443)
..|+..+.||+|+||.||+|.. +++.||+|++....... ...+.|+..+..++++||.++||.+..+ ..+|+
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g----~~Lwi 88 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKG----TKLWI 88 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeec----ccHHH
Confidence 4677789999999999999998 58999999986543222 2234566667779999999999999887 45899
Q ss_pred eecccCcccHHHHhcccCC-CHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCccc
Q psy14889 212 VTHYHSFGSLYDHLNRTTL-NHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVS 290 (443)
Q Consensus 212 v~e~~~~gsL~~~l~~~~l-~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~ 290 (443)
+||||.+|++.+.|+...+ .+..+.-+++++..||.|||++ +.+|||||+.|||+..+|.+||+|||.+..
T Consensus 89 iMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~--------~kiHrDIKaanil~s~~g~vkl~DfgVa~q 160 (467)
T KOG0201|consen 89 IMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSE--------KKIHRDIKAANILLSESGDVKLADFGVAGQ 160 (467)
T ss_pred HHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhc--------ceecccccccceeEeccCcEEEEecceeee
Confidence 9999999999999987665 8999999999999999999999 999999999999999999999999999987
Q ss_pred ccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCC
Q psy14889 291 YSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPS 370 (443)
Q Consensus 291 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~ 370 (443)
+...... ..+++||+.|||||++... .|+.|+||||||++.+||++| ..||.+..++
T Consensus 161 l~~~~~r----r~tfvGTPfwMAPEVI~~~------~Y~~KADIWSLGITaiEla~G----------ePP~s~~hPm--- 217 (467)
T KOG0201|consen 161 LTNTVKR----RKTFVGTPFWMAPEVIKQS------GYDTKADIWSLGITAIELAKG----------EPPHSKLHPM--- 217 (467)
T ss_pred eechhhc----cccccccccccchhhhccc------cccchhhhhhhhHHHHHHhcC----------CCCCcccCcc---
Confidence 7654333 2678999999999999965 777999999999999999999 7888887553
Q ss_pred hHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 371 FDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
+-++.+....|+.- ...++..+++++..||+.||+.||||.++++
T Consensus 218 ----rvlflIpk~~PP~L----~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 218 ----RVLFLIPKSAPPRL----DGDFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred ----eEEEeccCCCCCcc----ccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 22222222222221 2356778999999999999999999999886
|
|
| >KOG0583|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=343.77 Aligned_cols=252 Identities=24% Similarity=0.377 Sum_probs=203.0
Q ss_pred hccccccceeeeecCeEEEEEEE--CCceeEEEEeecc----Cc--cchHHHHHHHHHHhcc-CCCceeeeeeccccCCc
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSR----DE--ASWSRETEIYSTVLLR-HENILGYIGSDMTSRNS 205 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~----~~--~~~~~e~ei~~~~~l~-H~nIv~l~g~~~~~~~~ 205 (443)
.+.|.+.+.||+|+||.|+.|.. ++..||+|++... .. ......+|+..+..++ ||||++++.++...
T Consensus 16 ~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~--- 92 (370)
T KOG0583|consen 16 IGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP--- 92 (370)
T ss_pred cCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC---
Confidence 47899999999999999999987 6899999976543 11 1122235666666688 99999999999887
Q ss_pred ccEEEeeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCC-CcEEEE
Q psy14889 206 CTQLWLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTN-GTCVIA 283 (443)
Q Consensus 206 ~~~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~-~~~kl~ 283 (443)
..+++||||+.+|+|.+++.+ +++.+..+..++.|+++|++|+|+. +|+||||||+|||++.+ +.+||+
T Consensus 93 -~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~--------gi~HRDLK~ENilld~~~~~~Kl~ 163 (370)
T KOG0583|consen 93 -TKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSR--------GIVHRDLKPENILLDGNEGNLKLS 163 (370)
T ss_pred -CeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhC--------CEeeCCCCHHHEEecCCCCCEEEe
Confidence 458999999999999999976 7899999999999999999999999 99999999999999999 999999
Q ss_pred ecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCC
Q psy14889 284 DFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHD 363 (443)
Q Consensus 284 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~ 363 (443)
|||++..... .+....+.+||+.|+|||++.+...+. +.++||||+||+||-|++| ..||.+
T Consensus 164 DFG~s~~~~~----~~~~l~t~cGsp~Y~aPEvl~~~~~Y~----g~~aDvWS~GViLy~ml~G----------~~PF~d 225 (370)
T KOG0583|consen 164 DFGLSAISPG----EDGLLKTFCGSPAYAAPEVLSGKGTYS----GKAADVWSLGVILYVLLCG----------RLPFDD 225 (370)
T ss_pred ccccccccCC----CCCcccCCCCCcccCCHHHhCCCCCcC----CchhhhhhhHHHHHHHHhC----------CCCCCC
Confidence 9999987631 112235679999999999999874211 3799999999999999999 888887
Q ss_pred CCCCCCChHHHHhhhhhcCCCCCCCCCCCCchh-HHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHh
Q psy14889 364 LVPMDPSFDDMRKVICIDQQRPVLPNRWVSDST-LNAMTKVMKECWHQNANVRLSALRVKKTLIKLA 429 (443)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~ 429 (443)
. ....+...+. .....+|.. + +.+++.|+.+||..||.+|+|+.+|+ .-.-+.
T Consensus 226 ~-----~~~~l~~ki~--~~~~~~p~~-----~~S~~~~~Li~~mL~~~P~~R~t~~~i~-~h~w~~ 279 (370)
T KOG0583|consen 226 S-----NVPNLYRKIR--KGEFKIPSY-----LLSPEARSLIEKMLVPDPSTRITLLEIL-EHPWFQ 279 (370)
T ss_pred c-----cHHHHHHHHh--cCCccCCCC-----cCCHHHHHHHHHHcCCCcccCCCHHHHh-hChhhc
Confidence 3 2233333322 333444432 3 67899999999999999999999999 444444
|
|
| >KOG0694|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-44 Score=351.79 Aligned_cols=239 Identities=25% Similarity=0.386 Sum_probs=202.6
Q ss_pred hccccccceeeeecCeEEEEEEE--CCceeEEEEeeccC------ccchHHHHHHHHHHhccCCCceeeeeeccccCCcc
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRD------EASWSRETEIYSTVLLRHENILGYIGSDMTSRNSC 206 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~------~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~ 206 (443)
.++|.+.++||+|+||+|+++.+ +++.+|||++++.. .+....|+.|+.+.. +||.+++++..|.+.
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~-~HPFL~~L~~~fQT~---- 441 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELAN-RHPFLVNLFSCFQTK---- 441 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhc-cCCeEeecccccccC----
Confidence 47899999999999999999998 57899999987642 234455888888875 899999999999988
Q ss_pred cEEEeeecccCcccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecC
Q psy14889 207 TQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFG 286 (443)
Q Consensus 207 ~~~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfG 286 (443)
.++++||||+.|||+..+.+...+++..+..++..|+.||.|||++ +||+||||.+|||||.+|++||+|||
T Consensus 442 ~~l~fvmey~~Ggdm~~~~~~~~F~e~rarfyaAev~l~L~fLH~~--------~IIYRDlKLdNiLLD~eGh~kiADFG 513 (694)
T KOG0694|consen 442 EHLFFVMEYVAGGDLMHHIHTDVFSEPRARFYAAEVVLGLQFLHEN--------GIIYRDLKLDNLLLDTEGHVKIADFG 513 (694)
T ss_pred CeEEEEEEecCCCcEEEEEecccccHHHHHHHHHHHHHHHHHHHhc--------CceeeecchhheEEcccCcEEecccc
Confidence 5699999999999977666778999999999999999999999999 99999999999999999999999999
Q ss_pred CcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCC
Q psy14889 287 LAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVP 366 (443)
Q Consensus 287 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~ 366 (443)
+++.-... ...+++++||+.|||||++.+. .|+.++|+|||||+||||+.| +.||.+.
T Consensus 514 lcKe~m~~----g~~TsTfCGTpey~aPEil~e~------~Yt~aVDWW~lGVLlyeML~G----------q~PF~gd-- 571 (694)
T KOG0694|consen 514 LCKEGMGQ----GDRTSTFCGTPEFLAPEVLTEQ------SYTRAVDWWGLGVLLYEMLVG----------ESPFPGD-- 571 (694)
T ss_pred cccccCCC----CCccccccCChhhcChhhhccC------cccchhhHHHHHHHHHHHHcC----------CCCCCCC--
Confidence 99754422 2234778999999999999998 889999999999999999999 8999874
Q ss_pred CCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcH
Q psy14889 367 MDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSA 418 (443)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~ 418 (443)
+.+++...+..+ .+..| ..++.+...+|+++|..||++|.-+
T Consensus 572 ---dEee~FdsI~~d--~~~yP-----~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 572 ---DEEEVFDSIVND--EVRYP-----RFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred ---CHHHHHHHHhcC--CCCCC-----CcccHHHHHHHHHHhccCcccccCC
Confidence 345555444332 22233 3366789999999999999999965
|
|
| >KOG0585|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=336.14 Aligned_cols=260 Identities=26% Similarity=0.335 Sum_probs=204.1
Q ss_pred hccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc----------c-----hHHHHHHHHHHhccCCCceeeee
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA----------S-----WSRETEIYSTVLLRHENILGYIG 197 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~----------~-----~~~e~ei~~~~~l~H~nIv~l~g 197 (443)
-++|++.+.||+|.||.|-+|.. +++.||||++.+.... . ..-..||.++++++|||||+|+.
T Consensus 96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiE 175 (576)
T KOG0585|consen 96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIE 175 (576)
T ss_pred hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEE
Confidence 37899999999999999999987 6899999998543210 1 12246888888899999999999
Q ss_pred eccccCCcccEEEeeecccCcccHHHHhcccC-CCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcC
Q psy14889 198 SDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTT-LNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKT 276 (443)
Q Consensus 198 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~ 276 (443)
+..+... ..+|||+|||..|.+...=.... +++.++..+++++..||+|||.+ +||||||||+|+||++
T Consensus 176 vLDDP~s--~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~Q--------giiHRDIKPsNLLl~~ 245 (576)
T KOG0585|consen 176 VLDDPES--DKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQ--------GIIHRDIKPSNLLLSS 245 (576)
T ss_pred eecCccc--CceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhc--------CeeccccchhheEEcC
Confidence 9877665 67999999999998876554455 99999999999999999999999 9999999999999999
Q ss_pred CCcEEEEecCCcccccccCCcC-CCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCccc
Q psy14889 277 NGTCVIADFGLAVSYSQLSNKM-DIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFE 355 (443)
Q Consensus 277 ~~~~kl~DfGla~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~ 355 (443)
+|++||+|||.+.......... +......+||+.|+|||++.++... ...+.+.||||+||+||.|+.|
T Consensus 246 ~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~--~~~g~a~DiWalGVTLYCllfG-------- 315 (576)
T KOG0585|consen 246 DGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSF--SYSGFALDIWALGVTLYCLLFG-------- 315 (576)
T ss_pred CCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCc--cccchhhhhhhhhhhHHHhhhc--------
Confidence 9999999999987664331111 1111335899999999999875322 1345789999999999999999
Q ss_pred ccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHH
Q psy14889 356 EYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLI 426 (443)
Q Consensus 356 ~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 426 (443)
+.||.+.. ..+...+++.. ...+|. ..+..+.+++||+++|.+||++|.+..+|....-
T Consensus 316 --~~PF~~~~----~~~l~~KIvn~---pL~fP~---~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpw 374 (576)
T KOG0585|consen 316 --QLPFFDDF----ELELFDKIVND---PLEFPE---NPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPW 374 (576)
T ss_pred --cCCcccch----HHHHHHHHhcC---cccCCC---cccccHHHHHHHHHHhhcChhheeehhhheecce
Confidence 88987742 33444455432 223332 1235678999999999999999999999876543
|
|
| >KOG0588|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=346.60 Aligned_cols=245 Identities=23% Similarity=0.353 Sum_probs=206.3
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccC----ccchHHHHHHHHHHhccCCCceeeeeeccccCCcccEE
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRD----EASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQL 209 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~----~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~ 209 (443)
.-|++++.||+|+-|.|.+|++ +|+.+|||++.... .....-|.||.+++.+.|||++++|+++.+. .++
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~----~~l 87 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENK----QHL 87 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccC----ceE
Confidence 4588899999999999999998 79999999986542 2234457888888889999999999999877 679
Q ss_pred EeeecccCcccHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCc
Q psy14889 210 WLVTHYHSFGSLYDHL-NRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA 288 (443)
Q Consensus 210 ~lv~e~~~~gsL~~~l-~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla 288 (443)
|+|.||+++|.|++++ .++++++.++.+++.||+.|+.|+|.. +|+||||||+|+|||..+.+||+|||+|
T Consensus 88 ylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~--------~icHRDLKpENlLLd~~~nIKIADFGMA 159 (786)
T KOG0588|consen 88 YLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAF--------NICHRDLKPENLLLDVKNNIKIADFGMA 159 (786)
T ss_pred EEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhh--------cceeccCCchhhhhhcccCEeeecccee
Confidence 9999999999999988 468899999999999999999999998 9999999999999999999999999999
Q ss_pred ccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCC
Q psy14889 289 VSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMD 368 (443)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~ 368 (443)
..-..+.- ..+.+|++.|.|||++.+..+.+ .++||||.|||||.|+|| ..||.+.
T Consensus 160 sLe~~gkl-----LeTSCGSPHYA~PEIV~G~pYdG-----~~sDVWSCGVILfALLtG----------~LPFdDd---- 215 (786)
T KOG0588|consen 160 SLEVPGKL-----LETSCGSPHYAAPEIVSGRPYDG-----RPSDVWSCGVILFALLTG----------KLPFDDD---- 215 (786)
T ss_pred ecccCCcc-----ccccCCCcccCCchhhcCCCCCC-----CccccchhHHHHHHHHhC----------CCCCCCc----
Confidence 65544322 24558999999999999885443 699999999999999999 8888753
Q ss_pred CChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHH
Q psy14889 369 PSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKT 424 (443)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 424 (443)
....+...+.... ..+| ..++.++++|+.+|+..||++|.|++||++.
T Consensus 216 -Nir~LLlKV~~G~--f~MP-----s~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 216 -NIRVLLLKVQRGV--FEMP-----SNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred -cHHHHHHHHHcCc--ccCC-----CcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 3444444443322 2333 4477889999999999999999999999984
|
|
| >KOG0616|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=315.57 Aligned_cols=233 Identities=23% Similarity=0.347 Sum_probs=193.7
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccchHH----HHHHHHHHhccCCCceeeeeeccccCCcccEE
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEASWSR----ETEIYSTVLLRHENILGYIGSDMTSRNSCTQL 209 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~----e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~ 209 (443)
++|+..+.||.|+||.|.+++. +|..+|+|++.......... ..|...++.+.||.++++++.+.+. ..+
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~----~~l 119 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDN----SNL 119 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccC----CeE
Confidence 6899999999999999999987 68899999986644322111 2344444458999999999999887 468
Q ss_pred EeeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCc
Q psy14889 210 WLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA 288 (443)
Q Consensus 210 ~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla 288 (443)
+|||||.++|.|..+|++ +++++..+..++.||+.||+|||+. +|++|||||+|||||.+|.+||+|||+|
T Consensus 120 ymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~--------~iiYRDLKPENiLlD~~G~iKitDFGFA 191 (355)
T KOG0616|consen 120 YMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSL--------DIIYRDLKPENLLLDQNGHIKITDFGFA 191 (355)
T ss_pred EEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhc--------CeeeccCChHHeeeccCCcEEEEeccce
Confidence 999999999999999986 7899999999999999999999999 9999999999999999999999999999
Q ss_pred ccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCC
Q psy14889 289 VSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMD 368 (443)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~ 368 (443)
+...... -+.+||+.|+|||++... .+..++|.|||||++|||+.| ..||.+..+
T Consensus 192 K~v~~rT-------~TlCGTPeYLAPEii~sk------~ynkavDWWalGVLIYEMlaG----------~pPF~~~~~-- 246 (355)
T KOG0616|consen 192 KRVSGRT-------WTLCGTPEYLAPEIIQSK------GYNKAVDWWALGVLIYEMLAG----------YPPFYDDNP-- 246 (355)
T ss_pred EEecCcE-------EEecCCccccChHHhhcC------CCCcchhHHHHHHHHHHHHcC----------CCCCcCCCh--
Confidence 8776532 345899999999999987 778899999999999999999 788877532
Q ss_pred CChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCC
Q psy14889 369 PSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVR 415 (443)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 415 (443)
.....+++.. ...+|. -.+..+++|+.+.|+.|-.+|
T Consensus 247 --~~iY~KI~~~---~v~fP~-----~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 247 --IQIYEKILEG---KVKFPS-----YFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred --HHHHHHHHhC---cccCCc-----ccCHHHHHHHHHHHhhhhHhh
Confidence 3444444432 333443 245679999999999999999
|
|
| >KOG0597|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=341.49 Aligned_cols=243 Identities=29% Similarity=0.453 Sum_probs=199.6
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccc---hHHHHHHHHHHhccCCCceeeeeeccccCCcccEEE
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEAS---WSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLW 210 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~---~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~ 210 (443)
++|.+.+.||+|+||.||||+. +.+.||+|.+.+..... .....|+.++..++|||||.++++|.+. .++|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~----~~~~ 77 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETS----AHLW 77 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhccc----ceEE
Confidence 5788899999999999999976 67899999886544333 1123455556669999999999999887 5799
Q ss_pred eeecccCcccHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcc
Q psy14889 211 LVTHYHSFGSLYDHLN-RTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAV 289 (443)
Q Consensus 211 lv~e~~~~gsL~~~l~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~ 289 (443)
+|+||+.+ +|..+|. ++.++++.+..++.|+++||.|||+. +|+|||+||+|||++..+++|++|||+|+
T Consensus 78 vVte~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~--------rilhrd~kPqniLl~~~~~~KlcdFg~Ar 148 (808)
T KOG0597|consen 78 VVTEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSN--------RILHRDMKPQNILLEKGGTLKLCDFGLAR 148 (808)
T ss_pred EEehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhc--------CcccccCCcceeeecCCCceeechhhhhh
Confidence 99999986 9999996 47899999999999999999999999 99999999999999999999999999998
Q ss_pred cccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCC
Q psy14889 290 SYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDP 369 (443)
Q Consensus 290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~ 369 (443)
.+..... ..+...||+.|||||++.++ .|+..+|.||+||++||+++| +.||...
T Consensus 149 ~m~~~t~----vltsikGtPlYmAPElv~e~------pyd~~sDlWslGcilYE~~~G----------~PPF~a~----- 203 (808)
T KOG0597|consen 149 AMSTNTS----VLTSIKGTPLYMAPELVEEQ------PYDHTSDLWSLGCILYELYVG----------QPPFYAR----- 203 (808)
T ss_pred hcccCce----eeeeccCcccccCHHHHcCC------CccchhhHHHHHHHHHHHhcC----------CCCchHH-----
Confidence 8765332 23456899999999999987 777899999999999999999 6677542
Q ss_pred ChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 370 SFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
+...+.+.+..+..++ | ...+..+..+++..|.+||.+|.|-.+++.
T Consensus 204 si~~Lv~~I~~d~v~~--p-----~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 204 SITQLVKSILKDPVKP--P-----STASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred HHHHHHHHHhcCCCCC--c-----ccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 2233333333322222 2 346778999999999999999999998875
|
|
| >KOG0605|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=334.61 Aligned_cols=249 Identities=24% Similarity=0.355 Sum_probs=199.0
Q ss_pred hccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCc------cchHHHHHHHHHHhccCCCceeeeeeccccCCcc
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDE------ASWSRETEIYSTVLLRHENILGYIGSDMTSRNSC 206 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~------~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~ 206 (443)
.++|+++..||+|+||.||+|+- +|..+|+|++++... .....|+.|+.. .++|+||+++-.|.+.+
T Consensus 140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~--~ds~~vVKLyYsFQD~~--- 214 (550)
T KOG0605|consen 140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAE--VDSPWVVKLYYSFQDKE--- 214 (550)
T ss_pred cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhh--cCCCcEEEEEEEecCCC---
Confidence 37899999999999999999986 799999999976532 233446666666 79999999999999884
Q ss_pred cEEEeeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEec
Q psy14889 207 TQLWLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADF 285 (443)
Q Consensus 207 ~~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~Df 285 (443)
.+||||||.+|||+..+|.+ ..|++.++..++.+++.|++-||.. |+|||||||+|+|||..|++||+||
T Consensus 215 -~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~--------gyIHRDIKPdNlLiD~~GHiKLSDF 285 (550)
T KOG0605|consen 215 -YLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQL--------GYIHRDIKPDNLLIDAKGHIKLSDF 285 (550)
T ss_pred -eeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHc--------CcccccCChhheeecCCCCEeeccc
Confidence 58999999999999999964 7899999999999999999999999 9999999999999999999999999
Q ss_pred CCccccccc---------------C---CcCCCC-------------------------CCCcccccCcccccccccccc
Q psy14889 286 GLAVSYSQL---------------S---NKMDIP-------------------------PNPRVGTKRYMSPEILDESIN 322 (443)
Q Consensus 286 Gla~~~~~~---------------~---~~~~~~-------------------------~~~~~gt~~y~aPE~~~~~~~ 322 (443)
||+..+... . .....+ ....+|||.|||||++.+.
T Consensus 286 GLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~k-- 363 (550)
T KOG0605|consen 286 GLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGK-- 363 (550)
T ss_pred cccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcC--
Confidence 998533210 0 000000 0134799999999999988
Q ss_pred cCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHH
Q psy14889 323 MDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTK 402 (443)
Q Consensus 323 ~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 402 (443)
.|+..+|+||||||+|||+.| -.||.... ..+..++++.... ...+|.. ..++.+..+
T Consensus 364 ----gY~~~cDwWSLG~ImyEmLvG----------yPPF~s~t----p~~T~rkI~nwr~-~l~fP~~---~~~s~eA~D 421 (550)
T KOG0605|consen 364 ----GYGKECDWWSLGCIMYEMLVG----------YPPFCSET----PQETYRKIVNWRE-TLKFPEE---VDLSDEAKD 421 (550)
T ss_pred ----CCCccccHHHHHHHHHHHHhC----------CCCCCCCC----HHHHHHHHHHHhh-hccCCCc---CcccHHHHH
Confidence 778899999999999999999 77887643 2344555554432 2333332 335688999
Q ss_pred HHHHHhcCCcCCCCc---HHHHH
Q psy14889 403 VMKECWHQNANVRLS---ALRVK 422 (443)
Q Consensus 403 li~~cl~~dP~~Rps---~~evl 422 (443)
||.+|+. ||++|.- ++||.
T Consensus 422 LI~rll~-d~~~RLG~~G~~EIK 443 (550)
T KOG0605|consen 422 LITRLLC-DPENRLGSKGAEEIK 443 (550)
T ss_pred HHHHHhc-CHHHhcCcccHHHHh
Confidence 9999999 9999985 55544
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=341.75 Aligned_cols=254 Identities=23% Similarity=0.409 Sum_probs=194.0
Q ss_pred hccccccceeeeecCeEEEEEEE-------CCceeEEEEeeccCccc--hHHHHHHHHHHhc-cCCCceeeeeeccccCC
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVW-------HGENVAVKIFFSRDEAS--WSRETEIYSTVLL-RHENILGYIGSDMTSRN 204 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~-------~~~~vAvK~~~~~~~~~--~~~e~ei~~~~~l-~H~nIv~l~g~~~~~~~ 204 (443)
.++|++.+.||+|+||.||+|.+ ++..||||++....... .....|+..+..+ +||||+++++++....
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~- 112 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGG- 112 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC-
Confidence 35799999999999999999974 24589999886433221 1223455555557 8999999999997764
Q ss_pred cccEEEeeecccCcccHHHHhccc--------------------------------------------------------
Q psy14889 205 SCTQLWLVTHYHSFGSLYDHLNRT-------------------------------------------------------- 228 (443)
Q Consensus 205 ~~~~~~lv~e~~~~gsL~~~l~~~-------------------------------------------------------- 228 (443)
..++||||+++|+|.++++..
T Consensus 113 ---~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 189 (375)
T cd05104 113 ---PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSV 189 (375)
T ss_pred ---cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccc
Confidence 469999999999999988531
Q ss_pred --------------------CCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCc
Q psy14889 229 --------------------TLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA 288 (443)
Q Consensus 229 --------------------~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla 288 (443)
.+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~--------~ivH~Dlkp~Nill~~~~~~kl~DfG~a 261 (375)
T cd05104 190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK--------NCIHRDLAARNILLTHGRITKICDFGLA 261 (375)
T ss_pred ccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC--------CeeccCCchhhEEEECCCcEEEecCccc
Confidence 367888999999999999999998 9999999999999999999999999999
Q ss_pred ccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh-cccCCCcccccCCCCCCCCCC
Q psy14889 289 VSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR-RTKANGIFEEYKAPYHDLVPM 367 (443)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt-g~~~~~~~~~~~~P~~~~~~~ 367 (443)
+......... ......++..|+|||.+.+. .++.++|||||||++|||++ | ..||.....
T Consensus 262 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~------~~~~~sDi~slG~~l~ellt~g----------~~p~~~~~~- 322 (375)
T cd05104 262 RDIRNDSNYV--VKGNARLPVKWMAPESIFNC------VYTFESDVWSYGILLWEIFSLG----------SSPYPGMPV- 322 (375)
T ss_pred eeccCccccc--ccCCCCCCcceeChhHhcCC------CCCCCCCHHHHHHHHHHHHhcC----------CCCCCCCCc-
Confidence 7664332211 11223456789999999776 67789999999999999998 5 566655321
Q ss_pred CCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHH
Q psy14889 368 DPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKL 428 (443)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l 428 (443)
.....+.+.. ..++..+ ...+.++.+|+.+||+.||++|||+.||++.|++.
T Consensus 323 ---~~~~~~~~~~-~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 323 ---DSKFYKMIKE-GYRMLSP-----ECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred ---hHHHHHHHHh-CccCCCC-----CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 1222232221 2222222 22456899999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0658|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=325.37 Aligned_cols=266 Identities=24% Similarity=0.330 Sum_probs=200.4
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccchHHHHHHHHHHhccCCCceeeeeeccccCCc-ccEEEee
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIGSDMTSRNS-CTQLWLV 212 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~-~~~~~lv 212 (443)
-.|.-.+++|+|+||.||+|.. +++.||||....+.. -..+|.+++. .++|||||++.-+|....+. ...+.+|
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-~knrEl~im~--~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-YKNRELQIMR--KLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-cCcHHHHHHH--hcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 3677889999999999999998 578999998765433 3345666665 49999999999888766554 2357799
Q ss_pred ecccCcccHHHHhc-----ccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCC-CcEEEEecC
Q psy14889 213 THYHSFGSLYDHLN-----RTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTN-GTCVIADFG 286 (443)
Q Consensus 213 ~e~~~~gsL~~~l~-----~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~-~~~kl~DfG 286 (443)
||||+. +|.++++ +..++.-.+.-+..||.+||.|||+. +|+||||||+|+|+|.+ |.+||+|||
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~--------~IcHRDIKPqNlLvD~~tg~LKicDFG 171 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH--------GICHRDIKPQNLLVDPDTGVLKICDFG 171 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc--------CcccCCCChheEEEcCCCCeEEeccCC
Confidence 999997 9999997 47789999999999999999999998 99999999999999987 899999999
Q ss_pred CcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCC
Q psy14889 287 LAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVP 366 (443)
Q Consensus 287 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~ 366 (443)
.|+.+...... .+...|..|+|||++.+.. .|+.+.||||.|||+.||+-|++. |.+...
T Consensus 172 SAK~L~~~epn-----iSYicSRyYRaPELifga~-----~Yt~~IDiWSaGCV~aELl~g~pl----------FpG~s~ 231 (364)
T KOG0658|consen 172 SAKVLVKGEPN-----ISYICSRYYRAPELIFGAT-----EYTTSIDIWSAGCVMAELLKGQPL----------FPGDSS 231 (364)
T ss_pred cceeeccCCCc-----eeEEEeccccCHHHHcCcc-----ccCceeEEhhhhHHHHHHhcCCcc----------cCCCCH
Confidence 99988765433 3346788999999998873 777999999999999999999543 333111
Q ss_pred CC-----------CChHHHHhhhh--hcCCCCCCCC-CC---CCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH--HHHH
Q psy14889 367 MD-----------PSFDDMRKVIC--IDQQRPVLPN-RW---VSDSTLNAMTKVMKECWHQNANVRLSALRVKK--TLIK 427 (443)
Q Consensus 367 ~~-----------~~~~~~~~~~~--~~~~~~~~~~-~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~--~L~~ 427 (443)
.+ ++.+++..+-. .+...+.+.. .| .....+.++.+|+.++|.++|.+|.++.|++. ..++
T Consensus 232 ~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFde 311 (364)
T KOG0658|consen 232 VDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDE 311 (364)
T ss_pred HHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHH
Confidence 00 11111111100 0111111111 11 33456788999999999999999999999874 4556
Q ss_pred Hhhccc
Q psy14889 428 LACADM 433 (443)
Q Consensus 428 l~~~~~ 433 (443)
+...+.
T Consensus 312 lr~~~~ 317 (364)
T KOG0658|consen 312 LRDPNT 317 (364)
T ss_pred hhCcCc
Confidence 655533
|
|
| >KOG0660|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=325.41 Aligned_cols=283 Identities=25% Similarity=0.278 Sum_probs=206.6
Q ss_pred hccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCc---cchHHHHHHHHHHhccCCCceeeeeeccc-cCCcccE
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDE---ASWSRETEIYSTVLLRHENILGYIGSDMT-SRNSCTQ 208 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~---~~~~~e~ei~~~~~l~H~nIv~l~g~~~~-~~~~~~~ 208 (443)
...|...+.||+|+||.|..+.. +|+.||||.+...-. ....--+|+..++.++|+||+.+++++.. .......
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 35677789999999999999988 689999998753221 22222466667777999999999999876 3334467
Q ss_pred EEeeecccCcccHHHHhcccC-CCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCC
Q psy14889 209 LWLVTHYHSFGSLYDHLNRTT-LNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGL 287 (443)
Q Consensus 209 ~~lv~e~~~~gsL~~~l~~~~-l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGl 287 (443)
+|+|+|+|+. ||...++.+. ++......++.|+++||.|+|+. +|+||||||+|+|++.+..+||+|||+
T Consensus 101 vYiV~elMet-DL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSA--------nViHRDLKPsNll~n~~c~lKI~DFGL 171 (359)
T KOG0660|consen 101 VYLVFELMET-DLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSA--------NVIHRDLKPSNLLLNADCDLKICDFGL 171 (359)
T ss_pred eEEehhHHhh-HHHHHHHcCccccHHHHHHHHHHHHHhcchhhcc--------cccccccchhheeeccCCCEEeccccc
Confidence 9999999964 9999998776 99999999999999999999999 999999999999999999999999999
Q ss_pred cccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCC----------ccccc
Q psy14889 288 AVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANG----------IFEEY 357 (443)
Q Consensus 288 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~----------~~~~~ 357 (443)
|+..... ......+..+.|.+|.|||++... ..||.+.||||.||++.||++|++.|. +....
T Consensus 172 AR~~~~~--~~~~~mTeYVaTRWYRAPElll~~-----~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~l 244 (359)
T KOG0660|consen 172 ARYLDKF--FEDGFMTEYVATRWYRAPELLLNS-----SEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELL 244 (359)
T ss_pred eeecccc--CcccchhcceeeeeecCHHHHhcc-----ccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhc
Confidence 9988654 112223556889999999998655 278899999999999999999976532 01111
Q ss_pred CCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH--HHHHHhhcccc
Q psy14889 358 KAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK--TLIKLACADMY 434 (443)
Q Consensus 358 ~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~--~L~~l~~~~~~ 434 (443)
..|-.+.. .....+..+..+......+..+-...-........+|+++||..||.+|+|++|+++ .|...+..+..
T Consensus 245 GtP~~e~l-~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dE 322 (359)
T KOG0660|consen 245 GTPSEEDL-QKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDE 322 (359)
T ss_pred CCCCHHHH-HHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccC
Confidence 22211100 000111122222222233322211111245678999999999999999999999987 46666554433
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=325.12 Aligned_cols=251 Identities=22% Similarity=0.366 Sum_probs=197.3
Q ss_pred ccccccceeeeecCeEEEEEEEC-----CceeEEEEeeccCcc--chHHHHHHHHHHhccCCCceeeeeeccccCCcccE
Q psy14889 136 KQISLSECIGKGRYGEVWRGVWH-----GENVAVKIFFSRDEA--SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQ 208 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~~-----~~~vAvK~~~~~~~~--~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~ 208 (443)
++|++.+.||+|+||.||+|.+. +..||+|.+...... ....+.|+..+..++||||++++|++... ..
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----~~ 80 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRG----NT 80 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecC----CC
Confidence 57999999999999999999762 568999988654322 22345677777779999999999998765 34
Q ss_pred EEeeecccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecC
Q psy14889 209 LWLVTHYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFG 286 (443)
Q Consensus 209 ~~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfG 286 (443)
.++||||+++|+|.+++.. ..+++.+++.++.|++.||+|||+. +++||||||+|||++.++.+|++|||
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~--------~iiH~dikp~nili~~~~~~~l~dfg 152 (266)
T cd05064 81 MMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEM--------GYVHKGLAAHKVLVNSDLVCKISGFR 152 (266)
T ss_pred cEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC--------CEeeccccHhhEEEcCCCcEEECCCc
Confidence 7999999999999999865 4689999999999999999999998 99999999999999999999999999
Q ss_pred CcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh-cccCCCcccccCCCCCCCC
Q psy14889 287 LAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR-RTKANGIFEEYKAPYHDLV 365 (443)
Q Consensus 287 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt-g~~~~~~~~~~~~P~~~~~ 365 (443)
.+........ .......++..|+|||.+.+. .++.++|||||||++||+++ | ..||....
T Consensus 153 ~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~~l~ell~~g----------~~p~~~~~ 213 (266)
T cd05064 153 RLQEDKSEAI---YTTMSGKSPVLWAAPEAIQYH------HFSSASDVWSFGIVMWEVMSYG----------ERPYWDMS 213 (266)
T ss_pred ccccccccch---hcccCCCCceeecCHHHHhhC------CccchhHHHHHHHHHHHHhcCC----------CCCcCcCC
Confidence 8754322111 111123456789999998765 67789999999999999875 7 67776542
Q ss_pred CCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHH
Q psy14889 366 PMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKL 428 (443)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l 428 (443)
.....+.+.. ......+ ..++..+.+++.+||+.+|++|||+.+|++.|+++
T Consensus 214 -----~~~~~~~~~~-~~~~~~~-----~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 214 -----GQDVIKAVED-GFRLPAP-----RNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred -----HHHHHHHHHC-CCCCCCC-----CCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 2233333322 2222222 34677899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=332.41 Aligned_cols=259 Identities=24% Similarity=0.349 Sum_probs=192.1
Q ss_pred ccccccceeeeecCeEEEEEEEC------------------CceeEEEEeeccCccc--hHHHHHHHHHHhccCCCceee
Q psy14889 136 KQISLSECIGKGRYGEVWRGVWH------------------GENVAVKIFFSRDEAS--WSRETEIYSTVLLRHENILGY 195 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~~------------------~~~vAvK~~~~~~~~~--~~~e~ei~~~~~l~H~nIv~l 195 (443)
++|.+.+.||+|+||.||+|.+. +..||+|.+....... .....|+..+..++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 67999999999999999999752 2369999886543221 223355666666999999999
Q ss_pred eeeccccCCcccEEEeeecccCcccHHHHhccc--------------------CCCHHHHHHHHHHHHHHHHHHHHchhc
Q psy14889 196 IGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRT--------------------TLNHHQMMKICLSIVNGLVHLHTEIFG 255 (443)
Q Consensus 196 ~g~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~--------------------~l~~~~~~~i~~qia~gL~yLH~~~~~ 255 (443)
++++.+.. ..++||||+++|+|.+++... .+++..+..++.||+.||.|||+.
T Consensus 85 ~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~--- 157 (304)
T cd05096 85 LGVCVDED----PLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL--- 157 (304)
T ss_pred EEEEecCC----ceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---
Confidence 99987763 479999999999999998532 367788999999999999999998
Q ss_pred CCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchH
Q psy14889 256 TQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIY 335 (443)
Q Consensus 256 ~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvw 335 (443)
+|+||||||+|||++.++.+||+|||+++.+....... ......++..|+|||++..+ .++.++|||
T Consensus 158 -----~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~------~~~~~~Dv~ 224 (304)
T cd05096 158 -----NFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYR--IQGRAVLPIRWMAWECILMG------KFTTASDVW 224 (304)
T ss_pred -----CccccCcchhheEEcCCccEEECCCccceecccCceeE--ecCcCCCCccccCHHHHhcC------CCCchhhhH
Confidence 99999999999999999999999999997654322111 11233567889999998765 667899999
Q ss_pred HHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCC
Q psy14889 336 ALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVR 415 (443)
Q Consensus 336 S~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 415 (443)
|||+++|||+++.. ..||....... ........... ....... ..+..++..+.+++.+||+.||++|
T Consensus 225 slG~~l~el~~~~~--------~~p~~~~~~~~-~~~~~~~~~~~-~~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~R 292 (304)
T cd05096 225 AFGVTLWEILMLCK--------EQPYGELTDEQ-VIENAGEFFRD-QGRQVYL--FRPPPCPQGLYELMLQCWSRDCRER 292 (304)
T ss_pred HHHHHHHHHHHccC--------CCCCCcCCHHH-HHHHHHHHhhh-ccccccc--cCCCCCCHHHHHHHHHHccCCchhC
Confidence 99999999997522 45666542110 01111111111 1111100 0123466789999999999999999
Q ss_pred CcHHHHHHHHH
Q psy14889 416 LSALRVKKTLI 426 (443)
Q Consensus 416 ps~~evl~~L~ 426 (443)
||+.+|.+.|+
T Consensus 293 Ps~~~i~~~l~ 303 (304)
T cd05096 293 PSFSDIHAFLT 303 (304)
T ss_pred cCHHHHHHHHh
Confidence 99999998876
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=326.88 Aligned_cols=247 Identities=30% Similarity=0.520 Sum_probs=187.5
Q ss_pred cccceeeeecCeEEEEEEEC------CceeEEEEeeccCcc--chHHHHHHHHHHhccCCCceeeeeeccccCCcccEEE
Q psy14889 139 SLSECIGKGRYGEVWRGVWH------GENVAVKIFFSRDEA--SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLW 210 (443)
Q Consensus 139 ~~~~~lG~G~fg~Vy~~~~~------~~~vAvK~~~~~~~~--~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~ 210 (443)
.+.+.||.|.||.||+|.+. +..|+||.+...... ......|+..+..++||||++++|++.... ..+
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~----~~~ 77 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENE----PLF 77 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSS----SEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccc----ccc
Confidence 45688999999999999986 578999998553222 223345666666789999999999998543 379
Q ss_pred eeecccCcccHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCC
Q psy14889 211 LVTHYHSFGSLYDHLNRT---TLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGL 287 (443)
Q Consensus 211 lv~e~~~~gsL~~~l~~~---~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGl 287 (443)
+|+||+++|+|.++|... .+++.++..|+.||+.||.|||+. +++|+||+++||++++++.+||+|||+
T Consensus 78 lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~--------~iiH~~l~~~nill~~~~~~Kl~~f~~ 149 (259)
T PF07714_consen 78 LVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSN--------NIIHGNLSPSNILLDSNGQVKLSDFGL 149 (259)
T ss_dssp EEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHT--------TEEEST-SGGGEEEETTTEEEEESTTT
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccc--------ccccccccccccccccccccccccccc
Confidence 999999999999999764 799999999999999999999998 999999999999999999999999999
Q ss_pred cccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCC
Q psy14889 288 AVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPM 367 (443)
Q Consensus 288 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~ 367 (443)
+......... .......+...|+|||.+... .++.++||||||+++|||+++. ..||.+.
T Consensus 150 ~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~------~~~~ksDVysfG~~l~ei~~~~---------~~p~~~~--- 209 (259)
T PF07714_consen 150 SRPISEKSKY--KNDSSQQLPLRYLAPEVLKDG------EYTKKSDVYSFGMLLYEILTLG---------KFPFSDY--- 209 (259)
T ss_dssp GEETTTSSSE--EESTTSESGGGGS-HHHHHHS------EESHHHHHHHHHHHHHHHHTTS---------SGTTTTS---
T ss_pred cccccccccc--ccccccccccccccccccccc------cccccccccccccccccccccc---------ccccccc---
Confidence 9776322111 111223567789999999876 5668999999999999999941 5676654
Q ss_pred CCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHH
Q psy14889 368 DPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTL 425 (443)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 425 (443)
....+...+ .+..++..+ ..++..+.+++.+||+.||++|||+.++++.|
T Consensus 210 --~~~~~~~~~-~~~~~~~~~-----~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 210 --DNEEIIEKL-KQGQRLPIP-----DNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp --CHHHHHHHH-HTTEETTSB-----TTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred --ccccccccc-cccccceec-----cchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 233333333 233333333 33667899999999999999999999999886
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG1989|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=351.75 Aligned_cols=269 Identities=25% Similarity=0.428 Sum_probs=206.5
Q ss_pred hccccccceeeeecCeEEEEEEE-C-CceeEEEEeeccCccchHH-HHHHHHHHhcc-CCCceeeeee-cccc--CCccc
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVW-H-GENVAVKIFFSRDEASWSR-ETEIYSTVLLR-HENILGYIGS-DMTS--RNSCT 207 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~-~-~~~vAvK~~~~~~~~~~~~-e~ei~~~~~l~-H~nIv~l~g~-~~~~--~~~~~ 207 (443)
..++++.+.|.+|||+.||+|+. . |..+|+|++...++..... ..||..++.|. |+|||.|++. .... .....
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 35788999999999999999998 3 4899999987765443322 35565665576 9999999993 3322 22135
Q ss_pred EEEeeecccCcccHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEe
Q psy14889 208 QLWLVTHYHSFGSLYDHLNR---TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIAD 284 (443)
Q Consensus 208 ~~~lv~e~~~~gsL~~~l~~---~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~D 284 (443)
+++|.||||.+|+|-++++. ..|++.++++|+.|+++|+++||.. +|+|||||||.+||||+.++..||||
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~------~pPiIHRDLKiENvLls~~g~~KLCD 189 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL------KPPIIHRDLKIENVLLSADGNYKLCD 189 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC------CCccchhhhhhhheEEcCCCCEEeCc
Confidence 78999999999999999973 5699999999999999999999988 78999999999999999999999999
Q ss_pred cCCcccccccCC-cCCC----CCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCC
Q psy14889 285 FGLAVSYSQLSN-KMDI----PPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKA 359 (443)
Q Consensus 285 fGla~~~~~~~~-~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~ 359 (443)
||.|........ .... ..-...-|+.|+|||++.--.. ...++|+|||||||+||-|+.. ..
T Consensus 190 FGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg---~pI~eKsDIWALGclLYkLCy~----------t~ 256 (738)
T KOG1989|consen 190 FGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSG---LPIGEKSDIWALGCLLYKLCYF----------TT 256 (738)
T ss_pred ccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcC---CCCcchhHHHHHHHHHHHHHHh----------CC
Confidence 999853322110 0000 0001246899999999864322 2778999999999999999998 77
Q ss_pred CCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhhcccccc
Q psy14889 360 PYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLACADMYIH 436 (443)
Q Consensus 360 P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~~~~~~~ 436 (443)
||++.-. ..++.....-|.. +..+..+.+||+.||+.||++||++.+|+..+.+|......+.
T Consensus 257 PFe~sg~--------laIlng~Y~~P~~------p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~~ 319 (738)
T KOG1989|consen 257 PFEESGK--------LAILNGNYSFPPF------PNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPIP 319 (738)
T ss_pred CcCcCcc--------eeEEeccccCCCC------ccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCcc
Confidence 8876311 1122222222333 3478899999999999999999999999999999998776554
|
|
| >KOG4278|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-43 Score=339.43 Aligned_cols=260 Identities=22% Similarity=0.382 Sum_probs=210.6
Q ss_pred hhhhccccccceeeeecCeEEEEEEEC--CceeEEEEeeccCccchHHHHHHHHHHhccCCCceeeeeeccccCCcccEE
Q psy14889 132 RTLAKQISLSECIGKGRYGEVWRGVWH--GENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQL 209 (443)
Q Consensus 132 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~ 209 (443)
+..+.++.+..+||-|.||.||.|.|+ .-.||||.++.+...-..+..|...++.++|||+|+|+|+|....+ +
T Consensus 263 EmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpP----F 338 (1157)
T KOG4278|consen 263 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP----F 338 (1157)
T ss_pred hccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCC----e
Confidence 334467888899999999999999994 6789999987665443334445555555999999999999987744 7
Q ss_pred EeeecccCcccHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecC
Q psy14889 210 WLVTHYHSFGSLYDHLNR---TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFG 286 (443)
Q Consensus 210 ~lv~e~~~~gsL~~~l~~---~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfG 286 (443)
|||+|||.+|+|.+||++ ..++.-.++.++.||++||+||..+ ++|||||.++|||+.++..+||+|||
T Consensus 339 YIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkk--------nFIHRDLAARNCLVgEnhiVKvADFG 410 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKK--------NFIHRDLAARNCLVGENHIVKVADFG 410 (1157)
T ss_pred EEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHh--------hhhhhhhhhhhccccccceEEeeccc
Confidence 999999999999999974 5577788899999999999999988 88999999999999999999999999
Q ss_pred CcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCC
Q psy14889 287 LAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVP 366 (443)
Q Consensus 287 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~ 366 (443)
|++.+..+..... ....-.+.|.|||.+..+ .++.|+|||+|||+|||+.|- +..||.+.
T Consensus 411 LsRlMtgDTYTAH---AGAKFPIKWTAPEsLAyN------tFSiKSDVWAFGVLLWEIATY---------GMsPYPGi-- 470 (1157)
T KOG4278|consen 411 LSRLMTGDTYTAH---AGAKFPIKWTAPESLAYN------TFSIKSDVWAFGVLLWEIATY---------GMSPYPGI-- 470 (1157)
T ss_pred hhhhhcCCceecc---cCccCcccccCccccccc------ccccchhhHHHHHHHHHHHhc---------CCCCCCCc--
Confidence 9999876543322 122235689999999876 677899999999999999985 37888886
Q ss_pred CCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhhcc
Q psy14889 367 MDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLACAD 432 (443)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~~~ 432 (443)
+...+..+... ..+..-| ..|+..+++||+.||+++|.+||++.|+.+.++.+-++.
T Consensus 471 ---dlSqVY~LLEk-gyRM~~P-----eGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~s 527 (1157)
T KOG4278|consen 471 ---DLSQVYGLLEK-GYRMDGP-----EGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSS 527 (1157)
T ss_pred ---cHHHHHHHHhc-cccccCC-----CCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhccc
Confidence 33444444432 3333333 458999999999999999999999999999999887654
|
|
| >KOG1025|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=341.67 Aligned_cols=256 Identities=24% Similarity=0.458 Sum_probs=211.2
Q ss_pred ccccceeeeecCeEEEEEEE--CC----ceeEEEEeeccCcc--chHHHHHHHHHHhccCCCceeeeeeccccCCcccEE
Q psy14889 138 ISLSECIGKGRYGEVWRGVW--HG----ENVAVKIFFSRDEA--SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQL 209 (443)
Q Consensus 138 ~~~~~~lG~G~fg~Vy~~~~--~~----~~vAvK~~~~~~~~--~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~ 209 (443)
....++||+|+||+||+|.| .| -+||+|++...... ....-.|...+.+++|||+++++|+|..+. +
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-----~ 772 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-----L 772 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-----H
Confidence 44578999999999999998 43 47899988655433 233346777788899999999999998874 5
Q ss_pred EeeecccCcccHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCC
Q psy14889 210 WLVTHYHSFGSLYDHLN--RTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGL 287 (443)
Q Consensus 210 ~lv~e~~~~gsL~~~l~--~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGl 287 (443)
.||++||+.|+|.+|++ +..+..+..+.|..|||+||.|||.+ +++||||.++|||+.+...+||.|||+
T Consensus 773 qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~q--------rlVHrdLaaRNVLVksP~hvkitdfgl 844 (1177)
T KOG1025|consen 773 QLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQ--------RLVHRDLAARNVLVKSPNHVKITDFGL 844 (1177)
T ss_pred HHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhc--------chhhhhhhhhheeecCCCeEEEEecch
Confidence 89999999999999996 46799999999999999999999998 999999999999999999999999999
Q ss_pred cccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCC
Q psy14889 288 AVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPM 367 (443)
Q Consensus 288 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~ 367 (443)
|+.+.......... ...-.+.|||-|.+... .++.++|||||||++||++|- +..||.+.
T Consensus 845 a~ll~~d~~ey~~~--~gK~pikwmale~i~~~------~~thqSDVWsfGVtiWElmTF---------Ga~Py~gi--- 904 (1177)
T KOG1025|consen 845 AKLLAPDEKEYSAP--GGKVPIKWMALESIRIR------KYTHQSDVWSFGVTIWELMTF---------GAKPYDGI--- 904 (1177)
T ss_pred hhccCccccccccc--ccccCcHHHHHHHhhcc------CCCchhhhhhhhhhHHHHHhc---------CCCccCCC---
Confidence 99888766554332 12234689999998876 888999999999999999984 37788876
Q ss_pred CCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhhcccc
Q psy14889 368 DPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLACADMY 434 (443)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~~~~~ 434 (443)
..+++.+.+..... ..-| ..|+.+++.+|.+||..|+..||+++++...+.+++.....
T Consensus 905 --~~~eI~dlle~geR-LsqP-----piCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardpqr 963 (1177)
T KOG1025|consen 905 --PAEEIPDLLEKGER-LSQP-----PICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDPQR 963 (1177)
T ss_pred --CHHHhhHHHhcccc-CCCC-----CCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCcce
Confidence 44666666654333 3323 34888999999999999999999999999999998876554
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=340.08 Aligned_cols=255 Identities=21% Similarity=0.401 Sum_probs=195.2
Q ss_pred hccccccceeeeecCeEEEEEEEC-------CceeEEEEeeccCccc--hHHHHHHHHHHhc-cCCCceeeeeeccccCC
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVWH-------GENVAVKIFFSRDEAS--WSRETEIYSTVLL-RHENILGYIGSDMTSRN 204 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~~~--~~~e~ei~~~~~l-~H~nIv~l~g~~~~~~~ 204 (443)
.++|++.+.||+|+||.||+|.+. +..||||++....... .....|+..+..+ +|+||+++++++....
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~- 115 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG- 115 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC-
Confidence 367999999999999999999852 2479999886543221 1223455555557 8999999999987763
Q ss_pred cccEEEeeecccCcccHHHHhcc---------------------------------------------------------
Q psy14889 205 SCTQLWLVTHYHSFGSLYDHLNR--------------------------------------------------------- 227 (443)
Q Consensus 205 ~~~~~~lv~e~~~~gsL~~~l~~--------------------------------------------------------- 227 (443)
.+++||||+++|+|.+++..
T Consensus 116 ---~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (374)
T cd05106 116 ---PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSS 192 (374)
T ss_pred ---CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccc
Confidence 47999999999999998842
Q ss_pred --------------cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcccccc
Q psy14889 228 --------------TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQ 293 (443)
Q Consensus 228 --------------~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~~~ 293 (443)
..+++..++.++.||+.||.|||+. +|+||||||+|||+++++.+||+|||+++....
T Consensus 193 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~--------giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~ 264 (374)
T cd05106 193 QSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK--------NCIHRDVAARNVLLTDGRVAKICDFGLARDIMN 264 (374)
T ss_pred ccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC--------CEEeccCchheEEEeCCCeEEEeeceeeeeccC
Confidence 1367888999999999999999998 999999999999999999999999999976543
Q ss_pred cCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh-cccCCCcccccCCCCCCCCCCCCChH
Q psy14889 294 LSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR-RTKANGIFEEYKAPYHDLVPMDPSFD 372 (443)
Q Consensus 294 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt-g~~~~~~~~~~~~P~~~~~~~~~~~~ 372 (443)
..... ......++..|+|||++.+. .++.++|||||||++|||++ | ..||...... .
T Consensus 265 ~~~~~--~~~~~~~~~~y~aPE~~~~~------~~~~~~DvwSlGvil~ellt~G----------~~Pf~~~~~~----~ 322 (374)
T cd05106 265 DSNYV--VKGNARLPVKWMAPESIFDC------VYTVQSDVWSYGILLWEIFSLG----------KSPYPGILVN----S 322 (374)
T ss_pred Cccee--eccCCCCccceeCHHHhcCC------CCCccccHHHHHHHHHHHHhCC----------CCCCcccccc----H
Confidence 22111 11223456789999998765 67789999999999999997 8 6677654221 1
Q ss_pred HHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHh
Q psy14889 373 DMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLA 429 (443)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~ 429 (443)
....... ....+..+ ...+.++.+++.+||+.||++|||+.+|++.|+++.
T Consensus 323 ~~~~~~~-~~~~~~~~-----~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 323 KFYKMVK-RGYQMSRP-----DFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred HHHHHHH-cccCccCC-----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 2222221 12222222 224568999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=329.67 Aligned_cols=242 Identities=21% Similarity=0.296 Sum_probs=192.4
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCc----cchHHHHHHHHHHhccCCCceeeeeeccccCCcccEE
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDE----ASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQL 209 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~----~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~ 209 (443)
++|++.+.||+|+||.||+|.. +++.||+|++..... .......|+..+..++||||+++++++.+. ..+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~----~~~ 76 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQ----RFL 76 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccC----CeE
Confidence 3688899999999999999998 489999999864321 112234566666679999999999988765 468
Q ss_pred EeeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCc
Q psy14889 210 WLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA 288 (443)
Q Consensus 210 ~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla 288 (443)
++||||+++|+|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 77 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--------~i~H~dlkp~NIli~~~~~~kl~Dfg~~ 148 (291)
T cd05612 77 YMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK--------EIVYRDLKPENILLDKEGHIKLTDFGFA 148 (291)
T ss_pred EEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC--------CeeecCCCHHHeEECCCCCEEEEecCcc
Confidence 999999999999999864 5689999999999999999999998 9999999999999999999999999998
Q ss_pred ccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCC
Q psy14889 289 VSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMD 368 (443)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~ 368 (443)
+...... ....||+.|+|||++.+. .++.++|||||||++|||++| ..||...
T Consensus 149 ~~~~~~~-------~~~~gt~~y~aPE~~~~~------~~~~~~DiwSlG~il~~l~~g----------~~pf~~~---- 201 (291)
T cd05612 149 KKLRDRT-------WTLCGTPEYLAPEVIQSK------GHNKAVDWWALGILIYEMLVG----------YPPFFDD---- 201 (291)
T ss_pred hhccCCc-------ccccCChhhcCHHHHcCC------CCCchhhHHHHHHHHHHHHhC----------CCCCCCC----
Confidence 7654311 234689999999998765 567899999999999999999 6677653
Q ss_pred CChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCc-----HHHHHHH
Q psy14889 369 PSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLS-----ALRVKKT 424 (443)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~~ 424 (443)
........+.. ....++. ..+..+.+|+++||+.||.+||+ ++++++.
T Consensus 202 -~~~~~~~~i~~--~~~~~~~-----~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 202 -NPFGIYEKILA--GKLEFPR-----HLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred -CHHHHHHHHHh--CCcCCCc-----cCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 12222222221 2223332 24567999999999999999995 8887754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=329.64 Aligned_cols=256 Identities=22% Similarity=0.419 Sum_probs=198.6
Q ss_pred ccccccceeeeecCeEEEEEEE--CCc----eeEEEEeeccCcc--chHHHHHHHHHHhccCCCceeeeeeccccCCccc
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGE----NVAVKIFFSRDEA--SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCT 207 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~----~vAvK~~~~~~~~--~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~ 207 (443)
.+|+..+.||+|+||.||+|.+ ++. .||+|.+...... ......|+..+..++||||++++|++....
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~~---- 82 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST---- 82 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCCC----
Confidence 5799999999999999999987 344 3899987643221 122234555666699999999999987653
Q ss_pred EEEeeecccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEec
Q psy14889 208 QLWLVTHYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADF 285 (443)
Q Consensus 208 ~~~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~Df 285 (443)
.++++||+++|+|.+++.. ..+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+||
T Consensus 83 -~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~--------~iiH~dlkp~Nill~~~~~~kl~Df 153 (316)
T cd05108 83 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEER--------RLVHRDLAARNVLVKTPQHVKITDF 153 (316)
T ss_pred -ceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhc--------CeeccccchhheEecCCCcEEEccc
Confidence 4799999999999999965 3588999999999999999999998 9999999999999999999999999
Q ss_pred CCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh-cccCCCcccccCCCCCCC
Q psy14889 286 GLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR-RTKANGIFEEYKAPYHDL 364 (443)
Q Consensus 286 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt-g~~~~~~~~~~~~P~~~~ 364 (443)
|+++.+........ .....++..|+|||.+.+. .++.++||||||+++|||++ | ..||.+.
T Consensus 154 G~a~~~~~~~~~~~--~~~~~~~~~y~apE~~~~~------~~~~~~Di~slGv~l~el~t~g----------~~p~~~~ 215 (316)
T cd05108 154 GLAKLLGADEKEYH--AEGGKVPIKWMALESILHR------IYTHQSDVWSYGVTVWELMTFG----------SKPYDGI 215 (316)
T ss_pred cccccccCCCccee--ccCCccceeecChHHhccC------CCCchhhhHHHHHHHHHHHcCC----------CCCCCCC
Confidence 99987654322211 1222346789999998766 66789999999999999998 7 6676543
Q ss_pred CCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhhccc
Q psy14889 365 VPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLACADM 433 (443)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~~~~ 433 (443)
....+...... ......+ ..++..+.+++.+||..||++|||+.+++..|.++.....
T Consensus 216 -----~~~~~~~~~~~-~~~~~~~-----~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~~ 273 (316)
T cd05108 216 -----PASEISSILEK-GERLPQP-----PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQ 273 (316)
T ss_pred -----CHHHHHHHHhC-CCCCCCC-----CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCCc
Confidence 22333333322 2222222 2355679999999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=322.11 Aligned_cols=266 Identities=23% Similarity=0.345 Sum_probs=195.8
Q ss_pred ccccceeeeecCeEEEEEEE------CCceeEEEEeeccCc--cchHHHHHHHHHHhccCCCceeeeeeccccCCcccEE
Q psy14889 138 ISLSECIGKGRYGEVWRGVW------HGENVAVKIFFSRDE--ASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQL 209 (443)
Q Consensus 138 ~~~~~~lG~G~fg~Vy~~~~------~~~~vAvK~~~~~~~--~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~ 209 (443)
|++.+.||+|+||+||++.+ ++..||+|.+..... .......|+..+..++||||+++++++..... ..+
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~--~~~ 83 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGG--KGL 83 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC--ceE
Confidence 48899999999999988764 467899998865432 22233456666667999999999998765433 357
Q ss_pred EeeecccCcccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcc
Q psy14889 210 WLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAV 289 (443)
Q Consensus 210 ~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~ 289 (443)
+++|||+++|+|.+++....+++.++..++.|++.||.|||+. +|+||||||+|||+++++.+||+|||+++
T Consensus 84 ~lv~e~~~~~~l~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~--------~i~H~dlkp~Nili~~~~~~~l~dfg~~~ 155 (283)
T cd05080 84 QLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQ--------HYIHRDLAARNVLLDNDRLVKIGDFGLAK 155 (283)
T ss_pred EEEecCCCCCCHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHC--------CeeccccChheEEEcCCCcEEEeeccccc
Confidence 9999999999999999888899999999999999999999998 99999999999999999999999999997
Q ss_pred cccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCC--
Q psy14889 290 SYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPM-- 367 (443)
Q Consensus 290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~-- 367 (443)
........... .....++..|+|||.+... .++.++||||||+++|||+||+.|+.... ..+......
T Consensus 156 ~~~~~~~~~~~-~~~~~~~~~~~~PE~~~~~------~~~~~~Di~slG~~l~el~tg~~p~~~~~---~~~~~~~~~~~ 225 (283)
T cd05080 156 AVPEGHEYYRV-REDGDSPVFWYAVECLKEN------KFSYASDVWSFGVTLYELLTHCDSKQSPP---KKFEEMIGPKQ 225 (283)
T ss_pred ccCCcchhhcc-CCCCCCCceeeCHhHhccc------CCCcccccHHHHHHHHHHHhCCCCCCCCc---chhhhhhcccc
Confidence 66542221111 1122456679999998765 66789999999999999999954432110 000000000
Q ss_pred -CCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHh
Q psy14889 368 -DPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLA 429 (443)
Q Consensus 368 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~ 429 (443)
............ ....+.. +..++.++.+++.+||+.||++|||++++++.|+++.
T Consensus 226 ~~~~~~~~~~~~~-~~~~~~~-----~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 226 GQMTVVRLIELLE-RGMRLPC-----PKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred cccchhhhhhhhh-cCCCCCC-----CCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 000011111111 1111111 2346678999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=334.23 Aligned_cols=241 Identities=22% Similarity=0.340 Sum_probs=192.4
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCc----cchHHHHHHHHHHhccCCCceeeeeeccccCCcccEE
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDE----ASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQL 209 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~----~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~ 209 (443)
++|.+.+.||+|+||.||+|.+ +++.||+|++..... .......|+..+..++||||+++++++... ..+
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~----~~~ 93 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDE----NRV 93 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcC----CEE
Confidence 6799999999999999999998 578999999865321 111223556666669999999999998776 458
Q ss_pred EeeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCc
Q psy14889 210 WLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA 288 (443)
Q Consensus 210 ~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla 288 (443)
++||||+++|+|.+++.+ ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 94 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~--------~ivH~dlkp~NIll~~~~~~kl~Dfg~~ 165 (329)
T PTZ00263 94 YFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSK--------DIIYRDLKPENLLLDNKGHVKVTDFGFA 165 (329)
T ss_pred EEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC--------CeeecCCCHHHEEECCCCCEEEeeccCc
Confidence 999999999999999865 5689999999999999999999998 9999999999999999999999999999
Q ss_pred ccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCC
Q psy14889 289 VSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMD 368 (443)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~ 368 (443)
+...... ....||+.|+|||++.+. .++.++|||||||++|||++| ..||.+.
T Consensus 166 ~~~~~~~-------~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~elltg----------~~pf~~~---- 218 (329)
T PTZ00263 166 KKVPDRT-------FTLCGTPEYLAPEVIQSK------GHGKAVDWWTMGVLLYEFIAG----------YPPFFDD---- 218 (329)
T ss_pred eEcCCCc-------ceecCChhhcCHHHHcCC------CCCCcceeechHHHHHHHHcC----------CCCCCCC----
Confidence 7654321 234789999999999876 567899999999999999999 6777653
Q ss_pred CChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCc-----HHHHHH
Q psy14889 369 PSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLS-----ALRVKK 423 (443)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~ 423 (443)
........+. .....+|. ..+..+.+|+.+||+.||.+||+ +.++++
T Consensus 219 -~~~~~~~~i~--~~~~~~p~-----~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 219 -TPFRIYEKIL--AGRLKFPN-----WFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred -CHHHHHHHHh--cCCcCCCC-----CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 1122222221 12233332 24567899999999999999997 677764
|
|
| >KOG0594|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=317.64 Aligned_cols=271 Identities=26% Similarity=0.298 Sum_probs=203.6
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCc---cchHHHHHHHHHHhccCCC-ceeeeeeccccCC--ccc
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDE---ASWSRETEIYSTVLLRHEN-ILGYIGSDMTSRN--SCT 207 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~---~~~~~e~ei~~~~~l~H~n-Iv~l~g~~~~~~~--~~~ 207 (443)
..|...++||+|+||+||+|+. +|+.||+|.+....+ ......+|+..+..++|+| ||++++++.+... ...
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 5678888999999999999987 689999999876544 2233457777777799999 9999999987652 223
Q ss_pred EEEeeecccCcccHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEE
Q psy14889 208 QLWLVTHYHSFGSLYDHLNR-----TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVI 282 (443)
Q Consensus 208 ~~~lv~e~~~~gsL~~~l~~-----~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl 282 (443)
.+++|+||+.. +|..++.. ..++...+..++.||+.||+|||++ +|+||||||+||||+++|.+||
T Consensus 91 ~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~--------~IlHRDLKPQNlLi~~~G~lKl 161 (323)
T KOG0594|consen 91 KLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH--------GILHRDLKPQNLLISSSGVLKL 161 (323)
T ss_pred eEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC--------CeecccCCcceEEECCCCcEee
Confidence 68999999986 99999964 3578889999999999999999999 9999999999999999999999
Q ss_pred EecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCC----------
Q psy14889 283 ADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANG---------- 352 (443)
Q Consensus 283 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~---------- 352 (443)
+|||+|+...-.... .+..++|..|.|||++.+.. .|++..||||+||++.||+++++.+.
T Consensus 162 aDFGlAra~~ip~~~----yt~evvTlWYRaPEvLlGs~-----~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~ 232 (323)
T KOG0594|consen 162 ADFGLARAFSIPMRT----YTPEVVTLWYRAPEVLLGST-----SYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFR 232 (323)
T ss_pred eccchHHHhcCCccc----ccccEEEeeccCHHHhcCCC-----cCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHH
Confidence 999999866533322 35568999999999998873 56689999999999999999876542
Q ss_pred cccccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCC--chhHHHHHHHHHHHhcCCcCCCCcHHHHHHH--HHHH
Q psy14889 353 IFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVS--DSTLNAMTKVMKECWHQNANVRLSALRVKKT--LIKL 428 (443)
Q Consensus 353 ~~~~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~Rps~~evl~~--L~~l 428 (443)
+|.....|-...++......+....... ..-+..+.. ........+++.+||+.+|.+|.|++.+++. +..+
T Consensus 233 If~~lGtP~e~~Wp~v~~~~~~k~~f~~----~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 233 IFRLLGTPNEKDWPGVSSLPDYKAPFPK----WPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred HHHHcCCCCccCCCCccccccccccCcC----CCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 3444555544444333222221110000 000000000 1112468899999999999999999999875 4444
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=324.84 Aligned_cols=246 Identities=22% Similarity=0.301 Sum_probs=190.8
Q ss_pred cccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc----chHHHHHHHHHHhccCCCceeeeeeccccCCcccEEE
Q psy14889 137 QISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA----SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLW 210 (443)
Q Consensus 137 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~----~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~ 210 (443)
.|+..+.||+|+||.||+|.. +|+.||+|.+...... ......|+..+..++|+||+++++++.+. ..++
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~----~~~~ 76 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETK----DALC 76 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccC----CeEE
Confidence 367789999999999999987 6899999988643211 11223456666669999999999998766 3579
Q ss_pred eeecccCcccHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCC
Q psy14889 211 LVTHYHSFGSLYDHLNR---TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGL 287 (443)
Q Consensus 211 lv~e~~~~gsL~~~l~~---~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGl 287 (443)
+||||+++|+|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+
T Consensus 77 lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--------~iiH~dikp~Nill~~~~~~kl~Dfg~ 148 (285)
T cd05631 77 LVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE--------RIVYRDLKPENILLDDRGHIRISDLGL 148 (285)
T ss_pred EEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CEEeCCCCHHHEEECCCCCEEEeeCCC
Confidence 99999999999988743 3689999999999999999999998 999999999999999999999999999
Q ss_pred cccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCC
Q psy14889 288 AVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPM 367 (443)
Q Consensus 288 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~ 367 (443)
+........ .....||..|+|||++.+. .++.++|||||||++|||++| ..||......
T Consensus 149 ~~~~~~~~~-----~~~~~g~~~y~aPE~~~~~------~~~~~~DvwslGvil~el~~g----------~~pf~~~~~~ 207 (285)
T cd05631 149 AVQIPEGET-----VRGRVGTVGYMAPEVINNE------KYTFSPDWWGLGCLIYEMIQG----------QSPFRKRKER 207 (285)
T ss_pred cEEcCCCCe-----ecCCCCCCCccCHhhhcCC------CCCcccCchhHHHHHHHHHhC----------CCCCCCCCcc
Confidence 976543211 1234789999999999876 677899999999999999999 6677653211
Q ss_pred CCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCc-----HHHHHH
Q psy14889 368 DPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLS-----ALRVKK 423 (443)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~ 423 (443)
...+.+...+. ...... ....+..+.+|+++||+.||++||+ ++++++
T Consensus 208 -~~~~~~~~~~~--~~~~~~-----~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 208 -VKREEVDRRVK--EDQEEY-----SEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred -hhHHHHHHHhh--cccccC-----CccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 11122222211 111112 2335678999999999999999997 788776
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-42 Score=332.15 Aligned_cols=238 Identities=23% Similarity=0.330 Sum_probs=188.5
Q ss_pred ceeeeecCeEEEEEEE--CCceeEEEEeeccCc----cchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEeeecc
Q psy14889 142 ECIGKGRYGEVWRGVW--HGENVAVKIFFSRDE----ASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVTHY 215 (443)
Q Consensus 142 ~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~----~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e~ 215 (443)
+.||+|+||.||++.. +|+.||+|++..... .......|+..+..++||||+++++++... ..+++||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~----~~~~lv~e~ 76 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTH----DRLCFVMEY 76 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcC----CEEEEEEeC
Confidence 4699999999999987 688999999865321 112223456666669999999999988766 458999999
Q ss_pred cCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCccccccc
Q psy14889 216 HSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQL 294 (443)
Q Consensus 216 ~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~~~~ 294 (443)
+++|+|.+++.+ ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~--------~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~ 148 (323)
T cd05571 77 ANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSC--------DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD 148 (323)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC--------CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC
Confidence 999999998864 5789999999999999999999998 9999999999999999999999999998753221
Q ss_pred CCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCChHHH
Q psy14889 295 SNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFDDM 374 (443)
Q Consensus 295 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~~~~~ 374 (443)
.. ......||+.|+|||++.+. .++.++|||||||++|||++| ..||... .....
T Consensus 149 ~~----~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwSlG~il~elltg----------~~Pf~~~-----~~~~~ 203 (323)
T cd05571 149 GA----TMKTFCGTPEYLAPEVLEDN------DYGRAVDWWGLGVVMYEMMCG----------RLPFYNQ-----DHEKL 203 (323)
T ss_pred CC----cccceecCccccChhhhcCC------CCCccccCcccchhhhhhhcC----------CCCCCCC-----CHHHH
Confidence 11 12345799999999999776 677899999999999999999 6777543 22333
Q ss_pred HhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCC-----cHHHHHH
Q psy14889 375 RKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRL-----SALRVKK 423 (443)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~ 423 (443)
...+.. ....++ ...+.++.+++.+||+.||++|| ++.++++
T Consensus 204 ~~~~~~--~~~~~p-----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 204 FELILM--EEIRFP-----RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred HHHHHc--CCCCCC-----CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 333222 222333 23567899999999999999999 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=322.49 Aligned_cols=252 Identities=24% Similarity=0.400 Sum_probs=196.9
Q ss_pred ccccccceeeeecCeEEEEEEECC-------ceeEEEEeeccCccch--HHHHHHHHHHhccCCCceeeeeeccccCCcc
Q psy14889 136 KQISLSECIGKGRYGEVWRGVWHG-------ENVAVKIFFSRDEASW--SRETEIYSTVLLRHENILGYIGSDMTSRNSC 206 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~~~-------~~vAvK~~~~~~~~~~--~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~ 206 (443)
++|++.+.||+|+||.||+|...+ ..||+|.+........ ....|+..+..++||||+++++++....
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~--- 81 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQ--- 81 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCC---
Confidence 578999999999999999998732 4699998864432221 2245666666699999999999987653
Q ss_pred cEEEeeecccCcccHHHHhcc-----------------cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCC
Q psy14889 207 TQLWLVTHYHSFGSLYDHLNR-----------------TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKS 269 (443)
Q Consensus 207 ~~~~lv~e~~~~gsL~~~l~~-----------------~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~ 269 (443)
..+++|||+++|+|.+++.. ..+++.+++.++.|++.||.|||+. +++|+||||
T Consensus 82 -~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~--------~i~H~dlkp 152 (283)
T cd05048 82 -PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH--------HFVHRDLAA 152 (283)
T ss_pred -ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC--------Ceecccccc
Confidence 46899999999999999853 3478899999999999999999998 999999999
Q ss_pred CCEEEcCCCcEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh-cc
Q psy14889 270 KNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR-RT 348 (443)
Q Consensus 270 ~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt-g~ 348 (443)
+||++++++.+||+|||+++........ .......+++.|+|||.+... .++.++|||||||++|||++ |
T Consensus 153 ~Nil~~~~~~~~L~dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~------~~~~~sDv~slG~il~el~~~g- 223 (283)
T cd05048 153 RNCLVGEGLTVKISDFGLSRDIYSADYY--RVQSKSLLPVRWMPPEAILYG------KFTTESDIWSFGVVLWEIFSYG- 223 (283)
T ss_pred ceEEEcCCCcEEECCCcceeeccccccc--cccCCCcccccccCHHHhccC------cCchhhhHHHHHHHHHHHHcCC-
Confidence 9999999999999999999755332111 112234567889999998765 66789999999999999998 7
Q ss_pred cCCCcccccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHH
Q psy14889 349 KANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKL 428 (443)
Q Consensus 349 ~~~~~~~~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l 428 (443)
..||.+.. ..++...+.. ...+..+ ..++.++.+|+.+||+.||.+||++.+|++.|+++
T Consensus 224 ---------~~p~~~~~-----~~~~~~~i~~-~~~~~~~-----~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 224 ---------LQPYYGFS-----NQEVIEMIRS-RQLLPCP-----EDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred ---------CCCCCCCC-----HHHHHHHHHc-CCcCCCc-----ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 66776532 2333333322 2222222 34778899999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG2345|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=302.72 Aligned_cols=268 Identities=23% Similarity=0.324 Sum_probs=206.2
Q ss_pred hccccccceeeeecCeEEEEEEE--CCceeEEEEeeccC-ccchHHHHHHHHHHhccCCCceeeeeeccccCC-cccEEE
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRD-EASWSRETEIYSTVLLRHENILGYIGSDMTSRN-SCTQLW 210 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~-~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~-~~~~~~ 210 (443)
.++|.+.+.||+|||+-||+++. +++.+|+|++.... ++.....+|+...++++|||+++++++...... .....|
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y 99 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY 99 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence 47899999999999999999985 78999999886655 333333466666667999999999998765433 335689
Q ss_pred eeecccCcccHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEec
Q psy14889 211 LVTHYHSFGSLYDHLNR-----TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADF 285 (443)
Q Consensus 211 lv~e~~~~gsL~~~l~~-----~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~Df 285 (443)
|+++|...|+|.+.+.+ ..+++.+++.|+.+|++||++||+. .|++.||||||.|||+++++.++|.||
T Consensus 100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~------~~~yAH~DiKP~NILls~~~~~vl~D~ 173 (302)
T KOG2345|consen 100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK------EPPYAHRDIKPANILLSDSGLPVLMDL 173 (302)
T ss_pred EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc------CCcccccCCCcceeEecCCCceEEEec
Confidence 99999999999999853 3699999999999999999999998 567999999999999999999999999
Q ss_pred CCcccccccCCcCCC-----CCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCC
Q psy14889 286 GLAVSYSQLSNKMDI-----PPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAP 360 (443)
Q Consensus 286 Gla~~~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P 360 (443)
|.+....-....... .......|..|+|||++.-.... ..++++|||||||+||+|+.| ..|
T Consensus 174 GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~---ti~ertDIWSLGCtLYa~mf~----------~sP 240 (302)
T KOG2345|consen 174 GSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHC---TITERTDIWSLGCTLYAMMFG----------ESP 240 (302)
T ss_pred cCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCc---ccccccchhhhhHHHHHHHHc----------CCc
Confidence 998654321110000 00123578899999999765443 667899999999999999999 778
Q ss_pred CCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHh
Q psy14889 361 YHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLA 429 (443)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~ 429 (443)
|........+.. -.+ ......+|+ +...++.+.++++.|++.||.+||++.+++..++.+.
T Consensus 241 fe~~~~~GgSla---LAv--~n~q~s~P~---~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 241 FERIYQQGGSLA---LAV--QNAQISIPN---SSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred chHHhhcCCeEE---Eee--eccccccCC---CCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 876543221111 111 111223333 2336788999999999999999999999999998764
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=335.74 Aligned_cols=256 Identities=23% Similarity=0.412 Sum_probs=196.7
Q ss_pred hccccccceeeeecCeEEEEEEEC-------CceeEEEEeeccCcc--chHHHHHHHHHHhcc-CCCceeeeeeccccCC
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVWH-------GENVAVKIFFSRDEA--SWSRETEIYSTVLLR-HENILGYIGSDMTSRN 204 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~~--~~~~e~ei~~~~~l~-H~nIv~l~g~~~~~~~ 204 (443)
.++|.+.++||+|+||.||+|.+. +..||||++...... ......|+..+..+. ||||+++++++...
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~-- 113 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS-- 113 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC--
Confidence 468999999999999999999862 246999988643322 122334566666675 99999999999766
Q ss_pred cccEEEeeecccCcccHHHHhcc---------------------------------------------------------
Q psy14889 205 SCTQLWLVTHYHSFGSLYDHLNR--------------------------------------------------------- 227 (443)
Q Consensus 205 ~~~~~~lv~e~~~~gsL~~~l~~--------------------------------------------------------- 227 (443)
..+++||||+++|+|.+++..
T Consensus 114 --~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (400)
T cd05105 114 --GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPM 191 (400)
T ss_pred --CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchh
Confidence 347999999999999988743
Q ss_pred ----------------------------------------cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCC
Q psy14889 228 ----------------------------------------TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDI 267 (443)
Q Consensus 228 ----------------------------------------~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDl 267 (443)
..+++..+..++.|++.||.|||+. +|+||||
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~--------~ivH~di 263 (400)
T cd05105 192 LEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK--------NCVHRDL 263 (400)
T ss_pred hhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC--------CeeCCCC
Confidence 1367788899999999999999998 9999999
Q ss_pred CCCCEEEcCCCcEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh-
Q psy14889 268 KSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR- 346 (443)
Q Consensus 268 k~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt- 346 (443)
||+|||++.++.+||+|||+++........ .......++..|+|||.+.+. .++.++|||||||++|||++
T Consensus 264 kp~Nill~~~~~~kL~DfGla~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~------~~~~~~DiwSlGvil~ellt~ 335 (400)
T cd05105 264 AARNVLLAQGKIVKICDFGLARDIMHDSNY--VSKGSTFLPVKWMAPESIFDN------LYTTLSDVWSYGILLWEIFSL 335 (400)
T ss_pred ChHhEEEeCCCEEEEEeCCcceeccccccc--cccCCcCCCcceEChhhhcCC------CCCchhhHHHHHHHHHHHHHC
Confidence 999999999999999999999765432221 112234577889999998765 66789999999999999997
Q ss_pred cccCCCcccccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHH
Q psy14889 347 RTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLI 426 (443)
Q Consensus 347 g~~~~~~~~~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 426 (443)
| ..||..... .......+. ...++..+ ..++..+.+++.+||+.||++|||+.+|.+.|+
T Consensus 336 g----------~~P~~~~~~----~~~~~~~~~-~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~ 395 (400)
T cd05105 336 G----------GTPYPGMIV----DSTFYNKIK-SGYRMAKP-----DHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVE 395 (400)
T ss_pred C----------CCCCcccch----hHHHHHHHh-cCCCCCCC-----ccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHH
Confidence 6 667765321 112222222 12222222 346678999999999999999999999999999
Q ss_pred HHhh
Q psy14889 427 KLAC 430 (443)
Q Consensus 427 ~l~~ 430 (443)
++..
T Consensus 396 ~l~~ 399 (400)
T cd05105 396 SLLP 399 (400)
T ss_pred HHcC
Confidence 8764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=316.95 Aligned_cols=251 Identities=23% Similarity=0.409 Sum_probs=196.0
Q ss_pred ccccccceeeeecCeEEEEEEE-CCceeEEEEeeccCccchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEeeec
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW-HGENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVTH 214 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e 214 (443)
++|++.++||+|+||.||+|.. ++..||+|.+............|+..+..++|+||+++++.+.... ..+++||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~e 81 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEE----PIYIITE 81 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC----CcEEEEe
Confidence 6899999999999999999987 5678999987654332223334555555699999999999887653 4799999
Q ss_pred ccCcccHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcccc
Q psy14889 215 YHSFGSLYDHLNR---TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSY 291 (443)
Q Consensus 215 ~~~~gsL~~~l~~---~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~ 291 (443)
|+++|+|.++++. ..+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++...
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~--------~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 153 (261)
T cd05072 82 YMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK--------NYIHRDLRAANVLVSESLMCKIADFGLARVI 153 (261)
T ss_pred cCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--------CeeccccchhhEEecCCCcEEECCCccceec
Confidence 9999999999864 4588999999999999999999998 9999999999999999999999999999766
Q ss_pred cccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh-cccCCCcccccCCCCCCCCCCCCC
Q psy14889 292 SQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR-RTKANGIFEEYKAPYHDLVPMDPS 370 (443)
Q Consensus 292 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt-g~~~~~~~~~~~~P~~~~~~~~~~ 370 (443)
...... ......++..|+|||++... .++.++||||||+++|||+| | ..||....
T Consensus 154 ~~~~~~---~~~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~~l~~l~t~g----------~~p~~~~~----- 209 (261)
T cd05072 154 EDNEYT---AREGAKFPIKWTAPEAINFG------SFTIKSDVWSFGILLYEIVTYG----------KIPYPGMS----- 209 (261)
T ss_pred CCCcee---ccCCCccceecCCHHHhccC------CCChhhhhhhhHHHHHHHHccC----------CCCCCCCC-----
Confidence 432211 11223466789999998765 56789999999999999998 7 66775531
Q ss_pred hHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHH
Q psy14889 371 FDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKL 428 (443)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l 428 (443)
.......+.. ..+...+ ..++.++.+++.+||+.||++|||++++.+.|+++
T Consensus 210 ~~~~~~~~~~-~~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 210 NSDVMSALQR-GYRMPRM-----ENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred HHHHHHHHHc-CCCCCCC-----CCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 2222222221 1111111 23567899999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=330.03 Aligned_cols=258 Identities=22% Similarity=0.410 Sum_probs=197.6
Q ss_pred hccccccceeeeecCeEEEEEEEC-------CceeEEEEeeccCccc--hHHHHHHHHHHhc-cCCCceeeeeeccccCC
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVWH-------GENVAVKIFFSRDEAS--WSRETEIYSTVLL-RHENILGYIGSDMTSRN 204 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~~~--~~~e~ei~~~~~l-~H~nIv~l~g~~~~~~~ 204 (443)
.++|++.+.||+|+||.||+|... ++.||+|++....... .....|+..+..+ +|+||+++++++....
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~- 84 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG- 84 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC-
Confidence 368999999999999999999752 4689999886432211 1223455555557 8999999999887553
Q ss_pred cccEEEeeecccCcccHHHHhcc---------------------------------------------------------
Q psy14889 205 SCTQLWLVTHYHSFGSLYDHLNR--------------------------------------------------------- 227 (443)
Q Consensus 205 ~~~~~~lv~e~~~~gsL~~~l~~--------------------------------------------------------- 227 (443)
..+++++||+++|+|.+++..
T Consensus 85 --~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (337)
T cd05054 85 --GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEG 162 (337)
T ss_pred --CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhh
Confidence 347899999999999998842
Q ss_pred -----cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcccccccCCcCCCCC
Q psy14889 228 -----TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPP 302 (443)
Q Consensus 228 -----~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 302 (443)
..+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.+....... ..
T Consensus 163 ~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~--------~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~--~~ 232 (337)
T cd05054 163 DELYKEPLTLEDLISYSFQVARGMEFLASR--------KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV--RK 232 (337)
T ss_pred hHHhhcCCCHHHHHHHHHHHHHHHHHHHhC--------CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchh--hc
Confidence 2578999999999999999999998 99999999999999999999999999997764322111 12
Q ss_pred CCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh-cccCCCcccccCCCCCCCCCCCCChHHHHhhhhhc
Q psy14889 303 NPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR-RTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICID 381 (443)
Q Consensus 303 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt-g~~~~~~~~~~~~P~~~~~~~~~~~~~~~~~~~~~ 381 (443)
....++..|+|||++.+. .++.++|||||||++|||++ | ..||..... .+.+...+. .
T Consensus 233 ~~~~~~~~y~aPE~~~~~------~~~~~~Di~SlGv~l~el~t~g----------~~p~~~~~~----~~~~~~~~~-~ 291 (337)
T cd05054 233 GDARLPLKWMAPESIFDK------VYTTQSDVWSFGVLLWEIFSLG----------ASPYPGVQI----DEEFCRRLK-E 291 (337)
T ss_pred cCCCCCccccCcHHhcCC------CCCccccHHHHHHHHHHHHHcC----------CCCCCCCCc----cHHHHHHHh-c
Confidence 233567789999998776 67789999999999999998 7 667765321 122222221 2
Q ss_pred CCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhhc
Q psy14889 382 QQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLACA 431 (443)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~~ 431 (443)
...+..+ ...+.++.+++.+||+.+|++||++.|+++.|+++.+.
T Consensus 292 ~~~~~~~-----~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~~ 336 (337)
T cd05054 292 GTRMRAP-----EYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQE 336 (337)
T ss_pred cCCCCCC-----ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 2222222 23456799999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=329.81 Aligned_cols=249 Identities=20% Similarity=0.224 Sum_probs=193.5
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc----chHHHHHHHHHHhccCCCceeeeeeccccCCcccEE
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA----SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQL 209 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~----~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~ 209 (443)
++|++.+.||+|+||.||+|.+ +++.||||++...... ......|+..+..++||||+++++++... ...
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~----~~~ 76 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDD----EYL 76 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcC----CEE
Confidence 3689999999999999999998 5889999998653211 11223455555568999999999998766 458
Q ss_pred EeeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCc
Q psy14889 210 WLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA 288 (443)
Q Consensus 210 ~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla 288 (443)
++||||+++|+|.+++.. ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 77 ~lv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~--------~ivH~dlkp~Nil~~~~~~~kL~Dfg~a 148 (333)
T cd05600 77 YLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHEL--------GYIHRDLKPENFLIDASGHIKLTDFGLS 148 (333)
T ss_pred EEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC--------CccccCCCHHHEEECCCCCEEEEeCcCC
Confidence 999999999999999964 5689999999999999999999998 9999999999999999999999999999
Q ss_pred ccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCC
Q psy14889 289 VSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMD 368 (443)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~ 368 (443)
+.... ......||+.|+|||++.+. .++.++|||||||++|||++| ..||....
T Consensus 149 ~~~~~-------~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~il~ell~g----------~~pf~~~~--- 202 (333)
T cd05600 149 KGIVT-------YANSVVGSPDYMAPEVLRGK------GYDFTVDYWSLGCMLYEFLCG----------FPPFSGST--- 202 (333)
T ss_pred ccccc-------ccCCcccCccccChhHhcCC------CCCCccceecchHHHhhhhhC----------CCCCCCCC---
Confidence 75543 12345799999999999876 667899999999999999999 66776531
Q ss_pred CChHHHHhhhhhcCCCCCCCCCC-CCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHH
Q psy14889 369 PSFDDMRKVICIDQQRPVLPNRW-VSDSTLNAMTKVMKECWHQNANVRLSALRVKKT 424 (443)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 424 (443)
..+....+.........+... .....+.++.+++.+||..+|.+||++.++++.
T Consensus 203 --~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 203 --PNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred --HHHHHHHHHhccccccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 122211111111111111100 012356789999999999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=318.06 Aligned_cols=256 Identities=23% Similarity=0.435 Sum_probs=197.7
Q ss_pred ccccccceeeeecCeEEEEEEE--CCc----eeEEEEeeccCccc--hHHHHHHHHHHhccCCCceeeeeeccccCCccc
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGE----NVAVKIFFSRDEAS--WSRETEIYSTVLLRHENILGYIGSDMTSRNSCT 207 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~----~vAvK~~~~~~~~~--~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~ 207 (443)
++|++.+.||+|+||.||+|.+ +++ .+++|.+....... ...+.++..+..++||||+++++++...
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~~----- 81 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGA----- 81 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECCC-----
Confidence 5788899999999999999998 454 46777764332221 2234555566678999999999987543
Q ss_pred EEEeeecccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEec
Q psy14889 208 QLWLVTHYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADF 285 (443)
Q Consensus 208 ~~~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~Df 285 (443)
..++++||+++|+|.+++.. ..+++..+..++.||+.||.|||+. +++||||||+|||+++++.+||+||
T Consensus 82 ~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--------~iiH~dlkp~nili~~~~~~kl~Df 153 (279)
T cd05111 82 SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEH--------RMVHRNLAARNILLKSDSIVQIADF 153 (279)
T ss_pred ccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC--------CEeccccCcceEEEcCCCcEEEcCC
Confidence 35789999999999999964 5689999999999999999999998 9999999999999999999999999
Q ss_pred CCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh-cccCCCcccccCCCCCCC
Q psy14889 286 GLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR-RTKANGIFEEYKAPYHDL 364 (443)
Q Consensus 286 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt-g~~~~~~~~~~~~P~~~~ 364 (443)
|+++......... ......++..|+|||.+.++ .++.++||||||+++||+++ | ..||.+.
T Consensus 154 g~~~~~~~~~~~~--~~~~~~~~~~y~~pE~~~~~------~~~~~~Dv~slG~il~el~t~g----------~~p~~~~ 215 (279)
T cd05111 154 GVADLLYPDDKKY--FYSEHKTPIKWMALESILFG------RYTHQSDVWSYGVTVWEMMSYG----------AEPYAGM 215 (279)
T ss_pred ccceeccCCCccc--ccCCCCCcccccCHHHhccC------CcCchhhHHHHHHHHHHHHcCC----------CCCCCCC
Confidence 9997664322211 11234567789999999766 66789999999999999998 7 6677653
Q ss_pred CCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhhccc
Q psy14889 365 VPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLACADM 433 (443)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~~~~ 433 (443)
. .......+. ....+..+ ..++..+.+++.+||..||++|||+.|+++.|..+.+..+
T Consensus 216 ~-----~~~~~~~~~-~~~~~~~~-----~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~~ 273 (279)
T cd05111 216 R-----PHEVPDLLE-KGERLAQP-----QICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDPP 273 (279)
T ss_pred C-----HHHHHHHHH-CCCcCCCC-----CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCCc
Confidence 2 223333332 22222222 2245678999999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=334.01 Aligned_cols=254 Identities=19% Similarity=0.229 Sum_probs=197.1
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCc----cchHHHHHHHHHHhccCCCceeeeeeccccCCcccEE
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDE----ASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQL 209 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~----~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~ 209 (443)
++|++.+.||+|+||.||+++. +++.||+|++..... .......|+..+..++||||+++++++.+. ..+
T Consensus 43 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~----~~~ 118 (370)
T cd05596 43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDD----KYL 118 (370)
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecC----CEE
Confidence 6899999999999999999988 588999999864221 111223455555669999999999988766 458
Q ss_pred EeeecccCcccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcc
Q psy14889 210 WLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAV 289 (443)
Q Consensus 210 ~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~ 289 (443)
++||||+++|+|.+++.+..+++.++..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++.
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~~l~~~~~~~~~~qi~~aL~~LH~~--------~ivHrDLkp~NILl~~~~~~kL~DfG~~~ 190 (370)
T cd05596 119 YMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSM--------GFIHRDVKPDNMLLDKSGHLKLADFGTCM 190 (370)
T ss_pred EEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHC--------CeeccCCCHHHEEEcCCCCEEEEecccee
Confidence 9999999999999999888899999999999999999999998 99999999999999999999999999997
Q ss_pred cccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCC
Q psy14889 290 SYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDP 369 (443)
Q Consensus 290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~ 369 (443)
........ ......||+.|+|||++.+..... .++.++|||||||++|||++| ..||....
T Consensus 191 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~--~~~~~~DiwSlGvilyelltG----------~~Pf~~~~---- 251 (370)
T cd05596 191 KMDANGMV---RCDTAVGTPDYISPEVLKSQGGDG--YYGRECDWWSVGVFLYEMLVG----------DTPFYADS---- 251 (370)
T ss_pred eccCCCcc---cCCCCCCCcCeECHHHhccCCCCC--CCCCceeeeehhHHHHHHHhC----------CCCcCCCC----
Confidence 65432211 123457999999999987542211 467899999999999999999 67776531
Q ss_pred ChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCC--CCcHHHHHHH
Q psy14889 370 SFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANV--RLSALRVKKT 424 (443)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--Rps~~evl~~ 424 (443)
......+.. .......+|.. ...+.++.+++.+||+.+|.+ |+|++++++.
T Consensus 252 ~~~~~~~i~-~~~~~~~~~~~---~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 252 LVGTYSKIM-DHKNSLTFPDD---IEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred HHHHHHHHH-cCCCcCCCCCc---CCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 112222222 22222233321 235678999999999999988 9999999753
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=327.88 Aligned_cols=242 Identities=25% Similarity=0.385 Sum_probs=189.1
Q ss_pred ccccceeeeecCeEEEEEEE--CCceeEEEEeeccCc------cchHHHHHHH-HHHhccCCCceeeeeeccccCCcccE
Q psy14889 138 ISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDE------ASWSRETEIY-STVLLRHENILGYIGSDMTSRNSCTQ 208 (443)
Q Consensus 138 ~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~------~~~~~e~ei~-~~~~l~H~nIv~l~g~~~~~~~~~~~ 208 (443)
|++.+.||+|+||.||+|.+ +++.||||++..... .....|.++. .+..++||||+++++++... ..
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~----~~ 76 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTE----DH 76 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcC----CE
Confidence 56789999999999999987 588999999864321 1122233332 23347899999999998766 45
Q ss_pred EEeeecccCcccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCc
Q psy14889 209 LWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA 288 (443)
Q Consensus 209 ~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla 288 (443)
+++||||+++|+|..+++...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 77 ~~lv~E~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~--------~ivHrdlkp~Nill~~~~~~kL~Dfg~~ 148 (324)
T cd05589 77 VCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHEN--------KIVYRDLKLDNLLLDTEGFVKIADFGLC 148 (324)
T ss_pred EEEEEcCCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CeEecCCCHHHeEECCCCcEEeCcccCC
Confidence 89999999999999999888899999999999999999999998 9999999999999999999999999998
Q ss_pred ccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCC
Q psy14889 289 VSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMD 368 (443)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~ 368 (443)
+....... ......||+.|+|||.+.+. .++.++|||||||++|||++| ..||...
T Consensus 149 ~~~~~~~~----~~~~~~g~~~y~aPE~~~~~------~~~~~~DiwslG~il~el~~G----------~~pf~~~---- 204 (324)
T cd05589 149 KEGMGFGD----RTSTFCGTPEFLAPEVLTET------SYTRAVDWWGLGVLIYEMLVG----------ESPFPGD---- 204 (324)
T ss_pred ccCCCCCC----cccccccCccccCHhHhcCC------CCCcccchhhHHHHHHHHHhC----------CCCCCCC----
Confidence 64332111 12345799999999999876 667899999999999999999 6777643
Q ss_pred CChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCC-----cHHHHHH
Q psy14889 369 PSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRL-----SALRVKK 423 (443)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~ 423 (443)
........+.. ..+..| ...+..+.+++.+||+.||.+|| ++.++++
T Consensus 205 -~~~~~~~~i~~--~~~~~p-----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 205 -DEEEVFDSIVN--DEVRYP-----RFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred -CHHHHHHHHHh--CCCCCC-----CCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 22222222221 122222 23567799999999999999999 5666655
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=327.51 Aligned_cols=236 Identities=24% Similarity=0.326 Sum_probs=184.5
Q ss_pred eeeecCeEEEEEEE--CCceeEEEEeeccC----ccchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEeeecccC
Q psy14889 144 IGKGRYGEVWRGVW--HGENVAVKIFFSRD----EASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVTHYHS 217 (443)
Q Consensus 144 lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~----~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e~~~ 217 (443)
||+|+||.||+|.. +++.||+|++.... ........|+..+..++||||+++++++... ..+++||||++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----~~~~lv~e~~~ 76 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSP----EKLYLVLAFIN 76 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecC----CeEEEEEcCCC
Confidence 69999999999998 57899999886432 1112223455666669999999999988765 45899999999
Q ss_pred cccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcccccccCC
Q psy14889 218 FGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSN 296 (443)
Q Consensus 218 ~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~~~~~~ 296 (443)
+|+|.+++.+ ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 77 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~--------~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 148 (312)
T cd05585 77 GGELFHHLQREGRFDLSRARFYTAELLCALENLHKF--------NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD 148 (312)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC
Confidence 9999999854 5799999999999999999999998 999999999999999999999999999875432211
Q ss_pred cCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCChHHHHh
Q psy14889 297 KMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFDDMRK 376 (443)
Q Consensus 297 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~~~~~~~ 376 (443)
......||+.|+|||++.+. .++.++|||||||++|||++| ..||.+. .......
T Consensus 149 ----~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslGvil~el~tg----------~~pf~~~-----~~~~~~~ 203 (312)
T cd05585 149 ----KTNTFCGTPEYLAPELLLGH------GYTKAVDWWTLGVLLYEMLTG----------LPPFYDE-----NVNEMYR 203 (312)
T ss_pred ----ccccccCCcccCCHHHHcCC------CCCCccceechhHHHHHHHhC----------CCCcCCC-----CHHHHHH
Confidence 12345799999999999875 677899999999999999999 6777653 2222222
Q ss_pred hhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCc---HHHHHH
Q psy14889 377 VICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLS---ALRVKK 423 (443)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps---~~evl~ 423 (443)
.+. .....++ ...+.++.+++.+||+.||++||+ +.++++
T Consensus 204 ~~~--~~~~~~~-----~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 204 KIL--QEPLRFP-----DGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred HHH--cCCCCCC-----CcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 222 1222233 335678999999999999999985 555554
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=315.54 Aligned_cols=251 Identities=23% Similarity=0.421 Sum_probs=196.8
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEeee
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVT 213 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv~ 213 (443)
.+|.+.+.||+|+||.||+|.+ +++.||+|++............|+..+..++||||+++++++.... .++++|
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~ 81 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP----PFYIIT 81 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCC----CcEEEE
Confidence 5688899999999999999988 4789999988654332223344555666699999999999987663 478999
Q ss_pred cccCcccHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCccc
Q psy14889 214 HYHSFGSLYDHLNR---TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVS 290 (443)
Q Consensus 214 e~~~~gsL~~~l~~---~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~ 290 (443)
||+++|+|.+++.. ..+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||++..
T Consensus 82 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~--------~i~H~dlkp~nil~~~~~~~kl~df~~~~~ 153 (263)
T cd05052 82 EFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK--------NFIHRDLAARNCLVGENHLVKVADFGLSRL 153 (263)
T ss_pred EeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CEeecccCcceEEEcCCCcEEeCCCccccc
Confidence 99999999999854 3589999999999999999999998 999999999999999999999999999976
Q ss_pred ccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh-cccCCCcccccCCCCCCCCCCCC
Q psy14889 291 YSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR-RTKANGIFEEYKAPYHDLVPMDP 369 (443)
Q Consensus 291 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt-g~~~~~~~~~~~~P~~~~~~~~~ 369 (443)
........ .....++..|+|||.+.+. .++.++|||||||++|||++ | ..||...
T Consensus 154 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~------~~~~~~Dv~slG~il~el~t~g----------~~p~~~~----- 209 (263)
T cd05052 154 MTGDTYTA---HAGAKFPIKWTAPESLAYN------KFSIKSDVWAFGVLLWEIATYG----------MSPYPGI----- 209 (263)
T ss_pred cccceeec---cCCCCCccccCCHHHhccC------CCCchhHHHHHHHHHHHHHcCC----------CCCCCCC-----
Confidence 64322111 1122345689999998765 66789999999999999998 7 5666543
Q ss_pred ChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHH
Q psy14889 370 SFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKL 428 (443)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l 428 (443)
..+.....+.. ...+..+ ..++.++.+++.+||+.||++|||+.++++.|+.+
T Consensus 210 ~~~~~~~~~~~-~~~~~~~-----~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 210 DLSQVYELLEK-GYRMERP-----EGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CHHHHHHHHHC-CCCCCCC-----CCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 22233222221 1122222 34667899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=343.21 Aligned_cols=254 Identities=24% Similarity=0.343 Sum_probs=198.2
Q ss_pred hhccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCc---cchHHHHHHHHHHhccCCCceeeeeeccccCC----
Q psy14889 134 LAKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDE---ASWSRETEIYSTVLLRHENILGYIGSDMTSRN---- 204 (443)
Q Consensus 134 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~---~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~---- 204 (443)
..++|.+.+.||+|+||.||+|.. +|+.||||++..... .....+.|+..+..++|+||+++++.+.....
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~ 109 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE 109 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence 347999999999999999999987 689999999865432 12233466767777899999999887654332
Q ss_pred cccEEEeeecccCcccHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCc
Q psy14889 205 SCTQLWLVTHYHSFGSLYDHLNR-----TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGT 279 (443)
Q Consensus 205 ~~~~~~lv~e~~~~gsL~~~l~~-----~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~ 279 (443)
....+++||||+++|+|.++++. ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.
T Consensus 110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~--------~IiHrDLKP~NILl~~~~~ 181 (496)
T PTZ00283 110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK--------HMIHRDIKSANILLCSNGL 181 (496)
T ss_pred cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC--------CEecCCCCHHHEEEeCCCC
Confidence 11247899999999999999853 4689999999999999999999998 9999999999999999999
Q ss_pred EEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCC
Q psy14889 280 CVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKA 359 (443)
Q Consensus 280 ~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~ 359 (443)
+||+|||+++.+...... .......||+.|+|||++.+. .++.++|||||||++|||++| ..
T Consensus 182 vkL~DFGls~~~~~~~~~--~~~~~~~Gt~~Y~aPE~~~~~------~~s~k~DVwSlGvilyeLltG----------~~ 243 (496)
T PTZ00283 182 VKLGDFGFSKMYAATVSD--DVGRTFCGTPYYVAPEIWRRK------PYSKKADMFSLGVLLYELLTL----------KR 243 (496)
T ss_pred EEEEecccCeeccccccc--cccccccCCcceeCHHHhCCC------CCCcHHHHHHHHHHHHHHHHC----------CC
Confidence 999999999766532211 112345799999999999876 677899999999999999999 66
Q ss_pred CCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHH
Q psy14889 360 PYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKT 424 (443)
Q Consensus 360 P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 424 (443)
||... ....+...... .....++ ..++.++.+++.+||+.||.+|||+.++++.
T Consensus 244 Pf~~~-----~~~~~~~~~~~-~~~~~~~-----~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 244 PFDGE-----NMEEVMHKTLA-GRYDPLP-----PSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CCCCC-----CHHHHHHHHhc-CCCCCCC-----CCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 77543 22222222221 1222222 3366789999999999999999999999863
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=326.46 Aligned_cols=253 Identities=25% Similarity=0.329 Sum_probs=188.3
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc--chHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEe
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA--SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWL 211 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~--~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~l 211 (443)
++|++.+.||+|+||.||+|.. +++.||||++...... ......|+..+..++||||+++++++.+. ...++
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~----~~~~l 80 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTK----ETLTL 80 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecC----CeEEE
Confidence 6899999999999999999998 5889999988643322 22334566666679999999999998766 35799
Q ss_pred eecccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcc
Q psy14889 212 VTHYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAV 289 (443)
Q Consensus 212 v~e~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~ 289 (443)
||||+. ++|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 81 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~--------~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 151 (303)
T cd07869 81 VFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR--------YILHRDLKPQNLLISDTGELKLADFGLAR 151 (303)
T ss_pred EEECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC--------CeecCCCCHHHEEECCCCCEEECCCCcce
Confidence 999996 688888754 4689999999999999999999998 99999999999999999999999999986
Q ss_pred cccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCC
Q psy14889 290 SYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDP 369 (443)
Q Consensus 290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~ 369 (443)
....... ......||+.|+|||++.+.. .++.++|||||||++|||++| ..||.+...
T Consensus 152 ~~~~~~~----~~~~~~~~~~y~aPE~~~~~~-----~~~~~~DiwslG~il~~l~~g----------~~pf~~~~~--- 209 (303)
T cd07869 152 AKSVPSH----TYSNEVVTLWYRPPDVLLGST-----EYSTCLDMWGVGCIFVEMIQG----------VAAFPGMKD--- 209 (303)
T ss_pred eccCCCc----cCCCCcccCCCCChHHHcCCC-----CCCcHHHHHHHHHHHHHHHhC----------CCCCCCCcc---
Confidence 5432211 113346889999999986541 456789999999999999999 556654311
Q ss_pred ChHHHHhhhhhcCC---------------C---------CCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 370 SFDDMRKVICIDQQ---------------R---------PVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 370 ~~~~~~~~~~~~~~---------------~---------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
..+.+......... . ..+...|.....++.+.+|+.+||+.||++|||+.|+++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 210 IQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred HHHHHHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 11111111100000 0 000000111123356889999999999999999999985
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=326.98 Aligned_cols=238 Identities=24% Similarity=0.336 Sum_probs=187.0
Q ss_pred ceeeeecCeEEEEEEE--CCceeEEEEeeccCc----cchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEeeecc
Q psy14889 142 ECIGKGRYGEVWRGVW--HGENVAVKIFFSRDE----ASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVTHY 215 (443)
Q Consensus 142 ~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~----~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e~ 215 (443)
+.||+|+||.||+++. +|..||+|++..... .......|+..+..++||||+++++.+... ..+++||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~----~~~~lv~E~ 76 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH----DRLCFVMEY 76 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecC----CEEEEEEeC
Confidence 4699999999999987 588999999865321 111223456666669999999999998766 458999999
Q ss_pred cCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCccccccc
Q psy14889 216 HSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQL 294 (443)
Q Consensus 216 ~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~~~~ 294 (443)
+++|+|..++.+ ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~--------~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 148 (323)
T cd05595 77 ANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR--------DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 148 (323)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC--------CeEecCCCHHHEEEcCCCCEEecccHHhccccCC
Confidence 999999998864 5689999999999999999999998 9999999999999999999999999998653221
Q ss_pred CCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCChHHH
Q psy14889 295 SNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFDDM 374 (443)
Q Consensus 295 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~~~~~ 374 (443)
.. ......||+.|+|||++.+. .++.++|||||||++|||++| ..||... .....
T Consensus 149 ~~----~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwSlGvil~ell~g----------~~Pf~~~-----~~~~~ 203 (323)
T cd05595 149 GA----TMKTFCGTPEYLAPEVLEDN------DYGRAVDWWGLGVVMYEMMCG----------RLPFYNQ-----DHERL 203 (323)
T ss_pred CC----ccccccCCcCcCCcccccCC------CCCchhchhhhHHHHHHHHhC----------CCCCCCC-----CHHHH
Confidence 11 11335799999999999776 667899999999999999999 6777543 22222
Q ss_pred HhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCC-----cHHHHHH
Q psy14889 375 RKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRL-----SALRVKK 423 (443)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~ 423 (443)
...+.. ....+| ...+.++.+++.+||+.||++|| ++.++++
T Consensus 204 ~~~~~~--~~~~~p-----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 204 FELILM--EEIRFP-----RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred HHHHhc--CCCCCC-----CCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 222221 122233 23567899999999999999998 8888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=329.32 Aligned_cols=242 Identities=23% Similarity=0.265 Sum_probs=191.6
Q ss_pred ccccccceeeeecCeEEEEEEEC---CceeEEEEeeccCc----cchHHHHHHHHHHhccCCCceeeeeeccccCCcccE
Q psy14889 136 KQISLSECIGKGRYGEVWRGVWH---GENVAVKIFFSRDE----ASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQ 208 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~~---~~~vAvK~~~~~~~----~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~ 208 (443)
++|++.+.||+|+||.||+|.+. +..||+|++..... .......|+..+..++||||+++++++.+. ..
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~----~~ 105 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDE----SY 105 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeC----CE
Confidence 67999999999999999999863 35799998854321 111223455666669999999999998766 45
Q ss_pred EEeeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCC
Q psy14889 209 LWLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGL 287 (443)
Q Consensus 209 ~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGl 287 (443)
+++||||+++|+|.+++.. ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 106 ~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~--------~ivHrDLkp~NILl~~~~~ikL~DFG~ 177 (340)
T PTZ00426 106 LYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSL--------NIVYRDLKPENLLLDKDGFIKMTDFGF 177 (340)
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC--------CeEccCCCHHHEEECCCCCEEEecCCC
Confidence 8999999999999999964 5799999999999999999999998 999999999999999999999999999
Q ss_pred cccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCC
Q psy14889 288 AVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPM 367 (443)
Q Consensus 288 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~ 367 (443)
++..... .....||+.|+|||++.+. .++.++|||||||++|||++| ..||...
T Consensus 178 a~~~~~~-------~~~~~gt~~y~aPE~~~~~------~~~~~~DiwSlGvil~ell~G----------~~Pf~~~--- 231 (340)
T PTZ00426 178 AKVVDTR-------TYTLCGTPEYIAPEILLNV------GHGKAADWWTLGIFIYEILVG----------CPPFYAN--- 231 (340)
T ss_pred CeecCCC-------cceecCChhhcCHHHHhCC------CCCccccccchhhHHHHHhcC----------CCCCCCC---
Confidence 9765421 1234799999999999765 567899999999999999999 6777653
Q ss_pred CCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCC-----cHHHHHHH
Q psy14889 368 DPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRL-----SALRVKKT 424 (443)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~ 424 (443)
......+.+.. ....+| ...+..+.+++++||+.||++|+ +++++++.
T Consensus 232 --~~~~~~~~i~~--~~~~~p-----~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 232 --EPLLIYQKILE--GIIYFP-----KFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred --CHHHHHHHHhc--CCCCCC-----CCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 11222222221 112222 22456789999999999999995 88888763
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=313.84 Aligned_cols=248 Identities=22% Similarity=0.418 Sum_probs=193.0
Q ss_pred ccccccceeeeecCeEEEEEEE-CCceeEEEEeeccCccchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEeeec
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW-HGENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVTH 214 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e 214 (443)
++|++.+.||+|+||.||++.+ ++..+|+|.+............|+..+..++||||+++++++.... ..++|||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~iv~e 79 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQK----PLYIVTE 79 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCC----CEEEEEE
Confidence 5688899999999999999988 4568999987644333333345666666699999999999987663 4799999
Q ss_pred ccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCccccc
Q psy14889 215 YHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYS 292 (443)
Q Consensus 215 ~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~~ 292 (443)
|+++|+|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++...
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~--------~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~ 151 (256)
T cd05114 80 FMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERN--------SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVL 151 (256)
T ss_pred cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC--------CccccccCcceEEEcCCCeEEECCCCCccccC
Confidence 9999999999864 4589999999999999999999998 99999999999999999999999999987654
Q ss_pred ccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh-cccCCCcccccCCCCCCCCCCCCCh
Q psy14889 293 QLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR-RTKANGIFEEYKAPYHDLVPMDPSF 371 (443)
Q Consensus 293 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt-g~~~~~~~~~~~~P~~~~~~~~~~~ 371 (443)
..... ......++..|+|||.+.+. .++.++||||||+++|||++ | ..||... ..
T Consensus 152 ~~~~~---~~~~~~~~~~y~aPE~~~~~------~~~~~~Di~s~G~~l~el~~~g----------~~p~~~~-----~~ 207 (256)
T cd05114 152 DDEYT---SSSGAKFPVKWSPPEVFNFS------KYSSKSDVWSFGVLMWEVFTEG----------KMPFEKK-----SN 207 (256)
T ss_pred CCcee---ccCCCCCchhhCChhhcccC------ccchhhhhHHHHHHHHHHHcCC----------CCCCCCC-----CH
Confidence 32211 11223456689999998765 56689999999999999999 7 6677543 12
Q ss_pred HHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHH
Q psy14889 372 DDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTL 425 (443)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 425 (443)
......+.. ..++..+ ...+..+.+++.+||+.||++|||+.++++.|
T Consensus 208 ~~~~~~i~~-~~~~~~~-----~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 208 YEVVEMISR-GFRLYRP-----KLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred HHHHHHHHC-CCCCCCC-----CCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 222222221 2222222 22446799999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0589|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=330.07 Aligned_cols=247 Identities=24% Similarity=0.338 Sum_probs=202.6
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc---chHHHHHHHHHHhccCCCceeeeeeccccCCcccEEE
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA---SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLW 210 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~---~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~ 210 (443)
++|...+++|+|+||.++..++ +++.+++|.+...... ....+.|+..+.+++|||||.+.+.|..+. ..++
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~---~~l~ 80 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDG---QLLC 80 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCC---ceEE
Confidence 5788999999999999998776 5789999988654322 223356777777799999999999998874 3489
Q ss_pred eeecccCcccHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCC
Q psy14889 211 LVTHYHSFGSLYDHLNR---TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGL 287 (443)
Q Consensus 211 lv~e~~~~gsL~~~l~~---~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGl 287 (443)
|||+||+||+|.+.+.+ ..++++.+..++.|++.|+.|||++ +|+|||||+.||+++.++.+||+|||+
T Consensus 81 Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~--------~iLHRDlK~~Nifltk~~~VkLgDfGl 152 (426)
T KOG0589|consen 81 IVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHEN--------RVLHRDLKCANIFLTKDKKVKLGDFGL 152 (426)
T ss_pred EEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhh--------hhhcccchhhhhhccccCceeecchhh
Confidence 99999999999999964 3589999999999999999999988 999999999999999999999999999
Q ss_pred cccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCC
Q psy14889 288 AVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPM 367 (443)
Q Consensus 288 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~ 367 (443)
|+.+...... ..+.+||+.||+||++.+. +|..|+|||||||++|||++- +.+|...
T Consensus 153 aK~l~~~~~~----a~tvvGTp~YmcPEil~d~------pYn~KSDiWsLGC~~yEm~~l----------k~aF~a~--- 209 (426)
T KOG0589|consen 153 AKILNPEDSL----ASTVVGTPYYMCPEILSDI------PYNEKSDIWSLGCCLYEMCTL----------KPAFKAS--- 209 (426)
T ss_pred hhhcCCchhh----hheecCCCcccCHHHhCCC------CCCccCcchhhcchHHHHHhc----------ccccCcc---
Confidence 9988765422 2456899999999999987 888999999999999999998 5555542
Q ss_pred CCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHH
Q psy14889 368 DPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKT 424 (443)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 424 (443)
+...+...+.... ..++| ...+.+++.++..|+..+|..||++.+++.+
T Consensus 210 --~m~~Li~ki~~~~-~~Plp-----~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 210 --NMSELILKINRGL-YSPLP-----SMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred --chHHHHHHHhhcc-CCCCC-----ccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 2233333333222 23333 3366789999999999999999999999986
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-41 Score=314.00 Aligned_cols=252 Identities=23% Similarity=0.408 Sum_probs=197.2
Q ss_pred hccccccceeeeecCeEEEEEEE-CCceeEEEEeeccCccchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEeee
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVW-HGENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVT 213 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv~ 213 (443)
.++|++.+.||+|+||.||+|.+ +++.||+|.+............|+..+..++||||+++++++.... ..++||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~ 80 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEE----PIYIVT 80 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCC----Ceeeee
Confidence 36799999999999999999987 5678999988654433333445666666799999999999887653 479999
Q ss_pred cccCcccHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCccc
Q psy14889 214 HYHSFGSLYDHLNRT---TLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVS 290 (443)
Q Consensus 214 e~~~~gsL~~~l~~~---~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~ 290 (443)
||+++++|.+++... .+++..+..++.|++.||.|||+. +|+|+||||+||++++++.+||+|||+++.
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~--------~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~ 152 (261)
T cd05068 81 ELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ--------NYIHRDLAARNVLVGENNICKVADFGLARV 152 (261)
T ss_pred ecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CeeeccCCcceEEEcCCCCEEECCcceEEE
Confidence 999999999999653 589999999999999999999988 999999999999999999999999999987
Q ss_pred ccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh-cccCCCcccccCCCCCCCCCCCC
Q psy14889 291 YSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR-RTKANGIFEEYKAPYHDLVPMDP 369 (443)
Q Consensus 291 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt-g~~~~~~~~~~~~P~~~~~~~~~ 369 (443)
........ ......+..|+|||.+.+. .++.++||||||+++|||+| | ..||...
T Consensus 153 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~~l~el~t~g----------~~p~~~~----- 208 (261)
T cd05068 153 IKEDIYEA---REGAKFPIKWTAPEAALYN------RFSIKSDVWSFGILLTEIVTYG----------RMPYPGM----- 208 (261)
T ss_pred ccCCcccc---cCCCcCceeccCccccccC------CCCchhhHHHHHHHHHHHHhcC----------CCCCCCC-----
Confidence 65321111 1112234579999998765 66789999999999999999 7 6677553
Q ss_pred ChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHH
Q psy14889 370 SFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKL 428 (443)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l 428 (443)
........+.. ......+ ...+..+.+++.+||+.||++||++.++.+.|+++
T Consensus 209 ~~~~~~~~~~~-~~~~~~~-----~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 209 TNAEVLQQVDQ-GYRMPCP-----PGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred CHHHHHHHHHc-CCCCCCC-----CcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 12222222221 1122222 23567899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=330.33 Aligned_cols=251 Identities=24% Similarity=0.371 Sum_probs=189.5
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccc--hHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEe
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEAS--WSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWL 211 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~--~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~l 211 (443)
++|+..+.||+|+||.||+|.+ +++.||||++....... .....|+..+..++|+||+++++++... ..+++
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----~~~~l 149 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHN----GEIQV 149 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccC----CeEEE
Confidence 5678889999999999999998 58999999986543322 2234566666679999999999998765 45799
Q ss_pred eecccCcccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcccc
Q psy14889 212 VTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSY 291 (443)
Q Consensus 212 v~e~~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~ 291 (443)
||||+.+|+|.+. ...++..+..++.||+.||.|||+. +|+||||||+|||+++++.+||+|||+++.+
T Consensus 150 v~e~~~~~~L~~~---~~~~~~~~~~i~~qi~~aL~~LH~~--------~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~ 218 (353)
T PLN00034 150 LLEFMDGGSLEGT---HIADEQFLADVARQILSGIAYLHRR--------HIVHRDIKPSNLLINSAKNVKIADFGVSRIL 218 (353)
T ss_pred EEecCCCCccccc---ccCCHHHHHHHHHHHHHHHHHHHHC--------CEeecCCCHHHEEEcCCCCEEEcccccceec
Confidence 9999999998754 3356778889999999999999998 9999999999999999999999999999766
Q ss_pred cccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCCh
Q psy14889 292 SQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSF 371 (443)
Q Consensus 292 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~~ 371 (443)
...... .....||..|+|||++....... ...+.++|||||||++|||++| +.||.... ....
T Consensus 219 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~-~~~~~~~DvwslGvil~el~~g----------~~pf~~~~--~~~~ 281 (353)
T PLN00034 219 AQTMDP----CNSSVGTIAYMSPERINTDLNHG-AYDGYAGDIWSLGVSILEFYLG----------RFPFGVGR--QGDW 281 (353)
T ss_pred cccccc----ccccccCccccCccccccccccC-cCCCcchhHHHHHHHHHHHHhC----------CCCCCCCC--CccH
Confidence 432211 23457999999999986432211 1234689999999999999999 66665321 1122
Q ss_pred HHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHH
Q psy14889 372 DDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKT 424 (443)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 424 (443)
......+.. ...+..+ ..++.++.+||.+||+.||++|||+.|+++.
T Consensus 282 ~~~~~~~~~-~~~~~~~-----~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 282 ASLMCAICM-SQPPEAP-----ATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred HHHHHHHhc-cCCCCCC-----CccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 222222211 1122222 3356789999999999999999999999874
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=324.88 Aligned_cols=262 Identities=23% Similarity=0.309 Sum_probs=193.5
Q ss_pred hccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc--chHHHHHHHHHHhccCCCceeeeeeccccCCcccEEE
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA--SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLW 210 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~--~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~ 210 (443)
.++|++.+.||+|+||.||+++. ++..+|+|.+...... ......|+..+..++||||+++++++... ..++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----~~~~ 79 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD----GEIS 79 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC----CEEE
Confidence 36899999999999999999998 5788999988654221 12234566666679999999999998766 4579
Q ss_pred eeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcc
Q psy14889 211 LVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAV 289 (443)
Q Consensus 211 lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~ 289 (443)
+||||+++|+|.+++.. ..+++..+..++.|++.||.|||+.. +|+||||||+|||++.++.+||+|||++.
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~-------~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 152 (331)
T cd06649 80 ICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKH-------QIMHRDVKPSNILVNSRGEIKLCDFGVSG 152 (331)
T ss_pred EEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcC-------CEEcCCCChhhEEEcCCCcEEEccCcccc
Confidence 99999999999999965 56899999999999999999999851 69999999999999999999999999987
Q ss_pred cccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccc------cCCCCCC
Q psy14889 290 SYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEE------YKAPYHD 363 (443)
Q Consensus 290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~------~~~P~~~ 363 (443)
...... .....||..|+|||++.+. .++.++|||||||++|||++|+.|+..... ...|..+
T Consensus 153 ~~~~~~------~~~~~g~~~y~aPE~~~~~------~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~ 220 (331)
T cd06649 153 QLIDSM------ANSFVGTRSYMSPERLQGT------HYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVD 220 (331)
T ss_pred cccccc------cccCCCCcCcCCHhHhcCC------CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccc
Confidence 654321 1334689999999999876 667899999999999999999655421000 0000000
Q ss_pred C------------------C-----CCCC--ChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcH
Q psy14889 364 L------------------V-----PMDP--SFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSA 418 (443)
Q Consensus 364 ~------------------~-----~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~ 418 (443)
. . ...+ ........+ .....+..+ ....+.++.+|+.+||+.||++|||+
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~----~~~~~~~l~~li~~~L~~~P~~Rpt~ 295 (331)
T cd06649 221 GEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYI-VNEPPPKLP----NGVFTPDFQEFVNKCLIKNPAERADL 295 (331)
T ss_pred cccCCccccCcccccccccccccccccccchhHHHHHHHH-HhCCCcCCC----CccccHHHHHHHHHHccCCcccCCCH
Confidence 0 0 0000 000001111 111112222 12356789999999999999999999
Q ss_pred HHHHHH
Q psy14889 419 LRVKKT 424 (443)
Q Consensus 419 ~evl~~ 424 (443)
.++++.
T Consensus 296 ~ell~h 301 (331)
T cd06649 296 KMLMNH 301 (331)
T ss_pred HHHhcC
Confidence 999875
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=326.81 Aligned_cols=239 Identities=24% Similarity=0.330 Sum_probs=188.2
Q ss_pred ceeeeecCeEEEEEEE--CCceeEEEEeeccCc----cchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEeeecc
Q psy14889 142 ECIGKGRYGEVWRGVW--HGENVAVKIFFSRDE----ASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVTHY 215 (443)
Q Consensus 142 ~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~----~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e~ 215 (443)
+.||+|+||.||++.. +|+.||+|++..... .......|+..+..++||||+++++++... ..+++||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~----~~~~lv~Ey 76 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTK----DRLCFVMEY 76 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcC----CEEEEEEeC
Confidence 4699999999999987 588999999865321 112223456666669999999999988766 458999999
Q ss_pred cCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCccccccc
Q psy14889 216 HSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQL 294 (443)
Q Consensus 216 ~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~~~~ 294 (443)
+++|+|..++.. ..+++.++..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 77 ~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~--------~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~ 148 (328)
T cd05593 77 VNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSG--------KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD 148 (328)
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CeEecccCHHHeEECCCCcEEEecCcCCccCCCc
Confidence 999999998864 5689999999999999999999998 9999999999999999999999999998753321
Q ss_pred CCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCChHHH
Q psy14889 295 SNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFDDM 374 (443)
Q Consensus 295 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~~~~~ 374 (443)
.. ......||+.|+|||++.+. .++.++|||||||++|||++| ..||... .....
T Consensus 149 ~~----~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslGvil~elltG----------~~Pf~~~-----~~~~~ 203 (328)
T cd05593 149 AA----TMKTFCGTPEYLAPEVLEDN------DYGRAVDWWGLGVVMYEMMCG----------RLPFYNQ-----DHEKL 203 (328)
T ss_pred cc----ccccccCCcCccChhhhcCC------CCCccCCccccchHHHHHhhC----------CCCCCCC-----CHHHH
Confidence 11 11335799999999999766 667899999999999999999 6777653 22222
Q ss_pred HhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCC-----cHHHHHHH
Q psy14889 375 RKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRL-----SALRVKKT 424 (443)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~ 424 (443)
...+. .....+| ...+.++.+++.+||+.||++|| ++.++++.
T Consensus 204 ~~~~~--~~~~~~p-----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 204 FELIL--MEDIKFP-----RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred HHHhc--cCCccCC-----CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 22221 1222333 23567899999999999999997 89998763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=331.61 Aligned_cols=251 Identities=20% Similarity=0.274 Sum_probs=192.2
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCc----cchHHHHHHHHHHhccCCCceeeeeeccccCCcccEE
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDE----ASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQL 209 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~----~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~ 209 (443)
++|++.+.||+|+||.||+|+. +|+.||||++..... .......|+..+..++||||+++++++.+. ..+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~----~~~ 76 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDE----NYL 76 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcC----CeE
Confidence 3688999999999999999998 588999999865321 111223455556668999999999998876 468
Q ss_pred EeeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCc
Q psy14889 210 WLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA 288 (443)
Q Consensus 210 ~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla 288 (443)
++||||+++|+|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 77 ~lv~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~--------~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~ 148 (364)
T cd05599 77 YLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKL--------GYIHRDIKPDNLLLDAKGHIKLSDFGLC 148 (364)
T ss_pred EEEECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC--------CeEeccCCHHHeEECCCCCEEEeecccc
Confidence 999999999999999864 5689999999999999999999998 9999999999999999999999999998
Q ss_pred ccccccCCcCC----------------------------------CCCCCcccccCcccccccccccccCcCCCCCccch
Q psy14889 289 VSYSQLSNKMD----------------------------------IPPNPRVGTKRYMSPEILDESINMDCFESFKKADI 334 (443)
Q Consensus 289 ~~~~~~~~~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDv 334 (443)
+.+........ ......+||+.|+|||++... .++.++||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~Di 222 (364)
T cd05599 149 TGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQT------GYNKECDW 222 (364)
T ss_pred eeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCC------CCCCeeee
Confidence 75432111000 001124699999999998765 67789999
Q ss_pred HHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCC
Q psy14889 335 YALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANV 414 (443)
Q Consensus 335 wS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~ 414 (443)
|||||++|||++| ..||.... ..+....... .......+.. ...++++.+++.+|+. +|.+
T Consensus 223 wSlG~il~el~~G----------~~Pf~~~~----~~~~~~~i~~-~~~~~~~~~~---~~~s~~~~~li~~ll~-~p~~ 283 (364)
T cd05599 223 WSLGVIMYEMLVG----------YPPFCSDN----PQETYRKIIN-WKETLQFPDE---VPLSPEAKDLIKRLCC-EAER 283 (364)
T ss_pred ecchhHHHHhhcC----------CCCCCCCC----HHHHHHHHHc-CCCccCCCCC---CCCCHHHHHHHHHHcc-CHhh
Confidence 9999999999999 67776532 1122222221 1122222321 2356789999999996 9999
Q ss_pred CCc---HHHHHH
Q psy14889 415 RLS---ALRVKK 423 (443)
Q Consensus 415 Rps---~~evl~ 423 (443)
|++ +.++++
T Consensus 284 R~~~~~~~~ll~ 295 (364)
T cd05599 284 RLGNNGVNEIKS 295 (364)
T ss_pred cCCCCCHHHHhc
Confidence 998 888876
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0033|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-43 Score=304.11 Aligned_cols=248 Identities=25% Similarity=0.351 Sum_probs=196.8
Q ss_pred hccccccceeeeecCeEEEEEEE--CCceeEEEEeeccC---ccchHHHHHHHHHHhccCCCceeeeeeccccCCcccEE
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRD---EASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQL 209 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~---~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~ 209 (443)
.+.|++.+.||+|.|+.||++.. +|+.+|+|++..+. ......++|+.+...|+|||||++.+.+... ...
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~----~~~ 85 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE----SFH 85 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhccc----cee
Confidence 46899999999999999999987 68999999774321 2222335666666669999999999887655 568
Q ss_pred EeeecccCcccHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCC---CcEEEEec
Q psy14889 210 WLVTHYHSFGSLYDHL-NRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTN---GTCVIADF 285 (443)
Q Consensus 210 ~lv~e~~~~gsL~~~l-~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~---~~~kl~Df 285 (443)
|||+|+|.+|+|..-+ .+.-+++..+-.+++||+.+|.|+|++ +|||||+||.|+|+.+. .-+||+||
T Consensus 86 ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n--------~IvHRDvkP~nllLASK~~~A~vKL~~F 157 (355)
T KOG0033|consen 86 YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSN--------GIVHRDLKPENLLLASKAKGAAVKLADF 157 (355)
T ss_pred EEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhc--------CceeccCChhheeeeeccCCCceeeccc
Confidence 9999999999996544 566688999999999999999999999 99999999999999654 36899999
Q ss_pred CCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCC
Q psy14889 286 GLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLV 365 (443)
Q Consensus 286 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~ 365 (443)
|+|..+.... ....++||+.|||||++... +|+..+||||-||+||-|+.| ..||++.
T Consensus 158 GvAi~l~~g~-----~~~G~~GtP~fmaPEvvrkd------py~kpvDiW~cGViLfiLL~G----------~~PF~~~- 215 (355)
T KOG0033|consen 158 GLAIEVNDGE-----AWHGFAGTPGYLSPEVLKKD------PYSKPVDIWACGVILYILLVG----------YPPFWDE- 215 (355)
T ss_pred ceEEEeCCcc-----ccccccCCCcccCHHHhhcC------CCCCcchhhhhhHHHHHHHhC----------CCCCCCc-
Confidence 9998887322 22567899999999999887 788999999999999999999 7888874
Q ss_pred CCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 366 PMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
+...+.+.+........ ++.| +..+++.++|+++||..||.+|.|+.|.++
T Consensus 216 ----~~~rlye~I~~g~yd~~-~~~w--~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 216 ----DQHRLYEQIKAGAYDYP-SPEW--DTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred ----cHHHHHHHHhccccCCC-Cccc--CcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 22333333322222221 1133 346778999999999999999999999875
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=328.00 Aligned_cols=264 Identities=22% Similarity=0.259 Sum_probs=188.3
Q ss_pred cccccceeeeecCeEEEEEEE--CCceeEEEEeeccC---ccchHHHHHHHHHHhccCCCceeeeeeccccCC-cccEEE
Q psy14889 137 QISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRD---EASWSRETEIYSTVLLRHENILGYIGSDMTSRN-SCTQLW 210 (443)
Q Consensus 137 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~---~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~-~~~~~~ 210 (443)
+|++.+.||+|+||.||+|.. +|..||||++.... ........|+..+..++||||+++++++..... ....++
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 478899999999999999987 58899999885421 111223456666666999999999998765432 223589
Q ss_pred eeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcc
Q psy14889 211 LVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAV 289 (443)
Q Consensus 211 lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~ 289 (443)
+||||+. ++|.+++.. ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 81 lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~--------~ivH~dlkp~NIll~~~~~~kL~Dfg~~~ 151 (338)
T cd07859 81 VVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTA--------NVFHRDLKPKNILANADCKLKICDFGLAR 151 (338)
T ss_pred EEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHC--------CeecCCCCHHHeEECCCCcEEEccCcccc
Confidence 9999996 689988864 5699999999999999999999998 99999999999999999999999999997
Q ss_pred cccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCC--
Q psy14889 290 SYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPM-- 367 (443)
Q Consensus 290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~-- 367 (443)
......... .......||..|+|||++.+... .++.++|||||||++|||+|| +.||......
T Consensus 152 ~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~----~~~~~~DvwSlGvvl~el~tg----------~~pf~~~~~~~~ 216 (338)
T cd07859 152 VAFNDTPTA-IFWTDYVATRWYRAPELCGSFFS----KYTPAIDIWSIGCIFAEVLTG----------KPLFPGKNVVHQ 216 (338)
T ss_pred ccccccCcc-ccccCCCCCCCcCCHHHHhcccc----ccCchhHHHHHHHHHHHHHcC----------CCCCCCCChHHH
Confidence 543322111 11134578999999999865211 566899999999999999999 4455432100
Q ss_pred ---------CCChHHHHh--------hhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHH
Q psy14889 368 ---------DPSFDDMRK--------VICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKT 424 (443)
Q Consensus 368 ---------~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 424 (443)
.+....... ...........+....-...+..+.+++.+||+.||++|||+.|+++.
T Consensus 217 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 217 LDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 000000000 000000000000000001245678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG4257|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-42 Score=331.34 Aligned_cols=256 Identities=24% Similarity=0.413 Sum_probs=206.7
Q ss_pred hccccccceeeeecCeEEEEEEEC----Cc--eeEEEEeeccCc--cchHHHHHHHHHHhccCCCceeeeeeccccCCcc
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVWH----GE--NVAVKIFFSRDE--ASWSRETEIYSTVLLRHENILGYIGSDMTSRNSC 206 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~~----~~--~vAvK~~~~~~~--~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~ 206 (443)
++.+.+.+.||.|-||.||+|.++ |+ .||||..+.+.. ....+..|...++.++|||||+++|+|.+..
T Consensus 388 Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~P--- 464 (974)
T KOG4257|consen 388 RELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQP--- 464 (974)
T ss_pred hhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeeccc---
Confidence 456778889999999999999983 33 588887765332 2333446667777799999999999998753
Q ss_pred cEEEeeecccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEe
Q psy14889 207 TQLWLVTHYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIAD 284 (443)
Q Consensus 207 ~~~~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~D 284 (443)
.|+|||+++.|.|..||+. ..++......++.||+.||+|||+. ++|||||.++|||+.+...+||+|
T Consensus 465 --~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSk--------rfVHRDIAaRNiLVsSp~CVKLaD 534 (974)
T KOG4257|consen 465 --MWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESK--------RFVHRDIAARNILVSSPQCVKLAD 534 (974)
T ss_pred --eeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhh--------chhhhhhhhhheeecCcceeeecc
Confidence 6999999999999999975 5688899999999999999999999 889999999999999999999999
Q ss_pred cCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCC
Q psy14889 285 FGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDL 364 (443)
Q Consensus 285 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~ 364 (443)
||+++.+........ +...-.+.|||||.+.-. ++|.+||||-|||.+||++.- +..||.+.
T Consensus 535 FGLSR~~ed~~yYka---S~~kLPIKWmaPESINfR------rFTtASDVWMFgVCmWEIl~l---------GvkPfqgv 596 (974)
T KOG4257|consen 535 FGLSRYLEDDAYYKA---SRGKLPIKWMAPESINFR------RFTTASDVWMFGVCMWEILSL---------GVKPFQGV 596 (974)
T ss_pred cchhhhccccchhhc---cccccceeecCccccchh------cccchhhHHHHHHHHHHHHHh---------cCCccccc
Confidence 999998876543321 222345689999999876 788999999999999999874 37788876
Q ss_pred CCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhhcc
Q psy14889 365 VPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLACAD 432 (443)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~~~ 432 (443)
... ++...+ ..+.+++.| +.||..++.||.+||.+||.+||.+.++...|..+.+.+
T Consensus 597 kNs-----DVI~~i-EnGeRlP~P-----~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qee 653 (974)
T KOG4257|consen 597 KNS-----DVIGHI-ENGERLPCP-----PNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEE 653 (974)
T ss_pred ccc-----ceEEEe-cCCCCCCCC-----CCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHh
Confidence 432 222222 234555555 459999999999999999999999999999999988743
|
|
| >KOG0611|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-42 Score=316.71 Aligned_cols=247 Identities=24% Similarity=0.346 Sum_probs=201.4
Q ss_pred hhhhccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc---c-hHHHHHHHHHHhccCCCceeeeeeccccCCc
Q psy14889 132 RTLAKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA---S-WSRETEIYSTVLLRHENILGYIGSDMTSRNS 205 (443)
Q Consensus 132 ~~~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~---~-~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~ 205 (443)
..+..+|++.+.||+|.||.|-+|.. .|+.||||.+++.... + ....+||.++..|+||||+.++.+|...+
T Consensus 49 hnlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkd-- 126 (668)
T KOG0611|consen 49 HNLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKD-- 126 (668)
T ss_pred cchhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCc--
Confidence 34457899999999999999999976 5999999988654322 1 22235556666699999999999998774
Q ss_pred ccEEEeeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEe
Q psy14889 206 CTQLWLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIAD 284 (443)
Q Consensus 206 ~~~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~D 284 (443)
.+.|||||..+|.|++|+.+ +.|++.++.++++||.+|+.|+|.+ +++|||||.+|||+|.++++||+|
T Consensus 127 --KIvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHkn--------rVvHRDLKLENILLD~N~NiKIAD 196 (668)
T KOG0611|consen 127 --KIVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKN--------RVVHRDLKLENILLDQNNNIKIAD 196 (668)
T ss_pred --eEEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhc--------cceecccchhheeecCCCCeeeec
Confidence 57999999999999999974 7899999999999999999999998 999999999999999999999999
Q ss_pred cCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCC
Q psy14889 285 FGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDL 364 (443)
Q Consensus 285 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~ 364 (443)
||++..+.+... ..+++|++.|.+||++.+..+. ++..|-|||||+||-|+.| ..||.+.
T Consensus 197 FGLSNly~~~kf-----LqTFCGSPLYASPEIvNG~PY~-----GPEVDsWsLGvLLYtLVyG----------tMPFDG~ 256 (668)
T KOG0611|consen 197 FGLSNLYADKKF-----LQTFCGSPLYASPEIVNGTPYK-----GPEVDSWSLGVLLYTLVYG----------TMPFDGR 256 (668)
T ss_pred cchhhhhccccH-----HHHhcCCcccCCccccCCCCCC-----CCccchhhHHHHHHHHhhc----------ccccCCc
Confidence 999977654322 3568999999999999987443 2789999999999999999 8888775
Q ss_pred CCCCCChHHHHhhhhhcC-CCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHH
Q psy14889 365 VPMDPSFDDMRKVICIDQ-QRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKT 424 (443)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 424 (443)
+...+.+.+.... ..|. .+....-||++||-.||++|.|+.+|...
T Consensus 257 -----Dhk~lvrQIs~GaYrEP~---------~PSdA~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 257 -----DHKRLVRQISRGAYREPE---------TPSDASGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred -----hHHHHHHHhhcccccCCC---------CCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence 3333333333222 2222 33457889999999999999999998764
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=365.73 Aligned_cols=259 Identities=20% Similarity=0.287 Sum_probs=192.3
Q ss_pred hccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEee
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLV 212 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv 212 (443)
...+...+.||+|+||.||+|+. ++..||||.+..... ..+.|+..+.+++|||||+++|++.+.. ..++|
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~l~~l~HpnIv~~~~~~~~~~----~~~lv 761 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS---IPSSEIADMGKLQHPNIVKLIGLCRSEK----GAYLI 761 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc---ccHHHHHHHhhCCCCCcceEEEEEEcCC----CCEEE
Confidence 35677788999999999999996 688999998754322 1233455666699999999999998764 46999
Q ss_pred ecccCcccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCccccc
Q psy14889 213 THYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYS 292 (443)
Q Consensus 213 ~e~~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~~ 292 (443)
|||+++|+|.++++. ++|..+..++.|+|+||+|||+.+ .++|+||||||+||+++.++.+++. ||.+....
T Consensus 762 ~Ey~~~g~L~~~l~~--l~~~~~~~i~~~ia~~L~yLH~~~-----~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~ 833 (968)
T PLN00113 762 HEYIEGKNLSEVLRN--LSWERRRKIAIGIAKALRFLHCRC-----SPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC 833 (968)
T ss_pred EeCCCCCcHHHHHhc--CCHHHHHHHHHHHHHHHHHhccCC-----CCCeecCCCCHHhEEECCCCceEEE-eccccccc
Confidence 999999999999964 899999999999999999999542 4599999999999999999988876 66553322
Q ss_pred ccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCChH
Q psy14889 293 QLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFD 372 (443)
Q Consensus 293 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~~~ 372 (443)
. .....||..|+|||++.+. .++.++|||||||++|||+||+ .||...........
T Consensus 834 ~--------~~~~~~t~~y~aPE~~~~~------~~~~~sDv~S~Gvvl~el~tg~----------~p~~~~~~~~~~~~ 889 (968)
T PLN00113 834 T--------DTKCFISSAYVAPETRETK------DITEKSDIYGFGLILIELLTGK----------SPADAEFGVHGSIV 889 (968)
T ss_pred c--------CCCccccccccCcccccCC------CCCcccchhhHHHHHHHHHhCC----------CCCCcccCCCCcHH
Confidence 1 1223688999999998876 6778999999999999999994 44432221111111
Q ss_pred HHHhhhhh-----cCCCCCCCCC-CCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhhcc
Q psy14889 373 DMRKVICI-----DQQRPVLPNR-WVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLACAD 432 (443)
Q Consensus 373 ~~~~~~~~-----~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~~~ 432 (443)
...+.... ...++.+... ........++.+++.+||+.||++||||.||++.|+++....
T Consensus 890 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~ 955 (968)
T PLN00113 890 EWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSS 955 (968)
T ss_pred HHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhccc
Confidence 11111000 0011111111 112335567889999999999999999999999999987744
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=317.36 Aligned_cols=256 Identities=26% Similarity=0.401 Sum_probs=198.0
Q ss_pred ccccccceeeeecCeEEEEEEE-------CCceeEEEEeeccCcc-chHHHHHHHHHHhccCCCceeeeeeccccCCccc
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW-------HGENVAVKIFFSRDEA-SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCT 207 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~-------~~~~vAvK~~~~~~~~-~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~ 207 (443)
.+|.+.+.||+|+||.||++.. ++..+|+|.+...... ......|+..+..++||||+++++++... .
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----~ 80 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEG----D 80 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC----C
Confidence 5789999999999999999975 2356899987543322 22234556666669999999999998765 3
Q ss_pred EEEeeecccCcccHHHHhccc--------------CCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEE
Q psy14889 208 QLWLVTHYHSFGSLYDHLNRT--------------TLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNIL 273 (443)
Q Consensus 208 ~~~lv~e~~~~gsL~~~l~~~--------------~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiL 273 (443)
.+++||||+++|+|.+++... .+++.+++.++.|++.||+|||+. +++||||||+|||
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~--------~i~H~dlkp~Nil 152 (288)
T cd05093 81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ--------HFVHRDLATRNCL 152 (288)
T ss_pred ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CeeecccCcceEE
Confidence 479999999999999998532 389999999999999999999998 9999999999999
Q ss_pred EcCCCcEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh-cccCCC
Q psy14889 274 VKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR-RTKANG 352 (443)
Q Consensus 274 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt-g~~~~~ 352 (443)
+++++.+||+|||+++......... ......++..|+|||.+.+. .++.++|||||||++|||++ |
T Consensus 153 i~~~~~~kl~dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~------~~~~~sDiwslG~il~~l~t~g----- 219 (288)
T cd05093 153 VGENLLVKIGDFGMSRDVYSTDYYR--VGGHTMLPIRWMPPESIMYR------KFTTESDVWSLGVVLWEIFTYG----- 219 (288)
T ss_pred EccCCcEEeccCCccccccCCceee--cCCCCCccccccCHHHhccC------CCCchhhHHHHHHHHHHHHhCC-----
Confidence 9999999999999997654322111 11223457789999998765 66789999999999999998 6
Q ss_pred cccccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhhcc
Q psy14889 353 IFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLACAD 432 (443)
Q Consensus 353 ~~~~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~~~ 432 (443)
..||.... .......+.. ...+..+ ..++.++.+++.+||+.||.+|||+.++++.|+++....
T Consensus 220 -----~~p~~~~~-----~~~~~~~i~~-~~~~~~~-----~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~ 283 (288)
T cd05093 220 -----KQPWYQLS-----NNEVIECITQ-GRVLQRP-----RTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKAS 283 (288)
T ss_pred -----CCCCCCCC-----HHHHHHHHHc-CCcCCCC-----CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhc
Confidence 56665532 2222222222 1212222 235567999999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=317.06 Aligned_cols=253 Identities=22% Similarity=0.277 Sum_probs=188.8
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc---chHHHHHHHHHHhccCCCceeeeeeccccCCcccEEE
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA---SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLW 210 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~---~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~ 210 (443)
++|++.+.||+|+||.||+|++ +++.||+|++...... ......|+..+..++||||+++++++... ..++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----~~~~ 76 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRR----GKLY 76 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecC----CEEE
Confidence 3688999999999999999998 4789999988654221 12223566666669999999999998765 4589
Q ss_pred eeecccCcccHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcc
Q psy14889 211 LVTHYHSFGSLYDHLN-RTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAV 289 (443)
Q Consensus 211 lv~e~~~~gsL~~~l~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~ 289 (443)
+||||++++.+..+.. ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++.
T Consensus 77 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~--------~i~H~dlkp~Nill~~~~~~kl~Dfg~~~ 148 (287)
T cd07848 77 LVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKN--------DIVHRDIKPENLLISHNDVLKLCDFGFAR 148 (287)
T ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--------CeecCCCCHHHEEEcCCCcEEEeeccCcc
Confidence 9999999877765554 35689999999999999999999998 99999999999999999999999999997
Q ss_pred cccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCC
Q psy14889 290 SYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDP 369 (443)
Q Consensus 290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~ 369 (443)
........ ......||..|+|||++.+. .++.++|||||||++|||++| ..||.....
T Consensus 149 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~------~~~~~~DiwslGvil~el~~g----------~~pf~~~~~--- 206 (287)
T cd07848 149 NLSEGSNA---NYTEYVATRWYRSPELLLGA------PYGKAVDMWSVGCILGELSDG----------QPLFPGESE--- 206 (287)
T ss_pred cccccccc---cccccccccccCCcHHHcCC------CCCCchhHHhHHHHHHHHHhC----------CCCCCCCCH---
Confidence 76432211 11234689999999999766 567899999999999999999 555544211
Q ss_pred ChHHHHhhhhh--------------cC--CCCCCCCC--------CCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 370 SFDDMRKVICI--------------DQ--QRPVLPNR--------WVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 370 ~~~~~~~~~~~--------------~~--~~~~~~~~--------~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
.+........ .. .....+.. ......+..+.+|+++||+.||++|||++++++
T Consensus 207 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 207 -IDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred -HHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 1111100000 00 00000000 001124567999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=339.26 Aligned_cols=247 Identities=21% Similarity=0.340 Sum_probs=193.9
Q ss_pred ccccccceeeeecCeEEEEEEE--C-CceeEEEEeeccCccc-hHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEe
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--H-GENVAVKIFFSRDEAS-WSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWL 211 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~-~~~vAvK~~~~~~~~~-~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~l 211 (443)
..|.+.+.||+|+||.||+|.. + +..||+|.+....... .....|+..+..++||||+++++++... ..+++
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~----~~~~l 142 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSD----DKLLL 142 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEEC----CEEEE
Confidence 4599999999999999999986 3 6778888764433322 2234567777779999999999998776 45899
Q ss_pred eecccCcccHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecC
Q psy14889 212 VTHYHSFGSLYDHLNR-----TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFG 286 (443)
Q Consensus 212 v~e~~~~gsL~~~l~~-----~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfG 286 (443)
||||+++|+|.+++.+ ..+++.++..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||
T Consensus 143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~--------~ivHrDlkp~NIll~~~~~~kL~DFg 214 (478)
T PTZ00267 143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR--------KMMHRDLKSANIFLMPTGIIKLGDFG 214 (478)
T ss_pred EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC--------CEEECCcCHHhEEECCCCcEEEEeCc
Confidence 9999999999988753 3588999999999999999999998 99999999999999999999999999
Q ss_pred CcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCC
Q psy14889 287 LAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVP 366 (443)
Q Consensus 287 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~ 366 (443)
+++.+...... .......||+.|+|||++.+. .++.++|||||||++|||++| ..||...
T Consensus 215 la~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~slG~~l~el~tg----------~~Pf~~~-- 274 (478)
T PTZ00267 215 FSKQYSDSVSL--DVASSFCGTPYYLAPELWERK------RYSKKADMWSLGVILYELLTL----------HRPFKGP-- 274 (478)
T ss_pred CceecCCcccc--ccccccCCCccccCHhHhCCC------CCCcHHhHHHHHHHHHHHHhC----------CCCCCCC--
Confidence 99876542211 112345799999999999776 677899999999999999999 6677542
Q ss_pred CCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 367 MDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
....+...+... .....+ ..++.++.+++.+||+.||++|||+.+++.
T Consensus 275 ---~~~~~~~~~~~~-~~~~~~-----~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 275 ---SQREIMQQVLYG-KYDPFP-----CPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred ---CHHHHHHHHHhC-CCCCCC-----ccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 222222222221 112222 235568999999999999999999999864
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=328.66 Aligned_cols=253 Identities=19% Similarity=0.250 Sum_probs=189.9
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCc----cchHHHHHHHHHHhccCCCceeeeeeccccCCcccEE
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDE----ASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQL 209 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~----~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~ 209 (443)
++|++.+.||+|+||+||++.. +++.||||++..... .......|+..+..++|+||+++++.+.+. ..+
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~----~~~ 76 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDK----LNL 76 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecC----CeE
Confidence 3688999999999999999987 588999999865321 111223455555568999999999998776 458
Q ss_pred EeeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCc
Q psy14889 210 WLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA 288 (443)
Q Consensus 210 ~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla 288 (443)
++||||+++|+|.+++.+ ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 77 ~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~--------givHrDlKp~NILi~~~~~vkL~DFGla 148 (363)
T cd05628 77 YLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQL--------GFIHRDIKPDNLLLDSKGHVKLSDFGLC 148 (363)
T ss_pred EEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CeEecCCCHHHeEECCCCCEEEeeccCc
Confidence 999999999999999864 6799999999999999999999998 9999999999999999999999999998
Q ss_pred ccccccCCcC-------------------------------CCCCCCcccccCcccccccccccccCcCCCCCccchHHH
Q psy14889 289 VSYSQLSNKM-------------------------------DIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYAL 337 (443)
Q Consensus 289 ~~~~~~~~~~-------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~ 337 (443)
+.+....... .......+||+.|+|||++.+. .++.++|||||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~------~~~~~~DvwSl 222 (363)
T cd05628 149 TGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQT------GYNKLCDWWSL 222 (363)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCC------CCCCchhhhhh
Confidence 7653211000 0001235799999999999876 66789999999
Q ss_pred HHHHHHHHhcccCCCcccccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhc--CCcCCC
Q psy14889 338 GLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWH--QNANVR 415 (443)
Q Consensus 338 Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~--~dP~~R 415 (443)
||++|||++| ..||.+.. .......+........+|.. ...+.++.+++.+++. .++..|
T Consensus 223 Gvil~ell~G----------~~Pf~~~~-----~~~~~~~i~~~~~~~~~p~~---~~~s~~~~~li~~l~~~~~~r~~r 284 (363)
T cd05628 223 GVIMYEMLIG----------YPPFCSET-----PQETYKKVMNWKETLIFPPE---VPISEKAKDLILRFCCEWEHRIGA 284 (363)
T ss_pred HHHHHHHHhC----------CCCCCCCC-----HHHHHHHHHcCcCcccCCCc---CCCCHHHHHHHHHHcCChhhcCCC
Confidence 9999999999 77776532 22222222221122223321 1245678888888654 233456
Q ss_pred CcHHHHHHH
Q psy14889 416 LSALRVKKT 424 (443)
Q Consensus 416 ps~~evl~~ 424 (443)
|+++||++.
T Consensus 285 ~~~~ei~~h 293 (363)
T cd05628 285 PGVEEIKTN 293 (363)
T ss_pred CCHHHHhCC
Confidence 899999875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=329.83 Aligned_cols=252 Identities=23% Similarity=0.322 Sum_probs=195.5
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccC----ccchHHHHHHHHHHhccCCCceeeeeeccccCCcccEE
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRD----EASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQL 209 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~----~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~ 209 (443)
++|.+.+.||+|+||.||+|.. +|+.||||++.... ........|+..+..++||||+++++++.+. ..+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~----~~~ 76 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDE----EHL 76 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecC----CeE
Confidence 3688999999999999999998 48999999986532 1122233455556668999999999988765 458
Q ss_pred EeeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCc
Q psy14889 210 WLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA 288 (443)
Q Consensus 210 ~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla 288 (443)
++||||+++|+|.+++.+ ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 77 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~--------giiH~Dlkp~NIll~~~~~~kL~Dfg~~ 148 (350)
T cd05573 77 YLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKL--------GFIHRDIKPDNILIDADGHIKLADFGLC 148 (350)
T ss_pred EEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC--------CeeccCCCHHHeEECCCCCEEeecCCCC
Confidence 999999999999999965 5799999999999999999999998 9999999999999999999999999999
Q ss_pred ccccccCC-------------------------cCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHH
Q psy14889 289 VSYSQLSN-------------------------KMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWE 343 (443)
Q Consensus 289 ~~~~~~~~-------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~e 343 (443)
........ ..........||+.|+|||++.+. .++.++|||||||++||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwSlG~il~e 222 (350)
T cd05573 149 KKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT------PYGLECDWWSLGVILYE 222 (350)
T ss_pred ccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCC------CCCCceeeEecchhhhh
Confidence 76654320 000112345799999999999876 67789999999999999
Q ss_pred HHhcccCCCcccccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCc-HHHHH
Q psy14889 344 VCRRTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLS-ALRVK 422 (443)
Q Consensus 344 lltg~~~~~~~~~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-~~evl 422 (443)
|++| ..||.... ......+... ......+|.. ...+.++.+++.+||. ||.+||+ +.+++
T Consensus 223 ll~g----------~~Pf~~~~----~~~~~~~i~~-~~~~~~~p~~---~~~~~~~~~li~~ll~-dp~~R~~s~~~ll 283 (350)
T cd05573 223 MLYG----------FPPFYSDT----LQETYNKIIN-WKESLRFPPD---PPVSPEAIDLICRLLC-DPEDRLGSFEEIK 283 (350)
T ss_pred hccC----------CCCCCCCC----HHHHHHHHhc-cCCcccCCCC---CCCCHHHHHHHHHHcc-ChhhcCCCHHHHh
Confidence 9999 67776532 1122222221 1112222221 1256789999999997 9999999 99998
Q ss_pred HH
Q psy14889 423 KT 424 (443)
Q Consensus 423 ~~ 424 (443)
+.
T Consensus 284 ~h 285 (350)
T cd05573 284 SH 285 (350)
T ss_pred cC
Confidence 74
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=314.41 Aligned_cols=255 Identities=21% Similarity=0.423 Sum_probs=197.6
Q ss_pred ccccccceeeeecCeEEEEEEE--CCc----eeEEEEeeccCccc--hHHHHHHHHHHhccCCCceeeeeeccccCCccc
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGE----NVAVKIFFSRDEAS--WSRETEIYSTVLLRHENILGYIGSDMTSRNSCT 207 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~----~vAvK~~~~~~~~~--~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~ 207 (443)
++|++.+.||+|+||+||+|.+ +|+ .||+|++....... .....|+..+..++||||+++++++....
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~---- 82 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTST---- 82 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCCC----
Confidence 5789999999999999999987 444 48999886543222 22235566666689999999999987542
Q ss_pred EEEeeecccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEec
Q psy14889 208 QLWLVTHYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADF 285 (443)
Q Consensus 208 ~~~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~Df 285 (443)
.++++||+++|+|.+++.. ..+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+||
T Consensus 83 -~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~--------~iiH~dlkp~Nil~~~~~~~kL~df 153 (279)
T cd05109 83 -VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEV--------RLVHRDLAARNVLVKSPNHVKITDF 153 (279)
T ss_pred -cEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC--------CeeccccccceEEEcCCCcEEECCC
Confidence 4799999999999999964 4689999999999999999999998 9999999999999999999999999
Q ss_pred CCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh-cccCCCcccccCCCCCCC
Q psy14889 286 GLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR-RTKANGIFEEYKAPYHDL 364 (443)
Q Consensus 286 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt-g~~~~~~~~~~~~P~~~~ 364 (443)
|+++.......... .....++..|+|||.+.+. .++.++|||||||++|||++ | ..||...
T Consensus 154 G~~~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~------~~~~~~Di~slG~~l~el~t~g----------~~p~~~~ 215 (279)
T cd05109 154 GLARLLDIDETEYH--ADGGKVPIKWMALESILHR------RFTHQSDVWSYGVTVWELMTFG----------AKPYDGI 215 (279)
T ss_pred Cceeecccccceee--cCCCccchhhCCHHHhccC------CCCchhHHHHHHHHHHHHHcCC----------CCCCCCC
Confidence 99987653222111 1122356789999998765 66789999999999999998 6 5666543
Q ss_pred CCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhhcc
Q psy14889 365 VPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLACAD 432 (443)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~~~ 432 (443)
........+.. ...+..+ ..++..+.+++.+||+.||++||++.++++.|+++....
T Consensus 216 -----~~~~~~~~~~~-~~~~~~~-----~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 216 -----PAREIPDLLEK-GERLPQP-----PICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred -----CHHHHHHHHHC-CCcCCCC-----ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 12223333322 2222222 235678999999999999999999999999999987655
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=312.98 Aligned_cols=254 Identities=23% Similarity=0.381 Sum_probs=198.0
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCc----cchHHHHHHHHHHhccCCCceeeeeeccccCCcccEE
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDE----ASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQL 209 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~----~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~ 209 (443)
++|++.+.||+|+||.||+|.. +++.||||.+..... .......|+..+..++||||+++++++.+. ...
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----~~~ 77 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIED----NEL 77 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEEC----CeE
Confidence 5789999999999999999987 689999998754221 112234566667779999999999998765 357
Q ss_pred EeeecccCcccHHHHhc-----ccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEe
Q psy14889 210 WLVTHYHSFGSLYDHLN-----RTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIAD 284 (443)
Q Consensus 210 ~lv~e~~~~gsL~~~l~-----~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~D 284 (443)
++|+||+++|+|.+++. ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|
T Consensus 78 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--------~i~H~dl~~~nil~~~~~~~~l~d 149 (267)
T cd08228 78 NIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR--------RVMHRDIKPANVFITATGVVKLGD 149 (267)
T ss_pred EEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC--------CeeCCCCCHHHEEEcCCCCEEECc
Confidence 99999999999998884 24588999999999999999999998 999999999999999999999999
Q ss_pred cCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCC
Q psy14889 285 FGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDL 364 (443)
Q Consensus 285 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~ 364 (443)
||++......... .....|+..|+|||.+.+. .++.++|+||||+++|||++| ..||...
T Consensus 150 ~g~~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~------~~~~~~Di~slG~~l~el~~g----------~~p~~~~ 209 (267)
T cd08228 150 LGLGRFFSSKTTA----AHSLVGTPYYMSPERIHEN------GYNFKSDIWSLGCLLYEMAAL----------QSPFYGD 209 (267)
T ss_pred cccceeccchhHH----HhcCCCCccccChhhhccC------CCCchhhHHHHHHHHHHHhcC----------CCCCccc
Confidence 9998766532211 1234688899999998765 566899999999999999999 5666442
Q ss_pred CCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHh
Q psy14889 365 VPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLA 429 (443)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~ 429 (443)
.. ........+.. ...+..+ ....+..+.+++.+||+.+|++|||+.+|++.|+++.
T Consensus 210 ~~---~~~~~~~~~~~-~~~~~~~----~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 210 KM---NLFSLCQKIEQ-CDYPPLP----TEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred cc---cHHHHHHHHhc-CCCCCCC----hhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 11 11222222221 1222222 1235577999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=328.02 Aligned_cols=254 Identities=21% Similarity=0.258 Sum_probs=194.3
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCc----cchHHHHHHHHHHhccCCCceeeeeeccccCCcccEE
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDE----ASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQL 209 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~----~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~ 209 (443)
++|++.+.||+|+||.||++.. +|+.||+|++..... .....+.|+..+..++|+||+++++++.+. ..+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~----~~~ 76 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDK----DNL 76 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecC----CeE
Confidence 3688999999999999999987 688999999865422 122234455555568999999999988765 457
Q ss_pred EeeecccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCC
Q psy14889 210 WLVTHYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGL 287 (443)
Q Consensus 210 ~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGl 287 (443)
++||||+++|+|.+++++ ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 77 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~--------~i~H~Dlkp~NIll~~~~~~kL~Dfg~ 148 (330)
T cd05601 77 YLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQM--------GYVHRDIKPENVLIDRTGHIKLADFGS 148 (330)
T ss_pred EEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CeEcccCchHheEECCCCCEEeccCCC
Confidence 999999999999999975 5799999999999999999999998 999999999999999999999999999
Q ss_pred cccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCC
Q psy14889 288 AVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPM 367 (443)
Q Consensus 288 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~ 367 (443)
+..+...... ......||+.|+|||++..........++.++|||||||++|||++| ..||....
T Consensus 149 a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g----------~~Pf~~~~-- 213 (330)
T cd05601 149 AARLTANKMV---NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYG----------RSPFHEGT-- 213 (330)
T ss_pred CeECCCCCce---eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccC----------CCCCCCCC--
Confidence 9766532221 11234689999999998743221112567899999999999999999 67776532
Q ss_pred CCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 368 DPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
......+... .......+. ....+..+.+|+.+||. ||.+|||+.++++
T Consensus 214 --~~~~~~~i~~-~~~~~~~~~---~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 214 --SAKTYNNIMN-FQRFLKFPE---DPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred --HHHHHHHHHc-CCCccCCCC---CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 1122222221 111122222 12356779999999998 9999999999885
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=331.10 Aligned_cols=252 Identities=21% Similarity=0.270 Sum_probs=189.6
Q ss_pred cccccceeeeecCeEEEEEEE--CCceeEEEEeeccCc----cchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEE
Q psy14889 137 QISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDE----ASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLW 210 (443)
Q Consensus 137 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~----~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~ 210 (443)
.|++.+.||+|+||+||+|+. +++.||||++..... .......|+..+..++||||+++++++.+. ..++
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~----~~~~ 77 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDK----DNLY 77 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecC----CEEE
Confidence 588899999999999999988 578999999865421 111223455555669999999999998876 4589
Q ss_pred eeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcc
Q psy14889 211 LVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAV 289 (443)
Q Consensus 211 lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~ 289 (443)
+||||+++|+|.+++.+ ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 78 lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~--------givHrDlKp~Nili~~~~~~kL~DFGl~~ 149 (381)
T cd05626 78 FVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKM--------GFIHRDIKPDNILIDLDGHIKLTDFGLCT 149 (381)
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CeeecCCcHHHEEECCCCCEEEeeCcCCc
Confidence 99999999999999865 5689999999999999999999998 99999999999999999999999999986
Q ss_pred cccccCCc-------------------------------------------CCCCCCCcccccCcccccccccccccCcC
Q psy14889 290 SYSQLSNK-------------------------------------------MDIPPNPRVGTKRYMSPEILDESINMDCF 326 (443)
Q Consensus 290 ~~~~~~~~-------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 326 (443)
.+...... .........||+.|+|||++.+.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~------ 223 (381)
T cd05626 150 GFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRK------ 223 (381)
T ss_pred ccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCC------
Confidence 43211000 00001235799999999999765
Q ss_pred CCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHH
Q psy14889 327 ESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKE 406 (443)
Q Consensus 327 ~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 406 (443)
.++.++|||||||++|||+|| ..||..... .+....... .......+.. ...+.++.+++.+
T Consensus 224 ~~~~~~DiwSlG~il~elltG----------~~Pf~~~~~----~~~~~~i~~-~~~~~~~~~~---~~~s~~~~dli~~ 285 (381)
T cd05626 224 GYTQLCDWWSVGVILFEMLVG----------QPPFLAPTP----TETQLKVIN-WENTLHIPPQ---VKLSPEAVDLITK 285 (381)
T ss_pred CCCCccceeehhhHHHHHHhC----------CCCCcCCCH----HHHHHHHHc-cccccCCCCC---CCCCHHHHHHHHH
Confidence 667899999999999999999 677765321 122222221 1122222221 2255678899998
Q ss_pred --HhcCCcCCCCcHHHHHHH
Q psy14889 407 --CWHQNANVRLSALRVKKT 424 (443)
Q Consensus 407 --cl~~dP~~Rps~~evl~~ 424 (443)
|+..+|..||++.++++.
T Consensus 286 ll~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 286 LCCSAEERLGRNGADDIKAH 305 (381)
T ss_pred HccCcccccCCCCHHHHhcC
Confidence 445666679999999873
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=329.27 Aligned_cols=255 Identities=18% Similarity=0.246 Sum_probs=195.2
Q ss_pred hccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCc----cchHHHHHHHHHHhccCCCceeeeeeccccCCcccE
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDE----ASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQ 208 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~----~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~ 208 (443)
.++|++.+.||+|+||.||++.. +++.||+|++..... .......|+..+..++||||+++++++.+. ..
T Consensus 42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~----~~ 117 (370)
T cd05621 42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDD----KY 117 (370)
T ss_pred HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC----CE
Confidence 36899999999999999999998 578999998854211 111223445555559999999999998766 46
Q ss_pred EEeeecccCcccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCc
Q psy14889 209 LWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA 288 (443)
Q Consensus 209 ~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla 288 (443)
+++||||+++|+|.+++....+++.++..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~~~~~~~~~~~~~~qil~aL~~LH~~--------~IvHrDLKp~NILl~~~~~~kL~DFG~a 189 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSM--------GLIHRDVKPDNMLLDKHGHLKLADFGTC 189 (370)
T ss_pred EEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHC--------CeEecCCCHHHEEECCCCCEEEEecccc
Confidence 89999999999999999888899999999999999999999998 9999999999999999999999999999
Q ss_pred ccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCC
Q psy14889 289 VSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMD 368 (443)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~ 368 (443)
........ .......||+.|+|||++.+..... .++.++|||||||++|||++| ..||....
T Consensus 190 ~~~~~~~~---~~~~~~~gt~~Y~aPE~~~~~~~~~--~~~~~~DiwSlG~ilyell~G----------~~Pf~~~~--- 251 (370)
T cd05621 190 MKMDETGM---VRCDTAVGTPDYISPEVLKSQGGDG--YYGRECDWWSVGVFLFEMLVG----------DTPFYADS--- 251 (370)
T ss_pred eecccCCc---eecccCCCCcccCCHHHHhccCCCC--CCCcccCEEeehHHHHHHHhC----------CCCCCCCC---
Confidence 76543211 1123457999999999997642111 366899999999999999999 77776531
Q ss_pred CChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCC--CCcHHHHHHH
Q psy14889 369 PSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANV--RLSALRVKKT 424 (443)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--Rps~~evl~~ 424 (443)
......++. .......+|.. ...+..+.+++..|+..++.+ |+|+.|+++.
T Consensus 252 -~~~~~~~i~-~~~~~~~~p~~---~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 252 -LVGTYSKIM-DHKNSLNFPED---VEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred -HHHHHHHHH-hCCcccCCCCc---ccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 122222322 22222333321 235677899999999865543 8899998875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=326.10 Aligned_cols=239 Identities=23% Similarity=0.335 Sum_probs=187.1
Q ss_pred ceeeeecCeEEEEEEE--CCceeEEEEeeccCc----cchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEeeecc
Q psy14889 142 ECIGKGRYGEVWRGVW--HGENVAVKIFFSRDE----ASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVTHY 215 (443)
Q Consensus 142 ~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~----~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e~ 215 (443)
+.||+|+||.||++.. +|+.||+|++..... .......|+..+..++||||+++++++... ..+++||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~----~~~~lv~E~ 76 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTH----DRLCFVMEY 76 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcC----CEEEEEEeC
Confidence 4699999999999987 688999999865321 112223455556668999999999988766 458999999
Q ss_pred cCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHH-chhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcccccc
Q psy14889 216 HSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHT-EIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQ 293 (443)
Q Consensus 216 ~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~-~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~~~ 293 (443)
+++|+|..++.+ ..+++..+..++.||+.||.|||+ . +|+||||||+|||++.++.+||+|||+++....
T Consensus 77 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--------~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~ 148 (325)
T cd05594 77 ANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK--------NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 148 (325)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcC--------CEEecCCCCCeEEECCCCCEEEecCCCCeecCC
Confidence 999999998864 568999999999999999999997 5 999999999999999999999999999865332
Q ss_pred cCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCChHH
Q psy14889 294 LSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFDD 373 (443)
Q Consensus 294 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~~~~ 373 (443)
.... .....||+.|+|||++.+. .++.++|||||||++|||++| ..||... ..+.
T Consensus 149 ~~~~----~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~el~tG----------~~Pf~~~-----~~~~ 203 (325)
T cd05594 149 DGAT----MKTFCGTPEYLAPEVLEDN------DYGRAVDWWGLGVVMYEMMCG----------RLPFYNQ-----DHEK 203 (325)
T ss_pred CCcc----cccccCCcccCCHHHHccC------CCCCccccccccceeeeeccC----------CCCCCCC-----CHHH
Confidence 1111 1234699999999999776 667899999999999999999 6777553 2223
Q ss_pred HHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCC-----cHHHHHHH
Q psy14889 374 MRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRL-----SALRVKKT 424 (443)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~ 424 (443)
....+.. ....++ ...+.++.+++.+||+.||++|+ ++.++++.
T Consensus 204 ~~~~i~~--~~~~~p-----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 204 LFELILM--EEIRFP-----RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred HHHHHhc--CCCCCC-----CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 3333221 122233 23556799999999999999997 89998753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=312.11 Aligned_cols=252 Identities=27% Similarity=0.423 Sum_probs=197.2
Q ss_pred ccccccceeeeecCeEEEEEEEC-----CceeEEEEeeccCcc--chHHHHHHHHHHhccCCCceeeeeeccccCCcccE
Q psy14889 136 KQISLSECIGKGRYGEVWRGVWH-----GENVAVKIFFSRDEA--SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQ 208 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~~-----~~~vAvK~~~~~~~~--~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~ 208 (443)
++|++.+.||+|+||.||+|.+. ...||||.+...... ......|+..+..++||||+++++++... ..
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----~~ 79 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKS----RP 79 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecC----Cc
Confidence 57899999999999999999873 347999987643322 22234566666679999999999988765 34
Q ss_pred EEeeecccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecC
Q psy14889 209 LWLVTHYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFG 286 (443)
Q Consensus 209 ~~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfG 286 (443)
.+++|||+++|+|.+++.. ..+++..++.++.|++.||.|||+. +|+|+||||+|||+++++.+||+|||
T Consensus 80 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~--------~i~H~di~p~nili~~~~~~~l~dfg 151 (266)
T cd05033 80 VMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEM--------NYVHRDLAARNILVNSNLVCKVSDFG 151 (266)
T ss_pred eEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC--------CcccCCCCcceEEEcCCCCEEECccc
Confidence 7999999999999999864 4689999999999999999999998 99999999999999999999999999
Q ss_pred CcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh-cccCCCcccccCCCCCCCC
Q psy14889 287 LAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR-RTKANGIFEEYKAPYHDLV 365 (443)
Q Consensus 287 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt-g~~~~~~~~~~~~P~~~~~ 365 (443)
+++.......... .....++..|+|||.+.+. .++.++||||||+++|||++ | ..||.+.
T Consensus 152 ~~~~~~~~~~~~~--~~~~~~~~~y~~Pe~~~~~------~~~~~~Dv~slG~~l~~l~~~g----------~~p~~~~- 212 (266)
T cd05033 152 LSRRLEDSEATYT--TKGGKIPIRWTAPEAIAYR------KFTSASDVWSFGIVMWEVMSYG----------ERPYWDM- 212 (266)
T ss_pred hhhccccccccee--ccCCCCCccccChhhhccC------CCccccchHHHHHHHHHHHccC----------CCCCCCC-
Confidence 9987652221111 1122456789999998765 66789999999999999998 7 6677653
Q ss_pred CCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHH
Q psy14889 366 PMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKL 428 (443)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l 428 (443)
........+.. ......+ ..++..+.+++.+||+.+|++||++.+|++.|+++
T Consensus 213 ----~~~~~~~~~~~-~~~~~~~-----~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 213 ----SNQDVIKAVED-GYRLPPP-----MDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ----CHHHHHHHHHc-CCCCCCC-----CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 22333333322 1122222 23567899999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=322.21 Aligned_cols=236 Identities=23% Similarity=0.373 Sum_probs=183.0
Q ss_pred ceeeeecCeEEEEEEE--CCceeEEEEeeccCc------cchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEeee
Q psy14889 142 ECIGKGRYGEVWRGVW--HGENVAVKIFFSRDE------ASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVT 213 (443)
Q Consensus 142 ~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~------~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv~ 213 (443)
+.||+|+||.||+|.. +++.||+|++..... .....|.++... ..+||||+++++++... ..+++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~-~~~hp~i~~~~~~~~~~----~~~~lv~ 75 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLAL-AWEHPFLTHLFCTFQTK----EHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHh-ccCCCCccceeeEEEcC----CEEEEEE
Confidence 4699999999999998 477899998865321 111223333322 25899999999998765 4589999
Q ss_pred cccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCccccc
Q psy14889 214 HYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYS 292 (443)
Q Consensus 214 e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~~ 292 (443)
||+++|+|.+++.. ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 76 e~~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~--------~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~ 147 (316)
T cd05592 76 EYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKK--------GIIYRDLKLDNVLLDKDGHIKIADFGMCKENM 147 (316)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC--------CEEeCCCCHHHeEECCCCCEEEccCcCCeECC
Confidence 99999999998864 5799999999999999999999998 99999999999999999999999999997543
Q ss_pred ccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCChH
Q psy14889 293 QLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFD 372 (443)
Q Consensus 293 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~~~ 372 (443)
.... ......||+.|+|||++.+. .++.++|||||||++|||++| ..||... ...
T Consensus 148 ~~~~----~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~il~ell~G----------~~Pf~~~-----~~~ 202 (316)
T cd05592 148 NGEG----KASTFCGTPDYIAPEILKGQ------KYNESVDWWSFGVLLYEMLIG----------QSPFHGE-----DED 202 (316)
T ss_pred CCCC----ccccccCCccccCHHHHcCC------CCCCcccchhHHHHHHHHHhC----------CCCCCCC-----CHH
Confidence 2211 12345799999999999876 667899999999999999999 6777653 222
Q ss_pred HHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHH-HHH
Q psy14889 373 DMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSAL-RVK 422 (443)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~-evl 422 (443)
.+...+. ...+.++ ..++.++.+++.+||+.||++||++. +++
T Consensus 203 ~~~~~i~--~~~~~~~-----~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 203 ELFDSIL--NDRPHFP-----RWISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred HHHHHHH--cCCCCCC-----CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 3322222 2233333 23556789999999999999999875 454
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=312.82 Aligned_cols=254 Identities=21% Similarity=0.342 Sum_probs=190.3
Q ss_pred ccccceeeeecCeEEEEEEEC--Cc--eeEEEEeeccCc---cchHHHHHHHHHHhccCCCceeeeeeccccCC--cccE
Q psy14889 138 ISLSECIGKGRYGEVWRGVWH--GE--NVAVKIFFSRDE---ASWSRETEIYSTVLLRHENILGYIGSDMTSRN--SCTQ 208 (443)
Q Consensus 138 ~~~~~~lG~G~fg~Vy~~~~~--~~--~vAvK~~~~~~~---~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~--~~~~ 208 (443)
|.+.+.||+|+||.||+|.+. +. .||+|.+..... .......|+..+..++|+||+++++++..... ....
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 356788999999999999983 32 589998754321 11122345555666999999999998754321 1234
Q ss_pred EEeeecccCcccHHHHhc-------ccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEE
Q psy14889 209 LWLVTHYHSFGSLYDHLN-------RTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCV 281 (443)
Q Consensus 209 ~~lv~e~~~~gsL~~~l~-------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~k 281 (443)
.+++|||+++|+|.+++. ...+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+|
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~--------~i~H~dlkp~Nil~~~~~~~k 152 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK--------SFIHRDLAARNCMLNENMNVC 152 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC--------CeeccccchhheEEcCCCCEE
Confidence 689999999999999873 13478999999999999999999998 999999999999999999999
Q ss_pred EEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh-cccCCCcccccCCC
Q psy14889 282 IADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR-RTKANGIFEEYKAP 360 (443)
Q Consensus 282 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt-g~~~~~~~~~~~~P 360 (443)
|+|||+++......... ......+++.|+|||.+.+. .++.++||||||+++|||++ | ..|
T Consensus 153 l~Dfg~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~------~~~~~~Di~slG~il~el~~~g----------~~p 214 (272)
T cd05075 153 VADFGLSKKIYNGDYYR--QGRIAKMPVKWIAIESLADR------VYTTKSDVWSFGVTMWEIATRG----------QTP 214 (272)
T ss_pred ECCCCcccccCccccee--cCCcccCCcccCCHHHccCC------CcChHHHHHHHHHHHHHHHcCC----------CCC
Confidence 99999997664322111 11223456789999998765 66789999999999999999 5 567
Q ss_pred CCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHH
Q psy14889 361 YHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKL 428 (443)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l 428 (443)
|... ........+.. ...+..+ ..++..+.+++.+||+.||++|||+.++++.|+++
T Consensus 215 ~~~~-----~~~~~~~~~~~-~~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 215 YPGV-----ENSEIYDYLRQ-GNRLKQP-----PDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCCC-----CHHHHHHHHHc-CCCCCCC-----CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 7553 11222222221 1222222 23567799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=310.04 Aligned_cols=247 Identities=28% Similarity=0.513 Sum_probs=194.8
Q ss_pred ccccccceeeeecCeEEEEEEECCceeEEEEeeccCccchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEeeecc
Q psy14889 136 KQISLSECIGKGRYGEVWRGVWHGENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVTHY 215 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e~ 215 (443)
++|++.+.||+|+||.||++...|..||+|.+..... ......|+..+..++|+|++++++++.... ...++++||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~lv~e~ 81 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDAT-AQAFLAEASVMTQLRHSNLVQLLGVIVEEK---GGLYIVTEY 81 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCch-HHHHHHHHHHHHhCCCCCeeeEEEEEEcCC---CceEEEEEC
Confidence 5788999999999999999999999999998754322 222344555666699999999999865443 247999999
Q ss_pred cCcccHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCccccc
Q psy14889 216 HSFGSLYDHLNRT---TLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYS 292 (443)
Q Consensus 216 ~~~gsL~~~l~~~---~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~~ 292 (443)
+++|+|.+++... .+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||+++...
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~--------~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~ 153 (256)
T cd05082 82 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN--------NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 153 (256)
T ss_pred CCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CEeccccchheEEEcCCCcEEecCCccceecc
Confidence 9999999998642 478999999999999999999998 99999999999999999999999999987544
Q ss_pred ccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh-cccCCCcccccCCCCCCCCCCCCCh
Q psy14889 293 QLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR-RTKANGIFEEYKAPYHDLVPMDPSF 371 (443)
Q Consensus 293 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt-g~~~~~~~~~~~~P~~~~~~~~~~~ 371 (443)
... ....++..|+|||++.+. .++.++|||||||++|||++ | ..||... ..
T Consensus 154 ~~~-------~~~~~~~~y~aPE~~~~~------~~~~~~Dv~slG~i~~~l~~~g----------~~p~~~~-----~~ 205 (256)
T cd05082 154 STQ-------DTGKLPVKWTAPEALREK------KFSTKSDVWSFGILLWEIYSFG----------RVPYPRI-----PL 205 (256)
T ss_pred ccC-------CCCccceeecCHHHHccC------CCCchhhhHHHHHHHHHHHhCC----------CCCCCCC-----CH
Confidence 321 122345689999998765 66789999999999999998 7 5666542 22
Q ss_pred HHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHH
Q psy14889 372 DDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKL 428 (443)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l 428 (443)
......+... ..+..+ +.++..+.+++.+||+.||++|||+.++++.|+++
T Consensus 206 ~~~~~~~~~~-~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 206 KDVVPRVEKG-YKMDAP-----DGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred HHHHHHHhcC-CCCCCC-----CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 3333333221 122222 34667899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=315.44 Aligned_cols=254 Identities=21% Similarity=0.374 Sum_probs=192.9
Q ss_pred hhccccccceeeeecCeEEEEEEEC-------CceeEEEEeeccCcc--chHHHHHHHHHHhccCCCceeeeeeccccCC
Q psy14889 134 LAKQISLSECIGKGRYGEVWRGVWH-------GENVAVKIFFSRDEA--SWSRETEIYSTVLLRHENILGYIGSDMTSRN 204 (443)
Q Consensus 134 ~~~~~~~~~~lG~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~~--~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~ 204 (443)
..++|++.+.||+|+||.||+|.+. +..||||.+...... ......|+..+..++||||+++++++...
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~-- 81 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG-- 81 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC--
Confidence 3478999999999999999999863 357999987543221 11223455566669999999999998665
Q ss_pred cccEEEeeecccCcccHHHHhcc-----------cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEE
Q psy14889 205 SCTQLWLVTHYHSFGSLYDHLNR-----------TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNIL 273 (443)
Q Consensus 205 ~~~~~~lv~e~~~~gsL~~~l~~-----------~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiL 273 (443)
...++||||+++|+|.+++.+ ..+++..+..++.|++.||.|||+. +++|+||||+||+
T Consensus 82 --~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~--------~~vH~dlkp~Nil 151 (277)
T cd05062 82 --QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN--------KFVHRDLAARNCM 151 (277)
T ss_pred --CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC--------CcccCCcchheEE
Confidence 347999999999999999854 1357788999999999999999998 9999999999999
Q ss_pred EcCCCcEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCc
Q psy14889 274 VKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGI 353 (443)
Q Consensus 274 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~ 353 (443)
+++++.+||+|||+++......... ......++..|+|||.+.+. .++.++|||||||++|||+++.
T Consensus 152 ~~~~~~~~l~dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~~l~el~~~~----- 218 (277)
T cd05062 152 VAEDFTVKIGDFGMTRDIYETDYYR--KGGKGLLPVRWMSPESLKDG------VFTTYSDVWSFGVVLWEIATLA----- 218 (277)
T ss_pred EcCCCCEEECCCCCccccCCcceee--cCCCCccCHhhcChhHhhcC------CcCchhHHHHHHHHHHHHHcCC-----
Confidence 9999999999999987654322211 11223457789999998765 6678999999999999999941
Q ss_pred ccccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHH
Q psy14889 354 FEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIK 427 (443)
Q Consensus 354 ~~~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 427 (443)
..||.+. ........+.. ...+..+ ..++..+.+++.+||+.||++|||+.|+++.|++
T Consensus 219 ----~~p~~~~-----~~~~~~~~~~~-~~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 219 ----EQPYQGM-----SNEQVLRFVME-GGLLDKP-----DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred ----CCCCCCC-----CHHHHHHHHHc-CCcCCCC-----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 5566543 22233332221 1222222 3356789999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=317.44 Aligned_cols=254 Identities=26% Similarity=0.357 Sum_probs=185.3
Q ss_pred ccccccceeeeecCeEEEEEEE---CCceeEEEEeeccCcc-----chHHHHHHHH-HHhccCCCceeeeeeccccC-Cc
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW---HGENVAVKIFFSRDEA-----SWSRETEIYS-TVLLRHENILGYIGSDMTSR-NS 205 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~---~~~~vAvK~~~~~~~~-----~~~~e~ei~~-~~~l~H~nIv~l~g~~~~~~-~~ 205 (443)
++|++.+.||+|+||.||+|+. .++.||+|++...... ...+|.++.. +..++||||+++++++.... ..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 3688999999999999999987 3678999988643221 2223333322 22357999999999875321 12
Q ss_pred ccEEEeeecccCcccHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEE
Q psy14889 206 CTQLWLVTHYHSFGSLYDHLNR---TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVI 282 (443)
Q Consensus 206 ~~~~~lv~e~~~~gsL~~~l~~---~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl 282 (443)
...+++||||+. ++|.+++.. ..+++.++..++.||+.||.|||+. +|+||||||+|||++.++.+||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~--------~iiH~dlkp~Nil~~~~~~~kl 151 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH--------RVVHRDLKPQNILVTSSGQIKL 151 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC--------CeeeCCCCHHHEEEcCCCCEEE
Confidence 245899999997 699998854 4589999999999999999999998 9999999999999999999999
Q ss_pred EecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCC
Q psy14889 283 ADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYH 362 (443)
Q Consensus 283 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~ 362 (443)
+|||+++...... ......||+.|+|||.+.+. .++.++|||||||++|||++| ..||.
T Consensus 152 ~Dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~------~~~~~~DiwslG~il~el~~g----------~~~f~ 210 (290)
T cd07862 152 ADFGLARIYSFQM-----ALTSVVVTLWYRAPEVLLQS------SYATPVDLWSVGCIFAEMFRR----------KPLFR 210 (290)
T ss_pred ccccceEeccCCc-----ccccccccccccChHHHhCC------CCCCccchHHHHHHHHHHHcC----------CCCcC
Confidence 9999997654321 12345689999999998765 667899999999999999999 45554
Q ss_pred CCCCCCCChHHHHhhhhhcCC-------------------CCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 363 DLVPMDPSFDDMRKVICIDQQ-------------------RPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
+.. ..+.+...+..... .+..+........+..+.+++.+||+.||++|||+.|+++
T Consensus 211 ~~~----~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 211 GSS----DVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred CCC----HHHHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 421 11222222111000 0000000001234567899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=311.23 Aligned_cols=249 Identities=25% Similarity=0.443 Sum_probs=193.4
Q ss_pred ccccccceeeeecCeEEEEEEECC-ceeEEEEeeccCccchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEeeec
Q psy14889 136 KQISLSECIGKGRYGEVWRGVWHG-ENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVTH 214 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~vAvK~~~~~~~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e 214 (443)
++|++.+.||+|+||.||+|.+.+ ..+|+|.+............|+..+..++||||+++++++.... .+++|||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~e 79 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQR----PIYIVTE 79 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCC----CcEEEEE
Confidence 578899999999999999998854 46999987654332223345666666799999999999987653 3699999
Q ss_pred ccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCccccc
Q psy14889 215 YHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYS 292 (443)
Q Consensus 215 ~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~~ 292 (443)
|+.+|+|.+++.. ..+++.+++.++.||+.||.|||+. +++|+||||+||+++.++.+||+|||+++...
T Consensus 80 ~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~--------~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~ 151 (256)
T cd05113 80 YMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK--------QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVL 151 (256)
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC--------CeeccccCcceEEEcCCCCEEECCCccceecC
Confidence 9999999999864 3689999999999999999999998 99999999999999999999999999987654
Q ss_pred ccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh-cccCCCcccccCCCCCCCCCCCCCh
Q psy14889 293 QLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR-RTKANGIFEEYKAPYHDLVPMDPSF 371 (443)
Q Consensus 293 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt-g~~~~~~~~~~~~P~~~~~~~~~~~ 371 (443)
...... .....++..|+|||.+.+. .++.++||||||+++|||++ | ..||.... .
T Consensus 152 ~~~~~~---~~~~~~~~~y~~pe~~~~~------~~~~~~Di~slG~~l~~l~~~g----------~~p~~~~~-----~ 207 (256)
T cd05113 152 DDEYTS---SVGSKFPVRWSPPEVLLYS------KFSSKSDVWAFGVLMWEVYSLG----------KMPYERFN-----N 207 (256)
T ss_pred CCceee---cCCCccChhhCCHHHHhcC------cccchhHHHHHHHHHHHHhcCC----------CCCcCcCC-----H
Confidence 322111 1223456789999999765 56689999999999999998 7 56665431 1
Q ss_pred HHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHH
Q psy14889 372 DDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLI 426 (443)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 426 (443)
......+.. ..++..+ ...+..+.+++.+||+.||.+|||+.++++.|+
T Consensus 208 ~~~~~~~~~-~~~~~~~-----~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 208 SETVEKVSQ-GLRLYRP-----HLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred HHHHHHHhc-CCCCCCC-----CCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 222222221 2222222 224578999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=317.32 Aligned_cols=252 Identities=22% Similarity=0.294 Sum_probs=186.9
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc--chHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEe
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA--SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWL 211 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~--~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~l 211 (443)
++|++.+.||+|+||.||+|.. ++..||+|++...... ......|+..+..++||||+++++++.+. ...++
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~----~~~~l 80 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTE----RCLTL 80 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCC----CeEEE
Confidence 5799999999999999999987 5789999988643221 22233566666679999999999998765 35799
Q ss_pred eecccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcc
Q psy14889 212 VTHYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAV 289 (443)
Q Consensus 212 v~e~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~ 289 (443)
||||++ |+|.+++.. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 81 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~--------~ivH~dlkp~Nil~~~~~~~kl~DfG~~~ 151 (288)
T cd07871 81 VFEYLD-SDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR--------KILHRDLKPQNLLINEKGELKLADFGLAR 151 (288)
T ss_pred EEeCCC-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC--------CcccCCCCHHHEEECCCCCEEECcCccee
Confidence 999998 499998854 3478999999999999999999998 99999999999999999999999999987
Q ss_pred cccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCC
Q psy14889 290 SYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDP 369 (443)
Q Consensus 290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~ 369 (443)
....... ......||+.|+|||.+.+.. .++.++|||||||++|||+|| ..||....
T Consensus 152 ~~~~~~~----~~~~~~~~~~y~aPE~~~~~~-----~~~~~~DiwslG~~l~~l~~g----------~~pf~~~~---- 208 (288)
T cd07871 152 AKSVPTK----TYSNEVVTLWYRPPDVLLGST-----EYSTPIDMWGVGCILYEMATG----------RPMFPGST---- 208 (288)
T ss_pred eccCCCc----cccCceecccccChHHhcCCc-----ccCcHHHHHHHHHHHHHHHhC----------CCCCCCCC----
Confidence 5432211 123346889999999986531 466899999999999999999 44554321
Q ss_pred ChHHHHhhhhhcCC----------------CCCCCC----CC--CCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 370 SFDDMRKVICIDQQ----------------RPVLPN----RW--VSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 370 ~~~~~~~~~~~~~~----------------~~~~~~----~~--~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
..+.+......... ....+. .+ .....+.++.+|+.+||+.||.+|||++|+++
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 209 VKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred HHHHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 01111111000000 000000 00 01124567899999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=316.24 Aligned_cols=256 Identities=25% Similarity=0.378 Sum_probs=198.1
Q ss_pred ccccccceeeeecCeEEEEEEEC-------CceeEEEEeeccCcc-chHHHHHHHHHHhccCCCceeeeeeccccCCccc
Q psy14889 136 KQISLSECIGKGRYGEVWRGVWH-------GENVAVKIFFSRDEA-SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCT 207 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~~-~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~ 207 (443)
.+|.+.+.||+|+||.||+|+.. +..+++|.+...... ....+.|+..+..++|+||+++++++... .
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----~ 80 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDG----D 80 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccC----C
Confidence 56888999999999999999852 346888987544322 12234566666669999999999998765 3
Q ss_pred EEEeeecccCcccHHHHhcc-----------------cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCC
Q psy14889 208 QLWLVTHYHSFGSLYDHLNR-----------------TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSK 270 (443)
Q Consensus 208 ~~~lv~e~~~~gsL~~~l~~-----------------~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~ 270 (443)
..++||||+++++|.+++.. ..+++..++.++.||+.||+|||++ +|+||||||+
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~--------~i~H~dlkp~ 152 (291)
T cd05094 81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ--------HFVHRDLATR 152 (291)
T ss_pred ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC--------CeeecccCcc
Confidence 47999999999999999853 2378999999999999999999998 9999999999
Q ss_pred CEEEcCCCcEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh-ccc
Q psy14889 271 NILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR-RTK 349 (443)
Q Consensus 271 NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt-g~~ 349 (443)
|||++.++.+||+|||++......... .......++..|+|||.+.+. .++.++||||||+++|||+| |
T Consensus 153 Nil~~~~~~~~l~dfg~a~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~il~el~t~g-- 222 (291)
T cd05094 153 NCLVGANLLVKIGDFGMSRDVYSTDYY--RVGGHTMLPIRWMPPESIMYR------KFTTESDVWSFGVILWEIFTYG-- 222 (291)
T ss_pred eEEEccCCcEEECCCCcccccCCCcee--ecCCCCCcceeecChHHhccC------CCCchhhHHHHHHHHHHHHhCC--
Confidence 999999999999999999765432211 111234567889999998766 66789999999999999999 7
Q ss_pred CCCcccccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHh
Q psy14889 350 ANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLA 429 (443)
Q Consensus 350 ~~~~~~~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~ 429 (443)
..||.... .......+. ....+..+ ..++..+.+++.+||+.||++|||+.+|++.|+++.
T Consensus 223 --------~~p~~~~~-----~~~~~~~~~-~~~~~~~~-----~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~ 283 (291)
T cd05094 223 --------KQPWFQLS-----NTEVIECIT-QGRVLERP-----RVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALG 283 (291)
T ss_pred --------CCCCCCCC-----HHHHHHHHh-CCCCCCCC-----ccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence 66765532 122222221 11222222 235678999999999999999999999999999997
Q ss_pred hcc
Q psy14889 430 CAD 432 (443)
Q Consensus 430 ~~~ 432 (443)
...
T Consensus 284 ~~~ 286 (291)
T cd05094 284 KAT 286 (291)
T ss_pred hhc
Confidence 654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=315.20 Aligned_cols=251 Identities=22% Similarity=0.380 Sum_probs=193.7
Q ss_pred ccccccceeeeecCeEEEEEEE------CCceeEEEEeeccCccc--hHHHHHHHHHHhccCCCceeeeeeccccCCccc
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW------HGENVAVKIFFSRDEAS--WSRETEIYSTVLLRHENILGYIGSDMTSRNSCT 207 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~------~~~~vAvK~~~~~~~~~--~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~ 207 (443)
++|++.+.||+|+||.||+|.+ .+..||+|.+....... ...+.|+..+..++||||+++++++....
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---- 80 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ---- 80 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC----
Confidence 5788899999999999999985 35689999886433221 22345666666799999999999987663
Q ss_pred EEEeeecccCcccHHHHhcc------------------cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCC
Q psy14889 208 QLWLVTHYHSFGSLYDHLNR------------------TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKS 269 (443)
Q Consensus 208 ~~~lv~e~~~~gsL~~~l~~------------------~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~ 269 (443)
..++||||+++|+|.+++.. ..+++.+++.++.|++.||.|||+. +++||||||
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~--------~i~H~dlkp 152 (283)
T cd05090 81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH--------FFVHKDLAA 152 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc--------Ceehhcccc
Confidence 46999999999999999842 2478889999999999999999998 999999999
Q ss_pred CCEEEcCCCcEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh-cc
Q psy14889 270 KNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR-RT 348 (443)
Q Consensus 270 ~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt-g~ 348 (443)
+|||+++++.+||+|||+++......... ......++..|+|||.+.+. .++.++||||||+++|||++ |
T Consensus 153 ~nili~~~~~~kl~dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~------~~~~~~Dv~slG~il~el~~~g- 223 (283)
T cd05090 153 RNILIGEQLHVKISDLGLSREIYSADYYR--VQPKSLLPIRWMPPEAIMYG------KFSSDSDIWSFGVVLWEIFSFG- 223 (283)
T ss_pred ceEEEcCCCcEEeccccccccccCCccee--cccCCCccceecChHHhccC------CCCchhhhHHHHHHHHHHHcCC-
Confidence 99999999999999999997654322111 11233466789999998765 56789999999999999998 6
Q ss_pred cCCCcccccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHH
Q psy14889 349 KANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIK 427 (443)
Q Consensus 349 ~~~~~~~~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 427 (443)
..||... ....+...+... ..+..+ ..++..+.+++.+||+.||++||++.+|++.|..
T Consensus 224 ---------~~p~~~~-----~~~~~~~~~~~~-~~~~~~-----~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 224 ---------LQPYYGF-----SNQEVIEMVRKR-QLLPCS-----EDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred ---------CCCCCCC-----CHHHHHHHHHcC-CcCCCC-----CCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 5676553 122333333221 112222 3366789999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=324.47 Aligned_cols=249 Identities=23% Similarity=0.341 Sum_probs=189.0
Q ss_pred cccccceeeeecCeEEEEEEE-----CCceeEEEEeeccCc-----cchHHHHHHHHHHhc-cCCCceeeeeeccccCCc
Q psy14889 137 QISLSECIGKGRYGEVWRGVW-----HGENVAVKIFFSRDE-----ASWSRETEIYSTVLL-RHENILGYIGSDMTSRNS 205 (443)
Q Consensus 137 ~~~~~~~lG~G~fg~Vy~~~~-----~~~~vAvK~~~~~~~-----~~~~~e~ei~~~~~l-~H~nIv~l~g~~~~~~~~ 205 (443)
+|++.+.||+|+||.||+++. +++.||+|++..... .......|+..+..+ +|+||+++++++...
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~--- 77 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTE--- 77 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecC---
Confidence 478899999999999999875 478999998864321 111223444445456 599999999988765
Q ss_pred ccEEEeeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEe
Q psy14889 206 CTQLWLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIAD 284 (443)
Q Consensus 206 ~~~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~D 284 (443)
..+++||||+++|+|.+++.+ ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|
T Consensus 78 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~--------~ivHrDlkp~Nili~~~~~~kl~D 148 (332)
T cd05614 78 -AKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKL--------GIVYRDIKLENILLDSEGHVVLTD 148 (332)
T ss_pred -CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC--------CcEecCCCHHHeEECCCCCEEEee
Confidence 457999999999999999854 5799999999999999999999998 999999999999999999999999
Q ss_pred cCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCC
Q psy14889 285 FGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDL 364 (443)
Q Consensus 285 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~ 364 (443)
||+++........ ......||+.|+|||++.+.. .++.++|||||||++|||+|| ..||...
T Consensus 149 fG~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~-----~~~~~~DiwslG~il~elltg----------~~pf~~~ 210 (332)
T cd05614 149 FGLSKEFLSEEKE---RTYSFCGTIEYMAPEIIRGKG-----GHGKAVDWWSLGILIFELLTG----------ASPFTLE 210 (332)
T ss_pred CcCCccccccCCC---ccccccCCccccCHHHhcCCC-----CCCCccccccchhhhhhhhcC----------CCCCCCC
Confidence 9999765332211 122357999999999987542 355789999999999999999 6666532
Q ss_pred CCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCC-----cHHHHHH
Q psy14889 365 VPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRL-----SALRVKK 423 (443)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~ 423 (443)
.. ......+...+. ...+.++ ...+..+.+++.+||+.||++|| +++++++
T Consensus 211 ~~-~~~~~~~~~~~~--~~~~~~~-----~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 211 GE-RNTQSEVSRRIL--KCDPPFP-----SFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred CC-CCCHHHHHHHHh--cCCCCCC-----CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 21 112223322221 1223333 23556799999999999999999 7777765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=322.92 Aligned_cols=238 Identities=26% Similarity=0.383 Sum_probs=185.8
Q ss_pred ceeeeecCeEEEEEEE-----CCceeEEEEeeccCc-----cchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEe
Q psy14889 142 ECIGKGRYGEVWRGVW-----HGENVAVKIFFSRDE-----ASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWL 211 (443)
Q Consensus 142 ~~lG~G~fg~Vy~~~~-----~~~~vAvK~~~~~~~-----~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~l 211 (443)
+.||+|+||.||+++. .++.||||++..... .......|+..+..++||||+++++++... ..+++
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~----~~~~l 77 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTG----GKLYL 77 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecC----CeEEE
Confidence 6799999999999975 467899999864321 112224556666669999999999998766 45899
Q ss_pred eecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCccc
Q psy14889 212 VTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVS 290 (443)
Q Consensus 212 v~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~ 290 (443)
||||+++|+|.+++.+ ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--------~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 149 (323)
T cd05584 78 ILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQ--------GIIYRDLKPENILLDAQGHVKLTDFGLCKE 149 (323)
T ss_pred EEeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC--------CeecCCCCHHHeEECCCCCEEEeeCcCCee
Confidence 9999999999999864 5678899999999999999999998 999999999999999999999999999865
Q ss_pred ccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCC
Q psy14889 291 YSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPS 370 (443)
Q Consensus 291 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~ 370 (443)
...... ......||+.|+|||++.+. .++.++|||||||++|||++| ..||.... .
T Consensus 150 ~~~~~~----~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~ell~G----------~~pf~~~~----~ 205 (323)
T cd05584 150 SIHEGT----VTHTFCGTIEYMAPEILMRS------GHGKAVDWWSLGALMYDMLTG----------APPFTAEN----R 205 (323)
T ss_pred cccCCC----cccccCCCccccChhhccCC------CCCCcceecccHHHHHHHhcC----------CCCCCCCC----H
Confidence 432211 12335799999999999765 566899999999999999999 66776531 1
Q ss_pred hHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCC-----cHHHHHH
Q psy14889 371 FDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRL-----SALRVKK 423 (443)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~ 423 (443)
........ .....++ ...+..+.+++.+||+.||++|| ++.++++
T Consensus 206 ~~~~~~~~---~~~~~~~-----~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 206 KKTIDKIL---KGKLNLP-----PYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred HHHHHHHH---cCCCCCC-----CCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 12222222 1222233 23556799999999999999999 7888766
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0580|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-42 Score=297.09 Aligned_cols=241 Identities=26% Similarity=0.426 Sum_probs=197.7
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCc------cchHHHHHHHHHHhccCCCceeeeeeccccCCccc
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDE------ASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCT 207 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~------~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~ 207 (443)
++|++.+.||+|-||.||.|+. ++-.||+|++.+... ....+|.||. ..|+||||+++|+++.+. .
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIq--s~L~hpnilrlY~~fhd~----~ 95 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQ--SHLRHPNILRLYGYFHDS----K 95 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEee--cccCCccHHhhhhheecc----c
Confidence 6899999999999999999998 467899999866432 2333344444 449999999999999988 4
Q ss_pred EEEeeecccCcccHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEe
Q psy14889 208 QLWLVTHYHSFGSLYDHLNR---TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIAD 284 (443)
Q Consensus 208 ~~~lv~e~~~~gsL~~~l~~---~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~D 284 (443)
..||++||.+.|+|...|.. .++++.....++.|+|.||.|+|.. ++|||||||+|+|++..+.+||+|
T Consensus 96 riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k--------~VIhRdiKpenlLlg~~~~lkiAd 167 (281)
T KOG0580|consen 96 RIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLK--------RVIHRDIKPENLLLGSAGELKIAD 167 (281)
T ss_pred eeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccC--------CcccCCCCHHHhccCCCCCeeccC
Confidence 58999999999999999973 4699999999999999999999988 999999999999999999999999
Q ss_pred cCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCC
Q psy14889 285 FGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDL 364 (443)
Q Consensus 285 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~ 364 (443)
||-+..-.. + ...+.+||..|.+||+..+. ..+...|+|++|++.||++.| ..||...
T Consensus 168 fGwsV~~p~--~----kR~tlcgt~dyl~pEmv~~~------~hd~~Vd~w~lgvl~yeflvg----------~ppFes~ 225 (281)
T KOG0580|consen 168 FGWSVHAPS--N----KRKTLCGTLDYLPPEMVEGR------GHDKFVDLWSLGVLCYEFLVG----------LPPFESQ 225 (281)
T ss_pred CCceeecCC--C----CceeeecccccCCHhhcCCC------CccchhhHHHHHHHHHHHHhc----------CCchhhh
Confidence 999865442 1 22567999999999999987 666899999999999999999 6777764
Q ss_pred CCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHH
Q psy14889 365 VPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKT 424 (443)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 424 (443)
. ..+..+++...+ ..+| ..++.++.++|.+|+..+|.+|.+..|+++.
T Consensus 226 ~----~~etYkrI~k~~---~~~p-----~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 226 S----HSETYKRIRKVD---LKFP-----STISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred h----hHHHHHHHHHcc---ccCC-----cccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 3 222333333222 2233 3466789999999999999999999998763
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=315.17 Aligned_cols=251 Identities=25% Similarity=0.401 Sum_probs=195.0
Q ss_pred ccccccceeeeecCeEEEEEEEC-------CceeEEEEeeccCcc--chHHHHHHHHHHhccCCCceeeeeeccccCCcc
Q psy14889 136 KQISLSECIGKGRYGEVWRGVWH-------GENVAVKIFFSRDEA--SWSRETEIYSTVLLRHENILGYIGSDMTSRNSC 206 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~~--~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~ 206 (443)
++|.+.+.||+|+||.||+|... +..||||.+...... ......|+..+..++|+||+++++++...
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---- 80 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEG---- 80 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecC----
Confidence 57889999999999999999762 368999988654332 22334555566669999999999998776
Q ss_pred cEEEeeecccCcccHHHHhcc---------------cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCC
Q psy14889 207 TQLWLVTHYHSFGSLYDHLNR---------------TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKN 271 (443)
Q Consensus 207 ~~~~lv~e~~~~gsL~~~l~~---------------~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~N 271 (443)
...++||||+++|+|.+++.. ..+++..+..++.|++.||.|||+. +++||||||+|
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~--------~i~h~dlkp~n 152 (280)
T cd05049 81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ--------HFVHRDLATRN 152 (280)
T ss_pred CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC--------Ceeccccccce
Confidence 347999999999999999853 2378889999999999999999998 99999999999
Q ss_pred EEEcCCCcEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh-cccC
Q psy14889 272 ILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR-RTKA 350 (443)
Q Consensus 272 iLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt-g~~~ 350 (443)
|+++.++.+||+|||+++........ .......+++.|+|||++.+. .++.++||||||+++|||++ |
T Consensus 153 ili~~~~~~kl~d~g~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~il~e~~~~g--- 221 (280)
T cd05049 153 CLVGYDLVVKIGDFGMSRDVYTTDYY--RVGGHTMLPIRWMPPESIMYR------KFTTESDVWSFGVVLWEIFTYG--- 221 (280)
T ss_pred EEEcCCCeEEECCcccceecccCcce--ecCCCCcccceecChhhhccC------CcchhhhHHHHHHHHHHHHhcC---
Confidence 99999999999999998754332111 111233467889999999876 67789999999999999998 7
Q ss_pred CCcccccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHH
Q psy14889 351 NGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIK 427 (443)
Q Consensus 351 ~~~~~~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 427 (443)
..||.+.. .......+. ....+..+ ...+..+.+++.+||+.||++||++.|+++.|++
T Consensus 222 -------~~p~~~~~-----~~~~~~~~~-~~~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 222 -------KQPWYGLS-----NEEVIECIT-QGRLLQRP-----RTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred -------CCCCCCCC-----HHHHHHHHH-cCCcCCCC-----CCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 66776532 222222222 11111112 2356789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=321.64 Aligned_cols=233 Identities=25% Similarity=0.366 Sum_probs=180.3
Q ss_pred ceeeeecCeEEEEEEE--CCceeEEEEeeccC----ccchHHHHHHHHHHh-ccCCCceeeeeeccccCCcccEEEeeec
Q psy14889 142 ECIGKGRYGEVWRGVW--HGENVAVKIFFSRD----EASWSRETEIYSTVL-LRHENILGYIGSDMTSRNSCTQLWLVTH 214 (443)
Q Consensus 142 ~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~----~~~~~~e~ei~~~~~-l~H~nIv~l~g~~~~~~~~~~~~~lv~e 214 (443)
+.||+|+||.||+|+. +++.||||++.... ........|+..+.. .+||||+++++++... ..+++|||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~----~~~~iv~E 76 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTP----DRLFFVME 76 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcC----CEEEEEEc
Confidence 4699999999999998 57899999886432 111111223333332 4799999999998766 45899999
Q ss_pred ccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcccccc
Q psy14889 215 YHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQ 293 (443)
Q Consensus 215 ~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~~~ 293 (443)
|+++|+|.+++.+ ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 77 y~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~--------~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~ 148 (320)
T cd05590 77 FVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDK--------GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF 148 (320)
T ss_pred CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC--------CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCc
Confidence 9999999998864 5799999999999999999999998 999999999999999999999999999865322
Q ss_pred cCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCChHH
Q psy14889 294 LSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFDD 373 (443)
Q Consensus 294 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~~~~ 373 (443)
... ......||+.|+|||++.+. .++.++|||||||++|||++| ..||... ....
T Consensus 149 ~~~----~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~el~~g----------~~Pf~~~-----~~~~ 203 (320)
T cd05590 149 NGK----TTSTFCGTPDYIAPEILQEM------LYGPSVDWWAMGVLLYEMLCG----------HAPFEAE-----NEDD 203 (320)
T ss_pred CCC----cccccccCccccCHHHHcCC------CCCCccchhhhHHHHHHHhhC----------CCCCCCC-----CHHH
Confidence 111 12345799999999999765 667899999999999999999 6777653 2233
Q ss_pred HHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcH
Q psy14889 374 MRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSA 418 (443)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~ 418 (443)
+...+.. .....+ ...+.++.+++.+||+.||++||++
T Consensus 204 ~~~~i~~--~~~~~~-----~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 204 LFEAILN--DEVVYP-----TWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred HHHHHhc--CCCCCC-----CCCCHHHHHHHHHHcccCHHHCCCC
Confidence 3333321 222222 2255679999999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=329.23 Aligned_cols=255 Identities=24% Similarity=0.434 Sum_probs=195.4
Q ss_pred hccccccceeeeecCeEEEEEEEC-------CceeEEEEeeccCccc--hHHHHHHHHHHhcc-CCCceeeeeeccccCC
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVWH-------GENVAVKIFFSRDEAS--WSRETEIYSTVLLR-HENILGYIGSDMTSRN 204 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~~~--~~~e~ei~~~~~l~-H~nIv~l~g~~~~~~~ 204 (443)
.++|.+.+.||+|+||.||+|.+. ++.||||++....... .....|+..+..+. ||||+++++++....
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~- 114 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG- 114 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC-
Confidence 467889999999999999999864 3579999986542221 12234555555576 999999999987763
Q ss_pred cccEEEeeecccCcccHHHHhccc--------------------------------------------------------
Q psy14889 205 SCTQLWLVTHYHSFGSLYDHLNRT-------------------------------------------------------- 228 (443)
Q Consensus 205 ~~~~~~lv~e~~~~gsL~~~l~~~-------------------------------------------------------- 228 (443)
.+++||||+++|+|.+++++.
T Consensus 115 ---~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 115 ---PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred ---CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 479999999999999998531
Q ss_pred -------------------------------------------CCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEe
Q psy14889 229 -------------------------------------------TLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHR 265 (443)
Q Consensus 229 -------------------------------------------~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHr 265 (443)
.+++..++.++.|++.||+|||+. +++||
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~--------~ivHr 263 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK--------NCVHR 263 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC--------CcCcc
Confidence 256777889999999999999988 99999
Q ss_pred CCCCCCEEEcCCCcEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHH
Q psy14889 266 DIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVC 345 (443)
Q Consensus 266 Dlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ell 345 (443)
||||+|||+++++.+||+|||+++......... ......++..|+|||.+... .++.++||||||+++|||+
T Consensus 264 dlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~------~~~~~~DvwslGvil~e~l 335 (401)
T cd05107 264 DLAARNVLICEGKLVKICDFGLARDIMRDSNYI--SKGSTFLPLKWMAPESIFNN------LYTTLSDVWSFGILLWEIF 335 (401)
T ss_pred cCCcceEEEeCCCEEEEEecCcceecccccccc--cCCCcCCCCceeChHHhcCC------CCCcHhHHHHHHHHHHHHH
Confidence 999999999999999999999997654322111 11234577899999998765 5678999999999999999
Q ss_pred h-cccCCCcccccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHH
Q psy14889 346 R-RTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKT 424 (443)
Q Consensus 346 t-g~~~~~~~~~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 424 (443)
+ | ..||.... ..+.....+. ...++..+ ..++.++.+++.+||+.+|.+||++.+|++.
T Consensus 336 ~~g----------~~P~~~~~----~~~~~~~~~~-~~~~~~~p-----~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 336 TLG----------GTPYPELP----MNEQFYNAIK-RGYRMAKP-----AHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred HcC----------CCCCCCCC----chHHHHHHHH-cCCCCCCC-----CCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 8 6 56665431 2222222222 22223332 2356789999999999999999999999999
Q ss_pred HHHHh
Q psy14889 425 LIKLA 429 (443)
Q Consensus 425 L~~l~ 429 (443)
|+++.
T Consensus 396 L~~~~ 400 (401)
T cd05107 396 VGDLL 400 (401)
T ss_pred HHHHh
Confidence 99875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=320.62 Aligned_cols=236 Identities=23% Similarity=0.371 Sum_probs=183.1
Q ss_pred ceeeeecCeEEEEEEE--CCceeEEEEeeccC----cc--chHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEeee
Q psy14889 142 ECIGKGRYGEVWRGVW--HGENVAVKIFFSRD----EA--SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVT 213 (443)
Q Consensus 142 ~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~----~~--~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv~ 213 (443)
+.||+|+||.||+|.. +|+.||+|++.... .. ....|.++... .++||||+++++++.+. ..+++||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~-~~~~~~i~~~~~~~~~~----~~~~lv~ 75 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLAL-AWENPFLTHLYCTFQTK----EHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHh-ccCCCCccCeeEEEEeC----CEEEEEE
Confidence 4699999999999998 57899999986532 11 12223333322 25899999999998766 4689999
Q ss_pred cccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCccccc
Q psy14889 214 HYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYS 292 (443)
Q Consensus 214 e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~~ 292 (443)
||+.+|+|..++.. ..+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 76 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~--------~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~ 147 (316)
T cd05620 76 EFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSK--------GIIYRDLKLDNVMLDRDGHIKIADFGMCKENV 147 (316)
T ss_pred CCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC--------CeEecCCCHHHeEECCCCCEEeCccCCCeecc
Confidence 99999999998865 5789999999999999999999998 99999999999999999999999999986432
Q ss_pred ccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCChH
Q psy14889 293 QLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFD 372 (443)
Q Consensus 293 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~~~ 372 (443)
.... ......||+.|+|||++.+. .++.++|||||||++|||++| ..||... ...
T Consensus 148 ~~~~----~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslGvil~el~~g----------~~Pf~~~-----~~~ 202 (316)
T cd05620 148 FGDN----RASTFCGTPDYIAPEILQGL------KYTFSVDWWSFGVLLYEMLIG----------QSPFHGD-----DED 202 (316)
T ss_pred cCCC----ceeccCCCcCccCHHHHcCC------CCCcccchhhhHHHHHHHHhC----------CCCCCCC-----CHH
Confidence 1111 12345799999999999876 677899999999999999999 7777653 222
Q ss_pred HHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHH-HHH
Q psy14889 373 DMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSAL-RVK 422 (443)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~-evl 422 (443)
...+.+. ...+..+. ..+.++.+++.+||+.||++||++. +++
T Consensus 203 ~~~~~~~--~~~~~~~~-----~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 203 ELFESIR--VDTPHYPR-----WITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred HHHHHHH--hCCCCCCC-----CCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 3333222 12233332 2456799999999999999999974 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=310.02 Aligned_cols=251 Identities=24% Similarity=0.386 Sum_probs=195.1
Q ss_pred hccccccceeeeecCeEEEEEEEC-CceeEEEEeeccCccchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEeee
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVWH-GENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVT 213 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv~ 213 (443)
.++|++.+.||+|+||.||+|.+. +..||+|++............|+..+..++||||+++++.+... ..++||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~-----~~~lv~ 79 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE-----PIYIVT 79 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEECCC-----CcEEEE
Confidence 367999999999999999999884 45799998865433333334556666669999999999986433 358999
Q ss_pred cccCcccHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCccc
Q psy14889 214 HYHSFGSLYDHLNR---TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVS 290 (443)
Q Consensus 214 e~~~~gsL~~~l~~---~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~ 290 (443)
||+++|+|.+++.+ ..+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++.
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~--------~i~H~dl~p~Nill~~~~~~~L~dfg~~~~ 151 (262)
T cd05071 80 EYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM--------NYVHRDLRAANILVGENLVCKVADFGLARL 151 (262)
T ss_pred EcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHC--------CccccccCcccEEEcCCCcEEeccCCceee
Confidence 99999999999964 3588999999999999999999998 999999999999999999999999999976
Q ss_pred ccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh-cccCCCcccccCCCCCCCCCCCC
Q psy14889 291 YSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR-RTKANGIFEEYKAPYHDLVPMDP 369 (443)
Q Consensus 291 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt-g~~~~~~~~~~~~P~~~~~~~~~ 369 (443)
+....... .....++..|+|||...+. .++.++||||||+++|||+| | ..||....
T Consensus 152 ~~~~~~~~---~~~~~~~~~y~~PE~~~~~------~~~~~~DvwslG~~l~ellt~g----------~~p~~~~~---- 208 (262)
T cd05071 152 IEDNEYTA---RQGAKFPIKWTAPEAALYG------RFTIKSDVWSFGILLTELTTKG----------RVPYPGMV---- 208 (262)
T ss_pred cccccccc---ccCCcccceecCHhHhccC------CCCchhhHHHHHHHHHHHHcCC----------CCCCCCCC----
Confidence 64322111 1223466789999988765 66789999999999999999 5 56665532
Q ss_pred ChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHH
Q psy14889 370 SFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKL 428 (443)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l 428 (443)
.......+.. ...... ...++..+.+++.+||+.||++|||+.++++.|+..
T Consensus 209 -~~~~~~~~~~-~~~~~~-----~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 209 -NREVLDQVER-GYRMPC-----PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred -hHHHHHHHhc-CCCCCC-----ccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 1222222211 111111 134667899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=311.93 Aligned_cols=251 Identities=24% Similarity=0.448 Sum_probs=199.6
Q ss_pred hccccccceeeeecCeEEEEEEE-CCceeEEEEeeccCc-cchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEee
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVW-HGENVAVKIFFSRDE-ASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLV 212 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~-~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv 212 (443)
..+|++.+.||+|+||.||+|.+ .+..+|+|.+..... .....+.|+..+..++|+||+++++++.... ..++|
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~~lv 80 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGE----PVYII 80 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCC----CeEEE
Confidence 35799999999999999999998 578899998865543 2233455666777799999999999987663 47999
Q ss_pred ecccCcccHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcc
Q psy14889 213 THYHSFGSLYDHLNR---TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAV 289 (443)
Q Consensus 213 ~e~~~~gsL~~~l~~---~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~ 289 (443)
|||+++|+|.+++.+ ..+++..+..++.|++.||.|||+. +++|+||||+||++++++.+||+|||++.
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~--------~i~h~dl~~~nilv~~~~~~kl~d~g~~~ 152 (261)
T cd05148 81 TELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ--------NSIHRDLAARNILVGEDLVCKVADFGLAR 152 (261)
T ss_pred EeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC--------CeeccccCcceEEEcCCceEEEccccchh
Confidence 999999999999964 4589999999999999999999998 99999999999999999999999999997
Q ss_pred cccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh-cccCCCcccccCCCCCCCCCCC
Q psy14889 290 SYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR-RTKANGIFEEYKAPYHDLVPMD 368 (443)
Q Consensus 290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt-g~~~~~~~~~~~~P~~~~~~~~ 368 (443)
........ .....++..|+|||.+... .++.++||||||+++|||++ | ..||....
T Consensus 153 ~~~~~~~~----~~~~~~~~~~~~PE~~~~~------~~~~~~DiwslG~~l~~l~~~g----------~~p~~~~~--- 209 (261)
T cd05148 153 LIKEDVYL----SSDKKIPYKWTAPEAASHG------TFSTKSDVWSFGILLYEMFTYG----------QVPYPGMN--- 209 (261)
T ss_pred hcCCcccc----ccCCCCceEecCHHHHccC------CCCchhhHHHHHHHHHHHHcCC----------CCCCCcCC---
Confidence 66432211 1233456789999998765 56689999999999999998 6 66776532
Q ss_pred CChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHH
Q psy14889 369 PSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKL 428 (443)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l 428 (443)
..+....+. ...++..+ ..++..+.+++.+||+.||++|||+.++++.|+.+
T Consensus 210 --~~~~~~~~~-~~~~~~~~-----~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 210 --NHEVYDQIT-AGYRMPCP-----AKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred --HHHHHHHHH-hCCcCCCC-----CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 222222222 12222222 34667899999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=308.58 Aligned_cols=247 Identities=28% Similarity=0.500 Sum_probs=198.2
Q ss_pred ccccccceeeeecCeEEEEEEECCceeEEEEeeccCccchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEeeecc
Q psy14889 136 KQISLSECIGKGRYGEVWRGVWHGENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVTHY 215 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e~ 215 (443)
++|++.+.||+|+||.||+|...|+.||+|.+............|+..+..++|+||+++++++.+. ...++||||
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----~~~~~v~e~ 81 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQG----NPLYIVTEY 81 (256)
T ss_pred hhccceeeeecCCCceEEEEEecCcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCC----CCeEEEEEe
Confidence 5789999999999999999999999999999866544233334566666679999999999998764 347999999
Q ss_pred cCcccHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCccccc
Q psy14889 216 HSFGSLYDHLNRT---TLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYS 292 (443)
Q Consensus 216 ~~~gsL~~~l~~~---~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~~ 292 (443)
+++++|.+++... .+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||+++...
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~--------~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~ 153 (256)
T cd05039 82 MAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK--------NFVHRDLAARNVLVSEDLVAKVSDFGLAKEAS 153 (256)
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CccchhcccceEEEeCCCCEEEcccccccccc
Confidence 9999999999653 589999999999999999999998 99999999999999999999999999997663
Q ss_pred ccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh-cccCCCcccccCCCCCCCCCCCCCh
Q psy14889 293 QLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR-RTKANGIFEEYKAPYHDLVPMDPSF 371 (443)
Q Consensus 293 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt-g~~~~~~~~~~~~P~~~~~~~~~~~ 371 (443)
.... ...++..|+|||.+... .++.++||||||+++||+++ | ..||... ..
T Consensus 154 ~~~~-------~~~~~~~~~ape~~~~~------~~~~~~Di~slG~il~~l~~~g----------~~p~~~~-----~~ 205 (256)
T cd05039 154 QGQD-------SGKLPVKWTAPEALREK------KFSTKSDVWSFGILLWEIYSFG----------RVPYPRI-----PL 205 (256)
T ss_pred cccc-------cCCCcccccCchhhcCC------cCCcHHHHHHHHHHHHHHHhcC----------CCCCCCC-----CH
Confidence 2211 12345679999998765 56679999999999999997 7 5666543 22
Q ss_pred HHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHH
Q psy14889 372 DDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKL 428 (443)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l 428 (443)
..+...+.. ..+...+ ...+..+.+++.+||..+|++|||+.++++.|+.+
T Consensus 206 ~~~~~~~~~-~~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 206 KDVVPHVEK-GYRMEAP-----EGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred HHHHHHHhc-CCCCCCc-----cCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 333333221 1222222 33567899999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=320.95 Aligned_cols=194 Identities=25% Similarity=0.345 Sum_probs=161.6
Q ss_pred hccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc--chHHHHHHHHHHhccCCCceeeeeeccccCCcccEEE
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA--SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLW 210 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~--~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~ 210 (443)
.++|++.+.||+|+||.||++.+ ++..+|+|++...... ......|+..+..++||||+++++++.+. ..++
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----~~~~ 79 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD----GEIS 79 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEEC----CEEE
Confidence 47899999999999999999998 5788999987653221 22334566666679999999999998876 4689
Q ss_pred eeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcc
Q psy14889 211 LVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAV 289 (443)
Q Consensus 211 lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~ 289 (443)
+||||+++|+|.+++.+ ..+++..+..++.|++.||.|||+.. +|+||||||+|||++.++.+||+|||++.
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~-------~ivH~dlkp~Nili~~~~~~kL~Dfg~~~ 152 (333)
T cd06650 80 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH-------KIMHRDVKPSNILVNSRGEIKLCDFGVSG 152 (333)
T ss_pred EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcC-------CEEecCCChhhEEEcCCCCEEEeeCCcch
Confidence 99999999999999865 56889999999999999999999741 79999999999999999999999999987
Q ss_pred cccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCC
Q psy14889 290 SYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKAN 351 (443)
Q Consensus 290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~ 351 (443)
.+.... .....||..|+|||++.+. .++.++|||||||++|||++|+.|+
T Consensus 153 ~~~~~~------~~~~~~~~~y~aPE~~~~~------~~~~~~DvwslG~il~~l~~g~~p~ 202 (333)
T cd06650 153 QLIDSM------ANSFVGTRSYMSPERLQGT------HYSVQSDIWSMGLSLVEMAIGRYPI 202 (333)
T ss_pred hhhhhc------cccCCCCccccCHHHhcCC------CCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 553321 1234689999999999765 5678999999999999999995543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=320.21 Aligned_cols=237 Identities=23% Similarity=0.368 Sum_probs=183.6
Q ss_pred ceeeeecCeEEEEEEE--CCceeEEEEeeccC----c--cchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEeee
Q psy14889 142 ECIGKGRYGEVWRGVW--HGENVAVKIFFSRD----E--ASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVT 213 (443)
Q Consensus 142 ~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~----~--~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv~ 213 (443)
+.||+|+||.||+|.. +++.||||++.... . .....|.++... .++||||+++++++.+. ..+++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~-~~~hp~iv~~~~~~~~~----~~~~lv~ 75 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSL-AWEHPFLTHLYCTFQTK----ENLFFVM 75 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHh-ccCCCcCcceEEEEEeC----CEEEEEE
Confidence 4699999999999998 47889999886532 1 112223333322 26999999999998776 4589999
Q ss_pred cccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCccccc
Q psy14889 214 HYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYS 292 (443)
Q Consensus 214 e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~~ 292 (443)
||+++|+|.+++.. ..+++.++..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 76 ey~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~--------~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~ 147 (316)
T cd05619 76 EYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSK--------GIVYRDLKLDNILLDTDGHIKIADFGMCKENM 147 (316)
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC--------CeEeCCCCHHHEEECCCCCEEEccCCcceECC
Confidence 99999999999965 5789999999999999999999998 99999999999999999999999999986432
Q ss_pred ccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCChH
Q psy14889 293 QLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFD 372 (443)
Q Consensus 293 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~~~ 372 (443)
.... ......||..|+|||++.+. .++.++|||||||++|||++| ..||... ...
T Consensus 148 ~~~~----~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~il~el~~G----------~~pf~~~-----~~~ 202 (316)
T cd05619 148 LGDA----KTCTFCGTPDYIAPEILLGQ------KYNTSVDWWSFGVLLYEMLIG----------QSPFHGH-----DEE 202 (316)
T ss_pred CCCC----ceeeecCCccccCHHHHcCC------CCCchhhhhhHHHHHHHHHhC----------CCCCCCC-----CHH
Confidence 2111 12345789999999999876 667899999999999999999 6777653 223
Q ss_pred HHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHH-HHHH
Q psy14889 373 DMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSAL-RVKK 423 (443)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~-evl~ 423 (443)
.....+.. ..+..+. ..+.++.+++.+||+.||++||++. ++++
T Consensus 203 ~~~~~i~~--~~~~~~~-----~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 203 ELFQSIRM--DNPCYPR-----WLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred HHHHHHHh--CCCCCCc-----cCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 33333222 2233332 2456789999999999999999997 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=323.49 Aligned_cols=257 Identities=22% Similarity=0.400 Sum_probs=194.4
Q ss_pred ccccccceeeeecCeEEEEEEE-------CCceeEEEEeeccCccc--hHHHHHHHHHHhc-cCCCceeeeeeccccCCc
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW-------HGENVAVKIFFSRDEAS--WSRETEIYSTVLL-RHENILGYIGSDMTSRNS 205 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~-------~~~~vAvK~~~~~~~~~--~~~e~ei~~~~~l-~H~nIv~l~g~~~~~~~~ 205 (443)
++|++.+.||+|+||.||+|.+ +++.||||++....... .....|+..+..+ +||||+++++++....
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~-- 84 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG-- 84 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC--
Confidence 6899999999999999999974 35789999986533221 1223455555557 7899999999886543
Q ss_pred ccEEEeeecccCcccHHHHhcc----------------------------------------------------------
Q psy14889 206 CTQLWLVTHYHSFGSLYDHLNR---------------------------------------------------------- 227 (443)
Q Consensus 206 ~~~~~lv~e~~~~gsL~~~l~~---------------------------------------------------------- 227 (443)
..++++|||+++|+|.++++.
T Consensus 85 -~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (343)
T cd05103 85 -GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 163 (343)
T ss_pred -CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence 246899999999999998853
Q ss_pred ----------cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcccccccCCc
Q psy14889 228 ----------TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNK 297 (443)
Q Consensus 228 ----------~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~ 297 (443)
..+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~--------~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 235 (343)
T cd05103 164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR--------KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY 235 (343)
T ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC--------CeecCCCccCeEEEcCCCcEEEEecccccccccCcch
Confidence 1267788899999999999999998 9999999999999999999999999998765332211
Q ss_pred CCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh-cccCCCcccccCCCCCCCCCCCCChHHHHh
Q psy14889 298 MDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR-RTKANGIFEEYKAPYHDLVPMDPSFDDMRK 376 (443)
Q Consensus 298 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt-g~~~~~~~~~~~~P~~~~~~~~~~~~~~~~ 376 (443)
. ......++..|+|||.+.+. .++.++||||||+++|||++ | ..||..... ......
T Consensus 236 ~--~~~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~~l~el~~~g----------~~p~~~~~~----~~~~~~ 293 (343)
T cd05103 236 V--RKGDARLPLKWMAPETIFDR------VYTIQSDVWSFGVLLWEIFSLG----------ASPYPGVKI----DEEFCR 293 (343)
T ss_pred h--hcCCCCCCcceECcHHhcCC------CCCchhhHHHHHHHHHHHHHCC----------CCCCCCccc----cHHHHH
Confidence 1 11223456789999998765 66789999999999999997 6 566654311 112222
Q ss_pred hhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhhc
Q psy14889 377 VICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLACA 431 (443)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~~ 431 (443)
.+ ....++..+. ..+.++.+++.+||+.||++|||+.+|++.|+.+.+.
T Consensus 294 ~~-~~~~~~~~~~-----~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 294 RL-KEGTRMRAPD-----YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred HH-hccCCCCCCC-----CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 22 1222222222 2345799999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=315.21 Aligned_cols=251 Identities=25% Similarity=0.363 Sum_probs=193.6
Q ss_pred ccccccceeeeecCeEEEEEEEC-------CceeEEEEeeccCccc--hHHHHHHHHHHhccCCCceeeeeeccccCCcc
Q psy14889 136 KQISLSECIGKGRYGEVWRGVWH-------GENVAVKIFFSRDEAS--WSRETEIYSTVLLRHENILGYIGSDMTSRNSC 206 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~~~--~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~ 206 (443)
.+|.+.+.||+|+||.||+|... +..||+|++....... .....|+..+..++||||+++++++....
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~--- 81 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ--- 81 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC---
Confidence 46788899999999999999863 3679999886543322 12234555556699999999999987764
Q ss_pred cEEEeeecccCcccHHHHhcc-----------------cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCC
Q psy14889 207 TQLWLVTHYHSFGSLYDHLNR-----------------TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKS 269 (443)
Q Consensus 207 ~~~~lv~e~~~~gsL~~~l~~-----------------~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~ 269 (443)
..++++||+.+++|.+++.. ..+++..+..++.|++.||.|||+. +|+||||||
T Consensus 82 -~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~--------gi~H~dlkp 152 (283)
T cd05091 82 -PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH--------HVVHKDLAT 152 (283)
T ss_pred -ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc--------Cccccccch
Confidence 36899999999999999841 2478888999999999999999998 999999999
Q ss_pred CCEEEcCCCcEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh-cc
Q psy14889 270 KNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR-RT 348 (443)
Q Consensus 270 ~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt-g~ 348 (443)
+|||+++++.+||+|||+++......... ......+++.|+|||.+.+. .++.++||||||+++|||++ |
T Consensus 153 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~------~~~~~~Dv~slG~~l~el~~~g- 223 (283)
T cd05091 153 RNVLVFDKLNVKISDLGLFREVYAADYYK--LMGNSLLPIRWMSPEAIMYG------KFSIDSDIWSYGVVLWEVFSYG- 223 (283)
T ss_pred hheEecCCCceEecccccccccccchhee--eccCccCCccccCHHHHhcC------CCCcchhHHHHHHHHHHHHcCC-
Confidence 99999999999999999987654322111 11233467789999998765 56789999999999999998 5
Q ss_pred cCCCcccccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHH
Q psy14889 349 KANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIK 427 (443)
Q Consensus 349 ~~~~~~~~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 427 (443)
..||.+. ........+... ..... +..++..+.+++.+||+.+|++||++.+|+..|+.
T Consensus 224 ---------~~p~~~~-----~~~~~~~~i~~~-~~~~~-----~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 224 ---------LQPYCGY-----SNQDVIEMIRNR-QVLPC-----PDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred ---------CCCCCCC-----CHHHHHHHHHcC-CcCCC-----CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 5566543 222333333221 12222 24477889999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=313.24 Aligned_cols=267 Identities=25% Similarity=0.401 Sum_probs=194.5
Q ss_pred ccccccceeeeecCeEEEEEEE------CCceeEEEEeeccCccc-hHHHHHHHHHHhccCCCceeeeeeccccCCcccE
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW------HGENVAVKIFFSRDEAS-WSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQ 208 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~------~~~~vAvK~~~~~~~~~-~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~ 208 (443)
++|++.+.||+|+||.||++.+ ++..||+|.+....... ...+.|+..+..++||||+++++++..... ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~--~~ 81 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR--RN 81 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCC--Cc
Confidence 5788999999999999999975 37789999886544322 233456666667999999999998765432 34
Q ss_pred EEeeecccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecC
Q psy14889 209 LWLVTHYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFG 286 (443)
Q Consensus 209 ~~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfG 286 (443)
+++|+||+++|+|.+++.+ ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~--------~i~H~dlkp~nili~~~~~~~l~dfg 153 (284)
T cd05081 82 LRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSK--------RYVHRDLATRNILVESENRVKIGDFG 153 (284)
T ss_pred eEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHC--------CceeccCCHhhEEECCCCeEEECCCc
Confidence 7999999999999999964 4589999999999999999999998 99999999999999999999999999
Q ss_pred CcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCC
Q psy14889 287 LAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVP 366 (443)
Q Consensus 287 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~ 366 (443)
+++........... .....++..|+|||++.+. .++.++||||||+++|||++|..+..... ..+.....
T Consensus 154 ~~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~~l~el~~~~~~~~~~~---~~~~~~~~ 223 (284)
T cd05081 154 LTKVLPQDKEYYKV-REPGESPIFWYAPESLTES------KFSVASDVWSFGVVLYELFTYSDKSCSPP---AEFMRMMG 223 (284)
T ss_pred ccccccCCCcceee-cCCCCCceEeeCHHHhccC------CcChHHHHHHHHHHHHHHhhcCCcCCCcc---hhhhhhcc
Confidence 99876543221111 1112344569999998765 56689999999999999999854321100 00000000
Q ss_pred CC----CChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHH
Q psy14889 367 MD----PSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKL 428 (443)
Q Consensus 367 ~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l 428 (443)
.. .....+..... ....... ...++.++.+++.+||+.+|++|||+.+|++.|+++
T Consensus 224 ~~~~~~~~~~~~~~~~~-~~~~~~~-----~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 224 NDKQGQMIVYHLIELLK-NNGRLPA-----PPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred cccccccchHHHHHHHh-cCCcCCC-----CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 00 01111111111 1111111 233667899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=321.34 Aligned_cols=238 Identities=24% Similarity=0.353 Sum_probs=183.8
Q ss_pred ceeeeecCeEEEEEEE--CCceeEEEEeeccCc------cchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEeee
Q psy14889 142 ECIGKGRYGEVWRGVW--HGENVAVKIFFSRDE------ASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVT 213 (443)
Q Consensus 142 ~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~------~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv~ 213 (443)
+.||+|+||.||+|+. +++.||||++..... .....|.++... ..+||||+++++++... ..+++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~-~~~hp~i~~~~~~~~~~----~~~~lv~ 75 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILAL-AAKHPFLTALHCCFQTK----DRLFFVM 75 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHh-ccCCCCccceeeEEEcC----CeEEEEE
Confidence 4699999999999988 478999999865321 112234444333 24899999999998776 4589999
Q ss_pred cccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCccccc
Q psy14889 214 HYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYS 292 (443)
Q Consensus 214 e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~~ 292 (443)
||+++|+|..++.. ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 76 E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~--------~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~ 147 (321)
T cd05591 76 EYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRH--------GVIYRDLKLDNILLDAEGHCKLADFGMCKEGI 147 (321)
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC--------CeeccCCCHHHeEECCCCCEEEeecccceecc
Confidence 99999999988854 5789999999999999999999998 99999999999999999999999999986543
Q ss_pred ccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCChH
Q psy14889 293 QLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFD 372 (443)
Q Consensus 293 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~~~ 372 (443)
.... ......||+.|+|||++.+. .++.++|||||||++|||++| ..||... ...
T Consensus 148 ~~~~----~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~il~el~tg----------~~Pf~~~-----~~~ 202 (321)
T cd05591 148 LNGV----TTTTFCGTPDYIAPEILQEL------EYGPSVDWWALGVLMYEMMAG----------QPPFEAD-----NED 202 (321)
T ss_pred cCCc----cccccccCccccCHHHHcCC------CCCCccceechhHHHHHHhcC----------CCCCCCC-----CHH
Confidence 2111 12345789999999998765 667899999999999999999 6777653 222
Q ss_pred HHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCC-------cHHHHHHH
Q psy14889 373 DMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRL-------SALRVKKT 424 (443)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-------s~~evl~~ 424 (443)
.....+.. .....| ...+.++.+++.+||+.||++|| ++.++++.
T Consensus 203 ~~~~~i~~--~~~~~p-----~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 203 DLFESILH--DDVLYP-----VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred HHHHHHHc--CCCCCC-----CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 33332222 112222 22456799999999999999999 77777643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=311.87 Aligned_cols=255 Identities=29% Similarity=0.421 Sum_probs=193.6
Q ss_pred hccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccc-hHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEe
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEAS-WSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWL 211 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~-~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~l 211 (443)
.++|++.+.||+|+||.||+|.. +++.||+|++....... ...+.|+..+..++||||+++++++... ..+++
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~----~~~~i 83 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSR----EKLWI 83 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeC----CEEEE
Confidence 36899999999999999999997 67899999886543222 2234566667779999999999998765 45799
Q ss_pred eecccCcccHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCccc
Q psy14889 212 VTHYHSFGSLYDHLN-RTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVS 290 (443)
Q Consensus 212 v~e~~~~gsL~~~l~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~ 290 (443)
||||+++|+|.+++. +..+++.++..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++..
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--------~i~H~dl~p~nill~~~~~~~l~dfg~~~~ 155 (267)
T cd06646 84 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSK--------GKMHRDIKGANILLTDNGDVKLADFGVAAK 155 (267)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CccccCCCHHHEEECCCCCEEECcCcccee
Confidence 999999999999885 45789999999999999999999998 999999999999999999999999999976
Q ss_pred ccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCC
Q psy14889 291 YSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPS 370 (443)
Q Consensus 291 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~ 370 (443)
....... .....|+..|+|||.+...... .++.++|||||||++|||++| +.||....+.
T Consensus 156 ~~~~~~~----~~~~~~~~~y~~PE~~~~~~~~---~~~~~~Dvws~G~il~el~~g----------~~p~~~~~~~--- 215 (267)
T cd06646 156 ITATIAK----RKSFIGTPYWMAPEVAAVEKNG---GYNQLCDIWAVGITAIELAEL----------QPPMFDLHPM--- 215 (267)
T ss_pred ecccccc----cCccccCccccCHhHcccccCC---CCcchhhHHHHHHHHHHHHhC----------CCCccccchh---
Confidence 5432111 1234688999999988532111 456799999999999999999 5565433211
Q ss_pred hHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHH
Q psy14889 371 FDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTL 425 (443)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 425 (443)
....... ......+........+..+.+++++||+.||++|||++++++.|
T Consensus 216 -~~~~~~~---~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 216 -RALFLMS---KSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred -hhheeee---cCCCCCCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 1111110 11111111111223567899999999999999999999998753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=320.59 Aligned_cols=237 Identities=25% Similarity=0.336 Sum_probs=184.0
Q ss_pred ceeeeecCeEEEEEEE--CCceeEEEEeeccCc------cchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEeee
Q psy14889 142 ECIGKGRYGEVWRGVW--HGENVAVKIFFSRDE------ASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVT 213 (443)
Q Consensus 142 ~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~------~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv~ 213 (443)
+.||+|+||.||+|.+ +++.||||++..... .....|.++.... .+||||+++++++.+. ..+++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~-~~h~~i~~~~~~~~~~----~~~~lv~ 75 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALA-GKHPFLTQLHSCFQTK----DRLFFVM 75 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhc-cCCCCccceeeEEEcC----CEEEEEE
Confidence 4699999999999988 478999999865321 1122333443331 2799999999998766 4589999
Q ss_pred cccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCccccc
Q psy14889 214 HYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYS 292 (443)
Q Consensus 214 e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~~ 292 (443)
||+++|+|..++.+ ..+++..+..++.|++.||.|||+. +|+||||||+|||+++++.+||+|||+++...
T Consensus 76 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~--------~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 147 (318)
T cd05570 76 EYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHER--------GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGI 147 (318)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC--------CeEccCCCHHHeEECCCCcEEecccCCCeecC
Confidence 99999999998865 4799999999999999999999998 99999999999999999999999999986432
Q ss_pred ccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCChH
Q psy14889 293 QLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFD 372 (443)
Q Consensus 293 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~~~ 372 (443)
.... ......||..|+|||++.+. .++.++|||||||++|||++| ..||... ...
T Consensus 148 ~~~~----~~~~~~g~~~y~aPE~~~~~------~~~~~~DiwslGvil~~l~~G----------~~pf~~~-----~~~ 202 (318)
T cd05570 148 LGGV----TTSTFCGTPDYIAPEILSYQ------PYGPAVDWWALGVLLYEMLAG----------QSPFEGD-----DED 202 (318)
T ss_pred cCCC----cccceecCccccCHHHhcCC------CCCcchhhhhHHHHHHHHhhC----------CCCCCCC-----CHH
Confidence 2111 12334689999999999876 667899999999999999999 6777543 222
Q ss_pred HHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcH-----HHHHH
Q psy14889 373 DMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSA-----LRVKK 423 (443)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~-----~evl~ 423 (443)
.+...+.. .....+ ...+..+.+++++||+.||++|||+ .++++
T Consensus 203 ~~~~~i~~--~~~~~~-----~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 203 ELFQSILE--DEVRYP-----RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred HHHHHHHc--CCCCCC-----CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 33232221 222223 2356789999999999999999999 77765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=311.28 Aligned_cols=257 Identities=28% Similarity=0.464 Sum_probs=193.7
Q ss_pred hhccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccchHHHHHHHHHHhc-cCCCceeeeeeccccCCc--ccE
Q psy14889 134 LAKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEASWSRETEIYSTVLL-RHENILGYIGSDMTSRNS--CTQ 208 (443)
Q Consensus 134 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~e~ei~~~~~l-~H~nIv~l~g~~~~~~~~--~~~ 208 (443)
+.+.|++.+.||+|+||.||+|.. +++.||+|++............|+..+..+ +|+||+++++++...... ...
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 83 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ 83 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcE
Confidence 346789999999999999999987 578999998865543333334444444445 799999999998754321 145
Q ss_pred EEeeecccCcccHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEec
Q psy14889 209 LWLVTHYHSFGSLYDHLNR---TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADF 285 (443)
Q Consensus 209 ~~lv~e~~~~gsL~~~l~~---~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~Df 285 (443)
++++|||+++|+|.+++.. ..+++..+..++.|++.||+|||+. +|+|+||||+||++++++.+||+||
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~--------~ivh~dl~~~nili~~~~~~~l~Df 155 (272)
T cd06637 84 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH--------KVIHRDIKGQNVLLTENAEVKLVDF 155 (272)
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC--------CCccCCCCHHHEEECCCCCEEEccC
Confidence 8999999999999999864 3589999999999999999999998 9999999999999999999999999
Q ss_pred CCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCC
Q psy14889 286 GLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLV 365 (443)
Q Consensus 286 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~ 365 (443)
|++......... .....|+..|+|||++....... ..++.++|||||||++|||++| ..||.+..
T Consensus 156 g~~~~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~-~~~~~~~Dv~slGv~l~el~~g----------~~p~~~~~ 220 (272)
T cd06637 156 GVSAQLDRTVGR----RNTFIGTPYWMAPEVIACDENPD-ATYDFKSDLWSLGITAIEMAEG----------APPLCDMH 220 (272)
T ss_pred CCceeccccccc----CCcccccccccCHhHhccccCcC-CCCCchhhHHHHHHHHHHHHhC----------CCCccccC
Confidence 999765432211 23457889999999986432111 1566899999999999999999 56665432
Q ss_pred CCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 366 PMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
+ .... ..... ....... ...++..+.+|+.+||+.||.+|||+.++++
T Consensus 221 ~----~~~~-~~~~~-~~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 221 P----MRAL-FLIPR-NPAPRLK----SKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred H----HHHH-HHHhc-CCCCCCC----CCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 1 1111 11111 1111111 1235678999999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=308.32 Aligned_cols=250 Identities=24% Similarity=0.395 Sum_probs=195.0
Q ss_pred hccccccceeeeecCeEEEEEEE-CCceeEEEEeeccCccchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEeee
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVW-HGENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVT 213 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv~ 213 (443)
.++|++.+.||+|+||.||+|.. .+..||+|.+............|+..+..++|+||+++++++... ..+++|
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~-----~~~lv~ 79 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSEE-----PIYIVT 79 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEECCC-----CcEEEE
Confidence 36799999999999999999987 567899998865443333344566666669999999999987432 358999
Q ss_pred cccCcccHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCccc
Q psy14889 214 HYHSFGSLYDHLNR---TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVS 290 (443)
Q Consensus 214 e~~~~gsL~~~l~~---~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~ 290 (443)
||+++++|.+++.. ..+++.+++.++.|++.||.|||+. +++||||||+||++++++.+||+|||++..
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~--------~i~H~di~p~Nili~~~~~~~l~dfg~~~~ 151 (260)
T cd05070 80 EYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM--------NYIHRDLRSANILVGDGLVCKIADFGLARL 151 (260)
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC--------CcccCCCccceEEEeCCceEEeCCceeeee
Confidence 99999999999864 3589999999999999999999998 999999999999999999999999999976
Q ss_pred ccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh-cccCCCcccccCCCCCCCCCCCC
Q psy14889 291 YSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR-RTKANGIFEEYKAPYHDLVPMDP 369 (443)
Q Consensus 291 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt-g~~~~~~~~~~~~P~~~~~~~~~ 369 (443)
+....... .....++..|+|||.+.+. .++.++||||||+++|||++ | ..||.+..
T Consensus 152 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~~l~~l~~~g----------~~p~~~~~---- 208 (260)
T cd05070 152 IEDNEYTA---RQGAKFPIKWTAPEAALYG------RFTIKSDVWSFGILLTELVTKG----------RVPYPGMN---- 208 (260)
T ss_pred ccCccccc---ccCCCCCccccChHHHhcC------CCcchhhhHHHHHHHHHHHhcC----------CCCCCCCC----
Confidence 54322111 1222456789999988765 66789999999999999999 6 56775531
Q ss_pred ChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHH
Q psy14889 370 SFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIK 427 (443)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 427 (443)
..+....+.. ...+..+ ...+..+.+++.+||+.||++|||+.++.+.|++
T Consensus 209 -~~~~~~~~~~-~~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 209 -NREVLEQVER-GYRMPCP-----QDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred -HHHHHHHHHc-CCCCCCC-----CcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 2222222221 1222222 3356789999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=320.10 Aligned_cols=238 Identities=23% Similarity=0.323 Sum_probs=182.7
Q ss_pred cccccceeeeecCeEEEEEEE--CCceeEEEEeeccC----ccchHHHHHHHHHHhccCC-CceeeeeeccccCCcccEE
Q psy14889 137 QISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRD----EASWSRETEIYSTVLLRHE-NILGYIGSDMTSRNSCTQL 209 (443)
Q Consensus 137 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~----~~~~~~e~ei~~~~~l~H~-nIv~l~g~~~~~~~~~~~~ 209 (443)
+|++.+.||+|+||.||+|+. +++.||||++.... ........|+..+..++|+ +|+++++++... ..+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~----~~~ 76 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM----DRL 76 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcC----CEE
Confidence 478899999999999999988 46789999886432 1111222344444446665 578888887665 358
Q ss_pred EeeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCc
Q psy14889 210 WLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA 288 (443)
Q Consensus 210 ~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla 288 (443)
++||||+++|+|.+++.. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 77 ~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~--------~ivH~dlkp~Nill~~~~~~kL~Dfg~~ 148 (324)
T cd05587 77 YFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSK--------GIIYRDLKLDNVMLDAEGHIKIADFGMC 148 (324)
T ss_pred EEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC--------CeEecCCCHHHeEEcCCCCEEEeecCcc
Confidence 999999999999998864 5689999999999999999999998 9999999999999999999999999998
Q ss_pred ccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCC
Q psy14889 289 VSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMD 368 (443)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~ 368 (443)
+....... ......||+.|+|||++.+. .++.++|||||||++|||+|| ..||...
T Consensus 149 ~~~~~~~~----~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslGvil~elltG----------~~pf~~~---- 204 (324)
T cd05587 149 KENIFGGK----TTRTFCGTPDYIAPEIIAYQ------PYGKSVDWWAFGVLLYEMLAG----------QPPFDGE---- 204 (324)
T ss_pred eecCCCCC----ceeeecCCccccChhhhcCC------CCCcccchhhhHHHHHHHHhC----------CCCCCCC----
Confidence 64321111 12334689999999999876 667899999999999999999 6777643
Q ss_pred CChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcH
Q psy14889 369 PSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSA 418 (443)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~ 418 (443)
........+. .....++ ...+.++.+++.+||+.||.+|++.
T Consensus 205 -~~~~~~~~i~--~~~~~~~-----~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 205 -DEDELFQSIM--EHNVSYP-----KSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred -CHHHHHHHHH--cCCCCCC-----CCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 2222222222 1223333 2355679999999999999999976
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=328.56 Aligned_cols=262 Identities=20% Similarity=0.211 Sum_probs=185.9
Q ss_pred hccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEee
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLV 212 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv 212 (443)
..+|++.+.||+|+||.||++.. +++.||+|.... .... .|+..+..++||||+++++++... ...++|
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---~~~~--~E~~il~~l~HpnIv~~~~~~~~~----~~~~lv 161 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---GGTA--TEAHILRAINHPSIIQLKGTFTYN----KFTCLI 161 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---hhhH--HHHHHHHhCCCCCCCCEeEEEEEC----CeeEEE
Confidence 36799999999999999999988 588999996532 2233 445555569999999999998765 357899
Q ss_pred ecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcccc
Q psy14889 213 THYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSY 291 (443)
Q Consensus 213 ~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~ 291 (443)
+|++. ++|..++.. ..+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+|+..
T Consensus 162 ~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~--------~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~ 232 (391)
T PHA03212 162 LPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHEN--------RIIHRDIKAENIFINHPGDVCLGDFGAACFP 232 (391)
T ss_pred EecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CcccCCCChHhEEEcCCCCEEEEeCCccccc
Confidence 99986 689888854 5799999999999999999999998 9999999999999999999999999999654
Q ss_pred cccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccc---------------
Q psy14889 292 SQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEE--------------- 356 (443)
Q Consensus 292 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~--------------- 356 (443)
...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.++.....
T Consensus 233 ~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~ 303 (391)
T PHA03212 233 VDINAN---KYYGWAGTIATNAPELLARD------PYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLII 303 (391)
T ss_pred cccccc---ccccccCccCCCChhhhcCC------CCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHH
Confidence 322111 12345799999999999775 677899999999999999999543210000
Q ss_pred ---cCCCCCCCCCCCCChHHHH-hhhhhcCCCCCCCCCCC-CchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 357 ---YKAPYHDLVPMDPSFDDMR-KVICIDQQRPVLPNRWV-SDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 357 ---~~~P~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
+..|............... .........+.....|. ....+.++.+|+.+||+.||++|||+.|+++
T Consensus 304 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 304 RRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred HHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000000000000000000 00000001111110110 0124567999999999999999999999985
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=322.54 Aligned_cols=238 Identities=23% Similarity=0.306 Sum_probs=179.6
Q ss_pred ceeeeecCeEEEEEEE--CCceeEEEEeeccCcc----chHHHHHHHHHHh-ccCCCceeeeeeccccCCcccEEEeeec
Q psy14889 142 ECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA----SWSRETEIYSTVL-LRHENILGYIGSDMTSRNSCTQLWLVTH 214 (443)
Q Consensus 142 ~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~----~~~~e~ei~~~~~-l~H~nIv~l~g~~~~~~~~~~~~~lv~e 214 (443)
+.||+|+||.||++.. +++.||+|++...... ......|+..+.. .+||||+++++++... ..+++|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~----~~~~lv~E 76 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE----SRLFFVIE 76 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeC----CEEEEEEe
Confidence 4699999999999987 5789999998653211 1112233333333 4899999999998776 45899999
Q ss_pred ccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcccccc
Q psy14889 215 YHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQ 293 (443)
Q Consensus 215 ~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~~~ 293 (443)
|+++|+|..++.. ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 77 ~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~--------~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~ 148 (329)
T cd05618 77 YVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER--------GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 148 (329)
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC--------CeeeCCCCHHHEEECCCCCEEEeeCCccccccC
Confidence 9999999988854 5799999999999999999999998 999999999999999999999999999865322
Q ss_pred cCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCC----CC
Q psy14889 294 LSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPM----DP 369 (443)
Q Consensus 294 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~----~~ 369 (443)
... ......||..|+|||++.+. .++.++|||||||++|||++| ..||...... ..
T Consensus 149 ~~~----~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~el~~g----------~~Pf~~~~~~~~~~~~ 208 (329)
T cd05618 149 PGD----TTSTFCGTPNYIAPEILRGE------DYGFSVDWWALGVLMFEMMAG----------RSPFDIVGSSDNPDQN 208 (329)
T ss_pred CCC----ccccccCCccccCHHHHcCC------CCCCccceecccHHHHHHhhC----------CCCCccCCCcCCcccc
Confidence 111 12345799999999999876 667899999999999999999 5555321111 11
Q ss_pred ChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcH
Q psy14889 370 SFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSA 418 (443)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~ 418 (443)
....+.+.+. .....+| ...+..+.+++.+||+.||++||++
T Consensus 209 ~~~~~~~~i~--~~~~~~p-----~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 209 TEDYLFQVIL--EKQIRIP-----RSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred cHHHHHHHHh--cCCCCCC-----CCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 1122222222 1222333 2355679999999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=308.16 Aligned_cols=248 Identities=23% Similarity=0.424 Sum_probs=191.7
Q ss_pred ccccccceeeeecCeEEEEEEE-CCceeEEEEeeccCccchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEeeec
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW-HGENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVTH 214 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e 214 (443)
.+|++.+.||+|+||.||+|.+ .+..+|+|.+............|+..+..++||||+++++++.... ..++|||
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~~lv~e 79 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQR----PIFIVTE 79 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC----ceEEEEe
Confidence 4688899999999999999988 4568999987644332222334555556699999999999987653 4799999
Q ss_pred ccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCccccc
Q psy14889 215 YHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYS 292 (443)
Q Consensus 215 ~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~~ 292 (443)
|+++++|.+++.. ..+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++...
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--------~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~ 151 (256)
T cd05059 80 YMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESN--------GFIHRDLAARNCLVGEDNVVKVSDFGLARYVL 151 (256)
T ss_pred cCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC--------CcccccccHhhEEECCCCcEEECCcccceecc
Confidence 9999999999864 4689999999999999999999998 99999999999999999999999999987654
Q ss_pred ccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh-cccCCCcccccCCCCCCCCCCCCCh
Q psy14889 293 QLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR-RTKANGIFEEYKAPYHDLVPMDPSF 371 (443)
Q Consensus 293 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt-g~~~~~~~~~~~~P~~~~~~~~~~~ 371 (443)
..... ......++..|+|||.+.+. .++.++||||||+++|||++ | ..||.... .
T Consensus 152 ~~~~~---~~~~~~~~~~y~~Pe~~~~~------~~~~~~Di~slG~il~~l~~~g----------~~p~~~~~-----~ 207 (256)
T cd05059 152 DDQYT---SSQGTKFPVKWAPPEVFDYS------RFSSKSDVWSFGVLMWEVFSEG----------KMPYERFS-----N 207 (256)
T ss_pred ccccc---ccCCCCCCccccCHHHhccC------CCCchhhHHHHHHHHHHHhccC----------CCCCCCCC-----H
Confidence 32111 11122345679999998876 66789999999999999999 5 56665431 1
Q ss_pred HHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHH
Q psy14889 372 DDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTL 425 (443)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 425 (443)
......+. ...+...+ ..++.++.+++.+||+.+|++|||+.++++.|
T Consensus 208 ~~~~~~~~-~~~~~~~~-----~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 208 SEVVESVS-AGYRLYRP-----KLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred HHHHHHHH-cCCcCCCC-----CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 22222221 12222222 23667899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=325.44 Aligned_cols=255 Identities=19% Similarity=0.242 Sum_probs=194.1
Q ss_pred hccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCc----cchHHHHHHHHHHhccCCCceeeeeeccccCCcccE
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDE----ASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQ 208 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~----~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~ 208 (443)
.++|++.+.||+|+||.||++.. +++.||+|++..... .......|+..+..++||||+++++.+.+. ..
T Consensus 42 ~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~----~~ 117 (371)
T cd05622 42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD----RY 117 (371)
T ss_pred hhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC----CE
Confidence 37899999999999999999998 578999998854221 111123344455558999999999998765 46
Q ss_pred EEeeecccCcccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCc
Q psy14889 209 LWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA 288 (443)
Q Consensus 209 ~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla 288 (443)
+++||||+++|+|.++++...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 118 ~~lv~Ey~~gg~L~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~--------~ivHrDLkp~NIll~~~~~ikL~DfG~a 189 (371)
T cd05622 118 LYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSM--------GFIHRDVKPDNMLLDKSGHLKLADFGTC 189 (371)
T ss_pred EEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHC--------CEEeCCCCHHHEEECCCCCEEEEeCCce
Confidence 89999999999999999888899999999999999999999998 9999999999999999999999999999
Q ss_pred ccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCC
Q psy14889 289 VSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMD 368 (443)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~ 368 (443)
+.+...... ......||+.|+|||++....... .++.++|||||||++|||++| ..||...
T Consensus 190 ~~~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~--~~~~~~DiwSlGvilyell~G----------~~Pf~~~---- 250 (371)
T cd05622 190 MKMNKEGMV---RCDTAVGTPDYISPEVLKSQGGDG--YYGRECDWWSVGVFLYEMLVG----------DTPFYAD---- 250 (371)
T ss_pred eEcCcCCcc---cccCcccCccccCHHHHhccCCCc--cCCCccceeehhHHHHHHHhC----------CCCCCCC----
Confidence 766432211 123457999999999987542211 366899999999999999999 7777653
Q ss_pred CChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCC--CCcHHHHHHH
Q psy14889 369 PSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANV--RLSALRVKKT 424 (443)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--Rps~~evl~~ 424 (443)
........+........++. ....+..+.+++..|+..++.+ |+++.++++.
T Consensus 251 -~~~~~~~~i~~~~~~~~~~~---~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 251 -SLVGTYSKIMNHKNSLTFPD---DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred -CHHHHHHHHHcCCCcccCCC---cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 12222222222222222332 1236678999999999844433 7789988874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=323.04 Aligned_cols=234 Identities=26% Similarity=0.347 Sum_probs=180.6
Q ss_pred ceeeeecCeEEEEEEE--CCceeEEEEeeccCccc----hHHHHHHH-HHHhccCCCceeeeeeccccCCcccEEEeeec
Q psy14889 142 ECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEAS----WSRETEIY-STVLLRHENILGYIGSDMTSRNSCTQLWLVTH 214 (443)
Q Consensus 142 ~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~----~~~e~ei~-~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e 214 (443)
+.||+|+||+||+|.. +|+.||+|++....... .....|.. .+..++||||+++++.+... ..+++|||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~----~~~~lv~e 76 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTA----DKLYFVLD 76 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeC----CEEEEEEc
Confidence 4699999999999998 68999999986432111 11112222 23458999999999988765 45799999
Q ss_pred ccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcccccc
Q psy14889 215 YHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQ 293 (443)
Q Consensus 215 ~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~~~ 293 (443)
|+++|+|..++.+ ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 77 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~--------givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~ 148 (323)
T cd05575 77 YVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSL--------NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIE 148 (323)
T ss_pred CCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CeEeCCCCHHHeEECCCCcEEEeccCCCccccc
Confidence 9999999998864 5689999999999999999999998 999999999999999999999999999865322
Q ss_pred cCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCChHH
Q psy14889 294 LSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFDD 373 (443)
Q Consensus 294 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~~~~ 373 (443)
... ......||+.|+|||++.+. .++.++|||||||++|||++| ..||... ....
T Consensus 149 ~~~----~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~il~ell~g----------~~pf~~~-----~~~~ 203 (323)
T cd05575 149 HSK----TTSTFCGTPEYLAPEVLRKQ------PYDRTVDWWCLGAVLYEMLYG----------LPPFYSR-----DTAE 203 (323)
T ss_pred CCC----ccccccCChhhcChhhhcCC------CCCccccccccchhhhhhhcC----------CCCCCCC-----CHHH
Confidence 111 12345799999999999776 667899999999999999999 6777653 2223
Q ss_pred HHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHH
Q psy14889 374 MRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSAL 419 (443)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ 419 (443)
+...+.. ....++ ...+..+.+++.+||+.||++||++.
T Consensus 204 ~~~~i~~--~~~~~~-----~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 204 MYDNILN--KPLRLK-----PNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred HHHHHHc--CCCCCC-----CCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 2222211 111222 22467799999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=328.44 Aligned_cols=252 Identities=22% Similarity=0.289 Sum_probs=189.8
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCc----cchHHHHHHHHHHhccCCCceeeeeeccccCCcccEE
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDE----ASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQL 209 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~----~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~ 209 (443)
++|++.+.||+|+||.||++.. +++.||||++..... .....+.|+..+..++||||+++++++.+. ..+
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~----~~~ 76 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDA----QYL 76 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC----Cee
Confidence 3688999999999999999987 688999998854321 111223455555669999999999998776 458
Q ss_pred EeeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCc
Q psy14889 210 WLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA 288 (443)
Q Consensus 210 ~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla 288 (443)
++||||+++|+|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 77 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~--------givHrDlkp~NIll~~~~~~kl~DfGla 148 (377)
T cd05629 77 YLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKL--------GFIHRDIKPDNILIDRGGHIKLSDFGLS 148 (377)
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CeeccCCCHHHEEECCCCCEEEeecccc
Confidence 999999999999999864 5689999999999999999999998 9999999999999999999999999999
Q ss_pred ccccccCCc-----------CC--------------------------------CCCCCcccccCcccccccccccccCc
Q psy14889 289 VSYSQLSNK-----------MD--------------------------------IPPNPRVGTKRYMSPEILDESINMDC 325 (443)
Q Consensus 289 ~~~~~~~~~-----------~~--------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~ 325 (443)
+.+...... .. ......+||+.|+|||++.+.
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----- 223 (377)
T cd05629 149 TGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQ----- 223 (377)
T ss_pred cccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccC-----
Confidence 643211000 00 000124699999999999766
Q ss_pred CCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHH
Q psy14889 326 FESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMK 405 (443)
Q Consensus 326 ~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 405 (443)
.++.++|||||||++|||++| ..||.... ..+....... ......+|.. ...+.++.+++.
T Consensus 224 -~~~~~~DiwSlGvil~elltG----------~~Pf~~~~----~~~~~~~i~~-~~~~~~~p~~---~~~s~~~~dli~ 284 (377)
T cd05629 224 -GYGQECDWWSLGAIMFECLIG----------WPPFCSEN----SHETYRKIIN-WRETLYFPDD---IHLSVEAEDLIR 284 (377)
T ss_pred -CCCCceeeEecchhhhhhhcC----------CCCCCCCC----HHHHHHHHHc-cCCccCCCCC---CCCCHHHHHHHH
Confidence 677899999999999999999 67775532 1122222221 1122223321 124567999999
Q ss_pred HHhcCCcCCC---CcHHHHHHH
Q psy14889 406 ECWHQNANVR---LSALRVKKT 424 (443)
Q Consensus 406 ~cl~~dP~~R---ps~~evl~~ 424 (443)
+|+. +|.+| +|+.|+++.
T Consensus 285 ~lL~-~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 285 RLIT-NAENRLGRGGAHEIKSH 305 (377)
T ss_pred HHhc-CHhhcCCCCCHHHHhcC
Confidence 9997 77776 599998874
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=314.05 Aligned_cols=240 Identities=24% Similarity=0.313 Sum_probs=183.9
Q ss_pred eeeecCeEEEEEEE--CCceeEEEEeeccCccc----hHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEeeecccC
Q psy14889 144 IGKGRYGEVWRGVW--HGENVAVKIFFSRDEAS----WSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVTHYHS 217 (443)
Q Consensus 144 lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~----~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e~~~ 217 (443)
||+|+||+||++.. +++.||+|.+....... .....|+..+..++|+||+++.+++... ..+++||||++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~----~~~~lv~e~~~ 76 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTK----TDLCLVMTIMN 76 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCC----CeEEEEEeCCC
Confidence 69999999999987 58899999886432211 1223455566669999999999988765 45799999999
Q ss_pred cccHHHHhc-----ccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCccccc
Q psy14889 218 FGSLYDHLN-----RTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYS 292 (443)
Q Consensus 218 ~gsL~~~l~-----~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~~ 292 (443)
+|+|.+++. ...+++..+..++.||+.||.|||+. +|+||||||+||+++.++.+||+|||++..+.
T Consensus 77 ~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~--------~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 148 (280)
T cd05608 77 GGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR--------RIIYRDLKPENVLLDNDGNVRISDLGLAVELK 148 (280)
T ss_pred CCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC--------CcccCCCCHHHEEECCCCCEEEeeCccceecC
Confidence 999998773 24689999999999999999999998 99999999999999999999999999997654
Q ss_pred ccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCChH
Q psy14889 293 QLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFD 372 (443)
Q Consensus 293 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~~~ 372 (443)
..... .....||+.|+|||.+.+. .++.++|||||||++|||++| ..||....... ...
T Consensus 149 ~~~~~----~~~~~g~~~y~aPE~~~~~------~~~~~~DvwslG~il~el~~g----------~~pf~~~~~~~-~~~ 207 (280)
T cd05608 149 DGQSK----TKGYAGTPGFMAPELLQGE------EYDFSVDYFALGVTLYEMIAA----------RGPFRARGEKV-ENK 207 (280)
T ss_pred CCCcc----ccccCCCcCccCHHHhcCC------CCCccccHHHHHHHHHHHHhC----------CCCCCCCCcch-hHH
Confidence 32211 2334789999999999876 667899999999999999999 66775432111 111
Q ss_pred HHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCC-----cHHHHHH
Q psy14889 373 DMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRL-----SALRVKK 423 (443)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~ 423 (443)
.....+. ...... +...+..+.+++.+||+.||++|| +++++++
T Consensus 208 ~~~~~~~--~~~~~~-----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 208 ELKQRIL--NDSVTY-----PDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred HHHHhhc--ccCCCC-----cccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 1111111 111111 233667899999999999999999 6777775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=320.26 Aligned_cols=238 Identities=23% Similarity=0.310 Sum_probs=184.0
Q ss_pred cccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc----chHHHHHHHHHHhc-cCCCceeeeeeccccCCcccEE
Q psy14889 137 QISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA----SWSRETEIYSTVLL-RHENILGYIGSDMTSRNSCTQL 209 (443)
Q Consensus 137 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~----~~~~e~ei~~~~~l-~H~nIv~l~g~~~~~~~~~~~~ 209 (443)
+|.+.+.||+|+||.||+|+. +++.||+|++...... ......|...+..+ +|++|+++++++.+. ..+
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~----~~~ 76 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTM----DRL 76 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecC----CEE
Confidence 478899999999999999988 4679999988653211 11112233333223 689999999988765 458
Q ss_pred EeeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCc
Q psy14889 210 WLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA 288 (443)
Q Consensus 210 ~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla 288 (443)
++||||+++|+|.+++.. ..+++.++..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 77 ~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~--------~ivHrDlkp~Nill~~~~~~kL~DfG~~ 148 (323)
T cd05616 77 YFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK--------GIIYRDLKLDNVMLDSEGHIKIADFGMC 148 (323)
T ss_pred EEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC--------CEEecCCCHHHeEECCCCcEEEccCCCc
Confidence 999999999999998864 6799999999999999999999998 9999999999999999999999999998
Q ss_pred ccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCC
Q psy14889 289 VSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMD 368 (443)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~ 368 (443)
+....... ......||+.|+|||++.+. .++.++|||||||++|||+|| ..||...
T Consensus 149 ~~~~~~~~----~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwSlGvil~elltg----------~~Pf~~~---- 204 (323)
T cd05616 149 KENMWDGV----TTKTFCGTPDYIAPEIIAYQ------PYGKSVDWWAFGVLLYEMLAG----------QAPFEGE---- 204 (323)
T ss_pred eecCCCCC----ccccCCCChhhcCHHHhcCC------CCCCccchhchhHHHHHHHhC----------CCCCCCC----
Confidence 65432111 12345799999999999876 677899999999999999999 6777653
Q ss_pred CChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcH
Q psy14889 369 PSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSA 418 (443)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~ 418 (443)
....+...+.. ....+| ...+.++.+++.+||+.||++|++.
T Consensus 205 -~~~~~~~~i~~--~~~~~p-----~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 205 -DEDELFQSIME--HNVAYP-----KSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred -CHHHHHHHHHh--CCCCCC-----CcCCHHHHHHHHHHcccCHHhcCCC
Confidence 22233332221 222233 2356789999999999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=320.90 Aligned_cols=243 Identities=23% Similarity=0.294 Sum_probs=182.5
Q ss_pred ceeeeecCeEEEEEEE--CCceeEEEEeeccCcc----chHHHHHHHHHHhc-cCCCceeeeeeccccCCcccEEEeeec
Q psy14889 142 ECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA----SWSRETEIYSTVLL-RHENILGYIGSDMTSRNSCTQLWLVTH 214 (443)
Q Consensus 142 ~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~----~~~~e~ei~~~~~l-~H~nIv~l~g~~~~~~~~~~~~~lv~e 214 (443)
+.||+|+||.||++.. +++.||+|++...... ......|+..+..+ +||||+++++++.+. ..+++|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~----~~~~lv~e 76 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTE----SRLFFVIE 76 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcC----CEEEEEEe
Confidence 4699999999999988 5889999998653211 11122334443335 799999999998766 45899999
Q ss_pred ccCcccHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcccccc
Q psy14889 215 YHSFGSLYDHLN-RTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQ 293 (443)
Q Consensus 215 ~~~~gsL~~~l~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~~~ 293 (443)
|+++|+|.+++. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 77 ~~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~--------~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~ 148 (329)
T cd05588 77 FVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHER--------GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR 148 (329)
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC--------CeEecCCCHHHeEECCCCCEEECcCcccccccc
Confidence 999999998885 46799999999999999999999998 999999999999999999999999999864321
Q ss_pred cCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCC----CCC
Q psy14889 294 LSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVP----MDP 369 (443)
Q Consensus 294 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~----~~~ 369 (443)
... ......||..|+|||++.+. .++.++|||||||++|||++| ..||..... ...
T Consensus 149 ~~~----~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~~l~el~~g----------~~Pf~~~~~~~~~~~~ 208 (329)
T cd05588 149 PGD----TTSTFCGTPNYIAPEILRGE------DYGFSVDWWALGVLMFEMMAG----------RSPFDIVGMSDNPDQN 208 (329)
T ss_pred CCC----ccccccCCccccCHHHHcCC------CCCCccceechHHHHHHHHHC----------CCCccccccccccccc
Confidence 111 12345799999999999876 667899999999999999999 445532111 011
Q ss_pred ChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCc------HHHHHH
Q psy14889 370 SFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLS------ALRVKK 423 (443)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps------~~evl~ 423 (443)
..+...+.+. .....+| ...+.++.+++++||+.||.+||| +.++++
T Consensus 209 ~~~~~~~~~~--~~~~~~p-----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 209 TEDYLFQVIL--EKQIRIP-----RSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred chHHHHHHHH--cCCCCCC-----CCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 1122222222 1222333 235567999999999999999997 566653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=313.78 Aligned_cols=254 Identities=22% Similarity=0.385 Sum_probs=195.1
Q ss_pred cccccceeeeecCeEEEEEEEC-------CceeEEEEeeccCcc--chHHHHHHHHHHhccCCCceeeeeeccccCCccc
Q psy14889 137 QISLSECIGKGRYGEVWRGVWH-------GENVAVKIFFSRDEA--SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCT 207 (443)
Q Consensus 137 ~~~~~~~lG~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~~--~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~ 207 (443)
+|++.+.||+|+||.||+|... ...+|+|.+...... ......|+..+..++||||+++++.+....
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---- 76 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDG---- 76 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC----
Confidence 4778899999999999999863 246888877543322 122345666666799999999999987663
Q ss_pred EEEeeecccCcccHHHHhcc-------------------------cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCe
Q psy14889 208 QLWLVTHYHSFGSLYDHLNR-------------------------TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAI 262 (443)
Q Consensus 208 ~~~lv~e~~~~gsL~~~l~~-------------------------~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~i 262 (443)
..++++||+.+|+|.+++.. ..+++..++.++.|++.||.|||+. +|
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~--------~i 148 (290)
T cd05045 77 PLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM--------KL 148 (290)
T ss_pred CcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC--------Ce
Confidence 36899999999999998753 2478899999999999999999988 99
Q ss_pred EEeCCCCCCEEEcCCCcEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHH
Q psy14889 263 AHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLW 342 (443)
Q Consensus 263 iHrDlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ 342 (443)
+||||||+|||+++++.+||+|||+++......... ......++..|+|||.+.+. .++.++||||||+++|
T Consensus 149 vH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~--~~~~~~~~~~y~apE~~~~~------~~~~~~Di~slG~~l~ 220 (290)
T cd05045 149 VHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV--KRSKGRIPVKWMAIESLFDH------IYTTQSDVWSFGVLLW 220 (290)
T ss_pred ehhhhhhheEEEcCCCcEEeccccccccccCccchh--cccCCCCCccccCHHHHccC------CcchHhHHHHHHHHHH
Confidence 999999999999999999999999997654322111 11223456789999988765 5678999999999999
Q ss_pred HHHh-cccCCCcccccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHH
Q psy14889 343 EVCR-RTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRV 421 (443)
Q Consensus 343 ellt-g~~~~~~~~~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ev 421 (443)
||++ | ..||... ....+.+.... ......+ ..++..+.+++.+||+.||++||++.++
T Consensus 221 el~t~g----------~~p~~~~-----~~~~~~~~~~~-~~~~~~~-----~~~~~~~~~~i~~cl~~~P~~Rp~~~~i 279 (290)
T cd05045 221 EIVTLG----------GNPYPGI-----APERLFNLLKT-GYRMERP-----ENCSEEMYNLMLTCWKQEPDKRPTFADI 279 (290)
T ss_pred HHHhcC----------CCCCCCC-----CHHHHHHHHhC-CCCCCCC-----CCCCHHHHHHHHHHccCCcccCCCHHHH
Confidence 9998 7 6676543 22333333321 1222222 3356789999999999999999999999
Q ss_pred HHHHHHHhhc
Q psy14889 422 KKTLIKLACA 431 (443)
Q Consensus 422 l~~L~~l~~~ 431 (443)
++.|+++...
T Consensus 280 ~~~l~~~~~~ 289 (290)
T cd05045 280 SKELEKMMVK 289 (290)
T ss_pred HHHHHHHHhc
Confidence 9999998753
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=308.11 Aligned_cols=251 Identities=22% Similarity=0.397 Sum_probs=197.4
Q ss_pred hhccccccceeeeecCeEEEEEEE-CCceeEEEEeeccCccchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEee
Q psy14889 134 LAKQISLSECIGKGRYGEVWRGVW-HGENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLV 212 (443)
Q Consensus 134 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv 212 (443)
..++|++.++||+|+||.||+|.. +++.||+|.+..........+.|+..+..++|+||+++++++... ..+++
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~v 78 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQE-----PIYII 78 (260)
T ss_pred chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEccC-----CcEEE
Confidence 457899999999999999999987 678999998875544333445566666679999999999986432 36999
Q ss_pred ecccCcccHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcc
Q psy14889 213 THYHSFGSLYDHLNR---TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAV 289 (443)
Q Consensus 213 ~e~~~~gsL~~~l~~---~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~ 289 (443)
|||+++|+|.+++.. ..+++.++..++.|++.||+|||+. +++||||||+||++++++.++|+|||++.
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~--------~i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 150 (260)
T cd05067 79 TEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK--------NYIHRDLRAANILVSETLCCKIADFGLAR 150 (260)
T ss_pred EEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcC--------CeecccccHHhEEEcCCCCEEEccCccee
Confidence 999999999999854 4689999999999999999999988 99999999999999999999999999987
Q ss_pred cccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh-cccCCCcccccCCCCCCCCCCC
Q psy14889 290 SYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR-RTKANGIFEEYKAPYHDLVPMD 368 (443)
Q Consensus 290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt-g~~~~~~~~~~~~P~~~~~~~~ 368 (443)
........ ......++..|+|||++... .++.++||||||+++||+++ | ..||....
T Consensus 151 ~~~~~~~~---~~~~~~~~~~y~~pe~~~~~------~~~~~~Di~slG~~l~el~~~g----------~~p~~~~~--- 208 (260)
T cd05067 151 LIEDNEYT---AREGAKFPIKWTAPEAINYG------TFTIKSDVWSFGILLTEIVTYG----------RIPYPGMT--- 208 (260)
T ss_pred ecCCCCcc---cccCCcccccccCHHHhccC------CcCcccchHHHHHHHHHHHhCC----------CCCCCCCC---
Confidence 65532211 11223456789999998765 56689999999999999999 7 66776531
Q ss_pred CChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHH
Q psy14889 369 PSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIK 427 (443)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 427 (443)
.......... ..+...+ ...+.++.+++.+||+.||++|||++++++.|+.
T Consensus 209 --~~~~~~~~~~-~~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 209 --NPEVIQNLER-GYRMPRP-----DNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred --hHHHHHHHHc-CCCCCCC-----CCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 1222222221 2222222 2356789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=306.51 Aligned_cols=247 Identities=21% Similarity=0.367 Sum_probs=190.6
Q ss_pred ceeeeecCeEEEEEEEC--C---ceeEEEEeeccCcc--chHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEeeec
Q psy14889 142 ECIGKGRYGEVWRGVWH--G---ENVAVKIFFSRDEA--SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVTH 214 (443)
Q Consensus 142 ~~lG~G~fg~Vy~~~~~--~---~~vAvK~~~~~~~~--~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e 214 (443)
+.||+|+||.||+|.+. + ..+|+|.+...... ......|+..+..+.||||+++++++... ..++|||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~v~e 75 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKGE-----PLMLVME 75 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcCC-----ceEEEEE
Confidence 46999999999999872 2 67999988654432 22234566666679999999999987533 3689999
Q ss_pred ccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcccccc
Q psy14889 215 YHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQ 293 (443)
Q Consensus 215 ~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~~~ 293 (443)
|+++|+|.+++.+ ..+++..+..++.|++.||+|||+. +++|+||||+|||++.++.+||+|||+++....
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~--------~i~H~di~p~nili~~~~~~kl~df~~~~~~~~ 147 (257)
T cd05060 76 LAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESK--------HFVHRDLAARNVLLVNRHQAKISDFGMSRALGA 147 (257)
T ss_pred eCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhc--------CeeccCcccceEEEcCCCcEEeccccccceeec
Confidence 9999999999965 4599999999999999999999998 999999999999999999999999999976654
Q ss_pred cCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh-cccCCCcccccCCCCCCCCCCCCChH
Q psy14889 294 LSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR-RTKANGIFEEYKAPYHDLVPMDPSFD 372 (443)
Q Consensus 294 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt-g~~~~~~~~~~~~P~~~~~~~~~~~~ 372 (443)
...... ......++..|+|||.+.+. .++.++||||||+++|||++ | ..||... ...
T Consensus 148 ~~~~~~-~~~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~~l~~~~~~g----------~~p~~~~-----~~~ 205 (257)
T cd05060 148 GSDYYR-ATTAGRWPLKWYAPECINYG------KFSSKSDVWSYGVTLWEAFSYG----------AKPYGEM-----KGA 205 (257)
T ss_pred CCcccc-cccCccccccccCHHHhcCC------CCCccchHHHHHHHHHHHHcCC----------CCCcccC-----CHH
Confidence 322211 11122345689999998765 66789999999999999998 7 6677543 122
Q ss_pred HHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHh
Q psy14889 373 DMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLA 429 (443)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~ 429 (443)
.+...+.. ......+ ..++..+.+++.+||+.||++|||+.++++.|+++.
T Consensus 206 ~~~~~~~~-~~~~~~~-----~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 206 EVIAMLES-GERLPRP-----EECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred HHHHHHHc-CCcCCCC-----CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 33333322 1222222 335678999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=335.64 Aligned_cols=259 Identities=19% Similarity=0.277 Sum_probs=189.2
Q ss_pred hccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccchHHHHHHHHHHhccCCCceeeeeecccc----CCcccE
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIGSDMTS----RNSCTQ 208 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~----~~~~~~ 208 (443)
.++|++.+.||+|+||.||+|.. +++.||||++..... ....|+..+..++||||+++++++... ......
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~---~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 141 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQ---YKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIF 141 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcc---hHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceE
Confidence 46799999999999999999987 578999998754321 223456666669999999998876432 122235
Q ss_pred EEeeecccCcccHHHHhc-----ccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCC-cEEE
Q psy14889 209 LWLVTHYHSFGSLYDHLN-----RTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNG-TCVI 282 (443)
Q Consensus 209 ~~lv~e~~~~gsL~~~l~-----~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~-~~kl 282 (443)
+++||||+++ +|.+++. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++ .+||
T Consensus 142 l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~--------~IiHrDLKp~NILl~~~~~~vkL 212 (440)
T PTZ00036 142 LNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK--------FICHRDLKPQNLLIDPNTHTLKL 212 (440)
T ss_pred EEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC--------CEecCCcCHHHEEEcCCCCceee
Confidence 7899999985 7777663 35689999999999999999999998 999999999999998665 7999
Q ss_pred EecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCC
Q psy14889 283 ADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYH 362 (443)
Q Consensus 283 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~ 362 (443)
+|||+|+.+..... .....||+.|+|||++.+.. .++.++|||||||++|||++| ..||.
T Consensus 213 ~DFGla~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~-----~~~~~~DiwSlGvil~elltG----------~~pf~ 272 (440)
T PTZ00036 213 CDFGSAKNLLAGQR-----SVSYICSRFYRAPELMLGAT-----NYTTHIDLWSLGCIIAEMILG----------YPIFS 272 (440)
T ss_pred eccccchhccCCCC-----cccCCCCcCccCHHHhcCCC-----CCCcHHHHHHHHHHHHHHHhC----------CCCCC
Confidence 99999986643221 12346899999999986542 466899999999999999999 55665
Q ss_pred CCCCCCCChHHHHhhhhhcC--------------CCCCCCCC-------CCCchhHHHHHHHHHHHhcCCcCCCCcHHHH
Q psy14889 363 DLVPMDPSFDDMRKVICIDQ--------------QRPVLPNR-------WVSDSTLNAMTKVMKECWHQNANVRLSALRV 421 (443)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~-------~~~~~~~~~l~~li~~cl~~dP~~Rps~~ev 421 (443)
+... .+.+...+.... ....++.. ..+...+.++.+|+.+||..||.+|||+.|+
T Consensus 273 ~~~~----~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~ 348 (440)
T PTZ00036 273 GQSS----VDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEA 348 (440)
T ss_pred CCCh----HHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHH
Confidence 4321 111111111000 00001100 0112345789999999999999999999999
Q ss_pred HH--HHHHHh
Q psy14889 422 KK--TLIKLA 429 (443)
Q Consensus 422 l~--~L~~l~ 429 (443)
++ .+..+.
T Consensus 349 l~hp~f~~~~ 358 (440)
T PTZ00036 349 LADPFFDDLR 358 (440)
T ss_pred hCChhHHhhh
Confidence 84 344443
|
|
| >KOG0599|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=298.57 Aligned_cols=260 Identities=23% Similarity=0.335 Sum_probs=207.9
Q ss_pred hccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCc------c-----chHHHHHHHHHHhccCCCceeeeeeccc
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDE------A-----SWSRETEIYSTVLLRHENILGYIGSDMT 201 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~------~-----~~~~e~ei~~~~~l~H~nIv~l~g~~~~ 201 (443)
-+.|...+.||.|..++|.++.+ +|..+|+|++..... . ....|.+|+... ..||||+.+.+++.+
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv-~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQV-MGHPYIIDLQDVYES 94 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHh-cCCCcEEEeeeeccC
Confidence 35788889999999999999877 688999998743211 1 112234444443 589999999999987
Q ss_pred cCCcccEEEeeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcE
Q psy14889 202 SRNSCTQLWLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTC 280 (443)
Q Consensus 202 ~~~~~~~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~ 280 (443)
+ ..+++|+|.|+.|.|.++|.. -.+++....+|++|+..|+.|||.. +||||||||+|||+|++.++
T Consensus 95 ~----sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~--------~IVHRDLKpENILlddn~~i 162 (411)
T KOG0599|consen 95 D----AFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHAR--------NIVHRDLKPENILLDDNMNI 162 (411)
T ss_pred c----chhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHh--------hhhhcccChhheeeccccce
Confidence 7 568999999999999999965 5799999999999999999999999 99999999999999999999
Q ss_pred EEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCC
Q psy14889 281 VIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAP 360 (443)
Q Consensus 281 kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P 360 (443)
||+|||+|..+...... ...+||++|.|||.+..+.+.+...|+...|+||.||+||-|+.| ..|
T Consensus 163 ~isDFGFa~~l~~GekL-----relCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaG----------cpP 227 (411)
T KOG0599|consen 163 KISDFGFACQLEPGEKL-----RELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAG----------CPP 227 (411)
T ss_pred EEeccceeeccCCchhH-----HHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcC----------CCc
Confidence 99999999888765433 345899999999999988887777899999999999999999999 667
Q ss_pred CCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH--HHHHHhh
Q psy14889 361 YHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK--TLIKLAC 430 (443)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~--~L~~l~~ 430 (443)
|+.. ..-.+...+......-..| .| ++.+...++||.+||+.||.+|.|++|++. .+..++.
T Consensus 228 FwHR-----kQmlMLR~ImeGkyqF~sp-eW--adis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~ 291 (411)
T KOG0599|consen 228 FWHR-----KQMLMLRMIMEGKYQFRSP-EW--ADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQ 291 (411)
T ss_pred hhHH-----HHHHHHHHHHhcccccCCc-ch--hhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHH
Confidence 7653 1223334443333322222 34 346788999999999999999999999886 3444443
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=311.11 Aligned_cols=256 Identities=21% Similarity=0.339 Sum_probs=198.7
Q ss_pred ccccccceeeeecCeEEEEEEEC------CceeEEEEeeccCcc--chHHHHHHHHHHhccCCCceeeeeeccccCCccc
Q psy14889 136 KQISLSECIGKGRYGEVWRGVWH------GENVAVKIFFSRDEA--SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCT 207 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~~------~~~vAvK~~~~~~~~--~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~ 207 (443)
++|++.+.||+|+||.||+|.+. +..|++|++...... ......|+..+..++||||+++++++.... .
T Consensus 6 ~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~---~ 82 (280)
T cd05043 6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDG---E 82 (280)
T ss_pred hheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC---C
Confidence 68999999999999999999973 478999987643222 222345666666799999999999876643 2
Q ss_pred EEEeeecccCcccHHHHhcc---------cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCC
Q psy14889 208 QLWLVTHYHSFGSLYDHLNR---------TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNG 278 (443)
Q Consensus 208 ~~~lv~e~~~~gsL~~~l~~---------~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~ 278 (443)
..++++||+++|+|.+++.. ..+++.++..++.|++.||+|||+. +++||||||+||++++++
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~--------~i~H~di~p~nil~~~~~ 154 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR--------GVIHKDIAARNCVIDEEL 154 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC--------CEeecccCHhhEEEcCCC
Confidence 46899999999999999854 3588999999999999999999988 999999999999999999
Q ss_pred cEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh-cccCCCccccc
Q psy14889 279 TCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR-RTKANGIFEEY 357 (443)
Q Consensus 279 ~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt-g~~~~~~~~~~ 357 (443)
.+||+|||+++.+....... ......++..|+|||++.+. .++.++||||||+++||+++ |
T Consensus 155 ~~kl~d~g~~~~~~~~~~~~--~~~~~~~~~~y~apE~~~~~------~~~~~~Di~slG~~l~el~~~g---------- 216 (280)
T cd05043 155 QVKITDNALSRDLFPMDYHC--LGDNENRPVKWMALESLVNK------EYSSASDVWSFGVLLWELMTLG---------- 216 (280)
T ss_pred cEEECCCCCcccccCCceEE--eCCCCCcchhccCHHHHhcC------CCCchhhHHHhHHHHHHHhcCC----------
Confidence 99999999997654322111 11223466789999998765 56789999999999999999 7
Q ss_pred CCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhhc
Q psy14889 358 KAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLACA 431 (443)
Q Consensus 358 ~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~~ 431 (443)
..||.... ...+...+.. ......+ ..++..+.+++.+||+.||++|||+.++++.|+.+...
T Consensus 217 ~~p~~~~~-----~~~~~~~~~~-~~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 217 QTPYVEID-----PFEMAAYLKD-GYRLAQP-----INCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred CCCcCcCC-----HHHHHHHHHc-CCCCCCC-----CcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 66776532 1223332221 2222211 23567899999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=308.13 Aligned_cols=254 Identities=20% Similarity=0.351 Sum_probs=193.1
Q ss_pred ccccceeeeecCeEEEEEEEC-----CceeEEEEeeccCccc---hHHHHHHHHHHhccCCCceeeeeeccccCC--ccc
Q psy14889 138 ISLSECIGKGRYGEVWRGVWH-----GENVAVKIFFSRDEAS---WSRETEIYSTVLLRHENILGYIGSDMTSRN--SCT 207 (443)
Q Consensus 138 ~~~~~~lG~G~fg~Vy~~~~~-----~~~vAvK~~~~~~~~~---~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~--~~~ 207 (443)
|.+.+.||+|+||.||+|... +..||+|++....... .....|+..+..++||||+++++++..... ...
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 567889999999999999872 3679999886532221 122345556666999999999998765432 123
Q ss_pred EEEeeecccCcccHHHHhcc-------cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcE
Q psy14889 208 QLWLVTHYHSFGSLYDHLNR-------TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTC 280 (443)
Q Consensus 208 ~~~lv~e~~~~gsL~~~l~~-------~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~ 280 (443)
..++++||+++|+|..++.. ..+++..+..++.|++.||.|||+. +++||||||+||++++++.+
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~--------~i~H~dlkp~Nil~~~~~~~ 152 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR--------NFIHRDLAARNCMLREDMTV 152 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC--------CeeccccchheEEECCCCeE
Confidence 47899999999999998832 3589999999999999999999998 99999999999999999999
Q ss_pred EEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh-cccCCCcccccCC
Q psy14889 281 VIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR-RTKANGIFEEYKA 359 (443)
Q Consensus 281 kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt-g~~~~~~~~~~~~ 359 (443)
||+|||+++......... ......++..|+|||.+.+. .++.++||||||+++|||++ | ..
T Consensus 153 kl~dfg~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~------~~~~~~Dv~SlG~il~el~~~g----------~~ 214 (273)
T cd05035 153 CVADFGLSKKIYSGDYYR--QGRIAKMPVKWIAIESLADR------VYTSKSDVWAFGVTMWEIATRG----------QT 214 (273)
T ss_pred EECCccceeecccccccc--ccccccCCccccCHhhcccC------CCCcccchHHHHHHHHHHHhCC----------CC
Confidence 999999997664332211 11222356789999998765 56789999999999999999 6 56
Q ss_pred CCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHH
Q psy14889 360 PYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKL 428 (443)
Q Consensus 360 P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l 428 (443)
||.+.. .......+.. ...+..+ ..++..+.+++.+||+.||++|||+.|+++.|+++
T Consensus 215 p~~~~~-----~~~~~~~~~~-~~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 215 PYPGVE-----NHEIYDYLRH-GNRLKQP-----EDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCCCCC-----HHHHHHHHHc-CCCCCCC-----cCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 765532 1222222221 2222222 33667899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=327.97 Aligned_cols=250 Identities=21% Similarity=0.276 Sum_probs=188.3
Q ss_pred cccccceeeeecCeEEEEEEE--CCceeEEEEeeccCc----cchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEE
Q psy14889 137 QISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDE----ASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLW 210 (443)
Q Consensus 137 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~----~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~ 210 (443)
.|++.+.||+|+||.||+|+. +++.||+|++..... .......|+..+..++||||+++++.+.+. ..++
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~----~~~~ 77 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDK----DNLY 77 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeC----CEEE
Confidence 588899999999999999987 578999998865321 111223455555669999999999998876 4589
Q ss_pred eeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcc
Q psy14889 211 LVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAV 289 (443)
Q Consensus 211 lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~ 289 (443)
+||||+++|+|.+++.+ ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++.
T Consensus 78 lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~--------~ivHrDlKp~NILl~~~g~~kL~DFGla~ 149 (382)
T cd05625 78 FVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKM--------GFIHRDIKPDNILIDRDGHIKLTDFGLCT 149 (382)
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CeecCCCCHHHEEECCCCCEEEeECCCCc
Confidence 99999999999999865 5688999999999999999999998 99999999999999999999999999975
Q ss_pred cccccCC-------------------------------------------cCCCCCCCcccccCcccccccccccccCcC
Q psy14889 290 SYSQLSN-------------------------------------------KMDIPPNPRVGTKRYMSPEILDESINMDCF 326 (443)
Q Consensus 290 ~~~~~~~-------------------------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 326 (443)
.+..... ..........||+.|+|||++.+.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~------ 223 (382)
T cd05625 150 GFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRT------ 223 (382)
T ss_pred cccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCC------
Confidence 4321000 000001234799999999999866
Q ss_pred CCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHH
Q psy14889 327 ESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKE 406 (443)
Q Consensus 327 ~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 406 (443)
.++.++|||||||++|||++| ..||.... ..+...+... .......|. ....+.++.+++.+
T Consensus 224 ~~~~~~DiwSlGvil~elltG----------~~Pf~~~~----~~~~~~~i~~-~~~~~~~p~---~~~~s~~~~~li~~ 285 (382)
T cd05625 224 GYTQLCDWWSVGVILYEMLVG----------QPPFLAQT----PLETQMKVIN-WQTSLHIPP---QAKLSPEASDLIIK 285 (382)
T ss_pred CCCCeeeEEechHHHHHHHhC----------CCCCCCCC----HHHHHHHHHc-cCCCcCCCC---cccCCHHHHHHHHH
Confidence 677899999999999999999 67776531 1122222221 112222222 12345678888888
Q ss_pred HhcCCcCCCCc---HHHHHH
Q psy14889 407 CWHQNANVRLS---ALRVKK 423 (443)
Q Consensus 407 cl~~dP~~Rps---~~evl~ 423 (443)
++ .||++|++ +.++++
T Consensus 286 l~-~~p~~R~~~~~~~ei~~ 304 (382)
T cd05625 286 LC-RGPEDRLGKNGADEIKA 304 (382)
T ss_pred Hc-cCHhHcCCCCCHHHHhc
Confidence 76 59999997 887765
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=309.52 Aligned_cols=254 Identities=25% Similarity=0.394 Sum_probs=198.2
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc----chHHHHHHHHHHhccCCCceeeeeeccccCCcccEE
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA----SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQL 209 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~----~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~ 209 (443)
++|++.+.||+|+||.||++.. +++.+|||.+...... ......|+..+..++||||+++++++... ...
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~----~~~ 77 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIED----NEL 77 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeC----CeE
Confidence 4688899999999999999996 6899999987543211 11223466666669999999999998766 357
Q ss_pred EeeecccCcccHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEe
Q psy14889 210 WLVTHYHSFGSLYDHLNR-----TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIAD 284 (443)
Q Consensus 210 ~lv~e~~~~gsL~~~l~~-----~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~D 284 (443)
+++|||+++++|.+++.. ..+++..+..++.||+.||.|||+. +++|+||||+||+++.++.++|+|
T Consensus 78 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--------~i~H~dl~p~nili~~~~~~~l~d 149 (267)
T cd08229 78 NIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR--------RVMHRDIKPANVFITATGVVKLGD 149 (267)
T ss_pred EEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC--------CeecCCCCHHHEEEcCCCCEEECc
Confidence 999999999999998852 4589999999999999999999998 999999999999999999999999
Q ss_pred cCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCC
Q psy14889 285 FGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDL 364 (443)
Q Consensus 285 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~ 364 (443)
||++......... .....|+..|+|||.+.+. .++.++|+||||+++|||++| ..||...
T Consensus 150 fg~~~~~~~~~~~----~~~~~~~~~~~ape~~~~~------~~~~~~Dv~slG~il~~l~~g----------~~p~~~~ 209 (267)
T cd08229 150 LGLGRFFSSKTTA----AHSLVGTPYYMSPERIHEN------GYNFKSDIWSLGCLLYEMAAL----------QSPFYGD 209 (267)
T ss_pred chhhhccccCCcc----cccccCCcCccCHHHhcCC------CccchhhHHHHHHHHHHHHhC----------CCCcccc
Confidence 9998765432211 1234688899999998765 566899999999999999999 6676542
Q ss_pred CCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHh
Q psy14889 365 VPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLA 429 (443)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~ 429 (443)
.. ......+.+. ....+..+ ....+..+.+++.+||+.||++|||+.+|++.+.+++
T Consensus 210 ~~---~~~~~~~~~~-~~~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 210 KM---NLYSLCKKIE-QCDYPPLP----SDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred cc---hHHHHhhhhh-cCCCCCCC----cccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 11 1122222221 11122222 1336678999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-40 Score=306.56 Aligned_cols=245 Identities=22% Similarity=0.373 Sum_probs=188.8
Q ss_pred eeeeecCeEEEEEEE----CCceeEEEEeeccCccc---hHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEeeecc
Q psy14889 143 CIGKGRYGEVWRGVW----HGENVAVKIFFSRDEAS---WSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVTHY 215 (443)
Q Consensus 143 ~lG~G~fg~Vy~~~~----~~~~vAvK~~~~~~~~~---~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e~ 215 (443)
.||+|+||.||+|.+ ++..+|+|++....... .....|+..+..++||||+++++++... ..++||||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~lv~e~ 76 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEAE-----SWMLVMEL 76 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-----CcEEEEec
Confidence 589999999999976 46789999876443221 1223455566669999999999987533 35899999
Q ss_pred cCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCccccccc
Q psy14889 216 HSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQL 294 (443)
Q Consensus 216 ~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~~~~ 294 (443)
+++|+|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~--------~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~ 148 (257)
T cd05116 77 AELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEET--------NFVHRDLAARNVLLVTQHYAKISDFGLSKALGAD 148 (257)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CEeecccchhhEEEcCCCeEEECCCccccccCCC
Confidence 999999999964 5689999999999999999999988 9999999999999999999999999999766433
Q ss_pred CCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh-cccCCCcccccCCCCCCCCCCCCChHH
Q psy14889 295 SNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR-RTKANGIFEEYKAPYHDLVPMDPSFDD 373 (443)
Q Consensus 295 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt-g~~~~~~~~~~~~P~~~~~~~~~~~~~ 373 (443)
..... ......++..|+|||.+... .++.++||||||+++|||++ | ..||.... ...
T Consensus 149 ~~~~~-~~~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~~l~el~t~g----------~~p~~~~~-----~~~ 206 (257)
T cd05116 149 ENYYK-AKTHGKWPVKWYAPECMNYY------KFSSKSDVWSFGVLMWEAFSYG----------QKPYKGMK-----GNE 206 (257)
T ss_pred CCeee-ecCCCCCCccccCHhHhccC------CcCchhHHHHHHHHHHHHHhCC----------CCCCCCCC-----HHH
Confidence 22111 11222346789999998765 56679999999999999998 7 66776531 223
Q ss_pred HHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHH
Q psy14889 374 MRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKL 428 (443)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l 428 (443)
....+.. ...+..+ ..++.++.++|.+||+.||++||++.+|.+.|++.
T Consensus 207 ~~~~i~~-~~~~~~~-----~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 207 VTQMIES-GERMECP-----QRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred HHHHHHC-CCCCCCC-----CCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 3333322 2233333 23667899999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=322.22 Aligned_cols=237 Identities=25% Similarity=0.331 Sum_probs=181.5
Q ss_pred ceeeeecCeEEEEEEE--CCceeEEEEeeccCccc----hHHHHHH-HHHHhccCCCceeeeeeccccCCcccEEEeeec
Q psy14889 142 ECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEAS----WSRETEI-YSTVLLRHENILGYIGSDMTSRNSCTQLWLVTH 214 (443)
Q Consensus 142 ~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~----~~~e~ei-~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e 214 (443)
+.||+|+||.||+|+. +++.||+|++....... .....|. ..+..++||||+++++++... ..+++|||
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~----~~~~lv~e 76 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTA----DKLYFVLD 76 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcC----CeEEEEEe
Confidence 4699999999999998 57789999986532111 1111222 223448999999999998766 45799999
Q ss_pred ccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcccccc
Q psy14889 215 YHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQ 293 (443)
Q Consensus 215 ~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~~~ 293 (443)
|+++|+|.+++.. ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~--------giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~ 148 (325)
T cd05602 77 YINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSL--------NIVYRDLKPENILLDSQGHIVLTDFGLCKENIE 148 (325)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CeEecCCCHHHeEECCCCCEEEccCCCCccccc
Confidence 9999999999865 5688999999999999999999998 999999999999999999999999999875432
Q ss_pred cCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCChHH
Q psy14889 294 LSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFDD 373 (443)
Q Consensus 294 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~~~~ 373 (443)
... ......||+.|+|||++.+. .++.++|||||||++|||++| ..||... ....
T Consensus 149 ~~~----~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~el~~g----------~~pf~~~-----~~~~ 203 (325)
T cd05602 149 HNG----TTSTFCGTPEYLAPEVLHKQ------PYDRTVDWWCLGAVLYEMLYG----------LPPFYSR-----NTAE 203 (325)
T ss_pred CCC----CcccccCCccccCHHHHcCC------CCCCccccccccHHHHHHhcC----------CCCCCCC-----CHHH
Confidence 111 12345799999999999876 667899999999999999999 6777653 1222
Q ss_pred HHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHH
Q psy14889 374 MRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVK 422 (443)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl 422 (443)
....+... ....+ ...+..+.+++.+||+.||.+||++.+.+
T Consensus 204 ~~~~i~~~--~~~~~-----~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 204 MYDNILNK--PLQLK-----PNITNSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred HHHHHHhC--CcCCC-----CCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence 22222111 11111 23567899999999999999999887543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=314.83 Aligned_cols=256 Identities=22% Similarity=0.419 Sum_probs=196.8
Q ss_pred hccccccceeeeecCeEEEEEEEC---------CceeEEEEeeccCcc--chHHHHHHHHHHhc-cCCCceeeeeecccc
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVWH---------GENVAVKIFFSRDEA--SWSRETEIYSTVLL-RHENILGYIGSDMTS 202 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~~---------~~~vAvK~~~~~~~~--~~~~e~ei~~~~~l-~H~nIv~l~g~~~~~ 202 (443)
..+|.+.+.||+|+||.||+|++. +..||+|.+...... ....+.|+..+..+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 367899999999999999999751 346999987543221 12234455555557 899999999998766
Q ss_pred CCcccEEEeeecccCcccHHHHhcc-----------------cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEe
Q psy14889 203 RNSCTQLWLVTHYHSFGSLYDHLNR-----------------TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHR 265 (443)
Q Consensus 203 ~~~~~~~~lv~e~~~~gsL~~~l~~-----------------~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHr 265 (443)
...++||||+++|+|.+++.+ ..+++.+++.++.||+.||.|||+. +++||
T Consensus 94 ----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~--------givH~ 161 (304)
T cd05101 94 ----GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ--------KCIHR 161 (304)
T ss_pred ----CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC--------Ceeec
Confidence 347999999999999999854 2478888999999999999999998 99999
Q ss_pred CCCCCCEEEcCCCcEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHH
Q psy14889 266 DIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVC 345 (443)
Q Consensus 266 Dlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ell 345 (443)
||||+|||++.++.+||+|||+++......... ......++..|+|||++.+. .++.++||||||+++|||+
T Consensus 162 dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~~l~el~ 233 (304)
T cd05101 162 DLAARNVLVTENNVMKIADFGLARDVNNIDYYK--KTTNGRLPVKWMAPEALFDR------VYTHQSDVWSFGVLMWEIF 233 (304)
T ss_pred ccccceEEEcCCCcEEECCCccceecccccccc--cccCCCCCceeeCchhhccC------CCCchhhHHHHHHHHHHHH
Confidence 999999999999999999999997664322211 11223456789999998765 6678999999999999999
Q ss_pred h-cccCCCcccccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHH
Q psy14889 346 R-RTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKT 424 (443)
Q Consensus 346 t-g~~~~~~~~~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 424 (443)
+ | ..||... ....+.+.+.. ..+...+ ..++..+.+++.+||+.+|++|||+.++++.
T Consensus 234 ~~g----------~~p~~~~-----~~~~~~~~~~~-~~~~~~~-----~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 234 TLG----------GSPYPGI-----PVEELFKLLKE-GHRMDKP-----ANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred cCC----------CCCcccC-----CHHHHHHHHHc-CCcCCCC-----CCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 8 5 5566443 23333333322 1222222 3466789999999999999999999999999
Q ss_pred HHHHhhc
Q psy14889 425 LIKLACA 431 (443)
Q Consensus 425 L~~l~~~ 431 (443)
|+++...
T Consensus 293 l~~~~~~ 299 (304)
T cd05101 293 LDRILTL 299 (304)
T ss_pred HHHHHHh
Confidence 9998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=313.67 Aligned_cols=254 Identities=23% Similarity=0.454 Sum_probs=194.9
Q ss_pred hccccccceeeeecCeEEEEEEEC-------CceeEEEEeeccCccc--hHHHHHHHHHHhc-cCCCceeeeeeccccCC
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVWH-------GENVAVKIFFSRDEAS--WSRETEIYSTVLL-RHENILGYIGSDMTSRN 204 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~~~--~~~e~ei~~~~~l-~H~nIv~l~g~~~~~~~ 204 (443)
.++|++.+.||+|+||.||++.+. ...+|+|.+....... .....|+..+..+ +|+||+++++++...
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~-- 88 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE-- 88 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC--
Confidence 367999999999999999999873 2578999876432211 1122444455557 899999999998766
Q ss_pred cccEEEeeecccCcccHHHHhcc-----------------cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCC
Q psy14889 205 SCTQLWLVTHYHSFGSLYDHLNR-----------------TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDI 267 (443)
Q Consensus 205 ~~~~~~lv~e~~~~gsL~~~l~~-----------------~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDl 267 (443)
..++++|||+++|+|.++++. ..+++..++.++.|++.||.|||+. +|+||||
T Consensus 89 --~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~--------~ivH~dl 158 (293)
T cd05053 89 --GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK--------KCIHRDL 158 (293)
T ss_pred --CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC--------Ccccccc
Confidence 347999999999999999853 3588999999999999999999988 9999999
Q ss_pred CCCCEEEcCCCcEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh-
Q psy14889 268 KSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR- 346 (443)
Q Consensus 268 k~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt- 346 (443)
||+|||++.++.+||+|||+++.+........ .....++..|+|||.+.+. .++.++|||||||++|||++
T Consensus 159 kp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~il~el~~~ 230 (293)
T cd05053 159 AARNVLVTEDHVMKIADFGLARDIHHIDYYRK--TTNGRLPVKWMAPEALFDR------VYTHQSDVWSFGVLLWEIFTL 230 (293)
T ss_pred ceeeEEEcCCCeEEeCccccccccccccceec--cCCCCCCccccCHHHhccC------CcCcccceeehhhHHHHHhcC
Confidence 99999999999999999999986654221111 1222356789999998765 56789999999999999997
Q ss_pred cccCCCcccccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHH
Q psy14889 347 RTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLI 426 (443)
Q Consensus 347 g~~~~~~~~~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 426 (443)
| ..||... ......+.... ...+..+ ..++..+.+|+.+||+.||++|||+.++++.|+
T Consensus 231 g----------~~p~~~~-----~~~~~~~~~~~-~~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~ 289 (293)
T cd05053 231 G----------GSPYPGI-----PVEELFKLLKE-GYRMEKP-----QNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLD 289 (293)
T ss_pred C----------CCCCCCC-----CHHHHHHHHHc-CCcCCCC-----CCCCHHHHHHHHHHcccCcccCcCHHHHHHHHH
Confidence 6 5666543 22233333322 2222222 235678999999999999999999999999999
Q ss_pred HHh
Q psy14889 427 KLA 429 (443)
Q Consensus 427 ~l~ 429 (443)
++.
T Consensus 290 ~~~ 292 (293)
T cd05053 290 RML 292 (293)
T ss_pred Hhh
Confidence 875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=311.55 Aligned_cols=251 Identities=23% Similarity=0.404 Sum_probs=195.3
Q ss_pred hccccccceeeeecCeEEEEEEEC-------CceeEEEEeeccCcc--chHHHHHHHHHHhccCCCceeeeeeccccCCc
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVWH-------GENVAVKIFFSRDEA--SWSRETEIYSTVLLRHENILGYIGSDMTSRNS 205 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~~--~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~ 205 (443)
.++|++.+.||+|+||.||+|... +..||+|.+...... ......|+..+..++||||+++++++...
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--- 81 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG--- 81 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC---
Confidence 468999999999999999999874 267999987544321 11223455555668999999999998776
Q ss_pred ccEEEeeecccCcccHHHHhcc-----------cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEE
Q psy14889 206 CTQLWLVTHYHSFGSLYDHLNR-----------TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILV 274 (443)
Q Consensus 206 ~~~~~lv~e~~~~gsL~~~l~~-----------~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl 274 (443)
...++||||+++|+|.+++.. ..+++..++.++.|++.||.|||+. +++||||||+|||+
T Consensus 82 -~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~--------~i~H~di~p~nill 152 (277)
T cd05032 82 -QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK--------KFVHRDLAARNCMV 152 (277)
T ss_pred -CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CccccccChheEEE
Confidence 347999999999999999853 2367889999999999999999988 99999999999999
Q ss_pred cCCCcEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh-cccCCCc
Q psy14889 275 KTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR-RTKANGI 353 (443)
Q Consensus 275 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt-g~~~~~~ 353 (443)
+.++.+||+|||+++.+...... .......++..|+|||.+.+. .++.++|||||||++||++| |
T Consensus 153 ~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~il~el~t~g------ 218 (277)
T cd05032 153 AEDLTVKIGDFGMTRDIYETDYY--RKGGKGLLPVRWMAPESLKDG------VFTTKSDVWSFGVVLWEMATLA------ 218 (277)
T ss_pred cCCCCEEECCcccchhhccCccc--ccCCCCCccccccCHHHHhcC------CCCcccchHHHHHHHHHhhccC------
Confidence 99999999999998765432211 111234567899999998765 56789999999999999998 6
Q ss_pred ccccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHH
Q psy14889 354 FEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLI 426 (443)
Q Consensus 354 ~~~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 426 (443)
..||... ......+.+. ....+..+ ..++..+.+++.+||+.+|++|||+.++++.|+
T Consensus 219 ----~~p~~~~-----~~~~~~~~~~-~~~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 219 ----EQPYQGL-----SNEEVLKFVI-DGGHLDLP-----ENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred ----CCCCccC-----CHHHHHHHHh-cCCCCCCC-----CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 6677543 2233333333 22333333 235678999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=305.88 Aligned_cols=245 Identities=22% Similarity=0.355 Sum_probs=188.1
Q ss_pred eeeeecCeEEEEEEEC----CceeEEEEeeccCccc--hHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEeeeccc
Q psy14889 143 CIGKGRYGEVWRGVWH----GENVAVKIFFSRDEAS--WSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVTHYH 216 (443)
Q Consensus 143 ~lG~G~fg~Vy~~~~~----~~~vAvK~~~~~~~~~--~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e~~ 216 (443)
.||+|+||.||+|.+. +..||+|++....... .....|+..+..++||||+++++++... ..++||||+
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~-----~~~lv~e~~ 76 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAE-----ALMLVMEMA 76 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcCC-----CeEEEEEeC
Confidence 3899999999999873 4569999886543222 1223555666669999999999987533 368999999
Q ss_pred CcccHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCccccccc
Q psy14889 217 SFGSLYDHLN--RTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQL 294 (443)
Q Consensus 217 ~~gsL~~~l~--~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~~~~ 294 (443)
++|+|.+++. ...+++.+++.++.|++.||.|||+. +++||||||+|||++.++.+||+|||++......
T Consensus 77 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~--------~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 148 (257)
T cd05115 77 SGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGK--------NFVHRDLAARNVLLVNQHYAKISDFGLSKALGAD 148 (257)
T ss_pred CCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhc--------CeeecccchheEEEcCCCcEEeccCCccccccCC
Confidence 9999999995 35789999999999999999999998 9999999999999999999999999999765432
Q ss_pred CCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh-cccCCCcccccCCCCCCCCCCCCChHH
Q psy14889 295 SNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR-RTKANGIFEEYKAPYHDLVPMDPSFDD 373 (443)
Q Consensus 295 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt-g~~~~~~~~~~~~P~~~~~~~~~~~~~ 373 (443)
..... ......++..|+|||.+... .++.++||||||+++||+++ | ..||.+.. ...
T Consensus 149 ~~~~~-~~~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~~l~el~~~g----------~~p~~~~~-----~~~ 206 (257)
T cd05115 149 DSYYK-ARSAGKWPLKWYAPECINFR------KFSSRSDVWSYGITMWEAFSYG----------QKPYKKMK-----GPE 206 (257)
T ss_pred cccee-ccCCCCCCcccCCHHHHccC------CCCchhhHHHHHHHHHHHhcCC----------CCCcCcCC-----HHH
Confidence 22111 11122345789999998765 56689999999999999996 7 67776542 122
Q ss_pred HHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHH
Q psy14889 374 MRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKL 428 (443)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l 428 (443)
....+.. ..++..+ ..++.++.+++.+||+.||++||++.+|.+.|+.+
T Consensus 207 ~~~~~~~-~~~~~~~-----~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 207 VMSFIEQ-GKRLDCP-----AECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred HHHHHHC-CCCCCCC-----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 2232222 2223332 33567899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=313.52 Aligned_cols=247 Identities=23% Similarity=0.304 Sum_probs=191.1
Q ss_pred cccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc----chHHHHHHHHHHhccCCCceeeeeeccccCCcccEEE
Q psy14889 137 QISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA----SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLW 210 (443)
Q Consensus 137 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~----~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~ 210 (443)
+|+..+.||+|+||.||++.. +++.||+|++...... ......|+..+..++||||+++++.+.+. ..++
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----~~~~ 76 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETK----DALC 76 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCC----CeEE
Confidence 477889999999999999987 5889999988643211 11223466666669999999999998766 3589
Q ss_pred eeecccCcccHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCC
Q psy14889 211 LVTHYHSFGSLYDHLNR---TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGL 287 (443)
Q Consensus 211 lv~e~~~~gsL~~~l~~---~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGl 287 (443)
+||||+++|+|.+++.. ..+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||+
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--------~ivH~dlkp~Nil~~~~~~~~l~Dfg~ 148 (285)
T cd05605 77 LVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE--------RIVYRDLKPENILLDDYGHIRISDLGL 148 (285)
T ss_pred EEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHC--------CcEecCCCHHHEEECCCCCEEEeeCCC
Confidence 99999999999988743 4689999999999999999999998 999999999999999999999999999
Q ss_pred cccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCC
Q psy14889 288 AVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPM 367 (443)
Q Consensus 288 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~ 367 (443)
+........ .....|+..|+|||++.+. .++.++|||||||++|||++| ..||......
T Consensus 149 ~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~------~~~~~~Diws~G~~l~el~~g----------~~pf~~~~~~ 207 (285)
T cd05605 149 AVEIPEGET-----IRGRVGTVGYMAPEVVKNE------RYTFSPDWWGLGCLIYEMIEG----------KSPFRQRKEK 207 (285)
T ss_pred ceecCCCCc-----cccccCCCCccCcHHhcCC------CCCccccchhHHHHHHHHHHC----------CCCCCCCchh
Confidence 876542211 1234789999999999765 667899999999999999999 6777653211
Q ss_pred CCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCC-----cHHHHHHH
Q psy14889 368 DPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRL-----SALRVKKT 424 (443)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~ 424 (443)
...+.+...+. ......+ ...+..+.+|+.+||+.||++|| +++++++.
T Consensus 208 -~~~~~~~~~~~--~~~~~~~-----~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 208 -VKREEVERRVK--EDQEEYS-----EKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred -hHHHHHHHHhh--hcccccC-----cccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 11112222221 1112222 23567799999999999999999 88888653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=316.17 Aligned_cols=256 Identities=23% Similarity=0.418 Sum_probs=196.3
Q ss_pred hccccccceeeeecCeEEEEEEEC---------CceeEEEEeeccCcc--chHHHHHHHHHHhc-cCCCceeeeeecccc
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVWH---------GENVAVKIFFSRDEA--SWSRETEIYSTVLL-RHENILGYIGSDMTS 202 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~~---------~~~vAvK~~~~~~~~--~~~~e~ei~~~~~l-~H~nIv~l~g~~~~~ 202 (443)
.++|.+.+.||+|+||.||++.+. ...+|+|.+...... ......|+..+..+ +||||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 367999999999999999999862 246999988653211 11223455555556 799999999998766
Q ss_pred CCcccEEEeeecccCcccHHHHhcc-----------------cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEe
Q psy14889 203 RNSCTQLWLVTHYHSFGSLYDHLNR-----------------TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHR 265 (443)
Q Consensus 203 ~~~~~~~~lv~e~~~~gsL~~~l~~-----------------~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHr 265 (443)
...++||||+++|+|.+++.. ..+++.+++.++.|++.||+|||+. +++||
T Consensus 97 ----~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~--------gi~H~ 164 (307)
T cd05098 97 ----GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK--------KCIHR 164 (307)
T ss_pred ----CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC--------Ccccc
Confidence 347999999999999999964 2488899999999999999999988 99999
Q ss_pred CCCCCCEEEcCCCcEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHH
Q psy14889 266 DIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVC 345 (443)
Q Consensus 266 Dlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ell 345 (443)
||||+|||++.++.+||+|||+++......... ......++..|+|||.+.+. .++.++|||||||++|||+
T Consensus 165 dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~------~~~~~~DvwslG~~l~el~ 236 (307)
T cd05098 165 DLAARNVLVTEDNVMKIADFGLARDIHHIDYYK--KTTNGRLPVKWMAPEALFDR------IYTHQSDVWSFGVLLWEIF 236 (307)
T ss_pred cccHHheEEcCCCcEEECCCcccccccccchhh--ccccCCCccceeChHHhccC------CCCcHHHHHHHHHHHHHHH
Confidence 999999999999999999999987654321111 01122345689999998765 5678999999999999999
Q ss_pred h-cccCCCcccccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHH
Q psy14889 346 R-RTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKT 424 (443)
Q Consensus 346 t-g~~~~~~~~~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 424 (443)
+ | ..||... ..+.+...+.. ......+ ..++.++.+++.+||+.+|++|||+.++++.
T Consensus 237 ~~g----------~~p~~~~-----~~~~~~~~~~~-~~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 237 TLG----------GSPYPGV-----PVEELFKLLKE-GHRMDKP-----SNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred cCC----------CCCCCcC-----CHHHHHHHHHc-CCCCCCC-----CcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 8 5 5566542 22333333322 2222222 2356789999999999999999999999999
Q ss_pred HHHHhhc
Q psy14889 425 LIKLACA 431 (443)
Q Consensus 425 L~~l~~~ 431 (443)
|+++...
T Consensus 296 l~~~~~~ 302 (307)
T cd05098 296 LDRILAL 302 (307)
T ss_pred HHHHHHH
Confidence 9998865
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=328.10 Aligned_cols=252 Identities=21% Similarity=0.277 Sum_probs=189.5
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCc----cchHHHHHHHHHHhccCCCceeeeeeccccCCcccEE
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDE----ASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQL 209 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~----~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~ 209 (443)
++|++.+.||+|+||.||+++. +++.||||++..... .......|+..+..++||||+++++.+.+. ..+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~----~~~ 76 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDK----DNL 76 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcC----CEE
Confidence 3689999999999999999987 588999998854321 112223455555669999999999998766 468
Q ss_pred EeeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCc
Q psy14889 210 WLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA 288 (443)
Q Consensus 210 ~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla 288 (443)
++||||+++|+|.+++.+ ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+|
T Consensus 77 ~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~--------~ivHrDlkp~Nill~~~~~ikL~DFG~a 148 (376)
T cd05598 77 YFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKM--------GFIHRDIKPDNILIDRDGHIKLTDFGLC 148 (376)
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CeEeCCCCHHHEEECCCCCEEEEeCCCC
Confidence 999999999999999865 5678899999999999999999998 9999999999999999999999999998
Q ss_pred ccccccCCc---------------------------------------CCCCCCCcccccCcccccccccccccCcCCCC
Q psy14889 289 VSYSQLSNK---------------------------------------MDIPPNPRVGTKRYMSPEILDESINMDCFESF 329 (443)
Q Consensus 289 ~~~~~~~~~---------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~ 329 (443)
..+...... .........||+.|+|||++.+. .++
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~ 222 (376)
T cd05598 149 TGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRT------GYT 222 (376)
T ss_pred ccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCC------CCC
Confidence 533210000 00001234799999999999876 667
Q ss_pred CccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhc
Q psy14889 330 KKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWH 409 (443)
Q Consensus 330 ~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 409 (443)
.++|||||||++|||++| ..||....+ .+........ ......+. ....+.++.+++.+|+
T Consensus 223 ~~~DiwSlGvilyell~G----------~~Pf~~~~~----~~~~~~i~~~-~~~~~~~~---~~~~s~~~~~li~~l~- 283 (376)
T cd05598 223 QLCDWWSVGVILYEMLVG----------QPPFLADTP----AETQLKVINW-ETTLHIPS---QAKLSREASDLILRLC- 283 (376)
T ss_pred cceeeeeccceeeehhhC----------CCCCCCCCH----HHHHHHHhcc-CccccCCC---CCCCCHHHHHHHHHHh-
Confidence 899999999999999999 777765321 1121222111 11112221 1235667889999977
Q ss_pred CCcCCCC---cHHHHHHH
Q psy14889 410 QNANVRL---SALRVKKT 424 (443)
Q Consensus 410 ~dP~~Rp---s~~evl~~ 424 (443)
.+|.+|+ |+.++++.
T Consensus 284 ~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 284 CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred cCHhhcCCCCCHHHHhCC
Confidence 5999999 88988764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=305.92 Aligned_cols=249 Identities=24% Similarity=0.407 Sum_probs=193.8
Q ss_pred ccccccceeeeecCeEEEEEEEC-CceeEEEEeeccCccchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEeeec
Q psy14889 136 KQISLSECIGKGRYGEVWRGVWH-GENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVTH 214 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e 214 (443)
++|.+.+.||+|+||.||+|.+. +..+|+|.+............|+..+..++|+|++++++++... ..+++||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~v~e 80 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSEE-----PIYIVTE 80 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEcCC-----CcEEEEE
Confidence 57889999999999999999884 45799998765443333334566666669999999999987432 3589999
Q ss_pred ccCcccHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcccc
Q psy14889 215 YHSFGSLYDHLNR---TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSY 291 (443)
Q Consensus 215 ~~~~gsL~~~l~~---~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~ 291 (443)
|+++|+|.+++.. ..+++..+..++.|++.||.|||+. +++|+||||+||++++++.+||+|||++...
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~--------~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~ 152 (260)
T cd05069 81 FMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM--------NYIHRDLRAANILVGDNLVCKIADFGLARLI 152 (260)
T ss_pred cCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CEeecccCcceEEEcCCCeEEECCCccceEc
Confidence 9999999999964 3478999999999999999999988 9999999999999999999999999999765
Q ss_pred cccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh-cccCCCcccccCCCCCCCCCCCCC
Q psy14889 292 SQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR-RTKANGIFEEYKAPYHDLVPMDPS 370 (443)
Q Consensus 292 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt-g~~~~~~~~~~~~P~~~~~~~~~~ 370 (443)
....... .....++..|+|||...+. .++.++||||||+++|||+| | ..||.+..
T Consensus 153 ~~~~~~~---~~~~~~~~~y~~Pe~~~~~------~~~~~~Di~slG~~l~el~t~g----------~~p~~~~~----- 208 (260)
T cd05069 153 EDNEYTA---RQGAKFPIKWTAPEAALYG------RFTIKSDVWSFGILLTELVTKG----------RVPYPGMV----- 208 (260)
T ss_pred cCCcccc---cCCCccchhhCCHHHhccC------CcChHHHHHHHHHHHHHHHhCC----------CCCCCCCC-----
Confidence 4322111 1223466789999988765 66789999999999999999 6 66776532
Q ss_pred hHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHH
Q psy14889 371 FDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIK 427 (443)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 427 (443)
.......+.. ...+..+ ...+..+.+++.+||+.||++||+++++++.|++
T Consensus 209 ~~~~~~~~~~-~~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 209 NREVLEQVER-GYRMPCP-----QGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred HHHHHHHHHc-CCCCCCC-----cccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1222222221 1222222 2356789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-40 Score=305.62 Aligned_cols=244 Identities=23% Similarity=0.372 Sum_probs=186.4
Q ss_pred ceeeeecCeEEEEEEE--CCceeEEEEeeccCcc--chHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEeeecccC
Q psy14889 142 ECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA--SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVTHYHS 217 (443)
Q Consensus 142 ~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~--~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e~~~ 217 (443)
+.||+|+||.||+|.. +++.||+|.+...... ......|+..+..++||||+++++++.... ..++||||++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~e~~~ 76 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQ----PIYIVMELVQ 76 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCC----CeEEEEeecc
Confidence 4689999999999987 6889999987543221 122334555556699999999999987763 4799999999
Q ss_pred cccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcccccccC
Q psy14889 218 FGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLS 295 (443)
Q Consensus 218 ~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~~~~~ 295 (443)
+++|.+++.. ..+++.+++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 77 ~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~--------~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 148 (252)
T cd05084 77 GGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESK--------HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGV 148 (252)
T ss_pred CCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CccccccchheEEEcCCCcEEECccccCccccccc
Confidence 9999999864 3589999999999999999999998 99999999999999999999999999987544221
Q ss_pred CcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh-cccCCCcccccCCCCCCCCCCCCChHHH
Q psy14889 296 NKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR-RTKANGIFEEYKAPYHDLVPMDPSFDDM 374 (443)
Q Consensus 296 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt-g~~~~~~~~~~~~P~~~~~~~~~~~~~~ 374 (443)
... ......++..|+|||.+.++ .++.++||||||+++|||++ | ..||.... ....
T Consensus 149 ~~~--~~~~~~~~~~y~aPE~~~~~------~~~~~~Dv~slG~il~e~~~~~----------~~p~~~~~-----~~~~ 205 (252)
T cd05084 149 YAS--TGGMKQIPVKWTAPEALNYG------RYSSESDVWSFGILLWEAFSLG----------AVPYANLS-----NQQT 205 (252)
T ss_pred ccc--cCCCCCCceeecCchhhcCC------CCChHHHHHHHHHHHHHHHhCC----------CCCccccC-----HHHH
Confidence 110 01111234579999998776 56789999999999999998 6 56665431 1222
Q ss_pred HhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHH
Q psy14889 375 RKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLI 426 (443)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 426 (443)
...+.. ......+ ..++..+.+++.+||+.||++|||+.++++.|+
T Consensus 206 ~~~~~~-~~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 206 REAIEQ-GVRLPCP-----ELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred HHHHHc-CCCCCCc-----ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 222211 1122222 335678999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG0199|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-41 Score=327.83 Aligned_cols=249 Identities=25% Similarity=0.432 Sum_probs=202.1
Q ss_pred ccccccceeeeecCeEEEEEEEC---Cc--eeEEEEeeccCc----cchHHHHHHHHHHhccCCCceeeeeeccccCCcc
Q psy14889 136 KQISLSECIGKGRYGEVWRGVWH---GE--NVAVKIFFSRDE----ASWSRETEIYSTVLLRHENILGYIGSDMTSRNSC 206 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~~---~~--~vAvK~~~~~~~----~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~ 206 (443)
+++.+.++||+|.||.|++|.|+ |+ .||||.+..... +++.+|+.+ +.+|+|||+++|||+..+..
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~--M~~L~H~hliRLyGvVl~qp--- 184 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASH--MLKLQHPHLIRLYGVVLDQP--- 184 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHH--HHhccCcceeEEeeeeccch---
Confidence 56788899999999999999994 43 689999865433 344555544 44599999999999988742
Q ss_pred cEEEeeecccCcccHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEE
Q psy14889 207 TQLWLVTHYHSFGSLYDHLNR---TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIA 283 (443)
Q Consensus 207 ~~~~lv~e~~~~gsL~~~l~~---~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~ 283 (443)
+.||+|+++.|+|.+.|++ ..|.......++.|||.||.||.++ ++|||||.++|+|+...-.+||+
T Consensus 185 --~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLesk--------rlvHRDLAARNlllasprtVKI~ 254 (1039)
T KOG0199|consen 185 --AMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESK--------RLVHRDLAARNLLLASPRTVKIC 254 (1039)
T ss_pred --hhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhh--------hhhhhhhhhhhheecccceeeee
Confidence 5899999999999999975 4577888899999999999999999 89999999999999999999999
Q ss_pred ecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCC
Q psy14889 284 DFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHD 363 (443)
Q Consensus 284 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~ 363 (443)
||||.+.+......+.. .....-...|.|||.+... .++.+||||+|||++|||+|+ ++.||.+
T Consensus 255 DFGLmRaLg~ned~Yvm-~p~rkvPfAWCaPEsLrh~------kFShaSDvWmyGVTiWEMFty---------GEePW~G 318 (1039)
T KOG0199|consen 255 DFGLMRALGENEDMYVM-APQRKVPFAWCAPESLRHR------KFSHASDVWMYGVTIWEMFTY---------GEEPWVG 318 (1039)
T ss_pred cccceeccCCCCcceEe-cCCCcCcccccCHhHhccc------cccccchhhhhhhhHHhhhcc---------CCCCCCC
Confidence 99999988876554422 2233445789999999987 778899999999999999987 4889988
Q ss_pred CCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHH
Q psy14889 364 LVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLI 426 (443)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 426 (443)
.. -..+.+.+. +..+...| ..|++.++++|++||..+|++|||+..|.+.+-
T Consensus 319 ~~-----g~qIL~~iD-~~erLpRP-----k~csedIY~imk~cWah~paDRptFsair~~~~ 370 (1039)
T KOG0199|consen 319 CR-----GIQILKNID-AGERLPRP-----KYCSEDIYQIMKNCWAHNPADRPTFSAIREDLV 370 (1039)
T ss_pred CC-----HHHHHHhcc-ccccCCCC-----CCChHHHHHHHHHhccCCccccccHHHHHHhHH
Confidence 63 234444444 34444433 459999999999999999999999999985443
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=314.92 Aligned_cols=256 Identities=24% Similarity=0.405 Sum_probs=193.2
Q ss_pred ccccccceeeeecCeEEEEEEE--CCc--eeEEEEeeccCcc--chHHHHHHHHHHhc-cCCCceeeeeeccccCCcccE
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGE--NVAVKIFFSRDEA--SWSRETEIYSTVLL-RHENILGYIGSDMTSRNSCTQ 208 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~--~vAvK~~~~~~~~--~~~~e~ei~~~~~l-~H~nIv~l~g~~~~~~~~~~~ 208 (443)
++|++.+.||+|+||.||+|.+ ++. .+|+|.+...... ......|+..+..+ +||||+++++++.... .
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~----~ 82 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG----Y 82 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCC----C
Confidence 5789999999999999999987 344 4577766432211 11223455555557 8999999999987763 4
Q ss_pred EEeeecccCcccHHHHhccc-----------------CCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCC
Q psy14889 209 LWLVTHYHSFGSLYDHLNRT-----------------TLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKN 271 (443)
Q Consensus 209 ~~lv~e~~~~gsL~~~l~~~-----------------~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~N 271 (443)
+++||||+++|+|.+++++. .+++.+++.++.|++.||+|||+. +++||||||+|
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~--------gi~H~dlkp~N 154 (303)
T cd05088 83 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK--------QFIHRDLAARN 154 (303)
T ss_pred ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC--------Cccccccchhe
Confidence 79999999999999998532 478999999999999999999998 99999999999
Q ss_pred EEEcCCCcEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh-cccC
Q psy14889 272 ILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR-RTKA 350 (443)
Q Consensus 272 iLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt-g~~~ 350 (443)
||++.++.+||+|||++........ .....++..|+|||.+.+. .++.++|||||||++|||+| |
T Consensus 155 ili~~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~il~ellt~g--- 220 (303)
T cd05088 155 ILVGENYVAKIADFGLSRGQEVYVK-----KTMGRLPVRWMAIESLNYS------VYTTNSDVWSYGVLLWEIVSLG--- 220 (303)
T ss_pred EEecCCCcEEeCccccCcccchhhh-----cccCCCcccccCHHHHhcc------CCcccccchhhhhHHHHHHhcC---
Confidence 9999999999999999863321111 1112345679999988765 56689999999999999998 7
Q ss_pred CCcccccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhh
Q psy14889 351 NGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLAC 430 (443)
Q Consensus 351 ~~~~~~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~ 430 (443)
..||.... ..+..+... .......+ ...+..+.+|+.+||+.+|++||++.++++.|.++.+
T Consensus 221 -------~~p~~~~~-----~~~~~~~~~-~~~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~ 282 (303)
T cd05088 221 -------GTPYCGMT-----CAELYEKLP-QGYRLEKP-----LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 282 (303)
T ss_pred -------CCCcccCC-----hHHHHHHHh-cCCcCCCC-----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 66775431 122222221 11111122 2245679999999999999999999999999999877
Q ss_pred ccccc
Q psy14889 431 ADMYI 435 (443)
Q Consensus 431 ~~~~~ 435 (443)
.....
T Consensus 283 ~~~~~ 287 (303)
T cd05088 283 ERKTY 287 (303)
T ss_pred hhhhh
Confidence 65543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=310.55 Aligned_cols=266 Identities=23% Similarity=0.359 Sum_probs=196.0
Q ss_pred ccccccceeeeecCeEEEEEEE------CCceeEEEEeeccCcc--chHHHHHHHHHHhccCCCceeeeeeccccCCccc
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW------HGENVAVKIFFSRDEA--SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCT 207 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~------~~~~vAvK~~~~~~~~--~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~ 207 (443)
+.|++.+.||+|+||.||++++ ++..||+|.+...... ....+.|+..+..++||||+++++++..... .
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--~ 81 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGG--N 81 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC--C
Confidence 4578899999999999999975 3678999988644322 2233456667777999999999998876532 3
Q ss_pred EEEeeecccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEec
Q psy14889 208 QLWLVTHYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADF 285 (443)
Q Consensus 208 ~~~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~Df 285 (443)
..++||||+++++|.+++.+ ..+++.++..++.|++.||+|||+. +++||||||+||+++.++.+||+||
T Consensus 82 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~--------gi~H~dlkp~Nil~~~~~~~~l~df 153 (284)
T cd05079 82 GIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSR--------QYVHRDLAARNVLVESEHQVKIGDF 153 (284)
T ss_pred ceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC--------CeeecccchheEEEcCCCCEEECCC
Confidence 47899999999999999864 3589999999999999999999998 9999999999999999999999999
Q ss_pred CCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCc----ccccCCCC
Q psy14889 286 GLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGI----FEEYKAPY 361 (443)
Q Consensus 286 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~----~~~~~~P~ 361 (443)
|+++.+........ ......++..|+|||.+.+. .++.++||||||+++|||+|++.+... +.....|.
T Consensus 154 g~~~~~~~~~~~~~-~~~~~~~~~~y~apE~~~~~------~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~ 226 (284)
T cd05079 154 GLTKAIETDKEYYT-VKDDLDSPVFWYAPECLIQS------KFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPT 226 (284)
T ss_pred ccccccccCcccee-ecCCCCCCccccCHHHhccC------CCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccc
Confidence 99976653322111 11234567789999998765 667899999999999999998543210 00000010
Q ss_pred CCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHH
Q psy14889 362 HDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKL 428 (443)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l 428 (443)
.. ............ .......+ ..++..+.+|+.+||+.||++|||+.++++.|+.+
T Consensus 227 ~~----~~~~~~~~~~~~-~~~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 227 HG----QMTVTRLVRVLE-EGKRLPRP-----PNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred cc----cccHHHHHHHHH-cCccCCCC-----CCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 00 011111111111 11111112 33667899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=313.10 Aligned_cols=257 Identities=21% Similarity=0.430 Sum_probs=197.6
Q ss_pred ccccccceeeeecCeEEEEEEE--CCc----eeEEEEeeccCccc--hHHHHHHHHHHhccCCCceeeeeeccccCCccc
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGE----NVAVKIFFSRDEAS--WSRETEIYSTVLLRHENILGYIGSDMTSRNSCT 207 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~----~vAvK~~~~~~~~~--~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~ 207 (443)
++|+..+.||+|+||.||+|.+ +|. .||+|.+....... .....|+..+..++||||++++|++....
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~---- 82 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPT---- 82 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCCC----
Confidence 5788889999999999999987 444 47888775433221 12234556666699999999999986542
Q ss_pred EEEeeecccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEec
Q psy14889 208 QLWLVTHYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADF 285 (443)
Q Consensus 208 ~~~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~Df 285 (443)
.++++||+++|+|.+++.. ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+||
T Consensus 83 -~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~--------~ivH~dikp~Nill~~~~~~kL~Df 153 (303)
T cd05110 83 -IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEER--------RLVHRDLAARNVLVKSPNHVKITDF 153 (303)
T ss_pred -ceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhc--------CeeccccccceeeecCCCceEEccc
Confidence 4689999999999999865 3589999999999999999999998 9999999999999999999999999
Q ss_pred CCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh-cccCCCcccccCCCCCCC
Q psy14889 286 GLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR-RTKANGIFEEYKAPYHDL 364 (443)
Q Consensus 286 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt-g~~~~~~~~~~~~P~~~~ 364 (443)
|+++.+....... ......++..|+|||.+.+. .++.++||||||+++|||++ | +.||.+.
T Consensus 154 g~~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~------~~~~~~DiwslG~~l~el~t~g----------~~p~~~~ 215 (303)
T cd05110 154 GLARLLEGDEKEY--NADGGKMPIKWMALECIHYR------KFTHQSDVWSYGVTIWELMTFG----------GKPYDGI 215 (303)
T ss_pred cccccccCccccc--ccCCCccccccCCHHHhccC------CCChHHHHHHHHHHHHHHHhCC----------CCCCCCC
Confidence 9997665332211 11223456789999998765 66789999999999999997 6 5676553
Q ss_pred CCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhhcccc
Q psy14889 365 VPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLACADMY 434 (443)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~~~~~ 434 (443)
........+.. ...+..+ ..++..+.+++.+||..||++||++.++++.|+++......
T Consensus 216 -----~~~~~~~~~~~-~~~~~~~-----~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~~~ 274 (303)
T cd05110 216 -----PTREIPDLLEK-GERLPQP-----PICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQR 274 (303)
T ss_pred -----CHHHHHHHHHC-CCCCCCC-----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhchhh
Confidence 22333333322 2222222 22456799999999999999999999999999998766543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=312.99 Aligned_cols=253 Identities=25% Similarity=0.443 Sum_probs=192.2
Q ss_pred ccccccceeeeecCeEEEEEEEC--Cc--eeEEEEeeccCc--cchHHHHHHHHHHhc-cCCCceeeeeeccccCCcccE
Q psy14889 136 KQISLSECIGKGRYGEVWRGVWH--GE--NVAVKIFFSRDE--ASWSRETEIYSTVLL-RHENILGYIGSDMTSRNSCTQ 208 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~~--~~--~vAvK~~~~~~~--~~~~~e~ei~~~~~l-~H~nIv~l~g~~~~~~~~~~~ 208 (443)
++|++.+.||+|+||.||+|... +. .+++|.++.... .......|+..+.++ +||||+++++++... ..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~----~~ 77 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENR----GY 77 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccC----Cc
Confidence 57899999999999999999873 33 468887753221 112234455555556 799999999998765 34
Q ss_pred EEeeecccCcccHHHHhccc-----------------CCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCC
Q psy14889 209 LWLVTHYHSFGSLYDHLNRT-----------------TLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKN 271 (443)
Q Consensus 209 ~~lv~e~~~~gsL~~~l~~~-----------------~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~N 271 (443)
+++|+||+++|+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+|
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~--------~ivH~dlkp~N 149 (297)
T cd05089 78 LYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK--------QFIHRDLAARN 149 (297)
T ss_pred ceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC--------CcccCcCCcce
Confidence 79999999999999998542 478899999999999999999998 99999999999
Q ss_pred EEEcCCCcEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh-cccC
Q psy14889 272 ILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR-RTKA 350 (443)
Q Consensus 272 iLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt-g~~~ 350 (443)
||+++++.+||+|||++........ ......+..|+|||.+.+. .++.++|||||||++|||++ |
T Consensus 150 ill~~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~------~~~~~~DvwSlG~il~el~t~g--- 215 (297)
T cd05089 150 VLVGENLASKIADFGLSRGEEVYVK-----KTMGRLPVRWMAIESLNYS------VYTTKSDVWSFGVLLWEIVSLG--- 215 (297)
T ss_pred EEECCCCeEEECCcCCCccccceec-----cCCCCcCccccCchhhccC------CCCchhhHHHHHHHHHHHHcCC---
Confidence 9999999999999999864321111 1111234579999998765 66789999999999999997 7
Q ss_pred CCcccccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhh
Q psy14889 351 NGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLAC 430 (443)
Q Consensus 351 ~~~~~~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~ 430 (443)
..||.... .......+.. ...+..+ ..++..+.+|+.+||+.||.+|||+.++++.|+.+.+
T Consensus 216 -------~~pf~~~~-----~~~~~~~~~~-~~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~ 277 (297)
T cd05089 216 -------GTPYCGMT-----CAELYEKLPQ-GYRMEKP-----RNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLE 277 (297)
T ss_pred -------CCCCCCCC-----HHHHHHHHhc-CCCCCCC-----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 66776532 2222222211 1122222 2356789999999999999999999999999998886
Q ss_pred cc
Q psy14889 431 AD 432 (443)
Q Consensus 431 ~~ 432 (443)
..
T Consensus 278 ~~ 279 (297)
T cd05089 278 AR 279 (297)
T ss_pred hh
Confidence 44
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=311.05 Aligned_cols=249 Identities=33% Similarity=0.499 Sum_probs=192.1
Q ss_pred ccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccchHHH---HHHHHHHhccCCCceeeeeeccccCCcccEEEee
Q psy14889 138 ISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEASWSRE---TEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLV 212 (443)
Q Consensus 138 ~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~e---~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv 212 (443)
|++.+.||+|+||+||++.. +++.+|+|++..........+ .|+..+..++||||+++++++... ...++|
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~----~~~~~v 76 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDD----NYLYIV 76 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEES----SEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccc----cccccc
Confidence 67789999999999999998 466899999987655443332 366666668999999999998875 457899
Q ss_pred ecccCcccHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcccc
Q psy14889 213 THYHSFGSLYDHLN-RTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSY 291 (443)
Q Consensus 213 ~e~~~~gsL~~~l~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~ 291 (443)
|||+.+++|.+++. ...+++..+..++.|++.||.|||+. +|+|+||||+||++++++.++|+|||.+...
T Consensus 77 ~~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~--------~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~ 148 (260)
T PF00069_consen 77 MEYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSK--------GIVHRDIKPENILLDENGEVKLIDFGSSVKL 148 (260)
T ss_dssp EEEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHT--------TEEESSBSGGGEEESTTSEEEESSGTTTEES
T ss_pred ccccccccccccccccccccccccccccccccccccccccc--------ccccccccccccccccccccccccccccccc
Confidence 99999999999997 68899999999999999999999999 9999999999999999999999999998754
Q ss_pred cccCCcCCCCCCCcccccCcccccccc-cccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCC
Q psy14889 292 SQLSNKMDIPPNPRVGTKRYMSPEILD-ESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPS 370 (443)
Q Consensus 292 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~ 370 (443)
..... ......+|..|+|||++. +. ..+.++||||+|+++|+|++| ..||... .
T Consensus 149 ~~~~~----~~~~~~~~~~y~aPE~~~~~~------~~~~~~Di~slG~il~~l~~~----------~~p~~~~-----~ 203 (260)
T PF00069_consen 149 SENNE----NFNPFVGTPEYMAPEVLQQGK------KYTRKSDIWSLGIILYELLTG----------KLPFEES-----N 203 (260)
T ss_dssp TSTTS----EBSSSSSSGGGSCHHHHTTTS------SBSTHHHHHHHHHHHHHHHHS----------SSSSTTS-----S
T ss_pred ccccc----ccccccccccccccccccccc------ccccccccccccccccccccc----------ccccccc-----c
Confidence 21111 123457889999999987 44 666899999999999999999 6676653 1
Q ss_pred hHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 371 FDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
.............................+.+++.+||+.||++|||+.++++
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 204 SDDQLEIIEKILKRPLPSSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred chhhhhhhhhcccccccccccccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11111111100000000000001112478999999999999999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=313.46 Aligned_cols=254 Identities=23% Similarity=0.409 Sum_probs=195.5
Q ss_pred hccccccceeeeecCeEEEEEEE-------CCceeEEEEeeccCccc--hHHHHHHHHHHhc-cCCCceeeeeeccccCC
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVW-------HGENVAVKIFFSRDEAS--WSRETEIYSTVLL-RHENILGYIGSDMTSRN 204 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~-------~~~~vAvK~~~~~~~~~--~~~e~ei~~~~~l-~H~nIv~l~g~~~~~~~ 204 (443)
.++|.+.+.||+|+||.||++.. .+..||||++....... .....|+..+..+ +||||+++++++....
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~- 112 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG- 112 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC-
Confidence 36799999999999999999975 23479999876543221 1223455566668 7999999999987663
Q ss_pred cccEEEeeecccCcccHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEE
Q psy14889 205 SCTQLWLVTHYHSFGSLYDHLNRT---TLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCV 281 (443)
Q Consensus 205 ~~~~~~lv~e~~~~gsL~~~l~~~---~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~k 281 (443)
..++||||+++|+|.+++++. .+++.++..++.|++.||.|||+. +|+|+||||+|||++.++.+|
T Consensus 113 ---~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~--------~ivH~dlkp~Nil~~~~~~~~ 181 (302)
T cd05055 113 ---PILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK--------NCIHRDLAARNVLLTHGKIVK 181 (302)
T ss_pred ---ceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC--------CeehhhhccceEEEcCCCeEE
Confidence 479999999999999999642 389999999999999999999998 999999999999999999999
Q ss_pred EEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh-cccCCCcccccCCC
Q psy14889 282 IADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR-RTKANGIFEEYKAP 360 (443)
Q Consensus 282 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt-g~~~~~~~~~~~~P 360 (443)
|+|||+++.+....... ......++..|+|||.+.+. .++.++|||||||++|||++ | ..|
T Consensus 182 l~dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~------~~~~~~DiwslGvil~el~t~g----------~~p 243 (302)
T cd05055 182 ICDFGLARDIMNDSNYV--VKGNARLPVKWMAPESIFNC------VYTFESDVWSYGILLWEIFSLG----------SNP 243 (302)
T ss_pred ECCCcccccccCCCcee--ecCCCCcccccCCHhhhccC------CCCcHhHHHHHHHHHHHHHhCC----------CCC
Confidence 99999997664332111 11223467789999998776 56789999999999999998 7 566
Q ss_pred CCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHH
Q psy14889 361 YHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKL 428 (443)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l 428 (443)
|.... ..+...+... ....+..+ ...+.++.+++.+||+.+|++|||+.|+++.|+++
T Consensus 244 ~~~~~----~~~~~~~~~~-~~~~~~~~-----~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 244 YPGMP----VDSKFYKLIK-EGYRMAQP-----EHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred cCCCC----chHHHHHHHH-cCCcCCCC-----CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 65432 1222223222 12222222 22456899999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >KOG0610|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=306.09 Aligned_cols=248 Identities=23% Similarity=0.340 Sum_probs=200.1
Q ss_pred ccccccceeeeecCeEEEEEEECC--ceeEEEEeeccCc------cchHHHHHHHHHHhccCCCceeeeeeccccCCccc
Q psy14889 136 KQISLSECIGKGRYGEVWRGVWHG--ENVAVKIFFSRDE------ASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCT 207 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~~~--~~vAvK~~~~~~~------~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~ 207 (443)
+.|++.+.||.|.-|+||+++..+ ..+|+|++.+... .+.+.|+||+.+ ++||-+..||..+..+ .
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~--lDHPFlPTLYa~fet~----~ 150 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSL--LDHPFLPTLYASFETD----K 150 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHh--cCCCccchhhheeecc----c
Confidence 578899999999999999999954 7899999865322 233446777766 9999999999999887 4
Q ss_pred EEEeeecccCcccHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEe
Q psy14889 208 QLWLVTHYHSFGSLYDHLNR---TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIAD 284 (443)
Q Consensus 208 ~~~lv~e~~~~gsL~~~l~~---~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~D 284 (443)
..++|||||+||+|...+++ +.+++..+..++.+|+.||+|||-. |||.|||||+||||.++|++-|+|
T Consensus 151 ~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHml--------GivYRDLKPENILvredGHIMLsD 222 (459)
T KOG0610|consen 151 YSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHML--------GIVYRDLKPENILVREDGHIMLSD 222 (459)
T ss_pred eeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhh--------ceeeccCCcceeEEecCCcEEeee
Confidence 67999999999999999875 4699999999999999999999988 999999999999999999999999
Q ss_pred cCCccccccc--------------------------------C-Cc-------------------CCCCCCCcccccCcc
Q psy14889 285 FGLAVSYSQL--------------------------------S-NK-------------------MDIPPNPRVGTKRYM 312 (443)
Q Consensus 285 fGla~~~~~~--------------------------------~-~~-------------------~~~~~~~~~gt~~y~ 312 (443)
|.|+...... . .. .......++||-.|.
T Consensus 223 FDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYl 302 (459)
T KOG0610|consen 223 FDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYL 302 (459)
T ss_pred ccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccc
Confidence 9987432110 0 00 001123568999999
Q ss_pred cccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCC
Q psy14889 313 SPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWV 392 (443)
Q Consensus 313 aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (443)
|||++.+. ..+.++|+|+|||++|||+.| ..||.+.. ..+.+.+++. +.+.+|..
T Consensus 303 APEvI~G~------GHgsAVDWWtfGIflYEmLyG----------~TPFKG~~----~~~Tl~NIv~---~~l~Fp~~-- 357 (459)
T KOG0610|consen 303 APEVIRGE------GHGSAVDWWTFGIFLYEMLYG----------TTPFKGSN----NKETLRNIVG---QPLKFPEE-- 357 (459)
T ss_pred cceeeecC------CCCchhhHHHHHHHHHHHHhC----------CCCcCCCC----chhhHHHHhc---CCCcCCCC--
Confidence 99999987 666899999999999999999 88998752 3345555553 34445542
Q ss_pred CchhHHHHHHHHHHHhcCCcCCCCc----HHHHHH
Q psy14889 393 SDSTLNAMTKVMKECWHQNANVRLS----ALRVKK 423 (443)
Q Consensus 393 ~~~~~~~l~~li~~cl~~dP~~Rps----~~evl~ 423 (443)
...+..+++||++.|.+||++|.. +.||.+
T Consensus 358 -~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 358 -PEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKR 391 (459)
T ss_pred -CcchhHHHHHHHHHhccChhhhhccccchHHhhc
Confidence 246778999999999999999998 666644
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-40 Score=310.43 Aligned_cols=240 Identities=23% Similarity=0.325 Sum_probs=182.2
Q ss_pred eeeecCeEEEEEEE--CCceeEEEEeeccCcc----chHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEeeecccC
Q psy14889 144 IGKGRYGEVWRGVW--HGENVAVKIFFSRDEA----SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVTHYHS 217 (443)
Q Consensus 144 lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~----~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e~~~ 217 (443)
||+|+||.||++.. +|+.+|+|.+...... ......|+..+..++||||+++++++... ..+++||||++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~----~~~~lv~e~~~ 76 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESK----THLCLVMSLMN 76 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecC----CeEEEEEecCC
Confidence 69999999999987 5899999988542211 11122345555669999999999988765 45899999999
Q ss_pred cccHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCccccccc
Q psy14889 218 FGSLYDHLNR---TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQL 294 (443)
Q Consensus 218 ~gsL~~~l~~---~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~~~~ 294 (443)
+|+|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 77 g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~--------~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~ 148 (277)
T cd05607 77 GGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSM--------DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG 148 (277)
T ss_pred CCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC--------CEEEccCChHhEEEcCCCCEEEeeceeeeecCCC
Confidence 9999988743 3588999999999999999999998 9999999999999999999999999998765432
Q ss_pred CCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCChHHH
Q psy14889 295 SNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFDDM 374 (443)
Q Consensus 295 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~~~~~ 374 (443)
.. .....||..|+|||++.+. .++.++|||||||++|||++| ..||....... ....+
T Consensus 149 ~~-----~~~~~~~~~y~aPE~~~~~------~~~~~~DvwslGv~l~el~~g----------~~p~~~~~~~~-~~~~~ 206 (277)
T cd05607 149 KT-----ITQRAGTNGYMAPEILKEE------PYSYPVDWFAMGCSIYEMVAG----------RTPFKDHKEKV-AKEEL 206 (277)
T ss_pred ce-----eeccCCCCCccCHHHHccC------CCCCchhHHHHHHHHHHHHhC----------CCCCCCCcchh-hHHHH
Confidence 21 1234688999999999876 567899999999999999999 66665432111 11122
Q ss_pred HhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 375 RKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
...... .....+ ....+.++.+|+.+||+.||++||++.|+++
T Consensus 207 ~~~~~~--~~~~~~----~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~ 249 (277)
T cd05607 207 KRRTLE--DEVKFE----HQNFTEESKDICRLFLAKKPEDRLGSREKND 249 (277)
T ss_pred HHHhhc--cccccc----cccCCHHHHHHHHHHhccCHhhCCCCccchh
Confidence 111111 111111 1235678999999999999999999977654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=304.97 Aligned_cols=252 Identities=22% Similarity=0.357 Sum_probs=186.9
Q ss_pred ceeeeecCeEEEEEEEC-----CceeEEEEeeccCcc--chHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEeeec
Q psy14889 142 ECIGKGRYGEVWRGVWH-----GENVAVKIFFSRDEA--SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVTH 214 (443)
Q Consensus 142 ~~lG~G~fg~Vy~~~~~-----~~~vAvK~~~~~~~~--~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e 214 (443)
+.||+|+||.||+|.+. +..||+|.+...... ......|+..+..++||||+++++++...+. ..+++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~---~~~lv~e 77 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEG---SPLVVLP 77 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCC---CcEEEEe
Confidence 46899999999999862 357999987543221 1122345555666999999999998764432 3689999
Q ss_pred ccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCccccc
Q psy14889 215 YHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYS 292 (443)
Q Consensus 215 ~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~~ 292 (443)
|+.+|+|.+++.+ ..+++..++.++.|++.||.|||+. +++||||||+|||+++++.+||+|||+++...
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~--------~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~ 149 (262)
T cd05058 78 YMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASK--------KFVHRDLAARNCMLDESFTVKVADFGLARDIY 149 (262)
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC--------CccccccCcceEEEcCCCcEEECCcccccccc
Confidence 9999999999964 3467888899999999999999988 99999999999999999999999999997554
Q ss_pred ccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCChH
Q psy14889 293 QLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFD 372 (443)
Q Consensus 293 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~~~ 372 (443)
..............++..|+|||.+.+. .++.++||||||+++|||++|+ ..||... ...
T Consensus 150 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~~l~el~~~~---------~~~~~~~-----~~~ 209 (262)
T cd05058 150 DKEYYSVHNHTGAKLPVKWMALESLQTQ------KFTTKSDVWSFGVLLWELMTRG---------APPYPDV-----DSF 209 (262)
T ss_pred CCcceeecccccCcCCccccChhHhccC------ccchHHHHHHHHHHHHHHHcCC---------CCCCCCC-----CHH
Confidence 3211111111233467789999998765 6678999999999999999962 3344432 112
Q ss_pred HHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhh
Q psy14889 373 DMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLAC 430 (443)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~ 430 (443)
.....+. ....+..+ ..++..+.+++.+||+.+|++||++.++++.|+++..
T Consensus 210 ~~~~~~~-~~~~~~~~-----~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 210 DITVYLL-QGRRLLQP-----EYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred HHHHHHh-cCCCCCCC-----CcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 2222221 12222222 2345679999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=309.19 Aligned_cols=251 Identities=22% Similarity=0.377 Sum_probs=191.6
Q ss_pred hccccccceeeeecCeEEEEEEEC-------CceeEEEEeeccCcc--chHHHHHHHHHHhccCCCceeeeeeccccCCc
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVWH-------GENVAVKIFFSRDEA--SWSRETEIYSTVLLRHENILGYIGSDMTSRNS 205 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~~--~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~ 205 (443)
.++|++.+.||+|+||.||+|.+. +..||+|.+...... ......|+..+..++|+||+++++++.+..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-- 82 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERL-- 82 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC--
Confidence 367999999999999999999884 357888876533221 122334555666699999999999887663
Q ss_pred ccEEEeeecccCcccHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCC
Q psy14889 206 CTQLWLVTHYHSFGSLYDHLNRT--------TLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTN 277 (443)
Q Consensus 206 ~~~~~lv~e~~~~gsL~~~l~~~--------~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~ 277 (443)
..++||||+++|+|.+++... .+++..++.++.||+.||+|||+. +++||||||+||+++.+
T Consensus 83 --~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~--------~ivH~dlkp~nil~~~~ 152 (277)
T cd05036 83 --PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN--------HFIHRDIAARNCLLTCK 152 (277)
T ss_pred --CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC--------CEeecccchheEEEecc
Confidence 368999999999999998642 489999999999999999999998 99999999999999876
Q ss_pred C---cEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh-cccCCCc
Q psy14889 278 G---TCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR-RTKANGI 353 (443)
Q Consensus 278 ~---~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt-g~~~~~~ 353 (443)
+ .+||+|||+++.+....... .......+..|+|||++.+. .++.++|||||||++|||++ |
T Consensus 153 ~~~~~~kl~dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~------~~~~~~DiwslG~il~el~~~g------ 218 (277)
T cd05036 153 GPGRVAKIADFGMARDIYRASYYR--KGGRAMLPIKWMPPEAFLDG------IFTSKTDVWSFGVLLWEIFSLG------ 218 (277)
T ss_pred CCCcceEeccCccccccCCcccee--cCCCCCccHhhCCHHHHhcC------CcCchhHHHHHHHHHHHHHcCC------
Confidence 5 69999999997663321111 11122345689999999766 67789999999999999997 6
Q ss_pred ccccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHH
Q psy14889 354 FEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLI 426 (443)
Q Consensus 354 ~~~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 426 (443)
..||.... .......+.. ..+...+ ..++..+.+++.+||+.||++|||+.+|++.|+
T Consensus 219 ----~~pf~~~~-----~~~~~~~~~~-~~~~~~~-----~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 219 ----YMPYPGRT-----NQEVMEFVTG-GGRLDPP-----KGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred ----CCCCCCCC-----HHHHHHHHHc-CCcCCCC-----CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 66776532 2233333221 2222222 335678999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=312.93 Aligned_cols=257 Identities=24% Similarity=0.339 Sum_probs=190.9
Q ss_pred ccccccceeeeecCeEEEEEEECC----------------ceeEEEEeeccCcc--chHHHHHHHHHHhccCCCceeeee
Q psy14889 136 KQISLSECIGKGRYGEVWRGVWHG----------------ENVAVKIFFSRDEA--SWSRETEIYSTVLLRHENILGYIG 197 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~~~----------------~~vAvK~~~~~~~~--~~~~e~ei~~~~~l~H~nIv~l~g 197 (443)
++|++.+.||+|+||.||++...+ ..||+|.+...... ....+.|+..+..++|+||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 589999999999999999987522 24899987643221 122345666667799999999999
Q ss_pred eccccCCcccEEEeeecccCcccHHHHhccc-------------CCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEE
Q psy14889 198 SDMTSRNSCTQLWLVTHYHSFGSLYDHLNRT-------------TLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAH 264 (443)
Q Consensus 198 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~-------------~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiH 264 (443)
++.... ..++||||+++++|.+++... .+++.+++.++.|++.||.|||+. +++|
T Consensus 85 ~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~--------~i~H 152 (295)
T cd05097 85 VCVSDD----PLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL--------NFVH 152 (295)
T ss_pred EEcCCC----ccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc--------Ceec
Confidence 987663 479999999999999998542 368889999999999999999998 9999
Q ss_pred eCCCCCCEEEcCCCcEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHH
Q psy14889 265 RDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEV 344 (443)
Q Consensus 265 rDlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~el 344 (443)
+||||+||++++++.+||+|||++......... .......++..|+|||.+..+ .++.++|||||||++|||
T Consensus 153 ~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~------~~~~~~DvwSlG~~l~el 224 (295)
T cd05097 153 RDLATRNCLVGNHYTIKIADFGMSRNLYSGDYY--RIQGRAVLPIRWMAWESILLG------KFTTASDVWAFGVTLWEM 224 (295)
T ss_pred cccChhhEEEcCCCcEEecccccccccccCcce--eccCcCcCceeecChhhhccC------CcCchhhHHHHHHHHHHH
Confidence 999999999999999999999998765432111 111223456789999998765 667899999999999999
Q ss_pred HhcccCCCcccccCCCCCCCCCCCCChHHHHhhhh--hcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHH
Q psy14889 345 CRRTKANGIFEEYKAPYHDLVPMDPSFDDMRKVIC--IDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVK 422 (443)
Q Consensus 345 ltg~~~~~~~~~~~~P~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl 422 (443)
+++.. ..||..... .+....... .......... .+...+..+.+|+.+||+.||++|||+++|+
T Consensus 225 ~~~~~--------~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~ 290 (295)
T cd05097 225 FTLCK--------EQPYSLLSD----EQVIENTGEFFRNQGRQIYLS--QTPLCPSPVFKLMMRCWSRDIKDRPTFNKIH 290 (295)
T ss_pred HHcCC--------CCCCcccCh----HHHHHHHHHhhhhccccccCC--CCCCCCHHHHHHHHHHcCCCchhCcCHHHHH
Confidence 98521 456654321 111111110 0001111110 1123567899999999999999999999999
Q ss_pred HHHH
Q psy14889 423 KTLI 426 (443)
Q Consensus 423 ~~L~ 426 (443)
+.|+
T Consensus 291 ~~l~ 294 (295)
T cd05097 291 HFLR 294 (295)
T ss_pred HHHh
Confidence 9886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=312.89 Aligned_cols=255 Identities=23% Similarity=0.434 Sum_probs=194.6
Q ss_pred ccccccceeeeecCeEEEEEEEC---------CceeEEEEeeccCccc--hHHHHHHHHHHhc-cCCCceeeeeeccccC
Q psy14889 136 KQISLSECIGKGRYGEVWRGVWH---------GENVAVKIFFSRDEAS--WSRETEIYSTVLL-RHENILGYIGSDMTSR 203 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~~---------~~~vAvK~~~~~~~~~--~~~e~ei~~~~~l-~H~nIv~l~g~~~~~~ 203 (443)
.+|.+.+.||+|+||.||+++.. ...+|+|.+....... .....|+..+..+ +||||+++++++...
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~- 90 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE- 90 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC-
Confidence 67889999999999999999752 3468999876433221 1223455555556 699999999998765
Q ss_pred CcccEEEeeecccCcccHHHHhcc-----------------cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeC
Q psy14889 204 NSCTQLWLVTHYHSFGSLYDHLNR-----------------TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRD 266 (443)
Q Consensus 204 ~~~~~~~lv~e~~~~gsL~~~l~~-----------------~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrD 266 (443)
..++++|||+++|+|.+++.. ..+++.++..++.|++.||.|||+. +++|||
T Consensus 91 ---~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~--------gi~H~d 159 (314)
T cd05099 91 ---GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR--------RCIHRD 159 (314)
T ss_pred ---CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC--------Ceeecc
Confidence 347999999999999999853 2488999999999999999999998 999999
Q ss_pred CCCCCEEEcCCCcEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh
Q psy14889 267 IKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR 346 (443)
Q Consensus 267 lk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt 346 (443)
|||+|||++.++.+||+|||+++.......... .....++..|+|||.+.+. .++.++||||||+++|||++
T Consensus 160 lkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~------~~~~~~DiwslG~~l~el~~ 231 (314)
T cd05099 160 LAARNVLVTEDNVMKIADFGLARGVHDIDYYKK--TSNGRLPVKWMAPEALFDR------VYTHQSDVWSFGILMWEIFT 231 (314)
T ss_pred ccceeEEEcCCCcEEEccccccccccccccccc--cccCCCCccccCHHHHccC------CcCccchhhHHHHHHHHHHh
Confidence 999999999999999999999976543221110 1112345679999998765 66789999999999999999
Q ss_pred -cccCCCcccccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHH
Q psy14889 347 -RTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTL 425 (443)
Q Consensus 347 -g~~~~~~~~~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 425 (443)
| ..||... ........+.. ......+ ..++.++.+++.+||+.||++|||+.++++.|
T Consensus 232 ~g----------~~p~~~~-----~~~~~~~~~~~-~~~~~~~-----~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l 290 (314)
T cd05099 232 LG----------GSPYPGI-----PVEELFKLLRE-GHRMDKP-----SNCTHELYMLMRECWHAVPTQRPTFKQLVEAL 290 (314)
T ss_pred CC----------CCCCCCC-----CHHHHHHHHHc-CCCCCCC-----CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 5 5666543 22233333221 1222222 34567899999999999999999999999999
Q ss_pred HHHhhc
Q psy14889 426 IKLACA 431 (443)
Q Consensus 426 ~~l~~~ 431 (443)
+++...
T Consensus 291 ~~~~~~ 296 (314)
T cd05099 291 DKVLAA 296 (314)
T ss_pred HHHHHH
Confidence 998753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=306.43 Aligned_cols=253 Identities=26% Similarity=0.404 Sum_probs=194.6
Q ss_pred ccccccceeeeecCeEEEEEEE--CCc---eeEEEEeeccCcc--chHHHHHHHHHHhccCCCceeeeeeccccCCcccE
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGE---NVAVKIFFSRDEA--SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQ 208 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~---~vAvK~~~~~~~~--~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~ 208 (443)
++|+..+.||+|+||.||+|.. ++. .+|+|.+...... ......|+..+..++||||+++++++.... .
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~ 80 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFK----P 80 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCC----C
Confidence 5788899999999999999987 333 6899987543221 222345556666689999999999987663 4
Q ss_pred EEeeecccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecC
Q psy14889 209 LWLVTHYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFG 286 (443)
Q Consensus 209 ~~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfG 286 (443)
.++||||+++++|.+++.. ..+++.++..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~--------~i~H~dlkp~Nili~~~~~~kl~dfg 152 (268)
T cd05063 81 AMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDM--------NYVHRDLAARNILVNSNLECKVSDFG 152 (268)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--------CeeccccchhhEEEcCCCcEEECCCc
Confidence 6999999999999999964 5689999999999999999999998 99999999999999999999999999
Q ss_pred CcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh-cccCCCcccccCCCCCCCC
Q psy14889 287 LAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR-RTKANGIFEEYKAPYHDLV 365 (443)
Q Consensus 287 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt-g~~~~~~~~~~~~P~~~~~ 365 (443)
++........... .......+..|+|||++... .++.++|||||||++|||++ | ..||....
T Consensus 153 ~~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~------~~~~~~Dv~slG~il~ell~~g----------~~p~~~~~ 215 (268)
T cd05063 153 LSRVLEDDPEGTY-TTSGGKIPIRWTAPEAIAYR------KFTSASDVWSFGIVMWEVMSFG----------ERPYWDMS 215 (268)
T ss_pred cceecccccccce-eccCCCcCceecCHHHhhcC------CcChHhHHHHHHHHHHHHHhCC----------CCCCCcCC
Confidence 9876543221111 11112234579999998765 56789999999999999997 7 66775431
Q ss_pred CCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHH
Q psy14889 366 PMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKL 428 (443)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l 428 (443)
.......+... .....+ ..++..+.+++.+||+.||++||++.+|++.|+++
T Consensus 216 -----~~~~~~~i~~~-~~~~~~-----~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 216 -----NHEVMKAINDG-FRLPAP-----MDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred -----HHHHHHHHhcC-CCCCCC-----CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 22333333221 111111 23567899999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=320.32 Aligned_cols=235 Identities=26% Similarity=0.343 Sum_probs=180.3
Q ss_pred ceeeeecCeEEEEEEE--CCceeEEEEeeccCcc----chHHHHHHH-HHHhccCCCceeeeeeccccCCcccEEEeeec
Q psy14889 142 ECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA----SWSRETEIY-STVLLRHENILGYIGSDMTSRNSCTQLWLVTH 214 (443)
Q Consensus 142 ~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~----~~~~e~ei~-~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e 214 (443)
+.||+|+||+||+|+. +|+.||+|++...... ......|.. .+..++||||+++++++... ..+++|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~----~~~~lv~e 76 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTT----EKLYFVLD 76 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecC----CEEEEEEc
Confidence 4699999999999987 6899999998653211 111122222 23448999999999988766 45799999
Q ss_pred ccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcccccc
Q psy14889 215 YHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQ 293 (443)
Q Consensus 215 ~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~~~ 293 (443)
|+++|+|..++.+ ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 77 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~--------givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~ 148 (325)
T cd05604 77 FVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSI--------NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIA 148 (325)
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC--------CeeecCCCHHHeEECCCCCEEEeecCCcccCCC
Confidence 9999999988854 5799999999999999999999998 999999999999999999999999999864322
Q ss_pred cCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCChHH
Q psy14889 294 LSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFDD 373 (443)
Q Consensus 294 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~~~~ 373 (443)
... ......||+.|+|||++.+. .++.++|||||||++|||++| ..||... ....
T Consensus 149 ~~~----~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~il~el~~G----------~~pf~~~-----~~~~ 203 (325)
T cd05604 149 QSD----TTTTFCGTPEYLAPEVIRKQ------PYDNTVDWWCLGAVLYEMLYG----------LPPFYCR-----DVAE 203 (325)
T ss_pred CCC----CcccccCChhhCCHHHHcCC------CCCCcCccccccceehhhhcC----------CCCCCCC-----CHHH
Confidence 111 12345799999999999876 667899999999999999999 6677653 1222
Q ss_pred HHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHH
Q psy14889 374 MRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALR 420 (443)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e 420 (443)
+...+.. .....+ ...+..+.+++++||+.||.+||++.+
T Consensus 204 ~~~~~~~--~~~~~~-----~~~~~~~~~ll~~ll~~~p~~R~~~~~ 243 (325)
T cd05604 204 MYDNILH--KPLVLR-----PGASLTAWSILEELLEKDRQRRLGAKE 243 (325)
T ss_pred HHHHHHc--CCccCC-----CCCCHHHHHHHHHHhccCHHhcCCCCC
Confidence 2222211 111111 224567899999999999999998864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=303.36 Aligned_cols=254 Identities=24% Similarity=0.389 Sum_probs=198.5
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCc---c-chHHHHHHHHHHhccCCCceeeeeeccccCCcccEE
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDE---A-SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQL 209 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~---~-~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~ 209 (443)
++|++.+.||+|+||.||+|.. +|+.||+|.+..... . ......|+..+..++|+||+++++++... ...
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~----~~~ 77 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIEN----NEL 77 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecC----CeE
Confidence 5799999999999999999998 589999998753221 1 22234566666679999999999998776 357
Q ss_pred EeeecccCcccHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEe
Q psy14889 210 WLVTHYHSFGSLYDHLNR-----TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIAD 284 (443)
Q Consensus 210 ~lv~e~~~~gsL~~~l~~-----~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~D 284 (443)
++||||+++|+|.+++.+ ..+++.++..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|
T Consensus 78 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--------~i~h~dl~p~nil~~~~~~~~l~d 149 (267)
T cd08224 78 NIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK--------RIMHRDIKPANVFITATGVVKLGD 149 (267)
T ss_pred EEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC--------CEecCCcChhhEEECCCCcEEEec
Confidence 999999999999998852 4589999999999999999999998 999999999999999999999999
Q ss_pred cCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCC
Q psy14889 285 FGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDL 364 (443)
Q Consensus 285 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~ 364 (443)
||++..+...... .....|+..|+|||.+.+. .++.++||||||+++|||++| ..||...
T Consensus 150 ~~~~~~~~~~~~~----~~~~~~~~~y~apE~~~~~------~~~~~~Di~slG~il~~l~~g----------~~p~~~~ 209 (267)
T cd08224 150 LGLGRFFSSKTTA----AHSLVGTPYYMSPERIHEN------GYNFKSDIWSLGCLLYEMAAL----------QSPFYGD 209 (267)
T ss_pred cceeeeccCCCcc----cceecCCccccCHHHhccC------CCCchhcHHHHHHHHHHHHHC----------CCCcccC
Confidence 9998765432211 1234688899999998765 567899999999999999999 5666432
Q ss_pred CCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHh
Q psy14889 365 VPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLA 429 (443)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~ 429 (443)
. ............ ...+..+. ...+..+.+++.+||+.+|++|||+.+|++.|+++.
T Consensus 210 ~---~~~~~~~~~~~~-~~~~~~~~----~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 210 K---MNLYSLCKKIEK-CDYPPLPA----DHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred C---ccHHHHHhhhhc-CCCCCCCh----hhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 1 111122222111 12222221 235567999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=319.53 Aligned_cols=235 Identities=21% Similarity=0.336 Sum_probs=184.3
Q ss_pred ceeeeecCeEEEEEEE-----CCceeEEEEeeccCc---cchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEeee
Q psy14889 142 ECIGKGRYGEVWRGVW-----HGENVAVKIFFSRDE---ASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVT 213 (443)
Q Consensus 142 ~~lG~G~fg~Vy~~~~-----~~~~vAvK~~~~~~~---~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv~ 213 (443)
+.||+|+||.||+++. +|+.||+|++..... .......|+..+..++||||+++++++.+. ..+++||
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~----~~~~lv~ 77 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTE----GKLYLIL 77 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcC----CEEEEEE
Confidence 5799999999999875 478999999865321 122234566666679999999999998766 4589999
Q ss_pred cccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCccccc
Q psy14889 214 HYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYS 292 (443)
Q Consensus 214 e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~~ 292 (443)
||+++|+|.+++.+ ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 78 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~--------~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 149 (318)
T cd05582 78 DFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL--------GIIYRDLKPENILLDEEGHIKLTDFGLSKESI 149 (318)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC--------CEecCCCCHHHeEECCCCcEEEeeccCCcccC
Confidence 99999999999864 5689999999999999999999998 99999999999999999999999999987554
Q ss_pred ccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCChH
Q psy14889 293 QLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFD 372 (443)
Q Consensus 293 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~~~ 372 (443)
.... ......||+.|+|||.+.+. .++.++|||||||++|||++| ..||... ...
T Consensus 150 ~~~~----~~~~~~g~~~y~aPE~~~~~------~~~~~~DiwslG~il~el~tg----------~~p~~~~-----~~~ 204 (318)
T cd05582 150 DHEK----KAYSFCGTVEYMAPEVVNRR------GHTQSADWWSFGVLMFEMLTG----------SLPFQGK-----DRK 204 (318)
T ss_pred CCCC----ceecccCChhhcCHHHHcCC------CCCCccceeccceEeeeeccC----------CCCCCCC-----CHH
Confidence 3211 12345789999999999765 566899999999999999999 6777653 112
Q ss_pred HHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHH
Q psy14889 373 DMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALR 420 (443)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e 420 (443)
.....+. .....+| ...+..+.+++++||+.||++|||+.+
T Consensus 205 ~~~~~i~--~~~~~~p-----~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 205 ETMTMIL--KAKLGMP-----QFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred HHHHHHH--cCCCCCC-----CCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 2222221 1122223 235567999999999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=311.31 Aligned_cols=256 Identities=23% Similarity=0.351 Sum_probs=192.9
Q ss_pred ccccccceeeeecCeEEEEEEECC------------------ceeEEEEeeccCcc--chHHHHHHHHHHhccCCCceee
Q psy14889 136 KQISLSECIGKGRYGEVWRGVWHG------------------ENVAVKIFFSRDEA--SWSRETEIYSTVLLRHENILGY 195 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~~~------------------~~vAvK~~~~~~~~--~~~~e~ei~~~~~l~H~nIv~l 195 (443)
++|++.+.||+|+||.||+|...+ ..||+|.+...... ......|+..+..++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~ 84 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL 84 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 679999999999999999987632 45899987654322 2223456666666999999999
Q ss_pred eeeccccCCcccEEEeeecccCcccHHHHhccc------------CCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeE
Q psy14889 196 IGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRT------------TLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIA 263 (443)
Q Consensus 196 ~g~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~------------~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~ii 263 (443)
++++... ...+++|||+++++|.+++.+. .+++..++.++.|++.||+|||+. +++
T Consensus 85 ~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~--------~i~ 152 (296)
T cd05051 85 LGVCTVD----PPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL--------NFV 152 (296)
T ss_pred EEEEecC----CCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc--------Ccc
Confidence 9998776 3479999999999999998643 589999999999999999999998 999
Q ss_pred EeCCCCCCEEEcCCCcEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHH
Q psy14889 264 HRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWE 343 (443)
Q Consensus 264 HrDlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~e 343 (443)
||||||+||+++.++.++|+|||+++........ .......++..|+|||.+.+. .++.++|||||||++||
T Consensus 153 H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~------~~~~~~Dv~slG~~l~e 224 (296)
T cd05051 153 HRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYY--RVQGRAPLPIRWMAWESVLLG------KFTTKSDVWAFGVTLWE 224 (296)
T ss_pred ccccchhceeecCCCceEEccccceeecccCcce--eecCcCCCCceecCHHHhhcC------CCCccchhhhhHHHHHH
Confidence 9999999999999999999999998765432211 111233567889999998765 66789999999999999
Q ss_pred HHhcccCCCcccccCCCCCCCCCCCCChHHHHhhhhh---cCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHH
Q psy14889 344 VCRRTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICI---DQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALR 420 (443)
Q Consensus 344 lltg~~~~~~~~~~~~P~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e 420 (443)
|+++.. ..||.... ....+...... .......+. ...++.++.+++.+||+.||++|||+.+
T Consensus 225 l~~~~~--------~~p~~~~~----~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~~p~~Rpt~~e 289 (296)
T cd05051 225 ILTLCR--------EQPYEHLT----DQQVIENAGHFFRDDGRQIYLPR---PPNCPKDIYELMLECWRRDEEDRPTFRE 289 (296)
T ss_pred HHhcCC--------CCCCCCcC----hHHHHHHHHhccccccccccCCC---ccCCCHHHHHHHHHHhccChhcCCCHHH
Confidence 998411 45665431 11222222111 011111111 1235578999999999999999999999
Q ss_pred HHHHHH
Q psy14889 421 VKKTLI 426 (443)
Q Consensus 421 vl~~L~ 426 (443)
|++.|+
T Consensus 290 l~~~L~ 295 (296)
T cd05051 290 IHLFLQ 295 (296)
T ss_pred HHHHhc
Confidence 999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=310.39 Aligned_cols=247 Identities=26% Similarity=0.442 Sum_probs=194.5
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccc-hHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEee
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEAS-WSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLV 212 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~-~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv 212 (443)
.+|++.+.||+|+||.||+|.. ++..||+|.+....... .....|+..+..++|+||+++++.+... ...++|
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~----~~~~lv 95 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG----DELWVV 95 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeC----CEEEEe
Confidence 6899999999999999999986 58899999886543322 2223455556668999999999998765 458999
Q ss_pred ecccCcccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCccccc
Q psy14889 213 THYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYS 292 (443)
Q Consensus 213 ~e~~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~~ 292 (443)
|||+++|+|.+++.+..+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++....
T Consensus 96 ~e~~~~~~L~~~~~~~~~~~~~~~~i~~ql~~aL~~LH~~--------gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~ 167 (296)
T cd06654 96 MEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN--------QVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 167 (296)
T ss_pred ecccCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHC--------CcccCCCCHHHEEEcCCCCEEECccccchhcc
Confidence 9999999999999888899999999999999999999998 99999999999999999999999999987654
Q ss_pred ccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCChH
Q psy14889 293 QLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFD 372 (443)
Q Consensus 293 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~~~ 372 (443)
..... .....|++.|+|||.+.+. .++.++|||||||++|||++| ..||....+ ..
T Consensus 168 ~~~~~----~~~~~~~~~y~aPE~~~~~------~~~~~~Dv~s~Gvil~~l~~g----------~~pf~~~~~----~~ 223 (296)
T cd06654 168 PEQSK----RSTMVGTPYWMAPEVVTRK------AYGPKVDIWSLGIMAIEMIEG----------EPPYLNENP----LR 223 (296)
T ss_pred ccccc----cCcccCCccccCHHHHcCC------CCCccchHHHHHHHHHHHHhC----------CCCCCCCCH----HH
Confidence 32211 1234688999999998765 566899999999999999999 667754321 11
Q ss_pred HHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 373 DMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
...... . ...+..+ .+...+..+.+++.+||..||++|||+.++++
T Consensus 224 ~~~~~~-~-~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 224 ALYLIA-T-NGTPELQ---NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred hHHHHh-c-CCCCCCC---CccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 111111 1 1111111 12335567999999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0577|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-41 Score=322.47 Aligned_cols=250 Identities=28% Similarity=0.418 Sum_probs=199.3
Q ss_pred HHhhhhccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccchHH----HHHHHHHHhccCCCceeeeeeccccC
Q psy14889 130 IQRTLAKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEASWSR----ETEIYSTVLLRHENILGYIGSDMTSR 203 (443)
Q Consensus 130 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~----e~ei~~~~~l~H~nIv~l~g~~~~~~ 203 (443)
......+.|.-.+.||.|+||.||-|.. +.+.||||.+.....+.... -.|+.-+..++|||+|.+.|+|...
T Consensus 20 ~k~DPEklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre- 98 (948)
T KOG0577|consen 20 FKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLRE- 98 (948)
T ss_pred ccCCHHHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeecc-
Confidence 3444556788889999999999999987 67899999986554332222 3566666679999999999998876
Q ss_pred CcccEEEeeecccCcccHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEE
Q psy14889 204 NSCTQLWLVTHYHSFGSLYDHL--NRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCV 281 (443)
Q Consensus 204 ~~~~~~~lv~e~~~~gsL~~~l--~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~k 281 (443)
...|||||||- ||-.+++ ++.++.+-++..|+.+.+.||+|||+. +.||||||+.|||+++.|.||
T Consensus 99 ---~TaWLVMEYCl-GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~--------~~IHRDiKAGNILLse~g~VK 166 (948)
T KOG0577|consen 99 ---HTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH--------NRIHRDIKAGNILLSEPGLVK 166 (948)
T ss_pred ---chHHHHHHHHh-ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHh--------hHHhhhccccceEecCCCeee
Confidence 34699999997 5888887 467899999999999999999999999 889999999999999999999
Q ss_pred EEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCC
Q psy14889 282 IADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPY 361 (443)
Q Consensus 282 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~ 361 (443)
|+|||.|.... +.++++||+.|||||++...... .|+-|+||||||++..||..+ ++|+
T Consensus 167 LaDFGSAsi~~--------PAnsFvGTPywMAPEVILAMDEG---qYdgkvDvWSLGITCIELAER----------kPPl 225 (948)
T KOG0577|consen 167 LADFGSASIMA--------PANSFVGTPYWMAPEVILAMDEG---QYDGKVDVWSLGITCIELAER----------KPPL 225 (948)
T ss_pred eccccchhhcC--------chhcccCCccccchhHheecccc---ccCCccceeeccchhhhhhhc----------CCCc
Confidence 99999985543 34678999999999998754222 777899999999999999999 5565
Q ss_pred CCCCCCCCChHHHHhhhhhc-CCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHH
Q psy14889 362 HDLVPMDPSFDDMRKVICID-QQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKT 424 (443)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 424 (443)
..+ ..+..+.-+. ...|.++ ..+-+..++.++..||+.-|.+|||.+++++.
T Consensus 226 FnM-------NAMSALYHIAQNesPtLq----s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 226 FNM-------NAMSALYHIAQNESPTLQ----SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred cCc-------hHHHHHHHHHhcCCCCCC----CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 543 2333322222 2334444 35567789999999999999999999998763
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=309.67 Aligned_cols=256 Identities=22% Similarity=0.360 Sum_probs=194.4
Q ss_pred hccccccceeeeecCeEEEEEEEC-------CceeEEEEeeccCccc--hHHHHHHHHHHhccCCCceeeeeeccccCCc
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVWH-------GENVAVKIFFSRDEAS--WSRETEIYSTVLLRHENILGYIGSDMTSRNS 205 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~~~--~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~ 205 (443)
.++|++.+.||+|+||.||+|... +..||+|.+....... .....|+..+..++||||+++++++....
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-- 82 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ-- 82 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC--
Confidence 478999999999999999999752 3479999875433211 12234555556689999999999987663
Q ss_pred ccEEEeeecccCcccHHHHhcc-----------cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEE
Q psy14889 206 CTQLWLVTHYHSFGSLYDHLNR-----------TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILV 274 (443)
Q Consensus 206 ~~~~~lv~e~~~~gsL~~~l~~-----------~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl 274 (443)
..++||||+++|+|.+++++ ..+++..+..++.|++.||.|||+. +|+||||||+|||+
T Consensus 83 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~--------~i~H~dikp~nili 152 (288)
T cd05061 83 --PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK--------KFVHRDLAARNCMV 152 (288)
T ss_pred --CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CCcCCCCChheEEE
Confidence 46999999999999999953 2346678899999999999999988 99999999999999
Q ss_pred cCCCcEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcc
Q psy14889 275 KTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIF 354 (443)
Q Consensus 275 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~ 354 (443)
++++.+||+|||+++......... ......++..|+|||.+.++ .++.++|||||||++|||+++.
T Consensus 153 ~~~~~~~L~Dfg~~~~~~~~~~~~--~~~~~~~~~~y~~pE~~~~~------~~~~~~DvwslG~~l~el~~~~------ 218 (288)
T cd05061 153 AHDFTVKIGDFGMTRDIYETDYYR--KGGKGLLPVRWMAPESLKDG------VFTTSSDMWSFGVVLWEITSLA------ 218 (288)
T ss_pred cCCCcEEECcCCcccccccccccc--ccCCCcccccccCHHHhccC------CCChHhHHHHHHHHHHHHHhCC------
Confidence 999999999999987654322111 11223456789999998776 6678999999999999999831
Q ss_pred cccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhh
Q psy14889 355 EEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLAC 430 (443)
Q Consensus 355 ~~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~ 430 (443)
..||... ..+...+.+.. ...+..+ ..++..+.+++.+||+.||++|||+.++++.|++...
T Consensus 219 ---~~p~~~~-----~~~~~~~~~~~-~~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~ 280 (288)
T cd05061 219 ---EQPYQGL-----SNEQVLKFVMD-GGYLDQP-----DNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLH 280 (288)
T ss_pred ---CCCCCCC-----CHHHHHHHHHc-CCCCCCC-----CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcC
Confidence 5677553 22333333321 2222222 2355789999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=316.37 Aligned_cols=238 Identities=23% Similarity=0.294 Sum_probs=179.7
Q ss_pred ceeeeecCeEEEEEEE--CCceeEEEEeeccCcc----chHHHHHHHHHHhc-cCCCceeeeeeccccCCcccEEEeeec
Q psy14889 142 ECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA----SWSRETEIYSTVLL-RHENILGYIGSDMTSRNSCTQLWLVTH 214 (443)
Q Consensus 142 ~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~----~~~~e~ei~~~~~l-~H~nIv~l~g~~~~~~~~~~~~~lv~e 214 (443)
+.||+|+||.||+|.. +++.||+|++...... ......|+..+..+ +||||+++++++.+. ..+++|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~----~~~~lv~e 76 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTT----SRLFLVIE 76 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeC----CEEEEEEe
Confidence 4699999999999987 5789999998653211 11112333333334 799999999988766 45899999
Q ss_pred ccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcccccc
Q psy14889 215 YHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQ 293 (443)
Q Consensus 215 ~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~~~ 293 (443)
|+++|+|..++.. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 77 ~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~--------~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~ 148 (327)
T cd05617 77 YVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHER--------GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLG 148 (327)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC--------CeeccCCCHHHEEEeCCCCEEEeccccceeccC
Confidence 9999999998864 5799999999999999999999998 999999999999999999999999999864322
Q ss_pred cCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCC--CCCh
Q psy14889 294 LSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPM--DPSF 371 (443)
Q Consensus 294 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~--~~~~ 371 (443)
... ......||+.|+|||++.+. .++.++|||||||++|||++| ..||...... ....
T Consensus 149 ~~~----~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslGvil~ell~g----------~~pf~~~~~~~~~~~~ 208 (327)
T cd05617 149 PGD----TTSTFCGTPNYIAPEILRGE------EYGFSVDWWALGVLMFEMMAG----------RSPFDIITDNPDMNTE 208 (327)
T ss_pred CCC----ceecccCCcccCCHHHHCCC------CCCchheeehhHHHHHHHHhC----------CCCCCccCCCcccccH
Confidence 111 12345799999999999876 667899999999999999999 5566432211 1112
Q ss_pred HHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcH
Q psy14889 372 DDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSA 418 (443)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~ 418 (443)
+.....+.. ....+| ...+..+.+++.+||+.||++|+++
T Consensus 209 ~~~~~~~~~--~~~~~p-----~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 209 DYLFQVILE--KPIRIP-----RFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred HHHHHHHHh--CCCCCC-----CCCCHHHHHHHHHHhccCHHHcCCC
Confidence 222232221 122233 2355678999999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=318.49 Aligned_cols=257 Identities=24% Similarity=0.356 Sum_probs=188.7
Q ss_pred hhccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCc---cchHHHHHHHHHHhccCCCceeeeeeccccCC--cc
Q psy14889 134 LAKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDE---ASWSRETEIYSTVLLRHENILGYIGSDMTSRN--SC 206 (443)
Q Consensus 134 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~---~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~--~~ 206 (443)
+.++|++.+.||+|+||.||++.. +|..||||++..... .......|+..+..++||||+++++++..... ..
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 347899999999999999999987 588999998854321 12222356666667999999999998865432 12
Q ss_pred cEEEeeecccCcccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecC
Q psy14889 207 TQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFG 286 (443)
Q Consensus 207 ~~~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfG 286 (443)
..+++||||+.+ +|.+.+. ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~--------~ivHrDlkp~NIl~~~~~~~kl~Dfg 168 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIH-MELDHERMSYLLYQMLCGIKHLHSA--------GIIHRDLKPSNIVVKSDCTLKILDFG 168 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHh-ccCCHHHHHHHHHHHHHHHHHHHhC--------CcccCCCCHHHEEECCCCCEEEecCC
Confidence 357999999975 6776664 3588999999999999999999998 99999999999999999999999999
Q ss_pred CcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCC
Q psy14889 287 LAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVP 366 (443)
Q Consensus 287 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~ 366 (443)
+++...... ......||..|+|||++.+. .++.++|||||||++|||++| ..||.....
T Consensus 169 ~a~~~~~~~-----~~~~~~~t~~y~aPE~~~~~------~~~~~~DiwSlG~il~el~tg----------~~pf~~~~~ 227 (359)
T cd07876 169 LARTACTNF-----MMTPYVVTRYYRAPEVILGM------GYKENVDIWSVGCIMGELVKG----------SVIFQGTDH 227 (359)
T ss_pred CccccccCc-----cCCCCcccCCCCCchhccCC------CCCcchhhHHHHHHHHHHHhC----------CCCCCCCCH
Confidence 997543221 12335789999999999776 677899999999999999999 555543211
Q ss_pred CC-----------CChH-------HHHhhhhhcCCCCCCCC--------CC-------CCchhHHHHHHHHHHHhcCCcC
Q psy14889 367 MD-----------PSFD-------DMRKVICIDQQRPVLPN--------RW-------VSDSTLNAMTKVMKECWHQNAN 413 (443)
Q Consensus 367 ~~-----------~~~~-------~~~~~~~~~~~~~~~~~--------~~-------~~~~~~~~l~~li~~cl~~dP~ 413 (443)
.. +... ....... .++..+. .| .....+..+.+|+.+||+.||+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~ 304 (359)
T cd07876 228 IDQWNKVIEQLGTPSAEFMNRLQPTVRNYVE---NRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPD 304 (359)
T ss_pred HHHHHHHHHhcCCCcHHHHHHHHHHHHHHHh---hCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcc
Confidence 00 0000 0000000 1111110 00 0111346789999999999999
Q ss_pred CCCcHHHHHHH
Q psy14889 414 VRLSALRVKKT 424 (443)
Q Consensus 414 ~Rps~~evl~~ 424 (443)
+|||+.|+++.
T Consensus 305 ~R~t~~e~l~h 315 (359)
T cd07876 305 KRISVDEALRH 315 (359)
T ss_pred cCCCHHHHhcC
Confidence 99999999884
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=314.31 Aligned_cols=238 Identities=23% Similarity=0.310 Sum_probs=182.3
Q ss_pred cccccceeeeecCeEEEEEEE--CCceeEEEEeeccCc----cchHHHHHHHHHHhc-cCCCceeeeeeccccCCcccEE
Q psy14889 137 QISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDE----ASWSRETEIYSTVLL-RHENILGYIGSDMTSRNSCTQL 209 (443)
Q Consensus 137 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~----~~~~~e~ei~~~~~l-~H~nIv~l~g~~~~~~~~~~~~ 209 (443)
+|++.+.||+|+||.||+|+. +|+.||+|++..... .......|+..+..+ +|++|+++++++.+. ..+
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~----~~~ 76 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTV----DRL 76 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecC----CEE
Confidence 467889999999999999987 588999998864321 111122333333334 457788888887665 358
Q ss_pred EeeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCc
Q psy14889 210 WLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA 288 (443)
Q Consensus 210 ~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla 288 (443)
++||||+++|+|.+++.. ..+++.++..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 77 ~lv~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~--------~ivHrDikp~Nill~~~~~ikL~Dfg~~ 148 (323)
T cd05615 77 YFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRR--------GIIYRDLKLDNVMLDSEGHIKIADFGMC 148 (323)
T ss_pred EEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC--------CeeccCCCHHHeEECCCCCEEEeccccc
Confidence 999999999999999865 6799999999999999999999998 9999999999999999999999999998
Q ss_pred ccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCC
Q psy14889 289 VSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMD 368 (443)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~ 368 (443)
+....... ......||+.|+|||++.+. .++.++|||||||++|||++| ..||...
T Consensus 149 ~~~~~~~~----~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslGvil~elltG----------~~pf~~~---- 204 (323)
T cd05615 149 KEHMVDGV----TTRTFCGTPDYIAPEIIAYQ------PYGKSVDWWAYGVLLYEMLAG----------QPPFDGE---- 204 (323)
T ss_pred cccCCCCc----cccCccCCccccCHHHHcCC------CCCCccchhhhHHHHHHHHhC----------CCCCCCC----
Confidence 75432111 12334689999999999765 667899999999999999999 6777653
Q ss_pred CChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcH
Q psy14889 369 PSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSA 418 (443)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~ 418 (443)
........+.. .....| ...+.++.+++.+||+.||.+|++.
T Consensus 205 -~~~~~~~~i~~--~~~~~p-----~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 205 -DEDELFQSIME--HNVSYP-----KSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred -CHHHHHHHHHh--CCCCCC-----ccCCHHHHHHHHHHcccCHhhCCCC
Confidence 12222222221 122222 2355678999999999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=308.44 Aligned_cols=250 Identities=25% Similarity=0.390 Sum_probs=191.9
Q ss_pred ccccccceeeeecCeEEEEEEE-------CCceeEEEEeeccCcc-chHHHHHHHHHHhccCCCceeeeeeccccCCccc
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW-------HGENVAVKIFFSRDEA-SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCT 207 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~-------~~~~vAvK~~~~~~~~-~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~ 207 (443)
++|.+.++||+|+||.||++.. ++..+|+|.+...... ......|+..+..++|+||+++++++....
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---- 80 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGR---- 80 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCC----
Confidence 5788899999999999999964 2567899987543322 222345566666699999999999987663
Q ss_pred EEEeeecccCcccHHHHhccc----------------CCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCC
Q psy14889 208 QLWLVTHYHSFGSLYDHLNRT----------------TLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKN 271 (443)
Q Consensus 208 ~~~lv~e~~~~gsL~~~l~~~----------------~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~N 271 (443)
..+++|||+++|+|.+++... .+++..++.++.|++.||+|||+. +++||||||+|
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~--------~i~H~dlkp~n 152 (280)
T cd05092 81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL--------HFVHRDLATRN 152 (280)
T ss_pred ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC--------CeecccccHhh
Confidence 479999999999999998642 478999999999999999999998 99999999999
Q ss_pred EEEcCCCcEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh-cccC
Q psy14889 272 ILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR-RTKA 350 (443)
Q Consensus 272 iLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt-g~~~ 350 (443)
||+++++.+||+|||++.......... ......+++.|+|||.+.+. .++.++|||||||++|||++ |
T Consensus 153 il~~~~~~~kL~dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~il~el~~~g--- 221 (280)
T cd05092 153 CLVGQGLVVKIGDFGMSRDIYSTDYYR--VGGRTMLPIRWMPPESILYR------KFTTESDIWSFGVVLWEIFTYG--- 221 (280)
T ss_pred EEEcCCCCEEECCCCceeEcCCCceee--cCCCccccccccCHHHhccC------CcCchhhHHHHHHHHHHHHcCC---
Confidence 999999999999999987554321111 11223456789999998776 66789999999999999998 6
Q ss_pred CCcccccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHH
Q psy14889 351 NGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLI 426 (443)
Q Consensus 351 ~~~~~~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 426 (443)
..||.... .......+. .......+ ..++..+.+++.+||+.||++||++.+|++.|+
T Consensus 222 -------~~p~~~~~-----~~~~~~~~~-~~~~~~~~-----~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 222 -------KQPWYQLS-----NTEAIECIT-QGRELERP-----RTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred -------CCCCccCC-----HHHHHHHHH-cCccCCCC-----CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 56665431 112222221 11122222 336678999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=307.72 Aligned_cols=260 Identities=25% Similarity=0.359 Sum_probs=197.2
Q ss_pred ccccccceeeeecCeEEEEEEEC------CceeEEEEeeccCcc--chHHHHHHHHHHhccCCCceeeeeeccccCCccc
Q psy14889 136 KQISLSECIGKGRYGEVWRGVWH------GENVAVKIFFSRDEA--SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCT 207 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~~------~~~vAvK~~~~~~~~--~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~ 207 (443)
+.|++.+.||+|+||.||+|.++ ++.||||.+...... ....+.|+..+..++||||+++++++..... .
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~--~ 81 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGG--R 81 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCC--C
Confidence 46888899999999999999863 678999988655442 3334556666667999999999998866432 4
Q ss_pred EEEeeecccCcccHHHHhcccC--CCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEec
Q psy14889 208 QLWLVTHYHSFGSLYDHLNRTT--LNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADF 285 (443)
Q Consensus 208 ~~~lv~e~~~~gsL~~~l~~~~--l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~Df 285 (443)
..+++|||+++++|.+++.... +++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+||
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~--------~i~H~dl~p~nil~~~~~~~~l~df 153 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQ--------RYIHRDLAARNILVESEDLVKISDF 153 (284)
T ss_pred ceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhC--------CeecCCCCHHhEEEcCCCCEEEccc
Confidence 5799999999999999997644 99999999999999999999998 9999999999999999999999999
Q ss_pred CCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCC
Q psy14889 286 GLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLV 365 (443)
Q Consensus 286 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~ 365 (443)
|++............ .....++..|+|||.+.+. .++.++||||||+++|||+||+.| +....
T Consensus 154 g~~~~~~~~~~~~~~-~~~~~~~~~~~~Pe~~~~~------~~~~~~Di~slG~~l~el~tg~~p----------~~~~~ 216 (284)
T cd05038 154 GLAKVLPEDKDYYYV-KEPGESPIFWYAPECLRTS------KFSSASDVWSFGVTLYELFTYGDP----------SQSPP 216 (284)
T ss_pred ccccccccCCcceec-cCCCCCcccccCcHHHccC------CCCcccchHHHhhhhheeeccCCC----------ccccc
Confidence 999876532221111 1122455679999998765 566899999999999999999543 32211
Q ss_pred CC----------CCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHH
Q psy14889 366 PM----------DPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKL 428 (443)
Q Consensus 366 ~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l 428 (443)
.. ......+...... ..+... +..++.++.+++.+||+.||++|||+.||++.|+++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~-----~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 217 AEFLRMIGIAQGQMIVTRLLELLKE-GERLPR-----PPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred chhccccccccccccHHHHHHHHHc-CCcCCC-----CccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 10 0112222222221 111111 133567899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=344.65 Aligned_cols=258 Identities=26% Similarity=0.398 Sum_probs=194.0
Q ss_pred hhhccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc---chHHHHHHHHHHhccCCCceeeeeeccccCCccc
Q psy14889 133 TLAKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA---SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCT 207 (443)
Q Consensus 133 ~~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~---~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~ 207 (443)
...++|.+.+.||+|+||.||++.. .+..||+|.+...... ......|+..+..++|||||++++++..... .
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~--~ 87 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKAN--Q 87 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCC--C
Confidence 3447899999999999999999998 5778999988643221 2223356666667999999999998865543 4
Q ss_pred EEEeeecccCcccHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCC-----
Q psy14889 208 QLWLVTHYHSFGSLYDHLNR-----TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTN----- 277 (443)
Q Consensus 208 ~~~lv~e~~~~gsL~~~l~~-----~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~----- 277 (443)
.+||||||+++|+|.++|.. ..+++..++.|+.||+.||.|||+... .....+||||||||+||||+.+
T Consensus 88 ~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~-~~~~k~IVHRDLKPeNILL~s~~~~lg 166 (1021)
T PTZ00266 88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKD-GPNGERVLHRDLKPQNIFLSTGIRHIG 166 (1021)
T ss_pred EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhccc-ccccCCceeccCcHHHeEeecCccccc
Confidence 68999999999999999864 469999999999999999999998510 0001269999999999999642
Q ss_pred ------------CcEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHH
Q psy14889 278 ------------GTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVC 345 (443)
Q Consensus 278 ------------~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ell 345 (443)
..+||+|||++..+..... .....||+.|+|||++.+... .++.++|||||||+||||+
T Consensus 167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~-----~~s~vGTp~YmAPEvL~ge~~----~~s~KSDVWSLG~ILYELL 237 (1021)
T PTZ00266 167 KITAQANNLNGRPIAKIGDFGLSKNIGIESM-----AHSCVGTPYYWSPELLLHETK----SYDDKSDMWALGCIIYELC 237 (1021)
T ss_pred cccccccccCCCCceEEccCCcccccccccc-----ccccCCCccccCHHHHhccCC----CCCchhHHHHHHHHHHHHH
Confidence 3589999999976543221 133479999999999865321 4668999999999999999
Q ss_pred hcccCCCcccccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 346 RRTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 346 tg~~~~~~~~~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
|| ..||.... ....+...+. ..+.++. ...+.++.+||..||+.+|.+|||+.|++.
T Consensus 238 TG----------k~PF~~~~----~~~qli~~lk---~~p~lpi----~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 238 SG----------KTPFHKAN----NFSQLISELK---RGPDLPI----KGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred HC----------CCCCCcCC----cHHHHHHHHh---cCCCCCc----CCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 99 67775421 2233322222 1222221 224567999999999999999999999984
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=301.96 Aligned_cols=250 Identities=26% Similarity=0.378 Sum_probs=195.1
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc------chHHHHHHHHHHhccCCCceeeeeeccccCCccc
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA------SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCT 207 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~------~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~ 207 (443)
++|++.+.||+|+||.||++.. +++.||+|.+...... ....+.|+..+..++||||+++++++....
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---- 77 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDE---- 77 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCC----
Confidence 5788999999999999999986 5899999987643211 112345666666799999999999987763
Q ss_pred EEEeeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecC
Q psy14889 208 QLWLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFG 286 (443)
Q Consensus 208 ~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfG 286 (443)
.+++|+||+++++|.+++.. ..+++..+..++.|++.||.|||+. +|+|+||+|+||++++++.++|+|||
T Consensus 78 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~--------~i~H~dl~p~nilv~~~~~~~l~dfg 149 (263)
T cd06625 78 TLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSN--------MIVHRDIKGANILRDSAGNVKLGDFG 149 (263)
T ss_pred eEEEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhC--------CeecCCCCHHHEEEcCCCCEEEeecc
Confidence 68999999999999998864 5689999999999999999999998 99999999999999999999999999
Q ss_pred CcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCC
Q psy14889 287 LAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVP 366 (443)
Q Consensus 287 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~ 366 (443)
+++......... .......|+..|+|||.+.+. .++.++||||||+++|||++| +.||....
T Consensus 150 ~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~il~el~~g----------~~p~~~~~- 211 (263)
T cd06625 150 ASKRLQTICSSG-TGMKSVTGTPYWMSPEVISGE------GYGRKADVWSVGCTVVEMLTE----------KPPWAEFE- 211 (263)
T ss_pred cceecccccccc-ccccCCCcCccccCcceeccC------CCCchhhhHHHHHHHHHHHhC----------CCCccccc-
Confidence 987654322111 111234678899999999876 567899999999999999999 66765431
Q ss_pred CCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHH
Q psy14889 367 MDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKT 424 (443)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 424 (443)
......... .....+.++ ..++..+.+++.+||..+|++|||+.++++.
T Consensus 212 ---~~~~~~~~~-~~~~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 212 ---AMAAIFKIA-TQPTNPQLP-----SHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred ---hHHHHHHHh-ccCCCCCCC-----ccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 112222221 112222233 3356789999999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=305.02 Aligned_cols=253 Identities=26% Similarity=0.399 Sum_probs=194.8
Q ss_pred ccccccceeeeecCeEEEEEEE--CC---ceeEEEEeeccCcc--chHHHHHHHHHHhccCCCceeeeeeccccCCcccE
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HG---ENVAVKIFFSRDEA--SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQ 208 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~---~~vAvK~~~~~~~~--~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~ 208 (443)
.+|++.+.||+|+||.||+|.+ ++ ..+|+|.+...... ....+.|+..+..++||||+++++++... ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----~~ 79 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS----KP 79 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC----Cc
Confidence 5788999999999999999986 22 36899987543221 22334566666668999999999998765 34
Q ss_pred EEeeecccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecC
Q psy14889 209 LWLVTHYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFG 286 (443)
Q Consensus 209 ~~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfG 286 (443)
.++||||+++|+|.+++.. ..+++.+++.++.|++.||+|||+. +++||||||+|||++.++.+||+|||
T Consensus 80 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--------~i~h~dlkp~nili~~~~~~~l~dfg 151 (267)
T cd05066 80 VMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDM--------GYVHRDLAARNILVNSNLVCKVSDFG 151 (267)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--------CEeehhhchhcEEECCCCeEEeCCCC
Confidence 7999999999999999965 4689999999999999999999998 99999999999999999999999999
Q ss_pred CcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh-cccCCCcccccCCCCCCCC
Q psy14889 287 LAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR-RTKANGIFEEYKAPYHDLV 365 (443)
Q Consensus 287 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt-g~~~~~~~~~~~~P~~~~~ 365 (443)
++..+........ ......++..|+|||.+.+. .++.++||||||+++||+++ | ..||.+..
T Consensus 152 ~~~~~~~~~~~~~-~~~~~~~~~~y~~pe~~~~~------~~~~~~Dv~slG~~l~ell~~g----------~~p~~~~~ 214 (267)
T cd05066 152 LSRVLEDDPEAAY-TTRGGKIPIRWTAPEAIAYR------KFTSASDVWSYGIVMWEVMSYG----------ERPYWEMS 214 (267)
T ss_pred cccccccccceee-ecCCCccceeecCHhHhccC------ccCchhhhHHHHHHHHHHhcCC----------CCCcccCC
Confidence 9977654322111 11122345689999999765 66789999999999999886 7 66776542
Q ss_pred CCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHH
Q psy14889 366 PMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKL 428 (443)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l 428 (443)
. ......+.. ..++..+ ..++..+.+++.+||+.+|++|||+.++++.|+++
T Consensus 215 ~-----~~~~~~~~~-~~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 215 N-----QDVIKAIEE-GYRLPAP-----MDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred H-----HHHHHHHhC-CCcCCCC-----CCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 1 222222221 1122111 23567899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=304.91 Aligned_cols=254 Identities=27% Similarity=0.408 Sum_probs=194.2
Q ss_pred ccccccceeeeecCeEEEEEEEC--C---ceeEEEEeeccCcc--chHHHHHHHHHHhccCCCceeeeeeccccCCcccE
Q psy14889 136 KQISLSECIGKGRYGEVWRGVWH--G---ENVAVKIFFSRDEA--SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQ 208 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~~--~---~~vAvK~~~~~~~~--~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~ 208 (443)
+.|++.+.||+|+||.||+|.+. + ..||||.+...... ......|+..+..++||||+++++++.... .
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~----~ 79 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSR----P 79 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCC----c
Confidence 46888999999999999999873 3 35999987653221 223345666666699999999999987663 4
Q ss_pred EEeeecccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecC
Q psy14889 209 LWLVTHYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFG 286 (443)
Q Consensus 209 ~~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfG 286 (443)
.++||||+++|+|.+++.. ..+++.+++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~--------g~~H~dl~p~nili~~~~~~kl~dfg 151 (269)
T cd05065 80 VMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEM--------NYVHRDLAARNILVNSNLVCKVSDFG 151 (269)
T ss_pred eEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC--------CEeecccChheEEEcCCCcEEECCCc
Confidence 7999999999999999864 4689999999999999999999998 99999999999999999999999999
Q ss_pred CcccccccCCcCCCC-CCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh-cccCCCcccccCCCCCCC
Q psy14889 287 LAVSYSQLSNKMDIP-PNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR-RTKANGIFEEYKAPYHDL 364 (443)
Q Consensus 287 la~~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt-g~~~~~~~~~~~~P~~~~ 364 (443)
++............. ......+..|+|||.+.+. .++.++|||||||++||+++ | ..||.+.
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~------~~~~~~DvwslG~~l~e~l~~g----------~~p~~~~ 215 (269)
T cd05065 152 LSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYR------KFTSASDVWSYGIVMWEVMSYG----------ERPYWDM 215 (269)
T ss_pred cccccccCccccccccccCCCcceeecCHhHhccC------cccchhhhhhhHHHHHHHhcCC----------CCCCCCC
Confidence 987654322211110 0111124579999998765 66789999999999999886 7 6677653
Q ss_pred CCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHH
Q psy14889 365 VPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKL 428 (443)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l 428 (443)
. .......+... .....+ ..++..+.+++.+||+.+|++||++.+|+..|+++
T Consensus 216 ~-----~~~~~~~i~~~-~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 216 S-----NQDVINAIEQD-YRLPPP-----MDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred C-----HHHHHHHHHcC-CcCCCc-----ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 2 22333333222 111111 23567899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=321.31 Aligned_cols=251 Identities=22% Similarity=0.302 Sum_probs=189.0
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCc----cchHHHHHHHHHHhccCCCceeeeeeccccCCcccEE
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDE----ASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQL 209 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~----~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~ 209 (443)
++|++.+.||+|+||.||++.. +++.||+|++..... .......|+..+..++||||+++++.+.+. ..+
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~----~~~ 76 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDK----RNL 76 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC----CEE
Confidence 3688899999999999999988 588999999864321 111223455555568999999999998766 458
Q ss_pred EeeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCc
Q psy14889 210 WLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA 288 (443)
Q Consensus 210 ~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla 288 (443)
++||||+++|+|.+++.+ ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 77 ~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~--------givHrDLkp~NIli~~~~~vkL~DfG~~ 148 (360)
T cd05627 77 YLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQL--------GFIHRDIKPDNLLLDAKGHVKLSDFGLC 148 (360)
T ss_pred EEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CeEccCCCHHHEEECCCCCEEEeeccCC
Confidence 999999999999999864 6789999999999999999999998 9999999999999999999999999998
Q ss_pred ccccccCCc-------------------------------CCCCCCCcccccCcccccccccccccCcCCCCCccchHHH
Q psy14889 289 VSYSQLSNK-------------------------------MDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYAL 337 (443)
Q Consensus 289 ~~~~~~~~~-------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~ 337 (443)
+.+...... ........+||+.|+|||++.+. .++.++|||||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~------~~~~~~DiwSl 222 (360)
T cd05627 149 TGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQT------GYNKLCDWWSL 222 (360)
T ss_pred cccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCC------CCCCcceeccc
Confidence 754321100 00001235799999999999776 67789999999
Q ss_pred HHHHHHHHhcccCCCcccccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCc
Q psy14889 338 GLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLS 417 (443)
Q Consensus 338 Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps 417 (443)
||++|||++| ..||....+ ........ .......+|.. ...+.++.+++.+++ .||.+|++
T Consensus 223 Gvilyel~tG----------~~Pf~~~~~----~~~~~~i~-~~~~~~~~p~~---~~~s~~~~~li~~l~-~~p~~R~~ 283 (360)
T cd05627 223 GVIMYEMLIG----------YPPFCSETP----QETYRKVM-NWKETLVFPPE---VPISEKAKDLILRFC-TDSENRIG 283 (360)
T ss_pred cceeeecccC----------CCCCCCCCH----HHHHHHHH-cCCCceecCCC---CCCCHHHHHHHHHhc-cChhhcCC
Confidence 9999999999 677765321 12222222 11122223321 124567899999977 49999995
Q ss_pred ---HHHHHH
Q psy14889 418 ---ALRVKK 423 (443)
Q Consensus 418 ---~~evl~ 423 (443)
+.++++
T Consensus 284 ~~~~~ei~~ 292 (360)
T cd05627 284 SNGVEEIKS 292 (360)
T ss_pred CCCHHHHhc
Confidence 566654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=316.84 Aligned_cols=234 Identities=26% Similarity=0.359 Sum_probs=180.2
Q ss_pred ceeeeecCeEEEEEEE--CCceeEEEEeeccCcc----chHHHHHHH-HHHhccCCCceeeeeeccccCCcccEEEeeec
Q psy14889 142 ECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA----SWSRETEIY-STVLLRHENILGYIGSDMTSRNSCTQLWLVTH 214 (443)
Q Consensus 142 ~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~----~~~~e~ei~-~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e 214 (443)
+.||+|+||.||+|+. +++.||+|++...... ......|.. .+..++||||+++++++.+. ...++|||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~----~~~~lv~e 76 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTA----EKLYFVLD 76 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcC----CEEEEEEc
Confidence 4699999999999998 5889999998643211 111122222 23458999999999988766 45799999
Q ss_pred ccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcccccc
Q psy14889 215 YHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQ 293 (443)
Q Consensus 215 ~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~~~ 293 (443)
|+++|+|..++.+ ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 77 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~--------~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 148 (321)
T cd05603 77 YVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSL--------NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVE 148 (321)
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC--------CeEeccCCHHHeEECCCCCEEEccCCCCccCCC
Confidence 9999999988864 5689999999999999999999998 999999999999999999999999999865322
Q ss_pred cCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCChHH
Q psy14889 294 LSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFDD 373 (443)
Q Consensus 294 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~~~~ 373 (443)
... ......||+.|+|||.+.+. .++.++|||||||++|||++| ..||... ....
T Consensus 149 ~~~----~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~el~~g----------~~pf~~~-----~~~~ 203 (321)
T cd05603 149 PEE----TTSTFCGTPEYLAPEVLRKE------PYDRTVDWWCLGAVLYEMLYG----------LPPFYSR-----DVSQ 203 (321)
T ss_pred CCC----ccccccCCcccCCHHHhcCC------CCCCcCcccccchhhhhhhcC----------CCCCCCC-----CHHH
Confidence 111 12345789999999998765 667899999999999999999 6777653 2223
Q ss_pred HHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHH
Q psy14889 374 MRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSAL 419 (443)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ 419 (443)
+...+.. ....++ ...+..+.+++.+||+.||.+||++.
T Consensus 204 ~~~~i~~--~~~~~~-----~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 204 MYDNILH--KPLQLP-----GGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred HHHHHhc--CCCCCC-----CCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 3332221 122222 23456799999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=300.85 Aligned_cols=245 Identities=27% Similarity=0.396 Sum_probs=193.6
Q ss_pred cccccceeeeecCeEEEEEEE--CCceeEEEEeeccCc---cchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEe
Q psy14889 137 QISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDE---ASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWL 211 (443)
Q Consensus 137 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~---~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~l 211 (443)
+|++.+.||+|+||.||+|.. +++.|++|.+..... .......|+..+..++||||+++++++... ...++
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----~~~~l 76 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDK----GKLNI 76 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccC----CEEEE
Confidence 477889999999999999988 688999998764321 122233456666669999999999998776 45799
Q ss_pred eecccCcccHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCc
Q psy14889 212 VTHYHSFGSLYDHLNR---TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA 288 (443)
Q Consensus 212 v~e~~~~gsL~~~l~~---~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla 288 (443)
||||+++++|.+++.. ..+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++
T Consensus 77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~--------~i~h~dl~~~nili~~~~~~~l~df~~~ 148 (256)
T cd08529 77 VMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK--------KILHRDIKSLNLFLDAYDNVKIGDLGVA 148 (256)
T ss_pred EEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--------CcccCCCCcceEEEeCCCCEEEcccccc
Confidence 9999999999999864 4689999999999999999999988 9999999999999999999999999998
Q ss_pred ccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCC
Q psy14889 289 VSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMD 368 (443)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~ 368 (443)
+.+...... .....|+..|+|||++.+. .++.++|+||||+++|||++| ..||....
T Consensus 149 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~il~~l~~g----------~~p~~~~~--- 205 (256)
T cd08529 149 KLLSDNTNF----ANTIVGTPYYLSPELCEDK------PYNEKSDVWALGVVLYECCTG----------KHPFDANN--- 205 (256)
T ss_pred eeccCccch----hhccccCccccCHHHhcCC------CCCCccchHHHHHHHHHHHhC----------CCCCCCCC---
Confidence 766543221 1234688899999999876 566899999999999999999 66775431
Q ss_pred CChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHH
Q psy14889 369 PSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKT 424 (443)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 424 (443)
.......+. ....+.++ ...+..+.+++.+||+.+|++||++.++++.
T Consensus 206 --~~~~~~~~~-~~~~~~~~-----~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 206 --QGALILKII-RGVFPPVS-----QMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred --HHHHHHHHH-cCCCCCCc-----cccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 222222221 12222222 2356789999999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=304.85 Aligned_cols=255 Identities=23% Similarity=0.377 Sum_probs=183.7
Q ss_pred ceeeeecCeEEEEEEE-C---CceeEEEEeeccCccc--hHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEeeecc
Q psy14889 142 ECIGKGRYGEVWRGVW-H---GENVAVKIFFSRDEAS--WSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVTHY 215 (443)
Q Consensus 142 ~~lG~G~fg~Vy~~~~-~---~~~vAvK~~~~~~~~~--~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e~ 215 (443)
+.||+|+||.||+|.. + ...+|+|.+....... .....|+..+..++||||+++++.+.... .+++||||
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~----~~~lv~e~ 76 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESI----PYLLVLEF 76 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCC----ceEEEEEe
Confidence 3589999999999975 3 3468888765432221 12234555566689999999999987763 47999999
Q ss_pred cCcccHHHHhccc------CCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcc
Q psy14889 216 HSFGSLYDHLNRT------TLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAV 289 (443)
Q Consensus 216 ~~~gsL~~~l~~~------~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~ 289 (443)
+++|+|.+++... ..++..++.++.||+.||+|||+. +|+||||||+|||+++++.+||+|||++.
T Consensus 77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--------~ivH~dlkp~Nill~~~~~~kl~dfg~~~ 148 (269)
T cd05042 77 CPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA--------DFIHSDLALRNCQLTADLSVKIGDYGLAL 148 (269)
T ss_pred CCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc--------CEecccccHhheEecCCCcEEEecccccc
Confidence 9999999998642 246778899999999999999998 99999999999999999999999999986
Q ss_pred cccccCCcCCCCCCCcccccCcccccccccccc-cCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCC
Q psy14889 290 SYSQLSNKMDIPPNPRVGTKRYMSPEILDESIN-MDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMD 368 (443)
Q Consensus 290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~ 368 (443)
......... ......++..|+|||++..... .....++.++|||||||++|||+++. ..||....
T Consensus 149 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~---------~~p~~~~~--- 214 (269)
T cd05042 149 EQYPEDYYI--TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAA---------DQPYPDLS--- 214 (269)
T ss_pred ccccchhee--ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCC---------CCCCCcCC---
Confidence 543221111 1123346678999999864311 01125568999999999999999941 55665431
Q ss_pred CChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHH
Q psy14889 369 PSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLI 426 (443)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 426 (443)
..+.....+. .....++........+..+.+++..|| .||++|||+++|++.|.
T Consensus 215 -~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 215 -DEQVLKQVVR--EQDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred -HHHHHHHHhh--ccCccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 1122222222 222223332333456678899999999 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=302.94 Aligned_cols=251 Identities=25% Similarity=0.415 Sum_probs=196.8
Q ss_pred hccccccceeeeecCeEEEEEEE-CCceeEEEEeeccCccchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEeee
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVW-HGENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVT 213 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv~ 213 (443)
.++|.+.+.||+|+||.||+|.. ++..||||.+............|+..+..++|+||+++++++... ...++||
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----~~~~~v~ 80 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEE----EPIYIVT 80 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecC----CceEEEE
Confidence 46899999999999999999987 457899998875544333445566666679999999999998765 3479999
Q ss_pred cccCcccHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCccc
Q psy14889 214 HYHSFGSLYDHLNR---TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVS 290 (443)
Q Consensus 214 e~~~~gsL~~~l~~---~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~ 290 (443)
||+++++|.+++.. ..+++..+..++.|++.||.|||+. +++|+||||+||++++++.+||+|||++..
T Consensus 81 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~--------~i~h~di~p~nili~~~~~~~l~d~g~~~~ 152 (261)
T cd05034 81 EYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR--------NYIHRDLAARNILVGENLVCKIADFGLARL 152 (261)
T ss_pred eccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhC--------CcccCCcchheEEEcCCCCEEECcccccee
Confidence 99999999999965 3589999999999999999999998 999999999999999999999999999876
Q ss_pred ccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh-cccCCCcccccCCCCCCCCCCCC
Q psy14889 291 YSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR-RTKANGIFEEYKAPYHDLVPMDP 369 (443)
Q Consensus 291 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt-g~~~~~~~~~~~~P~~~~~~~~~ 369 (443)
+...... ......++..|+|||.+.+. .++.++||||||+++||+++ | ..||.+..
T Consensus 153 ~~~~~~~---~~~~~~~~~~y~~PE~~~~~------~~~~~~Di~slG~il~~l~t~g----------~~p~~~~~---- 209 (261)
T cd05034 153 IEDDEYT---AREGAKFPIKWTAPEAANYG------RFTIKSDVWSFGILLTEIVTYG----------RVPYPGMT---- 209 (261)
T ss_pred ccchhhh---hhhccCCCccccCHHHhccC------CcCchhHHHHHHHHHHHHHhCC----------CCCCCCCC----
Confidence 6532111 11122345689999998865 66789999999999999998 7 66775431
Q ss_pred ChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHH
Q psy14889 370 SFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIK 427 (443)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 427 (443)
.......+.. ......+ ...+.++.+++.+||+.||++||+++++.+.|+.
T Consensus 210 -~~~~~~~~~~-~~~~~~~-----~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 210 -NREVLEQVER-GYRMPRP-----PNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred -HHHHHHHHHc-CCCCCCC-----CCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 1222222211 1122222 2346789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=302.32 Aligned_cols=251 Identities=22% Similarity=0.393 Sum_probs=195.1
Q ss_pred hhccccccceeeeecCeEEEEEEE-CCceeEEEEeeccCccchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEee
Q psy14889 134 LAKQISLSECIGKGRYGEVWRGVW-HGENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLV 212 (443)
Q Consensus 134 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv 212 (443)
..++|++.+.||+|+||.||++.+ .+..+|+|.+............|+..+..++|+||+++++.+... ..+++
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~v 78 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKE-----PIYII 78 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcCC-----CeEEE
Confidence 347899999999999999999987 567799998765433222334455556669999999999987662 36899
Q ss_pred ecccCcccHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcc
Q psy14889 213 THYHSFGSLYDHLNR---TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAV 289 (443)
Q Consensus 213 ~e~~~~gsL~~~l~~---~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~ 289 (443)
|||+++|+|.+++.. ..+++.+++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++.
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~--------~i~H~dl~p~ni~i~~~~~~~l~d~~~~~ 150 (260)
T cd05073 79 TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR--------NYIHRDLRAANILVSASLVCKIADFGLAR 150 (260)
T ss_pred EEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhC--------CccccccCcceEEEcCCCcEEECCCccee
Confidence 999999999999964 3578899999999999999999988 99999999999999999999999999997
Q ss_pred cccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh-cccCCCcccccCCCCCCCCCCC
Q psy14889 290 SYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR-RTKANGIFEEYKAPYHDLVPMD 368 (443)
Q Consensus 290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt-g~~~~~~~~~~~~P~~~~~~~~ 368 (443)
.+...... ......++..|+|||++... .++.++|+||||+++||++| | ..||...
T Consensus 151 ~~~~~~~~---~~~~~~~~~~y~~PE~~~~~------~~~~~~Di~slG~~l~~l~t~g----------~~p~~~~---- 207 (260)
T cd05073 151 VIEDNEYT---AREGAKFPIKWTAPEAINFG------SFTIKSDVWSFGILLMEIVTYG----------RIPYPGM---- 207 (260)
T ss_pred eccCCCcc---cccCCcccccccCHhHhccC------CcCccccchHHHHHHHHHHhcC----------CCCCCCC----
Confidence 65432211 11223456789999998765 56789999999999999999 6 6677653
Q ss_pred CChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHH
Q psy14889 369 PSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIK 427 (443)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 427 (443)
........+.. ......+ ...+.++.+++.+||+.||++||++.++++.|+.
T Consensus 208 -~~~~~~~~~~~-~~~~~~~-----~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 208 -SNPEVIRALER-GYRMPRP-----ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred -CHHHHHHHHhC-CCCCCCc-----ccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 12222222221 1111111 3356789999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=314.04 Aligned_cols=256 Identities=22% Similarity=0.250 Sum_probs=189.5
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCc----cchHHHHHHHHHHhccCCCceeeeeeccccCCcccEE
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDE----ASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQL 209 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~----~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~ 209 (443)
++|++.+.||+|+||.||+++. +++.||+|++..... .......|+..+..++|+||+++++++.+. ..+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~----~~~ 76 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDE----NNL 76 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecC----CeE
Confidence 4688999999999999999987 588999999864221 111122344445558999999999998766 458
Q ss_pred EeeecccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCC
Q psy14889 210 WLVTHYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGL 287 (443)
Q Consensus 210 ~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGl 287 (443)
++||||+++|+|.+++.+ ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 77 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--------~ivH~dlkp~Nill~~~~~~kl~Dfg~ 148 (331)
T cd05597 77 YLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQL--------GYVHRDIKPDNVLLDKNGHIRLADFGS 148 (331)
T ss_pred EEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CeEECCCCHHHEEECCCCCEEEEECCc
Confidence 999999999999999964 5689999999999999999999998 999999999999999999999999999
Q ss_pred cccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCC
Q psy14889 288 AVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPM 367 (443)
Q Consensus 288 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~ 367 (443)
+..+...... ......||+.|+|||++....... ..++.++|||||||++|||++| ..||...
T Consensus 149 ~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~-~~~~~~~DiwslG~~l~el~~g----------~~Pf~~~--- 211 (331)
T cd05597 149 CLRLLADGTV---QSNVAVGTPDYISPEILQAMEDGK-GRYGPECDWWSLGVCMYEMLYG----------ETPFYAE--- 211 (331)
T ss_pred eeecCCCCCc---cccceeccccccCHHHHhhccccc-cCCCCcceeehhhhHHHHHhhC----------CCCCCCC---
Confidence 8765432211 112246899999999987421110 1456799999999999999999 7777653
Q ss_pred CCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcC--CCCcHHHHHHH
Q psy14889 368 DPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNAN--VRLSALRVKKT 424 (443)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~--~Rps~~evl~~ 424 (443)
...+....+........++.. ....+..+.+++++|+..+++ .||++.++++.
T Consensus 212 --~~~~~~~~i~~~~~~~~~~~~--~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 212 --SLVETYGKIMNHKEHFQFPPD--VTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred --CHHHHHHHHHcCCCcccCCCc--cCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 112222222222222222221 123567899999998865443 37899988875
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=305.52 Aligned_cols=252 Identities=27% Similarity=0.408 Sum_probs=191.4
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccch-HHHHHHHHHHhccCCCceeeeeeccccCCcccEEEee
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEASW-SRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLV 212 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~-~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv 212 (443)
++|++.+.||+|+||.||+|.. +++.||+|.+........ ....|+..+..++||||+++++.+... ..+++|
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~----~~~~lv 84 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRR----DKLWIC 84 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC----CEEEEE
Confidence 5899999999999999999987 588999998865433221 223455666668999999999998766 457999
Q ss_pred ecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcccc
Q psy14889 213 THYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSY 291 (443)
Q Consensus 213 ~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~ 291 (443)
|||+++++|.+++.. ..+++.+++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++...
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~--------~i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd06645 85 MEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSK--------GKMHRDIKGANILLTDNGHVKLADFGVSAQI 156 (267)
T ss_pred EeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CeecCCCCHHHEEECCCCCEEECcceeeeEc
Confidence 999999999998854 5799999999999999999999998 9999999999999999999999999998765
Q ss_pred cccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCCh
Q psy14889 292 SQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSF 371 (443)
Q Consensus 292 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~~ 371 (443)
..... ......|+..|+|||++..... ..++.++|||||||++|||++| ..||....+.
T Consensus 157 ~~~~~----~~~~~~~~~~y~aPE~~~~~~~---~~~~~~~DvwSlG~il~~l~~~----------~~p~~~~~~~---- 215 (267)
T cd06645 157 TATIA----KRKSFIGTPYWMAPEVAAVERK---GGYNQLCDIWAVGITAIELAEL----------QPPMFDLHPM---- 215 (267)
T ss_pred cCccc----ccccccCcccccChhhhccccC---CCCCchhhhHHHHHHHHHHhcC----------CCCcccccch----
Confidence 43211 1234478999999999752211 1466899999999999999999 5666543211
Q ss_pred HHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 372 DDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
.............+... .....+..+.+++.+||+.||++|||++++++
T Consensus 216 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 216 RALFLMTKSNFQPPKLK---DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred hhHHhhhccCCCCCccc---ccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 11111111111111111 11124567999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=303.37 Aligned_cols=254 Identities=23% Similarity=0.419 Sum_probs=196.8
Q ss_pred ccccccceeeeecCeEEEEEEEC-----CceeEEEEeeccCc--cchHHHHHHHHHHhccCCCceeeeeeccccCCcccE
Q psy14889 136 KQISLSECIGKGRYGEVWRGVWH-----GENVAVKIFFSRDE--ASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQ 208 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~~-----~~~vAvK~~~~~~~--~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~ 208 (443)
++|.+.+.||+|+||.||+|.+. ...||||....... .......|+..+..++||||+++++++.+. .
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~ 80 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITEN-----P 80 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCC-----C
Confidence 56889999999999999999873 23689997754432 122334566667779999999999988653 2
Q ss_pred EEeeecccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecC
Q psy14889 209 LWLVTHYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFG 286 (443)
Q Consensus 209 ~~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfG 286 (443)
.++||||+++|+|.+++.+ ..+++..++.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~--------~~~H~dl~p~nili~~~~~~~l~d~g 152 (270)
T cd05056 81 VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESK--------RFVHRDIAARNVLVSSPDCVKLGDFG 152 (270)
T ss_pred cEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CeeccccChheEEEecCCCeEEccCc
Confidence 5899999999999999964 3589999999999999999999988 99999999999999999999999999
Q ss_pred CcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh-cccCCCcccccCCCCCCCC
Q psy14889 287 LAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR-RTKANGIFEEYKAPYHDLV 365 (443)
Q Consensus 287 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt-g~~~~~~~~~~~~P~~~~~ 365 (443)
+++......... .....++..|+|||.+... .++.++||||||+++||+++ | ..||....
T Consensus 153 ~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~il~el~~~g----------~~pf~~~~ 213 (270)
T cd05056 153 LSRYLEDESYYK---ASKGKLPIKWMAPESINFR------RFTSASDVWMFGVCMWEILMLG----------VKPFQGVK 213 (270)
T ss_pred eeeeccccccee---cCCCCccccccChhhhccC------CCCchhhhHHHHHHHHHHHHcC----------CCCCCCCC
Confidence 987665432111 1122345689999988765 56789999999999999986 7 66775532
Q ss_pred CCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhhcc
Q psy14889 366 PMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLACAD 432 (443)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~~~ 432 (443)
.......+. ...+...+ ..++..+.+++.+||..+|++|||+.++++.|+++.+++
T Consensus 214 -----~~~~~~~~~-~~~~~~~~-----~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~~ 269 (270)
T cd05056 214 -----NNDVIGRIE-NGERLPMP-----PNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQEE 269 (270)
T ss_pred -----HHHHHHHHH-cCCcCCCC-----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 112222221 12222222 346678999999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=304.06 Aligned_cols=257 Identities=23% Similarity=0.433 Sum_probs=199.9
Q ss_pred ccccccceeeeecCeEEEEEEE--CCc----eeEEEEeeccCcc--chHHHHHHHHHHhccCCCceeeeeeccccCCccc
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGE----NVAVKIFFSRDEA--SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCT 207 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~----~vAvK~~~~~~~~--~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~ 207 (443)
.+|++.+.||+|+||.||+|.+ +|. .+|+|.+...... ....+.|+..+..++||||+++++++...
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 81 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLSS----- 81 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC-----
Confidence 5788999999999999999987 333 5899977544322 22334566666779999999999998762
Q ss_pred EEEeeecccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEec
Q psy14889 208 QLWLVTHYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADF 285 (443)
Q Consensus 208 ~~~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~Df 285 (443)
..++|+||+++|+|.+++.+ ..+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+||
T Consensus 82 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~--------~i~H~di~p~nil~~~~~~~kL~df 153 (279)
T cd05057 82 QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEK--------RLVHRDLAARNVLVKTPQHVKITDF 153 (279)
T ss_pred ceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC--------CEEecccCcceEEEcCCCeEEECCC
Confidence 46899999999999999965 4689999999999999999999998 9999999999999999999999999
Q ss_pred CCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh-cccCCCcccccCCCCCCC
Q psy14889 286 GLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR-RTKANGIFEEYKAPYHDL 364 (443)
Q Consensus 286 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt-g~~~~~~~~~~~~P~~~~ 364 (443)
|+++.......... .....++..|+|||.+... .++.++||||||+++||+++ | ..||...
T Consensus 154 g~~~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~------~~~~~~Di~slG~~l~el~~~g----------~~p~~~~ 215 (279)
T cd05057 154 GLAKLLDVDEKEYH--AEGGKVPIKWMALESILHR------IYTHKSDVWSYGVTVWELMTFG----------AKPYEGI 215 (279)
T ss_pred cccccccCccccee--cCCCcccccccCHHHhhcC------CcCchhhHHHHHHHHHHHhcCC----------CCCCCCC
Confidence 99977653322111 1122345689999988755 56689999999999999998 7 6677653
Q ss_pred CCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhhcccc
Q psy14889 365 VPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLACADMY 434 (443)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~~~~~ 434 (443)
...++...+.. ......+ ..++..+.+++.+||..||++||++.++++.|.++.+...+
T Consensus 216 -----~~~~~~~~~~~-~~~~~~~-----~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~~~ 274 (279)
T cd05057 216 -----PAVEIPDLLEK-GERLPQP-----PICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDPQR 274 (279)
T ss_pred -----CHHHHHHHHhC-CCCCCCC-----CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCCcc
Confidence 22334443332 2222222 22456789999999999999999999999999999876544
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=301.77 Aligned_cols=245 Identities=25% Similarity=0.419 Sum_probs=191.9
Q ss_pred cccccceeeeecCeEEEEEEE--CCceeEEEEeeccCc--cchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEee
Q psy14889 137 QISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDE--ASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLV 212 (443)
Q Consensus 137 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~--~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv 212 (443)
+|++.+.||+|+||.||++.. ++..+|+|.+..... .......|+..+..++|+||+++++.+.+. ..++++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----~~~~lv 76 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEAD----GHLYIV 76 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEEC----CEEEEE
Confidence 478889999999999999987 588999998754322 112223455556669999999999998766 468999
Q ss_pred ecccCcccHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcc
Q psy14889 213 THYHSFGSLYDHLNR---TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAV 289 (443)
Q Consensus 213 ~e~~~~gsL~~~l~~---~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~ 289 (443)
|||+++|+|.+++.. ..+++..++.++.|++.||.|||+. +|+|+||||+||++++++.++|+|||++.
T Consensus 77 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~--------~i~H~dl~p~nili~~~~~~~l~dfg~~~ 148 (255)
T cd08219 77 MEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK--------RVLHRDIKSKNIFLTQNGKVKLGDFGSAR 148 (255)
T ss_pred EeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhC--------CcccCCCCcceEEECCCCcEEEcccCcce
Confidence 999999999998853 4588999999999999999999998 99999999999999999999999999987
Q ss_pred cccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCC
Q psy14889 290 SYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDP 369 (443)
Q Consensus 290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~ 369 (443)
........ .....|+..|+|||++.+. .++.++|+||||+++|+|++| ..||...
T Consensus 149 ~~~~~~~~----~~~~~~~~~~~aPE~~~~~------~~~~~~Dv~slG~i~~~l~~g----------~~p~~~~----- 203 (255)
T cd08219 149 LLTSPGAY----ACTYVGTPYYVPPEIWENM------PYNNKSDIWSLGCILYELCTL----------KHPFQAN----- 203 (255)
T ss_pred eecccccc----cccccCCccccCHHHHccC------CcCchhhhhhhchhheehhhc----------cCCCCCC-----
Confidence 65432211 1234688899999998765 567899999999999999999 6677542
Q ss_pred ChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHH
Q psy14889 370 SFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKT 424 (443)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 424 (443)
........+. .......+ ...+..+.+++.+||+.||++|||+.+++..
T Consensus 204 ~~~~~~~~~~-~~~~~~~~-----~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 204 SWKNLILKVC-QGSYKPLP-----SHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CHHHHHHHHh-cCCCCCCC-----cccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 1222222222 12222233 2355679999999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=305.55 Aligned_cols=247 Identities=23% Similarity=0.381 Sum_probs=188.7
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccc--hHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEe
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEAS--WSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWL 211 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~--~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~l 211 (443)
++|++.+.||+|+||.||+|.. +++.||+|++....... .....|+..+..++||||+++++++... ...++
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----~~~~l 76 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVE----NRISI 76 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEEC----CEEEE
Confidence 3678889999999999999987 68899999886432211 1223455556668999999999998876 45789
Q ss_pred eecccCcccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcccc
Q psy14889 212 VTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSY 291 (443)
Q Consensus 212 v~e~~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~ 291 (443)
||||+++|+|..+ ..+++..+..++.|++.||.|||+. +|+|+||||+|||++.++.+||+|||++..+
T Consensus 77 v~e~~~~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~--------~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~ 145 (279)
T cd06619 77 CTEFMDGGSLDVY---RKIPEHVLGRIAVAVVKGLTYLWSL--------KILHRDVKPSNMLVNTRGQVKLCDFGVSTQL 145 (279)
T ss_pred EEecCCCCChHHh---hcCCHHHHHHHHHHHHHHHHHHHHC--------CEeeCCCCHHHEEECCCCCEEEeeCCcceec
Confidence 9999999999765 3478889999999999999999998 9999999999999999999999999999765
Q ss_pred cccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCC-
Q psy14889 292 SQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPS- 370 (443)
Q Consensus 292 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~- 370 (443)
.... .....||..|+|||.+.+. .++.++||||||+++|||++| ..||.........
T Consensus 146 ~~~~------~~~~~~~~~y~aPE~~~~~------~~~~~~DvwslG~~l~~l~~g----------~~pf~~~~~~~~~~ 203 (279)
T cd06619 146 VNSI------AKTYVGTNAYMAPERISGE------QYGIHSDVWSLGISFMELALG----------RFPYPQIQKNQGSL 203 (279)
T ss_pred cccc------ccCCCCChhhcCceeecCC------CCCCcchHHHHHHHHHHHHhC----------CCCchhhccccccc
Confidence 4321 1334789999999999876 667899999999999999999 5565443211111
Q ss_pred -hHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHH
Q psy14889 371 -FDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKT 424 (443)
Q Consensus 371 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 424 (443)
.......+. ....+..+ ....+.++.+++.+||+.||++||+++++++.
T Consensus 204 ~~~~~~~~~~-~~~~~~~~----~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 204 MPLQLLQCIV-DEDPPVLP----VGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred chHHHHHHHh-ccCCCCCC----CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 111111111 11122222 12345679999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=303.69 Aligned_cols=254 Identities=24% Similarity=0.375 Sum_probs=184.0
Q ss_pred ceeeeecCeEEEEEEEC----CceeEEEEeeccCcc--chHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEeeecc
Q psy14889 142 ECIGKGRYGEVWRGVWH----GENVAVKIFFSRDEA--SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVTHY 215 (443)
Q Consensus 142 ~~lG~G~fg~Vy~~~~~----~~~vAvK~~~~~~~~--~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e~ 215 (443)
+.||+|+||.||+|.+. +..+|+|.+...... ......|+..+..++||||+++++++.+.. ..++||||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~~~lv~e~ 76 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVT----PYLLVMEF 76 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC----CcEEEEEC
Confidence 35899999999999863 356899987554322 123344666666799999999999987663 46899999
Q ss_pred cCcccHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcc
Q psy14889 216 HSFGSLYDHLNR------TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAV 289 (443)
Q Consensus 216 ~~~gsL~~~l~~------~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~ 289 (443)
+++|+|.++++. ...++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++
T Consensus 77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~--------~i~H~dlkp~nil~~~~~~~kL~dfg~~~ 148 (269)
T cd05087 77 CPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN--------NFIHSDLALRNCLLTADLTVKIGDYGLSH 148 (269)
T ss_pred CCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC--------CEeccccCcceEEEcCCCcEEECCccccc
Confidence 999999999863 2356778889999999999999998 99999999999999999999999999986
Q ss_pred cccccCCcCCCCCCCcccccCccccccccccccc-CcCCCCCccchHHHHHHHHHHHh-cccCCCcccccCCCCCCCCCC
Q psy14889 290 SYSQLSNKMDIPPNPRVGTKRYMSPEILDESINM-DCFESFKKADIYALGLVLWEVCR-RTKANGIFEEYKAPYHDLVPM 367 (443)
Q Consensus 290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~~~~~~sDvwS~Gvvl~ellt-g~~~~~~~~~~~~P~~~~~~~ 367 (443)
........ .......|+..|+|||++...... ....++.++||||||+++|||++ | ..||.....
T Consensus 149 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g----------~~p~~~~~~- 215 (269)
T cd05087 149 NKYKEDYY--VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELG----------SQPYRHLSD- 215 (269)
T ss_pred cccCccee--ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCC----------CCCCCCCCh-
Confidence 54322111 112234577889999998643110 01145689999999999999996 8 667754321
Q ss_pred CCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHH
Q psy14889 368 DPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLI 426 (443)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 426 (443)
.+.....+. ......+........+..+.+++..|| .+|++|||++||+..|+
T Consensus 216 ---~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 216 ---EQVLTYTVR--EQQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred ---HHHHHHHhh--cccCCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 111111111 112222222222335667899999999 68999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=304.34 Aligned_cols=244 Identities=25% Similarity=0.423 Sum_probs=183.7
Q ss_pred ceeeeecCeEEEEEEEC--Cc--eeEEEEeeccCcc--chHHHHHHHHHHhc-cCCCceeeeeeccccCCcccEEEeeec
Q psy14889 142 ECIGKGRYGEVWRGVWH--GE--NVAVKIFFSRDEA--SWSRETEIYSTVLL-RHENILGYIGSDMTSRNSCTQLWLVTH 214 (443)
Q Consensus 142 ~~lG~G~fg~Vy~~~~~--~~--~vAvK~~~~~~~~--~~~~e~ei~~~~~l-~H~nIv~l~g~~~~~~~~~~~~~lv~e 214 (443)
+.||+|+||.||+|... +. .+|+|.+...... ......|+..+..+ +||||+++++++.... ..++|||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~----~~~lv~e 76 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG----YLYLAIE 76 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCC----CceEEEE
Confidence 36899999999999873 33 4688877542211 12223455555557 8999999999987663 4799999
Q ss_pred ccCcccHHHHhccc-----------------CCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCC
Q psy14889 215 YHSFGSLYDHLNRT-----------------TLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTN 277 (443)
Q Consensus 215 ~~~~gsL~~~l~~~-----------------~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~ 277 (443)
|+++|+|.+++... .+++.++..++.|++.||+|||+. +++||||||+|||++++
T Consensus 77 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~--------~i~H~dikp~nili~~~ 148 (270)
T cd05047 77 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK--------QFIHRDLAARNILVGEN 148 (270)
T ss_pred eCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC--------CEeecccccceEEEcCC
Confidence 99999999998542 378999999999999999999998 99999999999999999
Q ss_pred CcEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh-cccCCCcccc
Q psy14889 278 GTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR-RTKANGIFEE 356 (443)
Q Consensus 278 ~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt-g~~~~~~~~~ 356 (443)
+.+||+|||++........ ......+..|+|||++... .++.++||||||+++|||++ |
T Consensus 149 ~~~kl~dfgl~~~~~~~~~-----~~~~~~~~~y~apE~~~~~------~~~~~~Di~slG~il~el~~~g--------- 208 (270)
T cd05047 149 YVAKIADFGLSRGQEVYVK-----KTMGRLPVRWMAIESLNYS------VYTTNSDVWSYGVLLWEIVSLG--------- 208 (270)
T ss_pred CeEEECCCCCccccchhhh-----ccCCCCccccCChHHHccC------CCCchhhHHHHHHHHHHHHcCC---------
Confidence 9999999999853221110 1112335679999998765 66789999999999999997 7
Q ss_pred cCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHh
Q psy14889 357 YKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLA 429 (443)
Q Consensus 357 ~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~ 429 (443)
..||.+. ........+.. ......+ ..++.++.+++.+||+.||.+|||+.++++.|+++.
T Consensus 209 -~~pf~~~-----~~~~~~~~~~~-~~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 209 -GTPYCGM-----TCAELYEKLPQ-GYRLEKP-----LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred -CCCcccc-----CHHHHHHHHhC-CCCCCCC-----CcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 6677543 12222222211 1122222 235567999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=308.04 Aligned_cols=252 Identities=23% Similarity=0.371 Sum_probs=193.4
Q ss_pred hccccccceeeeecCeEEEEEEE-------CCceeEEEEeeccCcc--chHHHHHHHHHHhccCCCceeeeeeccccCCc
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVW-------HGENVAVKIFFSRDEA--SWSRETEIYSTVLLRHENILGYIGSDMTSRNS 205 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~-------~~~~vAvK~~~~~~~~--~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~ 205 (443)
.++|++.+.||+|+||.||++.. ++..||+|++...... ....+.|+..+..++||||+++++++....
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~-- 81 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGK-- 81 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC--
Confidence 36799999999999999999986 3578999988654322 122345666666799999999999987764
Q ss_pred ccEEEeeecccCcccHHHHhcc-----------------------cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCe
Q psy14889 206 CTQLWLVTHYHSFGSLYDHLNR-----------------------TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAI 262 (443)
Q Consensus 206 ~~~~~lv~e~~~~gsL~~~l~~-----------------------~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~i 262 (443)
..++++||+++|+|.+++.. ..+++..++.++.|++.||.|||+. ++
T Consensus 82 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~--------~i 151 (288)
T cd05050 82 --PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER--------KF 151 (288)
T ss_pred --ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC--------Ce
Confidence 36999999999999999853 1367888999999999999999998 99
Q ss_pred EEeCCCCCCEEEcCCCcEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHH
Q psy14889 263 AHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLW 342 (443)
Q Consensus 263 iHrDlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ 342 (443)
+||||||+||+++.++.+||+|||++.......... ......++..|+|||.+.+. .++.++|||||||++|
T Consensus 152 ~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~------~~~~~~Dv~slG~il~ 223 (288)
T cd05050 152 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK--ASENDAIPIRWMPPESIFYN------RYTTESDVWAYGVVLW 223 (288)
T ss_pred ecccccHhheEecCCCceEECccccceecccCcccc--ccCCCccChhhcCHHHHhcC------CCCchhHHHHHHHHHH
Confidence 999999999999999999999999987554322111 11122346679999998765 6678999999999999
Q ss_pred HHHh-cccCCCcccccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHH
Q psy14889 343 EVCR-RTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRV 421 (443)
Q Consensus 343 ellt-g~~~~~~~~~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ev 421 (443)
||++ | ..||.+. ...+....+.. ......+ ..++.++.+++.+||+.||++|||+.|+
T Consensus 224 el~~~~----------~~p~~~~-----~~~~~~~~~~~-~~~~~~~-----~~~~~~l~~li~~~l~~~p~~Rpt~~el 282 (288)
T cd05050 224 EIFSYG----------MQPYYGM-----AHEEVIYYVRD-GNVLSCP-----DNCPLELYNLMRLCWSKLPSDRPSFASI 282 (288)
T ss_pred HHHhCC----------CCCCCCC-----CHHHHHHHHhc-CCCCCCC-----CCCCHHHHHHHHHHcccCcccCCCHHHH
Confidence 9997 5 5566543 12222222221 1111112 2356789999999999999999999999
Q ss_pred HHHHHH
Q psy14889 422 KKTLIK 427 (443)
Q Consensus 422 l~~L~~ 427 (443)
++.|++
T Consensus 283 ~~~l~~ 288 (288)
T cd05050 283 NRILQR 288 (288)
T ss_pred HHHhhC
Confidence 999873
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=316.90 Aligned_cols=260 Identities=22% Similarity=0.284 Sum_probs=188.0
Q ss_pred hhccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc---chHHHHHHHHHHhccCCCceeeeeeccccCC--cc
Q psy14889 134 LAKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA---SWSRETEIYSTVLLRHENILGYIGSDMTSRN--SC 206 (443)
Q Consensus 134 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~---~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~--~~ 206 (443)
..++|++.+.||+|+||.||++.. .++.||||.+...... ......|+..+..++||||+++++++..... ..
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 347899999999999999999987 5889999988643221 1222345666666999999999998764432 12
Q ss_pred cEEEeeecccCcccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecC
Q psy14889 207 TQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFG 286 (443)
Q Consensus 207 ~~~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfG 286 (443)
...++||||+++ +|.+.+. ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~--------givHrDikp~Nill~~~~~~kl~Dfg 164 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQ-MELDHERMSYLLYQMLCGIKHLHSA--------GIIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHh-hcCCHHHHHHHHHHHHHHHHHHHhC--------CcccCCCChHHEEECCCCCEEEeeCc
Confidence 357999999975 7777764 3588999999999999999999998 99999999999999999999999999
Q ss_pred CcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCC
Q psy14889 287 LAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVP 366 (443)
Q Consensus 287 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~ 366 (443)
+++...... ......||..|+|||++.+. .++.++|||||||++|||++| ..||.+...
T Consensus 165 ~~~~~~~~~-----~~~~~~~t~~y~aPE~~~~~------~~~~~~DiwslG~il~el~~g----------~~pf~~~~~ 223 (355)
T cd07874 165 LARTAGTSF-----MMTPYVVTRYYRAPEVILGM------GYKENVDIWSVGCIMGEMVRH----------KILFPGRDY 223 (355)
T ss_pred ccccCCCcc-----ccCCccccCCccCHHHHcCC------CCCchhhHHHHHHHHHHHHhC----------CCCCCCCCH
Confidence 997654321 12345789999999999765 667899999999999999999 445543210
Q ss_pred CCC-----------Ch-------HHHHhhhhhcCC--CCCCC----CC------CCCchhHHHHHHHHHHHhcCCcCCCC
Q psy14889 367 MDP-----------SF-------DDMRKVICIDQQ--RPVLP----NR------WVSDSTLNAMTKVMKECWHQNANVRL 416 (443)
Q Consensus 367 ~~~-----------~~-------~~~~~~~~~~~~--~~~~~----~~------~~~~~~~~~l~~li~~cl~~dP~~Rp 416 (443)
... .. ............ ...++ .. ......+..+.+|+.+||+.||++||
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rp 303 (355)
T cd07874 224 IDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI 303 (355)
T ss_pred HHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcC
Confidence 000 00 000000000000 00000 00 01112345789999999999999999
Q ss_pred cHHHHHHH
Q psy14889 417 SALRVKKT 424 (443)
Q Consensus 417 s~~evl~~ 424 (443)
|+.|+++.
T Consensus 304 s~~ell~h 311 (355)
T cd07874 304 SVDEALQH 311 (355)
T ss_pred CHHHHhcC
Confidence 99999984
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=314.47 Aligned_cols=256 Identities=21% Similarity=0.251 Sum_probs=190.8
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCc----cchHHHHHHHHHHhccCCCceeeeeeccccCCcccEE
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDE----ASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQL 209 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~----~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~ 209 (443)
++|++.+.||+|+||.||+++. +++.+|+|++..... .......|+..+..++|+||+++++.+.+. ..+
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~----~~~ 76 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDE----NNL 76 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecC----CEE
Confidence 3688999999999999999998 467899998854211 111123344455558999999999998766 458
Q ss_pred EeeecccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCC
Q psy14889 210 WLVTHYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGL 287 (443)
Q Consensus 210 ~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGl 287 (443)
++||||+++|+|.+++++ ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 77 ~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~--------~iiHrDlkp~Nili~~~~~~kL~DfG~ 148 (332)
T cd05623 77 YLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQL--------HYVHRDIKPDNILMDMNGHIRLADFGS 148 (332)
T ss_pred EEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CeEecCCCHHHEEECCCCCEEEeecch
Confidence 999999999999999965 5689999999999999999999998 999999999999999999999999999
Q ss_pred cccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCC
Q psy14889 288 AVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPM 367 (443)
Q Consensus 288 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~ 367 (443)
+..+...... ......||+.|+|||++....... ..++.++|||||||++|||++| ..||...
T Consensus 149 a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~-~~~~~~~DvwSlGvil~ell~g----------~~Pf~~~--- 211 (332)
T cd05623 149 CLKLMEDGTV---QSSVAVGTPDYISPEILQAMEDGK-GKYGPECDWWSLGVCMYEMLYG----------ETPFYAE--- 211 (332)
T ss_pred heecccCCcc---eecccccCccccCHHHHhccccCC-CCCCCcCCEEeeHHHHHHHhcC----------CCCCCCC---
Confidence 8765432211 112347999999999986421110 1567899999999999999999 7777653
Q ss_pred CCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCC--CCcHHHHHHH
Q psy14889 368 DPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANV--RLSALRVKKT 424 (443)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--Rps~~evl~~ 424 (443)
........+.....+..+|.. ...++.++.+|+++|+..+++. |+++.++++.
T Consensus 212 --~~~~~~~~i~~~~~~~~~p~~--~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 212 --SLVETYGKIMNHKERFQFPAQ--VTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred --CHHHHHHHHhCCCccccCCCc--cccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 222222222222222223321 1335678999999998655444 6889998765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=309.56 Aligned_cols=260 Identities=27% Similarity=0.380 Sum_probs=190.9
Q ss_pred ccccccceeeeecCeEEEEEEEC------------------CceeEEEEeeccCcc--chHHHHHHHHHHhccCCCceee
Q psy14889 136 KQISLSECIGKGRYGEVWRGVWH------------------GENVAVKIFFSRDEA--SWSRETEIYSTVLLRHENILGY 195 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~~------------------~~~vAvK~~~~~~~~--~~~~e~ei~~~~~l~H~nIv~l 195 (443)
++|++.+.||+|+||.||++.+. +..||+|++...... ......|+..+..++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 67999999999999999998542 336899988643222 1223456666667999999999
Q ss_pred eeeccccCCcccEEEeeecccCcccHHHHhccc------------CCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeE
Q psy14889 196 IGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRT------------TLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIA 263 (443)
Q Consensus 196 ~g~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~------------~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~ii 263 (443)
++++.... ..++||||+++|+|.+++... .+++.++..++.|++.||+|||+. +++
T Consensus 85 ~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~--------~i~ 152 (296)
T cd05095 85 LAVCITSD----PLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL--------NFV 152 (296)
T ss_pred EEEEecCC----ccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC--------Cee
Confidence 99987764 369999999999999998642 367788999999999999999998 999
Q ss_pred EeCCCCCCEEEcCCCcEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHH
Q psy14889 264 HRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWE 343 (443)
Q Consensus 264 HrDlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~e 343 (443)
|+||||+|||++.++.+||+|||+++.+....... ......++..|+|||....+ .++.++|||||||++||
T Consensus 153 H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~------~~~~~~DiwSlG~~l~e 224 (296)
T cd05095 153 HRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYR--IQGRAVLPIRWMSWESILLG------KFTTASDVWAFGVTLWE 224 (296)
T ss_pred cccCChheEEEcCCCCEEeccCcccccccCCccee--ccCcCcCccccCCHHHHhcC------CccchhhhhHHHHHHHH
Confidence 99999999999999999999999997654322111 11222446789999987765 66789999999999999
Q ss_pred HHhcccCCCcccccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 344 VCRRTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 344 lltg~~~~~~~~~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
|+++.. ..||....... ..................+. +..++..+.+++.+||+.||++|||+.+|++
T Consensus 225 l~~~~~--------~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 225 ILTLCK--------EQPYSQLSDEQ-VIENTGEFFRDQGRQVYLPK---PALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred HHHhCC--------CCCccccChHH-HHHHHHHHHhhccccccCCC---CCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 998421 56665432111 00011111111111111111 1335678999999999999999999999999
Q ss_pred HHHH
Q psy14889 424 TLIK 427 (443)
Q Consensus 424 ~L~~ 427 (443)
.|++
T Consensus 293 ~l~~ 296 (296)
T cd05095 293 TLLE 296 (296)
T ss_pred HHhC
Confidence 8863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=301.65 Aligned_cols=244 Identities=27% Similarity=0.483 Sum_probs=192.2
Q ss_pred ccccccceeeeecCeEEEEEEECCceeEEEEeeccCccchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEeeecc
Q psy14889 136 KQISLSECIGKGRYGEVWRGVWHGENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVTHY 215 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e~ 215 (443)
++|++.+.||+|+||.||++..+++.||+|....... ......|+..+..++||||+++++++... ..+++|||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~~-~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~v~e~ 79 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDVT-AQAFLEETAVMTKLHHKNLVRLLGVILHN-----GLYIVMEL 79 (254)
T ss_pred HHceeeeeeccCCCCceEecccCCCceEEEeecCcch-HHHHHHHHHHHHhCCCCCcCeEEEEEcCC-----CcEEEEEC
Confidence 5789999999999999999999999999998854322 12223455555669999999999997653 25899999
Q ss_pred cCcccHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCccccc
Q psy14889 216 HSFGSLYDHLNR---TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYS 292 (443)
Q Consensus 216 ~~~gsL~~~l~~---~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~~ 292 (443)
+++|+|.+++.. ..+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++....
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~--------~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~ 151 (254)
T cd05083 80 MSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK--------KLVHRDLAARNILVSEDGVAKVSDFGLARVGS 151 (254)
T ss_pred CCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC--------CeeccccCcceEEEcCCCcEEECCCccceecc
Confidence 999999999964 3488999999999999999999988 99999999999999999999999999986543
Q ss_pred ccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh-cccCCCcccccCCCCCCCCCCCCCh
Q psy14889 293 QLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR-RTKANGIFEEYKAPYHDLVPMDPSF 371 (443)
Q Consensus 293 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt-g~~~~~~~~~~~~P~~~~~~~~~~~ 371 (443)
... .....+..|+|||.+.+. .++.++|+||||+++|||++ | ..||... ..
T Consensus 152 ~~~-------~~~~~~~~y~~pe~~~~~------~~~~~~Dv~slG~~l~el~~~g----------~~p~~~~-----~~ 203 (254)
T cd05083 152 MGV-------DNSKLPVKWTAPEALKHK------KFSSKSDVWSYGVLLWEVFSYG----------RAPYPKM-----SL 203 (254)
T ss_pred ccC-------CCCCCCceecCHHHhccC------CcCchhhHHHHHHHHHHHHhCC----------CCCCccC-----CH
Confidence 211 112345679999998765 66789999999999999998 6 5676553 22
Q ss_pred HHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHH
Q psy14889 372 DDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIK 427 (443)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 427 (443)
......+.. ..++..+ ..++..+.+++.+||+.+|++||++.++++.|++
T Consensus 204 ~~~~~~~~~-~~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 204 KEVKECVEK-GYRMEPP-----EGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred HHHHHHHhC-CCCCCCC-----CcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 333333322 1222222 3356789999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=305.84 Aligned_cols=253 Identities=29% Similarity=0.365 Sum_probs=184.9
Q ss_pred cccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc-----chHHHHHHHH-HHhccCCCceeeeeeccccCC-ccc
Q psy14889 137 QISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA-----SWSRETEIYS-TVLLRHENILGYIGSDMTSRN-SCT 207 (443)
Q Consensus 137 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~-----~~~~e~ei~~-~~~l~H~nIv~l~g~~~~~~~-~~~ 207 (443)
+|++.+.||+|+||.||+|.. +++.||+|.+...... ....|.++.. +..++||||+++++++..... ...
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 478889999999999999988 5889999988643211 2223433332 223589999999998765322 224
Q ss_pred EEEeeecccCcccHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEe
Q psy14889 208 QLWLVTHYHSFGSLYDHLNR---TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIAD 284 (443)
Q Consensus 208 ~~~lv~e~~~~gsL~~~l~~---~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~D 284 (443)
.++++|||+. ++|.+++.. ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~--------~ivH~dikp~Nili~~~~~~kl~d 151 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN--------CIVHRDLKPENILVTSGGQVKLAD 151 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CeecCCCCHHHEEECCCCCEEECc
Confidence 5899999998 489888864 3589999999999999999999998 999999999999999999999999
Q ss_pred cCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCC
Q psy14889 285 FGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDL 364 (443)
Q Consensus 285 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~ 364 (443)
||+++....... .....||..|+|||++.+. .++.++|||||||++|||++| ..||...
T Consensus 152 fg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~------~~~~~~DiwslG~~l~~l~~g----------~~~f~~~ 210 (288)
T cd07863 152 FGLARIYSCQMA-----LTPVVVTLWYRAPEVLLQS------TYATPVDMWSVGCIFAEMFRR----------KPLFCGN 210 (288)
T ss_pred cCccccccCccc-----CCCccccccccCchHhhCC------CCCCcchhhhHHHHHHHHHhC----------CcCcCCC
Confidence 999976543211 1334688999999999765 667899999999999999999 4444332
Q ss_pred CCCCCChHHHHhhhhhcC-----------------CCCCCCC--CCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 365 VPMDPSFDDMRKVICIDQ-----------------QRPVLPN--RWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~-----------------~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
. ..+.+.+...... ..+..+. .......+..+.+++.+||+.||++|||+.|++.
T Consensus 211 ~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 211 S----EADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred C----HHHHHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 1 1111111111000 0000000 0011235567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=305.74 Aligned_cols=258 Identities=27% Similarity=0.433 Sum_probs=193.4
Q ss_pred hhhccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccchHHHHHHHHHHhc-cCCCceeeeeeccccCC--ccc
Q psy14889 133 TLAKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEASWSRETEIYSTVLL-RHENILGYIGSDMTSRN--SCT 207 (443)
Q Consensus 133 ~~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~e~ei~~~~~l-~H~nIv~l~g~~~~~~~--~~~ 207 (443)
...+.|++.+.||+|+||.||+|.. +++.+|+|++..........+.|+..+..+ +|+||+++++++..... ...
T Consensus 13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 92 (282)
T cd06636 13 DPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDD 92 (282)
T ss_pred ChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCC
Confidence 3457899999999999999999998 578999998865433333334455554445 79999999999864321 225
Q ss_pred EEEeeecccCcccHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEe
Q psy14889 208 QLWLVTHYHSFGSLYDHLNR---TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIAD 284 (443)
Q Consensus 208 ~~~lv~e~~~~gsL~~~l~~---~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~D 284 (443)
.++++|||+++|+|.+++.. ..+++..+..++.|++.||.|||+. +|+|+||||+||++++++.++|+|
T Consensus 93 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~--------~ivH~dl~~~nili~~~~~~~l~d 164 (282)
T cd06636 93 QLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH--------KVIHRDIKGQNVLLTENAEVKLVD 164 (282)
T ss_pred EEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC--------CcccCCCCHHHEEECCCCCEEEee
Confidence 68999999999999999864 4588899999999999999999998 999999999999999999999999
Q ss_pred cCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCC
Q psy14889 285 FGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDL 364 (443)
Q Consensus 285 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~ 364 (443)
||++........ ......|+..|+|||.+...... ...++.++|||||||++|||++| ..||...
T Consensus 165 fg~~~~~~~~~~----~~~~~~~~~~y~aPE~l~~~~~~-~~~~~~~~DvwslG~~l~el~~g----------~~p~~~~ 229 (282)
T cd06636 165 FGVSAQLDRTVG----RRNTFIGTPYWMAPEVIACDENP-DATYDYRSDIWSLGITAIEMAEG----------APPLCDM 229 (282)
T ss_pred Ccchhhhhcccc----CCCcccccccccCHhhcCcccCc-CcCCCcccchhHHHHHHHHHHhC----------CCCcccc
Confidence 999875542211 12335688999999998642111 11566799999999999999999 5666543
Q ss_pred CCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 365 VPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
.+ ........ ....+. .....++..+.++|.+||+.||.+|||+.|+++
T Consensus 230 ~~----~~~~~~~~--~~~~~~----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 230 HP----MRALFLIP--RNPPPK----LKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred CH----HhhhhhHh--hCCCCC----CcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 21 11111111 111111 112345678999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=317.20 Aligned_cols=257 Identities=21% Similarity=0.313 Sum_probs=190.6
Q ss_pred hhhccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc---chHHHHHHHHHHhccCCCceeeeeeccccCC--c
Q psy14889 133 TLAKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA---SWSRETEIYSTVLLRHENILGYIGSDMTSRN--S 205 (443)
Q Consensus 133 ~~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~---~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~--~ 205 (443)
.+.++|++.+.||+|+||.||+|.. +++.||||++...... ......|+..+..++||||+++++++..... .
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 4457899999999999999999987 5789999988643221 1122346666777999999999998764321 2
Q ss_pred ccEEEeeecccCcccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEec
Q psy14889 206 CTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADF 285 (443)
Q Consensus 206 ~~~~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~Df 285 (443)
....++++|++ +++|.+++....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+||
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--------~ivHrdikp~Nil~~~~~~~kl~Df 162 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSA--------GIIHRDLKPSNVAVNEDCELRILDF 162 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CeecccCChhhEEECCCCCEEEcCC
Confidence 24578999988 67999998888899999999999999999999998 9999999999999999999999999
Q ss_pred CCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCC
Q psy14889 286 GLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLV 365 (443)
Q Consensus 286 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~ 365 (443)
|+++..... .....||..|+|||++.+.. .++.++|||||||++|||++| ..||....
T Consensus 163 g~~~~~~~~-------~~~~~~t~~y~aPE~~~~~~-----~~~~~~DiwslG~il~el~~g----------~~pf~~~~ 220 (343)
T cd07878 163 GLARQADDE-------MTGYVATRWYRAPEIMLNWM-----HYNQTVDIWSVGCIMAELLKG----------KALFPGND 220 (343)
T ss_pred ccceecCCC-------cCCccccccccCchHhcCCc-----cCCchhhhHhHHHHHHHHHHC----------CCCCCCCC
Confidence 999765432 13347899999999987631 466899999999999999999 55554321
Q ss_pred CCCCChHHHHhhhhhc--------------------CCCCCCCCCC---CCchhHHHHHHHHHHHhcCCcCCCCcHHHHH
Q psy14889 366 PMDPSFDDMRKVICID--------------------QQRPVLPNRW---VSDSTLNAMTKVMKECWHQNANVRLSALRVK 422 (443)
Q Consensus 366 ~~~~~~~~~~~~~~~~--------------------~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~evl 422 (443)
..+.+....... ...+..+... ........+.+|+.+||+.||++|||+.|++
T Consensus 221 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell 296 (343)
T cd07878 221 ----YIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEAL 296 (343)
T ss_pred ----HHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence 011111110000 0001111000 0011334678999999999999999999999
Q ss_pred HH
Q psy14889 423 KT 424 (443)
Q Consensus 423 ~~ 424 (443)
+.
T Consensus 297 ~h 298 (343)
T cd07878 297 AH 298 (343)
T ss_pred cC
Confidence 64
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=306.74 Aligned_cols=260 Identities=26% Similarity=0.415 Sum_probs=192.9
Q ss_pred hhhccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccchHHHHHHHHHHhc-cCCCceeeeeeccccC-CcccE
Q psy14889 133 TLAKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEASWSRETEIYSTVLL-RHENILGYIGSDMTSR-NSCTQ 208 (443)
Q Consensus 133 ~~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~e~ei~~~~~l-~H~nIv~l~g~~~~~~-~~~~~ 208 (443)
...++|++.+.||+|+||.||++.. +++.+|+|++..........+.|+..+..+ +||||+++++++.... .....
T Consensus 15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~ 94 (286)
T cd06638 15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQ 94 (286)
T ss_pred CcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCe
Confidence 3457899999999999999999987 578999998755333222333455555556 7999999999875332 12246
Q ss_pred EEeeecccCcccHHHHhc-----ccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEE
Q psy14889 209 LWLVTHYHSFGSLYDHLN-----RTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIA 283 (443)
Q Consensus 209 ~~lv~e~~~~gsL~~~l~-----~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~ 283 (443)
+++||||+++|+|.+++. ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+
T Consensus 95 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~--------~i~H~dlkp~nili~~~~~~kl~ 166 (286)
T cd06638 95 LWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN--------KTIHRDVKGNNILLTTEGGVKLV 166 (286)
T ss_pred EEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC--------CccccCCCHHhEEECCCCCEEEc
Confidence 899999999999998874 24688999999999999999999998 99999999999999999999999
Q ss_pred ecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCC
Q psy14889 284 DFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHD 363 (443)
Q Consensus 284 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~ 363 (443)
|||+++........ .....|+..|+|||++....... ..++.++|||||||++|||++| +.||..
T Consensus 167 dfg~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~-~~~~~~~Dv~slGvi~~el~~g----------~~p~~~ 231 (286)
T cd06638 167 DFGVSAQLTSTRLR----RNTSVGTPFWMAPEVIACEQQLD-STYDARCDVWSLGITAIELGDG----------DPPLAD 231 (286)
T ss_pred cCCceeecccCCCc----cccccCCCcccChhhhchhhhcc-ccccchhhhhhHHHHHHHHhcC----------CCCCCC
Confidence 99998765432211 12346889999999986432111 1467899999999999999999 666654
Q ss_pred CCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHH
Q psy14889 364 LVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKT 424 (443)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 424 (443)
... ........ ....+... .+...+..+.+++.+||+.||++|||+.|+++.
T Consensus 232 ~~~----~~~~~~~~--~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 232 LHP----MRALFKIP--RNPPPTLH---QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred Cch----hHHHhhcc--ccCCCccc---CCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 321 11111111 11111111 112245679999999999999999999999875
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=306.84 Aligned_cols=247 Identities=26% Similarity=0.433 Sum_probs=195.2
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccc-hHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEee
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEAS-WSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLV 212 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~-~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv 212 (443)
++|++.+.||.|+||.||+|.. +++.||+|.+....... .....|+..+..++||||+++++++... ..+++|
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----~~~~lv 94 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVG----DELFVV 94 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecC----ceEEEE
Confidence 5799999999999999999986 68999999886543222 2223456666669999999999998765 458999
Q ss_pred ecccCcccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCccccc
Q psy14889 213 THYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYS 292 (443)
Q Consensus 213 ~e~~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~~ 292 (443)
+||+++++|..++.+..+++.++..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++....
T Consensus 95 ~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~--------~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~ 166 (296)
T cd06655 95 MEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHAN--------QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQIT 166 (296)
T ss_pred EEecCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHC--------CcccCCCCHHHEEECCCCCEEEccCccchhcc
Confidence 9999999999999888899999999999999999999998 99999999999999999999999999987654
Q ss_pred ccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCChH
Q psy14889 293 QLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFD 372 (443)
Q Consensus 293 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~~~ 372 (443)
..... .....|+..|+|||.+.+. .++.++|||||||++|||++| ..||....+ ..
T Consensus 167 ~~~~~----~~~~~~~~~y~aPE~~~~~------~~~~~~Dv~slGvil~~lltg----------~~pf~~~~~----~~ 222 (296)
T cd06655 167 PEQSK----RSTMVGTPYWMAPEVVTRK------AYGPKVDIWSLGIMAIEMVEG----------EPPYLNENP----LR 222 (296)
T ss_pred ccccc----CCCcCCCccccCcchhcCC------CCCchhhHHHHHHHHHHHHhC----------CCCCCCCCH----HH
Confidence 32211 1234688899999998765 566899999999999999999 667755321 11
Q ss_pred HHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 373 DMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
...... . ...+.+. .+..++..+.+++.+||..||++|||+.++++
T Consensus 223 ~~~~~~-~-~~~~~~~---~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 223 ALYLIA-T-NGTPELQ---NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred HHHHHH-h-cCCcccC---CcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 222111 1 1111111 12335678999999999999999999999885
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0667|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=320.52 Aligned_cols=199 Identities=27% Similarity=0.356 Sum_probs=166.4
Q ss_pred CchHHHhhhhccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccchHHHHHHHHHHhcc-C-----CCceeeee
Q psy14889 126 LPLLIQRTLAKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEASWSRETEIYSTVLLR-H-----ENILGYIG 197 (443)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~-H-----~nIv~l~g 197 (443)
+.....+.+..+|.+.+.||+|+||.|.+|.. +++.||||+++.+.....+...|+..+..++ | -|+|++++
T Consensus 176 Y~~v~~d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d 255 (586)
T KOG0667|consen 176 YQLVVNDHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLD 255 (586)
T ss_pred eeEEecceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeee
Confidence 33444444556889999999999999999987 6899999999776554444456666666666 4 38999999
Q ss_pred eccccCCcccEEEeeecccCcccHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEE
Q psy14889 198 SDMTSRNSCTQLWLVTHYHSFGSLYDHLNR---TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILV 274 (443)
Q Consensus 198 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~---~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl 274 (443)
+|... ++++||+|.+.. +|+++++. .+++...+..++.||+.||.+||+. +|||+||||+||||
T Consensus 256 ~F~fr----~HlciVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l--------~IIHcDLKPENILL 322 (586)
T KOG0667|consen 256 YFYFR----NHLCIVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHEL--------GIIHCDLKPENILL 322 (586)
T ss_pred ccccc----cceeeeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CeeeccCChhheee
Confidence 99888 568999999976 99999975 5689999999999999999999988 99999999999999
Q ss_pred cCCC--cEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccC
Q psy14889 275 KTNG--TCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKA 350 (443)
Q Consensus 275 ~~~~--~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~ 350 (443)
.+.+ .+||+|||.|....+... +..-+..|+|||++.+. +|+.+.||||||||+.||++|.+.
T Consensus 323 ~~~~r~~vKVIDFGSSc~~~q~vy-------tYiQSRfYRAPEVILGl------pY~~~IDmWSLGCIlAEL~tG~PL 387 (586)
T KOG0667|consen 323 KDPKRSRIKVIDFGSSCFESQRVY-------TYIQSRFYRAPEVILGL------PYDTAIDMWSLGCILAELFTGEPL 387 (586)
T ss_pred ccCCcCceeEEecccccccCCcce-------eeeeccccccchhhccC------CCCCccceeehhhhHHhHhcCccc
Confidence 7654 799999999977654332 33667899999999998 888999999999999999999764
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=314.31 Aligned_cols=256 Identities=22% Similarity=0.243 Sum_probs=190.5
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCc----cchHHHHHHHHHHhccCCCceeeeeeccccCCcccEE
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDE----ASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQL 209 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~----~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~ 209 (443)
++|++.+.||+|+||.||+++. +++.||+|++..... .......|+..+..++|+||+++++++.+. ...
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~----~~~ 76 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDE----NYL 76 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC----CEE
Confidence 4689999999999999999987 578899998864221 111122344455558999999999998766 458
Q ss_pred EeeecccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCC
Q psy14889 210 WLVTHYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGL 287 (443)
Q Consensus 210 ~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGl 287 (443)
++||||+++|+|.+++.+ ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 77 ~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~--------~iiHrDlkp~Nill~~~~~~kl~DfG~ 148 (331)
T cd05624 77 YLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQL--------HYVHRDIKPDNVLLDMNGHIRLADFGS 148 (331)
T ss_pred EEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CeeeccCchHHEEEcCCCCEEEEeccc
Confidence 999999999999999965 5789999999999999999999998 999999999999999999999999999
Q ss_pred cccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCC
Q psy14889 288 AVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPM 367 (443)
Q Consensus 288 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~ 367 (443)
++........ ......||+.|+|||++.+..... ..++.++|||||||++|||++| ..||...
T Consensus 149 a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~-~~~~~~~DiwSlGvil~ell~g----------~~Pf~~~--- 211 (331)
T cd05624 149 CLKMNQDGTV---QSSVAVGTPDYISPEILQAMEDGM-GKYGPECDWWSLGVCMYEMLYG----------ETPFYAE--- 211 (331)
T ss_pred eeeccCCCce---eeccccCCcccCCHHHHhccccCC-CCCCCcccEEeeehhhhhhhhC----------CCCccCC---
Confidence 9765432211 112346999999999987521110 1456799999999999999999 6777643
Q ss_pred CCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCC--CCcHHHHHHH
Q psy14889 368 DPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANV--RLSALRVKKT 424 (443)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--Rps~~evl~~ 424 (443)
........+.....+..++..+ ...+.++.+++.+|+..++.+ |++++++++.
T Consensus 212 --~~~~~~~~i~~~~~~~~~p~~~--~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 212 --SLVETYGKIMNHEERFQFPSHI--TDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred --CHHHHHHHHHcCCCcccCCCcc--ccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 1122222222222233333322 235678999999999876544 4578887653
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=338.23 Aligned_cols=261 Identities=21% Similarity=0.231 Sum_probs=196.1
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc----chHHHHHHHHHHhccCCCceeeeeeccccCCcccEE
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA----SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQL 209 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~----~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~ 209 (443)
++|++.+.||+|+||.||+|.. +|+.||+|++...... ......|+..+..++||||+++++++.+. ...
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~----~~l 77 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDG----DPV 77 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeC----CEE
Confidence 5799999999999999999987 5889999988643211 12223456666669999999999998766 457
Q ss_pred EeeecccCcccHHHHhcc------------cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCC
Q psy14889 210 WLVTHYHSFGSLYDHLNR------------TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTN 277 (443)
Q Consensus 210 ~lv~e~~~~gsL~~~l~~------------~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~ 277 (443)
++||||+++|+|.+++.. ..+++..++.++.||+.||+|||+. +|+||||||+|||++.+
T Consensus 78 yLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~--------GIIHRDLKPeNILLd~d 149 (932)
T PRK13184 78 YYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK--------GVLHRDLKPDNILLGLF 149 (932)
T ss_pred EEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC--------CccccCCchheEEEcCC
Confidence 999999999999998853 2356678899999999999999998 99999999999999999
Q ss_pred CcEEEEecCCcccccccCCc--------------CCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHH
Q psy14889 278 GTCVIADFGLAVSYSQLSNK--------------MDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWE 343 (443)
Q Consensus 278 ~~~kl~DfGla~~~~~~~~~--------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~e 343 (443)
+.+||+|||+++........ .........||+.|+|||.+.+. .++.++|||||||++||
T Consensus 150 g~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~------~~S~kSDIWSLGVILyE 223 (932)
T PRK13184 150 GEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGV------PASESTDIYALGVILYQ 223 (932)
T ss_pred CCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCC------CCCcHhHHHHHHHHHHH
Confidence 99999999999766221100 00111235799999999998876 66789999999999999
Q ss_pred HHhcccCCCcccccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCC-cHHHHH
Q psy14889 344 VCRRTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRL-SALRVK 422 (443)
Q Consensus 344 lltg~~~~~~~~~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-s~~evl 422 (443)
|+|| ..||...... ....... ...+.... .....+..+.+++.+||+.||++|| ++++++
T Consensus 224 LLTG----------~~PF~~~~~~----ki~~~~~---i~~P~~~~--p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl 284 (932)
T PRK13184 224 MLTL----------SFPYRRKKGR----KISYRDV---ILSPIEVA--PYREIPPFLSQIAMKALAVDPAERYSSVQELK 284 (932)
T ss_pred HHHC----------CCCCCCcchh----hhhhhhh---ccChhhcc--ccccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 9999 6666542111 0000000 00110000 0123567799999999999999996 678888
Q ss_pred HHHHHHhhccc
Q psy14889 423 KTLIKLACADM 433 (443)
Q Consensus 423 ~~L~~l~~~~~ 433 (443)
+.|+...+..+
T Consensus 285 ~~Le~~lq~~p 295 (932)
T PRK13184 285 QDLEPHLQGSP 295 (932)
T ss_pred HHHHHHHhcCc
Confidence 88888776543
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=312.24 Aligned_cols=256 Identities=22% Similarity=0.420 Sum_probs=195.7
Q ss_pred ccccccceeeeecCeEEEEEEEC---------CceeEEEEeeccCccc--hHHHHHHHHHHhc-cCCCceeeeeeccccC
Q psy14889 136 KQISLSECIGKGRYGEVWRGVWH---------GENVAVKIFFSRDEAS--WSRETEIYSTVLL-RHENILGYIGSDMTSR 203 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~~---------~~~vAvK~~~~~~~~~--~~~e~ei~~~~~l-~H~nIv~l~g~~~~~~ 203 (443)
.+|++.+.||+|+||.||++.+. +..||+|.+....... .....|+..+.++ +||||+++++++....
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 57899999999999999999752 2368999876432221 2223455555557 8999999999987663
Q ss_pred CcccEEEeeecccCcccHHHHhcc-----------------cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeC
Q psy14889 204 NSCTQLWLVTHYHSFGSLYDHLNR-----------------TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRD 266 (443)
Q Consensus 204 ~~~~~~~lv~e~~~~gsL~~~l~~-----------------~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrD 266 (443)
.+++++||+++|+|.+++.+ ..+++.+++.++.|++.||.|||+. +++|||
T Consensus 92 ----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~--------givH~d 159 (334)
T cd05100 92 ----PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ--------KCIHRD 159 (334)
T ss_pred ----ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC--------Ceeccc
Confidence 47999999999999999853 2478889999999999999999998 999999
Q ss_pred CCCCCEEEcCCCcEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh
Q psy14889 267 IKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR 346 (443)
Q Consensus 267 lk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt 346 (443)
|||+|||++.++.+||+|||+++......... ......++..|+|||.+.+. .++.++||||||+++|||++
T Consensus 160 lkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~il~el~~ 231 (334)
T cd05100 160 LAARNVLVTEDNVMKIADFGLARDVHNIDYYK--KTTNGRLPVKWMAPEALFDR------VYTHQSDVWSFGVLLWEIFT 231 (334)
T ss_pred cccceEEEcCCCcEEECCcccceecccccccc--cccCCCcCceEcCHHHhccC------CcCchhhhHHHHHHHHHHHh
Confidence 99999999999999999999997654322111 11222345679999999776 66789999999999999998
Q ss_pred -cccCCCcccccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHH
Q psy14889 347 -RTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTL 425 (443)
Q Consensus 347 -g~~~~~~~~~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 425 (443)
| ..||... ..+.....+.. ......+ ..++.++.+++.+||+.+|++|||+.++++.|
T Consensus 232 ~g----------~~p~~~~-----~~~~~~~~~~~-~~~~~~~-----~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l 290 (334)
T cd05100 232 LG----------GSPYPGI-----PVEELFKLLKE-GHRMDKP-----ANCTHELYMIMRECWHAVPSQRPTFKQLVEDL 290 (334)
T ss_pred cC----------CCCCCCC-----CHHHHHHHHHc-CCCCCCC-----CCCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence 5 5666543 22333333322 1222222 23567899999999999999999999999999
Q ss_pred HHHhhcc
Q psy14889 426 IKLACAD 432 (443)
Q Consensus 426 ~~l~~~~ 432 (443)
+++....
T Consensus 291 ~~~~~~~ 297 (334)
T cd05100 291 DRVLTVT 297 (334)
T ss_pred HHHhhhc
Confidence 9988543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=299.24 Aligned_cols=248 Identities=24% Similarity=0.439 Sum_probs=193.3
Q ss_pred ccccccceeeeecCeEEEEEEE-CCceeEEEEeeccCccchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEeeec
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW-HGENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVTH 214 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e 214 (443)
.+|++.+.||+|+||.||++.+ ++..+|+|.+............|+..+..++||||+++++++... ...++|+|
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----~~~~~v~e 79 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTER----SPICLVFE 79 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccC----CceEEEEE
Confidence 4788899999999999999988 478999998865433333344566666669999999999998765 34799999
Q ss_pred ccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCccccc
Q psy14889 215 YHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYS 292 (443)
Q Consensus 215 ~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~~ 292 (443)
|+++|+|.+++.. ..+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++....
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~--------~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~ 151 (256)
T cd05112 80 FMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESS--------NVIHRDLAARNCLVGENQVVKVSDFGMTRFVL 151 (256)
T ss_pred cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC--------CccccccccceEEEcCCCeEEECCCcceeecc
Confidence 9999999999864 4589999999999999999999998 99999999999999999999999999987654
Q ss_pred ccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh-cccCCCcccccCCCCCCCCCCCCCh
Q psy14889 293 QLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR-RTKANGIFEEYKAPYHDLVPMDPSF 371 (443)
Q Consensus 293 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt-g~~~~~~~~~~~~P~~~~~~~~~~~ 371 (443)
..... ......++..|+|||.+.++ .++.++||||||+++|||++ | ..||... ..
T Consensus 152 ~~~~~---~~~~~~~~~~~~aPe~~~~~------~~~~~~Dv~slG~~l~el~~~g----------~~p~~~~-----~~ 207 (256)
T cd05112 152 DDQYT---SSTGTKFPVKWSSPEVFSFS------KYSSKSDVWSFGVLMWEVFSEG----------KTPYENR-----SN 207 (256)
T ss_pred cCccc---ccCCCccchhhcCHhHhccC------CcChHHHHHHHHHHHHHHHcCC----------CCCCCcC-----CH
Confidence 32111 11223356789999998765 56689999999999999998 6 5676542 12
Q ss_pred HHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHH
Q psy14889 372 DDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTL 425 (443)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 425 (443)
..+...... ..+...+ ...+..+.+|+.+||+.+|++|||+.++++.|
T Consensus 208 ~~~~~~~~~-~~~~~~~-----~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 208 SEVVETINA-GFRLYKP-----RLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred HHHHHHHhC-CCCCCCC-----CCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 222222221 1122122 22456799999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=307.45 Aligned_cols=262 Identities=16% Similarity=0.180 Sum_probs=185.3
Q ss_pred hhccccccceeeeecCeEEEEEEEC-----CceeEEEEeeccCccchHHH-------------HHHHHHHhccCCCceee
Q psy14889 134 LAKQISLSECIGKGRYGEVWRGVWH-----GENVAVKIFFSRDEASWSRE-------------TEIYSTVLLRHENILGY 195 (443)
Q Consensus 134 ~~~~~~~~~~lG~G~fg~Vy~~~~~-----~~~vAvK~~~~~~~~~~~~e-------------~ei~~~~~l~H~nIv~l 195 (443)
..++|.+.+.||+|+||.||+|.+. +..+|+|+....... ...| .+......+.|+||+++
T Consensus 10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~-~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 88 (294)
T PHA02882 10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENET-IVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY 88 (294)
T ss_pred CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCc-hhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence 3478999999999999999999973 346677754322211 1111 12223334789999999
Q ss_pred eeeccccCCcccEEEeeecccCcccHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEE
Q psy14889 196 IGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRT-TLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILV 274 (443)
Q Consensus 196 ~g~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~-~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl 274 (443)
++.+..........++++|++.. ++.+.+... ..++..+..++.|++.||+|||+. +|+||||||+|||+
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--------~iiHrDiKp~Nill 159 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEH--------GISHGDIKPENIMV 159 (294)
T ss_pred EEeeeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhC--------CeecCCCCHHHEEE
Confidence 99766554333345788887754 666666543 468888999999999999999998 99999999999999
Q ss_pred cCCCcEEEEecCCcccccccCCcCC---CCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCC
Q psy14889 275 KTNGTCVIADFGLAVSYSQLSNKMD---IPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKAN 351 (443)
Q Consensus 275 ~~~~~~kl~DfGla~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~ 351 (443)
+.++.+||+|||+|+.+........ .......||+.|+|||++.+. .++.++|||||||++|||++|
T Consensus 160 ~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~------~~~~~~DiwSlG~~l~el~~g---- 229 (294)
T PHA02882 160 DGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGA------CVTRRGDLESLGYCMLKWAGI---- 229 (294)
T ss_pred cCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCC------CCCcHHHHHHHHHHHHHHHhC----
Confidence 9999999999999987643221111 112234699999999998876 677899999999999999999
Q ss_pred CcccccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHH
Q psy14889 352 GIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTL 425 (443)
Q Consensus 352 ~~~~~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 425 (443)
..||........................... ...+++.+.+++..||..+|++||++.++++.|
T Consensus 230 ------~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 230 ------KLPWKGFGHNGNLIHAAKCDFIKRLHEGKIK----IKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred ------CCCCCccccchHHHHHhHHHHHHHhhhhhhc----cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 7787664221111111110000000011110 123567899999999999999999999999876
|
|
| >KOG0574|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=303.35 Aligned_cols=244 Identities=28% Similarity=0.495 Sum_probs=198.2
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeecc-CccchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEee
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSR-DEASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLV 212 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~-~~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv 212 (443)
+-|.+.++||+|+||.||+|.+ .|..||||.+... +.++.. .||-++.+.+.|++|++||.+... ..+|+|
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEII--KEISIMQQC~S~yVVKYYGSYFK~----sDLWIV 106 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEII--KEISIMQQCKSKYVVKYYGSYFKH----SDLWIV 106 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHH--HHHHHHHHcCCchhhhhhhhhccC----CceEee
Confidence 5688899999999999999988 6999999987543 223333 455555558999999999988766 348999
Q ss_pred ecccCcccHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCccc
Q psy14889 213 THYHSFGSLYDHLN--RTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVS 290 (443)
Q Consensus 213 ~e~~~~gsL~~~l~--~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~ 290 (443)
||||.-|++.+.++ +.++++.++..++...++||+|||.. .-||||||+.|||++.+|.+||+|||.|..
T Consensus 107 MEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~--------~KIHRDIKAGNILLNT~G~AKLADFGVAGQ 178 (502)
T KOG0574|consen 107 MEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDL--------KKIHRDIKAGNILLNTDGIAKLADFGVAGQ 178 (502)
T ss_pred hhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHH--------HHHHhhcccccEEEcccchhhhhhccccch
Confidence 99999999999885 67899999999999999999999988 669999999999999999999999999977
Q ss_pred ccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCC
Q psy14889 291 YSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPS 370 (443)
Q Consensus 291 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~ 370 (443)
+.+...+ .++..||+.|||||++..- .|..++||||||++..||..| +.||.+..++.
T Consensus 179 LTDTMAK----RNTVIGTPFWMAPEVI~EI------GY~~~ADIWSLGITaIEMAEG----------~PPYsDIHPMR-- 236 (502)
T KOG0574|consen 179 LTDTMAK----RNTVIGTPFWMAPEVIEEI------GYDTKADIWSLGITAIEMAEG----------RPPYSDIHPMR-- 236 (502)
T ss_pred hhhhHHh----hCccccCcccccHHHHHHh------ccchhhhHhhhcchhhhhhcC----------CCCcccccccc--
Confidence 6643322 3567899999999999875 677899999999999999999 77888876543
Q ss_pred hHHHHhhhhhcCCC-CCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 371 FDDMRKVICIDQQR-PVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 371 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
.++...... |.+. .+..-+.++.+++++||..+|++|-|+.++++
T Consensus 237 -----AIFMIPT~PPPTF~---KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 237 -----AIFMIPTKPPPTFK---KPEEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred -----eeEeccCCCCCCCC---ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 332222111 1111 12345678999999999999999999998876
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=299.77 Aligned_cols=245 Identities=27% Similarity=0.425 Sum_probs=190.4
Q ss_pred ceeeeecCeEEEEEEEC---Cc--eeEEEEeeccCcc--chHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEeeec
Q psy14889 142 ECIGKGRYGEVWRGVWH---GE--NVAVKIFFSRDEA--SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVTH 214 (443)
Q Consensus 142 ~~lG~G~fg~Vy~~~~~---~~--~vAvK~~~~~~~~--~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e 214 (443)
+.||+|+||.||+|.+. ++ .||||.+...... ......|+..+..++||||+++++++.. ..+++|||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~v~e 75 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-----HPLMMVTE 75 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-----CeEEEEEE
Confidence 46899999999999872 22 6899988654431 2233467777777999999999999876 24799999
Q ss_pred ccCcccHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcccc
Q psy14889 215 YHSFGSLYDHLNRT---TLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSY 291 (443)
Q Consensus 215 ~~~~gsL~~~l~~~---~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~ 291 (443)
|+++|+|.+++.+. .+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++.+
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~--------~i~H~di~p~nil~~~~~~~kl~dfg~~~~~ 147 (257)
T cd05040 76 LAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK--------RFIHRDLAARNILLASDDKVKIGDFGLMRAL 147 (257)
T ss_pred ecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhC--------CccccccCcccEEEecCCEEEeccccccccc
Confidence 99999999999653 589999999999999999999998 9999999999999999999999999999876
Q ss_pred cccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh-cccCCCcccccCCCCCCCCCCCCC
Q psy14889 292 SQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR-RTKANGIFEEYKAPYHDLVPMDPS 370 (443)
Q Consensus 292 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt-g~~~~~~~~~~~~P~~~~~~~~~~ 370 (443)
......... .....++..|+|||.+.+. .++.++||||||+++|||++ | ..||... .
T Consensus 148 ~~~~~~~~~-~~~~~~~~~y~~pE~~~~~------~~~~~~Di~slG~~l~el~t~g----------~~p~~~~-----~ 205 (257)
T cd05040 148 PQNEDHYVM-EEHLKVPFAWCAPESLRTR------TFSHASDVWMFGVTLWEMFTYG----------EEPWAGL-----S 205 (257)
T ss_pred cccccceec-ccCCCCCceecCHHHhccc------CcCchhhhHHHHHHHHHHHhCC----------CCCCCCC-----C
Confidence 543222111 1234577889999998766 66789999999999999998 8 6677543 2
Q ss_pred hHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHH
Q psy14889 371 FDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLI 426 (443)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 426 (443)
..+....+.........+ ...+..+.+++.+||+.+|++|||+.++++.|.
T Consensus 206 ~~~~~~~~~~~~~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 206 GSQILKKIDKEGERLERP-----EACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred HHHHHHHHHhcCCcCCCC-----ccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 222222222222222222 335678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=306.16 Aligned_cols=245 Identities=31% Similarity=0.463 Sum_probs=193.5
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc--chHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEe
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA--SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWL 211 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~--~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~l 211 (443)
+.|+..+.||+|+||.||+|.+ ++..||+|.+...... ....+.|+..+..++||||+++++.+... ...++
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----~~~~l 79 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKG----TKLWI 79 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccC----CceEE
Confidence 4577888999999999999987 5789999987643322 12234566666779999999999998765 45799
Q ss_pred eecccCcccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcccc
Q psy14889 212 VTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSY 291 (443)
Q Consensus 212 v~e~~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~ 291 (443)
||||+++++|.+++....+++..+..++.|++.||.|||+. +++|+||+|+||++++++.+||+|||++..+
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~--------~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~ 151 (277)
T cd06642 80 IMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSE--------RKIHRDIKAANVLLSEQGDVKLADFGVAGQL 151 (277)
T ss_pred EEEccCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcC--------CeeccCCChheEEEeCCCCEEEccccccccc
Confidence 99999999999999888899999999999999999999988 9999999999999999999999999998765
Q ss_pred cccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCCh
Q psy14889 292 SQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSF 371 (443)
Q Consensus 292 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~~ 371 (443)
..... ......|+..|+|||.+.+. .++.++||||||+++|||++| ..||.+..+.
T Consensus 152 ~~~~~----~~~~~~~~~~y~aPE~~~~~------~~~~~~Dv~slG~il~el~tg----------~~p~~~~~~~---- 207 (277)
T cd06642 152 TDTQI----KRNTFVGTPFWMAPEVIKQS------AYDFKADIWSLGITAIELAKG----------EPPNSDLHPM---- 207 (277)
T ss_pred cCcch----hhhcccCcccccCHHHhCcC------CCchhhhHHHHHHHHHHHHhC----------CCCCcccchh----
Confidence 43221 11234678899999999776 566899999999999999999 5566543211
Q ss_pred HHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 372 DDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
.....+ .....+.+ ....+..+.+++.+||+.+|++|||+.++++
T Consensus 208 -~~~~~~-~~~~~~~~-----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 208 -RVLFLI-PKNSPPTL-----EGQYSKPFKEFVEACLNKDPRFRPTAKELLK 252 (277)
T ss_pred -hHHhhh-hcCCCCCC-----CcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 111111 11111222 1335677999999999999999999999998
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=299.28 Aligned_cols=245 Identities=25% Similarity=0.406 Sum_probs=193.2
Q ss_pred ceeeeecCeEEEEEEEC-----CceeEEEEeeccCccc--hHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEeeec
Q psy14889 142 ECIGKGRYGEVWRGVWH-----GENVAVKIFFSRDEAS--WSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVTH 214 (443)
Q Consensus 142 ~~lG~G~fg~Vy~~~~~-----~~~vAvK~~~~~~~~~--~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e 214 (443)
+.||+|+||.||+|... +..||+|.+....... .....|+..+..++|+||+++++++... ..+++|||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~----~~~~lv~e 76 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEE----EPLYLVLE 76 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCC----CceEEEEE
Confidence 46899999999999984 7789999886554332 2334566666668999999999998874 45799999
Q ss_pred ccCcccHHHHhcc----------cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEe
Q psy14889 215 YHSFGSLYDHLNR----------TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIAD 284 (443)
Q Consensus 215 ~~~~gsL~~~l~~----------~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~D 284 (443)
|+++|+|.+++.. ..+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|
T Consensus 77 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~--------~i~H~di~p~nili~~~~~~~l~d 148 (262)
T cd00192 77 YMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK--------KFVHRDLAARNCLVGEDLVVKISD 148 (262)
T ss_pred eccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC--------CcccCccCcceEEECCCCcEEEcc
Confidence 9999999999964 5689999999999999999999998 999999999999999999999999
Q ss_pred cCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCC
Q psy14889 285 FGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDL 364 (443)
Q Consensus 285 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~ 364 (443)
||.+........ ........++..|+|||.+... .++.++||||||+++|||+++. ..||...
T Consensus 149 fg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~il~~l~~~g---------~~p~~~~ 211 (262)
T cd00192 149 FGLSRDVYDDDY--YRKKTGGKLPIRWMAPESLKDG------IFTSKSDVWSFGVLLWEIFTLG---------ATPYPGL 211 (262)
T ss_pred cccccccccccc--cccccCCCcCccccCHHHhccC------CcchhhccHHHHHHHHHHHhcC---------CCCCCCC
Confidence 999977654321 1112334678899999998776 5668999999999999999841 5666654
Q ss_pred CCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHH
Q psy14889 365 VPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLI 426 (443)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 426 (443)
....+...+.. ......+ ..++.++.+++.+||+.||++|||+.|+++.|+
T Consensus 212 -----~~~~~~~~~~~-~~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 212 -----SNEEVLEYLRK-GYRLPKP-----EYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred -----CHHHHHHHHHc-CCCCCCC-----ccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 22333333322 2222222 335678999999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=319.05 Aligned_cols=261 Identities=25% Similarity=0.347 Sum_probs=189.0
Q ss_pred cccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc---chHHHHHHHHHHhccCCCceeeeeeccccCCc-ccEEE
Q psy14889 137 QISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA---SWSRETEIYSTVLLRHENILGYIGSDMTSRNS-CTQLW 210 (443)
Q Consensus 137 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~---~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~-~~~~~ 210 (443)
+|++.+.||+|+||.||++.. +|+.||||.+...... ......|+..+..++||||+++++++...... ...++
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 477889999999999999987 6899999987543211 12223456666669999999999998765421 12589
Q ss_pred eeecccCcccHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcc
Q psy14889 211 LVTHYHSFGSLYDHLN-RTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAV 289 (443)
Q Consensus 211 lv~e~~~~gsL~~~l~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~ 289 (443)
+|+||+. ++|.+++. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 81 lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~--------~ivH~dlkp~Nili~~~~~~kL~Dfg~a~ 151 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSA--------GILHRDIKPGNLLVNSNCVLKICDFGLAR 151 (372)
T ss_pred EEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC--------CeeCCCCChHHEEECCCCCEEecccccee
Confidence 9999997 57887774 46799999999999999999999998 99999999999999999999999999997
Q ss_pred cccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCC--
Q psy14889 290 SYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPM-- 367 (443)
Q Consensus 290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~-- 367 (443)
........ ......+|..|+|||.+.+.. .++.++|||||||++|||++| ..||....+.
T Consensus 152 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~-----~~~~~~DiwslG~il~el~~g----------~~pf~~~~~~~~ 213 (372)
T cd07853 152 VEEPDESK---HMTQEVVTQYYRAPEILMGSR-----HYTSAVDIWSVGCIFAELLGR----------RILFQAQSPIQQ 213 (372)
T ss_pred ecccCccc---cCCCCCcCCCcCCHHHHcCCC-----CCCcHHHHHhHHHHHHHHHcC----------CCCCCCCCHHHH
Confidence 65432211 123346789999999987642 356799999999999999999 5555432110
Q ss_pred ---------CCChHHH-------HhhhhhcCCCCC-CCCC-CCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHH
Q psy14889 368 ---------DPSFDDM-------RKVICIDQQRPV-LPNR-WVSDSTLNAMTKVMKECWHQNANVRLSALRVKKT 424 (443)
Q Consensus 368 ---------~~~~~~~-------~~~~~~~~~~~~-~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 424 (443)
.+..+.+ ...+......+. .+.. ......+.++.+|+.+||+.||++|||+.|+++.
T Consensus 214 ~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 214 LDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 0001111 011111111111 0000 0112345679999999999999999999999863
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG4279|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=322.38 Aligned_cols=242 Identities=29% Similarity=0.410 Sum_probs=193.4
Q ss_pred eeeeecCeEEEEEEE--CCceeEEEEeeccCccch-HHHHHHHHHHhccCCCceeeeeeccccCCcccEEEeeecccCcc
Q psy14889 143 CIGKGRYGEVWRGVW--HGENVAVKIFFSRDEASW-SRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVTHYHSFG 219 (443)
Q Consensus 143 ~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~-~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e~~~~g 219 (443)
+||+|.||+||-|++ +...+|||.+..++.... -.-.||.....|+|.|||+++|.+... +.+-+.||-++||
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~sen----Gf~kIFMEqVPGG 657 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSEN----GFFKIFMEQVPGG 657 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCC----CeEEEEeecCCCC
Confidence 799999999999988 455679998865443322 223466666679999999999997665 5788999999999
Q ss_pred cHHHHhcc--cCC--CHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEc-CCCcEEEEecCCccccccc
Q psy14889 220 SLYDHLNR--TTL--NHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVK-TNGTCVIADFGLAVSYSQL 294 (443)
Q Consensus 220 sL~~~l~~--~~l--~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~-~~~~~kl~DfGla~~~~~~ 294 (443)
||.++|+. +++ ++.++-.+..||+.||.|||.+ .|||||||-+||||+ -.|.+||+|||-++.+...
T Consensus 658 SLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen--------~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi 729 (1226)
T KOG4279|consen 658 SLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHEN--------KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI 729 (1226)
T ss_pred cHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhc--------ceeeccccCCcEEEeeccceEEecccccchhhccC
Confidence 99999975 566 7888999999999999999999 999999999999996 4689999999999877653
Q ss_pred CCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCChHHH
Q psy14889 295 SNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFDDM 374 (443)
Q Consensus 295 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~~~~~ 374 (443)
.. .+.++.||..|||||++..+.. .|+.++|||||||++.||.|| +.||.+.-. ....+
T Consensus 730 nP----~TETFTGTLQYMAPEvIDqG~R----GYG~aADIWS~GCT~vEMATG----------rPPF~Elgs---pqAAM 788 (1226)
T KOG4279|consen 730 NP----CTETFTGTLQYMAPEVIDQGPR----GYGKAADIWSFGCTMVEMATG----------RPPFVELGS---PQAAM 788 (1226)
T ss_pred Cc----cccccccchhhhChHhhccCCc----CCCchhhhhhccceeEeeccC----------CCCeeecCC---hhHhh
Confidence 32 2356789999999999987743 778999999999999999999 666665421 11222
Q ss_pred HhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 375 RKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
.+. ..-...|++| .+.+.+.+.+|.+|+.+||.+||++.++++
T Consensus 789 FkV-GmyKvHP~iP-----eelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 789 FKV-GMYKVHPPIP-----EELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred hhh-cceecCCCCc-----HHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 221 1123445555 568889999999999999999999999885
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=296.81 Aligned_cols=243 Identities=24% Similarity=0.401 Sum_probs=187.2
Q ss_pred ceeeeecCeEEEEEEE-CCceeEEEEeeccCcc--chHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEeeecccCc
Q psy14889 142 ECIGKGRYGEVWRGVW-HGENVAVKIFFSRDEA--SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVTHYHSF 218 (443)
Q Consensus 142 ~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~--~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e~~~~ 218 (443)
++||+|+||.||+|.. ++..+|+|.+...... ......|+..+..++||||+++++++.... ..++||||+++
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~ 76 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQ----PIYIVMELVPG 76 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCC----ccEEEEECCCC
Confidence 4689999999999987 5788999987654322 122334555666699999999999987663 47999999999
Q ss_pred ccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcccccccCC
Q psy14889 219 GSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSN 296 (443)
Q Consensus 219 gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~~~~~~ 296 (443)
|+|.+++.. ..+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++........
T Consensus 77 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~--------~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 148 (250)
T cd05085 77 GDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESK--------NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY 148 (250)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC--------CeeecccChheEEEcCCCeEEECCCccceecccccc
Confidence 999999864 4589999999999999999999988 999999999999999999999999999865432211
Q ss_pred cCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh-cccCCCcccccCCCCCCCCCCCCChHHHH
Q psy14889 297 KMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR-RTKANGIFEEYKAPYHDLVPMDPSFDDMR 375 (443)
Q Consensus 297 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt-g~~~~~~~~~~~~P~~~~~~~~~~~~~~~ 375 (443)
.. .....++..|+|||++.+. .++.++||||||+++||+++ | ..||... ......
T Consensus 149 ~~---~~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~ll~~~~~~g----------~~p~~~~-----~~~~~~ 204 (250)
T cd05085 149 SS---SGLKQIPIKWTAPEALNYG------RYSSESDVWSYGILLWETFSLG----------VCPYPGM-----TNQQAR 204 (250)
T ss_pred cc---CCCCCCcccccCHHHhccC------CCCchhHHHHHHHHHHHHhcCC----------CCCCCCC-----CHHHHH
Confidence 11 1122345679999998765 56789999999999999998 7 6677653 122222
Q ss_pred hhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHH
Q psy14889 376 KVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLI 426 (443)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 426 (443)
..+. ...+...+ ..++..+.+++.+||+.+|++|||+.++++.|.
T Consensus 205 ~~~~-~~~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 205 EQVE-KGYRMSCP-----QKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHH-cCCCCCCC-----CCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 2221 12222222 335678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=307.59 Aligned_cols=248 Identities=27% Similarity=0.450 Sum_probs=194.9
Q ss_pred hccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccc-hHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEe
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEAS-WSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWL 211 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~-~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~l 211 (443)
.++|++.+.||+|+||.||+|.. +++.||+|.+....... .....|+..+..++|+||+++++++... ...++
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~----~~~~l 93 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG----DELWV 93 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecC----CEEEE
Confidence 37899999999999999999986 68999999886543322 2234556666669999999999998766 45799
Q ss_pred eecccCcccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcccc
Q psy14889 212 VTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSY 291 (443)
Q Consensus 212 v~e~~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~ 291 (443)
||||+++++|.+++.+..+++.++..++.|++.||.|||+. +++||||||+|||++.++.+||+|||++...
T Consensus 94 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~--------~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~ 165 (297)
T cd06656 94 VMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSN--------QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI 165 (297)
T ss_pred eecccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHC--------CcccCCCCHHHEEECCCCCEEECcCccceEc
Confidence 99999999999999888899999999999999999999998 9999999999999999999999999998765
Q ss_pred cccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCCh
Q psy14889 292 SQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSF 371 (443)
Q Consensus 292 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~~ 371 (443)
...... .....+++.|+|||.+.+. .++.++|||||||++|+|++| ..||....+.
T Consensus 166 ~~~~~~----~~~~~~~~~y~aPE~~~~~------~~~~~~Di~slGvil~~l~tg----------~~pf~~~~~~---- 221 (297)
T cd06656 166 TPEQSK----RSTMVGTPYWMAPEVVTRK------AYGPKVDIWSLGIMAIEMVEG----------EPPYLNENPL---- 221 (297)
T ss_pred cCCccC----cCcccCCccccCHHHHcCC------CCCcHHHHHHHHHHHHHHHhC----------CCCCCCCCcc----
Confidence 432211 1234688899999998765 566899999999999999999 5666542111
Q ss_pred HHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 372 DDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
..... .. ....+... .+...+..+.+++.+||+.||++|||+.++++
T Consensus 222 ~~~~~-~~-~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 222 RALYL-IA-TNGTPELQ---NPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred hheee-ec-cCCCCCCC---CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11111 10 11111111 12335567899999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=301.59 Aligned_cols=237 Identities=19% Similarity=0.325 Sum_probs=177.7
Q ss_pred ceeeeecCeEEEEEEEC--------------CceeEEEEeeccCccch-HHHHHHHHHHhccCCCceeeeeeccccCCcc
Q psy14889 142 ECIGKGRYGEVWRGVWH--------------GENVAVKIFFSRDEASW-SRETEIYSTVLLRHENILGYIGSDMTSRNSC 206 (443)
Q Consensus 142 ~~lG~G~fg~Vy~~~~~--------------~~~vAvK~~~~~~~~~~-~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~ 206 (443)
+.||+|+||.||+|.+. ...||+|.+........ ....++..+..++||||+++++++....
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~--- 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDV--- 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC---
Confidence 46899999999999852 22588887754433221 2234455555689999999999987663
Q ss_pred cEEEeeecccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCc-----
Q psy14889 207 TQLWLVTHYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGT----- 279 (443)
Q Consensus 207 ~~~~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~----- 279 (443)
..++||||+++|+|..++.+ ..+++.+++.++.||+.||+|||+. +|+||||||+|||++.++.
T Consensus 78 -~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--------~ivH~dlkp~Nill~~~~~~~~~~ 148 (262)
T cd05077 78 -ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDK--------DLVHGNVCTKNILLAREGIDGECG 148 (262)
T ss_pred -CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhC--------CeECCCCCcccEEEecCCccCCCC
Confidence 36899999999999998864 4689999999999999999999998 9999999999999987664
Q ss_pred --EEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh-cccCCCcccc
Q psy14889 280 --CVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR-RTKANGIFEE 356 (443)
Q Consensus 280 --~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt-g~~~~~~~~~ 356 (443)
+|++|||++...... ....++..|+|||.+.... .++.++|||||||++|||++ |
T Consensus 149 ~~~~l~d~g~~~~~~~~--------~~~~~~~~y~aPE~~~~~~-----~~~~~~DiwslG~~l~el~~~~--------- 206 (262)
T cd05077 149 PFIKLSDPGIPITVLSR--------QECVERIPWIAPECVEDSK-----NLSIAADKWSFGTTLWEICYNG--------- 206 (262)
T ss_pred ceeEeCCCCCCccccCc--------ccccccccccChhhhcCCC-----CCCchhHHHHHHHHHHHHHhCC---------
Confidence 899999998654321 2235788999999886431 46689999999999999985 5
Q ss_pred cCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHH
Q psy14889 357 YKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLI 426 (443)
Q Consensus 357 ~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 426 (443)
..||.... ..+...... .... .. ...+.++.+|+.+||+.||++||++.+|++.|+
T Consensus 207 -~~p~~~~~-----~~~~~~~~~--~~~~-~~-----~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 207 -EIPLKDKT-----LAEKERFYE--GQCM-LV-----TPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred -CCCCCCcc-----hhHHHHHHh--cCcc-CC-----CCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 55655431 111111111 1111 11 123467999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=303.43 Aligned_cols=252 Identities=23% Similarity=0.385 Sum_probs=190.3
Q ss_pred cccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc-chHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEeee
Q psy14889 137 QISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA-SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVT 213 (443)
Q Consensus 137 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~-~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv~ 213 (443)
.|++.+.||+|+||.||+|.. ++..+++|.+...... ......|+..+..++||||+++++++... ...++|+
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~----~~~~~v~ 81 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYE----NNLWILI 81 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeC----CEEEEEE
Confidence 467889999999999999998 4678899987544322 12223455566669999999999998765 4579999
Q ss_pred cccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcccc
Q psy14889 214 HYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSY 291 (443)
Q Consensus 214 e~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~ 291 (443)
||+++|+|..++.+ ..+++..+..++.|++.||.|||+. +++||||||+|||++.++.+||+|||++...
T Consensus 82 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~--------~i~H~dlkp~nili~~~~~~kl~dfg~~~~~ 153 (282)
T cd06643 82 EFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN--------KIIHRDLKAGNILFTLDGDIKLADFGVSAKN 153 (282)
T ss_pred EecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--------CeeecCCCcccEEEccCCCEEEccccccccc
Confidence 99999999998753 5689999999999999999999998 9999999999999999999999999998655
Q ss_pred cccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCCh
Q psy14889 292 SQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSF 371 (443)
Q Consensus 292 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~~ 371 (443)
...... .....|+..|+|||++....... ..++.++|||||||++|||++| ..||.... ..
T Consensus 154 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~-~~~~~~~Dv~slGvil~el~~g----------~~p~~~~~----~~ 214 (282)
T cd06643 154 TRTIQR----RDSFIGTPYWMAPEVVMCETSKD-RPYDYKADVWSLGITLIEMAQI----------EPPHHELN----PM 214 (282)
T ss_pred cccccc----cccccccccccCHhhccccCCCC-CCCCccchhhhHHHHHHHHccC----------CCCccccC----HH
Confidence 432211 13346889999999985322111 1566799999999999999999 66665431 11
Q ss_pred HHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHH
Q psy14889 372 DDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKT 424 (443)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 424 (443)
......... ..+..+ .+...+.++.+++.+||+.||++|||+.++++.
T Consensus 215 ~~~~~~~~~--~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 215 RVLLKIAKS--EPPTLA---QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred HHHHHHhhc--CCCCCC---CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 222222111 111111 122356789999999999999999999998753
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=304.40 Aligned_cols=245 Identities=24% Similarity=0.299 Sum_probs=188.7
Q ss_pred ccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccc----hHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEe
Q psy14889 138 ISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEAS----WSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWL 211 (443)
Q Consensus 138 ~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~----~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~l 211 (443)
|+..+.||+|+||.||++.. +++.||||.+....... .....|+..+..++|+||+.+++.+.+. ..+++
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~----~~~~l 77 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETK----DALCL 77 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecC----CEEEE
Confidence 67788999999999999988 58899999876432211 1122455566669999999999998766 35799
Q ss_pred eecccCcccHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCc
Q psy14889 212 VTHYHSFGSLYDHLNR---TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA 288 (443)
Q Consensus 212 v~e~~~~gsL~~~l~~---~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla 288 (443)
||||+++|+|.+++.. ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||++
T Consensus 78 v~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~--------~iiH~dikp~Nil~~~~~~~~l~Dfg~~ 149 (285)
T cd05630 78 VLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE--------RIVYRDLKPENILLDDHGHIRISDLGLA 149 (285)
T ss_pred EEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC--------CEEeCCCCHHHEEECCCCCEEEeeccce
Confidence 9999999999998843 3589999999999999999999988 9999999999999999999999999998
Q ss_pred ccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCC
Q psy14889 289 VSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMD 368 (443)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~ 368 (443)
........ .....||..|+|||++.+. .++.++||||||+++|||++| ..||......
T Consensus 150 ~~~~~~~~-----~~~~~g~~~y~aPE~~~~~------~~~~~~DiwslG~~l~~l~~g----------~~Pf~~~~~~- 207 (285)
T cd05630 150 VHVPEGQT-----IKGRVGTVGYMAPEVVKNE------RYTFSPDWWALGCLLYEMIAG----------QSPFQQRKKK- 207 (285)
T ss_pred eecCCCcc-----ccCCCCCccccChHHHcCC------CCCCccccHHHHHHHHHHHhC----------CCCCCCCCcc-
Confidence 65542221 1234689999999999776 667899999999999999999 6677653211
Q ss_pred CChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCc-----HHHHHH
Q psy14889 369 PSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLS-----ALRVKK 423 (443)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~ 423 (443)
........... ...... ....+.++.+|+.+||+.||++||| ++|+++
T Consensus 208 ~~~~~~~~~~~--~~~~~~-----~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 208 IKREEVERLVK--EVQEEY-----SEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred chHHHHHhhhh--hhhhhc-----CccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 01111111111 011111 1235567999999999999999999 888887
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=315.65 Aligned_cols=238 Identities=27% Similarity=0.414 Sum_probs=179.7
Q ss_pred eeeecCeEEEEEEE--CCceeEEEEeeccCcc------chHHHHHHHHHHh-ccCCCceeeeeeccccCCcccEEEeeec
Q psy14889 144 IGKGRYGEVWRGVW--HGENVAVKIFFSRDEA------SWSRETEIYSTVL-LRHENILGYIGSDMTSRNSCTQLWLVTH 214 (443)
Q Consensus 144 lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~------~~~~e~ei~~~~~-l~H~nIv~l~g~~~~~~~~~~~~~lv~e 214 (443)
||+|+||.||+|+. +++.||||++...... ....|.++..... -+||||+++++.+.+. ..+++|||
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~----~~~~lv~e 76 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTD----SDLYLVTD 76 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecC----CeEEEEEc
Confidence 69999999999987 5899999998643211 1112233332211 1799999999988776 45899999
Q ss_pred ccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcccccc
Q psy14889 215 YHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQ 293 (443)
Q Consensus 215 ~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~~~ 293 (443)
|+++|+|.+++.+ ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 77 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~--------~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~ 148 (330)
T cd05586 77 YMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKY--------DIVYRDLKPENILLDATGHIALCDFGLSKANLT 148 (330)
T ss_pred CCCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CeEeccCCHHHeEECCCCCEEEecCCcCcCCCC
Confidence 9999999998864 5699999999999999999999998 999999999999999999999999999865332
Q ss_pred cCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCChHH
Q psy14889 294 LSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFDD 373 (443)
Q Consensus 294 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~~~~ 373 (443)
... ......||..|+|||++.+.. .++.++|||||||++|||++| ..||... ....
T Consensus 149 ~~~----~~~~~~gt~~y~aPE~~~~~~-----~~~~~~DvwslGvil~elltG----------~~Pf~~~-----~~~~ 204 (330)
T cd05586 149 DNK----TTNTFCGTTEYLAPEVLLDEK-----GYTKHVDFWSLGVLVFEMCCG----------WSPFYAE-----DTQQ 204 (330)
T ss_pred CCC----CccCccCCccccCHHHHcCCC-----CCCCccceeccccEEEEeccC----------CCCCCCC-----CHHH
Confidence 111 123457999999999987542 356899999999999999999 6677553 2233
Q ss_pred HHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCC----cHHHHHH
Q psy14889 374 MRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRL----SALRVKK 423 (443)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp----s~~evl~ 423 (443)
+.+.+... ...++. ...+..+.+++++||+.||++|| ++.++++
T Consensus 205 ~~~~i~~~--~~~~~~----~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 205 MYRNIAFG--KVRFPK----NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred HHHHHHcC--CCCCCC----ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 33332221 222332 22456789999999999999999 4566554
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0032|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=311.92 Aligned_cols=252 Identities=21% Similarity=0.338 Sum_probs=203.4
Q ss_pred hhhhccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc----chHHHHHHHHHHhcc-CCCceeeeeeccccCC
Q psy14889 132 RTLAKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA----SWSRETEIYSTVLLR-HENILGYIGSDMTSRN 204 (443)
Q Consensus 132 ~~~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~----~~~~e~ei~~~~~l~-H~nIv~l~g~~~~~~~ 204 (443)
......|++.+.||+|.||.||+++. +|+.+|+|.+.+.... ....+.|+..+..+. |||||.+++++.+..
T Consensus 31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~- 109 (382)
T KOG0032|consen 31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPD- 109 (382)
T ss_pred ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCC-
Confidence 34457899999999999999999998 5899999998664432 123345666666688 999999999998884
Q ss_pred cccEEEeeecccCcccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCC----CcE
Q psy14889 205 SCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTN----GTC 280 (443)
Q Consensus 205 ~~~~~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~----~~~ 280 (443)
.+++|||++.+|.|.+.+....+++..+..++.|++.++.|||+. +|+||||||+|+|+... +.+
T Consensus 110 ---~~~lvmEL~~GGeLfd~i~~~~~sE~da~~~~~~il~av~~lH~~--------gvvHrDlKpEN~L~~~~~~~~~~i 178 (382)
T KOG0032|consen 110 ---SVYLVMELCEGGELFDRIVKKHYSERDAAGIIRQILEAVKYLHSL--------GVVHRDLKPENLLLASKDEGSGRI 178 (382)
T ss_pred ---eEEEEEEecCCchHHHHHHHccCCHHHHHHHHHHHHHHHHHHHhC--------CceeccCCHHHeeeccccCCCCcE
Confidence 589999999999999998654699999999999999999999998 99999999999999654 479
Q ss_pred EEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCC
Q psy14889 281 VIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAP 360 (443)
Q Consensus 281 kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P 360 (443)
|++|||+|....... . ....+||+.|+|||++... .|+..+||||+||++|.|++| ..|
T Consensus 179 k~~DFGla~~~~~~~-~----~~~~~Gtp~y~APEvl~~~------~y~~~~DiWS~Gvi~yiLL~G----------~~P 237 (382)
T KOG0032|consen 179 KLIDFGLAKFIKPGE-R----LHTIVGTPEYVAPEVLGGR------PYGDEVDVWSIGVILYILLSG----------VPP 237 (382)
T ss_pred EEeeCCCceEccCCc-e----EeeecCCccccCchhhcCC------CCCcccchhHHHHHHHHHhhC----------CCC
Confidence 999999998877521 1 2456899999999999875 788999999999999999999 788
Q ss_pred CCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHH
Q psy14889 361 YHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKT 424 (443)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 424 (443)
|.+.. ......++.. ....++..+. +..+..+.++++.++..||.+|+|+.++++.
T Consensus 238 F~~~~----~~~~~~~i~~---~~~~f~~~~w-~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 238 FWGET----EFEIFLAILR---GDFDFTSEPW-DDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred CcCCC----hhHHHHHHHc---CCCCCCCCCc-cccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 87752 1222232222 2223333222 3367889999999999999999999999984
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=315.51 Aligned_cols=255 Identities=23% Similarity=0.296 Sum_probs=187.6
Q ss_pred hccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCc---cchHHHHHHHHHHhccCCCceeeeeeccccCC--ccc
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDE---ASWSRETEIYSTVLLRHENILGYIGSDMTSRN--SCT 207 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~---~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~--~~~ 207 (443)
.++|++.+.||+|+||.||++.. .++.||||++..... .......|+..+..++||||+++++++..... ...
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 47899999999999999999987 588999998864321 11222345566666999999999998764321 223
Q ss_pred EEEeeecccCcccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCC
Q psy14889 208 QLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGL 287 (443)
Q Consensus 208 ~~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGl 287 (443)
.+++||||+++ +|.+++. ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 103 ~~~lv~e~~~~-~l~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~--------~ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 103 DVYIVMELMDA-NLCQVIQ-MELDHERMSYLLYQMLCGIKHLHSA--------GIIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred eEEEEEeCCCC-CHHHHHH-hcCCHHHHHHHHHHHHHHHHHHhhC--------CeecCCCCHHHEEECCCCcEEEEeCCC
Confidence 57999999975 7877774 3588999999999999999999998 999999999999999999999999999
Q ss_pred cccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCC
Q psy14889 288 AVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPM 367 (443)
Q Consensus 288 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~ 367 (443)
++...... ......||..|+|||++.+. .++.++|||||||++|||++| +.||.....
T Consensus 173 a~~~~~~~-----~~~~~~~t~~y~aPE~~~~~------~~~~~~DiwSlG~il~ell~g----------~~pf~~~~~- 230 (364)
T cd07875 173 ARTAGTSF-----MMTPYVVTRYYRAPEVILGM------GYKENVDIWSVGCIMGEMIKG----------GVLFPGTDH- 230 (364)
T ss_pred ccccCCCC-----cccCCcccCCcCCHHHHhCC------CCCchhhHHhHHHHHHHHHhC----------CCCCCCCCH-
Confidence 97654321 12345789999999999776 677899999999999999999 455543210
Q ss_pred CCChHHHHhhhhh-------------------cCCCCCCCC---------C------CCCchhHHHHHHHHHHHhcCCcC
Q psy14889 368 DPSFDDMRKVICI-------------------DQQRPVLPN---------R------WVSDSTLNAMTKVMKECWHQNAN 413 (443)
Q Consensus 368 ~~~~~~~~~~~~~-------------------~~~~~~~~~---------~------~~~~~~~~~l~~li~~cl~~dP~ 413 (443)
.+...+.+.. ...++.... . .........+++|+.+||+.||+
T Consensus 231 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~ 307 (364)
T cd07875 231 ---IDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDAS 307 (364)
T ss_pred ---HHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcc
Confidence 0111111000 000110000 0 00011235789999999999999
Q ss_pred CCCcHHHHHHH
Q psy14889 414 VRLSALRVKKT 424 (443)
Q Consensus 414 ~Rps~~evl~~ 424 (443)
+|||+.|+++.
T Consensus 308 ~R~t~~e~L~h 318 (364)
T cd07875 308 KRISVDEALQH 318 (364)
T ss_pred cCCCHHHHhcC
Confidence 99999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=310.10 Aligned_cols=252 Identities=23% Similarity=0.297 Sum_probs=187.1
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc--chHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEe
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA--SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWL 211 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~--~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~l 211 (443)
++|.+.+.||+|+||.||+|.. +++.||+|.+...... ......|+..+..++||||+++++++... ...++
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----~~~~l 81 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTD----KSLTL 81 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeC----CeEEE
Confidence 5799999999999999999987 5788999988643322 22233466666669999999999998766 35799
Q ss_pred eecccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcc
Q psy14889 212 VTHYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAV 289 (443)
Q Consensus 212 v~e~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~ 289 (443)
||||+++ +|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~--------~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 152 (309)
T cd07872 82 VFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR--------KVLHRDLKPQNLLINERGELKLADFGLAR 152 (309)
T ss_pred EEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--------CeecCCCCHHHEEECCCCCEEECccccce
Confidence 9999985 88888754 3588999999999999999999998 99999999999999999999999999987
Q ss_pred cccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCC
Q psy14889 290 SYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDP 369 (443)
Q Consensus 290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~ 369 (443)
........ .....+|..|+|||.+.+.. .++.++|||||||++|||+|| ..||......
T Consensus 153 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~-----~~~~~~DiwslG~il~el~tg----------~~pf~~~~~~-- 211 (309)
T cd07872 153 AKSVPTKT----YSNEVVTLWYRPPDVLLGSS-----EYSTQIDMWGVGCIFFEMASG----------RPLFPGSTVE-- 211 (309)
T ss_pred ecCCCccc----cccccccccccCCHHHhCCC-----CCCcHHHHHHHHHHHHHHHhC----------CCCCCCCChH--
Confidence 54332211 12346789999999986542 456899999999999999999 4555432110
Q ss_pred ChHHHHhhhhhc-------------------CCCCC-CCCC--CCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 370 SFDDMRKVICID-------------------QQRPV-LPNR--WVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 370 ~~~~~~~~~~~~-------------------~~~~~-~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
+......... ...+. .+.. ......+.++.+++.+||+.||.+|||+.|+++
T Consensus 212 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 212 --DELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred --HHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 1111110000 00000 0000 001234567899999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=303.19 Aligned_cols=246 Identities=24% Similarity=0.305 Sum_probs=187.9
Q ss_pred ccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc----chHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEe
Q psy14889 138 ISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA----SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWL 211 (443)
Q Consensus 138 ~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~----~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~l 211 (443)
|+..+.||+|+||+||+|.+ +++.||+|.+...... ......|+..+..++|+||+.+.+.+... ...++
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~----~~~~l 77 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETK----DALCL 77 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecC----CEEEE
Confidence 66778999999999999988 5889999988543211 11223455566669999999999888766 35799
Q ss_pred eecccCcccHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCc
Q psy14889 212 VTHYHSFGSLYDHLNR---TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA 288 (443)
Q Consensus 212 v~e~~~~gsL~~~l~~---~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla 288 (443)
||||+++|+|.+++.. ..+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||++
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~--------~iiH~dikp~Nili~~~~~~kl~Dfg~~ 149 (285)
T cd05632 78 VLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE--------NTVYRDLKPENILLDDYGHIRISDLGLA 149 (285)
T ss_pred EEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC--------CeeecCCCHHHEEECCCCCEEEecCCcc
Confidence 9999999999988853 3699999999999999999999998 9999999999999999999999999998
Q ss_pred ccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCC
Q psy14889 289 VSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMD 368 (443)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~ 368 (443)
........ .....|+..|+|||++.+. .++.++|+||||+++|||++| ..||......
T Consensus 150 ~~~~~~~~-----~~~~~g~~~~~aPE~~~~~------~~~~~~Di~slG~~l~~l~~g----------~~P~~~~~~~- 207 (285)
T cd05632 150 VKIPEGES-----IRGRVGTVGYMAPEVLNNQ------RYTLSPDYWGLGCLIYEMIEG----------QSPFRGRKEK- 207 (285)
T ss_pred eecCCCCc-----ccCCCCCcCccChHHhcCC------CCCcccchHHHHHHHHHHHhC----------CCCCCCCCHH-
Confidence 65532211 1234789999999999765 667899999999999999999 6777653110
Q ss_pred CChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCc-----HHHHHHH
Q psy14889 369 PSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLS-----ALRVKKT 424 (443)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~~ 424 (443)
.....+...+. ...... ....+..+.+|+.+||+.||++||+ +.++++.
T Consensus 208 ~~~~~~~~~~~--~~~~~~-----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 208 VKREEVDRRVL--ETEEVY-----SAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred HHHHHHHHhhh--cccccc-----CccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 00111111111 111111 2335567899999999999999999 6676663
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=322.22 Aligned_cols=256 Identities=22% Similarity=0.254 Sum_probs=185.8
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEeee
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVT 213 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv~ 213 (443)
..|.+.+.||+|+||.||+|.+ .++.||||.... .... .|+..+..++|+|||++++++... ...++||
T Consensus 169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---~~~~--~E~~iL~~L~HpnIv~l~~~~~~~----~~~~lv~ 239 (461)
T PHA03211 169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---ASSV--HEARLLRRLSHPAVLALLDVRVVG----GLTCLVL 239 (461)
T ss_pred CCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---cCHH--HHHHHHHHCCCCCCCcEEEEEEEC----CEEEEEE
Confidence 4799999999999999999998 478899996422 2233 345555569999999999998765 3578999
Q ss_pred cccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcccc
Q psy14889 214 HYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSY 291 (443)
Q Consensus 214 e~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~ 291 (443)
|++. ++|.+++.. ..+++.+++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.+
T Consensus 240 e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~--------gIvHrDLKP~NILl~~~~~vkL~DFGla~~~ 310 (461)
T PHA03211 240 PKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGE--------GIIHRDIKTENVLVNGPEDICLGDFGAACFA 310 (461)
T ss_pred EccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--------CEEECcCCHHHEEECCCCCEEEcccCCceec
Confidence 9995 699988854 4699999999999999999999998 9999999999999999999999999999765
Q ss_pred cccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCCh
Q psy14889 292 SQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSF 371 (443)
Q Consensus 292 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~~ 371 (443)
...... .......||..|+|||++.+. .++.++|||||||+||||++|..+. |.....|+.. ...
T Consensus 311 ~~~~~~--~~~~~~~GT~~Y~APE~~~~~------~~~~~sDvwSlGviL~El~~g~~~l--f~~~~~~~~~-----~~~ 375 (461)
T PHA03211 311 RGSWST--PFHYGIAGTVDTNAPEVLAGD------PYTPSVDIWSAGLVIFEAAVHTASL--FSASRGDERR-----PYD 375 (461)
T ss_pred cccccc--ccccccCCCcCCcCHHHHcCC------CCCchHHHHHHHHHHHHHHHcCCCc--ccCCcccccC-----CcH
Confidence 432211 111245799999999999876 6778999999999999999985432 1111111111 111
Q ss_pred HHHHhhhhhcC-------------------------CCCCCC-CCCCC-chhHHHHHHHHHHHhcCCcCCCCcHHHHHHH
Q psy14889 372 DDMRKVICIDQ-------------------------QRPVLP-NRWVS-DSTLNAMTKVMKECWHQNANVRLSALRVKKT 424 (443)
Q Consensus 372 ~~~~~~~~~~~-------------------------~~~~~~-~~~~~-~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 424 (443)
..+.+.+.... .++... ..|.. ......+.+|+.+||+.||.+|||+.|+++.
T Consensus 376 ~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 376 AQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred HHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 11211111100 001000 00100 0123468899999999999999999999863
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=305.81 Aligned_cols=261 Identities=23% Similarity=0.317 Sum_probs=189.9
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccc--hHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEe
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEAS--WSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWL 211 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~--~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~l 211 (443)
++|++.+.||+|+||.||++.+ ++..+|+|.+....... .....|+..+..++||||+++++.+.+. ..+++
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----~~~~l 76 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSD----GEISI 76 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC----CEEEE
Confidence 3688999999999999999988 57889999875432221 1223466666669999999999998776 46899
Q ss_pred eecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCccc
Q psy14889 212 VTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVS 290 (443)
Q Consensus 212 v~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~ 290 (443)
||||+++|+|.+++++ ..+++..+..++.|++.||.|||+.. +++|+||||+|||++.++.+||+|||++..
T Consensus 77 v~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~-------~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 149 (308)
T cd06615 77 CMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKH-------KIMHRDVKPSNILVNSRGEIKLCDFGVSGQ 149 (308)
T ss_pred EeeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhC-------CEEECCCChHHEEEecCCcEEEccCCCccc
Confidence 9999999999999965 56899999999999999999999731 899999999999999999999999999865
Q ss_pred ccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccC------CC---C
Q psy14889 291 YSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYK------AP---Y 361 (443)
Q Consensus 291 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~------~P---~ 361 (443)
..... .....|+..|+|||.+.+. .++.++||||||+++|||++|+.|+....... .+ .
T Consensus 150 ~~~~~------~~~~~~~~~~~aPE~~~~~------~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 217 (308)
T cd06615 150 LIDSM------ANSFVGTRSYMSPERLQGT------HYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEG 217 (308)
T ss_pred ccccc------cccCCCCcCccChhHhcCC------CCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccc
Confidence 43221 1335788999999998765 56689999999999999999955432100000 00 0
Q ss_pred CC---------CCCCC---CChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHH
Q psy14889 362 HD---------LVPMD---PSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKT 424 (443)
Q Consensus 362 ~~---------~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 424 (443)
.. ..... .......... .....+..+. ...+.++.+++.+||+.||++|||+.++++.
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~----~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 218 EAKESHRPVSGHPPDSPRPMAIFELLDYI-VNEPPPKLPS----GAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred cccCCcccccCCCCCccchhhHHHHHHHH-hcCCCccCcC----cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 00000 0000000000 1111222221 2255679999999999999999999999876
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=298.61 Aligned_cols=250 Identities=27% Similarity=0.415 Sum_probs=192.6
Q ss_pred cccccceeeeecCeEEEEEEE-CCceeEEEEeeccCcc-------chHHHHHHHHHHhccCCCceeeeeeccccCCcccE
Q psy14889 137 QISLSECIGKGRYGEVWRGVW-HGENVAVKIFFSRDEA-------SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQ 208 (443)
Q Consensus 137 ~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~-------~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~ 208 (443)
+|+..+.||+|+||.||+|.. +++.+|||.+...... ....+.|+..+..++|+||+++++++.+. ..
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----~~ 76 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDD----NT 76 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecC----Ce
Confidence 467789999999999999987 6889999987643211 11224466666669999999999998776 45
Q ss_pred EEeeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCC
Q psy14889 209 LWLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGL 287 (443)
Q Consensus 209 ~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGl 287 (443)
.++++||+++++|.+++.+ ..+++..+..++.|++.||+|||+. +|+|+||+|+||++++++.+||+|||+
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~--------~i~H~dl~p~nil~~~~~~~~l~dfg~ 148 (265)
T cd06631 77 ISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNN--------CVVHRDIKGNNVMLMPNGIIKLIDFGC 148 (265)
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CcccCCcCHHhEEECCCCeEEeccchh
Confidence 8999999999999999965 5789999999999999999999998 999999999999999999999999999
Q ss_pred cccccccCCc--CCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCC
Q psy14889 288 AVSYSQLSNK--MDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLV 365 (443)
Q Consensus 288 a~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~ 365 (443)
+......... .........|+..|+|||.+.+. .++.++||||||+++|||++| ..||....
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~------~~~~~~Dv~slG~~~~~l~~g----------~~p~~~~~ 212 (265)
T cd06631 149 ARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINES------GYGRKSDIWSIGCTVFEMATG----------KPPLASMD 212 (265)
T ss_pred hHhhhhccccccccccccccCCCccccChhhhcCC------CCcchhhHHHHHHHHHHHHhC----------CCccccCC
Confidence 8765321111 11112334688999999998765 566899999999999999999 66775431
Q ss_pred CCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 366 PMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
...............+.++ ...+.++.+++++||+.+|++||++.++++
T Consensus 213 ----~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 213 ----RLAAMFYIGAHRGLMPRLP-----DSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred ----hHHHHHHhhhccCCCCCCC-----CCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1122222211111222232 335678999999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=327.70 Aligned_cols=193 Identities=21% Similarity=0.288 Sum_probs=150.6
Q ss_pred hccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccchHHHHHHHHHHhcc------CCCceeeeeeccccCCcc
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEASWSRETEIYSTVLLR------HENILGYIGSDMTSRNSC 206 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~------H~nIv~l~g~~~~~~~~~ 206 (443)
.++|++.+.||+|+||.||+|.. +++.||||++............|+..+..++ |.+++++++++....
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~--- 204 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNET--- 204 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCC---
Confidence 47899999999999999999987 5788999998643222222223333333343 456888888876543
Q ss_pred cEEEeeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCC-------
Q psy14889 207 TQLWLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNG------- 278 (443)
Q Consensus 207 ~~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~------- 278 (443)
..+++|||++ +++|.+++.+ ..+++..+..++.||+.||+|||++. +||||||||+|||++.++
T Consensus 205 ~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~-------gIiHrDlKP~NILl~~~~~~~~~~~ 276 (467)
T PTZ00284 205 GHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTEL-------HLMHTDLKPENILMETSDTVVDPVT 276 (467)
T ss_pred ceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcC-------CeecCCCCHHHEEEecCCccccccc
Confidence 3578999988 5688888754 67999999999999999999999731 899999999999998765
Q ss_pred ---------cEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhccc
Q psy14889 279 ---------TCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTK 349 (443)
Q Consensus 279 ---------~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~ 349 (443)
.+||+|||++..... ......||+.|+|||++.+. .++.++|||||||++|||++|+.
T Consensus 277 ~~~~~~~~~~vkl~DfG~~~~~~~-------~~~~~~gt~~Y~APE~~~~~------~~~~~~DiwSlGvil~elltG~~ 343 (467)
T PTZ00284 277 NRALPPDPCRVRICDLGGCCDERH-------SRTAIVSTRHYRSPEVVLGL------GWMYSTDMWSMGCIIYELYTGKL 343 (467)
T ss_pred ccccCCCCceEEECCCCccccCcc-------ccccccCCccccCcHHhhcC------CCCcHHHHHHHHHHHHHHHhCCC
Confidence 499999998753321 12345799999999999876 67789999999999999999954
Q ss_pred CC
Q psy14889 350 AN 351 (443)
Q Consensus 350 ~~ 351 (443)
|+
T Consensus 344 pf 345 (467)
T PTZ00284 344 LY 345 (467)
T ss_pred CC
Confidence 43
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=302.04 Aligned_cols=258 Identities=26% Similarity=0.417 Sum_probs=193.9
Q ss_pred hhccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccchHHHHHHHHHHhc-cCCCceeeeeeccccCC-cccEE
Q psy14889 134 LAKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEASWSRETEIYSTVLL-RHENILGYIGSDMTSRN-SCTQL 209 (443)
Q Consensus 134 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~e~ei~~~~~l-~H~nIv~l~g~~~~~~~-~~~~~ 209 (443)
..++|.+.+.||+|+||.||++.. +++.+|+|++..........+.|+..+..+ +||||+++++++...+. ....+
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~ 99 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQL 99 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCee
Confidence 357899999999999999999987 588999998865433223334455555556 89999999999875432 12458
Q ss_pred EeeecccCcccHHHHhc-----ccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEe
Q psy14889 210 WLVTHYHSFGSLYDHLN-----RTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIAD 284 (443)
Q Consensus 210 ~lv~e~~~~gsL~~~l~-----~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~D 284 (443)
++||||+++|+|.++++ ...+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|
T Consensus 100 ~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~--------~ivH~dlkp~nili~~~~~~kl~d 171 (291)
T cd06639 100 WLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN--------RIIHRDVKGNNILLTTEGGVKLVD 171 (291)
T ss_pred EEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC--------CeeccCCCHHHEEEcCCCCEEEee
Confidence 99999999999999875 25689999999999999999999998 999999999999999999999999
Q ss_pred cCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCC
Q psy14889 285 FGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDL 364 (443)
Q Consensus 285 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~ 364 (443)
||++......... .....|+..|+|||.+....... ..++.++|||||||++|||++| ..||...
T Consensus 172 fg~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~-~~~~~~~Di~slGvi~~el~~g----------~~p~~~~ 236 (291)
T cd06639 172 FGVSAQLTSTRLR----RNTSVGTPFWMAPEVIACEQQYD-YSYDARCDVWSLGITAIELGDG----------DPPLFDM 236 (291)
T ss_pred cccchhccccccc----ccCccCCccccChhhhcCCCCcc-cccCCccchHHHHHHHHHHhhC----------CCCCCCC
Confidence 9998765432211 12346888999999986542111 1456899999999999999999 6676553
Q ss_pred CCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 365 VPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
.+ ......... ...+... ........+.+++.+||+.||++||++.++++
T Consensus 237 ~~----~~~~~~~~~--~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 237 HP----VKTLFKIPR--NPPPTLL---HPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred cH----HHHHHHHhc--CCCCCCC---cccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 21 112222111 1111111 12234567999999999999999999999886
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG4717|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=307.51 Aligned_cols=245 Identities=22% Similarity=0.336 Sum_probs=199.7
Q ss_pred hccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccch---HHHHHHHHHHhccCCCceeeeeeccccCCcccEE
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEASW---SRETEIYSTVLLRHENILGYIGSDMTSRNSCTQL 209 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~---~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~ 209 (443)
..-|.+.+.||+|.|.+|-+|++ +|..||||++.+...+.. ..-.|+.-++.++|||||++|.+..+. ..+
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQ----TKl 92 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQ----TKL 92 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhccc----ceE
Confidence 45689999999999999999986 899999999976544332 223455556668999999999998766 569
Q ss_pred EeeecccCcccHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcC-CCcEEEEecC
Q psy14889 210 WLVTHYHSFGSLYDHL--NRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKT-NGTCVIADFG 286 (443)
Q Consensus 210 ~lv~e~~~~gsL~~~l--~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~-~~~~kl~DfG 286 (443)
|||+|+-.+|+|++|+ +...+.+....+++.||+.|+.|+|.. .+|||||||+||++-+ -|-+||.|||
T Consensus 93 yLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqL--------HVVHRDLKPENVVFFEKlGlVKLTDFG 164 (864)
T KOG4717|consen 93 YLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQL--------HVVHRDLKPENVVFFEKLGLVKLTDFG 164 (864)
T ss_pred EEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhh--------hhhcccCCcceeEEeeecCceEeeecc
Confidence 9999999999999999 457899999999999999999999988 8899999999997755 4789999999
Q ss_pred CcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCC
Q psy14889 287 LAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVP 366 (443)
Q Consensus 287 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~ 366 (443)
++..+..... .++.+|+..|-|||++.+..+.. ++.||||||||||-|+.| +.||++..
T Consensus 165 FSNkf~PG~k-----L~TsCGSLAYSAPEILLGDsYDA-----PAVDiWSLGVILyMLVCG----------q~PFqeAN- 223 (864)
T KOG4717|consen 165 FSNKFQPGKK-----LTTSCGSLAYSAPEILLGDSYDA-----PAVDIWSLGVILYMLVCG----------QPPFQEAN- 223 (864)
T ss_pred ccccCCCcch-----hhcccchhhccCchhhhcCccCC-----cchhhhHHHHHHHHHHhC----------CCcccccc-
Confidence 9976655332 25679999999999999873322 789999999999999999 88888752
Q ss_pred CCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 367 MDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
+.+.+..++. ....+| ...+.+.++||..||..||++|.|.++|..
T Consensus 224 ---DSETLTmImD---CKYtvP-----shvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 224 ---DSETLTMIMD---CKYTVP-----SHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred ---chhhhhhhhc---ccccCc-----hhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 2233333332 233344 457889999999999999999999999865
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=297.50 Aligned_cols=252 Identities=29% Similarity=0.427 Sum_probs=193.8
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccc-hHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEee
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEAS-WSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLV 212 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~-~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv 212 (443)
++|++.+.||+|+||.||+|.. +++.+|+|.+....... .....|+..+..++||||+++++++... ..++++
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~----~~~~l~ 78 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRR----DKLWIV 78 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeC----CEEEEE
Confidence 6899999999999999999987 57889999886543322 2234556666669999999999988765 458999
Q ss_pred ecccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCccc
Q psy14889 213 THYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVS 290 (443)
Q Consensus 213 ~e~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~ 290 (443)
|||+++++|.+++.. ..+++..+..++.|++.||.|||+. +|+|+||||+||++++++.+||+|||++..
T Consensus 79 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~--------~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~ 150 (262)
T cd06613 79 MEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHET--------GKIHRDIKGANILLTEDGDVKLADFGVSAQ 150 (262)
T ss_pred EeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC--------CceecCCChhhEEECCCCCEEECccccchh
Confidence 999999999998864 5799999999999999999999998 999999999999999999999999999876
Q ss_pred ccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCC
Q psy14889 291 YSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPS 370 (443)
Q Consensus 291 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~ 370 (443)
....... .....++..|+|||.+..... ..++.++||||||+++|||+|| ..||.+..+
T Consensus 151 ~~~~~~~----~~~~~~~~~y~~Pe~~~~~~~---~~~~~~~Di~slG~~l~~~~tg----------~~p~~~~~~---- 209 (262)
T cd06613 151 LTATIAK----RKSFIGTPYWMAPEVAAVERK---GGYDGKCDIWALGITAIELAEL----------QPPMFDLHP---- 209 (262)
T ss_pred hhhhhhc----cccccCCccccCchhhccccc---CCcCchhhhHHHHHHHHHHHhC----------CCCCCCCCH----
Confidence 5432211 123467889999999865422 1455789999999999999999 667765321
Q ss_pred hHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 371 FDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
...... .......+.. .......+.++.+++++||..||.+|||+.+|+.
T Consensus 210 ~~~~~~-~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 210 MRALFL-ISKSNFPPPK--LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred HHHHHH-HHhccCCCcc--ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 111111 1111111111 1112345678999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=298.13 Aligned_cols=250 Identities=26% Similarity=0.372 Sum_probs=191.2
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCc------cchHHHHHHHHHHhccCCCceeeeeeccccCCccc
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDE------ASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCT 207 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~------~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~ 207 (443)
.+|+..+.||+|+||.||+|.. ++..||+|.+..... .....+.|+..+..++||||+++++++.+... .
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--~ 79 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAE--K 79 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCC--C
Confidence 4788899999999999999987 588999998754321 11223456667777999999999998765432 4
Q ss_pred EEEeeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecC
Q psy14889 208 QLWLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFG 286 (443)
Q Consensus 208 ~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfG 286 (443)
.+++++||+++++|.+++.+ ..+++.....++.|++.||+|||+. +|+|+||||+||+++.++.+||+|||
T Consensus 80 ~~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~--------~i~H~~l~p~nil~~~~~~~~l~dfg 151 (266)
T cd06651 80 TLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSN--------MIVHRDIKGANILRDSAGNVKLGDFG 151 (266)
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC--------CeeeCCCCHHHEEECCCCCEEEccCC
Confidence 57899999999999999865 5689999999999999999999988 99999999999999999999999999
Q ss_pred CcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCC
Q psy14889 287 LAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVP 366 (443)
Q Consensus 287 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~ 366 (443)
+++.+...... ........++..|+|||.+.+. .++.++|||||||++|||++| ..||....
T Consensus 152 ~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~------~~~~~~Dv~slG~i~~el~~g----------~~pf~~~~- 213 (266)
T cd06651 152 ASKRLQTICMS-GTGIRSVTGTPYWMSPEVISGE------GYGRKADVWSLGCTVVEMLTE----------KPPWAEYE- 213 (266)
T ss_pred Ccccccccccc-CCccccCCccccccCHHHhCCC------CCCchhhhHHHHHHHHHHHHC----------CCCccccc-
Confidence 98765432111 1111234588899999998765 667899999999999999999 66776431
Q ss_pred CCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 367 MDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
......... .....+.++ ...+..+.+++ +||..+|++||+++||++
T Consensus 214 ---~~~~~~~~~-~~~~~~~~~-----~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 214 ---AMAAIFKIA-TQPTNPQLP-----SHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred ---hHHHHHHHh-cCCCCCCCc-----hhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 122222221 122223333 23456678888 788899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=300.94 Aligned_cols=246 Identities=29% Similarity=0.466 Sum_probs=194.5
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCc--cchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEe
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDE--ASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWL 211 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~--~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~l 211 (443)
..|+..+.||+|+||.||+|.+ ++..||+|++..... .......|+..+..++||||+++++.+.+. ..+++
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----~~~~l 79 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKG----TKLWI 79 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC----CEEEE
Confidence 4678889999999999999987 578999998764332 122234456666669999999999998776 46899
Q ss_pred eecccCcccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcccc
Q psy14889 212 VTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSY 291 (443)
Q Consensus 212 v~e~~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~ 291 (443)
||||+++|+|.+++....+++.++..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++...
T Consensus 80 v~e~~~~~~L~~~i~~~~l~~~~~~~~~~~l~~~l~~lh~~--------~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~ 151 (277)
T cd06640 80 IMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSE--------KKIHRDIKAANVLLSEQGDVKLADFGVAGQL 151 (277)
T ss_pred EEecCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CccCcCCChhhEEEcCCCCEEEcccccceec
Confidence 99999999999999888899999999999999999999998 9999999999999999999999999999765
Q ss_pred cccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCCh
Q psy14889 292 SQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSF 371 (443)
Q Consensus 292 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~~ 371 (443)
..... ......++..|+|||++.+. .++.++|+||||+++|||+|| ..||....+.
T Consensus 152 ~~~~~----~~~~~~~~~~y~apE~~~~~------~~~~~~Dv~slG~il~el~tg----------~~p~~~~~~~---- 207 (277)
T cd06640 152 TDTQI----KRNTFVGTPFWMAPEVIQQS------AYDSKADIWSLGITAIELAKG----------EPPNSDMHPM---- 207 (277)
T ss_pred cCCcc----ccccccCcccccCHhHhccC------CCccHHHHHHHHHHHHHHHHC----------CCCCCCcChH----
Confidence 43221 11234678899999998765 566899999999999999999 6666543211
Q ss_pred HHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHH
Q psy14889 372 DDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKT 424 (443)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 424 (443)
.....+ .....+.+ ...++..+.+++.+||+.+|++||++.++++.
T Consensus 208 -~~~~~~-~~~~~~~~-----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 208 -RVLFLI-PKNNPPTL-----TGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred -hHhhhh-hcCCCCCC-----chhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 111111 11111222 23467789999999999999999999999775
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=302.72 Aligned_cols=254 Identities=22% Similarity=0.361 Sum_probs=193.1
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc--chHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEe
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA--SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWL 211 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~--~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~l 211 (443)
++|++.+.||+|+||.||++.. ++..||+|.+...... ......|+..+..++||||+++++.+... ..+++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~----~~~~l 76 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIE----GAVYM 76 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecC----CeEEE
Confidence 3688899999999999999998 5899999987643221 12223455556669999999999988765 45899
Q ss_pred eecccCcccHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCC
Q psy14889 212 VTHYHSFGSLYDHLNRT----TLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGL 287 (443)
Q Consensus 212 v~e~~~~gsL~~~l~~~----~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGl 287 (443)
||||+++++|..++... .+++..+..++.|++.||.|||+.. +|+|+||||+||+++.++.+||+|||+
T Consensus 77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~-------~i~H~dl~p~nil~~~~~~~~l~dfg~ 149 (286)
T cd06622 77 CMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH-------NIIHRDVKPTNVLVNGNGQVKLCDFGV 149 (286)
T ss_pred EEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC-------CEeeCCCCHHHEEECCCCCEEEeecCC
Confidence 99999999999998764 7999999999999999999999632 899999999999999999999999999
Q ss_pred cccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCC
Q psy14889 288 AVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPM 367 (443)
Q Consensus 288 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~ 367 (443)
+..+..... ....|+..|+|||.+.+........++.++|||||||++|||++| ..||.....
T Consensus 150 ~~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g----------~~pf~~~~~- 212 (286)
T cd06622 150 SGNLVASLA------KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALG----------RYPYPPETY- 212 (286)
T ss_pred cccccCCcc------ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhC----------CCCCCCcch-
Confidence 876533211 223578899999998665332222457899999999999999999 667654211
Q ss_pred CCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHH
Q psy14889 368 DPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKT 424 (443)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 424 (443)
......+.... ....+.++ ..++.++.+++.+||+.+|++||++.++++.
T Consensus 213 ~~~~~~~~~~~--~~~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 213 ANIFAQLSAIV--DGDPPTLP-----SGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred hhHHHHHHHHh--hcCCCCCC-----cccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 00111111111 12222333 2366789999999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=312.95 Aligned_cols=185 Identities=24% Similarity=0.292 Sum_probs=153.4
Q ss_pred hccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEee
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLV 212 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv 212 (443)
..+|.+.+.||+|+||.||+|.. ++..||+|+.... ... .|+..+..++||||+++++++... ...++|
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---~~~--~E~~~l~~l~h~~iv~~~~~~~~~----~~~~lv 135 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---TTL--IEAMLLQNVNHPSVIRMKDTLVSG----AITCMV 135 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---ccH--HHHHHHHhCCCCCCcChhheEEeC----CeeEEE
Confidence 35799999999999999999998 4678999974322 222 345555569999999999998876 347899
Q ss_pred ecccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCccc
Q psy14889 213 THYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVS 290 (443)
Q Consensus 213 ~e~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~ 290 (443)
+||+. |+|.+++.. ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 136 ~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~--------~ivHrDlkp~Nill~~~~~~kl~DfG~a~~ 206 (357)
T PHA03209 136 LPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQ--------RIIHRDVKTENIFINDVDQVCIGDLGAAQF 206 (357)
T ss_pred EEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC--------CeecCCCCHHHEEECCCCCEEEecCccccc
Confidence 99996 689988853 5689999999999999999999998 999999999999999999999999999864
Q ss_pred ccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcc
Q psy14889 291 YSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRT 348 (443)
Q Consensus 291 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~ 348 (443)
...... .....||..|+|||++.+. .++.++|||||||++|||+++.
T Consensus 207 ~~~~~~-----~~~~~gt~~y~aPE~~~~~------~~~~~~DiwSlGvvl~ell~~~ 253 (357)
T PHA03209 207 PVVAPA-----FLGLAGTVETNAPEVLARD------KYNSKADIWSAGIVLFEMLAYP 253 (357)
T ss_pred cccCcc-----cccccccccccCCeecCCC------CCCchhhHHHHHHHHHHHHHcC
Confidence 332111 1234689999999999876 6678999999999999999873
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=301.23 Aligned_cols=251 Identities=22% Similarity=0.388 Sum_probs=192.3
Q ss_pred ccccccceeeeecCeEEEEEEEC-------CceeEEEEeeccCcc--chHHHHHHHHHHhccCCCceeeeeeccccCCcc
Q psy14889 136 KQISLSECIGKGRYGEVWRGVWH-------GENVAVKIFFSRDEA--SWSRETEIYSTVLLRHENILGYIGSDMTSRNSC 206 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~~--~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~ 206 (443)
++|+..+.||+|+||.||+|+.. .+.||+|.+...... ......|+..+..++|+||+++++++.+..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--- 81 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE--- 81 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC---
Confidence 67889999999999999999862 457999987554332 122345566666699999999999987653
Q ss_pred cEEEeeecccCcccHHHHhccc----------CCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcC
Q psy14889 207 TQLWLVTHYHSFGSLYDHLNRT----------TLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKT 276 (443)
Q Consensus 207 ~~~~lv~e~~~~gsL~~~l~~~----------~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~ 276 (443)
..++||||+++|+|.+++... .+++..+..++.|++.||.|||+. +|+||||||+||+++.
T Consensus 82 -~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~--------~i~H~dlkp~Nili~~ 152 (275)
T cd05046 82 -PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA--------RFVHRDLAARNCLVSS 152 (275)
T ss_pred -cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc--------CcccCcCccceEEEeC
Confidence 469999999999999998642 489999999999999999999998 9999999999999999
Q ss_pred CCcEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccc
Q psy14889 277 NGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEE 356 (443)
Q Consensus 277 ~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~ 356 (443)
++.++|+|||++........ .......++..|+|||.+.+. ..+.++||||||+++|||+++.
T Consensus 153 ~~~~~l~~~~~~~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~------~~~~~~Di~slG~~l~~l~~~~-------- 215 (275)
T cd05046 153 QREVKVSLLSLSKDVYNSEY---YKLRNALIPLRWLAPEAVQED------DFSTKSDVWSFGVLMWEVFTQG-------- 215 (275)
T ss_pred CCcEEEcccccccccCcccc---cccCCceeEEeecChhhhccC------CCCchhhHHHHHHHHHHHHhCC--------
Confidence 99999999999864432111 112334567789999998765 5568999999999999999831
Q ss_pred cCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHH
Q psy14889 357 YKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLI 426 (443)
Q Consensus 357 ~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 426 (443)
..||.+.. ........... ....+ ....++..+.+++.+||+.||++|||+.++++.|.
T Consensus 216 -~~p~~~~~-----~~~~~~~~~~~--~~~~~---~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 216 -ELPFYGLS-----DEEVLNRLQAG--KLELP---VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred -CCCccccc-----hHHHHHHHHcC--CcCCC---CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 56775432 12222222111 11111 12346678999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=300.61 Aligned_cols=246 Identities=30% Similarity=0.467 Sum_probs=195.5
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCc--cchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEe
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDE--ASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWL 211 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~--~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~l 211 (443)
++|++.+.||.|+||.||+|.. +++.||+|.+..... .....+.|+..+..++|+||+++++++.+. ..+++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----~~~~~ 76 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKG----SKLWI 76 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEEC----CeEEE
Confidence 3688889999999999999987 588999998865431 112334566666679999999999998766 45899
Q ss_pred eecccCcccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcccc
Q psy14889 212 VTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSY 291 (443)
Q Consensus 212 v~e~~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~ 291 (443)
|+||+++++|.+++....+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||+++.+
T Consensus 77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~--------~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~ 148 (274)
T cd06609 77 IMEYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEE--------GKIHRDIKAANILLSEEGDVKLADFGVSGQL 148 (274)
T ss_pred EEEeeCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhC--------CcccCCCCHHHEEECCCCCEEEcccccceee
Confidence 99999999999999888899999999999999999999998 9999999999999999999999999999877
Q ss_pred cccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCCh
Q psy14889 292 SQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSF 371 (443)
Q Consensus 292 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~~ 371 (443)
...... .....|+..|+|||.+.+. .++.++||||||+++|||+|| ..||....+
T Consensus 149 ~~~~~~----~~~~~~~~~y~~PE~~~~~------~~~~~sDv~slG~il~~l~tg----------~~p~~~~~~----- 203 (274)
T cd06609 149 TSTMSK----RNTFVGTPFWMAPEVIKQS------GYDEKADIWSLGITAIELAKG----------EPPLSDLHP----- 203 (274)
T ss_pred cccccc----cccccCCccccChhhhccC------CCCchhhHHHHHHHHHHHHhC----------CCCcccCch-----
Confidence 643221 2334688899999999876 567899999999999999999 666654321
Q ss_pred HHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 372 DDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
......+. ....+.++. ...+..+.+++.+||..||++|||++++++
T Consensus 204 ~~~~~~~~-~~~~~~~~~----~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 204 MRVLFLIP-KNNPPSLEG----NKFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred HHHHHHhh-hcCCCCCcc----cccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 11111111 112222221 125667999999999999999999999976
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=297.09 Aligned_cols=250 Identities=27% Similarity=0.372 Sum_probs=191.7
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc------chHHHHHHHHHHhccCCCceeeeeeccccCCccc
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA------SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCT 207 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~------~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~ 207 (443)
.+|++.+.||+|+||.||+|.. ++..||||.+...... ....+.|+..+..++||||+++++++.+... .
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~--~ 79 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPME--R 79 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCC--c
Confidence 5789999999999999999987 5889999987532211 1123456677777999999999998766533 3
Q ss_pred EEEeeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecC
Q psy14889 208 QLWLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFG 286 (443)
Q Consensus 208 ~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfG 286 (443)
.++++|||+++|+|.+++.+ ..+++..++.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||
T Consensus 80 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~--------~i~H~dl~p~nil~~~~~~~~l~Dfg 151 (265)
T cd06652 80 TLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSN--------MIVHRDIKGANILRDSVGNVKLGDFG 151 (265)
T ss_pred eEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC--------CEecCCCCHHHEEecCCCCEEECcCc
Confidence 57899999999999999865 5689999999999999999999998 99999999999999999999999999
Q ss_pred CcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCC
Q psy14889 287 LAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVP 366 (443)
Q Consensus 287 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~ 366 (443)
+++......... .......|+..|+|||.+.+. .++.++||||||+++|||++| ..||....
T Consensus 152 ~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~------~~~~~~Dv~slG~il~el~~g----------~~p~~~~~- 213 (265)
T cd06652 152 ASKRLQTICLSG-TGMKSVTGTPYWMSPEVISGE------GYGRKADIWSVGCTVVEMLTE----------KPPWAEFE- 213 (265)
T ss_pred cccccccccccc-cccccCCCCccccChhhhcCC------CCCcchhHHHHHHHHHHHhhC----------CCCCCccc-
Confidence 987654321111 112334688999999998765 566899999999999999999 66765431
Q ss_pred CCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 367 MDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
......... .....+..| ...+..+.+++.+||. +|++||+++++++
T Consensus 214 ---~~~~~~~~~-~~~~~~~~~-----~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 214 ---AMAAIFKIA-TQPTNPVLP-----PHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred ---hHHHHHHHh-cCCCCCCCc-----hhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 112222221 111222222 3355678899999995 9999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=307.85 Aligned_cols=193 Identities=26% Similarity=0.374 Sum_probs=151.4
Q ss_pred cceeeeecCeEEEEEEE----CCceeEEEEeeccCccchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEeeeccc
Q psy14889 141 SECIGKGRYGEVWRGVW----HGENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVTHYH 216 (443)
Q Consensus 141 ~~~lG~G~fg~Vy~~~~----~~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e~~ 216 (443)
..+||+|+||.||+|.. +++.||+|.+..... ......|+..+..++||||+++++++..... ..++++|||+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~--~~~~lv~e~~ 82 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-SMSACREIALLRELKHPNVISLQKVFLSHAD--RKVWLLFDYA 82 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-cHHHHHHHHHHHhcCCCCCcceeeeEecCCC--cEEEEEEecc
Confidence 46799999999999986 357899998854332 2223445566666999999999998865443 4589999998
Q ss_pred CcccHHHHhcc----------cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEE----cCCCcEEE
Q psy14889 217 SFGSLYDHLNR----------TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILV----KTNGTCVI 282 (443)
Q Consensus 217 ~~gsL~~~l~~----------~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl----~~~~~~kl 282 (443)
. ++|.+++.. ..+++..+..++.||+.||.|||+. +|+||||||+|||+ +.++.+||
T Consensus 83 ~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~--------~ivHrDlkp~Nil~~~~~~~~~~~kl 153 (317)
T cd07868 83 E-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN--------WVLHRDLKPANILVMGEGPERGRVKI 153 (317)
T ss_pred C-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC--------CEEcCCCCHHHEEEecCCCCcCcEEE
Confidence 7 488887742 2488999999999999999999998 99999999999999 45678999
Q ss_pred EecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCC
Q psy14889 283 ADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKAN 351 (443)
Q Consensus 283 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~ 351 (443)
+|||+++........ ........||+.|+|||++.+.. .++.++|||||||++|||++|++++
T Consensus 154 ~DfG~a~~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~-----~~~~~~DiwslG~il~el~~g~~~f 216 (317)
T cd07868 154 ADMGFARLFNSPLKP-LADLDPVVVTFWYRAPELLLGAR-----HYTKAIDIWAIGCIFAELLTSEPIF 216 (317)
T ss_pred eecCceeccCCCCcc-ccccCCccccccccCCHHHcCCC-----CcCchhhHHHHHHHHHHHHhCCCCc
Confidence 999999776533211 11123457899999999987642 4568999999999999999996554
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=299.37 Aligned_cols=257 Identities=26% Similarity=0.401 Sum_probs=196.3
Q ss_pred hccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccchHHHHHHHHHHhc-cCCCceeeeeeccccCC--cccEE
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEASWSRETEIYSTVLL-RHENILGYIGSDMTSRN--SCTQL 209 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~e~ei~~~~~l-~H~nIv~l~g~~~~~~~--~~~~~ 209 (443)
.++|++.+.||+|+||.||+|.. +++.+++|++..........+.|+..+..+ +|+||+++++++..... ....+
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 84 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQL 84 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEE
Confidence 47899999999999999999998 578899998876544333445566555556 79999999999876542 23568
Q ss_pred EeeecccCcccHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEe
Q psy14889 210 WLVTHYHSFGSLYDHLNR-----TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIAD 284 (443)
Q Consensus 210 ~lv~e~~~~gsL~~~l~~-----~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~D 284 (443)
++||||+++++|.+++.. ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.+||+|
T Consensus 85 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~--------~i~H~~l~p~ni~~~~~~~~~l~d 156 (275)
T cd06608 85 WLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN--------KVIHRDIKGQNILLTKNAEVKLVD 156 (275)
T ss_pred EEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC--------CcccCCCCHHHEEEccCCeEEECC
Confidence 999999999999998853 4689999999999999999999998 999999999999999999999999
Q ss_pred cCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCC
Q psy14889 285 FGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDL 364 (443)
Q Consensus 285 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~ 364 (443)
||++......... .....|+..|+|||.+....... ..++.++||||||+++|||++| ..||...
T Consensus 157 ~~~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~-~~~~~~~Dv~slG~il~~l~~g----------~~p~~~~ 221 (275)
T cd06608 157 FGVSAQLDSTLGR----RNTFIGTPYWMAPEVIACDEQPD-ASYDARSDVWSLGITAIELADG----------KPPLCDM 221 (275)
T ss_pred Cccceecccchhh----hcCccccccccCHhHhccccccc-CCccccccHHHhHHHHHHHHhC----------CCCcccc
Confidence 9998765432221 12346889999999986542211 2566899999999999999999 6676543
Q ss_pred CCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 365 VPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
.. ......... ...+... .....+..+.+++.+||..||++|||+.++++
T Consensus 222 ~~----~~~~~~~~~--~~~~~~~---~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 222 HP----MRALFKIPR--NPPPTLK---SPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred ch----HHHHHHhhc--cCCCCCC---chhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 11 112222111 1111111 12235568999999999999999999999975
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=300.66 Aligned_cols=245 Identities=24% Similarity=0.431 Sum_probs=187.1
Q ss_pred ceeeeecCeEEEEEEECC--------ceeEEEEeeccC--ccchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEe
Q psy14889 142 ECIGKGRYGEVWRGVWHG--------ENVAVKIFFSRD--EASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWL 211 (443)
Q Consensus 142 ~~lG~G~fg~Vy~~~~~~--------~~vAvK~~~~~~--~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~l 211 (443)
+.||+|+||.||+|+... ..+|+|.+.... ........|+..+..++||||+++++++.... ..++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~~ 76 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNE----PQYI 76 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCC----CeEE
Confidence 368999999999998732 579999875432 12223345666667799999999999987663 4799
Q ss_pred eecccCcccHHHHhcc--------cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCC-----
Q psy14889 212 VTHYHSFGSLYDHLNR--------TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNG----- 278 (443)
Q Consensus 212 v~e~~~~gsL~~~l~~--------~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~----- 278 (443)
||||+++|+|.+++.+ ..+++.+++.++.|++.||.|||+. +++|+||||+||+++.++
T Consensus 77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~--------~i~H~dl~p~nil~~~~~~~~~~ 148 (269)
T cd05044 77 IMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM--------HFIHRDLAARNCLVSEKGYDADR 148 (269)
T ss_pred EEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC--------CcccCCCChheEEEecCCCCCCc
Confidence 9999999999999853 2378899999999999999999988 999999999999999887
Q ss_pred cEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh-cccCCCccccc
Q psy14889 279 TCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR-RTKANGIFEEY 357 (443)
Q Consensus 279 ~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt-g~~~~~~~~~~ 357 (443)
.+||+|||+++......... ......++..|+|||.+.++ .++.++||||||+++|||++ |
T Consensus 149 ~~~l~dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~------~~~~~~Dv~slG~il~ellt~g---------- 210 (269)
T cd05044 149 VVKIGDFGLARDIYKSDYYR--KEGEGLLPVRWMAPESLLDG------KFTTQSDVWSFGVLMWEILTLG---------- 210 (269)
T ss_pred ceEECCcccccccccccccc--cCcccCCCccccCHHHHccC------CcccchhHHHHHHHHHHHHHcC----------
Confidence 89999999987654321111 11223456789999999876 66789999999999999998 7
Q ss_pred CCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHH
Q psy14889 358 KAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIK 427 (443)
Q Consensus 358 ~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 427 (443)
..||... ........+.. ......+ ...+..+.+++.+||..+|++||+++++++.|++
T Consensus 211 ~~p~~~~-----~~~~~~~~~~~-~~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 211 QQPYPAL-----NNQEVLQHVTA-GGRLQKP-----ENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred CCCCccc-----CHHHHHHHHhc-CCccCCc-----ccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 6676543 11222222211 1122222 3467789999999999999999999999998863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=301.73 Aligned_cols=252 Identities=24% Similarity=0.385 Sum_probs=191.8
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccc-hHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEee
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEAS-WSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLV 212 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~-~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv 212 (443)
+.|++.+.||+|+||.||+|+. ++..||+|.+....... .....|+..+..++||||+++++.+... ..+++|
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----~~~~lv 87 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWD----GKLWIM 87 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeC----CeEEEE
Confidence 6799999999999999999988 47899999886544322 2223455566669999999999998765 458999
Q ss_pred ecccCcccHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCccc
Q psy14889 213 THYHSFGSLYDHLN--RTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVS 290 (443)
Q Consensus 213 ~e~~~~gsL~~~l~--~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~ 290 (443)
|||+++++|..++. ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++..
T Consensus 88 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~--------~i~H~dlkp~Nili~~~~~~kl~dfg~~~~ 159 (292)
T cd06644 88 IEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSM--------KIIHRDLKAGNVLLTLDGDIKLADFGVSAK 159 (292)
T ss_pred EecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcC--------CeeecCCCcceEEEcCCCCEEEccCcccee
Confidence 99999999988875 35689999999999999999999988 999999999999999999999999999865
Q ss_pred ccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCC
Q psy14889 291 YSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPS 370 (443)
Q Consensus 291 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~ 370 (443)
....... .....++..|+|||++.+..... ..++.++|||||||++|||++| ..||....+
T Consensus 160 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~-~~~~~~~Dv~slG~il~el~~g----------~~p~~~~~~---- 220 (292)
T cd06644 160 NVKTLQR----RDSFIGTPYWMAPEVVMCETMKD-TPYDYKADIWSLGITLIEMAQI----------EPPHHELNP---- 220 (292)
T ss_pred ccccccc----cceecCCccccCceeeccccccC-CCCCchhhhHhHHHHHHHHhcC----------CCCCccccH----
Confidence 4322111 12346788999999986432111 1466899999999999999999 666654311
Q ss_pred hHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 371 FDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
.....+.. ....+... .+...+.++.+++.+||+.||++||++.++++
T Consensus 221 ~~~~~~~~--~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 221 MRVLLKIA--KSEPPTLS---QPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred HHHHHHHh--cCCCccCC---CCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 11122221 11111111 12335567999999999999999999999976
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=303.21 Aligned_cols=252 Identities=23% Similarity=0.326 Sum_probs=185.3
Q ss_pred cccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc---chHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEe
Q psy14889 137 QISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA---SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWL 211 (443)
Q Consensus 137 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~---~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~l 211 (443)
+|++.+.||+|+||.||+|.. ++..||+|.+...... ......|+..+..++||||+++++++... ..+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----~~~~~ 76 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQE----SRLYL 76 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeC----CeEEE
Confidence 477889999999999999987 5889999987543221 12334566666679999999999998765 45799
Q ss_pred eecccCcccHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCC
Q psy14889 212 VTHYHSFGSLYDHLNR----TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGL 287 (443)
Q Consensus 212 v~e~~~~gsL~~~l~~----~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGl 287 (443)
||||++ ++|.+++.. ..+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||+
T Consensus 77 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~--------~i~H~dl~p~nil~~~~~~~~l~dfg~ 147 (285)
T cd07861 77 IFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR--------RVLHRDLKPQNLLIDNKGVIKLADFGL 147 (285)
T ss_pred EEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC--------CeeecCCCHHHEEEcCCCcEEECcccc
Confidence 999998 689888753 4689999999999999999999998 999999999999999999999999999
Q ss_pred cccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCC
Q psy14889 288 AVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPM 367 (443)
Q Consensus 288 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~ 367 (443)
+......... .....+++.|+|||.+.+.. .++.++||||||+++|||+||+ .||......
T Consensus 148 ~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~-----~~~~~~Dv~slG~il~~l~tg~----------~~~~~~~~~ 208 (285)
T cd07861 148 ARAFGIPVRV----YTHEVVTLWYRAPEVLLGSP-----RYSTPVDIWSIGTIFAEMATKK----------PLFHGDSEI 208 (285)
T ss_pred eeecCCCccc----ccCCcccccccChHHhcCCC-----CcCcHHHHHHHHHHHHHHHHCC----------CCCCCCCHH
Confidence 8755432111 12335788999999886542 3567899999999999999994 444332100
Q ss_pred --------------------CCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 368 --------------------DPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 368 --------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
............. ........ .....+.++.+++++||+.||++|||+.+|++
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~--~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 209 DQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPK-WKKGSLRS--AVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHHHHHHHHhCCCChhhhhcchhhHHHHhhccc-cCcchhHH--hcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000000000000 00000000 01225567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=301.41 Aligned_cols=253 Identities=25% Similarity=0.423 Sum_probs=194.1
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccch-HHHHHHHHHHhccCCCceeeeeeccccCCcccEEEee
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEASW-SRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLV 212 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~-~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv 212 (443)
++|++.+.||+|+||.||++.+ ++..||+|.......... ....|+..+..++||||+++++.+... ..+++|
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----~~~~lv 80 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYE----NKLWIL 80 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecC----CeEEEE
Confidence 6799999999999999999988 578999998865433221 233455666669999999999998765 457999
Q ss_pred ecccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCccc
Q psy14889 213 THYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVS 290 (443)
Q Consensus 213 ~e~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~ 290 (443)
|||+++|+|.+++.. ..+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.++|+|||++..
T Consensus 81 ~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~--------~i~h~dl~p~nili~~~~~~~l~d~g~~~~ 152 (280)
T cd06611 81 IEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH--------KVIHRDLKAGNILLTLDGDVKLADFGVSAK 152 (280)
T ss_pred eeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CcccCCCChhhEEECCCCCEEEccCccchh
Confidence 999999999999864 4699999999999999999999998 999999999999999999999999999865
Q ss_pred ccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCC
Q psy14889 291 YSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPS 370 (443)
Q Consensus 291 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~ 370 (443)
....... .....|+..|+|||.+....... ..++.++||||||+++|||++| ..||.....
T Consensus 153 ~~~~~~~----~~~~~~~~~y~~PE~~~~~~~~~-~~~~~~sDi~slG~il~~l~~g----------~~p~~~~~~---- 213 (280)
T cd06611 153 NKSTLQK----RDTFIGTPYWMAPEVVACETFKD-NPYDYKADIWSLGITLIELAQM----------EPPHHELNP---- 213 (280)
T ss_pred hcccccc----cceeecchhhcCHHHHhhcccCC-CCCCccccHHHHHHHHHHHHhC----------CCCcccCCH----
Confidence 4332211 12346889999999986432111 1456799999999999999999 667765311
Q ss_pred hHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHH
Q psy14889 371 FDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKT 424 (443)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 424 (443)
...+.+.. ....+.+. .+...+.++.+++.+||+.||.+|||+.++++.
T Consensus 214 ~~~~~~~~--~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 214 MRVLLKIL--KSEPPTLD---QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred HHHHHHHh--cCCCCCcC---CcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 11222221 11111111 122355679999999999999999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=297.41 Aligned_cols=248 Identities=28% Similarity=0.411 Sum_probs=192.5
Q ss_pred cccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccc----------hHHHHHHHHHHhccCCCceeeeeeccccCC
Q psy14889 137 QISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEAS----------WSRETEIYSTVLLRHENILGYIGSDMTSRN 204 (443)
Q Consensus 137 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~----------~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~ 204 (443)
+|.+...||+|+||.||+|.. +++.+|+|.+....... ...+.|+..+..++||||+++++++...
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-- 78 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDA-- 78 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC--
Confidence 367788999999999999987 57899999875432211 1224566666679999999999998765
Q ss_pred cccEEEeeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEE
Q psy14889 205 SCTQLWLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIA 283 (443)
Q Consensus 205 ~~~~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~ 283 (443)
...++||||+++++|.+++.. ..+++..+..++.|++.||+|||+. +++||||+|+||++++++.+||+
T Consensus 79 --~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~--------~ivH~di~p~nil~~~~~~~~l~ 148 (267)
T cd06628 79 --DHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNR--------GIIHRDIKGANILVDNKGGIKIS 148 (267)
T ss_pred --CccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhc--------CcccccCCHHHEEEcCCCCEEec
Confidence 357899999999999999965 5689999999999999999999998 99999999999999999999999
Q ss_pred ecCCcccccccCCcCC--CCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCC
Q psy14889 284 DFGLAVSYSQLSNKMD--IPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPY 361 (443)
Q Consensus 284 DfGla~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~ 361 (443)
|||+++.......... .......|+..|+|||.+.+. .++.++||||||+++|||++| ..||
T Consensus 149 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~------~~~~~~Dv~slG~il~~l~~g----------~~p~ 212 (267)
T cd06628 149 DFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQT------SYTRKADIWSLGCLVVEMLTG----------KHPF 212 (267)
T ss_pred ccCCCcccccccccCCccccccccCCCcCccChhHhccC------CCCchhhhHHHHHHHHHHhhC----------CCCC
Confidence 9999977653221111 111234588899999998765 566899999999999999999 6677
Q ss_pred CCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 362 HDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
.+.. ....+.... ....+.++ ...+..+.+++++||+.||.+||++.++++
T Consensus 213 ~~~~----~~~~~~~~~--~~~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 213 PDCT----QLQAIFKIG--ENASPEIP-----SNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred CCcc----HHHHHHHHh--ccCCCcCC-----cccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 6531 112222211 12233333 235678999999999999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=309.85 Aligned_cols=196 Identities=22% Similarity=0.361 Sum_probs=153.2
Q ss_pred ccceeeee--cCeEEEEEEE--CCceeEEEEeeccCc---cchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEee
Q psy14889 140 LSECIGKG--RYGEVWRGVW--HGENVAVKIFFSRDE---ASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLV 212 (443)
Q Consensus 140 ~~~~lG~G--~fg~Vy~~~~--~~~~vAvK~~~~~~~---~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv 212 (443)
+.++||+| +||+||++.. +|+.||+|++..... .......|+..+..++||||+++++++... ...++|
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~----~~~~lv 77 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD----NELWVV 77 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEEC----CEEEEE
Confidence 46789999 7889999987 689999999865322 112223455566668999999999999776 457999
Q ss_pred ecccCcccHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcc
Q psy14889 213 THYHSFGSLYDHLNR---TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAV 289 (443)
Q Consensus 213 ~e~~~~gsL~~~l~~---~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~ 289 (443)
|||+++|+|.+++.. ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.++++||+.+.
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~--------~iiH~dlkp~Nil~~~~~~~~l~~~~~~~ 149 (327)
T cd08227 78 TSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM--------GYVHRSVKASHILISVDGKVYLSGLRSNL 149 (327)
T ss_pred EeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC--------CEecCCCChhhEEEecCCcEEEcccchhh
Confidence 999999999999853 4589999999999999999999998 99999999999999999999999998754
Q ss_pred cccccCCcC---CCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCC
Q psy14889 290 SYSQLSNKM---DIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKAN 351 (443)
Q Consensus 290 ~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~ 351 (443)
......... ........++..|+|||++.+... .++.++|||||||++|||++|+.|+
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~----~~~~~~DiwslG~il~el~~g~~pf 210 (327)
T cd08227 150 SMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQ----GYDAKSDIYSVGITACELANGHVPF 210 (327)
T ss_pred ccccccccccccccccccccceecccChHHhhcccC----CCCchhhHHHHHHHHHHHHHCCCCC
Confidence 432211110 001122356788999999875311 4668999999999999999995443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=304.94 Aligned_cols=248 Identities=26% Similarity=0.407 Sum_probs=192.6
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc-chHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEee
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA-SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLV 212 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~-~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv 212 (443)
+.|.....||+|+||.||++.. ++..||||.+...... ......|+..+..++|+||+++++.+... ...++|
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~----~~~~lv 97 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVG----DELWVV 97 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecC----CeEEEE
Confidence 4555567899999999999987 5889999987543322 12234566666679999999999988765 457999
Q ss_pred ecccCcccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCccccc
Q psy14889 213 THYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYS 292 (443)
Q Consensus 213 ~e~~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~~ 292 (443)
|||+++++|.+++....+++.++..++.||+.||+|||+. +|+||||||+||++++++.+||+|||++....
T Consensus 98 ~e~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~--------~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~ 169 (292)
T cd06658 98 MEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQ--------GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVS 169 (292)
T ss_pred EeCCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CEeecCCCHHHEEEcCCCCEEEccCcchhhcc
Confidence 9999999999999888899999999999999999999998 99999999999999999999999999987554
Q ss_pred ccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCChH
Q psy14889 293 QLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFD 372 (443)
Q Consensus 293 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~~~ 372 (443)
..... .....|+..|+|||.+.+. .++.++||||||+++|||++| ..||.... ...
T Consensus 170 ~~~~~----~~~~~~~~~y~aPE~~~~~------~~~~~~Dv~slGvil~el~~g----------~~p~~~~~----~~~ 225 (292)
T cd06658 170 KEVPK----RKSLVGTPYWMAPEVISRL------PYGTEVDIWSLGIMVIEMIDG----------EPPYFNEP----PLQ 225 (292)
T ss_pred ccccc----CceeecCccccCHHHHccC------CCCchhhHHHHHHHHHHHHhC----------CCCCCCCC----HHH
Confidence 32211 1334688999999998765 567899999999999999999 66665431 112
Q ss_pred HHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHH
Q psy14889 373 DMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKT 424 (443)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 424 (443)
.+..... ...+..+. ....+..+.+++.+||..||++|||+.++++.
T Consensus 226 ~~~~~~~--~~~~~~~~---~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 226 AMRRIRD--NLPPRVKD---SHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred HHHHHHh--cCCCcccc---ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 2222111 11111111 12345679999999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=293.40 Aligned_cols=245 Identities=24% Similarity=0.382 Sum_probs=191.0
Q ss_pred cccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc---chHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEe
Q psy14889 137 QISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA---SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWL 211 (443)
Q Consensus 137 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~---~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~l 211 (443)
+|++.+.||+|+||.||++.. +++.||+|.+...... ....+.|+..+..++|+|++++++.+.... ..+++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~l 77 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGED---GLLYI 77 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCC---CEEEE
Confidence 478899999999999999987 5788999988643221 122345666666799999999998765432 35799
Q ss_pred eecccCcccHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCc
Q psy14889 212 VTHYHSFGSLYDHLNR---TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA 288 (443)
Q Consensus 212 v~e~~~~gsL~~~l~~---~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla 288 (443)
+|||+++++|.+++.. ..+++.++..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++
T Consensus 78 v~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~--------~i~H~di~p~nil~~~~~~~~l~df~~~ 149 (257)
T cd08223 78 VMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK--------HILHRDLKTQNVFLTRTNIIKVGDLGIA 149 (257)
T ss_pred EecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC--------CeeccCCCchhEEEecCCcEEEecccce
Confidence 9999999999999864 4589999999999999999999998 9999999999999999999999999999
Q ss_pred ccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCC
Q psy14889 289 VSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMD 368 (443)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~ 368 (443)
........ ......|++.|+|||.+.+. .++.++||||||+++|||++| ..||...
T Consensus 150 ~~~~~~~~----~~~~~~~~~~y~aPE~~~~~------~~~~~~Dv~slG~il~~l~~g----------~~~~~~~---- 205 (257)
T cd08223 150 RVLENQCD----MASTLIGTPYYMSPELFSNK------PYNYKSDVWALGCCVYEMATL----------KHAFNAK---- 205 (257)
T ss_pred EEecccCC----ccccccCCcCccChhHhcCC------CCCchhhhHHHHHHHHHHHcC----------CCCCCCC----
Confidence 76643221 12334688999999998776 566899999999999999999 5566432
Q ss_pred CChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 369 PSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
.......... ....+..+ ...+..+.+++.+||+.||++|||+.++++
T Consensus 206 -~~~~~~~~~~-~~~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 206 -DMNSLVYRII-EGKLPPMP-----KDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred -CHHHHHHHHH-hcCCCCCc-----cccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 1122221111 12222222 335678999999999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=294.40 Aligned_cols=245 Identities=25% Similarity=0.332 Sum_probs=192.7
Q ss_pred cccccceeeeecCeEEEEEEE--CCceeEEEEeeccC---ccchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEe
Q psy14889 137 QISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRD---EASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWL 211 (443)
Q Consensus 137 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~---~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~l 211 (443)
+|+..+.||+|+||.||.++. +++.+++|.+.... ........|+..+..++|+||+++++++.+. ..+++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~----~~~~~ 76 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDD----NTLLI 76 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecC----CeEEE
Confidence 478899999999999988876 68899999875432 1122234566666679999999999998776 45899
Q ss_pred eecccCcccHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCc
Q psy14889 212 VTHYHSFGSLYDHLNR---TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA 288 (443)
Q Consensus 212 v~e~~~~gsL~~~l~~---~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla 288 (443)
+|||+++|+|.+++.+ ..+++.++..++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||++
T Consensus 77 ~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--------~i~h~dl~p~ni~~~~~~~~kl~d~~~~ 148 (256)
T cd08221 77 EMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA--------GILHRDIKTLNIFLTKAGLIKLGDFGIS 148 (256)
T ss_pred EEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC--------CccccCCChHhEEEeCCCCEEECcCcce
Confidence 9999999999999965 3589999999999999999999998 9999999999999999999999999999
Q ss_pred ccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCC
Q psy14889 289 VSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMD 368 (443)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~ 368 (443)
........ ......|+..|+|||.+.+. ..+.++||||||+++|||++| ..||....
T Consensus 149 ~~~~~~~~----~~~~~~~~~~y~ape~~~~~------~~~~~~Dv~slG~i~~~l~~g----------~~~~~~~~--- 205 (256)
T cd08221 149 KILGSEYS----MAETVVGTPYYMSPELCQGV------KYNFKSDIWALGCVLYELLTL----------KRTFDATN--- 205 (256)
T ss_pred EEcccccc----cccccCCCccccCHhhcCCC------CCCCcchhHHHHHHHHHHHHC----------CCCCCCCC---
Confidence 76644331 12345688999999998765 556789999999999999999 55665421
Q ss_pred CChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHH
Q psy14889 369 PSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKT 424 (443)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 424 (443)
..+...... . ......+ ...+.++.+++.+||+.||.+|||+.++++.
T Consensus 206 -~~~~~~~~~-~-~~~~~~~-----~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 206 -PLNLVVKIV-Q-GNYTPVV-----SVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred -HHHHHHHHH-c-CCCCCCc-----cccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 112222222 1 1111111 3356789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >KOG0200|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=331.56 Aligned_cols=261 Identities=22% Similarity=0.404 Sum_probs=203.5
Q ss_pred HhhhhccccccceeeeecCeEEEEEEEC---------CceeEEEEeeccCcc----chHHHHHHHHHHhccCCCceeeee
Q psy14889 131 QRTLAKQISLSECIGKGRYGEVWRGVWH---------GENVAVKIFFSRDEA----SWSRETEIYSTVLLRHENILGYIG 197 (443)
Q Consensus 131 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~---------~~~vAvK~~~~~~~~----~~~~e~ei~~~~~l~H~nIv~l~g 197 (443)
.+...++..+.+.||+|.||.|++|... ...||||.++..... ....|.+++... .+|+||+.++|
T Consensus 291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~-g~H~niv~llG 369 (609)
T KOG0200|consen 291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKEL-GKHPNIVNLLG 369 (609)
T ss_pred eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHh-cCCcchhhhee
Confidence 3444566677789999999999999863 246999988654333 223344444432 57999999999
Q ss_pred eccccCCcccEEEeeecccCcccHHHHhcccC-----------------CCHHHHHHHHHHHHHHHHHHHHchhcCCCCC
Q psy14889 198 SDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTT-----------------LNHHQMMKICLSIVNGLVHLHTEIFGTQGKP 260 (443)
Q Consensus 198 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----------------l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~ 260 (443)
+|... ..+++|+||+..|+|.++|+..+ ++....+.++.|||.||+||++.
T Consensus 370 ~~t~~----~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~-------- 437 (609)
T KOG0200|consen 370 ACTQD----GPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV-------- 437 (609)
T ss_pred eeccC----CceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC--------
Confidence 99884 45799999999999999997655 99999999999999999999999
Q ss_pred CeEEeCCCCCCEEEcCCCcEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHH
Q psy14889 261 AIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLV 340 (443)
Q Consensus 261 ~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvv 340 (443)
++|||||.++|||+..+..+||+|||+|+................ -...|||||.+... .++.|||||||||+
T Consensus 438 ~~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~-LP~kWmApEsl~~~------~ft~kSDVWSfGI~ 510 (609)
T KOG0200|consen 438 PCVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGT-LPVKWMAPESLFDR------VFTSKSDVWSFGIL 510 (609)
T ss_pred CccchhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCc-cceeecCHHHhccC------cccccchhhHHHHH
Confidence 899999999999999999999999999986554332211101101 23469999999886 78899999999999
Q ss_pred HHHHHhcccCCCcccccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHH
Q psy14889 341 LWEVCRRTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALR 420 (443)
Q Consensus 341 l~elltg~~~~~~~~~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e 420 (443)
|||++|. +..||.+.. ...++.+ ....+.+...| ..|+++++++|+.||+.+|++||++.+
T Consensus 511 L~EifsL---------G~~PYp~~~----~~~~l~~-~l~~G~r~~~P-----~~c~~eiY~iM~~CW~~~p~~RP~F~~ 571 (609)
T KOG0200|consen 511 LWEIFTL---------GGTPYPGIP----PTEELLE-FLKEGNRMEQP-----EHCSDEIYDLMKSCWNADPEDRPTFSE 571 (609)
T ss_pred HHHHhhC---------CCCCCCCCC----cHHHHHH-HHhcCCCCCCC-----CCCCHHHHHHHHHHhCCCcccCCCHHH
Confidence 9999986 478887742 1233333 33445566655 347889999999999999999999999
Q ss_pred HHHHHHHHhh
Q psy14889 421 VKKTLIKLAC 430 (443)
Q Consensus 421 vl~~L~~l~~ 430 (443)
+.+.++.+..
T Consensus 572 ~~~~~~~~l~ 581 (609)
T KOG0200|consen 572 CVEFFEKHLQ 581 (609)
T ss_pred HHHHHHHHHH
Confidence 9999999643
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=315.58 Aligned_cols=255 Identities=22% Similarity=0.275 Sum_probs=189.6
Q ss_pred hhccccccceeeeecCeEEEEEEEC----CceeEEEEeeccCccchHHHHHHHHHHhccCCCceeeeeeccccCCcccEE
Q psy14889 134 LAKQISLSECIGKGRYGEVWRGVWH----GENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQL 209 (443)
Q Consensus 134 ~~~~~~~~~~lG~G~fg~Vy~~~~~----~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~ 209 (443)
...+|.+.+.||+|+||.||++... +..||+|.+.... . .+.|+..+..++||||+++++++... ..+
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~--~--~~~E~~il~~l~h~~iv~~~~~~~~~----~~~ 161 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK--T--PGREIDILKTISHRAIINLIHAYRWK----STV 161 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc--c--HHHHHHHHHhcCCCCccceeeeEeeC----CEE
Confidence 3467999999999999999999763 4679999875432 2 23455556669999999999988765 457
Q ss_pred EeeecccCcccHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCc
Q psy14889 210 WLVTHYHSFGSLYDHLN-RTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA 288 (443)
Q Consensus 210 ~lv~e~~~~gsL~~~l~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla 288 (443)
++|||++. ++|.+++. ...+++.+++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 162 ~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~--------givHrDlkp~Nill~~~~~~~l~DfG~a 232 (392)
T PHA03207 162 CMVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGR--------GIIHRDVKTENIFLDEPENAVLGDFGAA 232 (392)
T ss_pred EEEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CccccCCCHHHEEEcCCCCEEEccCccc
Confidence 99999986 68888885 36799999999999999999999998 9999999999999999999999999999
Q ss_pred ccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCC
Q psy14889 289 VSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMD 368 (443)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~ 368 (443)
..+...... .......||+.|+|||++.+. .++.++|||||||++|||++| ..||.+.....
T Consensus 233 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslGvil~el~~g----------~~pf~~~~~~~ 294 (392)
T PHA03207 233 CKLDAHPDT--PQCYGWSGTLETNSPELLALD------PYCAKTDIWSAGLVLFEMSVK----------NVTLFGKQVKS 294 (392)
T ss_pred cccCccccc--ccccccccccCccCHhHhcCC------CCCchhhHHHHHHHHHHHHHC----------CCCCCCCCCCC
Confidence 765543221 112345799999999999876 677899999999999999999 44544322111
Q ss_pred CChHHHHhhhhhc------------------------CCCC--CCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHH
Q psy14889 369 PSFDDMRKVICID------------------------QQRP--VLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVK 422 (443)
Q Consensus 369 ~~~~~~~~~~~~~------------------------~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl 422 (443)
....+...+... ..++ ..+........+.++.++|.+||..||++|||+.|++
T Consensus 295 -~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l 373 (392)
T PHA03207 295 -SSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDIL 373 (392)
T ss_pred -cHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHh
Confidence 111111111100 0011 1111111122456788999999999999999999998
Q ss_pred HH
Q psy14889 423 KT 424 (443)
Q Consensus 423 ~~ 424 (443)
..
T Consensus 374 ~~ 375 (392)
T PHA03207 374 SL 375 (392)
T ss_pred hC
Confidence 74
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=296.90 Aligned_cols=238 Identities=21% Similarity=0.376 Sum_probs=180.5
Q ss_pred ceeeeecCeEEEEEEEC--C----------ceeEEEEeeccCccchHHHHHHHHHHhccCCCceeeeeeccccCCcccEE
Q psy14889 142 ECIGKGRYGEVWRGVWH--G----------ENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQL 209 (443)
Q Consensus 142 ~~lG~G~fg~Vy~~~~~--~----------~~vAvK~~~~~~~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~ 209 (443)
+.||+|+||.||+|.+. + ..|++|.+............|+..+..++||||+++++++.. .. .
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~----~ 75 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DE----N 75 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CC----c
Confidence 46899999999999984 2 247888765544323333455556666999999999999876 22 4
Q ss_pred EeeecccCcccHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCC-------cE
Q psy14889 210 WLVTHYHSFGSLYDHLNRT--TLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNG-------TC 280 (443)
Q Consensus 210 ~lv~e~~~~gsL~~~l~~~--~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~-------~~ 280 (443)
++||||+++|+|.+++... .+++..++.++.||+.||.|||+. +|+||||||+|||++.++ .+
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--------~i~H~dlkp~Nill~~~~~~~~~~~~~ 147 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDK--------KLVHGNVCGKNILVARYGLNEGYVPFI 147 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhC--------CeecccCccceEEEecCccccCCceeE
Confidence 8999999999999999653 589999999999999999999998 999999999999999888 79
Q ss_pred EEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCC
Q psy14889 281 VIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAP 360 (443)
Q Consensus 281 kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P 360 (443)
||+|||++...... ....++..|+|||++.+.. ..++.++||||||+++|||++|. ..|
T Consensus 148 kl~Dfg~a~~~~~~--------~~~~~~~~y~aPE~~~~~~----~~~~~~~Di~slG~~~~~l~~~~---------~~p 206 (259)
T cd05037 148 KLSDPGIPITVLSR--------EERVERIPWIAPECIRNGQ----ASLTIAADKWSFGTTLLEICSNG---------EEP 206 (259)
T ss_pred EeCCCCcccccccc--------cccccCCCccChhhhcCCC----CCcchhhHHHHHHHHHHHHHhCC---------CCC
Confidence 99999998765431 1235667899999987642 14568999999999999999951 556
Q ss_pred CCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHH
Q psy14889 361 YHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLI 426 (443)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 426 (443)
|..... ......... ......+ ....+.+++.+||..+|.+|||+.++++.|+
T Consensus 207 ~~~~~~-----~~~~~~~~~-~~~~~~~-------~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 207 LSTLSS-----SEKERFYQD-QHRLPMP-------DCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred cccCCc-----hhHHHHHhc-CCCCCCC-------CchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 655321 111111111 1111111 1257899999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=295.13 Aligned_cols=254 Identities=22% Similarity=0.332 Sum_probs=178.3
Q ss_pred eeeeecCeEEEEEEE-CC---ceeEEEEeeccCcc--chHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEeeeccc
Q psy14889 143 CIGKGRYGEVWRGVW-HG---ENVAVKIFFSRDEA--SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVTHYH 216 (443)
Q Consensus 143 ~lG~G~fg~Vy~~~~-~~---~~vAvK~~~~~~~~--~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e~~ 216 (443)
.||+|+||.||+|.. ++ ..+++|.+...... ......|+..+..++||||+++++.+.... ..++||||+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~----~~~lv~e~~ 77 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAI----PYLLVFEYC 77 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCC----ccEEEEecC
Confidence 589999999999976 33 24566665433221 112234444455589999999999988763 479999999
Q ss_pred CcccHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcccc
Q psy14889 217 SFGSLYDHLNR-----TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSY 291 (443)
Q Consensus 217 ~~gsL~~~l~~-----~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~ 291 (443)
++|+|.+++++ ..+++..+..++.||+.||+|||+. +++||||||+|||++.++.+||+|||++...
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~--------~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~ 149 (268)
T cd05086 78 ELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH--------NFLHSDLALRNCFLTSDLTVKVGDYGIGPSR 149 (268)
T ss_pred CCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC--------CeeccCCccceEEEcCCccEEeccccccccc
Confidence 99999999964 2356677889999999999999998 9999999999999999999999999998543
Q ss_pred cccCCcCCCCCCCcccccCccccccccccccc-CcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCC
Q psy14889 292 SQLSNKMDIPPNPRVGTKRYMSPEILDESINM-DCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPS 370 (443)
Q Consensus 292 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~ 370 (443)
..... ........|+..|+|||++...... ....++.++||||||+++|||+++. ..||.... .
T Consensus 150 ~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~---------~~p~~~~~----~ 214 (268)
T cd05086 150 YKEDY--IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENA---------AQPYSHLS----D 214 (268)
T ss_pred Ccchh--hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCC---------CCCCCCCC----H
Confidence 21110 0111234678899999998642111 1124568999999999999999752 44664421 1
Q ss_pred hHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHH
Q psy14889 371 FDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLI 426 (443)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 426 (443)
.+.+........ ..++.........+.+.+++..|| .+|++||++++|++.|.
T Consensus 215 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 215 REVLNHVIKDQQ--VKLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred HHHHHHHHhhcc--cccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 122222222111 111111112235567899999999 67999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=294.69 Aligned_cols=247 Identities=24% Similarity=0.360 Sum_probs=193.8
Q ss_pred cccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccc---hHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEe
Q psy14889 137 QISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEAS---WSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWL 211 (443)
Q Consensus 137 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~---~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~l 211 (443)
+|++.+.||.|+||.||++.. ++..||+|.+....... .....|+..+..++||||+++++++..... ..+++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~--~~~~~ 78 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSN--QTLYI 78 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCC--CEEEE
Confidence 477889999999999999987 57899999886433221 122346666667999999999998765433 45799
Q ss_pred eecccCcccHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHH-----HchhcCCCCCCeEEeCCCCCCEEEcCCCcEE
Q psy14889 212 VTHYHSFGSLYDHLNR-----TTLNHHQMMKICLSIVNGLVHLH-----TEIFGTQGKPAIAHRDIKSKNILVKTNGTCV 281 (443)
Q Consensus 212 v~e~~~~gsL~~~l~~-----~~l~~~~~~~i~~qia~gL~yLH-----~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~k 281 (443)
+|||+++++|.+++.. ..+++..++.++.|++.||.||| +. +++|+||||+||++++++.+|
T Consensus 79 ~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~--------~i~h~dl~p~nili~~~~~~k 150 (265)
T cd08217 79 VMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN--------TVLHRDLKPANIFLDANNNVK 150 (265)
T ss_pred EehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC--------cceecCCCHHHEEEecCCCEE
Confidence 9999999999999853 56899999999999999999999 66 999999999999999999999
Q ss_pred EEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCC
Q psy14889 282 IADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPY 361 (443)
Q Consensus 282 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~ 361 (443)
|+|||++......... .....|+..|+|||.+... .++.++|+||||+++|+|++| ..||
T Consensus 151 l~d~g~~~~~~~~~~~----~~~~~~~~~~~~pE~~~~~------~~~~~~Dv~slG~il~~l~~g----------~~p~ 210 (265)
T cd08217 151 LGDFGLAKILGHDSSF----AKTYVGTPYYMSPEQLNHM------SYDEKSDIWSLGCLIYELCAL----------SPPF 210 (265)
T ss_pred EecccccccccCCccc----ccccccCCCccChhhhcCC------CCCchhHHHHHHHHHHHHHHC----------CCcc
Confidence 9999999876543221 1234688999999998765 566899999999999999999 6666
Q ss_pred CCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHH
Q psy14889 362 HDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKT 424 (443)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 424 (443)
... ....+.+.+.. ...+.++ ...+..+.+++.+||+.+|++|||+.+|++.
T Consensus 211 ~~~-----~~~~~~~~~~~-~~~~~~~-----~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 211 TAR-----NQLQLASKIKE-GKFRRIP-----YRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred cCc-----CHHHHHHHHhc-CCCCCCc-----cccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 543 12333333322 1222222 3356789999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=295.50 Aligned_cols=246 Identities=29% Similarity=0.493 Sum_probs=192.4
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEeee
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVT 213 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv~ 213 (443)
++|++.+.||+|+||.||+|.. ++..+|+|.+..... ......|+..+..++||||+++++.+... ..+++++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~----~~~~l~~ 77 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-LQEIIKEISILKQCDSPYIVKYYGSYFKN----TDLWIVM 77 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-HHHHHHHHHHHHhCCCCcEeeeeeeeecC----CcEEEEE
Confidence 6799999999999999999998 378999998865432 23334566666668999999999998776 4579999
Q ss_pred cccCcccHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcccc
Q psy14889 214 HYHSFGSLYDHLN--RTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSY 291 (443)
Q Consensus 214 e~~~~gsL~~~l~--~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~ 291 (443)
||+++++|.+++. ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||++...
T Consensus 78 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~--------~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~ 149 (256)
T cd06612 78 EYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSN--------KKIHRDIKAGNILLNEEGQAKLADFGVSGQL 149 (256)
T ss_pred ecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC--------CcccCCCCcceEEECCCCcEEEcccccchhc
Confidence 9999999999985 35689999999999999999999998 9999999999999999999999999998766
Q ss_pred cccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCCh
Q psy14889 292 SQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSF 371 (443)
Q Consensus 292 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~~ 371 (443)
...... .....|+..|+|||++.+. .++.++||||||+++|||++| ..||....+.
T Consensus 150 ~~~~~~----~~~~~~~~~y~~PE~~~~~------~~~~~~Di~s~G~il~~l~~g----------~~p~~~~~~~---- 205 (256)
T cd06612 150 TDTMAK----RNTVIGTPFWMAPEVIQEI------GYNNKADIWSLGITAIEMAEG----------KPPYSDIHPM---- 205 (256)
T ss_pred ccCccc----cccccCCccccCHHHHhcC------CCCchhhHHHHHHHHHHHHhC----------CCCCCCcchh----
Confidence 543211 1234578899999998776 667899999999999999999 5565543211
Q ss_pred HHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 372 DDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
........ ...+... .+...+..+.+++.+||+.||++|||+.|+++
T Consensus 206 ~~~~~~~~--~~~~~~~---~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 206 RAIFMIPN--KPPPTLS---DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred hhhhhhcc--CCCCCCC---chhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 11111100 0111111 12234567999999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >KOG0584|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=318.00 Aligned_cols=245 Identities=26% Similarity=0.433 Sum_probs=193.4
Q ss_pred ccccceeeeecCeEEEEEEE--CCceeEEEEe-----eccCccchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEE
Q psy14889 138 ISLSECIGKGRYGEVWRGVW--HGENVAVKIF-----FSRDEASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLW 210 (443)
Q Consensus 138 ~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~-----~~~~~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~ 210 (443)
..+..+||+|+|-+||+|.+ +|..||=-.+ ..........-.|+..++.|+|||||+++.++.+..+ ..+-
T Consensus 42 ~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n--~~in 119 (632)
T KOG0584|consen 42 LKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDN--KTIN 119 (632)
T ss_pred eehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCC--ceee
Confidence 35678999999999999988 4666652221 1112211222345666666999999999999998876 5688
Q ss_pred eeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCC-CcEEEEecCCc
Q psy14889 211 LVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTN-GTCVIADFGLA 288 (443)
Q Consensus 211 lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~-~~~kl~DfGla 288 (443)
+|+|.+..|+|..|+++ +.++.+.+..|++||++||.|||++ .|+|||||||.+||+|+.+ |.|||+|+|||
T Consensus 120 ~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~------~PPIIHRDLKCDNIFinG~~G~VKIGDLGLA 193 (632)
T KOG0584|consen 120 FITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQ------DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLA 193 (632)
T ss_pred eeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcC------CCCccccccccceEEEcCCcCceeecchhHH
Confidence 99999999999999976 6799999999999999999999998 8899999999999999766 79999999999
Q ss_pred ccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCC
Q psy14889 289 VSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMD 368 (443)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~ 368 (443)
........ ....|||.|||||++.. .|...+||||||+.|+||+|+ .+||.+-.
T Consensus 194 tl~r~s~a------ksvIGTPEFMAPEmYEE-------~YnE~VDVYaFGMCmLEMvT~----------eYPYsEC~--- 247 (632)
T KOG0584|consen 194 TLLRKSHA------KSVIGTPEFMAPEMYEE-------NYNELVDVYAFGMCMLEMVTS----------EYPYSECT--- 247 (632)
T ss_pred HHhhcccc------ceeccCccccChHHHhh-------hcchhhhhhhhhHHHHHHHhc----------cCChhhhC---
Confidence 87764332 23589999999999985 566899999999999999999 99998753
Q ss_pred CChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 369 PSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
....+.+.+........+... -..+++++|.+|+.. .++|||+.|+|+
T Consensus 248 -n~AQIYKKV~SGiKP~sl~kV-----~dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 248 -NPAQIYKKVTSGIKPAALSKV-----KDPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred -CHHHHHHHHHcCCCHHHhhcc-----CCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 334555555433322222211 135799999999999 999999999986
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=297.49 Aligned_cols=255 Identities=22% Similarity=0.300 Sum_probs=191.6
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc--chHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEe
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA--SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWL 211 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~--~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~l 211 (443)
++|...+.||.|++|.||++.. +++.+|+|.+...... ......|+..+..++||||+++++++..... ..+++
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~--~~~~l 78 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESS--SSIGI 78 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCC--CeEEE
Confidence 3678889999999999999998 5789999988654321 1222345566666999999999999865543 45799
Q ss_pred eecccCcccHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecC
Q psy14889 212 VTHYHSFGSLYDHLNR-----TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFG 286 (443)
Q Consensus 212 v~e~~~~gsL~~~l~~-----~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfG 286 (443)
||||+++++|.+++.. ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~--------~i~H~dl~~~nil~~~~~~~~l~dfg 150 (287)
T cd06621 79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR--------KIIHRDIKPSNILLTRKGQVKLCDFG 150 (287)
T ss_pred EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--------CcccCCCCHHHEEEecCCeEEEeecc
Confidence 9999999999988742 4588999999999999999999998 99999999999999999999999999
Q ss_pred CcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCC
Q psy14889 287 LAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVP 366 (443)
Q Consensus 287 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~ 366 (443)
++........ ....++..|+|||.+.+. .++.++||||||+++|||++| ..||.....
T Consensus 151 ~~~~~~~~~~------~~~~~~~~y~~pE~~~~~------~~~~~~Dv~slG~il~~l~~g----------~~p~~~~~~ 208 (287)
T cd06621 151 VSGELVNSLA------GTFTGTSFYMAPERIQGK------PYSITSDVWSLGLTLLEVAQN----------RFPFPPEGE 208 (287)
T ss_pred cccccccccc------ccccCCccccCHHHhcCC------CCCchhhHHHHHHHHHHHHhC----------CCCCCcccC
Confidence 9865432211 123577899999998765 667899999999999999999 555544311
Q ss_pred CCCChHHHHhhhhhcCCCCCCCCCCC-CchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 367 MDPSFDDMRKVICIDQQRPVLPNRWV-SDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
......+....+. ....+.++.... ....++.+.+++.+||+.||++|||+.|+++
T Consensus 209 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 209 PPLGPIELLSYIV-NMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred CCCChHHHHHHHh-cCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 1111122222221 112222221111 1224678999999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG1024|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=296.59 Aligned_cols=257 Identities=21% Similarity=0.316 Sum_probs=204.0
Q ss_pred ccccccceeeeecCeEEEEEEEC-------CceeEEEEeeccCccc--hHHHHHHHHHHhccCCCceeeeeeccccCCcc
Q psy14889 136 KQISLSECIGKGRYGEVWRGVWH-------GENVAVKIFFSRDEAS--WSRETEIYSTVLLRHENILGYIGSDMTSRNSC 206 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~~~--~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~ 206 (443)
.++++..++-+|.||.||+|.|. .+.|-||.++....+- ...-.|-+.+..+.|||+..+.+++.....
T Consensus 284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~-- 361 (563)
T KOG1024|consen 284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYA-- 361 (563)
T ss_pred hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccC--
Confidence 56888889999999999999773 2456777664433221 122345555555789999999999877543
Q ss_pred cEEEeeecccCcccHHHHhcc---------cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCC
Q psy14889 207 TQLWLVTHYHSFGSLYDHLNR---------TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTN 277 (443)
Q Consensus 207 ~~~~lv~e~~~~gsL~~~l~~---------~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~ 277 (443)
..++++.++..|+|..||.. +.++..+...++.|++.|++|||.+ ++||.||.++|++||+.
T Consensus 362 -~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~--------~ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 362 -TPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH--------GVIHKDIAARNCVIDDQ 432 (563)
T ss_pred -cceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc--------Ccccchhhhhcceehhh
Confidence 35888999999999999962 4578889999999999999999999 99999999999999999
Q ss_pred CcEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCccccc
Q psy14889 278 GTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEY 357 (443)
Q Consensus 278 ~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~ 357 (443)
.++||+|-.+++.+-.... ..-.........||+||.+... .|+.++|||||||+||||+|- +
T Consensus 433 LqVkltDsaLSRDLFP~DY--hcLGDnEnRPvkWMslEal~n~------~yssasDvWsfGVllWELmtl---------g 495 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDY--HCLGDNENRPVKWMSLEALQNS------HYSSASDVWSFGVLLWELMTL---------G 495 (563)
T ss_pred eeEEeccchhccccCcccc--cccCCCCCCcccccCHHHHhhh------hhcchhhhHHHHHHHHHHHhc---------C
Confidence 9999999999987654322 2222233455789999999987 788999999999999999985 3
Q ss_pred CCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhhc
Q psy14889 358 KAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLACA 431 (443)
Q Consensus 358 ~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~~ 431 (443)
+.||.+.. ..++...+ .++.+...| .+||+++..+|..||..+|++||++.|+...|.+...+
T Consensus 496 ~~PyaeID-----PfEm~~yl-kdGyRlaQP-----~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~q 558 (563)
T KOG1024|consen 496 KLPYAEID-----PFEMEHYL-KDGYRLAQP-----FNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQ 558 (563)
T ss_pred CCCccccC-----HHHHHHHH-hccceecCC-----CCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHH
Confidence 88998873 34555554 345555444 45999999999999999999999999999999988754
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=296.01 Aligned_cols=254 Identities=22% Similarity=0.357 Sum_probs=190.4
Q ss_pred ccccceeeeecCeEEEEEEE-----CCceeEEEEeeccCccc---hHHHHHHHHHHhccCCCceeeeeeccccCCc--cc
Q psy14889 138 ISLSECIGKGRYGEVWRGVW-----HGENVAVKIFFSRDEAS---WSRETEIYSTVLLRHENILGYIGSDMTSRNS--CT 207 (443)
Q Consensus 138 ~~~~~~lG~G~fg~Vy~~~~-----~~~~vAvK~~~~~~~~~---~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~--~~ 207 (443)
|.+.+.||+|+||.||+|.+ ++..||||++....... .....|+..+..++||||+++++++...... ..
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 56678999999999999986 25789999886543221 1223456666679999999999987654322 12
Q ss_pred EEEeeecccCcccHHHHhcc-------cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcE
Q psy14889 208 QLWLVTHYHSFGSLYDHLNR-------TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTC 280 (443)
Q Consensus 208 ~~~lv~e~~~~gsL~~~l~~-------~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~ 280 (443)
..++++||+.+|+|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~--------~i~H~dikp~nili~~~~~~ 152 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK--------NFIHRDLAARNCMLNENMTV 152 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CEeecccchhhEEEcCCCCE
Confidence 35789999999999988732 2478899999999999999999998 99999999999999999999
Q ss_pred EEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh-cccCCCcccccCC
Q psy14889 281 VIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR-RTKANGIFEEYKA 359 (443)
Q Consensus 281 kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt-g~~~~~~~~~~~~ 359 (443)
||+|||+++......... ......++..|++||.+... .++.++||||||+++|||++ | ..
T Consensus 153 kl~dfg~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~------~~~~~sDi~slG~il~el~~~g----------~~ 214 (273)
T cd05074 153 CVADFGLSKKIYSGDYYR--QGCASKLPVKWLALESLADN------VYTTHSDVWAFGVTMWEIMTRG----------QT 214 (273)
T ss_pred EECcccccccccCCccee--cCCCccCchhhcCHhHHhcC------ccchhhhhHHHHHHHHHHhhCC----------CC
Confidence 999999997654322111 11223456789999998766 56689999999999999999 5 55
Q ss_pred CCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHH
Q psy14889 360 PYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKL 428 (443)
Q Consensus 360 P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l 428 (443)
||... ........+.. ......+ ...+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus 215 p~~~~-----~~~~~~~~~~~-~~~~~~~-----~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 215 PYAGV-----ENSEIYNYLIK-GNRLKQP-----PDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CCCCC-----CHHHHHHHHHc-CCcCCCC-----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 66543 11222222211 1111111 23556899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=300.14 Aligned_cols=236 Identities=17% Similarity=0.273 Sum_probs=175.4
Q ss_pred eeeeecCeEEEEEEEC--------------------------CceeEEEEeeccCccc-hHHHHHHHHHHhccCCCceee
Q psy14889 143 CIGKGRYGEVWRGVWH--------------------------GENVAVKIFFSRDEAS-WSRETEIYSTVLLRHENILGY 195 (443)
Q Consensus 143 ~lG~G~fg~Vy~~~~~--------------------------~~~vAvK~~~~~~~~~-~~~e~ei~~~~~l~H~nIv~l 195 (443)
.||+|+||.||+|.+. ...||+|++....... .....++..+..++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 5899999999999751 1348888875433221 111223344455899999999
Q ss_pred eeeccccCCcccEEEeeecccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEE
Q psy14889 196 IGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNIL 273 (443)
Q Consensus 196 ~g~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiL 273 (443)
++++.... ..++||||+++|+|..++.+ ..+++.+++.++.||++||+|||+. +|+||||||+|||
T Consensus 82 ~~~~~~~~----~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--------~iiH~dlkp~Nil 149 (274)
T cd05076 82 HGVCVRGS----ENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDK--------NLVHGNVCAKNIL 149 (274)
T ss_pred EEEEEeCC----ceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcC--------CccCCCCCcccEE
Confidence 99987763 46899999999999999854 5689999999999999999999988 9999999999999
Q ss_pred EcCCC-------cEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHH-
Q psy14889 274 VKTNG-------TCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVC- 345 (443)
Q Consensus 274 l~~~~-------~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ell- 345 (443)
++..+ .+|++|||++...... ....++..|+|||.+.+.. .++.++||||||+++|||+
T Consensus 150 l~~~~~~~~~~~~~kl~d~g~~~~~~~~--------~~~~~~~~~~aPe~~~~~~-----~~~~~~Dv~slG~~l~el~~ 216 (274)
T cd05076 150 LARLGLAEGTSPFIKLSDPGVSFTALSR--------EERVERIPWIAPECVPGGN-----SLSTAADKWSFGTTLLEICF 216 (274)
T ss_pred EeccCcccCccceeeecCCccccccccc--------cccccCCcccCchhhcCCC-----CCCcHHHHHHHHHHHHHHHh
Confidence 97654 4899999987543221 1235778899999886531 5668999999999999995
Q ss_pred hcccCCCcccccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHH
Q psy14889 346 RRTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTL 425 (443)
Q Consensus 346 tg~~~~~~~~~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 425 (443)
+| ..||....+ ........ .....+. .....+.+++.+||+.+|++|||+.+|++.|
T Consensus 217 ~g----------~~p~~~~~~-----~~~~~~~~---~~~~~~~-----~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 217 DG----------EVPLKERTP-----SEKERFYE---KKHRLPE-----PSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred CC----------CCCccccCh-----HHHHHHHH---hccCCCC-----CCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 56 667655321 11112211 1112221 1234689999999999999999999999887
Q ss_pred H
Q psy14889 426 I 426 (443)
Q Consensus 426 ~ 426 (443)
+
T Consensus 274 ~ 274 (274)
T cd05076 274 T 274 (274)
T ss_pred C
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=302.40 Aligned_cols=247 Identities=24% Similarity=0.391 Sum_probs=191.4
Q ss_pred cccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc-chHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEeee
Q psy14889 137 QISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA-SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVT 213 (443)
Q Consensus 137 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~-~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv~ 213 (443)
.|.....||+|+||.||++.. +++.||+|.+...... ......|+..+..++||||+++++++... ...++|+
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~----~~~~iv~ 97 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVG----EELWVLM 97 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeC----CeEEEEE
Confidence 344556799999999999987 5889999988543322 22234566666669999999999998766 4579999
Q ss_pred cccCcccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcccccc
Q psy14889 214 HYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQ 293 (443)
Q Consensus 214 e~~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~~~ 293 (443)
||+++++|..++....+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++..+..
T Consensus 98 e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~--------~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~ 169 (297)
T cd06659 98 EFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQ--------GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISK 169 (297)
T ss_pred ecCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhC--------CeecCCCCHHHeEEccCCcEEEeechhHhhccc
Confidence 999999999999888899999999999999999999998 999999999999999999999999999865543
Q ss_pred cCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCChHH
Q psy14889 294 LSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFDD 373 (443)
Q Consensus 294 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~~~~ 373 (443)
.... .....|+..|+|||++.+. .++.++||||||+++|||++| ..||.... ....
T Consensus 170 ~~~~----~~~~~~~~~y~aPE~~~~~------~~~~~~Dv~slG~il~el~~g----------~~p~~~~~----~~~~ 225 (297)
T cd06659 170 DVPK----RKSLVGTPYWMAPEVISRT------PYGTEVDIWSLGIMVIEMVDG----------EPPYFSDS----PVQA 225 (297)
T ss_pred cccc----ccceecCccccCHHHHccC------CCCchhhHHHHHHHHHHHHhC----------CCCCCCCC----HHHH
Confidence 2211 1234688999999999765 567899999999999999999 66665421 1122
Q ss_pred HHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHH
Q psy14889 374 MRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKT 424 (443)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 424 (443)
+... . ...+.... .....+..+.+++.+||+.+|++||++.++++.
T Consensus 226 ~~~~-~--~~~~~~~~--~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 226 MKRL-R--DSPPPKLK--NAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred HHHH-h--ccCCCCcc--ccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 2211 1 11111111 112345679999999999999999999999884
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=292.88 Aligned_cols=247 Identities=26% Similarity=0.435 Sum_probs=190.8
Q ss_pred ccccceeeeecCeEEEEEEECC------ceeEEEEeeccCcc--chHHHHHHHHHHhccCCCceeeeeeccccCCcccEE
Q psy14889 138 ISLSECIGKGRYGEVWRGVWHG------ENVAVKIFFSRDEA--SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQL 209 (443)
Q Consensus 138 ~~~~~~lG~G~fg~Vy~~~~~~------~~vAvK~~~~~~~~--~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~ 209 (443)
+++.+.||.|+||.||++.+.. ..||+|.+...... ......|+..+..++|+||+++++++.+. ...
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----~~~ 76 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEE----EPL 76 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCC----Cee
Confidence 4567899999999999999843 78999988654332 22334455566668999999999998876 357
Q ss_pred EeeecccCcccHHHHhcccC---CCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecC
Q psy14889 210 WLVTHYHSFGSLYDHLNRTT---LNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFG 286 (443)
Q Consensus 210 ~lv~e~~~~gsL~~~l~~~~---l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfG 286 (443)
+++|||+++++|.+++.... +++..+..++.|++.||+|||+. +++|+||||+||++++++.++|+|||
T Consensus 77 ~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~--------~~~h~dl~~~nil~~~~~~~~l~dfg 148 (258)
T smart00219 77 MIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK--------NFIHRDLAARNCLVGENLVVKISDFG 148 (258)
T ss_pred EEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcC--------CeeecccccceEEEccCCeEEEcccC
Confidence 99999999999999996532 99999999999999999999998 99999999999999999999999999
Q ss_pred CcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCC
Q psy14889 287 LAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVP 366 (443)
Q Consensus 287 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~ 366 (443)
++.......... .....++..|+|||.+.+. .++.++||||||+++|||+++. ..||...
T Consensus 149 ~~~~~~~~~~~~---~~~~~~~~~y~~Pe~~~~~------~~~~~~Di~slG~i~~~l~~~g---------~~p~~~~-- 208 (258)
T smart00219 149 LSRDLYDDDYYK---KKGGKLPIRWMAPESLKDG------KFTSKSDVWSFGVLLWEIFTLG---------ESPYPGM-- 208 (258)
T ss_pred Cceecccccccc---cccCCCcccccChHHhccC------CCCcchhHHHHHHHHHHHHhCC---------CCCCCCC--
Confidence 997665432111 1122367899999998654 5678999999999999999831 5566542
Q ss_pred CCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHH
Q psy14889 367 MDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTL 425 (443)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 425 (443)
....+...+... ..+..+ ...+.++.+++.+||..||++|||+.++++.|
T Consensus 209 ---~~~~~~~~~~~~-~~~~~~-----~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 209 ---SNEEVLEYLKKG-YRLPKP-----ENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ---CHHHHHHHHhcC-CCCCCC-----CcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 222332222221 222222 23667899999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=294.41 Aligned_cols=249 Identities=29% Similarity=0.415 Sum_probs=187.3
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc-chHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEee
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA-SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLV 212 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~-~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv 212 (443)
+++.....||+|+||.||+|.+ ++..||+|.+...... ......|+..+..++|+||+++++++... ...++|
T Consensus 8 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----~~~~lv 83 (268)
T cd06624 8 DENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSEN----GFFKIF 83 (268)
T ss_pred ccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccC----CEEEEE
Confidence 4455567899999999999987 4678999987654332 22334556666669999999999998776 457999
Q ss_pred ecccCcccHHHHhcc--cCC--CHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcC-CCcEEEEecCC
Q psy14889 213 THYHSFGSLYDHLNR--TTL--NHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKT-NGTCVIADFGL 287 (443)
Q Consensus 213 ~e~~~~gsL~~~l~~--~~l--~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~-~~~~kl~DfGl 287 (443)
+||+++++|.+++.. ..+ ++..+..++.||+.||+|||+. +|+||||||+||+++. ++.+||+|||+
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~--------~i~h~dl~p~nil~~~~~~~~~l~dfg~ 155 (268)
T cd06624 84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN--------QIVHRDIKGDNVLVNTYSGVVKISDFGT 155 (268)
T ss_pred EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHC--------CEeecCCCHHHEEEcCCCCeEEEecchh
Confidence 999999999999965 345 7888999999999999999998 9999999999999976 67999999999
Q ss_pred cccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCC
Q psy14889 288 AVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPM 367 (443)
Q Consensus 288 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~ 367 (443)
+........ ......|+..|+|||++..... .++.++||||||+++|||++| ..||.....
T Consensus 156 ~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~----~~~~~~Dv~slGvvl~~l~~g----------~~p~~~~~~- 216 (268)
T cd06624 156 SKRLAGINP----CTETFTGTLQYMAPEVIDKGPR----GYGAPADIWSLGCTIVEMATG----------KPPFIELGE- 216 (268)
T ss_pred heecccCCC----ccccCCCCccccChhhhccccc----cCCchhhhHHHHHHHHHHHhC----------CCCCccccC-
Confidence 875543211 1123457889999999865421 356899999999999999999 566654311
Q ss_pred CCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 368 DPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
........ ......+.++ ...+.++.+++.+||+.+|++|||+.++++
T Consensus 217 --~~~~~~~~-~~~~~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 217 --PQAAMFKV-GMFKIHPEIP-----ESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred --hhhhHhhh-hhhccCCCCC-----cccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 11111111 1111222233 335678999999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=299.15 Aligned_cols=252 Identities=23% Similarity=0.306 Sum_probs=185.3
Q ss_pred cccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc---chHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEe
Q psy14889 137 QISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA---SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWL 211 (443)
Q Consensus 137 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~---~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~l 211 (443)
+|++.+.||+|+||.||+|.. +|+.||+|.+...... ......|+..+..++||||+++++++.+. ..+++
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~----~~~~l 76 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSD----KKLTL 76 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccC----CceEE
Confidence 478889999999999999998 6889999988643221 12233466666669999999999998766 45799
Q ss_pred eecccCcccHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcc
Q psy14889 212 VTHYHSFGSLYDHLN--RTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAV 289 (443)
Q Consensus 212 v~e~~~~gsL~~~l~--~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~ 289 (443)
|+||+. ++|.+++. ...+++..+..++.||+.||.|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 77 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~--------~i~H~dl~~~nil~~~~~~~~l~dfg~~~ 147 (284)
T cd07839 77 VFEYCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSH--------NVLHRDLKPQNLLINKNGELKLADFGLAR 147 (284)
T ss_pred EEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--------CEecCCCCHHHEEEcCCCcEEECccchhh
Confidence 999997 58888775 35689999999999999999999998 99999999999999999999999999997
Q ss_pred cccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCC
Q psy14889 290 SYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDP 369 (443)
Q Consensus 290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~ 369 (443)
........ .....++..|+|||.+.+.. .++.++|||||||++|||+|| ..|+.....
T Consensus 148 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~-----~~~~~~DiwslG~il~~l~tg----------~~p~~~~~~--- 205 (284)
T cd07839 148 AFGIPVRC----YSAEVVTLWYRPPDVLFGAK-----LYSTSIDMWSAGCIFAELANA----------GRPLFPGND--- 205 (284)
T ss_pred ccCCCCCC----cCCCccccCCcChHHHhCCc-----ccCcHHHHHHHHHHHHHHHhc----------CCCCcCCCC---
Confidence 65432211 12346788999999987642 356799999999999999999 444322110
Q ss_pred ChHHHHhhhhh--------------c---CCCCCCCCCC----CCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 370 SFDDMRKVICI--------------D---QQRPVLPNRW----VSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 370 ~~~~~~~~~~~--------------~---~~~~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
..+........ . ...+..+... .....+.++.+++++||+.||.+|||+.++++
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 206 VDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred HHHHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 11111111000 0 0000000000 01124567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=302.59 Aligned_cols=252 Identities=22% Similarity=0.284 Sum_probs=187.4
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc--chHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEe
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA--SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWL 211 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~--~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~l 211 (443)
++|.+.+.||+|+||.||+|.. +++.||+|.+...... ......|+..+..++||||+++++++... ..+++
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~----~~~~l 81 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTE----KSLTL 81 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecC----CeEEE
Confidence 5799999999999999999987 5789999988643322 22233566666679999999999998766 45799
Q ss_pred eecccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcc
Q psy14889 212 VTHYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAV 289 (443)
Q Consensus 212 v~e~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~ 289 (443)
||||++ ++|.+++.. ..+++..+..++.|++.||.|||+. +|+|+||||+|||+++++.+||+|||++.
T Consensus 82 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~--------~i~H~dlkp~Nil~~~~~~~kl~dfg~~~ 152 (301)
T cd07873 82 VFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRR--------KVLHRDLKPQNLLINERGELKLADFGLAR 152 (301)
T ss_pred EEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC--------CeeCCCCCHHHEEECCCCcEEECcCcchh
Confidence 999997 599988864 4688999999999999999999998 99999999999999999999999999986
Q ss_pred cccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCC
Q psy14889 290 SYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDP 369 (443)
Q Consensus 290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~ 369 (443)
........ .....++..|+|||.+.+.. .++.++|||||||++|||+||+ .||.....
T Consensus 153 ~~~~~~~~----~~~~~~~~~y~~PE~~~~~~-----~~~~~~Dv~slG~~l~el~tg~----------~~f~~~~~--- 210 (301)
T cd07873 153 AKSIPTKT----YSNEVVTLWYRPPDILLGST-----DYSTQIDMWGVGCIFYEMSTGR----------PLFPGSTV--- 210 (301)
T ss_pred ccCCCCCc----ccccceeecccCcHHHhCCC-----CCccHHHHHHHHHHHHHHHhCC----------CCCCCCCH---
Confidence 54322111 12345788999999986542 4567999999999999999994 44443210
Q ss_pred ChHHHHhhhh---------------hc-CCCCCCCCC------CCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 370 SFDDMRKVIC---------------ID-QQRPVLPNR------WVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 370 ~~~~~~~~~~---------------~~-~~~~~~~~~------~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
.+....... .. ......+.. ......++.+.+|+.+||+.||.+|||+.|+++
T Consensus 211 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 211 -EEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred -HHHHHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 011100000 00 000001100 001234567899999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=291.59 Aligned_cols=244 Identities=25% Similarity=0.395 Sum_probs=188.5
Q ss_pred ceeeeecCeEEEEEEEC-CceeEEEEeeccCcc--chHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEeeecccCc
Q psy14889 142 ECIGKGRYGEVWRGVWH-GENVAVKIFFSRDEA--SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVTHYHSF 218 (443)
Q Consensus 142 ~~lG~G~fg~Vy~~~~~-~~~vAvK~~~~~~~~--~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e~~~~ 218 (443)
++||+|+||.||++... ++.||+|.+...... ......|+..+..++|+||+++++++.... ..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~~~v~e~~~~ 76 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQ----PIYIVMELVPG 76 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCC----CeEEEEEcCCC
Confidence 46899999999999984 899999987654332 223345566666699999999999987663 47999999999
Q ss_pred ccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcccccccCC
Q psy14889 219 GSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSN 296 (443)
Q Consensus 219 gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~~~~~~ 296 (443)
++|.+++.+ ..+++..++.++.+++.||.|||++ +++||||||+|||++.++.+||+|||++........
T Consensus 77 ~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~--------~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 148 (251)
T cd05041 77 GSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESK--------NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIY 148 (251)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC--------CEehhhcCcceEEEcCCCcEEEeeccccccccCCcc
Confidence 999999854 4588999999999999999999998 999999999999999999999999999876542211
Q ss_pred cCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh-cccCCCcccccCCCCCCCCCCCCChHHHH
Q psy14889 297 KMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR-RTKANGIFEEYKAPYHDLVPMDPSFDDMR 375 (443)
Q Consensus 297 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt-g~~~~~~~~~~~~P~~~~~~~~~~~~~~~ 375 (443)
.. ......++..|+|||.+.++ .++.++||||||+++|||+| | ..||.... .....
T Consensus 149 ~~--~~~~~~~~~~y~~PE~~~~~------~~~~~~Di~slG~i~~~l~t~~----------~~p~~~~~-----~~~~~ 205 (251)
T cd05041 149 TV--SDGLKQIPIKWTAPEALNYG------RYTSESDVWSYGILLWETFSLG----------DTPYPGMS-----NQQTR 205 (251)
T ss_pred ee--ccccCcceeccCChHhhccC------CCCcchhHHHHHHHHHHHHhcc----------CCCCccCC-----HHHHH
Confidence 11 11122345679999998766 56789999999999999999 5 56775542 12222
Q ss_pred hhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHH
Q psy14889 376 KVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLI 426 (443)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 426 (443)
..+.. ......+ ...+.++.+++.+||+.+|++|||+.|+++.|+
T Consensus 206 ~~~~~-~~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 206 ERIES-GYRMPAP-----QLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred HHHhc-CCCCCCC-----ccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 22221 1122222 345678999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=293.05 Aligned_cols=254 Identities=27% Similarity=0.443 Sum_probs=195.2
Q ss_pred cccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc---chHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEe
Q psy14889 137 QISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA---SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWL 211 (443)
Q Consensus 137 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~---~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~l 211 (443)
+|+..+.||+|+||.||+|.. +++.||+|.+...... ......|+..+..++|+||+++++.+... ..+++
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~----~~~~l 76 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHR----EKVYI 76 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecC----CEEEE
Confidence 478889999999999999987 5789999998655432 22234566666679999999999987665 45799
Q ss_pred eecccCcccHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCccc
Q psy14889 212 VTHYHSFGSLYDHLNRT-TLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVS 290 (443)
Q Consensus 212 v~e~~~~gsL~~~l~~~-~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~ 290 (443)
|+||+++++|.+++... .+++..+..++.|++.||.|||+. +++|+||+|+||++++++.+||+|||++..
T Consensus 77 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~--------~i~H~dl~~~nil~~~~~~~kl~d~g~~~~ 148 (264)
T cd06626 77 FMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSH--------GIVHRDIKPANIFLDHNGVIKLGDFGCAVK 148 (264)
T ss_pred EEecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHC--------CcccCCCCHHHEEECCCCCEEEcccccccc
Confidence 99999999999999764 588999999999999999999998 999999999999999999999999999877
Q ss_pred ccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCC
Q psy14889 291 YSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPS 370 (443)
Q Consensus 291 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~ 370 (443)
................++..|+|||++.+... ...+.++||||||+++||+++| ..||.... ..
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~---~~~~~~~Dv~s~G~il~~l~~g----------~~pf~~~~---~~ 212 (264)
T cd06626 149 LKNNTTTMGEEVQSLAGTPAYMAPEVITGGKG---KGHGRAADIWSLGCVVLEMATG----------KRPWSELD---NE 212 (264)
T ss_pred cCCCCCcccccccCCcCCcCccChhhccCCCC---CCCCcccchHHHHHHHHHHHhC----------CCCccCCc---ch
Confidence 65433222111123467889999999876521 1366899999999999999999 66775431 11
Q ss_pred hHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 371 FDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
.. ....+.. ...+.+|.. ...+..+.+++.+||+.||++|||+.+++.
T Consensus 213 ~~-~~~~~~~-~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 213 FQ-IMFHVGA-GHKPPIPDS---LQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred HH-HHHHHhc-CCCCCCCcc---cccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 11 1111111 233334421 224667899999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=303.98 Aligned_cols=193 Identities=26% Similarity=0.387 Sum_probs=150.7
Q ss_pred cceeeeecCeEEEEEEEC----CceeEEEEeeccCccchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEeeeccc
Q psy14889 141 SECIGKGRYGEVWRGVWH----GENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVTHYH 216 (443)
Q Consensus 141 ~~~lG~G~fg~Vy~~~~~----~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e~~ 216 (443)
..+||+|+||.||+|... +..||+|.+..... ......|+..+..++||||+++++++..... ..+++|+||+
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~--~~~~lv~e~~ 82 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-SMSACREIALLRELKHPNVIALQKVFLSHSD--RKVWLLFDYA 82 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-cHHHHHHHHHHHhCCCCCeeeEEEEEeccCC--CeEEEEEeee
Confidence 357999999999999862 46899998764432 2223345555666999999999999865433 4579999998
Q ss_pred CcccHHHHhcc----------cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEE----cCCCcEEE
Q psy14889 217 SFGSLYDHLNR----------TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILV----KTNGTCVI 282 (443)
Q Consensus 217 ~~gsL~~~l~~----------~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl----~~~~~~kl 282 (443)
.+ +|.+++.. ..+++..+..++.||+.||.|||+. +|+||||||+|||+ +.++.+||
T Consensus 83 ~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~--------~ivH~Dlkp~Nil~~~~~~~~~~~kl 153 (317)
T cd07867 83 EH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN--------WVLHRDLKPANILVMGEGPERGRVKI 153 (317)
T ss_pred CC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC--------CEEcCCCCHHHEEEccCCCCCCcEEE
Confidence 75 88777631 2488899999999999999999998 99999999999999 56679999
Q ss_pred EecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCC
Q psy14889 283 ADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKAN 351 (443)
Q Consensus 283 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~ 351 (443)
+|||+++......... .......||+.|+|||++.+.. .++.++|||||||++|||+||++++
T Consensus 154 ~DfG~a~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~-----~~~~~~DiwSlG~il~el~tg~~~f 216 (317)
T cd07867 154 ADMGFARLFNSPLKPL-ADLDPVVVTFWYRAPELLLGAR-----HYTKAIDIWAIGCIFAELLTSEPIF 216 (317)
T ss_pred eeccceeccCCCcccc-cccCcceecccccCcHHhcCCC-----ccCcHHHHHhHHHHHHHHHhCCCCc
Confidence 9999998765432211 1123457899999999987642 4568999999999999999996554
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=300.31 Aligned_cols=251 Identities=23% Similarity=0.344 Sum_probs=192.8
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc--chHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEe
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA--SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWL 211 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~--~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~l 211 (443)
++|++.+.||+|+||+||++.. +|+.||+|++...... ......|+..+..++||||+++++++... ..+++
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~----~~~~l 80 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNE----NNICM 80 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecC----CEEEE
Confidence 5788999999999999999998 4889999987644322 12223455556668999999999998876 45899
Q ss_pred eecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCccc
Q psy14889 212 VTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVS 290 (443)
Q Consensus 212 v~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~ 290 (443)
||||+++|+|.+++.+ +.+++..+..++.+++.||.|||+.. +++||||||+||++++++.++|+|||++..
T Consensus 81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~-------~i~H~dl~p~nil~~~~~~~~l~d~gl~~~ 153 (284)
T cd06620 81 CMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVH-------RIMHRDIKPSNILVNSRGQIKLCDFGVSGE 153 (284)
T ss_pred EEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhc-------CeeccCCCHHHEEECCCCcEEEccCCcccc
Confidence 9999999999998865 56899999999999999999999742 899999999999999999999999999865
Q ss_pred ccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCC--
Q psy14889 291 YSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMD-- 368 (443)
Q Consensus 291 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~-- 368 (443)
..... .....|+..|+|||++.+. .++.++|||||||++||++|| ..||.......
T Consensus 154 ~~~~~------~~~~~~~~~~~aPE~~~~~------~~~~~~Di~slG~~l~~l~tg----------~~p~~~~~~~~~~ 211 (284)
T cd06620 154 LINSI------ADTFVGTSTYMSPERIQGG------KYTVKSDVWSLGISIIELALG----------KFPFAFSNIDDDG 211 (284)
T ss_pred hhhhc------cCccccCcccCCHHHHccC------CCCccchHHHHHHHHHHHHhC----------CCCCcccchhhhh
Confidence 43211 1234689999999998765 566899999999999999999 55655432110
Q ss_pred -CC----hHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHH
Q psy14889 369 -PS----FDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTL 425 (443)
Q Consensus 369 -~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 425 (443)
.. .+...... ....+.++ ...++..+.+|+.+||+.||++|||+.|+++..
T Consensus 212 ~~~~~~~~~~~~~~~--~~~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 212 QDDPMGILDLLQQIV--QEPPPRLP----SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred hhhhhHHHHHHHHHh--hccCCCCC----chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 00 01111111 11122222 123567899999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=300.07 Aligned_cols=253 Identities=23% Similarity=0.304 Sum_probs=184.8
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc--chHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEe
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA--SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWL 211 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~--~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~l 211 (443)
++|.+.+.||+|+||.||+|.. +|..||+|++...... ......|+..+..++|+||+++++++... ...++
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~----~~~~l 80 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTK----ETLTF 80 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecC----CeEEE
Confidence 6899999999999999999987 5889999988654322 22334556666669999999999998765 35799
Q ss_pred eecccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcc
Q psy14889 212 VTHYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAV 289 (443)
Q Consensus 212 v~e~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~ 289 (443)
|+||+. ++|.+++.. ..+++..+..++.|++.||.|||+. +|+|+||||+|||++.++.+||+|||+++
T Consensus 81 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~--------~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~ 151 (291)
T cd07870 81 VFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQ--------HILHRDLKPQNLLISYLGELKLADFGLAR 151 (291)
T ss_pred EEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CcccCCCChHHEEEcCCCcEEEecccccc
Confidence 999996 678777643 4578899999999999999999998 99999999999999999999999999987
Q ss_pred cccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCC
Q psy14889 290 SYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDP 369 (443)
Q Consensus 290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~ 369 (443)
........ .....++..|+|||.+.+.. .++.++||||||+++|||++| ..||.....
T Consensus 152 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~-----~~~~~~Dv~slG~~l~~l~~g----------~~~f~~~~~--- 209 (291)
T cd07870 152 AKSIPSQT----YSSEVVTLWYRPPDVLLGAT-----DYSSALDIWGAGCIFIEMLQG----------QPAFPGVSD--- 209 (291)
T ss_pred ccCCCCCC----CCCccccccccCCceeecCC-----CCCcHHHHHHHHHHHHHHHhC----------CCCCCCchh---
Confidence 54322111 12345788999999987541 355789999999999999999 445543211
Q ss_pred ChHHHHhhhhh------------------------cCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 370 SFDDMRKVICI------------------------DQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 370 ~~~~~~~~~~~------------------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
..+.+...... ..........+.....+..+.+++.+|+..||++|||+.|++.
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 210 VFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred HHHHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 00111111000 0000000000111112457899999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=296.97 Aligned_cols=249 Identities=23% Similarity=0.424 Sum_probs=188.4
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc----chHHHHHHHHHHhccCCCceeeeeeccccCCcccEE
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA----SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQL 209 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~----~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~ 209 (443)
++|++.+.||+|+||.||++.. +|+.||+|++...... ....|.++ .++.++||||+++++++... ...
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~-~~~~~~~~~iv~~~~~~~~~----~~~ 75 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDI-SMRSVDCPYTVTFYGALFRE----GDV 75 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHH-HHHHcCCCCeeeeeEEEecC----CcE
Confidence 3688899999999999999998 5899999988654321 12223232 23347999999999998765 347
Q ss_pred EeeecccCcccHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEe
Q psy14889 210 WLVTHYHSFGSLYDHLNR-----TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIAD 284 (443)
Q Consensus 210 ~lv~e~~~~gsL~~~l~~-----~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~D 284 (443)
+++|||++ |+|.+++.. ..+++..+..++.||+.||+|||++. +++||||||+||+++.++.+||+|
T Consensus 76 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~-------~i~h~dlkp~nil~~~~~~~kl~d 147 (283)
T cd06617 76 WICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL-------SVIHRDVKPSNVLINRNGQVKLCD 147 (283)
T ss_pred EEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC-------CeecCCCCHHHEEECCCCCEEEee
Confidence 99999997 688887743 36899999999999999999999752 899999999999999999999999
Q ss_pred cCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCC
Q psy14889 285 FGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDL 364 (443)
Q Consensus 285 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~ 364 (443)
||++..+..... .+...|+..|+|||.+.+..... .++.++|+||||+++|||++| ..||...
T Consensus 148 fg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~--~~~~~~Di~slG~~l~~l~~g----------~~p~~~~ 210 (283)
T cd06617 148 FGISGYLVDSVA-----KTIDAGCKPYMAPERINPELNQK--GYDVKSDVWSLGITMIELATG----------RFPYDSW 210 (283)
T ss_pred cccccccccccc-----cccccCCccccChhhcCCccccc--ccCccccchhhHHHHHHHHhC----------CCCCCcc
Confidence 999876543211 12346888999999987542211 566899999999999999999 6676542
Q ss_pred CCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 365 VPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
. ...+.+.... ....+.++. ...+.++.+++.+||..+|++|||+.++++
T Consensus 211 ~---~~~~~~~~~~--~~~~~~~~~----~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 211 K---TPFQQLKQVV--EEPSPQLPA----EKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred c---cCHHHHHHHH--hcCCCCCCc----cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1 1223333322 122233332 235678999999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=301.79 Aligned_cols=252 Identities=23% Similarity=0.315 Sum_probs=188.0
Q ss_pred cccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc------chHHHHHHHHHHhccCCCceeeeeeccccCCcccE
Q psy14889 137 QISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA------SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQ 208 (443)
Q Consensus 137 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~------~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~ 208 (443)
+|++.+.||+|+||.||+|.. +|+.||||.+...... ......|+..+..++|+||+++++++.+. ..
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~----~~ 76 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHK----SN 76 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecC----CE
Confidence 477889999999999999997 5789999988654322 12223456666669999999999998774 45
Q ss_pred EEeeecccCcccHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecC
Q psy14889 209 LWLVTHYHSFGSLYDHLNRT--TLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFG 286 (443)
Q Consensus 209 ~~lv~e~~~~gsL~~~l~~~--~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfG 286 (443)
.++||||+ +|+|.+++... .+++..+..++.||++||.|||+. +|+|+||||+||+++.++.+||+|||
T Consensus 77 ~~lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~--------~i~H~dl~p~nill~~~~~~~l~dfg 147 (298)
T cd07841 77 INLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSN--------WILHRDLKPNNLLIASDGVLKLADFG 147 (298)
T ss_pred EEEEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC--------CeeecCCChhhEEEcCCCCEEEccce
Confidence 89999999 89999999764 599999999999999999999998 99999999999999999999999999
Q ss_pred CcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCC
Q psy14889 287 LAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVP 366 (443)
Q Consensus 287 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~ 366 (443)
+++........ .....++..|+|||.+.+.. .++.++|||||||++|||++|. .||....
T Consensus 148 ~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~-----~~~~~~Dv~slG~il~e~~~g~----------~~~~~~~- 207 (298)
T cd07841 148 LARSFGSPNRK----MTHQVVTRWYRAPELLFGAR-----HYGVGVDMWSVGCIFAELLLRV----------PFLPGDS- 207 (298)
T ss_pred eeeeccCCCcc----ccccccceeeeCHHHHhCCC-----CCCcHHHHHHHHHHHHHHHcCC----------ccccCCc-
Confidence 99766543211 12335678899999885431 4567999999999999999993 3333211
Q ss_pred CCCChHHHHhhhhh--------------------cCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHH
Q psy14889 367 MDPSFDDMRKVICI--------------------DQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKT 424 (443)
Q Consensus 367 ~~~~~~~~~~~~~~--------------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 424 (443)
..+...+.... ....+..+........+..+.+++.+||+.||++|||+.|+++.
T Consensus 208 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 208 ---DIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred ---cHHHHHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 11111111100 00000011000112345779999999999999999999999883
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=293.83 Aligned_cols=255 Identities=27% Similarity=0.389 Sum_probs=194.9
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc--chHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEe
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA--SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWL 211 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~--~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~l 211 (443)
++|++.+.||.|+||.||+|.. ++..+|+|++...... ......|+..+..++|+||+++++.+... ...++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----~~~~i 76 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVG----DELWL 76 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeC----CEEEE
Confidence 4688999999999999999987 5789999988643322 12234555556669999999999988765 45799
Q ss_pred eecccCcccHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCC
Q psy14889 212 VTHYHSFGSLYDHLNR----TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGL 287 (443)
Q Consensus 212 v~e~~~~gsL~~~l~~----~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGl 287 (443)
|+||+++++|.+++.. ..+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||+
T Consensus 77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~--------~i~h~~l~p~ni~~~~~~~~~l~df~~ 148 (267)
T cd06610 77 VMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN--------GQIHRDIKAGNILLGEDGSVKIADFGV 148 (267)
T ss_pred EEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC--------CeecCCCCHHhEEEcCCCCEEEcccch
Confidence 9999999999999864 3589999999999999999999998 999999999999999999999999999
Q ss_pred cccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCC
Q psy14889 288 AVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPM 367 (443)
Q Consensus 288 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~ 367 (443)
+..+...............|+..|+|||.+.... ..+.++|+||||+++|||++| ..||.....
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~-----~~~~~~Dv~slG~i~~~l~~g----------~~p~~~~~~- 212 (267)
T cd06610 149 SASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVH-----GYDFKADIWSFGITAIELATG----------AAPYSKYPP- 212 (267)
T ss_pred HHHhccCccccccccccccCChhhcChHHHcccc-----CcCcccchHhHhHHHHHHHhC----------CCCccccCh-
Confidence 8766543322111223446889999999987641 456799999999999999999 667655322
Q ss_pred CCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 368 DPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
.....+.... ..+..+........+..+.+++.+||+.||++|||+.++++
T Consensus 213 ---~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 213 ---MKVLMLTLQN--DPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred ---hhhHHHHhcC--CCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 1122222211 11222211111245678999999999999999999999876
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=292.21 Aligned_cols=244 Identities=25% Similarity=0.398 Sum_probs=191.8
Q ss_pred cccccceeeeecCeEEEEEEE--CCceeEEEEeeccC---ccchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEe
Q psy14889 137 QISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRD---EASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWL 211 (443)
Q Consensus 137 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~---~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~l 211 (443)
+|++.+.||+|+||.||++.. +|+.||+|.+.... ......+.|+..++.++||||+++++++... ...++
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----~~~~l 76 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEEN----GNLYI 76 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCC----CeEEE
Confidence 478899999999999999987 68899999886432 1222335566677779999999999998765 46899
Q ss_pred eecccCcccHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCc
Q psy14889 212 VTHYHSFGSLYDHLNR---TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA 288 (443)
Q Consensus 212 v~e~~~~gsL~~~l~~---~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla 288 (443)
|+||+++++|.+++.. ..+++.+++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++
T Consensus 77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--------~i~h~~l~~~nil~~~~~~~~l~d~~~~ 148 (256)
T cd08218 77 VMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR--------KILHRDIKSQNIFLTKDGTIKLGDFGIA 148 (256)
T ss_pred EEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC--------CEecCCCCHHHEEEcCCCCEEEeeccce
Confidence 9999999999999864 3578999999999999999999998 9999999999999999999999999999
Q ss_pred ccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCC
Q psy14889 289 VSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMD 368 (443)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~ 368 (443)
......... .....|+..|+|||++.+. ..+.++|+|||||++|||++| ..||...
T Consensus 149 ~~~~~~~~~----~~~~~~~~~~~~pe~~~~~------~~~~~~Dv~slG~i~~~l~~g----------~~~~~~~---- 204 (256)
T cd08218 149 RVLNSTVEL----ARTCIGTPYYLSPEICENR------PYNNKSDIWALGCVLYEMCTL----------KHAFEAG---- 204 (256)
T ss_pred eecCcchhh----hhhccCCccccCHHHhCCC------CCCCccchhHHHHHHHHHHcC----------CCCccCC----
Confidence 765432211 1233578899999998776 566799999999999999999 5565432
Q ss_pred CChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 369 PSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
........+. ....+..+ ...+..+.+++.+||+.+|++||++.+|++
T Consensus 205 -~~~~~~~~~~-~~~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 205 -NMKNLVLKII-RGSYPPVS-----SHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred -CHHHHHHHHh-cCCCCCCc-----ccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 1122222211 12222222 235677999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=294.25 Aligned_cols=253 Identities=26% Similarity=0.395 Sum_probs=191.4
Q ss_pred cccccceeeeecCeEEEEEEE--CCceeEEEEeeccCc------cc-----hHHHHHHHHHHhccCCCceeeeeeccccC
Q psy14889 137 QISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDE------AS-----WSRETEIYSTVLLRHENILGYIGSDMTSR 203 (443)
Q Consensus 137 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~------~~-----~~~e~ei~~~~~l~H~nIv~l~g~~~~~~ 203 (443)
+|...+.||+|+||.||+|.. +|+.||+|.+..... .. .....|+..+..++||||+++++++...
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~- 80 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTE- 80 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccC-
Confidence 467788999999999999986 688999998753211 00 1123466666679999999999998765
Q ss_pred CcccEEEeeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEE
Q psy14889 204 NSCTQLWLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVI 282 (443)
Q Consensus 204 ~~~~~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl 282 (443)
...++||||+++|+|.+++.+ ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|
T Consensus 81 ---~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~--------~i~H~dl~~~nil~~~~~~~~l 149 (272)
T cd06629 81 ---EYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSK--------GILHRDLKADNLLVDADGICKI 149 (272)
T ss_pred ---CceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhC--------CeeecCCChhhEEEcCCCeEEE
Confidence 357999999999999999865 5789999999999999999999998 9999999999999999999999
Q ss_pred EecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCC
Q psy14889 283 ADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYH 362 (443)
Q Consensus 283 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~ 362 (443)
+|||+++......... ......|+..|+|||.+..... .++.++|+||||+++||+++| ..||.
T Consensus 150 ~d~~~~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~----~~~~~~Dv~slG~~l~~l~~g----------~~p~~ 213 (272)
T cd06629 150 SDFGISKKSDDIYDND--QNMSMQGSVFWMAPEVIHSYSQ----GYSAKVDIWSLGCVVLEMFAG----------RRPWS 213 (272)
T ss_pred eecccccccccccccc--ccccccCCccccCHHHhccccC----CCCccchhHHHHHHHHHHHhC----------CCCCc
Confidence 9999987544321111 1233468889999999876521 356899999999999999999 66664
Q ss_pred CCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 363 DLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
... ......... .....+.++... ...++..+.+++.+||+.||++|||+.++++
T Consensus 214 ~~~----~~~~~~~~~-~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 214 DEE----AIAAMFKLG-NKRSAPPIPPDV-SMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred Ccc----hHHHHHHhh-ccccCCcCCccc-cccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 321 111222211 112223333221 1235678999999999999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=296.39 Aligned_cols=246 Identities=30% Similarity=0.481 Sum_probs=190.8
Q ss_pred cccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc--chHHHHHHHHHHhcc---CCCceeeeeeccccCCcccEE
Q psy14889 137 QISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA--SWSRETEIYSTVLLR---HENILGYIGSDMTSRNSCTQL 209 (443)
Q Consensus 137 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~--~~~~e~ei~~~~~l~---H~nIv~l~g~~~~~~~~~~~~ 209 (443)
.|+..+.||+|+||.||+|.+ +++.||+|.+...... ....+.|+..+..++ |||++++++++... ...
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~----~~~ 77 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKG----PRL 77 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeC----CEE
Confidence 477889999999999999997 5889999987643221 222334555555565 99999999998765 457
Q ss_pred EeeecccCcccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcc
Q psy14889 210 WLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAV 289 (443)
Q Consensus 210 ~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~ 289 (443)
++||||+++++|.++++...+++..++.++.|++.||.|||+. +|+|+||+|+||+++.++.++|+|||++.
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--------~i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 149 (277)
T cd06917 78 WIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKV--------GVIHRDIKAANILVTNTGNVKLCDFGVAA 149 (277)
T ss_pred EEEEecCCCCcHHHHHHccCCCHHHHHHHHHHHHHHHHHHHhC--------CcccCCcCHHHEEEcCCCCEEEccCCcee
Confidence 9999999999999999888899999999999999999999998 99999999999999999999999999997
Q ss_pred cccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCC
Q psy14889 290 SYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDP 369 (443)
Q Consensus 290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~ 369 (443)
........ .....|+..|+|||.+.++. .++.++|+||||+++|||++| ..||.....
T Consensus 150 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~-----~~~~~~Dv~slG~~l~~ll~g----------~~p~~~~~~--- 207 (277)
T cd06917 150 LLNQNSSK----RSTFVGTPYWMAPEVITEGK-----YYDTKADIWSLGITIYEMATG----------NPPYSDVDA--- 207 (277)
T ss_pred ecCCCccc----cccccCCcceeCHHHhccCC-----ccccchhHHHHHHHHHHHHhC----------CCCCCCCCh---
Confidence 66543321 12346889999999986542 456799999999999999999 566654311
Q ss_pred ChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 370 SFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
.... ... .....+.++ ....+.++.+++.+||+.||++||++.++++
T Consensus 208 -~~~~-~~~-~~~~~~~~~----~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 208 -FRAM-MLI-PKSKPPRLE----DNGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred -hhhh-hcc-ccCCCCCCC----cccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 1111 111 011112222 1235678999999999999999999999976
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=293.89 Aligned_cols=252 Identities=21% Similarity=0.339 Sum_probs=192.4
Q ss_pred cccccceeeeecCeEEEEEEE--CCceeEEEEeeccCc-------cchHHHHHHHHHHhccCCCceeeeeeccccCCccc
Q psy14889 137 QISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDE-------ASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCT 207 (443)
Q Consensus 137 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~-------~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~ 207 (443)
+|+..+.||+|+||.||++.. +++.||+|.+..... .......|+..+..++|+||+++++++.+. .
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----~ 76 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCED----S 76 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccC----C
Confidence 477789999999999999986 688999998864321 112234566677779999999999998766 3
Q ss_pred EEEeeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCC-cEEEEec
Q psy14889 208 QLWLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNG-TCVIADF 285 (443)
Q Consensus 208 ~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~-~~kl~Df 285 (443)
.+++|+||+++++|.+++.+ ..+++..+..++.|++.||.|||+. +++|+||||+||+++.++ .+||+||
T Consensus 77 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~--------~i~H~~i~~~nil~~~~~~~~~l~df 148 (268)
T cd06630 77 HFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHEN--------QIIHRDVKGANLLIDSTGQRLRIADF 148 (268)
T ss_pred eEEEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhC--------CeecCCCCHHHEEEcCCCCEEEEccc
Confidence 57999999999999999965 5689999999999999999999998 999999999999998776 6999999
Q ss_pred CCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCC
Q psy14889 286 GLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLV 365 (443)
Q Consensus 286 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~ 365 (443)
|++..................|+..|+|||.+.+. .++.++||||||+++|||++| ..||....
T Consensus 149 g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~------~~~~~~Dv~slG~~l~~l~~g----------~~p~~~~~ 212 (268)
T cd06630 149 GAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGE------QYGRSCDVWSVGCVIIEMATA----------KPPWNAEK 212 (268)
T ss_pred ccccccccccccCCccccccccccceeCHhHhccC------CCCcccchHHHHHHHHHHHhC----------CCCCCCCC
Confidence 99977654322222222344688999999998765 566899999999999999999 55664321
Q ss_pred CCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 366 PMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
... ......... .....+..+ ...+.++.+++.+||..||++|||+.++++
T Consensus 213 ~~~-~~~~~~~~~-~~~~~~~~~-----~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 213 HSN-HLALIFKIA-SATTAPSIP-----EHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred Ccc-hHHHHHHHh-ccCCCCCCc-----hhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 111 111111111 111122222 335678999999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=298.88 Aligned_cols=253 Identities=23% Similarity=0.307 Sum_probs=188.8
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc---chHHHHHHHHHHhccCCCceeeeeeccccCCcccEEE
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA---SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLW 210 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~---~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~ 210 (443)
++|++.+.||+|+||.||+|.. +|+.||+|++...... ......|+..+..++||||+++++++... ..++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~----~~~~ 76 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRK----RKLH 76 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeC----CEEE
Confidence 3688899999999999999998 5889999987543221 12234566666669999999999998766 4579
Q ss_pred eeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcc
Q psy14889 211 LVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAV 289 (443)
Q Consensus 211 lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~ 289 (443)
+||||+++++|..++.. ..+++.+++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++.
T Consensus 77 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~--------~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 148 (286)
T cd07847 77 LVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKH--------NCIHRDVKPENILITKQGQIKLCDFGFAR 148 (286)
T ss_pred EEEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC--------CceecCCChhhEEEcCCCcEEECccccce
Confidence 99999999888887754 5699999999999999999999998 99999999999999999999999999997
Q ss_pred cccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCC
Q psy14889 290 SYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDP 369 (443)
Q Consensus 290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~ 369 (443)
........ .....++..|+|||.+.+.. .++.++||||||+++|||++| ..||.+....
T Consensus 149 ~~~~~~~~----~~~~~~~~~~~aPE~~~~~~-----~~~~~~Di~slG~i~~~l~~g----------~~p~~~~~~~-- 207 (286)
T cd07847 149 ILTGPGDD----YTDYVATRWYRAPELLVGDT-----QYGPPVDVWAIGCVFAELLTG----------QPLWPGKSDV-- 207 (286)
T ss_pred ecCCCccc----ccCcccccccCCHHHHhCCC-----CcCchhhhHHHHHHHHHHHhC----------CCCCCCCChH--
Confidence 66543211 12335778999999986531 456799999999999999999 5666543211
Q ss_pred ChHHHHhhhhh--------------cCC--CCCCCCCC-------CCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 370 SFDDMRKVICI--------------DQQ--RPVLPNRW-------VSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 370 ~~~~~~~~~~~--------------~~~--~~~~~~~~-------~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
+........ ... ....+... .....+..+.+++.+||+.||++|||+.|+++
T Consensus 208 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 208 --DQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred --HHHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 111110000 000 00000000 00124567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=299.62 Aligned_cols=254 Identities=20% Similarity=0.219 Sum_probs=190.7
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc----chHHHHHHHHHHhccCCCceeeeeeccccCCcccEE
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA----SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQL 209 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~----~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~ 209 (443)
++|++.+.||+|+||.||++.. .++.||+|.+...... ......|+..+..++||||+++++.+... ..+
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~----~~~ 76 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETK----RHL 76 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecC----CEE
Confidence 3688899999999999999988 5789999987654211 11223455555669999999999988765 458
Q ss_pred EeeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCc
Q psy14889 210 WLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA 288 (443)
Q Consensus 210 ~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla 288 (443)
++||||+++|+|.+++.. ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++
T Consensus 77 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~--------~i~H~dl~p~NIll~~~~~~~l~dfg~~ 148 (305)
T cd05609 77 CMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNY--------GIVHRDLKPDNLLITSMGHIKLTDFGLS 148 (305)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC--------CccccCCchHHEEECCCCCEEEeeCCCc
Confidence 999999999999999964 5689999999999999999999998 9999999999999999999999999998
Q ss_pred ccccccCCc-----------CCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCccccc
Q psy14889 289 VSYSQLSNK-----------MDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEY 357 (443)
Q Consensus 289 ~~~~~~~~~-----------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~ 357 (443)
+........ .........|+..|+|||.+... .++.++|+||||+++|||++|
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~vl~el~~g---------- 212 (305)
T cd05609 149 KIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQ------GYGKPVDWWAMGIILYEFLVG---------- 212 (305)
T ss_pred cccCcCccccccccccccchhhccccCCccCccccCchhccCC------CCCchhhHHHHHHHHHHHHhC----------
Confidence 642111000 00011224578899999998765 567899999999999999999
Q ss_pred CCCCCCCCCCCCChHHHHhhhhhcC-CCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHH
Q psy14889 358 KAPYHDLVPMDPSFDDMRKVICIDQ-QRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIK 427 (443)
Q Consensus 358 ~~P~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 427 (443)
..||.+. ....+........ ..+.. ....+.++.+++.+||+.||++||++.++.+.|+.
T Consensus 213 ~~pf~~~-----~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 213 CVPFFGD-----TPEELFGQVISDDIEWPEG-----DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred CCCCCCC-----CHHHHHHHHHhcccCCCCc-----cccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 6677543 1222222221111 11111 12356789999999999999999997666655554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG0579|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=316.17 Aligned_cols=252 Identities=25% Similarity=0.428 Sum_probs=194.0
Q ss_pred ccccccceeeeecCeEEEEEEEC--CceeEEEEeeccCccch-HHHHHHHHHHhccCCCceeeeeeccccCCcccEEEee
Q psy14889 136 KQISLSECIGKGRYGEVWRGVWH--GENVAVKIFFSRDEASW-SRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLV 212 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~-~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv 212 (443)
+.+.++..||.|+||.||+|... +-..|.|++........ ....||.++...+||+||++++.|+.. +.+|+.
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~e----nkLwil 107 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFE----NKLWIL 107 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhcc----CceEEE
Confidence 45677888999999999999874 44557787754433222 223455555558999999999988876 458999
Q ss_pred ecccCcccHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCccc
Q psy14889 213 THYHSFGSLYDHLN--RTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVS 290 (443)
Q Consensus 213 ~e~~~~gsL~~~l~--~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~ 290 (443)
.|||.||-.+..+- ...|++.++..++.|++.||.|||++ +|||||||+.|||++-+|.++|+|||.+..
T Consensus 108 iEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~--------~iIHRDLKAGNiL~TldGdirLADFGVSAK 179 (1187)
T KOG0579|consen 108 IEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQ--------NIIHRDLKAGNILLTLDGDIRLADFGVSAK 179 (1187)
T ss_pred EeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhc--------chhhhhccccceEEEecCcEeeeccccccc
Confidence 99999999988774 47899999999999999999999999 999999999999999999999999999754
Q ss_pred ccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCC
Q psy14889 291 YSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPS 370 (443)
Q Consensus 291 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~ 370 (443)
....... ...+.||+.|||||+.......+ .+|..++||||||++|.||..+ ..|.++..++
T Consensus 180 n~~t~qk----RDsFIGTPYWMAPEVvmCET~KD-~PYDykaDiWSlGITLIEMAqi----------EPPHhelnpM--- 241 (1187)
T KOG0579|consen 180 NKSTRQK----RDSFIGTPYWMAPEVVMCETFKD-QPYDYKADIWSLGITLIEMAQI----------EPPHHELNPM--- 241 (1187)
T ss_pred chhHHhh----hccccCCcccccchheeeccccC-CCchhhhhHHhhhhHHHHHhcc----------CCCccccchH---
Confidence 3322222 24578999999999987654333 2777899999999999999998 7776665332
Q ss_pred hHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 371 FDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
..+.++...+.....-|..| +..+.+++.+||..||..||++.++++
T Consensus 242 -RVllKiaKSePPTLlqPS~W-----s~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 242 -RVLLKIAKSEPPTLLQPSHW-----SRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred -HHHHHHhhcCCCcccCcchh-----hhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 22233332222222234334 456999999999999999999999886
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=291.66 Aligned_cols=245 Identities=28% Similarity=0.428 Sum_probs=191.1
Q ss_pred cccccceeeeecCeEEEEEEE--CCceeEEEEeeccCc------cchHHHHHHHHHHhccCCCceeeeeeccccCCcccE
Q psy14889 137 QISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDE------ASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQ 208 (443)
Q Consensus 137 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~------~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~ 208 (443)
+|+..+.||+|+||.||+|.. +++.|++|.+..... .......|+..+..++|+||+++++++... ..
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~----~~ 76 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREE----DN 76 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecC----Ce
Confidence 467788999999999999987 588999998765332 112334566666779999999999988765 45
Q ss_pred EEeeecccCcccHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCC
Q psy14889 209 LWLVTHYHSFGSLYDHLNRT-TLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGL 287 (443)
Q Consensus 209 ~~lv~e~~~~gsL~~~l~~~-~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGl 287 (443)
+++++||+++++|.+++.+. .+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||+
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~--------~i~H~dl~~~ni~~~~~~~~kl~d~~~ 148 (258)
T cd06632 77 LYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDR--------NTVHRDIKGANILVDTNGVVKLADFGM 148 (258)
T ss_pred EEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CcccCCCCHHHEEECCCCCEEEccCcc
Confidence 79999999999999999754 489999999999999999999998 999999999999999999999999999
Q ss_pred cccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCC
Q psy14889 288 AVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPM 367 (443)
Q Consensus 288 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~ 367 (443)
+....... ......|+..|+|||.+.... .++.++|+||||+++|||++| ..||....
T Consensus 149 ~~~~~~~~-----~~~~~~~~~~y~~pe~~~~~~-----~~~~~~D~~slG~~l~~l~~g----------~~pf~~~~-- 206 (258)
T cd06632 149 AKQVVEFS-----FAKSFKGSPYWMAPEVIAQQG-----GYGLAADIWSLGCTVLEMATG----------KPPWSQLE-- 206 (258)
T ss_pred ceeccccc-----cccccCCCcceeCHHHhcCCC-----CCCchhhhHHHHHHHHHHHhC----------CCCcccCc--
Confidence 87654322 113346888999999986541 256899999999999999999 66665432
Q ss_pred CCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 368 DPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
......... .....+.++ ...+..+.+++.+||+.+|++||++.+++.
T Consensus 207 --~~~~~~~~~-~~~~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 207 --GVAAVFKIG-RSKELPPIP-----DHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred --HHHHHHHHH-hcccCCCcC-----CCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 111111111 111222222 235677999999999999999999999875
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=294.62 Aligned_cols=246 Identities=30% Similarity=0.460 Sum_probs=193.2
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccc--hHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEe
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEAS--WSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWL 211 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~--~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~l 211 (443)
+-|++.+.||+|+||.||+|.. ++..||+|......... .....|+..+..++||||+++++++... ...++
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----~~~~l 79 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD----TKLWI 79 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeC----CeEEE
Confidence 4577889999999999999987 57899999875432211 1223455566669999999999998766 45799
Q ss_pred eecccCcccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcccc
Q psy14889 212 VTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSY 291 (443)
Q Consensus 212 v~e~~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~ 291 (443)
||||+++|+|.+++....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++..+
T Consensus 80 v~e~~~~~~l~~~i~~~~~~~~~~~~~~~~l~~~l~~lh~~--------~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~ 151 (277)
T cd06641 80 IMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSE--------KKIHRDIKAANVLLSEHGEVKLADFGVAGQL 151 (277)
T ss_pred EEEeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHccC--------CeecCCCCHHhEEECCCCCEEEeecccceec
Confidence 99999999999999888899999999999999999999988 9999999999999999999999999998765
Q ss_pred cccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCCh
Q psy14889 292 SQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSF 371 (443)
Q Consensus 292 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~~ 371 (443)
..... ......|+..|+|||.+.+. ..+.++|+|||||++|||++| ..||.....
T Consensus 152 ~~~~~----~~~~~~~~~~y~~PE~~~~~------~~~~~~Dv~slG~~l~~l~~g----------~~p~~~~~~----- 206 (277)
T cd06641 152 TDTQI----KRNTFVGTPFWMAPEVIKQS------AYDSKADIWSLGITAIELAKG----------EPPHSELHP----- 206 (277)
T ss_pred ccchh----hhccccCCccccChhhhccC------CCCchhhHHHHHHHHHHHHcC----------CCCCCccch-----
Confidence 43211 11234678899999998765 556799999999999999999 666654311
Q ss_pred HHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHH
Q psy14889 372 DDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKT 424 (443)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 424 (443)
......+ .....+.++ ...+.++.+++.+||+.+|.+||++.++++.
T Consensus 207 ~~~~~~~-~~~~~~~~~-----~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 207 MKVLFLI-PKNNPPTLE-----GNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred HHHHHHH-hcCCCCCCC-----cccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 1111111 112222222 3356779999999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=301.16 Aligned_cols=250 Identities=23% Similarity=0.337 Sum_probs=192.5
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccc----hHHHHHHHHHHhccCCCceeeeeeccccCCcccEE
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEAS----WSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQL 209 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~----~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~ 209 (443)
++|++.+.||+|+||.||+|.. +++.||+|.+....... .....|+..+..++|+||+++++.+... ...
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----~~~ 76 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTE----TYL 76 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecC----CEE
Confidence 3688899999999999999988 47999999886543221 1223455666669999999999998765 458
Q ss_pred EeeecccCcccHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecC
Q psy14889 210 WLVTHYHSFGSLYDHLNR---TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFG 286 (443)
Q Consensus 210 ~lv~e~~~~gsL~~~l~~---~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfG 286 (443)
++||||+.+++|.+++.+ ..+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||
T Consensus 77 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~--------~i~H~dlkp~Nili~~~~~~~l~dfg 148 (316)
T cd05574 77 CLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL--------GIVYRDLKPENILLHESGHIMLSDFD 148 (316)
T ss_pred EEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHC--------CeeccCCChHHeEEcCCCCEEEeecc
Confidence 999999999999999864 4689999999999999999999998 99999999999999999999999999
Q ss_pred CcccccccCCcC-------------------------CCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHH
Q psy14889 287 LAVSYSQLSNKM-------------------------DIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVL 341 (443)
Q Consensus 287 la~~~~~~~~~~-------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl 341 (443)
++.......... ........||..|+|||++.+. .++.++||||||+++
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~------~~~~~~Di~slG~ll 222 (316)
T cd05574 149 LSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGD------GHGSAVDWWTLGILL 222 (316)
T ss_pred hhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCC------CCCchHHHHHHHHHH
Confidence 986543321110 0111234688999999999765 567899999999999
Q ss_pred HHHHhcccCCCcccccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCc----
Q psy14889 342 WEVCRRTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLS---- 417 (443)
Q Consensus 342 ~elltg~~~~~~~~~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps---- 417 (443)
|||++| ..||..... ........ ......+.. ...+..+.+++.+||+.||++|||
T Consensus 223 ~~l~~g----------~~pf~~~~~----~~~~~~~~---~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~R~s~~~~ 282 (316)
T cd05574 223 YEMLYG----------TTPFKGSNR----DETFSNIL---KKEVTFPGS---PPVSSSARDLIRKLLVKDPSKRLGSKRG 282 (316)
T ss_pred HHHhhC----------CCCCCCCch----HHHHHHHh---cCCccCCCc---cccCHHHHHHHHHHccCCHhHCCCchhh
Confidence 999999 677754321 12222222 122222221 125678999999999999999999
Q ss_pred HHHHHH
Q psy14889 418 ALRVKK 423 (443)
Q Consensus 418 ~~evl~ 423 (443)
+.++++
T Consensus 283 ~~~ll~ 288 (316)
T cd05574 283 AAEIKQ 288 (316)
T ss_pred HHHHHc
Confidence 777666
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG0983|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=280.99 Aligned_cols=250 Identities=22% Similarity=0.375 Sum_probs=196.3
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccchHH--HHHHHHHHh-ccCCCceeeeeeccccCCcccEEE
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEASWSR--ETEIYSTVL-LRHENILGYIGSDMTSRNSCTQLW 210 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~--e~ei~~~~~-l~H~nIv~l~g~~~~~~~~~~~~~ 210 (443)
++++....||.|+-|.|+++++ +|...|||.+.......... ..++....+ -..|.||+.+|+|..... ++
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~d----V~ 167 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTD----VF 167 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCch----HH
Confidence 4567788899999999999998 57999999987654432221 122222221 236999999999998744 68
Q ss_pred eeecccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCc
Q psy14889 211 LVTHYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA 288 (443)
Q Consensus 211 lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla 288 (443)
+.||.|.. .++.++++ +++++..+-++...+++||.||-+++ +|+|||+||+|||+|+.|.+||+|||++
T Consensus 168 IcMelMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH-------~viHRDvKPSNILlDe~GniKlCDFGIs 239 (391)
T KOG0983|consen 168 ICMELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKH-------GVIHRDVKPSNILLDERGNIKLCDFGIS 239 (391)
T ss_pred HHHHHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhc-------ceeecccCccceEEccCCCEEeeccccc
Confidence 99999864 66666653 67889888999999999999999875 9999999999999999999999999999
Q ss_pred ccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCC
Q psy14889 289 VSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMD 368 (443)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~ 368 (443)
..+.+.... +...|.+.|||||.+.-.... .|..++||||||++++||+|| ++||..- +
T Consensus 240 GrlvdSkAh-----trsAGC~~YMaPERidp~~~~---kYDiRaDVWSlGITlveLaTg----------~yPy~~c---~ 298 (391)
T KOG0983|consen 240 GRLVDSKAH-----TRSAGCAAYMAPERIDPPDKP---KYDIRADVWSLGITLVELATG----------QYPYKGC---K 298 (391)
T ss_pred ceeeccccc-----ccccCCccccCccccCCCCCC---ccchhhhhhhhccchhhhhcc----------cCCCCCC---C
Confidence 776543322 344788999999998754322 677899999999999999999 8898874 3
Q ss_pred CChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 369 PSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
..++.+.++.. ...|.++.. ...+..+.+++..||..|+.+||...++++
T Consensus 299 tdFe~ltkvln--~ePP~L~~~---~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 299 TDFEVLTKVLN--EEPPLLPGH---MGFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred ccHHHHHHHHh--cCCCCCCcc---cCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 45666666654 334556542 236778999999999999999999999876
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=289.60 Aligned_cols=243 Identities=24% Similarity=0.351 Sum_probs=188.8
Q ss_pred cccccceeeeecCeEEEEEEE--CCceeEEEEeeccCc---cchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEe
Q psy14889 137 QISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDE---ASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWL 211 (443)
Q Consensus 137 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~---~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~l 211 (443)
+|++.+.||+|+||.||++.. +++.+|+|.+..... .......|+..+..++||||+++++.+... ...++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~----~~~~l 76 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLED----KALMI 76 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecC----CEEEE
Confidence 478899999999999999987 678999998865321 122234566666669999999999987655 45799
Q ss_pred eecccCcccHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCC-CcEEEEecCC
Q psy14889 212 VTHYHSFGSLYDHLNR---TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTN-GTCVIADFGL 287 (443)
Q Consensus 212 v~e~~~~gsL~~~l~~---~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~-~~~kl~DfGl 287 (443)
||||+++++|.+++.. ..+++..+..++.|++.||.|||++ +++|+||||+||+++.+ +.+||+|||+
T Consensus 77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~--------~i~h~dl~~~nil~~~~~~~~~l~d~~~ 148 (256)
T cd08220 77 VMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK--------LILHRDLKTQNILLDKHKMVVKIGDFGI 148 (256)
T ss_pred EEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC--------CeecCCCCHHHEEEcCCCCEEEEccCCC
Confidence 9999999999999964 3489999999999999999999998 99999999999999865 4689999999
Q ss_pred cccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCC
Q psy14889 288 AVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPM 367 (443)
Q Consensus 288 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~ 367 (443)
+........ .....|+..|+|||.+.+. .++.++||||||+++|+|++| ..||....
T Consensus 149 ~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~------~~~~~~Dv~slG~~l~~l~~~----------~~~~~~~~-- 205 (256)
T cd08220 149 SKILSSKSK-----AYTVVGTPCYISPELCEGK------PYNQKSDIWALGCVLYELASL----------KRAFEAAN-- 205 (256)
T ss_pred ceecCCCcc-----ccccccCCcccCchhccCC------CCCcccchHHHHHHHHHHHhC----------CCCcccCc--
Confidence 976653321 1234688899999998765 566899999999999999999 56665421
Q ss_pred CCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 368 DPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
......... . .....++ ...+..+.+++.+||+.||++|||+.|+++
T Consensus 206 --~~~~~~~~~-~-~~~~~~~-----~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 206 --LPALVLKIM-S-GTFAPIS-----DRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred --hHHHHHHHH-h-cCCCCCC-----CCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 111111221 1 1122222 235667999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=293.36 Aligned_cols=248 Identities=25% Similarity=0.401 Sum_probs=188.6
Q ss_pred cccccceeeeecCeEEEEEEEC---CceeEEEEeeccCcc--------c---hHHHHHHHHHH-hccCCCceeeeeeccc
Q psy14889 137 QISLSECIGKGRYGEVWRGVWH---GENVAVKIFFSRDEA--------S---WSRETEIYSTV-LLRHENILGYIGSDMT 201 (443)
Q Consensus 137 ~~~~~~~lG~G~fg~Vy~~~~~---~~~vAvK~~~~~~~~--------~---~~~e~ei~~~~-~l~H~nIv~l~g~~~~ 201 (443)
+|++.+.||+|+||.||+|.+. ++.+|+|.+...... . .....|+..+. .++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 4778899999999999999983 578999987532111 1 11123443333 3789999999999877
Q ss_pred cCCcccEEEeeecccCcccHHHHhc-----ccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcC
Q psy14889 202 SRNSCTQLWLVTHYHSFGSLYDHLN-----RTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKT 276 (443)
Q Consensus 202 ~~~~~~~~~lv~e~~~~gsL~~~l~-----~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~ 276 (443)
. ...+++|||+++++|.+++. ...+++..++.++.|++.||.|||+.. +++|+||+|+||+++.
T Consensus 81 ~----~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~-------~i~H~dl~~~nil~~~ 149 (269)
T cd08528 81 N----DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK-------RIVHRDLTPNNIMLGE 149 (269)
T ss_pred C----CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC-------ceeecCCCHHHEEECC
Confidence 6 45799999999999998873 346899999999999999999999631 8999999999999999
Q ss_pred CCcEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccc
Q psy14889 277 NGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEE 356 (443)
Q Consensus 277 ~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~ 356 (443)
++.+||+|||++....... ......|+..|+|||.+.+. .++.++||||||+++|||++|
T Consensus 150 ~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~~~~Pe~~~~~------~~~~~~Dv~slG~ll~~l~~g--------- 209 (269)
T cd08528 150 DDKVTITDFGLAKQKQPES-----KLTSVVGTILYSCPEIVKNE------PYGEKADVWAFGCILYQMCTL--------- 209 (269)
T ss_pred CCcEEEecccceeeccccc-----ccccccCcccCcChhhhcCC------CCchHHHHHHHHHHHHHHHhC---------
Confidence 9999999999997654322 12334688999999999865 567899999999999999999
Q ss_pred cCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHH
Q psy14889 357 YKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLI 426 (443)
Q Consensus 357 ~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 426 (443)
..||... ........+..... ...+. ...+..+.+++.+||+.||++||++.|+..++.
T Consensus 210 -~~p~~~~-----~~~~~~~~~~~~~~-~~~~~----~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 210 -QPPFYST-----NMLSLATKIVEAVY-EPLPE----GMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred -CCccccc-----CHHHHHHHHhhccC-CcCCc----ccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 6666542 11222222221111 11111 234567999999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=295.67 Aligned_cols=241 Identities=23% Similarity=0.326 Sum_probs=191.0
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCc----cchHHHHHHHHHHhccCCCceeeeeeccccCCcccEE
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDE----ASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQL 209 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~----~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~ 209 (443)
++|++.+.||+|+||.||++.+ +++.||+|++..... .......|+..+..++||||+++++++... ..+
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----~~~ 76 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDD----SNL 76 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcC----CeE
Confidence 3688999999999999999988 578999998864321 112223456666669999999999998766 457
Q ss_pred EeeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCc
Q psy14889 210 WLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA 288 (443)
Q Consensus 210 ~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla 288 (443)
++||||+++|+|.+++.. ..+++..+..++.|++.||.|||+. +++|+||+|+|||++.++.+||+|||++
T Consensus 77 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~--------~i~H~dl~p~nili~~~~~~kl~dfg~~ 148 (290)
T cd05580 77 YLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSL--------DIVYRDLKPENLLLDSDGYIKITDFGFA 148 (290)
T ss_pred EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC--------CEecCCCCHHHEEECCCCCEEEeeCCCc
Confidence 999999999999999864 5689999999999999999999998 9999999999999999999999999998
Q ss_pred ccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCC
Q psy14889 289 VSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMD 368 (443)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~ 368 (443)
...... .....|++.|+|||.+.+. ..+.++||||||+++|||++| ..||....
T Consensus 149 ~~~~~~-------~~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~il~~l~~g----------~~p~~~~~--- 202 (290)
T cd05580 149 KRVKGR-------TYTLCGTPEYLAPEIILSK------GYGKAVDWWALGILIYEMLAG----------YPPFFDDN--- 202 (290)
T ss_pred cccCCC-------CCCCCCCccccChhhhcCC------CCCccccHHHHHHHHHHHHhC----------CCCCCCCC---
Confidence 766432 1234688999999998765 556789999999999999999 66775432
Q ss_pred CChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCC-----cHHHHHH
Q psy14889 369 PSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRL-----SALRVKK 423 (443)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~ 423 (443)
.....+.+. .....++. ..+..+.+++.+||..||.+|+ ++.|+++
T Consensus 203 --~~~~~~~~~--~~~~~~~~-----~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 203 --PIQIYEKIL--EGKVRFPS-----FFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred --HHHHHHHHh--cCCccCCc-----cCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 122222221 22233332 2456799999999999999999 6666653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=298.35 Aligned_cols=248 Identities=27% Similarity=0.452 Sum_probs=193.2
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc-chHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEee
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA-SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLV 212 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~-~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv 212 (443)
++|.+.+.||+|+||.||++.. +++.||+|.+...... ......|+..+..++||||+++++.+... ...++|
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~----~~~~lv 94 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVG----DELWVV 94 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeC----CcEEEE
Confidence 6899999999999999999986 6789999987543222 12223455556668999999999998766 347999
Q ss_pred ecccCcccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCccccc
Q psy14889 213 THYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYS 292 (443)
Q Consensus 213 ~e~~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~~ 292 (443)
+||+++|+|.+++.+..+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++....
T Consensus 95 ~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~--------gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~ 166 (293)
T cd06647 95 MEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN--------QVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 166 (293)
T ss_pred EecCCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhC--------CEeeccCCHHHEEEcCCCCEEEccCcceeccc
Confidence 9999999999999888899999999999999999999998 99999999999999999999999999986554
Q ss_pred ccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCChH
Q psy14889 293 QLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFD 372 (443)
Q Consensus 293 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~~~ 372 (443)
..... .....|++.|+|||.+... .++.++||||||+++||+++| ..||..... ..
T Consensus 167 ~~~~~----~~~~~~~~~y~~PE~~~~~------~~~~~~Dv~slG~ll~~ll~g----------~~pf~~~~~----~~ 222 (293)
T cd06647 167 PEQSK----RSTMVGTPYWMAPEVVTRK------AYGPKVDIWSLGIMAIEMVEG----------EPPYLNENP----LR 222 (293)
T ss_pred ccccc----cccccCChhhcCchhhccC------CCCchhhHHHHHHHHHHHHhC----------CCCCCCCCh----hh
Confidence 32221 1234688899999998765 566899999999999999999 566654311 11
Q ss_pred HHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHH
Q psy14889 373 DMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKT 424 (443)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 424 (443)
...... ....+..+ .....+..+.+++.+||+.+|++||++.+++..
T Consensus 223 ~~~~~~--~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 223 ALYLIA--TNGTPELQ---NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred heeehh--cCCCCCCC---CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111110 01112221 123355679999999999999999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=298.95 Aligned_cols=264 Identities=23% Similarity=0.294 Sum_probs=186.9
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc---chHHHHHHHHHHhccCCCceeeeeeccccCC----cc
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA---SWSRETEIYSTVLLRHENILGYIGSDMTSRN----SC 206 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~---~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~----~~ 206 (443)
++|++.+.||+|+||.||+|.. +++.||||.+...... ......|+..+..++||||+++++++..... ..
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 5799999999999999999998 5889999987543221 1222345666666999999999998765432 12
Q ss_pred cEEEeeecccCcccHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEe
Q psy14889 207 TQLWLVTHYHSFGSLYDHLNRT--TLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIAD 284 (443)
Q Consensus 207 ~~~~lv~e~~~~gsL~~~l~~~--~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~D 284 (443)
...++||||+.+ +|.+++... .+++.++..++.||+.||.|||+. +++|+||||+||+++.++.+||+|
T Consensus 92 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~--------~i~H~dl~p~nil~~~~~~~kl~d 162 (310)
T cd07865 92 GSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRN--------KILHRDMKAANILITKDGILKLAD 162 (310)
T ss_pred ceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC--------CeeccCCCHHHEEECCCCcEEECc
Confidence 457999999974 888888654 689999999999999999999998 999999999999999999999999
Q ss_pred cCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCC
Q psy14889 285 FGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDL 364 (443)
Q Consensus 285 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~ 364 (443)
||++..................++..|+|||.+.+.. .++.++||||||+++|||++|+++ |...
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-----~~~~~~Di~slG~~l~el~t~~~~----------~~~~ 227 (310)
T cd07865 163 FGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGER-----DYGPPIDMWGAGCIMAEMWTRSPI----------MQGN 227 (310)
T ss_pred CCCcccccCCcccCCCCccCcccCccccCcHHhcCCc-----ccCchhhhHHHHHHHHHHHhCCCC----------CCCC
Confidence 9999766543222111223446788999999886542 345789999999999999999543 3321
Q ss_pred CCC--------------------CCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 365 VPM--------------------DPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 365 ~~~--------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
... ....................+...........+.+++.+||+.||++|||++++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 228 TEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred CHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 100 00000000000000000000000000112346789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=293.70 Aligned_cols=247 Identities=24% Similarity=0.354 Sum_probs=192.1
Q ss_pred cccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc--chHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEee
Q psy14889 137 QISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA--SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLV 212 (443)
Q Consensus 137 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~--~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv 212 (443)
+|+..+.||+|+||.||++.. +++.||+|.+...... ......|+..+..++||||+++++.+... ..++++
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~----~~~~lv 77 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNN----GDISIC 77 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecC----CEEEEE
Confidence 678889999999999999998 4889999988654322 12223455556668999999999998776 458999
Q ss_pred ecccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHH-chhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcc
Q psy14889 213 THYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHT-EIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAV 289 (443)
Q Consensus 213 ~e~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~-~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~ 289 (443)
+||+++++|.+++.. ..+++..+..++.|++.||+|||+ . +++|+||||+||++++++.+||+|||.+.
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--------~i~H~dl~~~ni~~~~~~~~~l~d~g~~~ 149 (265)
T cd06605 78 MEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKH--------KIIHRDVKPSNILVNSRGQIKLCDFGVSG 149 (265)
T ss_pred EEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCC--------CeecCCCCHHHEEECCCCCEEEeecccch
Confidence 999999999999964 578999999999999999999998 7 99999999999999999999999999986
Q ss_pred cccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCC
Q psy14889 290 SYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDP 369 (443)
Q Consensus 290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~ 369 (443)
........ ...++..|+|||.+.+. .++.++||||||+++|+|++| ..||........
T Consensus 150 ~~~~~~~~------~~~~~~~y~~PE~~~~~------~~~~~~Dv~slG~~l~~l~~g----------~~p~~~~~~~~~ 207 (265)
T cd06605 150 QLVNSLAK------TFVGTSSYMAPERIQGN------DYSVKSDIWSLGLSLIELATG----------RFPYPPENDPPD 207 (265)
T ss_pred hhHHHHhh------cccCChhccCHHHHcCC------CCCchhhHHHHHHHHHHHHhC----------CCCCCccccccc
Confidence 65432211 14688899999998776 667899999999999999999 566654321111
Q ss_pred Ch-HHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 370 SF-DDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 370 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
.. +.+.... ....+..+. ...+.++.++|.+||..||++|||+.+++.
T Consensus 208 ~~~~~~~~~~--~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 208 GIFELLQYIV--NEPPPRLPS----GKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred cHHHHHHHHh--cCCCCCCCh----hhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 11 1222221 122233332 125677999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=297.04 Aligned_cols=238 Identities=18% Similarity=0.315 Sum_probs=178.1
Q ss_pred ceeeeecCeEEEEEEEC---------CceeEEEEeeccCccc-hHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEe
Q psy14889 142 ECIGKGRYGEVWRGVWH---------GENVAVKIFFSRDEAS-WSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWL 211 (443)
Q Consensus 142 ~~lG~G~fg~Vy~~~~~---------~~~vAvK~~~~~~~~~-~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~l 211 (443)
+.||+|+||.||+|... ...||+|.+....... .....|+..+..++||||+++++++.... ..++
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~----~~~l 76 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGD----ESIM 76 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCC----CcEE
Confidence 46899999999999762 2348888775432211 12233444555589999999999988763 3689
Q ss_pred eecccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCc--------EE
Q psy14889 212 VTHYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGT--------CV 281 (443)
Q Consensus 212 v~e~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~--------~k 281 (443)
||||+++|+|.+++.. ..+++..++.++.||+.||+|||+. +|+||||||+||+++.++. +|
T Consensus 77 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--------~iiH~dlkp~nili~~~~~~~~~~~~~~~ 148 (258)
T cd05078 77 VQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDK--------GLTHGNVCAKNVLLIREEDRKTGNPPFIK 148 (258)
T ss_pred EEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC--------CeecCCCccceEEEecccccccCCCceEE
Confidence 9999999999999964 3589999999999999999999998 9999999999999987765 69
Q ss_pred EEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCC
Q psy14889 282 IADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPY 361 (443)
Q Consensus 282 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~ 361 (443)
++|||++..... .....++..|+|||++.+.. .++.++||||||+++|||++|. ..||
T Consensus 149 l~d~g~~~~~~~--------~~~~~~~~~y~aPE~~~~~~-----~~~~~~DiwslG~~l~~l~~g~---------~~~~ 206 (258)
T cd05078 149 LSDPGISITVLP--------KEILLERIPWVPPECIENPQ-----NLSLAADKWSFGTTLWEIFSGG---------DKPL 206 (258)
T ss_pred ecccccccccCC--------chhccccCCccCchhccCCC-----CCCchhhHHHHHHHHHHHHcCC---------CCCh
Confidence 999998854432 12245788999999987641 4567999999999999999982 2344
Q ss_pred CCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHH
Q psy14889 362 HDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLI 426 (443)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 426 (443)
.... ......... .+..+|. ....++.+++.+||+.||++|||++++++.|+
T Consensus 207 ~~~~-----~~~~~~~~~---~~~~~~~-----~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 207 SALD-----SQKKLQFYE---DRHQLPA-----PKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred hhcc-----HHHHHHHHH---ccccCCC-----CCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 3321 111111111 1222332 23467999999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=295.84 Aligned_cols=247 Identities=29% Similarity=0.396 Sum_probs=188.6
Q ss_pred hhccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccc----hHHHHHHHHHHhccCCCceeeeeeccccCCccc
Q psy14889 134 LAKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEAS----WSRETEIYSTVLLRHENILGYIGSDMTSRNSCT 207 (443)
Q Consensus 134 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~----~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~ 207 (443)
..+.|+..+.||+|+||.||+|.. +++.||+|.+....... .....|+..+..++||||+++++++.+..
T Consensus 13 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~---- 88 (307)
T cd06607 13 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREH---- 88 (307)
T ss_pred cchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCC----
Confidence 346799999999999999999987 58899999885432211 12234555666699999999999988763
Q ss_pred EEEeeecccCcccHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEec
Q psy14889 208 QLWLVTHYHSFGSLYDHLN--RTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADF 285 (443)
Q Consensus 208 ~~~lv~e~~~~gsL~~~l~--~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~Df 285 (443)
..++|+||+. |+|.+++. ...+++..+..++.|++.||.|||+. +|+|+||+|+||++++++.+||+||
T Consensus 89 ~~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~--------~i~H~dl~p~nIl~~~~~~~kL~df 159 (307)
T cd06607 89 TAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSH--------ERIHRDIKAGNILLTEPGTVKLADF 159 (307)
T ss_pred eEEEEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHC--------CceecCCCcccEEECCCCCEEEeec
Confidence 4799999997 57777764 45699999999999999999999998 9999999999999999999999999
Q ss_pred CCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCC
Q psy14889 286 GLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLV 365 (443)
Q Consensus 286 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~ 365 (443)
|++...... ....|+..|+|||++.+... ..++.++||||||+++|||+|| ..||....
T Consensus 160 g~~~~~~~~--------~~~~~~~~y~aPE~~~~~~~---~~~~~~sDv~s~G~il~el~tg----------~~p~~~~~ 218 (307)
T cd06607 160 GSASLVSPA--------NSFVGTPYWMAPEVILAMDE---GQYDGKVDVWSLGITCIELAER----------KPPLFNMN 218 (307)
T ss_pred CcceecCCC--------CCccCCccccCceeeeccCC---CCCCcccchHHHHHHHHHHHcC----------CCCCCCcc
Confidence 998654321 23467889999998853211 1566899999999999999999 56665431
Q ss_pred CCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHH
Q psy14889 366 PMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKT 424 (443)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 424 (443)
......... ....+..+ ....+..+.+++.+||+.||++||++.+|+..
T Consensus 219 -----~~~~~~~~~-~~~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 219 -----AMSALYHIA-QNDSPTLS----SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred -----HHHHHHHHh-cCCCCCCC----chhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 111111111 11122222 23356789999999999999999999999873
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=303.87 Aligned_cols=265 Identities=19% Similarity=0.258 Sum_probs=192.3
Q ss_pred hccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCc---cchHHHHHHHHHHhccCCCceeeeeeccccCCcccEE
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDE---ASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQL 209 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~---~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~ 209 (443)
.++|++.+.||+|+||.||+|.. +|+.||+|++..... .......|+..+..++||||+++++++.........+
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 36899999999999999999987 589999998865322 1122234566666699999999999877554444568
Q ss_pred EeeecccCcccHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCc
Q psy14889 210 WLVTHYHSFGSLYDHLN-RTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA 288 (443)
Q Consensus 210 ~lv~e~~~~gsL~~~l~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla 288 (443)
++||||+. |+|.+++. ...+++..+..++.||+.||.|||+. +|+||||||+||++++++.+||+|||++
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~--------~ivH~dlkp~Nil~~~~~~~kl~dfg~~ 154 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSA--------NVIHRDLKPSNLLVNEDCELRIGDFGMA 154 (334)
T ss_pred EEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC--------CeecCCCCHHHEEEcCCCcEEecccccc
Confidence 99999996 69999885 45689999999999999999999998 9999999999999999999999999999
Q ss_pred ccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCC
Q psy14889 289 VSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMD 368 (443)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~ 368 (443)
..................|+..|+|||.+.... .++.++||||||+++|||++|+ .||.......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-----~~~~~~Di~slG~~l~el~~g~----------~pf~~~~~~~ 219 (334)
T cd07855 155 RGLSSSPTEHKYFMTEYVATRWYRAPELLLSLP-----EYTTAIDMWSVGCIFAEMLGRR----------QLFPGKNYVH 219 (334)
T ss_pred eeecccCcCCCcccccccccccccChHHhcCCc-----ccccccchHHHHHHHHHHHcCC----------CccCCCChHH
Confidence 765443222211123447889999999986531 4568999999999999999994 4443321000
Q ss_pred -------------------CChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 369 -------------------PSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 369 -------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
...................+-.......+..+.+++++||+.||++|||+.+++.
T Consensus 220 ~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 220 QLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred HHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 0000011111100111111100001224678999999999999999999999887
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=292.03 Aligned_cols=244 Identities=25% Similarity=0.297 Sum_probs=192.4
Q ss_pred cccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc----chHHHHHHHHHHhccCCCceeeeeeccccCCcccEEE
Q psy14889 137 QISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA----SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLW 210 (443)
Q Consensus 137 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~----~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~ 210 (443)
+|++.+.||.|+||.||+|.. +++.||+|.+...... ......|+..+..++||||+++++.+... ..++
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----~~~~ 76 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDE----ENMY 76 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCC----CeEE
Confidence 478899999999999999998 4899999988653321 12234566666679999999999988765 4589
Q ss_pred eeecccCcccHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcc
Q psy14889 211 LVTHYHSFGSLYDHLNRT-TLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAV 289 (443)
Q Consensus 211 lv~e~~~~gsL~~~l~~~-~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~ 289 (443)
+|+||+.+++|.+++... .+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++.
T Consensus 77 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~--------~i~h~dl~~~nil~~~~~~~~l~d~~~~~ 148 (258)
T cd05578 77 LVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSK--------GIIHRDIKPDNILLDEQGHVHITDFNIAT 148 (258)
T ss_pred EEEeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhC--------CeeccCCCHHHeEEcCCCCEEEeeccccc
Confidence 999999999999999765 899999999999999999999998 99999999999999999999999999987
Q ss_pred cccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCC
Q psy14889 290 SYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDP 369 (443)
Q Consensus 290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~ 369 (443)
....... .....|+..|+|||.+... .++.++|+||||+++|+|++| ..||......
T Consensus 149 ~~~~~~~-----~~~~~~~~~y~~PE~~~~~------~~~~~~Di~slG~~l~~l~~g----------~~p~~~~~~~-- 205 (258)
T cd05578 149 KVTPDTL-----TTSTSGTPGYMAPEVLCRQ------GYSVAVDWWSLGVTAYECLRG----------KRPYRGHSRT-- 205 (258)
T ss_pred ccCCCcc-----ccccCCChhhcCHHHHccc------CCCCcccchhhHHHHHHHHhC----------CCCCCCCCcc--
Confidence 6543221 1234688899999998776 566899999999999999999 6677654221
Q ss_pred ChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcH--HHHH
Q psy14889 370 SFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSA--LRVK 422 (443)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~--~evl 422 (443)
....+...... ..+..+ ...+..+.+++.+||+.||.+||++ +|++
T Consensus 206 ~~~~~~~~~~~--~~~~~~-----~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 206 IRDQIRAKQET--ADVLYP-----ATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred HHHHHHHHhcc--ccccCc-----ccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 12222222211 222333 2355789999999999999999999 5554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=293.10 Aligned_cols=246 Identities=25% Similarity=0.405 Sum_probs=190.5
Q ss_pred cccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccc-hHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEeee
Q psy14889 137 QISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEAS-WSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVT 213 (443)
Q Consensus 137 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~-~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv~ 213 (443)
.|...+.||+|++|.||++.. +++.+|+|.+....... .....|+..+..++||||+++++++... ...++++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~----~~~~~v~ 95 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVG----DELWVVM 95 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcC----CeEEEEE
Confidence 455567999999999999987 57899999875433221 1223455566668999999999988765 4579999
Q ss_pred cccCcccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcccccc
Q psy14889 214 HYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQ 293 (443)
Q Consensus 214 e~~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~~~ 293 (443)
||+++++|.+++....+++..+..++.|++.||+|||+. +++||||+|+||+++.++.++|+|||++.....
T Consensus 96 e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~--------~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~ 167 (285)
T cd06648 96 EFLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQ--------GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSK 167 (285)
T ss_pred eccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhC--------CeecCCCChhhEEEcCCCcEEEcccccchhhcc
Confidence 999999999999888899999999999999999999998 999999999999999999999999998865543
Q ss_pred cCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCChHH
Q psy14889 294 LSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFDD 373 (443)
Q Consensus 294 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~~~~ 373 (443)
.... .....|+..|+|||.+.+. .++.++||||||+++|||++| ..||.... ....
T Consensus 168 ~~~~----~~~~~~~~~y~aPE~~~~~------~~~~~~Dv~slGv~l~ell~g----------~~p~~~~~----~~~~ 223 (285)
T cd06648 168 EVPR----RKSLVGTPYWMAPEVISRL------PYGTEVDIWSLGIMVIEMVDG----------EPPYFNEP----PLQA 223 (285)
T ss_pred CCcc----cccccCCccccCHHHhcCC------CCCCcccHHHHHHHHHHHHhC----------CCCCcCCC----HHHH
Confidence 2211 1234688999999998765 566899999999999999999 66665421 1122
Q ss_pred HHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 374 MRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
..... . ...+.... ....+..+.+++.+||+.||++|||+.++++
T Consensus 224 ~~~~~-~-~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 224 MKRIR-D-NLPPKLKN---LHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred HHHHH-h-cCCCCCcc---cccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 22211 1 11111111 1225578999999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=293.49 Aligned_cols=249 Identities=29% Similarity=0.465 Sum_probs=195.6
Q ss_pred hhccccccceeeeecCeEEEEEEEC--CceeEEEEeeccCccchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEe
Q psy14889 134 LAKQISLSECIGKGRYGEVWRGVWH--GENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWL 211 (443)
Q Consensus 134 ~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~l 211 (443)
..+.|+..+.||+|+||.||+|.+. +..||+|++..........+.|+..+..++|+||+++++.+... ...++
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----~~~~l 92 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVG----DELWV 92 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEEC----CEEEE
Confidence 3467899999999999999999984 88999999865543222334566666679999999999998776 45799
Q ss_pred eecccCcccHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcc
Q psy14889 212 VTHYHSFGSLYDHLNRT--TLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAV 289 (443)
Q Consensus 212 v~e~~~~gsL~~~l~~~--~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~ 289 (443)
++||+++++|.+++... .+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.
T Consensus 93 v~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~--------gi~H~dl~p~ni~i~~~~~~~l~d~~~~~ 164 (286)
T cd06614 93 VMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQ--------NVIHRDIKSDNILLSKDGSVKLADFGFAA 164 (286)
T ss_pred EEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhC--------CeeeCCCChhhEEEcCCCCEEECccchhh
Confidence 99999999999999765 799999999999999999999998 99999999999999999999999999986
Q ss_pred cccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCC
Q psy14889 290 SYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDP 369 (443)
Q Consensus 290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~ 369 (443)
........ .....++..|+|||.+.+. .++.++||||||+++|||++| ..||....
T Consensus 165 ~~~~~~~~----~~~~~~~~~y~~PE~~~~~------~~~~~~Dv~slGvil~~l~~g----------~~p~~~~~---- 220 (286)
T cd06614 165 QLTKEKSK----RNSVVGTPYWMAPEVIKRK------DYGPKVDIWSLGIMCIEMAEG----------EPPYLREP---- 220 (286)
T ss_pred hhccchhh----hccccCCcccCCHhHhcCC------CCCCccccHHHHHHHHHHHhC----------CCCCCCCC----
Confidence 55432211 1233578899999998765 567899999999999999999 66765431
Q ss_pred ChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 370 SFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
......... ....+.... ...++..+.+++.+||+.+|.+|||+.++++
T Consensus 221 ~~~~~~~~~--~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 221 PLRALFLIT--TKGIPPLKN---PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred HHHHHHHHH--hcCCCCCcc---hhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 111222211 111111111 1225678999999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=297.46 Aligned_cols=253 Identities=24% Similarity=0.338 Sum_probs=187.3
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccc---hHHHHHHHHHHhccCCCceeeeeeccccCCcccEEE
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEAS---WSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLW 210 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~---~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~ 210 (443)
++|++.+.||+|+||.||+|.+ +++.||+|++....... .....|+..+..++||||+++++++... ...+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----~~~~ 76 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRK----KRLY 76 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccC----CeEE
Confidence 3688899999999999999998 47899999875432221 1223455566669999999999998765 4589
Q ss_pred eeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcc
Q psy14889 211 LVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAV 289 (443)
Q Consensus 211 lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~ 289 (443)
+|+||+++++|..+... ..+++.+++.++.||+.||+|||+. +++|+||+|+||++++++.+||+|||++.
T Consensus 77 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--------~i~h~~l~p~ni~~~~~~~~~l~dfg~~~ 148 (286)
T cd07846 77 LVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSH--------NIIHRDIKPENILVSQSGVVKLCDFGFAR 148 (286)
T ss_pred EEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC--------CccccCCCHHHEEECCCCcEEEEeeeeee
Confidence 99999999999887754 4699999999999999999999998 99999999999999999999999999987
Q ss_pred cccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCC
Q psy14889 290 SYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDP 369 (443)
Q Consensus 290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~ 369 (443)
.+...... .....++..|+|||++.+.. .++.++||||||+++|||++|+ .||....
T Consensus 149 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~-----~~~~~~Dv~slG~~l~el~~g~----------~~~~~~~---- 205 (286)
T cd07846 149 TLAAPGEV----YTDYVATRWYRAPELLVGDT-----KYGRAVDIWAVGCLVTEMLTGE----------PLFPGDS---- 205 (286)
T ss_pred eccCCccc----cCcccceeeccCcHHhcccc-----ccCchHhHHHHHHHHHHHHcCC----------CCCCCCc----
Confidence 65432211 12346788999999986531 3557899999999999999994 4443211
Q ss_pred ChHHHHhhhhhc-------------------CCCCCCCC----CCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 370 SFDDMRKVICID-------------------QQRPVLPN----RWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 370 ~~~~~~~~~~~~-------------------~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
..+......... ...+.... .......+..+.+++.+||+.||++||++.++++
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 206 DIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred hHHHHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 111111111000 00000000 0001234677999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=304.59 Aligned_cols=270 Identities=23% Similarity=0.299 Sum_probs=193.7
Q ss_pred hccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc--chHHHHHHHHHHhccCCCceeeeeeccccCC-cccEE
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA--SWSRETEIYSTVLLRHENILGYIGSDMTSRN-SCTQL 209 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~--~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~-~~~~~ 209 (443)
.++|++.+.||+|+||.||+|.. +|+.||+|.+...... ......|+..+..++||||+++++++..... .....
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 46899999999999999999987 6889999988543222 1223456666667999999999988654421 22457
Q ss_pred EeeecccCcccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcc
Q psy14889 210 WLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAV 289 (443)
Q Consensus 210 ~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~ 289 (443)
++|+||+. ++|.+++....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++.
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~--------~ivH~dlkp~Nill~~~~~~kl~dfg~~~ 154 (336)
T cd07849 84 YIVQELME-TDLYKLIKTQHLSNDHIQYFLYQILRGLKYIHSA--------NVLHRDLKPSNLLLNTNCDLKICDFGLAR 154 (336)
T ss_pred EEEehhcc-cCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CeeccCCCHHHEEECCCCCEEECccccee
Confidence 99999997 4999999888899999999999999999999998 99999999999999999999999999997
Q ss_pred cccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCC---
Q psy14889 290 SYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVP--- 366 (443)
Q Consensus 290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~--- 366 (443)
.......... ......||..|+|||.+.+.. .++.++|||||||++|||++|+ .||.+...
T Consensus 155 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~-----~~~~~~DvwslGvil~el~~G~----------~~f~~~~~~~~ 218 (336)
T cd07849 155 IADPEHDHTG-FLTEYVATRWYRAPEIMLNSK-----GYTKAIDIWSVGCILAEMLSNR----------PLFPGKDYLHQ 218 (336)
T ss_pred eccccccccC-CcCCcCcCCCccChHHhhCCC-----CCCcHHHHHHHHHHHHHHHhCC----------CCCCCCCHHHH
Confidence 6543222111 123346889999999875431 4567999999999999999994 44433110
Q ss_pred --------CCCChHHHHhhhh--------hcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHH--HHHH
Q psy14889 367 --------MDPSFDDMRKVIC--------IDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKT--LIKL 428 (443)
Q Consensus 367 --------~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~--L~~l 428 (443)
..+..+....... .....+..+........+.++.+++.+||+.||++|||+.++++. ++..
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~ 298 (336)
T cd07849 219 LNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY 298 (336)
T ss_pred HHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence 0000011110000 000000000000001234678999999999999999999999886 5544
Q ss_pred h
Q psy14889 429 A 429 (443)
Q Consensus 429 ~ 429 (443)
.
T Consensus 299 ~ 299 (336)
T cd07849 299 H 299 (336)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=288.18 Aligned_cols=249 Identities=28% Similarity=0.411 Sum_probs=196.8
Q ss_pred cccccceeeeecCeEEEEEEE--CCceeEEEEeeccCc--cchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEee
Q psy14889 137 QISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDE--ASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLV 212 (443)
Q Consensus 137 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~--~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv 212 (443)
+|++.+.||+|++|.||+|.. +++.||||++..... .....+.|+..+..++|+||+++++++... ..+++|
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----~~~~lv 77 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKE----GEISIV 77 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccC----CeEEEE
Confidence 688899999999999999988 489999998865543 223345666666668999999999998776 458999
Q ss_pred ecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHH-chhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCccc
Q psy14889 213 THYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHT-EIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVS 290 (443)
Q Consensus 213 ~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~-~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~ 290 (443)
+||+++++|.+++.. ..+++..+..++.|++.||.|||+ . +++|+||+|+||+++.++.++|+|||++..
T Consensus 78 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~--------~~~H~~l~~~ni~~~~~~~~~l~df~~~~~ 149 (264)
T cd06623 78 LEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKR--------HIIHRDIKPSNLLINSKGEVKIADFGISKV 149 (264)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccC--------CCccCCCCHHHEEECCCCCEEEccCcccee
Confidence 999999999999965 779999999999999999999998 8 999999999999999999999999999876
Q ss_pred ccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCC
Q psy14889 291 YSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPS 370 (443)
Q Consensus 291 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~ 370 (443)
........ ....++..|+|||.+... .++.++|+||||+++|||+|| ..||..... ..
T Consensus 150 ~~~~~~~~----~~~~~~~~y~~pE~~~~~------~~~~~~Dv~slG~il~~l~tg----------~~p~~~~~~--~~ 207 (264)
T cd06623 150 LENTLDQC----NTFVGTVTYMSPERIQGE------SYSYAADIWSLGLTLLECALG----------KFPFLPPGQ--PS 207 (264)
T ss_pred cccCCCcc----cceeecccccCHhhhCCC------CCCchhhHHHHHHHHHHHHhC----------CCCCccccc--cC
Confidence 65432221 234678899999998776 566899999999999999999 566655321 12
Q ss_pred hHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHH
Q psy14889 371 FDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKT 424 (443)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 424 (443)
.......+. ....+..+. ...+..+.+++.+||+.+|++|||+.++++.
T Consensus 208 ~~~~~~~~~-~~~~~~~~~----~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 208 FFELMQAIC-DGPPPSLPA----EEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred HHHHHHHHh-cCCCCCCCc----ccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 223333222 112222221 1156789999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG4645|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=335.90 Aligned_cols=252 Identities=28% Similarity=0.439 Sum_probs=201.4
Q ss_pred hccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCc-----cchHHHHHHHHHHhccCCCceeeeeeccccCCccc
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDE-----ASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCT 207 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~-----~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~ 207 (443)
.-+++....||.|.||.||-|.. +|...|+|-+..... ....+|..++.. ++|||+|+++|+-.+.+
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~--lnHpNlV~YyGVEvHRe---- 1307 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEG--LNHPNLVRYYGVEVHRE---- 1307 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHh--ccCccccccCceeecHH----
Confidence 34667778999999999999987 789999997643322 223334444444 99999999999987774
Q ss_pred EEEeeecccCcccHHHHhcccC-CCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecC
Q psy14889 208 QLWLVTHYHSFGSLYDHLNRTT-LNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFG 286 (443)
Q Consensus 208 ~~~lv~e~~~~gsL~~~l~~~~-l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfG 286 (443)
.++|.||||.+|+|.+.+..++ .++.....+..|++.|++|||++ |||||||||.||+++.+|.+|++|||
T Consensus 1308 kv~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~--------gIVHRDIK~aNI~Ld~~g~iK~~DFG 1379 (1509)
T KOG4645|consen 1308 KVYIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEH--------GIVHRDIKPANILLDFNGLIKYGDFG 1379 (1509)
T ss_pred HHHHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhc--------CceecCCCccceeeecCCcEEeeccc
Confidence 4799999999999999997654 45555667889999999999999 99999999999999999999999999
Q ss_pred CcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCC
Q psy14889 287 LAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVP 366 (443)
Q Consensus 287 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~ 366 (443)
.|..+...............||+.|||||++.+.... .-.-+.||||+|||+.||+|| +.||...
T Consensus 1380 sa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~k---G~~~A~DiWslGCVVlEM~tG----------krPW~~~-- 1444 (1509)
T KOG4645|consen 1380 SAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGK---GHGGAADIWSLGCVVLEMATG----------KRPWAEL-- 1444 (1509)
T ss_pred ceeEecCchhcCCHHHHhhcCCchhcCchhhcccccC---CCCcchhhhcccceEEEeecC----------CCchhhc--
Confidence 9988876543333333456899999999999876432 333589999999999999999 7788775
Q ss_pred CCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 367 MDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
+..+..+.... .+..|++|.. .+.+-.+++.+||..||+.|.++.|+++
T Consensus 1445 -dne~aIMy~V~--~gh~Pq~P~~-----ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1445 -DNEWAIMYHVA--AGHKPQIPER-----LSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred -cchhHHHhHHh--ccCCCCCchh-----hhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 34555555543 3567777753 7788999999999999999998887765
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=288.08 Aligned_cols=250 Identities=26% Similarity=0.393 Sum_probs=193.0
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccC------ccchHHHHHHHHHHhccCCCceeeeeeccccCCccc
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRD------EASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCT 207 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~------~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~ 207 (443)
.+|.+.+.||+|+||.||+|.. +++.||+|.+.... ......+.|+..+..++|+||+++++++.+... .
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~--~ 79 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEE--K 79 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCC--C
Confidence 5789999999999999999987 58899999874321 111233456667777999999999998766543 4
Q ss_pred EEEeeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecC
Q psy14889 208 QLWLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFG 286 (443)
Q Consensus 208 ~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfG 286 (443)
.+++++||+++++|.+++.. ..+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||
T Consensus 80 ~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~--------~i~H~dl~p~ni~i~~~~~~~l~dfg 151 (264)
T cd06653 80 KLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSN--------MIVHRDIKGANILRDSAGNVKLGDFG 151 (264)
T ss_pred EEEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC--------CEecCCCCHHHEEEcCCCCEEECccc
Confidence 57899999999999999864 5689999999999999999999998 99999999999999999999999999
Q ss_pred CcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCC
Q psy14889 287 LAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVP 366 (443)
Q Consensus 287 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~ 366 (443)
+++........ ........|+..|+|||.+.+. .++.++|+|||||++|||++| ..||.+..
T Consensus 152 ~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~il~~l~~g----------~~p~~~~~- 213 (264)
T cd06653 152 ASKRIQTICMS-GTGIKSVTGTPYWMSPEVISGE------GYGRKADVWSVACTVVEMLTE----------KPPWAEYE- 213 (264)
T ss_pred ccccccccccc-CccccccCCcccccCHhhhcCC------CCCccccHHHHHHHHHHHHhC----------CCCCCccC-
Confidence 99765432111 1111234688999999998765 566899999999999999999 66775531
Q ss_pred CCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 367 MDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
....+.+.. ....++.+| ...++.+.+++.+||+ +|..||++.+++.
T Consensus 214 ---~~~~~~~~~-~~~~~~~~p-----~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 214 ---AMAAIFKIA-TQPTKPMLP-----DGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred ---HHHHHHHHH-cCCCCCCCC-----cccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 122222222 112222233 4466789999999999 5799999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=324.57 Aligned_cols=257 Identities=23% Similarity=0.380 Sum_probs=191.7
Q ss_pred hhccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccc--hHHHHHHHHHHhccCCCceeeeeeccccC------
Q psy14889 134 LAKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEAS--WSRETEIYSTVLLRHENILGYIGSDMTSR------ 203 (443)
Q Consensus 134 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~--~~~e~ei~~~~~l~H~nIv~l~g~~~~~~------ 203 (443)
...+|+..+.||+||||.||+++. +|+.+|||++..+.... ...-+|+..+.+|+|||||+++..+.+..
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence 446788999999999999999986 89999999986654222 22245788888899999999986332100
Q ss_pred --------------------------------------------------------------------------------
Q psy14889 204 -------------------------------------------------------------------------------- 203 (443)
Q Consensus 204 -------------------------------------------------------------------------------- 203 (443)
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence
Q ss_pred --------------------C---------cccEEEeeecccCcccHHHHhcccCCC--HHHHHHHHHHHHHHHHHHHHc
Q psy14889 204 --------------------N---------SCTQLWLVTHYHSFGSLYDHLNRTTLN--HHQMMKICLSIVNGLVHLHTE 252 (443)
Q Consensus 204 --------------------~---------~~~~~~lv~e~~~~gsL~~~l~~~~l~--~~~~~~i~~qia~gL~yLH~~ 252 (443)
+ ....+||-||||+.-.|++++++..+. ....++++++|+.||.|+|+.
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~ 716 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQ 716 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhC
Confidence 0 002479999999998888888776664 778899999999999999999
Q ss_pred hhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcccccc--------------cCCcCCCCCCCcccccCcccccccc
Q psy14889 253 IFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQ--------------LSNKMDIPPNPRVGTKRYMSPEILD 318 (443)
Q Consensus 253 ~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~~~--------------~~~~~~~~~~~~~gt~~y~aPE~~~ 318 (443)
|||||||||.||++|++..+||+|||+|..... .....+...+..+||.-|+|||++.
T Consensus 717 --------giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~ 788 (1351)
T KOG1035|consen 717 --------GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLS 788 (1351)
T ss_pred --------ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhc
Confidence 999999999999999999999999999976220 0111111335678999999999998
Q ss_pred cccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCC--CCCchh
Q psy14889 319 ESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNR--WVSDST 396 (443)
Q Consensus 319 ~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 396 (443)
+... ..|+.|+|+||+|||++||+ .||.- ..+....+... ..+.+|.. +..+ .
T Consensus 789 ~~~~---~~Yn~KiDmYSLGIVlFEM~-------------yPF~T------sMERa~iL~~L--R~g~iP~~~~f~~~-~ 843 (1351)
T KOG1035|consen 789 DTSS---NKYNSKIDMYSLGIVLFEML-------------YPFGT------SMERASILTNL--RKGSIPEPADFFDP-E 843 (1351)
T ss_pred cccc---ccccchhhhHHHHHHHHHHh-------------ccCCc------hHHHHHHHHhc--ccCCCCCCcccccc-c
Confidence 7632 26889999999999999996 35543 22222222222 23444432 2222 3
Q ss_pred HHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 397 LNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 397 ~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
...-..+|+++++.||.+||||.|+++
T Consensus 844 ~~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 844 HPEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred chHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 345678999999999999999999886
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=289.34 Aligned_cols=241 Identities=22% Similarity=0.275 Sum_probs=185.0
Q ss_pred cccccccee--eeecCeEEEEEEE--CCceeEEEEeeccCccchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEe
Q psy14889 136 KQISLSECI--GKGRYGEVWRGVW--HGENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWL 211 (443)
Q Consensus 136 ~~~~~~~~l--G~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~l 211 (443)
++|.+.+.+ |+|+||.||++.. ++..+|+|......... .|.++.... .+||||+++++.+... ..+++
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--~e~~~~~~~-~~h~~iv~~~~~~~~~----~~~~i 86 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--IEPMVHQLM-KDNPNFIKLYYSVTTL----KGHVL 86 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--hhHHHHHHh-hcCCCEEEEEEEEecC----CeeEE
Confidence 466666665 9999999999987 57889999875432221 133332221 3799999999998776 35899
Q ss_pred eecccCcccHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCC-cEEEEecCCcc
Q psy14889 212 VTHYHSFGSLYDHLNRT-TLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNG-TCVIADFGLAV 289 (443)
Q Consensus 212 v~e~~~~gsL~~~l~~~-~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~-~~kl~DfGla~ 289 (443)
||||+++|+|.++++.. .+++..+..++.|+++||.|||+. +++||||||+||+++.++ .++|+|||++.
T Consensus 87 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~--------~i~H~dl~p~nil~~~~~~~~~l~dfg~~~ 158 (267)
T PHA03390 87 IMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKH--------NIIHNDIKLENVLYDRAKDRIYLCDYGLCK 158 (267)
T ss_pred EEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CeeeCCCCHHHEEEeCCCCeEEEecCccce
Confidence 99999999999999764 799999999999999999999998 999999999999999998 99999999987
Q ss_pred cccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCC
Q psy14889 290 SYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDP 369 (443)
Q Consensus 290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~ 369 (443)
..... ....|+..|+|||++.+. .++.++||||||+++|||++| ..||........
T Consensus 159 ~~~~~--------~~~~~~~~y~aPE~~~~~------~~~~~~DvwslG~il~~l~~g----------~~p~~~~~~~~~ 214 (267)
T PHA03390 159 IIGTP--------SCYDGTLDYFSPEKIKGH------NYDVSFDWWAVGVLTYELLTG----------KHPFKEDEDEEL 214 (267)
T ss_pred ecCCC--------ccCCCCCcccChhhhcCC------CCCchhhHHHHHHHHHHHHHC----------CCCCCCCCcchh
Confidence 55422 123578899999999775 667899999999999999999 667764322211
Q ss_pred ChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCc-HHHHHH
Q psy14889 370 SFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLS-ALRVKK 423 (443)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-~~evl~ 423 (443)
......... ......+ ...+..+.+++.+||+.||.+||+ ++++++
T Consensus 215 ~~~~~~~~~---~~~~~~~-----~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 215 DLESLLKRQ---QKKLPFI-----KNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred hHHHHHHhh---cccCCcc-----cccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 122222221 1111111 236678999999999999999996 588874
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=296.25 Aligned_cols=253 Identities=23% Similarity=0.303 Sum_probs=184.2
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc--chHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEe
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA--SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWL 211 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~--~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~l 211 (443)
++|++.+.||+|+||.||+|.. +++.||+|.+...... ......|+..+..++|+||+++++++.+. ...++
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~----~~~~l 80 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTK----KTLTL 80 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecC----CeEEE
Confidence 6799999999999999999987 5889999988643221 12233456666669999999999998765 45799
Q ss_pred eecccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcc
Q psy14889 212 VTHYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAV 289 (443)
Q Consensus 212 v~e~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~ 289 (443)
||||+.+ +|.+++.+ ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 81 v~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~--------~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 151 (291)
T cd07844 81 VFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQR--------RVLHRDLKPQNLLISERGELKLADFGLAR 151 (291)
T ss_pred EEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CeecccCCHHHEEEcCCCCEEECcccccc
Confidence 9999984 99998864 4689999999999999999999998 99999999999999999999999999986
Q ss_pred cccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCC
Q psy14889 290 SYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDP 369 (443)
Q Consensus 290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~ 369 (443)
........ .....++..|+|||.+.+.. .++.++||||||+++|||++| ..||.....
T Consensus 152 ~~~~~~~~----~~~~~~~~~~~aPE~~~~~~-----~~~~~~Dv~slG~il~~l~~g----------~~~~~~~~~--- 209 (291)
T cd07844 152 AKSVPSKT----YSNEVVTLWYRPPDVLLGST-----EYSTSLDMWGVGCIFYEMATG----------RPLFPGSTD--- 209 (291)
T ss_pred ccCCCCcc----ccccccccccCCcHHhhcCc-----ccCcHHHHHHHHHHHHHHHhC----------CCCCCCCcc---
Confidence 54321111 12234678999999987531 456799999999999999999 445543210
Q ss_pred ChHHHHhhhhhcC----------------CC--------CCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 370 SFDDMRKVICIDQ----------------QR--------PVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 370 ~~~~~~~~~~~~~----------------~~--------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
..+.+........ .. ..+............+.+++.+||+.||++|||+.++++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 210 VEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred HHHHHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0011110000000 00 000000000111256889999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=288.70 Aligned_cols=244 Identities=26% Similarity=0.416 Sum_probs=188.9
Q ss_pred cccccceeeeecCeEEEEEEE--CCceeEEEEeeccC---ccchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEe
Q psy14889 137 QISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRD---EASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWL 211 (443)
Q Consensus 137 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~---~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~l 211 (443)
+|++.+.||+|+||.||+|.. +|..+|+|.+.... ......+.|+..+..++|+||+++++.+... ...++
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~----~~~~l 76 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQEN----GRLFI 76 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccC----CeEEE
Confidence 478889999999999999998 57899999885532 1222234566666679999999999988765 45799
Q ss_pred eecccCcccHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCC-cEEEEecCC
Q psy14889 212 VTHYHSFGSLYDHLNR---TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNG-TCVIADFGL 287 (443)
Q Consensus 212 v~e~~~~gsL~~~l~~---~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~-~~kl~DfGl 287 (443)
|+||+++++|.+++.+ ..+++..+..++.|++.||.|||+. +++|+||||+||++++++ .+||+|||.
T Consensus 77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--------~i~H~dl~~~nil~~~~~~~~~l~d~~~ 148 (257)
T cd08225 77 VMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR--------KILHRDIKSQNIFLSKNGMVAKLGDFGI 148 (257)
T ss_pred EEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC--------CcccccCCHHHEEEcCCCCeEEeccccc
Confidence 9999999999999864 2479999999999999999999998 999999999999999886 569999999
Q ss_pred cccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCC
Q psy14889 288 AVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPM 367 (443)
Q Consensus 288 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~ 367 (443)
+......... .....|++.|+|||.+.+. .++.++|+||||+++|||++| ..||....
T Consensus 149 ~~~~~~~~~~----~~~~~~~~~~~ape~~~~~------~~~~~~Dv~slG~il~~l~~g----------~~p~~~~~-- 206 (257)
T cd08225 149 ARQLNDSMEL----AYTCVGTPYYLSPEICQNR------PYNNKTDIWSLGCVLYELCTL----------KHPFEGNN-- 206 (257)
T ss_pred chhccCCccc----ccccCCCccccCHHHHcCC------CCCchhhHHHHHHHHHHHHhC----------CCCCCCcc--
Confidence 8766432211 1223588899999998765 566899999999999999999 66665421
Q ss_pred CCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 368 DPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
..+...... . ...+.. ....+..+.+++.+||+.+|++|||+.++++
T Consensus 207 --~~~~~~~~~-~-~~~~~~-----~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 207 --LHQLVLKIC-Q-GYFAPI-----SPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred --HHHHHHHHh-c-ccCCCC-----CCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 111222211 1 111111 1235567999999999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=320.88 Aligned_cols=258 Identities=21% Similarity=0.252 Sum_probs=179.3
Q ss_pred hhhccccccceeeeecCeEEEEEEEC---CceeEEE------------------EeeccCccchHHHHHHHHHHhccCCC
Q psy14889 133 TLAKQISLSECIGKGRYGEVWRGVWH---GENVAVK------------------IFFSRDEASWSRETEIYSTVLLRHEN 191 (443)
Q Consensus 133 ~~~~~~~~~~~lG~G~fg~Vy~~~~~---~~~vAvK------------------~~~~~~~~~~~~e~ei~~~~~l~H~n 191 (443)
.+.++|++.+.||+|+||+||++.+. +...++| .+..........+.|+..+..++|||
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence 34578999999999999999998752 2222222 11111112223356777777799999
Q ss_pred ceeeeeeccccCCcccEEEeeecccCcccHHHHhcccC------CCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEe
Q psy14889 192 ILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTT------LNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHR 265 (443)
Q Consensus 192 Iv~l~g~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~------l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHr 265 (443)
|+++++++.... ..++|+|++. ++|.+++.... .....+..++.||+.||.|||+. +|+||
T Consensus 225 Iv~l~~~~~~~~----~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~--------gIiHr 291 (501)
T PHA03210 225 ILKIEEILRSEA----NTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK--------KLIHR 291 (501)
T ss_pred cCcEeEEEEECC----eeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC--------CeecC
Confidence 999999987763 4689999986 58888775432 33566788999999999999998 99999
Q ss_pred CCCCCCEEEcCCCcEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHH
Q psy14889 266 DIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVC 345 (443)
Q Consensus 266 Dlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ell 345 (443)
||||+|||++.++.+||+|||+++.+....... .....||..|+|||++.+. .++.++|||||||++|||+
T Consensus 292 DLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~~DiwSlGvil~ell 362 (501)
T PHA03210 292 DIKLENIFLNCDGKIVLGDFGTAMPFEKEREAF---DYGWVGTVATNSPEILAGD------GYCEITDIWSCGLILLDML 362 (501)
T ss_pred CCCHHHEEECCCCCEEEEeCCCceecCcccccc---cccccCCcCCCCchhhcCC------CCCcHHHHHHHHHHHHHHH
Confidence 999999999999999999999998765432211 2345799999999999876 6778999999999999999
Q ss_pred hcccCCCcccccCCCCCCCCCCCCChHHHHhhhhh------------------------cCCCCCCCCCCCCchhHHHHH
Q psy14889 346 RRTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICI------------------------DQQRPVLPNRWVSDSTLNAMT 401 (443)
Q Consensus 346 tg~~~~~~~~~~~~P~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~~~~~~~~~l~ 401 (443)
+|.. .||..... . ....+.+.+.. ......++..+.....+..+.
T Consensus 363 ~~~~---------~p~~~~~~-~-~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 431 (501)
T PHA03210 363 SHDF---------CPIGDGGG-K-PGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFE 431 (501)
T ss_pred HCCC---------CCccCCCC-C-HHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHH
Confidence 9842 12221100 0 01111111100 000001111111112345678
Q ss_pred HHHHHHhcCCcCCCCcHHHHHH
Q psy14889 402 KVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 402 ~li~~cl~~dP~~Rps~~evl~ 423 (443)
+++.+||+.||++|||+.|+++
T Consensus 432 ~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 432 YPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred HHHHHHhccCcccCcCHHHHhh
Confidence 8899999999999999999986
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=292.37 Aligned_cols=251 Identities=25% Similarity=0.345 Sum_probs=185.7
Q ss_pred cccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc---chHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEe
Q psy14889 137 QISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA---SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWL 211 (443)
Q Consensus 137 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~---~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~l 211 (443)
+|+..+.||+|+||.||+|.. +|+.||||.+...... ....+.|+..+..++||||+++++++.+. ...++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~----~~~~~ 76 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTE----NKLYL 76 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccC----CcEEE
Confidence 478889999999999999987 5889999987543221 12334566677779999999999998765 35799
Q ss_pred eecccCcccHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCc
Q psy14889 212 VTHYHSFGSLYDHLNR---TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA 288 (443)
Q Consensus 212 v~e~~~~gsL~~~l~~---~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla 288 (443)
||||+. ++|.+++.. ..+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||++
T Consensus 77 v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~--------~i~H~~l~p~nill~~~~~~~l~dfg~~ 147 (284)
T cd07860 77 VFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH--------RVLHRDLKPQNLLINTEGAIKLADFGLA 147 (284)
T ss_pred Eeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC--------CeecCCCCHHHEEECCCCCEEEeeccch
Confidence 999996 689888853 5689999999999999999999988 9999999999999999999999999998
Q ss_pred ccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCC
Q psy14889 289 VSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMD 368 (443)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~ 368 (443)
......... .....++..|+|||.+.+.. .++.++||||||+++|||+|| ..||....
T Consensus 148 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~-----~~~~~~Dv~slG~il~~l~tg----------~~p~~~~~--- 205 (284)
T cd07860 148 RAFGVPVRT----YTHEVVTLWYRAPEILLGCK-----YYSTAVDIWSLGCIFAEMVTR----------RALFPGDS--- 205 (284)
T ss_pred hhcccCccc----cccccccccccCCeEEecCC-----CCCcHHHHHHHHHHHHHHHHC----------CCCCCCCC---
Confidence 765432211 12335678999999887542 345789999999999999999 55554321
Q ss_pred CChHHHHhhhhhcCCC---------------CCCCCC---C---CCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 369 PSFDDMRKVICIDQQR---------------PVLPNR---W---VSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 369 ~~~~~~~~~~~~~~~~---------------~~~~~~---~---~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
......+........ ..++.. . .....+.++.+++.+||+.||++|||+.++++
T Consensus 206 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 206 -EIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred -HHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 111111111100000 000000 0 00124467889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=295.25 Aligned_cols=254 Identities=24% Similarity=0.324 Sum_probs=187.3
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccc---hHHHHHHHHHHhccCCCceeeeeeccccCCcccEEE
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEAS---WSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLW 210 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~---~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~ 210 (443)
++|++.+.||+|+||.||+|.+ +++.+|+|.+....... .....|+..+..++||||+++++++..... ...+
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~--~~~~ 82 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNL--DKIY 82 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCC--CcEE
Confidence 5788999999999999999998 47899999886443221 122345666666999999999998876532 4589
Q ss_pred eeecccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCc
Q psy14889 211 LVTHYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA 288 (443)
Q Consensus 211 lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla 288 (443)
+||||+. ++|.+++.. ..+++..++.++.||+.||+|||+. +++|+||||+||+++.++.+||+|||++
T Consensus 83 lv~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--------~i~H~dl~p~nili~~~~~~~l~d~g~~ 153 (293)
T cd07843 83 MVMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDN--------WILHRDLKTSNLLLNNRGILKICDFGLA 153 (293)
T ss_pred EEehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC--------CeeeccCCHHHEEECCCCcEEEeecCce
Confidence 9999998 499998864 3589999999999999999999998 9999999999999999999999999998
Q ss_pred ccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCC
Q psy14889 289 VSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMD 368 (443)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~ 368 (443)
......... .....++..|+|||.+.+.. .++.++|+||||+++|||++|. .||.....
T Consensus 154 ~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~-----~~~~~~Di~slG~~l~~l~~g~----------~~f~~~~~-- 212 (293)
T cd07843 154 REYGSPLKP----YTQLVVTLWYRAPELLLGAK-----EYSTAIDMWSVGCIFAELLTKK----------PLFPGKSE-- 212 (293)
T ss_pred eeccCCccc----cccccccccccCchhhcCCc-----cccchhhHHHHHHHHHHHHhCC----------CCCCCCCh--
Confidence 766543211 12345788999999987542 3457999999999999999994 44433211
Q ss_pred CChHHHHhhhhh------------------c-----CCCC-CCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 369 PSFDDMRKVICI------------------D-----QQRP-VLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 369 ~~~~~~~~~~~~------------------~-----~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
.....+.... . .... .+...+.....++.+.+++++||+.||++|||+.|+++
T Consensus 213 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 213 --IDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred --HHHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 1111110000 0 0000 00000111113567899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG0596|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=299.88 Aligned_cols=252 Identities=20% Similarity=0.355 Sum_probs=187.4
Q ss_pred hccccccceeeeecCeEEEEEEE-CCceeEEEEeeccC-----ccchHHHHHHHHHHhccCCCceeeeeeccccCCcccE
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVW-HGENVAVKIFFSRD-----EASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQ 208 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~-----~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~ 208 (443)
...|++.++||+||.+.||++.. +.+.+|+|.+.... .+.+..|.+++...+ .|.+||++++|-..+ ..
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLk-g~~~IIqL~DYEv~d----~~ 434 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLK-GHDKIIQLYDYEVTD----GY 434 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhc-CCceEEEEeeeeccC----ce
Confidence 35699999999999999999988 45677887653322 223445555555432 589999999998775 67
Q ss_pred EEeeecccCcccHHHHhcccC--CCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecC
Q psy14889 209 LWLVTHYHSFGSLYDHLNRTT--LNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFG 286 (443)
Q Consensus 209 ~~lv~e~~~~gsL~~~l~~~~--l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfG 286 (443)
+||||||-+ -||..+|++.. +..-.+..+..|++.++.++|.+ ||||.||||.|+|+- .|.+||+|||
T Consensus 435 lYmvmE~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~--------gIVHSDLKPANFLlV-kG~LKLIDFG 504 (677)
T KOG0596|consen 435 LYMVMECGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQH--------GIVHSDLKPANFLLV-KGRLKLIDFG 504 (677)
T ss_pred EEEEeeccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHh--------ceeecCCCcccEEEE-eeeEEeeeec
Confidence 999999865 59999998644 23238888999999999999999 999999999999984 6789999999
Q ss_pred CcccccccCCcCCCCCCCcccccCccccccccccccc-----CcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCC
Q psy14889 287 LAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINM-----DCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPY 361 (443)
Q Consensus 287 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-----~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~ 361 (443)
+|..+..+.... -....+||+.||+||.+...... .....+.+|||||+||+||+|+.| +.||
T Consensus 505 IA~aI~~DTTsI--~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYg----------ktPf 572 (677)
T KOG0596|consen 505 IANAIQPDTTSI--VKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYG----------KTPF 572 (677)
T ss_pred hhcccCccccce--eeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhc----------CCch
Confidence 998887655433 23456899999999999754322 123567899999999999999999 6676
Q ss_pred CCCCCCCCChHHHHhhhhhcCCCC--CCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 362 HDLVPMDPSFDDMRKVICIDQQRP--VLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
.+.. ..+.+......... .+|. .....++.++|+.||..||++|||..++++
T Consensus 573 ~~~~------n~~aKl~aI~~P~~~Iefp~----~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 573 GQII------NQIAKLHAITDPNHEIEFPD----IPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred HHHH------HHHHHHHhhcCCCccccccC----CCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 6531 11222211111111 2222 112234999999999999999999999986
|
|
| >KOG0586|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=305.70 Aligned_cols=245 Identities=24% Similarity=0.340 Sum_probs=198.9
Q ss_pred hccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccch---HHHHHHHHHHhccCCCceeeeeeccccCCcccEE
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEASW---SRETEIYSTVLLRHENILGYIGSDMTSRNSCTQL 209 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~---~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~ 209 (443)
...|.+...||+|.|+.|.+|.+ ++..||||.+.+...... ..-+|+..++.++|||||+++.+.... ..+
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~----~~l 130 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETE----ATL 130 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeec----cee
Confidence 36799999999999999999998 799999998866543322 223566666679999999999998877 458
Q ss_pred EeeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCc
Q psy14889 210 WLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA 288 (443)
Q Consensus 210 ~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla 288 (443)
|+||||+.+|.+++|+.+ +.+.+..+..++.|+.+|++|||++ .|+|||||++||||+.+..+||+|||++
T Consensus 131 ylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k--------~ivHrdLk~eNilL~~~mnikIaDfgfS 202 (596)
T KOG0586|consen 131 YLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSK--------NIVHRDLKAENILLDENMNIKIADFGFS 202 (596)
T ss_pred EEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhc--------ceeccccchhhcccccccceeeeccccc
Confidence 999999999999999964 6678889999999999999999999 9999999999999999999999999999
Q ss_pred ccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCC
Q psy14889 289 VSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMD 368 (443)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~ 368 (443)
..+..... ..+.+|++.|.|||++.+... .++++|+||+|+++|-|+.| ..||.+..
T Consensus 203 ~~~~~~~~-----lqt~cgsppyAaPEl~~g~~y-----~gpe~D~Wslgvvly~LV~G----------sLPFDG~~--- 259 (596)
T KOG0586|consen 203 TFFDYGLM-----LQTFCGSPPYAAPELFNGKKY-----DGPEVDIWSLGVVLYALVEG----------SLPFDGQN--- 259 (596)
T ss_pred eeeccccc-----ccccCCCCCccChHhhcCccc-----CCcceehhhhhhhheeeeec----------ccccCCcc---
Confidence 87764332 245689999999999998742 23799999999999999999 78887642
Q ss_pred CChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 369 PSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
..+++..+.....+ +| ...+.+..++|+++|..+|.+|++++++.+
T Consensus 260 --lk~Lr~rvl~gk~r--Ip-----~~ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 260 --LKELRPRVLRGKYR--IP-----FYMSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred --cccccchheeeeec--cc-----ceeechhHHHHHHhhccCccccCCHHHhhh
Confidence 22222222222222 22 224557899999999999999999999876
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=292.63 Aligned_cols=253 Identities=23% Similarity=0.367 Sum_probs=185.8
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc--chHHHHHHHHHHhcc-CCCceeeeeeccccCCcccEEE
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA--SWSRETEIYSTVLLR-HENILGYIGSDMTSRNSCTQLW 210 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~--~~~~e~ei~~~~~l~-H~nIv~l~g~~~~~~~~~~~~~ 210 (443)
++|...+.||+|+||.||++.. +++.||+|.+...... ......|+..+..+. |+||+++++++.... ..+
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~----~~~ 79 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREG----DCW 79 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCC----cEE
Confidence 4677788999999999999988 5789999988643322 222344555555565 999999999887653 468
Q ss_pred eeecccCcccHHHHh---c---ccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEe
Q psy14889 211 LVTHYHSFGSLYDHL---N---RTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIAD 284 (443)
Q Consensus 211 lv~e~~~~gsL~~~l---~---~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~D 284 (443)
++|||+.. +|.++. . ...+++..+..++.|++.||+|||+.. +++||||||+||+++.++.+||+|
T Consensus 80 ~~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~-------~i~H~dlkp~Nil~~~~~~~kl~d 151 (288)
T cd06616 80 ICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL-------KIIHRDVKPSNILLDRNGNIKLCD 151 (288)
T ss_pred EEEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC-------CeeccCCCHHHEEEccCCcEEEee
Confidence 99999874 554432 1 356999999999999999999999742 899999999999999999999999
Q ss_pred cCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCC
Q psy14889 285 FGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDL 364 (443)
Q Consensus 285 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~ 364 (443)
||+++.+..... .....|+..|+|||.+.+... ..++.++|||||||++|||++| ..||...
T Consensus 152 fg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~---~~~~~~~Di~slG~il~el~~g----------~~p~~~~ 213 (288)
T cd06616 152 FGISGQLVDSIA-----KTRDAGCRPYMAPERIDPSAR---DGYDVRSDVWSLGITLYEVATG----------KFPYPKW 213 (288)
T ss_pred cchhHHhccCCc-----cccccCccCccCHHHhccccc---cCCcchhhhhHHHHHHHHHHhC----------CCCchhc
Confidence 999876543221 123368889999999875420 1456899999999999999999 6676543
Q ss_pred CCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHH
Q psy14889 365 VPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKT 424 (443)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 424 (443)
. ...+.+.+... ...+.++.. ....++.++.+|+.+||+.||++|||+++|++.
T Consensus 214 ~---~~~~~~~~~~~--~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 214 N---SVFDQLTQVVK--GDPPILSNS-EEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred c---hHHHHHhhhcC--CCCCcCCCc-CCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1 11122222211 112222211 113467789999999999999999999998874
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=289.34 Aligned_cols=250 Identities=23% Similarity=0.298 Sum_probs=183.0
Q ss_pred ccccceeeeecCeEEEEEEE--CCceeEEEEeeccCc--cchHHHHHHHHHHhc-cCCCceeeeeeccccCCcccEEEee
Q psy14889 138 ISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDE--ASWSRETEIYSTVLL-RHENILGYIGSDMTSRNSCTQLWLV 212 (443)
Q Consensus 138 ~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~--~~~~~e~ei~~~~~l-~H~nIv~l~g~~~~~~~~~~~~~lv 212 (443)
|++.+.||+|+||.||+|.. +++.||+|++..... .......|+..+..+ +|+||+++++++.+... ..+++|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~--~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKT--GRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCC--CcEEEE
Confidence 56788999999999999987 688999998765321 222223455555556 49999999999876532 357999
Q ss_pred ecccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCccc
Q psy14889 213 THYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVS 290 (443)
Q Consensus 213 ~e~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~ 290 (443)
+||++ |+|.+++.. ..+++.++..++.|++.||.|||+. +++||||||+||+++. +.+||+|||+++.
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~--------~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~ 148 (282)
T cd07831 79 FELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN--------GIFHRDIKPENILIKD-DILKLADFGSCRG 148 (282)
T ss_pred EecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC--------CceecccCHHHEEEcC-CCeEEEecccccc
Confidence 99997 588888864 4689999999999999999999998 9999999999999999 9999999999976
Q ss_pred ccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCC
Q psy14889 291 YSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPS 370 (443)
Q Consensus 291 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~ 370 (443)
+...... ....++..|+|||.+.... .++.++|||||||++|||++| ..||.....
T Consensus 149 ~~~~~~~-----~~~~~~~~y~aPE~~~~~~-----~~~~~~Di~slGv~l~el~~~----------~~p~~~~~~---- 204 (282)
T cd07831 149 IYSKPPY-----TEYISTRWYRAPECLLTDG-----YYGPKMDIWAVGCVFFEILSL----------FPLFPGTNE---- 204 (282)
T ss_pred cccCCCc-----CCCCCCcccCChhHhhcCC-----CCCcchhHHHHHHHHHHHHcC----------CcCCCCCCH----
Confidence 6432211 2245788999999875431 456799999999999999999 555544211
Q ss_pred hHHHHhhhhh--------------c-CCCCCCCCCC------CCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 371 FDDMRKVICI--------------D-QQRPVLPNRW------VSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 371 ~~~~~~~~~~--------------~-~~~~~~~~~~------~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
.+........ . ......+... .....+..+.+++.+||+.||++|||+.++++
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 205 LDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred HHHHHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 1111111000 0 0000111100 01235678999999999999999999999876
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=289.60 Aligned_cols=240 Identities=26% Similarity=0.386 Sum_probs=181.0
Q ss_pred eeeeecCeEEEEEEE--CCceeEEEEeeccCcc----c--hHHHHHHHHH-HhccCCCceeeeeeccccCCcccEEEeee
Q psy14889 143 CIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA----S--WSRETEIYST-VLLRHENILGYIGSDMTSRNSCTQLWLVT 213 (443)
Q Consensus 143 ~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~----~--~~~e~ei~~~-~~l~H~nIv~l~g~~~~~~~~~~~~~lv~ 213 (443)
.||+|+||.||++.. +++.+|+|.+...... . ...+..+... ...+||||+.+++++... ...++||
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~----~~~~lv~ 76 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTP----DKLCFIL 76 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecC----CeEEEEE
Confidence 489999999999987 5789999988543211 1 1122222222 224799999999988765 3579999
Q ss_pred cccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCccccc
Q psy14889 214 HYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYS 292 (443)
Q Consensus 214 e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~~ 292 (443)
||+++|+|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++....
T Consensus 77 e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~--------~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~ 148 (279)
T cd05633 77 DLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNR--------FVVYRDLKPANILLDEHGHVRISDLGLACDFS 148 (279)
T ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CcCCCCCCHHHEEECCCCCEEEccCCcceecc
Confidence 99999999998864 5699999999999999999999998 99999999999999999999999999986553
Q ss_pred ccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCChH
Q psy14889 293 QLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFD 372 (443)
Q Consensus 293 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~~~ 372 (443)
... .....||..|+|||.+..+. .++.++|||||||++|||++| ..||...... ...
T Consensus 149 ~~~------~~~~~~~~~y~aPE~~~~~~-----~~~~~~Di~slG~~l~~l~~g----------~~pf~~~~~~--~~~ 205 (279)
T cd05633 149 KKK------PHASVGTHGYMAPEVLQKGT-----AYDSSADWFSLGCMLFKLLRG----------HSPFRQHKTK--DKH 205 (279)
T ss_pred ccC------ccCcCCCcCccCHHHhcCCC-----CCCchhhhHHHHHHHHHHHhC----------CCCcCCCCCc--CHH
Confidence 221 12346899999999986431 456899999999999999999 6677553221 122
Q ss_pred HHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCC-----cHHHHHHH
Q psy14889 373 DMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRL-----SALRVKKT 424 (443)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~ 424 (443)
....... .....++ ...+.++.+++.+||+.||++|| |+.++++.
T Consensus 206 ~~~~~~~--~~~~~~~-----~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 206 EIDRMTL--TVNVELP-----DSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred HHHHHhh--cCCcCCc-----cccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 2222211 1122222 33567899999999999999999 58888773
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=298.67 Aligned_cols=256 Identities=24% Similarity=0.343 Sum_probs=188.6
Q ss_pred hhccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCc---cchHHHHHHHHHHhccCCCceeeeeeccccCC--cc
Q psy14889 134 LAKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDE---ASWSRETEIYSTVLLRHENILGYIGSDMTSRN--SC 206 (443)
Q Consensus 134 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~---~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~--~~ 206 (443)
+.++|+..+.||+|+||.||+|.. +|+.||+|++..... .......|+..+..++||||+++++++..... ..
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 447899999999999999999987 689999998754221 11122345666666999999999998764432 12
Q ss_pred cEEEeeecccCcccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecC
Q psy14889 207 TQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFG 286 (443)
Q Consensus 207 ~~~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfG 286 (443)
...++||||+. ++|.+.+... +++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~~-l~~~~~~~~~~ql~~aL~~LH~~--------gi~H~dlkp~Nil~~~~~~~kL~Dfg 163 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQMD-LDHERMSYLLYQMLCGIKHLHSA--------GIIHRDLKPSNIVVKSDCTLKILDFG 163 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhhc-CCHHHHHHHHHHHHHHHHHHHhC--------CeeeCCCCHHHEEECCCCCEEEccCc
Confidence 34799999997 5888888654 89999999999999999999998 99999999999999999999999999
Q ss_pred CcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCC
Q psy14889 287 LAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVP 366 (443)
Q Consensus 287 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~ 366 (443)
+++....... .....++..|+|||.+.+. .++.++|||||||++|+|++| ..||.....
T Consensus 164 ~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~------~~~~~~DvwslG~~l~~l~~g----------~~pf~~~~~ 222 (353)
T cd07850 164 LARTAGTSFM-----MTPYVVTRYYRAPEVILGM------GYKENVDIWSVGCIMGEMIRG----------TVLFPGTDH 222 (353)
T ss_pred cceeCCCCCC-----CCCCcccccccCHHHHhCC------CCCCchhhHhHHHHHHHHHHC----------CCCCCCCCH
Confidence 9976543211 1234678899999999776 667899999999999999999 444432210
Q ss_pred CCCChHHHHhhhh-------------------hcCCCCC---------CCCCC-------CCchhHHHHHHHHHHHhcCC
Q psy14889 367 MDPSFDDMRKVIC-------------------IDQQRPV---------LPNRW-------VSDSTLNAMTKVMKECWHQN 411 (443)
Q Consensus 367 ~~~~~~~~~~~~~-------------------~~~~~~~---------~~~~~-------~~~~~~~~l~~li~~cl~~d 411 (443)
......... ....++. .+... .....++.+.+++.+||+.|
T Consensus 223 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 298 (353)
T cd07850 223 ----IDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVID 298 (353)
T ss_pred ----HHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCC
Confidence 000000000 0000000 00000 01234567899999999999
Q ss_pred cCCCCcHHHHHHH
Q psy14889 412 ANVRLSALRVKKT 424 (443)
Q Consensus 412 P~~Rps~~evl~~ 424 (443)
|++|||+.|+++.
T Consensus 299 P~~R~t~~eiL~~ 311 (353)
T cd07850 299 PEKRISVDDALQH 311 (353)
T ss_pred hhhCcCHHHHhcC
Confidence 9999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=298.00 Aligned_cols=264 Identities=25% Similarity=0.359 Sum_probs=194.2
Q ss_pred hhccccccceeeeecCeEEEEEEE--CCceeEEEEeeccC---ccchHHHHHHHHHHhc-cCCCceeeeeeccccCCccc
Q psy14889 134 LAKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRD---EASWSRETEIYSTVLL-RHENILGYIGSDMTSRNSCT 207 (443)
Q Consensus 134 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~---~~~~~~e~ei~~~~~l-~H~nIv~l~g~~~~~~~~~~ 207 (443)
+.++|++.+.||+|+||.||+|.. +++.+|+|++.... ........|+..+..+ +||||+++++++..... .
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~--~ 82 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEND--K 82 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCC--c
Confidence 457899999999999999999987 57899999875421 1112223466666668 99999999998765432 4
Q ss_pred EEEeeecccCcccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCC
Q psy14889 208 QLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGL 287 (443)
Q Consensus 208 ~~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGl 287 (443)
.+++||||++ ++|..++....+++..+..++.||+.||.|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~--------~i~H~dl~p~nill~~~~~~kl~d~g~ 153 (337)
T cd07852 83 DIYLVFEYME-TDLHAVIRANILEDVHKRYIMYQLLKALKYIHSG--------NVIHRDLKPSNILLNSDCRVKLADFGL 153 (337)
T ss_pred eEEEEecccc-cCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CeecCCCCHHHEEEcCCCcEEEeeccc
Confidence 5799999998 5999999877889999999999999999999998 999999999999999999999999999
Q ss_pred cccccccCCcC-CCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCC
Q psy14889 288 AVSYSQLSNKM-DIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVP 366 (443)
Q Consensus 288 a~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~ 366 (443)
+..+....... ........||..|+|||.+.+.. .++.++||||||+++|||++| ..||.....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-----~~~~~sDi~slG~~l~el~tg----------~~pf~~~~~ 218 (337)
T cd07852 154 ARSLSELEENPENPVLTDYVATRWYRAPEILLGST-----RYTKGVDMWSVGCILGEMLLG----------KPLFPGTST 218 (337)
T ss_pred hhccccccccccCcchhcccccccccCceeeeccc-----cccccchHHHHHHHHHHHHhC----------CCCCCCCCh
Confidence 97665432211 01123346889999999886531 455789999999999999999 445533211
Q ss_pred CCCChHHHHhhhhhc-------------------------CCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHH
Q psy14889 367 MDPSFDDMRKVICID-------------------------QQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRV 421 (443)
Q Consensus 367 ~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ev 421 (443)
.+......... ....... ... ...+.++.+++.+||+.||++|||+.++
T Consensus 219 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~-~~~~~~l~~li~~~l~~~P~~Rps~~~i 292 (337)
T cd07852 219 ----LNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLD-ELL-PKASDDALDLLKKLLVFNPNKRLTAEEA 292 (337)
T ss_pred ----HHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchh-hhc-cCCCHHHHHHHHHhccCCcccccCHHHH
Confidence 01111100000 0000000 011 1256789999999999999999999999
Q ss_pred HHH--HHHHh
Q psy14889 422 KKT--LIKLA 429 (443)
Q Consensus 422 l~~--L~~l~ 429 (443)
++. +..+.
T Consensus 293 l~~~~~~~~~ 302 (337)
T cd07852 293 LEHPYVAQFH 302 (337)
T ss_pred hhChhhhhhc
Confidence 975 55543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=289.80 Aligned_cols=252 Identities=22% Similarity=0.295 Sum_probs=187.8
Q ss_pred cccccceeeeecCeEEEEEEE--CCceeEEEEeeccCc---cchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEe
Q psy14889 137 QISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDE---ASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWL 211 (443)
Q Consensus 137 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~---~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~l 211 (443)
+|++.+.||+|+||.||+|.+ +|+.||+|++..... .......|+..+..++||||+++++++... ..+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~----~~~~~ 76 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHG----SGFVL 76 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecC----CeeEE
Confidence 478889999999999999997 588999998865432 122334566666668999999999998775 45799
Q ss_pred eecccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcc
Q psy14889 212 VTHYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAV 289 (443)
Q Consensus 212 v~e~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~ 289 (443)
|+||+ +++|.+++.. ..+++.++..++.||+.||.|||+. +++|+||||+||+++.++.++|+|||++.
T Consensus 77 v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~--------~i~H~dl~p~ni~~~~~~~~~l~dfg~~~ 147 (286)
T cd07832 77 VMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN--------GIMHRDLKPANLLISADGVLKIADFGLAR 147 (286)
T ss_pred Eeccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--------CeecCCcCHHHEEEcCCCcEEEeeeeecc
Confidence 99999 9999999854 5689999999999999999999998 99999999999999999999999999987
Q ss_pred cccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCC
Q psy14889 290 SYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDP 369 (443)
Q Consensus 290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~ 369 (443)
........ ......|+..|+|||.+.+.. .++.++||||||+++|||++|. .||....
T Consensus 148 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~-----~~~~~~Di~slG~~l~~l~tg~----------~~~~~~~---- 205 (286)
T cd07832 148 LFSEEEPR---LYSHQVATRWYRAPELLYGAR-----KYDPGVDLWAVGCIFAELLNGS----------PLFPGEN---- 205 (286)
T ss_pred cccCCCCC---ccccccCcccccCceeeeccc-----cCCchhHHHHHHHHHHHHHcCC----------cCcCCCC----
Confidence 66543211 122346889999999986542 3467999999999999999993 3443211
Q ss_pred ChHHHHhhhhhcC----------------CCCCCCCC----C--CCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 370 SFDDMRKVICIDQ----------------QRPVLPNR----W--VSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 370 ~~~~~~~~~~~~~----------------~~~~~~~~----~--~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
...........-. .....+.. + .....+..+.+++++||+.||++|||++++++
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 206 DIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred HHHHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 0111111100000 00000000 0 00124578999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=291.50 Aligned_cols=253 Identities=26% Similarity=0.390 Sum_probs=191.5
Q ss_pred hhhccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccc----hHHHHHHHHHHhccCCCceeeeeeccccCCcc
Q psy14889 133 TLAKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEAS----WSRETEIYSTVLLRHENILGYIGSDMTSRNSC 206 (443)
Q Consensus 133 ~~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~----~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~ 206 (443)
...+.|...+.||+|+||.||+++. ++..||+|.+....... .....|+..+..++|||++++++++....
T Consensus 22 ~~~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--- 98 (317)
T cd06635 22 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREH--- 98 (317)
T ss_pred CchhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC---
Confidence 3345688899999999999999987 57899999886432221 12234566666699999999999987763
Q ss_pred cEEEeeecccCcccHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEe
Q psy14889 207 TQLWLVTHYHSFGSLYDHLN--RTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIAD 284 (443)
Q Consensus 207 ~~~~lv~e~~~~gsL~~~l~--~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~D 284 (443)
..++||||+. |+|.+.+. ...+++.++..++.|++.||.|||+. +++||||+|+||+++.++.+||+|
T Consensus 99 -~~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~--------~i~H~dL~p~Nil~~~~~~~kl~d 168 (317)
T cd06635 99 -TAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH--------NMIHRDIKAGNILLTEPGQVKLAD 168 (317)
T ss_pred -eEEEEEeCCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CcccCCCCcccEEECCCCCEEEec
Confidence 4799999997 58887774 45689999999999999999999998 999999999999999999999999
Q ss_pred cCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCC
Q psy14889 285 FGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDL 364 (443)
Q Consensus 285 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~ 364 (443)
||++..... .....|+..|+|||.+..... ..++.++|||||||++|||++| ..||...
T Consensus 169 fg~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~---~~~~~~~Dv~slGvil~el~~g----------~~p~~~~ 227 (317)
T cd06635 169 FGSASIASP--------ANSFVGTPYWMAPEVILAMDE---GQYDGKVDVWSLGITCIELAER----------KPPLFNM 227 (317)
T ss_pred CCCccccCC--------cccccCCccccChhhhhcCCC---CCCCccccHHHHHHHHHHHHhC----------CCCCCCc
Confidence 999865432 123468889999999753211 1456899999999999999999 6666543
Q ss_pred CCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHh
Q psy14889 365 VPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLA 429 (443)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~ 429 (443)
. .......... . ..+..+ ....+..+.+++.+||+.+|.+||++.++++.+-.+.
T Consensus 228 ~----~~~~~~~~~~-~-~~~~~~----~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 228 N----AMSALYHIAQ-N-ESPTLQ----SNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred c----HHHHHHHHHh-c-cCCCCC----CccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 1 1122222221 1 111111 1335667999999999999999999999998654433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG0604|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=280.75 Aligned_cols=254 Identities=22% Similarity=0.341 Sum_probs=203.8
Q ss_pred hhhcccccc-ceeeeecCeEEEEEEE--CCceeEEEEeeccCccchHHHHHHHHHHhccCCCceeeeeeccccCCcccEE
Q psy14889 133 TLAKQISLS-ECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQL 209 (443)
Q Consensus 133 ~~~~~~~~~-~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~ 209 (443)
.++++|++. ++||-|-.|.|..+.. +++.+|+|++.. ....++|.|+.-+. -.|||||++++++.........+
T Consensus 58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D--s~KARrEVeLHw~~-s~h~~iV~IidVyeNs~~~rkcL 134 (400)
T KOG0604|consen 58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD--SPKARREVELHWMA-SGHPHIVSIIDVYENSYQGRKCL 134 (400)
T ss_pred cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc--CHHHHhHhhhhhhh-cCCCceEEeehhhhhhccCceee
Confidence 345667655 5899999999998877 689999998753 34456677776665 48999999999998776666779
Q ss_pred EeeecccCcccHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCC---CcEEEE
Q psy14889 210 WLVTHYHSFGSLYDHLNR---TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTN---GTCVIA 283 (443)
Q Consensus 210 ~lv~e~~~~gsL~~~l~~---~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~---~~~kl~ 283 (443)
.+|||+|+||.|.+.+++ ..+++.++..|+.||+.|+.|||+. +|.||||||+|+|.... ..+||+
T Consensus 135 LiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~--------nIAHRDlKpENLLyt~t~~na~lKLt 206 (400)
T KOG0604|consen 135 LIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSM--------NIAHRDLKPENLLYTTTSPNAPLKLT 206 (400)
T ss_pred EeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhc--------chhhccCChhheeeecCCCCcceEec
Confidence 999999999999999964 4599999999999999999999999 99999999999999754 478999
Q ss_pred ecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCC
Q psy14889 284 DFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHD 363 (443)
Q Consensus 284 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~ 363 (443)
|||+|+.-.... ...+.+-|+.|.|||++... +|....|+||+||++|-|+.| ..||..
T Consensus 207 DfGFAK~t~~~~-----~L~TPc~TPyYvaPevlg~e------KydkscdmwSlgVimYIlLCG----------yPPFYS 265 (400)
T KOG0604|consen 207 DFGFAKETQEPG-----DLMTPCFTPYYVAPEVLGPE------KYDKSCDMWSLGVIMYILLCG----------YPPFYS 265 (400)
T ss_pred ccccccccCCCc-----cccCCcccccccCHHHhCch------hcCCCCCccchhHHHHHhhcC----------CCcccc
Confidence 999997654321 12345789999999999876 677889999999999999999 677777
Q ss_pred CCCCCCChHHHHhhhhhcCCCCCCCC-CCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 364 LVPMDPSFDDMRKVICIDQQRPVLPN-RWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
.... .....++..+...+. .+|+ +| +..++..+++|+.+|..+|.+|.|+.++++
T Consensus 266 ~hg~-aispgMk~rI~~gqy--~FP~pEW--s~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 266 NHGL-AISPGMKRRIRTGQY--EFPEPEW--SCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred cCCc-cCChhHHhHhhccCc--cCCChhH--hHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 6542 233455555544333 3332 24 447788999999999999999999999876
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=286.17 Aligned_cols=239 Identities=24% Similarity=0.308 Sum_probs=181.1
Q ss_pred ceeeeecCeEEEEEEE--CCceeEEEEeeccCccc------hHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEeee
Q psy14889 142 ECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEAS------WSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVT 213 (443)
Q Consensus 142 ~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~------~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv~ 213 (443)
+.||+|+||.||+|.. +|+.||+|++....... ...|.++. ....+|+||+++++++... ..+++|+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~-~~~~~~~~i~~~~~~~~~~----~~~~lv~ 76 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIM-MIQGESPYVAKLYYSFQSK----DYLYLVM 76 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHH-hhcCCCCCeeeeeeeEEcC----CeEEEEE
Confidence 5689999999999988 58899999885432111 11122222 2236899999999998765 4589999
Q ss_pred cccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCccccc
Q psy14889 214 HYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYS 292 (443)
Q Consensus 214 e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~~ 292 (443)
||+++++|.++++. ..+++.++..++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||+++...
T Consensus 77 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~--------~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 148 (260)
T cd05611 77 EYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQR--------GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGL 148 (260)
T ss_pred eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC--------CeecCCCCHHHeEECCCCcEEEeecccceecc
Confidence 99999999999965 5689999999999999999999998 99999999999999999999999999986543
Q ss_pred ccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCChH
Q psy14889 293 QLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFD 372 (443)
Q Consensus 293 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~~~ 372 (443)
. .....|+..|+|||.+.+. .++.++||||||+++|||++| ..||.... ..
T Consensus 149 ~--------~~~~~~~~~y~~pe~~~~~------~~~~~~Dv~slG~il~~l~~g----------~~p~~~~~-----~~ 199 (260)
T cd05611 149 E--------NKKFVGTPDYLAPETILGV------GDDKMSDWWSLGCVIFEFLFG----------YPPFHAET-----PD 199 (260)
T ss_pred c--------cccCCCCcCccChhhhcCC------CCcchhhhHHHHHHHHHHHHC----------CCCCCCCC-----HH
Confidence 2 1234578899999998876 456899999999999999999 66765431 12
Q ss_pred HHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHH
Q psy14889 373 DMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTL 425 (443)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 425 (443)
.....+... ....+.. ....++..+.+++.+||+.||++||++.++.+.|
T Consensus 200 ~~~~~~~~~--~~~~~~~-~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 200 AVFDNILSR--RINWPEE-VKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred HHHHHHHhc--ccCCCCc-ccccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence 222222111 1111111 1123567899999999999999999876554433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=289.27 Aligned_cols=251 Identities=24% Similarity=0.340 Sum_probs=186.1
Q ss_pred cccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc--chHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEee
Q psy14889 137 QISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA--SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLV 212 (443)
Q Consensus 137 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~--~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv 212 (443)
+|+..+.||+|++|.||+|.. +|+.||||.+...... ......|+..+..++||||+++++++.+.+ ..++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~----~~~lv 76 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTEN----KLMLV 76 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCC----cEEEE
Confidence 478899999999999999998 5889999988654322 122234566666699999999999988763 47999
Q ss_pred ecccCcccHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCc
Q psy14889 213 THYHSFGSLYDHLNR----TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA 288 (443)
Q Consensus 213 ~e~~~~gsL~~~l~~----~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla 288 (443)
|||+++ +|.+++.. ..+++..+..++.|++.||.|||+. +++|+||||+||++++++.+||+|||++
T Consensus 77 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--------~i~h~dl~p~ni~~~~~~~~~l~d~g~~ 147 (284)
T cd07836 77 FEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN--------RVLHRDLKPQNLLINKRGELKLADFGLA 147 (284)
T ss_pred EecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC--------CeeeCCCCHHHEEECCCCcEEEeecchh
Confidence 999985 89888754 3589999999999999999999998 9999999999999999999999999999
Q ss_pred ccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCC
Q psy14889 289 VSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMD 368 (443)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~ 368 (443)
......... .....++..|+|||.+.+.. .++.++||||||+++|||++| ..||.+...
T Consensus 148 ~~~~~~~~~----~~~~~~~~~y~~PE~~~~~~-----~~~~~~Dv~slG~~l~~l~~g----------~~~~~~~~~-- 206 (284)
T cd07836 148 RAFGIPVNT----FSNEVVTLWYRAPDVLLGSR-----TYSTSIDIWSVGCIMAEMITG----------RPLFPGTNN-- 206 (284)
T ss_pred hhhcCCccc----cccccccccccChHHhcCCC-----CCCcHHHHHHHHHHHHHHHhC----------CCCCCCCCc--
Confidence 755432211 12345788999999986542 345799999999999999999 555543211
Q ss_pred CChHHHHhhhh---------------hcCCCCCCCCCC------CCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 369 PSFDDMRKVIC---------------IDQQRPVLPNRW------VSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 369 ~~~~~~~~~~~---------------~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
.+....... ........+... .....+..+.+++.+||+.||.+||++.++++
T Consensus 207 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 207 --EDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred --HHHHHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 111111110 000001111000 00123567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=295.12 Aligned_cols=198 Identities=27% Similarity=0.416 Sum_probs=156.4
Q ss_pred cccccceeeeecCeEEEEEEE----CCceeEEEEeeccC---c-cchHHHHHHHHHHhccCCCceeeeeeccccCCcccE
Q psy14889 137 QISLSECIGKGRYGEVWRGVW----HGENVAVKIFFSRD---E-ASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQ 208 (443)
Q Consensus 137 ~~~~~~~lG~G~fg~Vy~~~~----~~~~vAvK~~~~~~---~-~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~ 208 (443)
+|++.+.||+|+||.||+|.. ++..||+|.+.... . .......|+..+..++||||+++++++.+... ..
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--~~ 78 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHAD--KS 78 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCC--ce
Confidence 477889999999999999998 46899999886532 1 11222345555666999999999999887633 46
Q ss_pred EEeeecccCcccHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcC----CC
Q psy14889 209 LWLVTHYHSFGSLYDHLNR------TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKT----NG 278 (443)
Q Consensus 209 ~~lv~e~~~~gsL~~~l~~------~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~----~~ 278 (443)
+++||||+++ +|.+++.. ..+++..+..++.|++.||.|||+. +|+||||||+||+++. ++
T Consensus 79 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--------~i~h~dlkp~Nil~~~~~~~~~ 149 (316)
T cd07842 79 VYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN--------WVLHRDLKPANILVMGEGPERG 149 (316)
T ss_pred EEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC--------CEeeCCCCHHHEEEcCCCCccc
Confidence 8999999985 77766632 2688999999999999999999998 9999999999999999 89
Q ss_pred cEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCC
Q psy14889 279 TCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKAN 351 (443)
Q Consensus 279 ~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~ 351 (443)
.+||+|||++......... ........+|..|+|||.+.+.. .++.++||||||+++|||++|++++
T Consensus 150 ~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~-----~~~~~~Dv~slG~~l~~l~~~~~~~ 216 (316)
T cd07842 150 VVKIGDLGLARLFNAPLKP-LADLDPVVVTIWYRAPELLLGAR-----HYTKAIDIWAIGCIFAELLTLEPIF 216 (316)
T ss_pred eEEECCCccccccCCCccc-ccccCCccccccccCHHHHhCCC-----CCCcHHHHHHHHHHHHHHHhcCCCC
Confidence 9999999999766543221 11223456889999999886542 3567999999999999999995443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=284.98 Aligned_cols=239 Identities=21% Similarity=0.272 Sum_probs=185.3
Q ss_pred eeeecCeEEEEEEEC--CceeEEEEeeccCcc----chHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEeeecccC
Q psy14889 144 IGKGRYGEVWRGVWH--GENVAVKIFFSRDEA----SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVTHYHS 217 (443)
Q Consensus 144 lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~----~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e~~~ 217 (443)
||.|+||.||++... ++.||+|++...... ......|+..+..++||||+++++.+.+. ..+++++||++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----~~~~lv~e~~~ 76 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDK----KYIYMLMEYCL 76 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcC----CccEEEEecCC
Confidence 699999999999985 899999988653321 12223455555668999999999988765 34799999999
Q ss_pred cccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcccccccCC
Q psy14889 218 FGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSN 296 (443)
Q Consensus 218 ~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~~~~~~ 296 (443)
+++|.+++.+ ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||++........
T Consensus 77 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~--------~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~ 148 (262)
T cd05572 77 GGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNR--------GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK 148 (262)
T ss_pred CCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC--------CcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccc
Confidence 9999999975 4689999999999999999999998 999999999999999999999999999976654321
Q ss_pred cCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCChHHHHh
Q psy14889 297 KMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFDDMRK 376 (443)
Q Consensus 297 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~~~~~~~ 376 (443)
.....|+..|+|||.+.+. .++.++|+||||+++|||++| ..||..... ........
T Consensus 149 -----~~~~~~~~~~~~PE~~~~~------~~~~~~Di~slG~il~~l~~g----------~~p~~~~~~--~~~~~~~~ 205 (262)
T cd05572 149 -----TWTFCGTPEYVAPEIILNK------GYDFSVDYWSLGILLYELLTG----------RPPFGEDDE--DPMEIYND 205 (262)
T ss_pred -----cccccCCcCccChhHhcCC------CCCChhhhhhhHHHHHHHHhC----------CCCcCCCCC--CHHHHHHH
Confidence 1234678899999998765 567899999999999999999 667765421 11122222
Q ss_pred hhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCc-----HHHHHH
Q psy14889 377 VICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLS-----ALRVKK 423 (443)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~ 423 (443)
+......+..|. ..+.++.+++.+||+.||++||+ +.|+++
T Consensus 206 -~~~~~~~~~~~~-----~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 206 -ILKGNGKLEFPN-----YIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred -HhccCCCCCCCc-----ccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 221123333332 23568999999999999999999 666665
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=291.32 Aligned_cols=255 Identities=22% Similarity=0.303 Sum_probs=184.0
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc---chHHHHHHHHHHhc-cCCCceeeeeeccccCC-cccE
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA---SWSRETEIYSTVLL-RHENILGYIGSDMTSRN-SCTQ 208 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~---~~~~e~ei~~~~~l-~H~nIv~l~g~~~~~~~-~~~~ 208 (443)
++|++.+.||+|+||.||+|.+ +++.||+|.+...... ......|+..+..+ +||||+++++++..... ....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 3688899999999999999997 5889999987543221 12223455555557 46999999998876543 2234
Q ss_pred EEeeecccCcccHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcC-CCcEE
Q psy14889 209 LWLVTHYHSFGSLYDHLNR------TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKT-NGTCV 281 (443)
Q Consensus 209 ~~lv~e~~~~gsL~~~l~~------~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~-~~~~k 281 (443)
.++||||+++ +|.+++.. ..+++..+..++.||+.||.|||+. +|+||||||+||+++. ++.+|
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~--------~i~H~dl~~~nil~~~~~~~~k 151 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH--------GVMHRDLKPQNLLVDKQKGLLK 151 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC--------CeeecCCChHHEEEecCCCeEE
Confidence 7999999985 89888742 3579999999999999999999998 9999999999999998 88999
Q ss_pred EEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCC
Q psy14889 282 IADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPY 361 (443)
Q Consensus 282 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~ 361 (443)
|+|||+++.+...... .....+++.|+|||.+.+.. .++.++||||||+++|||++| ..||
T Consensus 152 l~dfg~~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~-----~~~~~~Di~slG~~l~~l~~g----------~~~~ 212 (295)
T cd07837 152 IADLGLGRAFSIPVKS----YTHEIVTLWYRAPEVLLGST-----HYSTPVDIWSVGCIFAEMSRK----------QPLF 212 (295)
T ss_pred EeecccceecCCCccc----cCCcccccCCCChHHhhCCC-----CCCchHHHHHHHHHHHHHHcC----------CCCC
Confidence 9999998765432211 12235678899999886531 456899999999999999999 4555
Q ss_pred CCCCCCCCChHHHHhhhhhc---------------------CCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHH
Q psy14889 362 HDLVPMDPSFDDMRKVICID---------------------QQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALR 420 (443)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e 420 (443)
.... ............ ...+..... .....+.++.++|.+||+.||.+|||+.|
T Consensus 213 ~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~P~~R~~~~e 287 (295)
T cd07837 213 PGDS----ELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSR-AVPDLSPEGLDLLQKMLRYDPAKRISAKA 287 (295)
T ss_pred CCCC----HHHHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHH-hccccCHHHHHHHHHHccCChhhcCCHHH
Confidence 4321 111111111000 000000000 01235677999999999999999999999
Q ss_pred HHH
Q psy14889 421 VKK 423 (443)
Q Consensus 421 vl~ 423 (443)
++.
T Consensus 288 il~ 290 (295)
T cd07837 288 ALT 290 (295)
T ss_pred Hhc
Confidence 875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=294.85 Aligned_cols=259 Identities=21% Similarity=0.338 Sum_probs=183.8
Q ss_pred cccceeeeecCeEEEEEEECCceeEEEEeeccC---ccchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEeeecc
Q psy14889 139 SLSECIGKGRYGEVWRGVWHGENVAVKIFFSRD---EASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVTHY 215 (443)
Q Consensus 139 ~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~---~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e~ 215 (443)
.+.+.+|.|+++.||++..+++.||||++.... ......+.|+..+..++|+||+++++++... ...+++|||
T Consensus 5 ~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~----~~~~~~~e~ 80 (314)
T cd08216 5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVD----SELYVVSPL 80 (314)
T ss_pred hhhHhhcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecC----CeEEEEEec
Confidence 345556667777777777789999999986542 1222335666667779999999999998766 357999999
Q ss_pred cCcccHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCccccc
Q psy14889 216 HSFGSLYDHLNR---TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYS 292 (443)
Q Consensus 216 ~~~gsL~~~l~~---~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~~ 292 (443)
+++|+|.+++.+ ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.+....
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~--------~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~ 152 (314)
T cd08216 81 MAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK--------GFIHRSVKASHILLSGDGKVVLSGLRYSVSMI 152 (314)
T ss_pred cCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC--------CeecCCCCcceEEEecCCceEEecCccceeec
Confidence 999999999864 4688999999999999999999998 99999999999999999999999999986554
Q ss_pred ccCCc---CCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCC
Q psy14889 293 QLSNK---MDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDP 369 (443)
Q Consensus 293 ~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~ 369 (443)
..... .........++..|+|||++..... .++.++|||||||++|||++| ..||........
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~----~~~~~~Diws~G~il~el~~g----------~~pf~~~~~~~~ 218 (314)
T cd08216 153 KHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQ----GYNEKSDIYSVGITACELANG----------HVPFKDMPATQM 218 (314)
T ss_pred cccccccccccccccccccccccCHHHhcCCCC----CCCcchhHHHHHHHHHHHHhC----------CCCCCCCCHHHH
Confidence 32211 1111233457788999999875421 466899999999999999999 455543211000
Q ss_pred ChHHHHhhh---------hhc----------CCCC---CCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 370 SFDDMRKVI---------CID----------QQRP---VLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 370 ~~~~~~~~~---------~~~----------~~~~---~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
..+...... ... ...+ ...........+.++.+++.+||+.||++|||++++++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 219 LLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred HHHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 000000000 000 0000 00000011234567899999999999999999999987
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=298.03 Aligned_cols=277 Identities=20% Similarity=0.209 Sum_probs=192.5
Q ss_pred hccccccceeeeecCeEEEEEEE--CCceeEEEEeeccC---ccchHHHHHHHHHHhccCCCceeeeeeccccCC-cccE
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRD---EASWSRETEIYSTVLLRHENILGYIGSDMTSRN-SCTQ 208 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~---~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~-~~~~ 208 (443)
.++|.+.+.||+|+||.||+|.. +++.||||.+.... ........|+..+..++|+||+++++++..... ....
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 46899999999999999999987 58999999875431 112223345666666899999999998764421 2235
Q ss_pred EEeeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCC
Q psy14889 209 LWLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGL 287 (443)
Q Consensus 209 ~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGl 287 (443)
.++|+||+. ++|.+++.. ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--------~i~H~dlkp~Nil~~~~~~~kL~Dfg~ 154 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSA--------NVLHRDLKPSNLLLNANCDLKICDFGL 154 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC--------CEecCCCCHHHEEEcCCCCEEECcCcc
Confidence 799999997 689888854 6799999999999999999999998 999999999999999999999999999
Q ss_pred cccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccc----------c
Q psy14889 288 AVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEE----------Y 357 (443)
Q Consensus 288 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~----------~ 357 (443)
++........ .....++..|+|||.+.... .++.++|||||||++|||++|+.++..... .
T Consensus 155 ~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~-----~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 225 (337)
T cd07858 155 ARTTSEKGDF----MTEYVVTRWYRAPELLLNCS-----EYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELL 225 (337)
T ss_pred ccccCCCccc----ccccccccCccChHHHhcCC-----CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHh
Confidence 9765432211 12346788999999886531 456799999999999999999544321000 0
Q ss_pred CCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHH--HHHHhh
Q psy14889 358 KAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKT--LIKLAC 430 (443)
Q Consensus 358 ~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~--L~~l~~ 430 (443)
..|...... ........+.+......+..+.......++.++.+++++||+.||++|||+.++++. +..+..
T Consensus 226 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~ 299 (337)
T cd07858 226 GSPSEEDLG-FIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHD 299 (337)
T ss_pred CCCChHHhh-hcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcC
Confidence 000000000 000000011110000001000000112356789999999999999999999999986 665543
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=290.26 Aligned_cols=250 Identities=24% Similarity=0.323 Sum_probs=184.5
Q ss_pred ccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccc---hHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEee
Q psy14889 138 ISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEAS---WSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLV 212 (443)
Q Consensus 138 ~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~---~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv 212 (443)
|++.+.||+|++|.||+|.. +|..||+|++....... .....|+..+..++||||+++++++.+. ...+++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~----~~~~iv 76 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSE----NKLYLV 76 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccC----CeEEEE
Confidence 56788999999999999987 68999999886443211 2233456666669999999999998766 457999
Q ss_pred ecccCcccHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcc
Q psy14889 213 THYHSFGSLYDHLNRT---TLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAV 289 (443)
Q Consensus 213 ~e~~~~gsL~~~l~~~---~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~ 289 (443)
|||++ ++|.+++... .+++..++.++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++.
T Consensus 77 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~--------~~~H~dl~p~nil~~~~~~~~l~df~~~~ 147 (283)
T cd07835 77 FEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH--------RVLHRDLKPQNLLIDREGALKLADFGLAR 147 (283)
T ss_pred EeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC--------CeeCCCCCHHHEEEcCCCcEEEeeccccc
Confidence 99996 6999998653 589999999999999999999998 99999999999999999999999999987
Q ss_pred cccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCC
Q psy14889 290 SYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDP 369 (443)
Q Consensus 290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~ 369 (443)
........ .....++..|+|||++.+.. .++.++||||||+++|||++| ..||....
T Consensus 148 ~~~~~~~~----~~~~~~~~~~~aPE~~~~~~-----~~~~~~Di~slG~~l~~l~~g----------~~pf~~~~---- 204 (283)
T cd07835 148 AFGVPVRT----YTHEVVTLWYRAPEILLGSR-----QYSTPVDIWSIGCIFAEMVNR----------RPLFPGDS---- 204 (283)
T ss_pred ccCCCccc----cCccccccCCCCCceeecCc-----ccCcHHHHHHHHHHHHHHHhC----------CCCCCCCC----
Confidence 55432111 12235688999999886541 345789999999999999999 55554321
Q ss_pred ChHHHHhhhhhc---------------CCCCCCC------CCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 370 SFDDMRKVICID---------------QQRPVLP------NRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 370 ~~~~~~~~~~~~---------------~~~~~~~------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
......+..... ......+ ..-.....+..+.+++.+||+.||++|||++|+++
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 205 EIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred HHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 111111111000 0000000 00001234467899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=299.35 Aligned_cols=260 Identities=23% Similarity=0.243 Sum_probs=188.6
Q ss_pred hccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccc-hHHHHHHHHHHhccCCCceeeeeeccccCCcc-----
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEAS-WSRETEIYSTVLLRHENILGYIGSDMTSRNSC----- 206 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~-~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~----- 206 (443)
..+|.+.+.||+|+||.||+|.. +|+.||+|.+....... .....|+..+..++||||+++++++.......
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 36899999999999999999987 58899999886544322 22345566666799999999998876543221
Q ss_pred -----cEEEeeecccCcccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcC-CCcE
Q psy14889 207 -----TQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKT-NGTC 280 (443)
Q Consensus 207 -----~~~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~-~~~~ 280 (443)
...++||||++ ++|.+++....+++..+..++.||+.||.|||+. +|+||||||+||+++. ++.+
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~--------givH~dikp~Nili~~~~~~~ 154 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQGPLSEEHARLFMYQLLRGLKYIHSA--------NVLHRDLKPANVFINTEDLVL 154 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC--------CcccCCCCHHHEEEcCCCceE
Confidence 24789999997 5999999888899999999999999999999998 9999999999999974 5578
Q ss_pred EEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCC
Q psy14889 281 VIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAP 360 (443)
Q Consensus 281 kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P 360 (443)
||+|||+++.+....... .......|+..|+|||.+.... .++.++|||||||++|||++| ..|
T Consensus 155 kl~dfg~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~-----~~~~~~DiwSlGvil~el~~g----------~~p 218 (342)
T cd07854 155 KIGDFGLARIVDPHYSHK-GYLSEGLVTKWYRSPRLLLSPN-----NYTKAIDMWAAGCIFAEMLTG----------KPL 218 (342)
T ss_pred EECCcccceecCCccccc-cccccccccccccCHHHHhCcc-----ccCchhhHHHHHHHHHHHHhC----------CCC
Confidence 999999997654321111 1112235788999999875431 456799999999999999999 555
Q ss_pred CCCCCCCCCChHHHHhhh----------------------hhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcH
Q psy14889 361 YHDLVPMDPSFDDMRKVI----------------------CIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSA 418 (443)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~ 418 (443)
|....+ ........ ......+..+........+.++.+++.+||+.||++|||+
T Consensus 219 f~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~ 294 (342)
T cd07854 219 FAGAHE----LEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTA 294 (342)
T ss_pred CCCCCH----HHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCH
Confidence 543211 01111000 0000011111000011245678999999999999999999
Q ss_pred HHHHH
Q psy14889 419 LRVKK 423 (443)
Q Consensus 419 ~evl~ 423 (443)
.++++
T Consensus 295 ~ell~ 299 (342)
T cd07854 295 EEALM 299 (342)
T ss_pred HHHhC
Confidence 99984
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=290.11 Aligned_cols=245 Identities=26% Similarity=0.392 Sum_probs=188.8
Q ss_pred ccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc-chHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEeeec
Q psy14889 138 ISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA-SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVTH 214 (443)
Q Consensus 138 ~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~-~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e 214 (443)
|.....||+|+||.||++.. +++.||||.+...... ......|+..+..++|+||+++++.+... ...++|||
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----~~~~lv~e 97 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVG----DELWVVME 97 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeC----CEEEEEEe
Confidence 33456799999999999987 6889999987543221 22233456666669999999999998776 45799999
Q ss_pred ccCcccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCccccccc
Q psy14889 215 YHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQL 294 (443)
Q Consensus 215 ~~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~~~~ 294 (443)
|+++++|.+++....+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 98 ~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~--------givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~ 169 (292)
T cd06657 98 FLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQ--------GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE 169 (292)
T ss_pred cCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CeecCCCCHHHEEECCCCCEEEcccccceecccc
Confidence 99999999999888899999999999999999999998 9999999999999999999999999998655432
Q ss_pred CCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCChHHH
Q psy14889 295 SNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFDDM 374 (443)
Q Consensus 295 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~~~~~ 374 (443)
... .....|+..|+|||.+.+. .++.++|+||||+++|||++| ..||.... . ...
T Consensus 170 ~~~----~~~~~~~~~y~~pE~~~~~------~~~~~~Dv~slGvil~el~tg----------~~p~~~~~----~-~~~ 224 (292)
T cd06657 170 VPR----RKSLVGTPYWMAPELISRL------PYGPEVDIWSLGIMVIEMVDG----------EPPYFNEP----P-LKA 224 (292)
T ss_pred ccc----ccccccCccccCHHHhcCC------CCCchhhHHHHHHHHHHHHhC----------CCCCCCCC----H-HHH
Confidence 211 1234688999999998765 566899999999999999999 66665421 1 111
Q ss_pred HhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 375 RKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
...+.. ...+.+.. ....+..+.+++.+||+.||.+||++.++++
T Consensus 225 ~~~~~~-~~~~~~~~---~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 225 MKMIRD-NLPPKLKN---LHKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred HHHHHh-hCCcccCC---cccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 111111 11111111 1234567899999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=282.60 Aligned_cols=242 Identities=24% Similarity=0.422 Sum_probs=192.7
Q ss_pred cccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc---chHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEe
Q psy14889 137 QISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA---SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWL 211 (443)
Q Consensus 137 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~---~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~l 211 (443)
+|++.+.||+|+||.||++.. +++.+|+|.+...... ......|+..+..++|+||+++++++... ...++
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----~~~~~ 76 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDG----NKLCI 76 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccC----CEEEE
Confidence 478889999999999999987 5789999988653221 12223566666679999999999998776 46899
Q ss_pred eecccCcccHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecC
Q psy14889 212 VTHYHSFGSLYDHLNR-----TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFG 286 (443)
Q Consensus 212 v~e~~~~gsL~~~l~~-----~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfG 286 (443)
|+||+++++|.+++.+ ..+++..+..++.|++.||+|||+. +++|+||+|.||++++++.+||+|||
T Consensus 77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~--------~i~h~~l~~~ni~~~~~~~~kl~d~g 148 (256)
T cd08530 77 VMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ--------KILHRDLKSANILLVANDLVKIGDLG 148 (256)
T ss_pred EehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC--------CcccCCCCcceEEEecCCcEEEeecc
Confidence 9999999999999865 5689999999999999999999998 99999999999999999999999999
Q ss_pred CcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCC
Q psy14889 287 LAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVP 366 (443)
Q Consensus 287 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~ 366 (443)
+++...... .....++..|+|||.+.+. .++.++|+||||+++|||++| ..||...
T Consensus 149 ~~~~~~~~~------~~~~~~~~~~~~Pe~~~~~------~~~~~~D~~slG~~~~~l~~g----------~~p~~~~-- 204 (256)
T cd08530 149 ISKVLKKNM------AKTQIGTPHYMAPEVWKGR------PYSYKSDIWSLGCLLYEMATF----------APPFEAR-- 204 (256)
T ss_pred chhhhccCC------cccccCCccccCHHHHCCC------CCCchhhHHHHHHHHHHHHhC----------CCCCCCC--
Confidence 997765431 1224578899999998765 566799999999999999999 6676543
Q ss_pred CCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 367 MDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
........+. ....+..+ ...+.++.+++.+||+.+|++|||+.++++
T Consensus 205 ---~~~~~~~~~~-~~~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 205 ---SMQDLRYKVQ-RGKYPPIP-----PIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred ---CHHHHHHHHh-cCCCCCCc-----hhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 2222322222 12222222 245678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG4250|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=306.36 Aligned_cols=265 Identities=27% Similarity=0.371 Sum_probs=193.3
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeecc----CccchHHHHHHHHHHhccCCCceeeeeeccccCC--ccc
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSR----DEASWSRETEIYSTVLLRHENILGYIGSDMTSRN--SCT 207 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~----~~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~--~~~ 207 (443)
..+...+.||+|+||.||+|+. +|+.||||.++.. ..+.+.+| +..+++++|+|||+++++-.+... ...
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~E--ieilkKLnh~NIVk~f~iee~~~~~~~~~ 90 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCRE--IEILKKLNHPNIVKLFDIEETKFLGLVTR 90 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHH--HHHHHHcCchhhhhhcccCCccccCcccc
Confidence 3456678999999999999997 6999999988652 23334444 455555999999999998665541 013
Q ss_pred EEEeeecccCcccHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcC--CC--c
Q psy14889 208 QLWLVTHYHSFGSLYDHLNR----TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKT--NG--T 279 (443)
Q Consensus 208 ~~~lv~e~~~~gsL~~~l~~----~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~--~~--~ 279 (443)
...+|||||.+|||+..|++ .+|++.+.+.++.+++.||.|||++ +|+||||||.||++-. +| .
T Consensus 91 ~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn--------~IvHRDlKP~NIvl~~Gedgq~I 162 (732)
T KOG4250|consen 91 LPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN--------GIVHRDLKPGNIVLQIGEDGQSI 162 (732)
T ss_pred cceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc--------CceeccCCCCcEEEeecCCCceE
Confidence 46899999999999999975 4799999999999999999999988 9999999999999843 23 5
Q ss_pred EEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCC
Q psy14889 280 CVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKA 359 (443)
Q Consensus 280 ~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~ 359 (443)
.||+|||.|+.+.+.+ .....+||..|.+||++..+. .|+..+|.|||||++||.+||..
T Consensus 163 yKLtDfG~Arel~d~s-----~~~S~vGT~~YLhPel~E~q~-----~y~~tVDLWS~GvtlY~caTG~l---------- 222 (732)
T KOG4250|consen 163 YKLTDFGAARELDDNS-----LFTSLVGTEEYLHPELYERQK-----KYTATVDLWSFGVTLYECATGEL---------- 222 (732)
T ss_pred EeeecccccccCCCCC-----eeeeecCchhhcChHHHhhcc-----CcCceeehhhhhhHHHHHhccCC----------
Confidence 6999999999888755 235679999999999998521 56678999999999999999944
Q ss_pred CCCCCCCCCCChHHHHhhhhhcC----------CC------CCCCC-CCCCchhHHHHHHHHHHHhcCCcCCCC--cHHH
Q psy14889 360 PYHDLVPMDPSFDDMRKVICIDQ----------QR------PVLPN-RWVSDSTLNAMTKVMKECWHQNANVRL--SALR 420 (443)
Q Consensus 360 P~~~~~~~~~~~~~~~~~~~~~~----------~~------~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rp--s~~e 420 (443)
||..........+.+........ .. ..+|. ..........+...+..+|..||.+|- .+.+
T Consensus 223 PF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~ 302 (732)
T KOG4250|consen 223 PFIPFGGPKNNKEIMWHIITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDR 302 (732)
T ss_pred CCCcCCCccccchhhhhhhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcch
Confidence 44432222212222222211100 00 01111 011122345577788899999999999 7777
Q ss_pred HHHHHHHHhh
Q psy14889 421 VKKTLIKLAC 430 (443)
Q Consensus 421 vl~~L~~l~~ 430 (443)
....+..+.+
T Consensus 303 ~Fa~~~dIL~ 312 (732)
T KOG4250|consen 303 FFAEVDDILN 312 (732)
T ss_pred HHHHHHHHHh
Confidence 7777776654
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=279.56 Aligned_cols=245 Identities=33% Similarity=0.540 Sum_probs=192.3
Q ss_pred cccccceeeeecCeEEEEEEE--CCceeEEEEeeccCc-cchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEeee
Q psy14889 137 QISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDE-ASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVT 213 (443)
Q Consensus 137 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv~ 213 (443)
+|+..+.||+|++|.||++.. +++.+++|++..... .......|+..+..++|+||+++++.+... ...++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----~~~~l~~ 76 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKK----DELWIVM 76 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecC----CeEEEEE
Confidence 367789999999999999998 488999998865543 223334566666668999999999998776 3579999
Q ss_pred cccCcccHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcccc
Q psy14889 214 HYHSFGSLYDHLNRT--TLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSY 291 (443)
Q Consensus 214 e~~~~gsL~~~l~~~--~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~ 291 (443)
||+++++|.+++... .+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||.+...
T Consensus 77 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~--------~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~ 148 (253)
T cd05122 77 EFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN--------GIIHRDIKAANILLTSDGEVKLIDFGLSAQL 148 (253)
T ss_pred ecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcC--------CEecCCCCHHHEEEccCCeEEEeeccccccc
Confidence 999999999998654 799999999999999999999998 9999999999999999999999999998766
Q ss_pred cccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCCh
Q psy14889 292 SQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSF 371 (443)
Q Consensus 292 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~~ 371 (443)
..... .....|+..|+|||.+.+. .++.++||||||+++|+|++| ..||.... ..
T Consensus 149 ~~~~~-----~~~~~~~~~~~~PE~~~~~------~~~~~~Dv~slG~il~~l~~g----------~~p~~~~~----~~ 203 (253)
T cd05122 149 SDTKA-----RNTMVGTPYWMAPEVINGK------PYDYKADIWSLGITAIELAEG----------KPPYSELP----PM 203 (253)
T ss_pred ccccc-----ccceecCCcccCHHHHcCC------CCCccccHHHHHHHHHHHHhC----------CCCCCCCc----hH
Confidence 54321 1334688899999998766 466899999999999999999 56665431 11
Q ss_pred HHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 372 DDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
....... . ...+..+. ....+..+.+++.+||+.||++|||+.++++
T Consensus 204 ~~~~~~~-~-~~~~~~~~---~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 204 KALFKIA-T-NGPPGLRN---PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred HHHHHHH-h-cCCCCcCc---ccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1111111 1 12222221 1113567999999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG0986|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=293.96 Aligned_cols=241 Identities=25% Similarity=0.332 Sum_probs=194.0
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeecc------CccchHHHHHHHHHHhccCCCceeeeeeccccCCccc
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSR------DEASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCT 207 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~------~~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~ 207 (443)
+.|..-++||+|+||.||-++. +|+.+|.|.+.++ .+.....|++|+.. ++.+.||.+--.|.+.+
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~k--V~s~FiVslaYAfeTkd---- 258 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEK--VSSPFIVSLAYAFETKD---- 258 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHH--hccCcEEEEeeeecCCC----
Confidence 5688889999999999998765 7999999977432 22333445666555 88999999887777774
Q ss_pred EEEeeecccCcccHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEe
Q psy14889 208 QLWLVTHYHSFGSLYDHLNR---TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIAD 284 (443)
Q Consensus 208 ~~~lv~e~~~~gsL~~~l~~---~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~D 284 (443)
.+++|+..|.+|||.-+|.+ ..+++..+..++.+|+.||++||.. +||.|||||+|||+|+.|+++|+|
T Consensus 259 ~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~--------~iVYRDLKPeNILLDd~GhvRISD 330 (591)
T KOG0986|consen 259 ALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRR--------RIVYRDLKPENILLDDHGHVRISD 330 (591)
T ss_pred ceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhc--------ceeeccCChhheeeccCCCeEeec
Confidence 48999999999999988864 4799999999999999999999999 999999999999999999999999
Q ss_pred cCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCC
Q psy14889 285 FGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDL 364 (443)
Q Consensus 285 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~ 364 (443)
+|+|..+...... ...+||.+|||||++... .|+...|.|||||++|||+.| +.||...
T Consensus 331 LGLAvei~~g~~~-----~~rvGT~GYMAPEvl~ne------~Y~~s~Dwf~lGCllYemi~G----------~sPFr~~ 389 (591)
T KOG0986|consen 331 LGLAVEIPEGKPI-----RGRVGTVGYMAPEVLQNE------VYDFSPDWFSLGCLLYEMIAG----------HSPFRQR 389 (591)
T ss_pred cceEEecCCCCcc-----ccccCcccccCHHHHcCC------cccCCccHHHHHhHHHHHHcc----------cCchhhh
Confidence 9999888764332 455899999999999988 677899999999999999999 7888764
Q ss_pred CCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHH
Q psy14889 365 VPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSAL 419 (443)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ 419 (443)
.. ....+++.+.+..+.. . .++..++++++|.+..|..||++|....
T Consensus 390 Ke-Kvk~eEvdrr~~~~~~--e-----y~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 390 KE-KVKREEVDRRTLEDPE--E-----YSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred hh-hhhHHHHHHHHhcchh--h-----cccccCHHHHHHHHHHHccCHHHhccCC
Confidence 22 2233344443322211 1 2355778899999999999999998544
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=289.20 Aligned_cols=254 Identities=23% Similarity=0.319 Sum_probs=187.8
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc---chHHHHHHHHHHhccCCCceeeeeeccccCCcccEEE
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA---SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLW 210 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~---~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~ 210 (443)
++|++.+.||+|+||.||+|.. +++.||+|.+...... ......|+..+..++|+||+++++++... ...+
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----~~~~ 76 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRK----GRLY 76 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEEC----CEEE
Confidence 3688999999999999999988 5789999987543221 22334566666669999999999998775 4589
Q ss_pred eeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcc
Q psy14889 211 LVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAV 289 (443)
Q Consensus 211 lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~ 289 (443)
+||||++++.+..+..+ ..+++.++..++.||+.||.|||+. +++|+||+|+||++++++.+||+|||++.
T Consensus 77 iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--------~i~H~dl~~~ni~~~~~~~~kl~d~g~~~ 148 (288)
T cd07833 77 LVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSH--------NIIHRDIKPENILVSESGVLKLCDFGFAR 148 (288)
T ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--------CeecCCCCHHHeEECCCCCEEEEeeeccc
Confidence 99999998777766643 5699999999999999999999998 99999999999999999999999999987
Q ss_pred cccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCC
Q psy14889 290 SYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDP 369 (443)
Q Consensus 290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~ 369 (443)
........ ......++..|+|||++.+.. .++.++||||||+++|||++|++ ||....
T Consensus 149 ~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~-----~~~~~~Dv~slG~~l~~l~~g~~----------~~~~~~---- 206 (288)
T cd07833 149 ALRARPAS---PLTDYVATRWYRAPELLVGDT-----NYGKPVDVWAIGCIMAELLDGEP----------LFPGDS---- 206 (288)
T ss_pred ccCCCccc---cccCcccccCCcCCchhcCCC-----CcCchhhHHHHHHHHHHHHhCCC----------CCCCCC----
Confidence 76543321 123346788999999987642 45579999999999999999944 443211
Q ss_pred ChHHHHhhhh--------------hcC-CCC-CCCC--------CCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 370 SFDDMRKVIC--------------IDQ-QRP-VLPN--------RWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 370 ~~~~~~~~~~--------------~~~-~~~-~~~~--------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
..+....... ... ... ..++ ......++.++.+++++||+.||++|||+.++++
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 207 DIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred HHHHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 0011110000 000 000 0000 0111224678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=290.84 Aligned_cols=254 Identities=27% Similarity=0.340 Sum_probs=187.4
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc---chHHHHHHHHHHhccCCCceeeeeeccccCCcccEEE
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA---SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLW 210 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~---~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~ 210 (443)
++|++.+.||+|+||.||+|.. +|+.||+|.+...... ......|+..+..++|+||+++++++..... ..++
T Consensus 7 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~--~~~~ 84 (309)
T cd07845 7 TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHL--DSIF 84 (309)
T ss_pred cceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCC--CeEE
Confidence 6899999999999999999998 5899999988643221 1122346666666999999999999865432 3579
Q ss_pred eeecccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCc
Q psy14889 211 LVTHYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA 288 (443)
Q Consensus 211 lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla 288 (443)
+||||+.+ +|.+++.. ..+++.++..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++
T Consensus 85 lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~--------~i~H~dl~p~nil~~~~~~~kL~dfg~~ 155 (309)
T cd07845 85 LVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHEN--------FIIHRDLKVSNLLLTDKGCLKIADFGLA 155 (309)
T ss_pred EEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC--------CeecCCCCHHHEEECCCCCEEECcccee
Confidence 99999974 88888764 5689999999999999999999998 9999999999999999999999999999
Q ss_pred ccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCC
Q psy14889 289 VSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMD 368 (443)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~ 368 (443)
......... .....++..|+|||.+.+.. .++.++||||||+++|||++| ..||....
T Consensus 156 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~-----~~~~~~DvwslG~il~el~~g----------~~~f~~~~--- 213 (309)
T cd07845 156 RTYGLPAKP----MTPKVVTLWYRAPELLLGCT-----TYTTAIDMWAVGCILAELLAH----------KPLLPGKS--- 213 (309)
T ss_pred eecCCccCC----CCcccccccccChhhhcCCC-----CcCchHHHHHHHHHHHHHHhC----------CCCCCCCC---
Confidence 766543211 12234578899999987542 456899999999999999999 44554321
Q ss_pred CChHHHHhhhhhcC----------------CCCCCCCC-C-----CCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 369 PSFDDMRKVICIDQ----------------QRPVLPNR-W-----VSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 369 ~~~~~~~~~~~~~~----------------~~~~~~~~-~-----~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
..+.......... .....+.. + .....+..+.++|.+||+.||++|||+++++.
T Consensus 214 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 214 -EIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred -HHHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 1111111111000 00000000 0 00113567889999999999999999999886
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=287.29 Aligned_cols=239 Identities=25% Similarity=0.316 Sum_probs=181.9
Q ss_pred eeeecCeEEEEEEE--CCceeEEEEeeccCc----cchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEeeecccC
Q psy14889 144 IGKGRYGEVWRGVW--HGENVAVKIFFSRDE----ASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVTHYHS 217 (443)
Q Consensus 144 lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~----~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e~~~ 217 (443)
||+|+||+||++.. +|+.||+|.+..... .......|+..+..++||||+++++.+... ...++||||++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----~~~~lv~e~~~ 76 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETK----DDLCLVMTLMN 76 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecC----CeEEEEEecCC
Confidence 68999999999987 588999998854321 111223455556669999999999988765 45799999999
Q ss_pred cccHHHHhcc-c--CCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCccccccc
Q psy14889 218 FGSLYDHLNR-T--TLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQL 294 (443)
Q Consensus 218 ~gsL~~~l~~-~--~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~~~~ 294 (443)
+++|.+++.+ . .+++..+..++.|++.||.|||+. +++|+||+|+||++++++.+||+|||++......
T Consensus 77 ~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~--------~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~ 148 (277)
T cd05577 77 GGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR--------RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG 148 (277)
T ss_pred CCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhC--------CcccCCCCHHHEEECCCCCEEEccCcchhhhccC
Confidence 9999999854 2 589999999999999999999998 9999999999999999999999999998765431
Q ss_pred CCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCChHHH
Q psy14889 295 SNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFDDM 374 (443)
Q Consensus 295 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~~~~~ 374 (443)
.. .....++..|+|||.+.+. .++.++||||||+++|||++| ..||....... ....+
T Consensus 149 ~~-----~~~~~~~~~y~~PE~~~~~------~~~~~~Di~slG~il~~l~~g----------~~p~~~~~~~~-~~~~~ 206 (277)
T cd05577 149 KK-----IKGRAGTPGYMAPEVLQGE------VYDFSVDWFALGCTLYEMIAG----------RSPFRQRKEKV-EKEEL 206 (277)
T ss_pred Cc-----cccccCCCCcCCHHHhcCC------CCCchhhhHHHHHHHHHHhhC----------CCCCCCCcccc-cHHHH
Confidence 11 1234678899999998766 566899999999999999999 66765432111 11222
Q ss_pred HhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCC-----cHHHHHH
Q psy14889 375 RKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRL-----SALRVKK 423 (443)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~ 423 (443)
..... ......+ ...+..+.+++.+||+.||++|| ++.++++
T Consensus 207 ~~~~~--~~~~~~~-----~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 207 KRRTL--EMAVEYP-----DKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred Hhccc--cccccCC-----ccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 22111 1111222 23466799999999999999999 6666654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=285.52 Aligned_cols=239 Identities=26% Similarity=0.378 Sum_probs=181.4
Q ss_pred eeeeecCeEEEEEEE--CCceeEEEEeeccCcc------chHHHHHHH-HHHhccCCCceeeeeeccccCCcccEEEeee
Q psy14889 143 CIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA------SWSRETEIY-STVLLRHENILGYIGSDMTSRNSCTQLWLVT 213 (443)
Q Consensus 143 ~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~------~~~~e~ei~-~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv~ 213 (443)
.||+|+||.||++.. +++.||+|.+...... ....|..+. ......||||+.+++++... ..+++||
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~----~~~~~v~ 76 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP----DKLSFIL 76 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecC----CEEEEEE
Confidence 489999999999987 5789999987643211 112222222 22335899999999988766 3579999
Q ss_pred cccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCccccc
Q psy14889 214 HYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYS 292 (443)
Q Consensus 214 e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~~ 292 (443)
||+++|+|.+++.+ ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++..+.
T Consensus 77 e~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~--------~i~H~di~p~nili~~~~~~kl~dfg~~~~~~ 148 (278)
T cd05606 77 DLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNR--------FVVYRDLKPANILLDEHGHVRISDLGLACDFS 148 (278)
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CEEcCCCCHHHEEECCCCCEEEccCcCccccC
Confidence 99999999998854 5689999999999999999999998 99999999999999999999999999987554
Q ss_pred ccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCChH
Q psy14889 293 QLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFD 372 (443)
Q Consensus 293 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~~~ 372 (443)
... .....|+..|+|||.+.++. .++.++||||||+++|||++| ..||.+.... ...
T Consensus 149 ~~~------~~~~~~~~~y~aPE~~~~~~-----~~~~~~Di~s~G~~l~~l~~g----------~~p~~~~~~~--~~~ 205 (278)
T cd05606 149 KKK------PHASVGTHGYMAPEVLQKGV-----AYDSSADWFSLGCMLFKLLRG----------HSPFRQHKTK--DKH 205 (278)
T ss_pred ccC------CcCcCCCcCCcCcHHhcCCC-----CCCcccchHhHHHHHHHHHhC----------CCCCCCCCcc--chH
Confidence 221 12346899999999987541 456789999999999999999 6676553211 111
Q ss_pred HHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCC-----cHHHHHH
Q psy14889 373 DMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRL-----SALRVKK 423 (443)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~ 423 (443)
...... ....+.++ ...+..+.+++.+||..||.+|| ++.++++
T Consensus 206 ~~~~~~--~~~~~~~~-----~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 206 EIDRMT--LTMAVELP-----DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred HHHHHh--hccCCCCC-----CcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 111111 11222233 22467899999999999999999 9999885
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=285.75 Aligned_cols=253 Identities=24% Similarity=0.346 Sum_probs=186.2
Q ss_pred ccccceeeeecCeEEEEEEE--CCceeEEEEeeccC---ccchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEee
Q psy14889 138 ISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRD---EASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLV 212 (443)
Q Consensus 138 ~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~---~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv 212 (443)
|++.+.||+|+||.||+|.. +++.+|+|++.... ........|+..+..++|+|++++++++..... ...++|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~--~~~~lv 78 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGK--GSIYMV 78 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCC--CcEEEE
Confidence 56788999999999999988 47899999987653 112223456666666899999999999876521 357999
Q ss_pred ecccCcccHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCccc
Q psy14889 213 THYHSFGSLYDHLNRT--TLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVS 290 (443)
Q Consensus 213 ~e~~~~gsL~~~l~~~--~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~ 290 (443)
+||+++ +|.+++.+. .+++..++.++.||+.||+|||+. +++|+||||+||++++++.+||+|||++..
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~--------~~~h~dl~p~nil~~~~~~~~l~d~g~~~~ 149 (287)
T cd07840 79 FEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSN--------GILHRDIKGSNILINNDGVLKLADFGLARP 149 (287)
T ss_pred eccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC--------CceeccCcHHHeEEcCCCCEEEccccceee
Confidence 999985 899988653 799999999999999999999998 999999999999999999999999999976
Q ss_pred ccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCC
Q psy14889 291 YSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPS 370 (443)
Q Consensus 291 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~ 370 (443)
....... ......++..|+|||.+.+.. .++.++||||||+++|||++| ..||.....
T Consensus 150 ~~~~~~~---~~~~~~~~~~y~~PE~~~~~~-----~~~~~~Dv~slG~~l~el~t~----------~~p~~~~~~---- 207 (287)
T cd07840 150 YTKRNSA---DYTNRVITLWYRPPELLLGAT-----RYGPEVDMWSVGCILAELFLG----------KPIFQGSTE---- 207 (287)
T ss_pred ccCCCcc---cccccccccccCCceeeEccc-----cCChHHHHHHHHHHHHHHHhC----------CCCCCCCCh----
Confidence 6543211 112345678899999876531 456899999999999999999 455543211
Q ss_pred hHHHHhhhhhc------------------CCCCC--CCC---CCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 371 FDDMRKVICID------------------QQRPV--LPN---RWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 371 ~~~~~~~~~~~------------------~~~~~--~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
...+....... ...+. .+. ......++..+.+++++||+.||.+||++.++++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 208 LEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred HHHHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 11111111000 00000 000 0001113667899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=288.63 Aligned_cols=252 Identities=21% Similarity=0.347 Sum_probs=186.7
Q ss_pred ccccccceeeeecCeEEEEEEEC--CceeEEEEeeccCccc--hHHHHHHHHHHhc-cCCCceeeeeeccccCCcccEEE
Q psy14889 136 KQISLSECIGKGRYGEVWRGVWH--GENVAVKIFFSRDEAS--WSRETEIYSTVLL-RHENILGYIGSDMTSRNSCTQLW 210 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~--~~~e~ei~~~~~l-~H~nIv~l~g~~~~~~~~~~~~~ 210 (443)
++|++.+.||+|+||.||+|.+. ++.||||.+....... .....|+..+... .||||+++++++.+. ..++
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~----~~~~ 90 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITD----SDVF 90 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecC----CeEE
Confidence 67899999999999999999984 8999999986543221 1122333323333 599999999998776 3579
Q ss_pred eeecccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCc
Q psy14889 211 LVTHYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA 288 (443)
Q Consensus 211 lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla 288 (443)
++|||+. ++|.+++.. ..+++..+..++.|++.||.|||+.. +|+||||+|+||++++++.+||+|||++
T Consensus 91 ~v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~-------~i~H~dl~p~nill~~~~~~kL~dfg~~ 162 (296)
T cd06618 91 ICMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKH-------GVIHRDVKPSNILLDASGNVKLCDFGIS 162 (296)
T ss_pred EEeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhC-------CEecCCCcHHHEEEcCCCCEEECccccc
Confidence 9999986 477776643 56899999999999999999999731 8999999999999999999999999998
Q ss_pred ccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCC
Q psy14889 289 VSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMD 368 (443)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~ 368 (443)
..+...... ....++..|+|||.+.+..... .++.++||||||+++|||++| ..||....
T Consensus 163 ~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~--~~~~~~Di~slG~il~el~~g----------~~p~~~~~--- 222 (296)
T cd06618 163 GRLVDSKAK-----TRSAGCAAYMAPERIDPPDPNP--KYDIRADVWSLGISLVELATG----------QFPYKNCK--- 222 (296)
T ss_pred hhccCCCcc-----cCCCCCccccCHhhcCCCCCcc--ccccchhHHHHHHHHHHHHhC----------CCCCCcch---
Confidence 765432211 2235778999999987542111 466899999999999999999 66665421
Q ss_pred CChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHH
Q psy14889 369 PSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKT 424 (443)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 424 (443)
...+....... ...+..+. ...++.++.+++.+||+.||++||++.++++.
T Consensus 223 ~~~~~~~~~~~--~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 223 TEFEVLTKILQ--EEPPSLPP---NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred hHHHHHHHHhc--CCCCCCCC---CCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11222222221 11222221 11356789999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0612|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=320.40 Aligned_cols=252 Identities=24% Similarity=0.321 Sum_probs=205.1
Q ss_pred hccccccceeeeecCeEEEEEEE--CCceeEEEEeec------cCccchHHHHHHHHHHhccCCCceeeeeeccccCCcc
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFS------RDEASWSRETEIYSTVLLRHENILGYIGSDMTSRNSC 206 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~------~~~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~ 206 (443)
.++|.+.++||+|+||.|..+++ +++.+|.|++.+ .+..-+..|++|+.. .+.+-|+.++-.|.+.
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~--~ns~Wiv~LhyAFQD~---- 147 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVF--GNSEWIVQLHYAFQDE---- 147 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHc--CCcHHHHHHHHHhcCc----
Confidence 47899999999999999999988 588999998854 233456667888777 6788999999888887
Q ss_pred cEEEeeecccCcccHHHHhcccC-CCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEec
Q psy14889 207 TQLWLVTHYHSFGSLYDHLNRTT-LNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADF 285 (443)
Q Consensus 207 ~~~~lv~e~~~~gsL~~~l~~~~-l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~Df 285 (443)
.++|+|||||+||||..++.+.. +++.++..++..|..||.-||+. |+|||||||+|||||..|++||+||
T Consensus 148 ~~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~m--------gyVHRDiKPDNvLld~~GHikLADF 219 (1317)
T KOG0612|consen 148 RYLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSM--------GYVHRDIKPDNVLLDKSGHIKLADF 219 (1317)
T ss_pred cceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhc--------cceeccCCcceeEecccCcEeeccc
Confidence 46899999999999999998755 99999999999999999999998 9999999999999999999999999
Q ss_pred CCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCC
Q psy14889 286 GLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLV 365 (443)
Q Consensus 286 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~ 365 (443)
|.+..+....... ....+|||.|++||++...... .-.|++.+|+||+||++|||+.| ..||...
T Consensus 220 GsClkm~~dG~V~---s~~aVGTPDYISPEvLqs~~~~-~g~yG~ecDwWSlGV~~YEMlyG----------~TPFYad- 284 (1317)
T KOG0612|consen 220 GSCLKMDADGTVR---SSVAVGTPDYISPEVLQSQGDG-KGEYGRECDWWSLGVFMYEMLYG----------ETPFYAD- 284 (1317)
T ss_pred hhHHhcCCCCcEE---eccccCCCCccCHHHHHhhcCC-ccccCCccchhhhHHHHHHHHcC----------CCcchHH-
Confidence 9987776544332 3456899999999999765443 12788999999999999999999 8898763
Q ss_pred CCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCc---HHHHHH
Q psy14889 366 PMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLS---ALRVKK 423 (443)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps---~~evl~ 423 (443)
...+...++ ........+|+. ..++.+.++||++.+ -+|+.|.. ++++..
T Consensus 285 ---slveTY~KI-m~hk~~l~FP~~---~~VSeeakdLI~~ll-~~~e~RLgrngiedik~ 337 (1317)
T KOG0612|consen 285 ---SLVETYGKI-MNHKESLSFPDE---TDVSEEAKDLIEALL-CDREVRLGRNGIEDIKN 337 (1317)
T ss_pred ---HHHHHHHHH-hchhhhcCCCcc---cccCHHHHHHHHHHh-cChhhhcccccHHHHHh
Confidence 123333343 344455666632 337788999999877 56888887 777754
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=279.26 Aligned_cols=244 Identities=25% Similarity=0.395 Sum_probs=193.0
Q ss_pred cccccceeeeecCeEEEEEEEC--CceeEEEEeeccCc---cchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEe
Q psy14889 137 QISLSECIGKGRYGEVWRGVWH--GENVAVKIFFSRDE---ASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWL 211 (443)
Q Consensus 137 ~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~---~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~l 211 (443)
+|++.+.||+|+||.||++... +..||+|++..... .......|+..+..++|||++++++.+... ...++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~----~~~~l 76 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEK----GKLCI 76 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecC----CEEEE
Confidence 4788899999999999999984 88999998865432 222234556666668999999999988766 45799
Q ss_pred eecccCcccHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecC
Q psy14889 212 VTHYHSFGSLYDHLNR-----TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFG 286 (443)
Q Consensus 212 v~e~~~~gsL~~~l~~-----~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfG 286 (443)
|+||+++++|.+++.+ ..+++..+..++.+++.||.|||+. +++|+||+|+||+++.++.++|+|||
T Consensus 77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~--------~~~H~dl~~~nil~~~~~~~~l~d~~ 148 (258)
T cd08215 77 VMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR--------KILHRDIKPQNIFLTSNGLVKLGDFG 148 (258)
T ss_pred EEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC--------CEecccCChHHeEEcCCCcEEECCcc
Confidence 9999999999999864 5699999999999999999999998 99999999999999999999999999
Q ss_pred CcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCC
Q psy14889 287 LAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVP 366 (443)
Q Consensus 287 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~ 366 (443)
++........ ......|++.|+|||.+.+. .++.++|+||||+++|+|++| ..||....
T Consensus 149 ~~~~~~~~~~----~~~~~~~~~~y~~pe~~~~~------~~~~~~Dv~slG~~~~~l~~g----------~~p~~~~~- 207 (258)
T cd08215 149 ISKVLSSTVD----LAKTVVGTPYYLSPELCQNK------PYNYKSDIWSLGCVLYELCTL----------KHPFEGEN- 207 (258)
T ss_pred ceeecccCcc----eecceeeeecccChhHhccC------CCCccccHHHHHHHHHHHHcC----------CCCCCCCc-
Confidence 9976654321 11234688899999998765 566899999999999999999 66664431
Q ss_pred CCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 367 MDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
...+...... ...+.++ ...+..+.+++.+||+.+|++|||+.++++
T Consensus 208 ----~~~~~~~~~~-~~~~~~~-----~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 208 ----LLELALKILK-GQYPPIP-----SQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred ----HHHHHHHHhc-CCCCCCC-----CCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 2222222211 1222232 235678999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=293.39 Aligned_cols=263 Identities=21% Similarity=0.258 Sum_probs=184.7
Q ss_pred cccccceeeeecCeEEEEEEEC----CceeEEEEeeccCcc---chHHHHHHHHHHhc-cCCCceeeeeeccccCCcccE
Q psy14889 137 QISLSECIGKGRYGEVWRGVWH----GENVAVKIFFSRDEA---SWSRETEIYSTVLL-RHENILGYIGSDMTSRNSCTQ 208 (443)
Q Consensus 137 ~~~~~~~lG~G~fg~Vy~~~~~----~~~vAvK~~~~~~~~---~~~~e~ei~~~~~l-~H~nIv~l~g~~~~~~~~~~~ 208 (443)
+|++.+.||+|+||.||++... +..||+|.+...... ......|+..+..+ +||||+++++.+.........
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4778899999999999999983 668999987542211 11223445455446 599999999876543222345
Q ss_pred EEeeecccCcccHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCC
Q psy14889 209 LWLVTHYHSFGSLYDHLN-RTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGL 287 (443)
Q Consensus 209 ~~lv~e~~~~gsL~~~l~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGl 287 (443)
+++++||+. ++|.+++. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~--------givH~dlkp~Nili~~~~~~kl~Dfg~ 151 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSA--------NVLHRDLKPGNLLVNADCELKICDFGL 151 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC--------CcccCCCCHHHeEEcCCCCEEeCcCCC
Confidence 789999987 58998885 46789999999999999999999998 999999999999999999999999999
Q ss_pred cccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCC
Q psy14889 288 AVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPM 367 (443)
Q Consensus 288 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~ 367 (443)
++.+...............||..|+|||.+.+.. .++.++||||||+++|+|++|+ .||......
T Consensus 152 a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-----~~~~~~Di~slGv~l~~l~~g~----------~pf~~~~~~ 216 (332)
T cd07857 152 ARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQ-----SYTKAIDVWSVGCILAELLGRK----------PVFKGKDYV 216 (332)
T ss_pred ceecccccccccccccCcccCccccCcHHHhCCC-----CCCcHHHHHHHHHHHHHHHhCC----------cCCCCCCHH
Confidence 9866543322222223457899999999876531 4568999999999999999994 444331100
Q ss_pred -----------CCChHHHHh--------hhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 368 -----------DPSFDDMRK--------VICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 368 -----------~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
.+..+.... ........+..+-.......+..+.+++.+||+.||++|||+.++++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 217 DQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000000000 00000001111100111224567999999999999999999999875
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=278.39 Aligned_cols=250 Identities=28% Similarity=0.436 Sum_probs=195.1
Q ss_pred cccccceeeeecCeEEEEEEEC--CceeEEEEeeccCc---cchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEe
Q psy14889 137 QISLSECIGKGRYGEVWRGVWH--GENVAVKIFFSRDE---ASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWL 211 (443)
Q Consensus 137 ~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~---~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~l 211 (443)
+|+..+.||+|++|.||+|... ++.|++|++..... .......|+..+..++||||+++++.+..... ..+++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~--~~~~l 78 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEK--NTLNI 78 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCC--CeEEE
Confidence 4677899999999999999984 88999998865542 22333456666777999999999999876531 35799
Q ss_pred eecccCcccHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCccc
Q psy14889 212 VTHYHSFGSLYDHLNRT-TLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVS 290 (443)
Q Consensus 212 v~e~~~~gsL~~~l~~~-~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~ 290 (443)
++||+++++|.+++.+. .+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||.+..
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--------~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~ 150 (260)
T cd06606 79 FLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSN--------GIVHRDIKGANILVDSDGVVKLADFGCAKR 150 (260)
T ss_pred EEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC--------CccccCCCHHHEEEcCCCCEEEcccccEEe
Confidence 99999999999998654 799999999999999999999998 999999999999999999999999999877
Q ss_pred ccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCC
Q psy14889 291 YSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPS 370 (443)
Q Consensus 291 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~ 370 (443)
....... .......++..|+|||.+.+. ..+.++||||||+++|+|++| ..||.... ..
T Consensus 151 ~~~~~~~--~~~~~~~~~~~y~~pE~~~~~------~~~~~~Dv~slG~il~~l~~g----------~~p~~~~~---~~ 209 (260)
T cd06606 151 LGDIETG--EGTGSVRGTPYWMAPEVIRGE------EYGRAADIWSLGCTVIEMATG----------KPPWSELG---NP 209 (260)
T ss_pred ccccccc--ccccCCCCCccccCHhhhcCC------CCCchhhHHHHHHHHHHHHhC----------CCCCCCCC---ch
Confidence 6553321 011234688899999998776 466899999999999999999 66665532 11
Q ss_pred hHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 371 FDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
....... ......+.++ ...+..+.+++.+||+.||++||++.++++
T Consensus 210 ~~~~~~~-~~~~~~~~~~-----~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 210 MAALYKI-GSSGEPPEIP-----EHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred HHHHHhc-cccCCCcCCC-----cccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 1111111 1112222233 334678999999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=287.23 Aligned_cols=259 Identities=22% Similarity=0.298 Sum_probs=189.2
Q ss_pred hhccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCc---cchHHHHHHHHHHhccCCCceeeeeeccccCC----
Q psy14889 134 LAKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDE---ASWSRETEIYSTVLLRHENILGYIGSDMTSRN---- 204 (443)
Q Consensus 134 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~---~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~---- 204 (443)
..++|++.+.||+|+||.||+|.. +|+.||+|++..... .....+.|+..+..++||||+++++++.+...
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 347899999999999999999998 588999998864322 12233456666667999999999999876541
Q ss_pred --cccEEEeeecccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcE
Q psy14889 205 --SCTQLWLVTHYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTC 280 (443)
Q Consensus 205 --~~~~~~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~ 280 (443)
....+++|+||+++ +|..++.. ..+++..+..++.|++.||+|||+. +|+|+||||+||++++++.+
T Consensus 85 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~--------~i~H~dl~p~nili~~~~~~ 155 (302)
T cd07864 85 KKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKK--------NFLHRDIKCSNILLNNKGQI 155 (302)
T ss_pred cccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CeecCCCCHHHEEECCCCcE
Confidence 11368999999986 77777754 4689999999999999999999998 99999999999999999999
Q ss_pred EEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCC
Q psy14889 281 VIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAP 360 (443)
Q Consensus 281 kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P 360 (443)
||+|||++..+...... ......++..|+|||.+.+.. .++.++|||||||++|||++| ..|
T Consensus 156 kl~dfg~~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~-----~~~~~~Di~slG~~~~el~~g----------~~~ 217 (302)
T cd07864 156 KLADFGLARLYNSEESR---PYTNKVITLWYRPPELLLGEE-----RYGPAIDVWSCGCILGELFTK----------KPI 217 (302)
T ss_pred EeCcccccccccCCccc---ccccceeccCccChHHhcCCC-----CCCchhHHHHHHHHHHHHHhC----------CCC
Confidence 99999999766543221 112235678899999886531 346799999999999999999 445
Q ss_pred CCCCCCCCCChHHHHhhhhhcCCC-----CCC---------------CCC--CCCchhHHHHHHHHHHHhcCCcCCCCcH
Q psy14889 361 YHDLVPMDPSFDDMRKVICIDQQR-----PVL---------------PNR--WVSDSTLNAMTKVMKECWHQNANVRLSA 418 (443)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~-----~~~---------------~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~ 418 (443)
|.... ....+.......... +.+ ... ......+..+.+++.+||+.||++|||+
T Consensus 218 ~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~ 293 (302)
T cd07864 218 FQANQ----ELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTA 293 (302)
T ss_pred CCCCC----hHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCH
Confidence 54321 111111111100000 000 000 0011246789999999999999999999
Q ss_pred HHHHH
Q psy14889 419 LRVKK 423 (443)
Q Consensus 419 ~evl~ 423 (443)
.++++
T Consensus 294 ~~il~ 298 (302)
T cd07864 294 EEALN 298 (302)
T ss_pred HHHhc
Confidence 99875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG0587|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=304.92 Aligned_cols=259 Identities=26% Similarity=0.427 Sum_probs=207.7
Q ss_pred hhhccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccchHHHHHHHHHHh-ccCCCceeeeeeccccC-CcccE
Q psy14889 133 TLAKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEASWSRETEIYSTVL-LRHENILGYIGSDMTSR-NSCTQ 208 (443)
Q Consensus 133 ~~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~e~ei~~~~~-l~H~nIv~l~g~~~~~~-~~~~~ 208 (443)
..+..|.+.+.||.|.+|.||+++. +++.+|+|++....+.+...|.|..++.. -+|||++.++|++...+ ....+
T Consensus 16 dp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~Dq 95 (953)
T KOG0587|consen 16 DPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQ 95 (953)
T ss_pred CCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCe
Confidence 3346799999999999999999876 78999999987665555555555544433 47999999999986433 33468
Q ss_pred EEeeecccCcccHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEec
Q psy14889 209 LWLVTHYHSFGSLYDHLNR---TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADF 285 (443)
Q Consensus 209 ~~lv~e~~~~gsL~~~l~~---~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~Df 285 (443)
+|||||||.+||..+++++ .++.|..+..|++.++.||.+||.+ .++|||||-.|||++.++.+||.||
T Consensus 96 LWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~n--------kviHRDikG~NiLLT~e~~VKLvDF 167 (953)
T KOG0587|consen 96 LWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNN--------KVIHRDIKGQNVLLTENAEVKLVDF 167 (953)
T ss_pred EEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhc--------ceeeecccCceEEEeccCcEEEeee
Confidence 9999999999999999864 6799999999999999999999998 8999999999999999999999999
Q ss_pred CCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCC
Q psy14889 286 GLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLV 365 (443)
Q Consensus 286 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~ 365 (443)
|.+..+...... ..+..||+.|||||++......+ ..|+..+|+||||++..||.-| ..|+-++.
T Consensus 168 GvSaQldsT~gr----RnT~iGtP~WMAPEViac~e~~d-~tyd~R~D~WsLGITaIEladG----------~PPl~DmH 232 (953)
T KOG0587|consen 168 GVSAQLDSTVGR----RNTFIGTPYWMAPEVIACDESPD-ATYDYRSDLWSLGITAIEMAEG----------APPLCDMH 232 (953)
T ss_pred eeeeeeeccccc----ccCcCCCcccccceeeecccCCC-CCcccccchhhccceeehhcCC----------CCCccCcc
Confidence 999877654333 35678999999999998765554 2777899999999999999999 77887765
Q ss_pred CCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 366 PMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
+. +.++.+... +.|....+..-++++.++|..||..|.++||++.++++
T Consensus 233 Pm-------raLF~IpRN--PPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 233 PM-------RALFLIPRN--PPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred hh-------hhhccCCCC--CCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 53 333322221 12222223456788999999999999999999988765
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=286.89 Aligned_cols=254 Identities=24% Similarity=0.334 Sum_probs=190.2
Q ss_pred cccccceeeeecCeEEEEEEE-----CCceeEEEEeeccCc-----cchHHHHHHHHHHhc-cCCCceeeeeeccccCCc
Q psy14889 137 QISLSECIGKGRYGEVWRGVW-----HGENVAVKIFFSRDE-----ASWSRETEIYSTVLL-RHENILGYIGSDMTSRNS 205 (443)
Q Consensus 137 ~~~~~~~lG~G~fg~Vy~~~~-----~~~~vAvK~~~~~~~-----~~~~~e~ei~~~~~l-~H~nIv~l~g~~~~~~~~ 205 (443)
+|++.+.||+|+||.||++.. +++.||||++..... .....+.|+..+..+ +||||+++++.+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~--- 77 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTD--- 77 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecC---
Confidence 477889999999999999875 467899998864321 112233455555557 699999999887665
Q ss_pred ccEEEeeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEe
Q psy14889 206 CTQLWLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIAD 284 (443)
Q Consensus 206 ~~~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~D 284 (443)
..+++||||+++|+|.+++.. ..+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|
T Consensus 78 -~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~--------~~~H~dl~p~nil~~~~~~~~l~d 148 (288)
T cd05583 78 -TKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQL--------GIIYRDIKLENILLDSEGHVVLTD 148 (288)
T ss_pred -CEEEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHC--------CeeccCCCHHHeEECCCCCEEEEE
Confidence 457899999999999999864 5689999999999999999999988 999999999999999999999999
Q ss_pred cCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCC
Q psy14889 285 FGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDL 364 (443)
Q Consensus 285 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~ 364 (443)
||+++.+....... .....|+..|+|||.+.+... ..+.++||||||+++|||++| ..||...
T Consensus 149 fg~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~----~~~~~~Dv~slG~il~el~tg----------~~p~~~~ 211 (288)
T cd05583 149 FGLSKEFLAEEEER---AYSFCGTIEYMAPEVIRGGSG----GHDKAVDWWSLGVLTFELLTG----------ASPFTVD 211 (288)
T ss_pred Cccccccccccccc---cccccCCccccCHHHhcCCCC----CCcchhhhHHHHHHHHHHHhC----------CCCcccC
Confidence 99987654332111 123468889999999876421 245789999999999999999 6666432
Q ss_pred CCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHH
Q psy14889 365 VPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIK 427 (443)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 427 (443)
.. ......+.+.+.. ..+..+ ...+..+.+++.+||+.||++|||+.++.+.|+.
T Consensus 212 ~~-~~~~~~~~~~~~~--~~~~~~-----~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 212 GE-QNSQSEISRRILK--SKPPFP-----KTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred cc-cchHHHHHHHHHc--cCCCCC-----cccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 11 1112222222221 112222 2245679999999999999999998888776654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=285.39 Aligned_cols=250 Identities=24% Similarity=0.357 Sum_probs=187.1
Q ss_pred cccccceeeeecCeEEEEEEE-----CCceeEEEEeeccCc-----cchHHHHHHHHHHhc-cCCCceeeeeeccccCCc
Q psy14889 137 QISLSECIGKGRYGEVWRGVW-----HGENVAVKIFFSRDE-----ASWSRETEIYSTVLL-RHENILGYIGSDMTSRNS 205 (443)
Q Consensus 137 ~~~~~~~lG~G~fg~Vy~~~~-----~~~~vAvK~~~~~~~-----~~~~~e~ei~~~~~l-~H~nIv~l~g~~~~~~~~ 205 (443)
+|++.+.||+|+||.||++.. +|..||+|++..... .....+.|+..+..+ +|+||+++++.+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~--- 77 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTD--- 77 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecC---
Confidence 477889999999999999986 578999998864321 112224455555557 699999999887765
Q ss_pred ccEEEeeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEe
Q psy14889 206 CTQLWLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIAD 284 (443)
Q Consensus 206 ~~~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~D 284 (443)
..+++|+||+++++|.+++.. ..+++..+..++.|++.||.|||+. +++||||+|+|||++.++.+||+|
T Consensus 78 -~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~--------~i~H~dl~p~nil~~~~~~~kl~d 148 (290)
T cd05613 78 -TKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKL--------GIIYRDIKLENILLDSNGHVVLTD 148 (290)
T ss_pred -CeEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC--------CeeccCCCHHHeEECCCCCEEEee
Confidence 457899999999999999864 5689999999999999999999998 999999999999999999999999
Q ss_pred cCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCC
Q psy14889 285 FGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDL 364 (443)
Q Consensus 285 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~ 364 (443)
||++......... ......|+..|+|||.+..... .++.++||||||+++|||++| ..||...
T Consensus 149 fg~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~----~~~~~~Dv~slG~~l~~ll~g----------~~p~~~~ 211 (290)
T cd05613 149 FGLSKEFHEDEVE---RAYSFCGTIEYMAPDIVRGGDG----GHDKAVDWWSMGVLMYELLTG----------ASPFTVD 211 (290)
T ss_pred Cccceeccccccc---ccccccCCcccCChhhccCCCC----CCCccccHHHHHHHHHHHhcC----------CCCCCcC
Confidence 9998765432111 1123468899999999875321 345789999999999999999 5565432
Q ss_pred CCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCC-----cHHHHHH
Q psy14889 365 VPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRL-----SALRVKK 423 (443)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~ 423 (443)
.. ......+...+.. ..+..+ ..++..+.+++++||+.||++|| +++++++
T Consensus 212 ~~-~~~~~~~~~~~~~--~~~~~~-----~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 212 GE-KNSQAEISRRILK--SEPPYP-----QEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred Cc-cccHHHHHHHhhc--cCCCCC-----ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 11 1122222222211 122222 23566799999999999999997 6677665
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=285.55 Aligned_cols=248 Identities=23% Similarity=0.324 Sum_probs=191.1
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCc----cchHHHHHHHHHHhcc-CCCceeeeeeccccCCcccE
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDE----ASWSRETEIYSTVLLR-HENILGYIGSDMTSRNSCTQ 208 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~----~~~~~e~ei~~~~~l~-H~nIv~l~g~~~~~~~~~~~ 208 (443)
++|.+.+.||+|+||.||+|.. ++..||+|++..... .......|...+..++ ||||+++++++... ..
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~----~~ 76 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDE----EN 76 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCC----ce
Confidence 3688999999999999999988 689999998864321 1112223444455577 99999999988765 45
Q ss_pred EEeeecccCcccHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCC
Q psy14889 209 LWLVTHYHSFGSLYDHLNRT-TLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGL 287 (443)
Q Consensus 209 ~~lv~e~~~~gsL~~~l~~~-~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGl 287 (443)
.++||||+++++|.+++.+. .+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||+
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~--------~~~H~dl~~~ni~i~~~~~~~l~df~~ 148 (280)
T cd05581 77 LYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSK--------GIIHRDLKPENILLDKDMHIKITDFGT 148 (280)
T ss_pred EEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC--------CeeecCCCHHHeEECCCCCEEecCCcc
Confidence 79999999999999999764 799999999999999999999998 999999999999999999999999999
Q ss_pred cccccccCCcC----------------CCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCC
Q psy14889 288 AVSYSQLSNKM----------------DIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKAN 351 (443)
Q Consensus 288 a~~~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~ 351 (443)
+.......... ........|+..|+|||.+... ..+.++||||||++++|+++|
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~------~~~~~~Di~slG~~l~~l~~g---- 218 (280)
T cd05581 149 AKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEK------PAGKSSDLWALGCIIYQMLTG---- 218 (280)
T ss_pred ccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCC------CCChhhhHHHHHHHHHHHHhC----
Confidence 87665432210 0112334678899999988765 566899999999999999999
Q ss_pred CcccccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcH----HHHHH
Q psy14889 352 GIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSA----LRVKK 423 (443)
Q Consensus 352 ~~~~~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~----~evl~ 423 (443)
..||.... ......... .....++ ...+..+.+++++||+.||++|||+ .++++
T Consensus 219 ------~~p~~~~~----~~~~~~~~~---~~~~~~~-----~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 219 ------KPPFRGSN----EYLTFQKIL---KLEYSFP-----PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred ------CCCCCCcc----HHHHHHHHH---hcCCCCC-----CccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 66766532 112222222 1122222 2245679999999999999999999 77654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=293.36 Aligned_cols=258 Identities=22% Similarity=0.293 Sum_probs=188.8
Q ss_pred hhhhccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc---chHHHHHHHHHHhccCCCceeeeeeccccCC--
Q psy14889 132 RTLAKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA---SWSRETEIYSTVLLRHENILGYIGSDMTSRN-- 204 (443)
Q Consensus 132 ~~~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~---~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~-- 204 (443)
..+.++|++.+.||+|+||.||+|.. +++.||+|++...... ......|+..+..++||||+++++++.....
T Consensus 13 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~ 92 (345)
T cd07877 13 WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE 92 (345)
T ss_pred hhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccc
Confidence 44558899999999999999999986 6889999988643211 1222346666667999999999998764321
Q ss_pred cccEEEeeecccCcccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEe
Q psy14889 205 SCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIAD 284 (443)
Q Consensus 205 ~~~~~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~D 284 (443)
.....+++++++ +++|.+++....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|
T Consensus 93 ~~~~~~lv~~~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--------~ivH~dlkp~NIll~~~~~~kl~d 163 (345)
T cd07877 93 EFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA--------DIIHRDLKPSNLAVNEDCELKILD 163 (345)
T ss_pred ccccEEEEehhc-ccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CeeecCCChHHEEEcCCCCEEEec
Confidence 113468888887 67999998878899999999999999999999998 999999999999999999999999
Q ss_pred cCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCC
Q psy14889 285 FGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDL 364 (443)
Q Consensus 285 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~ 364 (443)
||+++..... .....|+..|+|||.+.+.. .++.++|||||||++|||++| ..||...
T Consensus 164 fg~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~-----~~~~~~DvwslG~il~el~~g----------~~pf~~~ 221 (345)
T cd07877 164 FGLARHTDDE-------MTGYVATRWYRAPEIMLNWM-----HYNQTVDIWSVGCIMAELLTG----------RTLFPGT 221 (345)
T ss_pred cccccccccc-------ccccccCCCccCHHHHhCcc-----CCCchhhHHHHHHHHHHHHhC----------CCCCCCC
Confidence 9998754321 12346788999999886531 456799999999999999999 4455332
Q ss_pred CCCCCChHHHHhh-----------------------hhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHH
Q psy14889 365 VPMDPSFDDMRKV-----------------------ICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRV 421 (443)
Q Consensus 365 ~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ev 421 (443)
.. ....... .......+...........+..+.+++.+||+.||.+|||+.++
T Consensus 222 ~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~ 297 (345)
T cd07877 222 DH----IDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 297 (345)
T ss_pred CH----HHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHH
Confidence 10 0111110 00000001000000001235678999999999999999999998
Q ss_pred HHH
Q psy14889 422 KKT 424 (443)
Q Consensus 422 l~~ 424 (443)
+..
T Consensus 298 l~h 300 (345)
T cd07877 298 LAH 300 (345)
T ss_pred hcC
Confidence 864
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0666|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=279.25 Aligned_cols=271 Identities=23% Similarity=0.316 Sum_probs=194.5
Q ss_pred ccccccceeeeecCeEEEEEEEC------CceeEEEEeeccCc---cchHHHHHHHHHHhccCCCceeeeeeccccCCcc
Q psy14889 136 KQISLSECIGKGRYGEVWRGVWH------GENVAVKIFFSRDE---ASWSRETEIYSTVLLRHENILGYIGSDMTSRNSC 206 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~~------~~~vAvK~~~~~~~---~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~ 206 (443)
..|+....||+|+||.||+|.-. .+.+|+|.++.... -+...-+||..++.++||||+.+..++...+
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d--- 100 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHD--- 100 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccC---
Confidence 57889999999999999999652 24789998865422 2334456777777799999999999998753
Q ss_pred cEEEeeecccCcccHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCC---
Q psy14889 207 TQLWLVTHYHSFGSLYDHLNR------TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTN--- 277 (443)
Q Consensus 207 ~~~~lv~e~~~~gsL~~~l~~------~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~--- 277 (443)
..+||++||.+. ||.+.++- ..++...+..|+.||+.|+.|||++ =|+||||||.|||+..+
T Consensus 101 ~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N--------WvlHRDLKPaNIlvmgdgpe 171 (438)
T KOG0666|consen 101 KKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN--------WVLHRDLKPANILVMGDGPE 171 (438)
T ss_pred ceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh--------heeeccCCcceEEEeccCCc
Confidence 468999999997 99998842 4588899999999999999999999 68999999999999887
Q ss_pred -CcEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCccc-
Q psy14889 278 -GTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFE- 355 (443)
Q Consensus 278 -~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~- 355 (443)
|.+||+|||+++.+....... ......+-|++|.|||++.+.. .||++.||||.||++.||+|-.+.+.-.+
T Consensus 172 rG~VKIaDlGlaR~~~~plkpl-~s~d~VVVTiWYRAPELLLGa~-----hYT~AiDvWAiGCIfaElLtl~PlF~g~E~ 245 (438)
T KOG0666|consen 172 RGRVKIADLGLARLFNNPLKPL-ASLDPVVVTIWYRAPELLLGAR-----HYTKAIDVWAIGCIFAELLTLEPLFKGREE 245 (438)
T ss_pred cCeeEeecccHHHHhhcccccc-ccCCceEEEEEecChHHhcccc-----cccchhhhHHHHHHHHHHHccCccccchhh
Confidence 899999999999887654332 1234567899999999999874 66789999999999999999876542111
Q ss_pred --ccCCCCCC----------------CCCCCCChHHHH---hhhhhcCCCCC-CCCCCCC--chhHHHHHHHHHHHhcCC
Q psy14889 356 --EYKAPYHD----------------LVPMDPSFDDMR---KVICIDQQRPV-LPNRWVS--DSTLNAMTKVMKECWHQN 411 (443)
Q Consensus 356 --~~~~P~~~----------------~~~~~~~~~~~~---~~~~~~~~~~~-~~~~~~~--~~~~~~l~~li~~cl~~d 411 (443)
..+.||+. .++.-....+.. ..+........ +. .|.. ..-++...+|+.++|..|
T Consensus 246 k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~-~~~~~~k~k~~~a~~LL~klL~yD 324 (438)
T KOG0666|consen 246 KIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLH-KYYHKHKVKDPSALDLLQKLLTYD 324 (438)
T ss_pred hcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHH-HHHHHhcCCCchHHHHHHHHhccC
Confidence 11224432 111100000110 00000001000 00 0000 001233789999999999
Q ss_pred cCCCCcHHHHHHHH
Q psy14889 412 ANVRLSALRVKKTL 425 (443)
Q Consensus 412 P~~Rps~~evl~~L 425 (443)
|.+|.|+++.++..
T Consensus 325 P~kRIta~qAleh~ 338 (438)
T KOG0666|consen 325 PIKRITAEQALEHP 338 (438)
T ss_pred chhhccHHHHhccc
Confidence 99999999987643
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=284.64 Aligned_cols=248 Identities=25% Similarity=0.345 Sum_probs=184.0
Q ss_pred ccccceeeeecCeEEEEEEE--CCceeEEEEeeccCc--cchHHHHHHHHHHhcc-CCCceeeeeeccccCCcccEEEee
Q psy14889 138 ISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDE--ASWSRETEIYSTVLLR-HENILGYIGSDMTSRNSCTQLWLV 212 (443)
Q Consensus 138 ~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~--~~~~~e~ei~~~~~l~-H~nIv~l~g~~~~~~~~~~~~~lv 212 (443)
|++.+.||+|+||.||+|.. +++.||||.+..... .......|+..+..++ |+||+++++++... ...++|
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~----~~~~lv 76 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFREN----DELYFV 76 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcC----CcEEEE
Confidence 56788999999999999998 478899998754322 2223345666666688 99999999998775 457999
Q ss_pred ecccCcccHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcc
Q psy14889 213 THYHSFGSLYDHLNR---TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAV 289 (443)
Q Consensus 213 ~e~~~~gsL~~~l~~---~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~ 289 (443)
|||+ +|+|.+++.. ..+++.++..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++.
T Consensus 77 ~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~--------~i~H~dl~~~ni~i~~~~~~~l~d~~~~~ 147 (283)
T cd07830 77 FEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH--------GFFHRDLKPENLLVSGPEVVKIADFGLAR 147 (283)
T ss_pred EecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHC--------CcccCCCChhhEEEcCCCCEEEeecccce
Confidence 9999 7899998864 3689999999999999999999998 99999999999999999999999999987
Q ss_pred cccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCC
Q psy14889 290 SYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDP 369 (443)
Q Consensus 290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~ 369 (443)
....... .....++..|+|||.+.... .++.++|+||||+++|||++|+ .||.....
T Consensus 148 ~~~~~~~-----~~~~~~~~~~~aPE~~~~~~-----~~~~~~Di~s~G~~l~el~~g~----------~~~~~~~~--- 204 (283)
T cd07830 148 EIRSRPP-----YTDYVSTRWYRAPEILLRST-----SYSSPVDIWALGCIMAELYTLR----------PLFPGSSE--- 204 (283)
T ss_pred eccCCCC-----cCCCCCcccccCceeeecCc-----CcCCccchhhHHHHHHHHHhCC----------CccCCCCh---
Confidence 6543221 12346788999999886542 4568999999999999999994 44433210
Q ss_pred ChHHHHhhhh----------------hcCCCCCCCC-------CCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 370 SFDDMRKVIC----------------IDQQRPVLPN-------RWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 370 ~~~~~~~~~~----------------~~~~~~~~~~-------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
.+...+... ........+. ... ...+..+.+++++||+.||++|||++|++.
T Consensus 205 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 205 -IDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLI-PNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred -HHHHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHc-ccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 011100000 0000000000 000 112467999999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=282.21 Aligned_cols=244 Identities=24% Similarity=0.300 Sum_probs=184.6
Q ss_pred eeeecCeEEEEEEE--CCceeEEEEeeccCc----cchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEeeecccC
Q psy14889 144 IGKGRYGEVWRGVW--HGENVAVKIFFSRDE----ASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVTHYHS 217 (443)
Q Consensus 144 lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~----~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e~~~ 217 (443)
||+|+||.||++.. +|+.+|+|.+..... .....+.|+..+..++||||+++++.+... ...++++||++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~----~~~~lv~e~~~ 76 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGK----KNLYLVMEYLP 76 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecC----cEEEEEEecCC
Confidence 68999999999998 489999998854432 122234556666668999999999887665 45799999999
Q ss_pred cccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcccccccCC
Q psy14889 218 FGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSN 296 (443)
Q Consensus 218 ~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~~~~~~ 296 (443)
+++|.+++.+ ..+++..+..++.||+.||+|||+. +++|+||+|+||+++.++.+||+|||++........
T Consensus 77 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~--------~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 148 (265)
T cd05579 77 GGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSN--------GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQ 148 (265)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHc--------CeecCCCCHHHeEEcCCCCEEEEecccchhcccCcc
Confidence 9999999975 5789999999999999999999998 999999999999999999999999999865433211
Q ss_pred cC----CCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCChH
Q psy14889 297 KM----DIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFD 372 (443)
Q Consensus 297 ~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~~~ 372 (443)
.. ........++..|+|||.+... ..+.++||||||+++|||++| ..||.... ..
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~------~~~~~~Dv~slG~~~~~l~~g----------~~p~~~~~-----~~ 207 (265)
T cd05579 149 INLNDDEKEDKRIVGTPDYIAPEVILGQ------GHSKTVDWWSLGCILYEFLVG----------IPPFHGET-----PE 207 (265)
T ss_pred cccccccccccCcccCccccCHHHhcCC------CCCcchhhHHHHHHHHHHHhC----------CCCCCCCC-----HH
Confidence 00 0112334678899999998765 566899999999999999999 66765431 22
Q ss_pred HHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHH
Q psy14889 373 DMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTL 425 (443)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 425 (443)
........ .....+.. ...+..+.+++.+||+.+|.+|||+.++.+.|
T Consensus 208 ~~~~~~~~--~~~~~~~~---~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l 255 (265)
T cd05579 208 EIFQNILN--GKIEWPED---VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK 255 (265)
T ss_pred HHHHHHhc--CCcCCCcc---ccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence 22222211 11222221 11367899999999999999999995555444
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=285.85 Aligned_cols=252 Identities=24% Similarity=0.318 Sum_probs=182.5
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc---chHHHHHHHHHHhccCCCceeeeeeccccCCcccEEE
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA---SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLW 210 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~---~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~ 210 (443)
++|++.+.||+|+||.||+|.. +|+.||+|.+...... ......|+..+..++||||+++++++... ...+
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----~~~~ 77 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSE----KRLY 77 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecC----CeEE
Confidence 4789999999999999999987 5789999987543221 12223456666669999999999998766 4579
Q ss_pred eeecccCcccHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcC-CCcEEEEecC
Q psy14889 211 LVTHYHSFGSLYDHLNR---TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKT-NGTCVIADFG 286 (443)
Q Consensus 211 lv~e~~~~gsL~~~l~~---~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~-~~~~kl~DfG 286 (443)
+||||++ ++|.+++.. ..+++..+..++.||+.||+|||+. +++|+||+|+||+++. ++.+||+|||
T Consensus 78 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~--------~i~H~dl~p~nill~~~~~~~kl~dfg 148 (294)
T PLN00009 78 LVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH--------RVLHRDLKPQNLLIDRRTNALKLADFG 148 (294)
T ss_pred EEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhC--------CeeCCCCCcceEEEECCCCEEEEcccc
Confidence 9999996 588887743 2357888889999999999999998 9999999999999985 4579999999
Q ss_pred CcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCC
Q psy14889 287 LAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVP 366 (443)
Q Consensus 287 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~ 366 (443)
++......... .....++..|+|||.+.+.. .++.++||||||+++|||+|| ..||....
T Consensus 149 ~~~~~~~~~~~----~~~~~~~~~y~~PE~~~~~~-----~~~~~~Dv~slG~i~~~l~tg----------~~pf~~~~- 208 (294)
T PLN00009 149 LARAFGIPVRT----FTHEVVTLWYRAPEILLGSR-----HYSTPVDIWSVGCIFAEMVNQ----------KPLFPGDS- 208 (294)
T ss_pred cccccCCCccc----cccCceeecccCHHHHhCCC-----CCCcHHHHHHHHHHHHHHHhC----------CCCCCCCC-
Confidence 99755432111 12346788999999886541 456799999999999999999 44544321
Q ss_pred CCCChHHHHhhhhhcC------------------CCCCCCCC---CCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 367 MDPSFDDMRKVICIDQ------------------QRPVLPNR---WVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 367 ~~~~~~~~~~~~~~~~------------------~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
..+...+...... ..+..+.. ......+..+.+++.+||+.||++||++.++++
T Consensus 209 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 209 ---EIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred ---HHHHHHHHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1111111111000 00000000 001224567899999999999999999999886
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=289.64 Aligned_cols=194 Identities=23% Similarity=0.342 Sum_probs=149.5
Q ss_pred ceeeee--cCeEEEEEEE--CCceeEEEEeeccCccc---hHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEeeec
Q psy14889 142 ECIGKG--RYGEVWRGVW--HGENVAVKIFFSRDEAS---WSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVTH 214 (443)
Q Consensus 142 ~~lG~G--~fg~Vy~~~~--~~~~vAvK~~~~~~~~~---~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e 214 (443)
..||+| +||+||++++ +|+.||+|++....... ...+.|+..+..++||||+++++++.... ..++|+|
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~----~~~~v~e 79 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGS----WLWVISP 79 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCC----ceEEEEe
Confidence 456666 9999999988 68999999886433211 22244555555689999999999998763 4799999
Q ss_pred ccCcccHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcccc
Q psy14889 215 YHSFGSLYDHLNR---TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSY 291 (443)
Q Consensus 215 ~~~~gsL~~~l~~---~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~ 291 (443)
|+.+|+|.+++.+ ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+|++||+.+...
T Consensus 80 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~--------~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~ 151 (328)
T cd08226 80 FMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN--------GYIHRNIKASHILISGDGLVSLSGLSHLYSL 151 (328)
T ss_pred cccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhC--------CeecCCCCHHHEEEeCCCcEEEechHHHhhh
Confidence 9999999999864 4589999999999999999999988 9999999999999999999999999865333
Q ss_pred cccCCcCC---CCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCC
Q psy14889 292 SQLSNKMD---IPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKAN 351 (443)
Q Consensus 292 ~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~ 351 (443)
........ .......++..|+|||++.+... .++.++|||||||++|||++|+.|+
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~----~~~~~~DiwslG~~l~el~~g~~p~ 210 (328)
T cd08226 152 VRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLY----GYNVKSDIYSVGITACELATGRVPF 210 (328)
T ss_pred hccCccccccccccccccCccCccChhhhcCCCC----CCCchhhHHHHHHHHHHHHhCCCCC
Confidence 22111100 00112235667999999876421 4568999999999999999995543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=276.75 Aligned_cols=244 Identities=30% Similarity=0.522 Sum_probs=192.7
Q ss_pred cccccceeeeecCeEEEEEEE--CCceeEEEEeeccCc---cchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEe
Q psy14889 137 QISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDE---ASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWL 211 (443)
Q Consensus 137 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~---~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~l 211 (443)
+|++.+.||+|+||.||++.. +++.||+|.+..... .......|+..+..++|+|++++++++.+. ...++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----~~~~~ 76 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETS----DSLYI 76 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeC----CEEEE
Confidence 477889999999999999987 578999998865543 122234566666668999999999998765 45799
Q ss_pred eecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCccc
Q psy14889 212 VTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVS 290 (443)
Q Consensus 212 v~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~ 290 (443)
+|||+++++|.+++.. ..+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.++|+|||++..
T Consensus 77 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~--------~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~ 148 (254)
T cd06627 77 ILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQ--------GVIHRDIKAANILTTKDGVVKLADFGVATK 148 (254)
T ss_pred EEecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhC--------CcccCCCCHHHEEECCCCCEEEecccccee
Confidence 9999999999999865 6789999999999999999999998 999999999999999999999999999977
Q ss_pred ccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCC
Q psy14889 291 YSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPS 370 (443)
Q Consensus 291 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~ 370 (443)
....... .....++..|+|||.+.+. ..+.++||||||+++|||++| ..||.... .
T Consensus 149 ~~~~~~~----~~~~~~~~~y~~pe~~~~~------~~~~~~Dv~~lG~~l~~l~~g----------~~p~~~~~----~ 204 (254)
T cd06627 149 LNDVSKD----DASVVGTPYWMAPEVIEMS------GASTASDIWSLGCTVIELLTG----------NPPYYDLN----P 204 (254)
T ss_pred cCCCccc----ccccccchhhcCHhhhcCC------CCCcchhHHHHHHHHHHHHhC----------CCCCCCcc----H
Confidence 6543321 1234678899999998765 456799999999999999999 66665431 1
Q ss_pred hHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 371 FDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
........ ....+.++ ...+..+.+++.+||+.+|++|||+.+++.
T Consensus 205 ~~~~~~~~--~~~~~~~~-----~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 205 MAALFRIV--QDDHPPLP-----EGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred HHHHHHHh--ccCCCCCC-----CCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 12222221 12222222 335678999999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=290.83 Aligned_cols=257 Identities=22% Similarity=0.269 Sum_probs=187.6
Q ss_pred hhccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCc---cchHHHHHHHHHHhccCCCceeeeeeccccCCcccE
Q psy14889 134 LAKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDE---ASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQ 208 (443)
Q Consensus 134 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~---~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~ 208 (443)
..++|++.+.||+|+||.||++.. +++.||||++..... .......|+..+..++||||+++++++.... ..
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~---~~ 84 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPL---ED 84 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCC---Cc
Confidence 457899999999999999999986 688999998753221 1122234566666699999999999886543 24
Q ss_pred EEeeecccCcccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCc
Q psy14889 209 LWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA 288 (443)
Q Consensus 209 ~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla 288 (443)
.++++||+. ++|.++++...+++..+..++.|++.||.|||+. +|+||||+|+||++++++.+||+|||++
T Consensus 85 ~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~ql~~aL~~LH~~--------~iiH~dl~p~Nili~~~~~~~l~dfg~~ 155 (328)
T cd07856 85 IYFVTELLG-TDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSA--------GVVHRDLKPSNILINENCDLKICDFGLA 155 (328)
T ss_pred EEEEeehhc-cCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CcccCCCCHHHEeECCCCCEEeCccccc
Confidence 689999985 6999999888899999999999999999999998 9999999999999999999999999998
Q ss_pred ccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCC
Q psy14889 289 VSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMD 368 (443)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~ 368 (443)
...... .....++..|+|||.+.+.. .++.++||||||+++|||++| ..||.......
T Consensus 156 ~~~~~~-------~~~~~~~~~y~aPE~~~~~~-----~~~~~~Dv~slG~il~el~tg----------~~~f~~~~~~~ 213 (328)
T cd07856 156 RIQDPQ-------MTGYVSTRYYRAPEIMLTWQ-----KYDVEVDIWSAGCIFAEMLEG----------KPLFPGKDHVN 213 (328)
T ss_pred cccCCC-------cCCCcccccccCceeeeccC-----CcCcHHHHHHHHHHHHHHHhC----------CCCCCCCCHHH
Confidence 654321 12346788999999876531 456899999999999999999 44543321100
Q ss_pred -----------CChHHHH--------hhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHH
Q psy14889 369 -----------PSFDDMR--------KVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKT 424 (443)
Q Consensus 369 -----------~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 424 (443)
+..+... +...........+..-.....+..+.++|++||+.+|++|||+.+++..
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 214 QFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000 0000000001111000012245789999999999999999999998765
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=286.98 Aligned_cols=248 Identities=26% Similarity=0.384 Sum_probs=187.6
Q ss_pred hccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc---c-hHHHHHHHHHHhccCCCceeeeeeccccCCcccE
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA---S-WSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQ 208 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~---~-~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~ 208 (443)
.+.|+..+.||+|+||.||+|.. ++..+|+|.+...... . .....|+..+..++|+|++++++++... ..
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----~~ 89 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE----HT 89 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcC----Ce
Confidence 35688889999999999999997 5788999987542211 1 1123456666669999999999998776 35
Q ss_pred EEeeecccCcccHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecC
Q psy14889 209 LWLVTHYHSFGSLYDHLN--RTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFG 286 (443)
Q Consensus 209 ~~lv~e~~~~gsL~~~l~--~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfG 286 (443)
.++||||+. |+|.+++. ...+++.++..++.|++.||.|||+. +++||||||+||+++.++.+||+|||
T Consensus 90 ~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~--------~i~H~dl~p~nil~~~~~~~kl~dfg 160 (308)
T cd06634 90 AWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH--------NMIHRDVKAGNILLSEPGLVKLGDFG 160 (308)
T ss_pred eEEEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC--------CcccCCCCHHhEEECCCCcEEECCcc
Confidence 799999997 68887764 35689999999999999999999998 99999999999999999999999999
Q ss_pred CcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCC
Q psy14889 287 LAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVP 366 (443)
Q Consensus 287 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~ 366 (443)
++...... ....|+..|+|||.+.+... ..++.++|||||||++|||++| ..||....
T Consensus 161 ~~~~~~~~--------~~~~~~~~y~aPE~~~~~~~---~~~~~~~Di~slG~il~el~~g----------~~p~~~~~- 218 (308)
T cd06634 161 SASIMAPA--------NXFVGTPYWMAPEVILAMDE---GQYDGKVDVWSLGITCIELAER----------KPPLFNMN- 218 (308)
T ss_pred cceeecCc--------ccccCCccccCHHHHhhccc---CCCCcccchHHHHHHHHHHHcC----------CCCCcccc-
Confidence 98654321 23467889999999753211 1456799999999999999999 56665431
Q ss_pred CCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHH
Q psy14889 367 MDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLI 426 (443)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 426 (443)
......... ....+... ....+..+.+++.+||+.+|++||++.++++.--
T Consensus 219 ---~~~~~~~~~--~~~~~~~~----~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 219 ---AMSALYHIA--QNESPALQ----SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred ---HHHHHHHHh--hcCCCCcC----cccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 111111111 11122221 2335677999999999999999999999987543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=280.61 Aligned_cols=243 Identities=23% Similarity=0.376 Sum_probs=184.3
Q ss_pred cccccceeeeecCeEEEEEEEC--CceeEEEEeeccC------ccchHHHHHHHHHHhccCCCceeeeeeccccCCcccE
Q psy14889 137 QISLSECIGKGRYGEVWRGVWH--GENVAVKIFFSRD------EASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQ 208 (443)
Q Consensus 137 ~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~------~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~ 208 (443)
+|.+.+.||+|+||.||++... +..+++|+++... ........|+..+..++||||+++++++.+.. .
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~ 76 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERD----A 76 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCC----c
Confidence 4788899999999999999873 4456666554311 11222334566666699999999999987663 4
Q ss_pred EEeeecccCcccHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEE
Q psy14889 209 LWLVTHYHSFGSLYDHLNR-----TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIA 283 (443)
Q Consensus 209 ~~lv~e~~~~gsL~~~l~~-----~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~ 283 (443)
.++|+||+++++|.+++.. ..+++..++.++.|++.||.|||+. +++|+||||+||++++ +.+||+
T Consensus 77 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~--------~i~h~~l~~~nili~~-~~~~l~ 147 (260)
T cd08222 77 FCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR--------RILHRDLKAKNIFLKN-NLLKIG 147 (260)
T ss_pred eEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc--------CccccCCChhheEeec-CCEeec
Confidence 7899999999999988752 5689999999999999999999998 9999999999999975 569999
Q ss_pred ecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCC
Q psy14889 284 DFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHD 363 (443)
Q Consensus 284 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~ 363 (443)
|||++......... .....|+..|+|||.+.+. .++.++|+||||+++|+|++| ..||..
T Consensus 148 d~g~~~~~~~~~~~----~~~~~~~~~~~~pe~~~~~------~~~~~~Dv~slG~~~~~l~~~----------~~~~~~ 207 (260)
T cd08222 148 DFGVSRLLMGSCDL----ATTFTGTPYYMSPEALKHQ------GYDSKSDIWSLGCILYEMCCL----------AHAFEG 207 (260)
T ss_pred ccCceeecCCCccc----ccCCCCCcCccCHHHHccC------CCCchhhHHHHHHHHHHHHhC----------CCCCCC
Confidence 99998765432211 1234678899999988655 556789999999999999999 566643
Q ss_pred CCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 364 LVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
. .......... ....+..+ ...+.++.+++.+||+.||++||++.++++
T Consensus 208 ~----~~~~~~~~~~--~~~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 208 Q----NFLSVVLRIV--EGPTPSLP-----ETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred c----cHHHHHHHHH--cCCCCCCc-----chhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 2 1112222221 12222222 346678999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=293.35 Aligned_cols=263 Identities=19% Similarity=0.293 Sum_probs=193.5
Q ss_pred hhhhccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccc---hHHHHHHHHHHhccCCCceeeeeeccccCC--
Q psy14889 132 RTLAKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEAS---WSRETEIYSTVLLRHENILGYIGSDMTSRN-- 204 (443)
Q Consensus 132 ~~~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~---~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~-- 204 (443)
+.+.++|++.+.||+|+||.||++.. ++..||||++....... .....|+..+..++||||+++++++.....
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence 34567899999999999999999987 58899999875432211 122346666667999999999998865432
Q ss_pred cccEEEeeecccCcccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEe
Q psy14889 205 SCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIAD 284 (443)
Q Consensus 205 ~~~~~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~D 284 (443)
....+++||||+ +++|.+++....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 91 ~~~~~~lv~e~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~--------gi~H~dlkp~Nill~~~~~~kl~d 161 (343)
T cd07880 91 RFHDFYLVMPFM-GTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAA--------GIIHRDLKPGNLAVNEDCELKILD 161 (343)
T ss_pred ccceEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CeecCCCCHHHEEEcCCCCEEEee
Confidence 123568999998 67999999888899999999999999999999998 999999999999999999999999
Q ss_pred cCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCC
Q psy14889 285 FGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDL 364 (443)
Q Consensus 285 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~ 364 (443)
||++...... .....++..|+|||.+.+.. .++.++|+||||+++|+|++| ..||...
T Consensus 162 fg~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~-----~~~~~~Di~slG~ll~~l~~g----------~~pf~~~ 219 (343)
T cd07880 162 FGLARQTDSE-------MTGYVVTRWYRAPEVILNWM-----HYTQTVDIWSVGCIMAEMLTG----------KPLFKGH 219 (343)
T ss_pred cccccccccC-------ccccccCCcccCHHHHhCCC-----CCCcHHHHHHHHHHHHHHHhC----------CCCCCCC
Confidence 9998755321 12346788999999986531 456799999999999999999 5555432
Q ss_pred CCCCCChHHHHhhhhhcC--------------------CCCCCC-CC--CCCchhHHHHHHHHHHHhcCCcCCCCcHHHH
Q psy14889 365 VPMDPSFDDMRKVICIDQ--------------------QRPVLP-NR--WVSDSTLNAMTKVMKECWHQNANVRLSALRV 421 (443)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~--------------------~~~~~~-~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~ev 421 (443)
.. ............ ..+... .. .....++..+.+++.+|++.||++|||+.++
T Consensus 220 ~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~ 295 (343)
T cd07880 220 DH----LDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEA 295 (343)
T ss_pred CH----HHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHH
Confidence 11 111111100000 000000 00 0012345678999999999999999999999
Q ss_pred H--HHHHHHh
Q psy14889 422 K--KTLIKLA 429 (443)
Q Consensus 422 l--~~L~~l~ 429 (443)
+ ..++...
T Consensus 296 l~~~~~~~~~ 305 (343)
T cd07880 296 LAHPYFEEFH 305 (343)
T ss_pred hcCccHhhhc
Confidence 8 4454443
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0669|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=275.57 Aligned_cols=274 Identities=24% Similarity=0.323 Sum_probs=195.0
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCc---cchHHHHHHHHHHhccCCCceeeeeeccccCCccc---
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDE---ASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCT--- 207 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~---~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~--- 207 (443)
+.|....+||+|.||+||+|+. .|+.||+|++.-.++ .....-+|+..+..++|+|++.++..|........
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 4677788999999999999987 578899986533222 12223345555555999999999999876543333
Q ss_pred -EEEeeecccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEe
Q psy14889 208 -QLWLVTHYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIAD 284 (443)
Q Consensus 208 -~~~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~D 284 (443)
.+|+|+.+|+. ||...|.+ .+++..++.+++.++..||.|+|.. .|+|||+||.|+||+.++.+||+|
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~--------kilHRDmKaaNvLIt~dgilklAD 167 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRN--------KILHRDMKAANVLITKDGILKLAD 167 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHh--------hHHhhcccHhhEEEcCCceEEeec
Confidence 38999999997 99999975 5799999999999999999999998 899999999999999999999999
Q ss_pred cCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccc--------
Q psy14889 285 FGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEE-------- 356 (443)
Q Consensus 285 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~-------- 356 (443)
||+++.+...........+.++-|.+|.+||.+.+.. .|+++.|||+.||++.||+||.+.+..-.+
T Consensus 168 FGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r-----~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is 242 (376)
T KOG0669|consen 168 FGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDR-----EYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLIS 242 (376)
T ss_pred cccccceecccccCCCCcccceeeeecCCHHHhhccc-----ccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHH
Confidence 9999888776555544456678899999999999874 667899999999999999999653220000
Q ss_pred --cCCCCCCCCCCCCChHHHHhhhhhc----CCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHH
Q psy14889 357 --YKAPYHDLVPMDPSFDDMRKVICID----QQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKT 424 (443)
Q Consensus 357 --~~~P~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 424 (443)
...--.+.+|+-.....+..+ ..+ .....+++...+-.-.++..+|+.+++..||.+|+++++++..
T Consensus 243 ~LcGs~tkevWP~~d~lpL~~si-e~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 243 QLCGSITKEVWPNVDNLPLYQSI-ELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred HHhccCCcccCCCcccchHHHhc-cCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 000000111111111111111 000 0000011100000012468899999999999999999998753
|
|
| >KOG0690|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=278.25 Aligned_cols=239 Identities=23% Similarity=0.343 Sum_probs=190.9
Q ss_pred hhccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccc----hHHHHHHHHHHhccCCCceeeeeeccccCCccc
Q psy14889 134 LAKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEAS----WSRETEIYSTVLLRHENILGYIGSDMTSRNSCT 207 (443)
Q Consensus 134 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~----~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~ 207 (443)
..++|.+.++||+|.||.|-+++- +++.+|+|++++.-.-. ..-..|-..+...+||.+..+.-.|.+. .
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~----d 241 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQ----D 241 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccC----c
Confidence 347899999999999999999876 69999999886532111 1111233344448999999888777766 4
Q ss_pred EEEeeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecC
Q psy14889 208 QLWLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFG 286 (443)
Q Consensus 208 ~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfG 286 (443)
++++||||..+|.|.-+|++ ..+++.....+...|++||.|||++ +||.||||.+|.|+|.+|++||+|||
T Consensus 242 rlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~--------~ivYRDlKLENLlLDkDGHIKitDFG 313 (516)
T KOG0690|consen 242 RLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSR--------NIVYRDLKLENLLLDKDGHIKITDFG 313 (516)
T ss_pred eEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhC--------CeeeeechhhhheeccCCceEeeecc
Confidence 68999999999999999975 5689999999999999999999999 99999999999999999999999999
Q ss_pred CcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCC
Q psy14889 287 LAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVP 366 (443)
Q Consensus 287 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~ 366 (443)
+++.--.. .....+++||+.|.|||++... .|+.+.|+|.+||++|||++| +.||...
T Consensus 314 LCKE~I~~----g~t~kTFCGTPEYLAPEVleDn------DYgraVDWWG~GVVMYEMmCG----------RLPFyn~-- 371 (516)
T KOG0690|consen 314 LCKEEIKY----GDTTKTFCGTPEYLAPEVLEDN------DYGRAVDWWGVGVVMYEMMCG----------RLPFYNK-- 371 (516)
T ss_pred cchhcccc----cceeccccCChhhcCchhhccc------cccceeehhhhhHHHHHHHhc----------cCccccc--
Confidence 99643322 2224678999999999999987 788999999999999999999 7888764
Q ss_pred CCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCC
Q psy14889 367 MDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRL 416 (443)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp 416 (443)
+.+.+..++... ...+| ...+++.+.|+...|..||.+|.
T Consensus 372 ---dh~kLFeLIl~e--d~kFP-----r~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 372 ---DHEKLFELILME--DLKFP-----RTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred ---chhHHHHHHHhh--hccCC-----ccCCHHHHHHHHHHhhcChHhhc
Confidence 223333433322 22333 33566899999999999999997
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=285.79 Aligned_cols=260 Identities=24% Similarity=0.322 Sum_probs=186.0
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc---chHHHHHHHHHHhccCCCceeeeeeccccCCc----c
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA---SWSRETEIYSTVLLRHENILGYIGSDMTSRNS----C 206 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~---~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~----~ 206 (443)
++|++.+.||+|+||.||+|.. +++.+|||++...... ......|+..+..++||||+++++++...... .
T Consensus 8 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 87 (311)
T cd07866 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKR 87 (311)
T ss_pred ccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccC
Confidence 7899999999999999999998 5789999987543221 12223455566669999999999987654321 2
Q ss_pred cEEEeeecccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEe
Q psy14889 207 TQLWLVTHYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIAD 284 (443)
Q Consensus 207 ~~~~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~D 284 (443)
..+++|+||+.. +|...+.. ..+++.++..++.|+++||.|||+. +|+|+||||+||++++++.+||+|
T Consensus 88 ~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~--------~i~H~dl~p~nil~~~~~~~~l~d 158 (311)
T cd07866 88 GSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHEN--------HILHRDIKAANILIDNQGILKIAD 158 (311)
T ss_pred ceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC--------CeecCCCCHHHEEECCCCCEEECc
Confidence 457999999875 77777653 4699999999999999999999998 999999999999999999999999
Q ss_pred cCCcccccccCCcCC-------CCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCccccc
Q psy14889 285 FGLAVSYSQLSNKMD-------IPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEY 357 (443)
Q Consensus 285 fGla~~~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~ 357 (443)
||+++.......... .......|++.|+|||.+.+.. .++.++||||||+++|||++|+
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-----~~~~~~Dv~slG~il~el~~g~--------- 224 (311)
T cd07866 159 FGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGER-----RYTTAVDIWGIGCVFAEMFTRR--------- 224 (311)
T ss_pred CccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCC-----ccCchhHhHHHHHHHHHHHhCC---------
Confidence 999976543322111 1112346788999999886541 4567999999999999999994
Q ss_pred CCCCCCCCCCCCChHHHHhhhhhcC--------------------CCCCCCCCC--CCchhHHHHHHHHHHHhcCCcCCC
Q psy14889 358 KAPYHDLVPMDPSFDDMRKVICIDQ--------------------QRPVLPNRW--VSDSTLNAMTKVMKECWHQNANVR 415 (443)
Q Consensus 358 ~~P~~~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~R 415 (443)
.||.+... ............ .....+... .-......+.+++.+||+.||++|
T Consensus 225 -~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R 299 (311)
T cd07866 225 -PILQGKSD----IDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKR 299 (311)
T ss_pred -CCCCCCCH----HHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccC
Confidence 44433211 011111100000 000000000 001123568899999999999999
Q ss_pred CcHHHHHH
Q psy14889 416 LSALRVKK 423 (443)
Q Consensus 416 ps~~evl~ 423 (443)
||+.+++.
T Consensus 300 ~t~~ell~ 307 (311)
T cd07866 300 LTASDALE 307 (311)
T ss_pred cCHHHHhc
Confidence 99999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=281.22 Aligned_cols=252 Identities=26% Similarity=0.331 Sum_probs=183.1
Q ss_pred ccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc-----chHHHHHHHH-HHhccCCCceeeeeeccccCC-cccE
Q psy14889 138 ISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA-----SWSRETEIYS-TVLLRHENILGYIGSDMTSRN-SCTQ 208 (443)
Q Consensus 138 ~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~-----~~~~e~ei~~-~~~l~H~nIv~l~g~~~~~~~-~~~~ 208 (443)
|++.+.||+|+||.||+|++ +++.||+|++...... ....|.++.. +..++||||+++++++...+. ....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 56788999999999999998 4789999988643222 1222333322 223579999999999876543 2234
Q ss_pred EEeeecccCcccHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEec
Q psy14889 209 LWLVTHYHSFGSLYDHLNR---TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADF 285 (443)
Q Consensus 209 ~~lv~e~~~~gsL~~~l~~---~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~Df 285 (443)
++++|||+. ++|.+++.+ ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.+||+||
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~--------~i~h~~l~~~nili~~~~~~~l~df 151 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSH--------RIVHRDLKPQNILVTSDGQVKIADF 151 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC--------CeeeccCChhhEEEccCCCEEEecc
Confidence 799999997 489888854 3589999999999999999999998 9999999999999999999999999
Q ss_pred CCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCC
Q psy14889 286 GLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLV 365 (443)
Q Consensus 286 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~ 365 (443)
|++..+..... .....++..|+|||.+.+. .++.++||||||+++|||++| ..||....
T Consensus 152 g~~~~~~~~~~-----~~~~~~~~~~~~PE~~~~~------~~~~~~Di~s~G~~l~~l~~~----------~~~~~~~~ 210 (287)
T cd07838 152 GLARIYSFEMA-----LTSVVVTLWYRAPEVLLQS------SYATPVDMWSVGCIFAELFRR----------RPLFRGTS 210 (287)
T ss_pred CcceeccCCcc-----cccccccccccChHHhccC------CCCCcchhhhHHHHHHHHHhC----------CCcccCCC
Confidence 99876643221 1233578899999999776 566899999999999999999 44554321
Q ss_pred CCCCChHHHHhhhhhcCC-------------CCCCCCC------CCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 366 PMDPSFDDMRKVICIDQQ-------------RPVLPNR------WVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~-------------~~~~~~~------~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
. .+...+....... ....+.. ......+..+.+++++||+.||++||++.+++.
T Consensus 211 ~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 211 E----ADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred h----HHHHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 1 1111111110000 0000000 001124567889999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG1006|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=277.26 Aligned_cols=252 Identities=23% Similarity=0.359 Sum_probs=192.8
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc----chHHHHHHHHHHhccCCCceeeeeeccccCCcccEE
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA----SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQL 209 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~----~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~ 209 (443)
.+.+-...||.|+||+|++-.+ .|+..|||++...... +...|.+.-.. .-+-||||+++|.+... +..
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mk-s~~cp~IVkfyGa~F~E----Gdc 138 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMK-SSNCPNIVKFYGALFSE----GDC 138 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHh-hcCCcHHHHHhhhhhcC----Cce
Confidence 3455677899999999999877 5899999999765432 22223333322 24789999999998766 346
Q ss_pred EeeecccCcccHHHHhc------ccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEE
Q psy14889 210 WLVTHYHSFGSLYDHLN------RTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIA 283 (443)
Q Consensus 210 ~lv~e~~~~gsL~~~l~------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~ 283 (443)
|+.||+|.- ||+.+.+ +..+++.-+-.|......||.||-... .|||||+||+|||++..|.+||+
T Consensus 139 WiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l-------kiIHRDvKPSNILldr~G~vKLC 210 (361)
T KOG1006|consen 139 WICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL-------KIIHRDVKPSNILLDRHGDVKLC 210 (361)
T ss_pred eeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh-------hhhhccCChhheEEecCCCEeee
Confidence 999999975 7766543 467999999999999999999999874 89999999999999999999999
Q ss_pred ecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCC
Q psy14889 284 DFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHD 363 (443)
Q Consensus 284 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~ 363 (443)
|||++..+..... .+.-.|...|||||.+..... .|..+|||||||++|||++|| ..||.+
T Consensus 211 DFGIcGqLv~SiA-----kT~daGCrpYmAPERi~p~~~----gyDiRSDvWSLGITL~EvAtG----------~fPyr~ 271 (361)
T KOG1006|consen 211 DFGICGQLVDSIA-----KTVDAGCRPYMAPERIDPSDK----GYDIRSDVWSLGITLYEVATG----------NFPYRK 271 (361)
T ss_pred cccchHhHHHHHH-----hhhccCCccccChhccCCccC----CcchhhhhhhhcceEeeeecC----------CCCcch
Confidence 9999876654322 233478899999999876532 466899999999999999999 889988
Q ss_pred CCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHH
Q psy14889 364 LVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKT 424 (443)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 424 (443)
|.. .++.+...+..+ .|.+......-+.+..+..++..|+.+|-+.||...++.+.
T Consensus 272 w~s---vfeql~~Vv~gd--pp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 272 WDS---VFEQLCQVVIGD--PPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred HHH---HHHHHHHHHcCC--CCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 732 445555555322 23332222223356789999999999999999999998763
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=281.06 Aligned_cols=250 Identities=25% Similarity=0.343 Sum_probs=186.5
Q ss_pred ccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc---chHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEee
Q psy14889 138 ISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA---SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLV 212 (443)
Q Consensus 138 ~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~---~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv 212 (443)
|+..+.||+|++|.||+|.. +++.+|+|.+...... ....+.|+..+..++|+||+++++++... ...++|
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----~~~~~v 76 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHK----GDLYLV 76 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccC----CCEEEE
Confidence 45678899999999999987 5889999987654322 22334566666668999999999998776 357999
Q ss_pred ecccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCccc
Q psy14889 213 THYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVS 290 (443)
Q Consensus 213 ~e~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~ 290 (443)
+||+++ +|.+++.. ..+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.+||+|||.+..
T Consensus 77 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--------~i~H~dl~p~nili~~~~~~~l~df~~~~~ 147 (283)
T cd05118 77 FEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH--------GILHRDLKPENLLINTEGVLKLADFGLARS 147 (283)
T ss_pred EeccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHC--------CeeecCcCHHHEEECCCCcEEEeeeeeeEe
Confidence 999985 89888865 4789999999999999999999998 999999999999999999999999999876
Q ss_pred ccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCC
Q psy14889 291 YSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPS 370 (443)
Q Consensus 291 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~ 370 (443)
...... ......++..|+|||.+.+.. .++.++|+||||+++|+|+|| +.||.... .
T Consensus 148 ~~~~~~----~~~~~~~~~~~~~PE~~~~~~-----~~~~~~Di~slG~~l~~l~tg----------~~~~~~~~----~ 204 (283)
T cd05118 148 FGSPVR----PYTHYVVTRWYRAPELLLGDK-----GYSTPVDIWSVGCIFAELLSR----------RPLFPGKS----E 204 (283)
T ss_pred cCCCcc----cccCccCcccccCcHHHhcCC-----CCCchhHHHHHHHHHHHHHhC----------CCCCCCCC----H
Confidence 654321 112345788999999986541 456799999999999999999 45554321 1
Q ss_pred hHHHHhhhhhcC----------------CCCCCCC------CCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 371 FDDMRKVICIDQ----------------QRPVLPN------RWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 371 ~~~~~~~~~~~~----------------~~~~~~~------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
.+.......... .....+. .......+.++.+++.+||+.||.+||++.+++.
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 205 IDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred HHHHHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 111111110000 0000000 0011235678999999999999999999999875
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=290.20 Aligned_cols=265 Identities=25% Similarity=0.306 Sum_probs=193.6
Q ss_pred cccccceeeeecCeEEEEEEE--CCceeEEEEeeccCc---cchHHHHHHHHHHhccCCCceeeeeeccccC-CcccEEE
Q psy14889 137 QISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDE---ASWSRETEIYSTVLLRHENILGYIGSDMTSR-NSCTQLW 210 (443)
Q Consensus 137 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~---~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~-~~~~~~~ 210 (443)
+|++.+.||+|+||.||+|.. +++.||||.+..... .......|+..+..++|+||+++++++.... .....++
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 478889999999999999997 478999998865321 1222344566666699999999999987764 2223579
Q ss_pred eeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcc
Q psy14889 211 LVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAV 289 (443)
Q Consensus 211 lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~ 289 (443)
++|||++ ++|.+++.+ ..+++..+..++.|++.||+|||+. +|+|+||||+|||++.++.++|+|||++.
T Consensus 81 lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~--------gi~H~dlkp~nili~~~~~~~L~dfg~~~ 151 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSA--------NVIHRDLKPSNILVNSNCDLKICDFGLAR 151 (330)
T ss_pred EEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CeecCCCCHHHEEEcCCCCEEEcccCceE
Confidence 9999998 489988865 4799999999999999999999998 99999999999999999999999999997
Q ss_pred cccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCC
Q psy14889 290 SYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDP 369 (443)
Q Consensus 290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~ 369 (443)
........ ........++..|+|||.+.+.. .++.++|+||||+++|+|++| ..||.....
T Consensus 152 ~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~-----~~~~~sDi~slG~il~~l~~g----------~~pf~~~~~--- 212 (330)
T cd07834 152 GVDPDEDE-KGFLTEYVVTRWYRAPELLLSSS-----RYTKAIDIWSVGCIFAELLTR----------KPLFPGRDY--- 212 (330)
T ss_pred eecccccc-cccccccccccCcCCceeeeccc-----CCCcchhHHHHHHHHHHHHcC----------CCCcCCCCH---
Confidence 76543211 01123346788999999987652 455799999999999999999 444433210
Q ss_pred ChHHHHhhh-----------------------hhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHH--
Q psy14889 370 SFDDMRKVI-----------------------CIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKT-- 424 (443)
Q Consensus 370 ~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~-- 424 (443)
.+...... .........+-.......+..+.+++.+||+.||++|||+.++++.
T Consensus 213 -~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~ 291 (330)
T cd07834 213 -IDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPY 291 (330)
T ss_pred -HHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCcc
Confidence 01111110 0000000000000012245679999999999999999999999984
Q ss_pred HHHHhh
Q psy14889 425 LIKLAC 430 (443)
Q Consensus 425 L~~l~~ 430 (443)
++.+..
T Consensus 292 ~~~~~~ 297 (330)
T cd07834 292 LAQLHD 297 (330)
T ss_pred HHhhcc
Confidence 655544
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=290.59 Aligned_cols=262 Identities=21% Similarity=0.331 Sum_probs=190.8
Q ss_pred hhccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc---chHHHHHHHHHHhccCCCceeeeeeccccCC--cc
Q psy14889 134 LAKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA---SWSRETEIYSTVLLRHENILGYIGSDMTSRN--SC 206 (443)
Q Consensus 134 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~---~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~--~~ 206 (443)
+..+|...+.||+|+||.||+|.. +|+.||||++...... ......|+..+..++||||+++++++..... ..
T Consensus 13 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 92 (342)
T cd07879 13 LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF 92 (342)
T ss_pred cccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence 347899999999999999999987 5899999988643211 1122355666666999999999998865432 12
Q ss_pred cEEEeeecccCcccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecC
Q psy14889 207 TQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFG 286 (443)
Q Consensus 207 ~~~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfG 286 (443)
..+++|+||+.. +|..++. ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||
T Consensus 93 ~~~~lv~e~~~~-~l~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~--------~i~H~dlkp~NIll~~~~~~kL~dfg 162 (342)
T cd07879 93 QDFYLVMPYMQT-DLQKIMG-HPLSEDKVQYLVYQMLCGLKYIHSA--------GIIHRDLKPGNLAVNEDCELKILDFG 162 (342)
T ss_pred ceEEEEeccccc-CHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC--------CcccCCCCHHHEEECCCCCEEEeeCC
Confidence 346999999974 7877653 4689999999999999999999998 99999999999999999999999999
Q ss_pred CcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCC
Q psy14889 287 LAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVP 366 (443)
Q Consensus 287 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~ 366 (443)
+++..... .....++..|+|||.+.+.. .++.++|||||||++|||++| +.||....
T Consensus 163 ~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~-----~~~~~~Dv~slGvil~el~~g----------~~pf~~~~- 219 (342)
T cd07879 163 LARHADAE-------MTGYVVTRWYRAPEVILNWM-----HYNQTVDIWSVGCIMAEMLTG----------KTLFKGKD- 219 (342)
T ss_pred CCcCCCCC-------CCCceeeecccChhhhcCcc-----ccCchHHHHHHHHHHHHHHhC----------CCCCCCCC-
Confidence 98654321 12346788999999986531 456799999999999999999 55554421
Q ss_pred CCCChHHHHhhhhhc--------------------CCCCCCCCC-CC--CchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 367 MDPSFDDMRKVICID--------------------QQRPVLPNR-WV--SDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 367 ~~~~~~~~~~~~~~~--------------------~~~~~~~~~-~~--~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
....+....... ...+..+.. +. ....+..+.+++.+||+.||++||++.+++.
T Consensus 220 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~ 296 (342)
T cd07879 220 ---YLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALE 296 (342)
T ss_pred ---HHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 111111111100 000111100 00 0124467899999999999999999999995
Q ss_pred H--HHHHhhc
Q psy14889 424 T--LIKLACA 431 (443)
Q Consensus 424 ~--L~~l~~~ 431 (443)
. ++.+...
T Consensus 297 h~~f~~~~~~ 306 (342)
T cd07879 297 HPYFDSFRDA 306 (342)
T ss_pred Ccchhhcccc
Confidence 4 6666543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=282.55 Aligned_cols=245 Identities=27% Similarity=0.394 Sum_probs=185.8
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccc----hHHHHHHHHHHhccCCCceeeeeeccccCCcccEE
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEAS----WSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQL 209 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~----~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~ 209 (443)
+-|...+.||+|+||.||+|.. +++.||+|.+....... .....|+..+..++|||++++++++.+. ...
T Consensus 21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----~~~ 96 (313)
T cd06633 21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKE----HTA 96 (313)
T ss_pred HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeC----CEE
Confidence 3466678899999999999987 68899999886432211 1223456666669999999999998776 357
Q ss_pred EeeecccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCC
Q psy14889 210 WLVTHYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGL 287 (443)
Q Consensus 210 ~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGl 287 (443)
++||||+. |+|.+++.. ..+++.++..++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||+
T Consensus 97 ~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~--------gi~H~dl~p~nili~~~~~~kL~dfg~ 167 (313)
T cd06633 97 WLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH--------NMIHRDIKAGNILLTEPGQVKLADFGS 167 (313)
T ss_pred EEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--------CeecCCCChhhEEECCCCCEEEeecCC
Confidence 99999996 588887743 5689999999999999999999998 999999999999999999999999999
Q ss_pred cccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCC
Q psy14889 288 AVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPM 367 (443)
Q Consensus 288 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~ 367 (443)
+..... .....|+..|+|||++..... ..++.++||||||+++|||++| ..||....
T Consensus 168 ~~~~~~--------~~~~~~~~~y~aPE~~~~~~~---~~~~~~sDv~slGvil~el~~g----------~~p~~~~~-- 224 (313)
T cd06633 168 ASKSSP--------ANSFVGTPYWMAPEVILAMDE---GQYDGKVDVWSLGITCIELAER----------KPPLFNMN-- 224 (313)
T ss_pred CcccCC--------CCCccccccccChhhccccCC---CCCCchhhHHHHHHHHHHHHhC----------CCCCCCCC--
Confidence 853221 123468899999999853211 1456799999999999999999 66665531
Q ss_pred CCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHH
Q psy14889 368 DPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKT 424 (443)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 424 (443)
.......... ...+... ....+..+.+++.+||+.+|.+||++.+++..
T Consensus 225 --~~~~~~~~~~--~~~~~~~----~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 225 --AMSALYHIAQ--NDSPTLQ----SNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred --hHHHHHHHHh--cCCCCCC----ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1122222211 1112211 12344679999999999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=286.37 Aligned_cols=256 Identities=24% Similarity=0.343 Sum_probs=185.0
Q ss_pred cccc-ccceeeeecCeEEEEEEE--CCceeEEEEeeccCccc---------------hHHHHHHHHHHhccCCCceeeee
Q psy14889 136 KQIS-LSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEAS---------------WSRETEIYSTVLLRHENILGYIG 197 (443)
Q Consensus 136 ~~~~-~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~---------------~~~e~ei~~~~~l~H~nIv~l~g 197 (443)
++|. +.+.||+|+||.||+|.. .++.||||.+....... .....|+..+..++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 5665 457899999999999987 58899999875432211 11234555666699999999999
Q ss_pred eccccCCcccEEEeeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcC
Q psy14889 198 SDMTSRNSCTQLWLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKT 276 (443)
Q Consensus 198 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~ 276 (443)
++... ...++||||+. |+|.+++.. ..+++.....++.|++.||.|||+. +++|+||+|+||+++.
T Consensus 88 ~~~~~----~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~--------~i~H~dl~~~nill~~ 154 (335)
T PTZ00024 88 VYVEG----DFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKW--------YFMHRDLSPANIFINS 154 (335)
T ss_pred EEecC----CcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CeecccccHHHeEECC
Confidence 98766 35799999997 699998864 5689999999999999999999998 9999999999999999
Q ss_pred CCcEEEEecCCcccccccCCc----------CCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh
Q psy14889 277 NGTCVIADFGLAVSYSQLSNK----------MDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR 346 (443)
Q Consensus 277 ~~~~kl~DfGla~~~~~~~~~----------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt 346 (443)
++.+||+|||++......... .........++..|+|||.+.+.. .++.++||||||+++|||++
T Consensus 155 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-----~~~~~~Dv~slG~~l~el~t 229 (335)
T PTZ00024 155 KGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAE-----KYHFAVDMWSVGCIFAELLT 229 (335)
T ss_pred CCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCC-----CCCcHHHHHHHHHHHHHHHh
Confidence 999999999999765421100 011112335678899999987542 34679999999999999999
Q ss_pred cccCCCcccccCCCCCCCCCCCCChHHHHhhhhhcCC------------------CCCCCCCC--CCchhHHHHHHHHHH
Q psy14889 347 RTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQ------------------RPVLPNRW--VSDSTLNAMTKVMKE 406 (443)
Q Consensus 347 g~~~~~~~~~~~~P~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~--~~~~~~~~l~~li~~ 406 (443)
| ..||.... ..+.+......... ....+... .....+..+.+++.+
T Consensus 230 g----------~~p~~~~~----~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 295 (335)
T PTZ00024 230 G----------KPLFPGEN----EIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQS 295 (335)
T ss_pred C----------CCCCCCCC----HHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHH
Confidence 9 44554321 11111111110000 00000000 011235678999999
Q ss_pred HhcCCcCCCCcHHHHHH
Q psy14889 407 CWHQNANVRLSALRVKK 423 (443)
Q Consensus 407 cl~~dP~~Rps~~evl~ 423 (443)
||+.||++|||++|++.
T Consensus 296 ~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 296 LLKLNPLERISAKEALK 312 (335)
T ss_pred HcCCCchhccCHHHHhc
Confidence 99999999999999986
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=290.53 Aligned_cols=255 Identities=22% Similarity=0.336 Sum_probs=188.7
Q ss_pred hhccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc---chHHHHHHHHHHhccCCCceeeeeeccccCC--cc
Q psy14889 134 LAKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA---SWSRETEIYSTVLLRHENILGYIGSDMTSRN--SC 206 (443)
Q Consensus 134 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~---~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~--~~ 206 (443)
+.++|++...||+|+||.||+|.. ++..||||++...... ......|+..+..++||||+++++++..... ..
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 457899999999999999999998 5789999987543211 1112245666666999999999987765432 12
Q ss_pred cEEEeeecccCcccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecC
Q psy14889 207 TQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFG 286 (443)
Q Consensus 207 ~~~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfG 286 (443)
..+++|+||+ +++|.+++....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~--------gi~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSA--------GIIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CeecCCCCHHHeEECCCCCEEEcccc
Confidence 3479999998 46999999888899999999999999999999998 99999999999999999999999999
Q ss_pred CcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCC
Q psy14889 287 LAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVP 366 (443)
Q Consensus 287 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~ 366 (443)
++...... .....++..|+|||.+.+.. .++.++||||||+++|||++| ..||....
T Consensus 164 ~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~-----~~~~~~DvwslGv~l~elltg----------~~pf~~~~- 220 (343)
T cd07851 164 LARHTDDE-------MTGYVATRWYRAPEIMLNWM-----HYNQTVDIWSVGCIMAELLTG----------KTLFPGSD- 220 (343)
T ss_pred cccccccc-------ccCCcccccccCHHHHhCCC-----CCCchHhHHHHHHHHHHHHhC----------CCCCCCCC-
Confidence 98765432 12346788999999986532 455799999999999999999 55554321
Q ss_pred CCCChHHHHhhhhhcCC--------------------CCCCCC-CC--CCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 367 MDPSFDDMRKVICIDQQ--------------------RPVLPN-RW--VSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 367 ~~~~~~~~~~~~~~~~~--------------------~~~~~~-~~--~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
.............. .+.... .+ .....+..+.+++.+||+.||++|||+.+|++
T Consensus 221 ---~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 221 ---HIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred ---hHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 11111111110000 000000 00 00123567999999999999999999999876
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0696|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=279.60 Aligned_cols=238 Identities=23% Similarity=0.340 Sum_probs=192.3
Q ss_pred hccccccceeeeecCeEEEEEEEC--CceeEEEEeecc------CccchHHHHHHHHHHhccCCCceeeeeeccccCCcc
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVWH--GENVAVKIFFSR------DEASWSRETEIYSTVLLRHENILGYIGSDMTSRNSC 206 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~------~~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~ 206 (443)
..+|.+..+||+|+||.|.+|... .+.+|||++++. +.+-...|..++.+. -+-|.+++++..+.+-
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~-~kppFL~qlHScFQTm---- 422 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALP-GKPPFLVQLHSCFQTM---- 422 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecC-CCCchHHHHHHHhhhh----
Confidence 357899999999999999999885 467999988653 122233466666653 3677889998888776
Q ss_pred cEEEeeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEec
Q psy14889 207 TQLWLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADF 285 (443)
Q Consensus 207 ~~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~Df 285 (443)
.++|+||||+.+|+|--++++ +.+.+..+..++..||-||-|||++ +||.||||..|||+|.+|++||+||
T Consensus 423 DRLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~k--------gIiYRDLKLDNvmLd~eGHiKi~DF 494 (683)
T KOG0696|consen 423 DRLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSK--------GIIYRDLKLDNVMLDSEGHIKIADF 494 (683)
T ss_pred hheeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcC--------CeeeeeccccceEeccCCceEeeec
Confidence 458999999999999888876 7899999999999999999999999 9999999999999999999999999
Q ss_pred CCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCC
Q psy14889 286 GLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLV 365 (443)
Q Consensus 286 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~ 365 (443)
|+++.--- ....+.+++||+.|+|||++..+ +|+..+|+|||||+||||+.| +.||.+.
T Consensus 495 GmcKEni~----~~~TTkTFCGTPdYiAPEIi~Yq------PYgksvDWWa~GVLLyEmlaG----------QpPFdGe- 553 (683)
T KOG0696|consen 495 GMCKENIF----DGVTTKTFCGTPDYIAPEIIAYQ------PYGKSVDWWAFGVLLYEMLAG----------QPPFDGE- 553 (683)
T ss_pred cccccccc----CCcceeeecCCCcccccceEEec------ccccchhHHHHHHHHHHHHcC----------CCCCCCC-
Confidence 99864221 12234678999999999999877 788899999999999999999 8888774
Q ss_pred CCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCc
Q psy14889 366 PMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLS 417 (443)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps 417 (443)
+.+++.+.+... ....| ...+.+...+.+..|...|.+|..
T Consensus 554 ----DE~elF~aI~eh--nvsyP-----KslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 554 ----DEDELFQAIMEH--NVSYP-----KSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred ----CHHHHHHHHHHc--cCcCc-----ccccHHHHHHHHHHhhcCCccccC
Confidence 334444444322 22233 447788999999999999999974
|
|
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=292.46 Aligned_cols=242 Identities=20% Similarity=0.287 Sum_probs=194.6
Q ss_pred hhccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEe
Q psy14889 134 LAKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWL 211 (443)
Q Consensus 134 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~l 211 (443)
..+.|.+...+|.|+|+.|-++.. +++..+||++... ..+...|.++..+. -+||||+++.+.+.+. .+.|+
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~-~~~~~~e~~~~~~~-~~h~niv~~~~v~~~~----~~~~~ 393 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR-ADDNQDEIPISLLV-RDHPNIVKSHDVYEDG----KEIYL 393 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccc-ccccccccchhhhh-cCCCcceeecceecCC----ceeee
Confidence 457788999999999999999987 6889999998665 23334455555553 5899999999999887 56899
Q ss_pred eecccCcccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEE-cCCCcEEEEecCCccc
Q psy14889 212 VTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILV-KTNGTCVIADFGLAVS 290 (443)
Q Consensus 212 v~e~~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl-~~~~~~kl~DfGla~~ 290 (443)
|||++.+|-|.+.+...+.....+..|+.+|+.|+.|||++ |+|||||||+|||+ ++.++++|+|||.++.
T Consensus 394 v~e~l~g~ell~ri~~~~~~~~e~~~w~~~lv~Av~~LH~~--------gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~ 465 (612)
T KOG0603|consen 394 VMELLDGGELLRRIRSKPEFCSEASQWAAELVSAVDYLHEQ--------GVVHRDLKPGNILLDGSAGHLRLTYFGFWSE 465 (612)
T ss_pred eehhccccHHHHHHHhcchhHHHHHHHHHHHHHHHHHHHhc--------CeeecCCChhheeecCCCCcEEEEEechhhh
Confidence 99999999888877665555578888999999999999998 99999999999999 5889999999999987
Q ss_pred ccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCC
Q psy14889 291 YSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPS 370 (443)
Q Consensus 291 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~ 370 (443)
.... ..+.+-|..|.|||++... .|+.++||||||++||+|++| ..||.... .
T Consensus 466 ~~~~-------~~tp~~t~~y~APEvl~~~------~yt~acD~WSLGvlLy~ML~G----------~tp~~~~P----~ 518 (612)
T KOG0603|consen 466 LERS-------CDTPALTLQYVAPEVLAIQ------EYTEACDWWSLGVLLYEMLTG----------RTLFAAHP----A 518 (612)
T ss_pred Cchh-------hcccchhhcccChhhhccC------CCCcchhhHHHHHHHHHHHhC----------CCccccCC----c
Confidence 7654 1223567899999999865 888999999999999999999 67776532 2
Q ss_pred hHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHH
Q psy14889 371 FDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTL 425 (443)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 425 (443)
..++...+ ..+.+. ...+...++|+++||+.||.+||++.++...=
T Consensus 519 ~~ei~~~i----~~~~~s-----~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~ 564 (612)
T KOG0603|consen 519 GIEIHTRI----QMPKFS-----ECVSDEAKDLLQQLLQVDPALRLGADEIGAHP 564 (612)
T ss_pred hHHHHHhh----cCCccc-----cccCHHHHHHHHHhccCChhhCcChhhhccCc
Confidence 23333332 222222 44677899999999999999999999987643
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=302.74 Aligned_cols=265 Identities=20% Similarity=0.249 Sum_probs=166.4
Q ss_pred hccccccceeeeecCeEEEEEEE--C----CceeEEEEeeccCccchHHHHHHHHHHhccCCCceeeeeeccccC--Ccc
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVW--H----GENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIGSDMTSR--NSC 206 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~--~----~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~--~~~ 206 (443)
.++|.+.+.||+|+||.||+|.+ + +..||||++............. +....+.++..++..+.... ...
T Consensus 131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~e~---l~~~~~~~~~~~~~~~~~~~~~~~~ 207 (566)
T PLN03225 131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNER---VRRACPNSCADFVYGFLEPVSSKKE 207 (566)
T ss_pred cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHHHHH---HHhhchhhHHHHHHhhhcccccccC
Confidence 46899999999999999999998 4 6799999875432211111111 11122333333332221110 112
Q ss_pred cEEEeeecccCcccHHHHhcccCC---------------------CHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEe
Q psy14889 207 TQLWLVTHYHSFGSLYDHLNRTTL---------------------NHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHR 265 (443)
Q Consensus 207 ~~~~lv~e~~~~gsL~~~l~~~~l---------------------~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHr 265 (443)
..+++|+||+.+++|.+++....+ ....+..++.||+.||.|||+. +|+||
T Consensus 208 ~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~--------gIiHR 279 (566)
T PLN03225 208 DEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST--------GIVHR 279 (566)
T ss_pred CceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC--------CEEeC
Confidence 468999999999999999864322 1234567999999999999998 99999
Q ss_pred CCCCCCEEEcC-CCcEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCc----------------CCC
Q psy14889 266 DIKSKNILVKT-NGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDC----------------FES 328 (443)
Q Consensus 266 Dlk~~NiLl~~-~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~----------------~~~ 328 (443)
||||+|||++. ++.+||+|||+|+.+...... ......||+.|+|||.+........ ..+
T Consensus 280 DLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~---~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~ 356 (566)
T PLN03225 280 DVKPQNIIFSEGSGSFKIIDLGAAADLRVGINY---IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNL 356 (566)
T ss_pred cCCHHHEEEeCCCCcEEEEeCCCcccccccccc---CCcccccCCCccChHHhhccCCCCCCccccccccccchhccccC
Confidence 99999999986 579999999999765432221 2244678999999997643321100 123
Q ss_pred CCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCC--------CCCCChHHHHhhhhhcCCCCCCCCCC-CCchhHHH
Q psy14889 329 FKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLV--------PMDPSFDDMRKVICIDQQRPVLPNRW-VSDSTLNA 399 (443)
Q Consensus 329 ~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 399 (443)
..++|||||||+||||+++. .|+.... ............... ...+.....+ ..+.....
T Consensus 357 ~~k~DVwSlGviL~el~~~~----------~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~d~~~~~ 425 (566)
T PLN03225 357 PDRFDIYSAGLIFLQMAFPN----------LRSDSNLIQFNRQLKRNDYDLVAWRKLVEP-RASPDLRRGFEVLDLDGGA 425 (566)
T ss_pred CCCcccHHHHHHHHHHHhCc----------CCCchHHHHHHHHHHhcCCcHHHHHHhhcc-ccchhhhhhhhhccccchH
Confidence 45679999999999999872 2221100 000000111111000 0000000000 00111234
Q ss_pred HHHHHHHHhcCCcCCCCcHHHHHHH
Q psy14889 400 MTKVMKECWHQNANVRLSALRVKKT 424 (443)
Q Consensus 400 l~~li~~cl~~dP~~Rps~~evl~~ 424 (443)
..+|+.+||+.||++|||+.++++.
T Consensus 426 ~~dLi~~mL~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 426 GWELLKSMMRFKGRQRISAKAALAH 450 (566)
T ss_pred HHHHHHHHccCCcccCCCHHHHhCC
Confidence 5689999999999999999999873
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=275.22 Aligned_cols=250 Identities=27% Similarity=0.341 Sum_probs=185.1
Q ss_pred ccccceeeeecCeEEEEEEE--CCceeEEEEeeccC---ccchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEee
Q psy14889 138 ISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRD---EASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLV 212 (443)
Q Consensus 138 ~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~---~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv 212 (443)
|+..+.||+|+||.||+|+. +++.||+|++.... ........|+..+..++|+||+++++++... ...++|
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~----~~~~~v 76 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTE----RKLYLV 76 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcC----CceEEE
Confidence 45678899999999999998 48999999886543 1122234566666668999999999998876 457999
Q ss_pred ecccCcccHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCccc
Q psy14889 213 THYHSFGSLYDHLNRT--TLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVS 290 (443)
Q Consensus 213 ~e~~~~gsL~~~l~~~--~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~ 290 (443)
+||++ ++|.+++.+. .+++..+..++.|++.||.|||+. +|+|+||+|+||++++++.+||+|||+++.
T Consensus 77 ~e~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--------~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~ 147 (282)
T cd07829 77 FEYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSH--------RILHRDLKPQNILINRDGVLKLADFGLARA 147 (282)
T ss_pred ecCcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHC--------CcccCCCChheEEEcCCCCEEEecCCcccc
Confidence 99998 5999999764 799999999999999999999998 999999999999999999999999999876
Q ss_pred ccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCC
Q psy14889 291 YSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPS 370 (443)
Q Consensus 291 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~ 370 (443)
....... .....++..|+|||.+.+.. .++.++||||||+++|||++| ..||.... .
T Consensus 148 ~~~~~~~----~~~~~~~~~~~aPE~~~~~~-----~~~~~~Dv~slG~~l~~l~~~----------~~~~~~~~----~ 204 (282)
T cd07829 148 FGIPLRT----YTHEVVTLWYRAPEILLGSK-----HYSTAVDIWSVGCIFAEMITG----------KPLFPGDS----E 204 (282)
T ss_pred cCCCccc----cCccccCcCcCChHHhcCCc-----CCCccccHHHHHHHHHHHHhC----------CCCCCCcc----H
Confidence 5432211 12335677899999986541 456799999999999999999 44543321 0
Q ss_pred hHHHHhhhh---------------h---cCCCCCCCCCC---CCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 371 FDDMRKVIC---------------I---DQQRPVLPNRW---VSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 371 ~~~~~~~~~---------------~---~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
.+...+... . ....+...... .-...+..+.+++.+||..||++||++.+++.
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 205 IDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred HHHHHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 111111000 0 00000000000 00123567999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=270.44 Aligned_cols=233 Identities=25% Similarity=0.335 Sum_probs=182.4
Q ss_pred eeeecCeEEEEEEE--CCceeEEEEeeccCcc----chHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEeeecccC
Q psy14889 144 IGKGRYGEVWRGVW--HGENVAVKIFFSRDEA----SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVTHYHS 217 (443)
Q Consensus 144 lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~----~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e~~~ 217 (443)
||+|+||.||++.. +++.+|+|++...... ......|+..+..++||||+++++.+... ...++||||++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----~~~~~v~e~~~ 76 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTE----EKLYLVLEYAP 76 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecC----CeeEEEEecCC
Confidence 69999999999998 4889999988654322 11234455566669999999999888665 45799999999
Q ss_pred cccHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcccccccCC
Q psy14889 218 FGSLYDHLNRT-TLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSN 296 (443)
Q Consensus 218 ~gsL~~~l~~~-~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~~~~~~ 296 (443)
+++|.+++... .+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 77 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~--------~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~ 148 (250)
T cd05123 77 GGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSL--------GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS 148 (250)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CceecCCCcceEEEcCCCcEEEeecCcceecccCCC
Confidence 99999999754 689999999999999999999998 999999999999999999999999999876543221
Q ss_pred cCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCChHHHHh
Q psy14889 297 KMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFDDMRK 376 (443)
Q Consensus 297 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~~~~~~~ 376 (443)
......++..|+|||.+.+. ..+.++|+||||+++||+++| ..||.... ......
T Consensus 149 ----~~~~~~~~~~~~~Pe~~~~~------~~~~~~D~~slG~~~~~l~~g----------~~p~~~~~-----~~~~~~ 203 (250)
T cd05123 149 ----RTNTFCGTPEYLAPEVLLGK------GYGKAVDWWSLGVLLYEMLTG----------KPPFYAED-----RKEIYE 203 (250)
T ss_pred ----cccCCcCCccccChHHhCCC------CCCchhhHHHHHHHHHHHHHC----------CCCCCCCC-----HHHHHH
Confidence 11334678899999998765 456799999999999999999 66775431 122222
Q ss_pred hhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHH
Q psy14889 377 VICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALR 420 (443)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e 420 (443)
.+.. ....++ ...+..+.+++++||..||++||++.+
T Consensus 204 ~~~~--~~~~~~-----~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 204 KILK--DPLRFP-----EFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred HHhc--CCCCCC-----CCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 2221 222333 224678999999999999999999944
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG1151|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=283.17 Aligned_cols=263 Identities=21% Similarity=0.270 Sum_probs=197.0
Q ss_pred hhhccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccc--------hHHHHHHHHHHhccCCCceeeeeecccc
Q psy14889 133 TLAKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEAS--------WSRETEIYSTVLLRHENILGYIGSDMTS 202 (443)
Q Consensus 133 ~~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~--------~~~e~ei~~~~~l~H~nIv~l~g~~~~~ 202 (443)
.+.++|-++.+||+|||+.||+|.+ ..+.||||+-..+.... ...-+|..+.+.|.||.||++|+++.-+
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD 539 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD 539 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence 3456888999999999999999986 57889999754322111 1112344555569999999999998765
Q ss_pred CCcccEEEeeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcC---CC
Q psy14889 203 RNSCTQLWLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKT---NG 278 (443)
Q Consensus 203 ~~~~~~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~---~~ 278 (443)
.. .++-|+|||++.+|+-||++ ..+++.++..|+.||+.||.||... +|+|||-||||.|||+-+ .|
T Consensus 540 td---sFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEi------kpPIIHYDLKPgNILLv~GtacG 610 (775)
T KOG1151|consen 540 TD---SFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEI------KPPIIHYDLKPGNILLVNGTACG 610 (775)
T ss_pred cc---cceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhcc------CCCeeeeccCCccEEEecCcccc
Confidence 43 37899999999999999976 5689999999999999999999988 789999999999999954 46
Q ss_pred cEEEEecCCcccccccCCcCCC---CCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCccc
Q psy14889 279 TCVIADFGLAVSYSQLSNKMDI---PPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFE 355 (443)
Q Consensus 279 ~~kl~DfGla~~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~ 355 (443)
.+||.|||+++.+...+..... .++...||.+|.+||.+.-+.... ..+.|+||||.||++|..+.|++
T Consensus 611 eIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePP--KIsnKVDVWSvGVIFyQClYGrK------ 682 (775)
T KOG1151|consen 611 EIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPP--KISNKVDVWSVGVIFYQCLYGRK------ 682 (775)
T ss_pred eeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCC--ccccceeeEeeehhhhhhhccCC------
Confidence 8999999999988876544221 134568999999999997654433 78899999999999999999955
Q ss_pred ccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHH
Q psy14889 356 EYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVK 422 (443)
Q Consensus 356 ~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl 422 (443)
||..... ..+.+..........-.+|. .+..+.+...+|++||++.-++|....++.
T Consensus 683 ----PFGhnqs---QQdILqeNTIlkAtEVqFP~---KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 683 ----PFGHNQS---QQDILQENTILKATEVQFPP---KPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred ----CCCCchh---HHHHHhhhchhcceeccCCC---CCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 4443211 11222221111112222332 123567899999999999999998877764
|
|
| >KOG0662|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=248.58 Aligned_cols=252 Identities=23% Similarity=0.333 Sum_probs=189.8
Q ss_pred cccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc---chHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEe
Q psy14889 137 QISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA---SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWL 211 (443)
Q Consensus 137 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~---~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~l 211 (443)
+|...++||+|.||+||+|+. +++.||+|.+...+.+ .....+||..++.++|.|||+++++.... ..+.+
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsd----kkltl 78 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD----KKLTL 78 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccC----ceeEE
Confidence 567788999999999999986 5889999988765443 23445778778789999999999987665 45899
Q ss_pred eecccCcccHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcc
Q psy14889 212 VTHYHSFGSLYDHLN--RTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAV 289 (443)
Q Consensus 212 v~e~~~~gsL~~~l~--~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~ 289 (443)
|+|||.. +|..|.. ++.++.+....++.|+++||.|+|++ ++.||||||.|.||+.+|++|++|||+++
T Consensus 79 vfe~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchsh--------nvlhrdlkpqnllin~ngelkladfglar 149 (292)
T KOG0662|consen 79 VFEFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSH--------NVLHRDLKPQNLLINRNGELKLADFGLAR 149 (292)
T ss_pred eHHHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhh--------hhhhccCCcceEEeccCCcEEecccchhh
Confidence 9999986 8988885 47799999999999999999999999 99999999999999999999999999998
Q ss_pred cccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCC
Q psy14889 290 SYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDP 369 (443)
Q Consensus 290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~ 369 (443)
.+.-..... +..+-|.+|.+|.++.+.. -|++..|+||.||++.|+.....| -|.+ ..
T Consensus 150 afgipvrcy----saevvtlwyrppdvlfgak-----ly~tsidmwsagcifaelanagrp---------lfpg----~d 207 (292)
T KOG0662|consen 150 AFGIPVRCY----SAEVVTLWYRPPDVLFGAK-----LYSTSIDMWSAGCIFAELANAGRP---------LFPG----ND 207 (292)
T ss_pred hcCCceEee----eceeeeeeccCcceeeeee-----hhccchHhhhcchHHHHHhhcCCC---------CCCC----Cc
Confidence 776543332 3457789999999998874 456889999999999999865222 1111 11
Q ss_pred ChHHHHhhhhhcC-----------------CCCCCCCC--CC--CchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 370 SFDDMRKVICIDQ-----------------QRPVLPNR--WV--SDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 370 ~~~~~~~~~~~~~-----------------~~~~~~~~--~~--~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
..+.+.+++...+ ..|..|.. |. -+.....-++++++.+.-+|.+|.++++.++
T Consensus 208 vddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 208 VDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred HHHHHHHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 1222222221111 01111111 00 0112344689999999999999999998765
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=303.77 Aligned_cols=142 Identities=24% Similarity=0.337 Sum_probs=122.0
Q ss_pred ccccccceeeeecCeEEEEEEEC--CceeEEEEeeccCcc----chHHHHHHHHHHhccCCCceeeeeeccccCCcccEE
Q psy14889 136 KQISLSECIGKGRYGEVWRGVWH--GENVAVKIFFSRDEA----SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQL 209 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~----~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~ 209 (443)
++|.+.+.||+|+||.||+|.+. ++.||||++...... ....+.|+..+..++||||+++++++... ..+
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~----~~~ 79 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSA----NNV 79 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEEC----CEE
Confidence 67999999999999999999984 899999998653321 12234455555668999999999887665 458
Q ss_pred EeeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCc
Q psy14889 210 WLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA 288 (443)
Q Consensus 210 ~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla 288 (443)
++||||+.+|+|.+++.. ..+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 80 ~lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~--------gIiHrDLKP~NILl~~~g~vkL~DFGls 151 (669)
T cd05610 80 YLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRH--------GIIHRDLKPDNMLISNEGHIKLTDFGLS 151 (669)
T ss_pred EEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CEEeCCccHHHEEEcCCCCEEEEeCCCC
Confidence 999999999999999864 5689999999999999999999998 9999999999999999999999999998
Q ss_pred c
Q psy14889 289 V 289 (443)
Q Consensus 289 ~ 289 (443)
+
T Consensus 152 ~ 152 (669)
T cd05610 152 K 152 (669)
T ss_pred c
Confidence 6
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=269.15 Aligned_cols=218 Identities=19% Similarity=0.231 Sum_probs=167.8
Q ss_pred ecCeEEEEEEE--CCceeEEEEeeccCccchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEeeecccCcccHHHH
Q psy14889 147 GRYGEVWRGVW--HGENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDH 224 (443)
Q Consensus 147 G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e~~~~gsL~~~ 224 (443)
|.||.||+++. +++.+|+|.+...... .. +........||||+++++++... ...++||||+++|+|.++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~~--~~--~~~~~~~~~~~~i~~~~~~~~~~----~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSEY--SR--ERLTIIPHCVPNMVCLHKYIVSE----DSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhhh--hh--HHHHHHhcCCCceeehhhheecC----CeEEEEEecCCCCCHHHH
Confidence 88999999988 6889999988654321 22 22333336799999999998766 457999999999999998
Q ss_pred hcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcccccccCCcCCCCCC
Q psy14889 225 LNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPN 303 (443)
Q Consensus 225 l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 303 (443)
+.+ ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++++|||.+....... .
T Consensus 76 l~~~~~l~~~~~~~~~~ql~~~l~~lH~~--------~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-------~ 140 (237)
T cd05576 76 ISKFLNIPEECVKRWAAEMVVALDALHRE--------GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-------D 140 (237)
T ss_pred HHHhcCCCHHHHHHHHHHHHHHHHHHHhC--------CeeccCCCHHHEEEcCCCCEEEecccchhcccccc-------c
Confidence 854 5699999999999999999999988 99999999999999999999999999876554321 2
Q ss_pred CcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCChHHHHhhhhhcCC
Q psy14889 304 PRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQ 383 (443)
Q Consensus 304 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~~~~~~~~~~~~~~ 383 (443)
...++..|+|||.+.+. .++.++||||+|+++|||++|. .|+..... ... ...
T Consensus 141 ~~~~~~~y~aPE~~~~~------~~~~~~DvwslG~il~el~~g~----------~~~~~~~~------~~~-----~~~ 193 (237)
T cd05576 141 GEAVENMYCAPEVGGIS------EETEACDWWSLGAILFELLTGK----------TLVECHPS------GIN-----THT 193 (237)
T ss_pred cCCcCccccCCcccCCC------CCCchhhHHHHHHHHHHHHHCc----------chhhcCch------hcc-----ccc
Confidence 23456789999988765 5678999999999999999994 33322100 000 001
Q ss_pred CCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHH
Q psy14889 384 RPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSAL 419 (443)
Q Consensus 384 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ 419 (443)
...+| ...+..+.+++.+||+.||++||++.
T Consensus 194 ~~~~~-----~~~~~~~~~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 194 TLNIP-----EWVSEEARSLLQQLLQFNPTERLGAG 224 (237)
T ss_pred ccCCc-----ccCCHHHHHHHHHHccCCHHHhcCCC
Confidence 11122 22456799999999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG4236|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=279.93 Aligned_cols=239 Identities=21% Similarity=0.345 Sum_probs=188.6
Q ss_pred cceeeeecCeEEEEEEE--CCceeEEEEeecc---CccchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEeeecc
Q psy14889 141 SECIGKGRYGEVWRGVW--HGENVAVKIFFSR---DEASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVTHY 215 (443)
Q Consensus 141 ~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~---~~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e~ 215 (443)
.++||+|.||+||-|++ +|+.||||++.+- ..++.....|+.++..++||.||.+...|.+. ..+++|||-
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~----ervFVVMEK 644 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETP----ERVFVVMEK 644 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCC----ceEEEEehh
Confidence 47899999999999987 6999999988542 12223334566666669999999999999887 458999999
Q ss_pred cCcccHHHHh-c--ccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCC---cEEEEecCCcc
Q psy14889 216 HSFGSLYDHL-N--RTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNG---TCVIADFGLAV 289 (443)
Q Consensus 216 ~~~gsL~~~l-~--~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~---~~kl~DfGla~ 289 (443)
+.+ |..+++ . ++++++.....++.||+.||.|||.+ +|+|+||||+|||+.+.. .+||+|||+|+
T Consensus 645 l~G-DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~k--------nIvHCDLKPENVLLas~~~FPQvKlCDFGfAR 715 (888)
T KOG4236|consen 645 LHG-DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFK--------NIVHCDLKPENVLLASASPFPQVKLCDFGFAR 715 (888)
T ss_pred hcc-hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhc--------ceeeccCCchheeeccCCCCCceeecccccee
Confidence 875 655554 3 47899999999999999999999998 999999999999997653 79999999999
Q ss_pred cccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCC
Q psy14889 290 SYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDP 369 (443)
Q Consensus 290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~ 369 (443)
.+.+.+.. ...+||+.|.|||+++.. .|...-|+||.||++|--++| ..||.+...
T Consensus 716 iIgEksFR-----rsVVGTPAYLaPEVLrnk------GyNrSLDMWSVGVIiYVsLSG----------TFPFNEdEd--- 771 (888)
T KOG4236|consen 716 IIGEKSFR-----RSVVGTPAYLAPEVLRNK------GYNRSLDMWSVGVIIYVSLSG----------TFPFNEDED--- 771 (888)
T ss_pred ecchhhhh-----hhhcCCccccCHHHHhhc------cccccccceeeeEEEEEEecc----------cccCCCccc---
Confidence 99875543 456899999999999987 777888999999999999999 778876311
Q ss_pred ChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 370 SFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
..+.+++ .....| +..| .+++.+..+||...|+..=.+|-|.++.+.
T Consensus 772 IndQIQN---AaFMyP--p~PW--~eis~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 772 INDQIQN---AAFMYP--PNPW--SEISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred hhHHhhc---cccccC--CCch--hhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 1122222 222223 3334 346678999999999999999999887654
|
|
| >KOG1027|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=295.77 Aligned_cols=246 Identities=25% Similarity=0.370 Sum_probs=187.8
Q ss_pred cccccceeeeecCe-EEEEEEECCceeEEEEeeccCccchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEeeecc
Q psy14889 137 QISLSECIGKGRYG-EVWRGVWHGENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVTHY 215 (443)
Q Consensus 137 ~~~~~~~lG~G~fg-~Vy~~~~~~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e~ 215 (443)
-|.-.+++|.|+.| .||+|.+.|+.||||++.........+|...+... =.|||||++++.-.+. ..+||..|.
T Consensus 510 ~~~~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e~~~~A~rEi~lL~eS-D~H~NviRyyc~E~d~----qF~YIalEL 584 (903)
T KOG1027|consen 510 FFSPKEILGYGSNGTVVFRGVYEGREVAVKRLLEEFFDFAQREIQLLQES-DEHPNVIRYYCSEQDR----QFLYIALEL 584 (903)
T ss_pred eeccHHHcccCCCCcEEEEEeeCCceehHHHHhhHhHHHHHHHHHHHHhc-cCCCceEEEEeeccCC----ceEEEEehH
Confidence 35566889999988 58999999999999988665555556666665554 4899999999886655 678999999
Q ss_pred cCcccHHHHhccc--CC---CHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcC---C--CcEEEEec
Q psy14889 216 HSFGSLYDHLNRT--TL---NHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKT---N--GTCVIADF 285 (443)
Q Consensus 216 ~~~gsL~~~l~~~--~l---~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~---~--~~~kl~Df 285 (443)
|.- +|.+++... .. .......++.|+++||++||+. +||||||||.||||+. + ..++|+||
T Consensus 585 C~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl--------~iVHRDLkPQNILI~~~~~~~~~ra~iSDf 655 (903)
T KOG1027|consen 585 CAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL--------KIVHRDLKPQNILISVPSADGTLRAKISDF 655 (903)
T ss_pred hhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc--------ccccccCCCceEEEEccCCCcceeEEeccc
Confidence 975 999999762 11 1134567889999999999998 9999999999999987 3 47899999
Q ss_pred CCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCC
Q psy14889 286 GLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLV 365 (443)
Q Consensus 286 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~ 365 (443)
|+++.+......... ..+..||-+|+|||++... .-+.++||+|+||++|+.++| +..||.+..
T Consensus 656 glsKkl~~~~sS~~r-~s~~sGt~GW~APE~L~~~------~~~~avDiFslGCvfyYvltg---------G~HpFGd~~ 719 (903)
T KOG1027|consen 656 GLSKKLAGGKSSFSR-LSGGSGTSGWQAPEQLRED------RKTQAVDIFSLGCVFYYVLTG---------GSHPFGDSL 719 (903)
T ss_pred ccccccCCCcchhhc-ccCCCCcccccCHHHHhcc------ccCcccchhhcCceEEEEecC---------CccCCCchH
Confidence 999988876544433 4566899999999999987 444689999999999999998 478887742
Q ss_pred CCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 366 PMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
. .-.+++........+.. ..++ +..+||.+|++.||..||++.+|+.
T Consensus 720 ~------R~~NIl~~~~~L~~L~~---~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 720 E------RQANILTGNYTLVHLEP---LPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred H------hhhhhhcCccceeeecc---CchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 1 11122211111111111 1122 7899999999999999999999974
|
|
| >KOG0607|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=259.20 Aligned_cols=257 Identities=26% Similarity=0.395 Sum_probs=192.9
Q ss_pred cceeeeecCeEEEEEEE--CCceeEEEEeeccCc---cchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEeeecc
Q psy14889 141 SECIGKGRYGEVWRGVW--HGENVAVKIFFSRDE---ASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVTHY 215 (443)
Q Consensus 141 ~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~---~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e~ 215 (443)
.+.||+|+|+.|--++. +|..+|||++.+... .+..+|.|++... -.|+||++++++|.+. ..+|||||-
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~C-qgh~nilqLiefFEdd----~~FYLVfEK 157 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQC-QGHKNILQLIEFFEDD----TRFYLVFEK 157 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHh-cCCccHHHHHHHhccc----ceEEEEEec
Confidence 46899999999998865 899999999866432 2344566666654 4799999999999887 458999999
Q ss_pred cCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCC---cEEEEecCCcccc
Q psy14889 216 HSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNG---TCVIADFGLAVSY 291 (443)
Q Consensus 216 ~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~---~~kl~DfGla~~~ 291 (443)
|.+|+|..++++ ..+++.++.++..+|+.||.|||.+ ||.||||||+|||-.+.. -+||+||.+...+
T Consensus 158 m~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~k--------gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~ 229 (463)
T KOG0607|consen 158 MRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTK--------GIAHRDLKPENILCESPNKVSPVKICDFDLGSGI 229 (463)
T ss_pred ccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhc--------CcccccCCccceeecCCCCcCceeeecccccccc
Confidence 999999998864 6799999999999999999999998 999999999999997765 4799999987543
Q ss_pred cccCCc---CCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCC
Q psy14889 292 SQLSNK---MDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMD 368 (443)
Q Consensus 292 ~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~ 368 (443)
...... ......+.+|+..|||||+..--... ...|..+.|.||||||||-|+.| ..||.+.-..+
T Consensus 230 k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~q-A~~YDKrCDlwSLGvIlYImLsG----------YpPFvG~Cg~d 298 (463)
T KOG0607|consen 230 KLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQ-ATFYDKRCDLWSLGVILYIMLSG----------YPPFVGHCGAD 298 (463)
T ss_pred ccCCCCCCCCCccccCcccchhhcchhHHhhhccc-cccccccccHHHHHHHHHHHHhC----------CCCccCccCCc
Confidence 321111 11112345899999999987532211 12567899999999999999999 66776654333
Q ss_pred CCh------HHHHhhh--hhcCCCCCCCCC-CCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 369 PSF------DDMRKVI--CIDQQRPVLPNR-WVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 369 ~~~------~~~~~~~--~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
-.+ ...++.. .+......+|+. | ..++.+..+++...+..||.+|.++.++++
T Consensus 299 CGWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdW--ahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 299 CGWDRGEVCRVCQNKLFESIQEGKYEFPDKDW--AHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred CCccCCCccHHHHHHHHHHHhccCCcCChhhh--HHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 221 1122211 122334445532 3 347788999999999999999999999887
|
|
| >KOG0984|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=243.97 Aligned_cols=221 Identities=24% Similarity=0.405 Sum_probs=167.0
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc--chHHHHHHHHH-HhccCCCceeeeeeccccCCcccEEE
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA--SWSRETEIYST-VLLRHENILGYIGSDMTSRNSCTQLW 210 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~--~~~~e~ei~~~-~~l~H~nIv~l~g~~~~~~~~~~~~~ 210 (443)
+.......||+|+||.|-+-++ +|...|+|.+...-.. ..+...|+... .....|.+|+|+|..... ...|
T Consensus 46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~re----gdvw 121 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFRE----GDVW 121 (282)
T ss_pred hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcc----ccEE
Confidence 4556678899999998766555 7999999988654322 12222233222 125689999999987665 4589
Q ss_pred eeecccCcccHHHHhc-----ccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEec
Q psy14889 211 LVTHYHSFGSLYDHLN-----RTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADF 285 (443)
Q Consensus 211 lv~e~~~~gsL~~~l~-----~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~Df 285 (443)
+.||.|.. ||+.+-+ ...+++..+-+|+..|..||.|||++. .+||||+||+||||+.+|++|++||
T Consensus 122 IcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL-------~vIHRDvKPsNiLIn~~GqVKiCDF 193 (282)
T KOG0984|consen 122 ICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL-------SVIHRDVKPSNILINYDGQVKICDF 193 (282)
T ss_pred EeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh-------hhhhccCCcceEEEccCCcEEEccc
Confidence 99999986 8877653 367899999999999999999999974 8999999999999999999999999
Q ss_pred CCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCC
Q psy14889 286 GLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLV 365 (443)
Q Consensus 286 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~ 365 (443)
|.+..+.+.... +-..|...|||||.+....+.. .|+.||||||||+++.||.++ ..||..+.
T Consensus 194 GIsG~L~dSiAk-----t~daGCkpYmaPEri~~e~n~~--gY~vksDvWSLGItmiElA~l----------r~PY~~w~ 256 (282)
T KOG0984|consen 194 GISGYLVDSIAK-----TMDAGCKPYMAPERINPELNQK--GYSVKSDVWSLGITMIEMAIL----------RFPYESWG 256 (282)
T ss_pred ccceeehhhhHH-----HHhcCCCccCChhhcCcccCcc--cceeehhhhhhhhhhhhhhhc----------cccccccC
Confidence 999766543222 2235778999999998765543 788899999999999999999 67776653
Q ss_pred CCCCChHHHHhhhhhcCCCCCCCCC
Q psy14889 366 PMDPSFDDMRKVICIDQQRPVLPNR 390 (443)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (443)
..++.+++.+. ...|.+|..
T Consensus 257 ---tpF~qLkqvVe--ep~P~Lp~~ 276 (282)
T KOG0984|consen 257 ---TPFQQLKQVVE--EPSPQLPAD 276 (282)
T ss_pred ---CHHHHHHHHhc--CCCCCCccc
Confidence 24555666553 344555543
|
|
| >KOG0614|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=276.62 Aligned_cols=237 Identities=21% Similarity=0.322 Sum_probs=193.1
Q ss_pred ccccccceeeeecCeEEEEEEECCce--eEEEEeeccCccc------hHHHHHHHHHHhccCCCceeeeeeccccCCccc
Q psy14889 136 KQISLSECIGKGRYGEVWRGVWHGEN--VAVKIFFSRDEAS------WSRETEIYSTVLLRHENILGYIGSDMTSRNSCT 207 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~~~~~--vAvK~~~~~~~~~------~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~ 207 (443)
++++....||-|+||.|-++..+++. +|+|++++....+ ...|+.|+.. .+.|.||++|-.|.+. .
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~--~~s~fIvrLYrTfrd~----k 493 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMME--CRSDFIVRLYRTFRDS----K 493 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHh--cCchHHHHHHHHhccc----h
Confidence 45677788999999999999886655 8999886654322 2234555554 7899999999998877 5
Q ss_pred EEEeeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecC
Q psy14889 208 QLWLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFG 286 (443)
Q Consensus 208 ~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfG 286 (443)
++|+.||-|-+|.|...|++ +.++..+...++..+..|++|||++ +||.|||||+|++++.+|-+||.|||
T Consensus 494 yvYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k--------~iIYRDLKPENllLd~~Gy~KLVDFG 565 (732)
T KOG0614|consen 494 YVYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRK--------GIIYRDLKPENLLLDNRGYLKLVDFG 565 (732)
T ss_pred hhhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhc--------CceeccCChhheeeccCCceEEeehh
Confidence 68999999999999999975 6799999999999999999999999 99999999999999999999999999
Q ss_pred CcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCC
Q psy14889 287 LAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVP 366 (443)
Q Consensus 287 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~ 366 (443)
+|+.+......+ +++||+.|.|||++... ....++|.||||+++|||++| ..||....+
T Consensus 566 FAKki~~g~KTw-----TFcGTpEYVAPEIILnK------GHD~avDyWaLGIli~ELL~G----------~pPFs~~dp 624 (732)
T KOG0614|consen 566 FAKKIGSGRKTW-----TFCGTPEYVAPEIILNK------GHDRAVDYWALGILIYELLTG----------SPPFSGVDP 624 (732)
T ss_pred hHHHhccCCcee-----eecCCcccccchhhhcc------CcchhhHHHHHHHHHHHHHcC----------CCCCCCCch
Confidence 999988765544 57999999999999876 445789999999999999999 788887644
Q ss_pred CCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCc
Q psy14889 367 MDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLS 417 (443)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps 417 (443)
+. ..+.+........+| ..++....+||++....+|.+|..
T Consensus 625 mk-----tYn~ILkGid~i~~P-----r~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 625 MK-----TYNLILKGIDKIEFP-----RRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred HH-----HHHHHHhhhhhhhcc-----cccchhHHHHHHHHHhcCcHhhhc
Confidence 32 222222222333344 235677899999999999999985
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=278.02 Aligned_cols=266 Identities=22% Similarity=0.312 Sum_probs=177.2
Q ss_pred hccccccceeeeecCeEEEEEEE------------------CCceeEEEEeeccCcc---ch------------HHHHHH
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVW------------------HGENVAVKIFFSRDEA---SW------------SRETEI 181 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~------------------~~~~vAvK~~~~~~~~---~~------------~~e~ei 181 (443)
.++|.+.++||+|+||.||+|.+ .++.||||++...... ++ ....|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 57899999999999999999964 2467999988543211 11 112355
Q ss_pred HHHHhccCCCc-----eeeeeeccccCC----cccEEEeeecccCcccHHHHhccc------------------------
Q psy14889 182 YSTVLLRHENI-----LGYIGSDMTSRN----SCTQLWLVTHYHSFGSLYDHLNRT------------------------ 228 (443)
Q Consensus 182 ~~~~~l~H~nI-----v~l~g~~~~~~~----~~~~~~lv~e~~~~gsL~~~l~~~------------------------ 228 (443)
.....++|.|+ ++++++|..... .....+|||||+++|+|.++++..
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 55555666654 677787754211 113479999999999999988531
Q ss_pred -CCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcccccccCCcCCCCCCCccc
Q psy14889 229 -TLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVG 307 (443)
Q Consensus 229 -~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~g 307 (443)
.+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++......... ......+
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~--------~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~---~~~~g~~ 372 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRI--------GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF---NPLYGML 372 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHC--------CeecCCCchHhEEECCCCcEEEEeCcCccccccCCcc---CccccCC
Confidence 245677889999999999999998 9999999999999999999999999999755432111 1112245
Q ss_pred ccCcccccccccccccC----------------cCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCCh
Q psy14889 308 TKRYMSPEILDESINMD----------------CFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSF 371 (443)
Q Consensus 308 t~~y~aPE~~~~~~~~~----------------~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~~ 371 (443)
|+.|+|||.+....... .+....+.||||+||+++||+++.. .||.+........
T Consensus 373 tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l---------~p~~~~~~f~~~~ 443 (507)
T PLN03224 373 DPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPEL---------RPVANIRLFNTEL 443 (507)
T ss_pred CcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCC---------CCccchhhhhhHH
Confidence 78999999986432110 0112235799999999999999832 2333221111010
Q ss_pred H----HHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCc---CCCCcHHHHHH
Q psy14889 372 D----DMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNA---NVRLSALRVKK 423 (443)
Q Consensus 372 ~----~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP---~~Rps~~evl~ 423 (443)
. ..............++. .+..+....+|+.++|..+| .+|+|+.|+++
T Consensus 444 ~~~~~~~~~~r~~~~~~~~~~~---~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 444 RQYDNDLNRWRMYKGQKYDFSL---LDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred hhccchHHHHHhhcccCCCccc---ccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 0 01111111111222221 13356779999999999866 68999999985
|
|
| >KOG0695|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=255.06 Aligned_cols=245 Identities=23% Similarity=0.317 Sum_probs=190.5
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeecc----C-c-cchHHHHHHHHHHhccCCCceeeeeeccccCCccc
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSR----D-E-ASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCT 207 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~----~-~-~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~ 207 (443)
++|.+..+||+|+|..|..+++ +.+.+|+|++++. + . +-.+.|..+.... -+||.+|.++.+|.+. .
T Consensus 250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~a-sn~pflvglhscfqte----s 324 (593)
T KOG0695|consen 250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQA-SNNPFLVGLHSCFQTE----S 324 (593)
T ss_pred ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhc-cCCCeEEehhhhhccc----c
Confidence 6899999999999999999987 5788999987542 1 1 1223466666665 5999999999988876 4
Q ss_pred EEEeeecccCcccHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecC
Q psy14889 208 QLWLVTHYHSFGSLYDHLN-RTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFG 286 (443)
Q Consensus 208 ~~~lv~e~~~~gsL~~~l~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfG 286 (443)
++++|.||+++|+|--+++ ++.++++.+..+...|+.||.|||+. |||.||||..|+|+|..|++||+|+|
T Consensus 325 rlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~r--------giiyrdlkldnvlldaeghikltdyg 396 (593)
T KOG0695|consen 325 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHER--------GIIYRDLKLDNVLLDAEGHIKLTDYG 396 (593)
T ss_pred eEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhc--------CeeeeeccccceEEccCCceeecccc
Confidence 6899999999999977765 46799999999999999999999999 99999999999999999999999999
Q ss_pred CcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCC
Q psy14889 287 LAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVP 366 (443)
Q Consensus 287 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~ 366 (443)
+++.--.. ...+++++||+.|+|||++++. .|+...|+|++||+++||+.|+.|+++.. ...|
T Consensus 397 mcke~l~~----gd~tstfcgtpnyiapeilrge------eygfsvdwwalgvlmfemmagrspfdivg-m~n~------ 459 (593)
T KOG0695|consen 397 MCKEGLGP----GDTTSTFCGTPNYIAPEILRGE------EYGFSVDWWALGVLMFEMMAGRSPFDIVG-MDNP------ 459 (593)
T ss_pred hhhcCCCC----CcccccccCCCcccchhhhccc------ccCceehHHHHHHHHHHHHcCCCCcceec-CCCc------
Confidence 98643222 2234678999999999999987 88899999999999999999966654432 1111
Q ss_pred CCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCc
Q psy14889 367 MDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLS 417 (443)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps 417 (443)
.....+-+.+++... ...+| ...+-....+++.-|++||.+|..
T Consensus 460 d~ntedylfqvilek--qirip-----rslsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 460 DMNTEDYLFQVILEK--QIRIP-----RSLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred ccchhHHHHHHHhhh--ccccc-----ceeehhhHHHHHHhhcCCcHHhcC
Confidence 111222233333222 22233 234456778999999999999974
|
|
| >KOG0671|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=263.00 Aligned_cols=263 Identities=17% Similarity=0.214 Sum_probs=186.5
Q ss_pred HHhhhhccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccchHHHHHHHHHHhccC--CC----ceeeeeeccc
Q psy14889 130 IQRTLAKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEASWSRETEIYSTVLLRH--EN----ILGYIGSDMT 201 (443)
Q Consensus 130 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~H--~n----Iv~l~g~~~~ 201 (443)
....+.++|.+.+.+|+|.||.|-.+.. .+..||||+++.-.........||..+.++.+ || +|.+.+++..
T Consensus 83 ~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdy 162 (415)
T KOG0671|consen 83 VGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDY 162 (415)
T ss_pred eccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhc
Confidence 3445578999999999999999999987 47899999987654444444455655555633 22 6777777765
Q ss_pred cCCcccEEEeeecccCcccHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCC-
Q psy14889 202 SRNSCTQLWLVTHYHSFGSLYDHLNR---TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTN- 277 (443)
Q Consensus 202 ~~~~~~~~~lv~e~~~~gsL~~~l~~---~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~- 277 (443)
. ++.++|+|.+. -|+.++|.. .+++...+..|+.|++.+++|||+. +++|-||||+|||+.+.
T Consensus 163 r----ghiCivfellG-~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~--------kl~HTDLKPENILfvss~ 229 (415)
T KOG0671|consen 163 R----GHICIVFELLG-LSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDL--------KLTHTDLKPENILFVSSE 229 (415)
T ss_pred c----CceEEEEeccC-hhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhc--------ceeecCCChheEEEeccc
Confidence 5 55789999884 499999975 4689999999999999999999999 99999999999999432
Q ss_pred -------------------CcEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHH
Q psy14889 278 -------------------GTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALG 338 (443)
Q Consensus 278 -------------------~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~G 338 (443)
..+||+|||.|..-.+.. +..+.|..|.|||++.+- .++.++||||+|
T Consensus 230 ~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-------s~iVsTRHYRAPEViLgL------GwS~pCDvWSiG 296 (415)
T KOG0671|consen 230 YFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-------STIVSTRHYRAPEVILGL------GWSQPCDVWSIG 296 (415)
T ss_pred eEEEeccCCccceeccCCCcceEEEecCCcceeccCc-------ceeeeccccCCchheecc------CcCCccCceeee
Confidence 258999999997655433 345789999999999987 778899999999
Q ss_pred HHHHHHHhcccCCCcccc-----------cCCCCCCCCCCCCChHHHHhhhhh------------------cCCCCCCCC
Q psy14889 339 LVLWEVCRRTKANGIFEE-----------YKAPYHDLVPMDPSFDDMRKVICI------------------DQQRPVLPN 389 (443)
Q Consensus 339 vvl~elltg~~~~~~~~~-----------~~~P~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~ 389 (443)
|||+|+.||...+..-+. +..|..-... .. ..+.... +..+|....
T Consensus 297 CIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r--~~---~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~ 371 (415)
T KOG0671|consen 297 CILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKK--TR---KEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKY 371 (415)
T ss_pred eEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhh--hh---hHhhhhcccccCccccccccchhhhcCCccHHHH
Confidence 999999999543221110 1111110000 00 0000000 000110000
Q ss_pred CCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 390 RWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 390 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
....+....++.+|+++||..||.+|+|+.|++.
T Consensus 372 ~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 372 MLQDDLEHVQLFDLLRRMLEFDPARRITLREALS 405 (415)
T ss_pred hccCcHHHhHHHHHHHHHHccCccccccHHHHhc
Confidence 1122445567999999999999999999999875
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-32 Score=250.07 Aligned_cols=235 Identities=27% Similarity=0.370 Sum_probs=181.7
Q ss_pred cCeEEEEEEE--CCceeEEEEeeccCccc--hHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEeeecccCcccHHH
Q psy14889 148 RYGEVWRGVW--HGENVAVKIFFSRDEAS--WSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYD 223 (443)
Q Consensus 148 ~fg~Vy~~~~--~~~~vAvK~~~~~~~~~--~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e~~~~gsL~~ 223 (443)
+||.||+|.. +|+.+|+|++....... .....|+.....++|+||+++++.+... ...++++||+++++|.+
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~----~~~~l~~e~~~~~~L~~ 76 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDE----DKLYLVMEYCDGGDLFD 76 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeC----CEEEEEEeCCCCCCHHH
Confidence 5899999998 46899999986554322 2334555566668999999999998765 45799999999999999
Q ss_pred HhcccC-CCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcccccccCCcCCCCC
Q psy14889 224 HLNRTT-LNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPP 302 (443)
Q Consensus 224 ~l~~~~-l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 302 (443)
++.... +++..+..++.+++.++.|||+. +++|+||+|+||++++++.++|+|||.+....... ..
T Consensus 77 ~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--------~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-----~~ 143 (244)
T smart00220 77 LLKKRGRLSEDEARFYARQILSALEYLHSN--------GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-----LL 143 (244)
T ss_pred HHHhccCCCHHHHHHHHHHHHHHHHHHHHc--------CeecCCcCHHHeEECCCCcEEEccccceeeecccc-----cc
Confidence 997544 89999999999999999999998 99999999999999999999999999997765432 11
Q ss_pred CCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCChHHHHhhhhhcC
Q psy14889 303 NPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQ 382 (443)
Q Consensus 303 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~~~~~~~~~~~~~ 382 (443)
....++..|+|||.+... .++.++||||||+++|+|++| ..||.... ............
T Consensus 144 ~~~~~~~~~~~pE~~~~~------~~~~~~Di~slG~~l~~l~~~----------~~p~~~~~----~~~~~~~~~~~~- 202 (244)
T smart00220 144 TTFVGTPEYMAPEVLLGK------GYGKAVDVWSLGVILYELLTG----------KPPFPGDD----QLLELFKKIGKP- 202 (244)
T ss_pred ccccCCcCCCCHHHHccC------CCCchhhHHHHHHHHHHHHhC----------CCCCCCCC----cHHHHHHHHhcc-
Confidence 334678899999998754 566899999999999999999 56665421 222222222111
Q ss_pred CCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 383 QRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 383 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
....... ....+.++.+++.+||..+|++||++.++++
T Consensus 203 ~~~~~~~---~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 203 KPPFPPP---EWKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred CCCCccc---cccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 1111110 1115568999999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.2e-33 Score=274.27 Aligned_cols=255 Identities=28% Similarity=0.413 Sum_probs=200.7
Q ss_pred hhhccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccchHH-HHHHHHHHhccCCCceeeeeeccccCCcccEE
Q psy14889 133 TLAKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEASWSR-ETEIYSTVLLRHENILGYIGSDMTSRNSCTQL 209 (443)
Q Consensus 133 ~~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~-e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~ 209 (443)
....+|.+.+++|.|+||.|||++. +++..|||+++....+.+.- ..||..+..-+|||||.++|.+...+ .+
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~d----kl 87 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRD----KL 87 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhc----Cc
Confidence 5567999999999999999999988 68999999987655444333 45666666689999999999988774 47
Q ss_pred EeeecccCcccHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCc
Q psy14889 210 WLVTHYHSFGSLYDHLN-RTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA 288 (443)
Q Consensus 210 ~lv~e~~~~gsL~~~l~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla 288 (443)
|+.||||.+|+|++.-+ .+.+++.++..+++..++||+|||+. +-+|||||-.|||+++.+.+|++|||.+
T Consensus 88 wicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~--------gk~hRdiKGanilltd~gDvklaDfgvs 159 (829)
T KOG0576|consen 88 WICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQ--------GKIHRDIKGANILLTDEGDVKLADFGVS 159 (829)
T ss_pred EEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcC--------CcccccccccceeecccCceeecccCch
Confidence 99999999999999776 47899999999999999999999998 8899999999999999999999999998
Q ss_pred ccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCC
Q psy14889 289 VSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMD 368 (443)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~ 368 (443)
..+.....+ ...+.||+.|||||+..-.... .|..++|||+.|+...|+-.- +.|..+..+
T Consensus 160 aqitati~K----rksfiGtpywmapEvaaverkg---gynqlcdiwa~gitAiel~eL----------qpplfdlhp-- 220 (829)
T KOG0576|consen 160 AQITATIAK----RKSFIGTPYWMAPEVAAVERKG---GYNQLCDIWALGITAIELGEL----------QPPLFDLHP-- 220 (829)
T ss_pred hhhhhhhhh----hhcccCCccccchhHHHHHhcc---cccccccccccccchhhhhhc----------CCcccccch--
Confidence 766543332 2457899999999987543332 567899999999999998665 566555433
Q ss_pred CChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 369 PSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
++.........+..|.......-.+.+.++++.|+..+|++|||++.++.
T Consensus 221 -----mr~l~LmTkS~~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 221 -----MRALFLMTKSGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred -----HHHHHHhhccCCCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 22222222222222222223344567999999999999999999987653
|
|
| >KOG0664|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-32 Score=242.80 Aligned_cols=269 Identities=25% Similarity=0.325 Sum_probs=191.0
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCc---cchHHHHHHHHHHhccCCCceeeeeeccccCCc-ccEE
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDE---ASWSRETEIYSTVLLRHENILGYIGSDMTSRNS-CTQL 209 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~---~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~-~~~~ 209 (443)
.+++..+.||-|+||.||...+ +|+.||+|.+..-.. .....-.|+..+..++|.|++..++...-.... ..++
T Consensus 53 ~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi 132 (449)
T KOG0664|consen 53 QDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL 132 (449)
T ss_pred ccCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence 3566678899999999999887 699999998743221 122223556666669999999998876543221 2347
Q ss_pred EeeecccCcccHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCc
Q psy14889 210 WLVTHYHSFGSLYDHL-NRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA 288 (443)
Q Consensus 210 ~lv~e~~~~gsL~~~l-~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla 288 (443)
|+++|.|.. ||...+ ....++.+.+.-+..||++||.|||+. +|.||||||.|.|++++-.+||+|||+|
T Consensus 133 YV~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA--------~ILHRDIKPGNLLVNSNCvLKICDFGLA 203 (449)
T KOG0664|consen 133 YVLTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTA--------NILHRDIKPGNLLVNSNCILKICDFGLA 203 (449)
T ss_pred HHHHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhc--------chhhccCCCccEEeccCceEEecccccc
Confidence 899999975 888876 457799999999999999999999999 9999999999999999999999999999
Q ss_pred ccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCC----
Q psy14889 289 VSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDL---- 364 (443)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~---- 364 (443)
+......... .+..+-|..|.|||++.+.+ .|+.+.||||.||++.||+.++..+.. +.|-+..
T Consensus 204 Rvee~d~~~h---MTqEVVTQYYRAPEiLMGaR-----hYs~AvDiWSVGCIFaELLgRrILFQA----q~PiqQL~lIt 271 (449)
T KOG0664|consen 204 RTWDQRDRLN---MTHEVVTQYYRAPELLMGAR-----RYTGAVDIWSVGCIFAELLQRKILFQA----AGPIEQLQMII 271 (449)
T ss_pred cccchhhhhh---hHHHHHHHHhccHHHhhcch-----hhcCccceehhhHHHHHHHhhhhhhhc----cChHHHHHHHH
Confidence 8766543322 24456788999999999875 566899999999999999988654321 1121110
Q ss_pred -CCCCCChHHHHhh-------hhhc-CCCCCCCCCC---CCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHH
Q psy14889 365 -VPMDPSFDDMRKV-------ICID-QQRPVLPNRW---VSDSTLNAMTKVMKECWHQNANVRLSALRVKKTL 425 (443)
Q Consensus 365 -~~~~~~~~~~~~~-------~~~~-~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 425 (443)
.-..++.+.++.. +... ...|.++..+ ..+....+...++.+++..||.+|.+..+.+..+
T Consensus 272 dLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 272 DLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred HHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 0112233333321 1111 1112222111 1223445677899999999999999988877643
|
|
| >KOG0608|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=257.10 Aligned_cols=242 Identities=24% Similarity=0.339 Sum_probs=178.5
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCc------cchHHHHHHHHHHhccCCCceeeeeeccccCCccc
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDE------ASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCT 207 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~------~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~ 207 (443)
.-|..++.||-|+||+|.++.. +...+|.|.+.+.+. .....|++|+.. -+.+-||+||-.|.+.++
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAE--ADn~WVVrLyySFQDkdn--- 703 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAE--ADNEWVVRLYYSFQDKDN--- 703 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhh--cCCcceEEEEEEeccCCc---
Confidence 4577889999999999999875 567889998765432 234446666666 689999999999998865
Q ss_pred EEEeeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecC
Q psy14889 208 QLWLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFG 286 (443)
Q Consensus 208 ~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfG 286 (443)
+|+||+|.++||+-.+|-+ +-|.+..+..++.++..|+++.|.. |+|||||||+|||||.+|++||+|||
T Consensus 704 -LYFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkm--------GFIHRDiKPDNILIDrdGHIKLTDFG 774 (1034)
T KOG0608|consen 704 -LYFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKM--------GFIHRDIKPDNILIDRDGHIKLTDFG 774 (1034)
T ss_pred -eEEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhc--------cceecccCccceEEccCCceeeeecc
Confidence 8999999999999998855 5677888888999999999999988 99999999999999999999999999
Q ss_pred Ccccccc--cCCc--------CC----------------------------CCCCCcccccCcccccccccccccCcCCC
Q psy14889 287 LAVSYSQ--LSNK--------MD----------------------------IPPNPRVGTKRYMSPEILDESINMDCFES 328 (443)
Q Consensus 287 la~~~~~--~~~~--------~~----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 328 (443)
|+.-+.- .+.. .+ ......+||..|+|||++... .+
T Consensus 775 LCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~------g~ 848 (1034)
T KOG0608|consen 775 LCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLART------GY 848 (1034)
T ss_pred ccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhccc------Cc
Confidence 9853321 0000 00 001234799999999999876 77
Q ss_pred CCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHh
Q psy14889 329 FKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECW 408 (443)
Q Consensus 329 ~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 408 (443)
+..+|+||.|||||||+.| +.||....+..... +++..+... .++ ...+.+.+..++|.+.+
T Consensus 849 ~q~cdwws~gvil~em~~g----------~~pf~~~tp~~tq~----kv~nw~~~l-~~~---~~~~ls~e~~~li~kLc 910 (1034)
T KOG0608|consen 849 TQLCDWWSVGVILYEMLVG----------QPPFLADTPGETQY----KVINWRNFL-HIP---YQGNLSKEALDLIQKLC 910 (1034)
T ss_pred cccchhhHhhHHHHHHhhC----------CCCccCCCCCccee----eeeehhhcc-ccc---cccccCHHHHHHHHHHh
Confidence 7899999999999999999 77777655432211 112111111 111 11335566777776643
Q ss_pred cCCcCCCC
Q psy14889 409 HQNANVRL 416 (443)
Q Consensus 409 ~~dP~~Rp 416 (443)
.+++.|.
T Consensus 911 -~sad~RL 917 (1034)
T KOG0608|consen 911 -CSADSRL 917 (1034)
T ss_pred -cChhhhh
Confidence 3456665
|
|
| >KOG0668|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=228.66 Aligned_cols=251 Identities=21% Similarity=0.323 Sum_probs=187.5
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccchHHHHHHHHHHhcc-CCCceeeeeeccccCCcccEEEee
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEASWSRETEIYSTVLLR-HENILGYIGSDMTSRNSCTQLWLV 212 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~-H~nIv~l~g~~~~~~~~~~~~~lv 212 (443)
++|++.+++|+|.|++||.|.. +++.++||+++.-......+|..|+.- |. ||||++++++..++.+ ....||
T Consensus 38 ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkkkKIkREikIL~n--L~gg~NIi~L~DiV~Dp~S--ktpaLi 113 (338)
T KOG0668|consen 38 DDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKKKKIKREIKILQN--LRGGPNIIKLLDIVKDPES--KTPSLI 113 (338)
T ss_pred chHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHHHHHHHHHHHHHh--ccCCCCeeehhhhhcCccc--cCchhH
Confidence 6899999999999999999985 788999999977665555555555444 65 9999999999887765 457899
Q ss_pred ecccCcccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCC-cEEEEecCCcccc
Q psy14889 213 THYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNG-TCVIADFGLAVSY 291 (443)
Q Consensus 213 ~e~~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~-~~kl~DfGla~~~ 291 (443)
+||..+-+...+. ..++...+..++.++++||.|+||. ||.|||+||.|++||... .++|+|+|+|.+.
T Consensus 114 FE~v~n~Dfk~ly--~tl~d~dIryY~~elLkALdyCHS~--------GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY 183 (338)
T KOG0668|consen 114 FEYVNNTDFKQLY--PTLTDYDIRYYIYELLKALDYCHSM--------GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
T ss_pred hhhhccccHHHHh--hhhchhhHHHHHHHHHHHHhHHHhc--------CcccccCCcceeeechhhceeeeeecchHhhc
Confidence 9999997776654 4578889999999999999999999 999999999999999765 6899999999877
Q ss_pred cccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCCh
Q psy14889 292 SQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSF 371 (443)
Q Consensus 292 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~~ 371 (443)
...... +-++.+..|.-||++..-. .|...-|+|||||+|..|+.. +.||..-.. ..
T Consensus 184 Hp~~eY-----nVRVASRyfKGPELLVdy~-----~YDYSLD~WS~GcmlA~miFr----------kepFFhG~d---N~ 240 (338)
T KOG0668|consen 184 HPGKEY-----NVRVASRYFKGPELLVDYQ-----MYDYSLDMWSLGCMLASMIFR----------KEPFFHGHD---NY 240 (338)
T ss_pred CCCcee-----eeeeehhhcCCchheeech-----hccccHHHHHHHHHHHHHHhc----------cCcccCCCC---CH
Confidence 654322 3346777899999997653 344578999999999999998 445443221 22
Q ss_pred HHHHhhhhhc----------CCCCCCCC------------CCC-------CchhHHHHHHHHHHHhcCCcCCCCcHHHHH
Q psy14889 372 DDMRKVICID----------QQRPVLPN------------RWV-------SDSTLNAMTKVMKECWHQNANVRLSALRVK 422 (443)
Q Consensus 372 ~~~~~~~~~~----------~~~~~~~~------------~~~-------~~~~~~~l~~li~~cl~~dP~~Rps~~evl 422 (443)
+.+.++.... .....+++ .|. ..-.++++.+++.+.|..|..+|||++|.+
T Consensus 241 DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam 320 (338)
T KOG0668|consen 241 DQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAM 320 (338)
T ss_pred HHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHh
Confidence 2221111000 00000110 110 011246789999999999999999999987
Q ss_pred H
Q psy14889 423 K 423 (443)
Q Consensus 423 ~ 423 (443)
.
T Consensus 321 ~ 321 (338)
T KOG0668|consen 321 A 321 (338)
T ss_pred c
Confidence 5
|
|
| >KOG1290|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-30 Score=243.78 Aligned_cols=141 Identities=21% Similarity=0.294 Sum_probs=115.8
Q ss_pred chHHHhhhh-ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccchHHHHHHHHHHhcc-----C---CCceee
Q psy14889 127 PLLIQRTLA-KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEASWSRETEIYSTVLLR-----H---ENILGY 195 (443)
Q Consensus 127 ~~~~~~~~~-~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~-----H---~nIv~l 195 (443)
|..+...+. .+|.+.++||=|.|++||++.+ ..+.||+|+.+...........||..+.+++ | .+||+|
T Consensus 68 pV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~L 147 (590)
T KOG1290|consen 68 PVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQL 147 (590)
T ss_pred eeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeee
Confidence 444556666 7899999999999999999988 4678999998765544433444555554432 3 369999
Q ss_pred eeeccccCCcccEEEeeecccCcccHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCE
Q psy14889 196 IGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNR---TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNI 272 (443)
Q Consensus 196 ~g~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~---~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~Ni 272 (443)
++.|....++..+++||+|++. -+|..++.. +.++...+..|+.||+.||.|||..+ +|||-||||+||
T Consensus 148 lD~FkhsGpNG~HVCMVfEvLG-dnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec-------gIIHTDlKPENv 219 (590)
T KOG1290|consen 148 LDHFKHSGPNGQHVCMVFEVLG-DNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC-------GIIHTDLKPENV 219 (590)
T ss_pred eccceecCCCCcEEEEEehhhh-hHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc-------CccccCCCccee
Confidence 9999998888899999999985 488888854 67999999999999999999999986 999999999999
Q ss_pred EEc
Q psy14889 273 LVK 275 (443)
Q Consensus 273 Ll~ 275 (443)
|+.
T Consensus 220 Ll~ 222 (590)
T KOG1290|consen 220 LLC 222 (590)
T ss_pred eee
Confidence 994
|
|
| >KOG1152|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=251.79 Aligned_cols=189 Identities=31% Similarity=0.494 Sum_probs=156.5
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccC--ccchHH-------HHHHHHHHhcc---CCCceeeeeeccc
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRD--EASWSR-------ETEIYSTVLLR---HENILGYIGSDMT 201 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~--~~~~~~-------e~ei~~~~~l~---H~nIv~l~g~~~~ 201 (443)
.+|+..+.+|+|+||.|+.|.+ +...|+||.+.+.. .+.|.+ -.||.++..++ |+||++++++|.+
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 3588999999999999999998 45689999875532 122222 14566666677 9999999999998
Q ss_pred cCCcccEEEeeeccc-CcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCc
Q psy14889 202 SRNSCTQLWLVTHYH-SFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGT 279 (443)
Q Consensus 202 ~~~~~~~~~lv~e~~-~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~ 279 (443)
.+ .+||+||-. ++-||.+++.. ..+++.++..|+.||+.|+++||++ +|||||||-+||.++.+|-
T Consensus 641 dd----~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~--------~ivhrdikdenvivd~~g~ 708 (772)
T KOG1152|consen 641 DD----YYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQ--------GIVHRDIKDENVIVDSNGF 708 (772)
T ss_pred CC----eeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhcccccccc--------CceecccccccEEEecCCe
Confidence 84 589999974 56789999964 6799999999999999999999999 9999999999999999999
Q ss_pred EEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhc
Q psy14889 280 CVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRR 347 (443)
Q Consensus 280 ~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg 347 (443)
+||+|||.|...... +...++||..|.|||++.+..+. +..-|||++|++||-++..
T Consensus 709 ~klidfgsaa~~ksg------pfd~f~gtv~~aapevl~g~~y~-----gk~qdiwalgillytivyk 765 (772)
T KOG1152|consen 709 VKLIDFGSAAYTKSG------PFDVFVGTVDYAAPEVLGGEKYL-----GKPQDIWALGILLYTIVYK 765 (772)
T ss_pred EEEeeccchhhhcCC------CcceeeeeccccchhhhCCCccC-----CCcchhhhhhheeeEEEec
Confidence 999999998654432 23457999999999999987433 3678999999999999887
|
|
| >KOG1345|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-30 Score=228.73 Aligned_cols=260 Identities=18% Similarity=0.317 Sum_probs=191.2
Q ss_pred hhhccccccceeeeecCeEEEEEEEC--CceeEEEEeeccCcc--chHHHHHHHHHHhccCCCceeeeeeccccCCcccE
Q psy14889 133 TLAKQISLSECIGKGRYGEVWRGVWH--GENVAVKIFFSRDEA--SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQ 208 (443)
Q Consensus 133 ~~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~--~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~ 208 (443)
.+.+.|.+.+.||+|.||.+-+++++ .+.+++|.+...... ++.+|...--. .-.|.||+.-|++..... ..
T Consensus 21 ~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~-Ls~H~hIi~tY~vaFqt~---d~ 96 (378)
T KOG1345|consen 21 DLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFF-LSPHQHIIDTYEVAFQTS---DA 96 (378)
T ss_pred chhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhcccee-eccchhhhHHHHHHhhcC---ce
Confidence 34578999999999999999999994 578999988654433 34444332222 146899998877644332 46
Q ss_pred EEeeecccCcccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcC--CCcEEEEecC
Q psy14889 209 LWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKT--NGTCVIADFG 286 (443)
Q Consensus 209 ~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~--~~~~kl~DfG 286 (443)
+.+++||++.|||.+-+...++.+....+++.|+++|+.|+|++ ++||||||.+||||-. ..++||+|||
T Consensus 97 YvF~qE~aP~gdL~snv~~~GigE~~~K~v~~ql~SAi~fMHsk--------nlVHRdlK~eNiLif~~df~rvKlcDFG 168 (378)
T KOG1345|consen 97 YVFVQEFAPRGDLRSNVEAAGIGEANTKKVFAQLLSAIEFMHSK--------NLVHRDLKAENILIFDADFYRVKLCDFG 168 (378)
T ss_pred EEEeeccCccchhhhhcCcccccHHHHHHHHHHHHHHHHHhhcc--------chhhcccccceEEEecCCccEEEeeecc
Confidence 78999999999999999888999999999999999999999999 9999999999999943 3489999999
Q ss_pred CcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCC
Q psy14889 287 LAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVP 366 (443)
Q Consensus 287 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~ 366 (443)
+.+..+..... ..-+..|-+||......+. .+...+.+|||.||+++|.++|| ..||+...-
T Consensus 169 ~t~k~g~tV~~-------~~~~~~y~~pe~~~~~~ne-~~~~~ps~D~WqfGIi~f~cltG----------~~PWQka~~ 230 (378)
T KOG1345|consen 169 LTRKVGTTVKY-------LEYVNNYHAPELCDTVVNE-KLVVNPSTDIWQFGIIFFYCLTG----------KFPWQKASI 230 (378)
T ss_pred cccccCceehh-------hhhhcccCCcHHHhhcccc-ceEecccccchheeeeeeeeecC----------CCcchhhhc
Confidence 98654432221 1234578899987654322 23566889999999999999999 667776554
Q ss_pred CCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHH
Q psy14889 367 MDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLI 426 (443)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 426 (443)
.+....+..+... ...+..|..+ ...++.+.++.++-+..+|++|--..++.++..
T Consensus 231 ~d~~Y~~~~~w~~--rk~~~~P~~F--~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk 286 (378)
T KOG1345|consen 231 MDKPYWEWEQWLK--RKNPALPKKF--NPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRK 286 (378)
T ss_pred cCchHHHHHHHhc--ccCccCchhh--cccCHHHHHHHHHhcCCcccccchhHHHHHHHH
Confidence 4444444444432 2334455433 225567889999999999999955555554443
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=221.92 Aligned_cols=207 Identities=32% Similarity=0.497 Sum_probs=173.0
Q ss_pred eeeecCeEEEEEEEC--CceeEEEEeeccCcc--chHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEeeecccCcc
Q psy14889 144 IGKGRYGEVWRGVWH--GENVAVKIFFSRDEA--SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVTHYHSFG 219 (443)
Q Consensus 144 lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~--~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e~~~~g 219 (443)
||+|++|.||++... ++.+++|++...... ......|+..+..+.|++|+++++++... ...++++||+.++
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~----~~~~~~~e~~~~~ 76 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDE----NHLYLVMEYCEGG 76 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecC----CeEEEEEecCCCC
Confidence 689999999999995 899999998765442 23344556666669999999999998775 3579999999999
Q ss_pred cHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcC-CCcEEEEecCCcccccccCC
Q psy14889 220 SLYDHLNRT--TLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKT-NGTCVIADFGLAVSYSQLSN 296 (443)
Q Consensus 220 sL~~~l~~~--~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~-~~~~kl~DfGla~~~~~~~~ 296 (443)
+|.+++... .+++..+..++.+++++|.|||+. +++|+||+|.||+++. ++.++|+|||.+........
T Consensus 77 ~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--------~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~ 148 (215)
T cd00180 77 SLKDLLKENEGKLSEDEILRILLQILEGLEYLHSN--------GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS 148 (215)
T ss_pred cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC--------CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc
Confidence 999999765 799999999999999999999998 9999999999999999 89999999999976654321
Q ss_pred cCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCChHHHHh
Q psy14889 297 KMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFDDMRK 376 (443)
Q Consensus 297 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~~~~~~~ 376 (443)
......+...|++||.+... ...+.++|+|++|+++++|
T Consensus 149 ----~~~~~~~~~~~~~pe~~~~~-----~~~~~~~D~~~lg~~~~~l-------------------------------- 187 (215)
T cd00180 149 ----LLKTIVGTPAYMAPEVLLGK-----GYYSEKSDIWSLGVILYEL-------------------------------- 187 (215)
T ss_pred ----hhhcccCCCCccChhHhccc-----CCCCchhhhHHHHHHHHHH--------------------------------
Confidence 11223577889999998664 1445789999999999997
Q ss_pred hhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHH
Q psy14889 377 VICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKT 424 (443)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 424 (443)
..+.+++.+|++.||++||++.++++.
T Consensus 188 ---------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 ---------------------PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred ---------------------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 248899999999999999999999865
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0665|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-30 Score=233.91 Aligned_cols=264 Identities=22% Similarity=0.269 Sum_probs=183.7
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccC---ccchHHHHHHHHHHhccCCCceeeeeeccccCC--cccE
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRD---EASWSRETEIYSTVLLRHENILGYIGSDMTSRN--SCTQ 208 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~---~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~--~~~~ 208 (443)
.+|.-.+.+|.|.- .|.-+-+ .++.||+|.+...- ......-.|...+..++|+||++++.++.-... ....
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 57777888898887 5555554 58999999764331 122233456666666999999999998864322 2245
Q ss_pred EEeeecccCcccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCc
Q psy14889 209 LWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA 288 (443)
Q Consensus 209 ~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla 288 (443)
+|+|||||. ++|...+. -.++-.++..+..|++.|+.|||+. +|+||||||+||++..+..+||.|||+|
T Consensus 96 ~y~v~e~m~-~nl~~vi~-~elDH~tis~i~yq~~~~ik~lhs~--------~IihRdLkPsnivv~~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 96 VYLVMELMD-ANLCQVIL-MELDHETISYILYQMLCGIKHLHSA--------GIIHRDLKPSNIVVNSDCTLKILDFGLA 165 (369)
T ss_pred HHHHHHhhh-hHHHHHHH-HhcchHHHHHHHHHHHHHHHHHHhc--------ceeecccCcccceecchhheeeccchhh
Confidence 799999997 49988876 5678889999999999999999999 9999999999999999999999999999
Q ss_pred ccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCC----------cccccC
Q psy14889 289 VSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANG----------IFEEYK 358 (443)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~----------~~~~~~ 358 (443)
+..... ...+..+.|..|.|||++.+. .+.+.+||||+||++.||++|+..+. +.+..+
T Consensus 166 r~e~~~-----~~mtpyVvtRyyrapevil~~------~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lg 234 (369)
T KOG0665|consen 166 RTEDTD-----FMMTPYVVTRYYRAPEVILGM------GYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLG 234 (369)
T ss_pred cccCcc-----cccCchhheeeccCchheecc------CCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhc
Confidence 755432 223556889999999999987 56789999999999999999964321 000111
Q ss_pred CCCCCCCCCCCChHHHHhhhhhcC------CCCCCCCCC-----C-CchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 359 APYHDLVPMDPSFDDMRKVICIDQ------QRPVLPNRW-----V-SDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 359 ~P~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~-----~-~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
.|-.... .......+..+.... ....+|+.. . +......+++++.+||-.||++|.|+++++.
T Consensus 235 tpd~~F~--~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 235 TPDPSFM--KQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred CCCHHHH--HHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 1100000 000000001110000 000111111 1 1123456899999999999999999999886
|
|
| >KOG0670|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.8e-30 Score=243.32 Aligned_cols=199 Identities=23% Similarity=0.248 Sum_probs=160.7
Q ss_pred chHHHhhhhccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccchHHHHHHHHHHhccC------CCceeeeee
Q psy14889 127 PLLIQRTLAKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEASWSRETEIYSTVLLRH------ENILGYIGS 198 (443)
Q Consensus 127 ~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~H------~nIv~l~g~ 198 (443)
...+.+.+..+|.+....|+|-|++|.+|.. .|..||||++..+..-...-..|+.++.+|+- -|+++|+-.
T Consensus 423 rv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~ 502 (752)
T KOG0670|consen 423 RVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRH 502 (752)
T ss_pred EEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHH
Confidence 3446677788999999999999999999988 58899999997765443333444545544542 378888888
Q ss_pred ccccCCcccEEEeeecccCcccHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEE
Q psy14889 199 DMTSRNSCTQLWLVTHYHSFGSLYDHLNR----TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILV 274 (443)
Q Consensus 199 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~----~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl 274 (443)
|... ++++||+|-+.. +|.+.|++ -.|....+..++.|+..||..|-.. +|+|.||||.|||+
T Consensus 503 F~hk----nHLClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c--------~vlHaDIKPDNiLV 569 (752)
T KOG0670|consen 503 FKHK----NHLCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC--------GVLHADIKPDNILV 569 (752)
T ss_pred hhhc----ceeEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc--------CeeecccCccceEe
Confidence 8776 679999998875 99999964 4688899999999999999999987 99999999999999
Q ss_pred cCCC-cEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccC
Q psy14889 275 KTNG-TCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKA 350 (443)
Q Consensus 275 ~~~~-~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~ 350 (443)
++.. .+||||||.|....... .+...-+..|.|||++.+- .|....|+||.||+||||.||+..
T Consensus 570 NE~k~iLKLCDfGSA~~~~ene------itPYLVSRFYRaPEIiLG~------~yd~~iD~WSvgctLYElYtGkIl 634 (752)
T KOG0670|consen 570 NESKNILKLCDFGSASFASENE------ITPYLVSRFYRAPEIILGL------PYDYPIDTWSVGCTLYELYTGKIL 634 (752)
T ss_pred ccCcceeeeccCcccccccccc------ccHHHHHHhccCcceeecC------cccCCccceeeceeeEEeecccee
Confidence 8764 67999999997665432 1334556789999999987 667789999999999999999753
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.6e-28 Score=211.97 Aligned_cols=167 Identities=25% Similarity=0.309 Sum_probs=125.3
Q ss_pred ccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcccccccCC
Q psy14889 219 GSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSN 296 (443)
Q Consensus 219 gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~~~~~~ 296 (443)
|||.++++. ..+++.++..++.||+.||.|||+. + ||+|||++.++.+|+ ||+++.....
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~--------~------kp~Nil~~~~~~~~~--fG~~~~~~~~-- 62 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQ--------A------KSGNILLTWDGLLKL--DGSVAFKTPE-- 62 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhc--------C------CcccEeEcCccceee--ccceEeeccc--
Confidence 789999974 4699999999999999999999988 5 999999999999999 9998765432
Q ss_pred cCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCChHHHHh
Q psy14889 297 KMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFDDMRK 376 (443)
Q Consensus 297 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~~~~~~~ 376 (443)
...||+.|||||++.+. .++.++|||||||++|||+|| ..||....... .....
T Consensus 63 -------~~~g~~~y~aPE~~~~~------~~~~~~DiwSlG~il~elltg----------~~p~~~~~~~~---~~~~~ 116 (176)
T smart00750 63 -------QSRVDPYFMAPEVIQGQ------SYTEKADIYSLGITLYEALDY----------ELPYNEERELS---AILEI 116 (176)
T ss_pred -------cCCCcccccChHHhcCC------CCcchhhHHHHHHHHHHHHhC----------CCCccccchhc---HHHHH
Confidence 12588999999999876 677899999999999999999 66665432111 12222
Q ss_pred hhhhcCCCCCCCC-CCCCchhHH--HHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhhc
Q psy14889 377 VICIDQQRPVLPN-RWVSDSTLN--AMTKVMKECWHQNANVRLSALRVKKTLIKLACA 431 (443)
Q Consensus 377 ~~~~~~~~~~~~~-~~~~~~~~~--~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~~ 431 (443)
.... ..+..+. ......... ++.+++.+||+.||.+|||+.++++.+..+...
T Consensus 117 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~ 172 (176)
T smart00750 117 LLNG--MPADDPRDRSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAE 172 (176)
T ss_pred HHHH--hccCCccccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence 2111 1111110 011122333 699999999999999999999999998877543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0195|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-28 Score=219.27 Aligned_cols=249 Identities=28% Similarity=0.510 Sum_probs=194.7
Q ss_pred cccccceeeeecCeEEEEEEECCceeEEEEeeccCc---cchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEeee
Q psy14889 137 QISLSECIGKGRYGEVWRGVWHGENVAVKIFFSRDE---ASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVT 213 (443)
Q Consensus 137 ~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~---~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv~ 213 (443)
+..+.-+|.+...|+.|+|+|.|..+++|++.-++- ....+..|.-.++.+.||||+.++|.|..+.+ +.++.
T Consensus 191 ~lnl~tkl~e~hsgelwrgrwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppn----lv~is 266 (448)
T KOG0195|consen 191 SLNLITKLAESHSGELWRGRWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPN----LVIIS 266 (448)
T ss_pred hhhhhhhhccCCCcccccccccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCC----ceEee
Confidence 455667889999999999999999999998754321 12233345555555899999999999988744 68999
Q ss_pred cccCcccHHHHhcccC---CCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEE--ecCCc
Q psy14889 214 HYHSFGSLYDHLNRTT---LNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIA--DFGLA 288 (443)
Q Consensus 214 e~~~~gsL~~~l~~~~---l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~--DfGla 288 (443)
.||+.|||+..|+.+. .+..++.+++.++|+|++|||+. +|-|.---|.+..++||++.+++|+ |--++
T Consensus 267 q~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhsl------ep~ipr~~lns~hvmidedltarismad~kfs 340 (448)
T KOG0195|consen 267 QYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL------EPMIPRFYLNSKHVMIDEDLTARISMADTKFS 340 (448)
T ss_pred eeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc------chhhhhhhcccceEEecchhhhheecccceee
Confidence 9999999999998653 67889999999999999999998 5555556799999999999988874 43322
Q ss_pred ccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCC
Q psy14889 289 VSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMD 368 (443)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~ 368 (443)
.. .....-.+.||+||.+....... --.++|+|||.+++|||.|+ +.||.++.++
T Consensus 341 fq-----------e~gr~y~pawmspealqrkped~---n~raadmwsfaillwel~tr----------evpfadlspm- 395 (448)
T KOG0195|consen 341 FQ-----------EVGRAYSPAWMSPEALQRKPEDL---NIRAADMWSFAILLWELNTR----------EVPFADLSPM- 395 (448)
T ss_pred ee-----------ccccccCcccCCHHHHhcCchhc---chhhhhHHHHHHHHHHhhcc----------ccccccCCch-
Confidence 11 11223457999999998764431 22578999999999999999 9999998654
Q ss_pred CChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHh
Q psy14889 369 PSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLA 429 (443)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~ 429 (443)
++--.+..++.++.+|+ ..+..+.+||.-|++.||.+||.++.|+-.|+++.
T Consensus 396 ----ecgmkialeglrv~ipp-----gis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 396 ----ECGMKIALEGLRVHIPP-----GISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred ----hhhhhhhhccccccCCC-----CccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 34445566777887774 35667999999999999999999999999999874
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-27 Score=216.13 Aligned_cols=196 Identities=30% Similarity=0.416 Sum_probs=159.3
Q ss_pred ccccceeeeecCeEEEEEEEC--CceeEEEEeeccCcc--chHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEeee
Q psy14889 138 ISLSECIGKGRYGEVWRGVWH--GENVAVKIFFSRDEA--SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVT 213 (443)
Q Consensus 138 ~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~--~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv~ 213 (443)
|.+.+.||+|++|.||++... ++.+|+|.+...... ......|+..+..++|+|++++++++... ...++++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~----~~~~~v~ 76 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDP----EPLYLVM 76 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecC----CceEEEE
Confidence 456789999999999999983 689999988654332 22334556666668999999999998765 3478999
Q ss_pred cccCcccHHHHhcccC--CCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcccc
Q psy14889 214 HYHSFGSLYDHLNRTT--LNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSY 291 (443)
Q Consensus 214 e~~~~gsL~~~l~~~~--l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~ 291 (443)
||+++++|.+++.... +++..+..++.+++.++.|||+. +++|+||+|.||+++.++.++|+|||++...
T Consensus 77 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--------~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~ 148 (225)
T smart00221 77 EYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSL--------GIVHRDLKPENILLGMDGLVKLADFGLARFI 148 (225)
T ss_pred eccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC--------CeecCCCCHHHEEEcCCCCEEEeeCceeeEe
Confidence 9999999999997543 89999999999999999999998 9999999999999999999999999998776
Q ss_pred cccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCC
Q psy14889 292 SQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHD 363 (443)
Q Consensus 292 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~ 363 (443)
...... ......++..|++||.+... ..++.++||||||++++||++| ..||..
T Consensus 149 ~~~~~~---~~~~~~~~~~~~~pe~~~~~-----~~~~~~~Dv~~lG~~~~~l~~g----------~~pf~~ 202 (225)
T smart00221 149 HRDLAA---LLKTVKGTPFYLAPEVLLGG-----KGYGEAVDIWSLGVILYELLWG----------PEPFSG 202 (225)
T ss_pred cCcccc---cccceeccCCcCCHhHhcCC-----CCCCchhhHHHHHHHHHHHHHC----------CCCccc
Confidence 543200 11234677889999998411 1566799999999999999999 777754
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-28 Score=263.73 Aligned_cols=199 Identities=16% Similarity=0.184 Sum_probs=136.0
Q ss_pred ccC-CCceeeeeeccccC---CcccEEEeeecccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCC
Q psy14889 187 LRH-ENILGYIGSDMTSR---NSCTQLWLVTHYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKP 260 (443)
Q Consensus 187 l~H-~nIv~l~g~~~~~~---~~~~~~~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~ 260 (443)
++| +||+++++++.... .....+++++||+. ++|.++|.. ..+++.+++.++.||++||+|||++
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~-------- 99 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECED-VSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQ-------- 99 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccCC-ccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhC--------
Confidence 456 68888888773222 11124678889875 599999964 4599999999999999999999998
Q ss_pred CeEEeCCCCCCEEEcCC-------------------CcEEEEecCCcccccccCCc------------CCCCCCCccccc
Q psy14889 261 AIAHRDIKSKNILVKTN-------------------GTCVIADFGLAVSYSQLSNK------------MDIPPNPRVGTK 309 (443)
Q Consensus 261 ~iiHrDlk~~NiLl~~~-------------------~~~kl~DfGla~~~~~~~~~------------~~~~~~~~~gt~ 309 (443)
+|+||||||+||||+.. +.+|++|||+++........ .........||+
T Consensus 100 gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 179 (793)
T PLN00181 100 GIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMS 179 (793)
T ss_pred CeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCc
Confidence 99999999999999654 44566666666432210000 000011246889
Q ss_pred CcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCC
Q psy14889 310 RYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPN 389 (443)
Q Consensus 310 ~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (443)
.|||||++.+. .++.++|||||||+||||++| ..|+... ...+.... .....+...
T Consensus 180 ~Y~APE~~~~~------~~~~~sDVwSlGviL~ELl~~----------~~~~~~~------~~~~~~~~-~~~~~~~~~- 235 (793)
T PLN00181 180 WYTSPEEDNGS------SSNCASDVYRLGVLLFELFCP----------VSSREEK------SRTMSSLR-HRVLPPQIL- 235 (793)
T ss_pred ceEChhhhccC------CCCchhhhhhHHHHHHHHhhC----------CCchhhH------HHHHHHHH-HhhcChhhh-
Confidence 99999998876 677899999999999999998 4444321 01111111 111111110
Q ss_pred CCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 390 RWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 390 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
. .......++.+||+.||.+|||+.|+++
T Consensus 236 ----~-~~~~~~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 236 ----L-NWPKEASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred ----h-cCHHHHHHHHHhCCCChhhCcChHHHhh
Confidence 1 1234678899999999999999999975
|
|
| >KOG1167|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-27 Score=222.87 Aligned_cols=198 Identities=24% Similarity=0.375 Sum_probs=155.9
Q ss_pred hhccccccceeeeecCeEEEEEEE-----CCceeEEEEeecc-CccchHHHHHHHHHHhccCCCceeeeeeccccCCccc
Q psy14889 134 LAKQISLSECIGKGRYGEVWRGVW-----HGENVAVKIFFSR-DEASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCT 207 (443)
Q Consensus 134 ~~~~~~~~~~lG~G~fg~Vy~~~~-----~~~~vAvK~~~~~-~~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~ 207 (443)
+.+.|...++||+|+|++||++.+ ..+.||+|.+... .......|.+++... .-+.||+++.+++...+
T Consensus 34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~-gG~~ni~~~~~~~rnnd---- 108 (418)
T KOG1167|consen 34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRL-GGSDNIIKLNGCFRNND---- 108 (418)
T ss_pred hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHh-ccchhhhcchhhhccCC----
Confidence 447789999999999999999976 3578999987543 345566677777664 57899999999887664
Q ss_pred EEEeeecccCcccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCC-CcEEEEecC
Q psy14889 208 QLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTN-GTCVIADFG 286 (443)
Q Consensus 208 ~~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~-~~~kl~DfG 286 (443)
...+|+||++.-+..++... ++...+..+++.+..||.++|.+ |||||||||+|+|.+.. +.-.|.|||
T Consensus 109 ~v~ivlp~~~H~~f~~l~~~--l~~~~i~~Yl~~ll~Al~~~h~~--------GIvHRDiKpsNFL~n~~t~rg~LvDFg 178 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYRS--LSLAEIRWYLRNLLKALAHLHKN--------GIVHRDIKPSNFLYNRRTQRGVLVDFG 178 (418)
T ss_pred eeEEEecccCccCHHHHHhc--CCHHHHHHHHHHHHHHhhhhhcc--------CccccCCCccccccccccCCceEEech
Confidence 47899999999888888754 66888999999999999999998 99999999999999765 567899999
Q ss_pred CcccccccC--------------C----cC-------------------C---CCCCCcccccCcccccccccccccCcC
Q psy14889 287 LAVSYSQLS--------------N----KM-------------------D---IPPNPRVGTKRYMSPEILDESINMDCF 326 (443)
Q Consensus 287 la~~~~~~~--------------~----~~-------------------~---~~~~~~~gt~~y~aPE~~~~~~~~~~~ 326 (443)
+|....... . .. + .......||++|.|||++..-.
T Consensus 179 LA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~----- 253 (418)
T KOG1167|consen 179 LAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCP----- 253 (418)
T ss_pred hHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhcc-----
Confidence 996211100 0 00 0 0011346999999999997642
Q ss_pred CCCCccchHHHHHHHHHHHhcccCC
Q psy14889 327 ESFKKADIYALGLVLWEVCRRTKAN 351 (443)
Q Consensus 327 ~~~~~sDvwS~Gvvl~elltg~~~~ 351 (443)
..++++||||.||+++-+++++.|+
T Consensus 254 ~QttaiDiws~GVI~Lslls~~~PF 278 (418)
T KOG1167|consen 254 RQTTAIDIWSAGVILLSLLSRRYPF 278 (418)
T ss_pred CcCCccceeeccceeehhhcccccc
Confidence 5668999999999999999996543
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-25 Score=217.01 Aligned_cols=167 Identities=21% Similarity=0.218 Sum_probs=125.0
Q ss_pred hhhhccccccceeeeecCeEEEEEEE---CCceeEEEEeeccC------ccchHHHHHHHHHHhccCCCcee-eeeeccc
Q psy14889 132 RTLAKQISLSECIGKGRYGEVWRGVW---HGENVAVKIFFSRD------EASWSRETEIYSTVLLRHENILG-YIGSDMT 201 (443)
Q Consensus 132 ~~~~~~~~~~~~lG~G~fg~Vy~~~~---~~~~vAvK~~~~~~------~~~~~~e~ei~~~~~l~H~nIv~-l~g~~~~ 201 (443)
..+..+|.+.+.||+|+||+||+|.+ +++.||||++.... ......+.|+..+..++|+||+. +++.
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--- 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT--- 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence 34557899999999999999999987 46778999864321 11222356666666799999985 5432
Q ss_pred cCCcccEEEeeecccCcccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCC-CCCCEEEcCCCcE
Q psy14889 202 SRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDI-KSKNILVKTNGTC 280 (443)
Q Consensus 202 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDl-k~~NiLl~~~~~~ 280 (443)
...++||||+++++|... .. .. ...++.|+++||.|||+. +|+|||| ||+|||++.++.+
T Consensus 91 -----~~~~LVmE~~~G~~L~~~-~~--~~---~~~~~~~i~~aL~~lH~~--------gIiHrDL~KP~NILv~~~~~i 151 (365)
T PRK09188 91 -----GKDGLVRGWTEGVPLHLA-RP--HG---DPAWFRSAHRALRDLHRA--------GITHNDLAKPQNWLMGPDGEA 151 (365)
T ss_pred -----CCcEEEEEccCCCCHHHh-Cc--cc---hHHHHHHHHHHHHHHHHC--------CCeeCCCCCcceEEEcCCCCE
Confidence 125899999999999732 21 11 246789999999999998 9999999 9999999999999
Q ss_pred EEEecCCcccccccCCcCCC----CCCCcccccCcccccccccc
Q psy14889 281 VIADFGLAVSYSQLSNKMDI----PPNPRVGTKRYMSPEILDES 320 (443)
Q Consensus 281 kl~DfGla~~~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~ 320 (443)
||+|||+|+.+......... ......+++.|+|||++...
T Consensus 152 kLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 152 AVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred EEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 99999999877653322111 11345788899999998654
|
|
| >KOG1164|consensus | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.7e-23 Score=197.81 Aligned_cols=260 Identities=20% Similarity=0.214 Sum_probs=188.9
Q ss_pred cccccceeeeecCeEEEEEEECC---ceeEEEEeeccCcc---chHHHHHHHHHHhc--cCCCceeeeeecc-ccCCccc
Q psy14889 137 QISLSECIGKGRYGEVWRGVWHG---ENVAVKIFFSRDEA---SWSRETEIYSTVLL--RHENILGYIGSDM-TSRNSCT 207 (443)
Q Consensus 137 ~~~~~~~lG~G~fg~Vy~~~~~~---~~vAvK~~~~~~~~---~~~~e~ei~~~~~l--~H~nIv~l~g~~~-~~~~~~~ 207 (443)
+|.+.+.||+|+||.||.+.... ..+|+|........ ....|..++....- .-+++..+++... .. .
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~----~ 94 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTE----D 94 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCC----c
Confidence 79999999999999999999743 46899977553221 34456555555321 1257888888774 32 3
Q ss_pred EEEeeecccCcccHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCC-----Cc
Q psy14889 208 QLWLVTHYHSFGSLYDHLNR---TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTN-----GT 279 (443)
Q Consensus 208 ~~~lv~e~~~~gsL~~~l~~---~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~-----~~ 279 (443)
..++||+.+. .||.++... +.++..+++.++.|++.+|++||+. |++||||||.|+++... ..
T Consensus 95 ~~~iVM~l~G-~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~--------G~iHRDiKp~N~~~g~~~~~~~~~ 165 (322)
T KOG1164|consen 95 FNFIVMSLLG-PSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSK--------GFIHRDIKPENFVVGQSSRSEVRT 165 (322)
T ss_pred eeEEEEeccC-ccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhc--------CcccCCcCHHHeeecCCCCcccce
Confidence 5699999874 599997742 5799999999999999999999999 99999999999999865 36
Q ss_pred EEEEecCCcc--cccccCCcC---CCC-CCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCc
Q psy14889 280 CVIADFGLAV--SYSQLSNKM---DIP-PNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGI 353 (443)
Q Consensus 280 ~kl~DfGla~--~~~~~~~~~---~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~ 353 (443)
+.|.|||+++ .+....... ... ...+.||..|+++.+..+. +.+.+.|+||++.++.|++.|
T Consensus 166 ~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~------e~~r~DDles~~Y~l~el~~g------ 233 (322)
T KOG1164|consen 166 LYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGI------EQGRRDDLESLFYMLLELLKG------ 233 (322)
T ss_pred EEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCC------ccCCchhhhhHHHHHHHHhcC------
Confidence 8999999998 433222211 111 2345699999999988876 777899999999999999999
Q ss_pred ccccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhhcc
Q psy14889 354 FEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLACAD 432 (443)
Q Consensus 354 ~~~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~~~ 432 (443)
..||....... ....+.+......... .....+.++.++...+-..+..++|....+...|+.+....
T Consensus 234 ----~LPW~~~~~~~-~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 234 ----SLPWEALEMTD-LKSKFEKDPRKLLTDR------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred ----CCCCccccccc-hHHHHHHHhhhhcccc------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 67886643211 1122222211111110 11234567888888888899999999999999998877654
|
|
| >KOG1165|consensus | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.3e-23 Score=188.48 Aligned_cols=265 Identities=21% Similarity=0.227 Sum_probs=202.1
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc-chHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEee
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA-SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLV 212 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~-~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv 212 (443)
-.|.+.++||+|+||+++.|+. +++.||||.-..+.+. ....|-....+. ...++|...+-+.... .+-.||
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL-~g~~GIP~vYYFGqeG----~~NiLV 102 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLL-GGTEGIPQVYYFGQEG----KYNILV 102 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHH-cCCCCCCceeeecccc----chhhhh
Confidence 4799999999999999999985 8999999976444333 334455555543 3668888887665554 344799
Q ss_pred ecccCcccHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCC-----cEEEEec
Q psy14889 213 THYHSFGSLYDHLN--RTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNG-----TCVIADF 285 (443)
Q Consensus 213 ~e~~~~gsL~~~l~--~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~-----~~kl~Df 285 (443)
+|+. +.||.++.. .+.++..+++.+|.|++.-++|+|++ .+|.|||||+|.||...+ .+.|+||
T Consensus 103 idLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k--------~LIYRDIKPdNFLIGrp~~k~~n~IhiiDF 173 (449)
T KOG1165|consen 103 IDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEK--------DLIYRDIKPDNFLIGRPGTKDANVIHIIDF 173 (449)
T ss_pred hhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhc--------ceeecccCccceeecCCCCCCCceEEEEec
Confidence 9987 468988875 57899999999999999999999999 899999999999997554 5899999
Q ss_pred CCcccccccCCcCCCCC---CCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCC
Q psy14889 286 GLAVSYSQLSNKMDIPP---NPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYH 362 (443)
Q Consensus 286 Gla~~~~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~ 362 (443)
|+|+.+.+..++...+. ....||.+||+--...+. +.+.+.|.=|+|-++...+.| ..||.
T Consensus 174 GmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGr------EQSRRDDLEaLGHvFmYFLRG----------sLPWQ 237 (449)
T KOG1165|consen 174 GMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGR------EQSRRDDLEALGHVFMYFLRG----------SLPWQ 237 (449)
T ss_pred cchhhhcCccccccCccccccccccceeeeEeeccccc------hhhhhhhHHHhhhhhhhhccC----------CCccc
Confidence 99999887776655543 345799999998877776 667889999999999999999 89999
Q ss_pred CCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhhcccc
Q psy14889 363 DLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLACADMY 434 (443)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~~~~~ 434 (443)
++... ...+...++ .. .....|-.-.....|.++..-+...-..+-.+-|..+-+...+..+......
T Consensus 238 GLKA~-tnK~kYeKI-Ge--~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~ 305 (449)
T KOG1165|consen 238 GLKAD-TNKEKYEKI-GE--TKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGE 305 (449)
T ss_pred cccCc-chHHHHHHh-cc--ccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCC
Confidence 87432 122222222 21 1222222222345778899999988899999999999999988888765443
|
|
| >KOG1163|consensus | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-23 Score=184.20 Aligned_cols=261 Identities=21% Similarity=0.297 Sum_probs=195.5
Q ss_pred hccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCc-cchHHHHHHHHHHhccC-CCceeeeeeccccCCcccEEE
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDE-ASWSRETEIYSTVLLRH-ENILGYIGSDMTSRNSCTQLW 210 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~e~ei~~~~~l~H-~nIv~l~g~~~~~~~~~~~~~ 210 (443)
..+|.+.++||+|+||.+|.|.. .|+.||||+-..+.. .....|..+... |+| ..|..+..+..+.. +-.
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~i--L~~g~GiP~i~~y~~e~~----ynv 87 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRI--LQGGVGIPHIRHYGTEKD----YNV 87 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHH--hccCCCCchhhhhccccc----cce
Confidence 36899999999999999999987 799999998755433 345567777777 444 35555555554442 347
Q ss_pred eeecccCcccHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCC---CcEEEEec
Q psy14889 211 LVTHYHSFGSLYDHLN--RTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTN---GTCVIADF 285 (443)
Q Consensus 211 lv~e~~~~gsL~~~l~--~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~---~~~kl~Df 285 (443)
+||+.. +.||.++++ ...++..+++-++-|++.-++|+|.+ ++|||||||+|.|..-+ ..+.++||
T Consensus 88 lVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r--------~fiHRDIKPdNFLMGlgrh~~kl~LIDF 158 (341)
T KOG1163|consen 88 LVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLR--------NFIHRDIKPDNFLMGLGRHCNKLYLIDF 158 (341)
T ss_pred eeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhh--------ccccccCCccceeeccccccceEEEEec
Confidence 999987 469999885 57799999999999999999999999 88999999999999644 46889999
Q ss_pred CCcccccccCCcCCCC---CCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCC
Q psy14889 286 GLAVSYSQLSNKMDIP---PNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYH 362 (443)
Q Consensus 286 Gla~~~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~ 362 (443)
|+|+.+.+..+....+ .....||.+|.+--...+. +.+.+.|+=|+|.+|...-.| ..||+
T Consensus 159 GLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~------eqSRRDDmeSvgYvLmYfnrG----------~LPWQ 222 (341)
T KOG1163|consen 159 GLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGI------EQSRRDDMESVGYVLMYFNRG----------SLPWQ 222 (341)
T ss_pred cchhhhccccccccCccccCCccceeeeehhhhhhhhh------hhhhhhhhhhhcceeeeeecC----------CCccc
Confidence 9998877655544433 3456799999987766654 556789999999999988777 89999
Q ss_pred CCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhh
Q psy14889 363 DLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLAC 430 (443)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~ 430 (443)
+...... .....++. ......+........|.++.-.+..|-..--++-|...-+.+.+.-+-.
T Consensus 223 glka~tk-~QKyEkI~---EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr 286 (341)
T KOG1163|consen 223 GLKAATK-KQKYEKIS---EKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFR 286 (341)
T ss_pred ccchhhH-HHHHHHHH---HhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHh
Confidence 8754321 11122221 2223333333345577889999999999999999998887777665543
|
|
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.8e-25 Score=226.07 Aligned_cols=254 Identities=20% Similarity=0.263 Sum_probs=180.2
Q ss_pred cccceeeeecCeEEEEEEE--CCceeEEEEeec---cCccchHH----HHHHHHHHhccCCCceeeeeeccccCCcccEE
Q psy14889 139 SLSECIGKGRYGEVWRGVW--HGENVAVKIFFS---RDEASWSR----ETEIYSTVLLRHENILGYIGSDMTSRNSCTQL 209 (443)
Q Consensus 139 ~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~---~~~~~~~~----e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~ 209 (443)
....++|.|++|.|+.... ..+..+.|.... ..+..... -.|......+.|||++..+....+... .
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~----~ 396 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDG----I 396 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhccc----c
Confidence 4678899999998777655 344445543321 11111111 123333445899999888777766543 2
Q ss_pred EeeecccCcccHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCc
Q psy14889 210 WLVTHYHSFGSLYDHLNRT-TLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA 288 (443)
Q Consensus 210 ~lv~e~~~~gsL~~~l~~~-~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla 288 (443)
.-+||||+. ||..++... .++..++-.++.|++.|+.|+|+. ||.|||||++|++++.++.+||+|||.+
T Consensus 397 ~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~--------GiahrdlK~enll~~~~g~lki~Dfg~~ 467 (601)
T KOG0590|consen 397 LQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSM--------GLAHRDLKLENLLVTENGILKIIDFGAA 467 (601)
T ss_pred hhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhc--------CceeccCccccEEEecCCceEEeecCcc
Confidence 344999999 999999775 899999999999999999999999 9999999999999999999999999999
Q ss_pred ccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCC
Q psy14889 289 VSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMD 368 (443)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~ 368 (443)
..+.-............+|+..|+|||.+.+..... ...||||.|+++..|++| +.||......+
T Consensus 468 ~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydp-----r~vDiwS~~ii~~~m~~~----------~~~Wk~a~~~~ 532 (601)
T KOG0590|consen 468 SVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDP-----RAVDVWSCGIIYICMILG----------RFPWKVAKKSD 532 (601)
T ss_pred eeeccCcchhhhhhcCcccCCcCcCcccccccccCc-----chhhhhhccceEEEEecC----------CCccccccccc
Confidence 766554443333456678999999999998873322 468999999999999999 55665543333
Q ss_pred CChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 369 PSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
..+.... ..................+.+.+.+|.++|+.||.+|.|+++|++
T Consensus 533 ~~~~~~~---~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 533 NSFKTNN---YSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred cchhhhc---cccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 2210000 000111111111112335677899999999999999999999986
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.7e-22 Score=191.17 Aligned_cols=259 Identities=27% Similarity=0.339 Sum_probs=187.8
Q ss_pred ccccceeeeecCeEEEEEEECCceeEEEEeeccCcc----chHHHHHHHHHHhccCC-CceeeeeeccccCCcccEEEee
Q psy14889 138 ISLSECIGKGRYGEVWRGVWHGENVAVKIFFSRDEA----SWSRETEIYSTVLLRHE-NILGYIGSDMTSRNSCTQLWLV 212 (443)
Q Consensus 138 ~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~----~~~~e~ei~~~~~l~H~-nIv~l~g~~~~~~~~~~~~~lv 212 (443)
|.+.+.||.|+||.||++... ..+++|.+...... ......|+.....+.|+ ||+++++.+... ...+++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~----~~~~~~ 76 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDE----GSLYLV 76 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecC----CEEEEE
Confidence 667889999999999999988 88899988654332 22234455555568888 799999998444 236999
Q ss_pred ecccCcccHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCC-cEEEEecCC
Q psy14889 213 THYHSFGSLYDHLNRT----TLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNG-TCVIADFGL 287 (443)
Q Consensus 213 ~e~~~~gsL~~~l~~~----~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~-~~kl~DfGl 287 (443)
++|+.++++.+++... .++......++.|++.++.|+|+. +++|||+||+||+++..+ .++++|||+
T Consensus 77 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~--------~~~hrd~kp~nil~~~~~~~~~l~dfg~ 148 (384)
T COG0515 77 MEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK--------GIIHRDIKPENILLDRDGRVVKLIDFGL 148 (384)
T ss_pred EecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC--------CeeccCCCHHHeeecCCCCeEEEeccCc
Confidence 9999999999877654 699999999999999999999998 899999999999999998 799999999
Q ss_pred cccccccCCcCC--CCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCC
Q psy14889 288 AVSYSQLSNKMD--IPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLV 365 (443)
Q Consensus 288 a~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~ 365 (443)
++.......... .......||..|+|||.+.+.. ...++...|+||+|++++++++| ..||....
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~---~~~~~~~~D~~s~g~~~~~~~~~----------~~p~~~~~ 215 (384)
T COG0515 149 AKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLS---LAYASSSSDIWSLGITLYELLTG----------LPPFEGEK 215 (384)
T ss_pred ceecCCCCccccccccccccccccccCCHHHhcCCC---CCCCCchHhHHHHHHHHHHHHhC----------CCCCCCCC
Confidence 975554332211 1235568999999999998631 00455789999999999999999 55544321
Q ss_pred CCCCChHHHHhhhhhcCCC---CCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHH
Q psy14889 366 PMDPSFDDMRKVICIDQQR---PVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKT 424 (443)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 424 (443)
.. .........+...... ........ ......+.+++..++..+|..|.+..+....
T Consensus 216 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 216 NS-SATSQTLKIILELPTPSLASPLSPSNP-ELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred cc-ccHHHHHHHHHhcCCcccccccCcccc-chhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 10 0122333333222211 11110000 1123568899999999999999998887764
|
|
| >KOG1023|consensus | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-23 Score=206.63 Aligned_cols=222 Identities=22% Similarity=0.382 Sum_probs=164.4
Q ss_pred hccCCCceeeeeeccccCCcccEEEeeecccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCe-
Q psy14889 186 LLRHENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAI- 262 (443)
Q Consensus 186 ~l~H~nIv~l~g~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~i- 262 (443)
.+.|.|+.+++|.+.+. ...++|.+||..|+|.+.+.. ..+++.-...++++|+.||.|||+. +|
T Consensus 3 ~l~h~n~~~f~g~~~~~----~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s--------~i~ 70 (484)
T KOG1023|consen 3 QLDHDNLNKFIGASVDG----PEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNS--------PIG 70 (484)
T ss_pred ccchhhhhhheeeEecC----CceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcC--------cce
Confidence 47899999999999988 457899999999999999975 4577888888999999999999987 44
Q ss_pred EEeCCCCCCEEEcCCCcEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccC-cCCCCCccchHHHHHHH
Q psy14889 263 AHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMD-CFESFKKADIYALGLVL 341 (443)
Q Consensus 263 iHrDlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~~~~~~sDvwS~Gvvl 341 (443)
.|+.|+++|+++|..+.+||+|||+......... ........-...|.|||.+....... ....+.+.||||||+++
T Consensus 71 ~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~--~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~ 148 (484)
T KOG1023|consen 71 YHGALKSSNCLVDSRWVLKLTDFGLNSLLEETAE--PEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIM 148 (484)
T ss_pred eeeeeccccceeeeeEEEEechhhhccccccccc--ccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHH
Confidence 9999999999999999999999999866543100 00011112335799999998753221 01256789999999999
Q ss_pred HHHHhcccCCCcccccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHH
Q psy14889 342 WEVCRRTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRV 421 (443)
Q Consensus 342 ~elltg~~~~~~~~~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ev 421 (443)
+|++++ +.||......... +++...+......+..|..+...+.++++..++++||..+|.+||++++|
T Consensus 149 ~ei~~r----------~~~~~~~~~~~~~-~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i 217 (484)
T KOG1023|consen 149 YEILFR----------SGPFDLRNLVEDP-DEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQI 217 (484)
T ss_pred HHHHhc----------cCccccccccCCh-HHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHH
Confidence 999999 6677654322222 23332232223333344333333566679999999999999999999999
Q ss_pred HHHHHHHhhcc
Q psy14889 422 KKTLIKLACAD 432 (443)
Q Consensus 422 l~~L~~l~~~~ 432 (443)
...++.+....
T Consensus 218 ~~~~~~~~~~~ 228 (484)
T KOG1023|consen 218 RSKLLTINKGG 228 (484)
T ss_pred Hhhhhhhcccc
Confidence 99998877643
|
|
| >KOG4158|consensus | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.5e-23 Score=192.41 Aligned_cols=211 Identities=23% Similarity=0.305 Sum_probs=152.3
Q ss_pred ccCCCceeeeeeccccCC-----------------------cccEEEeeecccCcccHHHHhcccCCCHHHHHHHHHHHH
Q psy14889 187 LRHENILGYIGSDMTSRN-----------------------SCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIV 243 (443)
Q Consensus 187 l~H~nIv~l~g~~~~~~~-----------------------~~~~~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~qia 243 (443)
-+|||||++.++|.++-. ....+|+||.-++. +|.+++-....+.....-++.|++
T Consensus 273 a~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~~s~r~~~~~laQlL 351 (598)
T KOG4158|consen 273 AKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRHRSYRTGRVILAQLL 351 (598)
T ss_pred CCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCCCchHHHHHHHHHHH
Confidence 469999999998865321 12358999998875 999999888888899999999999
Q ss_pred HHHHHHHHchhcCCCCCCeEEeCCCCCCEEE--cCCC--cEEEEecCCcccccccCCc--CCCCCCCcccccCccccccc
Q psy14889 244 NGLVHLHTEIFGTQGKPAIAHRDIKSKNILV--KTNG--TCVIADFGLAVSYSQLSNK--MDIPPNPRVGTKRYMSPEIL 317 (443)
Q Consensus 244 ~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl--~~~~--~~kl~DfGla~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~ 317 (443)
+|+.|||.+ ||.|||+|++|||+ |+|+ .+.|+|||.+---....-. .........|.-.-||||+.
T Consensus 352 Eav~hL~~h--------gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ 423 (598)
T KOG4158|consen 352 EAVTHLHKH--------GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIA 423 (598)
T ss_pred HHHHHHHHc--------cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhh
Confidence 999999999 99999999999999 4444 5689999987322211111 11111233577788999998
Q ss_pred ccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhH
Q psy14889 318 DESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTL 397 (443)
Q Consensus 318 ~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 397 (443)
..........-..|+|.|+.|.+.||+++. ..||.+.-.+..+... ..+.+.|.+| +.++
T Consensus 424 ta~PGp~avvny~kAD~WA~GalaYEIfg~----------~NPFY~rGem~L~~r~-----Yqe~qLPalp-----~~vp 483 (598)
T KOG4158|consen 424 TAVPGPNAVVNYEKADTWAAGALAYEIFGR----------SNPFYKRGEMLLDTRT-----YQESQLPALP-----SRVP 483 (598)
T ss_pred hcCCCCceeeccchhhhhhhhhhHHHHhcc----------CCcccccchheechhh-----hhhhhCCCCc-----ccCC
Confidence 765433222223689999999999999998 7788763211111111 1223445555 4578
Q ss_pred HHHHHHHHHHhcCCcCCCCcHHHHHHHHH
Q psy14889 398 NAMTKVMKECWHQNANVRLSALRVKKTLI 426 (443)
Q Consensus 398 ~~l~~li~~cl~~dP~~Rps~~evl~~L~ 426 (443)
..+++++...|+.||++|+|..-....|+
T Consensus 484 p~~rqlV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 484 PVARQLVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred hHHHHHHHHHhcCCccccCCccHHHhHHH
Confidence 88999999999999999999876665554
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.8e-22 Score=182.37 Aligned_cols=180 Identities=18% Similarity=0.099 Sum_probs=134.0
Q ss_pred hHHHhhhhccccccceeeeecCeEEEEEEECCceeEEEEeeccCccchH----------HHHHHHHHHhccCCCceeeee
Q psy14889 128 LLIQRTLAKQISLSECIGKGRYGEVWRGVWHGENVAVKIFFSRDEASWS----------RETEIYSTVLLRHENILGYIG 197 (443)
Q Consensus 128 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~----------~e~ei~~~~~l~H~nIv~l~g 197 (443)
......+.++|...++||.|+||.||+...++..+|||++......... .++|+..+.++.|++|....+
T Consensus 23 ~~~~~~l~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d 102 (232)
T PRK10359 23 EIFDDFLSYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLND 102 (232)
T ss_pred HHHHHHhhCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceE
Confidence 3455667789999999999999999998777889999998654322211 367777777799999999988
Q ss_pred eccccCCc----ccEEEeeecccCcccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEE
Q psy14889 198 SDMTSRNS----CTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNIL 273 (443)
Q Consensus 198 ~~~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiL 273 (443)
++...... +...+|+|||+++.+|.++.. ++. ....+++.+|..+|.. |++|||+||+|++
T Consensus 103 ~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~---~~~----~~~~~i~~~l~~lH~~--------gi~H~Dikp~Nil 167 (232)
T PRK10359 103 FYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE---ISE----DVKAKIKASIESLHQH--------GMVSGDPHKGNFI 167 (232)
T ss_pred eeeecccccccccCCeEEEEEEECCccHHHhhh---ccH----HHHHHHHHHHHHHHHc--------CCccCCCChHHEE
Confidence 86644211 234789999999999988742 332 3456999999999999 9999999999999
Q ss_pred EcCCCcEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHH
Q psy14889 274 VKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVC 345 (443)
Q Consensus 274 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ell 345 (443)
++.++ ++|+|||........... ..++... .+..++|+||||+++.-..
T Consensus 168 i~~~g-i~liDfg~~~~~~e~~a~----------------d~~vler------~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 168 VSKNG-LRIIDLSGKRCTAQRKAK----------------DRIDLER------HYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EeCCC-EEEEECCCcccccchhhH----------------HHHHHHh------HhcccccccceeEeehHHH
Confidence 99988 999999987544221100 0022222 3336899999999987654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.2e-22 Score=176.57 Aligned_cols=136 Identities=20% Similarity=0.248 Sum_probs=103.9
Q ss_pred cceeeeecCeEEEEEEE-CCceeEEEEeeccCc---c---------ch---------------HHHHHHHHHHhccCCCc
Q psy14889 141 SECIGKGRYGEVWRGVW-HGENVAVKIFFSRDE---A---------SW---------------SRETEIYSTVLLRHENI 192 (443)
Q Consensus 141 ~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~---~---------~~---------------~~e~ei~~~~~l~H~nI 192 (443)
...||+|+||.||+|.. +|+.||||+++.... . .+ ..+.|+..+..+.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 46799999999999987 699999999865321 0 11 11236666666777766
Q ss_pred eeeeeeccccCCcccEEEeeecccCcccHHHH-hcccCCCHHHHHHHHHHHHHHHHHH-HHchhcCCCCCCeEEeCCCCC
Q psy14889 193 LGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDH-LNRTTLNHHQMMKICLSIVNGLVHL-HTEIFGTQGKPAIAHRDIKSK 270 (443)
Q Consensus 193 v~l~g~~~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~l~~~~~~~i~~qia~gL~yL-H~~~~~~~~~~~iiHrDlk~~ 270 (443)
.....+... ..+|||||++++++... +....++...+..++.|++.+|.|+ |+. +|+||||||+
T Consensus 82 ~~p~~~~~~------~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~--------giiHrDlkP~ 147 (190)
T cd05147 82 PCPEPILLK------SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDC--------RLVHADLSEY 147 (190)
T ss_pred CCCcEEEec------CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhC--------CcccCCCCHH
Confidence 433222111 13799999998877654 4567899999999999999999999 677 9999999999
Q ss_pred CEEEcCCCcEEEEecCCcccc
Q psy14889 271 NILVKTNGTCVIADFGLAVSY 291 (443)
Q Consensus 271 NiLl~~~~~~kl~DfGla~~~ 291 (443)
|||++ ++.++|+|||+|...
T Consensus 148 NIli~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 148 NLLYH-DGKLYIIDVSQSVEH 167 (190)
T ss_pred HEEEE-CCcEEEEEccccccC
Confidence 99998 578999999998543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.7e-21 Score=172.91 Aligned_cols=137 Identities=21% Similarity=0.236 Sum_probs=106.4
Q ss_pred cceeeeecCeEEEEEEE-CCceeEEEEeeccCcc---------------------------chHHHHHHHHHHhccCCCc
Q psy14889 141 SECIGKGRYGEVWRGVW-HGENVAVKIFFSRDEA---------------------------SWSRETEIYSTVLLRHENI 192 (443)
Q Consensus 141 ~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~---------------------------~~~~e~ei~~~~~l~H~nI 192 (443)
...||+|+||.||+|.. +|+.||||++...... ....+.|...+..+.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 46799999999999987 5999999998654211 0011345566666888887
Q ss_pred eeeeeeccccCCcccEEEeeecccCcccHHH-HhcccCCCHHHHHHHHHHHHHHHHHHHH-chhcCCCCCCeEEeCCCCC
Q psy14889 193 LGYIGSDMTSRNSCTQLWLVTHYHSFGSLYD-HLNRTTLNHHQMMKICLSIVNGLVHLHT-EIFGTQGKPAIAHRDIKSK 270 (443)
Q Consensus 193 v~l~g~~~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~~~~~~iiHrDlk~~ 270 (443)
.....+.... .+|||||++++++.. .+.+..++......++.|++.+|.++|+ . ||+||||||+
T Consensus 82 ~~p~~~~~~~------~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~--------givHrDlkP~ 147 (190)
T cd05145 82 PVPEPILLKK------NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEA--------GLVHGDLSEY 147 (190)
T ss_pred CCceEEEecC------CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhC--------CEecCCCChh
Confidence 5443332221 379999999875543 4566678889999999999999999999 7 9999999999
Q ss_pred CEEEcCCCcEEEEecCCccccc
Q psy14889 271 NILVKTNGTCVIADFGLAVSYS 292 (443)
Q Consensus 271 NiLl~~~~~~kl~DfGla~~~~ 292 (443)
|||++ ++.++|+|||++....
T Consensus 148 NIll~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 148 NILYH-DGKPYIIDVSQAVELD 168 (190)
T ss_pred hEEEE-CCCEEEEEcccceecC
Confidence 99999 8899999999996554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.9e-22 Score=195.68 Aligned_cols=221 Identities=23% Similarity=0.377 Sum_probs=172.1
Q ss_pred eeeeecCeEEEEEE-----ECCceeEEEEeeccC-----ccchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEee
Q psy14889 143 CIGKGRYGEVWRGV-----WHGENVAVKIFFSRD-----EASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLV 212 (443)
Q Consensus 143 ~lG~G~fg~Vy~~~-----~~~~~vAvK~~~~~~-----~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv 212 (443)
.+|+|.||.|+++. ..|..+|.|++++.. ......|+.+.... -+||.+|++.-.+..+ ..++++
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~-~~~~f~v~lhyafqt~----~kl~l~ 75 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFV-HNTPFLVKLHYAFQTD----GKLYLI 75 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhc-cCCCceeeeeeeeccc----cchhHh
Confidence 37999999999653 246778888765432 22334456665552 2499999998888776 457999
Q ss_pred ecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcccc
Q psy14889 213 THYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSY 291 (443)
Q Consensus 213 ~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~ 291 (443)
++|..+|+|...+.+ ..+++.....+...++.|++++|+. +|+|||+|++||+++.+|++|+.|||+++..
T Consensus 76 ld~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l--------~iiyrd~k~enilld~~Ghi~~tdfglske~ 147 (612)
T KOG0603|consen 76 LDFLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKL--------GIAYRDYKLENVLLLLEGHIKLTDFGLSKEA 147 (612)
T ss_pred hhhcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchh--------HHHHhcccccceeecccCccccCCchhhhHh
Confidence 999999999998876 4567777788889999999999998 9999999999999999999999999999766
Q ss_pred cccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCCh
Q psy14889 292 SQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSF 371 (443)
Q Consensus 292 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~~ 371 (443)
-.... .+||..|||||++.+. ...+|.||||++++||+|| ..||..
T Consensus 148 v~~~~--------~cgt~eymApEI~~gh--------~~a~D~ws~gvl~felltg----------~~pf~~-------- 193 (612)
T KOG0603|consen 148 VKEKI--------ACGTYEYRAPEIINGH--------LSAADWWSFGVLAFELLTG----------TLPFGG-------- 193 (612)
T ss_pred Hhhhh--------cccchhhhhhHhhhcc--------CCcccchhhhhhHHHHhhC----------CCCCch--------
Confidence 54321 2799999999999833 2689999999999999999 667765
Q ss_pred HHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcH
Q psy14889 372 DDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSA 418 (443)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~ 418 (443)
+.+..+.. ..+..| ......+.+++..++..+|.+|.-.
T Consensus 194 ~~~~~Il~---~~~~~p-----~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 194 DTMKRILK---AELEMP-----RELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred HHHHHHhh---hccCCc-----hhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 33334332 223333 3466789999999999999999855
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=3e-20 Score=167.36 Aligned_cols=138 Identities=16% Similarity=0.165 Sum_probs=101.7
Q ss_pred ccceeeeecCeEEEEEEECCceeEEEEeeccCc-cchHHHHHHHHHHhc-----cCCCceeeeeeccccCCcccEEEeee
Q psy14889 140 LSECIGKGRYGEVWRGVWHGENVAVKIFFSRDE-ASWSRETEIYSTVLL-----RHENILGYIGSDMTSRNSCTQLWLVT 213 (443)
Q Consensus 140 ~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~-~~~~~e~ei~~~~~l-----~H~nIv~l~g~~~~~~~~~~~~~lv~ 213 (443)
-.+.||+|+||.||....++.. +||++..... .......|+..+..+ .||||++++|++.++......+.+|+
T Consensus 6 ~~~~LG~G~~~~Vy~hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~ 84 (210)
T PRK10345 6 EQSPLGTGRHRKCYAHPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIA 84 (210)
T ss_pred CcceecCCCceEEEECCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEe
Confidence 3578999999999962224444 6898765421 112223455555556 68999999999988754323355899
Q ss_pred cc--cCcccHHHHhcccCCCHHHHHHHHHHHHHHH-HHHHHchhcCCCCCCeEEeCCCCCCEEEcCC----CcEEEEecC
Q psy14889 214 HY--HSFGSLYDHLNRTTLNHHQMMKICLSIVNGL-VHLHTEIFGTQGKPAIAHRDIKSKNILVKTN----GTCVIADFG 286 (443)
Q Consensus 214 e~--~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL-~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~----~~~kl~DfG 286 (443)
|| +.+|+|.+++.+..+++. ..++.|++.++ +|||++ +|+||||||+|||++.. ..++|+||+
T Consensus 85 e~~G~~~~tL~~~l~~~~~~e~--~~~~~~~L~~l~~yLh~~--------~IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 85 DFDGKPSITLTEFAEQCRYEED--VAQLRQLLKKLKRYLLDN--------RIVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred cCCCCcchhHHHHHHcccccHh--HHHHHHHHHHHHHHHHHC--------CEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 99 558999999987766666 35678888888 999999 99999999999999743 489999954
Q ss_pred Cc
Q psy14889 287 LA 288 (443)
Q Consensus 287 la 288 (443)
.+
T Consensus 155 G~ 156 (210)
T PRK10345 155 GE 156 (210)
T ss_pred CC
Confidence 43
|
|
| >KOG1240|consensus | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.8e-21 Score=199.99 Aligned_cols=252 Identities=21% Similarity=0.253 Sum_probs=172.7
Q ss_pred cccccceeeeecCeEEEEEEECCceeEEEEeeccCcc----chHHH-HHHHHHHhccCCCceeeeeeccccCCcccEEEe
Q psy14889 137 QISLSECIGKGRYGEVWRGVWHGENVAVKIFFSRDEA----SWSRE-TEIYSTVLLRHENILGYIGSDMTSRNSCTQLWL 211 (443)
Q Consensus 137 ~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~----~~~~e-~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~l 211 (443)
++...+.||++.|=+|.+|+++.-.|+||++.+.+.. .+.++ .++. ...++|||.+.+.-+-.+. ...||
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~----kAAyl 98 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTD----KAAYL 98 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhh----HHHHH
Confidence 6778899999999999999997666999998765532 22222 3333 4448999999987775544 34589
Q ss_pred eecccCcccHHHHhcccC-CCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCccc
Q psy14889 212 VTHYHSFGSLYDHLNRTT-LNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVS 290 (443)
Q Consensus 212 v~e~~~~gsL~~~l~~~~-l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~ 290 (443)
|-+|..+ +|+|.+..++ +...+..-|+.|++.||.-+|.. ||+|+|||.+||||+.=+.+.|+||..-+.
T Consensus 99 vRqyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~--------gVcHGDIKsENILiTSWNW~~LtDFAsFKP 169 (1431)
T KOG1240|consen 99 VRQYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKL--------GVCHGDIKSENILITSWNWLYLTDFASFKP 169 (1431)
T ss_pred HHHHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHc--------CccccccccceEEEeeechhhhhcccccCC
Confidence 9999986 9999998665 56677788999999999999988 999999999999999999999999976542
Q ss_pred ccccCCcC---C-CCCCCcccccCccccccccccc-----ccCcCCCCCccchHHHHHHHHHHHhc-ccCCCcccccCCC
Q psy14889 291 YSQLSNKM---D-IPPNPRVGTKRYMSPEILDESI-----NMDCFESFKKADIYALGLVLWEVCRR-TKANGIFEEYKAP 360 (443)
Q Consensus 291 ~~~~~~~~---~-~~~~~~~gt~~y~aPE~~~~~~-----~~~~~~~~~~sDvwS~Gvvl~elltg-~~~~~~~~~~~~P 360 (443)
..-..... . ...+. ..-..|.|||.+.... ..+....+++-||||+||++.||++- +++++......
T Consensus 170 tYLPeDNPadf~fFFDTS-rRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~a-- 246 (1431)
T KOG1240|consen 170 TYLPEDNPADFTFFFDTS-RRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLA-- 246 (1431)
T ss_pred ccCCCCCcccceEEEecC-CceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHh--
Confidence 21111000 0 00011 1223699999886532 11111367889999999999999875 33332211100
Q ss_pred CCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHH
Q psy14889 361 YHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKT 424 (443)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 424 (443)
|.. .+....+...+.+ + ...++.++..|++.||++|.|+++.++.
T Consensus 247 Yr~--~~~~~~e~~Le~I---------e--------d~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 247 YRS--GNADDPEQLLEKI---------E--------DVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred Hhc--cCccCHHHHHHhC---------c--------CccHHHHHHHHHccCchhccCHHHHHHh
Confidence 000 0001111111111 1 1248999999999999999999999886
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.5e-20 Score=171.73 Aligned_cols=238 Identities=18% Similarity=0.245 Sum_probs=139.5
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccchHH----HHHHHHHHhcc----------CCCceeeeeec
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEASWSR----ETEIYSTVLLR----------HENILGYIGSD 199 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~----e~ei~~~~~l~----------H~nIv~l~g~~ 199 (443)
..+...+.||.|+|+.||.+.+ +|+.+|||++.......... +.|......+. |-.++.-++..
T Consensus 12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~ 91 (288)
T PF14531_consen 12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL 91 (288)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred eEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence 3566788999999999999999 57999999886543221111 11221111111 11111111111
Q ss_pred c--------ccCCcccE-----EEeeecccCcccHHHHhcc---c-----CCCHHHHHHHHHHHHHHHHHHHHchhcCCC
Q psy14889 200 M--------TSRNSCTQ-----LWLVTHYHSFGSLYDHLNR---T-----TLNHHQMMKICLSIVNGLVHLHTEIFGTQG 258 (443)
Q Consensus 200 ~--------~~~~~~~~-----~~lv~e~~~~gsL~~~l~~---~-----~l~~~~~~~i~~qia~gL~yLH~~~~~~~~ 258 (443)
. ........ .+++|+-+. +||.+++.- . .+....++.+..|+++.+++||+.
T Consensus 92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~------ 164 (288)
T PF14531_consen 92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY------ 164 (288)
T ss_dssp EETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT------
T ss_pred EEcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc------
Confidence 0 00000011 366777775 589887631 1 233445567779999999999999
Q ss_pred CCCeEEeCCCCCCEEEcCCCcEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccc--cCcCCCCCccchHH
Q psy14889 259 KPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESIN--MDCFESFKKADIYA 336 (443)
Q Consensus 259 ~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~~~~~sDvwS 336 (443)
|++|+||||+|++++.+|.++|+||+.....+..... ...+..|.+||....... .....++.+.|.|+
T Consensus 165 --GlVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-------~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~ 235 (288)
T PF14531_consen 165 --GLVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-------SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQ 235 (288)
T ss_dssp --TEEEST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-------GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHH
T ss_pred --ceEecccceeeEEEcCCCCEEEcChHHHeecCceeec-------cCCCcccCChhhhhhhcccCcccceeeeccCHHH
Confidence 9999999999999999999999999887655432221 133467999997754311 01125678999999
Q ss_pred HHHHHHHHHhcccCCCcccccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCC
Q psy14889 337 LGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVR 415 (443)
Q Consensus 337 ~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 415 (443)
+|+++|.|+++ ..||....+...... .+.. ..+.++.++.||..+|+.||.+|
T Consensus 236 LG~~ly~lWC~----------~lPf~~~~~~~~~~~-------------~f~~---C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 236 LGITLYSLWCG----------RLPFGLSSPEADPEW-------------DFSR---CRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHHHHHHS----------S-STCCCGGGSTSGG-------------GGTT---SS---HHHHHHHHHHT-SSGGGS
T ss_pred HHHHHHHHHHc----------cCCCCCCCccccccc-------------cchh---cCCcCHHHHHHHHHHccCCcccC
Confidence 99999999999 555544321111100 0110 11467889999999999999998
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=8.5e-20 Score=161.60 Aligned_cols=183 Identities=17% Similarity=0.163 Sum_probs=129.5
Q ss_pred cccceeeeecCeEEEEEEECCceeEEEEeeccCcc-----chHHHHHHHHHHhcc-CCCceeeeeeccccCCcccEEEee
Q psy14889 139 SLSECIGKGRYGEVWRGVWHGENVAVKIFFSRDEA-----SWSRETEIYSTVLLR-HENILGYIGSDMTSRNSCTQLWLV 212 (443)
Q Consensus 139 ~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~-----~~~~e~ei~~~~~l~-H~nIv~l~g~~~~~~~~~~~~~lv 212 (443)
.....|++|+||+||.+...+..++.+.+...... ....+.|+..+..+. |++|.+++++. ..+++
T Consensus 5 ~~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~--------~~~lv 76 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD--------GRHLD 76 (218)
T ss_pred ccceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc--------CEEEE
Confidence 34678999999999988778888887776543321 113455666666685 47899998861 24899
Q ss_pred ecccCcccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCC-CCCCEEEcCCCcEEEEecCCcccc
Q psy14889 213 THYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDI-KSKNILVKTNGTCVIADFGLAVSY 291 (443)
Q Consensus 213 ~e~~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDl-k~~NiLl~~~~~~kl~DfGla~~~ 291 (443)
|||+.+.+|.+.+... ...++.|++.+|.++|+. ||+|||| ||+|||++.++.++|+|||+|...
T Consensus 77 meyI~G~~L~~~~~~~------~~~~~~qi~~~L~~lH~~--------GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~ 142 (218)
T PRK12274 77 RSYLAGAAMYQRPPRG------DLAYFRAARRLLQQLHRC--------GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRG 142 (218)
T ss_pred EeeecCccHHhhhhhh------hHHHHHHHHHHHHHHHHC--------cCccCCCCCcceEEEcCCCCEEEEECCCceec
Confidence 9999999987654221 245778999999999999 9999999 799999999999999999999754
Q ss_pred cccCCc------CCCC---CCCcccccCcccccccccccccCcCCCC-CccchHHHHHHHHHHHhcc
Q psy14889 292 SQLSNK------MDIP---PNPRVGTKRYMSPEILDESINMDCFESF-KKADIYALGLVLWEVCRRT 348 (443)
Q Consensus 292 ~~~~~~------~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~-~~sDvwS~Gvvl~elltg~ 348 (443)
...... .+.. ..-...++.|++|+.-.--. ..+ ...+.++-|.-+|.++||+
T Consensus 143 ~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~-----~~~~~~~~w~~~g~~~~~~~~~~ 204 (218)
T PRK12274 143 NPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLK-----RTSWIRELWFATGKPVYRFVTRR 204 (218)
T ss_pred CCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhc-----cchhHHHHHHHhcchHHHHHhcc
Confidence 432210 0000 00112466777777543211 111 4568889999999999994
|
|
| >KOG1166|consensus | Back alignment and domain information |
|---|
Probab=99.81 E-value=6.2e-19 Score=185.80 Aligned_cols=247 Identities=17% Similarity=0.261 Sum_probs=176.0
Q ss_pred ccccccceeeeecCeEEEEEEE-CCceeEEEEeeccCccchHHHHHHHHHHhcc---CCCceeeeeeccccCCcccEEEe
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW-HGENVAVKIFFSRDEASWSRETEIYSTVLLR---HENILGYIGSDMTSRNSCTQLWL 211 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~---H~nIv~l~g~~~~~~~~~~~~~l 211 (443)
+.|.+...||+|+||+||+|.. +|+.||+|+-+.....++..-.+++.. |+ -+-|..+...+...+. -+|
T Consensus 698 ~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI~~q~~~R--Lk~~~~~~~~~~~~a~~~~~~----S~l 771 (974)
T KOG1166|consen 698 EKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYICLQVMER--LKPQMLPSIMHISSAHVFQNA----SVL 771 (974)
T ss_pred eeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeeehHHHHHh--hchhhhcchHHHHHHHccCCc----cee
Confidence 5788999999999999999987 799999998877666665554444444 33 2334444444443433 379
Q ss_pred eecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcC-------CCcEEEE
Q psy14889 212 VTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKT-------NGTCVIA 283 (443)
Q Consensus 212 v~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~-------~~~~kl~ 283 (443)
|+||.+.|+|.++++. +.++|..++.++.|+++-++.||.. +|||+||||+|.||.. ...++|+
T Consensus 772 v~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~--------~IIHgDiKPDNfll~~~~~~~~~~~~l~lI 843 (974)
T KOG1166|consen 772 VSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAM--------GIIHGDIKPDNFLLRREICADSDSKGLYLI 843 (974)
T ss_pred eeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhc--------ceecccCCcceeEeecccCCCCcccceEEE
Confidence 9999999999999974 5689999999999999999999998 9999999999999943 2468999
Q ss_pred ecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCC
Q psy14889 284 DFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHD 363 (443)
Q Consensus 284 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~ 363 (443)
|||.+..+.-.... ......++|-.+-.+|+..+. .++...|.|.|.-+++-|+.|+... +.+
T Consensus 844 DfG~siDm~lfp~~--~~F~~~~~td~f~C~EM~~gr------pWtYq~DyfGlAa~~h~mLFG~y~q---------~~~ 906 (974)
T KOG1166|consen 844 DFGRSIDMKLFPDG--TKFKAVWHTDLFDCIEMREGR------PWTYQIDYFGLAATVHVMLFGKYME---------VKN 906 (974)
T ss_pred ecccceeeeEcCCC--cEEeeeeccccchhHHHhcCC------CCchhhhhHHHHHHHHHHHHHHHHH---------hcC
Confidence 99998654432221 122456788899999999987 7778999999999999999994211 000
Q ss_pred CCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhhc
Q psy14889 364 LVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLACA 431 (443)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~~ 431 (443)
.. .......++..|.. +-..++...+|+.|-..=|...++...|++....
T Consensus 907 ---g~-----------~~~~~~~~~Ry~~~----~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~ 956 (974)
T KOG1166|consen 907 ---GS-----------SWMVKTNFPRYWKR----DMWNKFFDLLLNPDCDTLPNLQELRTELEEVLAE 956 (974)
T ss_pred ---Cc-----------ceeccccchhhhhH----HHHHHHHHHHhCcCcccchhHHHHHHHHHHHHHH
Confidence 00 00011112221211 1245666677776666667777777777766543
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.78 E-value=9.2e-19 Score=161.47 Aligned_cols=138 Identities=22% Similarity=0.296 Sum_probs=105.0
Q ss_pred cccccceeeeecCeEEEEEE-E--CCceeEEEEeeccCcc-------------------------chHHHHHHHHHHhcc
Q psy14889 137 QISLSECIGKGRYGEVWRGV-W--HGENVAVKIFFSRDEA-------------------------SWSRETEIYSTVLLR 188 (443)
Q Consensus 137 ~~~~~~~lG~G~fg~Vy~~~-~--~~~~vAvK~~~~~~~~-------------------------~~~~e~ei~~~~~l~ 188 (443)
-|++.+.||+|+||.||+|. . +|+.||||++...... ....+.|+..+..+.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47889999999999999998 3 7899999988643210 011234555555566
Q ss_pred CCC--ceeeeeeccccCCcccEEEeeecccCcccHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCC-eEE
Q psy14889 189 HEN--ILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHL-NRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPA-IAH 264 (443)
Q Consensus 189 H~n--Iv~l~g~~~~~~~~~~~~~lv~e~~~~gsL~~~l-~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~-iiH 264 (443)
+.+ +.++++. . ..++||||+++++|.... ....+.......++.|++.+|.+||+. + ++|
T Consensus 109 ~~~i~~p~~~~~---~-----~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~--------g~iiH 172 (237)
T smart00090 109 EAGVPVPKPIAW---R-----RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKE--------GELVH 172 (237)
T ss_pred hcCCCCCeeeEe---c-----CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhc--------CCEEe
Confidence 532 3344432 1 137999999998887654 445566667789999999999999998 8 999
Q ss_pred eCCCCCCEEEcCCCcEEEEecCCcccc
Q psy14889 265 RDIKSKNILVKTNGTCVIADFGLAVSY 291 (443)
Q Consensus 265 rDlk~~NiLl~~~~~~kl~DfGla~~~ 291 (443)
|||||+||+++ ++.++|+|||.+...
T Consensus 173 ~Dikp~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 173 GDLSEYNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred CCCChhhEEEE-CCCEEEEEChhhhcc
Confidence 99999999999 889999999998543
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.7e-18 Score=155.30 Aligned_cols=132 Identities=20% Similarity=0.247 Sum_probs=105.1
Q ss_pred ceeeeecCeEEEEEEECCceeEEEEeeccCcc---------chHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEee
Q psy14889 142 ECIGKGRYGEVWRGVWHGENVAVKIFFSRDEA---------SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLV 212 (443)
Q Consensus 142 ~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~---------~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv 212 (443)
+.||+|++|.||+|.+.|..|++|+....... ....+.|+..+..+.|+||.....++.... ..+++
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~----~~~lv 77 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPE----NFIIV 77 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCC----CCEEE
Confidence 57999999999999999999999976532211 012234555666688888876666554442 35899
Q ss_pred ecccCcccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcc
Q psy14889 213 THYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAV 289 (443)
Q Consensus 213 ~e~~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~ 289 (443)
|||+++++|.+++.... + .+..++.+++.+|.++|+. +++|+|++|.|||++ ++.++|+|||++.
T Consensus 78 ~e~~~G~~L~~~~~~~~--~-~~~~i~~~i~~~l~~lH~~--------~i~H~Dl~p~Nil~~-~~~~~liDf~~a~ 142 (211)
T PRK14879 78 MEYIEGEPLKDLINSNG--M-EELELSREIGRLVGKLHSA--------GIIHGDLTTSNMILS-GGKIYLIDFGLAE 142 (211)
T ss_pred EEEeCCcCHHHHHHhcc--H-HHHHHHHHHHHHHHHHHhC--------CcccCCCCcccEEEE-CCCEEEEECCccc
Confidence 99999999999986532 2 7889999999999999998 999999999999999 7889999999874
|
|
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.77 E-value=5.6e-19 Score=182.97 Aligned_cols=209 Identities=25% Similarity=0.384 Sum_probs=145.5
Q ss_pred hccccccceeeeecCeEEEEEEEC--CceeEEEEeeccCccchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEee
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVWH--GENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLV 212 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv 212 (443)
..+|..++.|..|+||.||..+++ .+.+|+|+-+.+ +--+||..+-|. .+.|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~----------------lilRnilt~a~n----------pfvv 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQN----------------LILRNILTFAGN----------PFVV 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcccccc----------------hhhhccccccCC----------ccee
Confidence 468999999999999999999874 678888643211 011133333221 1333
Q ss_pred ecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcccc
Q psy14889 213 THYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSY 291 (443)
Q Consensus 213 ~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~ 291 (443)
||-...++. +.++.. ++.+++|||+. +|+|||+||+|.+|+.-|++|+.|||+++..
T Consensus 136 ------gDc~tllk~~g~lPvd--------mvla~Eylh~y--------givhrdlkpdnllIT~mGhiKlTDfgLsk~G 193 (1205)
T KOG0606|consen 136 ------GDCATLLKNIGPLPVD--------MVLAVEYLHSY--------GIVHRDLKPDNLLITSMGHIKLTDFGLSKKG 193 (1205)
T ss_pred ------chhhhhcccCCCCcch--------hhHHhHhhccC--------CeecCCCCCCcceeeecccccccchhhhhhh
Confidence 555555554 233322 27789999998 9999999999999999999999999998653
Q ss_pred cccCCcC-----------CCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCC
Q psy14889 292 SQLSNKM-----------DIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAP 360 (443)
Q Consensus 292 ~~~~~~~-----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P 360 (443)
....... .......+||+.|+|||++... .|+..+|+|++|+++||.+.| ..|
T Consensus 194 Lms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrq------gygkpvdwwamGiIlyeFLVg----------cvp 257 (1205)
T KOG0606|consen 194 LMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQ------GYGKPVDWWAMGIILYEFLVG----------CVP 257 (1205)
T ss_pred hhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhh------ccCCCccHHHHHHHHHHHhee----------eee
Confidence 3211100 1112345899999999999876 788999999999999999999 677
Q ss_pred CCCCCCCCCChHHHHh-hhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCc
Q psy14889 361 YHDLVPMDPSFDDMRK-VICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLS 417 (443)
Q Consensus 361 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps 417 (443)
|.+..+ +++.. .+..+...+.- ....+.++++++.+.|+.+|..|.-
T Consensus 258 ffGdtp-----eelfg~visd~i~wpE~-----dea~p~Ea~dli~~LL~qnp~~Rlg 305 (1205)
T KOG0606|consen 258 FFGDTP-----EELFGQVISDDIEWPEE-----DEALPPEAQDLIEQLLRQNPLCRLG 305 (1205)
T ss_pred ccCCCH-----HHHHhhhhhhhcccccc-----CcCCCHHHHHHHHHHHHhChHhhcc
Confidence 776532 33333 33222222221 1335578999999999999999983
|
|
| >KOG1033|consensus | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.4e-19 Score=175.61 Aligned_cols=173 Identities=25% Similarity=0.361 Sum_probs=127.2
Q ss_pred cEEEeeecccCcccHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEE
Q psy14889 207 TQLWLVTHYHSFGSLYDHLNR----TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVI 282 (443)
Q Consensus 207 ~~~~lv~e~~~~gsL~~~l~~----~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl 282 (443)
.++|+.|++|...+|.++|.+ ...++...+.++.|++.|++| + +.+|||+||.||+...+..+||
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k--------~~ihrdlkp~nif~~~d~q~kI 397 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K--------GLIHRDLKPSNIFFSDDDQLKI 397 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c--------cchhhhccccccccccchhhhh
Confidence 358999999999999999964 346778889999999999999 5 8899999999999999999999
Q ss_pred EecCCcccccccCCcC--CCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCC
Q psy14889 283 ADFGLAVSYSQLSNKM--DIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAP 360 (443)
Q Consensus 283 ~DfGla~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P 360 (443)
.|||+........... ....+..+||..||+||.+.+. .|+.|+||||||++|+||++-- ..+
T Consensus 398 gDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~------~y~~kvdIyaLGlil~EL~~~f---------~T~ 462 (516)
T KOG1033|consen 398 GDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQ------QYSEKVDIYALGLILAELLIQF---------STQ 462 (516)
T ss_pred hhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhh------hhhhhcchhhHHHHHHHHHHHh---------ccH
Confidence 9999986655443110 1112455899999999999988 8889999999999999998720 111
Q ss_pred CCCCCCCCCChHHHHhhhhhcCCCCCCCCC-CCCchhHHHHHHHHHHHhcCCcCCCCcHHH
Q psy14889 361 YHDLVPMDPSFDDMRKVICIDQQRPVLPNR-WVSDSTLNAMTKVMKECWHQNANVRLSALR 420 (443)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rps~~e 420 (443)
+.. +... .+.....+|+. +.+ . ++-+.|+++++...|.+||++.+
T Consensus 463 ~er----------~~t~--~d~r~g~ip~~~~~d--~-p~e~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 463 FER----------IATL--TDIRDGIIPPEFLQD--Y-PEEYTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred HHH----------HHhh--hhhhcCCCChHHhhc--C-cHHHHHHHHhcCCCcccCchHHH
Confidence 111 1111 11122223311 111 1 23568999999999999995444
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.75 E-value=7.1e-18 Score=151.90 Aligned_cols=134 Identities=23% Similarity=0.223 Sum_probs=102.5
Q ss_pred ccccceeeeecCeEEEEEEE-CCceeEEEEeeccCcc-----------------------chHHHHHHHHHHhccCCC--
Q psy14889 138 ISLSECIGKGRYGEVWRGVW-HGENVAVKIFFSRDEA-----------------------SWSRETEIYSTVLLRHEN-- 191 (443)
Q Consensus 138 ~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~-----------------------~~~~e~ei~~~~~l~H~n-- 191 (443)
|.+.+.||+|+||.||++.. +|+.||||++...... ....+.|+..+..+.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 77789999999999999988 6999999987543210 011234555555577774
Q ss_pred ceeeeeeccccCCcccEEEeeecccCcccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCC
Q psy14889 192 ILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKN 271 (443)
Q Consensus 192 Iv~l~g~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~N 271 (443)
+...++. ...++||||+++++|...... .....++.+++.++.++|+. +|+||||||+|
T Consensus 97 v~~~~~~--------~~~~lv~e~~~g~~L~~~~~~-----~~~~~~~~~i~~~l~~lh~~--------gi~H~Dl~p~N 155 (198)
T cd05144 97 VPKPIDW--------NRHAVVMEYIDGVELYRVRVL-----EDPEEVLDEILEEIVKAYKH--------GIIHGDLSEFN 155 (198)
T ss_pred CCceeec--------CCceEEEEEeCCcchhhcccc-----ccHHHHHHHHHHHHHHHHHC--------CCCcCCCCccc
Confidence 3444432 124899999999999776431 34567889999999999998 99999999999
Q ss_pred EEEcCCCcEEEEecCCccccc
Q psy14889 272 ILVKTNGTCVIADFGLAVSYS 292 (443)
Q Consensus 272 iLl~~~~~~kl~DfGla~~~~ 292 (443)
|++++++.++|+|||++....
T Consensus 156 ill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 156 ILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred EEEcCCCcEEEEECCccccCC
Confidence 999999999999999985443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.75 E-value=7.6e-18 Score=151.79 Aligned_cols=129 Identities=20% Similarity=0.229 Sum_probs=98.3
Q ss_pred eeeeecCeEEEEEEECCceeEEEEeeccCc--c--c-----hHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEeee
Q psy14889 143 CIGKGRYGEVWRGVWHGENVAVKIFFSRDE--A--S-----WSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVT 213 (443)
Q Consensus 143 ~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~--~--~-----~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv~ 213 (443)
.||+|+||.||+|.++|..|++|....... . . ...+.|+..+..++|+++.....++.... ..++||
T Consensus 1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~----~~~lv~ 76 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPD----NKTIVM 76 (199)
T ss_pred CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECC----CCEEEE
Confidence 489999999999999999999998643211 0 0 11234555555577876544433333332 248999
Q ss_pred cccCcccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCccc
Q psy14889 214 HYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVS 290 (443)
Q Consensus 214 e~~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~ 290 (443)
||+++++|.+++..... .++.+++.+|.+||+. +++|+|++|.||+++ ++.++++|||++..
T Consensus 77 e~~~g~~l~~~~~~~~~------~~~~~i~~~l~~lH~~--------gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 77 EYIEGKPLKDVIEEGND------ELLREIGRLVGKLHKA--------GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred EEECCccHHHHHhhcHH------HHHHHHHHHHHHHHHC--------CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999999998754321 7899999999999998 999999999999999 88999999998743
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.3e-17 Score=172.41 Aligned_cols=135 Identities=19% Similarity=0.258 Sum_probs=106.1
Q ss_pred ccccccceeeeecCeEEEEEEECCceeEEEEeeccC--c---c----chHHHHHHHHHHhccCCCceeeeeeccccCCcc
Q psy14889 136 KQISLSECIGKGRYGEVWRGVWHGENVAVKIFFSRD--E---A----SWSRETEIYSTVLLRHENILGYIGSDMTSRNSC 206 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~--~---~----~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~ 206 (443)
..|...+.||+|+||.||+|.+.+..+++|+...+. . . ....+.|+..+..++|++++....++.+..
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~--- 409 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE--- 409 (535)
T ss_pred cccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC---
Confidence 345668899999999999999977777776543211 0 0 112235666666689999988776665543
Q ss_pred cEEEeeecccCcccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecC
Q psy14889 207 TQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFG 286 (443)
Q Consensus 207 ~~~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfG 286 (443)
..++||||+++++|.+++. ....++.+++.+|.|||+. +++||||||+|||+ +++.++|+|||
T Consensus 410 -~~~lv~E~~~g~~L~~~l~-------~~~~~~~~i~~~L~~lH~~--------giiHrDlkp~NILl-~~~~~~liDFG 472 (535)
T PRK09605 410 -EKTIVMEYIGGKDLKDVLE-------GNPELVRKVGEIVAKLHKA--------GIVHGDLTTSNFIV-RDDRLYLIDFG 472 (535)
T ss_pred -CCEEEEEecCCCcHHHHHH-------HHHHHHHHHHHHHHHHHhC--------CCccCCCChHHEEE-ECCcEEEEeCc
Confidence 2589999999999999875 4577899999999999998 99999999999999 67899999999
Q ss_pred Cccc
Q psy14889 287 LAVS 290 (443)
Q Consensus 287 la~~ 290 (443)
+++.
T Consensus 473 la~~ 476 (535)
T PRK09605 473 LGKY 476 (535)
T ss_pred cccc
Confidence 9854
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.68 E-value=9.1e-17 Score=143.23 Aligned_cols=134 Identities=25% Similarity=0.270 Sum_probs=91.7
Q ss_pred cceeeeecCeEEEEEEE-CCceeEEEEeeccCccchHH-------------------------HHHHHHHHhccCCC--c
Q psy14889 141 SECIGKGRYGEVWRGVW-HGENVAVKIFFSRDEASWSR-------------------------ETEIYSTVLLRHEN--I 192 (443)
Q Consensus 141 ~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~-------------------------e~ei~~~~~l~H~n--I 192 (443)
.+.||+|+||.||+|.. +|+.||||++.......... +.|...+..+.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 46799999999999988 49999999876432211111 12222222233322 3
Q ss_pred eeeeeeccccCCcccEEEeeecccCcccHHHH-hcccCCCHHHHHHHHHHHHHHHHHHHH-chhcCCCCCCeEEeCCCCC
Q psy14889 193 LGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDH-LNRTTLNHHQMMKICLSIVNGLVHLHT-EIFGTQGKPAIAHRDIKSK 270 (443)
Q Consensus 193 v~l~g~~~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~~~~~~iiHrDlk~~ 270 (443)
.+.++. ...++||||++++++... +...... .....++.+++.++.++|+ . +|+|+||||+
T Consensus 82 ~~~~~~--------~~~~lv~e~~~g~~~~~~~l~~~~~~-~~~~~~~~~~~~~l~~lh~~~--------~ivH~Dl~p~ 144 (187)
T cd05119 82 PKPIDL--------NRHVLVMEFIGGDGIPAPRLKDVRLL-EDPEELYDQILELMRKLYREA--------GLVHGDLSEY 144 (187)
T ss_pred CceEec--------CCCEEEEEEeCCCCccChhhhhhhhc-ccHHHHHHHHHHHHHHHhhcc--------CcCcCCCChh
Confidence 333332 124899999998543221 1111111 6678899999999999998 6 9999999999
Q ss_pred CEEEcCCCcEEEEecCCccccc
Q psy14889 271 NILVKTNGTCVIADFGLAVSYS 292 (443)
Q Consensus 271 NiLl~~~~~~kl~DfGla~~~~ 292 (443)
||+++ ++.++|+|||.+....
T Consensus 145 Nili~-~~~~~liDfg~a~~~~ 165 (187)
T cd05119 145 NILVD-DGKVYIIDVPQAVEID 165 (187)
T ss_pred hEEEE-CCcEEEEECccccccc
Confidence 99999 8999999999985443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.68 E-value=5.4e-16 Score=143.34 Aligned_cols=137 Identities=16% Similarity=0.186 Sum_probs=103.0
Q ss_pred cceee-eecCeEEEEEEECCceeEEEEeeccC--------c------cchHHHHHHHHHHhccCCCc--eeeeeeccccC
Q psy14889 141 SECIG-KGRYGEVWRGVWHGENVAVKIFFSRD--------E------ASWSRETEIYSTVLLRHENI--LGYIGSDMTSR 203 (443)
Q Consensus 141 ~~~lG-~G~fg~Vy~~~~~~~~vAvK~~~~~~--------~------~~~~~e~ei~~~~~l~H~nI--v~l~g~~~~~~ 203 (443)
...|| .|+.|+||++...+..++||++.... . .......|+..+..+.|++| +..+++.....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred CceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 35687 89999999999889999999874321 1 11122345666666888775 66676644332
Q ss_pred CcccEEEeeecccCc-ccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEE
Q psy14889 204 NSCTQLWLVTHYHSF-GSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVI 282 (443)
Q Consensus 204 ~~~~~~~lv~e~~~~-gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl 282 (443)
......++||||+++ .+|.+++.+..++... +.+++.+|.+||+. ||+||||||.|||++.++.++|
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~~l~~~~----~~~i~~~l~~lH~~--------GI~HrDlkp~NILv~~~~~v~L 183 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEAPLSEEQ----WQAIGQLIARFHDA--------GVYHADLNAHNILLDPDGKFWL 183 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcCCCCHHH----HHHHHHHHHHHHHC--------CCCCCCCCchhEEEcCCCCEEE
Confidence 211234699999997 6999998776666543 56899999999999 9999999999999999999999
Q ss_pred EecCCcc
Q psy14889 283 ADFGLAV 289 (443)
Q Consensus 283 ~DfGla~ 289 (443)
+|||.+.
T Consensus 184 IDfg~~~ 190 (239)
T PRK01723 184 IDFDRGE 190 (239)
T ss_pred EECCCcc
Confidence 9999874
|
|
| >KOG1266|consensus | Back alignment and domain information |
|---|
Probab=99.65 E-value=2.9e-16 Score=143.99 Aligned_cols=207 Identities=19% Similarity=0.263 Sum_probs=138.4
Q ss_pred HHHHHhccCCCceeeeeeccccCC-cccEEEeeecccCcccHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHHchh
Q psy14889 181 IYSTVLLRHENILGYIGSDMTSRN-SCTQLWLVTHYHSFGSLYDHLNR-----TTLNHHQMMKICLSIVNGLVHLHTEIF 254 (443)
Q Consensus 181 i~~~~~l~H~nIv~l~g~~~~~~~-~~~~~~lv~e~~~~gsL~~~l~~-----~~l~~~~~~~i~~qia~gL~yLH~~~~ 254 (443)
...+.++.|.|||+++.|+.+... ...+..+++|||..|+|..+|++ ..+......+|+.||..||.|||+.
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-- 195 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-- 195 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc--
Confidence 334445789999999999887654 33567899999999999999975 4588888899999999999999998
Q ss_pred cCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccch
Q psy14889 255 GTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADI 334 (443)
Q Consensus 255 ~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDv 334 (443)
.|+|+|+++..+-|++..++-+|+.--.....-...............|-++|.|||.-... ..+.++||
T Consensus 196 ----~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~t------n~~~a~dI 265 (458)
T KOG1266|consen 196 ----DPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTT------NTTGASDI 265 (458)
T ss_pred ----CCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCccc------ccccchhh
Confidence 78999999999999999998888743211100000000000011122456789999975443 44568999
Q ss_pred HHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCC
Q psy14889 335 YALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANV 414 (443)
Q Consensus 335 wS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~ 414 (443)
|+||....||..+... |-..... ....+.+.+.+. .+.+ ..-+.++.+|++..|..
T Consensus 266 y~fgmcAlemailEiq---------~tnseS~-~~~ee~ia~~i~------~len--------~lqr~~i~kcl~~eP~~ 321 (458)
T KOG1266|consen 266 YKFGMCALEMAILEIQ---------STNSESK-VEVEENIANVII------GLEN--------GLQRGSITKCLEGEPNG 321 (458)
T ss_pred hhhhHHHHHHHHheec---------cCCCcce-eehhhhhhhhee------eccC--------ccccCcCcccccCCCCC
Confidence 9999999999877211 1111000 000011111110 0111 11356899999999999
Q ss_pred CCcHHHHHH
Q psy14889 415 RLSALRVKK 423 (443)
Q Consensus 415 Rps~~evl~ 423 (443)
||+|.+++-
T Consensus 322 rp~ar~llf 330 (458)
T KOG1266|consen 322 RPDARLLLF 330 (458)
T ss_pred Ccchhhhhc
Confidence 999998764
|
|
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.4e-17 Score=171.93 Aligned_cols=253 Identities=25% Similarity=0.320 Sum_probs=178.1
Q ss_pred ccccccceeeeecCeEEEEEEE---CCceeEEEEeeccCccchHH---HHHHHHHHhcc-CCCceeeeeeccccCCcccE
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW---HGENVAVKIFFSRDEASWSR---ETEIYSTVLLR-HENILGYIGSDMTSRNSCTQ 208 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~---~~~~vAvK~~~~~~~~~~~~---e~ei~~~~~l~-H~nIv~l~g~~~~~~~~~~~ 208 (443)
..|.+.+.||+|+|+.|-.... ....+|+|.+.......... ..|......+. |+|++++++...... .
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~----~ 95 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPR----S 95 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCc----c
Confidence 4677788899999999987765 23456777554332111111 12333333355 999999999877764 4
Q ss_pred EEeeecccCcccHHHHh-ccc--CCCHHHHHHHHHHHHHHHHHHH-HchhcCCCCCCeEEeCCCCCCEEEcCCC-cEEEE
Q psy14889 209 LWLVTHYHSFGSLYDHL-NRT--TLNHHQMMKICLSIVNGLVHLH-TEIFGTQGKPAIAHRDIKSKNILVKTNG-TCVIA 283 (443)
Q Consensus 209 ~~lv~e~~~~gsL~~~l-~~~--~l~~~~~~~i~~qia~gL~yLH-~~~~~~~~~~~iiHrDlk~~NiLl~~~~-~~kl~ 283 (443)
.+++++|..+|++.+.+ ... ..+......+..|+..|+.|+| .. ++.|||+||+|.+++..+ ..|++
T Consensus 96 ~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~--------~~~h~~ikP~n~~l~~s~~~l~~~ 167 (601)
T KOG0590|consen 96 YLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPEN--------GVTHRDIKPSNSLLDESGSALKIA 167 (601)
T ss_pred cccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCccc--------ccccCCCCCccchhccCCCcccCC
Confidence 68999999999999988 432 5777888899999999999999 66 999999999999999999 99999
Q ss_pred ecCCcccccccCCcCCCCCCCccc-ccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCC
Q psy14889 284 DFGLAVSYSQLSNKMDIPPNPRVG-TKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYH 362 (443)
Q Consensus 284 DfGla~~~~~~~~~~~~~~~~~~g-t~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~ 362 (443)
|||+|..+....+. .......+| ++.|+|||...+.. ...+..|+||.|+++.-+++| ..||.
T Consensus 168 df~~At~~~~~~g~-~~~~~~~~g~s~~y~a~E~~~~~~-----~~~~~~d~~S~g~~l~~~~~g----------~~p~~ 231 (601)
T KOG0590|consen 168 DFGLATAYRNKNGA-ERSLKDRCGSSPPYGAPEHLSGKA-----YRGPSVDVWSLGIVLSAMLTG----------ELPWD 231 (601)
T ss_pred CchhhccccccCCc-ceeeecccCCCCCCCCcccccchh-----hcCCCcccccccccccccccC----------CCCcc
Confidence 99999776652111 111234567 99999999998742 223689999999999999999 56655
Q ss_pred CCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 363 DLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
.....+..... ...........+ .........+++.+++..+|..|.+.+++..
T Consensus 232 ~~~~~~~~~~~---~~~~~~~~~~~~----~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 232 FPSRKDGRYSS---WKSNKGRFTQLP----WNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred cccccccccee---ecccccccccCc----cccCChhhhhcccccccCCchhccccccccc
Confidence 54332211111 111100000111 1234456888999999999999999887643
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.63 E-value=2.9e-15 Score=127.92 Aligned_cols=133 Identities=21% Similarity=0.186 Sum_probs=104.6
Q ss_pred cceeeeecCeEEEEEEECCceeEEEEeeccCccchHHHHHHHHHHhccC--CCceeeeeeccccCCcccEEEeeecccCc
Q psy14889 141 SECIGKGRYGEVWRGVWHGENVAVKIFFSRDEASWSRETEIYSTVLLRH--ENILGYIGSDMTSRNSCTQLWLVTHYHSF 218 (443)
Q Consensus 141 ~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~H--~nIv~l~g~~~~~~~~~~~~~lv~e~~~~ 218 (443)
.+.||+|.++.||++...+..+++|....... ......|+..+..++| .++.+++++.... ...++++||+++
T Consensus 3 ~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~----~~~~~v~e~~~g 77 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKDEDYVLKINPSREK-GADREREVAILQLLARKGLPVPKVLASGESD----GWSYLLMEWIEG 77 (155)
T ss_pred ceecccccccceEEEEecCCeEEEEecCCCCc-hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCC----CccEEEEEecCC
Confidence 56799999999999999888999998755432 2223344444444666 5888888876654 346999999998
Q ss_pred ccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcc
Q psy14889 219 GSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAV 289 (443)
Q Consensus 219 gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~ 289 (443)
+++..+ +......++.+++.+|++||... .++++|+|++|.||+++.++.++++|||.+.
T Consensus 78 ~~~~~~------~~~~~~~~~~~~~~~l~~lh~~~-----~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~ 137 (155)
T cd05120 78 ETLDEV------SEEEKEDIAEQLAELLAKLHQLP-----LLVLCHGDLHPGNILVDDGKILGIIDWEYAG 137 (155)
T ss_pred eecccC------CHHHHHHHHHHHHHHHHHHhCCC-----ceEEEecCCCcceEEEECCcEEEEEeccccc
Confidence 877654 56677888999999999999751 2379999999999999998999999999874
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.54 E-value=4.1e-13 Score=134.73 Aligned_cols=139 Identities=17% Similarity=0.170 Sum_probs=92.5
Q ss_pred ceeeeecCeEEEEEEE-CCceeEEEEeeccCccchHHH-----------------------------------------H
Q psy14889 142 ECIGKGRYGEVWRGVW-HGENVAVKIFFSRDEASWSRE-----------------------------------------T 179 (443)
Q Consensus 142 ~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~e-----------------------------------------~ 179 (443)
+.||.|++|+||+|++ +|+.||||+.+.........+ .
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 6799999999999998 799999998754321111110 1
Q ss_pred HHHHHHh----ccCCCceeeeeeccccCCcccEEEeeecccCcccHHHHhcccCCCHHHHHHHHHHHHH-HHHHHHHchh
Q psy14889 180 EIYSTVL----LRHENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVN-GLVHLHTEIF 254 (443)
Q Consensus 180 ei~~~~~----l~H~nIv~l~g~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~qia~-gL~yLH~~~~ 254 (443)
|...... +.|.+-+.+-.++.+.. ...+|||||+++++|.++........ ....++.+++. .+..+|..
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~---~~~vLvmE~i~G~~L~~~~~~~~~~~-~~~~ia~~~~~~~l~ql~~~-- 276 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRT---SERVLTMEWIDGIPLSDIAALDEAGL-DRKALAENLARSFLNQVLRD-- 276 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhc---CCceEEEEeECCcccccHHHHHhcCC-CHHHHHHHHHHHHHHHHHhC--
Confidence 1111111 22333333333332211 23589999999999988764321111 23456666665 46788887
Q ss_pred cCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCccccc
Q psy14889 255 GTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYS 292 (443)
Q Consensus 255 ~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~~ 292 (443)
|++|+|++|.||+++.++.++++|||++..+.
T Consensus 277 ------g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 277 ------GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred ------CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 99999999999999999999999999986554
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=99.45 E-value=1.3e-13 Score=136.87 Aligned_cols=248 Identities=22% Similarity=0.287 Sum_probs=171.2
Q ss_pred hccccccceeee--ecCeEEEEEEE----CCceeEEEEeecc---CccchHHHHHHHHHHhc-cCCCceeeeeeccccCC
Q psy14889 135 AKQISLSECIGK--GRYGEVWRGVW----HGENVAVKIFFSR---DEASWSRETEIYSTVLL-RHENILGYIGSDMTSRN 204 (443)
Q Consensus 135 ~~~~~~~~~lG~--G~fg~Vy~~~~----~~~~vAvK~~~~~---~~~~~~~e~ei~~~~~l-~H~nIv~l~g~~~~~~~ 204 (443)
...+.+.+.+|. |.+|.||.+.. ++..+|+|.-+.. .......-.++.....+ .|+|.++.+..+...
T Consensus 113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~-- 190 (524)
T KOG0601|consen 113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGS-- 190 (524)
T ss_pred hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccC--
Confidence 356777888999 99999998876 4778999863221 12223333444443333 589999977777666
Q ss_pred cccEEEeeecccCcccHHHHhcc--cCCCHHHHHHHHHHHHH----HHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCC-
Q psy14889 205 SCTQLWLVTHYHSFGSLYDHLNR--TTLNHHQMMKICLSIVN----GLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTN- 277 (443)
Q Consensus 205 ~~~~~~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~----gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~- 277 (443)
..+++-+|++. .+|..+... .-++...++....+... ||.++|+. +++|-|+||.||++..+
T Consensus 191 --~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~--------~~~~~~~kp~~i~~~~~~ 259 (524)
T KOG0601|consen 191 --GILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSN--------NIVHDDLKPANIFTTSDW 259 (524)
T ss_pred --Ccceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCC--------cccccccchhheeccccc
Confidence 45789999987 588888764 23677788888888888 99999998 99999999999999999
Q ss_pred CcEEEEecCCcccccccCCcCCCCC-CCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccc
Q psy14889 278 GTCVIADFGLAVSYSQLSNKMDIPP-NPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEE 356 (443)
Q Consensus 278 ~~~kl~DfGla~~~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~ 356 (443)
...+++|||+...+....-...... ....|...|++||...+ .++.++|+||+|.++.|..++...
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-------l~~~~~di~sl~ev~l~~~l~~~~------ 326 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-------LATFASDIFSLGEVILEAILGSHL------ 326 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc-------ccchHhhhcchhhhhHhhHhhccc------
Confidence 7899999999887765432211111 11256778999999886 456899999999999999988321
Q ss_pred cCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 357 YKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 357 ~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
|-.+. ...+...++ ..++.++. ......+...+..+++.+|-.|+++..+..
T Consensus 327 ---~~~g~---~~~W~~~r~--------~~ip~e~~-~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 327 ---PSVGK---NSSWSQLRQ--------GYIPLEFC-EGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred ---ccCCC---CCCcccccc--------ccCchhhh-cCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 11110 001111111 11222222 123345667999999999999998776543
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.44 E-value=4.7e-13 Score=117.14 Aligned_cols=132 Identities=19% Similarity=0.120 Sum_probs=91.7
Q ss_pred cceeeeecCeEEEEEEECCceeEEEEeeccCccchHHHHHHHHHHhccCCCce-eeeeeccccCCcccEEEeeecccCcc
Q psy14889 141 SECIGKGRYGEVWRGVWHGENVAVKIFFSRDEASWSRETEIYSTVLLRHENIL-GYIGSDMTSRNSCTQLWLVTHYHSFG 219 (443)
Q Consensus 141 ~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~H~nIv-~l~g~~~~~~~~~~~~~lv~e~~~~g 219 (443)
.+.|+.|.++.||++...+..+++|+...........+.|...+..+.+.+++ +++.+.... .++||||+++.
T Consensus 3 ~~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~~~~------~~lv~e~i~G~ 76 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVANKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFDPET------GVLITEFIEGS 76 (170)
T ss_pred eeecCCcccCceEEEEECCeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEeCCC------CeEEEEecCCC
Confidence 35689999999999999999999998754432222334444444445554443 455443211 37999999998
Q ss_pred cHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcc
Q psy14889 220 SLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAV 289 (443)
Q Consensus 220 sL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~ 289 (443)
++.+. . .....++.+++++|+.||+... ...+++|+|++|.||+++ ++.++++|||.+.
T Consensus 77 ~l~~~----~---~~~~~~~~~l~~~l~~LH~~~~---~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 77 ELLTE----D---FSDPENLEKIAKLLKKLHSSPL---PDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred ccccc----c---ccCHHHHHHHHHHHHHHhCCCC---CCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 87643 1 1123456789999999998711 122469999999999999 6789999999873
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.37 E-value=4e-11 Score=122.02 Aligned_cols=137 Identities=15% Similarity=0.179 Sum_probs=86.4
Q ss_pred cccccceeeeecCeEEEEEEE-C-CceeEEEEeeccCccch-------------------------------------HH
Q psy14889 137 QISLSECIGKGRYGEVWRGVW-H-GENVAVKIFFSRDEASW-------------------------------------SR 177 (443)
Q Consensus 137 ~~~~~~~lG~G~fg~Vy~~~~-~-~~~vAvK~~~~~~~~~~-------------------------------------~~ 177 (443)
.|+. +.||+|++|+||+|++ + |+.||||+....-.... ..
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ 199 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD 199 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence 4665 7899999999999998 4 89999999864321100 00
Q ss_pred H----HHHHHHHh----ccCCCceeeeeeccccCCcccEEEeeecccCcccHHHH--hcccCCC-----HHHHHHHHHHH
Q psy14889 178 E----TEIYSTVL----LRHENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDH--LNRTTLN-----HHQMMKICLSI 242 (443)
Q Consensus 178 e----~ei~~~~~----l~H~nIv~l~g~~~~~~~~~~~~~lv~e~~~~gsL~~~--l~~~~l~-----~~~~~~i~~qi 242 (443)
| .|.....+ +.+.+.+.+-.++.+- +...+|||||+.|+.+.++ +.....+ ...+..++.|+
T Consensus 200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~---st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi 276 (537)
T PRK04750 200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDY---CSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV 276 (537)
T ss_pred hhCHHHHHHHHHHHHHHccCCCCeecceeeccc---CCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH
Confidence 1 11111111 2233333332222211 1335899999999999874 3333332 22233333443
Q ss_pred HHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCC----cEEEEecCCccccc
Q psy14889 243 VNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNG----TCVIADFGLAVSYS 292 (443)
Q Consensus 243 a~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~----~~kl~DfGla~~~~ 292 (443)
. .. |++|+|++|.||+++.++ .+++.|||++..++
T Consensus 277 f-------~~--------GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 277 F-------RD--------GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred H-------hC--------CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 3 34 999999999999999988 99999999986554
|
|
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=99.24 E-value=9.8e-12 Score=123.59 Aligned_cols=245 Identities=20% Similarity=0.189 Sum_probs=166.7
Q ss_pred hhccccccceeeeecCeEEEEEEE---CCceeEEEEeeccCccchHH-----HHHHHHHHhccCCCceeeeeeccccCCc
Q psy14889 134 LAKQISLSECIGKGRYGEVWRGVW---HGENVAVKIFFSRDEASWSR-----ETEIYSTVLLRHENILGYIGSDMTSRNS 205 (443)
Q Consensus 134 ~~~~~~~~~~lG~G~fg~Vy~~~~---~~~~vAvK~~~~~~~~~~~~-----e~ei~~~~~l~H~nIv~l~g~~~~~~~~ 205 (443)
...+|.+...||.|.|+.|+.... ++..+++|.+.......... |.-+... ...|.++++++..+...+.
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~-l~~~~~~~g~~~~W~~~r~- 340 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAI-LGSHLPSVGKNSSWSQLRQ- 340 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhH-hhcccccCCCCCCcccccc-
Confidence 345788899999999999998765 46788999765432222221 2222222 2568888887776665543
Q ss_pred ccEEEeeecccCcccHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCC-CcEEEE
Q psy14889 206 CTQLWLVTHYHSFGSLYDHLN-RTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTN-GTCVIA 283 (443)
Q Consensus 206 ~~~~~lv~e~~~~gsL~~~l~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~-~~~kl~ 283 (443)
.|+-.||+.++++..... ...+.+..++++..|++.++.++|+. .++|+|+||+||++..+ +..++.
T Consensus 341 ---~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~--------~~~~~d~~psni~i~~~~~~~~~~ 409 (524)
T KOG0601|consen 341 ---GYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK--------LFVHLDVKPSNILISNDGFFSKLG 409 (524)
T ss_pred ---ccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccch--------hhhcccccccceeeccchhhhhcc
Confidence 478999999999877663 24578888999999999999999987 89999999999999887 788999
Q ss_pred ecCCcccccccCCcCCCCCCCcccccCcc-cccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCC
Q psy14889 284 DFGLAVSYSQLSNKMDIPPNPRVGTKRYM-SPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYH 362 (443)
Q Consensus 284 DfGla~~~~~~~~~~~~~~~~~~gt~~y~-aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~ 362 (443)
|||.+..+.-.. ....+..++. .+|.+... +.+..+.|++|||..+.|.+++.+ .+..
T Consensus 410 ~~~~~t~~~~~~-------~~~~~~~r~~p~~~~~~e~-----~~~~~~~~~~sl~~~~~e~~~~~~---------ls~~ 468 (524)
T KOG0601|consen 410 DFGCWTRLAFSS-------GVFHHIDRLYPIAEILLED-----YPHLSKADIFSLGLSVDEAITGSP---------LSES 468 (524)
T ss_pred ccccccccceec-------ccccccccccccchhhccc-----cccccccccccccccccccccCcc---------cCcc
Confidence 999985422111 1122333444 24544443 255579999999999999999832 1111
Q ss_pred CCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHH
Q psy14889 363 DLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKL 428 (443)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l 428 (443)
.. ....+ .....+..+. ...++..+.+.+...++..||++.++.......
T Consensus 469 ~~--------~~~~i--~~~~~p~~~~------~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 469 GV--------QSLTI--RSGDTPNLPG------LKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred cc--------cceee--ecccccCCCc------hHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 10 00010 1112233332 236688899999999999999998876655443
|
|
| >KOG1243|consensus | Back alignment and domain information |
|---|
Probab=99.23 E-value=3e-10 Score=114.33 Aligned_cols=163 Identities=20% Similarity=0.279 Sum_probs=118.5
Q ss_pred CCceeEEEEeeccCcc-chHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEeeecccCcccHHHHhcccCCCHHHHH
Q psy14889 158 HGENVAVKIFFSRDEA-SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMM 236 (443)
Q Consensus 158 ~~~~vAvK~~~~~~~~-~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~l~~~~~~ 236 (443)
++.+|.|...+..... ....++.+..++.++||||++++..+... ..+|||+|-+. -|..++++. +...+.
T Consensus 36 ~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~----~~~ylvTErV~--Pl~~~lk~l--~~~~v~ 107 (690)
T KOG1243|consen 36 DGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEE----GTLYLVTERVR--PLETVLKEL--GKEEVC 107 (690)
T ss_pred cCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhccc----CceEEEeeccc--cHHHHHHHh--HHHHHH
Confidence 6788888877655441 22235667777779999999999988776 45899999875 567777553 366667
Q ss_pred HHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcccccccCCcCCCCCCCcccccCcccccc
Q psy14889 237 KICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEI 316 (443)
Q Consensus 237 ~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 316 (443)
--+.||+.||.|||..+ +++|++|....|+++..|.-||++|-++....+..... ....---.|..|+.
T Consensus 108 ~Gl~qIl~AL~FL~~d~-------~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~----~~~~~~~s~~~P~~ 176 (690)
T KOG1243|consen 108 LGLFQILAALSFLNDDC-------NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPA----KSLYLIESFDDPEE 176 (690)
T ss_pred HHHHHHHHHHHHHhccC-------CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCccc----ccchhhhcccChhh
Confidence 77899999999999764 89999999999999999999999998875443322100 00111124566665
Q ss_pred cccccccCcCCCCCccchHHHHHHHHHHHhc
Q psy14889 317 LDESINMDCFESFKKADIYALGLVLWEVCRR 347 (443)
Q Consensus 317 ~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg 347 (443)
+... .-..|.|-||++++|++.|
T Consensus 177 ~~~s--------~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 177 IDPS--------EWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cCcc--------ccchhhhhHHHHHHHHhCc
Confidence 4321 1246999999999999998
|
|
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.23 E-value=4.3e-12 Score=132.54 Aligned_cols=245 Identities=21% Similarity=0.267 Sum_probs=163.2
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeecc------CccchHHHHHHHHHHhccCCCceeeeeeccccCCccc
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSR------DEASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCT 207 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~------~~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~ 207 (443)
+.+.+.+-+-+|.++.++.+.- .|...++|+.... +-.....+..+.+. .+||-++...--+....
T Consensus 804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~--p~~P~v~~~~~s~~~rs---- 877 (1205)
T KOG0606|consen 804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILIT--PRSPAVVRSFPSFPCRS---- 877 (1205)
T ss_pred ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCcccc--CCCCceecccCCCCCCC----
Confidence 5677778889999999997765 3444555543221 11222223333222 34566665544422222
Q ss_pred EEEeeecccCcccHHHHhcccC-CCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecC
Q psy14889 208 QLWLVTHYHSFGSLYDHLNRTT-LNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFG 286 (443)
Q Consensus 208 ~~~lv~e~~~~gsL~~~l~~~~-l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfG 286 (443)
-.+|+++|..+++|...|+..+ .+..-.......+..+++|||+. .+.|+|++|.|.|+..++..+++|||
T Consensus 878 P~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~--------~r~h~~~~p~~~l~~~~gh~~l~~~~ 949 (1205)
T KOG0606|consen 878 PLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSS--------LRKHRDLKPDSLLIAYDGHRPLTDFG 949 (1205)
T ss_pred CcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccc--------hhhcccccccchhhcccCCcccCccc
Confidence 2689999999999999998744 66666666777888999999987 68999999999999999999999998
Q ss_pred Cccccccc---------------------CCcCC------CCCCCcccccCcccccccccccccCcCCCCCccchHHHHH
Q psy14889 287 LAVSYSQL---------------------SNKMD------IPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGL 339 (443)
Q Consensus 287 la~~~~~~---------------------~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gv 339 (443)
........ ..... .......||+.|.+||.+.+. .....+|+|++|+
T Consensus 950 t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~------~hgs~ad~~~~g~ 1023 (1205)
T KOG0606|consen 950 TLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGR------RHGSAADWWSSGV 1023 (1205)
T ss_pred cccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccc------cCCCcchhhhhhh
Confidence 43221110 00000 112334799999999999887 5557899999999
Q ss_pred HHHHHHhcccCCCcccccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHH
Q psy14889 340 VLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSAL 419 (443)
Q Consensus 340 vl~elltg~~~~~~~~~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ 419 (443)
+++|.++| ..||....+. ..+.++... ....+. .+...+.+..+++...+..+|.+|..+.
T Consensus 1024 ~l~e~l~g----------~pp~na~tpq----~~f~ni~~~---~~~~p~--g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1024 CLFEVLTG----------IPPFNAETPQ----QIFENILNR---DIPWPE--GPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred hhhhhhcC----------CCCCCCcchh----hhhhccccC---CCCCCC--CccccChhhhhhhhhhhccCchhccCcc
Confidence 99999999 5555554322 122222211 111111 1233556789999999999999998776
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.23 E-value=1.9e-10 Score=101.97 Aligned_cols=133 Identities=18% Similarity=0.244 Sum_probs=92.0
Q ss_pred ceeeeecCeEEEEEEEC--------CceeEEEEeecc------------Cccch---------H------HHHHHHHHHh
Q psy14889 142 ECIGKGRYGEVWRGVWH--------GENVAVKIFFSR------------DEASW---------S------RETEIYSTVL 186 (443)
Q Consensus 142 ~~lG~G~fg~Vy~~~~~--------~~~vAvK~~~~~------------~~~~~---------~------~e~ei~~~~~ 186 (443)
..||.|--+.||.|... +..+|||+.+.. .+..+ . .+.|...+.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 46899999999999763 378999976321 01000 0 1355555554
Q ss_pred ccC--CCceeeeeeccccCCcccEEEeeecccCcccHH-HHhcccCCCHHHHHHHHHHHHHHHHHH-HHchhcCCCCCCe
Q psy14889 187 LRH--ENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLY-DHLNRTTLNHHQMMKICLSIVNGLVHL-HTEIFGTQGKPAI 262 (443)
Q Consensus 187 l~H--~nIv~l~g~~~~~~~~~~~~~lv~e~~~~gsL~-~~l~~~~l~~~~~~~i~~qia~gL~yL-H~~~~~~~~~~~i 262 (443)
+.. -++...+++ . .-+|||||+.++.+. ..+++..++..+...+..+++.+|..| |.. +|
T Consensus 83 l~~~Gv~vP~pi~~---~-----~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~--------gl 146 (197)
T cd05146 83 MQKAGIPCPEVVVL---K-----KHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKEC--------NL 146 (197)
T ss_pred HHHcCCCCCeEEEe---c-----CCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhC--------Ce
Confidence 433 344555544 1 127999999765442 234444566667778889999999999 777 99
Q ss_pred EEeCCCCCCEEEcCCCcEEEEecCCcccc
Q psy14889 263 AHRDIKSKNILVKTNGTCVIADFGLAVSY 291 (443)
Q Consensus 263 iHrDlk~~NiLl~~~~~~kl~DfGla~~~ 291 (443)
||+||++.|||++ ++.+.|+|||.+...
T Consensus 147 VHGDLs~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 147 VHADLSEYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred ecCCCCHHHEEEE-CCcEEEEECCCceeC
Confidence 9999999999997 467999999987544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.16 E-value=4.4e-10 Score=102.63 Aligned_cols=145 Identities=15% Similarity=0.158 Sum_probs=105.2
Q ss_pred ceeeeecCeEEEEEEECC-ceeEEEEeeccC----ccchHHHHHHHHHHhccC--CCceeeeeeccccCCcccEEEeeec
Q psy14889 142 ECIGKGRYGEVWRGVWHG-ENVAVKIFFSRD----EASWSRETEIYSTVLLRH--ENILGYIGSDMTSRNSCTQLWLVTH 214 (443)
Q Consensus 142 ~~lG~G~fg~Vy~~~~~~-~~vAvK~~~~~~----~~~~~~e~ei~~~~~l~H--~nIv~l~g~~~~~~~~~~~~~lv~e 214 (443)
+.|+.|.++.||++...+ +.+++|...... ......|.++... +.+ .++.+++.+...... ....++|||
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~--l~~~~~~vp~~~~~~~~~~~-~~~~~~v~e 80 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRA--LAGTGVPVPKVLALCEDPSV-LGTPFYVME 80 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHH--hhCCCCCCCCEEEECCCCCc-cCCceEEEE
Confidence 568999999999998854 899999875432 2334445555444 554 345667766554321 123589999
Q ss_pred ccCcccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhcC--------------------------------------
Q psy14889 215 YHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGT-------------------------------------- 256 (443)
Q Consensus 215 ~~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~-------------------------------------- 256 (443)
|+++.++.+.+....++..+...++.+++++|..||+.....
T Consensus 81 ~i~G~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 81 RVDGRVLRDRLLRPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred EeCCEecCCCCCCCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 999998887664456788888999999999999999642110
Q ss_pred ----------CCCCCeEEeCCCCCCEEEcC--CCcEEEEecCCcc
Q psy14889 257 ----------QGKPAIAHRDIKSKNILVKT--NGTCVIADFGLAV 289 (443)
Q Consensus 257 ----------~~~~~iiHrDlk~~NiLl~~--~~~~kl~DfGla~ 289 (443)
.....++|+|+.+.||+++. ++.+.|+||+.+.
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 01467899999999999998 5678999999773
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3741|consensus | Back alignment and domain information |
|---|
Probab=99.12 E-value=2.4e-09 Score=104.72 Aligned_cols=213 Identities=17% Similarity=0.169 Sum_probs=145.6
Q ss_pred CeEEEEEEE--CCceeEEEEeeccCccchHH-HHHHHHHHhccCCCceeeeeeccccCCcccEEEeeecccCc-ccHHHH
Q psy14889 149 YGEVWRGVW--HGENVAVKIFFSRDEASWSR-ETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVTHYHSF-GSLYDH 224 (443)
Q Consensus 149 fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~-e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e~~~~-gsL~~~ 224 (443)
-.+.|++.. +|..+++|++.......... -.-+...+++.|+|+|.|..++.+.......+.+|++|+++ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 347888876 79999999984433222211 12233444589999999999988554444568999999876 567664
Q ss_pred h-c---------------ccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCc
Q psy14889 225 L-N---------------RTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA 288 (443)
Q Consensus 225 l-~---------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla 288 (443)
- . ....++..++.++.|+..||.++|+. |+.-+-|.+.+||++.+.+++|+..|..
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss--------GLAck~L~~~kIlv~G~~RIriS~C~i~ 440 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS--------GLACKTLDLKKILVTGKMRIRISGCGIM 440 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc--------CceeecccHhHeEeeCcceEEEecccce
Confidence 3 1 13477899999999999999999999 8888999999999999999999998887
Q ss_pred ccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCC
Q psy14889 289 VSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMD 368 (443)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~ 368 (443)
..+..+.. |-+... .+-|.=.||.+++.|.||+.. -+...
T Consensus 441 Dvl~~d~~------------------~~le~~---------Qq~D~~~lG~ll~aLAt~~~n---------s~~~d---- 480 (655)
T KOG3741|consen 441 DVLQEDPT------------------EPLESQ---------QQNDLRDLGLLLLALATGTEN---------SNRTD---- 480 (655)
T ss_pred eeecCCCC------------------cchhHH---------hhhhHHHHHHHHHHHhhcccc---------ccccc----
Confidence 55443210 222222 467999999999999999421 11110
Q ss_pred CChHHH-HhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHH
Q psy14889 369 PSFDDM-RKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTL 425 (443)
Q Consensus 369 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 425 (443)
..... ...+ ....+.++++++......++++ -+..+++.++
T Consensus 481 -~~~~s~~~~I--------------~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~ 522 (655)
T KOG3741|consen 481 -STQSSHLTRI--------------TTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMI 522 (655)
T ss_pred -chHHHHHHHh--------------hhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHH
Confidence 00111 0111 1234556788888888888876 5666666544
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.12 E-value=1e-09 Score=94.27 Aligned_cols=127 Identities=20% Similarity=0.218 Sum_probs=87.9
Q ss_pred ceeeeecCeEEEEEEECCceeEEEEeeccC------c-----cchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEE
Q psy14889 142 ECIGKGRYGEVWRGVWHGENVAVKIFFSRD------E-----ASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLW 210 (443)
Q Consensus 142 ~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~------~-----~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~ 210 (443)
..+++|+-+.+|.+.+.|..+++|.-.++. . .....|+.+.....-.--+...++++. .++ ..
T Consensus 2 ~~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD--~~~----~~ 75 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVD--PDN----GL 75 (204)
T ss_pred chhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEc--CCC----CE
Confidence 357899999999998888888888542211 1 112234444443322223344444443 322 36
Q ss_pred eeecccCcccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcc
Q psy14889 211 LVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAV 289 (443)
Q Consensus 211 lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~ 289 (443)
|+|||.++-.|.+++... ...++..|=.-+.-||.. +|+|+||.++||++..+. +.++||||+.
T Consensus 76 I~me~I~G~~lkd~l~~~------~~~~~r~vG~~vg~lH~~--------givHGDLTtsNiIl~~~~-i~~IDfGLg~ 139 (204)
T COG3642 76 IVMEYIEGELLKDALEEA------RPDLLREVGRLVGKLHKA--------GIVHGDLTTSNIILSGGR-IYFIDFGLGE 139 (204)
T ss_pred EEEEEeCChhHHHHHHhc------chHHHHHHHHHHHHHHhc--------CeecCCCccceEEEeCCc-EEEEECCccc
Confidence 999999998888888665 245556666667779988 999999999999997765 9999999984
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.12 E-value=7.3e-09 Score=99.04 Aligned_cols=270 Identities=14% Similarity=0.143 Sum_probs=162.2
Q ss_pred ccccceeeeecCeEEEEEEECCceeEEEEeeccCccchHHHHHHHHHHhccCCCceeeeeec---cccCCcccEEEeeec
Q psy14889 138 ISLSECIGKGRYGEVWRGVWHGENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIGSD---MTSRNSCTQLWLVTH 214 (443)
Q Consensus 138 ~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~H~nIv~l~g~~---~~~~~~~~~~~lv~e 214 (443)
+.....||+|+-+.+|-.---+..|| |+.............+.+.. .-.||-+-.-+.+- ..........-+.|.
T Consensus 13 i~~gr~LgqGgea~ly~l~e~~d~VA-KIYh~Pppa~~aqk~a~la~-~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP 90 (637)
T COG4248 13 IPPGRPLGQGGEADLYTLGEVRDQVA-KIYHAPPPAAQAQKVAELAA-TPDAPLLNYRVAWPQATLHGGRRGKVIGFLMP 90 (637)
T ss_pred cCCCccccCCccceeeecchhhchhh-eeecCCCchHHHHHHHHhcc-CCCCcchhhhhcccHHHhhCCCccceeEEecc
Confidence 45567899999999985433233344 76655443332222222211 13455332211110 011111123566777
Q ss_pred ccCcc-cHHHHhc----c---cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecC
Q psy14889 215 YHSFG-SLYDHLN----R---TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFG 286 (443)
Q Consensus 215 ~~~~g-sL~~~l~----~---~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfG 286 (443)
..++- -+..+++ + ....|.-.+++++.+|.+.+-||.. |.+-+|+.++|+|+++++.+.|.|-.
T Consensus 91 ~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~--------Gh~vGDVn~~~~lVsd~~~V~LVdsD 162 (637)
T COG4248 91 KVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH--------GHVVGDVNQNSFLVSDDSKVVLVDSD 162 (637)
T ss_pred cCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc--------CCcccccCccceeeecCceEEEEccc
Confidence 66542 2233332 1 2478999999999999999999998 88999999999999999999998754
Q ss_pred CcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCC
Q psy14889 287 LAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVP 366 (443)
Q Consensus 287 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~ 366 (443)
.-..-.. .. .....+|...|.+||.-.-... ....-+...|-|.||+++++++.| +..||.+...
T Consensus 163 sfqi~~n-g~----~~~cpVg~~eftPPElQ~~~sf-~g~~r~~~hD~FGLavLiF~lL~g---------grHPysGI~~ 227 (637)
T COG4248 163 SFQINAN-GT----LHLCPVGVSEFTPPELQTLPSF-VGFERTANHDNFGLAVLIFHLLFG---------GRHPYSGIPL 227 (637)
T ss_pred ceeeccC-Cc----eEecccCccccCCHHHhccccc-cccCCCccccchhHHHHHHHHHhc---------CCCCCCcccc
Confidence 3221111 11 1123478899999997653322 123556789999999999999987 3556655432
Q ss_pred CCCCh---H-HHH-hh--hhhcCCCCC--CCCCCCCchhHHHHHHHHHHHhcC--CcCCCCcHHHHHHHHHHHhhcc
Q psy14889 367 MDPSF---D-DMR-KV--ICIDQQRPV--LPNRWVSDSTLNAMTKVMKECWHQ--NANVRLSALRVKKTLIKLACAD 432 (443)
Q Consensus 367 ~~~~~---~-~~~-~~--~~~~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~--dP~~Rps~~evl~~L~~l~~~~ 432 (443)
..... + .+. .. ...+..++. .|..|.-.-.+..+..|..+|+.. ++.-|||++.-+..|.++.++.
T Consensus 228 ~~~ap~p~E~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L 304 (637)
T COG4248 228 ISDAPNPLETDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQL 304 (637)
T ss_pred cCCCCCcchhhhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhh
Confidence 21111 1 111 10 111122222 222333344567789999999964 3678999999999999887764
|
|
| >KOG3087|consensus | Back alignment and domain information |
|---|
Probab=99.02 E-value=4.2e-09 Score=90.14 Aligned_cols=138 Identities=22% Similarity=0.258 Sum_probs=91.1
Q ss_pred ccceeeeecCeEEEEEEECCceeEEEEeeccC-c-----cc---hHHHHHHHHHHhccCCCceeeeeeccccCCcccEEE
Q psy14889 140 LSECIGKGRYGEVWRGVWHGENVAVKIFFSRD-E-----AS---WSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLW 210 (443)
Q Consensus 140 ~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~-~-----~~---~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~ 210 (443)
....|-+|+-+.|+++.+.|+...||.-..+. . .. ..-..|+..+.+++--.|..-.-++.+.... .
T Consensus 11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~----~ 86 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGG----Q 86 (229)
T ss_pred cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCC----e
Confidence 46789999999999999999999999543221 0 01 1112344443333222222211122233222 6
Q ss_pred eeecccCc-ccHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCC---cEEEE
Q psy14889 211 LVTHYHSF-GSLYDHLNR---TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNG---TCVIA 283 (443)
Q Consensus 211 lv~e~~~~-gsL~~~l~~---~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~---~~kl~ 283 (443)
|+|||.++ .++.+++.. ..........++..|-..+.-||.+ +|||+||..+||++..++ .+.++
T Consensus 87 i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~n--------diiHGDLTTSNill~~~~~~~~~~lI 158 (229)
T KOG3087|consen 87 IYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDN--------DIIHGDLTTSNILLRSDGNQITPILI 158 (229)
T ss_pred EEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhC--------CeecccccccceEEecCCCcCceEEE
Confidence 89999975 477888753 2223333367888888889999999 999999999999997665 45899
Q ss_pred ecCCcc
Q psy14889 284 DFGLAV 289 (443)
Q Consensus 284 DfGla~ 289 (443)
|||++.
T Consensus 159 dfgls~ 164 (229)
T KOG3087|consen 159 DFGLSS 164 (229)
T ss_pred eecchh
Confidence 999973
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.00 E-value=1.1e-08 Score=95.84 Aligned_cols=139 Identities=12% Similarity=0.039 Sum_probs=91.2
Q ss_pred eeeeecCeEEEEEEECCceeEEEEeeccCcc------------chHHHHHHHHHHhccCCC--ceeeeeeccccC-Cccc
Q psy14889 143 CIGKGRYGEVWRGVWHGENVAVKIFFSRDEA------------SWSRETEIYSTVLLRHEN--ILGYIGSDMTSR-NSCT 207 (443)
Q Consensus 143 ~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~------------~~~~e~ei~~~~~l~H~n--Iv~l~g~~~~~~-~~~~ 207 (443)
.+-+-....|++..+.|+.+.||........ ......|...+..+...+ ....+++..... ....
T Consensus 29 ~v~~~~~rrvvr~~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~ 108 (268)
T PRK15123 29 VFRELEGRRTLRFELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATR 108 (268)
T ss_pred EEecCCCceEEEEEECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccc
Confidence 3443344457788889999999976432211 001223333333232222 222333332211 1113
Q ss_pred EEEeeecccCcc-cHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcC-------
Q psy14889 208 QLWLVTHYHSFG-SLYDHLNR---TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKT------- 276 (443)
Q Consensus 208 ~~~lv~e~~~~g-sL~~~l~~---~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~------- 276 (443)
.-+||||++++- +|.+++.+ ...+......++.+++..+.-||.. ||+|+|++++|||++.
T Consensus 109 ~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~--------Gi~HgDL~~~NiLl~~~~~~~~~ 180 (268)
T PRK15123 109 TSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAA--------GINHRDCYICHFLLHLPFPGREE 180 (268)
T ss_pred eeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC--------cCccCCCChhhEEEeccccCCCC
Confidence 458999999875 79988752 4456677789999999999999999 9999999999999985
Q ss_pred CCcEEEEecCCcc
Q psy14889 277 NGTCVIADFGLAV 289 (443)
Q Consensus 277 ~~~~kl~DfGla~ 289 (443)
+..+.|+||+.+.
T Consensus 181 ~~~~~LIDl~r~~ 193 (268)
T PRK15123 181 DLKLSVIDLHRAQ 193 (268)
T ss_pred CceEEEEECCccc
Confidence 4688999999874
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.86 E-value=2.2e-08 Score=88.54 Aligned_cols=122 Identities=25% Similarity=0.321 Sum_probs=76.2
Q ss_pred EEEEEEE-CCceeEEEEeeccC------------ccc---------------hHHHHHHHHHHhccCC--Cceeeeeecc
Q psy14889 151 EVWRGVW-HGENVAVKIFFSRD------------EAS---------------WSRETEIYSTVLLRHE--NILGYIGSDM 200 (443)
Q Consensus 151 ~Vy~~~~-~~~~vAvK~~~~~~------------~~~---------------~~~e~ei~~~~~l~H~--nIv~l~g~~~ 200 (443)
.||.|.. +|..+|||+.+... ... ...+.|...+..+..- ++.+.+++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 3899987 78899999863210 000 1113566666556655 455555442
Q ss_pred ccCCcccEEEeeecccC--cccHHHHhcccCCCHHHHHHHHHHHHHHHHHH-HHchhcCCCCCCeEEeCCCCCCEEEcCC
Q psy14889 201 TSRNSCTQLWLVTHYHS--FGSLYDHLNRTTLNHHQMMKICLSIVNGLVHL-HTEIFGTQGKPAIAHRDIKSKNILVKTN 277 (443)
Q Consensus 201 ~~~~~~~~~~lv~e~~~--~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yL-H~~~~~~~~~~~iiHrDlk~~NiLl~~~ 277 (443)
. -.|||||++ +..+.. |....++......++.+++..+..+ |.. ||+|+||.+.|||++++
T Consensus 80 --~-----~~ivME~I~~~G~~~~~-l~~~~~~~~~~~~~~~~il~~~~~~~~~~--------givHGDLs~~NIlv~~~ 143 (188)
T PF01163_consen 80 --R-----NVIVMEYIGEDGVPLPR-LKDVDLSPEEPKELLEEILEEIIKMLHKA--------GIVHGDLSEYNILVDDG 143 (188)
T ss_dssp --T-----TEEEEE--EETTEEGGC-HHHCGGGGSTHHHHHHHHHHHHHHHHHCT--------TEEESS-STTSEEEETT
T ss_pred --C-----CEEEEEecCCCccchhh-HHhccccchhHHHHHHHHHHHHHHHHHhc--------CceecCCChhhEEeecc
Confidence 1 279999998 544433 4443444566677888888866665 566 99999999999999887
Q ss_pred CcEEEEecCCccc
Q psy14889 278 GTCVIADFGLAVS 290 (443)
Q Consensus 278 ~~~kl~DfGla~~ 290 (443)
.+.|+|||.+..
T Consensus 144 -~~~iIDf~qav~ 155 (188)
T PF01163_consen 144 -KVYIIDFGQAVD 155 (188)
T ss_dssp -CEEE--GTTEEE
T ss_pred -eEEEEecCccee
Confidence 999999998754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG2137|consensus | Back alignment and domain information |
|---|
Probab=98.82 E-value=1.9e-09 Score=108.98 Aligned_cols=152 Identities=17% Similarity=0.268 Sum_probs=100.7
Q ss_pred HHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcccccccCCc----CCCCC-CCcccccCccccc
Q psy14889 241 SIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNK----MDIPP-NPRVGTKRYMSPE 315 (443)
Q Consensus 241 qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~----~~~~~-~~~~gt~~y~aPE 315 (443)
+++.||.|+|.. +++||++|.|++|.++..+..||+.|+++......... ++... .-..-...|.|||
T Consensus 107 ~v~dgl~flh~s-------Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE 179 (700)
T KOG2137|consen 107 NVADGLAFLHRS-------AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPE 179 (700)
T ss_pred cccchhhhhccC-------cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccch
Confidence 345999999976 49999999999999999999999999988655442211 11110 1112346799999
Q ss_pred ccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCch
Q psy14889 316 ILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDS 395 (443)
Q Consensus 316 ~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 395 (443)
++.+. ..+.++|++|+|+++|-+..|.+.. +.....+-. .... ...........+.+
T Consensus 180 ~~~~~------~~~~~sd~fSlG~li~~i~~~gk~i--~~a~~~~~~--------~~~~-------~~~~~~~~~~~s~~ 236 (700)
T KOG2137|consen 180 YLLGT------TNTPASDVFSLGVLIYTIYNGGKSI--IAANGGLLS--------YSFS-------RNLLNAGAFGYSNN 236 (700)
T ss_pred hhccc------cccccccceeeeeEEEEEecCCcch--hhccCCcch--------hhhh-------hccccccccccccc
Confidence 99875 5568999999999999998553321 000000100 0000 00111111112355
Q ss_pred hHHHHHHHHHHHhcCCcCCCCcHHHHH
Q psy14889 396 TLNAMTKVMKECWHQNANVRLSALRVK 422 (443)
Q Consensus 396 ~~~~l~~li~~cl~~dP~~Rps~~evl 422 (443)
.+.++++=+.+++..++..||++.++.
T Consensus 237 ~p~el~~~l~k~l~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 237 LPSELRESLKKLLNGDSAVRPTLDLLL 263 (700)
T ss_pred CcHHHHHHHHHHhcCCcccCcchhhhh
Confidence 778999999999999999999777654
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.71 E-value=1.5e-07 Score=85.04 Aligned_cols=91 Identities=19% Similarity=0.216 Sum_probs=71.4
Q ss_pred ceeeeeeccccCCcccEEEeeecccCc-ccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCC
Q psy14889 192 ILGYIGSDMTSRNSCTQLWLVTHYHSF-GSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKS 269 (443)
Q Consensus 192 Iv~l~g~~~~~~~~~~~~~lv~e~~~~-gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~ 269 (443)
+.+.+++..........-++|+|++++ -+|.+++.. ...+......++.+++..+.-||.. ||+|+|+++
T Consensus 75 tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH~~--------gi~H~Dl~~ 146 (206)
T PF06293_consen 75 TPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLHDA--------GIYHGDLNP 146 (206)
T ss_pred CCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHHHC--------cCCCCCCCc
Confidence 334444444433322446899999987 479998865 3467777889999999999999999 999999999
Q ss_pred CCEEEcCCC---cEEEEecCCccc
Q psy14889 270 KNILVKTNG---TCVIADFGLAVS 290 (443)
Q Consensus 270 ~NiLl~~~~---~~kl~DfGla~~ 290 (443)
.|||++.+. .+.++||+-++.
T Consensus 147 ~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 147 SNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred ccEEEeCCCCceeEEEEcchhcee
Confidence 999999887 899999987653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.70 E-value=4.1e-07 Score=81.06 Aligned_cols=136 Identities=15% Similarity=0.097 Sum_probs=94.6
Q ss_pred eeeecCeEEEEEEECCceeEEEEee---------ccCccchHHHHHHHHHHhccCC--CceeeeeeccccCCcccEEEee
Q psy14889 144 IGKGRYGEVWRGVWHGENVAVKIFF---------SRDEASWSRETEIYSTVLLRHE--NILGYIGSDMTSRNSCTQLWLV 212 (443)
Q Consensus 144 lG~G~fg~Vy~~~~~~~~vAvK~~~---------~~~~~~~~~e~ei~~~~~l~H~--nIv~l~g~~~~~~~~~~~~~lv 212 (443)
-|+||.+-|++-.+.|..+-+|.-. ......+.+|. ..+..+..- .+.+.........+...+-+||
T Consensus 26 ~~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~--~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREV--AVIKELERAGVIVPKIVFGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeCCcEEEEEeccCcccccccCCCCchHHHHHH--HHHHHHHHcCCCCCccceeeeeccCCceEEEEE
Confidence 3678999999999888888899653 11223344443 333333322 2333332222222223456899
Q ss_pred ecccC-cccHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCc--EEEEecC
Q psy14889 213 THYHS-FGSLYDHLNRT---TLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGT--CVIADFG 286 (443)
Q Consensus 213 ~e~~~-~gsL~~~l~~~---~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~--~kl~DfG 286 (443)
+|-+. .-||.+++.+. +.+......++.+++..+.-||+. |+.|+|+.+.||+++.++. ++++||.
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~--------Gv~Hgdly~khIll~~~g~~~v~lIDlE 175 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSV--------NRQHGCCYVRHIYVKTEGKAEAGFLDLE 175 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHC--------CCcCCCCCHhheeecCCCCeeEEEEEhh
Confidence 99665 35899888664 346777889999999999999999 9999999999999986666 9999997
Q ss_pred Ccc
Q psy14889 287 LAV 289 (443)
Q Consensus 287 la~ 289 (443)
-++
T Consensus 176 k~r 178 (216)
T PRK09902 176 KSR 178 (216)
T ss_pred ccc
Confidence 553
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.54 E-value=4.5e-07 Score=82.78 Aligned_cols=131 Identities=24% Similarity=0.271 Sum_probs=87.0
Q ss_pred ccccceeeeecCeEEEEEEE-CCceeEEEEeecc-----------------Ccc------chHHHHHHHHHHhccCC--C
Q psy14889 138 ISLSECIGKGRYGEVWRGVW-HGENVAVKIFFSR-----------------DEA------SWSRETEIYSTVLLRHE--N 191 (443)
Q Consensus 138 ~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~-----------------~~~------~~~~e~ei~~~~~l~H~--n 191 (443)
..+...||-|--+.||.|.. .|.++|||.-+.. ... ....++|...+..|.-. .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 45778999999999999998 6999999953210 001 11224555555545433 4
Q ss_pred ceeeeeeccccCCcccEEEeeecccCcccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCC
Q psy14889 192 ILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKN 271 (443)
Q Consensus 192 Iv~l~g~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~N 271 (443)
+.+-+++ +.-.+||||.++--|... +++....-.++..|+.-+.-+-.. ||||+|+.+-|
T Consensus 173 VP~P~~~--------nRHaVvMe~ieG~eL~~~----r~~~en~~~il~~il~~~~~~~~~--------GiVHGDlSefN 232 (304)
T COG0478 173 VPKPIAW--------NRHAVVMEYIEGVELYRL----RLDVENPDEILDKILEEVRKAYRR--------GIVHGDLSEFN 232 (304)
T ss_pred CCCcccc--------ccceeeeehcccceeecc----cCcccCHHHHHHHHHHHHHHHHHc--------CccccCCchhe
Confidence 5554443 334799999987555432 223344444444455444444455 99999999999
Q ss_pred EEEcCCCcEEEEecCCc
Q psy14889 272 ILVKTNGTCVIADFGLA 288 (443)
Q Consensus 272 iLl~~~~~~kl~DfGla 288 (443)
|+++++|.+.++||=-+
T Consensus 233 IlV~~dg~~~vIDwPQ~ 249 (304)
T COG0478 233 ILVTEDGDIVVIDWPQA 249 (304)
T ss_pred EEEecCCCEEEEeCccc
Confidence 99999999999999543
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.51 E-value=7.8e-06 Score=83.13 Aligned_cols=138 Identities=20% Similarity=0.214 Sum_probs=86.2
Q ss_pred ceeeeecCeEEEEEEE-CCceeEEEEeeccCccchHH-------------------------------------H----H
Q psy14889 142 ECIGKGRYGEVWRGVW-HGENVAVKIFFSRDEASWSR-------------------------------------E----T 179 (443)
Q Consensus 142 ~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~-------------------------------------e----~ 179 (443)
+.|+.++-|+||+|++ +|+.||||+.+..-...... | .
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 6799999999999999 59999999874421111000 0 1
Q ss_pred HHHHHHh----ccCCCceeeeeeccccCCcccEEEeeecccCcccHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHHch
Q psy14889 180 EIYSTVL----LRHENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDH--LNRTTLNHHQMMKICLSIVNGLVHLHTEI 253 (443)
Q Consensus 180 ei~~~~~----l~H~nIv~l~g~~~~~~~~~~~~~lv~e~~~~gsL~~~--l~~~~l~~~~~~~i~~qia~gL~yLH~~~ 253 (443)
|...... ++...=+.+=.++.+- ++.-.|+|||+.|-.+.+. ++...++...+.....++.--.-+-|
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~---t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f~~q~~~d--- 284 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEY---TTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAFLRQLLRD--- 284 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhc---cCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHHHHHHHhc---
Confidence 1111111 2222212222222211 1234899999999888887 45566665554443333332222223
Q ss_pred hcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCccccc
Q psy14889 254 FGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYS 292 (443)
Q Consensus 254 ~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~~ 292 (443)
|+.|.|..|.||+++.++++.+.|||+...+.
T Consensus 285 -------gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 285 -------GFFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred -------CccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 88999999999999999999999999985544
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.39 E-value=4.5e-06 Score=74.77 Aligned_cols=144 Identities=18% Similarity=0.122 Sum_probs=92.5
Q ss_pred HHhhhhccccccceeeeecCeEEEEEEECCceeEEEEeeccCccchHH----------HHHHHHHHhccCC---Cceeee
Q psy14889 130 IQRTLAKQISLSECIGKGRYGEVWRGVWHGENVAVKIFFSRDEASWSR----------ETEIYSTVLLRHE---NILGYI 196 (443)
Q Consensus 130 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~----------e~ei~~~~~l~H~---nIv~l~ 196 (443)
....+..+|...+++-......|.+-..+|..+.+|.........+.+ ...+.....++.. .+..++
T Consensus 25 ~~~i~~~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~y 104 (229)
T PF06176_consen 25 GEKILDNNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPY 104 (229)
T ss_pred HHHHHhCCceEEEeecCCCccEEEEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccce
Confidence 345566889999999888888888888899999999775533211111 1122222222221 222222
Q ss_pred eecccc-CCcccEEEeeecccCcccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEc
Q psy14889 197 GSDMTS-RNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVK 275 (443)
Q Consensus 197 g~~~~~-~~~~~~~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~ 275 (443)
.+.... ..-....+|+|||++|-.|.++.. +++ .++..++.++.-||.. |+.|+|..|.|++++
T Consensus 105 l~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~---i~e----~~~~ki~~~ikqlH~~--------G~~HGD~hpgNFlv~ 169 (229)
T PF06176_consen 105 LAAEKKIFRYTSSYVLLMEYIEGVELNDIED---IDE----DLAEKIVEAIKQLHKH--------GFYHGDPHPGNFLVS 169 (229)
T ss_pred eeeeeeeccceeEEEEEEEEecCeecccchh---cCH----HHHHHHHHHHHHHHHc--------CCccCCCCcCcEEEE
Confidence 221111 111134578999999988776532 222 2456677889999999 999999999999998
Q ss_pred CCCcEEEEecCCcc
Q psy14889 276 TNGTCVIADFGLAV 289 (443)
Q Consensus 276 ~~~~~kl~DfGla~ 289 (443)
+++ ++++||+..+
T Consensus 170 ~~~-i~iID~~~k~ 182 (229)
T PF06176_consen 170 NNG-IRIIDTQGKR 182 (229)
T ss_pred CCc-EEEEECcccc
Confidence 555 9999998653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.35 E-value=6.9e-06 Score=75.29 Aligned_cols=144 Identities=19% Similarity=0.211 Sum_probs=78.1
Q ss_pred cceeeeecCeEEEEEEECCceeEEEEeecc-CccchHHHHHHHHHHhccCC--CceeeeeeccccCCcccEEEeeecccC
Q psy14889 141 SECIGKGRYGEVWRGVWHGENVAVKIFFSR-DEASWSRETEIYSTVLLRHE--NILGYIGSDMTSRNSCTQLWLVTHYHS 217 (443)
Q Consensus 141 ~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~-~~~~~~~e~ei~~~~~l~H~--nIv~l~g~~~~~~~~~~~~~lv~e~~~ 217 (443)
.+.|+.|..+.||+...++..+++|..... .......|.++... +... .+.+++........ ....+++|++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~~~~vlK~~~~~~~~~~~~~e~~~~~~--l~~~~~pvP~~~~~~~~~~~-~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDDGRYVLKFYRPPDAAERLRREAAVLRQ--LAEHGIPVPRVLAFDTSDEF-NGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETTSEEEEEEESSHHHHHHHHHHHHHHHH--HHHTTSBS--EEEEEEETEE-TSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECCcEEEEEEeCCCCCHHHHHHHHHHHHH--HHhcCCCCceEEeecccccc-cccceEEEEEec
Confidence 467899999999999997789999987554 22333445444444 3322 34556654322221 134789999999
Q ss_pred cccHHH----------------Hh---ccc--C---CCHHH---------HHHH------------HHHHHH-HHHHHHH
Q psy14889 218 FGSLYD----------------HL---NRT--T---LNHHQ---------MMKI------------CLSIVN-GLVHLHT 251 (443)
Q Consensus 218 ~gsL~~----------------~l---~~~--~---l~~~~---------~~~i------------~~qia~-gL~yLH~ 251 (443)
+..+.. .+ +.. . +.... .... ...+.. .+..++.
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 887777 11 010 0 01000 0000 111222 2333333
Q ss_pred chhcCCCCCCeEEeCCCCCCEEEc-CCCcEEEEecCCc
Q psy14889 252 EIFGTQGKPAIAHRDIKSKNILVK-TNGTCVIADFGLA 288 (443)
Q Consensus 252 ~~~~~~~~~~iiHrDlk~~NiLl~-~~~~~kl~DfGla 288 (443)
... ......++|+|+.|.|||++ +++.+.|+||+.+
T Consensus 159 ~~~-~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a 195 (239)
T PF01636_consen 159 LLP-KPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDA 195 (239)
T ss_dssp HHH-CCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-
T ss_pred hhc-cCCCcEEEEeccccccceeeeccceeEEEecccc
Confidence 211 01245799999999999999 6666689999876
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1235|consensus | Back alignment and domain information |
|---|
Probab=98.23 E-value=7.9e-06 Score=82.86 Aligned_cols=136 Identities=21% Similarity=0.226 Sum_probs=91.1
Q ss_pred ceeeeecCeEEEEEEE-CCceeEEEEeeccCc----------------------------------------cchHHHHH
Q psy14889 142 ECIGKGRYGEVWRGVW-HGENVAVKIFFSRDE----------------------------------------ASWSRETE 180 (443)
Q Consensus 142 ~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~----------------------------------------~~~~~e~e 180 (443)
+.||.-+.|+|++|+. +|+.||||+-+..-. -++..|++
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 6799999999999998 789999998543211 01112211
Q ss_pred HH--HHHhccCCC------ceeeeeeccccCCcccEEEeeecccCcccHHH--HhcccCCCHHHHHHHHHHHHHHHHHHH
Q psy14889 181 IY--STVLLRHEN------ILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYD--HLNRTTLNHHQMMKICLSIVNGLVHLH 250 (443)
Q Consensus 181 i~--~~~~l~H~n------Iv~l~g~~~~~~~~~~~~~lv~e~~~~gsL~~--~l~~~~l~~~~~~~i~~qia~gL~yLH 250 (443)
-. ....+.|-+ |.+++-.+. ....|+||||+|..+.+ .+.+..++...+..-+.++..-+-+-|
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~s------t~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~~qIf~~ 320 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLS------TKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYLEQIFKT 320 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcC------cceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHHHHHHhc
Confidence 11 011144555 333332222 23589999999987755 456677888877666666554444444
Q ss_pred HchhcCCCCCCeEEeCCCCCCEEEcC----CCcEEEEecCCcccccc
Q psy14889 251 TEIFGTQGKPAIAHRDIKSKNILVKT----NGTCVIADFGLAVSYSQ 293 (443)
Q Consensus 251 ~~~~~~~~~~~iiHrDlk~~NiLl~~----~~~~kl~DfGla~~~~~ 293 (443)
|++|+|=.|.||++.. ++.+.+-|||+...+..
T Consensus 321 ----------GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 321 ----------GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred ----------CCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 8899999999999984 56899999999876654
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.22 E-value=2e-05 Score=71.47 Aligned_cols=140 Identities=21% Similarity=0.233 Sum_probs=87.7
Q ss_pred ccccccce---eeeecCeEEEEEEE-CCceeEEEEeeccCccc------------h-------HH------HHHHHHHHh
Q psy14889 136 KQISLSEC---IGKGRYGEVWRGVW-HGENVAVKIFFSRDEAS------------W-------SR------ETEIYSTVL 186 (443)
Q Consensus 136 ~~~~~~~~---lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~------------~-------~~------e~ei~~~~~ 186 (443)
++..+... |++|--+.||+|.- ++..+|||+.+...... + .. ++|...+.+
T Consensus 45 ~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R 124 (268)
T COG1718 45 SRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKR 124 (268)
T ss_pred cCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHH
Confidence 44444444 45566668999986 68999999875321110 0 00 233333333
Q ss_pred ccCC--CceeeeeeccccCCcccEEEeeecccCcc-cHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeE
Q psy14889 187 LRHE--NILGYIGSDMTSRNSCTQLWLVTHYHSFG-SLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIA 263 (443)
Q Consensus 187 l~H~--nIv~l~g~~~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~ii 263 (443)
+.-- .+.+-+++ ..-.|||||+... .-.-.|+.-++...+...+..++++.+.-|-..+ ++|
T Consensus 125 ~~eAGVrvP~Pi~~--------~~nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a-------~LV 189 (268)
T COG1718 125 AYEAGVRVPEPIAF--------RNNVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEA-------GLV 189 (268)
T ss_pred HHHcCCCCCCceee--------cCCeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhc-------Ccc
Confidence 2211 11122222 1126999998653 2222334444555577888889999998888732 999
Q ss_pred EeCCCCCCEEEcCCCcEEEEecCCcccc
Q psy14889 264 HRDIKSKNILVKTNGTCVIADFGLAVSY 291 (443)
Q Consensus 264 HrDlk~~NiLl~~~~~~kl~DfGla~~~ 291 (443)
|+||..-|||+. ++.+.|+|||-|...
T Consensus 190 HgDLSEyNiL~~-~~~p~iID~~QaV~~ 216 (268)
T COG1718 190 HGDLSEYNILVH-DGEPYIIDVSQAVTI 216 (268)
T ss_pred cccchhhheEEE-CCeEEEEECcccccc
Confidence 999999999999 889999999987543
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.18 E-value=1.9e-05 Score=67.77 Aligned_cols=129 Identities=16% Similarity=0.247 Sum_probs=83.0
Q ss_pred cccccceeeeecCeEEEEEEECCceeEEEEeeccC-ccchHHHHHHHHHHhccCCCce-eeeeeccccCCcccEEEeeec
Q psy14889 137 QISLSECIGKGRYGEVWRGVWHGENVAVKIFFSRD-EASWSRETEIYSTVLLRHENIL-GYIGSDMTSRNSCTQLWLVTH 214 (443)
Q Consensus 137 ~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~-~~~~~~e~ei~~~~~l~H~nIv-~l~g~~~~~~~~~~~~~lv~e 214 (443)
.....+.|++|++|.||+|.|.|..+|+|+-..+. ......|++++.. +.-.++- +++.|.. -++.||
T Consensus 23 ~~~v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds~r~~l~kEakiLei--l~g~~~~p~vy~yg~--------~~i~me 92 (201)
T COG2112 23 ELRVEKELAKGTTSVVYLGEWRGGEVALKVRRRDSPRRNLEKEAKILEI--LAGEGVTPEVYFYGE--------DFIRME 92 (201)
T ss_pred hhhhhhhhhcccccEEEEeeccCceEEEEEecCCcchhhHHHHHHHHHH--hhhcCCCceEEEech--------hhhhhh
Confidence 34556789999999999999999999999765433 3344556666555 4444443 3444422 246799
Q ss_pred ccCcccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCC-CCCEEEcCCCcEEEEecCCcc
Q psy14889 215 YHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIK-SKNILVKTNGTCVIADFGLAV 289 (443)
Q Consensus 215 ~~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk-~~NiLl~~~~~~kl~DfGla~ 289 (443)
|..+-.|.+.-... +.+++..+ +.. +|.-+.. ||-|..|. |...+|..+..+.|+||..|+
T Consensus 93 ~i~G~~L~~~~~~~--~rk~l~~v----lE~-a~~LD~~-------GI~H~El~~~~k~vlv~~~~~~iIDFd~At 154 (201)
T COG2112 93 YIDGRPLGKLEIGG--DRKHLLRV----LEK-AYKLDRL-------GIEHGELSRPWKNVLVNDRDVYIIDFDSAT 154 (201)
T ss_pred hhcCcchhhhhhcc--cHHHHHHH----HHH-HHHHHHh-------ccchhhhcCCceeEEecCCcEEEEEccchh
Confidence 99987887765322 33334333 333 3333321 88888875 444455555599999998875
|
|
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=98.18 E-value=4.3e-06 Score=89.69 Aligned_cols=203 Identities=18% Similarity=0.257 Sum_probs=136.4
Q ss_pred HHHHHHHHHHhccCCCceeeeeeccccCCcccEEEeeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchh
Q psy14889 176 SRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIF 254 (443)
Q Consensus 176 ~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~ 254 (443)
..|.|+..+.++.|+|++.+++|..........+.+..|++..-++...+.. ..++....+.+..++..||+|+|+.
T Consensus 228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~-- 305 (1351)
T KOG1035|consen 228 TTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSL-- 305 (1351)
T ss_pred HHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHh--
Confidence 3467777888899999999999876654432234455688888888888764 6688889999999999999999988
Q ss_pred cCCCCCCeEEeCCCCC---CEEEcCCCcEEEE--ecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCC
Q psy14889 255 GTQGKPAIAHRDIKSK---NILVKTNGTCVIA--DFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESF 329 (443)
Q Consensus 255 ~~~~~~~iiHrDlk~~---NiLl~~~~~~kl~--DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~ 329 (443)
...|.-|..+ +--.+..+...++ ||+.++.+....... ...-+..|.+||....... ...
T Consensus 306 ------~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~-----~~~~~~~~~~~e~~~~~~~----~~~ 370 (1351)
T KOG1035|consen 306 ------SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF-----SDLLAEIRNADEDLKENTA----KKS 370 (1351)
T ss_pred ------ccceeEEecccccccccCccceeecchhhhcccccCCCcccch-----hhcCccccccccccccccc----hhh
Confidence 4455555444 4445556666666 888876665433221 1123456778887765522 222
Q ss_pred CccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhc
Q psy14889 330 KKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWH 409 (443)
Q Consensus 330 ~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 409 (443)
...|+|.+|..+..+..|...... ...+....+........+...+|+.
T Consensus 371 r~~dL~~lgll~~~~~~~~~i~~~-------------------------------~~~~~~~l~~~~~~~~~d~~~~~~~ 419 (1351)
T KOG1035|consen 371 RLTDLWCLGLLLLQLSQGEDISEK-------------------------------SAVPVSLLDVLSTSELLDALPKCLD 419 (1351)
T ss_pred hhhHHHHHHHHHhhhhhcCccccc-------------------------------ccchhhhhccccchhhhhhhhhhcc
Confidence 446999999999999887221100 0000000111122257789999999
Q ss_pred CCcCCCCcHHHHHHHHH
Q psy14889 410 QNANVRLSALRVKKTLI 426 (443)
Q Consensus 410 ~dP~~Rps~~evl~~L~ 426 (443)
.++++|+++.+++...-
T Consensus 420 ~~~~~Rl~~~~ll~~~f 436 (1351)
T KOG1035|consen 420 EDSEERLSALELLTHPF 436 (1351)
T ss_pred hhhhhccchhhhhhchh
Confidence 99999999999987654
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.15 E-value=3.2e-05 Score=71.81 Aligned_cols=135 Identities=17% Similarity=0.140 Sum_probs=78.9
Q ss_pred eeeecC-eEEEEEEECCceeEEEEeeccCccchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEeeecccCcccHH
Q psy14889 144 IGKGRY-GEVWRGVWHGENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLY 222 (443)
Q Consensus 144 lG~G~f-g~Vy~~~~~~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e~~~~gsL~ 222 (443)
|-.|.+ ..||+....+..+.||+...........|.+++.... .+--+.+++++.... ...++|||+.++.+|.
T Consensus 6 ~~~g~~~~~v~~~~~~~~~~~vk~~~~~~~~~~~~E~~~l~~l~-~~~~vP~v~~~~~~~----~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 6 VTEGQSGATVYRLDGKNPGLYLKIAPSGPTYELEREAERLRWLA-GKLPVPEVIDYGSDD----GRAWLLTSAVPGVPAA 80 (244)
T ss_pred cCCCCCcCeEEEEcCCCCcEEEEecCCCcccchHHHHHHHHHHH-hcCCCCeEEEEEecC----CccEEEEEeeCCccHh
Confidence 445555 6899987777788889775443333445555554432 233345566655443 2348999999987776
Q ss_pred HHhcccCCCHHHHHHHHHHHHHHHHHHHHc-----------------------------------------------h--
Q psy14889 223 DHLNRTTLNHHQMMKICLSIVNGLVHLHTE-----------------------------------------------I-- 253 (443)
Q Consensus 223 ~~l~~~~l~~~~~~~i~~qia~gL~yLH~~-----------------------------------------------~-- 253 (443)
.... ......++.++++.|.-||+. .
T Consensus 81 ~~~~-----~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 155 (244)
T cd05150 81 ALWE-----ELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEA 155 (244)
T ss_pred Hhhc-----ccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHh
Confidence 4321 000111122222222222211 0
Q ss_pred -hcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCc
Q psy14889 254 -FGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA 288 (443)
Q Consensus 254 -~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla 288 (443)
......+.++|+|+.|.|||++++....|+||+.+
T Consensus 156 ~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a 191 (244)
T cd05150 156 TRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRL 191 (244)
T ss_pred hCCCcCceEEECCCCCCccEEEeCCcEEEEEEcccc
Confidence 00123467999999999999999888899999876
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=98.11 E-value=5.8e-07 Score=90.51 Aligned_cols=187 Identities=18% Similarity=0.170 Sum_probs=126.3
Q ss_pred hhhccccccceeeeecCeEEEEEEEC-CceeEEEEeeccCccchHHHHHHHHHHhccCCC-ceeeeeeccccCCcccEEE
Q psy14889 133 TLAKQISLSECIGKGRYGEVWRGVWH-GENVAVKIFFSRDEASWSRETEIYSTVLLRHEN-ILGYIGSDMTSRNSCTQLW 210 (443)
Q Consensus 133 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~H~n-Iv~l~g~~~~~~~~~~~~~ 210 (443)
...+-+....-+++|+++.++|.+-. .+....+.+... ..+..++..+.+.+||| .+..++-+... ...+
T Consensus 239 Dk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E----~~~~ 310 (829)
T KOG0576|consen 239 DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT----LSRRLAIELLDKVNNPNPVVRYLEDYDGE----DYLW 310 (829)
T ss_pred CCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc----hhhHHHHHHHHHccCCCCcccccccCCcc----cccc
Confidence 33455666677899999999998764 233335544332 22233344444589999 55555443332 4579
Q ss_pred eeecccCcc-cHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCC
Q psy14889 211 LVTHYHSFG-SLYDHLN--RTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGL 287 (443)
Q Consensus 211 lv~e~~~~g-sL~~~l~--~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGl 287 (443)
++++++..| +-..... ...+..-+...+.+.-.++|+|||+. .=+|+| ||+..+ +..|..||+.
T Consensus 311 i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~--------~~~~~d----~~l~s~-~~~~~~~~~v 377 (829)
T KOG0576|consen 311 IPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSS--------YKVHRD----NILGSE-EEVKLLDFAV 377 (829)
T ss_pred hhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccc--------cccCcc----cccccc-cccccccccC
Confidence 999999887 2222211 22344555666777788999999976 348998 777755 6789999999
Q ss_pred cccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCC
Q psy14889 288 AVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKAN 351 (443)
Q Consensus 288 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~ 351 (443)
...+.... ..+...+|+.|+|||+...+ .+..+.|+||+|+--.++.-|-+|.
T Consensus 378 ~~~L~~~~-----~~~t~~~~~~~~~pev~~~~------~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 378 PPQLTRTM-----KPRTAIGTPEPLAPEVIQEN------TIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred CcccCccc-----ccccCCCCCCCCCchhhccc------ccccCCCccCCCcchhhcCCCCCCC
Confidence 87665432 24566899999999988877 4556899999998777777775543
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.11 E-value=6.8e-05 Score=68.71 Aligned_cols=135 Identities=14% Similarity=0.107 Sum_probs=75.6
Q ss_pred ceeeeecCeEEEEEEECCceeEEEEeeccC-ccchHHHHHHHHHHhccCCC--ceeeeeeccccCCcccEEEeeecccCc
Q psy14889 142 ECIGKGRYGEVWRGVWHGENVAVKIFFSRD-EASWSRETEIYSTVLLRHEN--ILGYIGSDMTSRNSCTQLWLVTHYHSF 218 (443)
Q Consensus 142 ~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~-~~~~~~e~ei~~~~~l~H~n--Iv~l~g~~~~~~~~~~~~~lv~e~~~~ 218 (443)
..||+|..+.||+. .|..+++|...... .....+|.++... +..-. +.+.+++.... ....+|||+++|
T Consensus 7 ~~i~~G~t~~~y~~--~~~~~VlR~~~~~~~~~~i~~E~~~l~~--l~~~glpvP~~~~~~~~~----~~~glv~e~i~G 78 (226)
T TIGR02172 7 TQTGEGGNGESYTH--KTGKWMLKLYNPGFDKETIKREFDASRK--VFSLGIPTPHPFDLVEDG----GRLGLIYELIVG 78 (226)
T ss_pred eeecCCCCcceeEe--cCCCEEEEeCCCCCCHHHHHHHHHHHHH--HHHcCCCCCceEEEEecC----CeeeeeeeecCC
Confidence 56899999999984 35567888765432 2233344444433 33222 34445554333 235789999988
Q ss_pred cc-HHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchh-----------------------------------cCCCCCCe
Q psy14889 219 GS-LYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIF-----------------------------------GTQGKPAI 262 (443)
Q Consensus 219 gs-L~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~-----------------------------------~~~~~~~i 262 (443)
.+ +...+. .+......++.++++.+.-||+... .-...+.+
T Consensus 79 ~~~~~~~~~---~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~ 155 (226)
T TIGR02172 79 KRSFSRIIS---DNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTC 155 (226)
T ss_pred ccchhhhhc---CCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCce
Confidence 53 221111 1111112222222222222332100 00124567
Q ss_pred EEeCCCCCCEEEcCCCcEEEEecCCc
Q psy14889 263 AHRDIKSKNILVKTNGTCVIADFGLA 288 (443)
Q Consensus 263 iHrDlk~~NiLl~~~~~~kl~DfGla 288 (443)
+|+|+.|.||++++++ +.|+||+.+
T Consensus 156 ~HgD~~~~Nii~~~~~-~~iIDwe~a 180 (226)
T TIGR02172 156 LHGDFQIGNLITSGKG-TYWIDLGDF 180 (226)
T ss_pred EecCCCCCcEEEcCCC-cEEEechhc
Confidence 9999999999999888 999999976
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.04 E-value=9e-05 Score=65.70 Aligned_cols=128 Identities=20% Similarity=0.216 Sum_probs=85.6
Q ss_pred ccccccceeeeecC-eEEEEEEECCceeEEEEeec---cCc---------cc----------hHHHHHHHHHHh---ccC
Q psy14889 136 KQISLSECIGKGRY-GEVWRGVWHGENVAVKIFFS---RDE---------AS----------WSRETEIYSTVL---LRH 189 (443)
Q Consensus 136 ~~~~~~~~lG~G~f-g~Vy~~~~~~~~vAvK~~~~---~~~---------~~----------~~~e~ei~~~~~---l~H 189 (443)
.+++..+.||.|.- |.||+++.+|+.+|+|++.. ... .. .-+..|...-.+ ..+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~ 116 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGR 116 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccc
Confidence 68999999999999 99999999999999998321 000 00 011223332222 455
Q ss_pred CCc--eeeeeeccccC--------------CcccEEEeeecccCcccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHch
Q psy14889 190 ENI--LGYIGSDMTSR--------------NSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEI 253 (443)
Q Consensus 190 ~nI--v~l~g~~~~~~--------------~~~~~~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~ 253 (443)
.++ |+.+|+..-.. .......||-||.+... .++... +.+|.+-|..+|..
T Consensus 117 e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~--------~~~~~~----~~~~~~dl~~~~k~- 183 (207)
T PF13095_consen 117 EGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP--------PLQIRD----IPQMLRDLKILHKL- 183 (207)
T ss_pred cCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc--------ccchhH----HHHHHHHHHHHHHC-
Confidence 567 88999864331 11123567888776533 233333 35566667889988
Q ss_pred hcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCc
Q psy14889 254 FGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA 288 (443)
Q Consensus 254 ~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla 288 (443)
||+-+|+++.|.. .-||+|||.+
T Consensus 184 -------gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 184 -------GIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred -------CeeeccCcccccc-----CCEEEecccC
Confidence 9999999999986 3589999864
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.95 E-value=3.6e-05 Score=68.33 Aligned_cols=99 Identities=23% Similarity=0.202 Sum_probs=76.1
Q ss_pred HHHHHHhccC-CCceeeeeeccccCCcccEEEeeecccCcccHHHH----hcccCCCHHHHHHHHHHHHHHHHHHHHchh
Q psy14889 180 EIYSTVLLRH-ENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDH----LNRTTLNHHQMMKICLSIVNGLVHLHTEIF 254 (443)
Q Consensus 180 ei~~~~~l~H-~nIv~l~g~~~~~~~~~~~~~lv~e~~~~gsL~~~----l~~~~l~~~~~~~i~~qia~gL~yLH~~~~ 254 (443)
|...+..+++ +++.+++|+|-. ++|.||...+++... .+-...+|..+.+|+.+++..+.+|++...
T Consensus 9 E~lll~~l~~~~~~pk~lG~CG~--------~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~ 80 (188)
T PF12260_consen 9 EPLLLQLLQGSEPFPKLLGSCGR--------FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPL 80 (188)
T ss_pred HHHHHHHcCCCCCCCCeeeECCC--------EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCC
Confidence 4444544666 599999999832 578899987766421 111347899999999999999999998532
Q ss_pred cCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcccc
Q psy14889 255 GTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSY 291 (443)
Q Consensus 255 ~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~ 291 (443)
. .+.-.|++++|+-+++++++|++|...+...
T Consensus 81 ----~-~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 81 ----G-FFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred ----C-cEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 1 4677999999999999999999999876443
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.91 E-value=0.00031 Score=67.24 Aligned_cols=82 Identities=17% Similarity=0.053 Sum_probs=52.2
Q ss_pred cccccceeeeecCeEEEEEEECCceeEEEEeecc-CccchHHHHHHHHHHhccC---CCceeeeeeccccCCcccEEEee
Q psy14889 137 QISLSECIGKGRYGEVWRGVWHGENVAVKIFFSR-DEASWSRETEIYSTVLLRH---ENILGYIGSDMTSRNSCTQLWLV 212 (443)
Q Consensus 137 ~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~-~~~~~~~e~ei~~~~~l~H---~nIv~l~g~~~~~~~~~~~~~lv 212 (443)
...-.+.||.|..+.||+....+..+.+|..+.. ....+..|.+.+.. +.- -.+.++++++..... .+.-+||
T Consensus 15 ~~~~~~~i~~G~~~~vy~~~~~~~~~~~k~~~~~~~~~~~~~Ea~~L~~--L~~~~~vpVP~V~~~~~~~~~-~g~~~LV 91 (297)
T PRK10593 15 KLSRVECISEQPYAALWALYDSQGNPMPLMARSFSTPGVAQQEAWKLSM--LARSGTVRMPTVYGVMTHEQS-PGPDVLL 91 (297)
T ss_pred hhheeeecCCccceeEEEEEcCCCCEEEEEecccccchHHHHHHHHHHH--HccCCCCCcCcEEEEeccCCc-CCCeEEE
Confidence 3444678999999999998775556777875432 23345556555544 332 356677776654321 1336999
Q ss_pred ecccCcccH
Q psy14889 213 THYHSFGSL 221 (443)
Q Consensus 213 ~e~~~~gsL 221 (443)
||+++++++
T Consensus 92 mE~i~G~~~ 100 (297)
T PRK10593 92 LERLRGVSV 100 (297)
T ss_pred EeccCCEec
Confidence 999988654
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.85 E-value=0.00021 Score=65.88 Aligned_cols=72 Identities=15% Similarity=0.126 Sum_probs=43.4
Q ss_pred ceeeeecCeEEEEEEEC---CceeEEEEeeccCccchHHHHHHHHHHhccCCC-ceeeeeeccccCCcccEEEeeecccC
Q psy14889 142 ECIGKGRYGEVWRGVWH---GENVAVKIFFSRDEASWSRETEIYSTVLLRHEN-ILGYIGSDMTSRNSCTQLWLVTHYHS 217 (443)
Q Consensus 142 ~~lG~G~fg~Vy~~~~~---~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~H~n-Iv~l~g~~~~~~~~~~~~~lv~e~~~ 217 (443)
+.|..|-...+|+.... +..+++|+..........++.|+..+..+...+ ..++++... . .++|||++
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~-~-------~~l~e~i~ 75 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATFQ-N-------GLIYEFIP 75 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEeC-C-------cEEEEeeC
Confidence 56777888899998764 578889976543333334444554444453333 334444321 1 47999998
Q ss_pred cccH
Q psy14889 218 FGSL 221 (443)
Q Consensus 218 ~gsL 221 (443)
+.++
T Consensus 76 G~~l 79 (235)
T cd05157 76 GRTL 79 (235)
T ss_pred CCcC
Confidence 8655
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.84 E-value=0.00045 Score=61.64 Aligned_cols=127 Identities=21% Similarity=0.225 Sum_probs=83.8
Q ss_pred cceeeeecCeEEEEEEECCceeEEEEeeccC-------------------ccchHHHHHHHHH----HhccCCCceeeee
Q psy14889 141 SECIGKGRYGEVWRGVWHGENVAVKIFFSRD-------------------EASWSRETEIYST----VLLRHENILGYIG 197 (443)
Q Consensus 141 ~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~-------------------~~~~~~e~ei~~~----~~l~H~nIv~l~g 197 (443)
...||+|+.-.||.-- ......||+..... ..+..+|..-... ....+.+|.+++|
T Consensus 6 ~~~i~~G~~R~cy~HP-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G 84 (199)
T PF10707_consen 6 SDLIAQGGERDCYQHP-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG 84 (199)
T ss_pred CcccccCCCceEEECC-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence 4679999999998643 34556788876544 2222333222221 1234788999999
Q ss_pred eccccCCcccEEEeeecccCc------ccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCC
Q psy14889 198 SDMTSRNSCTQLWLVTHYHSF------GSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKN 271 (443)
Q Consensus 198 ~~~~~~~~~~~~~lv~e~~~~------gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~N 271 (443)
+..++.. +.+|+|...+ -+|.+++.+..++. .....+.+. ..||-.+ .|+.+||+|.|
T Consensus 85 ~veT~~G----~Glv~e~I~d~dG~~s~TL~~~l~~~~~~~-~~~~~L~~f---~~~l~~~--------~Iv~~dl~~~N 148 (199)
T PF10707_consen 85 FVETNLG----LGLVVELIRDADGNISPTLEDYLKEGGLTE-ELRQALDEF---KRYLLDH--------HIVIRDLNPHN 148 (199)
T ss_pred EEecCCc----eEEEEEEEECCCCCcCccHHHHHHcCCccH-HHHHHHHHH---HHHHHHc--------CCeecCCCccc
Confidence 9988865 3566665322 46888888777777 444444443 4566666 89999999999
Q ss_pred EEEcCCC----cEEEEe
Q psy14889 272 ILVKTNG----TCVIAD 284 (443)
Q Consensus 272 iLl~~~~----~~kl~D 284 (443)
|++.... .+.|+|
T Consensus 149 Iv~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 149 IVVQRRDSGEFRLVLID 165 (199)
T ss_pred EEEEecCCCceEEEEEe
Confidence 9996543 577787
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.00019 Score=66.27 Aligned_cols=30 Identities=30% Similarity=0.513 Sum_probs=26.2
Q ss_pred CCCeEEeCCCCCCEEEcCCCcEEEEecCCc
Q psy14889 259 KPAIAHRDIKSKNILVKTNGTCVIADFGLA 288 (443)
Q Consensus 259 ~~~iiHrDlk~~NiLl~~~~~~kl~DfGla 288 (443)
.+.++|+|+.+.|||++++...-|+||+.+
T Consensus 163 ~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a 192 (235)
T cd05155 163 PPVWFHGDLAPGNLLVQDGRLSAVIDFGCL 192 (235)
T ss_pred CceEEeCCCCCCcEEEECCCEEEEEeCccc
Confidence 456999999999999987766789999976
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.77 E-value=0.0003 Score=76.85 Aligned_cols=148 Identities=12% Similarity=0.079 Sum_probs=83.3
Q ss_pred cceeeeecCeEEEEEEECC----ceeEEEEeeccCc--cchHHHHHHHHHHhcc-CCCc--eeeeeeccccCCcccEEEe
Q psy14889 141 SECIGKGRYGEVWRGVWHG----ENVAVKIFFSRDE--ASWSRETEIYSTVLLR-HENI--LGYIGSDMTSRNSCTQLWL 211 (443)
Q Consensus 141 ~~~lG~G~fg~Vy~~~~~~----~~vAvK~~~~~~~--~~~~~e~ei~~~~~l~-H~nI--v~l~g~~~~~~~~~~~~~l 211 (443)
.+.|+.|.+..+|+....+ ..+++|+...... .....+.|...+..+. |.++ .++++++.+... ....|+
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v-~G~~fl 121 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASV-IGTAFY 121 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCc-CCCceE
Confidence 5678999999999987743 4677776533221 1112334444444454 6654 677777765421 134589
Q ss_pred eecccCcccHHHHhcccCCCHHHHHHHHHHHHHH----------------------------------------------
Q psy14889 212 VTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNG---------------------------------------------- 245 (443)
Q Consensus 212 v~e~~~~gsL~~~l~~~~l~~~~~~~i~~qia~g---------------------------------------------- 245 (443)
||||+++..+.+.. -..++..++..++.++++.
T Consensus 122 VME~v~G~~~~~~~-~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~ 200 (822)
T PLN02876 122 IMEYLEGRIFVDPK-LPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPR 200 (822)
T ss_pred EEEecCCcccCCcc-CCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCC
Confidence 99999875432110 0012222233333333333
Q ss_pred -------HHHHHHchhcCCC---CCCeEEeCCCCCCEEEcCC-C-cEEEEecCCccc
Q psy14889 246 -------LVHLHTEIFGTQG---KPAIAHRDIKSKNILVKTN-G-TCVIADFGLAVS 290 (443)
Q Consensus 246 -------L~yLH~~~~~~~~---~~~iiHrDlk~~NiLl~~~-~-~~kl~DfGla~~ 290 (443)
+.+|..+...... .+.+||+|+++.|||++.+ . ..-|.||+++..
T Consensus 201 ~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~ 257 (822)
T PLN02876 201 NPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTL 257 (822)
T ss_pred ChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence 3444333111000 2469999999999999853 3 357999998753
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.00028 Score=66.05 Aligned_cols=136 Identities=17% Similarity=0.148 Sum_probs=71.2
Q ss_pred eeeecCeEEEEEEECCceeEEEEeeccCccc-hHHHHHHHHHHhccCCCc-eeeeeeccccCCcccEEEeeecccCcccH
Q psy14889 144 IGKGRYGEVWRGVWHGENVAVKIFFSRDEAS-WSRETEIYSTVLLRHENI-LGYIGSDMTSRNSCTQLWLVTHYHSFGSL 221 (443)
Q Consensus 144 lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~-~~~e~ei~~~~~l~H~nI-v~l~g~~~~~~~~~~~~~lv~e~~~~gsL 221 (443)
+..|-.+.+|+...++..+++|+.......- ..++.|...+..+....+ .++++.. . -++|+||+++..+
T Consensus 4 ~~~G~tn~~y~~~~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~------~~~v~e~i~G~~~ 75 (256)
T TIGR02721 4 LSGGLTNRSWRIEHPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E------HWLLVEWLEGEVI 75 (256)
T ss_pred CCCcCcCCeEEEEeCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C------CEEEEEeccCccc
Confidence 4567788999988888889999754332221 233444444433433222 2333332 1 1689999987655
Q ss_pred HHH--------------h---ccc-----CCCHHH-HHHHHHHH---------HHHHHHHHHchhcCCCCCCeEEeCCCC
Q psy14889 222 YDH--------------L---NRT-----TLNHHQ-MMKICLSI---------VNGLVHLHTEIFGTQGKPAIAHRDIKS 269 (443)
Q Consensus 222 ~~~--------------l---~~~-----~l~~~~-~~~i~~qi---------a~gL~yLH~~~~~~~~~~~iiHrDlk~ 269 (443)
... + +.. .++... +..+..++ ..-+..+-.........+.++|+|+.|
T Consensus 76 ~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~ 155 (256)
T TIGR02721 76 TLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHA 155 (256)
T ss_pred ccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCc
Confidence 321 1 111 111111 11111111 111111111100011234689999999
Q ss_pred CCEEEcCCCcEEEEecCCc
Q psy14889 270 KNILVKTNGTCVIADFGLA 288 (443)
Q Consensus 270 ~NiLl~~~~~~kl~DfGla 288 (443)
.||++++++ +.|+||..|
T Consensus 156 ~Nil~~~~~-~~lIDwE~a 173 (256)
T TIGR02721 156 YNLVVTPQG-LKLIDWEYA 173 (256)
T ss_pred CcEEEeCCC-CEEEecccc
Confidence 999999877 789999877
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.00059 Score=65.25 Aligned_cols=145 Identities=12% Similarity=0.062 Sum_probs=79.2
Q ss_pred cceeeeecCeEEEEEEECCceeEEEEeeccCccchHHHHHHHHHHhccCC--CceeeeeeccccC--CcccEEEeeeccc
Q psy14889 141 SECIGKGRYGEVWRGVWHGENVAVKIFFSRDEASWSRETEIYSTVLLRHE--NILGYIGSDMTSR--NSCTQLWLVTHYH 216 (443)
Q Consensus 141 ~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~H~--nIv~l~g~~~~~~--~~~~~~~lv~e~~ 216 (443)
.+.|..|....+|+...++..+++|+...........|.++... +.+. .+.+.+....... ...+..+++++|+
T Consensus 19 i~~i~~G~~n~~y~v~~~~~~~vLr~~~~~~~~~~~~e~~~l~~--L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i 96 (296)
T cd05153 19 FEGISAGIENTNYFVTTDSGRYVLTLFEKVSAEELPFFLALLDH--LAERGLPVPRPIADRDGEYLSELAGKPAALVEFL 96 (296)
T ss_pred eecccCccccceEEEEeCCCcEEEEEcCCCChHhccHHHHHHHH--HHHCCCCCCccccCCCCcEeeeeCCceEEEEEeC
Confidence 45677787789999887777899998754333333344444443 4332 2344433211000 0012458899999
Q ss_pred CcccHHH----H-------h---cc--cC----------CCHHHHH----------HHHHHHHHHHHHHHHchhcCCCCC
Q psy14889 217 SFGSLYD----H-------L---NR--TT----------LNHHQMM----------KICLSIVNGLVHLHTEIFGTQGKP 260 (443)
Q Consensus 217 ~~gsL~~----~-------l---~~--~~----------l~~~~~~----------~i~~qia~gL~yLH~~~~~~~~~~ 260 (443)
+|..+.. . + +. .. ..|.... .....+...+.++.... ......
T Consensus 97 ~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~-~~~~~~ 175 (296)
T cd05153 97 AGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFD-PSDLPR 175 (296)
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhh-hhcCCC
Confidence 8765422 0 0 10 00 0111110 01111233444444320 011234
Q ss_pred CeEEeCCCCCCEEEcCCCcEEEEecCCc
Q psy14889 261 AIAHRDIKSKNILVKTNGTCVIADFGLA 288 (443)
Q Consensus 261 ~iiHrDlk~~NiLl~~~~~~kl~DfGla 288 (443)
+++|+|+.|.|||++++..+.|.||+.+
T Consensus 176 ~l~HgD~~~~Nil~~~~~~~~iIDfe~a 203 (296)
T cd05153 176 GVIHADLFRDNVLFDGDELSGVIDFYFA 203 (296)
T ss_pred cCCccCcCcccEEEeCCceEEEeehhhh
Confidence 7999999999999999877899999876
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.00083 Score=64.47 Aligned_cols=30 Identities=30% Similarity=0.455 Sum_probs=26.9
Q ss_pred CCCeEEeCCCCCCEEEcCC----CcEEEEecCCc
Q psy14889 259 KPAIAHRDIKSKNILVKTN----GTCVIADFGLA 288 (443)
Q Consensus 259 ~~~iiHrDlk~~NiLl~~~----~~~kl~DfGla 288 (443)
...++|+|+.+.|||++++ +.++++||..|
T Consensus 178 ~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya 211 (302)
T cd05156 178 PVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYA 211 (302)
T ss_pred CceEEecCCCcCeEEecCCCCCCCcEEEEeeCCC
Confidence 4589999999999999985 78999999876
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG1826|consensus | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.00013 Score=80.45 Aligned_cols=147 Identities=15% Similarity=0.060 Sum_probs=103.8
Q ss_pred ccCCCceeeeeeccccCCcccEEEeeecccCcccHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCC
Q psy14889 187 LRHENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNR-----TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPA 261 (443)
Q Consensus 187 l~H~nIv~l~g~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~-----~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~ 261 (443)
..|+++.....-.....+ .+.|.+++|+.+|++.+.+-+ ..+...-+.....+...+..-+|+.. ....-
T Consensus 1286 ~~h~~~~~~p~rI~ps~s--~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t---nlg~T 1360 (2724)
T KOG1826|consen 1286 AKHYLTEVDPLRIPPSES--TEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT---NLGNT 1360 (2724)
T ss_pred hhceeeecccccCCCCCC--hHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc---cCCcc
Confidence 589998877655443333 456899999999999998843 22333333333334366666666652 22224
Q ss_pred eEEeCCCCCCEEEcCCCcEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHH
Q psy14889 262 IAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVL 341 (443)
Q Consensus 262 iiHrDlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl 341 (443)
-+|++||+-|.+|..+..+|+.++|+.+........ ....++++.|++|++...- .++.++|+|+.|+-+
T Consensus 1361 ~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf----~Gl~l~sp~~v~qli~N~i------k~t~rsdilr~s~~l 1430 (2724)
T KOG1826|consen 1361 NVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSF----FGLELCSPIYVLQLIKNEI------KFTKRSDILRRSLSL 1430 (2724)
T ss_pred chhhhhhhhccceecCCcccccccccccccCchHhh----hhhhhCCHHHHHHHHHHHH------hhhhHHHHHHHHHHH
Confidence 589999999999999999999999999733322211 2345678889999988765 666779999999999
Q ss_pred HHHHhcc
Q psy14889 342 WEVCRRT 348 (443)
Q Consensus 342 ~elltg~ 348 (443)
|++..|.
T Consensus 1431 y~rs~~n 1437 (2724)
T KOG1826|consen 1431 YLRSDGN 1437 (2724)
T ss_pred HHHhccc
Confidence 9988773
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.10 E-value=0.0055 Score=58.94 Aligned_cols=147 Identities=12% Similarity=0.021 Sum_probs=77.9
Q ss_pred cceeeeecCeEEEEEEECCceeEEEEeeccC-ccchHHHHHHHHHHhccCCCceeeeeecccc--CCcccEEEeeecccC
Q psy14889 141 SECIGKGRYGEVWRGVWHGENVAVKIFFSRD-EASWSRETEIYSTVLLRHENILGYIGSDMTS--RNSCTQLWLVTHYHS 217 (443)
Q Consensus 141 ~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~-~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~--~~~~~~~~lv~e~~~ 217 (443)
.+.++.|....+|+...++..+++|+..... ......+.++.....-..-.+.+.+...... ....+..++++||++
T Consensus 27 i~~~~~G~~n~~y~v~t~~~~~vLK~~~~~~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~i~ 106 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVGRYILTLYEKRVKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEFLQ 106 (307)
T ss_pred ccccCCccccceEEEEeCCCcEEEEEecCCCCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEeCC
Confidence 4567777778999987766678889764421 2233344444433211111233333321100 000134689999988
Q ss_pred cccHH-----H------Hh---cc--cCC-----------CHHHHH------------HHHHHHHHHHHHHHHchhcCCC
Q psy14889 218 FGSLY-----D------HL---NR--TTL-----------NHHQMM------------KICLSIVNGLVHLHTEIFGTQG 258 (443)
Q Consensus 218 ~gsL~-----~------~l---~~--~~l-----------~~~~~~------------~i~~qia~gL~yLH~~~~~~~~ 258 (443)
|..+. . .+ +. ..+ .|.... .....+...++++..... ...
T Consensus 107 G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~-~~~ 185 (307)
T TIGR00938 107 GLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWP-RDL 185 (307)
T ss_pred CCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhh-hcC
Confidence 74431 1 11 11 111 111100 011123345555543211 112
Q ss_pred CCCeEEeCCCCCCEEEcCCCcEEEEecCCc
Q psy14889 259 KPAIAHRDIKSKNILVKTNGTCVIADFGLA 288 (443)
Q Consensus 259 ~~~iiHrDlk~~NiLl~~~~~~kl~DfGla 288 (443)
..+++|+|+.+.|++++.++...|+||+.+
T Consensus 186 ~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~ 215 (307)
T TIGR00938 186 PRGVIHADLFPDNVLFDGDSVKGVIDFYFA 215 (307)
T ss_pred CCccCCCCCCcCcEEEECCceEEEeecccc
Confidence 458999999999999999887789999976
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.06 E-value=0.015 Score=57.70 Aligned_cols=74 Identities=19% Similarity=0.030 Sum_probs=45.7
Q ss_pred cceeeeecCeEEEEEEEC-C-ceeEEEEeecc----------CccchHHHHHHHHHHh-ccCCCceeeeeeccccCCccc
Q psy14889 141 SECIGKGRYGEVWRGVWH-G-ENVAVKIFFSR----------DEASWSRETEIYSTVL-LRHENILGYIGSDMTSRNSCT 207 (443)
Q Consensus 141 ~~~lG~G~fg~Vy~~~~~-~-~~vAvK~~~~~----------~~~~~~~e~ei~~~~~-l~H~nIv~l~g~~~~~~~~~~ 207 (443)
.+.||.|.+..||++... | +.|+||.-... .......|.+.+.... ..-.++.+++.+..+.
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~~~----- 105 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDEEL----- 105 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECCCC-----
Confidence 357899999999999984 4 48999974311 1122334555444321 1224577777773322
Q ss_pred EEEeeecccCccc
Q psy14889 208 QLWLVTHYHSFGS 220 (443)
Q Consensus 208 ~~~lv~e~~~~gs 220 (443)
.++||||+++..
T Consensus 106 -~~lVME~L~~~~ 117 (401)
T PRK09550 106 -AVTVMEDLSDHK 117 (401)
T ss_pred -CEEEEecCCCcc
Confidence 379999987643
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.05 E-value=0.0068 Score=58.60 Aligned_cols=30 Identities=23% Similarity=0.349 Sum_probs=26.3
Q ss_pred CCCeEEeCCCCCCEEEcCCCcEEEEecCCc
Q psy14889 259 KPAIAHRDIKSKNILVKTNGTCVIADFGLA 288 (443)
Q Consensus 259 ~~~iiHrDlk~~NiLl~~~~~~kl~DfGla 288 (443)
..++||+|+.+.|||++.+...-|+||+.+
T Consensus 186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~ 215 (319)
T PRK05231 186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFA 215 (319)
T ss_pred CcccCCCCCCCCcEEEECCceEEEEecccc
Confidence 458999999999999997766689999976
|
|
| >KOG2270|consensus | Back alignment and domain information |
|---|
Probab=97.01 E-value=0.0055 Score=58.92 Aligned_cols=136 Identities=21% Similarity=0.251 Sum_probs=94.3
Q ss_pred cceeeeecCeEEEEEEE-CCceeEEEEeecc------------Cccc---------------hHHHHHHHHHHhccCCCc
Q psy14889 141 SECIGKGRYGEVWRGVW-HGENVAVKIFFSR------------DEAS---------------WSRETEIYSTVLLRHENI 192 (443)
Q Consensus 141 ~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~------------~~~~---------------~~~e~ei~~~~~l~H~nI 192 (443)
-..|..|--+.||.+.- +|..+|||+.+.. .+.+ .-.|.|+..+.+++...|
T Consensus 149 nGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGI 228 (520)
T KOG2270|consen 149 NGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGI 228 (520)
T ss_pred ccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCC
Confidence 34678888899999987 7999999986421 0111 112567777666554443
Q ss_pred eeeeeeccccCCcccEEEeeecccCc-ccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCC
Q psy14889 193 LGYIGSDMTSRNSCTQLWLVTHYHSF-GSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKN 271 (443)
Q Consensus 193 v~l~g~~~~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~N 271 (443)
..---+.. ..-.|||+|+.. |--.-.|+...++...+..+-.|++.-|.-|...| ++||.||.--|
T Consensus 229 P~PePIlL------k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c-------~LVHADLSEfN 295 (520)
T KOG2270|consen 229 PCPEPILL------KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKC-------RLVHADLSEFN 295 (520)
T ss_pred CCCCceee------ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHh-------ceeccchhhhh
Confidence 21111111 112699999853 22333456677888889999999999999998876 89999999999
Q ss_pred EEEcCCCcEEEEecCCccc
Q psy14889 272 ILVKTNGTCVIADFGLAVS 290 (443)
Q Consensus 272 iLl~~~~~~kl~DfGla~~ 290 (443)
+|+ .+|.+.|+|-+-+..
T Consensus 296 ~Ly-hdG~lyiIDVSQSVE 313 (520)
T KOG2270|consen 296 LLY-HDGKLYIIDVSQSVE 313 (520)
T ss_pred heE-ECCEEEEEEcccccc
Confidence 998 467899999987643
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.91 E-value=0.01 Score=56.26 Aligned_cols=145 Identities=19% Similarity=0.219 Sum_probs=67.9
Q ss_pred ccccceeeeecCeEEEEEEECCceeEEEEeeccCccchHHHHHHHHHH-hccCCCceeeeeeccccCCcccEEEeeeccc
Q psy14889 138 ISLSECIGKGRYGEVWRGVWHGENVAVKIFFSRDEASWSRETEIYSTV-LLRHENILGYIGSDMTSRNSCTQLWLVTHYH 216 (443)
Q Consensus 138 ~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~e~ei~~~~-~l~H~nIv~l~g~~~~~~~~~~~~~lv~e~~ 216 (443)
++-.+.++-|....+|+...+++.+.||+-.......+..|.+-+... ...--.+.+.+++...... -+||+||.
T Consensus 19 i~~~~~v~GG~i~~a~~~~~~~~~~FvK~~~~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~----~fLlle~l 94 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLDTDGGSYFVKVNSESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDD----AFLLLEFL 94 (288)
T ss_dssp --EEEEE--SSSSEEEEEETTS-EEEEEEEEGGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSC----CEEEEE--
T ss_pred eeeeEecCCCChhheEEEECCCccEEEEecChhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCC----ceEEEEee
Confidence 455677898999999998878899999987644444455554444332 1123346667776554433 38999998
Q ss_pred Cccc--------HHHH---hcc-c---C-------------------CCHHH-----HHHHHHHHH-----------HHH
Q psy14889 217 SFGS--------LYDH---LNR-T---T-------------------LNHHQ-----MMKICLSIV-----------NGL 246 (443)
Q Consensus 217 ~~gs--------L~~~---l~~-~---~-------------------l~~~~-----~~~i~~qia-----------~gL 246 (443)
+.+. |-.. |++ . . -+|.. ++....+.+ +-+
T Consensus 95 ~~~~~~~~~~~~lg~~LA~LH~~~~~~~FGf~~~~~~G~~~q~N~w~~~W~~Ff~~~RL~~~l~~~~~~~~~~~~~~~l~ 174 (288)
T PF03881_consen 95 EMGSPSPPDWEELGRQLAALHQWSPAGKFGFPVDTYIGSLPQPNTWTDSWEEFFAEQRLRPQLELAREKGGLDAELERLV 174 (288)
T ss_dssp ------CCHHHHHHHHHHHHHH-T--SSBB-SS-EEETTEEE----BS-HHHHHHHHCCHHHHHHHHHCTSS-CHHHHHH
T ss_pred cCCCCCchhHHHHHHHHHHHhhhcCCCCcCCCcCCcccCcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCchhHHHHHH
Confidence 7761 1111 111 0 0 11211 111111111 112
Q ss_pred HHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecC
Q psy14889 247 VHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFG 286 (443)
Q Consensus 247 ~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfG 286 (443)
+-+.+...+...+|-++|+||-+.|++.+.++.+.|.|=.
T Consensus 175 ~~~~~~l~~~~~~PsLlHGDLW~GN~~~~~~g~p~l~DPa 214 (288)
T PF03881_consen 175 ERLPSLLPGREPKPSLLHGDLWSGNVGFDADGEPVLFDPA 214 (288)
T ss_dssp HHHHHCCTTS----EEE-SS-SGGGEEEETTE-EEE-S--
T ss_pred HHHHHHhcCCCCCceeeEcCccccceeecCCCCceeeccc
Confidence 2233222223347899999999999999999889888743
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.88 E-value=0.019 Score=56.18 Aligned_cols=139 Identities=18% Similarity=0.231 Sum_probs=74.7
Q ss_pred ceeeeecCeEEEEEEEC------CceeEEEEeeccCccchHHHHHHHHHHhccCCCce-eeeeeccccCCcccEEEeeec
Q psy14889 142 ECIGKGRYGEVWRGVWH------GENVAVKIFFSRDEASWSRETEIYSTVLLRHENIL-GYIGSDMTSRNSCTQLWLVTH 214 (443)
Q Consensus 142 ~~lG~G~fg~Vy~~~~~------~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~H~nIv-~l~g~~~~~~~~~~~~~lv~e 214 (443)
+.|-.|-.-.+|+..+. ++.|++|+..........++.|...+..+..-++. ++++.+.. ..|+|
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~--------g~v~e 113 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRFPN--------GRVEE 113 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEECC--------ceEEE
Confidence 34545777899998752 35788997755444333445555544444433332 34454322 25678
Q ss_pred ccCcccHHHH-----------------hcccC-------CCHHHHHHHHHH-----------------HHHHHHHHHHch
Q psy14889 215 YHSFGSLYDH-----------------LNRTT-------LNHHQMMKICLS-----------------IVNGLVHLHTEI 253 (443)
Q Consensus 215 ~~~~gsL~~~-----------------l~~~~-------l~~~~~~~i~~q-----------------ia~gL~yLH~~~ 253 (443)
|+++.+|... +++.. ..+.++..+..+ +...+..|....
T Consensus 114 fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~ 193 (344)
T PLN02236 114 FIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKEL 193 (344)
T ss_pred eeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHh
Confidence 8766554311 01111 112222222211 112222232221
Q ss_pred hcCCCCCCeEEeCCCCCCEEEcC-CCcEEEEecCCc
Q psy14889 254 FGTQGKPAIAHRDIKSKNILVKT-NGTCVIADFGLA 288 (443)
Q Consensus 254 ~~~~~~~~iiHrDlk~~NiLl~~-~~~~kl~DfGla 288 (443)
........++|+|+++.|||+++ ++.+.++||..|
T Consensus 194 ~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya 229 (344)
T PLN02236 194 SGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYA 229 (344)
T ss_pred cccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhc
Confidence 11123457899999999999986 468999999876
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.75 E-value=0.012 Score=57.12 Aligned_cols=28 Identities=29% Similarity=0.534 Sum_probs=24.8
Q ss_pred CeEEeCCCCCCEEEcC-CCcEEEEecCCc
Q psy14889 261 AIAHRDIKSKNILVKT-NGTCVIADFGLA 288 (443)
Q Consensus 261 ~iiHrDlk~~NiLl~~-~~~~kl~DfGla 288 (443)
-++|.|+.+.|||+++ ++.++++||..|
T Consensus 183 v~CHnDl~~~NiL~~~~~~~l~lID~EYa 211 (330)
T PLN02421 183 VFAHNDLLSGNLMLNEDEGKLYFIDFEYG 211 (330)
T ss_pred EEEECCCCcccEEEeCCCCcEEEEccccc
Confidence 5799999999999975 478999999887
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.32 E-value=0.043 Score=52.59 Aligned_cols=45 Identities=20% Similarity=0.333 Sum_probs=35.6
Q ss_pred HHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCccc
Q psy14889 246 LVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVS 290 (443)
Q Consensus 246 L~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~ 290 (443)
..||+.+......++.++|+|+.+.|++++.+.-+-|.||+++..
T Consensus 184 ~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 184 IKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred HHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 455555543344567899999999999999998899999999854
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.18 E-value=0.019 Score=51.88 Aligned_cols=28 Identities=32% Similarity=0.638 Sum_probs=20.4
Q ss_pred CeEEeCCCCCCEEE-cCCCcEEEEecCCc
Q psy14889 261 AIAHRDIKSKNILV-KTNGTCVIADFGLA 288 (443)
Q Consensus 261 ~iiHrDlk~~NiLl-~~~~~~kl~DfGla 288 (443)
.++|+||.+.|||+ +.++.++++||..|
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya 172 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYA 172 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHH
Confidence 67899999999999 88899999999876
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >KOG2268|consensus | Back alignment and domain information |
|---|
Probab=96.15 E-value=0.0044 Score=58.58 Aligned_cols=130 Identities=19% Similarity=0.234 Sum_probs=79.3
Q ss_pred ccccceeeeecCeEEEEEEE-CCceeEEEEeec-----------------cCccchHH------HHHHHHHHhccC-C-C
Q psy14889 138 ISLSECIGKGRYGEVWRGVW-HGENVAVKIFFS-----------------RDEASWSR------ETEIYSTVLLRH-E-N 191 (443)
Q Consensus 138 ~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~-----------------~~~~~~~~------e~ei~~~~~l~H-~-n 191 (443)
+.+.+.||-|--+.||.+-. .|++.++|.-.. .....|.. ..|..-+..|.- - -
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp 173 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP 173 (465)
T ss_pred hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence 56789999999999999988 599999984210 11112221 223333333321 1 1
Q ss_pred ceeeeeeccccCCcccEEEeeecccCcccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCC
Q psy14889 192 ILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKN 271 (443)
Q Consensus 192 Iv~l~g~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~N 271 (443)
+.+-+++ .+-++|||+..+-.|...-+ -.+..++..-+..+ +--|-.+ |+||+|..-=|
T Consensus 174 VPkpiD~--------~RH~Vvmelv~g~Pl~~v~~--v~d~~~ly~~lm~~---Iv~la~~--------GlIHgDFNEFN 232 (465)
T KOG2268|consen 174 VPKPIDH--------NRHCVVMELVDGYPLRQVRH--VEDPPTLYDDLMGL---IVRLANH--------GLIHGDFNEFN 232 (465)
T ss_pred CCCcccc--------cceeeHHHhhcccceeeeee--cCChHHHHHHHHHH---HHHHHHc--------Cceecccchhe
Confidence 2222222 34579999988766655422 12233333322222 2233344 99999999999
Q ss_pred EEEcCCCcEEEEecCCc
Q psy14889 272 ILVKTNGTCVIADFGLA 288 (443)
Q Consensus 272 iLl~~~~~~kl~DfGla 288 (443)
|++++++.++++||--.
T Consensus 233 imv~dd~~i~vIDFPQm 249 (465)
T KOG2268|consen 233 IMVKDDDKIVVIDFPQM 249 (465)
T ss_pred eEEecCCCEEEeechHh
Confidence 99999999999999643
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.11 E-value=0.1 Score=51.82 Aligned_cols=79 Identities=15% Similarity=0.039 Sum_probs=49.0
Q ss_pred cceeeeecCeEEEEEEECCceeEEEEeec-----c-----CccchHHHHHHHHHH-hccCCCceeeeeeccccCCcccEE
Q psy14889 141 SECIGKGRYGEVWRGVWHGENVAVKIFFS-----R-----DEASWSRETEIYSTV-LLRHENILGYIGSDMTSRNSCTQL 209 (443)
Q Consensus 141 ~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~-----~-----~~~~~~~e~ei~~~~-~l~H~nIv~l~g~~~~~~~~~~~~ 209 (443)
.+.||-|....||+....+..++||.-.. . ...+...|.+.+... .+...++.+++.++.+. -
T Consensus 37 ~~eiggGn~N~VyrV~~~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded~------~ 110 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSSSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRTM------A 110 (418)
T ss_pred EEEcCCCceeeEEEEEcCCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCCC------C
Confidence 56789999999999887777899996531 1 122223343333221 12224777888887643 2
Q ss_pred EeeecccCc--ccHHHHh
Q psy14889 210 WLVTHYHSF--GSLYDHL 225 (443)
Q Consensus 210 ~lv~e~~~~--gsL~~~l 225 (443)
.++|||+++ ..+.+.+
T Consensus 111 vlvME~L~~~~~ilr~~L 128 (418)
T PLN02756 111 LIGMRYLEPPHIILRKGL 128 (418)
T ss_pred EEEEeecCCcceehhhhh
Confidence 789999976 3454444
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.11 E-value=0.084 Score=51.42 Aligned_cols=28 Identities=25% Similarity=0.380 Sum_probs=23.9
Q ss_pred CeEEeCCCCCCEEEcCCCcEEEEecCCcc
Q psy14889 261 AIAHRDIKSKNILVKTNGTCVIADFGLAV 289 (443)
Q Consensus 261 ~iiHrDlk~~NiLl~~~~~~kl~DfGla~ 289 (443)
.++|+|+.+.||+++++. ++++|+.++.
T Consensus 193 ~llHGDl~~gNi~~~~~~-~~~iD~e~~~ 220 (370)
T TIGR01767 193 TLLHGDLHSGSIFVSEHE-TKVIDPEFAF 220 (370)
T ss_pred eeeeccCCcccEEEcCCC-CEEEcCcccc
Confidence 789999999999997654 7899998663
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.92 E-value=0.079 Score=50.98 Aligned_cols=30 Identities=13% Similarity=0.245 Sum_probs=27.3
Q ss_pred CCCeEEeCCCCCCEEEcCCCcEEEEecCCc
Q psy14889 259 KPAIAHRDIKSKNILVKTNGTCVIADFGLA 288 (443)
Q Consensus 259 ~~~iiHrDlk~~NiLl~~~~~~kl~DfGla 288 (443)
..+++|+|+.+.|+|++.++.+.++||..+
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~ 224 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKA 224 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhc
Confidence 448999999999999999999999999876
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >KOG1093|consensus | Back alignment and domain information |
|---|
Probab=95.70 E-value=0.0028 Score=63.27 Aligned_cols=44 Identities=20% Similarity=0.237 Sum_probs=33.2
Q ss_pred HHHHhccCCCceeeeeeccccCCcccEEEeeecccCcccHHHHhcccC
Q psy14889 182 YSTVLLRHENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTT 229 (443)
Q Consensus 182 ~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~ 229 (443)
..++.+.|+|+..++.+..... ....+|+|++.. ||++++..+.
T Consensus 34 ~~lktl~~~~l~~yl~~~r~~~---~r~IVV~e~~~~-Sled~~~~~~ 77 (725)
T KOG1093|consen 34 QYLKSLQHDNLCQYLDFSRGKH---ERVIVVMEHYTM-SLEDILKTGN 77 (725)
T ss_pred HHHHhhcCccceeeEeeecCcc---ceEEEEehhhcc-chHHHHHhcc
Confidence 3444589999999998865543 347899999975 9999886544
|
|
| >PF06697 DUF1191: Protein of unknown function (DUF1191); InterPro: IPR010605 This family contains hypothetical plant proteins of unknown function | Back alignment and domain information |
|---|
Probab=95.68 E-value=0.016 Score=53.48 Aligned_cols=37 Identities=22% Similarity=0.619 Sum_probs=22.6
Q ss_pred cccchhhhhhHHhHHHHHHHHHHHHHHHHHHHHhhhh
Q psy14889 42 QRYDYILKLSMAILGPVIVLGMLAAVIVLFMRRNHRK 78 (443)
Q Consensus 42 ~~~~~~~~i~~~i~~~~~~l~~~~~~~~~~~~~~~~~ 78 (443)
++....|.+++++++++++++++.++++++.|.++++
T Consensus 207 ~~~~~~W~iv~g~~~G~~~L~ll~~lv~~~vr~krk~ 243 (278)
T PF06697_consen 207 RKRSWWWKIVVGVVGGVVLLGLLSLLVAMLVRYKRKK 243 (278)
T ss_pred CCcceeEEEEEEehHHHHHHHHHHHHHHhhhhhhHHH
Confidence 4444566677787787777777765555444444333
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.65 E-value=0.15 Score=50.63 Aligned_cols=28 Identities=29% Similarity=0.293 Sum_probs=23.4
Q ss_pred CCeEEeCCCCCCEEEcCCCcEEEEecCCc
Q psy14889 260 PAIAHRDIKSKNILVKTNGTCVIADFGLA 288 (443)
Q Consensus 260 ~~iiHrDlk~~NiLl~~~~~~kl~DfGla 288 (443)
...+|.|+-+.|||.++ ..+.++||-.|
T Consensus 227 ~VfCHNDL~~gNIL~~~-~~l~lID~EYA 254 (383)
T PTZ00384 227 VLFCHNDLFFTNILDFN-QGIYFIDFDFA 254 (383)
T ss_pred eeeeeccCCcccEEecC-CCEEEEEeccc
Confidence 46799999999998754 46999999765
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=95.53 E-value=0.3 Score=46.87 Aligned_cols=29 Identities=28% Similarity=0.454 Sum_probs=25.4
Q ss_pred CCCeEEeCCCCCCEEEcCCCcEEEEecCCc
Q psy14889 259 KPAIAHRDIKSKNILVKTNGTCVIADFGLA 288 (443)
Q Consensus 259 ~~~iiHrDlk~~NiLl~~~~~~kl~DfGla 288 (443)
.++++|+|+.+.||+++. +.+.|+||+.+
T Consensus 186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~ 214 (313)
T TIGR02906 186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYC 214 (313)
T ss_pred cCceEcCCCCcccEEEeC-CcEEEEECccc
Confidence 458999999999999987 66889999865
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >KOG4258|consensus | Back alignment and domain information |
|---|
Probab=95.52 E-value=0.0032 Score=65.62 Aligned_cols=29 Identities=21% Similarity=0.392 Sum_probs=24.2
Q ss_pred cCCCCCeeEecCCCCCCCCCCCCCCCCCC
Q psy14889 6 SVNVGQFTIQCCDGDFCNNGSFPILPPSY 34 (443)
Q Consensus 6 ~~~~~~~~~~~~~~~~c~~~~~~~~~~~~ 34 (443)
+.+.|.|++.-..+++-+||+++.++-+.
T Consensus 893 ~l~~G~y~~~vratSlaGng~~t~~~~~~ 921 (1025)
T KOG4258|consen 893 RLNPGNYSVRVRATSLAGNGSWTESVIFY 921 (1025)
T ss_pred ecCCCcEEEEEEEEeeccCCCCcCCcceE
Confidence 45679999999999999999998865443
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=95.49 E-value=0.12 Score=48.82 Aligned_cols=31 Identities=19% Similarity=0.373 Sum_probs=25.8
Q ss_pred CCCeEEeCCCCCCEEEcCCCc-EEEEecCCcc
Q psy14889 259 KPAIAHRDIKSKNILVKTNGT-CVIADFGLAV 289 (443)
Q Consensus 259 ~~~iiHrDlk~~NiLl~~~~~-~kl~DfGla~ 289 (443)
.+.++|+|+.+.|||+++++. .-|.||+.+.
T Consensus 184 ~~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~ 215 (276)
T cd05152 184 HTVLVHGDLHPGHILIDEDARVTGLIDWTEAK 215 (276)
T ss_pred CCeeEeCCCCCCcEEEeCCCCEEEEECcHhcc
Confidence 457899999999999997554 5699999873
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=95.31 E-value=0.24 Score=44.93 Aligned_cols=78 Identities=21% Similarity=0.187 Sum_probs=46.0
Q ss_pred cccceeeeecCeEEEEEEECCceeEEEEeeccCccchHHHHHHHHHHhcc---CCCceeeeeeccccCCcccEEEeeecc
Q psy14889 139 SLSECIGKGRYGEVWRGVWHGENVAVKIFFSRDEASWSRETEIYSTVLLR---HENILGYIGSDMTSRNSCTQLWLVTHY 215 (443)
Q Consensus 139 ~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~---H~nIv~l~g~~~~~~~~~~~~~lv~e~ 215 (443)
+..+.+.-|.--..|+..+....+-||+-.......+..| +..+..+. .-++.+++.+.... ..-|+|+||
T Consensus 19 ~er~~v~gG~inea~~v~dg~~~~FvK~n~~~~~~~f~AE--a~gL~~la~s~ti~VP~vi~~G~~~----~~sylVle~ 92 (286)
T COG3001 19 KEREEVSGGDINEAWRLRDGTDPFFVKCNQREQLSMFTAE--ADGLELLARSNTITVPKVIAVGASR----DHSYLVLEY 92 (286)
T ss_pred hcccccCCccccceeEeecCCcceEEEecchhhHHHHHHH--HHHHHHHHhcCCccccceEEecCCC----CeeEEEEee
Confidence 3344555565666676666778899997544333444444 33333233 33455555554444 457999999
Q ss_pred cCcccHH
Q psy14889 216 HSFGSLY 222 (443)
Q Consensus 216 ~~~gsL~ 222 (443)
.+.|.+.
T Consensus 93 L~~~~~d 99 (286)
T COG3001 93 LPTGPLD 99 (286)
T ss_pred ccCCCCC
Confidence 9887664
|
|
| >PF08693 SKG6: Transmembrane alpha-helix domain; InterPro: IPR014805 SKG6 and AXL2 are membrane proteins that show polarised intracellular localisation [, ] | Back alignment and domain information |
|---|
Probab=95.08 E-value=0.0023 Score=40.27 Aligned_cols=32 Identities=16% Similarity=0.335 Sum_probs=21.8
Q ss_pred cchhhhhhHHhHHHHHHHHHHHHHHHHHHHHh
Q psy14889 44 YDYILKLSMAILGPVIVLGMLAAVIVLFMRRN 75 (443)
Q Consensus 44 ~~~~~~i~~~i~~~~~~l~~~~~~~~~~~~~~ 75 (443)
++....|+++++++++++++++++++++.|||
T Consensus 7 ~~~~vaIa~~VvVPV~vI~~vl~~~l~~~~rR 38 (40)
T PF08693_consen 7 NSNTVAIAVGVVVPVGVIIIVLGAFLFFWYRR 38 (40)
T ss_pred CCceEEEEEEEEechHHHHHHHHHHhheEEec
Confidence 34555678888888888877776666654444
|
This entry represents the highly conserved transmembrane alpha-helical domain found in these proteins [, ]. The full-length AXL2 protein has a negative regulatory function in cytokinesis []. |
| >KOG1236|consensus | Back alignment and domain information |
|---|
Probab=94.98 E-value=0.065 Score=52.45 Aligned_cols=62 Identities=23% Similarity=0.256 Sum_probs=45.5
Q ss_pred EEeeecccCcccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCC
Q psy14889 209 LWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTN 277 (443)
Q Consensus 209 ~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~ 277 (443)
..|+-+|+.+-++..+++....++.-..+++.--+.|+.-+---- +.+|.|+.|.||++.-+
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~~~~pe~l~kkva~lg~~AllkMl~vD-------NFvHaDlHPGNVlirf~ 381 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKWKSQPEALVKKVAKLGVNALLKMLIVD-------NFVHADLHPGNVLIRFN 381 (565)
T ss_pred ceeeeeccccccHHhhhhcccChHHHHHHHHHHHHHHHHHHHHhh-------cceecccCCCcEEEEec
Confidence 467778999999999998777777666666665566654332211 78999999999999543
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=94.84 E-value=0.27 Score=48.59 Aligned_cols=79 Identities=18% Similarity=-0.036 Sum_probs=46.9
Q ss_pred cceeeeecCeEEEEEEEC--CceeEEEEeec----c-----CccchHHHHHHHHHHhccCC-CceeeeeeccccCCcccE
Q psy14889 141 SECIGKGRYGEVWRGVWH--GENVAVKIFFS----R-----DEASWSRETEIYSTVLLRHE-NILGYIGSDMTSRNSCTQ 208 (443)
Q Consensus 141 ~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~----~-----~~~~~~~e~ei~~~~~l~H~-nIv~l~g~~~~~~~~~~~ 208 (443)
.+.||-|.-..||++... ++.|+||.-.. . ...+...|.+++....---| .+.+++.+-.+.
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D~e~------ 107 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFDSVM------ 107 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEECcHH------
Confidence 467899999999999974 67899996421 1 11233446555554321223 455666653222
Q ss_pred EEeeecccCc-ccHHHHh
Q psy14889 209 LWLVTHYHSF-GSLYDHL 225 (443)
Q Consensus 209 ~~lv~e~~~~-gsL~~~l 225 (443)
..+|||+++. ..|.+.|
T Consensus 108 ~~~vMEdL~~~~ilR~~L 125 (409)
T PRK12396 108 NCCVMEDLSDHTILRTAL 125 (409)
T ss_pred hhHHHHhCcccHHHHHHH
Confidence 3689999854 2344443
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.82 E-value=0.061 Score=51.92 Aligned_cols=72 Identities=21% Similarity=0.262 Sum_probs=54.7
Q ss_pred cEEEeeecccCcccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecC
Q psy14889 207 TQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFG 286 (443)
Q Consensus 207 ~~~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfG 286 (443)
.+.|++|++.. ++|.. ...-.+++.+.++.+.++-++-+... .+.=|||+.-.||||+ +|.+.|+||-
T Consensus 299 ~y~yl~~kdhg-t~is~---ik~~~~~e~lsff~s~~sil~~lekk-------f~fehrnlt~~niLId-~GnvtLIDfk 366 (488)
T COG5072 299 LYLYLHFKDHG-TPISI---IKADRSEEELSFFWSCISILDILEKK-------FPFEHRNLTLDNILID-EGNVTLIDFK 366 (488)
T ss_pred eEEEEEEecCC-ceeee---eecccHHHHHHHHHHHHHHHhhhhhc-------CCcccccccccceeee-cCceEEEEee
Confidence 45677887752 34332 13356888899999888766666554 2789999999999999 9999999999
Q ss_pred Cccc
Q psy14889 287 LAVS 290 (443)
Q Consensus 287 la~~ 290 (443)
+++.
T Consensus 367 lsRl 370 (488)
T COG5072 367 LSRL 370 (488)
T ss_pred eeec
Confidence 9974
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.76 E-value=0.39 Score=46.51 Aligned_cols=143 Identities=14% Similarity=0.123 Sum_probs=78.3
Q ss_pred eeeecCeEEEEEEECCceeEEEEeecc-CccchHHHHHHHHHHh-----ccCCCceeeeeeccccCCcccEEEeeecccC
Q psy14889 144 IGKGRYGEVWRGVWHGENVAVKIFFSR-DEASWSRETEIYSTVL-----LRHENILGYIGSDMTSRNSCTQLWLVTHYHS 217 (443)
Q Consensus 144 lG~G~fg~Vy~~~~~~~~vAvK~~~~~-~~~~~~~e~ei~~~~~-----l~H~nIv~l~g~~~~~~~~~~~~~lv~e~~~ 217 (443)
|.+ .-..+|+....+..+++|+.... .......|.+.+.... +--| +..+=|-....-....+.+-+.+|++
T Consensus 34 l~s-~eN~~f~~~~~~g~~iLki~~~~~~~~~i~~el~~l~~La~~~i~v~~P-l~~~dG~~l~~~~~~~r~a~lf~~l~ 111 (331)
T COG2334 34 LNS-EENSNFRVQTEDGRYILKIYRPGWTRAEIPFELALLQHLAERGIPVPAP-LPSLDGELLEALSGGPRPAALFEYLP 111 (331)
T ss_pred ccc-ccCceEEEEecCCCeEEEEecCCCCHHHHHHHHHHHHHHHHcCCCCCCC-ccCCCcchhhhccCCceeEEEEEecC
Confidence 444 44578988886666699987664 3333334444433321 0112 22222222211110025678889998
Q ss_pred cccHHH-H-----------h---c----c---------cCCCHHH-------------HHHHHHHHHHHHHHHHHchhcC
Q psy14889 218 FGSLYD-H-----------L---N----R---------TTLNHHQ-------------MMKICLSIVNGLVHLHTEIFGT 256 (443)
Q Consensus 218 ~gsL~~-~-----------l---~----~---------~~l~~~~-------------~~~i~~qia~gL~yLH~~~~~~ 256 (443)
|..+.. . + + + ....|.. -.....++...++.+.+.....
T Consensus 112 G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~ 191 (331)
T COG2334 112 GRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAH 191 (331)
T ss_pred CcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhh
Confidence 877662 1 1 0 0 0123320 0123445566666666653322
Q ss_pred CCCCC--eEEeCCCCCCEEEcCCCc-EEEEecCCc
Q psy14889 257 QGKPA--IAHRDIKSKNILVKTNGT-CVIADFGLA 288 (443)
Q Consensus 257 ~~~~~--iiHrDlk~~NiLl~~~~~-~kl~DfGla 288 (443)
....+ +||+|+.|.||+++.+.. +.+.||+-+
T Consensus 192 lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa 226 (331)
T COG2334 192 LPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDA 226 (331)
T ss_pred CCcccceeeecCCCccceeEcCCCCeeeEEEcccc
Confidence 22223 999999999999999884 899999976
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 443 | ||||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-131 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-129 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-129 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-123 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-115 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-113 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-113 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-112 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-112 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-112 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-111 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-58 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 6e-55 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 5e-48 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-23 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-23 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-21 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 5e-21 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 5e-21 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-20 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 9e-19 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-18 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 4e-18 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-18 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 5e-18 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-18 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-18 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 7e-18 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 9e-18 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-17 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-17 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-17 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-17 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-17 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-17 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-17 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-17 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-17 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-17 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-17 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 6e-17 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-17 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-16 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-16 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 4e-16 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-15 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-15 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-15 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 6e-15 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-14 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 5e-14 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 7e-14 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-13 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-13 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-13 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-13 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-13 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-13 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 4e-13 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 4e-13 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-13 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 6e-13 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 6e-13 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 6e-13 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 6e-13 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-13 | ||
| 3iok_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 6e-13 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 6e-13 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 7e-13 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 7e-13 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 8e-13 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 8e-13 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 9e-13 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 9e-13 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-12 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-12 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-12 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-12 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-12 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-12 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-12 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-12 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-12 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-12 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-12 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-12 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-12 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-12 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-12 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-12 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-12 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-12 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-12 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-12 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-12 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-12 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-12 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-12 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-12 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 4e-12 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-12 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-12 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 4e-12 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-12 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-12 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 4e-12 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 4e-12 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-12 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 4e-12 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 4e-12 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 5e-12 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 5e-12 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 5e-12 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 5e-12 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 5e-12 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-12 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 6e-12 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 6e-12 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 7e-12 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 8e-12 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 9e-12 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 9e-12 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-11 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-11 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-11 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-11 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-11 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-11 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-11 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-11 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-11 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-11 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-11 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-11 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-11 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-11 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-11 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-11 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-11 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-11 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-11 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-11 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-11 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-11 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-11 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-11 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-11 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-11 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-11 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-11 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-11 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-11 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-11 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-11 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-11 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-11 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-11 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-11 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-11 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-11 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-11 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-11 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-11 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-11 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-11 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-11 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-11 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-11 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 4e-11 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 4e-11 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 4e-11 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 5e-11 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 5e-11 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 5e-11 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 5e-11 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 5e-11 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 6e-11 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 6e-11 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-11 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 7e-11 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 8e-11 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 8e-11 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 8e-11 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 8e-11 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 9e-11 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 9e-11 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 9e-11 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 9e-11 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 9e-11 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 9e-11 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 9e-11 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 9e-11 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 9e-11 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 9e-11 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-10 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-10 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-10 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-10 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-10 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-10 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-10 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-10 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-10 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-10 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-10 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-10 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-10 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-10 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-10 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-10 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-10 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-10 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-10 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-10 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-10 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-10 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-10 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-10 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-10 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-10 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-10 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-10 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-10 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-10 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-10 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-10 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-10 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-10 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-10 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-10 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-10 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-10 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 4e-10 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 4e-10 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 5e-10 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 5e-10 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 5e-10 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-10 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 6e-10 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-10 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 6e-10 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 6e-10 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 6e-10 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-10 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 6e-10 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-10 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 6e-10 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 7e-10 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 7e-10 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 7e-10 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 7e-10 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 7e-10 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-10 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 8e-10 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-10 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 8e-10 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-10 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 9e-10 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-09 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-09 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-09 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-09 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-09 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-09 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-09 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-09 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-09 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-09 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-09 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-09 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-09 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-09 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-09 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-09 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-09 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-09 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-09 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-09 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-09 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 4e-09 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-09 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-09 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-09 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 4e-09 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 4e-09 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-09 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 4e-09 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-09 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 5e-09 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 5e-09 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 5e-09 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 5e-09 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 5e-09 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-09 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-09 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 6e-09 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 6e-09 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 6e-09 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 6e-09 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-09 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 6e-09 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 7e-09 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 7e-09 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 7e-09 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 7e-09 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 7e-09 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 8e-09 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 8e-09 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-09 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 9e-09 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 9e-09 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 9e-09 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 9e-09 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 9e-09 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-08 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-08 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-08 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-08 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-08 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-08 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-08 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-08 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-08 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-08 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-08 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-08 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-08 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-08 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-08 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-08 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-08 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-08 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-08 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-08 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-08 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-08 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-08 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-08 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-08 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-08 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-08 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-08 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-08 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-08 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-08 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-08 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-08 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 3e-08 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-08 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-08 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-08 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-08 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-08 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 4e-08 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 4e-08 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-08 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-08 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-08 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 4e-08 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-08 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 4e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 4e-08 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 4e-08 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-08 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-08 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 4e-08 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 4e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 4e-08 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 4e-08 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-08 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 5e-08 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 5e-08 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-08 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 5e-08 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 5e-08 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-08 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 5e-08 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 5e-08 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 5e-08 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 5e-08 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 5e-08 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-08 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 6e-08 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 6e-08 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 6e-08 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 6e-08 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 6e-08 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 6e-08 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 6e-08 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-08 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-08 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-08 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 7e-08 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 7e-08 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-08 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-08 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 7e-08 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 7e-08 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 7e-08 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 7e-08 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 7e-08 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 8e-08 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 8e-08 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 8e-08 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-08 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 8e-08 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 8e-08 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 8e-08 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 8e-08 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 8e-08 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 8e-08 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 8e-08 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 8e-08 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 9e-08 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 9e-08 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 9e-08 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 9e-08 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 9e-08 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 9e-08 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 9e-08 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 9e-08 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-07 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-07 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-07 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-07 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-07 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-07 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-07 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-07 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-07 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-07 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-07 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-07 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-07 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-07 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-07 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-07 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-07 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-07 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-07 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-07 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-07 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-07 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-07 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-07 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-07 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-07 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-07 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-07 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-07 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-07 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-07 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-07 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-07 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-07 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-07 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-07 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-07 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-07 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-07 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-07 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-07 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-07 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-07 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-07 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-07 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-07 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-07 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-07 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-07 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-07 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-07 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-07 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-07 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-07 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-07 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-07 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-07 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-07 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-07 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-07 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-07 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-07 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-07 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-07 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 3e-07 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-07 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-07 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-07 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-07 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-07 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-07 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-07 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-07 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-07 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-07 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-07 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-07 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-07 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 4e-07 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 4e-07 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 4e-07 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 4e-07 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-07 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 4e-07 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-07 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 4e-07 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 5e-07 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 5e-07 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 5e-07 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 5e-07 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 5e-07 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 5e-07 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 5e-07 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-07 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 6e-07 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 6e-07 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-07 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 6e-07 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-07 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 6e-07 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 7e-07 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 7e-07 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 7e-07 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 7e-07 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 7e-07 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 7e-07 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 7e-07 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 7e-07 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-07 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 8e-07 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-07 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 8e-07 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 8e-07 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 8e-07 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 8e-07 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 8e-07 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-07 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 8e-07 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 8e-07 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 8e-07 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 8e-07 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 8e-07 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 8e-07 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 8e-07 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-07 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 8e-07 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 8e-07 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 8e-07 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 8e-07 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 8e-07 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 8e-07 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 8e-07 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 9e-07 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 9e-07 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 9e-07 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 9e-07 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 9e-07 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 9e-07 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 9e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-06 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-06 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-06 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-06 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-06 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-06 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-06 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-06 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-06 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-06 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-06 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-06 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-06 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-06 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-06 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-06 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-06 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-06 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-06 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-06 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-06 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-06 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-06 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-06 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-06 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-06 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-06 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-06 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-06 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-06 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-06 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-06 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-06 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-06 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-06 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-06 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-06 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-06 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-06 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-06 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 3e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-06 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-06 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-06 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-06 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-06 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-06 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-06 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-06 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-06 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-06 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 4e-06 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 4e-06 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-06 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 4e-06 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-06 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 4e-06 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 4e-06 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-06 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-06 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 4e-06 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 5e-06 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 5e-06 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 5e-06 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 5e-06 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 5e-06 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-06 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 5e-06 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 5e-06 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-06 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 5e-06 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 5e-06 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 5e-06 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 5e-06 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 6e-06 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 6e-06 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 6e-06 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 6e-06 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 6e-06 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-06 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 7e-06 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 7e-06 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 7e-06 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-06 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 7e-06 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 7e-06 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-06 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 8e-06 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 8e-06 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 8e-06 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 8e-06 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 8e-06 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 8e-06 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 8e-06 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 8e-06 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 8e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 9e-06 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-06 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 9e-06 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 9e-06 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-06 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-05 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-05 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-05 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-05 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-05 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-05 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-05 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-05 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-05 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 1e-05 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-05 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-05 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-05 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-05 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-05 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-05 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-05 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-05 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-05 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-05 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-05 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-05 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-05 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-05 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-05 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-05 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-05 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-05 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-05 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-05 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-05 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-05 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-05 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-05 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-05 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-05 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-05 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-05 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-05 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-05 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-05 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-05 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-05 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-05 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-05 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-05 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-05 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-05 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-05 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-05 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-05 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-05 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-05 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-05 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-05 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-05 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-05 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-05 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-05 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-05 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-05 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-05 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-05 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-05 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-05 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-05 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-05 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-05 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-05 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-05 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-05 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-05 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-05 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 4e-05 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 4e-05 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-05 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-05 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 4e-05 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-05 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 5e-05 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-05 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 6e-05 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 6e-05 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 6e-05 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 7e-05 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 7e-05 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 7e-05 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 7e-05 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-05 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 7e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 8e-05 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 8e-05 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 8e-05 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 8e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 8e-05 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 8e-05 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 8e-05 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 9e-05 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-05 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 9e-05 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 9e-05 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 9e-05 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-04 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-04 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-04 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-04 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-04 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-04 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-04 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-04 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 1e-04 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-04 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-04 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-04 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-04 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-04 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-04 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-04 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-04 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-04 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-04 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-04 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-04 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-04 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-04 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-04 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-04 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-04 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-04 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-04 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-04 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-04 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-04 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-04 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-04 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-04 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-04 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-04 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-04 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-04 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-04 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-04 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-04 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-04 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-04 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 4e-04 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-04 | ||
| 2c47_A | 313 | Structure Of Casein Kinase 1 Gamma 2 Length = 313 | 4e-04 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 4e-04 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-04 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 4e-04 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 4e-04 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-04 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 4e-04 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 4e-04 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-04 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 4e-04 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 4e-04 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-04 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-04 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 4e-04 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 4e-04 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 4e-04 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 4e-04 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-04 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-04 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 4e-04 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 4e-04 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 4e-04 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-04 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-04 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-04 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-04 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 5e-04 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 5e-04 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 5e-04 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 5e-04 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 5e-04 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-04 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-04 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 5e-04 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 6e-04 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 6e-04 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 6e-04 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 6e-04 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 6e-04 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 7e-04 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 7e-04 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 7e-04 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 7e-04 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 8e-04 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 9e-04 |
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3IOK|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 443 | |||
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 1e-174 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 1e-173 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 1e-167 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 1e-163 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 1e-153 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 1e-140 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 7e-59 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 4e-57 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 3e-55 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 3e-53 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 4e-53 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 7e-53 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 2e-52 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 7e-51 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 3e-46 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 5e-38 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 8e-37 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 6e-35 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 9e-34 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 3e-33 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 4e-33 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 9e-33 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 1e-32 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 3e-32 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 6e-32 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 6e-32 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 3e-31 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 4e-31 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 1e-30 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 4e-30 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 4e-30 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 5e-30 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 5e-30 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 1e-29 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 1e-29 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 5e-29 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 7e-29 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 1e-28 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 2e-28 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 2e-28 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 3e-28 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 4e-28 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 5e-28 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 7e-28 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 8e-28 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 2e-27 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 3e-27 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 4e-27 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 5e-27 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 5e-27 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 5e-27 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 7e-27 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 7e-27 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 1e-26 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 2e-26 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 2e-26 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 2e-26 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 2e-26 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 2e-26 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 3e-26 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 4e-26 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 5e-26 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 6e-26 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 8e-26 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 1e-25 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 2e-25 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 2e-25 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 3e-25 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 3e-25 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 3e-25 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 7e-25 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 8e-25 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 9e-25 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 1e-24 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 1e-24 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 2e-24 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 6e-24 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 1e-23 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 1e-23 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 7e-23 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 1e-22 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 2e-22 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 2e-22 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 2e-22 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 3e-22 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 3e-22 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 3e-22 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 4e-22 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 5e-22 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 9e-22 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 1e-21 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 1e-21 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 2e-21 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 2e-21 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 3e-21 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 3e-21 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 5e-21 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 7e-21 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 1e-20 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 1e-20 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 3e-20 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 6e-20 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 6e-20 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 9e-20 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 1e-19 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 2e-19 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 2e-19 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 3e-19 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 3e-19 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 5e-19 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 5e-19 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 5e-19 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 6e-19 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 6e-19 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 7e-19 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 7e-19 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 1e-18 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 2e-18 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 2e-18 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 3e-18 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 3e-18 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 4e-18 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 4e-18 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 4e-18 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 6e-18 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 6e-18 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 2e-17 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 2e-17 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 2e-17 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 2e-17 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 3e-17 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 3e-17 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 4e-17 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 6e-17 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 1e-16 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 3e-16 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 3e-16 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 3e-16 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 9e-16 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 1e-15 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 2e-15 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 2e-15 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 2e-15 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 3e-15 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 3e-15 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 3e-15 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 4e-15 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 6e-15 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 8e-15 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 1e-14 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 2e-14 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 2e-14 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 3e-14 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 3e-14 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 3e-14 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 1e-13 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 1e-13 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 2e-13 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 2e-13 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 2e-13 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 3e-13 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 4e-13 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 6e-13 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 7e-13 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 9e-13 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 1e-12 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 1e-12 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 1e-12 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 2e-12 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 2e-12 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 2e-12 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 2e-12 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 3e-12 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 3e-12 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 4e-12 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 5e-12 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 5e-12 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 7e-12 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 7e-12 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 8e-12 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 8e-12 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 9e-12 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 1e-11 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 1e-11 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 2e-11 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 2e-11 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 2e-11 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 3e-11 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 4e-11 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 5e-11 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 5e-11 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 6e-11 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 6e-11 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 7e-11 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 7e-11 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 8e-11 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 9e-11 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 9e-11 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 1e-10 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 1e-10 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 1e-10 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 1e-10 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 1e-10 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 2e-10 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 2e-10 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 2e-10 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 4e-10 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 4e-10 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 4e-10 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 4e-10 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 4e-10 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 7e-10 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 1e-09 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 1e-09 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 2e-09 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 2e-09 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 3e-09 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 3e-09 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 2e-05 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 5e-09 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 6e-09 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 1e-08 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 5e-08 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 7e-08 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 9e-08 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 2e-07 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 2e-07 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 4e-07 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 6e-07 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 6e-07 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 3e-06 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 5e-06 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 6e-06 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 1e-05 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 2e-05 | |
| 2h62_C | 129 | Bone morphogenetic protein receptor type IA; TGF-b | 7e-05 |
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 491 bits (1265), Expect = e-174
Identities = 203/322 (63%), Positives = 251/322 (77%)
Query: 108 STLREYLDASLTSGSGSGLPLLIQRTLAKQISLSECIGKGRYGEVWRGVWHGENVAVKIF 167
+LR+ ++ S +SGSGSGLPLL+QRT+AKQI + + IGKGRYGEVW G W GE VAVK+F
Sbjct: 9 ESLRDLIEQSQSSGSGSGLPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVF 68
Query: 168 FSRDEASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNR 227
F+ +EASW RETEIY TVL+RHENILG+I +D+ S TQL+L+T YH GSLYD+L
Sbjct: 69 FTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKS 128
Query: 228 TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGL 287
TTL+ M+K+ S V+GL HLHTEIF TQGKPAIAHRD+KSKNILVK NGTC IAD GL
Sbjct: 129 TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 188
Query: 288 AVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRR 347
AV + +N++DIPPN RVGTKRYM PE+LDES+N + F+S+ AD+Y+ GL+LWEV RR
Sbjct: 189 AVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARR 248
Query: 348 TKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKEC 407
+ GI EEY+ PYHDLVP DPS++DMR+++CI + RP PNRW SD L M K+M EC
Sbjct: 249 CVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTEC 308
Query: 408 WHQNANVRLSALRVKKTLIKLA 429
W N RL+ALRVKKTL K++
Sbjct: 309 WAHNPASRLTALRVKKTLAKMS 330
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 488 bits (1257), Expect = e-173
Identities = 203/334 (60%), Positives = 250/334 (74%)
Query: 96 DADLLRATAAGDSTLREYLDASLTSGSGSGLPLLIQRTLAKQISLSECIGKGRYGEVWRG 155
D L R + +TL++ + TSGSGSGLPLL+QRT+A+ I L E IGKGR+GEVWRG
Sbjct: 2 DPSLDRPFISEGTTLKDLIYDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRG 61
Query: 156 VWHGENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVTHY 215
W GE VAVKIF SR+E SW RE EIY TV+LRHENILG+I +D + TQLWLV+ Y
Sbjct: 62 KWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY 121
Query: 216 HSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVK 275
H GSL+D+LNR T+ M+K+ LS +GL HLH EI GTQGKPAIAHRD+KSKNILVK
Sbjct: 122 HEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK 181
Query: 276 TNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIY 335
NGTC IAD GLAV + ++ +DI PN RVGTKRYM+PE+LD+SINM FESFK+ADIY
Sbjct: 182 KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIY 241
Query: 336 ALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDS 395
A+GLV WE+ RR GI E+Y+ PY+DLVP DPS ++MRKV+C + RP +PNRW S
Sbjct: 242 AMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCE 301
Query: 396 TLNAMTKVMKECWHQNANVRLSALRVKKTLIKLA 429
L M K+M+ECW+ N RL+ALR+KKTL +L+
Sbjct: 302 ALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 335
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 471 bits (1213), Expect = e-167
Identities = 206/299 (68%), Positives = 253/299 (84%)
Query: 130 IQRTLAKQISLSECIGKGRYGEVWRGVWHGENVAVKIFFSRDEASWSRETEIYSTVLLRH 189
+QRT+A+ I+L EC+GKGRYGEVWRG W GENVAVKIF SRDE SW RETE+Y+TV+LRH
Sbjct: 2 MQRTVARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRH 61
Query: 190 ENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHL 249
ENILG+I SDMTSR+S TQLWL+THYH GSLYD+L TTL+ ++I LSI +GL HL
Sbjct: 62 ENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHL 121
Query: 250 HTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTK 309
H EIFGTQGKPAIAHRD+KSKNILVK NG C IAD GLAV +SQ +N++D+ NPRVGTK
Sbjct: 122 HIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTK 181
Query: 310 RYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDP 369
RYM+PE+LDE+I +DCF+S+K+ DI+A GLVLWEV RR +NGI E+YK P++D+VP DP
Sbjct: 182 RYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDP 241
Query: 370 SFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKL 428
SF+DMRKV+C+DQQRP +PNRW SD TL ++ K+MKECW+QN + RL+ALR+KKTL K+
Sbjct: 242 SFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 437 bits (1125), Expect = e-153
Identities = 119/318 (37%), Positives = 189/318 (59%), Gaps = 8/318 (2%)
Query: 115 DASLTSGSGSGLPLLIQRTLAKQISLSECIGKGRYGEVWRGVWHGENVAVKIFFSRDEAS 174
+SG G L ++ + L E +GR+G VW+ E VAVKIF +D+ S
Sbjct: 5 HHHHSSGVDLGTENLYFQS--MPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQS 62
Query: 175 WSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQ 234
W E E+YS ++HENIL +IG++ + LWL+T +H GSL D L ++ ++
Sbjct: 63 WQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNE 122
Query: 235 MMKICLSIVNGLVHLHTEIFGTQG--KPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYS 292
+ I ++ GL +LH +I G + KPAI+HRDIKSKN+L+K N T IADFGLA+ +
Sbjct: 123 LCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFE 182
Query: 293 QLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKA-N 351
+ D + +VGT+RYM+PE+L+ +IN ++F + D+YA+GLVLWE+ R A +
Sbjct: 183 AGKSAGDT--HGQVGTRRYMAPEVLEGAINFQ-RDAFLRIDMYAMGLVLWELASRCTAAD 239
Query: 352 GIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQN 411
G +EY P+ + + PS +DM++V+ ++RPVL + W + + + + ++ECW +
Sbjct: 240 GPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHD 299
Query: 412 ANVRLSALRVKKTLIKLA 429
A RLSA V + + ++
Sbjct: 300 AEARLSAGCVGERITQMQ 317
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 404 bits (1040), Expect = e-140
Identities = 105/304 (34%), Positives = 171/304 (56%), Gaps = 11/304 (3%)
Query: 136 KQISLSECIGKGRYGEVWRGVWHGENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGY 195
+ L E IG+GRYG V++G VAVK+F + ++ E IY L+ H+NI +
Sbjct: 13 DNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARF 72
Query: 196 IGSD-MTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEI- 253
I D + + + LV Y+ GSL +L+ T + ++ S+ GL +LHTE+
Sbjct: 73 IVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELP 132
Query: 254 FGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQ----LSNKMDIPPNPRVGTK 309
G KPAI+HRD+ S+N+LVK +GTCVI+DFGL++ + + D VGT
Sbjct: 133 RGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTI 192
Query: 310 RYMSPEILDESINMDCFES-FKKADIYALGLVLWEVCRRTKA---NGIFEEYKAPYHDLV 365
RYM+PE+L+ ++N+ ES K+ D+YALGL+ WE+ R EY+ + V
Sbjct: 193 RYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEV 252
Query: 366 PMDPSFDDMRKVICIDQQRPVLPNRWVSDS-TLNAMTKVMKECWHQNANVRLSALRVKKT 424
P+F+DM+ ++ ++QRP P W +S + ++ + +++CW Q+A RL+A ++
Sbjct: 253 GNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEER 312
Query: 425 LIKL 428
+ +L
Sbjct: 313 MAEL 316
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 7e-59
Identities = 61/286 (21%), Positives = 121/286 (42%), Gaps = 46/286 (16%)
Query: 136 KQISLSECIGKGRYGEVWRGVWHGENVAVKIFFSRDEASWSRE---TEIYSTVLLRHENI 192
KQ++ + + GE+W+G W G ++ VK+ RD ++ E + H N+
Sbjct: 10 KQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNV 69
Query: 193 LGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTT---LNHHQMMKICLSIVNGLVHL 249
L +G+ L+TH+ +GSLY+ L+ T ++ Q +K L + G+ L
Sbjct: 70 LPVLGA--CQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFL 127
Query: 250 HTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTK 309
HT +P I + S+++++ + T I+ + S+ R+
Sbjct: 128 HTL------EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPG---------RMYAP 172
Query: 310 RYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDP 369
+++PE L + AD+++ ++LWE+ R + P+ DL M+
Sbjct: 173 AWVAPEALQKKPEDTNRR---SADMWSFAVLLWELVTR----------EVPFADLSNMEI 219
Query: 370 SFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVR 415
+ ++ RP +P ++K+MK C +++ R
Sbjct: 220 GMK-----VALEGLRPTIP-----PGISPHVSKLMKICMNEDPAKR 255
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 4e-57
Identities = 76/291 (26%), Positives = 124/291 (42%), Gaps = 55/291 (18%)
Query: 136 KQISLSECIGKGRYGEVWRGVWHGENVAVKIFFSRDEASWSRE---TEIYSTVLLRHENI 192
+++ E IG G +G V R WHG +VAVKI +D + E+ LRH NI
Sbjct: 37 CDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNI 96
Query: 193 LGYIGSDMTSRNSCTQ---LWLVTHYHSFGSLYDHL----NRTTLNHHQMMKICLSIVNG 245
+ ++G+ TQ L +VT Y S GSLY L R L+ + + + + G
Sbjct: 97 VLFMGA-------VTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKG 149
Query: 246 LVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPR 305
+ +LH P I HR++KS N+LV T + DFGL+ +
Sbjct: 150 MNYLHNR------NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSS----KSA 199
Query: 306 VGTKRYMSPEILDESINMDCFESF-KKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDL 364
GT +M+PE+L + E +K+D+Y+ G++LWE+ + P+ +L
Sbjct: 200 AGTPEWMAPEVLRD-------EPSNEKSDVYSFGVILWELATL----------QQPWGNL 242
Query: 365 VPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVR 415
P + +R +P + + +++ CW R
Sbjct: 243 NPAQVVAA-----VGFKCKRLEIP-----RNLNPQVAAIIEGCWTNEPWKR 283
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 3e-55
Identities = 70/300 (23%), Positives = 127/300 (42%), Gaps = 61/300 (20%)
Query: 136 KQISLSECIGKGRYGEVWRGVWHGENVAVKIFFSRDE-----ASWSRETEIYSTVLLRHE 190
+Q+ + E IGKGR+G+V+ G WHGE VA+++ + ++ RE Y RHE
Sbjct: 33 EQLEIGELIGKGRFGQVYHGRWHGE-VAIRLIDIERDNEDQLKAFKREVMAYRQ--TRHE 89
Query: 191 NILGYIGSDMTSRNSCTQ---LWLVTHYHSFGSLYDHL--NRTTLNHHQMMKICLSIVNG 245
N++ ++G +C L ++T +LY + + L+ ++ +I IV G
Sbjct: 90 NVVLFMG-------ACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKG 142
Query: 246 LVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA-----VSYSQLSNKMDI 300
+ +LH I H+D+KSKN+ NG VI DFGL + + +K+ I
Sbjct: 143 MGYLHA--------KGILHKDLKSKNVFY-DNGKVVITDFGLFSISGVLQAGRREDKLRI 193
Query: 301 PPNPRVGTKRYMSPEILDESINMDCFESF---KKADIYALGLVLWEVCRRTKANGIFEEY 357
G +++PEI+ + + K +D++ALG + +E+ R
Sbjct: 194 QN----GWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAR---------- 239
Query: 358 KAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLS 417
+ P+ + +P L + ++ ++ CW R +
Sbjct: 240 EWPFKTQPAEAIIW------QMGTGMKPNLSQIGMGK----EISDILLFCWAFEQEERPT 289
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 3e-53
Identities = 72/288 (25%), Positives = 121/288 (42%), Gaps = 55/288 (19%)
Query: 136 KQISLSECIGKGRYGEVWRGVWHGENVAVKIFFSRDE-ASWSRETEIYSTVLLRHENILG 194
K+I + E +G+G +G V + W ++VA+K S E ++ E S + H NI+
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESESERKAFIVELRQLSR--VNHPNIVK 65
Query: 195 YIGSDMTSRNSCTQ-LWLVTHYHSFGSLYDHL----NRTTLNHHQMMKICLSIVNGLVHL 249
G +C + LV Y GSLY+ L M CL G+ +L
Sbjct: 66 LYG-------ACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYL 118
Query: 250 HTEIFGTQGKPAIAHRDIKSKNILVKTNGTCV-IADFGLAVSYSQLSNKMDIPPNPRVGT 308
H+ A+ HRD+K N+L+ GT + I DFG A G+
Sbjct: 119 HSMQP-----KALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNN-------KGS 166
Query: 309 KRYMSPEILDESINMDCFESF-KKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPM 367
+M+PE+ + ++ +K D+++ G++LWEV R + P+ ++
Sbjct: 167 AAWMAPEVFEG-------SNYSEKCDVFSWGIILWEVITR----------RKPFDEI--G 207
Query: 368 DPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVR 415
P+F M V + RP L + + +M CW ++ + R
Sbjct: 208 GPAFRIMWAV--HNGTRPPLI-----KNLPKPIESLMTRCWSKDPSQR 248
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 4e-53
Identities = 68/297 (22%), Positives = 125/297 (42%), Gaps = 62/297 (20%)
Query: 136 KQISLSECIGKGRYGEVWRGVWHGENVAVKIFFSRDEASWSR-----ETEIYSTVLLRHE 190
+++L E IG G +G+V+R W G+ VAVK + S+ E +L+H
Sbjct: 7 AELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHP 66
Query: 191 NILGYIGSDMTSRNSCTQ---LWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLV 247
NI+ G C + L LV + G L L+ + ++ + I G+
Sbjct: 67 NIIALRG-------VCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMN 119
Query: 248 HLHTEIFGTQGKPAIAHRDIKSKNILV--------KTNGTCVIADFGLAVSYSQLSNKMD 299
+LH + I HRD+KS NIL+ +N I DFGLA + + + KM
Sbjct: 120 YLH-----DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHR-TTKMS 173
Query: 300 IPPNPRVGTKRYMSPEILDESINMDCFESF-KKADIYALGLVLWEVCRRTKANGIFEEYK 358
G +M+PE++ F K +D+++ G++LWE+ +
Sbjct: 174 -----AAGAYAWMAPEVIRA-------SMFSKGSDVWSYGVLLWELLTG----------E 211
Query: 359 APYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVR 415
P+ + + ++ + +++ +P + K+M++CW+ + + R
Sbjct: 212 VPFRGIDGLAVAYG-----VAMNKLALPIP-----STCPEPFAKLMEDCWNPDPHSR 258
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 7e-53
Identities = 77/292 (26%), Positives = 127/292 (43%), Gaps = 54/292 (18%)
Query: 136 KQISLSECIGKGRYGEVWRGVWHGENVAVKIFFSRD-----EASWSRETEIYSTVLLRHE 190
QI++ + IG G +G V++G WHG+ VAVK+ ++ E + RH
Sbjct: 24 GQITVGQRIGSGSFGTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRK--TRHV 80
Query: 191 NILGYIGSDMTSRNSCTQ--LWLVTHYHSFGSLYDHL--NRTTLNHHQMMKICLSIVNGL 246
NIL ++G T L +VT + SLY HL + T +++ I G+
Sbjct: 81 NILLFMGY-------STAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGM 133
Query: 247 VHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA--VSYSQLSNKMDIPPNP 304
+LH +I HRD+KS NI + + T I DFGLA S S++ +
Sbjct: 134 DYLHA--------KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLS-- 183
Query: 305 RVGTKRYMSPEILDESINMDCFESF-KKADIYALGLVLWEVCRRTKANGIFEEYKAPYHD 363
G+ +M+PE+ I M + ++D+YA G+VL+E+ + PY +
Sbjct: 184 --GSILWMAPEV----IRMQDSNPYSFQSDVYAFGIVLYELMTG----------QLPYSN 227
Query: 364 LVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVR 415
+ D + ++ P L V + M ++M EC + + R
Sbjct: 228 INNRDQIIE----MVGRGSLSPDLSK--VRSNCPKRMKRLMAECLKKKRDER 273
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 7e-51
Identities = 65/313 (20%), Positives = 115/313 (36%), Gaps = 64/313 (20%)
Query: 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEASWS----------RETEIYS 183
+I + IGKG +G V +G VA+K D + RE I S
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 184 TVLLRHENILGYIGSDMTSRNSCTQ-LWLVTHYHSFGSLYDHL--NRTTLNHHQMMKICL 240
L H NI+ G +V + G LY L + +++ L
Sbjct: 79 N--LNHPNIVKLYG-------LMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLML 129
Query: 241 SIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNG-----TCVIADFGLAVSYSQLS 295
I G+ ++ + P I HRD++S NI +++ +ADFGL+
Sbjct: 130 DIALGIEYMQNQ------NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSV 183
Query: 296 NKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFE 355
+ + +G ++M+PE + +KAD Y+ ++L+ +
Sbjct: 184 SGL-------LGNFQWMAPETIGAEEES----YTEKADTYSFAMILYTILTG-------- 224
Query: 356 EYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVR 415
+ P+ + F +M I + RP +P + + V++ CW + R
Sbjct: 225 --EGPFDEYSYGKIKFINM---IREEGLRPTIP-----EDCPPRLRNVIELCWSGDPKKR 274
Query: 416 LSALRVKKTLIKL 428
+ K L +L
Sbjct: 275 PHFSYIVKELSEL 287
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 3e-46
Identities = 62/300 (20%), Positives = 106/300 (35%), Gaps = 64/300 (21%)
Query: 137 QISLSECIGKGRYGEVWRGVWH--GENVAVKIFFSRDEASWS---RETEIYSTVLLRHEN 191
+ E +GKG +G+ + GE + +K DE + +E ++ L H N
Sbjct: 11 DLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRC--LEHPN 68
Query: 192 ILGYIGSDMTSRNSCTQ---LWLVTHYHSFGSLYDHL--NRTTLNHHQMMKICLSIVNGL 246
+L +IG + L +T Y G+L + + Q + I +G+
Sbjct: 69 VLKFIGV-------LYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGM 121
Query: 247 VHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA----------VSYSQLSN 296
+LH+ I HRD+ S N LV+ N V+ADFGLA L
Sbjct: 122 AYLHS-----MN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKK 173
Query: 297 KMDIPPNPRVGTKRYMSPEILDESINMDCFESF-KKADIYALGLVLWEVCRRTKANGIFE 355
VG +M+PE+++ S+ +K D+++ G+VL E+
Sbjct: 174 PDRKKRYTVVGNPYWMAPEMIN-------GRSYDEKVDVFSFGIVLCEII---------- 216
Query: 356 EYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVR 415
D +P F + P + + + C + R
Sbjct: 217 GRVNADPDYLPRTMDFG----LNVRGFLDRYCP-----PNCPPSFFPITVRCCDLDPEKR 267
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 5e-38
Identities = 62/286 (21%), Positives = 108/286 (37%), Gaps = 49/286 (17%)
Query: 142 ECIGKGRYGEVWRGVW--HGENVAVKIF-----FSRDEASWSRETEIYSTVLLRHENILG 194
IG+G + V++G+ VA + + E E+ L+H NI+
Sbjct: 32 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKG--LQHPNIVR 89
Query: 195 YIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRT-TLNHHQMMKICLSIVNGLVHLHTEI 253
+ S ++ + LVT + G+L +L R + + C I+ GL LHT
Sbjct: 90 FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR- 148
Query: 254 FGTQGKPAIAHRDIKSKNILV-KTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYM 312
P I HRD+K NI + G+ I D GLA K +GT +M
Sbjct: 149 -----TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAV------IGTPEFM 197
Query: 313 SPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFD 372
+PE+ +E + + D+YA G+ + E+ + PY + +
Sbjct: 198 APEMYEEKYD-------ESVDVYAFGMCMLEMA----------TSEYPYSECQNAAQIY- 239
Query: 373 DMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSA 418
+P ++ + ++++ C QN + R S
Sbjct: 240 ----RRVTSGVKPASFDKVAIP----EVKEIIEGCIRQNKDERYSI 277
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 8e-37
Identities = 60/287 (20%), Positives = 96/287 (33%), Gaps = 60/287 (20%)
Query: 142 ECIGKGRYGEVWRGVWH---GENVAVKIFF-----SRDEASWSRETEIYSTVLLRHENIL 193
+G G YGEV++ G AVK +D A E + + +H +
Sbjct: 63 SRLGHGSYGEVFKVR-SKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHE-KVGQHPCCV 120
Query: 194 GYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHT 251
+ L+L T SL H +L Q+ + L HLH+
Sbjct: 121 RLEQAWEEG----GILYLQTEL-CGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHS 175
Query: 252 EIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRY 311
+ + H D+K NI + G C + DFGL +L + G RY
Sbjct: 176 Q--------GLVHLDVKPANIFLGPRGRCKLGDFGLL---VELGTAG--AGEVQEGDPRY 222
Query: 312 MSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSF 371
M+PE+L S AD+++LGL + EV + H
Sbjct: 223 MAPELLQGSYG-------TAADVFSLGLTILEVACNME----------LPHGGEGWQQ-- 263
Query: 372 DDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSA 418
+R+ P S+ + V+ + +R +A
Sbjct: 264 --LRQGYL----PPEFTAGLSSE-----LRSVLVMMLEPDPKLRATA 299
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 6e-35
Identities = 48/225 (21%), Positives = 89/225 (39%), Gaps = 28/225 (12%)
Query: 136 KQISLSECIGKGRYGEVW--RGVWHGENVAVKIFFSRDEASWS---RETEIYSTVLLRHE 190
K + +G+G + V G+ G A+K ++ RE +++ L H
Sbjct: 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHR--LFNHP 86
Query: 191 NILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQM-----MKICLSIVNG 245
NIL + + R + + WL+ + G+L++ + R + + + + L I G
Sbjct: 87 NILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRG 146
Query: 246 LVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA-VSYSQLSNKMDIPPNP 304
L +H AHRD+K NIL+ G V+ D G + +
Sbjct: 147 LEAIH--------AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQ 198
Query: 305 ----RVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVC 345
+ T Y +PE+ + E + D+++LG VL+ +
Sbjct: 199 DWAAQRCTISYRAPELFSVQSHCVIDE---RTDVWSLGCVLYAMM 240
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 9e-34
Identities = 84/308 (27%), Positives = 124/308 (40%), Gaps = 63/308 (20%)
Query: 135 AKQISLSECIGKGRYGEVWRG--VWHGENVAVKIFFSRDEASWSRET---EIYSTVLLRH 189
L E IG G V E VA+K + ++ S + EI + H
Sbjct: 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRI-NLEKCQTSMDELLKEIQAMSQCHH 72
Query: 190 ENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYD---------HLNRTTLNHHQMMKICL 240
NI+ Y S + +LWLV S GS+ D L+ + I
Sbjct: 73 PNIVSYYTSFVVK----DELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILR 128
Query: 241 SIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDI 300
++ GL +LH G+ I HRD+K+ NIL+ +G+ IADFG VS + L+ DI
Sbjct: 129 EVLEGLEYLHK-----NGQ--I-HRDVKAGNILLGEDGSVQIADFG--VS-AFLATGGDI 177
Query: 301 PPNPR----VGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEE 356
N VGT +M+PE++++ D KADI++ G+ E+ A G
Sbjct: 178 TRNKVRKTFVGTPCWMAPEVMEQVRGYDF-----KADIWSFGITAIEL-----ATG---- 223
Query: 357 YKAPYHDLVPMDPSFDDMRKVICIDQQR--PVLPNRWVSDSTLNAMTKVMKE----CWHQ 410
APYH PM KV+ + Q P L L K ++ C +
Sbjct: 224 -AAPYHKYPPM--------KVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQK 274
Query: 411 NANVRLSA 418
+ R +A
Sbjct: 275 DPEKRPTA 282
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 3e-33
Identities = 54/244 (22%), Positives = 99/244 (40%), Gaps = 45/244 (18%)
Query: 140 LSECIGKGR--YGEVWRG--VWHGENVAVKIFFSRDEASWSRET------EIYSTVLLRH 189
L IGKG V GE V V+ + + S E E++ + L H
Sbjct: 29 LLTVIGKGFEDLMTVNLARYKPTGEYVTVRRI---NLEACSNEMVTFLQGELHVSKLFNH 85
Query: 190 ENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRT---TLNHHQMMKICLSIVNGL 246
NI+ Y + + +LW+VT + ++GS D + +N + I ++ L
Sbjct: 86 PNIVPYRATFIAD----NELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKAL 141
Query: 247 VHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNK---MDIPPN 303
++H G + HR +K+ +IL+ +G ++ +S + + P
Sbjct: 142 DYIHH-----MGY--V-HRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPK 193
Query: 304 PRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHD 363
V ++SPE+L +++ K+DIY++G+ E+ ANG P+ D
Sbjct: 194 YSVKVLPWLSPEVLQQNLQGYDA----KSDIYSVGITACEL-----ANG-----HVPFKD 239
Query: 364 LVPM 367
+
Sbjct: 240 MPAT 243
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 4e-33
Identities = 61/305 (20%), Positives = 118/305 (38%), Gaps = 71/305 (23%)
Query: 142 ECIGKGRYGEVWRGVWH---GENVAVK-IFFSRDEASWSRETEIYSTVLLRHENILGYIG 197
E IG G +G+V++ H G+ +K + ++ ++A RE + + L H NI+ Y G
Sbjct: 17 ELIGSGGFGQVFK-AKHRIDGKTYVIKRVKYNNEKAE--REVKALAK--LDHVNIVHYNG 71
Query: 198 S------------DMTSRNSCTQLWLVTHYHSFGSLYDHL---NRTTLNHHQMMKICLSI 242
+SR+ L++ + G+L + L+ +++ I
Sbjct: 72 CWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQI 131
Query: 243 VNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPP 302
G+ ++H++ + +RD+K NI + I DFGL + L N
Sbjct: 132 TKGVDYIHSK--------KLINRDLKPSNIFLVDTKQVKIGDFGLV---TSLKNDGKR-- 178
Query: 303 NPRVGTKRYMSPEIL-DESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPY 361
GT RYMSPE + + K+ D+YALGL+L E+
Sbjct: 179 TRSKGTLRYMSPEQISSQDYG-------KEVDLYALGLILAELLH--------------- 216
Query: 362 HDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRV 421
+ + + K D + ++ + + ++++ + R + +
Sbjct: 217 -----VCDTAFETSKFFT-DLRDGIISDIFDKK-----EKTLLQKLLSKKPEDRPNTSEI 265
Query: 422 KKTLI 426
+TL
Sbjct: 266 LRTLT 270
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 9e-33
Identities = 82/288 (28%), Positives = 129/288 (44%), Gaps = 57/288 (19%)
Query: 140 LSECIGKGRYGEVWRGV--WHGENVAVKIF-FSRDEASWSR-ETEIYSTVLLRHENILGY 195
E IGKG +GEV++G+ + VA+KI E + EI + Y
Sbjct: 26 KLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKY 85
Query: 196 IGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFG 255
GS + T+LW++ Y GS D L L+ Q+ I I+ GL +LH+E
Sbjct: 86 YGSYLKD----TKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSE--- 138
Query: 256 TQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPE 315
HRDIK+ N+L+ +G +ADFG+A QL++ N VGT +M+PE
Sbjct: 139 -----KKIHRDIKAANVLLSEHGEVKLADFGVA---GQLTDTQI-KRNTFVGTPFWMAPE 189
Query: 316 ILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFDDMR 375
++ +S D KADI++LG+ E+ A G + P+ +L P M+
Sbjct: 190 VIKQS-AYDS-----KADIWSLGITAIEL-----ARG-----EPPHSELHP-------MK 226
Query: 376 KVICIDQQR-PVLPNRWVSDSTLNAMTKVMKE----CWHQNANVRLSA 418
+ I + P L + +K +KE C ++ + R +A
Sbjct: 227 VLFLIPKNNPPTLEGNY---------SKPLKEFVEACLNKEPSFRPTA 265
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-32
Identities = 72/235 (30%), Positives = 110/235 (46%), Gaps = 41/235 (17%)
Query: 139 SLSECIGKGRYGEVWRG--VWHGENVAVKIFFSRDEASWSRETEIYSTVL--LRHENILG 194
+ E +G+G YG V++ G+ VA+K + EI +++ +++
Sbjct: 32 DVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQ-EIIKEI--SIMQQCDSPHVVK 88
Query: 195 YIGSDMTSRNSCTQLWLVTHYHSFGSLYD--HLNRTTLNHHQMMKICLSIVNGLVHLHTE 252
Y GS + T LW+V Y GS+ D L TL ++ I S + GL +LH
Sbjct: 89 YYGSYFKN----TDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM 144
Query: 253 IFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYM 312
HRDIK+ NIL+ T G +ADFG+A QL++ M N +GT +M
Sbjct: 145 --------RKIHRDIKAGNILLNTEGHAKLADFGVA---GQLTDTMA-KRNTVIGTPFWM 192
Query: 313 SPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPM 367
+PE++ E +C ADI++LG+ E+ A G K PY D+ PM
Sbjct: 193 APEVIQEI-GYNC-----VADIWSLGITAIEM-----AEG-----KPPYADIHPM 231
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-32
Identities = 60/229 (26%), Positives = 103/229 (44%), Gaps = 35/229 (15%)
Query: 142 ECIGKGRYGEVWRG--VWHGENVAVKIF-FSRDEASWSRETEIYSTVLLRHENILGYIGS 198
E IG+G G V+ V G+ VA++ + EI ++ NI+ Y+ S
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 199 DMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQG 258
+ +LW+V Y + GSL D + T ++ Q+ +C + L LH+
Sbjct: 86 YLVG----DELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN------ 135
Query: 259 KPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILD 318
+ HRDIKS NIL+ +G+ + DFG +Q++ + + VGT +M+PE++
Sbjct: 136 --QVIHRDIKSDNILLGMDGSVKLTDFGFC---AQITPEQS-KRSTMVGTPYWMAPEVVT 189
Query: 319 ESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPM 367
K DI++LG++ E+ G + PY + P+
Sbjct: 190 RK-AYGP-----KVDIWSLGIMAIEM-----IEG-----EPPYLNENPL 222
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 6e-32
Identities = 71/241 (29%), Positives = 108/241 (44%), Gaps = 39/241 (16%)
Query: 139 SLSECIGKGRYGEVWRGV--WHGENVAVKIF-FSRDEASW-SRETEIYSTVLLRHENILG 194
L E +G G YG+V++G G+ A+K+ + DE +E + H NI
Sbjct: 27 ELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKK-YSHHRNIAT 85
Query: 195 YIGS--DMTSRNSCTQLWLVTHYHSFGSLYDHLNRT---TLNHHQMMKICLSIVNGLVHL 249
Y G+ QLWLV + GS+ D + T TL + IC I+ GL HL
Sbjct: 86 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHL 145
Query: 250 HTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPR---V 306
H + HRDIK +N+L+ N + DFG++ +QL + R +
Sbjct: 146 HQH--------KVIHRDIKGQNVLLTENAEVKLVDFGVS---AQLDRTV----GRRNTFI 190
Query: 307 GTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVP 366
GT +M+PE++ N D F K+D+++LG+ E+ A G P D+ P
Sbjct: 191 GTPYWMAPEVIACDENPDATYDF-KSDLWSLGITAIEM-----AEG-----APPLCDMHP 239
Query: 367 M 367
M
Sbjct: 240 M 240
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 6e-32
Identities = 49/235 (20%), Positives = 88/235 (37%), Gaps = 57/235 (24%)
Query: 142 ECIGKGRYGEVWRGVWH---GENVAVKIFFSRDEASWSRET---EIYS-TVLLRHENILG 194
E IG G +G V++ V G A+K S + E+Y+ VL +H +++
Sbjct: 17 EKIGSGEFGSVFKCV-KRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVR 75
Query: 195 YIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNR-----TTLNHHQMMKICLSIVNGLVHL 249
Y + + + Y + GSL D ++ + ++ + L + GL ++
Sbjct: 76 YFSAWAED----DHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 131
Query: 250 HTEIFGTQGKPAIAHRDIKSKNILVKTNGTCV-------------------IADFGLAVS 290
H+ ++ H DIK NI + I D G
Sbjct: 132 HSM--------SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHV-- 181
Query: 291 YSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVC 345
+++S+ P G R+++ E+L E+ KADI+AL L +
Sbjct: 182 -TRISS-----PQVEEGDSRFLANEVLQENYTHL-----PKADIFALALTVVCAA 225
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-31
Identities = 58/232 (25%), Positives = 107/232 (46%), Gaps = 41/232 (17%)
Query: 142 ECIGKGRYGEVWRG--VWHGENVAVKIFFSRDEASWSRETEIYSTVLL----RHENILGY 195
IG+G G V G VAVK+ D R +++ V++ +H N++
Sbjct: 51 VKIGEGSTGIVCLAREKHSGRQVAVKMM---DLRKQQRRELLFNEVVIMRDYQHFNVVEM 107
Query: 196 IGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFG 255
S + +LW++ + G+L D +++ LN Q+ +C +++ L +LH +
Sbjct: 108 YKSYLVG----EELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQ--- 160
Query: 256 TQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPE 315
+ HRDIKS +IL+ +G ++DFG +Q+S + VGT +M+PE
Sbjct: 161 -----GVIHRDIKSDSILLTLDGRVKLSDFGFC---AQISKDVP-KRKSLVGTPYWMAPE 211
Query: 316 ILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPM 367
++ S + DI++LG+++ E+ +G + PY P+
Sbjct: 212 VISRS------LYATEVDIWSLGIMVIEM-----VDG-----EPPYFSDSPV 247
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 4e-31
Identities = 49/228 (21%), Positives = 100/228 (43%), Gaps = 38/228 (16%)
Query: 142 ECIGKGRYGEVWRGVWH---GENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIGS 198
+G+G +G+V + + A+K +E + +E+ L H+ ++ Y +
Sbjct: 12 AVLGQGAFGQVVKAR-NALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAA 70
Query: 199 ---------DMTSRNSCTQLWLVTHYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLV 247
MT+ + L++ Y G+LYD ++ + ++ I+ L
Sbjct: 71 WLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALS 130
Query: 248 HLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNP--- 304
++H+ QG I HRD+K NI + + I DFGLA + + + + +
Sbjct: 131 YIHS-----QG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 305 -------RVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVC 345
+GT Y++ E+LD + + + +K D+Y+LG++ +E+
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDGTGHYN-----EKIDMYSLGIIFFEMI 225
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-30
Identities = 60/258 (23%), Positives = 101/258 (39%), Gaps = 43/258 (16%)
Query: 116 ASLTSGSGSGLPLLIQRTLA---KQISLSECIGKGRYGEVW--RGVWHGENVAVKIFFSR 170
SL SG + +T+ ++ + + +G + V+ + V G A+K S
Sbjct: 5 GSLGGASGRDQSDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN 64
Query: 171 DEASWS---RETEIYSTVLLRHENILGYIGSDMTSR----NSCTQLWLVTHYHSFGSLYD 223
+E +E L H NI+ + + + + L+T G L +
Sbjct: 65 EEEKNRAIIQEVCFMKK-LSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCK-GQLVE 122
Query: 224 HLNRTTLNHH----QMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGT 279
L + ++KI + H+H + KP I HRD+K +N+L+ GT
Sbjct: 123 FLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ------KPPIIHRDLKVENLLLSNQGT 176
Query: 280 CVIADFGLA--------VSYSQLSNKMDIPPNPRVGTKRYMSPEILD----ESINMDCFE 327
+ DFG A S+S + R T Y +PEI+D I
Sbjct: 177 IKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIG----- 231
Query: 328 SFKKADIYALGLVLWEVC 345
+K DI+ALG +L+ +C
Sbjct: 232 --EKQDIWALGCILYLLC 247
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-30
Identities = 52/232 (22%), Positives = 86/232 (37%), Gaps = 46/232 (19%)
Query: 142 ECIGKGRYGEVWRGVWH---GENVAVKI----FFSRDEASWSRETEIYSTVLLRHENILG 194
+C+G+G +G V+ + N A+K RE + + L H I+
Sbjct: 11 QCLGRGGFGVVFE-AKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAK--LEHPGIVR 67
Query: 195 YIGSDMTSRNSCTQ--------LWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLS----I 242
Y + + + L++ +L D +N + +CL I
Sbjct: 68 YFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQI 127
Query: 243 VNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA--------VSYSQL 294
+ LH+ +G + HRD+K NI + + DFGL
Sbjct: 128 AEAVEFLHS-----KG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 179
Query: 295 SNKMDIPPNPRVGTKRYMSPEIL-DESINMDCFESFKKADIYALGLVLWEVC 345
+VGTK YMSPE + S + K DI++LGL+L+E+
Sbjct: 180 PMPAYARHTGQVGTKLYMSPEQIHGNSYS-------HKVDIFSLGLILFELL 224
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 4e-30
Identities = 47/231 (20%), Positives = 82/231 (35%), Gaps = 37/231 (16%)
Query: 142 ECIGKGRYGEVWRGVWH--GENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIGSD 199
+G+G +GEV R G AVK R E E + L I+ G+
Sbjct: 64 PRVGRGSFGEVHRMKDKQTGFQCAVKKV--RLEVFRVEELVACAG--LSSPRIVPLYGAV 119
Query: 200 MTSRNSCTQLWLVTHYHSFGSLYDHLNRT-TLNHHQMMKICLSIVNGLVHLHTEIFGTQG 258
+ + GSL + + L + + + GL +LHT
Sbjct: 120 REG----PWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTR------ 169
Query: 259 KPAIAHRDIKSKNILVKTNGTCV-IADFGLAVSYSQLSNKMDIPPNPR-VGTKRYMSPEI 316
I H D+K+ N+L+ ++G+ + DFG A+ + GT+ +M+PE+
Sbjct: 170 --RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEV 227
Query: 317 LDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPM 367
+ K DI++ ++ + NG P+
Sbjct: 228 VMGK------PCDAKVDIWSSCCMMLHM-----LNG-----CHPWTQYFRG 262
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 5e-30
Identities = 73/286 (25%), Positives = 113/286 (39%), Gaps = 49/286 (17%)
Query: 142 ECIGKGRYGEVWRGVWH--GENVAVK-IFFSRDEASWSRETEIYSTVLLRHENILGYIGS 198
+GKG YG V+ G +A+K I S EI L+H+NI+ Y+GS
Sbjct: 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGS 87
Query: 199 DMTSRNSCTQLWLVTHYHSFGSLYDHL----NRTTLNHHQMMKICLSIVNGLVHLHTEIF 254
+ + + GSL L N + I+ GL +LH
Sbjct: 88 FSEN----GFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN-- 141
Query: 255 GTQGKPAIAHRDIKSKNILVKT-NGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMS 313
I HRDIK N+L+ T +G I+DFG + +L+ GT +YM+
Sbjct: 142 ------QIVHRDIKGDNVLINTYSGVLKISDFGTS---KRLAGINPC-TETFTGTLQYMA 191
Query: 314 PEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLV-PMDPSFD 372
PEI I+ K ADI++LG + E+ A G K P+++L P F
Sbjct: 192 PEI----IDKGPRGYGKAADIWSLGCTIIEM-----ATG-----KPPFYELGEPQAAMFK 237
Query: 373 DMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSA 418
+ + + P +P S + +C+ + + R A
Sbjct: 238 -----VGMFKVHPEIPESM-SA----EAKAFILKCFEPDPDKRACA 273
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 5e-30
Identities = 56/233 (24%), Positives = 104/233 (44%), Gaps = 36/233 (15%)
Query: 142 ECIGKGRYGEVWRG--VWHGENVAVKIFFSRDEASWS---RETEIYSTVLLRHENILGYI 196
+G G +G+V++ G A K+ ++ E E EI +T H I+ +
Sbjct: 25 GELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILAT--CDHPYIVKLL 82
Query: 197 GSDMTSRNSCTQLWLVTHYHSFGSLYD--HLNRTTLNHHQMMKICLSIVNGLVHLHTEIF 254
G+ +LW++ + G++ L Q+ +C ++ L LH++
Sbjct: 83 GAYYHD----GKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK-- 136
Query: 255 GTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSP 314
I HRD+K+ N+L+ G +ADFG++ ++ + + +GT +M+P
Sbjct: 137 ------RIIHRDLKAGNVLMTLEGDIRLADFGVS---AKNLKTLQ-KRDSFIGTPYWMAP 186
Query: 315 EILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPM 367
E++ D + KADI++LG+ L E+ A + P+H+L PM
Sbjct: 187 EVVMCETMKDTPYDY-KADIWSLGITLIEM-----AQI-----EPPHHELNPM 228
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-29
Identities = 62/291 (21%), Positives = 110/291 (37%), Gaps = 57/291 (19%)
Query: 142 ECIGKGRYGEVWRGV--WHGENVAVK-IFFSRDEASWSRE---TEIYSTVL--LRHENIL 193
+ IG+G++ EV+R G VA+K + + +R EI +L L H N++
Sbjct: 38 KKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEI--DLLKQLNHPNVI 95
Query: 194 GYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNR-----TTLNHHQMMKICLSIVNGLVH 248
Y S + +L +V G L + + + K + + + L H
Sbjct: 96 KYYASFIED----NELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 249 LHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGT 308
+H+ + HRDIK N+ + G + D GL S+K + VGT
Sbjct: 152 MHSR--------RVMHRDIKPANVFITATGVVKLGDLGLG---RFFSSKTTA-AHSLVGT 199
Query: 309 KRYMSPEIL-DESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPM 367
YMSPE + + N K+DI++LG +L+E+ F K + L
Sbjct: 200 PYYMSPERIHENGYN-------FKSDIWSLGCLLYEMAALQSP---FYGDKMNLYSLCKK 249
Query: 368 DPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSA 418
I P+ + + + + +++ C + + R
Sbjct: 250 ----------IEQCDYPPLPSDHYSEE-----LRQLVNMCINPDPEKRPDV 285
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-29
Identities = 58/305 (19%), Positives = 116/305 (38%), Gaps = 63/305 (20%)
Query: 136 KQISLSECIGKGRYGEVWRGVWHGEN------VAVKI----FFSRDEASWSRETEIYSTV 185
+ + +G+G +G+V + E VAVK A +E EI
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRN- 79
Query: 186 LLRHENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHL--NRTTLNHHQMMKICLSIV 243
L HENI+ Y G + + + + L+ + GSL ++L N+ +N Q +K + I
Sbjct: 80 -LYHENIVKYKG--ICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQIC 136
Query: 244 NGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPN 303
G+ +L + + HRD+ ++N+LV++ I DFGL I +
Sbjct: 137 KGMDYLGSRQY--------VHRDLAARNVLVESEHQVKIGDFGLT---------KAIETD 179
Query: 304 P-----RVGTK---RYMSPEILDESINMDCFESFKKADIYALGLVLWEV---CRRTKA-- 350
+ + +P E + F +D+++ G+ L E+ C +
Sbjct: 180 KEYYTVKDDRDSPVFWYAP----ECLMQSKFYI--ASDVWSFGVTLHELLTYCDSDSSPM 233
Query: 351 NGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQ 410
+ + + ++ ++ LP + + + ++M++CW
Sbjct: 234 ALFLKMIGPTHGQMTVTR--------LVNTLKEGKRLPC---PPNCPDEVYQLMRKCWEF 282
Query: 411 NANVR 415
+ R
Sbjct: 283 QPSNR 287
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 5e-29
Identities = 78/316 (24%), Positives = 147/316 (46%), Gaps = 74/316 (23%)
Query: 136 KQISLSECIGKGRYGEVWRGVWHGENVAVKIFFSRDEASWS---RETEIYSTVLLRHENI 192
K++ L + IGKG +G+V G + G VAVK +++A+ E + + LRH N+
Sbjct: 21 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCI--KNDATAQAFLAEASVMTQ--LRHSNL 76
Query: 193 LGYIGSDMTSRNSCTQ----LWLVTHYHSFGSLYDHL---NRTTLNHHQMMKICLSIVNG 245
+ +G + L++VT Y + GSL D+L R+ L ++K L +
Sbjct: 77 VQLLG-------VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA 129
Query: 246 LVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA--VSYSQLSNKMDIPPN 303
+ +L F HRD+ ++N+LV + ++DFGL S +Q + K+ +
Sbjct: 130 MEYLEGNNF--------VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV--- 178
Query: 304 PRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHD 363
++ +P E++ F + K+D+++ G++LWE I+ + PY
Sbjct: 179 ------KWTAP----EALREKKFST--KSDVWSFGILLWE---------IYSFGRVPYPR 217
Query: 364 LVPMDPSFDDMRKVICIDQ----QRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSAL 419
+ P D + +V ++ P D A+ +VMK CWH +A +R S L
Sbjct: 218 I----PLKDVVPRV---EKGYKMDAP--------DGCPPAVYEVMKNCWHLDAAMRPSFL 262
Query: 420 RVKKTLIKLACADMYI 435
++++ L + ++++
Sbjct: 263 QLREQLEHIKTHELHL 278
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 7e-29
Identities = 61/238 (25%), Positives = 96/238 (40%), Gaps = 50/238 (21%)
Query: 142 ECIGKGRYGEVWRG--VWHGENVAVKIF----FSRDEASWSRETEIYSTVL--LRHENIL 193
IG G +G V+ V + E VA+K +E E+ L LRH N +
Sbjct: 60 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEV--RFLQKLRHPNTI 117
Query: 194 GYIGSDMTSRNSCTQLWLVTHYHSFGSLYD--HLNRTTLNHHQMMKICLSIVNGLVHLHT 251
Y G + WLV Y GS D +++ L ++ + + GL +LH+
Sbjct: 118 QYRGCYLRE----HTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS 172
Query: 252 EIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRY 311
+ HRD+K+ NIL+ G + DFG A S ++ N VGT +
Sbjct: 173 H--------NMIHRDVKAGNILLSEPGLVKLGDFGSA---SIMAPA-----NSFVGTPYW 216
Query: 312 MSPEI--LDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPM 367
M+PE+ + D K D+++LG+ E+ A K P ++ M
Sbjct: 217 MAPEVILAMDEGQYDG-----KVDVWSLGITCIEL-----AER-----KPPLFNMNAM 259
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-28
Identities = 69/267 (25%), Positives = 114/267 (42%), Gaps = 47/267 (17%)
Query: 135 AKQISLSECIGKGRYGEVWRG--VWHGENVAVK-IFFSRDEASWSR-ETEIYSTVLLR-- 188
A+ + IG+G YG V + G+ +AVK I + DE + ++ V++R
Sbjct: 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDL--DVVMRSS 78
Query: 189 -HENILGYIGSDMTSRNSCTQLWLVTHY--HSFGSLYDHLNRT---TLNHHQMMKICLSI 242
I+ + G+ W+ SF Y ++ + + KI L+
Sbjct: 79 DCPYIVQFYGALFRE----GDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLAT 134
Query: 243 VNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPP 302
V L HL K I HRDIK NIL+ +G + DFG +S QL + +
Sbjct: 135 VKALNHLKEN-----LK--IIHRDIKPSNILLDRSGNIKLCDFG--IS-GQLVDSIA--K 182
Query: 303 NPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYH 362
G + YM+PE +D S + ++ ++D+++LG+ L+E+ A G F PY
Sbjct: 183 TRDAGCRPYMAPERIDPSASRQGYDV--RSDVWSLGITLYEL-----ATGRF-----PYP 230
Query: 363 DLVPMDPSFDDMRKVICIDQQRPVLPN 389
+ FD + +V + P L N
Sbjct: 231 KWNSV---FDQLTQV--VKGDPPQLSN 252
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-28
Identities = 64/303 (21%), Positives = 114/303 (37%), Gaps = 61/303 (20%)
Query: 136 KQISLSECIGKGRYGEVWRGVWHGEN------VAVKI----FFSRDEASWSRETEIYSTV 185
+ + +G+G +G+V + N VAVK + + W +E +I T
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRT- 89
Query: 186 LLRHENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNG 245
L HE+I+ Y G L LV Y GSL D+L R ++ Q++ I G
Sbjct: 90 -LYHEHIIKYKG--CCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEG 146
Query: 246 LVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNP- 304
+ +LH + + HRD+ ++N+L+ + I DFGLA +P
Sbjct: 147 MAYLHAQHY--------IHRDLAARNVLLDNDRLVKIGDFGLA---------KAVPEGHE 189
Query: 305 ----RVGTK---RYMSPEILDESINMDCFESFKKADIYALGLVLWEVC-----RRTKANG 352
R + +P E + F +D+++ G+ L+E+ ++
Sbjct: 190 YYRVREDGDSPVFWYAP----ECLKEYKFYY--ASDVWSFGVTLYELLTHCDSSQSPPTK 243
Query: 353 IFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNA 412
E + + + + ++ LP D + +MK CW A
Sbjct: 244 FLELIGIAQGQMTVLR--------LTELLERGERLPR---PDKCPAEVYHLMKNCWETEA 292
Query: 413 NVR 415
+ R
Sbjct: 293 SFR 295
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-28
Identities = 60/290 (20%), Positives = 108/290 (37%), Gaps = 52/290 (17%)
Query: 142 ECIGKGRYGEVW--RGVWHGENVAVK-IFFS----RDEASWSRETEIYSTVLLRHENILG 194
IG G YG R G+ + K + + ++ E + L+H NI+
Sbjct: 12 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRE--LKHPNIVR 69
Query: 195 YIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNH-----HQMMKICLSIVNGLVHL 249
Y + N+ L++V Y G L + + T ++++ + L
Sbjct: 70 YYDRIIDRTNTT--LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 127
Query: 250 HTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTK 309
H + G + HRD+K N+ + + DFGLA + ++ VGT
Sbjct: 128 HRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA----KTFVGTP 180
Query: 310 RYMSPEIL-DESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMD 368
YMSPE + S N +K+DI++LG +L+E+C F
Sbjct: 181 YYMSPEQMNRMSYN-------EKSDIWSLGCLLYELCALMPP---FT------------A 218
Query: 369 PSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSA 418
S ++ I + R +P R+ + + +++ + R S
Sbjct: 219 FSQKELAGKIREGKFRR-IPYRYSDE-----LNEIITRMLNLKDYHRPSV 262
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-28
Identities = 76/316 (24%), Positives = 143/316 (45%), Gaps = 74/316 (23%)
Query: 136 KQISLSECIGKGRYGEVWRGVWHGENVAVKIFFSRDEASWS---RETEIYSTVLLRHENI 192
K++ L + IGKG +G+V G + G VAVK +++A+ E + + LRH N+
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCI--KNDATAQAFLAEASVMTQ--LRHSNL 248
Query: 193 LGYIGSDMTSRNSCTQ----LWLVTHYHSFGSLYDHL---NRTTLNHHQMMKICLSIVNG 245
+ +G + L++VT Y + GSL D+L R+ L ++K L +
Sbjct: 249 VQLLG-------VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA 301
Query: 246 LVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA--VSYSQLSNKMDIPPN 303
+ +L F + HRD+ ++N+LV + ++DFGL S +Q + K+ +
Sbjct: 302 MEYLEGNNF-------V-HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV--- 350
Query: 304 PRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHD 363
++ +P E++ F + K+D+++ G++LWE I+ + PY
Sbjct: 351 ------KWTAP----EALREKKFST--KSDVWSFGILLWE---------IYSFGRVPY-- 387
Query: 364 LVPMDPSFDDMRKVICIDQ----QRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSAL 419
P V +++ P D A+ VMK CWH +A R + L
Sbjct: 388 -----PRIPLKDVVPRVEKGYKMDAP--------DGCPPAVYDVMKNCWHLDAATRPTFL 434
Query: 420 RVKKTLIKLACADMYI 435
++++ L + ++++
Sbjct: 435 QLREQLEHIRTHELHL 450
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 4e-28
Identities = 62/309 (20%), Positives = 121/309 (39%), Gaps = 78/309 (25%)
Query: 129 LIQRTLAKQISLSECIGKGRYGEVWRGVWHGEN------VAVKIFFSRDEASWSRETEIY 182
+++ T + + +G G +G V++G+W E VA+K R+ S EI
Sbjct: 11 ILKET---EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEIL 65
Query: 183 STVL----LRHENILGYIGSDMTSRNSCTQ--LWLVTHYHSFGSLYDHL--NRTTLNHHQ 234
+ + ++ +G C + L+T FG L D++ ++ +
Sbjct: 66 DEAYVMASVDNPHVCRLLGI-------CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQY 118
Query: 235 MMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA------ 288
++ C+ I G+ +L HRD+ ++N+LVKT I DFGLA
Sbjct: 119 LLNWCVQIAKGMNYLEDRRL--------VHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170
Query: 289 -VSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRR 347
Y K+ I ++M+ ESI + ++D+++ G+ +WE
Sbjct: 171 EKEYHAEGGKVPI---------KWMAL----ESILHRIYTH--QSDVWSYGVTVWE---- 211
Query: 348 TKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQ-QRPVLPNRWVSDSTLNAMTKVMKE 406
+ PY + P+ + +++ +R P + +M++
Sbjct: 212 -----LMTFGSKPYDGI----PASEISSI---LEKGERLPQP-----PICTIDVYMIMRK 254
Query: 407 CWHQNANVR 415
CW +A+ R
Sbjct: 255 CWMIDADSR 263
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 5e-28
Identities = 65/305 (21%), Positives = 118/305 (38%), Gaps = 63/305 (20%)
Query: 136 KQISLSECIGKGRYGEVWRGVWHGEN------VAVKIF---FSRDEASWSRETEIYSTVL 186
+ + + +GKG +G V + VAVK + RE EI +
Sbjct: 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKS-- 98
Query: 187 LRHENILGYIGSDMTSRNSCTQ-----LWLVTHYHSFGSLYDHL--NRTTLNHHQMMKIC 239
L+H+NI+ Y G C L L+ Y +GSL D+L ++ ++H ++++
Sbjct: 99 LQHDNIVKYKGV-------CYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 151
Query: 240 LSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA--VSYSQLSNK 297
I G+ +L T+ + HRD+ ++NILV+ I DFGL + + K
Sbjct: 152 SQICKGMEYLGTKRY--------IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYK 203
Query: 298 MDIPPNPRVGTK---RYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIF 354
+ + + + +P ES+ F +D+++ G+VL+E+ + +
Sbjct: 204 V------KEPGESPIFWYAP----ESLTESKFSV--ASDVWSFGVVLYELFTYIEKSKSP 251
Query: 355 EEYKAPYHDLVPMDPSFDDMRKVICIDQ----QRPVLPNRWVSDSTLNAMTKVMKECWHQ 410
+ + RP D + + +M ECW+
Sbjct: 252 PAEFMRMIGNDK-QGQMIVFHLIELLKNNGRLPRP--------DGCPDEIYMIMTECWNN 302
Query: 411 NANVR 415
N N R
Sbjct: 303 NVNQR 307
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 7e-28
Identities = 65/308 (21%), Positives = 117/308 (37%), Gaps = 69/308 (22%)
Query: 136 KQISLSECIGKGRYGEVWRGVWHGEN------VAVKIF---FSRDEASWSRETEIYSTVL 186
+ + + +GKG +G V + VAVK + RE EI +
Sbjct: 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKS-- 67
Query: 187 LRHENILGYIGSDMTSRNSCTQ-----LWLVTHYHSFGSLYDHL--NRTTLNHHQMMKIC 239
L+H+NI+ Y G C L L+ Y +GSL D+L ++ ++H ++++
Sbjct: 68 LQHDNIVKYKGV-------CYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 120
Query: 240 LSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMD 299
I G+ +L T+ + HRD+ ++NILV+ I DFGL
Sbjct: 121 SQICKGMEYLGTKRY--------IHRDLATRNILVENENRVKIGDFGLT---------KV 163
Query: 300 IPPNP-----RVGTK---RYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKAN 351
+P + + + + +P ES+ F +D+++ G+VL+E+ + +
Sbjct: 164 LPQDKEFFKVKEPGESPIFWYAP----ESLTESKFSV--ASDVWSFGVVLYELFTYIEKS 217
Query: 352 GIFEEYKAPYHDLVPMDPSFDDMRKVICIDQ----QRPVLPNRWVSDSTLNAMTKVMKEC 407
+ + RP D + + +M EC
Sbjct: 218 KSPPAEFMRMIGNDK-QGQMIVFHLIELLKNNGRLPRP--------DGCPDEIYMIMTEC 268
Query: 408 WHQNANVR 415
W+ N N R
Sbjct: 269 WNNNVNQR 276
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 8e-28
Identities = 68/305 (22%), Positives = 119/305 (39%), Gaps = 64/305 (20%)
Query: 136 KQISLSECIGKGRYGEVWRGVWHGEN------VAVKIF---FSRDEASWSRETEIYSTVL 186
+ + +GKG +G V + VAVK + + RE +I
Sbjct: 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKA-- 80
Query: 187 LRHENILGYIG-SDMTSRNSCTQLWLVTHYHSFGSLYDHL--NRTTLNHHQMMKICLSIV 243
L + I+ Y G S R S L LV Y G L D L +R L+ +++ I
Sbjct: 81 LHSDFIVKYRGVSYGPGRQS---LRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQIC 137
Query: 244 NGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPN 303
G+ +L + HRD+ ++NILV++ IADFGLA +P +
Sbjct: 138 KGMEYLGSRRC--------VHRDLAARNILVESEAHVKIADFGLA---------KLLPLD 180
Query: 304 P-----RVGTK---RYMSPEILDESINMDCFESFKKADIYALGLVLWEV---CRRTKANG 352
R + + +P ES++ + F ++D+++ G+VL+E+ C +
Sbjct: 181 KDYYVVREPGQSPIFWYAP----ESLSDNIFSR--QSDVWSFGVVLYELFTYCDK----- 229
Query: 353 IFEEYKAPYHDLVPMDPSFDDM--RKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQ 410
L M D +++ + ++ LP + + ++MK CW
Sbjct: 230 ---SCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPA---PPACPAEVHELMKLCWAP 283
Query: 411 NANVR 415
+ R
Sbjct: 284 SPQDR 288
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 2e-27
Identities = 69/309 (22%), Positives = 123/309 (39%), Gaps = 66/309 (21%)
Query: 136 KQISLSECIGKGRYGEVWRGVWHGEN--VAVKIF----FSRDEASWSRETEIYSTVLLRH 189
+ + L E IG+G +GEV+ G +N VAVK +A + +E I H
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQ--YSH 171
Query: 190 ENILGYIGSDMTSRNSCTQ---LWLVTHYHSFGSLYDHL--NRTTLNHHQMMKICLSIVN 244
NI+ IG CTQ +++V G L L ++++
Sbjct: 172 PNIVRLIGV-------CTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAA 224
Query: 245 GLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA-----VSYSQLSNKMD 299
G+ +L + K I HRD+ ++N LV I+DFG++ Y+
Sbjct: 225 GMEYLES-------KCCI-HRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQ 276
Query: 300 IPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKA 359
+P V ++ +P E++N + S ++D+++ G++LWE F +
Sbjct: 277 VP----V---KWTAP----EALNYGRYSS--ESDVWSFGILLWE---------TFSLGAS 314
Query: 360 PYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSAL 419
PY +L + V R P + +A+ ++M++CW R S
Sbjct: 315 PYPNL----SNQQTREFV--EKGGRLPCP-----ELCPDAVFRLMEQCWAYEPGQRPSFS 363
Query: 420 RVKKTLIKL 428
+ + L +
Sbjct: 364 TIYQELQSI 372
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-27
Identities = 58/263 (22%), Positives = 107/263 (40%), Gaps = 42/263 (15%)
Query: 135 AKQISLSECIGKGRYGEVWRG--VWHGENVAVK-IFFSRDEASWSR-ETEIYSTVLLR-- 188
+ +G G G+VW+ G +AVK + S ++ R ++ V+L+
Sbjct: 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDL--DVVLKSH 81
Query: 189 -HENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRT-TLNHHQMMKICLSIVNGL 246
I+ G+ +T+ T +++ + + + K+ ++IV L
Sbjct: 82 DCPYIVQCFGTFITN----TDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKAL 137
Query: 247 VHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRV 306
+L + + HRD+K NIL+ G + DFG +S +L + +
Sbjct: 138 YYLKEKH-------GVIHRDVKPSNILLDERGQIKLCDFG--IS-GRLVDDKA--KDRSA 185
Query: 307 GTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVP 366
G YM+PE +D +AD+++LG+ L E+ A G F PY
Sbjct: 186 GCAAYMAPERIDPPDPTKPDYDI-RADVWSLGISLVEL-----ATGQF-----PYK---N 231
Query: 367 MDPSFDDMRKVICIDQQRPVLPN 389
F+ + KV + ++ P+LP
Sbjct: 232 CKTDFEVLTKV--LQEEPPLLPG 252
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 4e-27
Identities = 60/215 (27%), Positives = 100/215 (46%), Gaps = 36/215 (16%)
Query: 142 ECIGKGRYGEVWRG--VWHGENVAVK-IFFS----RDEASWSRETEIYSTVLLRHENILG 194
+ IG+G +G+ G +K I S ++ RE + + ++H NI+
Sbjct: 30 QKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLAN--MKHPNIVQ 87
Query: 195 YIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNR---TTLNHHQMMKICLSIVNGLVHLHT 251
Y S + + L++V Y G L+ +N Q++ + I L H+H
Sbjct: 88 YRESFEENGS----LYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH- 142
Query: 252 EIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRY 311
I HRDIKS+NI + +GT + DFG+A L++ +++ +GT Y
Sbjct: 143 -------DRKILHRDIKSQNIFLTKDGTVQLGDFGIA---RVLNSTVEL-ARACIGTPYY 191
Query: 312 MSPEIL-DESINMDCFESFKKADIYALGLVLWEVC 345
+SPEI ++ N K+DI+ALG VL+E+C
Sbjct: 192 LSPEICENKPYN-------NKSDIWALGCVLYELC 219
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 5e-27
Identities = 59/220 (26%), Positives = 98/220 (44%), Gaps = 37/220 (16%)
Query: 142 ECIGKGRYGEVWRG--VWHGENVAVK-IFFSRDEASWS---RETEIYSTVLLRHENILGY 195
+G G G V++ G +A K I A + RE ++ I+G+
Sbjct: 39 SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC--NSPYIVGF 96
Query: 196 IGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRT-TLNHHQMMKICLSIVNGLVHLHTEIF 254
G+ + ++ + + GSL L + + + K+ ++++ GL +L +
Sbjct: 97 YGAFYSD----GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK-- 150
Query: 255 GTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSP 314
K I HRD+K NILV + G + DFG VS QL + M N VGT+ YMSP
Sbjct: 151 ---HK--IMHRDVKPSNILVNSRGEIKLCDFG--VS-GQLIDSM---ANSFVGTRSYMSP 199
Query: 315 EILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIF 354
E L + + ++DI+++GL L E+ A G +
Sbjct: 200 ERLQGT-HYSV-----QSDIWSMGLSLVEM-----AVGRY 228
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 5e-27
Identities = 45/216 (20%), Positives = 87/216 (40%), Gaps = 26/216 (12%)
Query: 137 QISLSECIGKGRYGEVW-RGVWHGENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGY 195
+ +G G G + RG++ +VAVK + RE ++ H N++ Y
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRE-SDEHPNVIRY 83
Query: 196 IGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNH--HQMMKICLSIVNGLVHLHTEI 253
++ + ++ + +L +++ + H + + + +GL HLH+
Sbjct: 84 FCTEKDRQF----QYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHS-- 136
Query: 254 FGTQGKPAIAHRDIKSKNILVKTNGTC-----VIADFGLAVSYSQLSNKMDIPPNPRVGT 308
I HRD+K NIL+ +I+DFGL + + + GT
Sbjct: 137 ---LN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSR-RSGVPGT 189
Query: 309 KRYMSPEILDESINMDCFESFKKADIYALGLVLWEV 344
+ +++PE+L E DI++ G V + V
Sbjct: 190 EGWIAPEMLSEDCKE---NPTYTVDIFSAGCVFYYV 222
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 5e-27
Identities = 70/318 (22%), Positives = 136/318 (42%), Gaps = 76/318 (23%)
Query: 136 KQISLSECIGKGRYGEVWRGVWHGE-NVAVKIF--FSRDEASWSRETEIYSTVLLRHENI 192
++I+L + +G G++G V G W G+ +VAVK+ S E + +E + L H +
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMK--LSHPKL 65
Query: 193 LGYIGSDMTSRNSCTQ---LWLVTHYHSFGSLYDHL--NRTTLNHHQMMKICLSIVNGLV 247
+ + G C++ +++VT Y S G L ++L + L Q++++C + G+
Sbjct: 66 VKFYGV-------CSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMA 118
Query: 248 HLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPN---P 304
L + F HRD+ ++N LV + ++DFG+ + +
Sbjct: 119 FLESHQF--------IHRDLAARNCLVDRDLCVKVSDFGMT---------RYVLDDQYVS 161
Query: 305 RVGTK---RYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPY 361
VGTK ++ +P E + + S K+D++A G+++WE +F K PY
Sbjct: 162 SVGTKFPVKWSAP----EVFHYFKYSS--KSDVWAFGILMWE---------VFSLGKMPY 206
Query: 362 HDLVPMDPSFDDMRKVI-CIDQ----QRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRL 416
+V+ + Q RP + + ++M CWH+ R
Sbjct: 207 DLY--------TNSEVVLKVSQGHRLYRP--------HLASDTIYQIMYSCWHELPEKRP 250
Query: 417 SALRVKKTLIKLACADMY 434
+ ++ ++ L D +
Sbjct: 251 TFQQLLSSIEPLREKDKH 268
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 7e-27
Identities = 63/299 (21%), Positives = 115/299 (38%), Gaps = 76/299 (25%)
Query: 136 KQISLSECIGKGRYGEVWRGVWHGEN-VAVKIF--FSRDEASWSRETEIYSTVLLRHENI 192
+++ + IG G++G V G W ++ VA+K + E + E E+ L H +
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMK--LSHPKL 65
Query: 193 LGYIGSDMTSRNSCTQ---LWLVTHYHSFGSLYDHL--NRTTLNHHQMMKICLSIVNGLV 247
+ G C + + LVT + G L D+L R ++ +CL + G+
Sbjct: 66 VQLYGV-------CLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMA 118
Query: 248 HLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPN---P 304
+L HRD+ ++N LV N ++DFG+ + +
Sbjct: 119 YLEEACV--------IHRDLAARNCLVGENQVIKVSDFGMT---------RFVLDDQYTS 161
Query: 305 RVGTK---RYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPY 361
GTK ++ SP E + + S K+D+++ G+++WE +F E K PY
Sbjct: 162 STGTKFPVKWASP----EVFSFSRYSS--KSDVWSFGVLMWE---------VFSEGKIPY 206
Query: 362 HDLVPMDPSFDDMRKVI-CIDQ----QRPVLPNRWVSDSTLNAMTKVMKECWHQNANVR 415
+ +V+ I +P + ++M CW + R
Sbjct: 207 ENR--------SNSEVVEDISTGFRLYKP--------RLASTHVYQIMNHCWRERPEDR 249
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 7e-27
Identities = 64/296 (21%), Positives = 119/296 (40%), Gaps = 70/296 (23%)
Query: 136 KQISLSECIGKGRYGEVWRGVWHGE-NVAVKIFFSRDEASWSRETEIYSTVLLRHENILG 194
+ + L +G+G +GEVW G W+G VA+K + + E LRHE ++
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQ 326
Query: 195 YIGSDMTSRNSCTQ--LWLVTHYHSFGSLYDHL---NRTTLNHHQMMKICLSIVNGLVHL 249
++ +++VT Y S GSL D L L Q++ + I +G+ ++
Sbjct: 327 LYAV-------VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV 379
Query: 250 HTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA------VSYSQLSNKMDIPPN 303
+ HRD+++ NILV N C +ADFGLA ++ K I
Sbjct: 380 ERMNY--------VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI--- 428
Query: 304 PRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHD 363
++ +P E+ F K+D+++ G++L E + + + PY
Sbjct: 429 ------KWTAP----EAALYGRFTI--KSDVWSFGILLTE---------LTTKGRVPYPG 467
Query: 364 LVPMDPSFDDMRKVICIDQ----QRPVLPNRWVSDSTLNAMTKVMKECWHQNANVR 415
+ + + + +V ++ P ++ +M +CW + R
Sbjct: 468 M----VNREVLDQV---ERGYRMPCP--------PECPESLHDLMCQCWRKEPEER 508
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-26
Identities = 61/258 (23%), Positives = 109/258 (42%), Gaps = 46/258 (17%)
Query: 142 ECIGKGRYGEVWRG--VWHGENVAVK-IFFSRDEASWSR-ETEIYSTVLLR---HENILG 194
+G+G YG V + V G+ +AVK I + + R ++ + +R +
Sbjct: 13 MELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDL--DISMRTVDCPFTVT 70
Query: 195 YIGSDMTSRNSCTQLWLVTHY--HSFGSLYDHLNRT--TLNHHQMMKICLSIVNGLVHLH 250
+ G+ +W+ S Y + T+ + KI +SIV L HLH
Sbjct: 71 FYGALFRE----GDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH 126
Query: 251 TEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKR 310
+++ ++ HRD+K N+L+ G + DFG +S L + + + G K
Sbjct: 127 SKL-------SVIHRDVKPSNVLINALGQVKMCDFG--IS-GYLVDDVA--KDIDAGCKP 174
Query: 311 YMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPS 370
YM+PE ++ +N + K+DI++LG+ + E+ A F PY
Sbjct: 175 YMAPERINPELNQKGYSV--KSDIWSLGITMIEL-----AILRF-----PYDS---WGTP 219
Query: 371 FDDMRKVICIDQQRPVLP 388
F +++V+ P LP
Sbjct: 220 FQQLKQVVEEPS--PQLP 235
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-26
Identities = 67/298 (22%), Positives = 131/298 (43%), Gaps = 72/298 (24%)
Query: 136 KQISLSECIGKGRYGEVWRGVWHGEN--VAVKIF--FSRDEASWSRETEIYSTVLLRHEN 191
I++ +G G+YGEV+ GVW + VAVK + + + +E + ++H N
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKE--IKHPN 70
Query: 192 ILGYIGSDMTSRNSCTQ---LWLVTHYHSFGSLYDHL---NRTTLNHHQMMKICLSIVNG 245
++ +G CT+ +++T + ++G+L D+L NR ++ ++ + I +
Sbjct: 71 LVQLLGV-------CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 123
Query: 246 LVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPR 305
+ +L + F HRD+ ++N LV N +ADFGL+ +
Sbjct: 124 MEYLEKKNF--------IHRDLAARNCLVGENHLVKVADFGLSRLMT------GDTYTAH 169
Query: 306 VGTK---RYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYH 362
G K ++ +P ES+ + F K+D++A G++LWE I +PY
Sbjct: 170 AGAKFPIKWTAP----ESLAYNKFSI--KSDVWAFGVLLWE---------IATYGMSPYP 214
Query: 363 DLVPMDPSFDDMRKVI-CIDQ----QRPVLPNRWVSDSTLNAMTKVMKECWHQNANVR 415
+ D+ +V +++ +RP + + ++M+ CW N + R
Sbjct: 215 GI--------DLSQVYELLEKDYRMERP--------EGCPEKVYELMRACWQWNPSDR 256
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 64/296 (21%), Positives = 119/296 (40%), Gaps = 70/296 (23%)
Query: 136 KQISLSECIGKGRYGEVWRGVWHGE-NVAVKIFFSRDEASWSRETEIYSTVLLRHENILG 194
+ + L +G+G +GEVW G W+G VA+K + + E LRHE ++
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQ 243
Query: 195 YIGSDMTSRNSCTQ--LWLVTHYHSFGSLYDHL---NRTTLNHHQMMKICLSIVNGLVHL 249
++ +++VT Y S GSL D L L Q++ + I +G+ ++
Sbjct: 244 LYAV-------VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV 296
Query: 250 HTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA------VSYSQLSNKMDIPPN 303
+ HRD+++ NILV N C +ADFGLA ++ K I
Sbjct: 297 ERMNY--------VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI--- 345
Query: 304 PRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHD 363
++ +P E+ F K+D+++ G++L E + + + PY
Sbjct: 346 ------KWTAP----EAALYGRFTI--KSDVWSFGILLTE---------LTTKGRVPYPG 384
Query: 364 LVPMDPSFDDMRKVICIDQ----QRPVLPNRWVSDSTLNAMTKVMKECWHQNANVR 415
+ + + + +V ++ P ++ +M +CW + R
Sbjct: 385 M----VNREVLDQV---ERGYRMPCP--------PECPESLHDLMCQCWRKEPEER 425
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-26
Identities = 67/311 (21%), Positives = 132/311 (42%), Gaps = 72/311 (23%)
Query: 136 KQISLSECIGKGRYGEVWRGVWHGEN--VAVKIFF--SRDEASWSRETEIYSTVLLRHEN 191
I++ +G G+YGEV+ GVW + VAVK + + + +E + ++H N
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKE--IKHPN 277
Query: 192 ILGYIGSDMTSRNSCTQ---LWLVTHYHSFGSLYDHL---NRTTLNHHQMMKICLSIVNG 245
++ +G CT+ +++T + ++G+L D+L NR ++ ++ + I +
Sbjct: 278 LVQLLGV-------CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 330
Query: 246 LVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYS----QLSNKMDIP 301
+ +L + F I HR++ ++N LV N +ADFGL+ + P
Sbjct: 331 MEYLEKKNF-------I-HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 382
Query: 302 PNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPY 361
++ +PE L + F K+D++A G++LWE I +PY
Sbjct: 383 -------IKWTAPESLAYNK----FSI--KSDVWAFGVLLWE---------IATYGMSPY 420
Query: 362 HDLVPMDPSFDDMRKVICIDQ----QRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLS 417
P D + +++ +RP + + ++M+ CW N + R S
Sbjct: 421 -------PGIDLSQVYELLEKDYRMERP--------EGCPEKVYELMRACWQWNPSDRPS 465
Query: 418 ALRVKKTLIKL 428
+ + +
Sbjct: 466 FAEIHQAFETM 476
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-26
Identities = 71/300 (23%), Positives = 125/300 (41%), Gaps = 78/300 (26%)
Query: 136 KQISLSECIGKGRYGEVWRGVWHGE-NVAVKIF--FSRDEASWSRETEIYSTVLLRHENI 192
K ++ + +G G++G V G W G+ +VA+K+ S E + E ++ L HE +
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMN--LSHEKL 81
Query: 193 LGYIGSDMTSRNSCTQ---LWLVTHYHSFGSLYDHL--NRTTLNHHQMMKICLSIVNGLV 247
+ G CT+ ++++T Y + G L ++L R Q++++C + +
Sbjct: 82 VQLYGV-------CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAME 134
Query: 248 HLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPN---P 304
+L ++ F HRD+ ++N LV G ++DFGL+ + +
Sbjct: 135 YLESKQF--------LHRDLAARNCLVNDQGVVKVSDFGLSR---------YVLDDEYTS 177
Query: 305 RVGTK---RYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPY 361
VG+K R+ P E + F S K+DI+A G+++WE I+ K PY
Sbjct: 178 SVGSKFPVRWSPP----EVLMYSKFSS--KSDIWAFGVLMWE---------IYSLGKMPY 222
Query: 362 HDLVPMDPSFDDMRKVI-CIDQ----QRPVL-PNRWVSDSTLNAMTKVMKECWHQNANVR 415
+ I Q RP L + +M CWH+ A+ R
Sbjct: 223 ERF--------TNSETAEHIAQGLRLYRPHLAS---------EKVYTIMYSCWHEKADER 265
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-26
Identities = 49/298 (16%), Positives = 113/298 (37%), Gaps = 53/298 (17%)
Query: 136 KQISLSECIGKGRYGEVWRGV-WHGENVAVKI-----FFSRDEASWSRETEIYSTVLLRH 189
+ S+ + IG G +V++ + + A+K ++ S+ E + L+
Sbjct: 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLN--KLQQ 66
Query: 190 --ENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHL-NRTTLNHHQMMKICLSIVNGL 246
+ I+ ++T + +++V + L L + +++ + +++ +
Sbjct: 67 HSDKIIRLYDYEITDQY----IYMVMECGN-IDLNSWLKKKKSIDPWERKSYWKNMLEAV 121
Query: 247 VHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRV 306
+H G I H D+K N L+ +G + DFG+A + + + +V
Sbjct: 122 HTIHQ-----HG---IVHSDLKPANFLI-VDGMLKLIDFGIANQMQ--PDTTSVVKDSQV 170
Query: 307 GTKRYMSPEILDESINMDCFESF-----KKADIYALGLVLWE-VCRRTKANGIFEEYKAP 360
GT YM PE + + + K+D+++LG +L+ +T P
Sbjct: 171 GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT-----------P 219
Query: 361 YHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSA 418
+ + + +I + + P+ + V+K C ++ R+S
Sbjct: 220 FQQI---INQISKLHAIIDPNHEIE-FPD-IPEKDLQD----VLKCCLKRDPKQRISI 268
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 4e-26
Identities = 65/317 (20%), Positives = 123/317 (38%), Gaps = 78/317 (24%)
Query: 121 GSGSGLPLLIQRTLAKQISLSECIGKGRYGEVWRGVWHGEN------VAVKI----FFSR 170
G+ L + + T ++ + +G G +G V +GVW E V +K+ +
Sbjct: 1 GAMKVLARIFKET---ELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQ 57
Query: 171 DEASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQ--LWLVTHYHSFGSLYDHL--N 226
+ + + L H +I+ +G C L LVT Y GSL DH+ +
Sbjct: 58 SFQAVTDHMLAIGS--LDHAHIVRLLGL-------CPGSSLQLVTQYLPLGSLLDHVRQH 108
Query: 227 RTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFG 286
R L ++ + I G+ +L HR++ ++N+L+K+ +ADFG
Sbjct: 109 RGALGPQLLLNWGVQIAKGMYYLEEHGM--------VHRNLAARNVLLKSPSQVQVADFG 160
Query: 287 LAVSYSQLSNKMDIPPN----PRVGTK---RYMSPEILDESINMDCFESFKKADIYALGL 339
+A +PP+ K ++M+ ESI+ + ++D+++ G+
Sbjct: 161 VA---------DLLPPDDKQLLYSEAKTPIKWMAL----ESIHFGKYTH--QSDVWSYGV 205
Query: 340 VLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQ-QRPVLPNRWVSDSTLN 398
+WE + PY L + +++ +R P
Sbjct: 206 TVWE---------LMTFGAEPYAGL----RLAEVPDL---LEKGERLAQP-----QICTI 244
Query: 399 AMTKVMKECWHQNANVR 415
+ VM +CW + N+R
Sbjct: 245 DVYMVMVKCWMIDENIR 261
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 5e-26
Identities = 62/309 (20%), Positives = 120/309 (38%), Gaps = 78/309 (25%)
Query: 129 LIQRTLAKQISLSECIGKGRYGEVWRGVWHGEN------VAVKIFFSRDEASWSRETEIY 182
+++ T + + +G G +G V++G+W E VA+K R+ S EI
Sbjct: 11 ILKET---EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEIL 65
Query: 183 STVL----LRHENILGYIGSDMTSRNSCTQ--LWLVTHYHSFGSLYDHL--NRTTLNHHQ 234
+ + ++ +G C + L+T FG L D++ ++ +
Sbjct: 66 DEAYVMASVDNPHVCRLLGI-------CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQY 118
Query: 235 MMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA------ 288
++ C+ I G+ +L HRD+ ++N+LVKT I DFGLA
Sbjct: 119 LLNWCVQIAKGMNYLEDRRL--------VHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170
Query: 289 -VSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRR 347
Y K+ I ++M+ ESI + ++D+++ G+ +WE
Sbjct: 171 EKEYHAEGGKVPI---------KWMAL----ESILHRIYTH--QSDVWSYGVTVWE---- 211
Query: 348 TKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQ-QRPVLPNRWVSDSTLNAMTKVMKE 406
+ PY + P+ + +++ +R P + +M +
Sbjct: 212 -----LMTFGSKPYDGI----PASEISSI---LEKGERLPQP-----PICTIDVYMIMVK 254
Query: 407 CWHQNANVR 415
CW +A+ R
Sbjct: 255 CWMIDADSR 263
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 6e-26
Identities = 70/298 (23%), Positives = 126/298 (42%), Gaps = 74/298 (24%)
Query: 136 KQISLSECIGKGRYGEVWRGVWHGEN-VAVKIF--FSRDEASWSRETEIYSTVLLRHENI 192
+ + L E +G G++GEVW G ++G VAVK S ++ E + L+H+ +
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQ--LQHQRL 70
Query: 193 LGYIGSDMTSRNSCTQ--LWLVTHYHSFGSLYDHL---NRTTLNHHQMMKICLSIVNGLV 247
+ TQ ++++T Y GSL D L + L ++++ + I G+
Sbjct: 71 VRLYAV-------VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 123
Query: 248 HLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPN---P 304
+ + HRD+++ NILV +C IADFGLA I N
Sbjct: 124 FIEERNY--------IHRDLRAANILVSDTLSCKIADFGLA---------RLIEDNEYTA 166
Query: 305 RVGTK---RYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPY 361
R G K ++ +P E+IN F K+D+++ G++L E I + PY
Sbjct: 167 REGAKFPIKWTAP----EAINYGTFTI--KSDVWSFGILLTE---------IVTHGRIPY 211
Query: 362 HDLVPMDPSFDDMRKVICIDQ----QRPVLPNRWVSDSTLNAMTKVMKECWHQNANVR 415
+ + + ++ + ++ RP D+ + ++M+ CW + R
Sbjct: 212 PGM----TNPEVIQNL---ERGYRMVRP--------DNCPEELYQLMRLCWKERPEDR 254
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 8e-26
Identities = 65/306 (21%), Positives = 111/306 (36%), Gaps = 69/306 (22%)
Query: 129 LIQRTLAKQISLSECIGKGRYGEVWRGVWHGEN-----VAVKIFFSRDEASWSRET---- 179
LI + L E +G G +G V RG W + VAVK + + E
Sbjct: 14 LIGEK---DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCL--KPDVLSQPEAMDDF 68
Query: 180 --EIYSTVLLRHENILGYIGSDMTSRNSCTQ--LWLVTHYHSFGSLYDHL--NRTTLNHH 233
E+ + L H N++ G + +VT GSL D L ++
Sbjct: 69 IREVNAMHSLDHRNLIRLYGV-------VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLG 121
Query: 234 QMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQ 293
+ + + + G+ +L ++ F HRD+ ++N+L+ T I DFGL + Q
Sbjct: 122 TLSRYAVQVAEGMGYLESKRF--------IHRDLAARNLLLATRDLVKIGDFGLMRALPQ 173
Query: 294 LSNKMDIPPNPRVGTK---RYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKA 350
+ + K + +P ES+ F +D + G+ LWE
Sbjct: 174 NDDHY----VMQEHRKVPFAWCAP----ESLKTRTFSH--ASDTWMFGVTLWE------- 216
Query: 351 NGIFEEYKAPYHDLVPMDPSFDDMRKVI-CIDQQRPVLPNRWVSDSTLNAMTKVMKECWH 409
+F + P+ L ++ ID++ LP + + VM +CW
Sbjct: 217 --MFTYGQEPWIGLNGSQ--------ILHKIDKEGERLPR---PEDCPQDIYNVMVQCWA 263
Query: 410 QNANVR 415
R
Sbjct: 264 HKPEDR 269
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-25
Identities = 60/334 (17%), Positives = 121/334 (36%), Gaps = 79/334 (23%)
Query: 136 KQISLSECIGKGRYGEVWRGVWHGEN-----VAVK-----IFFSRDEASWSRETEIYSTV 185
+Q +L +GKG +G V E+ VAVK I S D + RE
Sbjct: 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKE- 81
Query: 186 LLRHENILGYIG--SDMTSRNSCTQLWLVTHYHSFGSLYDHL-------NRTTLNHHQMM 236
H ++ +G ++ ++ + G L+ L N L ++
Sbjct: 82 -FDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLV 140
Query: 237 KICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA------VS 290
+ + I G+ +L + F HRD+ ++N ++ + T +ADFGL+
Sbjct: 141 RFMVDIACGMEYLSSRNF--------IHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDY 192
Query: 291 YSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKA 350
Y Q +P V ++++ ES+ + + +D++A G+ +WE+ T+
Sbjct: 193 YRQGCASK-LP----V---KWLAL----ESLADNLYTV--HSDVWAFGVTMWEIM--TRG 236
Query: 351 NGIFEEYKAPYHDLVPMDPSFDDMRKVI-CIDQ----QRPVLPNRWVSDSTLNAMTKVMK 405
+ PY + + + + ++P + + +M
Sbjct: 237 -------QTPYAGIENAE--------IYNYLIGGNRLKQP--------PECMEEVYDLMY 273
Query: 406 ECWHQNANVRLSALRVKKTLIKLACADMYIHCSD 439
+CW + R S ++ L + + S
Sbjct: 274 QCWSADPKQRPSFTCLRMELENILGHLSVLSTSQ 307
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 50/298 (16%), Positives = 112/298 (37%), Gaps = 53/298 (17%)
Query: 136 KQISLSECIGKGRYGEVWRGV-WHGENVAVKI--FFSRDEASWS---RETEIYSTVLLRH 189
+ S+ + IG G +V++ + + A+K D + E + L+
Sbjct: 28 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLN--KLQQ 85
Query: 190 --ENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHL-NRTTLNHHQMMKICLSIVNGL 246
+ I+ ++T + +++V + L L + +++ + +++ +
Sbjct: 86 HSDKIIRLYDYEITDQY----IYMVMECGN-IDLNSWLKKKKSIDPWERKSYWKNMLEAV 140
Query: 247 VHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRV 306
+H G I H D+K N L+ +G + DFG+A + + + +V
Sbjct: 141 HTIHQ-----HG---IVHSDLKPANFLI-VDGMLKLIDFGIANQMQ--PDTTSVVKDSQV 189
Query: 307 GTKRYMSPEILDESINMDCFESFK-----KADIYALGLVLWE-VCRRTKANGIFEEYKAP 360
GT YM PE + + + K K+D+++LG +L+ +T P
Sbjct: 190 GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT-----------P 238
Query: 361 YHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSA 418
+ + + +I + + P+ + V+K C ++ R+S
Sbjct: 239 FQQI---INQISKLHAIIDPNHEIE-FPD-IPEKDLQD----VLKCCLKRDPKQRISI 287
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-25
Identities = 66/306 (21%), Positives = 115/306 (37%), Gaps = 85/306 (27%)
Query: 136 KQISLSECIGKGRYGEVWRGVWHGEN-----VAVKIFFSRDEASWS------RETEIYST 184
+ + L+ +G+G +GEV+ GV+ VAVK + + + E I
Sbjct: 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTC--KKDCTLDNKEKFMSEAVIMKN 69
Query: 185 VLLRHENILGYIGSDMTSRNSCTQ--LWLVTHYHSFGSLYDHL--NRTTLNHHQMMKICL 240
L H +I+ IG + W++ + +G L +L N+ +L ++ L
Sbjct: 70 --LDHPHIVKLIGI-------IEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSL 120
Query: 241 SIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA------VSYSQL 294
I + +L + HRDI +NILV + + DFGL+ Y
Sbjct: 121 QICKAMAYLESINC--------VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKAS 172
Query: 295 SNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIF 354
++ I ++MSP ESIN F + +D++ + +WE I
Sbjct: 173 VTRLPI---------KWMSP----ESINFRRFTT--ASDVWMFAVCMWE---------IL 208
Query: 355 EEYKAPYHDLVPMDPSFDDMRKVI-CIDQ----QRPVLPNRWVSDSTLNAMTKVMKECWH 409
K P+ L D VI +++ +P D + +M CW
Sbjct: 209 SFGKQPFFWLENKD--------VIGVLEKGDRLPKP--------DLCPPVLYTLMTRCWD 252
Query: 410 QNANVR 415
+ + R
Sbjct: 253 YDPSDR 258
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 3e-25
Identities = 56/232 (24%), Positives = 94/232 (40%), Gaps = 39/232 (16%)
Query: 131 QRTLAKQISLSECIGKGRYGEVWRGVWH---GENVAVKIF----FSRDEASWSRETEIYS 183
Q T LS+ +G+G V+RG H G+ A+K+F F R RE E+
Sbjct: 4 QSTSNHLWLLSDILGQGATANVFRGR-HKKTGDLFAIKVFNNISFLRPVDVQMREFEVLK 62
Query: 184 TVLLRHENI--LGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHL----NRTTLNHHQMMK 237
L H+NI L I + T+R+ L+ + GSLY L N L + +
Sbjct: 63 --KLNHKNIVKLFAIEEETTTRH----KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLI 116
Query: 238 ICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKT----NGTCVIADFGLAVSYSQ 293
+ +V G+ HL + I HR+IK NI+ + DFG A
Sbjct: 117 VLRDVVGGMNHLR--------ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED 168
Query: 294 LSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESF--KKADIYALGLVLWE 343
+ GT+ Y+ P++ + ++ + D++++G+ +
Sbjct: 169 -DEQF----VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYH 215
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 62/295 (21%), Positives = 116/295 (39%), Gaps = 68/295 (23%)
Query: 136 KQISLSECIGKGRYGEVWRGVWHGE-NVAVKIFFSRDEASWSRE--TEIYSTVLLRHENI 192
+ + L + +G G++GEVW ++ VAVK + + E L+H+ +
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM--KPGSMSVEAFLAEANVMKTLQHDKL 245
Query: 193 LGYIGSDMTSRNSCTQ--LWLVTHYHSFGSLYDHL---NRTTLNHHQMMKICLSIVNGLV 247
+ T+ ++++T + + GSL D L + +++ I G+
Sbjct: 246 VKLHAV-------VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMA 298
Query: 248 HLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVG 307
+ + HRD+++ NILV + C IADFGLA D R G
Sbjct: 299 FIEQRNY--------IHRDLRAANILVSASLVCKIADFGLARVIE------DNEYTAREG 344
Query: 308 TK---RYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDL 364
K ++ +P E+IN F K+D+++ G++L E I + PY +
Sbjct: 345 AKFPIKWTAP----EAINFGSFTI--KSDVWSFGILLME---------IVTYGRIPYPGM 389
Query: 365 VPMDPSFDDMRKVICIDQ----QRPVLPNRWVSDSTLNAMTKVMKECWHQNANVR 415
+ + +R + ++ RP ++ + +M CW R
Sbjct: 390 ----SNPEVIRAL---ERGYRMPRP--------ENCPEELYNIMMRCWKNRPEER 429
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-25
Identities = 56/232 (24%), Positives = 94/232 (40%), Gaps = 39/232 (16%)
Query: 131 QRTLAKQISLSECIGKGRYGEVWRGVWH---GENVAVKIF----FSRDEASWSRETEIYS 183
Q T LS+ +G+G V+RG H G+ A+K+F F R RE E+
Sbjct: 4 QSTSNHLWLLSDILGQGATANVFRGR-HKKTGDLFAIKVFNNISFLRPVDVQMREFEVLK 62
Query: 184 TVLLRHENI--LGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHL----NRTTLNHHQMMK 237
L H+NI L I + T+R+ L+ + GSLY L N L + +
Sbjct: 63 --KLNHKNIVKLFAIEEETTTRH----KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLI 116
Query: 238 ICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKT----NGTCVIADFGLAVSYSQ 293
+ +V G+ HL + I HR+IK NI+ + DFG A
Sbjct: 117 VLRDVVGGMNHLR--------ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED 168
Query: 294 LSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESF--KKADIYALGLVLWE 343
+ GT+ Y+ P++ + ++ + D++++G+ +
Sbjct: 169 -DEQF----VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYH 215
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 7e-25
Identities = 61/299 (20%), Positives = 120/299 (40%), Gaps = 71/299 (23%)
Query: 136 KQISLSECIGKGRYGEVWRGVWHGEN-----VAVKI----FFSRDEASWSRETEIYSTVL 186
++I L CIG+G++G+V +G++ VA+K + +E
Sbjct: 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQ-- 72
Query: 187 LRHENILGYIGSDMTSRNSCTQ--LWLVTHYHSFGSLYDHL--NRTTLNHHQMMKICLSI 242
H +I+ IG T+ +W++ + G L L + +L+ ++ +
Sbjct: 73 FDHPHIVKLIGV-------ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQL 125
Query: 243 VNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA------VSYSQLSN 296
L +L ++ F HRDI ++N+LV +N + DFGL+ Y
Sbjct: 126 STALAYLESKRF--------VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG 177
Query: 297 KMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEE 356
K+ I ++M+P ESIN F S +D++ G+ +WE+
Sbjct: 178 KLPI---------KWMAP----ESINFRRFTS--ASDVWMFGVCMWEIL--MHG------ 214
Query: 357 YKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVR 415
P+ + + D + ++ + +R +P + + +M +CW + + R
Sbjct: 215 -VKPFQGV----KNNDVIGRI--ENGERLPMP-----PNCPPTLYSLMTKCWAYDPSRR 261
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 8e-25
Identities = 49/298 (16%), Positives = 111/298 (37%), Gaps = 53/298 (17%)
Query: 136 KQISLSECIGKGRYGEVWRGV-WHGENVAVKI-----FFSRDEASWSRETEIYSTVLLRH 189
+ S+ + IG G +V++ + + A+K ++ S+ E + L+
Sbjct: 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLN--KLQQ 113
Query: 190 --ENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHL-NRTTLNHHQMMKICLSIVNGL 246
+ I+ ++T + +++V + L L + +++ + +++ +
Sbjct: 114 HSDKIIRLYDYEITDQY----IYMVMECGN-IDLNSWLKKKKSIDPWERKSYWKNMLEAV 168
Query: 247 VHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRV 306
+H G I H D+K N L+ +G + DFG+A + + + +V
Sbjct: 169 HTIHQ-----HG---IVHSDLKPANFLI-VDGMLKLIDFGIANQMQ--PDTTSVVKDSQV 217
Query: 307 GTKRYMSPEILDESINMDCFESFK-----KADIYALGLVLWE-VCRRTKANGIFEEYKAP 360
G YM PE + + + K K+D+++LG +L+ +T P
Sbjct: 218 GAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT-----------P 266
Query: 361 YHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSA 418
+ + + +I P+ + V+K C ++ R+S
Sbjct: 267 FQQI---INQISKLHAIID-PNHEIEFPD-IPEKDLQD----VLKCCLKRDPKQRISI 315
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 9e-25
Identities = 75/384 (19%), Positives = 144/384 (37%), Gaps = 75/384 (19%)
Query: 51 SMAILGPVIVLGMLAAVIVLFMRRNHRKKLLAARAIQSDPDCFLADADLLRATAAGDSTL 110
+MA L + A +R + + + + +
Sbjct: 309 NMADLIDGYCRLVNGATQSFIIRPQKEGERALPSIPKLANN-EKQGVRSHTVSVSETDDY 367
Query: 111 REYLDASLTSGSGSGLPLLIQRTLAKQISLSECIGKGRYGEVWRGVWHGEN-----VAVK 165
E +D T S IQR ++I L CIG+G++G+V +G++ VA+K
Sbjct: 368 AEIIDEEDTYTMPSTRDYEIQR---ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIK 424
Query: 166 IFFSRDEASWSRETEIYSTVL----LRHENILGYIGSDMTSRNSCTQ--LWLVTHYHSFG 219
++ S S + L H +I+ IG T+ +W++ + G
Sbjct: 425 TC--KNCTSDSVREKFLQEALTMRQFDHPHIVKLIGV-------ITENPVWIIMELCTLG 475
Query: 220 SLYDHL--NRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTN 277
L L + +L+ ++ + L +L ++ F HRDI ++N+LV +N
Sbjct: 476 ELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRF--------VHRDIAARNVLVSSN 527
Query: 278 GTCVIADFGLA------VSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKK 331
+ DFGL+ Y K+ I ++M+P ESIN F S
Sbjct: 528 DCVKLGDFGLSRYMEDSTYYKASKGKLPI---------KWMAP----ESINFRRFTS--A 572
Query: 332 ADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRW 391
+D++ G+ +WE+ P+ + + D + ++ + +R +P
Sbjct: 573 SDVWMFGVCMWEIL--MHG-------VKPFQGV----KNNDVIGRI--ENGERLPMP--- 614
Query: 392 VSDSTLNAMTKVMKECWHQNANVR 415
+ + +M +CW + + R
Sbjct: 615 --PNCPPTLYSLMTKCWAYDPSRR 636
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-24
Identities = 66/303 (21%), Positives = 119/303 (39%), Gaps = 75/303 (24%)
Query: 136 KQISLSECIGKGRYGEVWRGVWHGEN------VAVKIF----FSRDEASWSRETEIYSTV 185
++ + IG G +GEV++G+ + VA+K + + E I
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQ- 102
Query: 186 LLRHENILGYIGSDMTSRNSCTQ---LWLVTHYHSFGSLYDHL--NRTTLNHHQMMKICL 240
H NI+ G ++ + ++T Y G+L L + Q++ +
Sbjct: 103 -FSHHNIIRLEGV-------ISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLR 154
Query: 241 SIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDI 300
I G+ +L + HRD+ ++NILV +N C ++DFGL S++
Sbjct: 155 GIAAGMKYLANMNY--------VHRDLAARNILVNSNLVCKVSDFGL----SRVLEDDPE 202
Query: 301 PPNPRVGTK---RYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEY 357
G K R+ +P E+I+ F S +D+++ G+V+WEV T
Sbjct: 203 ATYTTSGGKIPIRWTAP----EAISYRKFTS--ASDVWSFGIVMWEVM--TYG------- 247
Query: 358 KAPYHDLVPMDPSFDDMRKVI-CIDQ----QRPVLPNRWVSDSTLNAMTKVMKECWHQNA 412
+ PY +L +V+ I+ P +A+ ++M +CW Q
Sbjct: 248 ERPYWEL--------SNHEVMKAINDGFRLPTP--------MDCPSAIYQLMMQCWQQER 291
Query: 413 NVR 415
R
Sbjct: 292 ARR 294
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 1e-24
Identities = 62/305 (20%), Positives = 117/305 (38%), Gaps = 78/305 (25%)
Query: 136 KQISLSECIGKGRYGEVWRGVWHGEN-----VAVK----IFFSRDEASWSRETEIYSTVL 186
+ +E IG+G +G V+ G + AVK I + + + E I
Sbjct: 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKD-- 82
Query: 187 LRHENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHL--NRTTLNHHQMMKICLSIVN 244
H N+L +G S +V Y G L + + ++ L +
Sbjct: 83 FSHPNVLSLLG---ICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 139
Query: 245 GLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA---------VSYSQLS 295
G+ +L ++ F HRD+ ++N ++ T +ADFGLA +++
Sbjct: 140 GMKYLASKKF--------VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTG 191
Query: 296 NKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFE 355
K+ + ++M+ ES+ F + K+D+++ G++LWE+ T+
Sbjct: 192 AKLPV---------KWMAL----ESLQTQKFTT--KSDVWSFGVLLWELM--TRG----- 229
Query: 356 EYKAPYHDLVPMDPSFDDMRKVI-CIDQ----QRPVLPNRWVSDSTLNAMTKVMKECWHQ 410
PY D+ D + + Q +P + + + +VM +CWH
Sbjct: 230 --APPYPDVNTFD--------ITVYLLQGRRLLQP--------EYCPDPLYEVMLKCWHP 271
Query: 411 NANVR 415
A +R
Sbjct: 272 KAEMR 276
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 2e-24
Identities = 58/304 (19%), Positives = 113/304 (37%), Gaps = 78/304 (25%)
Query: 137 QISLSECIGKGRYGEVWRGVWHGEN-----VAVK----IFFSRDEASWSRETEIYSTVLL 187
IGKG +G V+ G + + A+K I + ++ RE + L
Sbjct: 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRG--L 79
Query: 188 RHENILGYIGSDMTSRNSCTQ----LWLVTHYHSFGSLYDHL--NRTTLNHHQMMKICLS 241
H N+L IG ++ Y G L + + ++ L
Sbjct: 80 NHPNVLALIGI-------MLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQ 132
Query: 242 IVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA-VSYSQLSNKMDI 300
+ G+ +L + F HRD+ ++N ++ + T +ADFGLA + +
Sbjct: 133 VARGMEYLAEQKF--------VHRDLAARNCMLDESFTVKVADFGLARDILDR-----EY 179
Query: 301 -PPNPRVGTK---RYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEE 356
+ ++ + ES+ F + K+D+++ G++LWE+ T+
Sbjct: 180 YSVQQHRHARLPVKWTAL----ESLQTYRFTT--KSDVWSFGVLLWELL--TRG------ 225
Query: 357 YKAPYHDLVPMDPSFDDMRKVI-CIDQ----QRPVLPNRWVSDSTLNAMTKVMKECWHQN 411
PY + P D + + Q +P + +++ +VM++CW +
Sbjct: 226 -APPYRHIDPFD--------LTHFLAQGRRLPQP--------EYCPDSLYQVMQQCWEAD 268
Query: 412 ANVR 415
VR
Sbjct: 269 PAVR 272
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 6e-24
Identities = 68/302 (22%), Positives = 115/302 (38%), Gaps = 74/302 (24%)
Query: 136 KQISLSECIGKGRYGEVWRGVWHGEN-----VAVKIF----FSRDEASWSRETEIYSTVL 186
+I + + IG G GEV G VA+K R + E I
Sbjct: 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQ-- 106
Query: 187 LRHENILGYIGSDMTSRNSCTQ---LWLVTHYHSFGSLYDHL--NRTTLNHHQMMKICLS 241
H NI+ G T+ +VT Y GSL L + Q++ +
Sbjct: 107 FDHPNIIRLEGV-------VTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRG 159
Query: 242 IVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIP 301
+ G+ +L + HRD+ ++N+LV +N C ++DFGL S++
Sbjct: 160 VGAGMRYLSDLGY--------VHRDLAARNVLVDSNLVCKVSDFGL----SRVLEDDPDA 207
Query: 302 PNPRVGTK---RYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYK 358
G K R+ +P E+I F S +D+++ G+V+WEV +
Sbjct: 208 AYTTTGGKIPIRWTAP----EAIAFRTFSS--ASDVWSFGVVMWEVL--AYG-------E 252
Query: 359 APYHDLVPMDPSFDDMRKVI-CIDQ----QRPVLPNRWVSDSTLNAMTKVMKECWHQNAN 413
PY ++ R VI +++ P +A+ ++M +CWH++
Sbjct: 253 RPYWNM--------TNRDVISSVEEGYRLPAP--------MGCPHALHQLMLDCWHKDRA 296
Query: 414 VR 415
R
Sbjct: 297 QR 298
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 64/304 (21%), Positives = 115/304 (37%), Gaps = 76/304 (25%)
Query: 136 KQISLSECIGKGRYGEVWRGVWHGEN-----VAVK----IFFSRDEASWSRETEIYSTVL 186
+ +E IG+G +G V+ G + AVK I + + + E I
Sbjct: 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKD-- 146
Query: 187 LRHENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHL--NRTTLNHHQMMKICLSIVN 244
H N+L +G S +V Y G L + + ++ L +
Sbjct: 147 FSHPNVLSLLG---ICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 203
Query: 245 GLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA--------VSYSQLSN 296
G+ L ++ F HRD+ ++N ++ T +ADFGLA S +
Sbjct: 204 GMKFLASKKF--------VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTG 255
Query: 297 KMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEE 356
+P V ++M+ ES+ F + K+D+++ G++LWE+ T+
Sbjct: 256 AK-LP----V---KWMAL----ESLQTQKFTT--KSDVWSFGVLLWELM--TRG------ 293
Query: 357 YKAPYHDLVPMDPSFDDMRKVI-CIDQ----QRPVLPNRWVSDSTLNAMTKVMKECWHQN 411
PY D+ D + + Q +P + + + +VM +CWH
Sbjct: 294 -APPYPDVNTFD--------ITVYLLQGRRLLQP--------EYCPDPLYEVMLKCWHPK 336
Query: 412 ANVR 415
A +R
Sbjct: 337 AEMR 340
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 72/330 (21%), Positives = 125/330 (37%), Gaps = 74/330 (22%)
Query: 108 STLREYLDASLTSGSGSGLPLLIQRTLAKQISLSECIGKGRYGEVWRGVWHGEN-----V 162
LR ++D + + A IS+ + +G G +GEV G + V
Sbjct: 17 PGLRTFVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISV 76
Query: 163 AVKIF----FSRDEASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQ---LWLVTHY 215
A+K + + E I H NI+ G T+ + +VT Y
Sbjct: 77 AIKTLKVGYTEKQRRDFLGEASIMGQ--FDHPNIIRLEGV-------VTKSKPVMIVTEY 127
Query: 216 HSFGSLYDHL--NRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNIL 273
GSL L + Q++ + I +G+ +L + HRD+ ++NIL
Sbjct: 128 MENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY--------VHRDLAARNIL 179
Query: 274 VKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTK---RYMSPEILDESINMDCFESFK 330
+ +N C ++DFGL ++ G K R+ SP E+I F S
Sbjct: 180 INSNLVCKVSDFGL----GRVLEDDPEAAYTTRGGKIPIRWTSP----EAIAYRKFTS-- 229
Query: 331 KADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFDDMRKVI-CIDQ----QRP 385
+D+++ G+VLWE + + PY ++ + VI +D+ P
Sbjct: 230 ASDVWSYGIVLWE---------VMSYGERPYWEM--------SNQDVIKAVDEGYRLPPP 272
Query: 386 VLPNRWVSDSTLNAMTKVMKECWHQNANVR 415
A+ ++M +CW ++ N R
Sbjct: 273 --------MDCPAALYQLMLDCWQKDRNNR 294
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 7e-23
Identities = 63/298 (21%), Positives = 111/298 (37%), Gaps = 67/298 (22%)
Query: 136 KQISLSEC-IGKGRYGEVWRGVWHGEN----VAVKI----FFSRDEASWSRETEIYSTVL 186
+ +++ +G G +G V +GV+ VA+K+ D RE +I
Sbjct: 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ-- 66
Query: 187 LRHENILGYIGSDMTSRNSCTQ--LWLVTHYHSFGSLYDHL--NRTTLNHHQMMKICLSI 242
L + I+ IG C L LV G L+ L R + + ++ +
Sbjct: 67 LDNPYIVRLIGV-------CQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQV 119
Query: 243 VNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPP 302
G+ +L + F HRD+ ++N+L+ I+DFGL S+ D
Sbjct: 120 SMGMKYLEEKNF--------VHRDLAARNVLLVNRHYAKISDFGL----SKALGADDSYY 167
Query: 303 NPRVGTK---RYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKA 359
R K ++ +P E IN F S ++D+++ G+ +WE +
Sbjct: 168 TARSAGKWPLKWYAP----ECINFRKFSS--RSDVWSYGVTMWE---------ALSYGQK 212
Query: 360 PYHDLVPMDPSFDDMRKVI-CIDQ-QRPVLPNRWVSDSTLNAMTKVMKECWHQNANVR 415
PY + +V+ I+Q +R P + +M +CW R
Sbjct: 213 PYKKM--------KGPEVMAFIEQGKRMECP-----PECPPELYALMSDCWIYKWEDR 257
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 1e-22
Identities = 60/214 (28%), Positives = 92/214 (42%), Gaps = 38/214 (17%)
Query: 144 IGKGRYGEVWRGV-WHGENVAVKIFFSRDEASWSRE--TEIYSTVLLRHENILGYIGSDM 200
+G+G +G+V++G G VAVK + TE+ + H N+L G M
Sbjct: 38 LGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 97
Query: 201 TSRNSCTQLWLVTHYHSFGSLYDHL-----NRTTLNHHQMMKICLSIVNGLVHLHTEIFG 255
T T+ LV Y + GS+ L ++ L+ + +I L GL +LH
Sbjct: 98 TP----TERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHC-- 151
Query: 256 TQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRV-GTKRYMSP 314
P I HRD+K+ NIL+ V+ DFGLA +L + D V GT +++P
Sbjct: 152 ---DPKIIHRDVKAANILLDEEFEAVVGDFGLA----KLMDYKDTHVTTAVRGTIGHIAP 204
Query: 315 E-----ILDESINMDCFESFKKADIYALGLVLWE 343
E E K D++ G++L E
Sbjct: 205 EYLSTGKSSE-----------KTDVFGYGVMLLE 227
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 2e-22
Identities = 66/326 (20%), Positives = 128/326 (39%), Gaps = 86/326 (26%)
Query: 136 KQISLSECIGKGRYGEVWRGVWHGEN-------VAVKIFFSRDEASWS------RETEIY 182
++I++S +G+G +G V+ GV G VA+K + AS E +
Sbjct: 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV--NEAASMRERIEFLNEASVM 82
Query: 183 STVLLRHENILGYIGSDMTSRNSCTQ---LWLVTHYHSFGSLYDHL-----------NRT 228
+++ +G +Q ++ + G L +L
Sbjct: 83 KE--FNCHHVVRLLGV-------VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLA 133
Query: 229 TLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA 288
+ +M+++ I +G+ +L+ F HRD+ ++N +V + T I DFG+
Sbjct: 134 PPSLSKMIQMAGEIADGMAYLNANKF--------VHRDLAARNCMVAEDFTVKIGDFGMT 185
Query: 289 ------VSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLW 342
Y + + +P V R+MSP ES+ F + +D+++ G+VLW
Sbjct: 186 RDIYETDYYRKGGKGL-LP----V---RWMSP----ESLKDGVFTT--YSDVWSFGVVLW 231
Query: 343 EVCRRTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTK 402
E I + PY L + +R V ++ P D+ + + +
Sbjct: 232 E---------IATLAEQPYQGL----SNEQVLRFV--MEGGLLDKP-----DNCPDMLFE 271
Query: 403 VMKECWHQNANVRLSALRVKKTLIKL 428
+M+ CW N +R S L + ++ +
Sbjct: 272 LMRMCWQYNPKMRPSFLEIISSIKEE 297
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 2e-22
Identities = 60/322 (18%), Positives = 120/322 (37%), Gaps = 78/322 (24%)
Query: 136 KQISLSECIGKGRYGEVWRGVWHGEN-----VAVK-----IFFSRDEASWSRETEIYSTV 185
+ L + +G+G +G V G E+ VAVK R+ + E
Sbjct: 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKD- 92
Query: 186 LLRHENILGYIG-SDMTSRNSCTQLWLVTHYHSFGSLYDHL-------NRTTLNHHQMMK 237
H N++ +G S + ++ + +G L+ +L + ++K
Sbjct: 93 -FSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLK 151
Query: 238 ICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA------VSY 291
+ I G+ +L F HRD+ ++N +++ + T +ADFGL+ Y
Sbjct: 152 FMVDIALGMEYLSNRNF--------LHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYY 203
Query: 292 SQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKAN 351
Q +P V ++++ ES+ + S K+D++A G+ +WE
Sbjct: 204 RQGRIAK-MP----V---KWIAI----ESLADRVYTS--KSDVWAFGVTMWE-------- 241
Query: 352 GIFEEYKAPYHDLVPMDPSFDDMRKVI-CIDQ----QRPVLPNRWVSDSTLNAMTKVMKE 406
I PY + + + + ++P + L+ + ++M
Sbjct: 242 -IATRGMTPYPGVQNHE--------MYDYLLHGHRLKQP--------EDCLDELYEIMYS 284
Query: 407 CWHQNANVRLSALRVKKTLIKL 428
CW + R + ++ L KL
Sbjct: 285 CWRTDPLDRPTFSVLRLQLEKL 306
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 2e-22
Identities = 56/235 (23%), Positives = 94/235 (40%), Gaps = 37/235 (15%)
Query: 130 IQRTLAKQISLSECIGKGRYGEVW-RGVWHGENVAVKIFFSRDEASWSRETEIYSTVLLR 188
+++L + + +G G G V +G + G VAVK E ++ +
Sbjct: 9 FEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTE-SDD 67
Query: 189 HENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYD--------HLNRTTLNHHQMMKICL 240
H N++ Y S+ T R L++ + +L D N + + +
Sbjct: 68 HPNVIRYYCSETTDRF----LYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLR 122
Query: 241 SIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKT-------------NGTCVIADFGL 287
I +G+ HLH+ I HRD+K +NILV T N +I+DFGL
Sbjct: 123 QIASGVAHLHS-----LK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGL 174
Query: 288 AVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESF-KKADIYALGLVL 341
+ N GT + +PE+L+ES N+ + DI+++G V
Sbjct: 175 CKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVF 229
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 3e-22
Identities = 63/300 (21%), Positives = 114/300 (38%), Gaps = 71/300 (23%)
Query: 136 KQISLSE-CIGKGRYGEVWRGVWHGEN----VAVKIFFSRDEASWS-------RETEIYS 183
K ++L + +G G +G V +G + + VAVKI ++EA+ E +
Sbjct: 16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKIL--KNEANDPALKDELLAEANVMQ 73
Query: 184 TVLLRHENILGYIGSDMTSRNSCTQ--LWLVTHYHSFGSLYDHL-NRTTLNHHQMMKICL 240
L + I+ IG C LV G L +L + ++++
Sbjct: 74 Q--LDNPYIVRMIGI-------CEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVH 124
Query: 241 SIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDI 300
+ G+ +L F HRD+ ++N+L+ T I+DFGL S+ +
Sbjct: 125 QVSMGMKYLEESNF--------VHRDLAARNVLLVTQHYAKISDFGL----SKALRADEN 172
Query: 301 PPNPRVGTK---RYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEY 357
+ K ++ +P E IN F S K+D+++ G+++WE F
Sbjct: 173 YYKAQTHGKWPVKWYAP----ECINYYKFSS--KSDVWSFGVLMWE---------AFSYG 217
Query: 358 KAPYHDLVPMDPSFDDMRKVI-CIDQ-QRPVLPNRWVSDSTLNAMTKVMKECWHQNANVR 415
+ PY + +V +++ +R P M +M CW + R
Sbjct: 218 QKPYRGM--------KGSEVTAMLEKGERMGCP-----AGCPREMYDLMNLCWTYDVENR 264
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 3e-22
Identities = 79/335 (23%), Positives = 125/335 (37%), Gaps = 97/335 (28%)
Query: 136 KQISLSECIGKGRYGEVWRGVWHGEN-------VAVKIF---FSRDEASWSRETEIYSTV 185
+ I L +G+G +G+V+ + + VAVK + RE E+ +
Sbjct: 15 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTN- 73
Query: 186 LLRHENILGYIGSDMTSRNSCTQ---LWLVTHYHSFGSLYDHL----------------- 225
L+HE+I+ + G C L +V Y G L L
Sbjct: 74 -LQHEHIVKFYGV-------CGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQ 125
Query: 226 NRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADF 285
+ L QM+ I I +G+V+L ++ F HRD+ ++N LV N I DF
Sbjct: 126 AKGELGLSQMLHIASQIASGMVYLASQHF--------VHRDLATRNCLVGANLLVKIGDF 177
Query: 286 GLAVSYSQLSNKMDIPPNP--RVGTK-----RYMSPEILDESINMDCFESFKKADIYALG 338
G++ D+ RVG R+M P ESI F + ++D+++ G
Sbjct: 178 GMS---------RDVYSTDYYRVGGHTMLPIRWMPP----ESIMYRKFTT--ESDVWSFG 222
Query: 339 LVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQ----QRPVLPNRWVSD 394
++LWE IF K P+ + + CI Q +RP
Sbjct: 223 VILWE---------IFTYGKQPW-------FQLSNTEVIECITQGRVLERP--------R 258
Query: 395 STLNAMTKVMKECWHQNANVRLSALRVKKTLIKLA 429
+ VM CW + RL+ + K L L
Sbjct: 259 VCPKEVYDVMLGCWQREPQQRLNIKEIYKILHALG 293
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 98.6 bits (245), Expect = 3e-22
Identities = 53/238 (22%), Positives = 90/238 (37%), Gaps = 40/238 (16%)
Query: 123 GSGLPLLIQRTLAKQISLSECIGKGRYGEVWRGVWH---GENVAVKIF----FSRDEASW 175
G G + + E +G G +G V R + H GE VA+K ++ W
Sbjct: 1 GGGRSPSLPTQTCGPWEMKERLGTGGFGYVLRWI-HQDTGEQVAIKQCRQELSPKNRERW 59
Query: 176 SRETEIYSTVLLRHENI--LGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNR----TT 229
E +I L H N+ + + L Y G L +LN+
Sbjct: 60 CLEIQIMK--KLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCG 117
Query: 230 LNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCV---IADFG 286
L + + I + L +LH + I HRD+K +NI+++ + I D G
Sbjct: 118 LKEGPIRTLLSDISSALRYLH--------ENRIIHRDLKPENIVLQPGPQRLIHKIIDLG 169
Query: 287 LAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESF-KKADIYALGLVLWE 343
A Q VGT +Y++PE+L++ + + D ++ G + +E
Sbjct: 170 YAKELDQ-GELCT----EFVGTLQYLAPELLEQ-------KKYTVTVDYWSFGTLAFE 215
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 4e-22
Identities = 52/331 (15%), Positives = 107/331 (32%), Gaps = 93/331 (28%)
Query: 136 KQISLSECIGKGRYGEVWRGVWHGEN---------VAVKIFFSRDEASWS------RETE 180
+ + +E +G+G + ++++GV V +K+ D+A +
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVL---DKAHRNYSESFFEAAS 64
Query: 181 IYSTVLLRHENILGYIGSDMTSRNSCTQ---LWLVTHYHSFGSLYDHL--NRTTLNHHQM 235
+ S L H++++ G C LV + FGSL +L N+ +N
Sbjct: 65 MMSK--LSHKHLVLNYG-------VCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWK 115
Query: 236 MKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKT--------NGTCVIADFGL 287
+++ + + L H ++ +KNIL+ ++D G+
Sbjct: 116 LEVAKQLAAAMHFLEENTL--------IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGI 167
Query: 288 A-VSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR 346
+ + + I ++ PE + N D ++ G LWE+C
Sbjct: 168 SITVLPKDILQERI---------PWVPPECI---ENPKNLNL--ATDKWSFGTTLWEIC- 212
Query: 347 RTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQ----QRPVLPNRWVSDSTLNAMTK 402
+ P + D RK+ + P +
Sbjct: 213 -SGG-------DKPL-------SALDSQRKLQFYEDRHQLPAPKAAE----------LAN 247
Query: 403 VMKECWHQNANVRLSALRVKKTLIKLACADM 433
++ C + R S + + L L D+
Sbjct: 248 LINNCMDYEPDHRPSFRAIIRDLNSLFTPDL 278
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 5e-22
Identities = 71/335 (21%), Positives = 113/335 (33%), Gaps = 92/335 (27%)
Query: 137 QISLSECIGKGRYGEVWRGVWHGEN-------VAVK----IFFSRDEASWSRETEIYSTV 185
I+L +G G +GEV+ G G VAVK + +DE + E I S
Sbjct: 31 NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK- 89
Query: 186 LLRHENILGYIGSDMTSRNSCTQ---LWLVTHYHSFGSLYDHL--------NRTTLNHHQ 234
H+NI+ IG Q +++ + G L L ++L
Sbjct: 90 -FNHQNIVRCIG-------VSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLD 141
Query: 235 MMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNG---TCVIADFGLAVSY 291
++ + I G +L F HRDI ++N L+ G I DFG+A
Sbjct: 142 LLHVARDIACGCQYLEENHF--------IHRDIAARNCLLTCPGPGRVAKIGDFGMA--- 190
Query: 292 SQLSNKMDIPPNP--RVGTK-----RYMSPEILDESINMDCFESFKKADIYALGLVLWEV 344
DI R G ++M P E+ F S K D ++ G++LWE
Sbjct: 191 ------RDIYRASYYRKGGCAMLPVKWMPP----EAFMEGIFTS--KTDTWSFGVLLWE- 237
Query: 345 CRRTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQ----QRPVLPNRWVSDSTLNAM 400
IF PY PS + + + P + +
Sbjct: 238 --------IFSLGYMPY-------PSKSNQEVLEFVTSGGRMDPP--------KNCPGPV 274
Query: 401 TKVMKECWHQNANVRLSALRVKKTLIKLACADMYI 435
++M +CW R + + + + I
Sbjct: 275 YRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVI 309
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 95.5 bits (237), Expect = 9e-22
Identities = 36/284 (12%), Positives = 72/284 (25%), Gaps = 62/284 (21%)
Query: 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEASWSRET----EIYSTVLLRH 189
+++ L E + G V+ E+ A+K+F E S S ++ L
Sbjct: 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG 121
Query: 190 ENILGYIG----------------------SDMTSRNSCTQLWLVTHY-----HSFGSLY 222
E+ S + L+ S
Sbjct: 122 ESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTL 181
Query: 223 DHL--NRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTC 280
D + R + + ++ +L + +G + H N+ + +G
Sbjct: 182 DFVYVFRGDEGILALHILTAQLIRLAANLQS-----KG---LVHGHFTPDNLFIMPDGRL 233
Query: 281 VIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILD-ESINMDCFESFKKADIYALGL 339
++ D Y E L+ + + + LGL
Sbjct: 234 MLGDVSALWKVGTRGPAS-------SVPVTYAPREFLNASTATFT-----HALNAWQLGL 281
Query: 340 VLWE-VCRRT----KANGIFEEYKAPY-HDLVPMDPSFDDMRKV 377
++ C GI +K P +F +
Sbjct: 282 SIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPL 325
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 1e-21
Identities = 68/263 (25%), Positives = 108/263 (41%), Gaps = 75/263 (28%)
Query: 119 TSGSGSGLPLLIQRTLAKQISLSE------------CIGKGRYGEVWRGVWH-GENVAVK 165
S + + + + ++ L + IG G +G+V++GV G VA+K
Sbjct: 10 NSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALK 69
Query: 166 IFFSRDEASWSRE--TEIYSTVLLRHENI---LGYIGSDMTSRNSCT---QLWLVTHYHS 217
+ + + E TEI + RH ++ +G+ C ++ L+ Y
Sbjct: 70 RR-TPESSQGIEEFETEIETLSFCRHPHLVSLIGF----------CDERNEMILIYKYME 118
Query: 218 FGSLYDHLNRTTLNHHQM-----MKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNI 272
G+L HL + L M ++IC+ GL +LHT AI HRD+KS NI
Sbjct: 119 NGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT--------RAIIHRDVKSINI 170
Query: 273 LVKTNGTCVIADFGLAVSYSQLSNKMDIPPNP-----RV-GTKRYMSPE-----ILDESI 321
L+ N I DFG++ K + V GT Y+ PE L E
Sbjct: 171 LLDENFVPKITDFGIS--------KKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTE-- 220
Query: 322 NMDCFESFKKADIYALGLVLWEV 344
K+D+Y+ G+VL+EV
Sbjct: 221 ---------KSDVYSFGVVLFEV 234
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 1e-21
Identities = 70/336 (20%), Positives = 114/336 (33%), Gaps = 92/336 (27%)
Query: 136 KQISLSECIGKGRYGEVWRGVWHGEN-------VAVK----IFFSRDEASWSRETEIYST 184
K I+L +G G +GEV+ G G VAVK + +DE + E I S
Sbjct: 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 130
Query: 185 VLLRHENILGYIGSDMTSRNSCTQ---LWLVTHYHSFGSLYDHL--------NRTTLNHH 233
H+NI+ IG Q +++ + G L L ++L
Sbjct: 131 --FNHQNIVRCIG-------VSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAML 181
Query: 234 QMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNG---TCVIADFGLAVS 290
++ + I G +L F HRDI ++N L+ G I DFG+A
Sbjct: 182 DLLHVARDIACGCQYLEENHF--------IHRDIAARNCLLTCPGPGRVAKIGDFGMA-- 231
Query: 291 YSQLSNKMDIPPNP--RVGTK-----RYMSPEILDESINMDCFESFKKADIYALGLVLWE 343
DI R G ++M P E+ F S K D ++ G++LWE
Sbjct: 232 -------RDIYRAGYYRKGGCAMLPVKWMPP----EAFMEGIFTS--KTDTWSFGVLLWE 278
Query: 344 VCRRTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQ----QRPVLPNRWVSDSTLNA 399
+ + PY PS + + + P +
Sbjct: 279 IF--SLG-------YMPY-------PSKSNQEVLEFVTSGGRMDPP--------KNCPGP 314
Query: 400 MTKVMKECWHQNANVRLSALRVKKTLIKLACADMYI 435
+ ++M +CW R + + + + I
Sbjct: 315 VYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVI 350
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 2e-21
Identities = 66/310 (21%), Positives = 119/310 (38%), Gaps = 81/310 (26%)
Query: 137 QISLSECIGKGRYGEVWRGVWHGEN----VAVKI----FFSRDEASWSRETEIYSTVLLR 188
I + IG+G +G+V + + A+K D ++ E E+ L
Sbjct: 26 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCK-LGH 84
Query: 189 HENILGYIGSDMTSRNSCTQ---LWLVTHYHSFGSLYDHL-----------------NRT 228
H NI+ +G+ C L+L Y G+L D L +
Sbjct: 85 HPNIINLLGA-------CEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS 137
Query: 229 TLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA 288
TL+ Q++ + G+ +L + F HRD+ ++NILV N IADFGL+
Sbjct: 138 TLSSQQLLHFAADVARGMDYLSQKQF--------IHRDLAARNILVGENYVAKIADFGLS 189
Query: 289 VS---YSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVC 345
Y + + +P V R+M+ ES+N + + +D+++ G++LWE+
Sbjct: 190 RGQEVYVKKTMGR-LP----V---RWMAI----ESLNYSVYTT--NSDVWSYGVLLWEIV 235
Query: 346 RRTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMK 405
+ PY + + K+ Q L + + + +M+
Sbjct: 236 --SLG-------GTPYCGM----TCAELYEKL----PQGYRLEK---PLNCDDEVYDLMR 275
Query: 406 ECWHQNANVR 415
+CW + R
Sbjct: 276 QCWREKPYER 285
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 2e-21
Identities = 77/334 (23%), Positives = 123/334 (36%), Gaps = 96/334 (28%)
Query: 136 KQISLSECIGKGRYGEVWRGVWHGEN-------VAVKIF---FSRDEASWSRETEIYSTV 185
+ I L +G+G +G+V+ H VAVK + RE E+ +
Sbjct: 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTM- 99
Query: 186 LLRHENILGYIGSDMTSRNSCTQ---LWLVTHYHSFGSLYDHL----------------N 226
L+H++I+ + G CT+ L +V Y G L L
Sbjct: 100 -LQHQHIVRFFGV-------CTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVA 151
Query: 227 RTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFG 286
L Q++ + + G+V+L F HRD+ ++N LV I DFG
Sbjct: 152 PGPLGLGQLLAVASQVAAGMVYLAGLHF--------VHRDLATRNCLVGQGLVVKIGDFG 203
Query: 287 LAVSYSQLSNKMDIPPNP--RVGTK-----RYMSPEILDESINMDCFESFKKADIYALGL 339
++ DI RVG + R+M P ESI F + ++D+++ G+
Sbjct: 204 MS---------RDIYSTDYYRVGGRTMLPIRWMPP----ESILYRKFTT--ESDVWSFGV 248
Query: 340 VLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQ----QRPVLPNRWVSDS 395
VLWE+ T K P+ + + CI Q +RP +
Sbjct: 249 VLWEIF--TYG-------KQPW-------YQLSNTEAIDCITQGRELERP--------RA 284
Query: 396 TLNAMTKVMKECWHQNANVRLSALRVKKTLIKLA 429
+ +M+ CW + R S V L LA
Sbjct: 285 CPPEVYAIMRGCWQREPQQRHSIKDVHARLQALA 318
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 93.4 bits (232), Expect = 3e-21
Identities = 53/274 (19%), Positives = 88/274 (32%), Gaps = 85/274 (31%)
Query: 142 ECIGKGRYGEVWRGVWH---GENVAVKIFFSRDEASWSRETEIYSTVL--LRHENILGYI 196
+C+G+G +G V+ + N A+K + + L L H I+ Y
Sbjct: 12 QCMGRGGFGVVFE-AKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYF 70
Query: 197 GS--------------------------------------DMTSRNSCTQLWLVTHYHSF 218
+ + + + V
Sbjct: 71 NAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPS 130
Query: 219 ---------------GSLYDHLNR----TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGK 259
+L D +NR H + I + I + LH ++G
Sbjct: 131 SPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH-----SKG- 184
Query: 260 PAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNP--------RVGTKRY 311
+ HRD+K NI + + DFGL + Q + + +VGTK Y
Sbjct: 185 --LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242
Query: 312 MSPEILDESINMDCFESFKKADIYALGLVLWEVC 345
MSPE + N K DI++LGL+L+E+
Sbjct: 243 MSPEQI-HGNNYS-----HKVDIFSLGLILFELL 270
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 3e-21
Identities = 66/321 (20%), Positives = 121/321 (37%), Gaps = 92/321 (28%)
Query: 136 KQISLSECIGKGRYGEVWRGVWHGEN-------VAVKIFFSRDEASWS------RETEIY 182
+ E +G+ R+G+V++G G VA+K +D+A E +
Sbjct: 9 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL--KDKAEGPLREEFRHEAMLR 66
Query: 183 STVLLRHENILGYIGSDMTSRNSCTQ---LWLVTHYHSFGSLYDHL-------------- 225
+ L+H N++ +G T+ L ++ Y S G L++ L
Sbjct: 67 AR--LQHPNVVCLLGV-------VTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDD 117
Query: 226 ---NRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVI 282
++ L + + I G+ +L + H+D+ ++N+LV I
Sbjct: 118 DRTVKSALEPPDFVHLVAQIAAGMEYLSSHHV--------VHKDLATRNVLVYDKLNVKI 169
Query: 283 ADFGLA------VSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYA 336
+D GL Y L N + +P + R+M+P E+I F +DI++
Sbjct: 170 SDLGLFREVYAADYYKLLGNSL-LP----I---RWMAP----EAIMYGKFSI--DSDIWS 215
Query: 337 LGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDST 396
G+VLWEV + PY + D + + ++Q P D
Sbjct: 216 YGVVLWEVF--SYG-------LQPYCGY----SNQDVVEMI--RNRQVLPCP-----DDC 255
Query: 397 LNAMTKVMKECWHQNANVRLS 417
+ +M ECW++ + R
Sbjct: 256 PAWVYALMIECWNEFPSRRPR 276
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 95.0 bits (236), Expect = 5e-21
Identities = 62/289 (21%), Positives = 107/289 (37%), Gaps = 66/289 (22%)
Query: 144 IGKGRYGEVWRGVWHGEN----VAVKI----FFSRDEASWSRETEIYSTVLLRHENILGY 195
+G G +G V +GV+ VA+K+ D RE +I L + I+
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ--LDNPYIVRL 401
Query: 196 IGSDMTSRNSCTQ--LWLVTHYHSFGSLYDHL--NRTTLNHHQMMKICLSIVNGLVHLHT 251
IG C L LV G L+ L R + + ++ + G+ +L
Sbjct: 402 IGV-------CQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE 454
Query: 252 EIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTK-- 309
+ F HR++ ++N+L+ I+DFGL S+ D R K
Sbjct: 455 KNF--------VHRNLAARNVLLVNRHYAKISDFGL----SKALGADDSYYTARSAGKWP 502
Query: 310 -RYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMD 368
++ +P E IN F S ++D+++ G+ +WE + PY +
Sbjct: 503 LKWYAP----ECINFRKFSS--RSDVWSYGVTMWE---------ALSYGQKPYKKM---- 543
Query: 369 PSFDDMRKVI-CIDQ-QRPVLPNRWVSDSTLNAMTKVMKECWHQNANVR 415
+V+ I+Q +R P + +M +CW R
Sbjct: 544 ----KGPEVMAFIEQGKRMECP-----PECPPELYALMSDCWIYKWEDR 583
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 7e-21
Identities = 55/229 (24%), Positives = 95/229 (41%), Gaps = 28/229 (12%)
Query: 125 GLPLLIQRTLAKQISLSECIGKGRYGEVWRGVWH--GENVAVKIF---FSRDEASWSR-E 178
G + L+ + L E +G G EV +VAVK+ +RD + + R
Sbjct: 1 GSHMTTPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFR 60
Query: 179 TEIYSTVLLRHENILG-Y-IGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRT-TLNHHQM 235
E + L H I+ Y G T ++V Y +L D ++ + +
Sbjct: 61 REAQNAAALNHPAIVAVYDTGEAETPAGPLP--YIVMEYVDGVTLRDIVHTEGPMTPKRA 118
Query: 236 MKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLS 295
+++ L H G I HRD+K NI++ + DFG+A + +
Sbjct: 119 IEVIADACQALNFSHQ-----NG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSG 170
Query: 296 NKMDIPPNPRVGTKRYMSPE-ILDESINMDCFESFKKADIYALGLVLWE 343
N + +GT +Y+SPE +S++ ++D+Y+LG VL+E
Sbjct: 171 NSVTQ-TAAVIGTAQYLSPEQARGDSVD-------ARSDVYSLGCVLYE 211
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 92.8 bits (230), Expect = 1e-20
Identities = 35/310 (11%), Positives = 80/310 (25%), Gaps = 54/310 (17%)
Query: 107 DSTLREYLDASLTSGSGSGLPLLIQRTLA---KQISLSECIGKGRYGEVWRGVWH--GEN 161
+ TS +G P ++ L + + +G+ GE+
Sbjct: 46 EYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGES 105
Query: 162 VAVKIFFSRDEASWS------RETEIYSTV--------------------LLRHENILGY 195
V + + + + E + L++
Sbjct: 106 FEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKM 165
Query: 196 IGSDMTSRNSCTQLWLVTHYHSFGSLYDHL--------NRTTLNHHQMMKICLSIVNGLV 247
I + R+ + +L +L HH +++ L ++ L
Sbjct: 166 IRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLA 225
Query: 248 HLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVG 307
LH G + H ++ +I++ G + F V P
Sbjct: 226 SLH-----HYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVR---DGASAVSPIGRGFA 274
Query: 308 TKRYMSPEILDESINMDCFESFKKADIYALGLVLWE-VCRRT--KANGIFEEYKAPYHDL 364
+ +L + +F D + LGL ++ C + + +
Sbjct: 275 PPETTAERMLPFGQHHPTLMTF-AFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFRSC 333
Query: 365 VPMDPSFDDM 374
+ +
Sbjct: 334 KNIPQPVRAL 343
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 1e-20
Identities = 63/335 (18%), Positives = 124/335 (37%), Gaps = 97/335 (28%)
Query: 137 QISLSECIGKGRYGEVWRGVWHGEN-------VAVKI----FFSRDEASWSRETEIYSTV 185
++ L + +G+G +G+V G + VAVK+ + + E +I
Sbjct: 28 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH- 86
Query: 186 LLRHENILGYIGSDMTSRNSCTQ----LWLVTHYHSFGSLYDHL---------------- 225
+ H N++ +G+ CT+ L ++ + FG+L +L
Sbjct: 87 IGHHLNVVNLLGA-------CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPED 139
Query: 226 -NRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIAD 284
+ L ++ + G+ L K HRD+ ++NIL+ I D
Sbjct: 140 LYKDFLTLEHLICYSFQVAKGMEFL------ASRK--CIHRDLAARNILLSEKNVVKICD 191
Query: 285 FGLA------VSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALG 338
FGLA Y + + +P + ++M+P E+I + ++D+++ G
Sbjct: 192 FGLARDIYKDPDYVRKGDAR-LP----L---KWMAP----ETIFDRVYTI--QSDVWSFG 237
Query: 339 LVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFDDMRKVI-CIDQ----QRPVLPNRWVS 393
++LWE+ + +PY P + + + + P
Sbjct: 238 VLLWEIF--SLG-------ASPY-------PGVKIDEEFCRRLKEGTRMRAP-------- 273
Query: 394 DSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKL 428
D T M + M +CWH + R + + + L L
Sbjct: 274 DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 3e-20
Identities = 67/325 (20%), Positives = 117/325 (36%), Gaps = 102/325 (31%)
Query: 137 QISLSECIGKGRYGEVWRGVWHGEN-------VAVKIFFSRDEASWS------RETEIYS 183
++S + +G G +G+V +G VAVK+ + A + E ++ S
Sbjct: 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML--KPSAHLTEREALMSELKVLS 81
Query: 184 TVLLRHENILGYIGSDMTSRNSCTQ---LWLVTHYHSFGSLYDHL--------------- 225
L H NI+ +G+ CT ++T Y +G L + L
Sbjct: 82 Y-LGNHMNIVNLLGA-------CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPA 133
Query: 226 ----NRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCV 281
+ L+ ++ + G+ L ++ I HRD+ ++NIL+
Sbjct: 134 IMEDDELALDLEDLLSFSYQVAKGMAFLASKNC-------I-HRDLAARNILLTHGRITK 185
Query: 282 IADFGLA------VSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIY 335
I DFGLA +Y N +P V ++M+P ESI + ++D++
Sbjct: 186 ICDFGLARDIKNDSNYVVKGNAR-LP----V---KWMAP----ESIFNCVYTF--ESDVW 231
Query: 336 ALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFDDMRKVI-CIDQ----QRPVLPNR 390
+ G+ LWE+ + +PY P K I + P
Sbjct: 232 SYGIFLWELF--SLG-------SSPY-------PGMPVDSKFYKMIKEGFRMLSP----- 270
Query: 391 WVSDSTLNAMTKVMKECWHQNANVR 415
+ M +MK CW + R
Sbjct: 271 ---EHAPAEMYDIMKTCWDADPLKR 292
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 90.1 bits (223), Expect = 6e-20
Identities = 37/287 (12%), Positives = 73/287 (25%), Gaps = 67/287 (23%)
Query: 101 RATAAGDSTLREYL---DASLTSGSGSGLPLLIQRTLAKQISLSECIGKGRYGEVWRGVW 157
+A DS + L S G + + +G+
Sbjct: 42 YMQSAADSLVSTSLWNTGQPFRVESELGER-------PRTLVRGTVLGQEDPYAYLEATD 94
Query: 158 H--GENVAVKIFFSRDEASWSRET----EIYSTVLLRHENILGYIGSDMTSRNSCTQLWL 211
GE+ V + + + + E+ LLR + +
Sbjct: 95 QETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKD 154
Query: 212 VTH-----------------------------YHSFGSLYDHL-NRTTLNHHQMMKICLS 241
L H +L HH +++ L
Sbjct: 155 PQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQ 214
Query: 242 IVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIP 301
++ L LH G + H ++ +I++ G + F V
Sbjct: 215 VIRLLASLH-----HYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGARVVSS--- 263
Query: 302 PNPRVGTKRYMSPEILDESINMDCFESFK-----KADIYALGLVLWE 343
++ + PE+ + + D +ALGLV++
Sbjct: 264 -----VSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYW 305
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 91.5 bits (227), Expect = 6e-20
Identities = 50/260 (19%), Positives = 90/260 (34%), Gaps = 37/260 (14%)
Query: 127 PLLIQRTLAKQISLSECIGKGRYGEVWRG---VWHGENVAVKI-FFSRDEASWSR-ETEI 181
L +A Q + CI G G ++ +G V +K S D + + E
Sbjct: 71 QLNPGDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAER 130
Query: 182 YSTVLLRHENILG-Y-IGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKIC 239
+ H +I+ + T R+ ++V Y SL + L + +
Sbjct: 131 QFLAEVVHPSIVQIFNFVEH-TDRHGDPVGYIVMEYVGGQSLKRSKGQK-LPVAEAIAYL 188
Query: 240 LSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMD 299
L I+ L +LH+ G + + D+K +NI++ T + D G +
Sbjct: 189 LEILPALSYLHS-----IG---LVYNDLKPENIML-TEEQLKLIDLGAVSRINS------ 233
Query: 300 IPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWE-VCRRTKANGIFEEYK 358
GT + +PEI+ DIY +G L NG Y
Sbjct: 234 --FGYLYGTPGFQAPEIVRT-------GPTVATDIYTVGRTLAALTLDLPTRNG---RYV 281
Query: 359 APYHDLVPMDPSFDDMRKVI 378
+ P+ ++D +++
Sbjct: 282 DGLPEDDPVLKTYDSYGRLL 301
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 9e-20
Identities = 58/216 (26%), Positives = 98/216 (45%), Gaps = 49/216 (22%)
Query: 144 IGKGRYGEVW--RGVWHGENVAVKIFF------SRDEASWSRETEIYSTVLLRHENIL-- 193
+GKG++G V+ R +A+K+ F + E RE EI S LRH NIL
Sbjct: 17 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS--HLRHPNILRL 74
Query: 194 -GYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTT-LNHHQMMKICLSIVNGLVHLHT 251
GY T+++L+ Y G++Y L + + + + + N L + H+
Sbjct: 75 YGYFHDA-------TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 127
Query: 252 EIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRV----G 307
+ + HRDIK +N+L+ + G IADFG +V P+ R G
Sbjct: 128 K--------RVIHRDIKPENLLLGSAGELKIADFGWSV----------HAPSSRRTDLCG 169
Query: 308 TKRYMSPEILDESINMDCFESFKKADIYALGLVLWE 343
T Y+ PE+++ +K D+++LG++ +E
Sbjct: 170 TLDYLPPEMIEGR------MHDEKVDLWSLGVLCYE 199
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 1e-19
Identities = 65/322 (20%), Positives = 112/322 (34%), Gaps = 100/322 (31%)
Query: 137 QISLSECIGKGRYGEVWRGVWHGEN-------VAVKIFFSRDEASWS------RETEIYS 183
+ + +G G +G+V G VAVK+ + A E +I S
Sbjct: 47 NLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML--KSTAHADEKEALMSELKIMS 104
Query: 184 TVLLRHENILGYIGSDMTSRNSCTQ---LWLVTHYHSFGSLYDHL--------------- 225
L +HENI+ +G+ CT + ++T Y +G L + L
Sbjct: 105 H-LGQHENIVNLLGA-------CTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAI 156
Query: 226 NRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADF 285
+T + ++ + G+ L ++ I HRD+ ++N+L+ I DF
Sbjct: 157 ANSTASTRDLLHFSSQVAQGMAFLASKNC-------I-HRDVAARNVLLTNGHVAKIGDF 208
Query: 286 GLAVSYSQLSNKMDIPPNP--RVGTK-----RYMSPEILDESINMDCFESFKKADIYALG 338
GLA DI + V ++M+P ESI + ++D+++ G
Sbjct: 209 GLA---------RDIMNDSNYIVKGNARLPVKWMAP----ESIFDCVYTV--QSDVWSYG 253
Query: 339 LVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFDDMRKVI-CIDQ----QRPVLPNRWVS 393
++LWE IF PY P K + +P
Sbjct: 254 ILLWE---------IFSLGLNPY-------PGILVNSKFYKLVKDGYQMAQP-------- 289
Query: 394 DSTLNAMTKVMKECWHQNANVR 415
+ +M+ CW R
Sbjct: 290 AFAPKNIYSIMQACWALEPTHR 311
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 2e-19
Identities = 65/336 (19%), Positives = 136/336 (40%), Gaps = 97/336 (28%)
Query: 136 KQISLSECIGKGRYGEVWRGVWHGEN---------VAVKI----FFSRDEASWSRETEIY 182
+++L + +G+G +G+V G + VAVK+ +D + E E+
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 183 STVLLRHENILGYIGSDMTSRNSCTQ---LWLVTHYHSFGSLYDHL-------------- 225
+ +H+NI+ +G+ CTQ L+++ Y S G+L ++L
Sbjct: 95 KM-IGKHKNIINLLGA-------CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDI 146
Query: 226 ---NRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVI 282
+ ++ + G+ +L ++ HRD+ ++N+LV N I
Sbjct: 147 NRVPEEQMTFKDLVSCTYQLARGMEYLASQKC--------IHRDLAARNVLVTENNVMKI 198
Query: 283 ADFGLA------VSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYA 336
ADFGLA Y + +N +P V ++M+P E++ + ++D+++
Sbjct: 199 ADFGLARDINNIDYYKKTTNGR-LP----V---KWMAP----EALFDRVYTH--QSDVWS 244
Query: 337 LGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQ----QRPVLPNRWV 392
G+++WE+ T +PY P + + +P
Sbjct: 245 FGVLMWEIF--TLG-------GSPY-------PGIPVEELFKLLKEGHRMDKP------- 281
Query: 393 SDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKL 428
+ N + +M++CWH + R + ++ + L ++
Sbjct: 282 -ANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 2e-19
Identities = 68/341 (19%), Positives = 122/341 (35%), Gaps = 102/341 (29%)
Query: 136 KQISLSECIGKGRYGEVWRGVWHG-------ENVAVKIFFSRDEASWS------RETEIY 182
I IG+G +G V++ G VAVK+ ++EAS RE +
Sbjct: 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML--KEEASADMQADFQREAALM 104
Query: 183 STVLLRHENILGYIGSDMTSRNSCTQ---LWLVTHYHSFGSLYDHL-------------- 225
+ + NI+ +G C + L+ Y ++G L + L
Sbjct: 105 AE--FDNPNIVKLLGV-------CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHS 155
Query: 226 -----------NRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILV 274
L+ + + I + G+ +L F HRD+ ++N LV
Sbjct: 156 DLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKF--------VHRDLATRNCLV 207
Query: 275 KTNGTCVIADFGLAVSYSQLSNKMDIPPNP--RVGTK-----RYMSPEILDESINMDCFE 327
N IADFGL+ +I + R+M P ESI + +
Sbjct: 208 GENMVVKIADFGLS---------RNIYSADYYKADGNDAIPIRWMPP----ESIFYNRYT 254
Query: 328 SFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVL 387
+ ++D++A G+VLWE+ + PY+ + + + V D
Sbjct: 255 T--ESDVWAYGVVLWEIF--SYG-------LQPYYGM----AHEEVIYYV--RDGNILAC 297
Query: 388 PNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKL 428
P ++ + +M+ CW + R S + + L ++
Sbjct: 298 P-----ENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 333
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 3e-19
Identities = 67/338 (19%), Positives = 139/338 (41%), Gaps = 101/338 (29%)
Query: 136 KQISLSECIGKGRYGEVWRGVWHGEN---------VAVKIFFSRDEASWS------RETE 180
+++L + +G+G +G+V G + VAVK+ +D+A+ E E
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML--KDDATEKDLSDLVSEME 138
Query: 181 IYSTVLLRHENILGYIGSDMTSRNSCTQ---LWLVTHYHSFGSLYDHL------------ 225
+ + +H+NI+ +G+ CTQ L+++ Y S G+L ++L
Sbjct: 139 MMKM-IGKHKNIINLLGA-------CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 190
Query: 226 -----NRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTC 280
+ ++ + G+ +L ++ I HRD+ ++N+LV N
Sbjct: 191 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKC-------I-HRDLAARNVLVTENNVM 242
Query: 281 VIADFGLA------VSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADI 334
IADFGLA Y + +N +P V ++M+P E++ + ++D+
Sbjct: 243 KIADFGLARDINNIDYYKKTTNGR-LP----V---KWMAP----EALFDRVYTH--QSDV 288
Query: 335 YALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQ----QRPVLPNR 390
++ G+++WE+ T +PY P + + +P
Sbjct: 289 WSFGVLMWEIF--TLG-------GSPY-------PGIPVEELFKLLKEGHRMDKP----- 327
Query: 391 WVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKL 428
+ N + +M++CWH + R + ++ + L ++
Sbjct: 328 ---ANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 3e-19
Identities = 66/338 (19%), Positives = 137/338 (40%), Gaps = 101/338 (29%)
Query: 136 KQISLSECIGKGRYGEVWRGVWHGEN---------VAVKIFFSRDEASWS------RETE 180
++ L + +G+G +G+V G + VAVK+ + +A+ E E
Sbjct: 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML--KSDATEKDLSDLISEME 126
Query: 181 IYSTVLLRHENILGYIGSDMTSRNSCTQ---LWLVTHYHSFGSLYDHL------------ 225
+ + +H+NI+ +G+ CTQ L+++ Y S G+L ++L
Sbjct: 127 MMKM-IGKHKNIINLLGA-------CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSY 178
Query: 226 -----NRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTC 280
L+ ++ + G+ +L ++ HRD+ ++N+LV +
Sbjct: 179 NPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKC--------IHRDLAARNVLVTEDNVM 230
Query: 281 VIADFGLA------VSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADI 334
IADFGLA Y + +N +P V ++M+P E++ + ++D+
Sbjct: 231 KIADFGLARDIHHIDYYKKTTNGR-LP----V---KWMAP----EALFDRIYTH--QSDV 276
Query: 335 YALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQ----QRPVLPNR 390
++ G++LWE+ T +PY P + + +P
Sbjct: 277 WSFGVLLWEIF--TLG-------GSPY-------PGVPVEELFKLLKEGHRMDKP----- 315
Query: 391 WVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKL 428
+ N + +M++CWH + R + ++ + L ++
Sbjct: 316 ---SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 350
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 5e-19
Identities = 65/223 (29%), Positives = 97/223 (43%), Gaps = 58/223 (26%)
Query: 144 IGKGRYGEVWRGVWHGENVAVKIFFSRDEAS-------WSRETEIYSTVLLRHEN---IL 193
+G+G +G V++G + VAVK + + + + +E ++ + +HEN +L
Sbjct: 39 MGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMA--KCQHENLVELL 96
Query: 194 GYIGSDMTSRNSCT---QLWLVTHYHSFGSLYDHL----NRTTLNHHQMMKICLSIVNGL 246
G+ + L LV Y GSL D L L+ H KI NG+
Sbjct: 97 GF----------SSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGI 146
Query: 247 VHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA-----VSYSQLSNKMDIP 301
LH HRDIKS NIL+ T I+DFGLA + + +++
Sbjct: 147 NFLHEN--------HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTS----- 193
Query: 302 PNPRV-GTKRYMSPEILDESINMDCFESFKKADIYALGLVLWE 343
R+ GT YM+PE L I K+DIY+ G+VL E
Sbjct: 194 ---RIVGTTAYMAPEALRGEIT-------PKSDIYSFGVVLLE 226
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 5e-19
Identities = 58/229 (25%), Positives = 99/229 (43%), Gaps = 42/229 (18%)
Query: 129 LIQRTLAKQISLSECIGKGRYGEVWRGVWH--GENVAVKIF---FSRDEASWSR-ETEIY 182
+I + + ++ + + +G G V+ VA+K E + R E E++
Sbjct: 4 MIGKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVH 63
Query: 183 STVLLRHENILG-Y-IGSDMTSRNSCTQLWLVTHYHSFGSLYDHLN-RTTLNHHQMMKIC 239
++ L H+NI+ + + +LV Y +L +++ L+ +
Sbjct: 64 NSSQLSHQNIVSMIDVDEEDDCY------YLVMEYIEGPTLSEYIESHGPLSVDTAINFT 117
Query: 240 LSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMD 299
I++G+ H H I HRDIK +NIL+ +N T I DFG+A + S+ S
Sbjct: 118 NQILDGIKHAHD-----MR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ- 168
Query: 300 IPPNPRVGTKRYMSPE-----ILDESINMDCFESFKKADIYALGLVLWE 343
N +GT +Y SPE DE DIY++G+VL+E
Sbjct: 169 --TNHVLGTVQYFSPEQAKGEATDE-----------CTDIYSIGIVLYE 204
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 5e-19
Identities = 56/216 (25%), Positives = 90/216 (41%), Gaps = 49/216 (22%)
Query: 144 IGKGRYGEVW--RGVWHGENVAVKIFF------SRDEASWSRETEIYSTVLLRHENIL-- 193
+GKG++G V+ R + +A+K+ F E RE EI S LRH NIL
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQS--HLRHPNILRM 79
Query: 194 -GYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTT-LNHHQMMKICLSIVNGLVHLHT 251
Y +++L+ + G LY L + + + + + L + H
Sbjct: 80 YNYFHDR-------KRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHE 132
Query: 252 EIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRV----G 307
+ HRDIK +N+L+ G IADFG +V P+ R G
Sbjct: 133 R--------KVIHRDIKPENLLMGYKGELKIADFGWSV----------HAPSLRRRTMCG 174
Query: 308 TKRYMSPEILDESINMDCFESFKKADIYALGLVLWE 343
T Y+ PE++ E D +K D++ G++ +E
Sbjct: 175 TLDYLPPEMI-EGKTHD-----EKVDLWCAGVLCYE 204
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 6e-19
Identities = 54/215 (25%), Positives = 102/215 (47%), Gaps = 39/215 (18%)
Query: 139 SLSECIGKGRYGEVWRGVWH---GENVAVKI-----FFSRDEASWSRETEIYSTVLLRHE 190
++ +GKG +GEV + + AVK+ ++D ++ RE E+ L H
Sbjct: 25 NIVCMLGKGSFGEVLKCK-DRITQQEYAVKVINKASAKNKDTSTILREVELLKK--LDHP 81
Query: 191 NILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDH-LNRTTLNHHQMMKICLSIVNGLVHL 249
NI+ S + ++V ++ G L+D + R + H +I + +G+ ++
Sbjct: 82 NIMKLFEILEDSSS----FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYM 137
Query: 250 HTEIFGTQGKPAIAHRDIKSKNILVKT---NGTCVIADFGLAVSYSQLSNKMDIPPNPRV 306
H I HRD+K +NIL+++ + I DFGL+ + Q + KM R+
Sbjct: 138 HK-----HN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ-NTKM----KDRI 184
Query: 307 GTKRYMSPEILDESINMDCFESFKKADIYALGLVL 341
GT Y++PE+L + + +K D+++ G++L
Sbjct: 185 GTAYYIAPEVLRGTYD-------EKCDVWSAGVIL 212
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 6e-19
Identities = 49/215 (22%), Positives = 89/215 (41%), Gaps = 39/215 (18%)
Query: 139 SLSECIGKGRYGEVWRGVWH---GENVAVKI-----FFSRDEASWSRETEIYSTVLLRHE 190
+ +G G YGEV A+KI + + E + L H
Sbjct: 40 QRVKKLGSGAYGEVLLCR-DKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKL--LDHP 96
Query: 191 NILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHL-NRTTLNHHQMMKICLSIVNGLVHL 249
NI+ RN +LV + G L+D + +R N I +++G+ +L
Sbjct: 97 NIMKLYDFFEDKRN----YYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYL 152
Query: 250 HTEIFGTQGKPAIAHRDIKSKNILVKT---NGTCVIADFGLAVSYSQLSNKMDIPPNPRV 306
H I HRD+K +N+L+++ + I DFGL+ + + +
Sbjct: 153 HK-----HN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKER-----L 199
Query: 307 GTKRYMSPEILDESINMDCFESFKKADIYALGLVL 341
GT Y++PE+L + + +K D++++G++L
Sbjct: 200 GTAYYIAPEVLRKKYD-------EKCDVWSIGVIL 227
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 7e-19
Identities = 52/213 (24%), Positives = 99/213 (46%), Gaps = 37/213 (17%)
Query: 140 LSECIGKGRYGEVWRGVWH--GENVAVKIF-----FSRDEASWSRETEIYSTVLLRHENI 192
+ +GKG +GEV + + AVK+ ++D ++ RE E+ L H NI
Sbjct: 26 IVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKK--LDHPNI 83
Query: 193 LGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDH-LNRTTLNHHQMMKICLSIVNGLVHLHT 251
+ S + ++V ++ G L+D + R + H +I + +G+ ++H
Sbjct: 84 MKLFEILEDSSS----FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHK 139
Query: 252 EIFGTQGKPAIAHRDIKSKNILVKT---NGTCVIADFGLAVSYSQLSNKMDIPPNPRVGT 308
I HRD+K +NIL+++ + I DFGL+ + Q + D +GT
Sbjct: 140 -----HN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR-----IGT 186
Query: 309 KRYMSPEILDESINMDCFESFKKADIYALGLVL 341
Y++PE+L + + +K D+++ G++L
Sbjct: 187 AYYIAPEVLRGTYD-------EKCDVWSAGVIL 212
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 7e-19
Identities = 50/218 (22%), Positives = 92/218 (42%), Gaps = 35/218 (16%)
Query: 140 LSECIGKGRYGEVWRGVWH---GENVAVKIF------------FSRDEASWSRETEIYST 184
E +G+G V R + H + AVKI + +E +I
Sbjct: 21 PKEILGRGVSSVVRRCI-HKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRK 79
Query: 185 VLLRHENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHL-NRTTLNHHQMMKICLSIV 243
+ H NI+ + T+ +LV G L+D+L + TL+ + KI +++
Sbjct: 80 -VSGHPNIIQLKDTYETNTF----FFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALL 134
Query: 244 NGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPN 303
+ LH I HRD+K +NIL+ + + DFG + ++
Sbjct: 135 EVICALHK-----LN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREV--- 183
Query: 304 PRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVL 341
GT Y++PEI++ S+N + K+ D+++ G+++
Sbjct: 184 --CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 86.2 bits (213), Expect = 1e-18
Identities = 37/310 (11%), Positives = 97/310 (31%), Gaps = 49/310 (15%)
Query: 136 KQISLSECIGKGRYGEVWRGVWH-------GENVAVKIFFSRDEASWSRETEIYSTVL-L 187
K + + +G+G + +V+ + +K+ + + T++ +
Sbjct: 65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPS 124
Query: 188 RHENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRT------TLNHHQMMKICLS 241
+ + + + S LV +S+G+L + +N + ++ +
Sbjct: 125 MQHMFMKFYSAHLFQNGSV----LVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMR 180
Query: 242 IVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKT-----------NGTCVIADFGLAVS 290
++ + +H I H DIK N ++ + + D G ++
Sbjct: 181 MLYMIEQVH--------DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSID 232
Query: 291 YSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKA 350
+ T + E+L + D + + ++ + T
Sbjct: 233 MKLFPKGTIF--TAKCETSGFQCVEMLSNK------PWNYQIDYFGVAATVYCMLFGTYM 284
Query: 351 NGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQ 410
E + L P D + + +L+ + + +K+ + Q
Sbjct: 285 KVKNEGGECKPEGLFRRLPHLDMWNEFF----HVMLNIPDCHHLPSLDLLRQKLKKVFQQ 340
Query: 411 NANVRLSALR 420
+ ++ ALR
Sbjct: 341 HYTNKIRALR 350
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 2e-18
Identities = 51/226 (22%), Positives = 87/226 (38%), Gaps = 50/226 (22%)
Query: 139 SLSECIGKGRYGEVWRGVWH---GENVAVKI----------------FFSRDEASWSRET 179
+G G YGEV A+K+ + E
Sbjct: 39 FKVRKLGSGAYGEVLLCK-EKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEI 97
Query: 180 EIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHL-NRTTLNHHQMMKI 238
+ + L H NI+ + +LVT ++ G L++ + NR + I
Sbjct: 98 SLLKS--LDHPNIIKLFDVFEDKKY----FYLVTEFYEGGELFEQIINRHKFDECDAANI 151
Query: 239 CLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKT---NGTCVIADFGLAVSYSQLS 295
I++G+ +LH I HRDIK +NIL++ I DFGL+ +
Sbjct: 152 MKQILSGICYLHK-----HN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFF---- 199
Query: 296 NKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVL 341
D R+GT Y++PE+L + N +K D+++ G+++
Sbjct: 200 -SKDYKLRDRLGTAYYIAPEVLKKKYN-------EKCDVWSCGVIM 237
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 2e-18
Identities = 63/331 (19%), Positives = 117/331 (35%), Gaps = 107/331 (32%)
Query: 136 KQISLSECIGKGRYGEVWRGVWHGEN-------VAVKIFFSRDEASWS------RETEIY 182
+ + + +G G +G+V +G + VAVK+ +++A S E ++
Sbjct: 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKML--KEKADSSEREALMSELKMM 102
Query: 183 STVLLRHENILGYIGSDMTSRNSCTQ---LWLVTHYHSFGSLYDHL-------------- 225
+ L HENI+ +G+ CT ++L+ Y +G L ++L
Sbjct: 103 TQ-LGSHENIVNLLGA-------CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEY 154
Query: 226 ----------NRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVK 275
+ L ++ + G+ L HRD+ ++N+LV
Sbjct: 155 ENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFL------EFKS--CVHRDLAARNVLVT 206
Query: 276 TNGTCVIADFGLA------VSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESF 329
I DFGLA +Y N +P V ++M+P ES+ +
Sbjct: 207 HGKVVKICDFGLARDIMSDSNYVVRGNAR-LP----V---KWMAP----ESLFEGIYTI- 253
Query: 330 KKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFDDMRKVI-CIDQ----QR 384
K+D+++ G++LWE+ + PY P I +
Sbjct: 254 -KSDVWSYGILLWEIF--SLG-------VNPY-------PGIPVDANFYKLIQNGFKMDQ 296
Query: 385 PVLPNRWVSDSTLNAMTKVMKECWHQNANVR 415
P + +M+ CW ++ R
Sbjct: 297 P--------FYATEEIYIIMQSCWAFDSRKR 319
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 3e-18
Identities = 52/216 (24%), Positives = 96/216 (44%), Gaps = 40/216 (18%)
Query: 139 SLSECIGKGRYGEVWRGVWH---GENVAVKIF------FSRDEASWSRETEIYSTVLLRH 189
+GKG +GEV G+ AVK+ D+ S RE ++ L H
Sbjct: 29 KGQRVLGKGSFGEVILCK-DKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQ--LDH 85
Query: 190 ENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHL-NRTTLNHHQMMKICLSIVNGLVH 248
NI+ +LV ++ G L+D + +R + +I +++G+ +
Sbjct: 86 PNIMKLYEFFEDKGY----FYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITY 141
Query: 249 LHTEIFGTQGKPAIAHRDIKSKNILVKT---NGTCVIADFGLAVSYSQLSNKMDIPPNPR 305
+H I HRD+K +N+L+++ + I DFGL+ + S KM +
Sbjct: 142 MHK-----NK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA-SKKM----KDK 188
Query: 306 VGTKRYMSPEILDESINMDCFESFKKADIYALGLVL 341
+GT Y++PE+L + + +K D+++ G++L
Sbjct: 189 IGTAYYIAPEVLHGTYD-------EKCDVWSTGVIL 217
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 3e-18
Identities = 57/313 (18%), Positives = 114/313 (36%), Gaps = 63/313 (20%)
Query: 122 SGSGLPLLIQRTLAKQISLS-------ECIGKGRYGEVWRGVWH---GENVAVKIFFSRD 171
SGL +L Q K+ +++ + +G G G+V H G+ A+K+ D
Sbjct: 8 HSSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECF-HRRTGQKCALKLL--YD 64
Query: 172 EASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLN 231
+E + + +I+ + + L ++ G L+ +
Sbjct: 65 SPKARQEVDHHWQ-ASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQ 123
Query: 232 H---HQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCV---IADF 285
+ +I I + LH+ IAHRD+K +N+L + + DF
Sbjct: 124 AFTEREAAEIMRDIGTAIQFLHS-----HN---IAHRDVKPENLLYTSKEKDAVLKLTDF 175
Query: 286 GLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVL---- 341
G A +Q N + P T Y++PE+L D K D+++LG+++
Sbjct: 176 GFAKETTQ--NALQTP----CYTPYYVAPEVLGPE-KYD-----KSCDMWSLGVIMYILL 223
Query: 342 ------WEVCRRTKANGIFE-------EYKAPYHDLVPMDPSFDDMRKVICID-QQRP-- 385
+ + + G+ + P V + + +R ++ D +R
Sbjct: 224 CGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVS-EDAKQLIRLLLKTDPTERLTI 282
Query: 386 --VLPNRWVSDST 396
+ + W++ S
Sbjct: 283 TQFMNHPWINQSM 295
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 4e-18
Identities = 64/342 (18%), Positives = 120/342 (35%), Gaps = 106/342 (30%)
Query: 137 QISLSECIGKGRYGEVWRGVWHGEN-------VAVKI----FFSRDEASWSRETEIYSTV 185
+ L + +G+G +G+V + VAVK+ + E +
Sbjct: 24 NLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ- 82
Query: 186 LLRHENILGYIGSDMTSRNSCTQ---LWLVTHYHSFGSLYDHL----------------- 225
+ H +++ G+ C+Q L L+ Y +GSL L
Sbjct: 83 -VNHPHVIKLYGA-------CSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSR 134
Query: 226 --------NRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTN 277
+ L ++ I G+ +L + K + HRD+ ++NILV
Sbjct: 135 NSSSLDHPDERALTMGDLISFAWQISQGMQYL------AEMK--LVHRDLAARNILVAEG 186
Query: 278 GTCVIADFGLAVSYSQLSNKMDIPPNP--RVGTK-----RYMSPEILDESINMDCFESFK 330
I+DFGL+ D+ ++ ++M+ ES+ + +
Sbjct: 187 RKMKISDFGLS---------RDVYEEDSYVKRSQGRIPVKWMAI----ESLFDHIYTT-- 231
Query: 331 KADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQ----QRPV 386
++D+++ G++LWE+ T PY P R + +RP
Sbjct: 232 QSDVWSFGVLLWEIV--TLG-------GNPY-------PGIPPERLFNLLKTGHRMERP- 274
Query: 387 LPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKL 428
D+ M ++M +CW Q + R + K L K+
Sbjct: 275 -------DNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 4e-18
Identities = 57/217 (26%), Positives = 91/217 (41%), Gaps = 34/217 (15%)
Query: 140 LSECIGKGRYGEVWRGVWH---GENVAVKIF-----------FSRDEASWSRETEIYSTV 185
+ IG+G V R V H G AVKI + RET I
Sbjct: 98 PKDVIGRGVSSVVRRCV-HRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQ- 155
Query: 186 LLRHENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHL-NRTTLNHHQMMKICLSIVN 244
+ H +I+ I S +S ++LV G L+D+L + L+ + I S++
Sbjct: 156 VAGHPHIITLIDSYESSSF----MFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLE 211
Query: 245 GLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNP 304
+ LH I HRD+K +NIL+ N ++DFG + ++
Sbjct: 212 AVSFLHA-----NN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLREL---- 259
Query: 305 RVGTKRYMSPEILDESINMDCFESFKKADIYALGLVL 341
GT Y++PEIL S++ K+ D++A G++L
Sbjct: 260 -CGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 4e-18
Identities = 47/210 (22%), Positives = 85/210 (40%), Gaps = 31/210 (14%)
Query: 139 SLSECIGKGRYGEVWRGVWH---GENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGY 195
+ +G+G + + V H + AVKI R EA+ +E H NI+
Sbjct: 14 LKDKPLGEGSFSICRKCV-HKKSNQAFAVKIISKRMEANTQKEITALKL-CEGHPNIVKL 71
Query: 196 IGSDMTSRNSCTQLWLVTHYHSFGSLYDH-LNRTTLNHHQMMKICLSIVNGLVHLHTEIF 254
+ +LV + G L++ + + + I +V+ + H+H
Sbjct: 72 HEVFHDQLH----TFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHD--- 124
Query: 255 GTQGKPAIAHRDIKSKNILVKT---NGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRY 311
G + HRD+K +N+L N I DFG A + + P T Y
Sbjct: 125 --VG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTP----CFTLHY 175
Query: 312 MSPEILDESINMDCFESFKKADIYALGLVL 341
+PE+L+++ D + D+++LG++L
Sbjct: 176 AAPELLNQN-GYD-----ESCDLWSLGVIL 199
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 6e-18
Identities = 68/321 (21%), Positives = 112/321 (34%), Gaps = 61/321 (19%)
Query: 140 LSECIGKGRYGEVWRGVWH---GENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYI 196
+ E IG G Y R + H AVKI + + + E EI +H NI+
Sbjct: 26 VKEDIGVGSYSVCKRCI-HKATNMEFAVKII-DKSKRDPTEEIEILLR-YGQHPNIITLK 82
Query: 197 GSDMTSRNSCTQLWLVTHYHSFGSLYDH-LNRTTLNHHQMMKICLSIVNGLVHLHTEIFG 255
+ +++VT G L D L + + + + +I + +LH
Sbjct: 83 DVYDDGKY----VYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHA---- 134
Query: 256 TQGKPAIAHRDIKSKNILVKT---NGTCV-IADFGLAVSYSQLSNKMDIPPNPRVGTKRY 311
QG + HRD+K NIL N + I DFG A + + P T +
Sbjct: 135 -QG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTP----CYTANF 186
Query: 312 MSPEILDESINMDCFESFKKADIYALGLVL----------WEVCRRTKANGIFE------ 355
++PE+L+ D DI++LG++L T I
Sbjct: 187 VAPEVLERQ-GYD-----AACDIWSLGVLLYTMLTGYTPFANGPDDT-PEEILARIGSGK 239
Query: 356 -EYKAPYHDLVPMDPSFDDMRKVICID-QQRP----VLPNRWVSD----STLNAMTKVMK 405
Y + V D + D + K++ +D QR VL + W+ +
Sbjct: 240 FSLSGGYWNSVS-DTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLPQYQLNRQDAP 298
Query: 406 ECWHQNANVRLSALRVKKTLI 426
SAL ++ +
Sbjct: 299 HLVKGAMAATYSALNRNQSPV 319
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 6e-18
Identities = 39/236 (16%), Positives = 83/236 (35%), Gaps = 66/236 (27%)
Query: 144 IGKGRYGEVWRGVWHGENVAVKIFF--------------------SRDEASWSRETEIYS 183
+ +G++ ++ + A+K + + E +I +
Sbjct: 39 LNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIIT 98
Query: 184 TVLLRHENIL---GYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHL---------NRTTLN 231
+++E L G I + +++++ Y S+ +
Sbjct: 99 --DIKNEYCLTCEGIITNY-------DEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIP 149
Query: 232 HHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSY 291
+ I S++N ++H + I HRD+K NIL+ NG ++DFG +
Sbjct: 150 IQVIKCIIKSVLNSFSYIHN-------EKNICHRDVKPSNILMDKNGRVKLSDFGESE-- 200
Query: 292 SQLSNKMDIPPNPRV----GTKRYMSPEILDESINMDCFESFKKADIYALGLVLWE 343
+ ++ GT +M PE + + K DI++LG+ L+
Sbjct: 201 --------YMVDKKIKGSRGTYEFMPPEFFSNESSYNG----AKVDIWSLGICLYV 244
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 81.4 bits (202), Expect = 2e-17
Identities = 58/214 (27%), Positives = 88/214 (41%), Gaps = 38/214 (17%)
Query: 140 LSECIGKGRYGEVWRGVWH---GENVAVKIF-----FSRDEASWSRETEIYSTVLLRHEN 191
+ E +GKG + V R V H G A KI +RD RE I L+H N
Sbjct: 10 VKEELGKGAFSVVRRCV-HKTTGLEFAAKIINTKKLSARDFQKLEREARICR--KLQHPN 66
Query: 192 ILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHL-NRTTLNHHQMMKICLSIVNGLVHLH 250
I+ S +LV + G L++ + R + I+ + + H
Sbjct: 67 IVRLHDSIQEESF----HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCH 122
Query: 251 TEIFGTQGKPAIAHRDIKSKNILV--KTNGTCV-IADFGLAVSYSQLSNKMDIPPNPRVG 307
+ G I HR++K +N+L+ K G V +ADFGLA+ + G
Sbjct: 123 S-----NG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGF-----AG 169
Query: 308 TKRYMSPEILDESINMDCFESFKKADIYALGLVL 341
T Y+SPE+L + K DI+A G++L
Sbjct: 170 TPGYLSPEVLKKDPYS------KPVDIWACGVIL 197
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 82.6 bits (204), Expect = 2e-17
Identities = 56/256 (21%), Positives = 82/256 (32%), Gaps = 73/256 (28%)
Query: 140 LSECIGKGRYGEVWRGVWH---GENVAVKIF--------FSRDEASWSRETEIYSTVLLR 188
L IG+G YG V + A+KI +D E + L
Sbjct: 30 LKGAIGQGSYGVVRVAI-ENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMK--KLH 86
Query: 189 HENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMM------------ 236
H NI + + LV G L D LN +
Sbjct: 87 HPNIARLYEVYEDEQY----ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPC 142
Query: 237 -----------------------------KICLSIVNGLVHLHTEIFGTQGKPAIAHRDI 267
I I + L +LH QG I HRDI
Sbjct: 143 PECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN-----QG---ICHRDI 194
Query: 268 KSKNILVKTNGTCV--IADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDC 325
K +N L TN + + DFGL+ + +L+N + GT +++PE+L N
Sbjct: 195 KPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVL----NTTN 250
Query: 326 FESFKKADIYALGLVL 341
K D ++ G++L
Sbjct: 251 ESYGPKCDAWSAGVLL 266
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 2e-17
Identities = 66/331 (19%), Positives = 121/331 (36%), Gaps = 66/331 (19%)
Query: 140 LSECIGKGRYGEVWRGVWH---GENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYI 196
S+ +G G G+V + + E A+K+ +D RE E++ + +I+ +
Sbjct: 66 TSQVLGLGINGKVLQIF-NKRTQEKFALKML--QDCPKARREVELHWR-ASQCPHIVRIV 121
Query: 197 GSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNH---HQMMKICLSIVNGLVHLHTEI 253
L +V G L+ + + +I SI + +LH+
Sbjct: 122 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS-- 179
Query: 254 FGTQGKPAIAHRDIKSKNILVKT---NGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKR 310
IAHRD+K +N+L + N + DFG A + N + P T
Sbjct: 180 ---IN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS-HNSLTTP----CYTPY 228
Query: 311 YMSPEILDESINMDCFESFKKADIYALGLVL----------WEVCRRTKANGIFE----- 355
Y++PE+L D K D+++LG+++ + + G+
Sbjct: 229 YVAPEVLGPE-KYD-----KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG 282
Query: 356 --EYKAPYHDLVPMDPSFDDMRKVICID-QQRP----VLPNRWVSDSTLNA--------M 400
E+ P V + +R ++ + QR + + W+ ST +
Sbjct: 283 QYEFPNPEWSEVS-EEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRV 341
Query: 401 TKVMKECWH---QNANVRLSALRVKKTLIKL 428
K KE W + L+ +RV IK+
Sbjct: 342 LKEDKERWEDVKEEMTSALATMRVDYEQIKI 372
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 2e-17
Identities = 64/241 (26%), Positives = 98/241 (40%), Gaps = 40/241 (16%)
Query: 116 ASLTSGSGSGLPLLIQRTLAKQIS----LSECIGKGRYGEVWRGVWH--GENVAVKI--- 166
AS+T G G + + S + E +GKG + V R V G A KI
Sbjct: 5 ASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINT 64
Query: 167 --FFSRDEASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDH 224
+RD RE I L+H NI+ S +LV + G L++
Sbjct: 65 KKLSARDFQKLEREARICR--KLQHPNIVRLHDSIQEESF----HYLVFDLVTGGELFED 118
Query: 225 L-NRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILV--KTNGTCV 281
+ R + I+ + + H+ G I HR++K +N+L+ K G V
Sbjct: 119 IVAREFYSEADASHCIQQILESIAYCHS-----NG---IVHRNLKPENLLLASKAKGAAV 170
Query: 282 -IADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLV 340
+ADFGLA+ + S + GT Y+SPE+L + K DI+A G++
Sbjct: 171 KLADFGLAIEVND-SEAW----HGFAGTPGYLSPEVLKKDPYS------KPVDIWACGVI 219
Query: 341 L 341
L
Sbjct: 220 L 220
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 3e-17
Identities = 54/217 (24%), Positives = 84/217 (38%), Gaps = 40/217 (18%)
Query: 140 LSECIGKGRYGEVWRGVWH--GENVAVKIF---FSRDEASWSR-ETEIYSTVLLRHENIL 193
L +G+G G+V+ VA+K+ S D +R + E + L+ +++
Sbjct: 38 LRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVV 97
Query: 194 -----GYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRT-TLNHHQMMKICLSIVNGLV 247
G I QL++ + L L R L + + I I + L
Sbjct: 98 PIHDFGEIDG---------QLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALD 148
Query: 248 HLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVG 307
H G HRD+K +NILV + + DFG+A + + VG
Sbjct: 149 AAHA-----AG---ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQ---LGNTVG 197
Query: 308 TKRYMSPE-ILDESINMDCFESFKKADIYALGLVLWE 343
T YM+PE + +ADIYAL VL+E
Sbjct: 198 TLYYMAPERFSESHAT-------YRADIYALTCVLYE 227
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 3e-17
Identities = 49/212 (23%), Positives = 89/212 (41%), Gaps = 37/212 (17%)
Query: 140 LSECIGKGRYGEVWRGVWH--GENVAVKIF---FSRDEASWSRETEIYSTVLLRHENILG 194
E +G G + EV+ G+ A+K + ++S E + ++HENI+
Sbjct: 13 FMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKK--IKHENIVT 70
Query: 195 YIGSDMTSRNSCTQLWLVTHYHSFGSLYDH-LNRTTLNHHQMMKICLSIVNGLVHLHTEI 253
++ + +LV S G L+D L R + +++ + +LH
Sbjct: 71 LEDIYESTTH----YYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHE-- 124
Query: 254 FGTQGKPAIAHRDIKSKNILVKT---NGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKR 310
G I HRD+K +N+L T N +I DFGL+ M + GT
Sbjct: 125 ---NG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN--GIM----STACGTPG 172
Query: 311 YMSPEILDESINMDCFESF-KKADIYALGLVL 341
Y++PE+L + + + K D +++G++
Sbjct: 173 YVAPEVLAQ-------KPYSKAVDCWSIGVIT 197
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 4e-17
Identities = 53/214 (24%), Positives = 86/214 (40%), Gaps = 35/214 (16%)
Query: 139 SLSECIGKGRYGEVWRGVWH--GENVAVKIF-----FSRDEASWSRETEIYSTVLLRHEN 191
L E +GKG + V R V G+ A I +RD RE I LL+H N
Sbjct: 14 QLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICR--LLKHPN 71
Query: 192 ILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDH-LNRTTLNHHQMMKICLSIVNGLVHLH 250
I+ S + +L+ + G L++ + R + I+ ++H H
Sbjct: 72 IVRLHDSISEEGH----HYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCH 127
Query: 251 TEIFGTQGKPAIAHRDIKSKNILVKT---NGTCVIADFGLAVSYSQLSNKMDIPPNPRVG 307
G + HR++K +N+L+ + +ADFGLA+ G
Sbjct: 128 Q-----MG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAW----FGFAG 175
Query: 308 TKRYMSPEILDESINMDCFESFKKADIYALGLVL 341
T Y+SPE+L + K D++A G++L
Sbjct: 176 TPGYLSPEVLRKDPYG------KPVDLWACGVIL 203
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 6e-17
Identities = 49/213 (23%), Positives = 81/213 (38%), Gaps = 28/213 (13%)
Query: 142 ECIGKGRYGEVWRGVWH---GENVAVKI---FFSRDEASWSRETEIYSTVLLRHENILGY 195
+ +G+G + V + + + AVKI + RE E+ H N+L
Sbjct: 19 DVLGEGAHARVQTCI-NLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQ-CQGHRNVLEL 76
Query: 196 IGSDMTSRNSCTQLWLVTHYHSFGSLYDH-LNRTTLNHHQMMKICLSIVNGLVHLHTEIF 254
I +LV GS+ H R N + + + + L LH
Sbjct: 77 IEFFEEEDR----FYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHN--- 129
Query: 255 GTQGKPAIAHRDIKSKNILVKTNGTCV---IADFGLAVSYSQLSNKMDIPPNP---RVGT 308
+G IAHRD+K +NIL + I DF L + I G+
Sbjct: 130 --KG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGS 184
Query: 309 KRYMSPEILDESINMDCFESFKKADIYALGLVL 341
YM+PE+++ K+ D+++LG++L
Sbjct: 185 AEYMAPEVVEAFSEEASIYD-KRCDLWSLGVIL 216
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 1e-16
Identities = 48/211 (22%), Positives = 87/211 (41%), Gaps = 35/211 (16%)
Query: 140 LSECIGKGRYGEVWRGV--WHGENVAVKIF---FSRDEASWSRETEIYSTVLLRHENILG 194
L IG+G +GEV V A K F D + +E EI L H NI+
Sbjct: 13 LENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMK--SLDHPNIIR 70
Query: 195 YIGSDMTSRNSCTQLWLVTHYHSFGSLYDH-LNRTTLNHHQMMKICLSIVNGLVHLHTEI 253
+ + + ++LV + G L++ +++ +I +++ + + H
Sbjct: 71 LYETFEDNTD----IYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHK-- 124
Query: 254 FGTQGKPAIAHRDIKSKNILVKT---NGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKR 310
+AHRD+K +N L T + + DFGLA + M +VGT
Sbjct: 125 ---LN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP-GKMM----RTKVGTPY 173
Query: 311 YMSPEILDESINMDCFESFKKADIYALGLVL 341
Y+SP++L+ + D ++ G+++
Sbjct: 174 YVSPQVLEGLYG-------PECDEWSAGVMM 197
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 3e-16
Identities = 47/220 (21%), Positives = 85/220 (38%), Gaps = 54/220 (24%)
Query: 144 IGKGRYGEVW--RGVWHGENVAVKIFF------SRDEASWSRETEIYSTVLLRHENIL-- 193
+GKG + V+ + G VA+K+ + E +I+ L+H +IL
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHC--QLKHPSILEL 76
Query: 194 -GYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHL--NRTTLNHHQMMKICLSIVNGLVHLH 250
Y ++LV G + +L + ++ I+ G+++LH
Sbjct: 77 YNYFEDS-------NYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH 129
Query: 251 TEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRV---G 307
+ I HRD+ N+L+ N IADFG L+ ++ +P G
Sbjct: 130 SH--------GILHRDLTLSNLLLTRNMNIKIADFG-------LATQLKMPHEKHYTLCG 174
Query: 308 TKRYMSPEILDESINMDCFESFK----KADIYALGLVLWE 343
T Y+SPEI ++D+++LG + +
Sbjct: 175 TPNYISPEIATR----------SAHGLESDVWSLGCMFYT 204
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 3e-16
Identities = 43/217 (19%), Positives = 77/217 (35%), Gaps = 40/217 (18%)
Query: 139 SLSECIGKGRYGEVWRGV--WHGENVAVKIF----FSRDEASWSRETEIYSTVLLRHENI 192
+G G +G+V G +K E E+ + L H NI
Sbjct: 25 IFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKS--LDHPNI 82
Query: 193 LGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDH-LNRTTLNHH----QMMKICLSIVNGLV 247
+ N +++V G L + ++ + ++ ++N L
Sbjct: 83 IKIFEVFEDYHN----MYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALA 138
Query: 248 HLHTEIFGTQGKPAIAHRDIKSKNILVKT---NGTCVIADFGLAVSYSQLSNKMDIPPNP 304
+ H+ Q + H+D+K +NIL + + I DFGLA +
Sbjct: 139 YFHS-----QH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS-DEHS----TN 185
Query: 305 RVGTKRYMSPEILDESINMDCFESFKKADIYALGLVL 341
GT YM+PE+ + K DI++ G+V+
Sbjct: 186 AAGTALYMAPEVFKRDVT-------FKCDIWSAGVVM 215
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 3e-16
Identities = 45/221 (20%), Positives = 80/221 (36%), Gaps = 44/221 (19%)
Query: 140 LSECIGKGRYGEVWRGVWH---GENVAVKIF-----------FSRDEASWSRETEIYSTV 185
+S+ +G G GEV + VA++I + + E EI
Sbjct: 139 MSKTLGSGACGEVKLAF-ERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILK-- 195
Query: 186 LLRHENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHL-NRTTLNHHQMMKICLSIVN 244
L H I+ ++V G L+D + L ++
Sbjct: 196 KLNHPCIIKIKNFFDAE-----DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL 250
Query: 245 GLVHLHTEIFGTQGKPAIAHRDIKSKNILVKT---NGTCVIADFGLAVSYSQLSNKMDIP 301
+ +LH G I HRD+K +N+L+ + + I DFG + + S +
Sbjct: 251 AVQYLHE-----NG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL- 301
Query: 302 PNPRVGTKRYMSPEILDESINMDCFESF-KKADIYALGLVL 341
GT Y++PE+L + + D ++LG++L
Sbjct: 302 ----CGTPTYLAPEVLVSVGT----AGYNRAVDCWSLGVIL 334
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 9e-16
Identities = 45/209 (21%), Positives = 79/209 (37%), Gaps = 32/209 (15%)
Query: 140 LSECIGKGRYGEVWRGVW--HGENVAVKIFF-SRDEASWSRETEIYSTVLLRHENILGYI 196
+ +G+G V+R + A+K+ + D+ E + L H NI+
Sbjct: 57 VESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLR--LSHPNIIKLK 114
Query: 197 GSDMTSRNSCTQLWLVTHYHSFGSLYDH-LNRTTLNHHQMMKICLSIVNGLVHLHTEIFG 255
T + LV + G L+D + + + I+ + +LH
Sbjct: 115 EIFETPTE----ISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHE---- 166
Query: 256 TQGKPAIAHRDIKSKNILVKT---NGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYM 312
G I HRD+K +N+L T + IADFGL+ + GT Y
Sbjct: 167 -NG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTV-----CGTPGYC 217
Query: 313 SPEILDESINMDCFESFKKADIYALGLVL 341
+PEIL + D++++G++
Sbjct: 218 APEILRGC-AYG-----PEVDMWSVGIIT 240
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 1e-15
Identities = 55/246 (22%), Positives = 93/246 (37%), Gaps = 45/246 (18%)
Query: 116 ASLTSGSGSGLPLLIQRTLAKQI-SLSECIGKGRYGEVWRGVWH---GENVAVKI----- 166
++ G G L + L + + L E IGKG + V R + + G+ AVKI
Sbjct: 3 PGISGGGGGILDMADDDVLFEDVYELCEVIGKGPFSVVRRCI-NRETGQQFAVKIVDVAK 61
Query: 167 FFSRDEASWS---RETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYD 223
F S S RE I +L+H +I+ + + + L++V + L
Sbjct: 62 FTSSPGLSTEDLKREASICH--MLKHPHIVELLETYSSDGM----LYMVFEFMDGADLCF 115
Query: 224 HL-----NRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILV--KT 276
+ + I+ L + H I HRD+K +L+ K
Sbjct: 116 EIVKRADAGFVYSEAVASHYMRQILEALRYCHD-----NN---IIHRDVKPHCVLLASKE 167
Query: 277 NGTCV-IADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIY 335
N V + FG+A+ + RVGT +M+PE++ K D++
Sbjct: 168 NSAPVKLGGFGVAIQLGESGLVA----GGRVGTPHFMAPEVVKREPYG------KPVDVW 217
Query: 336 ALGLVL 341
G++L
Sbjct: 218 GCGVIL 223
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 2e-15
Identities = 46/220 (20%), Positives = 79/220 (35%), Gaps = 42/220 (19%)
Query: 140 LSECIGKGRYGEVWRGVWH---GENVAVKIF-----------FSRDEASWSRETEIYSTV 185
+S+ +G G GEV + VA+KI + + E EI
Sbjct: 14 MSKTLGSGACGEVKLAF-ERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK-- 70
Query: 186 LLRHENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHL-NRTTLNHHQMMKICLSIVN 244
L H I+ ++V G L+D + L ++
Sbjct: 71 KLNHPCIIKIKNFFDA-----EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL 125
Query: 245 GLVHLHTEIFGTQGKPAIAHRDIKSKNILVKT---NGTCVIADFGLAVSYSQLSNKMDIP 301
+ +LH G I HRD+K +N+L+ + + I DFG + + S +
Sbjct: 126 AVQYLHE-----NG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL- 176
Query: 302 PNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVL 341
GT Y++PE+L + D ++LG++L
Sbjct: 177 ----CGTPTYLAPEVLVSVGTA---GYNRAVDCWSLGVIL 209
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 2e-15
Identities = 42/215 (19%), Positives = 80/215 (37%), Gaps = 45/215 (20%)
Query: 144 IGKGRYGEVWRG--VWHGENVAVKIFF------SRDEASWSRETEIYSTVLLRHENIL-- 193
+GKG + + + E A KI S E I+ L H++++
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHR--SLAHQHVVGF 106
Query: 194 -GYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHL-NRTTLNHHQMMKICLSIVNGLVHLHT 251
G+ + +++V SL + R L + IV G +LH
Sbjct: 107 HGFFEDN-------DFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR 159
Query: 252 EIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRV---GT 308
+ HRD+K N+ + + I DFG L+ K++ + GT
Sbjct: 160 N--------RVIHRDLKLGNLFLNEDLEVKIGDFG-------LATKVEYDGERKKVLCGT 204
Query: 309 KRYMSPEILDESINMDCFESFKKADIYALGLVLWE 343
Y++PE+L + + D++++G +++
Sbjct: 205 PNYIAPEVLSKK-GHSF-----EVDVWSIGCIMYT 233
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 2e-15
Identities = 46/214 (21%), Positives = 80/214 (37%), Gaps = 38/214 (17%)
Query: 139 SLSECIGKGRYGEVWRGVWH---GENVAVKIFFSR---DEASWSRETEIYSTVLLRHENI 192
+ E +G G +G V R V G K + D+ + E I + L H +
Sbjct: 54 DILEELGSGAFGVVHRCV-EKATGRVFVAKFINTPYPLDKYTVKNEISIMNQ--LHHPKL 110
Query: 193 LGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLH 250
+ + + L+ + S G L+D + ++ +++ GL H+H
Sbjct: 111 INLHDAFEDKYE----MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH 166
Query: 251 TEIFGTQGKPAIAHRDIKSKNILV--KTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGT 308
I H DIK +NI+ K + I DFGLA + T
Sbjct: 167 E-----HS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT-----TAT 213
Query: 309 KRYMSPEILD-ESINMDCFESFKKADIYALGLVL 341
+ +PEI+D E + D++A+G++
Sbjct: 214 AEFAAPEIVDREPVG-------FYTDMWAIGVLG 240
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 77.2 bits (190), Expect = 3e-15
Identities = 39/214 (18%), Positives = 83/214 (38%), Gaps = 38/214 (17%)
Query: 139 SLSECIGKGRYGEVWRGVWH---GENVAVKIFFSR---DEASWSRETEIYSTVLLRHENI 192
+ E +G G +G V R G N A K + D+ + +E + S LRH +
Sbjct: 160 DIHEELGTGAFGVVHRVT-ERATGNNFAAKFVMTPHESDKETVRKEIQTMSV--LRHPTL 216
Query: 193 LGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHL--NRTTLNHHQMMKICLSIVNGLVHLH 250
+ + + ++ + S G L++ + ++ + ++ + GL H+H
Sbjct: 217 VNLHDAFEDDNE----MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH 272
Query: 251 TEIFGTQGKPAIAHRDIKSKNILVKTNGTCVI--ADFGLAVSYSQLSNKMDIPPNPRVGT 308
H D+K +NI+ T + + DFGL + + GT
Sbjct: 273 E-----NN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP-KQSVKV----TTGT 319
Query: 309 KRYMSPEILD-ESINMDCFESFKKADIYALGLVL 341
+ +PE+ + + + D++++G++
Sbjct: 320 AEFAAPEVAEGKPVG-------YYTDMWSVGVLS 346
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 3e-15
Identities = 51/191 (26%), Positives = 89/191 (46%), Gaps = 28/191 (14%)
Query: 142 ECIGKGRYGEVWRG--VWHGENVAVK-IFFSRDEASW----SRETEIYSTVL--LRHENI 192
IG+G +GEV++ G+ VA+K + ++ + RE +I L L+HEN+
Sbjct: 23 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKI----LQLLKHENV 78
Query: 193 ---LGYIGSDMTSRNSC-TQLWLVTHY--HSFGSLYDHLNRTTLNHHQMMKICLSIVNGL 246
+ + + N C ++LV + H L ++ ++ ++ ++NGL
Sbjct: 79 VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL-VKFTLSEIKRVMQMLLNGL 137
Query: 247 VHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRV 306
++H I HRD+K+ N+L+ +G +ADFGLA ++S N RV
Sbjct: 138 YYIHRN--------KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV 189
Query: 307 GTKRYMSPEIL 317
T Y PE+L
Sbjct: 190 VTLWYRPPELL 200
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 3e-15
Identities = 48/221 (21%), Positives = 78/221 (35%), Gaps = 47/221 (21%)
Query: 140 LSECIGKGRYGEVWRGVWH---GENVAVKI---------FFSRDEASWSRETEIYSTVLL 187
+G G +G VW V + V VK + D EI +
Sbjct: 28 TMSPLGSGAFGFVWTAV-DKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRV 86
Query: 188 RHENI---LGYIGSDMTSRNSCTQLWLVTHYHSFGS-LYDHL-NRTTLNHHQMMKICLSI 242
H NI L + LV H G L+ + L+ I +
Sbjct: 87 EHANIIKVLDIFENQ-------GFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQL 139
Query: 243 VNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPP 302
V+ + +L + I HRDIK +NI++ + T + DFG A +Y +
Sbjct: 140 VSAVGYLRLK--------DIIHRDIKDENIVIAEDFTIKLIDFGSA-AYLERGKLFYTF- 189
Query: 303 NPRVGTKRYMSPEILDESINMDCFESF--KKADIYALGLVL 341
GT Y +PE+L + + ++++LG+ L
Sbjct: 190 ---CGTIEYCAPEVLMG-------NPYRGPELEMWSLGVTL 220
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 4e-15
Identities = 49/212 (23%), Positives = 89/212 (41%), Gaps = 38/212 (17%)
Query: 138 ISLSECIGKGRYGEVWRGVWH---GENVAVKIFFSR---DEASWSRETEIYSTVLLRHEN 191
+S +E +G GR+G+V + G +A KI +R D+ E + + L H N
Sbjct: 91 VSKTEILGGGRFGQVHKCE-ETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQ--LDHAN 147
Query: 192 ILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHL 249
++ + + + + LV Y G L+D + L + I G+ H+
Sbjct: 148 LIQLYDAFESKND----IVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHM 203
Query: 250 HTEIFGTQGKPAIAHRDIKSKNILV--KTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVG 307
H I H D+K +NIL + I DFGLA Y K+ + G
Sbjct: 204 HQ-----MY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP-REKLKV----NFG 250
Query: 308 TKRYMSPEILD-ESINMDCFESFKKADIYALG 338
T +++PE+++ + ++ D++++G
Sbjct: 251 TPEFLAPEVVNYDFVS-------FPTDMWSVG 275
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 6e-15
Identities = 51/213 (23%), Positives = 87/213 (40%), Gaps = 46/213 (21%)
Query: 144 IGKGRYGEVWRGVWH---GENVAVKI-----FFSRDEASWSRETEIYSTVLLRHENILG- 194
IGKG + +V H G VA+KI RE I +L H NI+
Sbjct: 23 IGKGNFAKVKLAR-HILTGREVAIKIIDKTQLNPTSLQKLFREVRIMK--ILNHPNIVKL 79
Query: 195 Y--IGSDMTSRNSCTQLWLVTHYHSFGSLYDHL-NRTTLNHHQMMKICLSIVNGLVHLHT 251
+ I ++ L+L+ Y S G ++D+L + + IV+ + + H
Sbjct: 80 FEVIETE-------KTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCH- 131
Query: 252 EIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNP---RVGT 308
+ I HRD+K++N+L+ + IADFG SN+ G
Sbjct: 132 -------QKRIVHRDLKAENLLLDADMNIKIADFG-------FSNEFT-VGGKLDAFCGA 176
Query: 309 KRYMSPEILDESINMDCFESFKKADIYALGLVL 341
Y +PE+ ++ + D+++LG++L
Sbjct: 177 PPYAAPEL----FQGKKYDG-PEVDVWSLGVIL 204
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 8e-15
Identities = 42/213 (19%), Positives = 79/213 (37%), Gaps = 45/213 (21%)
Query: 144 IGKGRYGEVWRG--VWHGENVAVKIFF------SRDEASWSRETEIYSTVLLRHENIL-- 193
+GKG + + + E A KI S E I+ L H++++
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHR--SLAHQHVVGF 80
Query: 194 -GYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHL-NRTTLNHHQMMKICLSIVNGLVHLHT 251
G+ + +++V SL + R L + IV G +LH
Sbjct: 81 HGFFEDN-------DFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR 133
Query: 252 EIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRV---GT 308
+ HRD+K N+ + + I DFG L+ K++ + GT
Sbjct: 134 N--------RVIHRDLKLGNLFLNEDLEVKIGDFG-------LATKVEYDGERKKVLCGT 178
Query: 309 KRYMSPEILDESINMDCFESFKKADIYALGLVL 341
Y++PE+L + + D++++G ++
Sbjct: 179 PNYIAPEVLSKK-GHSF-----EVDVWSIGCIM 205
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 1e-14
Identities = 42/212 (19%), Positives = 84/212 (39%), Gaps = 35/212 (16%)
Query: 139 SLSECIGKGRYGEVWRGVW--HGENVAVKIFFSR--DEASWSRETEIYSTVLLRHENILG 194
++E +G+G +G V R V + K + D+ +E I + + RH NIL
Sbjct: 8 MIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILN--IARHRNILH 65
Query: 195 YIGSDMTSRNSCTQLWLVTHYHSFGSLYDHL--NRTTLNHHQMMKICLSIVNGLVHLHTE 252
S + L ++ + S +++ + + LN +++ + L LH+
Sbjct: 66 LHESFESMEE----LVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS- 120
Query: 253 IFGTQGKPAIAHRDIKSKNILV--KTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKR 310
I H DI+ +NI+ + + T I +FG A N +
Sbjct: 121 ----HN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL-----FTAPE 168
Query: 311 YMSPEILD-ESINMDCFESFKKADIYALGLVL 341
Y +PE+ + ++ D+++LG ++
Sbjct: 169 YYAPEVHQHDVVS-------TATDMWSLGTLV 193
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 2e-14
Identities = 46/221 (20%), Positives = 86/221 (38%), Gaps = 45/221 (20%)
Query: 139 SLSECIGKGRYGEVWRGVWH---GENVAVKI---------FFSRDEASWSRETEIYSTVL 186
E +G G++ V + G A K RE I
Sbjct: 14 DTGEELGSGQFAVVKKCR-EKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK--E 70
Query: 187 LRHENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHL-NRTTLNHHQMMKICLSIVNG 245
++H N++ + + L+ + G L+D L + +L + + I+NG
Sbjct: 71 IQHPNVITLHEVYENKTD----VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG 126
Query: 246 LVHLHTEIFGTQGKPAIAHRDIKSKNILVKT----NGTCVIADFGLAVSYSQLSNKMDIP 301
+ +LH+ IAH D+K +NI++ I DFGLA + +I
Sbjct: 127 VYYLHS-----LQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI- 177
Query: 302 PNPRVGTKRYMSPEILD-ESINMDCFESFKKADIYALGLVL 341
GT +++PEI++ E + +AD++++G++
Sbjct: 178 ----FGTPEFVAPEIVNYEPLG-------LEADMWSIGVIT 207
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 2e-14
Identities = 47/221 (21%), Positives = 90/221 (40%), Gaps = 45/221 (20%)
Query: 139 SLSECIGKGRYGEVWRGVWH---GENVAVKIF---------FSRDEASWSRETEIYSTVL 186
+ E +G G++ V + G+ A K RE I
Sbjct: 8 EMGEELGSGQFAIVRKCR-QKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR--E 64
Query: 187 LRHENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHL-NRTTLNHHQMMKICLSIVNG 245
+RH NI+ + + L+ S G L+D L + +L + + I++G
Sbjct: 65 IRHPNIITLHDIFENKTD----VVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDG 120
Query: 246 LVHLHTEIFGTQGKPAIAHRDIKSKNILVKT----NGTCVIADFGLAVSYSQLSNKMDIP 301
+ +LH+ + IAH D+K +NI++ N + DFG+A + +I
Sbjct: 121 VHYLHS-----KR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNI- 171
Query: 302 PNPRVGTKRYMSPEILD-ESINMDCFESFKKADIYALGLVL 341
GT +++PEI++ E + +AD++++G++
Sbjct: 172 ----FGTPEFVAPEIVNYEPLG-------LEADMWSIGVIT 201
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 3e-14
Identities = 47/219 (21%), Positives = 88/219 (40%), Gaps = 41/219 (18%)
Query: 139 SLSECIGKGRYGEVWRGVWH---GENVAVKIF----FSRDEASWSRE---TEIYSTVLLR 188
+ E +G G++ V + G A K SRE E+ +
Sbjct: 15 DIGEELGSGQFAIVKKCR-EKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 189 HENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHL-NRTTLNHHQMMKICLSIVNGLV 247
H N++ + + L+ S G L+D L + +L+ + I++G+
Sbjct: 74 HHNVITLHDVYENRTD----VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVN 129
Query: 248 HLHTEIFGTQGKPAIAHRDIKSKNILVKT----NGTCVIADFGLAVSYSQLSNKMDIPPN 303
+LHT + IAH D+K +NI++ + DFGLA +I
Sbjct: 130 YLHT-----KK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNI--- 178
Query: 304 PRVGTKRYMSPEILD-ESINMDCFESFKKADIYALGLVL 341
GT +++PEI++ E + +AD++++G++
Sbjct: 179 --FGTPEFVAPEIVNYEPLG-------LEADMWSIGVIT 208
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 3e-14
Identities = 50/214 (23%), Positives = 86/214 (40%), Gaps = 37/214 (17%)
Query: 144 IGKGRYGEVWRGVWH---GENVAVKIF----FSRDEASWSR-ETEIYSTVLLRHENILGY 195
+G+G YG+V + AVKI R + + EI LRH+N++
Sbjct: 13 LGEGSYGKVKEVL-DSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 196 IGSDMTSRNSCTQLWLVTHYHSFGS--LYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEI 253
+ D+ ++++V Y G + D + Q +++GL +LH+
Sbjct: 72 V--DVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHS-- 127
Query: 254 FGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRV-----GT 308
QG I H+DIK N+L+ T GT I+ G ++ + G+
Sbjct: 128 ---QG---IVHKDIKPGNLLLTTGGTLKISALG-------VAEALHPFAADDTCRTSQGS 174
Query: 309 KRYMSPEILDESINMDCFESFKKADIYALGLVLW 342
+ PEI + F K DI++ G+ L+
Sbjct: 175 PAFQPPEIANGLDTFSGF----KVDIWSAGVTLY 204
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 3e-14
Identities = 49/235 (20%), Positives = 91/235 (38%), Gaps = 45/235 (19%)
Query: 125 GLPLLIQRTLAKQISLSECIGKGRYGEVWRGVWH---GENVAVKIF---------FSRDE 172
G+ Q+ + + E +G G++ V + G A K
Sbjct: 1 GMETFKQQKVEDFYDIGEELGSGQFAIVKKCR-EKSTGLEYAAKFIKKRQSRASRRGVCR 59
Query: 173 ASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHL-NRTTLN 231
RE I + H NI+ + + L+ S G L+D L + +L+
Sbjct: 60 EEIEREVSILR--QVLHPNIITLHDVYENRTD----VVLILELVSGGELFDFLAQKESLS 113
Query: 232 HHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKT----NGTCVIADFGL 287
+ I++G+ +LHT + IAH D+K +NI++ + DFGL
Sbjct: 114 EEEATSFIKQILDGVNYLHT-----KK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165
Query: 288 AVSYSQLSNKMDIPPNPRVGTKRYMSPEILD-ESINMDCFESFKKADIYALGLVL 341
A +I GT +++PEI++ E + +AD++++G++
Sbjct: 166 AHEIEDGVEFKNI-----FGTPEFVAPEIVNYEPLG-------LEADMWSIGVIT 208
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 1e-13
Identities = 47/186 (25%), Positives = 77/186 (41%), Gaps = 30/186 (16%)
Query: 142 ECIGKGRYGEVWRGV--WHGENVAVKIFFSRDEASWSRET---EIYSTVLLRHENILGYI 196
IG+G YG V++ G+ VA+K F ++ ++ EI L+H N++ +
Sbjct: 9 GKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLL 68
Query: 197 GSDMTSRNSCTQLWLVTHY--HSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIF 254
++ R +L LV Y H+ D R + H + I + + H
Sbjct: 69 --EVFRRKR--RLHLVFEYCDHTVLHELDRYQRG-VPEHLVKSITWQTLQAVNFCH---- 119
Query: 255 GTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNP---RVGTKRY 311
K HRD+K +NIL+ + + DFG A + P + V T+ Y
Sbjct: 120 ----KHNCIHRDVKPENILITKHSVIKLCDFGFARLLT-------GPSDYYDDEVATRWY 168
Query: 312 MSPEIL 317
SPE+L
Sbjct: 169 RSPELL 174
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 1e-13
Identities = 56/211 (26%), Positives = 88/211 (41%), Gaps = 40/211 (18%)
Query: 144 IGKGRYGEVWRGVWH---GENVAVKIF----FSRDEASWSRETEIYSTVLLRHENILGYI 196
+G+G YGEV V + E VAVKI + +E I +L HEN++ +
Sbjct: 15 LGEGAYGEVQLAV-NRVTEEAVAVKIVDMKRAVDCPENIKKEICINK--MLNHENVVKFY 71
Query: 197 GSDMTSRNSCTQLWLVTHYHSFGSLYDHL-NRTTLNHHQMMKICLSIVNGLVHLHTEIFG 255
G +L Y S G L+D + + + ++ G+V+LH
Sbjct: 72 GH-RREG---NIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI--- 124
Query: 256 TQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPE 315
I HRDIK +N+L+ I+DFGLA + N + N GT Y++PE
Sbjct: 125 -----GITHRDIKPENLLLDERDNLKISDFGLATVFRY--NNRERLLNKMCGTLPYVAPE 177
Query: 316 ILDESINMDCFESFK-----KADIYALGLVL 341
+L + D+++ G+VL
Sbjct: 178 LL----------KRREFHAEPVDVWSCGIVL 198
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 71.5 bits (175), Expect = 2e-13
Identities = 50/216 (23%), Positives = 90/216 (41%), Gaps = 45/216 (20%)
Query: 144 IGKGRYGEVW--RGVWHGENVAVKIF-----FSRDEASWSRETEIYSTVLLRHENILGYI 196
IG+G +GEV+ R G+ A+K + + + E +L +
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLAL-NE---------RIMLSLV 246
Query: 197 GSD----MTSRNSCTQ----LWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLS-IVNGLV 247
+ + + L + + G L+ HL++ + M+ + I+ GL
Sbjct: 247 STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLE 306
Query: 248 HLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVG 307
H+H + +RD+K NIL+ +G I+D GLA + P+ VG
Sbjct: 307 HMHNR--------FVVYRDLKPANILLDEHGHVRISDLGLACDF------SKKKPHASVG 352
Query: 308 TKRYMSPEILDESINMDCFESFKKADIYALGLVLWE 343
T YM+PE+L + + D AD ++LG +L++
Sbjct: 353 THGYMAPEVLQKGVAYD-----SSADWFSLGCMLFK 383
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 2e-13
Identities = 49/184 (26%), Positives = 80/184 (43%), Gaps = 30/184 (16%)
Query: 144 IGKGRYGEVWRGV--WHGENVAVKIFFSRDEASWSRET---EIYSTVLLRHENILGYIGS 198
+G+G YG V + G VA+K F D+ ++ EI LRHEN++ +
Sbjct: 33 VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLL-- 90
Query: 199 DMTSRNSCTQLWLVTHY--HSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGT 256
++ + + +LV + H+ + L++ + K I+NG+ H
Sbjct: 91 EVCKKKK--RWYLVFEFVDHTILDDLEL-FPNGLDYQVVQKYLFQIINGIGFCH------ 141
Query: 257 QGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNP---RVGTKRYMS 313
I HRDIK +NILV +G + DFG A + + P V T+ Y +
Sbjct: 142 --SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLA-------APGEVYDDEVATRWYRA 192
Query: 314 PEIL 317
PE+L
Sbjct: 193 PELL 196
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 2e-13
Identities = 39/217 (17%), Positives = 83/217 (38%), Gaps = 41/217 (18%)
Query: 140 LSECIGKGRYGEVWRGVWH---GENVAVKI-----FFSRDEASWSRETEIYSTVLLRHEN 191
S+ +G+G++ V + + G+ A K A E +
Sbjct: 33 TSKELGRGKFAVVRQCI-SKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLEL-AKSCPR 90
Query: 192 ILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHL---NRTTLNHHQMMKICLSIVNGLVH 248
++ + + L+ Y + G ++ ++ + ++++ I+ G+ +
Sbjct: 91 VINLHEVYENTSE----IILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYY 146
Query: 249 LHTEIFGTQGKPAIAHRDIKSKNILVKT---NGTCVIADFGLAVSYSQLSNKMDIPPNPR 305
LH I H D+K +NIL+ + G I DFG++ +I
Sbjct: 147 LHQ-----NN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREI----- 193
Query: 306 VGTKRYMSPEILD-ESINMDCFESFKKADIYALGLVL 341
+GT Y++PEIL+ + I D++ +G++
Sbjct: 194 MGTPEYLAPEILNYDPIT-------TATDMWNIGIIA 223
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 3e-13
Identities = 54/228 (23%), Positives = 84/228 (36%), Gaps = 48/228 (21%)
Query: 144 IGKGRYGEVWRGVWH---GENVAVKIF----------FSRDEASWSRETEIYSTV----- 185
IGKG YG V + A+K+ F R +
Sbjct: 21 IGKGSYGVVKLAY-NENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 186 ------------LLRHENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHH 233
L H N++ + ++ + L++V + G + + L+
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKLV--EVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSED 137
Query: 234 QMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQ 293
Q ++ G+ +LH Q I HRDIK N+LV +G IADFG+ S
Sbjct: 138 QARFYFQDLIKGIEYLHY-----QK---IIHRDIKPSNLLVGEDGHIKIADFGV----SN 185
Query: 294 LSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVL 341
D + VGT +M+PE L S F K D++A+G+ L
Sbjct: 186 EFKGSDALLSNTVGTPAFMAPESL--SETRKIFSG-KALDVWAMGVTL 230
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 4e-13
Identities = 56/211 (26%), Positives = 88/211 (41%), Gaps = 40/211 (18%)
Query: 144 IGKGRYGEVWRGVWH---GENVAVKIF----FSRDEASWSRETEIYSTVLLRHENILGYI 196
+G+G YGEV V + E VAVKI + +E I +L HEN++ +
Sbjct: 15 LGEGAYGEVQLAV-NRVTEEAVAVKIVDMKRAVDCPENIKKEICINK--MLNHENVVKFY 71
Query: 197 GSDMTSRNSCTQLWLVTHYHSFGSLYDHL-NRTTLNHHQMMKICLSIVNGLVHLHTEIFG 255
G +L Y S G L+D + + + ++ G+V+LH
Sbjct: 72 GH-RREG---NIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI--- 124
Query: 256 TQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPE 315
I HRDIK +N+L+ I+DFGLA + N + N GT Y++PE
Sbjct: 125 -----GITHRDIKPENLLLDERDNLKISDFGLATVFRY--NNRERLLNKMCGTLPYVAPE 177
Query: 316 ILDESINMDCFESFK-----KADIYALGLVL 341
+L + D+++ G+VL
Sbjct: 178 LL----------KRREFHAEPVDVWSCGIVL 198
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 6e-13
Identities = 58/225 (25%), Positives = 86/225 (38%), Gaps = 41/225 (18%)
Query: 142 ECIGKGRYGEVWRGV-WHGENVAVK-IFFSRDEASWSR--ETEIYSTVLLR--------- 188
I G YG V GV G VA+K +F + + +LR
Sbjct: 28 RFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH 87
Query: 189 HENILGYIGSDM---TSRNSCTQLWLVTHYHSFGSLYD--HLNRTTLNHHQMMKICLSIV 243
H NILG D+ + +L+LVT L H R ++ + I+
Sbjct: 88 HPNILGLR--DIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHIL 144
Query: 244 NGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPN 303
GL LH + HRD+ NIL+ N I DF LA + +NK
Sbjct: 145 LGLHVLHEA--------GVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTH---- 192
Query: 304 PRVGTKRYMSPEILDESINMDCFESFKKA-DIYALGLVLWEVCRR 347
V + Y +PE+ + F+ F K D+++ G V+ E+ R
Sbjct: 193 -YVTHRWYRAPEL------VMQFKGFTKLVDMWSAGCVMAEMFNR 230
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 7e-13
Identities = 51/190 (26%), Positives = 73/190 (38%), Gaps = 31/190 (16%)
Query: 144 IGKGRYGEVWRG--VWHGENVAVK--IFFSRDEASWS------RETEIYSTV-LLRHENI 192
IG G YG V++ G VA+K + RE + + H N+
Sbjct: 17 IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76
Query: 193 LGYIGSDMTSRNSC-TQLWLVTHY--HSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHL 249
+ + TSR ++ LV + + D L + + + GL L
Sbjct: 77 VRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFL 136
Query: 250 HTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPN--PRVG 307
H I HRD+K +NILV + GT +ADFGLA YS P V
Sbjct: 137 HAN--------CIVHRDLKPENILVTSGGTVKLADFGLARIYS-------YQMALTPVVV 181
Query: 308 TKRYMSPEIL 317
T Y +PE+L
Sbjct: 182 TLWYRAPEVL 191
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 68.0 bits (165), Expect = 9e-13
Identities = 30/199 (15%), Positives = 54/199 (27%), Gaps = 51/199 (25%)
Query: 137 QISLSECIGKGRYGEVWRGVWHGENVAVKIFFSRDEASW-----SRETEIYSTVLL---- 187
++ E IG+G +GEV++ + VA+KI EI +++
Sbjct: 21 KLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKEL 80
Query: 188 ---------RHENILGYIG--------------------------SDMTSRNSCTQLWLV 212
R E +G +D QL++V
Sbjct: 81 SLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIV 140
Query: 213 THYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNI 272
+ G + + + I + L HRD+ N+
Sbjct: 141 LEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA-------SLRFEHRDLHWGNV 193
Query: 273 LVKTNGTCVIADFGLAVSY 291
L+K + S
Sbjct: 194 LLKKTSLKKLHYTLNGKSS 212
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 1e-12
Identities = 56/207 (27%), Positives = 85/207 (41%), Gaps = 35/207 (16%)
Query: 144 IGKGRYGEVW--RGVWHGENVAVKIFFSRDEASWSR-ETEIYSTVLLRHENILGY---IG 197
IG G +G R E VAVK R A + EI + LRH NI+ + I
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYI-ERGAAIDENVQREIINHRSLRHPNIVRFKEVIL 86
Query: 198 SDMTSRNSCTQLWLVTHYHSFGSLYDHL-NRTTLNHHQMMKICLSIVNGLVHLHTEIFGT 256
+ T L ++ Y S G LY+ + N + + +++G+ + H
Sbjct: 87 TP-------THLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCH------ 133
Query: 257 QGKPAIAHRDIKSKNILVKTNGTCV--IADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSP 314
I HRD+K +N L+ + I DFG + S P VGT Y++P
Sbjct: 134 --SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-----HSQPKSTVGTPAYIAP 186
Query: 315 EILDESINMDCFESFKKADIYALGLVL 341
E+L D K AD+++ G+ L
Sbjct: 187 EVL-LRQEYDG----KIADVWSCGVTL 208
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 68.7 bits (168), Expect = 1e-12
Identities = 57/223 (25%), Positives = 86/223 (38%), Gaps = 60/223 (26%)
Query: 144 IGKGRYGEVW--RGVWHGENVAVKIF-----FSRDEASWSRETEIYSTVLLRHENILGYI 196
+GKG +GEV + G+ A K R + + E + IL +
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMAL-NE---------KQILEKV 241
Query: 197 GSD-MTSRNSCTQ----LWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLS---------- 241
S + S + L LV + G L H+ + M +
Sbjct: 242 NSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHI-------YHMGQAGFPEARAVFYAAE 294
Query: 242 IVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIP 301
I GL LH E I +RD+K +NIL+ +G I+D GLAV +
Sbjct: 295 ICCGLEDLHRE--------RIVYRDLKPENILLDDHGHIRISDLGLAVHVPE-----GQT 341
Query: 302 PNPRVGTKRYMSPEILDESINMDCFESFKKA-DIYALGLVLWE 343
RVGT YM+PE++ E + + D +ALG +L+E
Sbjct: 342 IKGRVGTVGYMAPEVVKN-------ERYTFSPDWWALGCLLYE 377
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 1e-12
Identities = 54/219 (24%), Positives = 80/219 (36%), Gaps = 44/219 (20%)
Query: 144 IGKGRYGEVW--RGVWHGENVAVKIF-----FSRDEASWSR-ETEIYSTVLLRHENILGY 195
IG+G + EV + G+ A+KI R E S R E ++ I
Sbjct: 69 IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNG--DRRWITQL 126
Query: 196 IGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLS----------IVNG 245
+ L+LV Y+ G L L++ + IV
Sbjct: 127 HFAFQDENY----LYLVMEYYVGGDLLTLLSK--------FGERIPAEMARFYLAEIVMA 174
Query: 246 LVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPR 305
+ +H + HRDIK NIL+ G +ADFG + +L +
Sbjct: 175 IDSVH--------RLGYVHRDIKPDNILLDRCGHIRLADFGSCL---KLRADGTVRSLVA 223
Query: 306 VGTKRYMSPEILDESINMDCFESFKKA-DIYALGLVLWE 343
VGT Y+SPEIL S+ D +ALG+ +E
Sbjct: 224 VGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYE 262
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 66.8 bits (164), Expect = 2e-12
Identities = 51/190 (26%), Positives = 80/190 (42%), Gaps = 41/190 (21%)
Query: 144 IGKGRYGEVWRG--VWHGENVAVKIFFSRDEASWSRETE-IYSTVL--------LRHENI 192
IG+G YG V++ GE VA+K + ETE + ST + L H NI
Sbjct: 11 IGEGTYGVVYKARNKLTGEVVALK------KIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 193 LGYIGSDMTSRNSCTQLWLVTHY--HSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLH 250
+ + D+ + +L+LV + D T + + ++ GL H
Sbjct: 65 VKLL--DVIHTEN--KLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 251 TEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNP---RVG 307
+ + HRD+K +N+L+ T G +ADFGLA ++ +P V
Sbjct: 121 SH--------RVLHRDLKPQNLLINTEGAIKLADFGLARAFG-------VPVRTYTHEVV 165
Query: 308 TKRYMSPEIL 317
T Y +PEIL
Sbjct: 166 TLWYRAPEIL 175
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 67.5 bits (165), Expect = 2e-12
Identities = 43/191 (22%), Positives = 75/191 (39%), Gaps = 29/191 (15%)
Query: 144 IGKGRYGEVWRGVWH----GENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIGSD 199
+G+G YG V++ ++ A+K S S EI L+H N++
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQI-EGTGISMSACREIALLRELKHPNVISLQ--K 85
Query: 200 MTSRNSCTQLWLVTHY---------HSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLH 250
+ ++ ++WL+ Y + + L + + I++G+ +LH
Sbjct: 86 VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 145
Query: 251 TEIFGTQGKPAIAHRDIKSKNILVKT----NGTCVIADFGLAVSYSQLSNKMDIPPNPRV 306
+ HRD+K NILV G IAD G A ++ + +P V
Sbjct: 146 AN--------WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLA-DLDPVV 196
Query: 307 GTKRYMSPEIL 317
T Y +PE+L
Sbjct: 197 VTFWYRAPELL 207
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 2e-12
Identities = 49/224 (21%), Positives = 92/224 (41%), Gaps = 39/224 (17%)
Query: 142 ECIGKGRYGEVWRGVWH--GENVAVK---IFFSRDEASWS-RETEIYSTVLLRHENILGY 195
+G+G YG V GE VA+K F A + RE +I +HENI+
Sbjct: 17 SLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILK--HFKHENIITI 74
Query: 196 IGSDM---TSRNSCTQLWLVTHYHSFGS-LYDHLNRTTLNHHQMMKICLSIVNGLVHLHT 251
++ S + +++++ + L+ ++ L+ + + + LH
Sbjct: 75 F--NIQRPDSFENFNEVYIIQEL--MQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHG 130
Query: 252 EIFGTQGKPA-IAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPR----- 305
+ + HRD+K N+L+ +N + DFGLA + + P +
Sbjct: 131 ---------SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVE 181
Query: 306 -VGTKRYMSPEILDESINMDCFESFKKA-DIYALGLVLWEVCRR 347
V T+ Y +PE+ M + +A D+++ G +L E+ R
Sbjct: 182 FVATRWYRAPEV------MLTSAKYSRAMDVWSCGCILAELFLR 219
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 67.5 bits (165), Expect = 2e-12
Identities = 53/218 (24%), Positives = 86/218 (39%), Gaps = 47/218 (21%)
Query: 144 IGKGRYGEVW--RGVWHGENVAVKIF-----FSRDEASWSRETEIYSTVLLRHENILGYI 196
+G+G +GEV+ + G+ A K R + E + IL +
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAM-VE---------KKILAKV 242
Query: 197 GSD-MTSRNSCTQ----LWLVTHYHSFGSLYDHLNRTTLNHH----QMMKICLS-IVNGL 246
S + S + L LV + G + H+ ++ + IV+GL
Sbjct: 243 HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGL 302
Query: 247 VHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRV 306
HLH I +RD+K +N+L+ +G I+D GLAV K
Sbjct: 303 EHLHQR--------NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK----TKGYA 350
Query: 307 GTKRYMSPEILDESINMDCFESFKKA-DIYALGLVLWE 343
GT +M+PE+L E + + D +ALG+ L+E
Sbjct: 351 GTPGFMAPELLLG-------EEYDFSVDYFALGVTLYE 381
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 67.2 bits (164), Expect = 3e-12
Identities = 54/213 (25%), Positives = 93/213 (43%), Gaps = 32/213 (15%)
Query: 144 IGKGRYGEVWRGV--WHGENVAVK----IFFSRDEASWS-RETEIYSTVLLRHENILG-- 194
IG G G V NVA+K F ++ A + RE + + H+NI+
Sbjct: 70 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMK--CVNHKNIISLL 127
Query: 195 YIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIF 254
+ + + ++LV + + + L+H +M + ++ G+ HLH+
Sbjct: 128 NVFTPQKTLEEFQDVYLVMEL--MDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA-- 183
Query: 255 GTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSP 314
I HRD+K NI+VK++ T I DFGLA + S M P V T+ Y +P
Sbjct: 184 ------GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMM----TPYVVTRYYRAP 232
Query: 315 EILDESINMDCFESFKKADIYALGLVLWEVCRR 347
E+ + + DI+++G ++ E+ R
Sbjct: 233 EV------ILGMGYKENVDIWSVGCIMGEMVRH 259
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 3e-12
Identities = 52/213 (24%), Positives = 92/213 (43%), Gaps = 32/213 (15%)
Query: 144 IGKGRYGEVWRGV--WHGENVAVK----IFFSRDEASWS-RETEIYSTVLLRHENILG-- 194
IG G G V NVA+K F ++ A + RE + + H+NI+G
Sbjct: 33 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMK--CVNHKNIIGLL 90
Query: 195 YIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIF 254
+ + S +++V +L + + L+H +M + ++ G+ HLH+
Sbjct: 91 NVFTPQKSLEEFQDVYIVMELMDA-NLCQVI-QMELDHERMSYLLYQMLCGIKHLHSA-- 146
Query: 255 GTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSP 314
I HRD+K NI+VK++ T I DFGLA + V T+ Y +P
Sbjct: 147 ------GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP-----YVVTRYYRAP 195
Query: 315 EILDESINMDCFESFKKADIYALGLVLWEVCRR 347
E+ + + DI+++G ++ E+ +
Sbjct: 196 EV------ILGMGYKENVDIWSVGCIMGEMIKG 222
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 4e-12
Identities = 47/213 (22%), Positives = 90/213 (42%), Gaps = 33/213 (15%)
Query: 144 IGKGRYGEVWRGV--WHGENVAVK----IFFSRDEASWS-RETEIYSTVLLRHENILG-- 194
+G G YG V + GE VA+K F S A + RE + ++HEN++G
Sbjct: 32 VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLK--HMQHENVIGLL 89
Query: 195 YIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIF 254
+ + +S + +LV + + + + ++ + ++ GL ++H+
Sbjct: 90 DVFTPASSLRNFYDFYLVMPF--MQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSA-- 145
Query: 255 GTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSP 314
+ HRD+K N+ V + I DFGLA +M V T+ Y +P
Sbjct: 146 ------GVVHRDLKPGNLAVNEDCELKILDFGLARHA---DAEM----TGYVVTRWYRAP 192
Query: 315 EILDESINMDCFESFKKADIYALGLVLWEVCRR 347
E++ + + DI+++G ++ E+
Sbjct: 193 EVI-----LSWMHYNQTVDIWSVGCIMAEMLTG 220
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 65.2 bits (159), Expect = 5e-12
Identities = 24/212 (11%), Positives = 48/212 (22%), Gaps = 60/212 (28%)
Query: 140 LSECIGKGRYGEVWRGV--WHGENVAVKIF---FSRDEASWSR-ETEIYSTVLLRHENIL 193
L G + W+ + VA+ + + + +
Sbjct: 35 LLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVA 94
Query: 194 G-Y-IGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHT 251
+ +V + GSL + T+ + ++ S+ H
Sbjct: 95 RVLDVVHTRA------GGLVVAEWIRGGSLQEVA-DTSPSPVGAIRAMQSLAAAADAAHR 147
Query: 252 EIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRY 311
G +A + V +G V+A NP+
Sbjct: 148 -----AG---VALSIDHPSRVRVSIDGDVVLAYPATMP-----------DANPQ------ 182
Query: 312 MSPEILDESINMDCFESFKKADIYALGLVLWE 343
DI +G L+
Sbjct: 183 --------------------DDIRGIGASLYA 194
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 5e-12
Identities = 50/240 (20%), Positives = 82/240 (34%), Gaps = 50/240 (20%)
Query: 130 IQRTLAKQISLSECIGKGRYGEVWRGVWH--GENVAVK-IFFSRDEASWSRE-TEIYSTV 185
R + + G+G +G V G G +VA+K + + RE +
Sbjct: 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRN--RELQIMQDLA 74
Query: 186 LLRHENILG---YIGSDMTSRNSCTQLWLVTHY-----HSFGSLYDHLNRT-TLNH---- 232
+L H NI+ Y + L +V Y H Y
Sbjct: 75 VLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVF 134
Query: 233 -HQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILV-KTNGTCVIADFGLAVS 290
Q+++ + LH + HRDIK N+LV + +GT + DFG A
Sbjct: 135 LFQLIR-------SIGCLHLPSVN------VCHRDIKPHNVLVNEADGTLKLCDFGSA-- 179
Query: 291 YSQLSNKMDIPPNPRVG---TKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRR 347
K P P V ++ Y +PE++ DI+++G + E+
Sbjct: 180 ------KKLSPSEPNVAYICSRYYRAPELI-----FGNQHYTTAVDIWSVGCIFAEMMLG 228
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 7e-12
Identities = 44/210 (20%), Positives = 90/210 (42%), Gaps = 31/210 (14%)
Query: 144 IGKGRYGEVW--RGVWHGENVAVKIF-----FSRDEASWSR-ETEIYSTVLLRHENILGY 195
IG+G +GEV R + A+K+ R ++++ E +I + ++
Sbjct: 77 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA--NSPWVVQL 134
Query: 196 IGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLS-IVNGLVHLHTEIF 254
+ R L++V Y G L + ++ + + + +V L +H
Sbjct: 135 FYAFQDDRY----LYMVMEYMPGGDLVNLMSNYDVPEK-WARFYTAEVVLALDAIH---- 185
Query: 255 GTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSP 314
HRD+K N+L+ +G +ADFG + +++ + + + VGT Y+SP
Sbjct: 186 ----SMGFIHRDVKPDNMLLDKSGHLKLADFGTCM---KMNKEGMVRCDTAVGTPDYISP 238
Query: 315 EILDESINMDCFESFKKA-DIYALGLVLWE 343
E+L + + + D +++G+ L+E
Sbjct: 239 EVLK---SQGGDGYYGRECDWWSVGVFLYE 265
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 7e-12
Identities = 49/207 (23%), Positives = 83/207 (40%), Gaps = 47/207 (22%)
Query: 131 QRTLAKQISLSECIGKGRYGEVWRGVWH--GENVAVK-IFFSRDEASWSRETEIYSTVLL 187
R + ++ IG G +G V++ GE VA+K + +D+ +RE +I L
Sbjct: 49 DRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL--QDKRFKNRELQIMR--KL 104
Query: 188 RHENI--LGYIGSDMTSRNSCTQLWLVTHY-----HSFGSLYDHLNRT-TLNH-----HQ 234
H NI L Y + L LV Y + Y +T + + +Q
Sbjct: 105 DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 164
Query: 235 MMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTN-GTCVIADFGLAVSYSQ 293
+ + L ++H+ G I HRDIK +N+L+ + + DFG A
Sbjct: 165 LFR-------SLAYIHS-----FG---ICHRDIKPQNLLLDPDTAVLKLCDFGSA----- 204
Query: 294 LSNKMDIPPNPRVG---TKRYMSPEIL 317
K + P V ++ Y +PE++
Sbjct: 205 ---KQLVRGEPNVSYICSRYYRAPELI 228
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 8e-12
Identities = 51/213 (23%), Positives = 90/213 (42%), Gaps = 32/213 (15%)
Query: 144 IGKGRYGEVWRGV--WHGENVAVK----IFFSRDEASWS-RETEIYSTVLLRHENILG-- 194
+G G YG V V G VA+K F S A + RE + +RHEN++G
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLK--HMRHENVIGLL 90
Query: 195 YIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIF 254
+ + + + T +LV + L + L ++ + ++ GL ++H
Sbjct: 91 DVFTPDETLDDFTDFYLVMPFMG-TDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAA-- 147
Query: 255 GTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSP 314
I HRD+K N+ V + I DFGLA ++M V T+ Y +P
Sbjct: 148 ------GIIHRDLKPGNLAVNEDCELKILDFGLARQA---DSEM----TGYVVTRWYRAP 194
Query: 315 EILDESINMDCFESFKKADIYALGLVLWEVCRR 347
E++ ++ + DI+++G ++ E+
Sbjct: 195 EVI-----LNWMRYTQTVDIWSVGCIMAEMITG 222
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 8e-12
Identities = 51/195 (26%), Positives = 81/195 (41%), Gaps = 43/195 (22%)
Query: 144 IGKGRYGEVWRGV---WHGENVAVK-IFFSRDE----ASWSRETEIYSTVLLR------H 189
IG+G YG+V++ G VA+K + E S RE +LR H
Sbjct: 19 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVA-----VLRHLETFEH 73
Query: 190 ENILGYIGSDM---TSRNSCTQLWLVTHY--HSFGSLYDHLNRTTLNHHQMMKICLSIVN 244
N++ D+ + + T+L LV + + D + + + + ++
Sbjct: 74 PNVVRLF--DVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLR 131
Query: 245 GLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPN- 303
GL LH+ + HRD+K +NILV ++G +ADFGLA YS
Sbjct: 132 GLDFLHSH--------RVVHRDLKPQNILVTSSGQIKLADFGLARIYS-------FQMAL 176
Query: 304 -PRVGTKRYMSPEIL 317
V T Y +PE+L
Sbjct: 177 TSVVVTLWYRAPEVL 191
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 9e-12
Identities = 47/226 (20%), Positives = 80/226 (35%), Gaps = 41/226 (18%)
Query: 142 ECIGKGRYGEVWRGV--WHGENVAVK--IFFSRDEASWS-RETEIYSTVLLRHENILGYI 196
+ +G G G V+ V + VA+K + + RE +I L H+NI+
Sbjct: 17 KPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIR--RLDHDNIVKVF 74
Query: 197 GSDMTSRNSCTQLWLVTHYHSFGSLY--------D-----HLNRTTLNHHQMMKICLSIV 243
++ + V S+Y D H ++ ++
Sbjct: 75 --EILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARL--FMYQLL 130
Query: 244 NGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCV--IADFGLAVSYSQLSNKMDIP 301
GL ++H+ + HRD+K N+ + T V I DFGLA +
Sbjct: 131 RGLKYIHSA--------NVLHRDLKPANLFINTE-DLVLKIGDFGLARIMDPHYSHKGHL 181
Query: 302 PNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRR 347
+ TK Y SP +L + K D++A G + E+
Sbjct: 182 S-EGLVTKWYRSPRLL-----LSPNNYTKAIDMWAAGCIFAEMLTG 221
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 64.5 bits (158), Expect = 1e-11
Identities = 50/187 (26%), Positives = 76/187 (40%), Gaps = 37/187 (19%)
Query: 144 IGKGRYGEVWRGVWH--GENVAVK-IFFSRDE---ASWSRETEIYSTVL--LRHENILGY 195
+G+G Y V++G VA+K I +E + RE + L L+H NI+
Sbjct: 10 LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSL----LKDLKHANIVTL 65
Query: 196 IGSDMTSRNSCTQLWLVTHY--HSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEI 253
T ++ L LV Y D +N H + ++ GL + H
Sbjct: 66 HDIIHTEKS----LTLVFEYLDKDLKQYLDDCG-NIINMHNVKLFLFQLLRGLAYCH--- 117
Query: 254 FGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNP---RVGTKR 310
+ + HRD+K +N+L+ G +ADFGLA + S IP V T
Sbjct: 118 -----RQKVLHRDLKPQNLLINERGELKLADFGLARAKS-------IPTKTYDNEVVTLW 165
Query: 311 YMSPEIL 317
Y P+IL
Sbjct: 166 YRPPDIL 172
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 1e-11
Identities = 35/158 (22%), Positives = 62/158 (39%), Gaps = 21/158 (13%)
Query: 140 LSECIGKGRYGEVWRGVWH---GENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYI 196
S+ +G G G+V + + E A+K+ +D RE E++ + +I+ +
Sbjct: 22 TSQVLGLGINGKVLQIF-NKRTQEKFALKML--QDCPKARREVELHWR-ASQCPHIVRIV 77
Query: 197 GSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNH---HQMMKICLSIVNGLVHLHTEI 253
L +V G L+ + + +I SI + +LH+
Sbjct: 78 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS-- 135
Query: 254 FGTQGKPAIAHRDIKSKNILVKT---NGTCVIADFGLA 288
IAHRD+K +N+L + N + DFG A
Sbjct: 136 ---IN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 167
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 2e-11
Identities = 39/226 (17%), Positives = 71/226 (31%), Gaps = 57/226 (25%)
Query: 140 LSECIGKGRYGEVWRGVWH---GENVAVKIFFSRDEASWSR-------ETEIYSTVLLRH 189
+ +G G +G V+ G+ VA+K + W E+ +
Sbjct: 47 VGPLLGSGGFGSVYSGI-RVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 105
Query: 190 E--NILG---YIGSDMTSRNSCTQLWLVTHYHS-FGSLYDHL-NRTTLNHHQMMKICLSI 242
++ + L+ L+D + R L +
Sbjct: 106 GFSGVIRLLDWFERP-------DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 158
Query: 243 VNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCV-IADFGLAVSYSQLSNKM-DI 300
+ + H H + HRDIK +NIL+ N + + DFG + D
Sbjct: 159 LEAVRHCHNC--------GVLHRDIKDENILIDLNRGELKLIDFG-------SGALLKDT 203
Query: 301 PPNPRVGTKRYMSPEILDESINMDCFESFK-----KADIYALGLVL 341
GT+ Y PE + + A +++LG++L
Sbjct: 204 VYTDFDGTRVYSPPEWI----------RYHRYHGRSAAVWSLGILL 239
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 2e-11
Identities = 54/215 (25%), Positives = 94/215 (43%), Gaps = 42/215 (19%)
Query: 143 CIGKGRYGEVW--RGVWHGENVAVKIF-----FSRDEASWSR-ETEIYSTVLLRHENILG 194
+GKG +G+V + G A+KI ++DE + + E + RH +
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS--RHPFLTA 212
Query: 195 YIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKI-CLSIVNGLVHLHTEI 253
S T +L V Y + G L+ HL+R + + IV+ L +LH+E
Sbjct: 213 LKYSFQTH----DRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK 268
Query: 254 FGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRV----GTK 309
+ +RD+K +N+++ +G I DFGL K I + GT
Sbjct: 269 -------NVVYRDLKLENLMLDKDGHIKITDFGLC--------KEGIKDGATMKTFCGTP 313
Query: 310 RYMSPEILDESINMDCFESFKKA-DIYALGLVLWE 343
Y++PE+L++ + +A D + LG+V++E
Sbjct: 314 EYLAPEVLED-------NDYGRAVDWWGLGVVMYE 341
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 2e-11
Identities = 54/215 (25%), Positives = 91/215 (42%), Gaps = 32/215 (14%)
Query: 142 ECIGKGRYGEVW--RGVWHGENVAVK----IFFSRDEASWS-RETEIYSTVLLRHENILG 194
+G G YG V G VAVK F S A + RE + ++HEN++G
Sbjct: 35 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK--HMKHENVIG 92
Query: 195 --YIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTE 252
+ + S ++LVTH L + + L + + I+ GL ++H+
Sbjct: 93 LLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 151
Query: 253 IFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYM 312
I HRD+K N+ V + I DFGLA +++M V T+ Y
Sbjct: 152 --------DIIHRDLKPSNLAVNEDCELKILDFGLARHT---ADEMT----GYVATRWYR 196
Query: 313 SPEILDESINMDCFESFKKADIYALGLVLWEVCRR 347
+PEI+ ++ + DI+++G ++ E+
Sbjct: 197 APEIM-----LNWMHYNQTVDIWSVGCIMAELLTG 226
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 3e-11
Identities = 53/215 (24%), Positives = 84/215 (39%), Gaps = 38/215 (17%)
Query: 144 IGKGRYGEVW--RGVWHGENVAVKIF-----FSRDEASWSR-ETEIYSTVLLRHENILGY 195
IG+G +GEV + + A+KI R E + R E ++ + I
Sbjct: 82 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG--DSKWITTL 139
Query: 196 IGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLN-HHQMMKICLS-IVNGLVHLHTEI 253
+ N L+LV Y+ G L L++ +M + L+ +V + +H
Sbjct: 140 HYAFQDDNN----LYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVH--- 192
Query: 254 FGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPR-----VGT 308
+ HRDIK NIL+ NG +ADFG + VGT
Sbjct: 193 -----QLHYVHRDIKPDNILMDMNGHIRLADFGSC--------LKLMEDGTVQSSVAVGT 239
Query: 309 KRYMSPEILDESINMDCFESFKKADIYALGLVLWE 343
Y+SPEIL + D ++LG+ ++E
Sbjct: 240 PDYISPEILQAMEGGKGRYG-PECDWWSLGVCMYE 273
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 4e-11
Identities = 52/253 (20%), Positives = 94/253 (37%), Gaps = 52/253 (20%)
Query: 114 LDASLTSGSGSGLPLLIQRTLAKQISLS-------ECIGKGRYGEVW--RGVWHGENVAV 164
+D + L + + + +G+G + V R + A+
Sbjct: 1 MDGTAAEPRPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAI 60
Query: 165 KIFFSRDEASWSRETEIYST-----VL--LRHENILGYIGSDMTSRNSCTQLWLVTHYHS 217
KI ++ +E ++ V+ L H + + L+ Y
Sbjct: 61 KIL---EKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEK----LYFGLSYAK 113
Query: 218 FGSLYDHLNRTTLNHHQMMKICLS-IVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKT 276
G L ++ + + + IV+ L +LH +G I HRD+K +NIL+
Sbjct: 114 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG-----KG---IIHRDLKPENILLNE 165
Query: 277 NGTCVIADFGLAVSYSQLSNK--MDIPPNPR----VGTKRYMSPEILDESINMDCFESFK 330
+ I DFG A K R VGT +Y+SPE+L E + K
Sbjct: 166 DMHIQITDFGTA--------KVLSPESKQARANSFVGTAQYVSPELLTEK------SACK 211
Query: 331 KADIYALGLVLWE 343
+D++ALG ++++
Sbjct: 212 SSDLWALGCIIYQ 224
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 5e-11
Identities = 52/189 (27%), Positives = 79/189 (41%), Gaps = 41/189 (21%)
Query: 144 IGKGRYGEVWRGV-WHGENVAVKIFFSRDEASWSRETE-IYSTVL--------LRHENIL 193
+G+G YG V++ G VA+K E E I ST + L H NI+
Sbjct: 29 VGEGTYGVVYKAKDSQGRIVALK------RIRLDAEDEGIPSTAIREISLLKELHHPNIV 82
Query: 194 GYIGSDMTSRNSCTQLWLVTHY--HSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHT 251
I D+ L LV + + D N+T L Q+ ++ G+ H H
Sbjct: 83 SLI--DVIHSER--CLTLVFEFMEKDLKKVLDE-NKTGLQDSQIKIYLYQLLRGVAHCHQ 137
Query: 252 EIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNP---RVGT 308
I HRD+K +N+L+ ++G +ADFGLA ++ IP V T
Sbjct: 138 H--------RILHRDLKPQNLLINSDGALKLADFGLARAFG-------IPVRSYTHEVVT 182
Query: 309 KRYMSPEIL 317
Y +P++L
Sbjct: 183 LWYRAPDVL 191
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 5e-11
Identities = 46/195 (23%), Positives = 83/195 (42%), Gaps = 46/195 (23%)
Query: 142 ECIGKGRYGEVWRGV-WHGENVAVK-IFFSRDEASWSRETEIYSTVLLRHENI--LGYIG 197
+ IG G +G V++ + VA+K + +D+ +RE +I +++H N+ L
Sbjct: 46 KVIGNGSFGVVFQAKLVESDEVAIKKVL--QDKRFKNRELQIMR--IVKHPNVVDLKAFF 101
Query: 198 SDMTSRNSCTQLWLVTHY-----HSFGSLYDHLNRT-TLNH-----HQMMKICLSIVNGL 246
+ L LV Y + Y L +T + +Q+++ L
Sbjct: 102 YSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLR-------SL 154
Query: 247 VHLHTEIFGTQGKPAIAHRDIKSKNILV-KTNGTCVIADFGLAVSYSQLSNKMDIPPNPR 305
++H+ G I HRDIK +N+L+ +G + DFG A K+ I P
Sbjct: 155 AYIHS-----IG---ICHRDIKPQNLLLDPPSGVLKLIDFGSA--------KILIAGEPN 198
Query: 306 VG---TKRYMSPEIL 317
V ++ Y +PE++
Sbjct: 199 VSYICSRYYRAPELI 213
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 62.1 bits (152), Expect = 6e-11
Identities = 50/189 (26%), Positives = 78/189 (41%), Gaps = 41/189 (21%)
Query: 144 IGKGRYGEVWRGVWH-GENVAVKIFFSRDEASWSRETE-IYSTVL--------LRHENIL 193
IG+G YG V++ + GE A+K + +E E I ST + L+H NI+
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALK------KIRLEKEDEGIPSTTIREISILKELKHSNIV 63
Query: 194 GYIGSDMTSRNSCTQLWLVTHY--HSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHT 251
D+ +L LV + L D L L ++NG+ + H
Sbjct: 64 KLY--DVIHTKK--RLVLVFEHLDQDLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHD 118
Query: 252 EIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNP---RVGT 308
+ HRD+K +N+L+ G IADFGLA ++ IP + T
Sbjct: 119 R--------RVLHRDLKPQNLLINREGELKIADFGLARAFG-------IPVRKYTHEIVT 163
Query: 309 KRYMSPEIL 317
Y +P++L
Sbjct: 164 LWYRAPDVL 172
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 61.8 bits (151), Expect = 6e-11
Identities = 53/218 (24%), Positives = 90/218 (41%), Gaps = 55/218 (25%)
Query: 144 IGKGRYGEVWRGVWH---GENVAVKIF------FSRDEASWSRETEIYSTVLLRHENILG 194
+G G +G+V G H G VAVKI RE + L RH +I+
Sbjct: 19 LGVGTFGKVKIGE-HQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLK--LFRHPHIIK 75
Query: 195 -Y--IGSDMTSRNSCTQLWLVTHYHSFGSLYDHL-NRTTLNHHQMMKICLSIVNGLVHLH 250
Y I + T ++V Y S G L+D++ + + ++ I++ + + H
Sbjct: 76 LYQVISTP-------TDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCH 128
Query: 251 TEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKM--DIPPNPRVGT 308
+ + HRD+K +N+L+ + IADFG LSN M G+
Sbjct: 129 --------RHMVVHRDLKPENVLLDAHMNAKIADFG-------LSNMMSDGEFLRTSCGS 173
Query: 309 KRYMSPEILDESINMDCFESFK-----KADIYALGLVL 341
Y +PE++ S + + DI++ G++L
Sbjct: 174 PNYAAPEVI----------SGRLYAGPEVDIWSCGVIL 201
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 61.8 bits (151), Expect = 7e-11
Identities = 47/190 (24%), Positives = 78/190 (41%), Gaps = 42/190 (22%)
Query: 144 IGKGRYGEVWRG--VWHGENVAVKIFFSRDEASWSRETE-IYSTVL--------LRHENI 192
IG+G YG V++ E VA+K + E + S+ L L+H+NI
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALK------RVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 193 LGYIGSDMTSRNSCTQLWLVTHY--HSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLH 250
+ D+ + +L LV + +D N L+ + ++ GL H
Sbjct: 64 VRLH--DVLHSDK--KLTLVFEFCDQDLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCH 118
Query: 251 TEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNP---RVG 307
+ + HRD+K +N+L+ NG +A+FGLA ++ IP V
Sbjct: 119 SR--------NVLHRDLKPQNLLINRNGELKLANFGLARAFG-------IPVRCYSAEVV 163
Query: 308 TKRYMSPEIL 317
T Y P++L
Sbjct: 164 TLWYRPPDVL 173
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 61.8 bits (151), Expect = 7e-11
Identities = 47/191 (24%), Positives = 75/191 (39%), Gaps = 40/191 (20%)
Query: 144 IGKGRYGEVWRG--VWHGENVAVK-IFFSRDE---ASWSRETEIYSTVL--LRHENILGY 195
+G G Y V++G G VA+K + +E ++ RE + + L+HENI+
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISL----MKELKHENIVRL 68
Query: 196 IGSDMTSRNSCTQLWLVTHY--HSFGSLYDHLNRTT----LNHHQMMKICLSIVNGLVHL 249
T L LV + + D L + + ++ GL
Sbjct: 69 YDVIHTENK----LTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFC 124
Query: 250 HTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNP---RV 306
H I HRD+K +N+L+ G + DFGLA ++ IP N V
Sbjct: 125 HENK--------ILHRDLKPQNLLINKRGQLKLGDFGLARAFG-------IPVNTFSSEV 169
Query: 307 GTKRYMSPEIL 317
T Y +P++L
Sbjct: 170 VTLWYRAPDVL 180
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 8e-11
Identities = 48/197 (24%), Positives = 81/197 (41%), Gaps = 43/197 (21%)
Query: 144 IGKGRYGEVWRGV--WHGENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIGSD-M 200
+G+G+Y EV+ + + E V VKI + RE +I L NI+ D +
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKIL-ENLRGGPNIITLA--DIV 100
Query: 201 TSRNSCTQLWLVTHYHS--FGSLYDHLNRTTLNH-----HQMMKICLSIVNGLVHLHTEI 253
S T + H ++ F LY L T ++++K L + H+
Sbjct: 101 KDPVSRTPALVFEHVNNTDFKQLYQTL---TDYDIRFYMYEILK-------ALDYCHSM- 149
Query: 254 FGTQGKPAIAHRDIKSKNILV-KTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYM 312
I HRD+K N+++ + + D+GLA Y + N RV ++ +
Sbjct: 150 -------GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP-GQEY----NVRVASRYFK 197
Query: 313 SPEIL------DESINM 323
PE+L D S++M
Sbjct: 198 GPELLVDYQMYDYSLDM 214
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 9e-11
Identities = 50/219 (22%), Positives = 88/219 (40%), Gaps = 52/219 (23%)
Query: 144 IGKGRYGEVW--RGVWHGENVAVKI-----FFSRDEASWSRETEIYSTVLLRHENILGYI 196
IG+G Y +V R A+K+ ++ W + TE +++
Sbjct: 17 IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQ-TE---------KHVFEQA 66
Query: 197 GSD--MTSRNSCTQ----LWLVTHYHSFGSLYDHLNRTTLNHHQMMKI-CLSIVNGLVHL 249
+ + +SC Q L+ V Y + G L H+ R + + I L +L
Sbjct: 67 SNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYL 126
Query: 250 HTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPR---- 305
H +G I +RD+K N+L+ + G + D+G+ K + P
Sbjct: 127 HE-----RG---IIYRDLKLDNVLLDSEGHIKLTDYGMC--------KEGLRPGDTTSTF 170
Query: 306 VGTKRYMSPEILDESINMDCFESFKKA-DIYALGLVLWE 343
GT Y++PEIL E + + D +ALG++++E
Sbjct: 171 CGTPNYIAPEILRG-------EDYGFSVDWWALGVLMFE 202
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 9e-11
Identities = 55/215 (25%), Positives = 90/215 (41%), Gaps = 32/215 (14%)
Query: 144 IGKGRYGEVWRGV--WHGENVAVK---IFFSRDEASWS-RETEIYSTVLLRHENILGYIG 197
IG+G YG V + VA+K F + + RE +I RHENI+G
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILL--RFRHENIIGIN- 91
Query: 198 SDM---TSRNSCTQLWLVTHYHSFGS-LYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEI 253
D+ + +++V + LY L L++ + I+ GL ++H+
Sbjct: 92 -DIIRAPTIEQMKDVYIVQDL--METDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA- 147
Query: 254 FGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMS 313
+ HRD+K N+L+ T I DFGLA + V T+ Y +
Sbjct: 148 -------NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE-YVATRWYRA 199
Query: 314 PEILDESINMDCFESFKKA-DIYALGLVLWEVCRR 347
PEI M + + K+ DI+++G +L E+
Sbjct: 200 PEI------MLNSKGYTKSIDIWSVGCILAEMLSN 228
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 1e-10
Identities = 55/219 (25%), Positives = 90/219 (41%), Gaps = 52/219 (23%)
Query: 144 IGKGRYGEVW--RGVWHGENVAVKIF-----FSRDEASWSRETEIYSTVLLRHENILGYI 196
+GKG +G+V R G+ AVK+ D+ + TE + IL
Sbjct: 31 LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTM-TE---------KRILSLA 80
Query: 197 GSD--MTSRNSCTQ----LWLVTHYHSFGSLYDHLNRTTLNHHQMMKI-CLSIVNGLVHL 249
+ +T C Q L+ V + + G L H+ ++ + I++ L+ L
Sbjct: 81 RNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFL 140
Query: 250 HTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPR---- 305
H + I +RD+K N+L+ G C +ADFG+ K I
Sbjct: 141 HDK--------GIIYRDLKLDNVLLDHEGHCKLADFGMC--------KEGICNGVTTATF 184
Query: 306 VGTKRYMSPEILDESINMDCFESFKKA-DIYALGLVLWE 343
GT Y++PEIL E + A D +A+G++L+E
Sbjct: 185 CGTPDYIAPEILQE-------MLYGPAVDWWAMGVLLYE 216
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 1e-10
Identities = 55/218 (25%), Positives = 93/218 (42%), Gaps = 51/218 (23%)
Query: 144 IGKGRYGEVW--RGVWHGENVAVKI-----FFSRDEASWSRETEIYSTVLLRHENILGYI 196
+GKG +G+V R G A+KI ++DE + + TE +L
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTV-TE---------SRVLQNT 62
Query: 197 GSD-MTSRNSCTQ----LWLVTHYHSFGSLYDHLNRTTLNHHQMMKI-CLSIVNGLVHLH 250
+T+ Q L V Y + G L+ HL+R + + + IV+ L +LH
Sbjct: 63 RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH 122
Query: 251 TEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRV---- 306
+ +RDIK +N+++ +G I DFGL K I +
Sbjct: 123 --------SRDVVYRDIKLENLMLDKDGHIKITDFGLC--------KEGISDGATMKTFC 166
Query: 307 GTKRYMSPEILDESINMDCFESFKKA-DIYALGLVLWE 343
GT Y++PE+L++ + +A D + LG+V++E
Sbjct: 167 GTPEYLAPEVLED-------NDYGRAVDWWGLGVVMYE 197
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 1e-10
Identities = 47/228 (20%), Positives = 78/228 (34%), Gaps = 59/228 (25%)
Query: 140 LSECIGKGRYGEVWRGVWH---GENVAVKI-------FFSRDEASWSRETEIYSTVLLR- 188
L +GKG +G V+ G VA+K+ +S S + E+ +
Sbjct: 35 LGPLLGKGGFGTVFAGH-RLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGA 93
Query: 189 ---HENI---LGYIGSDMTSRNSCTQLWLVTHYH-SFGSLYDHL-NRTTLNHHQMMKICL 240
H + L + + LV L+D++ + L
Sbjct: 94 GGGHPGVIRLLDWFETQ-------EGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFG 146
Query: 241 SIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCV-IADFGLAVSYSQLSNKM- 298
+V + H H+ + HRDIK +NIL+ C + DFG +
Sbjct: 147 QVVAAIQHCHSR--------GVVHRDIKDENILIDLRRGCAKLIDFG-------SGALLH 191
Query: 299 DIPPNPRVGTKRYMSPEILDESINMDCFESFK-----KADIYALGLVL 341
D P GT+ Y PE + S A +++LG++L
Sbjct: 192 DEPYTDFDGTRVYSPPEWI----------SRHQYHALPATVWSLGILL 229
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 1e-10
Identities = 49/219 (22%), Positives = 89/219 (40%), Gaps = 52/219 (23%)
Query: 144 IGKGRYGEVW--RGVWHGENVAVKI-----FFSRDEASWSRETEIYSTVLLRHENILGYI 196
IG+G Y +V R A+++ ++ W + TE +++
Sbjct: 60 IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQ-TE---------KHVFEQA 109
Query: 197 GSD--MTSRNSCTQ----LWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLS-IVNGLVHL 249
+ + +SC Q L+ V Y + G L H+ R + + + I L +L
Sbjct: 110 SNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYL 169
Query: 250 HTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRV--- 306
H +G I +RD+K N+L+ + G + D+G+ K + P
Sbjct: 170 HE-----RG---IIYRDLKLDNVLLDSEGHIKLTDYGMC--------KEGLRPGDTTSTF 213
Query: 307 -GTKRYMSPEILDESINMDCFESFKKA-DIYALGLVLWE 343
GT Y++PEIL E + + D +ALG++++E
Sbjct: 214 CGTPNYIAPEILRG-------EDYGFSVDWWALGVLMFE 245
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 61.4 bits (150), Expect = 1e-10
Identities = 51/191 (26%), Positives = 78/191 (40%), Gaps = 41/191 (21%)
Query: 144 IGKGRYGEVWRG--VWHGENVAVK--IFFSRDEASWS------RETEIYSTVL--LRHEN 191
+G+G++ V++ + VA+K R EA RE ++ L L H N
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKL----LQELSHPN 73
Query: 192 ILGYIGSDMTSRNSCTQLWLVTHY--HSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHL 249
I+G + D S + LV + + N L + L + GL +L
Sbjct: 74 IIGLL--DAFGHKS--NISLVFDFMETDLEVIIKD-NSLVLTPSHIKAYMLMTLQGLEYL 128
Query: 250 HTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNP---RV 306
H I HRD+K N+L+ NG +ADFGLA S+ P +V
Sbjct: 129 HQH--------WILHRDLKPNNLLLDENGVLKLADFGLAKSFG-------SPNRAYTHQV 173
Query: 307 GTKRYMSPEIL 317
T+ Y +PE+L
Sbjct: 174 VTRWYRAPELL 184
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 47/259 (18%), Positives = 93/259 (35%), Gaps = 69/259 (26%)
Query: 142 ECIGKGRYGEVWRGV--WHGENVAVK----IFFSRDEASWSRET--EIYSTVLLRHENIL 193
IG+G YG V+ +NVA+K +F + + EI L+ + I+
Sbjct: 32 HLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDC---KRILREITILNRLKSDYII 88
Query: 194 GYIGSDM---TSRNSCTQLWLVTHY---------HSFGSLYDHLNRTTLNHHQMMKICLS 241
D+ +L++V + L + H + I +
Sbjct: 89 RLY--DLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTE-------EHIKT--ILYN 137
Query: 242 IVNGLVHLHTEIFGTQGKPA-IAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDI 300
++ G +H + I HRD+K N L+ + + + DFGLA + + + +
Sbjct: 138 LLLGENFIHE---------SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIV 188
Query: 301 PPNPR------------------VGTKRYMSPEILDESINMDCFESFKKA-DIYALGLVL 341
V T+ Y +PE+ + E++ K+ DI++ G +
Sbjct: 189 NDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPEL------ILLQENYTKSIDIWSTGCIF 242
Query: 342 WEVCRRTKANGIFEEYKAP 360
E+ +++ + P
Sbjct: 243 AELLNMLQSHINDPTNRFP 261
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 54/218 (24%), Positives = 93/218 (42%), Gaps = 55/218 (25%)
Query: 144 IGKGRYGEVWRGVWH---GENVAVKIF------FSRDEASWSRETEIYSTVLLRHENILG 194
+G G +G+V G H G VAVKI RE + L RH +I+
Sbjct: 24 LGVGTFGKVKVGK-HELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLK--LFRHPHIIK 80
Query: 195 -Y--IGSDMTSRNSCTQLWLVTHYHSFGSLYDHL-NRTTLNHHQMMKICLSIVNGLVHLH 250
Y I + + +++V Y S G L+D++ L+ + ++ I++G+ + H
Sbjct: 81 LYQVISTP-------SDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCH 133
Query: 251 TEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKM--DIPPNPRVGT 308
+ + HRD+K +N+L+ + IADFG LSN M G+
Sbjct: 134 --------RHMVVHRDLKPENVLLDAHMNAKIADFG-------LSNMMSDGEFLRTSCGS 178
Query: 309 KRYMSPEILDESINMDCFESFK-----KADIYALGLVL 341
Y +PE++ S + + DI++ G++L
Sbjct: 179 PNYAAPEVI----------SGRLYAGPEVDIWSSGVIL 206
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 2e-10
Identities = 38/200 (19%), Positives = 70/200 (35%), Gaps = 40/200 (20%)
Query: 142 ECIGKGRYGEVWRGV--WHGENVAVK----IFFSRDEASWS-RETEIYSTVLLRHENILG 194
IG G YG V VA+K +F + RE I + L H++++
Sbjct: 59 HLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILN--RLNHDHVVK 116
Query: 195 YIGSDM---TSRNSCTQLWLVTHY---------HSFGSLYDHLNRTTLNHHQMMKICLSI 242
+ D+ +L++V + L T H + + ++
Sbjct: 117 VL--DIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYL-------TELHIKT--LLYNL 165
Query: 243 VNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPP 302
+ G+ ++H+ I HRD+K N LV + + + DFGLA + N P
Sbjct: 166 LVGVKYVHSA--------GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLP 217
Query: 303 NPRVGTKRYMSPEILDESIN 322
+ +++
Sbjct: 218 ISPREDDMNLVTFPHTKNLK 237
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 4e-10
Identities = 53/219 (24%), Positives = 87/219 (39%), Gaps = 52/219 (23%)
Query: 144 IGKGRYGEVW--RGVWHGENVAVKIF-----FSRDEASWSRETEIYSTVLLRHENILGYI 196
+GKG +G+V E AVKI D+ + E + +L
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTM-VE---------KRVLALP 77
Query: 197 GSD--MTSRNSCTQ----LWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLS-IVNGLVHL 249
G +T +SC Q L+ V Y + G L H+ + + I GL L
Sbjct: 78 GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFL 137
Query: 250 HTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRV--- 306
++ I +RD+K N+++ + G IADFG+ K +I
Sbjct: 138 QSK--------GIIYRDLKLDNVMLDSEGHIKIADFGMC--------KENIWDGVTTKTF 181
Query: 307 -GTKRYMSPEILDESINMDCFESFKKA-DIYALGLVLWE 343
GT Y++PEI+ + + K+ D +A G++L+E
Sbjct: 182 CGTPDYIAPEIIAY-------QPYGKSVDWWAFGVLLYE 213
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 4e-10
Identities = 56/216 (25%), Positives = 85/216 (39%), Gaps = 41/216 (18%)
Query: 143 CIGKGRYGEV-----WRGVWHGENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIG 197
+GKG YG+V G G+ A+K+ + + T R NIL +
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVL--KKAMIVRNAKDTAHTKAER--NILEEVK 79
Query: 198 SD-MTSRNSCTQ----LWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLS-IVNGLVHLHT 251
+ Q L+L+ Y S G L+ L R + L+ I L HLH
Sbjct: 80 HPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQ 139
Query: 252 EIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPR----VG 307
+G I +RD+K +NI++ G + DFGL K I G
Sbjct: 140 -----KG---IIYRDLKPENIMLNHQGHVKLTDFGLC--------KESIHDGTVTHTFCG 183
Query: 308 TKRYMSPEILDESINMDCFESFKKADIYALGLVLWE 343
T YM+PEIL S + D ++LG ++++
Sbjct: 184 TIEYMAPEILMRS------GHNRAVDWWSLGALMYD 213
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 4e-10
Identities = 35/139 (25%), Positives = 58/139 (41%), Gaps = 17/139 (12%)
Query: 209 LWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLS-IVNGLVHLHTEIFGTQGKPAIAHRDI 267
+++V G L HL + + +K+ + +V L +L Q I HRD+
Sbjct: 90 MFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQN-----QR---IIHRDM 141
Query: 268 KSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFE 327
K NIL+ +G I DF +A + + GTK YM+PE+
Sbjct: 142 KPDNILLDEHGHVHITDFNIAAMLPR-----ETQITTMAGTKPYMAPEMFSSRKGAGY-- 194
Query: 328 SFKKADIYALGLVLWEVCR 346
D ++LG+ +E+ R
Sbjct: 195 -SFAVDWWSLGVTAYELLR 212
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 60.8 bits (147), Expect = 4e-10
Identities = 53/221 (23%), Positives = 87/221 (39%), Gaps = 52/221 (23%)
Query: 144 IGKGRYGEVW--RGVWHGENVAVKI-----FFSRDEASWSRETEIYSTVLLRHENILGYI 196
+GKG +G+V E AVKI D+ + E + +L
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTM-VE---------KRVLALP 398
Query: 197 GSD--MTSRNSCTQ----LWLVTHYHSFGSLYDHLNRTTLNHHQMMKI-CLSIVNGLVHL 249
G +T +SC Q L+ V Y + G L H+ + I GL L
Sbjct: 399 GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFL 458
Query: 250 HTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRV--- 306
++ I +RD+K N+++ + G IADFG+ K +I
Sbjct: 459 QSK--------GIIYRDLKLDNVMLDSEGHIKIADFGMC--------KENIWDGVTTKTF 502
Query: 307 -GTKRYMSPEILDESINMDCFESFKKA-DIYALGLVLWEVC 345
GT Y++PEI+ + + K+ D +A G++L+E+
Sbjct: 503 CGTPDYIAPEIIAY-------QPYGKSVDWWAFGVLLYEML 536
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 4e-10
Identities = 53/224 (23%), Positives = 91/224 (40%), Gaps = 60/224 (26%)
Query: 140 LSECIGKGRYGEVWRGVWH---GENVAVKIF------FSRDEASWSRETEIYSTVLLRHE 190
+ E +G+G +G+V H + VA+K S RE LLRH
Sbjct: 13 IRETLGEGSFGKVKLAT-HYKTQQKVALKFISRQLLKKSDMHMRVEREISYLK--LLRHP 69
Query: 191 NILG-Y--IGSDMTSRNSCTQLWLVTHYHSFGSLYDHL-NRTTLNHHQMMKICLSIVNGL 246
+I+ Y I + T + +V Y G L+D++ + + + + I+ +
Sbjct: 70 HIIKLYDVITTP-------TDIVMVIEYAG-GELFDYIVEKKRMTEDEGRRFFQQIICAI 121
Query: 247 VHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRV 306
+ H + I HRD+K +N+L+ N IADFG LSN M +
Sbjct: 122 EYCH--------RHKIVHRDLKPENLLLDDNLNVKIADFG-------LSNIM--TDGNFL 164
Query: 307 ----GTKRYMSPEILDESINMDCFESFK-----KADIYALGLVL 341
G+ Y +PE++ + K + D+++ G+VL
Sbjct: 165 KTSCGSPNYAAPEVI----------NGKLYAGPEVDVWSCGIVL 198
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 59.1 bits (144), Expect = 7e-10
Identities = 49/218 (22%), Positives = 92/218 (42%), Gaps = 47/218 (21%)
Query: 143 CIGKGRYGEV-----WRGVWHGENVAVKIF-----FSRDEASWSRETEIYSTVLL--RHE 190
+G+G +G+V G + A+K+ RD T++ +L+ H
Sbjct: 31 VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRV----RTKMERDILVEVNHP 86
Query: 191 NILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLS-IVNGLVHL 249
I+ + T +L+L+ + G L+ L++ + + +K L+ + L HL
Sbjct: 87 FIVKLHYAFQTE----GKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHL 142
Query: 250 HTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPR---- 305
H I +RD+K +NIL+ G + DFGL+ K I +
Sbjct: 143 H--------SLGIIYRDLKPENILLDEEGHIKLTDFGLS--------KESIDHEKKAYSF 186
Query: 306 VGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWE 343
GT YM+PE+++ + AD ++ G++++E
Sbjct: 187 CGTVEYMAPEVVNRR------GHTQSADWWSFGVLMFE 218
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 1e-09
Identities = 45/195 (23%), Positives = 72/195 (36%), Gaps = 48/195 (24%)
Query: 144 IGKGRYGEVWRG--VWHGENVAVKIFFSRDEASWSRETE-IYSTVL--------LRHENI 192
+G+G YGEV++ E VA+K E E + T + L+H NI
Sbjct: 42 LGEGTYGEVYKAIDTVTNETVAIK------RIRLEHEEEGVPGTAIREVSLLKELQHRNI 95
Query: 193 LGYIGSDMTSRNSCTQLWLVTHY--HSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLH 250
+ + N +L L+ Y + D ++ + ++NG+ H
Sbjct: 96 IELK--SVIHHNH--RLHLIFEYAENDLKKYMDK--NPDVSMRVIKSFLYQLINGVNFCH 149
Query: 251 TEIFGTQGKPAIAHRDIKSKNILVKTNGTCV-----IADFGLAVSYSQLSNKMDIPPNP- 304
HRD+K +N+L+ + I DFGLA ++ IP
Sbjct: 150 --------SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG-------IPIRQF 194
Query: 305 --RVGTKRYMSPEIL 317
+ T Y PEIL
Sbjct: 195 THEIITLWYRPPEIL 209
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 2e-09
Identities = 57/241 (23%), Positives = 99/241 (41%), Gaps = 67/241 (27%)
Query: 144 IGKGRYGEVWRGV--WHGENVAVK-IFFSRDEASWSRET--EIYSTVLLR----HENILG 194
+GKG YG VW+ + GE VAVK IF + ++ ++ T EI ++L HENI+
Sbjct: 17 LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREI---MILTELSGHENIVN 73
Query: 195 YIGSDMTSRNSCTQLWLVTHY---------HSFGSLYDHLNRTTLNHHQMMKICLSIVNG 245
+ ++ ++ ++LV Y + N H Q + ++
Sbjct: 74 LL--NVLRADNDRDVYLVFDYMETDLHAVIRA--------NILEPVHKQY--VVYQLIKV 121
Query: 246 LVHLHTEIFGTQGKPA-IAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNP 304
+ +LH+ + HRD+K NIL+ +ADFGL+ S+ + + P
Sbjct: 122 IKYLHS---------GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLS 172
Query: 305 R-----------------VGTKRYMSPEILDESINMDCFESFKKA-DIYALGLVLWEVCR 346
V T+ Y +PEI + + K D+++LG +L E+
Sbjct: 173 INENTENFDDDQPILTDYVATRWYRAPEI------LLGSTKYTKGIDMWSLGCILGEILC 226
Query: 347 R 347
Sbjct: 227 G 227
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 2e-09
Identities = 48/219 (21%), Positives = 86/219 (39%), Gaps = 52/219 (23%)
Query: 144 IGKGRYGEVW--RGVWHGENVAVKIF-----FSRDEASWSRETEIYSTVLLRHENILGYI 196
+GKG +G+V+ + A+K D+ + E + +L
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTM-VE---------KRVLSLA 74
Query: 197 GSD--MTSRNSCTQ----LWLVTHYHSFGSLYDHLNRT-TLNHHQMMKICLSIVNGLVHL 249
+T Q L+ V Y + G L H+ + + I+ GL L
Sbjct: 75 WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFL 134
Query: 250 HTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRV--- 306
H++ I +RD+K NIL+ +G IADFG+ K ++ + +
Sbjct: 135 HSK--------GIVYRDLKLDNILLDKDGHIKIADFGMC--------KENMLGDAKTNTF 178
Query: 307 -GTKRYMSPEILDESINMDCFESFKKA-DIYALGLVLWE 343
GT Y++PEIL + + + D ++ G++L+E
Sbjct: 179 CGTPDYIAPEILLG-------QKYNHSVDWWSFGVLLYE 210
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 3e-09
Identities = 32/107 (29%), Positives = 50/107 (46%), Gaps = 28/107 (26%)
Query: 242 IVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIP 301
I + L +LH I +RD+K +NIL+ + G V+ DFGL K +I
Sbjct: 148 IASALGYLH--------SLNIVYRDLKPENILLDSQGHIVLTDFGLC--------KENIE 191
Query: 302 PNPR----VGTKRYMSPEILDESINMDCFESFKKA-DIYALGLVLWE 343
N GT Y++PE+L + + + + D + LG VL+E
Sbjct: 192 HNSTTSTFCGTPEYLAPEVLHK-------QPYDRTVDWWCLGAVLYE 231
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 3e-09
Identities = 49/230 (21%), Positives = 85/230 (36%), Gaps = 49/230 (21%)
Query: 193 LGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTE 252
L I S +S +S + L + L ++ + G+ L +
Sbjct: 153 LDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR 212
Query: 253 IFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA------VSYSQLSN-KMDIPPNPR 305
HRD+ ++NIL+ I DFGLA Y + + ++ +
Sbjct: 213 KC--------IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL----- 259
Query: 306 VGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLV 365
++M+P E+I + ++D+++ G++LWE IF +PY V
Sbjct: 260 ----KWMAP----ETIFDRVYTI--QSDVWSFGVLLWE---------IFSLGASPYPG-V 299
Query: 366 PMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVR 415
+D F K + R P D T M + M +CWH + R
Sbjct: 300 KIDEEFCRRLK----EGTRMRAP-----DYTTPEMYQTMLDCWHGEPSQR 340
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 45.3 bits (107), Expect = 2e-05
Identities = 28/184 (15%), Positives = 60/184 (32%), Gaps = 34/184 (18%)
Query: 137 QISLSECIGKGRYGEVWRGVWHG-------ENVAVK----IFFSRDEASWSRETEIYSTV 185
++ L + +G+G +G+V G VAVK + + E +I
Sbjct: 23 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH- 81
Query: 186 LLRHENILGYIGSDMTSRNSCTQ----LWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLS 241
+ H N++ +G +CT+ L ++ + FG+L +L
Sbjct: 82 IGHHLNVVNLLG-------ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGAR 134
Query: 242 IVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIP 301
G + D+K + + ++ + + F S S + +
Sbjct: 135 FRQG-----------KDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPE 183
Query: 302 PNPR 305
+
Sbjct: 184 DLYK 187
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 57.1 bits (138), Expect = 5e-09
Identities = 52/266 (19%), Positives = 94/266 (35%), Gaps = 78/266 (29%)
Query: 131 QRTLAKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEASWSRETEIYSTVLLR 188
T +K+ SL + +G G +G V G+ A+K +D +RE +I +L
Sbjct: 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVL-QDPRYKNRELDIMK--VLD 58
Query: 189 HENILG----------------------------------YIGSDMTSRNSCTQLWLVTH 214
H NI+ + S + + + L ++
Sbjct: 59 HVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIME 118
Query: 215 Y-----HSFGSLYDHLNRT-TLNHHQ--MMKICLSIVNGLVHLHTEIFGTQGKPAIAHRD 266
Y H + R+ +N + ++ + +H+ I HRD
Sbjct: 119 YVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFR----AVGFIHSL--------GICHRD 166
Query: 267 IKSKNILVKTNGTCV--IADFGLAVSYSQLSNKMDIPPNPRVG---TKRYMSPEILDESI 321
IK +N+LV + + DFG A K IP P V ++ Y +PE++
Sbjct: 167 IKPQNLLVNSK-DNTLKLCDFGSA--------KKLIPSEPSVAYICSRFYRAPELM---- 213
Query: 322 NMDCFESFKKADIYALGLVLWEVCRR 347
+ E D++++G V E+
Sbjct: 214 -LGATEYTPSIDLWSIGCVFGELILG 238
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 6e-09
Identities = 46/231 (19%), Positives = 79/231 (34%), Gaps = 61/231 (26%)
Query: 144 IGKGRYGEVWRGVW---HGENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIGSDM 200
+G G + VW + +VA+KI + + E EI LL+ N D
Sbjct: 27 LGWGHFSTVWL-AKDMVNNTHVAMKIVRGDKVYTEAAEDEI---KLLQRVNDADNTKEDS 82
Query: 201 TSRNSCTQLWLVTHYHSF------------------GSLYDHLNRTT---LNHHQMMKIC 239
N +L F +L + + + + +I
Sbjct: 83 MGANHILKL-----LDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQIS 137
Query: 240 LSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCV------IADFGLAVSYSQ 293
++ GL ++H I H DIK +N+L++ + IAD G A Y +
Sbjct: 138 KQLLLGLDYMHRRC-------GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE 190
Query: 294 LSNKMDIPPNPRVGTKRYMSPE-ILDESINMDCFESFKKADIYALGLVLWE 343
+ T+ Y SPE +L ADI++ +++E
Sbjct: 191 -------HYTNSIQTREYRSPEVLLGAPWGC-------GADIWSTACLIFE 227
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 1e-08
Identities = 56/218 (25%), Positives = 93/218 (42%), Gaps = 41/218 (18%)
Query: 143 CIGKGRYGEVW-----RGVWHGENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIG 197
+G G YG+V+ G G+ A+K+ + + T R +L +I
Sbjct: 61 VLGTGAYGKVFLVRKISGHDTGKLYAMKVL--KKATIVQKAKTTEHTRTER--QVLEHIR 116
Query: 198 SD--MTSRNSCTQ----LWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLS-IVNGLVHLH 250
+ + + Q L L+ Y + G L+ HL++ ++I + IV L HLH
Sbjct: 117 QSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLH 176
Query: 251 TEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRV---- 306
G I +RDIK +NIL+ +NG V+ DFGL+ K +
Sbjct: 177 K-----LG---IIYRDIKLENILLDSNGHVVLTDFGLS--------KEFVADETERAYDF 220
Query: 307 -GTKRYMSPEILDESINMDCFESFKKADIYALGLVLWE 343
GT YM+P+I+ K D ++LG++++E
Sbjct: 221 CGTIEYMAPDIVRG----GDSGHDKAVDWWSLGVLMYE 254
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 54.5 bits (130), Expect = 5e-08
Identities = 66/481 (13%), Positives = 144/481 (29%), Gaps = 130/481 (27%)
Query: 20 DFCNNGSFPILPPSY------RELPEYAQR------YDYILKLSMAILGPVIVLGML--- 64
+ + ++ +++ + + D+I+ A+ G + + L
Sbjct: 15 QYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSK 74
Query: 65 -AAVIVLFMRRNHRK--KLLAARAIQSDPDCFLADADLLRATAAGDSTLREYLDASLTSG 121
++ F+ R K L + I+++ R + E D L +
Sbjct: 75 QEEMVQKFVEEVLRINYKFLMSP-IKTEQ----------RQPSMMTRMYIEQRD-RLYND 122
Query: 122 SGSGLPLLIQRTLAKQISLSECIGKGRYGEVWRGVWHG--------------ENVAVKIF 167
+ + R L + L + + + R + + G + V+
Sbjct: 123 NQVFAKYNVSR-LQPYLKLRQALLELRPAK-NVLI-DGVLGSGKTWVALDVCLSYKVQCK 179
Query: 168 FSRDEASW--SRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHL 225
+ W + TVL + +L I + TSR+ + S+ L
Sbjct: 180 MD-FKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSS----NIKLRIHSIQAEL 234
Query: 226 NRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADF 285
R L + + CL ++ + Q A ++ K IL+ T V DF
Sbjct: 235 RR--LLKSKPYENCLLVLLNV----------QNAKAWNAFNLSCK-ILLTTRFKQV-TDF 280
Query: 286 GLAVSYSQLSNKM-----------------------DIPP-----NPRVGTKRYMSPEIL 317
A + + +S D+P NPR + + E +
Sbjct: 281 LSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLS---IIAESI 337
Query: 318 DESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFDDMRKV 377
+ + ++++K + L ++ E EY+ + L PS +
Sbjct: 338 RDGLAT--WDNWKHVNCDKLTTII-ESSLNVLE---PAEYRKMFDRLSVFPPSAHIPTIL 391
Query: 378 ICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLACADM--YI 435
+ + + W + M V+ + K +L++ + I
Sbjct: 392 LSL------I---WFDVIKSDVM-VVVNKL-------------HKYSLVEKQPKESTISI 428
Query: 436 H 436
Sbjct: 429 P 429
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 7e-08
Identities = 34/213 (15%), Positives = 67/213 (31%), Gaps = 44/213 (20%)
Query: 130 IQRTLAKQISLSECIGKGRYGEVWRG--VWHGENVAVKI--FFSRDEASWSRETEIYSTV 185
+ Q L + IG G +G ++ E A + ++ E + Y
Sbjct: 31 LDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFY--- 87
Query: 186 LLRHENILGYIGSDMTSRNSCTQLWLVTHYHSFG-------------------SLYDHLN 226
+ + + ++ G L
Sbjct: 88 ----QRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISG 143
Query: 227 RT-TLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILV--KTNGTCVIA 283
+ T ++++ + +++ L ++H + H DIK+ N+L+ K +A
Sbjct: 144 QNGTFKKSTVLQLGIRMLDVLEYIHENEY--------VHGDIKAANLLLGYKNPDQVYLA 195
Query: 284 DFGLAVSYSQLSNKMDIPPNPR---VGTKRYMS 313
D+GL+ Y N NPR GT + S
Sbjct: 196 DYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTS 228
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 9e-08
Identities = 45/209 (21%), Positives = 81/209 (38%), Gaps = 36/209 (17%)
Query: 144 IGKGRYGEVW--RGVWHGENVAVKIF-----FSRDEASWSR-ETEIYSTVLLRHENILGY 195
+G G +G V + G + A+KI + + E I V ++
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV--NFPFLVKL 106
Query: 196 IGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLS-IVNGLVHLHTEIF 254
S + N L++V Y + G ++ HL R + + IV +LH+
Sbjct: 107 EFSFKDNSN----LYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL-- 160
Query: 255 GTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSP 314
+ +RD+K +N+L+ G + DFG A + + GT ++P
Sbjct: 161 ------DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTL-------CGTPEALAP 207
Query: 315 EILDESINMDCFESFKKADIYALGLVLWE 343
EI+ K D +ALG++++E
Sbjct: 208 EIILSK------GYNKAVDWWALGVLIYE 230
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 52.1 bits (125), Expect = 2e-07
Identities = 31/195 (15%), Positives = 59/195 (30%), Gaps = 33/195 (16%)
Query: 144 IGKGRYGEVWRGVWH-GENVAVKI-----FFSRDEASWSRETEIYSTVLLRHENILGYIG 197
IG+G +G ++ + E+V D E + Y +
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 198 SDMTSRNSCTQLWLVTHYHSFG------------SLYDHLNRT--TLNHHQMMKICLSIV 243
+ H + L + ++++ L I+
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRIL 162
Query: 244 NGLVHLHTEIFGTQGKPAIAHRDIKSKNILV--KTNGTCVIADFGLAVSYSQLSNKMDIP 301
+ L ++H + H DIK+ N+L+ K + D+GLA Y
Sbjct: 163 DILEYIHEHEY--------VHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYA 214
Query: 302 PNPR---VGTKRYMS 313
+P+ GT + S
Sbjct: 215 ADPKRCHDGTIEFTS 229
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 45/204 (22%), Positives = 71/204 (34%), Gaps = 61/204 (29%)
Query: 140 LSECIGKGRYGEVWRG--VWHGENVAVKIFFSRDEASW-SRETEIYSTVLLRHENILGYI 196
+ + IG G +GE+ G ++ E VA+K+ + A E Y +
Sbjct: 13 VGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQ-------LGSGD 65
Query: 197 GSDMTSRNSCTQLWLVTHYHSFG---------------SLYDHLNRTTLNHHQMMKICLS 241
G + + FG SL D + + +K L
Sbjct: 66 G--------------IPQVYYFGPCGKYNAMVLELLGPSLEDLFDL--CDRTFSLKTVLM 109
Query: 242 I----VNGLVHLHTEIFGTQGKPAIAHRDIKSKNILV-----KTNGTCVIADFGLAVSYS 292
I ++ + ++H++ +RD+K +N L+ KT I DF LA Y
Sbjct: 110 IAIQLISRMEYVHSKNL--------IYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI 161
Query: 293 QLSNKMDIPPNPR---VGTKRYMS 313
K IP GT RYMS
Sbjct: 162 DPETKKHIPYREHKSLTGTARYMS 185
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 4e-07
Identities = 48/206 (23%), Positives = 82/206 (39%), Gaps = 48/206 (23%)
Query: 142 ECIGKGRYGEVWRGVWH--GENVAVKIFFSRDEASWSR--ETEIYSTVLLRHENILGYI- 196
IGKG +G+V + E VA+KI +++ ++ + E+ +L +
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKII--KNKKAFLNQAQIEV---------RLLELMN 108
Query: 197 GSDMTSRNSCTQL--WLVTHYH---SF----GSLYDHLNRTT---LNHHQMMKICLSIVN 244
D + L + H F +LYD L T ++ + K +
Sbjct: 109 KHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCT 168
Query: 245 GLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVI--ADFGLAVSYSQLSNKMDIPP 302
L+ L T + +I H D+K +NIL+ I DFG S QL ++
Sbjct: 169 ALLFLATP------ELSIIHCDLKPENILLCNPKRSAIKIVDFG---SSCQLGQRI---- 215
Query: 303 NPRVGTKRYMSPEIL-----DESINM 323
+ ++ Y SPE+L D +I+M
Sbjct: 216 YQYIQSRFYRSPEVLLGMPYDLAIDM 241
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 50.2 bits (121), Expect = 6e-07
Identities = 45/209 (21%), Positives = 88/209 (42%), Gaps = 36/209 (17%)
Query: 144 IGKGRYGEVW--RGVWHGENVAVKIF-----FSRDEASWSR-ETEIYSTVLLRHENILGY 195
+G G +G V R +G A+K+ + + E + S V H I+
Sbjct: 14 LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV--THPFIIRM 71
Query: 196 IGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLS-IVNGLVHLHTEIF 254
G+ ++ ++++ Y G L+ L ++ + + K + + L +LH++
Sbjct: 72 WGTFQDAQQ----IFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK-- 125
Query: 255 GTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSP 314
I +RD+K +NIL+ NG I DFG A ++ + GT Y++P
Sbjct: 126 ------DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTL-------CGTPDYIAP 172
Query: 315 EILDESINMDCFESFKKADIYALGLVLWE 343
E++ K D ++ G++++E
Sbjct: 173 EVVSTK------PYNKSIDWWSFGILIYE 195
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 6e-07
Identities = 51/229 (22%), Positives = 89/229 (38%), Gaps = 63/229 (27%)
Query: 142 ECIGKGRYGEVWRGVWH--GENVAVKIFFSRDEASWSR--ETEIYSTVLLRHENILGYI- 196
+ IGKG +G+V + H ++VA+K+ R+E + R EI IL ++
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMV--RNEKRFHRQAAEEI---------RILEHLR 151
Query: 197 GSDMTSRNSCTQLW----------LVTHYHSFGSLYDHLNRTT---LNHHQMMKICLSIV 243
D + + + + S +LY+ + + + + K SI+
Sbjct: 152 KQDKDNTMNVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSIL 210
Query: 244 NGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVI--ADFGLAVSYSQLSNKMDIP 301
L LH K I H D+K +NIL+K G I DFG + Q
Sbjct: 211 QCLDALH--------KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ-------R 255
Query: 302 PNPRVGTKRYMSPEIL-----DESINMDCFESFKKADIYALGLVLWEVC 345
+ ++ Y +PE++ I D+++LG +L E+
Sbjct: 256 VYTYIQSRFYRAPEVILGARYGMPI-----------DMWSLGCILAELL 293
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 3e-06
Identities = 23/214 (10%), Positives = 55/214 (25%), Gaps = 71/214 (33%)
Query: 144 IGKGRYGEVWRGV----------WHGENVAVKIFFSRDEASWSR---ETEIYSTVLLRHE 190
+ G ++ + ++K+ +A R E + +
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKL-----DAKDGRLFNEQNFFQRAAKPLQ 104
Query: 191 -------NILGYIGSDMTSRNSCTQLWLVTHYHSFGS-------------------LYDH 224
+ + FG D
Sbjct: 105 VNKWKKLYSTPLLA--------------IPTCMGFGVHQDKYRFLVLPSLGRSLQSALDV 150
Query: 225 LNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILV--KTNGTCVI 282
+ L+ ++++ +++ L LH + H ++ ++NI V + +
Sbjct: 151 SPKHVLSERSVLQVACRLLDALEFLHENEY--------VHGNVTAENIFVDPEDQSQVTL 202
Query: 283 ADFGLAVSYSQLSNKMDIPPNPR---VGTKRYMS 313
A +G A Y + R G ++S
Sbjct: 203 AGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFIS 236
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 47.7 bits (113), Expect = 5e-06
Identities = 46/183 (25%), Positives = 74/183 (40%), Gaps = 21/183 (11%)
Query: 140 LSECIGKGRYGEVWRG--VWHGENVAVKIFFSRDEASW-SRETEIYSTVLLRHENILGYI 196
L IG G +GE++ G + E VA+K+ + + E++IY L I
Sbjct: 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRI-LQGGTGIPNVR 69
Query: 197 GSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGT 256
+ + + L+ S L++ +R L+ ++ + ++N + +H++ F
Sbjct: 70 WFGVEGDYNVLVMDLLGP--SLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKSF-- 124
Query: 257 QGKPAIAHRDIKSKNILVKTNGTC---VIADFGLAVSYSQLSNKMDIPPNPR---VGTKR 310
HRDIK N L+ I DFGLA Y S IP GT R
Sbjct: 125 ------LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTAR 178
Query: 311 YMS 313
Y S
Sbjct: 179 YAS 181
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 6e-06
Identities = 42/183 (22%), Positives = 74/183 (40%), Gaps = 21/183 (11%)
Query: 140 LSECIGKGRYGEVWRG--VWHGENVAVKIFFSRDEASW-SRETEIYSTVLLRHENILGYI 196
L IG G +G+++ G + GE VA+K+ + + E++IY + I
Sbjct: 13 LGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKM-MQGGVGIPTIR 71
Query: 197 GSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGT 256
+ + L+ S L++ +R + ++ + +++ + ++H++ F
Sbjct: 72 WCGAEGDYNVMVMELLGP--SLEDLFNFCSRK-FSLKTVLLLADQMISRIEYIHSKNF-- 126
Query: 257 QGKPAIAHRDIKSKNILV---KTNGTCVIADFGLAVSYSQLSNKMDIPPNPR---VGTKR 310
HRD+K N L+ K I DFGLA Y IP GT R
Sbjct: 127 ------IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTAR 180
Query: 311 YMS 313
Y S
Sbjct: 181 YAS 183
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 1e-05
Identities = 44/209 (21%), Positives = 69/209 (33%), Gaps = 71/209 (33%)
Query: 140 LSECIGKGRYGEVWRG--VWHGENVAVKIFFSRDEASW-SRETEIYSTVLLRHENILGYI 196
+ IG+G +G ++ G + + + VA+K R +A E Y + G
Sbjct: 14 VGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKL-------LAGCT 66
Query: 197 GSDMTSRNSCTQLWLVTHYHSFG---------------SLYDHLN--------RTTLN-H 232
G + + + FG SL D L+ +T
Sbjct: 67 G--------------IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAA 112
Query: 233 HQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILV-----KTNGTCVIADFGL 287
QM+ + +H + +RDIK N L+ K + DFG+
Sbjct: 113 KQMLAR-------VQSIHEKSL--------VYRDIKPDNFLIGRPNSKNANMIYVVDFGM 157
Query: 288 AVSYSQLSNKMDIPPNPR---VGTKRYMS 313
Y K IP + GT RYMS
Sbjct: 158 VKFYRDPVTKQHIPYREKKNLSGTARYMS 186
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 45.3 bits (107), Expect = 2e-05
Identities = 46/261 (17%), Positives = 77/261 (29%), Gaps = 81/261 (31%)
Query: 144 IGKGRYGEVW--RGVWHGENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIGSDMT 201
+G G + VW + + VA+K+ S A ET + LL+ + +
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKS---AEHYTETALDEIRLLKS---VRNSDPNDP 98
Query: 202 SRNSCTQLW--------------LVTHY--HSFGSLYDHLNRTTLNHHQMMKICLSIVNG 245
+R QL +V H N L + KI ++ G
Sbjct: 99 NREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQG 158
Query: 246 LVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKM------- 298
L +LHT+ I H DIK +NIL+ N + A + +
Sbjct: 159 LDYLHTKC-------RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVS 211
Query: 299 -----------------------------------DIPPNPRVGTKRYMSPE-ILDESIN 322
+ T++Y S E ++ N
Sbjct: 212 TAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYN 271
Query: 323 MDCFESFKKADIYALGLVLWE 343
ADI++ + +E
Sbjct: 272 T-------PADIWSTACMAFE 285
|
| >2h62_C Bone morphogenetic protein receptor type IA; TGF-beta superfamily, ligand-receptor complex, hormone/growth factor complex; 1.85A {Homo sapiens} SCOP: g.7.1.3 PDB: 2h64_B 3nh7_A 1rew_C 3qb4_B 2goo_B* 2qj9_D 2qja_C 2qjb_C 2k3g_A 1es7_B Length = 129 | Back alignment and structure |
|---|
Score = 41.3 bits (96), Expect = 7e-05
Identities = 10/30 (33%), Positives = 13/30 (43%)
Query: 4 CHSVNVGQFTIQCCDGDFCNNGSFPILPPS 33
+ TI+CC + CN P LPP
Sbjct: 89 DSPKAQLRRTIECCRTNLCNQYLQPTLPPV 118
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 443 | |||
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.94 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.9 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.83 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.7 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.33 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.14 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.06 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.78 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.58 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.44 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.35 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.33 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.26 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.18 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.92 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.86 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.8 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.77 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.62 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.5 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.47 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.23 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.16 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.06 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.05 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 96.97 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.96 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 96.95 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.52 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.45 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.37 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 96.13 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.61 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.16 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 92.78 | |
| 4fao_E | 124 | Activin receptor type-2B; TGF-beta, CTK, cystine k | 92.33 | |
| 1iij_A | 35 | ERBB-2 receptor protein-tyrosine kinase; alpha-hel | 92.27 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 90.32 | |
| 2k9y_A | 41 | Ephrin type-A receptor 2; receptor tyrosine kinase | 89.72 | |
| 1bte_A | 97 | Protein (activin receptor type II); serine kinase, | 89.3 | |
| 2l8s_A | 54 | Integrin alpha-1; transmembrane region, detergent | 86.48 | |
| 2klu_A | 70 | T-cell surface glycoprotein CD4; cell membrane, di | 85.94 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 85.65 | |
| 2knc_A | 54 | Integrin alpha-IIB; transmembrane signaling, prote | 85.17 | |
| 4fao_C | 106 | Serine/threonine-protein kinase receptor R3; TGF-b | 80.45 | |
| 2knc_B | 79 | Integrin beta-3; transmembrane signaling, protein | 80.18 |
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-65 Score=488.31 Aligned_cols=298 Identities=62% Similarity=1.061 Sum_probs=254.8
Q ss_pred hccccccceeeeecCeEEEEEEECCceeEEEEeeccCccchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEeeec
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVWHGENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVTH 214 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e 214 (443)
.++|.+.+.||+|+||+||+|+++|+.||||++.......+.+|.|+..+..++|||||+++|++.+.......++||||
T Consensus 2 ar~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E 81 (303)
T 3hmm_A 2 ARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence 36789999999999999999999999999999987776677778888888789999999999999877655457899999
Q ss_pred ccCcccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCccccccc
Q psy14889 215 YHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQL 294 (443)
Q Consensus 215 ~~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~~~~ 294 (443)
||++|||.+++++..+++..+.+++.|+|+||+|||++.......++||||||||+||||+.++++||+|||+|+.....
T Consensus 82 y~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~ 161 (303)
T 3hmm_A 82 YHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSA 161 (303)
T ss_dssp CCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETT
T ss_pred CCCCCcHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCC
Confidence 99999999999999999999999999999999999987544445679999999999999999999999999999877654
Q ss_pred CCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCChHHH
Q psy14889 295 SNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFDDM 374 (443)
Q Consensus 295 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~~~~~ 374 (443)
...........+||+.|||||++.+........++.++|||||||+||||+||+++++.....+.||.+..+..+..+.+
T Consensus 162 ~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~ 241 (303)
T 3hmm_A 162 TDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241 (303)
T ss_dssp TTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHH
T ss_pred CCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHHH
Confidence 44333334456899999999999765332222456799999999999999999999888888899999988888888888
Q ss_pred HhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhhcc
Q psy14889 375 RKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLACAD 432 (443)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~~~ 432 (443)
.+.+.....+|.+|..+.+.+++..+.+||.+||+.||++||||.||++.|+++.+..
T Consensus 242 ~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~ 299 (303)
T 3hmm_A 242 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp HHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHc
Confidence 8887777788888877777778889999999999999999999999999999998653
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-58 Score=439.14 Aligned_cols=266 Identities=29% Similarity=0.428 Sum_probs=208.3
Q ss_pred hhccccccceeeeecCeEEEEEEECCceeEEEEeeccCcc---chHHHHHHHHHHhccCCCceeeeeeccccCCcccEEE
Q psy14889 134 LAKQISLSECIGKGRYGEVWRGVWHGENVAVKIFFSRDEA---SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLW 210 (443)
Q Consensus 134 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~---~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~ 210 (443)
..+++.+.+.||+|+||+||+|++++ .||||+++..... ......|+..+..++|||||+++|++..+ .++
T Consensus 34 ~~~~l~l~~~iG~G~fG~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~-----~~~ 107 (307)
T 3omv_A 34 EASEVMLSTRIGSGSFGTVYKGKWHG-DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKD-----NLA 107 (307)
T ss_dssp CTTSCCEEEECCCCSSSEEEEEESSS-EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS-----SCE
T ss_pred cHHHeEEeeEEeeCCCcEEEEEEECC-cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEECC-----eEE
Confidence 34688999999999999999999865 5999998643322 22335677777789999999999988543 268
Q ss_pred eeecccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCc
Q psy14889 211 LVTHYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA 288 (443)
Q Consensus 211 lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla 288 (443)
||||||++|||.++|+. ..+++.+++.|+.|||+||+|||++ +||||||||+||||++++.+||+|||+|
T Consensus 108 iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~--------~IiHRDlKp~NILl~~~~~~Ki~DFGla 179 (307)
T 3omv_A 108 IVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAK--------NIIHRDMKSNNIFLHEGLTVKIGDFGLA 179 (307)
T ss_dssp EEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHT--------TCBCSCCCSSSEEEETTEEEEECCCSSC
T ss_pred EEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC--------CccCCccCHHHEEECCCCcEEEeeccCc
Confidence 99999999999999954 5799999999999999999999998 9999999999999999999999999999
Q ss_pred ccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCC
Q psy14889 289 VSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMD 368 (443)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~ 368 (443)
+......... .....+||+.|||||++.+.... .|+.++|||||||+||||+|| +.||.+..
T Consensus 180 ~~~~~~~~~~--~~~~~~GT~~ymAPE~l~~~~~~---~y~~ksDVwS~Gvvl~Elltg----------~~Pf~~~~--- 241 (307)
T 3omv_A 180 TVKSRWSGSQ--QVEQPTGSVLWMAPEVIRMQDNN---PFSFQSDVYSYGIVLYELMTG----------ELPYSHIN--- 241 (307)
T ss_dssp BC--------------CCCCTTSCCHHHHHCCSSC---CCCHHHHHHHHHHHHHHHHHS----------SCTTTTCC---
T ss_pred eecccCCcce--eecccccCCCccCHHHhhccCCC---CCCcHHHhHhHHHHHHHHHHC----------CCCCCCCC---
Confidence 8765432221 12446899999999999754221 577899999999999999999 77886642
Q ss_pred CChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhhcccc
Q psy14889 369 PSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLACADMY 434 (443)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~~~~~ 434 (443)
....+...+......|.++. ....+++++.+||.+||+.||++|||+.||++.|+.+....+.
T Consensus 242 -~~~~~~~~~~~~~~~p~~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lpk 304 (307)
T 3omv_A 242 -NRDQIIFMVGRGYASPDLSK--LYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPK 304 (307)
T ss_dssp -CHHHHHHHHHTTCCCCCSTT--SCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCCC
T ss_pred -hHHHHHHHHhcCCCCCCccc--ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCCC
Confidence 23344444443333343332 2345788999999999999999999999999999998876554
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-59 Score=441.91 Aligned_cols=258 Identities=26% Similarity=0.389 Sum_probs=210.7
Q ss_pred hccccccceeeeecCeEEEEEEEC-------CceeEEEEeeccCcc-chHHHHHHHHHHhccCCCceeeeeeccccCCcc
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVWH-------GENVAVKIFFSRDEA-SWSRETEIYSTVLLRHENILGYIGSDMTSRNSC 206 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~~-~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~ 206 (443)
.++|.+.+.||+|+||+||+|++. +..||||+++..... ......|+..+.+++|||||+++|++.+..
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~--- 88 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD--- 88 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS---
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC---
Confidence 468999999999999999999873 578999998654332 223456777777799999999999998764
Q ss_pred cEEEeeecccCcccHHHHhcc--------------cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCE
Q psy14889 207 TQLWLVTHYHSFGSLYDHLNR--------------TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNI 272 (443)
Q Consensus 207 ~~~~lv~e~~~~gsL~~~l~~--------------~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~Ni 272 (443)
.++||||||++|||.++|+. ..++|.+++.++.|||+||+|||++ +||||||||+||
T Consensus 89 -~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~--------~iiHRDlKp~NI 159 (299)
T 4asz_A 89 -PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ--------HFVHRDLATRNC 159 (299)
T ss_dssp -SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT--------TCCCSCCSGGGE
T ss_pred -EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CcccCccCHhhE
Confidence 47999999999999999964 3599999999999999999999998 999999999999
Q ss_pred EEcCCCcEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh-cccCC
Q psy14889 273 LVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR-RTKAN 351 (443)
Q Consensus 273 Ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt-g~~~~ 351 (443)
||++++.+||+|||+|+......... ......||+.|||||++.+. .++.++|||||||+||||+| |
T Consensus 160 Ll~~~~~~Ki~DFGla~~~~~~~~~~--~~~~~~gt~~ymAPE~~~~~------~~~~k~DVwS~Gvvl~Ellt~G---- 227 (299)
T 4asz_A 160 LVGENLLVKIGDFGMSRDVYSTDYYR--VGGHTMLPIRWMPPESIMYR------KFTTESDVWSLGVVLWEIFTYG---- 227 (299)
T ss_dssp EECGGGCEEECCCSCHHHHTGGGCEE--ETTTEEECGGGCCHHHHHHC------CCCHHHHHHHHHHHHHHHHTTT----
T ss_pred EECCCCcEEECCcccceecCCCCcee--ecCceecChhhcCHHHHcCC------CCCchhhHHHHHHHHHHHHcCC----
Confidence 99999999999999998665432211 12345799999999999887 78899999999999999999 7
Q ss_pred CcccccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhhc
Q psy14889 352 GIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLACA 431 (443)
Q Consensus 352 ~~~~~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~~ 431 (443)
+.||.+. ...++...+.. ..++..| ..+++++.+||.+||+.||++|||+.||++.|+++.+.
T Consensus 228 ------~~Pf~~~-----~~~~~~~~i~~-~~~~~~p-----~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 228 ------KQPWYQL-----SNNEVIECITQ-GRVLQRP-----RTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp ------CCTTTTS-----CHHHHHHHHHH-TCCCCCC-----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ------CCCCCCC-----CHHHHHHHHHc-CCCCCCC-----ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 7788764 33444444433 3334444 34778899999999999999999999999999999876
Q ss_pred cc
Q psy14889 432 DM 433 (443)
Q Consensus 432 ~~ 433 (443)
.+
T Consensus 291 ~p 292 (299)
T 4asz_A 291 SP 292 (299)
T ss_dssp SC
T ss_pred CC
Confidence 54
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-58 Score=442.13 Aligned_cols=252 Identities=24% Similarity=0.370 Sum_probs=206.2
Q ss_pred ccccccceeeeecCeEEEEEEE-------CCceeEEEEeeccCcc--chHHHHHHHHHHhccCCCceeeeeeccccCCcc
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW-------HGENVAVKIFFSRDEA--SWSRETEIYSTVLLRHENILGYIGSDMTSRNSC 206 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~-------~~~~vAvK~~~~~~~~--~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~ 206 (443)
+++++.+.||+|+||+||+|.+ +++.||||+++..... ......|+..+.+++|||||+++|+|.+...
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~-- 103 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQP-- 103 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS--
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCE--
Confidence 5788899999999999999987 3578999998654322 2234456666677999999999999987643
Q ss_pred cEEEeeecccCcccHHHHhcc-----------------cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCC
Q psy14889 207 TQLWLVTHYHSFGSLYDHLNR-----------------TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKS 269 (443)
Q Consensus 207 ~~~~lv~e~~~~gsL~~~l~~-----------------~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~ 269 (443)
++||||||++|||.++|.. ..++|.+++.|+.|||+||+|||++ +||||||||
T Consensus 104 --~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~--------~iiHRDLK~ 173 (308)
T 4gt4_A 104 --LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH--------HVVHKDLAT 173 (308)
T ss_dssp --CEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT--------TCCCSCCSG
T ss_pred --EEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC--------CCCCCCccc
Confidence 6999999999999999942 3589999999999999999999999 999999999
Q ss_pred CCEEEcCCCcEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh-cc
Q psy14889 270 KNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR-RT 348 (443)
Q Consensus 270 ~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt-g~ 348 (443)
+||||++++.+||+|||+|+.+...... .......||+.|||||++.++ .++.++|||||||+||||+| |
T Consensus 174 ~NILl~~~~~~Ki~DFGlar~~~~~~~~--~~~~~~~gt~~ymAPE~l~~~------~~s~ksDVwSfGvvl~El~t~g- 244 (308)
T 4gt4_A 174 RNVLVYDKLNVKISDLGLFREVYAADYY--KLLGNSLLPIRWMAPEAIMYG------KFSIDSDIWSYGVVLWEVFSYG- 244 (308)
T ss_dssp GGEEECGGGCEEECCSCCBCGGGGGGCB--CSSSSSCBCGGGCCHHHHHHC------CCCHHHHHHHHHHHHHHHHTTT-
T ss_pred cceEECCCCCEEECCcccceeccCCCce--eEecccccCCcccCHHHHhCC------CCCccchhhhHHHHHHHHHhCC-
Confidence 9999999999999999999876543222 122456799999999999887 78899999999999999998 6
Q ss_pred cCCCcccccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHH
Q psy14889 349 KANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKL 428 (443)
Q Consensus 349 ~~~~~~~~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l 428 (443)
..||.+. ...++...+.. ..++..| +.++.++.+||.+||+.||++|||+.||++.|+.+
T Consensus 245 ---------~~Pf~~~-----~~~~~~~~i~~-~~~~~~p-----~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 245 ---------LQPYCGY-----SNQDVVEMIRN-RQVLPCP-----DDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp ---------CCTTTTC-----CHHHHHHHHHT-TCCCCCC-----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred ---------CCCCCCC-----CHHHHHHHHHc-CCCCCCc-----ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 6788764 33444444433 3333344 45778999999999999999999999999999865
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-58 Score=442.81 Aligned_cols=258 Identities=25% Similarity=0.378 Sum_probs=204.9
Q ss_pred hccccccceeeeecCeEEEEEEEC-------CceeEEEEeeccCcc-chHHHHHHHHHHhccCCCceeeeeeccccCCcc
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVWH-------GENVAVKIFFSRDEA-SWSRETEIYSTVLLRHENILGYIGSDMTSRNSC 206 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~~-~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~ 206 (443)
.++|.+.++||+|+||+||+|++. ++.||||+++..... ......|+..+..++|||||+++|+|.+..
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~--- 116 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGR--- 116 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS---
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC---
Confidence 367889999999999999999873 678999998654332 223456777777799999999999998764
Q ss_pred cEEEeeecccCcccHHHHhcc----------------cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCC
Q psy14889 207 TQLWLVTHYHSFGSLYDHLNR----------------TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSK 270 (443)
Q Consensus 207 ~~~~lv~e~~~~gsL~~~l~~----------------~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~ 270 (443)
.++||||||++|||.+++++ ..++|.+++.|+.|||+||+|||+. +||||||||+
T Consensus 117 -~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~--------~iiHRDLKp~ 187 (329)
T 4aoj_A 117 -PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL--------HFVHRDLATR 187 (329)
T ss_dssp -SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT--------TCCCSCCCGG
T ss_pred -EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC--------CeecccccHh
Confidence 47999999999999999853 3589999999999999999999998 9999999999
Q ss_pred CEEEcCCCcEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh-ccc
Q psy14889 271 NILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR-RTK 349 (443)
Q Consensus 271 NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt-g~~ 349 (443)
||||++++.+||+|||+|+.+...... .......||+.|||||++.+. .++.++|||||||+||||+| |
T Consensus 188 NILl~~~~~~Ki~DFGla~~~~~~~~~--~~~~~~~gt~~ymAPE~~~~~------~~~~~sDvwS~Gvvl~Ellt~G-- 257 (329)
T 4aoj_A 188 NCLVGQGLVVKIGDFGMSRDIYSTDYY--RVGGRTMLPIRWMPPESILYR------KFTTESDVWSFGVVLWEIFTYG-- 257 (329)
T ss_dssp GEEEETTTEEEECCCC------------------CCCCGGGCCHHHHTTC------CCCHHHHHHHHHHHHHHHHTTS--
T ss_pred hEEECCCCcEEEcccccceeccCCCcc--eecCcccccccccChhhhcCC------CCCccccccchHHHHHHHHcCC--
Confidence 999999999999999999876543221 112345799999999999877 78899999999999999999 7
Q ss_pred CCCcccccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHh
Q psy14889 350 ANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLA 429 (443)
Q Consensus 350 ~~~~~~~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~ 429 (443)
+.||.+. ...++...+.. ..++..| ..+++++.+||.+||+.||++|||+.||++.|+.+.
T Consensus 258 --------~~Pf~~~-----~~~~~~~~i~~-g~~~~~p-----~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~ 318 (329)
T 4aoj_A 258 --------KQPWYQL-----SNTEAIDCITQ-GRELERP-----RACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALA 318 (329)
T ss_dssp --------CCTTCSS-----CHHHHHHHHHH-TCCCCCC-----TTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHH
T ss_pred --------CCCCCCC-----CHHHHHHHHHc-CCCCCCc-----ccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHh
Confidence 7788764 23344443332 3344444 347788999999999999999999999999999998
Q ss_pred hccc
Q psy14889 430 CADM 433 (443)
Q Consensus 430 ~~~~ 433 (443)
+..+
T Consensus 319 ~~pp 322 (329)
T 4aoj_A 319 QAPP 322 (329)
T ss_dssp HSCC
T ss_pred hCCc
Confidence 8754
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-56 Score=431.86 Aligned_cols=247 Identities=26% Similarity=0.383 Sum_probs=203.7
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc-chHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEee
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA-SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLV 212 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~-~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv 212 (443)
+.|++.+.||+|+||+||+|++ +|+.||||++...... ......|+..+..++|||||++++++.+. ..+|||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~----~~~~iv 149 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVG----DELWVV 149 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEET----TEEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC----CEEEEE
Confidence 5799999999999999999998 5899999998654322 22234556666669999999999999877 468999
Q ss_pred ecccCcccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCccccc
Q psy14889 213 THYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYS 292 (443)
Q Consensus 213 ~e~~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~~ 292 (443)
||||++|+|.+++.+..+++.++..++.||+.||+|||++ +||||||||+||||+.++.+||+|||+|+.+.
T Consensus 150 mEy~~gg~L~~~l~~~~l~e~~~~~~~~qi~~aL~ylH~~--------~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 221 (346)
T 4fih_A 150 MEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQ--------GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS 221 (346)
T ss_dssp ECCCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT--------TEECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC--------CcccccCCHHHEEECCCCCEEEecCcCceecC
Confidence 9999999999999989999999999999999999999999 99999999999999999999999999998775
Q ss_pred ccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCChH
Q psy14889 293 QLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFD 372 (443)
Q Consensus 293 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~~~ 372 (443)
..... ....+||+.|||||++.+. .|+.++|||||||++|||++| ..||.+. ...
T Consensus 222 ~~~~~----~~~~~GTp~YmAPEvl~~~------~y~~~~DiWSlGvilyeml~G----------~~PF~~~-----~~~ 276 (346)
T 4fih_A 222 KEVPR----RKSLVGTPYWMAPELISRL------PYGPEVDIWSLGIMVIEMVDG----------EPPYFNE-----PPL 276 (346)
T ss_dssp SSSCC----BCCCCSCGGGCCHHHHTTC------CBCTHHHHHHHHHHHHHHHHS----------SCTTTTS-----CHH
T ss_pred CCCCc----ccccccCcCcCCHHHHCCC------CCCcHHHHHHHHHHHHHHHHC----------CCCCCCc-----CHH
Confidence 43322 2456899999999999876 778999999999999999999 7788653 223
Q ss_pred HHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 373 DMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
+....+.. ...+.++. ...+++++.+||.+||+.||++|||+.|+++
T Consensus 277 ~~~~~i~~-~~~~~~~~---~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 277 KAMKMIRD-NLPPRLKN---LHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp HHHHHHHH-SSCCCCSC---GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHHHc-CCCCCCCc---cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 33333322 22222221 2346788999999999999999999999876
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-56 Score=436.86 Aligned_cols=262 Identities=22% Similarity=0.393 Sum_probs=210.1
Q ss_pred hhhhccccccceeeeecCeEEEEEEECC-------ceeEEEEeeccCccc--hHHHHHHHHHHhccC-CCceeeeeeccc
Q psy14889 132 RTLAKQISLSECIGKGRYGEVWRGVWHG-------ENVAVKIFFSRDEAS--WSRETEIYSTVLLRH-ENILGYIGSDMT 201 (443)
Q Consensus 132 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~-------~~vAvK~~~~~~~~~--~~~e~ei~~~~~l~H-~nIv~l~g~~~~ 201 (443)
+...++|++.+.||+|+||+||+|.+.+ +.||||++....... .....|+..+..++| ||||+++|+|..
T Consensus 60 Ei~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~ 139 (353)
T 4ase_A 60 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK 139 (353)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred EecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEe
Confidence 4456789999999999999999998742 579999986543322 223456666655755 899999999876
Q ss_pred cCCcccEEEeeecccCcccHHHHhcc-----------------cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEE
Q psy14889 202 SRNSCTQLWLVTHYHSFGSLYDHLNR-----------------TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAH 264 (443)
Q Consensus 202 ~~~~~~~~~lv~e~~~~gsL~~~l~~-----------------~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiH 264 (443)
.. ..++||||||++|+|.++|+. ..+++.+++.++.|||+||+|||++ +|||
T Consensus 140 ~~---~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~--------~iiH 208 (353)
T 4ase_A 140 PG---GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR--------KCIH 208 (353)
T ss_dssp TT---SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT--------TCCC
T ss_pred cC---CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC--------Ceec
Confidence 53 247999999999999999953 2389999999999999999999999 9999
Q ss_pred eCCCCCCEEEcCCCcEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHH
Q psy14889 265 RDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEV 344 (443)
Q Consensus 265 rDlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~el 344 (443)
|||||+|||+++++.+||+|||+|+.+....... ......||+.|||||++.+. .|+.++|||||||+||||
T Consensus 209 RDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~--~~~~~~gt~~ymAPE~l~~~------~y~~ksDVwS~Gv~l~El 280 (353)
T 4ase_A 209 RDLAARNILLSEKNVVKICDFGLARDIYKDPDYV--RKGDARLPLKWMAPETIFDR------VYTIQSDVWSFGVLLWEI 280 (353)
T ss_dssp SCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSE--EETTEEECGGGCCHHHHHHC------CCCHHHHHHHHHHHHHHH
T ss_pred CccCccceeeCCCCCEEECcchhhhhcccCCCce--eeccccccccccCHHHHhcC------CCCCcccEeehHHHHHHH
Confidence 9999999999999999999999998765432211 12345799999999999887 788999999999999999
Q ss_pred Hh-cccCCCcccccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 345 CR-RTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 345 lt-g~~~~~~~~~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
+| | ..||.+.. ..+.+.+.+. ...++..| +.+++++.++|.+||+.||++|||+.||++
T Consensus 281 ~t~G----------~~Pf~~~~----~~~~~~~~i~-~g~~~~~p-----~~~~~~~~~li~~c~~~dP~~RPt~~eil~ 340 (353)
T 4ase_A 281 FSLG----------ASPYPGVK----IDEEFCRRLK-EGTRMRAP-----DYTTPEMYQTMLDCWHGEPSQRPTFSELVE 340 (353)
T ss_dssp TTTS----------CCSSTTCC----CSHHHHHHHH-HTCCCCCC-----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HhCC----------CCCCCCCC----HHHHHHHHHH-cCCCCCCC-----ccCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 98 7 77887642 2233444433 33455555 346778999999999999999999999999
Q ss_pred HHHHHhhcc
Q psy14889 424 TLIKLACAD 432 (443)
Q Consensus 424 ~L~~l~~~~ 432 (443)
.|+++.++.
T Consensus 341 ~L~~llq~~ 349 (353)
T 4ase_A 341 HLGNLLQAN 349 (353)
T ss_dssp HHHHHHHHT
T ss_pred HHHHHHHHh
Confidence 999998764
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-56 Score=426.18 Aligned_cols=257 Identities=19% Similarity=0.204 Sum_probs=203.4
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEeee
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVT 213 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv~ 213 (443)
+.|.+.++||+|+||+||+|++ +|+.||||++..... . ..|+..+..++|||||++++++.+. ..+||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~--~--~~E~~il~~l~HpnIV~l~~~~~~~----~~~~ivm 129 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF--R--VEELVACAGLSSPRIVPLYGAVREG----PWVNIFM 129 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--C--THHHHTTTTCCCTTBCCEEEEEEET----TEEEEEE
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh--H--HHHHHHHHhCCCCCCCcEEEEEEEC----CEEEEEE
Confidence 5688899999999999999998 589999999865322 2 2355566669999999999999876 4689999
Q ss_pred cccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCC-cEEEEecCCcccc
Q psy14889 214 HYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNG-TCVIADFGLAVSY 291 (443)
Q Consensus 214 e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~-~~kl~DfGla~~~ 291 (443)
|||++|+|.+++++ +.+++.++..++.||+.||+|||++ +||||||||+||||+.++ .+||+|||+|+.+
T Consensus 130 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~--------~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~ 201 (336)
T 4g3f_A 130 ELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTR--------RILHGDVKADNVLLSSDGSRAALCDFGHALCL 201 (336)
T ss_dssp CCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTT--------TEECSCCCGGGEEECTTSCCEEECCCTTCEEC
T ss_pred eccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC--------CceecccCHHHEEEeCCCCEEEEeeCCCCeEc
Confidence 99999999999965 6799999999999999999999998 999999999999999987 6999999999877
Q ss_pred cccCCcCC-CCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCC
Q psy14889 292 SQLSNKMD-IPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPS 370 (443)
Q Consensus 292 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~ 370 (443)
........ ......+||+.|||||++.+. .|+.++|||||||++|||+|| ..||.+.....
T Consensus 202 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~------~y~~~~DiwSlGvilyemltG----------~~Pf~~~~~~~-- 263 (336)
T 4g3f_A 202 QPDGLGKSLLTGDYIPGTETHMAPEVVMGK------PCDAKVDIWSSCCMMLHMLNG----------CHPWTQYFRGP-- 263 (336)
T ss_dssp ------------CCCCCCGGGCCHHHHTTC------CCCTHHHHHHHHHHHHHHHHS----------SCSSTTTCCSC--
T ss_pred cCCCcccceecCCccccCccccCHHHHCCC------CCCcHHHHHHHHHHHHHHHHC----------cCCCCCCCHHH--
Confidence 64322211 122345799999999999876 778899999999999999999 77776643221
Q ss_pred hHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhhccc
Q psy14889 371 FDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLACADM 433 (443)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~~~~ 433 (443)
.+.++.........+ +..+++++.+||.+||+.||++|||+.|+++.|.++.+...
T Consensus 264 --~~~~i~~~~~~~~~~-----~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~ 319 (336)
T 4g3f_A 264 --LCLKIASEPPPIREI-----PPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVG 319 (336)
T ss_dssp --CHHHHHHSCCGGGGS-----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred --HHHHHHcCCCCchhc-----CccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhh
Confidence 122222111111112 23467889999999999999999999999999988776543
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-56 Score=429.73 Aligned_cols=245 Identities=25% Similarity=0.386 Sum_probs=195.1
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc---chHHHHHHHHHHhccCCCceeeeeeccccCCcccEEE
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA---SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLW 210 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~---~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~ 210 (443)
++|++.+.||+|+||+||+|++ +|+.||||++...... ......|+..+..++|||||++++++.+. ..+|
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~----~~~y 99 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEEN----GSLY 99 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET----TEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEEC----CEEE
Confidence 6899999999999999999998 5899999998654322 22334677777779999999999999876 4689
Q ss_pred eeecccCcccHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCC
Q psy14889 211 LVTHYHSFGSLYDHLNR---TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGL 287 (443)
Q Consensus 211 lv~e~~~~gsL~~~l~~---~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGl 287 (443)
||||||++|+|.+++.. ..+++.+++.++.||+.||+|||++ +||||||||+||||+.++.+||+|||+
T Consensus 100 iVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~--------~IiHRDlKp~NILl~~~g~vKl~DFGl 171 (350)
T 4b9d_A 100 IVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR--------KILHRDIKSQNIFLTKDGTVQLGDFGI 171 (350)
T ss_dssp EEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT--------TCEETTCCGGGEEECTTCCEEECSTTE
T ss_pred EEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC--------CeeeccCCHHHEEECCCCCEEEccccc
Confidence 99999999999999953 3478999999999999999999999 999999999999999999999999999
Q ss_pred cccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCC
Q psy14889 288 AVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPM 367 (443)
Q Consensus 288 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~ 367 (443)
|+.+...... ....+||+.|||||++.+. .|+.++|||||||+||||+|| ..||.+.
T Consensus 172 a~~~~~~~~~----~~~~~GT~~YmAPE~l~~~------~y~~~~DiwSlGvilyemltG----------~~PF~~~--- 228 (350)
T 4b9d_A 172 ARVLNSTVEL----ARACIGTPYYLSPEICENK------PYNNKSDIWALGCVLYELCTL----------KHAFEAG--- 228 (350)
T ss_dssp ESCCCHHHHH----HHHHHSCCTTCCHHHHTTC------CCCHHHHHHHHHHHHHHHHHS----------SCSCCCS---
T ss_pred ceeecCCccc----ccccCCCccccCHHHHCCC------CCCcHHHHHHHHHHHHHHHHC----------CCCCCCc---
Confidence 9876543211 1235799999999999876 778899999999999999999 7788653
Q ss_pred CCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 368 DPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
+..++...+... ..+..+ ..++.++.+||.+||+.||++|||+.|+++
T Consensus 229 --~~~~~~~~i~~~-~~~~~~-----~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 229 --SMKNLVLKIISG-SFPPVS-----LHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp --SHHHHHHHHHHT-CCCCCC-----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --CHHHHHHHHHcC-CCCCCC-----ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 233333333222 222232 346678999999999999999999999986
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-55 Score=416.11 Aligned_cols=248 Identities=24% Similarity=0.390 Sum_probs=195.6
Q ss_pred ccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc---chHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEee
Q psy14889 138 ISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA---SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLV 212 (443)
Q Consensus 138 ~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~---~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv 212 (443)
|.+.+.||+|+||+||+|.+ ++..||||++...... ......|+..+..++|||||++++++.+.......++||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 46778899999999999998 5889999998654322 222346777777799999999999987643333568999
Q ss_pred ecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcC-CCcEEEEecCCccc
Q psy14889 213 THYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKT-NGTCVIADFGLAVS 290 (443)
Q Consensus 213 ~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~-~~~~kl~DfGla~~ 290 (443)
||||++|+|.+++++ ..+++..+..++.||+.||+|||++ .++||||||||+||||+. ++.+||+|||+|+.
T Consensus 108 mEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~------~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~ 181 (290)
T 3fpq_A 108 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR------TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS------SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC------CCCEEecccChhheeEECCCCCEEEEeCcCCEe
Confidence 999999999999965 6799999999999999999999998 224999999999999985 78999999999975
Q ss_pred ccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCC
Q psy14889 291 YSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPS 370 (443)
Q Consensus 291 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~ 370 (443)
..... ..+.+||+.|||||++.+ .|+.++|||||||++|||+|| ..||.+.. .
T Consensus 182 ~~~~~------~~~~~GTp~YmAPE~~~~-------~y~~~~DiwSlGvilyelltg----------~~Pf~~~~----~ 234 (290)
T 3fpq_A 182 KRASF------AKAVIGTPEFMAPEMYEE-------KYDESVDVYAFGMCMLEMATS----------EYPYSECQ----N 234 (290)
T ss_dssp CCTTS------BEESCSSCCCCCGGGGGT-------CCCTHHHHHHHHHHHHHHHHS----------SCTTTTCS----S
T ss_pred CCCCc------cCCcccCccccCHHHcCC-------CCCcHHHHHHHHHHHHHHHHC----------CCCCCCCC----c
Confidence 43221 234589999999998864 567899999999999999999 77886531 2
Q ss_pred hHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 371 FDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
...+...+......+.++ ...++++.+||.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~~i~~~~~~~~~~-----~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 235 AAQIYRRVTSGVKPASFD-----KVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp HHHHHHHHTTTCCCGGGG-----GCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHcCCCCCCCC-----ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 333444333222111121 234567999999999999999999999875
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-55 Score=433.01 Aligned_cols=248 Identities=26% Similarity=0.383 Sum_probs=204.6
Q ss_pred hccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc-chHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEe
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA-SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWL 211 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~-~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~l 211 (443)
.+.|++.+.||+|+||.||+|++ +|+.||||++...... ......|+..+..++|||||++++++.+. ..+||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~----~~~~i 225 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVG----DELWV 225 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEET----TEEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEEC----CEEEE
Confidence 36799999999999999999998 5899999998654332 22334566666669999999999999876 46899
Q ss_pred eecccCcccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcccc
Q psy14889 212 VTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSY 291 (443)
Q Consensus 212 v~e~~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~ 291 (443)
|||||++|+|.++++...+++.++..++.||+.||+|||++ +||||||||+||||+.++.+||+|||+|+.+
T Consensus 226 VmEy~~gG~L~~~i~~~~l~e~~~~~~~~qil~aL~ylH~~--------~IiHRDiKp~NILl~~~g~vKl~DFGla~~~ 297 (423)
T 4fie_A 226 VMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQ--------GVIHRDIKSDSILLTHDGRVKLSDFGFCAQV 297 (423)
T ss_dssp EEECCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT--------TEECCCCSTTTEEECTTCCEEECCCTTCEEC
T ss_pred EEeCCCCCcHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHC--------CeecccCCHHHEEEcCCCCEEEecCccceEC
Confidence 99999999999999988999999999999999999999999 9999999999999999999999999999877
Q ss_pred cccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCCh
Q psy14889 292 SQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSF 371 (443)
Q Consensus 292 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~~ 371 (443)
...... ....+||+.|||||++.+. .|+.++|||||||++|||++| ..||.+. ..
T Consensus 298 ~~~~~~----~~~~~GTp~YmAPEvl~~~------~y~~~~DiWSlGvilyeml~G----------~~PF~~~-----~~ 352 (423)
T 4fie_A 298 SKEVPR----RKSLVGTPYWMAPELISRL------PYGPEVDIWSLGIMVIEMVDG----------EPPYFNE-----PP 352 (423)
T ss_dssp CSSCCC----BCCCEECTTTCCHHHHTTC------CBCTHHHHHHHHHHHHHHHHS----------SCTTTTS-----CH
T ss_pred CCCCcc----ccccccCcCcCCHHHHCCC------CCCcHHHHHHHHHHHHHHHHC----------CCCCCCc-----CH
Confidence 543322 2456899999999999876 778999999999999999999 7788653 22
Q ss_pred HHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 372 DDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
......+... ..+.++. ...++.++.+||.+||+.||++|||+.|+++
T Consensus 353 ~~~~~~i~~~-~~~~~~~---~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 353 LKAMKMIRDN-LPPRLKN---LHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp HHHHHHHHHS-CCCCCSC---TTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHHHHcC-CCCCCcc---cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 3333333222 2222221 2346678999999999999999999999886
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-55 Score=418.75 Aligned_cols=246 Identities=22% Similarity=0.294 Sum_probs=202.7
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccC----ccchHHHHHHHHHHhccCCCceeeeeeccccCCcccEE
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRD----EASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQL 209 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~----~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~ 209 (443)
++|++.+.||+|+||+||+|+. +|+.||||++.... ........|+..+..++|||||++++++.+. ..+
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~----~~~ 107 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD----EKL 107 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS----SEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC----CEE
Confidence 6799999999999999999998 68999999986432 2222334566667779999999999999876 468
Q ss_pred EeeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCc
Q psy14889 210 WLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA 288 (443)
Q Consensus 210 ~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla 288 (443)
|||||||++|+|.+++.+ +.+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|
T Consensus 108 yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~--------~IiHRDlKPeNILl~~~g~vKl~DFGla 179 (311)
T 4aw0_A 108 YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK--------GIIHRDLKPENILLNEDMHIQITDFGTA 179 (311)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT--------TEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC--------CCccCCCCHHHeEEcCCCCEEEEEcCCc
Confidence 999999999999999965 6899999999999999999999999 9999999999999999999999999999
Q ss_pred ccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCC
Q psy14889 289 VSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMD 368 (443)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~ 368 (443)
+.+...... ....+.+||+.|||||++.+. .|+.++||||+||++|||+|| ..||.+.
T Consensus 180 ~~~~~~~~~--~~~~~~~GTp~YmAPEvl~~~------~y~~~~DiWSlGvilyeml~G----------~~PF~~~---- 237 (311)
T 4aw0_A 180 KVLSPESKQ--ARANSFVGTAQYVSPELLTEK------SACKSSDLWALGCIIYQLVAG----------LPPFRAG---- 237 (311)
T ss_dssp EECCTTTTC--CCBCCCCSCGGGCCHHHHHHS------CBCHHHHHHHHHHHHHHHHHS----------SCSSCCS----
T ss_pred eecCCCCCc--ccccCcccCcccCCHHHHcCC------CCCcHHHHHHHHHHHHHHHhC----------CCCCCCC----
Confidence 877543221 123456899999999999876 677899999999999999999 7788653
Q ss_pred CChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 369 PSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
+..++...+... ...+|. ..++++++|+.+||+.||++|||++|++.
T Consensus 238 -~~~~~~~~i~~~--~~~~p~-----~~s~~~~dli~~lL~~dp~~R~t~~e~~~ 284 (311)
T 4aw0_A 238 -NEGLIFAKIIKL--EYDFPE-----KFFPKARDLVEKLLVLDATKRLGCEEMEG 284 (311)
T ss_dssp -SHHHHHHHHHHT--CCCCCT-----TCCHHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred -CHHHHHHHHHcC--CCCCCc-----ccCHHHHHHHHHHccCCHhHCcChHHHcC
Confidence 333333333222 233442 35678999999999999999999998743
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-54 Score=403.20 Aligned_cols=243 Identities=23% Similarity=0.356 Sum_probs=186.3
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccC----ccchHHHHHHHHHHhccCCCceeeeeeccccCCcccEE
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRD----EASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQL 209 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~----~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~ 209 (443)
++|++.+.||+|+||+||+|+. +|+.||||++.... ......+.|+..+..++|||||++++++.+. ..+
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~----~~~ 88 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSK----DEI 88 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECS----SEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC----CEE
Confidence 6899999999999999999997 58999999986532 1122335666677779999999999998876 468
Q ss_pred EeeecccCcccHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCc
Q psy14889 210 WLVTHYHSFGSLYDHLN-RTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA 288 (443)
Q Consensus 210 ~lv~e~~~~gsL~~~l~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla 288 (443)
|+||||+ +|+|.+++. +..+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|
T Consensus 89 ~ivmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~--------~IiHRDiKP~NILl~~~~~vkl~DFGla 159 (275)
T 3hyh_A 89 IMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH--------KIVHRDLKPENLLLDEHLNVKIADFGLS 159 (275)
T ss_dssp EEEEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHT--------TCCCCCCCTTTEEECTTCCEEECCSSCC
T ss_pred EEEEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC--------CcccccCChHHeEECCCCCEEEeecCCC
Confidence 9999999 579999885 46899999999999999999999999 9999999999999999999999999999
Q ss_pred ccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCC
Q psy14889 289 VSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMD 368 (443)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~ 368 (443)
+....... ..+.+||+.|||||++.+.. .++.++||||+||++|||+|| ..||.+.
T Consensus 160 ~~~~~~~~-----~~~~~GT~~Y~APE~~~~~~-----y~~~~~DiwSlGvily~lltg----------~~PF~~~---- 215 (275)
T 3hyh_A 160 NIMTDGNF-----LKTSCGSPNYAAPEVISGKL-----YAGPEVDVWSCGVILYVMLCR----------RLPFDDE---- 215 (275)
T ss_dssp --------------------CTTSCHHHHSSSS-----CCCTHHHHHHHHHHHHHHHHS----------SCSSCCS----
T ss_pred eecCCCCc-----cCCeeECcccCChhhhcCCC-----CCCChhhhHHHHHHHHHHHHC----------CCCCCCC----
Confidence 76654221 23468999999999998762 124799999999999999999 7788653
Q ss_pred CChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 369 PSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
....+.+.+.. ..+.+| ..+++++.+|+.+||+.||++|||++|+++
T Consensus 216 -~~~~~~~~i~~--~~~~~p-----~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 216 -SIPVLFKNISN--GVYTLP-----KFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp -SHHHHHHHHHH--TCCCCC-----TTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -CHHHHHHHHHc--CCCCCC-----CCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 33444443332 223333 235678999999999999999999999987
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-54 Score=412.02 Aligned_cols=244 Identities=22% Similarity=0.344 Sum_probs=193.7
Q ss_pred ccccccceeeeecCeEEEEEEE-----CCceeEEEEeeccC---ccchHHHHHHHHHHhccCCCceeeeeeccccCCccc
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW-----HGENVAVKIFFSRD---EASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCT 207 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~-----~~~~vAvK~~~~~~---~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~ 207 (443)
++|++.+.||+|+||+||+|+. +++.||||++.... ......+.|+..+..++|||||++++++.+. .
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~----~ 99 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTE----G 99 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEET----T
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC----C
Confidence 6899999999999999999986 36789999986432 1222334566666669999999999999876 4
Q ss_pred EEEeeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecC
Q psy14889 208 QLWLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFG 286 (443)
Q Consensus 208 ~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfG 286 (443)
.+|||||||++|+|.+++.+ ..+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 100 ~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~--------~IiHRDlKp~NILl~~~g~vKl~DFG 171 (304)
T 3ubd_A 100 KLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL--------GIIYRDLKPENILLDEEGHIKLTDFG 171 (304)
T ss_dssp EEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT--------TCCCSSCCGGGEEECTTSCEEEESSE
T ss_pred EEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CCcCCCCCHHHeEEcCCCCEEecccc
Confidence 68999999999999999965 6799999999999999999999999 99999999999999999999999999
Q ss_pred CcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCC
Q psy14889 287 LAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVP 366 (443)
Q Consensus 287 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~ 366 (443)
+|+........ ..+.+||+.|||||++.+. .|+.++|||||||++|||+|| ..||.+.
T Consensus 172 la~~~~~~~~~----~~~~~GT~~YmAPE~~~~~------~y~~~~DiwSlGvilyemltG----------~~PF~~~-- 229 (304)
T 3ubd_A 172 LSKESIDHEKK----AYSFCGTVEYMAPEVVNRR------GHTQSADWWSFGVLMFEMLTG----------TLPFQGK-- 229 (304)
T ss_dssp EEEC-----CC----CCSCCCCGGGCCHHHHHTS------CCCTHHHHHHHHHHHHHHHHS----------SCSSCCS--
T ss_pred cceeccCCCcc----ccccccCcccCCHHHhccC------CCCCCCcccchHHHHHHHHhC----------CCCCCCc--
Confidence 99865432221 2456899999999999876 777899999999999999999 7788653
Q ss_pred CCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcH-----HHHHH
Q psy14889 367 MDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSA-----LRVKK 423 (443)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~-----~evl~ 423 (443)
+..++...+.. ..+.+| ..+++++.+|+.+||+.||++|||+ +|+++
T Consensus 230 ---~~~~~~~~i~~--~~~~~p-----~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 230 ---DRKETMTMILK--AKLGMP-----QFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp ---SHHHHHHHHHH--CCCCCC-----TTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred ---CHHHHHHHHHc--CCCCCC-----CcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 23333333322 223333 2366789999999999999999984 56654
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-53 Score=404.54 Aligned_cols=297 Identities=69% Similarity=1.189 Sum_probs=250.1
Q ss_pred hhhhccccccceeeeecCeEEEEEEECCceeEEEEeeccCccchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEe
Q psy14889 132 RTLAKQISLSECIGKGRYGEVWRGVWHGENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWL 211 (443)
Q Consensus 132 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~l 211 (443)
+.+.++|++.+.||+|+||.||+|.++++.||||++..........|.++.....++||||+++++++.........+++
T Consensus 4 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~l 83 (301)
T 3q4u_A 4 RTVARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWL 83 (301)
T ss_dssp CCCGGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred ccccCcEEEEEeeccCCCcEEEEEEECCEEEEEEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEE
Confidence 34558999999999999999999999999999999977766667778888877778999999999998765544467899
Q ss_pred eecccCcccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcccc
Q psy14889 212 VTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSY 291 (443)
Q Consensus 212 v~e~~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~ 291 (443)
||||+++|+|.++++...+++..++.++.|++.||+|||+..++.....+|+||||||+|||++.++.+||+|||+++..
T Consensus 84 v~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~ 163 (301)
T 3q4u_A 84 ITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMH 163 (301)
T ss_dssp EECCCTTCBHHHHHTTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred ehhhccCCCHHHHHhhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCeeec
Confidence 99999999999999988999999999999999999999932111111239999999999999999999999999999876
Q ss_pred cccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCCh
Q psy14889 292 SQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSF 371 (443)
Q Consensus 292 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~~ 371 (443)
...............||+.|+|||++.+......+.++.++|||||||++|||+||..+.+....+..||.+..+.....
T Consensus 164 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~ 243 (301)
T 3q4u_A 164 SQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSF 243 (301)
T ss_dssp ETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred ccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcch
Confidence 65444333333455899999999999876332222344689999999999999999888888888899999888777778
Q ss_pred HHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHH
Q psy14889 372 DDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKL 428 (443)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l 428 (443)
..+.........++..+..+....++..+.+|+.+||+.||++|||+.+|++.|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 244 EDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp HHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred hhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 888887777777888887777778899999999999999999999999999999986
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-52 Score=406.25 Aligned_cols=319 Identities=63% Similarity=1.077 Sum_probs=264.0
Q ss_pred hhcccCCCCCCCchHHHhhhhccccccceeeeecCeEEEEEEECCceeEEEEeeccCccchHHHHHHHHHHhccCCCcee
Q psy14889 115 DASLTSGSGSGLPLLIQRTLAKQISLSECIGKGRYGEVWRGVWHGENVAVKIFFSRDEASWSRETEIYSTVLLRHENILG 194 (443)
Q Consensus 115 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~H~nIv~ 194 (443)
..+..+.+....+......+.++|++.+.||+|+||.||+|+++++.||||++..........|.++.....++||||++
T Consensus 16 ~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~ 95 (337)
T 3mdy_A 16 EQSQSSGSGSGLPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILG 95 (337)
T ss_dssp HHHHHHCSCSSSCHHHHTTHHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCC
T ss_pred cccccCCCCCCCCcccccccccceEEEeEeecCCCeEEEEEEECCceEEEEEEeccccchhhhHHHHHHHHhhcCCCeee
Confidence 33334445566777888888899999999999999999999999999999999776666667777777776679999999
Q ss_pred eeeeccccCCcccEEEeeecccCcccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEE
Q psy14889 195 YIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILV 274 (443)
Q Consensus 195 l~g~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl 274 (443)
+++++.........+++||||+++|+|.++++...+++..++.++.|++.||.|||+..+...++++|+||||||+|||+
T Consensus 96 ~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill 175 (337)
T 3mdy_A 96 FIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILV 175 (337)
T ss_dssp EEEEEEESCGGGCEEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEE
T ss_pred EEEEEccCCCCCCceEEEEeccCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEE
Confidence 99998876554457899999999999999999889999999999999999999999875555556699999999999999
Q ss_pred cCCCcEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcc
Q psy14889 275 KTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIF 354 (443)
Q Consensus 275 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~ 354 (443)
+.++.+||+|||+++.+...............||+.|+|||++.+.........+.++|||||||++|||+||+.+++..
T Consensus 176 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~ 255 (337)
T 3mdy_A 176 KKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIV 255 (337)
T ss_dssp CTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred CCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccc
Confidence 99999999999999776654443333334568999999999998763321111122499999999999999999988888
Q ss_pred cccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhhccc
Q psy14889 355 EEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLACADM 433 (443)
Q Consensus 355 ~~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~~~~ 433 (443)
.....||....+.................++..+..+....++.++.+|+.+||+.||++|||+.++++.|+++.++..
T Consensus 256 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 334 (337)
T 3mdy_A 256 EEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQD 334 (337)
T ss_dssp CCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTTT
T ss_pred ccccccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhcc
Confidence 8889999998887778888888777777777777777677899999999999999999999999999999999998653
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-52 Score=400.26 Aligned_cols=251 Identities=22% Similarity=0.361 Sum_probs=182.3
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccc--hHHHHHHHHHHhccCCCceeeeeeccccCCc------
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEAS--WSRETEIYSTVLLRHENILGYIGSDMTSRNS------ 205 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~--~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~------ 205 (443)
++|++.+.||+|+||+||+|++ +|+.||||++....... .....|+..+..++|||||++++++.+....
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 4699999999999999999998 58999999986543322 2335677777789999999999998765421
Q ss_pred --ccEEEeeecccCcccHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCc
Q psy14889 206 --CTQLWLVTHYHSFGSLYDHLNRT----TLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGT 279 (443)
Q Consensus 206 --~~~~~lv~e~~~~gsL~~~l~~~----~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~ 279 (443)
...+|+|||||++|+|.++++.. ..++..++.++.||+.||+|||++ +|+||||||+|||++.++.
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~--------~IiHRDlKp~NILl~~~~~ 156 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK--------GLMHRDLKPSNIFFTMDDV 156 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT--------TCCCCCCCGGGEEECTTCC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC--------cCccccCcHHHeEECCCCc
Confidence 13579999999999999999753 345667889999999999999999 9999999999999999999
Q ss_pred EEEEecCCcccccccCCcCC--------CCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCC
Q psy14889 280 CVIADFGLAVSYSQLSNKMD--------IPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKAN 351 (443)
Q Consensus 280 ~kl~DfGla~~~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~ 351 (443)
+||+|||+|+.+........ ...++.+||+.|||||++.+. .|+.++|||||||++|||++
T Consensus 157 vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~------~y~~~~DiwSlGvilyell~----- 225 (299)
T 4g31_A 157 VKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGN------SYSHKVDIFSLGLILFELLY----- 225 (299)
T ss_dssp EEECCCCCC--------------------------CCCTTSCHHHHTTC------CCCTHHHHHHHHHHHHHHHS-----
T ss_pred EEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCC------CCCCHHHHHHHHHHHHHHcc-----
Confidence 99999999987765332211 112345799999999999876 77899999999999999985
Q ss_pred CcccccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 352 GIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 352 ~~~~~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
||... .+.......... ...|.. ....++.+.+|+.+||+.||++|||+.|+++
T Consensus 226 --------Pf~~~------~~~~~~~~~~~~--~~~p~~--~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 226 --------PFSTQ------MERVRTLTDVRN--LKFPPL--FTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp --------CCSSH------HHHHHHHHHHHT--TCCCHH--HHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --------CCCCc------cHHHHHHHHHhc--CCCCCC--CcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 44321 111211111111 112211 1223456789999999999999999999986
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-51 Score=397.63 Aligned_cols=324 Identities=62% Similarity=1.052 Sum_probs=263.9
Q ss_pred hhHHhhhhcccCCCCCCCchHHHhhhhccccccceeeeecCeEEEEEEECCceeEEEEeeccCccchHHHHHHHHHHhcc
Q psy14889 109 TLREYLDASLTSGSGSGLPLLIQRTLAKQISLSECIGKGRYGEVWRGVWHGENVAVKIFFSRDEASWSRETEIYSTVLLR 188 (443)
Q Consensus 109 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~ 188 (443)
++.........+++....+......+.++|.+.+.||+|+||.||+|+++|+.||||++..........|.++.....++
T Consensus 15 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~ 94 (342)
T 1b6c_B 15 TLKDLIYDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLR 94 (342)
T ss_dssp CHHHHHHHTCCTTCCSSSCHHHHHHHHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHHHSCCC
T ss_pred chhheeeeccccCCCCCCceeecccccccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCchhHHHHHHHHHHHHHhhcC
Confidence 44555666666777788899999999999999999999999999999999999999999776666666677777766689
Q ss_pred CCCceeeeeeccccCCcccEEEeeecccCcccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCC
Q psy14889 189 HENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIK 268 (443)
Q Consensus 189 H~nIv~l~g~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk 268 (443)
||||+++++++.........+++||||+++|+|.+++.+..+++..++.++.|++.||.|||+......+..+|+|||||
T Consensus 95 h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlk 174 (342)
T 1b6c_B 95 HENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLK 174 (342)
T ss_dssp CTTBCCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCS
T ss_pred CCcEEEEEeeecccCCccceeEEEEeecCCCcHHHHHhccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCC
Confidence 99999999998877543346899999999999999999889999999999999999999999321111112299999999
Q ss_pred CCCEEEcCCCcEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcc
Q psy14889 269 SKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRT 348 (443)
Q Consensus 269 ~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~ 348 (443)
|+|||++.++.+||+|||++..................||+.|+|||++.+......+.++.++||||||+++|||+||+
T Consensus 175 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~ 254 (342)
T 1b6c_B 175 SKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRC 254 (342)
T ss_dssp GGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTB
T ss_pred HHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhcc
Confidence 99999999999999999999776544322221234557999999999997653322112336899999999999999998
Q ss_pred cCCCcccccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHH
Q psy14889 349 KANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKL 428 (443)
Q Consensus 349 ~~~~~~~~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l 428 (443)
.+.+.......||............+...+.....++.++..+....++..+.+|+.+||+.||++|||+.+|++.|+++
T Consensus 255 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i 334 (342)
T 1b6c_B 255 SIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 334 (342)
T ss_dssp CBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred CcCCcccccccCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 77766667788998877666677777777666666777776666677889999999999999999999999999999999
Q ss_pred hhcc
Q psy14889 429 ACAD 432 (443)
Q Consensus 429 ~~~~ 432 (443)
.+..
T Consensus 335 ~~~~ 338 (342)
T 1b6c_B 335 SQQE 338 (342)
T ss_dssp HHTT
T ss_pred HHHh
Confidence 8754
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-50 Score=400.28 Aligned_cols=261 Identities=20% Similarity=0.296 Sum_probs=195.7
Q ss_pred hccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccc---hHHHHHHHHHHhccCCCceeeeeeccccC--Cccc
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEAS---WSRETEIYSTVLLRHENILGYIGSDMTSR--NSCT 207 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~---~~~e~ei~~~~~l~H~nIv~l~g~~~~~~--~~~~ 207 (443)
.++|++.+.||+|+||+||+|++ +|+.||||++....... ....+|+..+..++|||||++++++.... ....
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 36799999999999999999998 69999999986543221 12235666677799999999999876532 1224
Q ss_pred EEEeeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecC
Q psy14889 208 QLWLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFG 286 (443)
Q Consensus 208 ~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfG 286 (443)
.+|||||||+ |+|.+++.+ +.+++.++..++.||+.||.|||++ +||||||||+|||++.++.+||+|||
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~--------~iiHRDlKP~NIl~~~~~~~Ki~DFG 203 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSA--------QVIHRDLKPSNLLVNENCELKIGDFG 203 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHT--------TCBCCCCCGGGEEECTTCCEEECCCT
T ss_pred EEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------cCcCCCcCccccccCCCCCEEEeecc
Confidence 6899999996 689999864 6799999999999999999999999 99999999999999999999999999
Q ss_pred CcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCC
Q psy14889 287 LAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVP 366 (443)
Q Consensus 287 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~ 366 (443)
+|+.+............+.+||+.|||||++.+.. .++.++||||+||++|||++| ..||.+..
T Consensus 204 la~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~-----~~~~~~DiWSlG~il~ell~G----------~~pF~g~~- 267 (398)
T 4b99_A 204 MARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLH-----EYTQAIDLWSVGCIFGEMLAR----------RQLFPGKN- 267 (398)
T ss_dssp TCBCC-------CCCCCSSCCCCTTCCHHHHTTCS-----CCCTHHHHHHHHHHHHHHHHT----------SCSSCCSS-
T ss_pred eeeecccCccccccccccceeChHhcCHHHhcCCC-----CCCChhheehhHHHHHHHHHC----------CCCCCCCC-
Confidence 99877544333333345678999999999987652 456899999999999999999 56665421
Q ss_pred CCCChHHHHhhhhhcCC---------------------CCCCCCCC--CCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 367 MDPSFDDMRKVICIDQQ---------------------RPVLPNRW--VSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 367 ~~~~~~~~~~~~~~~~~---------------------~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
..+.+..+...... .+..+..| .....+.++.+||.+||..||++|||+.|+++
T Consensus 268 ---~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 268 ---YVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp ---HHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---HHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 11222222111110 00001000 01124567999999999999999999999886
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-50 Score=389.05 Aligned_cols=293 Identities=38% Similarity=0.690 Sum_probs=232.6
Q ss_pred ccccccceeeeecCeEEEEEEECCceeEEEEeeccCccchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEeeecc
Q psy14889 136 KQISLSECIGKGRYGEVWRGVWHGENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVTHY 215 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e~ 215 (443)
++|++.+.||+|+||.||+|++.++.||||++..........+.|+..+..++||||+++++++.........+++||||
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~ 103 (322)
T 3soc_A 24 MPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAF 103 (322)
T ss_dssp EEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred hhchhhheecccCceEEEEEEECCCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEec
Confidence 68999999999999999999999999999999776666666677888887899999999999998765544668999999
Q ss_pred cCcccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchh--cCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcccccc
Q psy14889 216 HSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIF--GTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQ 293 (443)
Q Consensus 216 ~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~--~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~~~ 293 (443)
+++|+|.++++...+++..+..++.|++.||.|||+... ...+.++|+||||||+|||++.++.+||+|||+++.+..
T Consensus 104 ~~~g~L~~~l~~~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~ 183 (322)
T 3soc_A 104 HEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEA 183 (322)
T ss_dssp CTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEEECT
T ss_pred CCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCccccccc
Confidence 999999999998889999999999999999999996510 011133899999999999999999999999999987654
Q ss_pred cCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCc-ccccCCCCCCCCCCCCChH
Q psy14889 294 LSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGI-FEEYKAPYHDLVPMDPSFD 372 (443)
Q Consensus 294 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~-~~~~~~P~~~~~~~~~~~~ 372 (443)
.... .......||+.|+|||++.+..... ..++.++|||||||++|||+||+.|+.. ......||.......+...
T Consensus 184 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~-~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 260 (322)
T 3soc_A 184 GKSA--GDTHGQVGTRRYMAPEVLEGAINFQ-RDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLE 260 (322)
T ss_dssp TSCC--CCCTTCCCCGGGCCHHHHTTCCCCC-HHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHH
T ss_pred ccCc--cccccCccCccccCHhhcccccccC-cCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchh
Confidence 3322 1223457999999999997642211 1345688999999999999999665431 1122333333223344555
Q ss_pred HHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhhc
Q psy14889 373 DMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLACA 431 (443)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~~ 431 (443)
.+...+.....++.++..+....++.++.+|+.+||+.||++|||+.||++.|+++.+.
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 261 DMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp HHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 66666666666777776666677888899999999999999999999999999998764
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-49 Score=384.22 Aligned_cols=196 Identities=21% Similarity=0.374 Sum_probs=158.0
Q ss_pred hhccccccceeeeecCeEEEEEEE-----CCceeEEEEeeccCccchHHHHHHHHHHhc-cCCCceeeeeeccccCCccc
Q psy14889 134 LAKQISLSECIGKGRYGEVWRGVW-----HGENVAVKIFFSRDEASWSRETEIYSTVLL-RHENILGYIGSDMTSRNSCT 207 (443)
Q Consensus 134 ~~~~~~~~~~lG~G~fg~Vy~~~~-----~~~~vAvK~~~~~~~~~~~~e~ei~~~~~l-~H~nIv~l~g~~~~~~~~~~ 207 (443)
+.+.|++.+.||+|+||+||+|+. +++.||||++..... ......|+..+..+ +|||||++++++.+. .
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~-~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~----~ 93 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH-PIRIAAELQCLTVAGGQDNVMGVKYCFRKN----D 93 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC-HHHHHHHHHHHHHTCSBTTBCCCSEEEEET----T
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC-HHHHHHHHHHHHHhcCCCCCceEEEEEEEC----C
Confidence 457899999999999999999986 257899998865432 22233455544445 799999999998876 4
Q ss_pred EEEeeecccCcccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCC-CcEEEEecC
Q psy14889 208 QLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTN-GTCVIADFG 286 (443)
Q Consensus 208 ~~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~-~~~kl~DfG 286 (443)
.+++||||+++|+|.++++ .+++.++..++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||
T Consensus 94 ~~~lvmE~~~g~~L~~~~~--~l~~~~~~~~~~qll~al~ylH~~--------gIiHRDiKPeNiLl~~~~~~~kl~DFG 163 (361)
T 4f9c_A 94 HVVIAMPYLEHESFLDILN--SLSFQEVREYMLNLFKALKRIHQF--------GIVHRDVKPSNFLYNRRLKKYALVDFG 163 (361)
T ss_dssp EEEEEEECCCCCCHHHHHT--TCCHHHHHHHHHHHHHHHHHHHHT--------TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred EEEEEEeCCCcccHHHHHc--CCCHHHHHHHHHHHHHHHHHHHHC--------CeEeCcCCHHHeEEeCCCCeEEECcCC
Confidence 6899999999999999985 599999999999999999999999 99999999999999887 799999999
Q ss_pred CcccccccCCcC------------------------CCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHH
Q psy14889 287 LAVSYSQLSNKM------------------------DIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLW 342 (443)
Q Consensus 287 la~~~~~~~~~~------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ 342 (443)
+|+......... .......+||+.|||||++.+.. .++.++||||+||++|
T Consensus 164 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-----~y~~~~DiWSlG~il~ 238 (361)
T 4f9c_A 164 LAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCP-----NQTTAIDMWSAGVIFL 238 (361)
T ss_dssp TCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCS-----CCCTHHHHHHHHHHHH
T ss_pred CCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCC-----CCCCccchhhhHHHHH
Confidence 997654321100 01123457999999999997652 4668999999999999
Q ss_pred HHHhccc
Q psy14889 343 EVCRRTK 349 (443)
Q Consensus 343 elltg~~ 349 (443)
||+||+.
T Consensus 239 ell~G~~ 245 (361)
T 4f9c_A 239 SLLSGRY 245 (361)
T ss_dssp HHHHTCS
T ss_pred HHHHCCC
Confidence 9999943
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=403.57 Aligned_cols=248 Identities=17% Similarity=0.314 Sum_probs=200.8
Q ss_pred hccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc-chHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEe
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA-SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWL 211 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~-~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~l 211 (443)
.++|++.+.||+|+||.||+|+. +|+.||+|++...... ......|+..+..++|||||++++++.+. ..++|
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~----~~~~i 231 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD----NEMVM 231 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECS----SEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEEC----CEEEE
Confidence 36899999999999999999998 6899999998664432 22234566666779999999999999876 56899
Q ss_pred eecccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCC--CcEEEEecCC
Q psy14889 212 VTHYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTN--GTCVIADFGL 287 (443)
Q Consensus 212 v~e~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~--~~~kl~DfGl 287 (443)
|||||++|+|.+++.+ ..+++.++..++.||+.||.|||++ +|+||||||+|||++.+ +.+||+|||+
T Consensus 232 v~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~--------~iiHRDlKp~Nill~~~~~~~vKl~DFG~ 303 (573)
T 3uto_A 232 IYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN--------NYVHLDLKPENIMFTTKRSNELKLIDFGL 303 (573)
T ss_dssp EEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHT--------TEECCCCCGGGEEESSSSCCCEEECCCSS
T ss_pred EEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC--------CeeeccCChhhccccCCCCCCEEEeeccc
Confidence 9999999999999853 5799999999999999999999999 99999999999999865 7999999999
Q ss_pred cccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCC
Q psy14889 288 AVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPM 367 (443)
Q Consensus 288 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~ 367 (443)
|+.+...... ...+||+.|||||++.+. .|+.++|||||||++|||++| ..||.+.
T Consensus 304 a~~~~~~~~~-----~~~~GT~~y~APEv~~~~------~y~~~~DiWSlGvilyeml~G----------~~Pf~~~--- 359 (573)
T 3uto_A 304 TAHLDPKQSV-----KVTTGTAEFAAPEVAEGK------PVGYYTDMWSVGVLSYILLSG----------LSPFGGE--- 359 (573)
T ss_dssp CEECCTTSEE-----EEECSSGGGCCHHHHTTC------CBCHHHHHHHHHHHHHHHHHS----------CCSSCCS---
T ss_pred eeEccCCCce-----eeeEECccccCHHHhCCC------CCCcHHHHHHHHHHHHHHHHC----------CCCCCCc---
Confidence 9877543221 335799999999999886 777899999999999999999 7788653
Q ss_pred CCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 368 DPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
...+....+... ...++.. ....+++++.+||.+||+.||++|||+.|+++
T Consensus 360 --~~~~~~~~i~~~--~~~~~~~-~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 360 --NDDETLRNVKSC--DWNMDDS-AFSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp --SHHHHHHHHHTT--CCCCCSG-GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred --CHHHHHHHHHhC--CCCCCcc-cccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 223333333221 1122211 11235678999999999999999999999986
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=401.01 Aligned_cols=246 Identities=26% Similarity=0.385 Sum_probs=197.0
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccC------ccchHHHHHH-HHHHhccCCCceeeeeeccccCCcc
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRD------EASWSRETEI-YSTVLLRHENILGYIGSDMTSRNSC 206 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~------~~~~~~e~ei-~~~~~l~H~nIv~l~g~~~~~~~~~ 206 (443)
++|++.+.||+|+||+||+|+. +|+.||||++.+.. ......|..+ ..+..++|||||++++++.+.
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~---- 264 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP---- 264 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS----
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEEC----
Confidence 5799999999999999999998 68999999986432 1222334333 344457999999999999887
Q ss_pred cEEEeeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEec
Q psy14889 207 TQLWLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADF 285 (443)
Q Consensus 207 ~~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~Df 285 (443)
..+|||||||++|+|.++|.+ +.+++..+..++.||+.||+|||++ +||||||||+||||+.+|++||+||
T Consensus 265 ~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~--------gIiHRDLKPeNILld~~G~vKL~DF 336 (689)
T 3v5w_A 265 DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR--------FVVYRDLKPANILLDEHGHVRISDL 336 (689)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTT--------TEECCCCSGGGEEECTTSCEEECCC
T ss_pred CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CccccCCchHHeEEeCCCCEEeccc
Confidence 468999999999999999965 6799999999999999999999998 9999999999999999999999999
Q ss_pred CCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCC
Q psy14889 286 GLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLV 365 (443)
Q Consensus 286 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~ 365 (443)
|+|+.+.... ..+.+||+.|||||++..+. .|+.++|||||||++|||++| ..||.+..
T Consensus 337 GlA~~~~~~~------~~t~~GTp~YmAPEvl~~~~-----~y~~~vDiWSLGvilYEmLtG----------~~PF~~~~ 395 (689)
T 3v5w_A 337 GLACDFSKKK------PHASVGTHGYMAPEVLQKGV-----AYDSSADWFSLGCMLFKLLRG----------HSPFRQHK 395 (689)
T ss_dssp TTCEECSSCC------CCSCCSCGGGCCHHHHSTTC-----CCCTHHHHHHHHHHHHHHHHS----------SCTTCGGG
T ss_pred ceeeecCCCC------CCCccCCcCccCHHHHhCCC-----CCCcHHHHHHHHHHHHHHHhC----------CCCCCCCC
Confidence 9998765422 24568999999999997541 567899999999999999999 77886532
Q ss_pred CCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCc-----HHHHHH
Q psy14889 366 PMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLS-----ALRVKK 423 (443)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~ 423 (443)
.. ....+...+.. ....+| ..++.++.+||.+||+.||++|++ ++||++
T Consensus 396 ~~--~~~~i~~~i~~--~~~~~p-----~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 396 TK--DKHEIDRMTLT--MAVELP-----DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp CC--CHHHHHHHHHH--CCCCCC-----TTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred hH--HHHHHHHhhcC--CCCCCC-----ccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 21 22233332222 223333 335678999999999999999998 677765
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-47 Score=364.57 Aligned_cols=257 Identities=29% Similarity=0.505 Sum_probs=199.7
Q ss_pred hccccccceeeeecCeEEEEEEECCceeEEEEeeccCccc---hHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEe
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVWHGENVAVKIFFSRDEAS---WSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWL 211 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~---~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~l 211 (443)
.++|++.+.||+|+||.||+|+++|+.||||++....... .....|+..+..++||||+++++++.+.. .+++
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~----~~~l 111 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPP----NLSI 111 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT----CCEE
T ss_pred hhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC----ceEE
Confidence 4789999999999999999999999999999986543221 12245666666799999999999987764 4699
Q ss_pred eecccCcccHHHHhcccC----CCHHHHHHHHHHHHHHHHHHHHchhcCCCCCC--eEEeCCCCCCEEEcCCCcEEEEec
Q psy14889 212 VTHYHSFGSLYDHLNRTT----LNHHQMMKICLSIVNGLVHLHTEIFGTQGKPA--IAHRDIKSKNILVKTNGTCVIADF 285 (443)
Q Consensus 212 v~e~~~~gsL~~~l~~~~----l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~--iiHrDlk~~NiLl~~~~~~kl~Df 285 (443)
||||+++|+|.+++.... +++..++.++.|++.||+|||+. + |+||||||+|||++.++.+||+||
T Consensus 112 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~--------~~~ivH~Dikp~NIll~~~~~~kL~Df 183 (309)
T 3p86_A 112 VTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR--------NPPIVHRNLKSPNLLVDKKYTVKVCDF 183 (309)
T ss_dssp EEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS--------SSCCCCTTCCGGGEEECTTCCEEECCC
T ss_pred EEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC--------CCCEECCCCChhhEEEeCCCcEEECCC
Confidence 999999999999997543 99999999999999999999998 7 999999999999999999999999
Q ss_pred CCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCC
Q psy14889 286 GLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLV 365 (443)
Q Consensus 286 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~ 365 (443)
|+++....... ......||+.|+|||++.+. .++.++||||||+++|||++| ..||...
T Consensus 184 g~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~elltg----------~~Pf~~~- 242 (309)
T 3p86_A 184 GLSRLKASTFL----SSKSAAGTPEWMAPEVLRDE------PSNEKSDVYSFGVILWELATL----------QQPWGNL- 242 (309)
T ss_dssp C---------------------CCTTSCHHHHTTC------CCCTTHHHHHHHHHHHHHHHC----------CCTTTTS-
T ss_pred CCCcccccccc----ccccCCCCccccChhhhcCC------CCCchhhHHHHHHHHHHHHhC----------CCCCCCC-
Confidence 99975443221 12345799999999999876 667899999999999999999 7777654
Q ss_pred CCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhhccc
Q psy14889 366 PMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLACADM 433 (443)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~~~~ 433 (443)
........+.........+ ..++.++.+|+.+||+.||++|||+.++++.|+.+.+...
T Consensus 243 ----~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~ 301 (309)
T 3p86_A 243 ----NPAQVVAAVGFKCKRLEIP-----RNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAV 301 (309)
T ss_dssp ----CHHHHHHHHHHSCCCCCCC-----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC---
T ss_pred ----CHHHHHHHHHhcCCCCCCC-----ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCC
Confidence 2233333333333444444 3366789999999999999999999999999999987543
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-47 Score=367.05 Aligned_cols=301 Identities=34% Similarity=0.599 Sum_probs=223.1
Q ss_pred ccccccceeeeecCeEEEEEEECCceeEEEEeeccCccchHHHHHHHHHHhccCCCceeeeeecccc-CCcccEEEeeec
Q psy14889 136 KQISLSECIGKGRYGEVWRGVWHGENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIGSDMTS-RNSCTQLWLVTH 214 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~-~~~~~~~~lv~e 214 (443)
++|++.+.||+|+||.||+|+++++.||||++..........|.++..+..++||||+++++.+... ......+++|||
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e 92 (336)
T 3g2f_A 13 DNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVME 92 (336)
T ss_dssp TSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEEC
T ss_pred HHhheeeecccCCCeEEEEEEECCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEe
Confidence 7899999999999999999999999999999987766667777888777678999999999865421 111245789999
Q ss_pred ccCcccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchh-cCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcccccc
Q psy14889 215 YHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIF-GTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQ 293 (443)
Q Consensus 215 ~~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~-~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~~~ 293 (443)
|+++|+|.+++.....++..+..++.||+.||.|||+... +....++|+||||||+|||++.++.+||+|||+++.+..
T Consensus 93 ~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~ 172 (336)
T 3g2f_A 93 YYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTG 172 (336)
T ss_dssp CCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred cCCCCcHHHHHhhcccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccceeeccc
Confidence 9999999999988888999999999999999999997521 011234899999999999999999999999999987654
Q ss_pred cCCc----CCCCCCCcccccCcccccccccccccC-cCCCCCccchHHHHHHHHHHHhcccCCCccc---ccCCCCCCCC
Q psy14889 294 LSNK----MDIPPNPRVGTKRYMSPEILDESINMD-CFESFKKADIYALGLVLWEVCRRTKANGIFE---EYKAPYHDLV 365 (443)
Q Consensus 294 ~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~---~~~~P~~~~~ 365 (443)
.... .........||+.|+|||++.+..... ...++.++|||||||++|||++|+.|+.... .....+....
T Consensus 173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~ 252 (336)
T 3g2f_A 173 NRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEV 252 (336)
T ss_dssp SSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHH
T ss_pred ccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhccc
Confidence 3211 111123457999999999997632110 0144578999999999999999954421110 0000000001
Q ss_pred CCCCChHHHHhhhhhcCCCCCCCCCCCC-chhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhhcccccc
Q psy14889 366 PMDPSFDDMRKVICIDQQRPVLPNRWVS-DSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLACADMYIH 436 (443)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~~~~~~~ 436 (443)
...+....+...+.....++.++..+.. ..++..+.+||.+||+.||++|||+.|+++.|+++...-.+..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~~ 324 (336)
T 3g2f_A 253 GNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNK 324 (336)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC--
T ss_pred CCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHhcc
Confidence 1223344555555556666777665543 3467789999999999999999999999999999997665543
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=357.50 Aligned_cols=248 Identities=26% Similarity=0.427 Sum_probs=201.5
Q ss_pred hccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc-chHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEe
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA-SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWL 211 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~-~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~l 211 (443)
.++|++.+.||+|+||.||+|.. +|+.||||++...... ......|+..+..++||||+++++++... ..+++
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~----~~~~l 94 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG----DELWV 94 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEET----TEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEEC----CEEEE
Confidence 36899999999999999999986 6899999998654332 22334566666679999999999998876 45899
Q ss_pred eecccCcccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcccc
Q psy14889 212 VTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSY 291 (443)
Q Consensus 212 v~e~~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~ 291 (443)
||||+++|+|.+++.+..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++...
T Consensus 95 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--------~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (297)
T 3fxz_A 95 VMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN--------QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI 166 (297)
T ss_dssp EEECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT--------TEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEECCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhC--------CceeCCCCHHHEEECCCCCEEEeeCCCceec
Confidence 99999999999999988999999999999999999999999 9999999999999999999999999999776
Q ss_pred cccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCCh
Q psy14889 292 SQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSF 371 (443)
Q Consensus 292 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~~ 371 (443)
...... .....||+.|+|||++.+. .++.++|||||||++|||++| ..||.... ..
T Consensus 167 ~~~~~~----~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~ell~g----------~~pf~~~~----~~ 222 (297)
T 3fxz_A 167 TPEQSK----RSTMVGTPYWMAPEVVTRK------AYGPKVDIWSLGIMAIEMIEG----------EPPYLNEN----PL 222 (297)
T ss_dssp CSTTCC----BCCCCSCGGGCCHHHHHCS------CBCTHHHHHHHHHHHHHHHHS----------SCTTTTSC----HH
T ss_pred CCcccc----cCCccCCcCccChhhhcCC------CCCcHHHHHHHHHHHHHHHhC----------CCCCCCCC----HH
Confidence 543322 2345799999999999876 677899999999999999999 77776531 11
Q ss_pred HHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 372 DDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
.......... .+... .+..++..+.+++.+||+.||++|||+.|+++
T Consensus 223 ~~~~~~~~~~--~~~~~---~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 223 RALYLIATNG--TPELQ---NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp HHHHHHHHHC--SCCCS---CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHHHhCC--CCCCC---CccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 2222222211 11111 12446778999999999999999999999986
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-46 Score=357.71 Aligned_cols=259 Identities=25% Similarity=0.374 Sum_probs=201.3
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc-chHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEee
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA-SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLV 212 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~-~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv 212 (443)
++|.+.+.||+|+||.||+|.+ +++.||+|++...... ......|+..+..++||||+++++++.+. ...++|
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~----~~~~lv 85 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKD----KRLNFI 85 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET----TEEEEE
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecC----CeeEEE
Confidence 6899999999999999999998 5889999987553322 22335667777779999999999998876 458999
Q ss_pred ecccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCccc
Q psy14889 213 THYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVS 290 (443)
Q Consensus 213 ~e~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~ 290 (443)
|||+++|+|.+++.. ..+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~--------~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 157 (310)
T 3s95_A 86 TEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSM--------NIIHRDLNSHNCLVRENKNVVVADFGLARL 157 (310)
T ss_dssp EECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHT--------TEECSCCSTTSEEECTTSCEEECCCTTCEE
T ss_pred EEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC--------CccCCCCCcCeEEECCCCCEEEeeccccee
Confidence 999999999999975 6799999999999999999999999 999999999999999999999999999987
Q ss_pred ccccCCcCC----------CCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCC
Q psy14889 291 YSQLSNKMD----------IPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAP 360 (443)
Q Consensus 291 ~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P 360 (443)
......... .......||+.|+|||++.+. .++.++||||||+++|||++| ..|
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~Di~slG~~l~el~~g----------~~~ 221 (310)
T 3s95_A 158 MVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGR------SYDEKVDVFSFGIVLCEIIGR----------VNA 221 (310)
T ss_dssp CC--------------------CCCCSCGGGCCHHHHTTC------CCCTHHHHHHHHHHHHHHHHT----------CCS
T ss_pred cccccccccccccccccccccccccCCCcceeCHHHhcCC------CCCcHHHHHHHHHHHHHHhcC----------CCC
Confidence 654322110 011245799999999999876 677899999999999999999 444
Q ss_pred CCCCCCCCCChHH-HHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhhcc
Q psy14889 361 YHDLVPMDPSFDD-MRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLACAD 432 (443)
Q Consensus 361 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~~~ 432 (443)
|............ ...... ... + ..++..+.+++.+||+.||++|||+.++++.|+++....
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~-~~~----~-----~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~ 284 (310)
T 3s95_A 222 DPDYLPRTMDFGLNVRGFLD-RYC----P-----PNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL 284 (310)
T ss_dssp STTTSCBCTTSSBCHHHHHH-HTC----C-----TTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CcchhhhHHHHhhhhhcccc-ccC----C-----CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 4433221111111 111111 111 1 224456999999999999999999999999999987643
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=362.42 Aligned_cols=266 Identities=23% Similarity=0.337 Sum_probs=206.1
Q ss_pred hhhccccccceeeeecCeEEEEEEEC-----CceeEEEEeeccCcc--chHHHHHHHHHHhccCCCceeeeeeccccCCc
Q psy14889 133 TLAKQISLSECIGKGRYGEVWRGVWH-----GENVAVKIFFSRDEA--SWSRETEIYSTVLLRHENILGYIGSDMTSRNS 205 (443)
Q Consensus 133 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-----~~~vAvK~~~~~~~~--~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~ 205 (443)
...++|.+.+.||+|+||.||+|.+. +..||||++...... ......|+..+..++||||+++++++.+.
T Consensus 46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--- 122 (325)
T 3kul_A 46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRG--- 122 (325)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGG---
T ss_pred cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC---
Confidence 34478999999999999999999982 345999998654322 22334567777779999999999998766
Q ss_pred ccEEEeeecccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEE
Q psy14889 206 CTQLWLVTHYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIA 283 (443)
Q Consensus 206 ~~~~~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~ 283 (443)
...++||||+++|+|.++++. ..+++.+++.++.|++.||.|||+. +|+||||||+|||++.++.+||+
T Consensus 123 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~--------~ivH~Dlkp~NIll~~~~~~kl~ 193 (325)
T 3kul_A 123 -RLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDL--------GYVHRDLAARNVLVDSNLVCKVS 193 (325)
T ss_dssp -GCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT--------TEECSCCSGGGEEECTTCCEEEC
T ss_pred -CccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC--------CeeCCCCCcceEEECCCCCEEEC
Confidence 347999999999999999954 5799999999999999999999999 99999999999999999999999
Q ss_pred ecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh-cccCCCcccccCCCCC
Q psy14889 284 DFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR-RTKANGIFEEYKAPYH 362 (443)
Q Consensus 284 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt-g~~~~~~~~~~~~P~~ 362 (443)
|||+++......... .......+|+.|+|||++.+. .++.++||||||+++|||++ | ..||.
T Consensus 194 Dfg~a~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~------~~~~~~Di~slG~il~ell~~g----------~~p~~ 256 (325)
T 3kul_A 194 DFGLSRVLEDDPDAA-YTTTGGKIPIRWTAPEAIAFR------TFSSASDVWSFGVVMWEVLAYG----------ERPYW 256 (325)
T ss_dssp CCSSCEECC----CC-EECC---CCGGGSCHHHHHHC------EECHHHHHHHHHHHHHHHHTTS----------CCTTT
T ss_pred CCCcccccccCccce-eeccCCCCcccccCHhHhcCC------CCCcHHHHHHHHHHHHHHHcCC----------CCCcc
Confidence 999998765432211 112233567889999999766 56689999999999999999 7 77776
Q ss_pred CCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhhccccccCC
Q psy14889 363 DLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLACADMYIHCS 438 (443)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~~~~~~~~~ 438 (443)
.. ........+... .....+ ..++..+.+|+.+||+.||++|||+.+|++.|+.+.......+.+
T Consensus 257 ~~-----~~~~~~~~~~~~-~~~~~~-----~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~~~~~ 321 (325)
T 3kul_A 257 NM-----TNRDVISSVEEG-YRLPAP-----MGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPESLRAT 321 (325)
T ss_dssp TS-----CHHHHHHHHHTT-CCCCCC-----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC-----
T ss_pred cC-----CHHHHHHHHHcC-CCCCCC-----CCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCccccccc
Confidence 54 233333333222 222222 346678999999999999999999999999999999887665543
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-46 Score=366.22 Aligned_cols=256 Identities=22% Similarity=0.423 Sum_probs=203.7
Q ss_pred hccccccceeeeecCeEEEEEEEC---------CceeEEEEeeccCccc--hHHHHHHHHHHhc-cCCCceeeeeecccc
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVWH---------GENVAVKIFFSRDEAS--WSRETEIYSTVLL-RHENILGYIGSDMTS 202 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~~---------~~~vAvK~~~~~~~~~--~~~e~ei~~~~~l-~H~nIv~l~g~~~~~ 202 (443)
.++|.+.+.||+|+||.||+|.+. +..||||++....... .....|+..+..+ +||||+++++++.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 478999999999999999999862 3469999986543221 1234556666668 899999999998776
Q ss_pred CCcccEEEeeecccCcccHHHHhccc-----------------CCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEe
Q psy14889 203 RNSCTQLWLVTHYHSFGSLYDHLNRT-----------------TLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHR 265 (443)
Q Consensus 203 ~~~~~~~~lv~e~~~~gsL~~~l~~~-----------------~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHr 265 (443)
. .+++||||+++|+|.+++... .+++.+++.++.||+.||.|||+. +|+||
T Consensus 160 ~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~--------~ivHr 227 (370)
T 2psq_A 160 G----PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ--------KCIHR 227 (370)
T ss_dssp S----SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT--------TEECS
T ss_pred C----CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC--------Ceecc
Confidence 3 479999999999999999642 478999999999999999999999 99999
Q ss_pred CCCCCCEEEcCCCcEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHH
Q psy14889 266 DIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVC 345 (443)
Q Consensus 266 Dlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ell 345 (443)
||||+|||++.++.+||+|||+++......... ......+|+.|+|||++.+. .++.++|||||||++|||+
T Consensus 228 Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~------~~~~~~DvwslG~il~ell 299 (370)
T 2psq_A 228 DLAARNVLVTENNVMKIADFGLARDINNIDYYK--KTTNGRLPVKWMAPEALFDR------VYTHQSDVWSFGVLMWEIF 299 (370)
T ss_dssp CCCGGGEEECTTCCEEECCCSSCEETTCCCTTC--TTTTTTSCGGGCCHHHHHTC------CCCHHHHHHHHHHHHHHHH
T ss_pred ccchhhEEECCCCCEEEccccCCcccCccccee--cccCCCcccceECHhHhcCC------CCCcHHHHHHHHHHHHHHH
Confidence 999999999999999999999998665432211 12334678899999999876 6778999999999999999
Q ss_pred h-cccCCCcccccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHH
Q psy14889 346 R-RTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKT 424 (443)
Q Consensus 346 t-g~~~~~~~~~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 424 (443)
| | ..||.+. ....+...+.. ..++..+ ..++.++.++|.+||+.||++|||+.|+++.
T Consensus 300 t~g----------~~p~~~~-----~~~~~~~~~~~-~~~~~~~-----~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 300 TLG----------GSPYPGI-----PVEELFKLLKE-GHRMDKP-----ANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp TTS----------CCSSTTC-----CGGGHHHHHHT-TCCCCCC-----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCC----------CCCCCCC-----CHHHHHHHHhc-CCCCCCC-----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9 7 6677653 22333333322 2233333 3466789999999999999999999999999
Q ss_pred HHHHhhc
Q psy14889 425 LIKLACA 431 (443)
Q Consensus 425 L~~l~~~ 431 (443)
|+++...
T Consensus 359 L~~il~~ 365 (370)
T 2psq_A 359 LDRILTL 365 (370)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9998764
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-46 Score=348.77 Aligned_cols=254 Identities=23% Similarity=0.411 Sum_probs=207.7
Q ss_pred ccccccceeeeecCeEEEEEEE-CCceeEEEEeeccCccchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEeeec
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW-HGENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVTH 214 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e 214 (443)
++|++.+.||+|+||.||+|.+ +++.||+|++............|+..+..++||||+++++++.+.. ..++|||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~e 85 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA----PICLVFE 85 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSS----SEEEEEE
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCC----ceEEEEE
Confidence 6899999999999999999998 6788999999766544445566777777799999999999987763 4799999
Q ss_pred ccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCccccc
Q psy14889 215 YHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYS 292 (443)
Q Consensus 215 ~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~~ 292 (443)
|+++|+|.+++.. ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--------~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 157 (269)
T 4hcu_A 86 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA--------CVIHRDLAARNCLVGENQVIKVSDFGMTRFVL 157 (269)
T ss_dssp CCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT--------TCCCSCCCGGGEEECGGGCEEECCTTGGGGBC
T ss_pred eCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhC--------CeecCCcchheEEEcCCCCEEecccccccccc
Confidence 9999999999964 4589999999999999999999999 99999999999999999999999999997664
Q ss_pred ccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh-cccCCCcccccCCCCCCCCCCCCCh
Q psy14889 293 QLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR-RTKANGIFEEYKAPYHDLVPMDPSF 371 (443)
Q Consensus 293 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt-g~~~~~~~~~~~~P~~~~~~~~~~~ 371 (443)
...... .....+|+.|+|||.+.+. .++.++||||||+++|||++ | ..||... ..
T Consensus 158 ~~~~~~---~~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~~l~~ll~~g----------~~p~~~~-----~~ 213 (269)
T 4hcu_A 158 DDQYTS---STGTKFPVKWASPEVFSFS------RYSSKSDVWSFGVLMWEVFSEG----------KIPYENR-----SN 213 (269)
T ss_dssp CHHHHS---TTSTTCCGGGCCHHHHHHC------CCCHHHHHHHHHHHHHHHHTTS----------CCTTTTC-----CH
T ss_pred cccccc---ccCcccccccCCHHHhcCC------CCCchhhhHHHHHHHHHHhcCC----------CCCCCCC-----CH
Confidence 432111 2334578889999999766 67789999999999999999 7 6677653 22
Q ss_pred HHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhhc
Q psy14889 372 DDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLACA 431 (443)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~~ 431 (443)
......+.. ...+..+ ...+..+.+++.+||+.||++|||+.++++.|+++.+.
T Consensus 214 ~~~~~~~~~-~~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 214 SEVVEDIST-GFRLYKP-----RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp HHHHHHHHT-TCCCCCC-----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHHhc-CccCCCC-----CcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 333333322 2222222 23567899999999999999999999999999999865
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=373.45 Aligned_cols=252 Identities=28% Similarity=0.498 Sum_probs=204.4
Q ss_pred hccccccceeeeecCeEEEEEEECCceeEEEEeeccCccchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEeeec
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVWHGENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVTH 214 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e 214 (443)
.++|++.+.||+|+||.||+|.++|+.||||+++... .......|+..+..++||||+++++++..... .+++|||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~~~iv~e 267 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG---GLYIVTE 267 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCT-TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTS---CEEEEEE
T ss_pred hHHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCch-HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCC---ceEEEEE
Confidence 4689999999999999999999999999999986543 23334456666667999999999999876542 4799999
Q ss_pred ccCcccHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcccc
Q psy14889 215 YHSFGSLYDHLNRT---TLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSY 291 (443)
Q Consensus 215 ~~~~gsL~~~l~~~---~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~ 291 (443)
|+++|+|.+++... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 268 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~--------~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 339 (450)
T 1k9a_A 268 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN--------NFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 339 (450)
T ss_dssp CCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHT--------TEECSCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CeeCCCCCHhhEEECCCCCEEEeeCCCcccc
Confidence 99999999999753 379999999999999999999999 9999999999999999999999999999754
Q ss_pred cccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh-cccCCCcccccCCCCCCCCCCCCC
Q psy14889 292 SQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR-RTKANGIFEEYKAPYHDLVPMDPS 370 (443)
Q Consensus 292 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt-g~~~~~~~~~~~~P~~~~~~~~~~ 370 (443)
.... ....+|..|+|||++.+. .++.++|||||||++|||+| | ..||.....
T Consensus 340 ~~~~-------~~~~~~~~y~aPE~~~~~------~~~~~sDvwslG~~l~el~t~g----------~~P~~~~~~---- 392 (450)
T 1k9a_A 340 SSTQ-------DTGKLPVKWTAPEALREK------KFSTKSDVWSFGILLWEIYSFG----------RVPYPRIPL---- 392 (450)
T ss_dssp C-------------CCCTTTSCHHHHHSS------CCCHHHHHHHHHHHHHHHHTTT----------CCSSTTSCT----
T ss_pred cccc-------cCCCCCcceeCHHHhcCC------CCCcHHHHHHHHHHHHHHHhCC----------CCCCCCCCH----
Confidence 3211 123578899999999876 67789999999999999998 7 677766422
Q ss_pred hHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhhcc
Q psy14889 371 FDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLACAD 432 (443)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~~~ 432 (443)
.++...+. ...++..| ..++..+.+||.+||+.||++|||+.++++.|+.+....
T Consensus 393 -~~~~~~i~-~~~~~~~p-----~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~~ 447 (450)
T 1k9a_A 393 -KDVVPRVE-KGYKMDAP-----DGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTHE 447 (450)
T ss_dssp -TTHHHHHH-TTCCCCCC-----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred -HHHHHHHH-cCCCCCCC-----CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHhh
Confidence 22222222 22333333 346788999999999999999999999999999988654
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-46 Score=368.10 Aligned_cols=256 Identities=23% Similarity=0.363 Sum_probs=204.3
Q ss_pred hccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccc--hHHHHHHHHHHhccCCCceeeeeeccccCCcccEEE
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEAS--WSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLW 210 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~--~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~ 210 (443)
.++|.+.+.||+|+||.||+|.+ +++.||||++....... .....|+..+..++||||+++++++.... .++
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~----~~~ 188 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQ----PIY 188 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSS----SCE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCC----CcE
Confidence 46899999999999999999998 58899999886542211 12234555666699999999999997764 369
Q ss_pred eeecccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCc
Q psy14889 211 LVTHYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA 288 (443)
Q Consensus 211 lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla 288 (443)
+||||+++|+|.++++. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 189 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~--------~ivHrDlkp~Nil~~~~~~~kl~DfG~s 260 (377)
T 3cbl_A 189 IVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK--------CCIHRDLAARNCLVTEKNVLKISDFGMS 260 (377)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT--------TEECSCCSGGGEEECTTCCEEECCGGGC
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--------CcCCcccCHHHEEEcCCCcEEECcCCCc
Confidence 99999999999999965 4599999999999999999999999 9999999999999999999999999999
Q ss_pred ccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh-cccCCCcccccCCCCCCCCCC
Q psy14889 289 VSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR-RTKANGIFEEYKAPYHDLVPM 367 (443)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt-g~~~~~~~~~~~~P~~~~~~~ 367 (443)
+........ .......++..|+|||.+.+. .++.++|||||||++|||+| | ..||...
T Consensus 261 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~------~~~~~~DvwslG~il~el~t~g----------~~p~~~~--- 319 (377)
T 3cbl_A 261 REEADGVYA--ASGGLRQVPVKWTAPEALNYG------RYSSESDVWSFGILLWETFSLG----------ASPYPNL--- 319 (377)
T ss_dssp EECTTSEEE--CCSSCCEEEGGGSCHHHHHHC------EEEHHHHHHHHHHHHHHHHTTS----------CCSSTTS---
T ss_pred eecCCCcee--ecCCCCCCCcCcCCHhHhccC------CCCchhhHHHHHHHHHHHHhCC----------CCCCCCC---
Confidence 765432111 111223467789999999866 56689999999999999998 7 6777664
Q ss_pred CCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhhc
Q psy14889 368 DPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLACA 431 (443)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~~ 431 (443)
........+.. ..+...| ..++..+.+||.+||+.||++|||+.++++.|+++...
T Consensus 320 --~~~~~~~~~~~-~~~~~~~-----~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 320 --SNQQTREFVEK-GGRLPCP-----ELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp --CHHHHHHHHHT-TCCCCCC-----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --CHHHHHHHHHc-CCCCCCC-----CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 23344444332 2333333 33667899999999999999999999999999998753
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=355.56 Aligned_cols=271 Identities=27% Similarity=0.358 Sum_probs=208.8
Q ss_pred hhhhccccccceeeeecCeEEEEEEE-CCceeEEEEeeccCccc-hHHHHHHHHHHhccCCCceeeeeeccccCCcccEE
Q psy14889 132 RTLAKQISLSECIGKGRYGEVWRGVW-HGENVAVKIFFSRDEAS-WSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQL 209 (443)
Q Consensus 132 ~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~-~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~ 209 (443)
+...++|++.+.||+|+||.||+|.+ +|+.||||++....... ...+.|+..+..++||||+++++++.... ..
T Consensus 35 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~~ 110 (321)
T 2qkw_B 35 EEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN----EM 110 (321)
T ss_dssp CCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT----CC
T ss_pred HHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC----eE
Confidence 34568999999999999999999998 58999999876543322 23356677777799999999999987663 47
Q ss_pred EeeecccCcccHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEe
Q psy14889 210 WLVTHYHSFGSLYDHLNRT-----TLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIAD 284 (443)
Q Consensus 210 ~lv~e~~~~gsL~~~l~~~-----~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~D 284 (443)
++||||+++|+|.+++... .+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|
T Consensus 111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--------~ivH~dlkp~Nil~~~~~~~kl~D 182 (321)
T 2qkw_B 111 ILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR--------AIIHRDVKSINILLDENFVPKITD 182 (321)
T ss_dssp EEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT--------TEECSCCCSTTEEECTTCCEEECC
T ss_pred EEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC--------CeecCCCCHHHEEECCCCCEEEee
Confidence 9999999999999999643 489999999999999999999998 999999999999999999999999
Q ss_pred cCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCC
Q psy14889 285 FGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDL 364 (443)
Q Consensus 285 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~ 364 (443)
||+++........ .......||+.|+|||++.+. .++.++||||||+++|||++| ..||...
T Consensus 183 fg~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~~Di~slG~il~ell~g----------~~p~~~~ 244 (321)
T 2qkw_B 183 FGISKKGTELDQT--HLSTVVKGTLGYIDPEYFIKG------RLTEKSDVYSFGVVLFEVLCA----------RSAIVQS 244 (321)
T ss_dssp CTTCEECSSSSCC--CCBCCCEEETTTCCHHHHHHC------BCCTHHHHHHHHHHHHHHHHC----------CTTCSCS
T ss_pred ccccccccccccc--ccccccCCCccccCHHHhcCC------CCCcccchHhHHHHHHHHHhC----------CCccccc
Confidence 9999765432211 112344689999999999776 667899999999999999999 5555543
Q ss_pred CCCCCCh-HH-HHhhhhhcC----CCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhhccc
Q psy14889 365 VPMDPSF-DD-MRKVICIDQ----QRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLACADM 433 (443)
Q Consensus 365 ~~~~~~~-~~-~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~~~~ 433 (443)
.+..... .. ......... ..+... ......++..+.+++.+||+.||++|||+.|+++.|+.+.....
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~~ 318 (321)
T 2qkw_B 245 LPREMVNLAEWAVESHNNGQLEQIVDPNLA-DKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQE 318 (321)
T ss_dssp SSSSCCCHHHHTHHHHTTTCCCSSSSSSCT-TCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSC
T ss_pred CcHHHHHHHHHhhhccccccHHHhcChhhc-cccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhccc
Confidence 3221111 11 001110000 011111 12235678899999999999999999999999999999886543
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=347.54 Aligned_cols=249 Identities=27% Similarity=0.495 Sum_probs=192.7
Q ss_pred ccccccceeeeecCeEEEEEEECCceeEEEEeeccCccc-----hHHHHHHHHHHhccCCCceeeeeeccccCCcccEEE
Q psy14889 136 KQISLSECIGKGRYGEVWRGVWHGENVAVKIFFSRDEAS-----WSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLW 210 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~-----~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~ 210 (443)
++|++.+.||+|+||.||+|.+.++.||||++....... .....|+..+..++||||+++++++.+.. ..+
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~ 82 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEP----NLC 82 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC------CE
T ss_pred hheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC----ceE
Confidence 689999999999999999999999999999886432211 22345556666699999999999988763 479
Q ss_pred eeecccCcccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCC---eEEeCCCCCCEEEcC--------CCc
Q psy14889 211 LVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPA---IAHRDIKSKNILVKT--------NGT 279 (443)
Q Consensus 211 lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~---iiHrDlk~~NiLl~~--------~~~ 279 (443)
+||||+++|+|.++++...+++..+..++.|++.||.|||+. + |+||||||+|||++. ++.
T Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~--------~~~~i~H~dikp~Nil~~~~~~~~~~~~~~ 154 (271)
T 3dtc_A 83 LVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDE--------AIVPIIHRDLKSSNILILQKVENGDLSNKI 154 (271)
T ss_dssp EEEECCTTEEHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHS--------SSSCCCCSCCSGGGEEESSCCSSSCCSSCC
T ss_pred EEEEcCCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CCCceeecCCchHHEEEecccccccccCcc
Confidence 999999999999999988999999999999999999999998 6 999999999999986 678
Q ss_pred EEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCC
Q psy14889 280 CVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKA 359 (443)
Q Consensus 280 ~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~ 359 (443)
+||+|||++........ ....||+.|+|||.+.+. .++.++||||||+++|||++| ..
T Consensus 155 ~kl~Dfg~~~~~~~~~~------~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~~l~~l~~g----------~~ 212 (271)
T 3dtc_A 155 LKITDFGLAREWHRTTK------MSAAGAYAWMAPEVIRAS------MFSKGSDVWSYGVLLWELLTG----------EV 212 (271)
T ss_dssp EEECCCCC-------------------CCGGGSCHHHHHHC------CCSHHHHHHHHHHHHHHHHHC----------CC
T ss_pred eEEccCCcccccccccc------cCCCCccceeCHHHhccC------CCCchhhHHHHHHHHHHHHhC----------CC
Confidence 99999999976543221 234689999999999876 667899999999999999999 77
Q ss_pred CCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHH
Q psy14889 360 PYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKL 428 (443)
Q Consensus 360 P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l 428 (443)
||... ..................+ ..++..+.+++.+||+.||++|||+.|+++.|+++
T Consensus 213 p~~~~-----~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 213 PFRGI-----DGLAVAYGVAMNKLALPIP-----STCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp TTTTS-----CHHHHHHHHHTSCCCCCCC-----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred CCCCC-----CHHHHHHhhhcCCCCCCCC-----cccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 77653 2222222222222223333 34667899999999999999999999999999864
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=356.22 Aligned_cols=245 Identities=22% Similarity=0.341 Sum_probs=199.2
Q ss_pred hccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccc---hHHHHHHHHHHhccCCCceeeeeeccccCCcccEE
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEAS---WSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQL 209 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~---~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~ 209 (443)
.++|++.+.||+|+||.||+|.+ +|+.||||++....... .....|+..+..++||||+++++++.+. ..+
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~----~~~ 89 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETE----KTL 89 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS----SEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC----CEE
Confidence 36899999999999999999998 68999999986543221 1223566666679999999999998766 458
Q ss_pred EeeecccCcccHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCc
Q psy14889 210 WLVTHYHSFGSLYDHLN-RTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA 288 (443)
Q Consensus 210 ~lv~e~~~~gsL~~~l~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla 288 (443)
++||||+++|+|.+++. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~--------~ivHrDlkp~NIll~~~~~~kl~DFG~a 161 (328)
T 3fe3_A 90 YLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQK--------RIVHRDLKAENLLLDADMNIKIADFGFS 161 (328)
T ss_dssp EEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT--------TCCCSCCCGGGEEECTTSCEEECSTTCC
T ss_pred EEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC--------CEeccCCCHHHEEEcCCCCEEEeeccCc
Confidence 99999999999999985 46799999999999999999999999 9999999999999999999999999999
Q ss_pred ccccccCCcCCCCCCCcccccCcccccccccccccCcCCC-CCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCC
Q psy14889 289 VSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFES-FKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPM 367 (443)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~-~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~ 367 (443)
........ .....||+.|+|||++.+. .+ +.++|||||||++|||++| ..||.+.
T Consensus 162 ~~~~~~~~-----~~~~~gt~~y~aPE~~~~~------~~~~~~~DiwslG~il~ell~g----------~~pf~~~--- 217 (328)
T 3fe3_A 162 NEFTVGGK-----LDAFCGAPPYAAPELFQGK------KYDGPEVDVWSLGVILYTLVSG----------SLPFDGQ--- 217 (328)
T ss_dssp GGGSSSCG-----GGTTSSSGGGCCHHHHHTC------CCCSHHHHHHHHHHHHHHHHHS----------SCSSCCS---
T ss_pred eecCCCCc-----cccccCCcceeCcccccCC------CcCCchhhhhhhHHHHHHHHhC----------CCCCCCC---
Confidence 76654322 2345799999999999876 33 3789999999999999999 7777653
Q ss_pred CCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHH
Q psy14889 368 DPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKT 424 (443)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 424 (443)
....+...+.... ...| ...+.++.+|+.+||+.||.+|||+.|+++.
T Consensus 218 --~~~~~~~~i~~~~--~~~p-----~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 218 --NLKELRERVLRGK--YRIP-----FYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp --SHHHHHHHHHHCC--CCCC-----TTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred --CHHHHHHHHHhCC--CCCC-----CCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 3344444433322 2223 2255679999999999999999999999863
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=373.98 Aligned_cols=259 Identities=21% Similarity=0.380 Sum_probs=209.9
Q ss_pred hhhhccccccceeeeecCeEEEEEEE-CCceeEEEEeeccCccchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEE
Q psy14889 132 RTLAKQISLSECIGKGRYGEVWRGVW-HGENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLW 210 (443)
Q Consensus 132 ~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~ 210 (443)
+...++|++.+.||+|+||.||+|.+ ++..||||++............|+..+..++||||+++++++... .++
T Consensus 184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~-----~~~ 258 (454)
T 1qcf_A 184 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKE-----PIY 258 (454)
T ss_dssp BCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEECSS-----SCE
T ss_pred eechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEeCC-----ccE
Confidence 34457899999999999999999999 477899999876554444455667777779999999999998632 368
Q ss_pred eeecccCcccHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCC
Q psy14889 211 LVTHYHSFGSLYDHLNR---TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGL 287 (443)
Q Consensus 211 lv~e~~~~gsL~~~l~~---~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGl 287 (443)
+||||+++|+|.++++. ..+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 259 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~--------~ivHrDlkp~Nill~~~~~~kl~DFG~ 330 (454)
T 1qcf_A 259 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR--------NYIHRDLRAANILVSASLVCKIADFGL 330 (454)
T ss_dssp EEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHT--------TCCCSSCSGGGEEECTTCCEEECSTTG
T ss_pred EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC--------CccCCCCCHHHEEECCCCcEEEeeCCC
Confidence 99999999999999974 3689999999999999999999999 999999999999999999999999999
Q ss_pred cccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh-cccCCCcccccCCCCCCCCC
Q psy14889 288 AVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR-RTKANGIFEEYKAPYHDLVP 366 (443)
Q Consensus 288 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt-g~~~~~~~~~~~~P~~~~~~ 366 (443)
++......... .....+|..|+|||++... .++.++|||||||++|||+| | ..||.+.
T Consensus 331 a~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~------~~~~~~DvwslG~~l~el~t~g----------~~P~~~~-- 389 (454)
T 1qcf_A 331 ARVIEDNEYTA---REGAKFPIKWTAPEAINFG------SFTIKSDVWSFGILLMEIVTYG----------RIPYPGM-- 389 (454)
T ss_dssp GGGBCCHHHHT---TCSSSSCGGGSCHHHHHHC------CCCHHHHHHHHHHHHHHHHTTS----------CCSSTTC--
T ss_pred ceEcCCCceec---cCCCcccccccCHHHhccC------CCCcHHHHHhHHHHHHHHHhCC----------CCCCCCC--
Confidence 98765322111 1233567899999999876 67789999999999999999 7 7787654
Q ss_pred CCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhhccc
Q psy14889 367 MDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLACADM 433 (443)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~~~~ 433 (443)
...++...+... .+...+ ..++.++.+||.+||+.||++|||+.+|++.|+.+.....
T Consensus 390 ---~~~~~~~~i~~~-~~~~~~-----~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~~ 447 (454)
T 1qcf_A 390 ---SNPEVIRALERG-YRMPRP-----ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATE 447 (454)
T ss_dssp ---CHHHHHHHHHHT-CCCCCC-----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSSC
T ss_pred ---CHHHHHHHHHcC-CCCCCC-----CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhccc
Confidence 233444433322 233233 3467889999999999999999999999999999876543
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-46 Score=353.29 Aligned_cols=271 Identities=26% Similarity=0.393 Sum_probs=199.8
Q ss_pred hccccccceeeeecCeEEEEEEE------CCceeEEEEeeccCccc-hHHHHHHHHHHhccCCCceeeeeeccccCCccc
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVW------HGENVAVKIFFSRDEAS-WSRETEIYSTVLLRHENILGYIGSDMTSRNSCT 207 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~------~~~~vAvK~~~~~~~~~-~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~ 207 (443)
.++|++.+.||+|+||.||+|++ +++.||||++....... ...+.|+..+..++||||+++++++..... .
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~--~ 86 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR--R 86 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHH--T
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC--C
Confidence 47899999999999999999985 47899999986544332 233567777777999999999999865432 2
Q ss_pred EEEeeecccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEec
Q psy14889 208 QLWLVTHYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADF 285 (443)
Q Consensus 208 ~~~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~Df 285 (443)
.+++||||+++|+|.+++.. ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+||
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--------~ivH~Dikp~Nil~~~~~~~kl~Df 158 (295)
T 3ugc_A 87 NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK--------RYIHRDLATRNILVENENRVKIGDF 158 (295)
T ss_dssp SCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHT--------TCCCSCCSGGGEEEEETTEEEECCC
T ss_pred ceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcC--------CcccCCCCHhhEEEcCCCeEEEccC
Confidence 46899999999999999965 3599999999999999999999998 9999999999999999999999999
Q ss_pred CCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCC
Q psy14889 286 GLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLV 365 (443)
Q Consensus 286 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~ 365 (443)
|+++......... .......+|..|+|||.+.+. .++.++||||||+++|||+||..++...... +....
T Consensus 159 g~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~---~~~~~ 228 (295)
T 3ugc_A 159 GLTKVLPQDKEFF-KVKEPGESPIFWYAPESLTES------KFSVASDVWSFGVVLYELFTYIEKSKSPPAE---FMRMI 228 (295)
T ss_dssp CSCC--------------CTTCGGGGCCHHHHHHC------CCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH---HHHHH
T ss_pred cccccccCCccee-eeccCCCCccceeCcHHhcCC------CCChHHHHHHHHHHHHHHHhcccccCCChHH---HHhhh
Confidence 9998765432211 112334577889999999876 6778999999999999999994433211000 00000
Q ss_pred CCCCC-h---HHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhhc
Q psy14889 366 PMDPS-F---DDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLACA 431 (443)
Q Consensus 366 ~~~~~-~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~~ 431 (443)
..... . ......+. ...+...+ ..++.++.+++.+||+.||++|||+.|+++.|+++.+.
T Consensus 229 ~~~~~~~~~~~~~~~~~~-~~~~~~~~-----~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 229 GNDKQGQMIVFHLIELLK-NNGRLPRP-----DGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp CTTCCTHHHHHHHHHHHH-TTCCCCCC-----TTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred cCccccchhHHHHHHHHh-ccCcCCCC-----cCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 00000 0 01111221 12222222 34678899999999999999999999999999999865
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=344.90 Aligned_cols=255 Identities=22% Similarity=0.401 Sum_probs=204.6
Q ss_pred hccccccceeeeecCeEEEEEEEC-CceeEEEEeeccCccchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEeee
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVWH-GENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVT 213 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv~ 213 (443)
.++|++.+.||+|+||.||+|.+. +..||||++............|+..+..++||||+++++++.+.. ..++||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~ 82 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEY----PIYIVT 82 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS----SEEEEE
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCC----ceEEEE
Confidence 478999999999999999999984 568999998765544444556666677799999999999987663 479999
Q ss_pred cccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcccc
Q psy14889 214 HYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSY 291 (443)
Q Consensus 214 e~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~ 291 (443)
||+++|+|.+++.. ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++...
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--------~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~ 154 (268)
T 3sxs_A 83 EYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESH--------QFIHRDLAARNCLVDRDLCVKVSDFGMTRYV 154 (268)
T ss_dssp ECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT--------TEEESSCSGGGEEECTTCCEEECCTTCEEEC
T ss_pred EccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC--------CeecCCcCcceEEECCCCCEEEccCccceec
Confidence 99999999999965 4599999999999999999999999 9999999999999999999999999999766
Q ss_pred cccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh-cccCCCcccccCCCCCCCCCCCCC
Q psy14889 292 SQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR-RTKANGIFEEYKAPYHDLVPMDPS 370 (443)
Q Consensus 292 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt-g~~~~~~~~~~~~P~~~~~~~~~~ 370 (443)
....... .....+|+.|+|||.+.+. .++.++||||||+++|||++ | ..||... .
T Consensus 155 ~~~~~~~---~~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~il~~l~~~g----------~~p~~~~-----~ 210 (268)
T 3sxs_A 155 LDDQYVS---SVGTKFPVKWSAPEVFHYF------KYSSKSDVWAFGILMWEVFSLG----------KMPYDLY-----T 210 (268)
T ss_dssp CTTCEEE---CCSCCCCGGGCCHHHHHHS------EEETTHHHHHHHHHHHHHHTTT----------CCTTTTS-----C
T ss_pred chhhhhc---ccCCCcCcccCCHHHHhcc------CCchhhhhHHHHHHHHHHHcCC----------CCCcccc-----C
Confidence 5432221 1234567889999999775 56689999999999999999 7 6677653 2
Q ss_pred hHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhhc
Q psy14889 371 FDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLACA 431 (443)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~~ 431 (443)
.......+.. ......+ ...++.+.+++.+||+.||++|||+.++++.|+++.+.
T Consensus 211 ~~~~~~~~~~-~~~~~~~-----~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 211 NSEVVLKVSQ-GHRLYRP-----HLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp HHHHHHHHHT-TCCCCCC-----TTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred hHHHHHHHHc-CCCCCCC-----CcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 2222222221 2222222 23456799999999999999999999999999998754
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=349.43 Aligned_cols=257 Identities=23% Similarity=0.417 Sum_probs=205.3
Q ss_pred hhccccccceeeeecCeEEEEEEEC-CceeEEEEeeccCccchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEee
Q psy14889 134 LAKQISLSECIGKGRYGEVWRGVWH-GENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLV 212 (443)
Q Consensus 134 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv 212 (443)
..++|++.+.||+|+||.||+|.+. +..||||++............|+..+..++||||+++++++.+.. ..++|
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~----~~~lv 97 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQR----PIFII 97 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSS----SEEEE
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCC----CeEEE
Confidence 3478999999999999999999984 568999999765544444556777777799999999999987663 47999
Q ss_pred ecccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCccc
Q psy14889 213 THYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVS 290 (443)
Q Consensus 213 ~e~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~ 290 (443)
|||+++|+|.+++.. ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--------~i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 169 (283)
T 3gen_A 98 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK--------QFLHRDLAARNCLVNDQGVVKVSDFGLSRY 169 (283)
T ss_dssp ECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHT--------TCCCSSCSGGGEEECTTSCEEECSTTGGGG
T ss_pred EeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHC--------CccCCCCccceEEEcCCCCEEEcccccccc
Confidence 999999999999965 6799999999999999999999999 999999999999999999999999999976
Q ss_pred ccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh-cccCCCcccccCCCCCCCCCCCC
Q psy14889 291 YSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR-RTKANGIFEEYKAPYHDLVPMDP 369 (443)
Q Consensus 291 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt-g~~~~~~~~~~~~P~~~~~~~~~ 369 (443)
........ .....+|+.|+|||.+.+. .++.++||||||+++|||+| | ..||...
T Consensus 170 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~------~~~~~~Dv~slG~~l~~l~t~g----------~~p~~~~----- 225 (283)
T 3gen_A 170 VLDDEYTS---SVGSKFPVRWSPPEVLMYS------KFSSKSDIWAFGVLMWEIYSLG----------KMPYERF----- 225 (283)
T ss_dssp BCCHHHHS---TTSTTSCGGGCCHHHHHHC------CCSHHHHHHHHHHHHHHHHTTT----------CCTTTTS-----
T ss_pred cccccccc---ccCCccCcccCCHHHhccC------CCCchhhHHHHHHHHHHHHhCC----------CCCcccc-----
Confidence 64432111 1234577889999999876 66789999999999999998 7 6777654
Q ss_pred ChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhhcc
Q psy14889 370 SFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLACAD 432 (443)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~~~ 432 (443)
........+.. ......+ ...++.+.+++.+||+.||++|||+.++++.|+++.+.+
T Consensus 226 ~~~~~~~~~~~-~~~~~~~-----~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~e 282 (283)
T 3gen_A 226 TNSETAEHIAQ-GLRLYRP-----HLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEE 282 (283)
T ss_dssp CHHHHHHHHHT-TCCCCCC-----TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred ChhHHHHHHhc-ccCCCCC-----CcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhcc
Confidence 22333333322 2222222 234578999999999999999999999999999998653
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-46 Score=365.84 Aligned_cols=261 Identities=26% Similarity=0.376 Sum_probs=195.4
Q ss_pred hhccccccceeeeecCeEEEEEEEC-----CceeEEEEeeccCcc--chHHHHHHHHHHhccCCCceeeeeeccccCCcc
Q psy14889 134 LAKQISLSECIGKGRYGEVWRGVWH-----GENVAVKIFFSRDEA--SWSRETEIYSTVLLRHENILGYIGSDMTSRNSC 206 (443)
Q Consensus 134 ~~~~~~~~~~lG~G~fg~Vy~~~~~-----~~~vAvK~~~~~~~~--~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~ 206 (443)
..++|++.+.||+|+||.||+|++. +..||||++...... ......|+..+..++||||+++++++....
T Consensus 43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--- 119 (373)
T 2qol_A 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSK--- 119 (373)
T ss_dssp CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS---
T ss_pred CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC---
Confidence 3468999999999999999999863 567999998654322 223346677777799999999999987763
Q ss_pred cEEEeeecccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEe
Q psy14889 207 TQLWLVTHYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIAD 284 (443)
Q Consensus 207 ~~~~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~D 284 (443)
.+++||||+++|+|.+++++ ..+++.+++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|
T Consensus 120 -~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~--------~ivH~Dlkp~NIll~~~~~~kl~D 190 (373)
T 2qol_A 120 -PVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM--------GYVHRDLAARNILINSNLVCKVSD 190 (373)
T ss_dssp -SCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT--------TCCCSCCCGGGEEECTTCCEEECC
T ss_pred -ceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC--------CeeCCCCCcceEEEcCCCCEEECc
Confidence 46999999999999999975 3699999999999999999999998 999999999999999999999999
Q ss_pred cCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh-cccCCCcccccCCCCCC
Q psy14889 285 FGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR-RTKANGIFEEYKAPYHD 363 (443)
Q Consensus 285 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt-g~~~~~~~~~~~~P~~~ 363 (443)
||+++......... .......+|+.|+|||++.+. .++.++||||||+++|||++ | ..||..
T Consensus 191 fg~a~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~------~~~~~~Dv~SlG~il~ellt~g----------~~P~~~ 253 (373)
T 2qol_A 191 FGLGRVLEDDPEAA-YTTRGGKIPIRWTSPEAIAYR------KFTSASDVWSYGIVLWEVMSYG----------ERPYWE 253 (373)
T ss_dssp C-----------------------CTTSCHHHHHHC------CCCHHHHHHHHHHHHHHHHTTC-----------CTTTT
T ss_pred CccccccccCCccc-eeccCCCcCCCccChhhhccC------CcCchhcHHHHHHHHHHHHhCC----------CCCCCC
Confidence 99998765432211 111223457789999999876 67789999999999999998 7 677765
Q ss_pred CCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhhcccc
Q psy14889 364 LVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLACADMY 434 (443)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~~~~~ 434 (443)
. ....+...+... .+...+ ..++..+.+++.+||+.||++|||+.+|++.|+++......
T Consensus 254 ~-----~~~~~~~~i~~~-~~~~~~-----~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~~~ 313 (373)
T 2qol_A 254 M-----SNQDVIKAVDEG-YRLPPP-----MDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGS 313 (373)
T ss_dssp C-----CHHHHHHHHHTT-EECCCC-----TTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCGGG
T ss_pred C-----CHHHHHHHHHcC-CCCCCC-----ccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCccc
Confidence 4 233333333222 222222 33667899999999999999999999999999999876543
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=349.94 Aligned_cols=272 Identities=19% Similarity=0.279 Sum_probs=206.7
Q ss_pred hccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc--chHHHHHHHHHHhccCCCceeeeeeccccCCcccEEE
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA--SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLW 210 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~--~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~ 210 (443)
.++|.+.+.||+|+||.||+|.+ +++.||||++...... ......|+..+..++||||+++++++..... ...+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~--~~~~ 85 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTT--RHKV 85 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTT--CCEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCC--ceEE
Confidence 47899999999999999999998 4899999998653322 1223456666666999999999999876543 3579
Q ss_pred eeecccCcccHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEE----cCCCcEEE
Q psy14889 211 LVTHYHSFGSLYDHLNRT----TLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILV----KTNGTCVI 282 (443)
Q Consensus 211 lv~e~~~~gsL~~~l~~~----~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl----~~~~~~kl 282 (443)
+||||+++|+|.+++... .+++.++..++.||+.||.|||+. +|+||||||+|||+ +.++.+||
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~--------~ivH~Dlkp~NIll~~~~~~~~~~kL 157 (319)
T 4euu_A 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN--------GIVHRNIKPGNIMRVIGEDGQSVYKL 157 (319)
T ss_dssp EEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT--------TEECSCCSGGGEEEEECTTSCEEEEE
T ss_pred EEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC--------CEecCCCCHHHEEEeccCCCCceEEE
Confidence 999999999999999653 399999999999999999999999 99999999999999 77888999
Q ss_pred EecCCcccccccCCcCCCCCCCcccccCccccccccccccc--CcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCC
Q psy14889 283 ADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINM--DCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAP 360 (443)
Q Consensus 283 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~--~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P 360 (443)
+|||+++........ ....||+.|+|||++...... ....++.++|||||||++|||++| ..|
T Consensus 158 ~Dfg~a~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g----------~~p 222 (319)
T 4euu_A 158 TDFGAARELEDDEQF-----VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATG----------SLP 222 (319)
T ss_dssp CCCTTCEECCTTCCB-----CCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHS----------SCS
T ss_pred ccCCCceecCCCCce-----eecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhC----------CCC
Confidence 999999876543221 335799999999998632100 011677899999999999999999 666
Q ss_pred CCCCCCCCCChHHHHhhhhhcCCC----------------CCCC-CCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 361 YHDLVPMDPSFDDMRKVICIDQQR----------------PVLP-NRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~----------------~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
|..........+.+.+........ ..++ ........+..+.+++.+||+.||++|||++|+++
T Consensus 223 f~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~ 302 (319)
T 4euu_A 223 FRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302 (319)
T ss_dssp EECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred CCCCCccchhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhh
Confidence 654432222333333333221100 0111 11233567888999999999999999999999999
Q ss_pred HHHHHhhc
Q psy14889 424 TLIKLACA 431 (443)
Q Consensus 424 ~L~~l~~~ 431 (443)
..++-...
T Consensus 303 h~~d~~~~ 310 (319)
T 4euu_A 303 ETSDILHR 310 (319)
T ss_dssp HHHHHTC-
T ss_pred ccHHHhhc
Confidence 98876543
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=346.36 Aligned_cols=253 Identities=25% Similarity=0.474 Sum_probs=204.2
Q ss_pred ccccccceeeeecCeEEEEEEECCceeEEEEeeccCcc---chHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEee
Q psy14889 136 KQISLSECIGKGRYGEVWRGVWHGENVAVKIFFSRDEA---SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLV 212 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~---~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv 212 (443)
++|++.+.||+|+||.||+|+++++.||||++...... ......|+..+..++||||+++++++.+... ...++|
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~--~~~~lv 87 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPA--PHPTLI 87 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTS--SSCEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEECCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCC--CCeEee
Confidence 68999999999999999999999999999998654322 1223456666667899999999999877633 347999
Q ss_pred ecccCcccHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCC--eEEeCCCCCCEEEcCCCcEEEEecCC
Q psy14889 213 THYHSFGSLYDHLNRT---TLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPA--IAHRDIKSKNILVKTNGTCVIADFGL 287 (443)
Q Consensus 213 ~e~~~~gsL~~~l~~~---~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~--iiHrDlk~~NiLl~~~~~~kl~DfGl 287 (443)
|||+++|+|.+++... .+++..+..++.|++.||.|||+. + |+||||||+|||++.++.++|+|||+
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--------~~~i~H~dikp~Nil~~~~~~~~l~~~~~ 159 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL--------EPLIPRHALNSRSVMIDEDMTARISMADV 159 (271)
T ss_dssp EECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTS--------SSCCTTCCCSGGGEEECTTSCEEEEGGGS
T ss_pred ecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC--------CCceecCCCccceEEEcCCcceeEEeccc
Confidence 9999999999999764 489999999999999999999988 6 99999999999999999999999998
Q ss_pred cccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCC
Q psy14889 288 AVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPM 367 (443)
Q Consensus 288 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~ 367 (443)
+..... ....||+.|+|||.+.+.... .++.++||||||+++|||++| ..||.+.
T Consensus 160 ~~~~~~---------~~~~~t~~y~aPE~~~~~~~~---~~~~~~Di~slG~il~el~~g----------~~p~~~~--- 214 (271)
T 3kmu_A 160 KFSFQS---------PGRMYAPAWVAPEALQKKPED---TNRRSADMWSFAVLLWELVTR----------EVPFADL--- 214 (271)
T ss_dssp CCTTSC---------TTCBSCGGGSCHHHHHSCGGG---SCHHHHHHHHHHHHHHHHHHC----------SCTTTTS---
T ss_pred eeeecc---------cCccCCccccChhhhccCCCC---CCCchhhHHHHHHHHHHHHhC----------CCCcccc---
Confidence 754221 234789999999999865221 333479999999999999999 7777653
Q ss_pred CCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhh
Q psy14889 368 DPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLAC 430 (443)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~ 430 (443)
...............+..+ ..++..+.+++.+||+.||++|||+.++++.|+++.+
T Consensus 215 --~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 215 --SNMEIGMKVALEGLRPTIP-----PGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp --CHHHHHHHHHHSCCCCCCC-----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred --ChHHHHHHHHhcCCCCCCC-----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 2233333333344444444 3366789999999999999999999999999999864
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=361.32 Aligned_cols=262 Identities=22% Similarity=0.380 Sum_probs=205.4
Q ss_pred hhhhccccccceeeeecCeEEEEEEE-------CCceeEEEEeeccCccc--hHHHHHHHHHHhc-cCCCceeeeeeccc
Q psy14889 132 RTLAKQISLSECIGKGRYGEVWRGVW-------HGENVAVKIFFSRDEAS--WSRETEIYSTVLL-RHENILGYIGSDMT 201 (443)
Q Consensus 132 ~~~~~~~~~~~~lG~G~fg~Vy~~~~-------~~~~vAvK~~~~~~~~~--~~~e~ei~~~~~l-~H~nIv~l~g~~~~ 201 (443)
+...++|++.+.||+|+||.||+|.+ +++.||||++....... .....|+..+..+ +||||+++++++..
T Consensus 18 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~ 97 (359)
T 3vhe_A 18 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK 97 (359)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeec
Confidence 34457899999999999999999985 24789999986543222 2234555555557 89999999999877
Q ss_pred cCCcccEEEeeecccCcccHHHHhcccC----------------------------------------------------
Q psy14889 202 SRNSCTQLWLVTHYHSFGSLYDHLNRTT---------------------------------------------------- 229 (443)
Q Consensus 202 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~---------------------------------------------------- 229 (443)
... .+++||||+++|+|.+++....
T Consensus 98 ~~~---~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (359)
T 3vhe_A 98 PGG---PLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLS 174 (359)
T ss_dssp TTS---CCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------------
T ss_pred CCC---ceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccc
Confidence 543 3689999999999999996422
Q ss_pred ---------------CCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCccccccc
Q psy14889 230 ---------------LNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQL 294 (443)
Q Consensus 230 ---------------l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~~~~ 294 (443)
+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.+...
T Consensus 175 ~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~--------~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 246 (359)
T 3vhe_A 175 DVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR--------KCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 246 (359)
T ss_dssp ---------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT--------TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSC
T ss_pred hhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC--------CcccCCCChhhEEEcCCCcEEEEeccceeeeccc
Confidence 89999999999999999999999 9999999999999999999999999999766443
Q ss_pred CCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh-cccCCCcccccCCCCCCCCCCCCChHH
Q psy14889 295 SNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR-RTKANGIFEEYKAPYHDLVPMDPSFDD 373 (443)
Q Consensus 295 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt-g~~~~~~~~~~~~P~~~~~~~~~~~~~ 373 (443)
.... ......||+.|+|||++.+. .++.++||||||+++|||+| | ..||..... ...
T Consensus 247 ~~~~--~~~~~~~t~~y~aPE~~~~~------~~~~~~Di~slG~il~ellt~g----------~~p~~~~~~----~~~ 304 (359)
T 3vhe_A 247 PDYV--RKGDARLPLKWMAPETIFDR------VYTIQSDVWSFGVLLWEIFSLG----------ASPYPGVKI----DEE 304 (359)
T ss_dssp TTCE--EC--CEECGGGCCHHHHHHC------CCCHHHHHHHHHHHHHHHTTTS----------CCSSTTCCC----SHH
T ss_pred ccch--hccccCCCceeEChhhhcCC------CCCchhhhhhHHHHHHHHHhcC----------CCCCCccch----hHH
Confidence 2211 12345788999999999876 67789999999999999998 8 677765321 223
Q ss_pred HHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhhcc
Q psy14889 374 MRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLACAD 432 (443)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~~~ 432 (443)
+...+.. ......+ ..++.++.+++.+||+.||++|||+.|+++.|+++.+++
T Consensus 305 ~~~~~~~-~~~~~~~-----~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 357 (359)
T 3vhe_A 305 FCRRLKE-GTRMRAP-----DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 357 (359)
T ss_dssp HHHHHHH-TCCCCCC-----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHc-CCCCCCC-----CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence 3333322 2233333 235678999999999999999999999999999998754
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-45 Score=352.93 Aligned_cols=244 Identities=23% Similarity=0.338 Sum_probs=198.4
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccC----ccchHHHHHHHHHHhccCCCceeeeeeccccCCcccEE
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRD----EASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQL 209 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~----~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~ 209 (443)
++|++.+.||+|+||.||+|+. +|+.||+|++.... ........|+..+..++||||+++++++.+. ..+
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~----~~~ 80 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH----DRL 80 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECS----SEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeC----CEE
Confidence 6899999999999999999998 58999999986532 1222334555666669999999999999876 458
Q ss_pred EeeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCc
Q psy14889 210 WLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA 288 (443)
Q Consensus 210 ~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla 288 (443)
++||||+++|+|.+++.+ ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 81 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~--------~ivHrDlkp~NIll~~~g~vkL~DFG~a 152 (337)
T 1o6l_A 81 CFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR--------DVVYRDIKLENLMLDKDGHIKITDFGLC 152 (337)
T ss_dssp EEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT--------TCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CeecCcCCHHHEEECCCCCEEEeeccch
Confidence 999999999999999965 5799999999999999999999999 9999999999999999999999999999
Q ss_pred ccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCC
Q psy14889 289 VSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMD 368 (443)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~ 368 (443)
+....... ......||+.|+|||++.+. .++.++|||||||++|||++| ..||...
T Consensus 153 ~~~~~~~~----~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~ell~g----------~~Pf~~~---- 208 (337)
T 1o6l_A 153 KEGISDGA----TMKTFCGTPEYLAPEVLEDN------DYGRAVDWWGLGVVMYEMMCG----------RLPFYNQ---- 208 (337)
T ss_dssp BCSCCTTC----CBCCCEECGGGCCGGGGSSS------CBCTTHHHHHHHHHHHHHHHS----------SCSSCCS----
T ss_pred hhcccCCC----cccccccChhhCChhhhcCC------CCCchhhcccchhHHHHHhcC----------CCCCCCC----
Confidence 75432221 12456899999999999876 677899999999999999999 7777653
Q ss_pred CChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCC-----cHHHHHH
Q psy14889 369 PSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRL-----SALRVKK 423 (443)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~ 423 (443)
....+...+... ...+| ...+.++.+|+.+||+.||++|| ++.|+++
T Consensus 209 -~~~~~~~~i~~~--~~~~p-----~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 209 -DHERLFELILME--EIRFP-----RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp -SHHHHHHHHHHC--CCCCC-----TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -CHHHHHHHHHcC--CCCCC-----CCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 233343333322 22233 23567899999999999999999 8999876
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-45 Score=360.95 Aligned_cols=262 Identities=22% Similarity=0.406 Sum_probs=208.0
Q ss_pred hhhhccccccceeeeecCeEEEEEEEC---------CceeEEEEeeccCccc--hHHHHHHHHHHhc-cCCCceeeeeec
Q psy14889 132 RTLAKQISLSECIGKGRYGEVWRGVWH---------GENVAVKIFFSRDEAS--WSRETEIYSTVLL-RHENILGYIGSD 199 (443)
Q Consensus 132 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~---------~~~vAvK~~~~~~~~~--~~~e~ei~~~~~l-~H~nIv~l~g~~ 199 (443)
+...++|.+.+.||+|+||.||+|.+. +..||||++....... .....|+..+..+ +||||+++++++
T Consensus 65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 144 (382)
T 3tt0_A 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 144 (382)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence 344578999999999999999999863 2479999986543322 2233555555557 999999999999
Q ss_pred cccCCcccEEEeeecccCcccHHHHhccc-----------------CCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCe
Q psy14889 200 MTSRNSCTQLWLVTHYHSFGSLYDHLNRT-----------------TLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAI 262 (443)
Q Consensus 200 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~-----------------~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~i 262 (443)
.... .+++||||+++|+|.+++... .+++..++.++.||+.||.|||+. +|
T Consensus 145 ~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--------~i 212 (382)
T 3tt0_A 145 TQDG----PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK--------KC 212 (382)
T ss_dssp CSSS----SCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT--------TC
T ss_pred ccCC----ceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC--------CE
Confidence 8764 369999999999999999653 389999999999999999999999 99
Q ss_pred EEeCCCCCCEEEcCCCcEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHH
Q psy14889 263 AHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLW 342 (443)
Q Consensus 263 iHrDlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ 342 (443)
+||||||+|||++.++.+||+|||+++........ .......||+.|+|||++.+. .++.++|||||||++|
T Consensus 213 vH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~------~~~~~~DiwslG~il~ 284 (382)
T 3tt0_A 213 IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY--KKTTNGRLPVKWMAPEALFDR------IYTHQSDVWSFGVLLW 284 (382)
T ss_dssp CCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTT--CCCTTCCCGGGGSCHHHHHSC------CCCHHHHHHHHHHHHH
T ss_pred ecCCCCcceEEEcCCCcEEEcccCccccccccccc--ccccCCCCCcceeCHHHhcCC------CCCchhHHHHHHHHHH
Confidence 99999999999999999999999999866543221 112344678899999999876 6778999999999999
Q ss_pred HHHh-cccCCCcccccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHH
Q psy14889 343 EVCR-RTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRV 421 (443)
Q Consensus 343 ellt-g~~~~~~~~~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ev 421 (443)
||++ | ..||... ....+...+.. ..++..+ ..++.++.+|+.+||+.||++|||+.||
T Consensus 285 ellt~g----------~~p~~~~-----~~~~~~~~~~~-~~~~~~~-----~~~~~~l~~li~~~l~~dP~~Rps~~el 343 (382)
T 3tt0_A 285 EIFTLG----------GSPYPGV-----PVEELFKLLKE-GHRMDKP-----SNCTNELYMMMRDCWHAVPSQRPTFKQL 343 (382)
T ss_dssp HHHTTS----------CCSSTTC-----CHHHHHHHHHT-TCCCCCC-----SSCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHhCC----------CCCCCCC-----CHHHHHHHHHc-CCCCCCC-----ccCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 9999 7 6677653 33444444332 2233333 3466789999999999999999999999
Q ss_pred HHHHHHHhhcccc
Q psy14889 422 KKTLIKLACADMY 434 (443)
Q Consensus 422 l~~L~~l~~~~~~ 434 (443)
++.|+++......
T Consensus 344 l~~L~~~~~~~~~ 356 (382)
T 3tt0_A 344 VEDLDRIVALTSN 356 (382)
T ss_dssp HHHHHHHHHHSCS
T ss_pred HHHHHHHHHHHhc
Confidence 9999999865433
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-46 Score=363.84 Aligned_cols=273 Identities=16% Similarity=0.210 Sum_probs=203.6
Q ss_pred hhccccccceeeeecCeEEEEEEEC-------CceeEEEEeeccCccchHHH-------------HHHHHHHhccCCCce
Q psy14889 134 LAKQISLSECIGKGRYGEVWRGVWH-------GENVAVKIFFSRDEASWSRE-------------TEIYSTVLLRHENIL 193 (443)
Q Consensus 134 ~~~~~~~~~~lG~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~e-------------~ei~~~~~l~H~nIv 193 (443)
..++|++.+.||+|+||.||+|.+. ++.||||++..... ....| .++..+..++||||+
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv 111 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNG-PLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP 111 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCH-HHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccch-hHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence 3468999999999999999999883 47899999865432 12222 233344557899999
Q ss_pred eeeeeccccCCcccEEEeeecccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCC
Q psy14889 194 GYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKN 271 (443)
Q Consensus 194 ~l~g~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~N 271 (443)
++++++..........++||||+ +|+|.+++.. ..+++..++.++.||+.||+|||+. +|+||||||+|
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~--------~iiHrDlkp~N 182 (364)
T 3op5_A 112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEH--------EYVHGDIKASN 182 (364)
T ss_dssp CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT--------TEECCCCCGGG
T ss_pred eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC--------CeEEecCCHHH
Confidence 99999887655446689999999 9999999965 5699999999999999999999999 99999999999
Q ss_pred EEEc--CCCcEEEEecCCcccccccCCcCC---CCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh
Q psy14889 272 ILVK--TNGTCVIADFGLAVSYSQLSNKMD---IPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR 346 (443)
Q Consensus 272 iLl~--~~~~~kl~DfGla~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt 346 (443)
||++ .++.+||+|||+++.+........ .......||+.|+|||++.+. .++.++|||||||++|||+|
T Consensus 183 ill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~Di~slG~~l~el~~ 256 (364)
T 3op5_A 183 LLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGV------APSRRGDLEILGYCMIQWLT 256 (364)
T ss_dssp EEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTC------CCCHHHHHHHHHHHHHHHHH
T ss_pred EEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCC------CCCchhhHHHHHHHHHHHHh
Confidence 9999 889999999999987654332211 112345699999999999876 67789999999999999999
Q ss_pred cccCCCcccccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHH
Q psy14889 347 RTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLI 426 (443)
Q Consensus 347 g~~~~~~~~~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 426 (443)
| ..||.+................ ......+...+....++.++.+++..||+.||++||++.+|++.|+
T Consensus 257 g----------~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~ 325 (364)
T 3op5_A 257 G----------HLPWEDNLKDPKYVRDSKIRYR-ENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILL 325 (364)
T ss_dssp S----------CCTTGGGTTCHHHHHHHHHHHH-HCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHH
T ss_pred C----------CCCccccccCHHHHHHHHHHhh-hhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Confidence 9 6777653221100000110000 0000000000001235678999999999999999999999999999
Q ss_pred HHhhccc
Q psy14889 427 KLACADM 433 (443)
Q Consensus 427 ~l~~~~~ 433 (443)
++.+...
T Consensus 326 ~~~~~~~ 332 (364)
T 3op5_A 326 QGLKAIG 332 (364)
T ss_dssp HHHHHTT
T ss_pred HHHHHcC
Confidence 9887543
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-45 Score=348.45 Aligned_cols=251 Identities=24% Similarity=0.333 Sum_probs=195.5
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc---------------------------chHHHHHHHHHHh
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA---------------------------SWSRETEIYSTVL 186 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~---------------------------~~~~e~ei~~~~~ 186 (443)
++|++.+.||+|+||.||+|.. +++.||||++...... ......|+..+..
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 92 (298)
T 2zv2_A 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK 92 (298)
T ss_dssp TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence 6899999999999999999987 5889999998654211 1123456666677
Q ss_pred ccCCCceeeeeeccccCCcccEEEeeecccCcccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeC
Q psy14889 187 LRHENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRD 266 (443)
Q Consensus 187 l~H~nIv~l~g~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrD 266 (443)
++||||+++++++.+... ..+++||||+++|+|.+++....+++..+..++.||+.||.|||+. +|+|||
T Consensus 93 l~h~~iv~~~~~~~~~~~--~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--------~ivH~D 162 (298)
T 2zv2_A 93 LDHPNVVKLVEVLDDPNE--DHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQ--------KIIHRD 162 (298)
T ss_dssp CCCTTBCCEEEEEECSSS--SEEEEEEECCTTCBSCCSSCSSCCCHHHHHHHHHHHHHHHHHHHHT--------TEECCC
T ss_pred CCCCCCCeEEEEEEcCCC--CEEEEEEecCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CeeccC
Confidence 999999999999876433 4689999999999999988888899999999999999999999999 999999
Q ss_pred CCCCCEEEcCCCcEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh
Q psy14889 267 IKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR 346 (443)
Q Consensus 267 lk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt 346 (443)
|||+|||++.++.+||+|||+++........ .....||+.|+|||.+.+.... .++.++|||||||++|||++
T Consensus 163 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~---~~~~~~Di~slG~~l~~l~~ 235 (298)
T 2zv2_A 163 IKPSNLLVGEDGHIKIADFGVSNEFKGSDAL----LSNTVGTPAFMAPESLSETRKI---FSGKALDVWAMGVTLYCFVF 235 (298)
T ss_dssp CCGGGEEECTTSCEEECCCTTCEECSSSSCE----ECCCCSCGGGCCGGGCCTTCCC---EESHHHHHHHHHHHHHHHHH
T ss_pred CCHHHEEECCCCCEEEecCCCcccccccccc----ccCCcCCccccChhhhccCCCC---CCCchhhhHhHHHHHHHHHH
Confidence 9999999999999999999999876543221 1345799999999999765210 13578999999999999999
Q ss_pred cccCCCcccccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 347 RTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 347 g~~~~~~~~~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
| ..||.+. ........+.... ...+. ...++..+.+++.+||+.||++|||+.|+++
T Consensus 236 g----------~~pf~~~-----~~~~~~~~~~~~~--~~~~~---~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 236 G----------QCPFMDE-----RIMCLHSKIKSQA--LEFPD---QPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp S----------SCSSCCS-----SHHHHHHHHHHCC--CCCCS---SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred C----------CCCCCCc-----cHHHHHHHHhccc--CCCCC---ccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 9 6777653 2223333322221 11221 1235678999999999999999999999875
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-45 Score=369.31 Aligned_cols=260 Identities=23% Similarity=0.362 Sum_probs=203.9
Q ss_pred hhhccccccceeeeecCeEEEEEEEC-CceeEEEEeeccCccchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEe
Q psy14889 133 TLAKQISLSECIGKGRYGEVWRGVWH-GENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWL 211 (443)
Q Consensus 133 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~l 211 (443)
...++|++.+.||+|+||.||+|.+. +..||||++............|+..+..++||||+++++++... ..++
T Consensus 181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~i 255 (452)
T 1fmk_A 181 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE-----PIYI 255 (452)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SCEE
T ss_pred cChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcCC-----ceEE
Confidence 44578999999999999999999995 46799999876543333345566666669999999999998653 2689
Q ss_pred eecccCcccHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCc
Q psy14889 212 VTHYHSFGSLYDHLNR---TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA 288 (443)
Q Consensus 212 v~e~~~~gsL~~~l~~---~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla 288 (443)
||||+++|+|.+++.. ..+++.+++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 256 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~--------~ivHrDlkp~Nill~~~~~~kl~DfG~a 327 (452)
T 1fmk_A 256 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM--------NYVHRDLRAANILVGENLVCKVADFGLA 327 (452)
T ss_dssp EECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT--------TCCCSCCSGGGEEECGGGCEEECCCCTT
T ss_pred EehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CeeCCCCChhhEEECCCCCEEECCCccc
Confidence 9999999999999964 4599999999999999999999999 9999999999999999999999999999
Q ss_pred ccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh-cccCCCcccccCCCCCCCCCC
Q psy14889 289 VSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR-RTKANGIFEEYKAPYHDLVPM 367 (443)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt-g~~~~~~~~~~~~P~~~~~~~ 367 (443)
+........ ......+|..|+|||.+... .++.++||||||+++|||+| | ..||.+.
T Consensus 328 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~------~~~~~sDvwslG~~l~el~t~g----------~~P~~~~--- 385 (452)
T 1fmk_A 328 RLIEDNEYT---ARQGAKFPIKWTAPEAALYG------RFTIKSDVWSFGILLTELTTKG----------RVPYPGM--- 385 (452)
T ss_dssp C-----------------CCGGGSCHHHHHHC------CCCHHHHHHHHHHHHHHHHTTT----------CCSSTTC---
T ss_pred eecCCCcee---cccCCcccccccCHhHHhcC------CCCccccHHhHHHHHHHHHhCC----------CCCCCCC---
Confidence 876532211 11234577899999999876 67789999999999999999 7 6777654
Q ss_pred CCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhhccccc
Q psy14889 368 DPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLACADMYI 435 (443)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~~~~~~ 435 (443)
...++...+.. ..+...+ ..++..+.+||.+||+.||++|||+.++++.|+.+.......
T Consensus 386 --~~~~~~~~i~~-~~~~~~~-----~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~~ 445 (452)
T 1fmk_A 386 --VNREVLDQVER-GYRMPCP-----PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 445 (452)
T ss_dssp --CHHHHHHHHHT-TCCCCCC-----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCC
T ss_pred --CHHHHHHHHHc-CCCCCCC-----CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCcc
Confidence 22333333322 2233333 346778999999999999999999999999999988765543
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=349.43 Aligned_cols=263 Identities=25% Similarity=0.359 Sum_probs=202.7
Q ss_pred hhhccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccc----hHHHHHHHHHHhccCCCceeeeeeccccCCcc
Q psy14889 133 TLAKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEAS----WSRETEIYSTVLLRHENILGYIGSDMTSRNSC 206 (443)
Q Consensus 133 ~~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~----~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~ 206 (443)
.+.++|++.+.||+|+||.||+|.. +++.||+|++....... ...+.|+..+..++||||+++++++.+.
T Consensus 8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~---- 83 (294)
T 4eqm_A 8 IINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEED---- 83 (294)
T ss_dssp CEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECS----
T ss_pred HhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeC----
Confidence 4457899999999999999999997 58899999885433221 2335677777779999999999998765
Q ss_pred cEEEeeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEec
Q psy14889 207 TQLWLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADF 285 (443)
Q Consensus 207 ~~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~Df 285 (443)
..+++||||+++|+|.+++.. ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+||
T Consensus 84 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~--------~i~H~Dlkp~Nil~~~~~~~kl~Df 155 (294)
T 4eqm_A 84 DCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDM--------RIVHRDIKPQNILIDSNKTLKIFDF 155 (294)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT--------TCCCCCCCGGGEEECTTSCEEECCC
T ss_pred CeEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CcccCCCCHHHEEECCCCCEEEEeC
Confidence 458999999999999999965 5799999999999999999999999 9999999999999999999999999
Q ss_pred CCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCC
Q psy14889 286 GLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLV 365 (443)
Q Consensus 286 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~ 365 (443)
|+++........ ......||+.|+|||.+.+. .++.++||||||+++|||+|| ..||....
T Consensus 156 g~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~~~Di~slG~~l~~ll~g----------~~pf~~~~ 216 (294)
T 4eqm_A 156 GIAKALSETSLT---QTNHVLGTVQYFSPEQAKGE------ATDECTDIYSIGIVLYEMLVG----------EPPFNGET 216 (294)
T ss_dssp SSSTTC----------------CCSSCCHHHHHTC------CCCTTHHHHHHHHHHHHHHHS----------SCSSCSSC
T ss_pred CCcccccccccc---ccCccccCccccCHhHhcCC------CCCchHhHHHHHHHHHHHHhC----------CCCCCCCC
Confidence 999766533211 12345799999999999876 667899999999999999999 77776531
Q ss_pred CCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCC-cHHHHHHHHHHHhhccc
Q psy14889 366 PMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRL-SALRVKKTLIKLACADM 433 (443)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-s~~evl~~L~~l~~~~~ 433 (443)
......+.+ ....+..+. .....++..+.+++.+||+.||++|| +++++.+.|+++.....
T Consensus 217 ----~~~~~~~~~--~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~ 278 (294)
T 4eqm_A 217 ----AVSIAIKHI--QDSVPNVTT-DVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENR 278 (294)
T ss_dssp ----HHHHHHHHH--SSCCCCHHH-HSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSS
T ss_pred ----hHHHHHHHh--hccCCCcch-hcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhcc
Confidence 111112221 111111110 01233667899999999999999999 89999999998876543
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=348.92 Aligned_cols=247 Identities=25% Similarity=0.368 Sum_probs=199.6
Q ss_pred cccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccc-hHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEeee
Q psy14889 137 QISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEAS-WSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVT 213 (443)
Q Consensus 137 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~-~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv~ 213 (443)
.|...+.||+|+||.||+|.. +|+.||||++....... .....|+..+..++||||+++++++... ...++||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~----~~~~lv~ 121 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVG----EELWVLM 121 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEET----TEEEEEE
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEEC----CEEEEEE
Confidence 477778999999999999998 58999999987554332 2334667777779999999999998876 4589999
Q ss_pred cccCcccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcccccc
Q psy14889 214 HYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQ 293 (443)
Q Consensus 214 e~~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~~~ 293 (443)
||+++|+|.+++.+..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 122 e~~~~~~L~~~l~~~~l~~~~~~~i~~qi~~~L~~LH~~--------~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 193 (321)
T 2c30_A 122 EFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQ--------GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISK 193 (321)
T ss_dssp CCCCSCBHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT--------TEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred ecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHC--------CeecCCCCHHHEEECCCCcEEEeeeeeeeeccc
Confidence 999999999999988999999999999999999999998 999999999999999999999999999977654
Q ss_pred cCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCChHH
Q psy14889 294 LSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFDD 373 (443)
Q Consensus 294 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~~~~ 373 (443)
.... .....||+.|+|||++.+. .++.++||||||+++|||++| ..||... ....
T Consensus 194 ~~~~----~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~slG~il~el~~g----------~~pf~~~-----~~~~ 248 (321)
T 2c30_A 194 DVPK----RKSLVGTPYWMAPEVISRS------LYATEVDIWSLGIMVIEMVDG----------EPPYFSD-----SPVQ 248 (321)
T ss_dssp SSCC----BCCCCSCGGGCCHHHHTTC------CBCTHHHHHHHHHHHHHHHHS----------SCTTTTS-----CHHH
T ss_pred Cccc----cccccCCccccCHhhhcCC------CCCchhhHHHHHHHHHHHHhC----------CCCCCCC-----CHHH
Confidence 3222 2345799999999999776 677899999999999999999 6677553 1222
Q ss_pred HHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHH
Q psy14889 374 MRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKT 424 (443)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 424 (443)
....+.. ...+... .....+..+.+++.+||+.||++|||+.|+++.
T Consensus 249 ~~~~~~~-~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 249 AMKRLRD-SPPPKLK---NSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp HHHHHHH-SSCCCCT---TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHhc-CCCCCcC---ccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 2222221 1222221 123456789999999999999999999999873
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=355.51 Aligned_cols=249 Identities=19% Similarity=0.270 Sum_probs=199.5
Q ss_pred hhccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEe
Q psy14889 134 LAKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWL 211 (443)
Q Consensus 134 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~l 211 (443)
+.++|.+.+.||+|+||.||+|.. +++.||+|.+............|+..+..++||||+++++++.+. ..+++
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~----~~~~l 78 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESM----EELVM 78 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEET----TEEEE
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecC----CEEEE
Confidence 457899999999999999999998 588999999876544444445566666679999999999998776 45899
Q ss_pred eecccCcccHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcC--CCcEEEEecCC
Q psy14889 212 VTHYHSFGSLYDHLNRT--TLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKT--NGTCVIADFGL 287 (443)
Q Consensus 212 v~e~~~~gsL~~~l~~~--~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~--~~~~kl~DfGl 287 (443)
||||+++|+|.+++... .+++.++..++.||+.||.|||+. +|+||||||+|||++. ++.+||+|||+
T Consensus 79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~--------givH~Dlkp~NIl~~~~~~~~~kl~Dfg~ 150 (321)
T 1tki_A 79 IFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH--------NIGHFDIRPENIIYQTRRSSTIKIIEFGQ 150 (321)
T ss_dssp EECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHT--------TEECCCCCGGGEEESSSSCCCEEECCCTT
T ss_pred EEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--------CCCcCCCCHHHEEEccCCCCCEEEEECCC
Confidence 99999999999999753 699999999999999999999999 9999999999999987 78999999999
Q ss_pred cccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCC
Q psy14889 288 AVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPM 367 (443)
Q Consensus 288 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~ 367 (443)
++.+..... .....||+.|+|||++.+. .++.++|||||||++|||++| ..||...
T Consensus 151 a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~~ll~g----------~~pf~~~--- 206 (321)
T 1tki_A 151 ARQLKPGDN-----FRLLFTAPEYYAPEVHQHD------VVSTATDMWSLGTLVYVLLSG----------INPFLAE--- 206 (321)
T ss_dssp CEECCTTCE-----EEEEESCGGGSCHHHHTTC------EECHHHHHHHHHHHHHHHHHS----------SCTTCCS---
T ss_pred CeECCCCCc-----cccccCChhhcCcHHhcCC------CCCchhhHHHHHHHHHHHHhC----------CCCCcCC---
Confidence 987654221 1234689999999999875 456899999999999999999 6777653
Q ss_pred CCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 368 DPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
........+...... .+.. .....+.++.+|+.+||+.||++|||+.|+++
T Consensus 207 --~~~~~~~~i~~~~~~--~~~~-~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 207 --TNQQIIENIMNAEYT--FDEE-AFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp --SHHHHHHHHHHTCCC--CCHH-HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred --CHHHHHHHHHcCCCC--CChh-hhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 223333322222111 1100 00235678999999999999999999999987
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=362.84 Aligned_cols=260 Identities=22% Similarity=0.338 Sum_probs=205.0
Q ss_pred hhhccccccceeeeecCeEEEEEEE-------CCceeEEEEeeccCc--cchHHHHHHHHHHhccCCCceeeeeeccccC
Q psy14889 133 TLAKQISLSECIGKGRYGEVWRGVW-------HGENVAVKIFFSRDE--ASWSRETEIYSTVLLRHENILGYIGSDMTSR 203 (443)
Q Consensus 133 ~~~~~~~~~~~lG~G~fg~Vy~~~~-------~~~~vAvK~~~~~~~--~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~ 203 (443)
...++|++.+.||+|+||.||+|.+ +++.||||++..... .......|+..+..++||||+++++++....
T Consensus 68 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 147 (367)
T 3l9p_A 68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 147 (367)
T ss_dssp CCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred cCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 3347899999999999999999995 356899999854322 2223345666666799999999999988764
Q ss_pred CcccEEEeeecccCcccHHHHhcc--------cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEc
Q psy14889 204 NSCTQLWLVTHYHSFGSLYDHLNR--------TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVK 275 (443)
Q Consensus 204 ~~~~~~~lv~e~~~~gsL~~~l~~--------~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~ 275 (443)
..++||||+++|+|.+++.. ..+++.+++.++.||+.||+|||+. +|+||||||+|||++
T Consensus 148 ----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~--------~ivHrDlkp~NIll~ 215 (367)
T 3l9p_A 148 ----PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN--------HFIHRDIAARNCLLT 215 (367)
T ss_dssp ----SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT--------TCCCSCCCGGGEEES
T ss_pred ----CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC--------CeeCCCCChhhEEEe
Confidence 35899999999999999964 3489999999999999999999999 999999999999999
Q ss_pred CCC---cEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh-cccCC
Q psy14889 276 TNG---TCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR-RTKAN 351 (443)
Q Consensus 276 ~~~---~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt-g~~~~ 351 (443)
.++ .+||+|||+++.+....... ......||+.|+|||++.+. .++.++|||||||++|||++ |
T Consensus 216 ~~~~~~~~kL~DFG~a~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~------~~~~~~DvwslG~il~ellt~g---- 283 (367)
T 3l9p_A 216 CPGPGRVAKIGDFGMARDIYRAGYYR--KGGCAMLPVKWMPPEAFMEG------IFTSKTDTWSFGVLLWEIFSLG---- 283 (367)
T ss_dssp CSSTTCCEEECCCHHHHHHHHHSSCT--TCCGGGSCGGGCCHHHHHHC------CCCHHHHHHHHHHHHHHHHTTS----
T ss_pred cCCCCceEEECCCccccccccccccc--cCCCcCCcccEECHHHhcCC------CCCcHHHHHHHHHHHHHHHhCC----
Confidence 555 59999999997654322211 12345688999999999876 67789999999999999998 7
Q ss_pred CcccccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhhc
Q psy14889 352 GIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLACA 431 (443)
Q Consensus 352 ~~~~~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~~ 431 (443)
..||... ....+...+... ..+..+ ..++..+.+|+.+||+.||++|||+.+|++.|+.+.+.
T Consensus 284 ------~~pf~~~-----~~~~~~~~i~~~-~~~~~~-----~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 284 ------YMPYPSK-----SNQEVLEFVTSG-GRMDPP-----KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp ------CCSSTTC-----CHHHHHHHHHTT-CCCCCC-----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ------CCCCCCC-----CHHHHHHHHHcC-CCCCCC-----ccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 6777653 333444433322 222222 34667899999999999999999999999999998875
Q ss_pred cc
Q psy14889 432 DM 433 (443)
Q Consensus 432 ~~ 433 (443)
..
T Consensus 347 ~~ 348 (367)
T 3l9p_A 347 PD 348 (367)
T ss_dssp HH
T ss_pred hh
Confidence 43
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-45 Score=356.19 Aligned_cols=260 Identities=22% Similarity=0.355 Sum_probs=206.5
Q ss_pred hhhhccccccceeeeecCeEEEEEEECC-------ceeEEEEeeccCcc--chHHHHHHHHHHhccCCCceeeeeecccc
Q psy14889 132 RTLAKQISLSECIGKGRYGEVWRGVWHG-------ENVAVKIFFSRDEA--SWSRETEIYSTVLLRHENILGYIGSDMTS 202 (443)
Q Consensus 132 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~-------~~vAvK~~~~~~~~--~~~~e~ei~~~~~l~H~nIv~l~g~~~~~ 202 (443)
+...++|++.+.||+|+||.||+|.+.+ +.||||++...... ....+.|+..+..++||||+++++++.+.
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 122 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG 122 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC
Confidence 3445789999999999999999999853 78999998654322 22335667777779999999999998776
Q ss_pred CCcccEEEeeecccCcccHHHHhcc-------------------------cCCCHHHHHHHHHHHHHHHHHHHHchhcCC
Q psy14889 203 RNSCTQLWLVTHYHSFGSLYDHLNR-------------------------TTLNHHQMMKICLSIVNGLVHLHTEIFGTQ 257 (443)
Q Consensus 203 ~~~~~~~~lv~e~~~~gsL~~~l~~-------------------------~~l~~~~~~~i~~qia~gL~yLH~~~~~~~ 257 (443)
. ..++||||+++|+|.+++.. ..+++.+++.++.||+.||.|||+.
T Consensus 123 ~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~----- 193 (343)
T 1luf_A 123 K----PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER----- 193 (343)
T ss_dssp S----SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT-----
T ss_pred C----ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC-----
Confidence 3 46999999999999999964 4689999999999999999999999
Q ss_pred CCCCeEEeCCCCCCEEEcCCCcEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHH
Q psy14889 258 GKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYAL 337 (443)
Q Consensus 258 ~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~ 337 (443)
+|+||||||+|||++.++.+||+|||+++........ .......||+.|+|||.+.+. .++.++|||||
T Consensus 194 ---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~------~~~~~~Di~sl 262 (343)
T 1luf_A 194 ---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY--KADGNDAIPIRWMPPESIFYN------RYTTESDVWAY 262 (343)
T ss_dssp ---TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCB--C----CCBCGGGCCHHHHHHC------CCCHHHHHHHH
T ss_pred ---CeecCCCCcceEEECCCCeEEEeecCCCcccccCccc--cccCCCcccceecChhhhccC------CcCcccccHHH
Confidence 9999999999999999999999999999766432211 112344688999999999876 67789999999
Q ss_pred HHHHHHHHh-cccCCCcccccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCC
Q psy14889 338 GLVLWEVCR-RTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRL 416 (443)
Q Consensus 338 Gvvl~ellt-g~~~~~~~~~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp 416 (443)
|+++|||+| | ..||.+. ........+.. ...+..+ ..++..+.+++.+||+.||++||
T Consensus 263 G~il~el~t~g----------~~p~~~~-----~~~~~~~~~~~-~~~~~~~-----~~~~~~l~~li~~~l~~~p~~Rp 321 (343)
T 1luf_A 263 GVVLWEIFSYG----------LQPYYGM-----AHEEVIYYVRD-GNILACP-----ENCPLELYNLMRLCWSKLPADRP 321 (343)
T ss_dssp HHHHHHHHTTT----------CCTTTTS-----CHHHHHHHHHT-TCCCCCC-----TTCCHHHHHHHHHHTCSSGGGSC
T ss_pred HHHHHHHHhcC----------CCcCCCC-----ChHHHHHHHhC-CCcCCCC-----CCCCHHHHHHHHHHcccCcccCC
Confidence 999999999 7 6677653 23333333322 2222333 34667899999999999999999
Q ss_pred cHHHHHHHHHHHhhcc
Q psy14889 417 SALRVKKTLIKLACAD 432 (443)
Q Consensus 417 s~~evl~~L~~l~~~~ 432 (443)
|+.++++.|+++.+..
T Consensus 322 s~~~~~~~L~~~~~~~ 337 (343)
T 1luf_A 322 SFCSIHRILQRMCERA 337 (343)
T ss_dssp CHHHHHHHHHHTTC--
T ss_pred CHHHHHHHHHHHHhhh
Confidence 9999999999987643
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-45 Score=353.71 Aligned_cols=254 Identities=23% Similarity=0.430 Sum_probs=196.7
Q ss_pred ccccccceeeeecCeEEEEEEE--CCce----eEEEEeeccCc--cchHHHHHHHHHHhccCCCceeeeeeccccCCccc
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGEN----VAVKIFFSRDE--ASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCT 207 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~----vAvK~~~~~~~--~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~ 207 (443)
++|++.+.||+|+||.||+|.+ +++. ||+|.+..... .......|+..+..++||||+++++++.+..
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---- 90 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST---- 90 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS----
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC----
Confidence 6899999999999999999997 4444 57777643322 2223345666666699999999999987653
Q ss_pred EEEeeecccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEec
Q psy14889 208 QLWLVTHYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADF 285 (443)
Q Consensus 208 ~~~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~Df 285 (443)
.++|+||+.+|+|.+++.. ..+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+||
T Consensus 91 -~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~--------~ivH~Dikp~NIll~~~~~~kl~Df 161 (327)
T 3poz_A 91 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR--------RLVHRDLAARNVLVKTPQHVKITDF 161 (327)
T ss_dssp -EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHT--------TCCCSCCCGGGEEEEETTEEEECCT
T ss_pred -eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC--------CeeCCCCChheEEECCCCCEEEccC
Confidence 5799999999999999964 5699999999999999999999999 9999999999999999999999999
Q ss_pred CCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh-cccCCCcccccCCCCCCC
Q psy14889 286 GLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR-RTKANGIFEEYKAPYHDL 364 (443)
Q Consensus 286 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt-g~~~~~~~~~~~~P~~~~ 364 (443)
|+++......... ......||+.|+|||++.+. .++.++|||||||++|||+| | ..||...
T Consensus 162 g~a~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~------~~~~~~Di~slG~il~ellt~g----------~~p~~~~ 223 (327)
T 3poz_A 162 GLAKLLGAEEKEY--HAEGGKVPIKWMALESILHR------IYTHQSDVWSYGVTVWELMTFG----------SKPYDGI 223 (327)
T ss_dssp THHHHHTTTCC---------CCCGGGSCHHHHHHC------CCCHHHHHHHHHHHHHHHHTTS----------CCTTTTC
T ss_pred cceeEccCCcccc--cccCCCccccccChHHhccC------CCCchhhhhhhHHHHHHHHhcC----------CCCccCC
Confidence 9998765433221 12334578899999999876 67789999999999999999 8 6677653
Q ss_pred CCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhhc
Q psy14889 365 VPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLACA 431 (443)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~~ 431 (443)
....+...+... .....+ ..++..+.+++.+||+.||++|||+.++++.|+++...
T Consensus 224 -----~~~~~~~~~~~~-~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 224 -----PASEISSILEKG-ERLPQP-----PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp -----CGGGHHHHHHTT-CCCCCC-----TTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred -----CHHHHHHHHHcC-CCCCCC-----ccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 223333333322 222222 33667899999999999999999999999999998764
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=375.53 Aligned_cols=257 Identities=22% Similarity=0.400 Sum_probs=207.6
Q ss_pred hhccccccceeeeecCeEEEEEEEC--CceeEEEEeeccCccchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEe
Q psy14889 134 LAKQISLSECIGKGRYGEVWRGVWH--GENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWL 211 (443)
Q Consensus 134 ~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~l 211 (443)
..++|++.+.||+|+||.||+|.+. +..||||++............|+..+..++||||+++++++.... .+++
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----~~~l 293 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP----PFYI 293 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS----SCEE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCC----cEEE
Confidence 4467999999999999999999984 789999998765444344455666666699999999999997764 3699
Q ss_pred eecccCcccHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCc
Q psy14889 212 VTHYHSFGSLYDHLNR---TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA 288 (443)
Q Consensus 212 v~e~~~~gsL~~~l~~---~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla 288 (443)
||||+++|+|.++++. ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 294 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~--------~ivHrDlkp~NIll~~~~~~kl~DFG~a 365 (495)
T 1opk_A 294 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK--------NFIHRNLAARNCLVGENHLVKVADFGLS 365 (495)
T ss_dssp EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT--------TEECSCCSGGGEEECGGGCEEECCTTCE
T ss_pred EEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC--------CcccCCCChhhEEECCCCcEEEeecccc
Confidence 9999999999999964 4589999999999999999999999 9999999999999999999999999999
Q ss_pred ccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh-cccCCCcccccCCCCCCCCCC
Q psy14889 289 VSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR-RTKANGIFEEYKAPYHDLVPM 367 (443)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt-g~~~~~~~~~~~~P~~~~~~~ 367 (443)
+........ ......+|..|+|||++... .++.++|||||||++|||+| | ..||....
T Consensus 366 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~------~~~~~sDvwSlG~~l~el~t~g----------~~p~~~~~-- 424 (495)
T 1opk_A 366 RLMTGDTYT---AHAGAKFPIKWTAPESLAYN------KFSIKSDVWAFGVLLWEIATYG----------MSPYPGID-- 424 (495)
T ss_dssp ECCTTCCEE---CCTTCCCCGGGCCHHHHHHC------EECHHHHHHHHHHHHHHHHTTS----------CCSSTTCC--
T ss_pred eeccCCcee---ecCCCcCCcceeCHhHHhcC------CCCcHHhHHhHHHHHHHHHhCC----------CCCCCCCC--
Confidence 876543211 12234567899999999876 56789999999999999999 7 66776542
Q ss_pred CCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhhcc
Q psy14889 368 DPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLACAD 432 (443)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~~~ 432 (443)
...+...+.. ..+...+ ..++..+.+||.+||+.||++|||+.+|++.|+.+.+..
T Consensus 425 ---~~~~~~~~~~-~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~~ 480 (495)
T 1opk_A 425 ---LSQVYELLEK-DYRMERP-----EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 480 (495)
T ss_dssp ---GGGHHHHHHT-TCCCCCC-----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSSS
T ss_pred ---HHHHHHHHHc-CCCCCCC-----CCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhcc
Confidence 2333333322 2223333 346788999999999999999999999999999886543
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=347.32 Aligned_cols=254 Identities=27% Similarity=0.482 Sum_probs=195.5
Q ss_pred ccccccceeeeecCeEEEEEEECCceeEEEEeeccCccchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEeeecc
Q psy14889 136 KQISLSECIGKGRYGEVWRGVWHGENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVTHY 215 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e~ 215 (443)
++|++.+.||+|+||.||+|++.++.||||++.... .......|+..+..++||||+++++++.+. .++||||
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~------~~lv~e~ 80 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESES-ERKAFIVELRQLSRVNHPNIVKLYGACLNP------VCLVMEY 80 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETTEEEEEEECSSTT-HHHHHHHHHHHHHHCCCTTBCCEEEBCTTT------TEEEEEC
T ss_pred hHeeeeeEeecCCCceEEEEEECCeeEEEEEecChh-HHHHHHHHHHHHhcCCCCCcCeEEEEEcCC------cEEEEEc
Confidence 689999999999999999999999999999885432 223334566666679999999999998743 5899999
Q ss_pred cCcccHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCc-EEEEecCCccc
Q psy14889 216 HSFGSLYDHLNRT----TLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGT-CVIADFGLAVS 290 (443)
Q Consensus 216 ~~~gsL~~~l~~~----~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~-~kl~DfGla~~ 290 (443)
+++|+|.+++... .+++..++.++.|++.||+|||+.. ..+|+||||||+|||++.++. +||+|||++..
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~-----~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~ 155 (307)
T 2eva_A 81 AEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ-----PKALIHRDLKPPNLLLVAGGTVLKICDFGTACD 155 (307)
T ss_dssp CTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCS-----SSCCCCCCCSGGGEEEETTTTEEEECCCCC---
T ss_pred CCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCC-----CCCeecCCCChhHEEEeCCCCEEEEcccccccc
Confidence 9999999999753 3789999999999999999999830 128999999999999998886 79999999975
Q ss_pred ccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCC
Q psy14889 291 YSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPS 370 (443)
Q Consensus 291 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~ 370 (443)
..... ....||+.|+|||++.+. .++.++||||||+++|||++| ..||..... .
T Consensus 156 ~~~~~-------~~~~gt~~y~aPE~~~~~------~~~~~~Di~slG~il~el~~g----------~~p~~~~~~---~ 209 (307)
T 2eva_A 156 IQTHM-------TNNKGSAAWMAPEVFEGS------NYSEKCDVFSWGIILWEVITR----------RKPFDEIGG---P 209 (307)
T ss_dssp ----------------CCTTSSCHHHHTCC------CCCTHHHHHHHHHHHHHHHHT----------CCTTTTTCS---S
T ss_pred ccccc-------ccCCCCCceEChhhhCCC------CCCcHHHHHHHHHHHHHHHHC----------CCCchhhCc---c
Confidence 54321 234689999999999876 677899999999999999999 667754321 1
Q ss_pred hHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhhccc
Q psy14889 371 FDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLACADM 433 (443)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~~~~ 433 (443)
........ .....+..+ ..++..+.+++.+||+.||++|||+.++++.|+.+.+...
T Consensus 210 ~~~~~~~~-~~~~~~~~~-----~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 266 (307)
T 2eva_A 210 AFRIMWAV-HNGTRPPLI-----KNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFP 266 (307)
T ss_dssp HHHHHHHH-HTTCCCCCB-----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCC
T ss_pred HHHHHHHH-hcCCCCCcc-----cccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhcc
Confidence 11111111 122223222 3366789999999999999999999999999999886543
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=354.41 Aligned_cols=263 Identities=20% Similarity=0.227 Sum_probs=203.3
Q ss_pred hccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCc-cchHHHHHHHHHHhc-cCCCceeeeeeccccCCcccEEE
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDE-ASWSRETEIYSTVLL-RHENILGYIGSDMTSRNSCTQLW 210 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~e~ei~~~~~l-~H~nIv~l~g~~~~~~~~~~~~~ 210 (443)
.++|++.+.||+|+||.||+|.. +|+.||||++..... .....|.++ +..+ +||||+++++++... ...+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~--l~~l~~h~~i~~~~~~~~~~----~~~~ 81 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRF--YKQLGSGDGIPQVYYFGPCG----KYNA 81 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHH--HHHHCSCTTSCCEEEEEEET----TEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHH--HHHhhCCCCCCEEEEEEecC----CccE
Confidence 36899999999999999999996 689999998865432 334444444 4447 999999999998775 4579
Q ss_pred eeecccCcccHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCc-----EEEE
Q psy14889 211 LVTHYHSFGSLYDHLN--RTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGT-----CVIA 283 (443)
Q Consensus 211 lv~e~~~~gsL~~~l~--~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~-----~kl~ 283 (443)
+||||+ +|+|.+++. ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++. +||+
T Consensus 82 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~--------~iiHrDlkp~Nill~~~~~~~~~~~kl~ 152 (330)
T 2izr_A 82 MVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSK--------NLIYRDVKPENFLIGRPGNKTQQVIHII 152 (330)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT--------TEECCCCCGGGEEECCGGGTCTTSEEEC
T ss_pred EEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC--------CeeccCCCHHHeeeccCCCCCCceEEEE
Confidence 999999 899999997 46799999999999999999999999 9999999999999998887 9999
Q ss_pred ecCCcccccccCCcCCC---CCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCC
Q psy14889 284 DFGLAVSYSQLSNKMDI---PPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAP 360 (443)
Q Consensus 284 DfGla~~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P 360 (443)
|||+++.+......... ......||+.|+|||++.+. .++.++|||||||++|||++| ..|
T Consensus 153 DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~Di~slG~il~ell~g----------~~P 216 (330)
T 2izr_A 153 DFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGK------EQSRRDDLEALGHMFMYFLRG----------SLP 216 (330)
T ss_dssp CCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC------CCCHHHHHHHHHHHHHHHHHS----------SCT
T ss_pred EcccceeeecCCCCccccccccCCcCCCccccChHHHcCC------CCCchhHHHHHHHHHHHHhcC----------CCC
Confidence 99999876543322111 12456899999999999876 677899999999999999999 777
Q ss_pred CCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhhccc
Q psy14889 361 YHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLACADM 433 (443)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~~~~ 433 (443)
|.+.... ........+..... ..+........+ ++.+++..||+.||.+||++++|++.|+++.+...
T Consensus 217 f~~~~~~--~~~~~~~~i~~~~~--~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~ 284 (330)
T 2izr_A 217 WQGLKAD--TLKERYQKIGDTKR--ATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKG 284 (330)
T ss_dssp TTTCCCS--SHHHHHHHHHHHHH--HSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred ccccccc--cHHHHHHHHHhhhc--cCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcC
Confidence 7764221 22222221111100 011000112244 89999999999999999999999999999887543
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-45 Score=356.00 Aligned_cols=250 Identities=20% Similarity=0.275 Sum_probs=200.1
Q ss_pred hhhccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc-------chHHHHHHHHHHhccCCCceeeeeeccccC
Q psy14889 133 TLAKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA-------SWSRETEIYSTVLLRHENILGYIGSDMTSR 203 (443)
Q Consensus 133 ~~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~-------~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~ 203 (443)
.+.+.|.+.+.||+|+||.||+|.. +|+.||+|++...... ....+.|+..+..++||||+++++++.+.
T Consensus 9 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~- 87 (361)
T 2yab_A 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENR- 87 (361)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECS-
T ss_pred ChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeC-
Confidence 4557899999999999999999998 5899999998654321 12345677777779999999999998776
Q ss_pred CcccEEEeeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCC----
Q psy14889 204 NSCTQLWLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNG---- 278 (443)
Q Consensus 204 ~~~~~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~---- 278 (443)
..+++||||+++|+|.+++.. ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++
T Consensus 88 ---~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~--------givHrDlkp~NIll~~~~~~~~ 156 (361)
T 2yab_A 88 ---TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTK--------KIAHFDLKPENIMLLDKNIPIP 156 (361)
T ss_dssp ---SEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHT--------TEECCCCSGGGEEESCTTSSSC
T ss_pred ---CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CcccCCCCHHHEEEeCCCCCcc
Confidence 468999999999999999964 5799999999999999999999999 999999999999998877
Q ss_pred cEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccC
Q psy14889 279 TCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYK 358 (443)
Q Consensus 279 ~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~ 358 (443)
.+||+|||+++....... .....||+.|+|||++.+. .++.++|||||||++|||++| .
T Consensus 157 ~vkl~DFG~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslGvil~~ll~g----------~ 215 (361)
T 2yab_A 157 HIKLIDFGLAHEIEDGVE-----FKNIFGTPEFVAPEIVNYE------PLGLEADMWSIGVITYILLSG----------A 215 (361)
T ss_dssp CEEECCCSSCEECCTTCC-----CCCCCSCGGGCCHHHHTTC------CCCTHHHHHHHHHHHHHHHHS----------C
T ss_pred CEEEEecCCceEcCCCCc-----cccCCCCccEECchHHcCC------CCCccccHHHHHHHHHHHHhC----------C
Confidence 799999999987654221 2345799999999999876 677899999999999999999 7
Q ss_pred CCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 359 APYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 359 ~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
.||.+. ........+... ...++... ....+..+.+||.+||..||++|||+.|+++
T Consensus 216 ~Pf~~~-----~~~~~~~~i~~~--~~~~~~~~-~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 216 SPFLGD-----TKQETLANITAV--SYDFDEEF-FSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp CSSCCS-----SHHHHHHHHHTT--CCCCCHHH-HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCCCC-----CHHHHHHHHHhc--CCCCCchh-ccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 777653 223333322211 11121100 1235678999999999999999999999885
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=361.89 Aligned_cols=251 Identities=24% Similarity=0.347 Sum_probs=199.1
Q ss_pred hhhccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc---chHHHHHHHHHHhccCCCceeeeeeccccCCccc
Q psy14889 133 TLAKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA---SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCT 207 (443)
Q Consensus 133 ~~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~---~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~ 207 (443)
.+.++|++.+.||+|+||.||+|.. +|+.||+|++...... ....+.|+..+..++||||+++++++.+. .
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~----~ 83 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEE----G 83 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECS----S
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEEC----C
Confidence 3457899999999999999999987 6899999998654322 22234566666779999999999998766 4
Q ss_pred EEEeeecccCcccHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEc---CCCcEEEE
Q psy14889 208 QLWLVTHYHSFGSLYDHLN-RTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVK---TNGTCVIA 283 (443)
Q Consensus 208 ~~~lv~e~~~~gsL~~~l~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~---~~~~~kl~ 283 (443)
..++||||+.+|+|.+++. +..+++..+..++.||+.||.|||+. +|+||||||+|||++ .++.+||+
T Consensus 84 ~~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~--------givHrDlKp~NIll~~~~~~~~vkL~ 155 (444)
T 3soa_A 84 HHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM--------GVVHRNLKPENLLLASKLKGAAVKLA 155 (444)
T ss_dssp EEEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT--------TCBCCCCSSTTEEESBSSTTCCEEEC
T ss_pred EEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC--------CccccCCCHHHEEEeccCCCCcEEEc
Confidence 6899999999999999885 46799999999999999999999999 999999999999998 45789999
Q ss_pred ecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCC
Q psy14889 284 DFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHD 363 (443)
Q Consensus 284 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~ 363 (443)
|||++......... .....||+.|+|||++.+. .++.++|||||||++|||++| ..||.+
T Consensus 156 DFG~a~~~~~~~~~----~~~~~gt~~Y~APE~l~~~------~~~~~~DIwSlGvilyell~G----------~~Pf~~ 215 (444)
T 3soa_A 156 DFGLAIEVEGEQQA----WFGFAGTPGYLSPEVLRKD------PYGKPVDLWACGVILYILLVG----------YPPFWD 215 (444)
T ss_dssp CCSSCBCCCTTCCB----CCCSCSCGGGCCHHHHTTC------CBCTHHHHHHHHHHHHHHHHS----------SCSCCC
T ss_pred cCceeEEecCCCce----eecccCCcccCCHHHhcCC------CCCCccccHHHHHHHHHHHhC----------CCCCCC
Confidence 99999766543222 2345799999999999876 677899999999999999999 677765
Q ss_pred CCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 364 LVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
. ....+...+.........+ .| ..+++++.+|+.+||+.||++|||+.|+++
T Consensus 216 ~-----~~~~~~~~i~~~~~~~~~~-~~--~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 216 E-----DQHRLYQQIKAGAYDFPSP-EW--DTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp S-----SHHHHHHHHHHTCCCCCTT-TT--TTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred c-----cHHHHHHHHHhCCCCCCcc-cc--ccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 3 2333333333322222111 11 236678999999999999999999999987
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=339.17 Aligned_cols=254 Identities=23% Similarity=0.420 Sum_probs=206.3
Q ss_pred ccccccceeeeecCeEEEEEEE-CCceeEEEEeeccCccchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEeeec
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW-HGENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVTH 214 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e 214 (443)
++|++.+.||+|+||.||+|.+ ++..||+|++............|+..+..++||||+++++++.+.. ..++|||
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~e 83 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA----PICLVTE 83 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSS----SCEEEEC
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCC----CeEEEEe
Confidence 6899999999999999999998 6788999999766544444556677777799999999999987763 4699999
Q ss_pred ccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCccccc
Q psy14889 215 YHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYS 292 (443)
Q Consensus 215 ~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~~ 292 (443)
|+++|+|.+++.. ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 84 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~--------~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 155 (267)
T 3t9t_A 84 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA--------CVIHRDLAARNCLVGENQVIKVSDFGMTRFVL 155 (267)
T ss_dssp CCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT--------TCCCSSCCGGGEEECGGGCEEECCTTGGGGBC
T ss_pred CCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhC--------CcccCCCchheEEECCCCCEEEcccccccccc
Confidence 9999999999975 4589999999999999999999999 99999999999999999999999999997654
Q ss_pred ccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh-cccCCCcccccCCCCCCCCCCCCCh
Q psy14889 293 QLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR-RTKANGIFEEYKAPYHDLVPMDPSF 371 (443)
Q Consensus 293 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt-g~~~~~~~~~~~~P~~~~~~~~~~~ 371 (443)
..... ......||..|+|||.+.+. .++.++||||||+++|||++ | ..||... ..
T Consensus 156 ~~~~~---~~~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~il~~l~~~g----------~~p~~~~-----~~ 211 (267)
T 3t9t_A 156 DDQYT---SSTGTKFPVKWASPEVFSFS------RYSSKSDVWSFGVLMWEVFSEG----------KIPYENR-----SN 211 (267)
T ss_dssp CHHHH---STTSTTCCGGGCCHHHHHHC------CCCHHHHHHHHHHHHHHHHTTS----------CCTTTTC-----CH
T ss_pred ccccc---ccccccccccccChhhhcCC------CccchhchhhhHHHHHHHhccC----------CCCCCCC-----CH
Confidence 32211 11234578899999999765 66789999999999999999 7 6677653 22
Q ss_pred HHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhhc
Q psy14889 372 DDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLACA 431 (443)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~~ 431 (443)
......+.. ......+ ...+..+.+++.+||+.||++|||+.++++.|+++.+.
T Consensus 212 ~~~~~~i~~-~~~~~~~-----~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 212 SEVVEDIST-GFRLYKP-----RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp HHHHHHHHT-TCCCCCC-----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHHhc-CCcCCCC-----ccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 333333322 2222222 23557899999999999999999999999999999865
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=344.12 Aligned_cols=251 Identities=24% Similarity=0.419 Sum_probs=199.5
Q ss_pred hccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccc--------hHHHHHHHHHHhccCCCceeeeeeccccCC
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEAS--------WSRETEIYSTVLLRHENILGYIGSDMTSRN 204 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~--------~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~ 204 (443)
.++|++.+.||+|+||.||+|.+ +++.||||++....... ...+.|+..+..++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 47899999999999999999998 68899999885433211 23356677777799999999999986652
Q ss_pred cccEEEeeecccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCC--eEEeCCCCCCEEEcCCCc-
Q psy14889 205 SCTQLWLVTHYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPA--IAHRDIKSKNILVKTNGT- 279 (443)
Q Consensus 205 ~~~~~~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~--iiHrDlk~~NiLl~~~~~- 279 (443)
++||||+++|+|.+++.+ ..+++..+..++.|++.||+|||+. + |+||||||+|||++.++.
T Consensus 97 -----~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~--------~~~ivH~dikp~Nil~~~~~~~ 163 (287)
T 4f0f_A 97 -----RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQ--------NPPIVHRDLRSPNIFLQSLDEN 163 (287)
T ss_dssp -----EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTS--------SSCCBCSCCSGGGEEESCCCTT
T ss_pred -----eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhC--------CCCeecCCCCcceEEEeccCCC
Confidence 699999999999998843 5699999999999999999999998 7 999999999999988776
Q ss_pred ----EEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCccc
Q psy14889 280 ----CVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFE 355 (443)
Q Consensus 280 ----~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~ 355 (443)
+||+|||+++..... .....||+.|+|||.+..... .++.++||||||+++|||++|
T Consensus 164 ~~~~~kl~Dfg~~~~~~~~-------~~~~~g~~~y~aPE~~~~~~~----~~~~~~Di~slG~~l~~l~~g-------- 224 (287)
T 4f0f_A 164 APVCAKVADFGLSQQSVHS-------VSGLLGNFQWMAPETIGAEEE----SYTEKADTYSFAMILYTILTG-------- 224 (287)
T ss_dssp CSCCEEECCCTTCBCCSSC-------EECCCCCCTTSCGGGSSCSSC----EECHHHHHHHHHHHHHHHHHS--------
T ss_pred CceeEEeCCCCcccccccc-------ccccCCCccccCchhhccCCC----CcCchhhHHHHHHHHHHHHcC--------
Confidence 999999999754332 123478999999999843211 456799999999999999999
Q ss_pred ccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHH
Q psy14889 356 EYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKL 428 (443)
Q Consensus 356 ~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l 428 (443)
..||..... ...............+..+ ..++..+.+++.+||+.||++|||+.++++.|+++
T Consensus 225 --~~pf~~~~~---~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 225 --EGPFDEYSY---GKIKFINMIREEGLRPTIP-----EDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp --SCTTTTCCC---CHHHHHHHHHHSCCCCCCC-----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred --CCCCccccc---cHHHHHHHHhccCCCCCCC-----cccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 677765421 2222233333333444444 34667899999999999999999999999999864
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-45 Score=355.06 Aligned_cols=244 Identities=25% Similarity=0.365 Sum_probs=190.9
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccC----ccchHHHHHHHHHHhc-cCCCceeeeeeccccCCcccE
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRD----EASWSRETEIYSTVLL-RHENILGYIGSDMTSRNSCTQ 208 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~----~~~~~~e~ei~~~~~l-~H~nIv~l~g~~~~~~~~~~~ 208 (443)
++|++.+.||+|+||.||+|+. +|+.||||++.... ........|...+..+ +||||+++++++.+. ..
T Consensus 23 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~----~~ 98 (353)
T 3txo_A 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTP----DR 98 (353)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECS----SE
T ss_pred hheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeC----CE
Confidence 7899999999999999999998 58899999986532 1111122333344335 799999999999876 45
Q ss_pred EEeeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCC
Q psy14889 209 LWLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGL 287 (443)
Q Consensus 209 ~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGl 287 (443)
+++||||+++|+|.+++.+ ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 99 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~--------givHrDlkp~NILl~~~g~ikL~DFG~ 170 (353)
T 3txo_A 99 LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDK--------GIIYRDLKLDNVLLDHEGHCKLADFGM 170 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT--------TCBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC--------CCcccCCCHHHEEECCCCCEEEccccc
Confidence 8999999999999999965 6799999999999999999999999 999999999999999999999999999
Q ss_pred cccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCC
Q psy14889 288 AVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPM 367 (443)
Q Consensus 288 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~ 367 (443)
++....... .....+||+.|+|||++.+. .++.++|||||||++|||++| ..||...
T Consensus 171 a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~ell~G----------~~Pf~~~--- 227 (353)
T 3txo_A 171 CKEGICNGV----TTATFCGTPDYIAPEILQEM------LYGPAVDWWAMGVLLYEMLCG----------HAPFEAE--- 227 (353)
T ss_dssp CBCSCC-------------CCGGGCCHHHHHHH------HCTTHHHHHHHHHHHHHHHHS----------SCSSCCS---
T ss_pred eeecccCCc----cccccCCCcCeEChhhcCCC------CcCCccCCCcchHHHHHHHhC----------CCCCCCC---
Confidence 975432211 22456899999999999876 667899999999999999999 7787653
Q ss_pred CCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcH------HHHHH
Q psy14889 368 DPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSA------LRVKK 423 (443)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~------~evl~ 423 (443)
....+...+... ...+| ...+..+.+|+.+||+.||++||++ .|+++
T Consensus 228 --~~~~~~~~i~~~--~~~~p-----~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 228 --NEDDLFEAILND--EVVYP-----TWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp --SHHHHHHHHHHC--CCCCC-----TTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred --CHHHHHHHHHcC--CCCCC-----CCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 233333333222 22233 2255679999999999999999998 66664
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-45 Score=361.65 Aligned_cols=253 Identities=20% Similarity=0.284 Sum_probs=199.5
Q ss_pred hccccccceeeeecCeEEEEEEE--CCceeEEEEeecc------CccchHHHHHHHHHHhccCCCceeeeeeccccCCcc
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSR------DEASWSRETEIYSTVLLRHENILGYIGSDMTSRNSC 206 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~------~~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~ 206 (443)
.++|++.+.||+|+||.||+|++ +++.||+|++... .......|.+++ ..++||||+++++++.+.
T Consensus 68 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il--~~l~hp~Iv~l~~~~~~~---- 141 (410)
T 3v8s_A 68 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIM--AFANSPWVVQLFYAFQDD---- 141 (410)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHH--HHCCCTTBCCEEEEEECS----
T ss_pred ccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHH--HhCCCCCCCeEEEEEEEC----
Confidence 47899999999999999999998 5889999998642 122334455554 448999999999999876
Q ss_pred cEEEeeecccCcccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecC
Q psy14889 207 TQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFG 286 (443)
Q Consensus 207 ~~~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfG 286 (443)
..+++||||+++|+|.+++++..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~~~~~e~~~~~~~~qi~~aL~~LH~~--------givHrDLKp~NILl~~~g~ikL~DFG 213 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSM--------GFIHRDVKPDNMLLDKSGHLKLADFG 213 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT--------TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC--------CeEeccCCHHHeeECCCCCEEEeccc
Confidence 4689999999999999999988999999999999999999999999 99999999999999999999999999
Q ss_pred CcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCC
Q psy14889 287 LAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVP 366 (443)
Q Consensus 287 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~ 366 (443)
+++........ .....+||+.|+|||++.+..... .++.++|||||||++|||++| ..||...
T Consensus 214 ~a~~~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~~~--~~~~~~DiwSlGvilyell~G----------~~Pf~~~-- 276 (410)
T 3v8s_A 214 TCMKMNKEGMV---RCDTAVGTPDYISPEVLKSQGGDG--YYGRECDWWSVGVFLYEMLVG----------DTPFYAD-- 276 (410)
T ss_dssp TCEECCTTSEE---ECCSCCSCGGGCCHHHHHTTTTTC--EEETHHHHHHHHHHHHHHHHS----------SCTTCCS--
T ss_pred eeEeeccCCcc---cccCCcCCccccCHHHhhccCCCc--CCCCcceEecchHHHHHHHhC----------CCCCCCC--
Confidence 99776543211 123458999999999997652110 266899999999999999999 7777653
Q ss_pred CCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCC--CCcHHHHHHH
Q psy14889 367 MDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANV--RLSALRVKKT 424 (443)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--Rps~~evl~~ 424 (443)
........+........+|. ...++.++.+||.+||..+|.+ ||+++||++.
T Consensus 277 ---~~~~~~~~i~~~~~~~~~p~---~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 277 ---SLVGTYSKIMNHKNSLTFPD---DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp ---SHHHHHHHHHTHHHHCCCCT---TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred ---ChhhHHHHHHhccccccCCC---cccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 22233222221111122222 1235678999999999999988 9999999863
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-45 Score=353.46 Aligned_cols=276 Identities=25% Similarity=0.317 Sum_probs=206.1
Q ss_pred chHHHhhhhccccccceeeeecCeEEEEEEE-CCceeEEEEeeccCc--cchHHHHHHHHHHhccCCCceeeeeeccccC
Q psy14889 127 PLLIQRTLAKQISLSECIGKGRYGEVWRGVW-HGENVAVKIFFSRDE--ASWSRETEIYSTVLLRHENILGYIGSDMTSR 203 (443)
Q Consensus 127 ~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~--~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~ 203 (443)
.........++|++.+.||+|+||.||+|.. +|+.||||++..... .......|+..+..++||||+++++++.+..
T Consensus 21 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 100 (326)
T 3uim_A 21 SLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT 100 (326)
T ss_dssp CTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSS
T ss_pred cHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCC
Confidence 3445556678999999999999999999987 689999999865332 1223455666666799999999999998764
Q ss_pred CcccEEEeeecccCcccHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCC
Q psy14889 204 NSCTQLWLVTHYHSFGSLYDHLNRT-----TLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNG 278 (443)
Q Consensus 204 ~~~~~~~lv~e~~~~gsL~~~l~~~-----~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~ 278 (443)
..++||||+++|+|.+++... .+++..+..++.|++.||.|||+.+ .++|+||||||+|||++.++
T Consensus 101 ----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~-----~~~ivH~Dlkp~Nil~~~~~ 171 (326)
T 3uim_A 101 ----ERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHC-----DPKIIHRDVKAANILLDEEF 171 (326)
T ss_dssp ----CCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSS-----SSCEECCCCSGGGEEECTTC
T ss_pred ----ceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeEeCCCchhhEEECCCC
Confidence 368999999999999999642 3999999999999999999999862 45899999999999999999
Q ss_pred cEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccC
Q psy14889 279 TCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYK 358 (443)
Q Consensus 279 ~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~ 358 (443)
.+||+|||+++......... .....||+.|+|||++.+. .++.++||||||+++|||++| .
T Consensus 172 ~~kl~Dfg~~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~~Di~slG~il~~l~~g----------~ 232 (326)
T 3uim_A 172 EAVVGDFGLAKLMDYKDTHV---TTAVRGTIGHIAPEYLSTG------KSSEKTDVFGYGVMLLELITG----------Q 232 (326)
T ss_dssp CEEECCCSSCEECCSSSSCE---ECCCCSCGGGCCHHHHHHS------EECHHHHHHHHHHHHHHHHHC----------C
T ss_pred CEEeccCccccccCcccccc---cccccCCcCccCHHHhccC------CCCccccchhHHHHHHHHHhC----------C
Confidence 99999999998765332221 2334699999999999776 566899999999999999999 4
Q ss_pred CCCCCCC---CCCCChH-HHHhhhhhcC----CCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhh
Q psy14889 359 APYHDLV---PMDPSFD-DMRKVICIDQ----QRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLAC 430 (443)
Q Consensus 359 ~P~~~~~---~~~~~~~-~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~ 430 (443)
.||.... ....... .+........ ...... .......+..+.+++.+||+.||++|||+.||++.|+....
T Consensus 233 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~ 311 (326)
T 3uim_A 233 RAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQ-GNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL 311 (326)
T ss_dssp CSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCT-TSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSC
T ss_pred CcccccccccccchhHHHHHHHHhhchhhhhhcChhhc-cccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcch
Confidence 5553110 0000001 1111110000 001111 11234567889999999999999999999999999987543
Q ss_pred c
Q psy14889 431 A 431 (443)
Q Consensus 431 ~ 431 (443)
.
T Consensus 312 ~ 312 (326)
T 3uim_A 312 A 312 (326)
T ss_dssp S
T ss_pred h
Confidence 3
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=353.53 Aligned_cols=252 Identities=23% Similarity=0.321 Sum_probs=199.8
Q ss_pred hhhhccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc---chHHHHHHHHHHhccCCCceeeeeeccccCCcc
Q psy14889 132 RTLAKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA---SWSRETEIYSTVLLRHENILGYIGSDMTSRNSC 206 (443)
Q Consensus 132 ~~~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~---~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~ 206 (443)
..+.++|++.+.||+|+||.||+|.. +|+.||+|++...... ....+.|+..+..++||||+++++++.+.
T Consensus 25 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~---- 100 (362)
T 2bdw_A 25 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE---- 100 (362)
T ss_dssp CHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS----
T ss_pred CCcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC----
Confidence 34557899999999999999999998 5889999998654322 12234566666679999999999998776
Q ss_pred cEEEeeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCC---cEEE
Q psy14889 207 TQLWLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNG---TCVI 282 (443)
Q Consensus 207 ~~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~---~~kl 282 (443)
...++||||+++|+|.+++.. ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++ .+||
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~--------~ivH~Dlkp~NIll~~~~~~~~~kl 172 (362)
T 2bdw_A 101 SFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN--------GIVHRNLKPENLLLASKAKGAAVKL 172 (362)
T ss_dssp SEEEEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHT--------TCBCCCCSGGGEEESCSSTTCCEEE
T ss_pred CEEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC--------CeEeccCchHHEEEecCCCCCCEEE
Confidence 457999999999999998864 5689999999999999999999999 999999999999998654 5999
Q ss_pred EecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCC
Q psy14889 283 ADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYH 362 (443)
Q Consensus 283 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~ 362 (443)
+|||++........ .....||+.|+|||++.+. .++.++|||||||++|||++| ..||.
T Consensus 173 ~DfG~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~~ll~g----------~~Pf~ 231 (362)
T 2bdw_A 173 ADFGLAIEVNDSEA-----WHGFAGTPGYLSPEVLKKD------PYSKPVDIWACGVILYILLVG----------YPPFW 231 (362)
T ss_dssp CCCTTCBCCTTCCS-----CCCSCSCTTTCCHHHHTTC------CCCTHHHHHHHHHHHHHHHHS----------SCSSC
T ss_pred eecCcceEecCCcc-----cccCCCCccccCHHHHccC------CCCchhhHHHHHHHHHHHHHC----------CCCCC
Confidence 99999976653221 2345799999999999876 677899999999999999999 67776
Q ss_pred CCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHH
Q psy14889 363 DLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKT 424 (443)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 424 (443)
+. ....+...+...... .+.. ....++.++.+|+.+||+.||++|||+.++++.
T Consensus 232 ~~-----~~~~~~~~i~~~~~~--~~~~-~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 232 DE-----DQHRLYAQIKAGAYD--YPSP-EWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp CS-----SHHHHHHHHHHTCCC--CCTT-GGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CC-----CHHHHHHHHHhCCCC--CCcc-cccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 53 223333333222221 1111 113456789999999999999999999998764
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=354.34 Aligned_cols=264 Identities=24% Similarity=0.346 Sum_probs=203.8
Q ss_pred ccc-cccceeeeecCeEEEEEEE------CCceeEEEEeeccCcc--chHHHHHHHHHHhccCCCceeeeeeccccCCcc
Q psy14889 136 KQI-SLSECIGKGRYGEVWRGVW------HGENVAVKIFFSRDEA--SWSRETEIYSTVLLRHENILGYIGSDMTSRNSC 206 (443)
Q Consensus 136 ~~~-~~~~~lG~G~fg~Vy~~~~------~~~~vAvK~~~~~~~~--~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~ 206 (443)
++| ++.+.||+|+||.||++.+ +++.||||++...... ......|+..+..++||||+++++++.+...
T Consensus 30 ~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-- 107 (318)
T 3lxp_A 30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGA-- 107 (318)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTT--
T ss_pred HHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCC--
Confidence 455 9999999999999999876 4788999998754322 2223456666667999999999999887543
Q ss_pred cEEEeeecccCcccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecC
Q psy14889 207 TQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFG 286 (443)
Q Consensus 207 ~~~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfG 286 (443)
..+++||||+++|+|.+++.+..+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~i~~~l~~~l~~LH~~--------~ivH~Dikp~Nil~~~~~~~kl~Dfg 179 (318)
T 3lxp_A 108 ASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQ--------HYIHRDLAARNVLLDNDRLVKIGDFG 179 (318)
T ss_dssp TEEEEEECCCTTCBHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHT--------TEECSCCSGGGEEECTTCCEEECCGG
T ss_pred ceEEEEEecccCCcHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhC--------CccCCCCchheEEEcCCCCEEECCcc
Confidence 4689999999999999999988899999999999999999999999 99999999999999999999999999
Q ss_pred CcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCC
Q psy14889 287 LAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVP 366 (443)
Q Consensus 287 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~ 366 (443)
++.......... .......||..|+|||.+.+. .++.++||||||+++|||+||+ .||.....
T Consensus 180 ~a~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~il~~ll~g~----------~p~~~~~~ 242 (318)
T 3lxp_A 180 LAKAVPEGHEYY-RVREDGDSPVFWYAPECLKEY------KFYYASDVWSFGVTLYELLTHC----------DSSQSPPT 242 (318)
T ss_dssp GCEECCTTCSEE-EC---CCCCGGGCCHHHHHHC------EEEHHHHHHHHHHHHHHHHTTT----------CGGGSHHH
T ss_pred cccccccccccc-ccccCCCCCceeeChHHhcCC------CCCcHHHHHHHHHHHHHHHhCC----------Ccccccch
Confidence 998765432211 112334688899999999876 5567999999999999999994 44432100
Q ss_pred ----------CCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhhcc
Q psy14889 367 ----------MDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLACAD 432 (443)
Q Consensus 367 ----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~~~ 432 (443)
.......+...+. .......+ ..++.++.+|+.+||+.||++|||+.|+++.|+++.+..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~-----~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 312 (318)
T 3lxp_A 243 KFLELIGIAQGQMTVLRLTELLE-RGERLPRP-----DKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKY 312 (318)
T ss_dssp HHHHHHCSCCHHHHHHHHHHHHH-TTCCCCCC-----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred hhhhhhcccccchhHHHHHHHHh-cccCCCCC-----ccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhh
Confidence 0000111112221 12222222 346678999999999999999999999999999987654
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=355.74 Aligned_cols=251 Identities=24% Similarity=0.337 Sum_probs=190.3
Q ss_pred hccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEee
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLV 212 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv 212 (443)
.++|++.+.||+|+||.||+++. +++.||||++............|+..+..++||||+++++++.+. ..+++|
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~----~~~~lv 94 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTP----THLAII 94 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECS----SEEEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeC----CEEEEE
Confidence 36899999999999999999998 688999999876554444555677777779999999999999876 458999
Q ss_pred ecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCc--EEEEecCCcc
Q psy14889 213 THYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGT--CVIADFGLAV 289 (443)
Q Consensus 213 ~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~--~kl~DfGla~ 289 (443)
|||+++|+|.+++.. ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++. +||+|||+++
T Consensus 95 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~--------~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~ 166 (361)
T 3uc3_A 95 MEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSM--------QICHRDLKLENTLLDGSPAPRLKICDFGYSK 166 (361)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT--------TCCSCCCCGGGEEECSSSSCCEEECCCCCC-
T ss_pred EEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CcccCCCCHHHEEEcCCCCceEEEeecCccc
Confidence 999999999999854 6799999999999999999999998 9999999999999987765 9999999987
Q ss_pred cccccCCcCCCCCCCcccccCcccccccccccccCcCCCC-CccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCC
Q psy14889 290 SYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESF-KKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMD 368 (443)
Q Consensus 290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~-~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~ 368 (443)
...... ......||+.|+|||++.+. .++ .++|||||||++|||++| ..||.......
T Consensus 167 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~------~~~~~~~DiwslG~il~ell~g----------~~Pf~~~~~~~ 225 (361)
T 3uc3_A 167 SSVLHS-----QPKSTVGTPAYIAPEVLLRQ------EYDGKIADVWSCGVTLYVMLVG----------AYPFEDPEEPR 225 (361)
T ss_dssp -------------------CTTSCHHHHHCS------SCCHHHHHHHHHHHHHHHHHHS----------SCSCC----CC
T ss_pred cccccC-----CCCCCcCCCCcCChhhhcCC------CCCCCeeeeehhHHHHHHHHhC----------CCCCCCCccHH
Confidence 433221 12345799999999999765 333 348999999999999999 67776543222
Q ss_pred CChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHH
Q psy14889 369 PSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKT 424 (443)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 424 (443)
.....+..... .....+. ....+.++.+|+.+||+.||++|||+.|+++.
T Consensus 226 ~~~~~~~~~~~---~~~~~~~---~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 226 DYRKTIQRILS---VKYSIPD---DIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp CHHHHHHHHHT---TCCCCCT---TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHHHHHhc---CCCCCCC---cCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 22222222222 1222222 12355789999999999999999999999874
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=343.44 Aligned_cols=256 Identities=21% Similarity=0.403 Sum_probs=192.0
Q ss_pred hhccccccceeeeecCeEEEEEEEC-----CceeEEEEeeccCcc--chHHHHHHHHHHhccCCCceeeeeeccccCCcc
Q psy14889 134 LAKQISLSECIGKGRYGEVWRGVWH-----GENVAVKIFFSRDEA--SWSRETEIYSTVLLRHENILGYIGSDMTSRNSC 206 (443)
Q Consensus 134 ~~~~~~~~~~lG~G~fg~Vy~~~~~-----~~~vAvK~~~~~~~~--~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~ 206 (443)
..++|++.+.||+|+||.||+|.+. +..||+|++...... ......|+..+..++||||+++++++.+.
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---- 88 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN---- 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS----
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEccC----
Confidence 3478999999999999999999873 346999987653322 12234566677779999999999997543
Q ss_pred cEEEeeecccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEe
Q psy14889 207 TQLWLVTHYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIAD 284 (443)
Q Consensus 207 ~~~~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~D 284 (443)
..++||||+++|+|.+++.. ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|
T Consensus 89 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--------~i~H~dlkp~Nil~~~~~~~kl~D 159 (281)
T 1mp8_A 89 -PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK--------RFVHRDIAARNVLVSSNDCVKLGD 159 (281)
T ss_dssp -SCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT--------TCCCSCCSGGGEEEEETTEEEECC
T ss_pred -ccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC--------CeecccccHHHEEECCCCCEEECc
Confidence 36899999999999999974 3699999999999999999999999 999999999999999999999999
Q ss_pred cCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh-cccCCCcccccCCCCCC
Q psy14889 285 FGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR-RTKANGIFEEYKAPYHD 363 (443)
Q Consensus 285 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt-g~~~~~~~~~~~~P~~~ 363 (443)
||+++........ ......+|+.|+|||.+.+. .++.++||||||+++|||++ | ..||..
T Consensus 160 fg~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~~l~ell~~g----------~~pf~~ 220 (281)
T 1mp8_A 160 FGLSRYMEDSTYY---KASKGKLPIKWMAPESINFR------RFTSASDVWMFGVCMWEILMHG----------VKPFQG 220 (281)
T ss_dssp ----------------------CCGGGCCHHHHHHC------CCSHHHHHHHHHHHHHHHHTTS----------CCTTTT
T ss_pred cccccccCccccc---ccccCCCcccccChhhcccC------CCCCccCchHHHHHHHHHHhcC----------CCCCCc
Confidence 9999776543211 11233577899999999765 66789999999999999997 7 667765
Q ss_pred CCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhhcc
Q psy14889 364 LVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLACAD 432 (443)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~~~ 432 (443)
.. .......+.. ......+ ..++..+.+++.+||+.||++|||+.++++.|+++.+..
T Consensus 221 ~~-----~~~~~~~i~~-~~~~~~~-----~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 278 (281)
T 1mp8_A 221 VK-----NNDVIGRIEN-GERLPMP-----PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 278 (281)
T ss_dssp CC-----GGGHHHHHHT-TCCCCCC-----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CC-----HHHHHHHHHc-CCCCCCC-----CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 32 1222222222 2222222 346678999999999999999999999999999998653
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=339.13 Aligned_cols=255 Identities=24% Similarity=0.412 Sum_probs=205.2
Q ss_pred hccccccceeeeecCeEEEEEEEC-CceeEEEEeeccCccchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEeee
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVWH-GENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVT 213 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv~ 213 (443)
.++|++.+.||+|+||.||+|.+. +..||||++............|+..+..++||||+++++++... ..++||
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~v~ 86 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE-----PIYIIT 86 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SCEEEE
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEcCC-----CcEEEE
Confidence 478999999999999999999985 56899999876544444445666666679999999999997643 268999
Q ss_pred cccCcccHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCccc
Q psy14889 214 HYHSFGSLYDHLNRT---TLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVS 290 (443)
Q Consensus 214 e~~~~gsL~~~l~~~---~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~ 290 (443)
||+++|+|.+++... .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++..
T Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--------~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 158 (279)
T 1qpc_A 87 EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER--------NYIHRDLRAANILVSDTLSCKIADFGLARL 158 (279)
T ss_dssp ECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT--------TEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred ecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC--------CeeccCCCHhhEEEcCCCCEEECCCccccc
Confidence 999999999999753 699999999999999999999999 999999999999999999999999999987
Q ss_pred ccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh-cccCCCcccccCCCCCCCCCCCC
Q psy14889 291 YSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR-RTKANGIFEEYKAPYHDLVPMDP 369 (443)
Q Consensus 291 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt-g~~~~~~~~~~~~P~~~~~~~~~ 369 (443)
........ .....+|..|+|||.+.+. .++.++||||||+++|||++ | ..||.+.
T Consensus 159 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~il~el~~~g----------~~p~~~~----- 214 (279)
T 1qpc_A 159 IEDNEYTA---REGAKFPIKWTAPEAINYG------TFTIKSDVWSFGILLTEIVTHG----------RIPYPGM----- 214 (279)
T ss_dssp CSSSCEEC---CTTCCCCTTTSCHHHHHHC------EECHHHHHHHHHHHHHHHHTTT----------CCSSTTC-----
T ss_pred ccCccccc---ccCCCCccCccChhhhccC------CCCchhhhHHHHHHHHHHHhCC----------CCCCccc-----
Confidence 65432211 2234577899999999765 56689999999999999999 7 6677653
Q ss_pred ChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhhcc
Q psy14889 370 SFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLACAD 432 (443)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~~~ 432 (443)
........+.. ......+ ..++.++.+++.+||+.||++|||+.++++.|+++....
T Consensus 215 ~~~~~~~~~~~-~~~~~~~-----~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 271 (279)
T 1qpc_A 215 TNPEVIQNLER-GYRMVRP-----DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271 (279)
T ss_dssp CHHHHHHHHHT-TCCCCCC-----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CHHHHHHHHhc-ccCCCCc-----ccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhc
Confidence 22333333322 2222222 346678999999999999999999999999999987654
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=343.63 Aligned_cols=264 Identities=30% Similarity=0.483 Sum_probs=195.8
Q ss_pred hhhhccccccceeeeecCeEEEEEEECCceeEEEEeeccCcc---chHHHHHHHHHHhccCCCceeeeeeccccCCcccE
Q psy14889 132 RTLAKQISLSECIGKGRYGEVWRGVWHGENVAVKIFFSRDEA---SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQ 208 (443)
Q Consensus 132 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~---~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~ 208 (443)
+...++|++.+.||+|+||.||+|++.+ .||||++...... ......|+..+..++||||++++++.... .
T Consensus 20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~~-~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~ 93 (289)
T 3og7_A 20 EIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAP-----Q 93 (289)
T ss_dssp BCCTTSCEEEEEEEECSSEEEEEEESSS-EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS-----S
T ss_pred ccCccceeeeeEecCCCCeEEEEEEEcC-ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccCC-----c
Confidence 4445789999999999999999998765 5999988654322 12234667777779999999999976443 3
Q ss_pred EEeeecccCcccHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecC
Q psy14889 209 LWLVTHYHSFGSLYDHLN--RTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFG 286 (443)
Q Consensus 209 ~~lv~e~~~~gsL~~~l~--~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfG 286 (443)
.++||||+++++|.+++. ...+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~--------~i~H~Dlkp~Nil~~~~~~~kl~Dfg 165 (289)
T 3og7_A 94 LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAK--------SIIHRDLKSNNIFLHEDNTVKIGDFG 165 (289)
T ss_dssp CEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHT--------TCCCSCCCGGGEEEETTTEEEECCCC
T ss_pred cEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC--------CcccccCccceEEECCCCCEEEccce
Confidence 689999999999999995 35699999999999999999999999 99999999999999999999999999
Q ss_pred CcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCC
Q psy14889 287 LAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVP 366 (443)
Q Consensus 287 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~ 366 (443)
++.......... ......||+.|+|||.+..... ..++.++||||||+++|||++| ..||....
T Consensus 166 ~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~---~~~~~~~Di~slG~il~el~~g----------~~p~~~~~- 229 (289)
T 3og7_A 166 LATEKSRWSGSH--QFEQLSGSILWMAPEVIRMQDS---NPYSFQSDVYAFGIVLYELMTG----------QLPYSNIN- 229 (289)
T ss_dssp --------------------CCCTTCCHHHHC-------CCSCHHHHHHHHHHHHHHHHHS----------SCTTSSCC-
T ss_pred eccccccccccc--cccccCCCccccCchhhcccCC---CCCCcccchHHHHHHHHHHHHC----------CCCccccc-
Confidence 997654322111 1234578999999999863211 1567899999999999999999 77776532
Q ss_pred CCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhh
Q psy14889 367 MDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLAC 430 (443)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~ 430 (443)
....+...+......+..+. ....++..+.+|+.+||+.||++|||+.++++.|+++.+
T Consensus 230 ---~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 230 ---NRDQIIEMVGRGSLSPDLSK--VRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp ---CHHHHHHHHHHTSCCCCTTS--SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred ---hHHHHHHHhcccccCcchhh--ccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 23344444433333332221 224567889999999999999999999999999999875
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=350.50 Aligned_cols=252 Identities=25% Similarity=0.372 Sum_probs=195.3
Q ss_pred hccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc--chHHHHHHHHHHhccCCCceeeeeeccccCCcccEEE
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA--SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLW 210 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~--~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~ 210 (443)
.++|++.+.||+|+||.||+|.+ +++.||||++...... ......|+..+..++||||+++++++.+. ...+
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~----~~~~ 81 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG----NIQY 81 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECS----SEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecC----CeEE
Confidence 47899999999999999999988 5889999998644321 12234455555669999999999998776 4579
Q ss_pred eeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcc
Q psy14889 211 LVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAV 289 (443)
Q Consensus 211 lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~ 289 (443)
+||||+++|+|.+++.. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~--------givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 153 (323)
T 3tki_A 82 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI--------GITHRDIKPENLLLDERDNLKISDFGLAT 153 (323)
T ss_dssp EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHT--------TEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CccccccchHHEEEeCCCCEEEEEeeccc
Confidence 99999999999999975 4799999999999999999999998 99999999999999999999999999997
Q ss_pred cccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCC
Q psy14889 290 SYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDP 369 (443)
Q Consensus 290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~ 369 (443)
.+....... ......||+.|+|||++.+.. ..+.++|||||||++|||++| ..||.....
T Consensus 154 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~-----~~~~~~DiwslG~il~~ll~g----------~~pf~~~~~--- 213 (323)
T 3tki_A 154 VFRYNNRER--LLNKMCGTLPYVAPELLKRRE-----FHAEPVDVWSCGIVLTAMLAG----------ELPWDQPSD--- 213 (323)
T ss_dssp ECEETTEEC--CBCSCCSCGGGSCHHHHHCSS-----BCHHHHHHHHHHHHHHHHHHS----------SCSCSSSCT---
T ss_pred eeccCCccc--ccCCCccCcCccCcHHhccCC-----CCCCcccHHHHHHHHHHHHhC----------CCCCCCCch---
Confidence 664322211 123457999999999997652 124689999999999999999 677765422
Q ss_pred ChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHH
Q psy14889 370 SFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKT 424 (443)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 424 (443)
........... ....+. ...++..+.+|+.+||+.||++|||+.|+++.
T Consensus 214 ~~~~~~~~~~~---~~~~~~---~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 214 SCQEYSDWKEK---KTYLNP---WKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp TSHHHHHHHTT---CTTSTT---GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHHHHHhcc---cccCCc---cccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 11222222211 111111 13456789999999999999999999999763
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-45 Score=351.72 Aligned_cols=255 Identities=23% Similarity=0.440 Sum_probs=198.2
Q ss_pred ccccccceeeeecCeEEEEEEE--CCce----eEEEEeeccCcc--chHHHHHHHHHHhccCCCceeeeeeccccCCccc
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGEN----VAVKIFFSRDEA--SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCT 207 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~----vAvK~~~~~~~~--~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~ 207 (443)
++|++.+.||+|+||.||+|.+ +++. ||+|.+...... ......|+..+..++||||+++++++...
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----- 87 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGS----- 87 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECBS-----
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC-----
Confidence 6899999999999999999998 4554 777776433211 11223455555668999999999998543
Q ss_pred EEEeeecccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEec
Q psy14889 208 QLWLVTHYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADF 285 (443)
Q Consensus 208 ~~~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~Df 285 (443)
..++||||+++|+|.+++.. ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+||
T Consensus 88 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--------~ivH~Dikp~Nil~~~~~~~kl~Df 159 (325)
T 3kex_A 88 SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEH--------GMVHRNLAARNVLLKSPSQVQVADF 159 (325)
T ss_dssp SEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHT--------TCCCSCCSSTTEEESSSSCEEECSC
T ss_pred ccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhC--------CCCCCccchheEEECCCCeEEECCC
Confidence 36899999999999999965 4799999999999999999999999 9999999999999999999999999
Q ss_pred CCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh-cccCCCcccccCCCCCCC
Q psy14889 286 GLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR-RTKANGIFEEYKAPYHDL 364 (443)
Q Consensus 286 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt-g~~~~~~~~~~~~P~~~~ 364 (443)
|+++......... ......||..|+|||++.+. .++.++||||||+++|||+| | ..||...
T Consensus 160 g~a~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~~l~el~~~g----------~~p~~~~ 221 (325)
T 3kex_A 160 GVADLLPPDDKQL--LYSEAKTPIKWMALESIHFG------KYTHQSDVWSYGVTVWELMTFG----------AEPYAGL 221 (325)
T ss_dssp SGGGGSCCCTTCC--C-----CCTTTSCHHHHHHC------CCCHHHHHHHHHHHHHHHHTTS----------CCTTTTS
T ss_pred CcccccCcccccc--cccCCCCcccccChHHhccC------CCChhhHhHHhHHHHHHHHhCC----------CCCcccc
Confidence 9998765433221 12345688899999999876 67789999999999999999 8 6777654
Q ss_pred CCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhhcc
Q psy14889 365 VPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLACAD 432 (443)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~~~ 432 (443)
. ...+...+.. ......+. .++..+.+++.+||+.||++|||+.++++.|+++....
T Consensus 222 ~-----~~~~~~~~~~-~~~~~~~~-----~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~ 278 (325)
T 3kex_A 222 R-----LAEVPDLLEK-GERLAQPQ-----ICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDP 278 (325)
T ss_dssp C-----TTHHHHHHHT-TCBCCCCT-----TBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSH
T ss_pred C-----HHHHHHHHHc-CCCCCCCC-----cCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 2 2233333322 22233332 24456899999999999999999999999999997654
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=355.44 Aligned_cols=243 Identities=22% Similarity=0.333 Sum_probs=191.2
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCc------cchHHHHHHHHHHhccCCCceeeeeeccccCCccc
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDE------ASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCT 207 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~------~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~ 207 (443)
++|++.+.||+|+||.||+|+. +++.||||++..... .....|.+++... .+||||+++++++.+. .
T Consensus 52 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~-~~hp~Iv~l~~~~~~~----~ 126 (396)
T 4dc2_A 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQA-SNHPFLVGLHSCFQTE----S 126 (396)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHH-TTCTTBCCEEEEEECS----S
T ss_pred hHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhc-CCCCCcCeeEEEEEEC----C
Confidence 6899999999999999999998 578999999875321 1233344444332 4899999999998876 4
Q ss_pred EEEeeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecC
Q psy14889 208 QLWLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFG 286 (443)
Q Consensus 208 ~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfG 286 (443)
.+++||||+++|+|..++.+ ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 127 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~--------givHrDLKp~NILl~~~g~ikL~DFG 198 (396)
T 4dc2_A 127 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER--------GIIYRDLKLDNVLLDSEGHIKLTDYG 198 (396)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT--------TCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred EEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC--------CEEeccCCHHHEEECCCCCEEEeecc
Confidence 68999999999999999865 6799999999999999999999999 99999999999999999999999999
Q ss_pred CcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCC
Q psy14889 287 LAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVP 366 (443)
Q Consensus 287 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~ 366 (443)
+++....... .....+||+.|+|||++.+. .++.++|||||||++|||++| ..||.....
T Consensus 199 la~~~~~~~~----~~~~~~gt~~Y~aPE~l~~~------~~~~~~DiwslGvllyell~G----------~~Pf~~~~~ 258 (396)
T 4dc2_A 199 MCKEGLRPGD----TTSTFCGTPNYIAPEILRGE------DYGFSVDWWALGVLMFEMMAG----------RSPFDIVGS 258 (396)
T ss_dssp TCBCCCCTTC----CBCCCCBCGGGCCHHHHTTC------CBCTHHHHHHHHHHHHHHHHS----------SCSSTTTTC
T ss_pred eeeecccCCC----ccccccCCcccCCchhhcCC------CCChHHHHHHHHHHHHHHHhC----------CCCCccccc
Confidence 9975332211 22456899999999999876 677899999999999999999 566643211
Q ss_pred C----CCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcH
Q psy14889 367 M----DPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSA 418 (443)
Q Consensus 367 ~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~ 418 (443)
. ......+...+.. ....+| ...+.++.+||++||+.||++||++
T Consensus 259 ~~~~~~~~~~~~~~~i~~--~~~~~p-----~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 259 SDNPDQNTEDYLFQVILE--KQIRIP-----RSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp ------CCHHHHHHHHHH--CCCCCC-----TTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred ccccchhhHHHHHHHHhc--cccCCC-----CcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 1 1122333333322 223333 2356789999999999999999985
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=343.45 Aligned_cols=265 Identities=20% Similarity=0.210 Sum_probs=204.2
Q ss_pred hhccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCc-cchHHHHHHHHHHhc-cCCCceeeeeeccccCCcccEE
Q psy14889 134 LAKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDE-ASWSRETEIYSTVLL-RHENILGYIGSDMTSRNSCTQL 209 (443)
Q Consensus 134 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~e~ei~~~~~l-~H~nIv~l~g~~~~~~~~~~~~ 209 (443)
+.++|++.+.||+|+||.||+|.. +|+.||||++..... .....|.+ .+..+ +|+||+++++++... ...
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~--~~~~l~~~~~i~~~~~~~~~~----~~~ 81 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYR--TYKLLAGCTGIPNVYYFGQEG----LHN 81 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHH--HHHHTTTCTTCCCEEEEEEET----TEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHH--HHHHHhcCCCCCeEEeecCCC----cee
Confidence 447899999999999999999996 689999998865432 33444444 44446 899999999998665 457
Q ss_pred EeeecccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCc-----EEE
Q psy14889 210 WLVTHYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGT-----CVI 282 (443)
Q Consensus 210 ~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~-----~kl 282 (443)
++||||+ +|+|.+++.. ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++. +||
T Consensus 82 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--------~ivH~Dlkp~NIl~~~~~~~~~~~~kl 152 (298)
T 1csn_A 82 VLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK--------SLVYRDIKPDNFLIGRPNSKNANMIYV 152 (298)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTT--------TEECCCCCGGGEEECCSSSTTTTCEEE
T ss_pred EEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhC--------CEecCCCCHHHEEeccCCCCCCCeEEE
Confidence 9999999 8999999974 4699999999999999999999998 9999999999999987775 999
Q ss_pred EecCCcccccccCCcCC---CCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCC
Q psy14889 283 ADFGLAVSYSQLSNKMD---IPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKA 359 (443)
Q Consensus 283 ~DfGla~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~ 359 (443)
+|||+++.......... .......||+.|+|||.+.+. .++.++||||||+++|||++| ..
T Consensus 153 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~Di~slG~il~el~~g----------~~ 216 (298)
T 1csn_A 153 VDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGR------EQSRRDDLEALGHVFMYFLRG----------SL 216 (298)
T ss_dssp CCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC------CCCHHHHHHHHHHHHHHHHHS----------SC
T ss_pred EECccccccccccccccccccCccCCCCCcccCCchhhcCC------CCChHHHHHHHHHHHHHHHcC----------CC
Confidence 99999987665432211 123455799999999999876 677899999999999999999 77
Q ss_pred CCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhhccc
Q psy14889 360 PYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLACADM 433 (443)
Q Consensus 360 P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~~~~ 433 (443)
||...... ........+......+..+. ....++.++.+++.+||+.||++|||+.+|++.|+++.+...
T Consensus 217 pf~~~~~~--~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~ 286 (298)
T 1csn_A 217 PWQGLKAA--TNKQKYERIGEKKQSTPLRE--LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 286 (298)
T ss_dssp TTSSCCSC--CHHHHHHHHHHHHHHSCHHH--HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred Ccchhhcc--ccHHHHHHHHhhccCccHHH--HHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcC
Confidence 77664221 11222111111111111110 012356789999999999999999999999999999987643
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=346.70 Aligned_cols=256 Identities=23% Similarity=0.398 Sum_probs=203.9
Q ss_pred hccccccceeeeecCeEEEEEEE-------CCceeEEEEeeccCccc--hHHHHHHHHHHhccCCCceeeeeeccccCCc
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVW-------HGENVAVKIFFSRDEAS--WSRETEIYSTVLLRHENILGYIGSDMTSRNS 205 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~-------~~~~vAvK~~~~~~~~~--~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~ 205 (443)
.++|.+.+.||+|+||.||+|.. ++..||||++....... .....|+..+..++||||+++++++.+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-- 99 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDG-- 99 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS--
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCC--
Confidence 47899999999999999999986 24789999986543222 22345677777799999999999987763
Q ss_pred ccEEEeeecccCcccHHHHhccc-------------------------CCCHHHHHHHHHHHHHHHHHHHHchhcCCCCC
Q psy14889 206 CTQLWLVTHYHSFGSLYDHLNRT-------------------------TLNHHQMMKICLSIVNGLVHLHTEIFGTQGKP 260 (443)
Q Consensus 206 ~~~~~lv~e~~~~gsL~~~l~~~-------------------------~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~ 260 (443)
..++||||+++|+|.+++... .+++.+++.++.||+.||.|||+.
T Consensus 100 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-------- 169 (314)
T 2ivs_A 100 --PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM-------- 169 (314)
T ss_dssp --SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT--------
T ss_pred --ceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC--------
Confidence 469999999999999999642 388999999999999999999999
Q ss_pred CeEEeCCCCCCEEEcCCCcEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHH
Q psy14889 261 AIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLV 340 (443)
Q Consensus 261 ~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvv 340 (443)
+|+||||||+|||++.++.+||+|||+++......... ......+|+.|+|||.+.+. .++.++||||||++
T Consensus 170 ~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~i 241 (314)
T 2ivs_A 170 KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYV--KRSQGRIPVKWMAIESLFDH------IYTTQSDVWSFGVL 241 (314)
T ss_dssp TEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEE--CSSCCCSCGGGCCHHHHHHC------EECHHHHHHHHHHH
T ss_pred CCcccccchheEEEcCCCCEEEccccccccccccccce--eccCCCCcccccChhhhcCC------CcCchhhHHHHHHH
Confidence 99999999999999999999999999997665432211 12334678899999999875 56689999999999
Q ss_pred HHHHHh-cccCCCcccccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHH
Q psy14889 341 LWEVCR-RTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSAL 419 (443)
Q Consensus 341 l~ellt-g~~~~~~~~~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ 419 (443)
+|||++ | ..||.... ...+...+.. ...+..+ ..++..+.+++.+||+.||++|||+.
T Consensus 242 l~el~t~g----------~~p~~~~~-----~~~~~~~~~~-~~~~~~~-----~~~~~~~~~li~~~l~~dp~~Rps~~ 300 (314)
T 2ivs_A 242 LWEIVTLG----------GNPYPGIP-----PERLFNLLKT-GHRMERP-----DNCSEEMYRLMLQCWKQEPDKRPVFA 300 (314)
T ss_dssp HHHHHTTS----------CCSSTTCC-----GGGHHHHHHT-TCCCCCC-----TTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred HHHHHhCC----------CCCCCCCC-----HHHHHHHhhc-CCcCCCC-----ccCCHHHHHHHHHHccCChhhCcCHH
Confidence 999999 7 66776542 2233333322 2222222 34667899999999999999999999
Q ss_pred HHHHHHHHHhhc
Q psy14889 420 RVKKTLIKLACA 431 (443)
Q Consensus 420 evl~~L~~l~~~ 431 (443)
++++.|+++...
T Consensus 301 ~l~~~l~~~~~~ 312 (314)
T 2ivs_A 301 DISKDLEKMMVK 312 (314)
T ss_dssp HHHHHHHHHHHT
T ss_pred HHHHHHHHHHhh
Confidence 999999998764
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=351.87 Aligned_cols=260 Identities=23% Similarity=0.372 Sum_probs=201.7
Q ss_pred hhccccccceeeeecCeEEEEEEE-------CCceeEEEEeeccCc--cchHHHHHHHHHHhc-cCCCceeeeeeccccC
Q psy14889 134 LAKQISLSECIGKGRYGEVWRGVW-------HGENVAVKIFFSRDE--ASWSRETEIYSTVLL-RHENILGYIGSDMTSR 203 (443)
Q Consensus 134 ~~~~~~~~~~lG~G~fg~Vy~~~~-------~~~~vAvK~~~~~~~--~~~~~e~ei~~~~~l-~H~nIv~l~g~~~~~~ 203 (443)
..++|.+.+.||+|+||.||+|.+ ++..||||++..... .......|+..+..+ +||||+++++++....
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 347899999999999999999996 245799999864322 222334566666668 8999999999988764
Q ss_pred CcccEEEeeecccCcccHHHHhccc------------------------CCCHHHHHHHHHHHHHHHHHHHHchhcCCCC
Q psy14889 204 NSCTQLWLVTHYHSFGSLYDHLNRT------------------------TLNHHQMMKICLSIVNGLVHLHTEIFGTQGK 259 (443)
Q Consensus 204 ~~~~~~~lv~e~~~~gsL~~~l~~~------------------------~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~ 259 (443)
.+++||||+++|+|.+++... .+++..++.++.||+.||.|||+.
T Consensus 123 ----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~------- 191 (344)
T 1rjb_A 123 ----PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK------- 191 (344)
T ss_dssp ----SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT-------
T ss_pred ----ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC-------
Confidence 469999999999999999642 278999999999999999999999
Q ss_pred CCeEEeCCCCCCEEEcCCCcEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHH
Q psy14889 260 PAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGL 339 (443)
Q Consensus 260 ~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gv 339 (443)
+|+||||||+|||++.++.+||+|||++.......... ......||+.|+|||.+.+. .++.++||||||+
T Consensus 192 -~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~------~~~~~~Di~slG~ 262 (344)
T 1rjb_A 192 -SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYV--VRGNARLPVKWMAPESLFEG------IYTIKSDVWSYGI 262 (344)
T ss_dssp -TEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSE--EETTEEECGGGCCHHHHHHC------CCCHHHHHHHHHH
T ss_pred -CcccCCCChhhEEEcCCCcEEeCCCccCcccccCccce--eccCccCccCccCHHHhccC------CCChhHhHHHHHH
Confidence 99999999999999999999999999997665432211 12344678899999999776 6778999999999
Q ss_pred HHHHHHh-cccCCCcccccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcH
Q psy14889 340 VLWEVCR-RTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSA 418 (443)
Q Consensus 340 vl~ellt-g~~~~~~~~~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~ 418 (443)
++|||+| | ..||..... ...+...+. ....+..+ ..++.++.+|+.+||+.||.+|||+
T Consensus 263 il~el~t~g----------~~p~~~~~~----~~~~~~~~~-~~~~~~~~-----~~~~~~l~~li~~~l~~dp~~Rps~ 322 (344)
T 1rjb_A 263 LLWEIFSLG----------VNPYPGIPV----DANFYKLIQ-NGFKMDQP-----FYATEEIYIIMQSCWAFDSRKRPSF 322 (344)
T ss_dssp HHHHHTTTS----------CCSSTTCCC----SHHHHHHHH-TTCCCCCC-----TTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred HHHHHHcCC----------CCCcccCCc----HHHHHHHHh-cCCCCCCC-----CCCCHHHHHHHHHHcCCCchhCcCH
Confidence 9999998 7 667765421 223333332 22223222 2356789999999999999999999
Q ss_pred HHHHHHHHHHhhccc
Q psy14889 419 LRVKKTLIKLACADM 433 (443)
Q Consensus 419 ~evl~~L~~l~~~~~ 433 (443)
.++++.|+.+.....
T Consensus 323 ~~l~~~l~~~~~~~~ 337 (344)
T 1rjb_A 323 PNLTSFLGCQLADAE 337 (344)
T ss_dssp HHHHHHHHHHC----
T ss_pred HHHHHHHHHHHHHHH
Confidence 999999999887643
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=356.74 Aligned_cols=253 Identities=19% Similarity=0.270 Sum_probs=188.9
Q ss_pred cccccc-ceeeeecCeEEEEEEE--CCceeEEEEeeccCccchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEee
Q psy14889 136 KQISLS-ECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLV 212 (443)
Q Consensus 136 ~~~~~~-~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv 212 (443)
++|.+. +.||+|+||.||+|.+ +|+.||||++... ....+|.++... ..+||||+++++++.........+++|
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--~~~~~E~~~~~~-~~~hp~iv~l~~~~~~~~~~~~~~~lv 137 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--PKARREVELHWR-ASQCPHIVRIVDVYENLYAGRKCLLIV 137 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--HHHHHHHHHHHH-HTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--hhHHHHHHHHHH-hcCCCCcceEeEEEeecccCCcEEEEE
Confidence 567766 7899999999999998 5889999998532 233445554433 368999999999986533223568999
Q ss_pred ecccCcccHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcC---CCcEEEEecC
Q psy14889 213 THYHSFGSLYDHLNRT---TLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKT---NGTCVIADFG 286 (443)
Q Consensus 213 ~e~~~~gsL~~~l~~~---~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~---~~~~kl~DfG 286 (443)
|||+++|+|.+++... .+++..+..++.||+.||.|||+. +|+||||||+|||++. ++.+||+|||
T Consensus 138 ~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--------~ivHrDlkp~Nill~~~~~~~~~kl~DFG 209 (400)
T 1nxk_A 138 MECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI--------NIAHRDVKPENLLYTSKRPNAILKLTDFG 209 (400)
T ss_dssp EECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHT--------TEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred EEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC--------CccccCcCcceEEEecCCCCccEEEEecc
Confidence 9999999999999753 599999999999999999999998 9999999999999998 7899999999
Q ss_pred CcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCC
Q psy14889 287 LAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVP 366 (443)
Q Consensus 287 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~ 366 (443)
+++....... .....||+.|+|||++.+. .++.++|||||||++|||++| ..||.....
T Consensus 210 ~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~ell~g----------~~pf~~~~~ 268 (400)
T 1nxk_A 210 FAKETTSHNS-----LTTPCYTPYYVAPEVLGPE------KYDKSCDMWSLGVIMYILLCG----------YPPFYSNHG 268 (400)
T ss_dssp TCEECC----------------CTTCCGGGSCCC------CSSSHHHHHHHHHHHHHHHHS----------SCSCCCCTT
T ss_pred cccccCCCCc-----cccCCCCCCccCHhhcCCC------CCCCcccHHHHHHHHHHHHhC----------CCCCCCCcc
Confidence 9976543221 2345789999999999765 677899999999999999999 666655432
Q ss_pred CCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHH
Q psy14889 367 MDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKT 424 (443)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 424 (443)
...... +...+.........+ . ...++.++.+||.+||+.||++|||+.|+++.
T Consensus 269 ~~~~~~-~~~~i~~~~~~~~~~-~--~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 269 LAISPG-MKTRIRMGQYEFPNP-E--WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp CSSCCS-HHHHHHHTCCCCCTT-T--TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ccccHH-HHHHHHcCcccCCCc-c--cccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 221111 222222222211111 1 12366789999999999999999999999874
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=353.62 Aligned_cols=249 Identities=19% Similarity=0.314 Sum_probs=195.1
Q ss_pred hhccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCc------cchHHHHHHHHHHhccCCCceeeeeeccccCCc
Q psy14889 134 LAKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDE------ASWSRETEIYSTVLLRHENILGYIGSDMTSRNS 205 (443)
Q Consensus 134 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~------~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~ 205 (443)
+.+.|++.+.||+|+||.||+|.. +|+.||||++..... .......|+..+..++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--- 98 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSD--- 98 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEET---
T ss_pred cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeC---
Confidence 457899999999999999999988 589999999854211 122234556666669999999999998776
Q ss_pred ccEEEeeecccCcccHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCc-
Q psy14889 206 CTQLWLVTHYHSFGSLYDHLNR-----TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGT- 279 (443)
Q Consensus 206 ~~~~~lv~e~~~~gsL~~~l~~-----~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~- 279 (443)
..+++||||+++|+|.+++.. ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.
T Consensus 99 -~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~--------~ivHrDlkp~NIl~~~~~~~ 169 (351)
T 3c0i_A 99 -GMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN--------NIIHRDVKPHCVLLASKENS 169 (351)
T ss_dssp -TEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT--------TEECSCCSGGGEEECSSSTT
T ss_pred -CEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC--------CceeccCChHHeEEecCCCC
Confidence 468999999999999888753 2489999999999999999999999 9999999999999987654
Q ss_pred --EEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCccccc
Q psy14889 280 --CVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEY 357 (443)
Q Consensus 280 --~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~ 357 (443)
+||+|||+++........ .....||+.|+|||++.+. .++.++|||||||++|||++|
T Consensus 170 ~~vkl~Dfg~a~~~~~~~~~----~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~~ll~g---------- 229 (351)
T 3c0i_A 170 APVKLGGFGVAIQLGESGLV----AGGRVGTPHFMAPEVVKRE------PYGKPVDVWGCGVILFILLSG---------- 229 (351)
T ss_dssp CCEEECCCTTCEECCTTSCB----CCCCCSCGGGCCHHHHTTC------CBCTHHHHHHHHHHHHHHHHS----------
T ss_pred CcEEEecCcceeEecCCCee----ecCCcCCcCccCHHHHcCC------CCCchHhhHHHHHHHHHHHHC----------
Confidence 999999999876543221 2345799999999999876 667899999999999999999
Q ss_pred CCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 358 KAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 358 ~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
..||... .......+....... .+..| ..++.++.+|+.+||+.||++|||+.|+++
T Consensus 230 ~~pf~~~------~~~~~~~i~~~~~~~-~~~~~--~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 230 CLPFYGT------KERLFEGIIKGKYKM-NPRQW--SHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp SCSSCSS------HHHHHHHHHHTCCCC-CHHHH--TTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCCCCc------HHHHHHHHHcCCCCC-Ccccc--ccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 6777652 222322222211111 11000 235678999999999999999999999986
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=351.88 Aligned_cols=243 Identities=23% Similarity=0.374 Sum_probs=195.2
Q ss_pred hccccccceeeeecCeEEEEEEE--CCceeEEEEeeccC------ccchHHHHHHHHHHhccCCCceeeeeeccccCCcc
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRD------EASWSRETEIYSTVLLRHENILGYIGSDMTSRNSC 206 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~------~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~ 206 (443)
.++|.+.+.||+|+||.||+|++ +|+.||||++.... ......|.+++... .+||||+++++++.+.
T Consensus 16 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~-~~hp~iv~l~~~~~~~---- 90 (345)
T 1xjd_A 16 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA-WEHPFLTHMFCTFQTK---- 90 (345)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHH-TTCTTBCCEEEEEECS----
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhc-CCCCCCCcEEEEEEeC----
Confidence 37899999999999999999998 58899999986532 12223344444332 4999999999999876
Q ss_pred cEEEeeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEec
Q psy14889 207 TQLWLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADF 285 (443)
Q Consensus 207 ~~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~Df 285 (443)
..+++||||+++|+|.+++.+ ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+||
T Consensus 91 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~--------~ivHrDlkp~NIll~~~g~vkL~DF 162 (345)
T 1xjd_A 91 ENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK--------GIVYRDLKLDNILLDKDGHIKIADF 162 (345)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT--------TCBCCCCCGGGEEECTTSCEEECCC
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC--------CeEeCCCChhhEEECCCCCEEEeEC
Confidence 458999999999999999975 6799999999999999999999999 9999999999999999999999999
Q ss_pred CCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCC
Q psy14889 286 GLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLV 365 (443)
Q Consensus 286 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~ 365 (443)
|+++....... .....+||+.|+|||++.+. .++.++|||||||++|||++| ..||...
T Consensus 163 G~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~ell~g----------~~Pf~~~- 221 (345)
T 1xjd_A 163 GMCKENMLGDA----KTNTFCGTPDYIAPEILLGQ------KYNHSVDWWSFGVLLYEMLIG----------QSPFHGQ- 221 (345)
T ss_dssp TTCBCCCCTTC----CBCCCCSCGGGCCHHHHTTC------CBCTHHHHHHHHHHHHHHHHS----------SCSSCCS-
T ss_pred hhhhhcccCCC----cccCCCCCcccCChhhhcCC------CCCChhhhHHHHHHHHHHhcC----------CCCCCCC-
Confidence 99975432211 12456899999999999876 677899999999999999999 7777653
Q ss_pred CCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHH-HHH
Q psy14889 366 PMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSAL-RVK 422 (443)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~-evl 422 (443)
....+...+... .+.+| ...+.++.+|+.+||+.||++||++. +++
T Consensus 222 ----~~~~~~~~i~~~--~~~~p-----~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 222 ----DEEELFHSIRMD--NPFYP-----RWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp ----SHHHHHHHHHHC--CCCCC-----TTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred ----CHHHHHHHHHhC--CCCCC-----cccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 233333333222 23333 23567899999999999999999987 654
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=346.13 Aligned_cols=259 Identities=23% Similarity=0.392 Sum_probs=204.9
Q ss_pred hhccccccceeeeecCeEEEEEEE-------CCceeEEEEeeccCcc--chHHHHHHHHHHhc-cCCCceeeeeeccccC
Q psy14889 134 LAKQISLSECIGKGRYGEVWRGVW-------HGENVAVKIFFSRDEA--SWSRETEIYSTVLL-RHENILGYIGSDMTSR 203 (443)
Q Consensus 134 ~~~~~~~~~~lG~G~fg~Vy~~~~-------~~~~vAvK~~~~~~~~--~~~~e~ei~~~~~l-~H~nIv~l~g~~~~~~ 203 (443)
..++|++.+.||+|+||.||+|.+ +++.||||++...... ......|+..+..+ +||||+++++++....
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 100 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence 347899999999999999999985 3578999998654322 12234566666668 9999999999998764
Q ss_pred CcccEEEeeecccCcccHHHHhccc-------------------CCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEE
Q psy14889 204 NSCTQLWLVTHYHSFGSLYDHLNRT-------------------TLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAH 264 (443)
Q Consensus 204 ~~~~~~~lv~e~~~~gsL~~~l~~~-------------------~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiH 264 (443)
..++||||+++|+|.+++... .+++..++.++.|++.||.|||+. +|+|
T Consensus 101 ----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--------~i~H 168 (313)
T 1t46_A 101 ----PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK--------NCIH 168 (313)
T ss_dssp ----SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT--------TCCC
T ss_pred ----CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC--------Ceec
Confidence 369999999999999999643 389999999999999999999999 9999
Q ss_pred eCCCCCCEEEcCCCcEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHH
Q psy14889 265 RDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEV 344 (443)
Q Consensus 265 rDlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~el 344 (443)
|||||+|||++.++.+||+|||+++......... ......||+.|+|||.+.+. .++.++||||||+++|||
T Consensus 169 ~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~il~el 240 (313)
T 1t46_A 169 RDLAARNILLTHGRITKICDFGLARDIKNDSNYV--VKGNARLPVKWMAPESIFNC------VYTFESDVWSYGIFLWEL 240 (313)
T ss_dssp SCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSE--ECSSSEECGGGCCHHHHHHC------CCCHHHHHHHHHHHHHHH
T ss_pred CCCccceEEEcCCCCEEEccccccccccccccce--eccCCCCcceeeChHHhcCC------CCChHHHHHHHHHHHHHH
Confidence 9999999999999999999999997765432211 12334678899999998776 677899999999999999
Q ss_pred Hh-cccCCCcccccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 345 CR-RTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 345 lt-g~~~~~~~~~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
+| | ..||.... ........+.. ...+..+ ...+..+.+++.+||+.||.+|||+.|+++
T Consensus 241 lt~g----------~~p~~~~~----~~~~~~~~~~~-~~~~~~~-----~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 300 (313)
T 1t46_A 241 FSLG----------SSPYPGMP----VDSKFYKMIKE-GFRMLSP-----EHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (313)
T ss_dssp HTTT----------CCSSTTCC----SSHHHHHHHHH-TCCCCCC-----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HhCC----------CCCCCccc----chhHHHHHhcc-CCCCCCc-----ccCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 99 7 66776532 11223333322 2222222 335678999999999999999999999999
Q ss_pred HHHHHhhcc
Q psy14889 424 TLIKLACAD 432 (443)
Q Consensus 424 ~L~~l~~~~ 432 (443)
.|+++....
T Consensus 301 ~L~~~~~~~ 309 (313)
T 1t46_A 301 LIEKQISES 309 (313)
T ss_dssp HHHHHHHHT
T ss_pred HHHHHHHHh
Confidence 999988653
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=347.38 Aligned_cols=250 Identities=19% Similarity=0.261 Sum_probs=198.1
Q ss_pred hhhccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc-------chHHHHHHHHHHhccCCCceeeeeeccccC
Q psy14889 133 TLAKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA-------SWSRETEIYSTVLLRHENILGYIGSDMTSR 203 (443)
Q Consensus 133 ~~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~-------~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~ 203 (443)
.+.+.|.+.+.||+|+||.||+|.. +|+.||+|++...... ....+.|+..+..++||||+++++++.+.
T Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~- 86 (326)
T 2y0a_A 8 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK- 86 (326)
T ss_dssp CHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-
T ss_pred CcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeC-
Confidence 3457899999999999999999998 5899999988654321 22334566666679999999999998765
Q ss_pred CcccEEEeeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCC----
Q psy14889 204 NSCTQLWLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNG---- 278 (443)
Q Consensus 204 ~~~~~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~---- 278 (443)
..+++||||+++|+|.+++.. ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++
T Consensus 87 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~--------~ivH~Dlkp~NIll~~~~~~~~ 155 (326)
T 2y0a_A 87 ---TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL--------QIAHFDLKPENIMLLDRNVPKP 155 (326)
T ss_dssp ---SEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHT--------TEECCCCCGGGEEESCSSSSSC
T ss_pred ---CEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHC--------CeEcCCCCHHHEEEecCCCCCC
Confidence 458999999999999999964 5699999999999999999999998 999999999999999887
Q ss_pred cEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccC
Q psy14889 279 TCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYK 358 (443)
Q Consensus 279 ~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~ 358 (443)
.+||+|||+++....... .....||+.|+|||++.+. .++.++|||||||++|||++| .
T Consensus 156 ~~kl~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~~ll~g----------~ 214 (326)
T 2y0a_A 156 RIKIIDFGLAHKIDFGNE-----FKNIFGTPEFVAPEIVNYE------PLGLEADMWSIGVITYILLSG----------A 214 (326)
T ss_dssp CEEECCCTTCEECCTTSC-----CCCCCSCTTTCCHHHHTTC------CCCTHHHHHHHHHHHHHHHHS----------C
T ss_pred CEEEEECCCCeECCCCCc-----cccccCCcCcCCceeecCC------CCCcHHHHHHHHHHHHHHHHC----------c
Confidence 899999999987653221 2345799999999999765 677899999999999999999 6
Q ss_pred CCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 359 APYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 359 ~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
.||... ........+.... ...+.. .....+..+.+|+.+||+.||++|||+.|+++
T Consensus 215 ~pf~~~-----~~~~~~~~~~~~~--~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 215 SPFLGD-----TKQETLANVSAVN--YEFEDE-YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp CSSCCS-----SHHHHHHHHHHTC--CCCCHH-HHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCCCC-----CHHHHHHHHHhcC--CCcCcc-ccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 777553 2222222222111 111110 01234577999999999999999999999986
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-45 Score=347.65 Aligned_cols=269 Identities=22% Similarity=0.337 Sum_probs=201.1
Q ss_pred hccccccceeeeecCeEEEEEEE------CCceeEEEEeeccCcc--chHHHHHHHHHHhccCCCceeeeeeccccCCcc
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVW------HGENVAVKIFFSRDEA--SWSRETEIYSTVLLRHENILGYIGSDMTSRNSC 206 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~------~~~~vAvK~~~~~~~~--~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~ 206 (443)
.+.|++.+.||+|+||.||+|++ +++.||||++...... ....+.|+..+..++||||+++++++.....
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-- 97 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGG-- 97 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC--
Confidence 36799999999999999999985 5789999998654322 2333566777777999999999999876543
Q ss_pred cEEEeeecccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEe
Q psy14889 207 TQLWLVTHYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIAD 284 (443)
Q Consensus 207 ~~~~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~D 284 (443)
..+++||||+++|+|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|
T Consensus 98 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~--------~i~H~dikp~Nil~~~~~~~kl~D 169 (302)
T 4e5w_A 98 NGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSR--------QYVHRDLAARNVLVESEHQVKIGD 169 (302)
T ss_dssp CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT--------TEECSCCSGGGEEEEETTEEEECC
T ss_pred ceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcC--------CcccCCCchheEEEcCCCCEEECc
Confidence 347899999999999999943 5699999999999999999999999 999999999999999999999999
Q ss_pred cCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCccc----ccCCC
Q psy14889 285 FGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFE----EYKAP 360 (443)
Q Consensus 285 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~----~~~~P 360 (443)
||++.......... .......||..|+|||.+.+. .++.++||||||+++|||+||+.|+.... ....|
T Consensus 170 fg~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 242 (302)
T 4e5w_A 170 FGLTKAIETDKEYY-TVKDDRDSPVFWYAPECLMQS------KFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGP 242 (302)
T ss_dssp CTTCEECCTTCCEE-ECCCCTTCCGGGCCHHHHHHC------EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCS
T ss_pred ccccccccCCCcce-eccCCCCCCccccCCeeecCC------CCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCC
Confidence 99998765433211 112345688899999999776 55679999999999999999954421100 00011
Q ss_pred CCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhh
Q psy14889 361 YHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLAC 430 (443)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~ 430 (443)
+.. ..........+. ...+...+ ..++..+.+|+.+||+.||++|||+.++++.|+++.+
T Consensus 243 ~~~----~~~~~~~~~~~~-~~~~~~~~-----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll~ 302 (302)
T 4e5w_A 243 THG----QMTVTRLVNTLK-EGKRLPCP-----PNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 302 (302)
T ss_dssp CCG----GGHHHHHHHHHH-TTCCCCCC-----TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred ccc----ccCHHHHHHHHh-ccCCCCCC-----CCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhC
Confidence 111 111122222222 12222222 3466789999999999999999999999999998863
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=348.67 Aligned_cols=263 Identities=24% Similarity=0.362 Sum_probs=200.8
Q ss_pred hhhccccccceeeeecCeEEEEEEEC------CceeEEEEeeccCcc--chHHHHHHHHHHhccCCCceeeeeeccccCC
Q psy14889 133 TLAKQISLSECIGKGRYGEVWRGVWH------GENVAVKIFFSRDEA--SWSRETEIYSTVLLRHENILGYIGSDMTSRN 204 (443)
Q Consensus 133 ~~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~vAvK~~~~~~~~--~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~ 204 (443)
...++|++.+.||+|+||.||+|.+. +..||||++...... ......|+..+..++||||+++++++...
T Consensus 41 i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-- 118 (333)
T 1mqb_A 41 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY-- 118 (333)
T ss_dssp CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS--
T ss_pred CChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecC--
Confidence 34478999999999999999999873 235999998654322 22234566677779999999999998765
Q ss_pred cccEEEeeecccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEE
Q psy14889 205 SCTQLWLVTHYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVI 282 (443)
Q Consensus 205 ~~~~~~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl 282 (443)
...++||||+++|+|.+++.. ..+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||
T Consensus 119 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~--------~ivH~Dikp~NIl~~~~~~~kl 188 (333)
T 1mqb_A 119 --KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM--------NYVHRDLAARNILVNSNLVCKV 188 (333)
T ss_dssp --SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT--------TCCCSCCCGGGEEECTTCCEEE
T ss_pred --CCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CeeCCCCChheEEECCCCcEEE
Confidence 347999999999999999964 5699999999999999999999999 9999999999999999999999
Q ss_pred EecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh-cccCCCcccccCCCC
Q psy14889 283 ADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR-RTKANGIFEEYKAPY 361 (443)
Q Consensus 283 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt-g~~~~~~~~~~~~P~ 361 (443)
+|||+++......... .......+|+.|+|||.+.+. .++.++||||||+++|||++ | ..||
T Consensus 189 ~Dfg~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~il~ellt~g----------~~pf 251 (333)
T 1mqb_A 189 SDFGLSRVLEDDPEAT-YTTSGGKIPIRWTAPEAISYR------KFTSASDVWSFGIVMWEVMTYG----------ERPY 251 (333)
T ss_dssp CCCCC------------------CCCGGGSCHHHHHSC------CCCHHHHHHHHHHHHHHHHTTS----------CCTT
T ss_pred CCCCcchhhccccccc-cccCCCCccccccCchhcccC------CCCchhhhHHHHHHHHHHHcCC----------CCCc
Confidence 9999998765432211 111233567889999999765 67789999999999999999 8 6777
Q ss_pred CCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhhccccc
Q psy14889 362 HDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLACADMYI 435 (443)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~~~~~~ 435 (443)
.+. ....+...+.. ..+...+ ..++..+.+++.+||+.||++|||+.++++.|+++.......
T Consensus 252 ~~~-----~~~~~~~~~~~-~~~~~~~-----~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~~ 314 (333)
T 1mqb_A 252 WEL-----SNHEVMKAIND-GFRLPTP-----MDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSL 314 (333)
T ss_dssp TTC-----CHHHHHHHHHT-TCCCCCC-----TTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGGG
T ss_pred ccC-----CHHHHHHHHHC-CCcCCCc-----ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchhh
Confidence 653 22333333322 2222222 336678999999999999999999999999999988765544
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=349.00 Aligned_cols=265 Identities=19% Similarity=0.311 Sum_probs=191.0
Q ss_pred hccccccceeeeecCeEEEEEEEC--C---ceeEEEEeeccC---ccchHHHHHHHHHHhccCCCceeeeeeccccCCc-
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVWH--G---ENVAVKIFFSRD---EASWSRETEIYSTVLLRHENILGYIGSDMTSRNS- 205 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~~--~---~~vAvK~~~~~~---~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~- 205 (443)
.++|++.+.||+|+||.||+|.+. + ..||||++.... ........|+..+..++||||+++++++......
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG 101 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence 468999999999999999999873 2 279999886532 1222334666677779999999999998765432
Q ss_pred -ccEEEeeecccCcccHHHHhccc-------CCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCC
Q psy14889 206 -CTQLWLVTHYHSFGSLYDHLNRT-------TLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTN 277 (443)
Q Consensus 206 -~~~~~lv~e~~~~gsL~~~l~~~-------~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~ 277 (443)
....++||||+.+|+|.+++... .+++..+..++.|++.||.|||+. +|+||||||+|||++.+
T Consensus 102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~--------~ivH~Dikp~NIli~~~ 173 (323)
T 3qup_A 102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR--------NFIHRDLAARNCMLAED 173 (323)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT--------TCCCSCCSGGGEEECTT
T ss_pred CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC--------CcccCCCCcceEEEcCC
Confidence 11248999999999999998532 589999999999999999999999 99999999999999999
Q ss_pred CcEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh-cccCCCcccc
Q psy14889 278 GTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR-RTKANGIFEE 356 (443)
Q Consensus 278 ~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt-g~~~~~~~~~ 356 (443)
+.+||+|||+++......... ......+|+.|+|||.+.+. .++.++|||||||++|||++ |
T Consensus 174 ~~~kl~Dfg~a~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~il~ell~~g--------- 236 (323)
T 3qup_A 174 MTVCVADFGLSRKIYSGDYYR--QGCASKLPVKWLALESLADN------LYTVHSDVWAFGVTMWEIMTRG--------- 236 (323)
T ss_dssp SCEEECCCCC-------------------CCGGGCCHHHHHHC------CCCHHHHHHHHHHHHHHHHTTS---------
T ss_pred CCEEEeecccccccccccccc--ccccccCcccccCchhhcCC------CCCCccchhhHHHHHHHHHhCC---------
Confidence 999999999997665432211 12234577899999999876 67789999999999999999 7
Q ss_pred cCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhhcccccc
Q psy14889 357 YKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLACADMYIH 436 (443)
Q Consensus 357 ~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~~~~~~~ 436 (443)
..||.+.. .......+.. ......+ ..++.++.+++.+||+.||++|||+.++++.|+++.....-..
T Consensus 237 -~~p~~~~~-----~~~~~~~~~~-~~~~~~~-----~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~ 304 (323)
T 3qup_A 237 -QTPYAGIE-----NAEIYNYLIG-GNRLKQP-----PECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLS 304 (323)
T ss_dssp -CCTTTTCC-----GGGHHHHHHT-TCCCCCC-----TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-----
T ss_pred -CCCccccC-----hHHHHHHHhc-CCCCCCC-----CccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcC
Confidence 66776532 2223332222 2222222 3356789999999999999999999999999999987664443
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=372.06 Aligned_cols=259 Identities=24% Similarity=0.365 Sum_probs=207.7
Q ss_pred hhhccccccceeeeecCeEEEEEEEC-CceeEEEEeeccCccchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEe
Q psy14889 133 TLAKQISLSECIGKGRYGEVWRGVWH-GENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWL 211 (443)
Q Consensus 133 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~l 211 (443)
...++|++.+.||+|+||.||+|.+. +..||||++............|+..+..++||||+++++++.+. .+++
T Consensus 264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~~l 338 (535)
T 2h8h_A 264 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE-----PIYI 338 (535)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SCEE
T ss_pred cchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEeec-----cceE
Confidence 34567999999999999999999995 46799999876544333445566666669999999999998653 3689
Q ss_pred eecccCcccHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCc
Q psy14889 212 VTHYHSFGSLYDHLNR---TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA 288 (443)
Q Consensus 212 v~e~~~~gsL~~~l~~---~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla 288 (443)
||||+.+|+|.+++.. ..+++.+++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 339 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~--------~ivHrDlkp~NIll~~~~~~kl~DFG~a 410 (535)
T 2h8h_A 339 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM--------NYVHRDLRAANILVGENLVCKVADFGLA 410 (535)
T ss_dssp EECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT--------TCCCSCCSGGGEEECGGGCEEECCTTST
T ss_pred eeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CeeCCCCCHhhEEEcCCCcEEEcccccc
Confidence 9999999999999964 4599999999999999999999999 9999999999999999999999999999
Q ss_pred ccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh-cccCCCcccccCCCCCCCCCC
Q psy14889 289 VSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR-RTKANGIFEEYKAPYHDLVPM 367 (443)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt-g~~~~~~~~~~~~P~~~~~~~ 367 (443)
+......... .....++..|+|||++... .++.++|||||||+||||++ | ..||.+.
T Consensus 411 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~------~~~~~sDvwSlGv~l~el~t~g----------~~P~~~~--- 468 (535)
T 2h8h_A 411 RLIEDNEYTA---RQGAKFPIKWTAPEAALYG------RFTIKSDVWSFGILLTELTTKG----------RVPYPGM--- 468 (535)
T ss_dssp TTCCCHHHHT---TCSTTSCGGGSCHHHHHHC------CCCHHHHHHHHHHHHHHHTTTT----------CCSSTTC---
T ss_pred eecCCCceec---ccCCcCcccccCHHHhccC------CCCchhhHHHHHHHHHHHHhCC----------CCCCCCC---
Confidence 8765322111 1233577899999999876 67789999999999999999 7 6777654
Q ss_pred CCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhhcccc
Q psy14889 368 DPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLACADMY 434 (443)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~~~~~ 434 (443)
...++...+.. ..+...+ ..++..+.+||.+||+.||++|||+.+|++.|+.+......
T Consensus 469 --~~~~~~~~i~~-~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~ 527 (535)
T 2h8h_A 469 --VNREVLDQVER-GYRMPCP-----PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 527 (535)
T ss_dssp --CHHHHHHHHHT-TCCCCCC-----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCSC
T ss_pred --CHHHHHHHHHc-CCCCCCC-----CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccCc
Confidence 23334333322 2233333 34677899999999999999999999999999998765543
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-44 Score=343.55 Aligned_cols=241 Identities=21% Similarity=0.318 Sum_probs=195.9
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCc----cchHHHHHHHHHHhccCCCceeeeeeccccCCcccEE
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDE----ASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQL 209 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~----~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~ 209 (443)
++|++.+.||+|+||.||+|+. +|+.||+|++..... .......|+..+..++||||+++++++.+. ..+
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~----~~~ 81 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA----QQI 81 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECS----SEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeC----CEE
Confidence 6899999999999999999998 589999999865321 112223455556669999999999998776 458
Q ss_pred EeeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCc
Q psy14889 210 WLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA 288 (443)
Q Consensus 210 ~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla 288 (443)
++||||+++|+|.+++.+ ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 82 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~--------~ivHrDlkp~NIll~~~g~~kL~Dfg~a 153 (318)
T 1fot_A 82 FMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK--------DIIYRDLKPENILLDKNGHIKITDFGFA 153 (318)
T ss_dssp EEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTT--------TEECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred EEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC--------CccccCCChheEEEcCCCCEEEeecCcc
Confidence 999999999999999965 6799999999999999999999998 9999999999999999999999999999
Q ss_pred ccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCC
Q psy14889 289 VSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMD 368 (443)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~ 368 (443)
+..... .....||+.|+|||++.+. .++.++|||||||++|||++| ..||.+.
T Consensus 154 ~~~~~~-------~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~ell~g----------~~pf~~~---- 206 (318)
T 1fot_A 154 KYVPDV-------TYTLCGTPDYIAPEVVSTK------PYNKSIDWWSFGILIYEMLAG----------YTPFYDS---- 206 (318)
T ss_dssp EECSSC-------BCCCCSCTTTCCHHHHTTC------CBCTTHHHHHHHHHHHHHHHS----------SCTTCCS----
T ss_pred eecCCc-------cccccCCccccCHhHhcCC------CCCcccchhhhHHHHHHHHhC----------CCCCCCC----
Confidence 765432 1345799999999999876 677899999999999999999 7777653
Q ss_pred CChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCC-----cHHHHHH
Q psy14889 369 PSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRL-----SALRVKK 423 (443)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~ 423 (443)
........+... ...+| ...+.++.+++.+||+.||++|| +++++++
T Consensus 207 -~~~~~~~~i~~~--~~~~p-----~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 207 -NTMKTYEKILNA--ELRFP-----PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp -SHHHHHHHHHHC--CCCCC-----TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred -CHHHHHHHHHhC--CCCCC-----CCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 222222222221 22233 23557899999999999999999 8888874
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-44 Score=355.48 Aligned_cols=273 Identities=19% Similarity=0.274 Sum_probs=208.1
Q ss_pred hccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc--chHHHHHHHHHHhccCCCceeeeeeccccCCcccEEE
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA--SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLW 210 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~--~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~ 210 (443)
.++|.+.+.||+|+||.||+|.+ +|+.||||++...... ......|+..+..++||||+++++++..... ...+
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~--~~~~ 85 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTT--RHKV 85 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTT--CCEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCC--CeeE
Confidence 47899999999999999999998 4899999998653321 1222356666666999999999999876543 3579
Q ss_pred eeecccCcccHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEE----cCCCcEEE
Q psy14889 211 LVTHYHSFGSLYDHLNRT----TLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILV----KTNGTCVI 282 (443)
Q Consensus 211 lv~e~~~~gsL~~~l~~~----~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl----~~~~~~kl 282 (443)
+||||+++|+|.+++... .+++..++.++.||+.||+|||+. +|+||||||+|||+ +.++.+||
T Consensus 86 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--------~ivH~Dlkp~NIll~~~~~~~~~~kL 157 (396)
T 4eut_A 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN--------GIVHRNIKPGNIMRVIGEDGQSVYKL 157 (396)
T ss_dssp EEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT--------TEECCCCCGGGEEEEECTTSCEEEEE
T ss_pred EEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC--------CEEECCcCHHHEEEeecCCCceeEEE
Confidence 999999999999999753 299999999999999999999999 99999999999999 77788999
Q ss_pred EecCCcccccccCCcCCCCCCCcccccCcccccccccccccC--cCCCCCccchHHHHHHHHHHHhcccCCCcccccCCC
Q psy14889 283 ADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMD--CFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAP 360 (443)
Q Consensus 283 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P 360 (443)
+|||+++........ ....||+.|+|||++.+..... ...++.++|||||||++|||++| ..|
T Consensus 158 ~DFG~a~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg----------~~P 222 (396)
T 4eut_A 158 TDFGAARELEDDEQF-----VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATG----------SLP 222 (396)
T ss_dssp CCGGGCEECCCGGGS-----SCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHS----------SCS
T ss_pred ecCCCceEccCCCcc-----ccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHC----------CCC
Confidence 999999876543321 2357999999999986521000 00445789999999999999999 666
Q ss_pred CCCCCCCCCChHHHHhhhhhcCCC----------------CCCC-CCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 361 YHDLVPMDPSFDDMRKVICIDQQR----------------PVLP-NRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~----------------~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
|..........+.+.+........ ..++ ........+..+.+++.+||+.||++|||+.++++
T Consensus 223 f~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~ 302 (396)
T 4eut_A 223 FRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302 (396)
T ss_dssp EECTTCTTTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred CCCCCcccchHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence 665433333344444433211100 0011 11123567788999999999999999999999999
Q ss_pred HHHHHhhcc
Q psy14889 424 TLIKLACAD 432 (443)
Q Consensus 424 ~L~~l~~~~ 432 (443)
.++++.+..
T Consensus 303 ~l~~il~~~ 311 (396)
T 4eut_A 303 ETSDILHRM 311 (396)
T ss_dssp HHHHHHTCE
T ss_pred HHHHHhhce
Confidence 999988653
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=339.85 Aligned_cols=251 Identities=28% Similarity=0.508 Sum_probs=196.5
Q ss_pred ccccccceeeeecCeEEEEEEECCceeEEEEeeccCccchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEeeecc
Q psy14889 136 KQISLSECIGKGRYGEVWRGVWHGENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVTHY 215 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e~ 215 (443)
++|++.+.||+|+||.||+|.++|+.||||++.... .......|+..+..++||||+++++++.... ...++||||
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---~~~~lv~e~ 96 (278)
T 1byg_A 21 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK---GGLYIVTEY 96 (278)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC-----CCEEEECC
T ss_pred hhceEEeEEecCCCceEEEEEEcCCEEEEEEecchh-HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC---CceEEEEec
Confidence 689999999999999999999999999999886543 2223345666667799999999999876543 246999999
Q ss_pred cCcccHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCccccc
Q psy14889 216 HSFGSLYDHLNRT---TLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYS 292 (443)
Q Consensus 216 ~~~gsL~~~l~~~---~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~~ 292 (443)
+++|+|.+++... .+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 97 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~--------~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 168 (278)
T 1byg_A 97 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN--------NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 168 (278)
T ss_dssp CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT--------TCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred CCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhC--------CccccCCCcceEEEeCCCcEEEeecccccccc
Confidence 9999999999653 389999999999999999999999 99999999999999999999999999987554
Q ss_pred ccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh-cccCCCcccccCCCCCCCCCCCCCh
Q psy14889 293 QLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR-RTKANGIFEEYKAPYHDLVPMDPSF 371 (443)
Q Consensus 293 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt-g~~~~~~~~~~~~P~~~~~~~~~~~ 371 (443)
... ....+++.|+|||.+.+. .++.++||||||+++|||+| | ..||... ..
T Consensus 169 ~~~-------~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~il~~l~t~g----------~~p~~~~-----~~ 220 (278)
T 1byg_A 169 STQ-------DTGKLPVKWTAPEALREK------KFSTKSDVWSFGILLWEIYSFG----------RVPYPRI-----PL 220 (278)
T ss_dssp --------------CCTTTSCHHHHHHC------CCCHHHHHHHHHHHHHHHHTTS----------CCSCTTS-----CG
T ss_pred ccc-------cCCCccccccCHHHhCCC------CCCchhcHHHHHHHHHHHHhCC----------CCCCCCC-----CH
Confidence 321 223578899999999765 67789999999999999998 7 6666553 12
Q ss_pred HHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhhcc
Q psy14889 372 DDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLACAD 432 (443)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~~~ 432 (443)
......+.. ...+..+ ..++..+.+++.+||+.||++|||+.++++.|+++....
T Consensus 221 ~~~~~~~~~-~~~~~~~-----~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~ 275 (278)
T 1byg_A 221 KDVVPRVEK-GYKMDAP-----DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 275 (278)
T ss_dssp GGHHHHHTT-TCCCCCC-----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred HHHHHHHhc-CCCCCCc-----ccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence 222222221 1222222 346678999999999999999999999999999987654
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=349.43 Aligned_cols=258 Identities=25% Similarity=0.322 Sum_probs=194.9
Q ss_pred hhhhccccccceeeeecCeEEEEEEE--CCceeEEEEeeccC------ccchHHHHHHHHHHhccCCCceeeeeeccccC
Q psy14889 132 RTLAKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRD------EASWSRETEIYSTVLLRHENILGYIGSDMTSR 203 (443)
Q Consensus 132 ~~~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~------~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~ 203 (443)
..+.++|++.+.||+|+||.||+|.. +++.||+|++.... ........|+..+..++||||+++++++.+.
T Consensus 22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~- 100 (345)
T 3hko_A 22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE- 100 (345)
T ss_dssp HHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS-
T ss_pred hhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC-
Confidence 34568899999999999999999998 57899999986432 1122334566666679999999999999776
Q ss_pred CcccEEEeeecccCcccHHHHhcc-----------------------------------------cCCCHHHHHHHHHHH
Q psy14889 204 NSCTQLWLVTHYHSFGSLYDHLNR-----------------------------------------TTLNHHQMMKICLSI 242 (443)
Q Consensus 204 ~~~~~~~lv~e~~~~gsL~~~l~~-----------------------------------------~~l~~~~~~~i~~qi 242 (443)
...++||||+++|+|.+++.. ..+++..+..++.||
T Consensus 101 ---~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi 177 (345)
T 3hko_A 101 ---QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQI 177 (345)
T ss_dssp ---SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHH
T ss_pred ---CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHH
Confidence 458999999999999999851 123567788999999
Q ss_pred HHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCC--cEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccc
Q psy14889 243 VNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNG--TCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDES 320 (443)
Q Consensus 243 a~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~--~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 320 (443)
+.||+|||+. +|+||||||+|||++.++ .+||+|||+++.+...............||+.|+|||++.+.
T Consensus 178 ~~~l~~LH~~--------~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 249 (345)
T 3hko_A 178 FSALHYLHNQ--------GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTT 249 (345)
T ss_dssp HHHHHHHHHT--------TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCS
T ss_pred HHHHHHHHHC--------CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccC
Confidence 9999999999 999999999999998776 899999999987654333222223455799999999998753
Q ss_pred cccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHH
Q psy14889 321 INMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAM 400 (443)
Q Consensus 321 ~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 400 (443)
.. .++.++||||||+++|||++| ..||.... ..+...... ........+. ....+..+
T Consensus 250 ~~----~~~~~~DiwslG~il~el~~g----------~~pf~~~~----~~~~~~~~~-~~~~~~~~~~---~~~~~~~~ 307 (345)
T 3hko_A 250 NE----SYGPKCDAWSAGVLLHLLLMG----------AVPFPGVN----DADTISQVL-NKKLCFENPN---YNVLSPLA 307 (345)
T ss_dssp SS----CCCTHHHHHHHHHHHHHHHHS----------SCSSCCSS----HHHHHHHHH-HCCCCTTSGG---GGGSCHHH
T ss_pred CC----CCCcHHHHHHHHHHHHHHHHC----------CCCCCCCC----hHHHHHHHH-hcccccCCcc---cccCCHHH
Confidence 11 567899999999999999999 77776531 122222322 2222111111 12356789
Q ss_pred HHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 401 TKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 401 ~~li~~cl~~dP~~Rps~~evl~ 423 (443)
.+|+.+||+.||.+|||+.++++
T Consensus 308 ~~li~~~l~~~p~~Rps~~~~l~ 330 (345)
T 3hko_A 308 RDLLSNLLNRNVDERFDAMRALQ 330 (345)
T ss_dssp HHHHHHHSCSCTTTSCCHHHHHH
T ss_pred HHHHHHHcCCChhHCCCHHHHhc
Confidence 99999999999999999999987
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=347.97 Aligned_cols=244 Identities=22% Similarity=0.364 Sum_probs=194.2
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccC----ccchHHHHHHHHHHhccCCCceeeeeeccccCCcccEE
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRD----EASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQL 209 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~----~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~ 209 (443)
++|.+.+.||+|+||.||+|.+ +++.||||++.... ......+.|+..+..++||||+++++++.+. ..+
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~----~~~ 84 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTP----TDI 84 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECS----SEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC----CEE
Confidence 6899999999999999999998 68999999986431 2223445677777779999999999998876 458
Q ss_pred EeeecccCcccHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCc
Q psy14889 210 WLVTHYHSFGSLYDHLN-RTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA 288 (443)
Q Consensus 210 ~lv~e~~~~gsL~~~l~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla 288 (443)
++||||+ +|+|.+++. ...+++.++..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 85 ~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~--------givH~Dlkp~NIll~~~~~~kl~DFG~s 155 (336)
T 3h4j_B 85 VMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRH--------KIVHRDLKPENLLLDDNLNVKIADFGLS 155 (336)
T ss_dssp EEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHH--------TCCCCCCSTTTEEECTTCCEEECCSSCT
T ss_pred EEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC--------CeEecCCchhhEEEcCCCCEEEEEeccc
Confidence 9999999 679988875 46799999999999999999999999 9999999999999999999999999999
Q ss_pred ccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCC
Q psy14889 289 VSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMD 368 (443)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~ 368 (443)
........ .....||+.|+|||++.+... .+.++|||||||++|||++| ..||.+....
T Consensus 156 ~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~-----~~~~~DiwslG~il~~ll~g----------~~Pf~~~~~~- 214 (336)
T 3h4j_B 156 NIMTDGNF-----LKTSCGSPNYAAPEVINGKLY-----AGPEVDVWSCGIVLYVMLVG----------RLPFDDEFIP- 214 (336)
T ss_dssp BTTTTSBT-----TCCCTTSTTTSCGGGSCCSGG-----GCHHHHHHHHHHHHHHHHHS----------SCSSBCSSST-
T ss_pred eeccCCcc-----cccccCCcCcCCHHHHcCCCC-----CCCccchhHHHHHHHHHHhC----------CCCCCCccHH-
Confidence 76654321 234579999999999986521 24789999999999999999 6666543211
Q ss_pred CChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHH
Q psy14889 369 PSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKT 424 (443)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 424 (443)
.+...+ .......| ...+.++.+|+.+||+.||.+|||+.|+++.
T Consensus 215 ----~~~~~i--~~~~~~~p-----~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 215 ----NLFKKV--NSCVYVMP-----DFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp ----TCBCCC--CSSCCCCC-----TTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred ----HHHHHH--HcCCCCCc-----ccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 111111 01111222 3356789999999999999999999999863
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=344.70 Aligned_cols=256 Identities=25% Similarity=0.325 Sum_probs=191.9
Q ss_pred hhhhccccccceeeeecCeEEEEEEE-CCceeEEEEeeccCccc---hHHHHHHHHHHhccCCCceeeeeeccccCCccc
Q psy14889 132 RTLAKQISLSECIGKGRYGEVWRGVW-HGENVAVKIFFSRDEAS---WSRETEIYSTVLLRHENILGYIGSDMTSRNSCT 207 (443)
Q Consensus 132 ~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~---~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~ 207 (443)
+.+.++|++.+.||+|+||.||+|.. +|+.||||++....... .....|+..+..++||||+++++++.+. .
T Consensus 17 q~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~----~ 92 (311)
T 3niz_A 17 QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSE----R 92 (311)
T ss_dssp ECSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCS----S
T ss_pred cchHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccC----C
Confidence 44568999999999999999999998 68999999986443221 2234566666679999999999998766 3
Q ss_pred EEEeeecccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEec
Q psy14889 208 QLWLVTHYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADF 285 (443)
Q Consensus 208 ~~~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~Df 285 (443)
.+++||||+++ +|.+++.. ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+||
T Consensus 93 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~--------~ivH~Dikp~NIl~~~~~~~kl~Df 163 (311)
T 3niz_A 93 CLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH--------RILHRDLKPQNLLINSDGALKLADF 163 (311)
T ss_dssp CEEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT--------TEECCCCCGGGEEECTTCCEEECCC
T ss_pred EEEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC--------CcccCCCchHhEEECCCCCEEEccC
Confidence 57999999984 88888754 4599999999999999999999999 9999999999999999999999999
Q ss_pred CCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCC
Q psy14889 286 GLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLV 365 (443)
Q Consensus 286 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~ 365 (443)
|+++........ .....||+.|+|||++.+.. .++.++|||||||++|||++| ..||....
T Consensus 164 g~a~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~-----~~~~~~DiwslG~il~~ll~g----------~~pf~~~~ 224 (311)
T 3niz_A 164 GLARAFGIPVRS----YTHEVVTLWYRAPDVLMGSK-----KYSTSVDIWSIGCIFAEMITG----------KPLFPGVT 224 (311)
T ss_dssp TTCEETTSCCC-------CCCCCCTTCCHHHHTTCC-----SCCTHHHHHHHHHHHHHHHHS----------SCSCCCSS
T ss_pred cCceecCCCccc----ccCCcccCCcCCHHHhcCCC-----CCCchHHhHHHHHHHHHHHhC----------CCCCCCCC
Confidence 999876532222 23457899999999987641 466899999999999999999 56665432
Q ss_pred CCCCChHHHHhhhhhcCCCC-------------------CCCCC---CCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 366 PMDPSFDDMRKVICIDQQRP-------------------VLPNR---WVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~-------------------~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
.. +.+........... ..... ......+.++.+|+.+||+.||++|||+.|+++
T Consensus 225 ~~----~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 225 DD----DQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp TT----THHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hH----HHHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 21 11111111000000 00000 001224567899999999999999999999886
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=342.03 Aligned_cols=257 Identities=22% Similarity=0.406 Sum_probs=207.7
Q ss_pred hhccccccceeeeecCeEEEEEEEC--CceeEEEEeeccCccchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEe
Q psy14889 134 LAKQISLSECIGKGRYGEVWRGVWH--GENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWL 211 (443)
Q Consensus 134 ~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~l 211 (443)
..++|++.+.||+|+||.||+|.+. +..||+|++............|+..+..++||||+++++++.+.. .+++
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~----~~~~ 86 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP----PFYI 86 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS----SEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC----CEEE
Confidence 4478999999999999999999984 889999998765544444456666777799999999999987663 4799
Q ss_pred eecccCcccHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCc
Q psy14889 212 VTHYHSFGSLYDHLNR---TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA 288 (443)
Q Consensus 212 v~e~~~~gsL~~~l~~---~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla 288 (443)
||||+++|+|.+++.. ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 87 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--------~i~H~dikp~Nil~~~~~~~~l~Dfg~~ 158 (288)
T 3kfa_A 87 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK--------NFIHRDLAARNCLVGENHLVKVADFGLS 158 (288)
T ss_dssp EEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHH--------TCCCSCCSGGGEEECGGGCEEECCCCGG
T ss_pred EEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHC--------CccCCCCCcceEEEcCCCCEEEccCccc
Confidence 9999999999999964 4599999999999999999999999 9999999999999999999999999999
Q ss_pred ccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh-cccCCCcccccCCCCCCCCCC
Q psy14889 289 VSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR-RTKANGIFEEYKAPYHDLVPM 367 (443)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt-g~~~~~~~~~~~~P~~~~~~~ 367 (443)
.......... .....+|+.|+|||.+.+. .++.++||||||+++|||++ | ..||...
T Consensus 159 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~il~~ll~~g----------~~p~~~~--- 216 (288)
T 3kfa_A 159 RLMTGDTYTA---HAGAKFPIKWTAPESLAYN------KFSIKSDVWAFGVLLWEIATYG----------MSPYPGI--- 216 (288)
T ss_dssp GTSCSSSSEE---ETTEEECGGGCCHHHHHHC------CCCHHHHHHHHHHHHHHHHTTS----------CCSSTTC---
T ss_pred eeccCCcccc---ccCCccccCcCChhhhccC------CCCchhhHHHHHHHHHHHHhCC----------CCCCCCC---
Confidence 7665432211 2334578899999999876 67789999999999999999 7 6677653
Q ss_pred CCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhhcc
Q psy14889 368 DPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLACAD 432 (443)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~~~ 432 (443)
........+.. ......+ ..++..+.+++.+||+.||++|||+.++++.|+++.+..
T Consensus 217 --~~~~~~~~~~~-~~~~~~~-----~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~ 273 (288)
T 3kfa_A 217 --DLSQVYELLEK-DYRMERP-----EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 273 (288)
T ss_dssp --CGGGHHHHHHT-TCCCCCC-----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred --CHHHHHHHHhc-cCCCCCC-----CCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence 22233333322 2222222 336678999999999999999999999999999987653
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-44 Score=346.18 Aligned_cols=258 Identities=22% Similarity=0.423 Sum_probs=203.7
Q ss_pred hccccccceeeeecCeEEEEEEEC---------CceeEEEEeeccCccc--hHHHHHHHHHHhc-cCCCceeeeeecccc
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVWH---------GENVAVKIFFSRDEAS--WSRETEIYSTVLL-RHENILGYIGSDMTS 202 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~~---------~~~vAvK~~~~~~~~~--~~~e~ei~~~~~l-~H~nIv~l~g~~~~~ 202 (443)
.++|++.+.||+|+||.||+|.+. +..||||++....... .....|+..+..+ +||||+++++++...
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 478999999999999999999863 4679999986543221 2223555555557 899999999998776
Q ss_pred CCcccEEEeeecccCcccHHHHhccc-----------------CCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEe
Q psy14889 203 RNSCTQLWLVTHYHSFGSLYDHLNRT-----------------TLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHR 265 (443)
Q Consensus 203 ~~~~~~~~lv~e~~~~gsL~~~l~~~-----------------~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHr 265 (443)
. .+++||||+++|+|.+++... .+++..++.++.||+.||.|||+. +|+||
T Consensus 114 ~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~--------~ivH~ 181 (334)
T 2pvf_A 114 G----PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ--------KCIHR 181 (334)
T ss_dssp S----CCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT--------TEECS
T ss_pred C----ceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC--------CeeCC
Confidence 3 479999999999999999643 389999999999999999999999 99999
Q ss_pred CCCCCCEEEcCCCcEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHH
Q psy14889 266 DIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVC 345 (443)
Q Consensus 266 Dlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ell 345 (443)
||||+|||++.++.+||+|||+++......... ......+|+.|+|||++.+. .++.++||||||+++|||+
T Consensus 182 Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~il~ell 253 (334)
T 2pvf_A 182 DLAARNVLVTENNVMKIADFGLARDINNIDYYK--KTTNGRLPVKWMAPEALFDR------VYTHQSDVWSFGVLMWEIF 253 (334)
T ss_dssp CCSGGGEEECTTCCEEECCCTTCEECTTTSSEE--CCSCCCCCGGGCCHHHHHHC------EECHHHHHHHHHHHHHHHH
T ss_pred CCccceEEEcCCCCEEEcccccccccccccccc--ccCCCCcccceeChHHhcCC------CcChHHHHHHHHHHHHHHH
Confidence 999999999999999999999998665432211 12334578899999999765 5668999999999999999
Q ss_pred h-cccCCCcccccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHH
Q psy14889 346 R-RTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKT 424 (443)
Q Consensus 346 t-g~~~~~~~~~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 424 (443)
+ | ..||... ...++...+... ..+..+ ..++..+.+++.+||+.||.+|||+.++++.
T Consensus 254 t~g----------~~p~~~~-----~~~~~~~~~~~~-~~~~~~-----~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 254 TLG----------GSPYPGI-----PVEELFKLLKEG-HRMDKP-----ANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp TTS----------CCSSTTC-----CHHHHHHHHHHT-CCCCCC-----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hCC----------CCCcCcC-----CHHHHHHHHhcC-CCCCCC-----ccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 9 7 6677653 233444333322 222222 3366789999999999999999999999999
Q ss_pred HHHHhhccc
Q psy14889 425 LIKLACADM 433 (443)
Q Consensus 425 L~~l~~~~~ 433 (443)
|+++.....
T Consensus 313 L~~l~~~~~ 321 (334)
T 2pvf_A 313 LDRILTLTT 321 (334)
T ss_dssp HHHHHHHHC
T ss_pred HHHHHhccc
Confidence 999986543
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-44 Score=339.38 Aligned_cols=253 Identities=23% Similarity=0.289 Sum_probs=191.5
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccc---hHHHHHHHHHHhccCCCceeeeeeccccCCcccEEE
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEAS---WSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLW 210 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~---~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~ 210 (443)
++|++.+.||+|+||+||+|.. +++.||||++....... .....|+..+..++||||+++++++.+. ..++
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----~~~~ 77 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD----KKLT 77 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEET----TEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeC----CEEE
Confidence 5799999999999999999998 58899999987543322 2334677777779999999999998776 4689
Q ss_pred eeecccCcccHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCc
Q psy14889 211 LVTHYHSFGSLYDHLN--RTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA 288 (443)
Q Consensus 211 lv~e~~~~gsL~~~l~--~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla 288 (443)
+||||+++ +|.+++. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 78 lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~--------~ivH~dikp~Nil~~~~~~~kl~Dfg~~ 148 (292)
T 3o0g_A 78 LVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR--------NVLHRDLKPQNLLINRNGELKLANFGLA 148 (292)
T ss_dssp EEEECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT--------TEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CeecCCCCHHHEEEcCCCCEEEeecccc
Confidence 99999986 6666553 46799999999999999999999999 9999999999999999999999999999
Q ss_pred ccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCC
Q psy14889 289 VSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMD 368 (443)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~ 368 (443)
+........ .....||+.|+|||++.+.. .++.++|||||||++|||++| ..||....
T Consensus 149 ~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~-----~~~~~~DiwslG~il~~l~~~----------~~p~~~~~--- 206 (292)
T 3o0g_A 149 RAFGIPVRC----YSAEVVTLWYRPPDVLFGAK-----LYSTSIDMWSAGCIFAELANA----------GRPLFPGN--- 206 (292)
T ss_dssp EECCSCCSC----CCSCCSCGGGCCHHHHTTCS-----CCCTHHHHHHHHHHHHHHTTT----------SCCSCCCS---
T ss_pred eecCCcccc----ccCCccccCCcChHHHcCCC-----CcCchHHHHHHHHHHHHHHHc----------CCCCcCCC---
Confidence 876532222 23457899999999987652 367899999999999999998 44433211
Q ss_pred CChHHHHhhhhhcCCC-----------------CCCCC----CCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 369 PSFDDMRKVICIDQQR-----------------PVLPN----RWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 369 ~~~~~~~~~~~~~~~~-----------------~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
...+.+.......... +..+. .......+..+.+|+.+||+.||++|||+.|+++
T Consensus 207 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 207 DVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp SHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CHHHHHHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 1111112211110000 00000 0011235678999999999999999999999885
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=348.87 Aligned_cols=276 Identities=23% Similarity=0.308 Sum_probs=203.1
Q ss_pred ccccccceeeeecCeEEEEEEE------CCceeEEEEeeccCccc-hHHHHHHHHHHhccCCCceeeeeeccccCCcccE
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW------HGENVAVKIFFSRDEAS-WSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQ 208 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~------~~~~vAvK~~~~~~~~~-~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~ 208 (443)
++|++.+.||+|+||.||+|++ +++.||||++....... .....|+..+..++||||+++++++..... ..
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~--~~ 100 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGR--QS 100 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSS--CE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCC--ce
Confidence 6899999999999999999985 47889999986554322 223566667777999999999999875443 46
Q ss_pred EEeeecccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecC
Q psy14889 209 LWLVTHYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFG 286 (443)
Q Consensus 209 ~~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfG 286 (443)
+++||||+++|+|.+++.. ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~--------~ivH~Dikp~NIl~~~~~~~kl~Dfg 172 (327)
T 3lxl_A 101 LRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSR--------RCVHRDLAARNILVESEAHVKIADFG 172 (327)
T ss_dssp EEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT--------TEECSCCSGGGEEEEETTEEEECCGG
T ss_pred EEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC--------CccCCCCChhhEEECCCCCEEEcccc
Confidence 8999999999999999964 5699999999999999999999998 99999999999999999999999999
Q ss_pred CcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCC
Q psy14889 287 LAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVP 366 (443)
Q Consensus 287 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~ 366 (443)
+++......... .......||..|+|||++.+. .++.++||||||+++|||++|+.|+...............
T Consensus 173 ~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~ 245 (327)
T 3lxl_A 173 LAKLLPLDKDYY-VVREPGQSPIFWYAPESLSDN------IFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCER 245 (327)
T ss_dssp GCEECCTTCSEE-ECSSCCCSCGGGSCHHHHHHC------EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC---
T ss_pred cceecccCCccc-eeeccCCccccccCHHHhccC------CCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhccccc
Confidence 998765432211 112344688899999999776 5568999999999999999995443211000000000000
Q ss_pred CCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhhcccc
Q psy14889 367 MDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLACADMY 434 (443)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~~~~~ 434 (443)
.......+...+.. ......+ ..++..+.+|+.+||+.||++|||+.++++.|+++......
T Consensus 246 ~~~~~~~~~~~~~~-~~~~~~~-----~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~ 307 (327)
T 3lxl_A 246 DVPALSRLLELLEE-GQRLPAP-----PACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRG 307 (327)
T ss_dssp -CCHHHHHHHHHHT-TCCCCCC-----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC------
T ss_pred ccccHHHHHHHhhc-ccCCCCC-----CcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcC
Confidence 01111222222221 2222222 34667899999999999999999999999999998765443
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=343.43 Aligned_cols=258 Identities=19% Similarity=0.323 Sum_probs=195.6
Q ss_pred hccccccceeeeecCeEEEEEEEC--C-------ceeEEEEeeccCcc-chHHHHHHHHHHhccCCCceeeeeeccccCC
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVWH--G-------ENVAVKIFFSRDEA-SWSRETEIYSTVLLRHENILGYIGSDMTSRN 204 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~~--~-------~~vAvK~~~~~~~~-~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~ 204 (443)
.++|.+.+.||+|+||.||+|.+. + ..||+|++...... ......|+..+..++||||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 85 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGD- 85 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTT-
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC-
Confidence 478999999999999999999873 3 46999988654332 223345666777799999999999998764
Q ss_pred cccEEEeeecccCcccHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCc---
Q psy14889 205 SCTQLWLVTHYHSFGSLYDHLNRT--TLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGT--- 279 (443)
Q Consensus 205 ~~~~~~lv~e~~~~gsL~~~l~~~--~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~--- 279 (443)
..++||||+++|+|.+++... .+++..+..++.||+.||.|||+. +|+||||||+|||++.++.
T Consensus 86 ---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~--------~ivH~Dlkp~NIll~~~~~~~~ 154 (289)
T 4fvq_A 86 ---ENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEEN--------TLIHGNVCAKNILLIREEDRKT 154 (289)
T ss_dssp ---CCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHT--------TCCCCCCCGGGEEEEECCBGGG
T ss_pred ---CCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhC--------CeECCCcCcceEEEecCCcccc
Confidence 368999999999999999753 399999999999999999999999 9999999999999999887
Q ss_pred -----EEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcc
Q psy14889 280 -----CVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIF 354 (443)
Q Consensus 280 -----~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~ 354 (443)
+||+|||++...... ....||+.|+|||++.+.. .++.++||||||+++|||++|.
T Consensus 155 ~~~~~~kl~Dfg~~~~~~~~--------~~~~~~~~y~aPE~~~~~~-----~~~~~~DiwslG~il~el~~g~------ 215 (289)
T 4fvq_A 155 GNPPFIKLSDPGISITVLPK--------DILQERIPWVPPECIENPK-----NLNLATDKWSFGTTLWEICSGG------ 215 (289)
T ss_dssp TBCCEEEECCCCSCTTTSCH--------HHHHHTTTTSCHHHHHCGG-----GCCHHHHHHHHHHHHHHHHTTT------
T ss_pred cccceeeeccCcccccccCc--------cccCCcCcccCHHHhCCCC-----CCCchhHHHHHHHHHHHHHcCC------
Confidence 999999998654322 1235788999999998631 5668999999999999999972
Q ss_pred cccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhhcccc
Q psy14889 355 EEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLACADMY 434 (443)
Q Consensus 355 ~~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~~~~~ 434 (443)
..||... .......... .....+.. .+.++.+++.+||+.||++|||+.++++.|+++......
T Consensus 216 ---~~~~~~~-----~~~~~~~~~~---~~~~~~~~-----~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~ 279 (289)
T 4fvq_A 216 ---DKPLSAL-----DSQRKLQFYE---DRHQLPAP-----KAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLV 279 (289)
T ss_dssp ---CCTTTTS-----CHHHHHHHHH---TTCCCCCC-----SSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-----
T ss_pred ---CCCcccc-----chHHHHHHhh---ccCCCCCC-----CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCC
Confidence 3344332 2222222221 12222221 234589999999999999999999999999999886655
Q ss_pred ccCCC
Q psy14889 435 IHCSD 439 (443)
Q Consensus 435 ~~~~~ 439 (443)
...++
T Consensus 280 ~~~~~ 284 (289)
T 4fvq_A 280 PRGSH 284 (289)
T ss_dssp -----
T ss_pred CCCcc
Confidence 54443
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-44 Score=338.01 Aligned_cols=256 Identities=23% Similarity=0.349 Sum_probs=198.9
Q ss_pred hccccccceeeeecCeEEEEEEEC-----CceeEEEEeeccCcc--chHHHHHHHHHHhccCCCceeeeeeccccCCccc
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVWH-----GENVAVKIFFSRDEA--SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCT 207 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~~-----~~~vAvK~~~~~~~~--~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~ 207 (443)
.++|.+.+.||+|+||.||+|.+. +..||||++...... ......|+..+..++||||+++++++.+..
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---- 86 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEP---- 86 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSSS----
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCCC----
Confidence 378999999999999999999873 235999988654221 222345666666689999999999976542
Q ss_pred EEEeeecccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEec
Q psy14889 208 QLWLVTHYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADF 285 (443)
Q Consensus 208 ~~~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~Df 285 (443)
.++||||+++|+|.+++.. ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+||
T Consensus 87 -~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~--------~i~H~dlkp~Nil~~~~~~~kl~Df 157 (281)
T 3cc6_A 87 -TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESI--------NCVHRDIAVRNILVASPECVKLGDF 157 (281)
T ss_dssp -CEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT--------TCCCCCCSGGGEEEEETTEEEECCC
T ss_pred -CEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHC--------CcccCCCccceEEECCCCcEEeCcc
Confidence 4899999999999999964 4599999999999999999999998 9999999999999999999999999
Q ss_pred CCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh-cccCCCcccccCCCCCCC
Q psy14889 286 GLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR-RTKANGIFEEYKAPYHDL 364 (443)
Q Consensus 286 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt-g~~~~~~~~~~~~P~~~~ 364 (443)
|++......... ......+|+.|+|||.+.+. .++.++||||||+++|||++ | ..||...
T Consensus 158 g~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~il~~llt~g----------~~p~~~~ 218 (281)
T 3cc6_A 158 GLSRYIEDEDYY---KASVTRLPIKWMSPESINFR------RFTTASDVWMFAVCMWEILSFG----------KQPFFWL 218 (281)
T ss_dssp CGGGCC------------CCCCCGGGCCHHHHHHC------CCCHHHHHHHHHHHHHHHHTTT----------CCTTTTS
T ss_pred CCCccccccccc---ccccCCCCcceeCchhhccC------CCCchhccHHHHHHHHHHHhCC----------CCCcccC
Confidence 999766543211 12334578899999999765 66789999999999999998 8 6677543
Q ss_pred CCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhhccc
Q psy14889 365 VPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLACADM 433 (443)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~~~~ 433 (443)
. .......+... .....+ ..++..+.+++.+||+.||++|||+.|+++.|+++.+...
T Consensus 219 ~-----~~~~~~~~~~~-~~~~~~-----~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~ 276 (281)
T 3cc6_A 219 E-----NKDVIGVLEKG-DRLPKP-----DLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEK 276 (281)
T ss_dssp C-----GGGHHHHHHHT-CCCCCC-----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred C-----hHHHHHHHhcC-CCCCCC-----CCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhhh
Confidence 2 12222322222 222222 2356789999999999999999999999999999887543
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=337.62 Aligned_cols=258 Identities=30% Similarity=0.415 Sum_probs=197.2
Q ss_pred cccceeeeecCeEEEEEEECCceeEEEEeeccC-----ccchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEeee
Q psy14889 139 SLSECIGKGRYGEVWRGVWHGENVAVKIFFSRD-----EASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVT 213 (443)
Q Consensus 139 ~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~-----~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv~ 213 (443)
...+.||+|+||.||+|.++++.||||++.... ........|+..+..++||||+++++++.+.. ..++||
T Consensus 34 ~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~ 109 (307)
T 2nru_A 34 VGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGD----DLCLVY 109 (307)
T ss_dssp TTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS----SCEEEE
T ss_pred ccCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCC----ceEEEE
Confidence 344899999999999999999999999886432 11223345666666799999999999987764 469999
Q ss_pred cccCcccHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcc
Q psy14889 214 HYHSFGSLYDHLNR----TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAV 289 (443)
Q Consensus 214 e~~~~gsL~~~l~~----~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~ 289 (443)
||+++|+|.+++.. ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 110 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--------~i~H~dlkp~Nili~~~~~~kl~Dfg~~~ 181 (307)
T 2nru_A 110 VYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN--------HHIHRDIKSANILLDEAFTAKISDFGLAR 181 (307)
T ss_dssp ECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT--------TEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC--------CeecCCCCHHHEEEcCCCcEEEeeccccc
Confidence 99999999999863 4599999999999999999999998 99999999999999999999999999997
Q ss_pred cccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCC
Q psy14889 290 SYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDP 369 (443)
Q Consensus 290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~ 369 (443)
......... ......||+.|+|||.+.+ .++.++||||||+++|||++| ..||........
T Consensus 182 ~~~~~~~~~--~~~~~~g~~~y~aPE~~~~-------~~~~~~Dv~slG~il~~l~~g----------~~p~~~~~~~~~ 242 (307)
T 2nru_A 182 ASEKFAQTV--MTSRIVGTTAYMAPEALRG-------EITPKSDIYSFGVVLLEIITG----------LPAVDEHREPQL 242 (307)
T ss_dssp ECCSCSSCE--ECSSCCSCGGGCCHHHHTT-------EECTHHHHHHHHHHHHHHHHC----------CCSBCTTBSSSB
T ss_pred ccccccccc--cccccCCCcCcCChHHhcC-------CCCccchhHHHHHHHHHHHHC----------CCCcccCcchHH
Confidence 665422211 1233578999999998865 345799999999999999999 556654322111
Q ss_pred ChHHHHhhhhhcC------CCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhh
Q psy14889 370 SFDDMRKVICIDQ------QRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLAC 430 (443)
Q Consensus 370 ~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~ 430 (443)
. ..+........ ....++. .....+..+.+++.+||+.||++|||+.++++.|+++..
T Consensus 243 ~-~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 243 L-LDIKEEIEDEEKTIEDYIDKKMND--ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp T-THHHHHHHTTSCCHHHHSCSSCSC--CCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred H-HHHHHHhhhhhhhhhhhccccccc--cchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 1 11111111000 0011111 134567889999999999999999999999999999864
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=339.25 Aligned_cols=261 Identities=23% Similarity=0.360 Sum_probs=200.8
Q ss_pred ccccccceeeeecCeEEEEEEEC-----CceeEEEEeeccCcc--chHHHHHHHHHHhccCCCceeeeeeccccCCcccE
Q psy14889 136 KQISLSECIGKGRYGEVWRGVWH-----GENVAVKIFFSRDEA--SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQ 208 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~~-----~~~vAvK~~~~~~~~--~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~ 208 (443)
.+|++.+.||+|+||.||+|.+. ...||+|.+...... ......|+..+..++||||+++++++..... .
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---~ 101 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG---S 101 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSS---C
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCC---c
Confidence 57899999999999999999872 225899987653322 1223456667777999999999998765443 4
Q ss_pred EEeeecccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecC
Q psy14889 209 LWLVTHYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFG 286 (443)
Q Consensus 209 ~~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfG 286 (443)
.++||||+++|+|.+++.. ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||
T Consensus 102 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~--------~i~H~dikp~Nil~~~~~~~kl~Dfg 173 (298)
T 3f66_A 102 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK--------KFVHRDLAARNCMLDEKFTVKVADFG 173 (298)
T ss_dssp CEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHT--------TCCCSCCSGGGEEECTTCCEEECSCG
T ss_pred eEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC--------CccCCCCchheEEECCCCCEEECccc
Confidence 6899999999999999964 4589999999999999999999999 99999999999999999999999999
Q ss_pred CcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCC
Q psy14889 287 LAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVP 366 (443)
Q Consensus 287 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~ 366 (443)
+++.................||+.|+|||.+.+. .++.++||||||+++|||++|. ..||.....
T Consensus 174 ~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~il~~l~~~~---------~~~~~~~~~ 238 (298)
T 3f66_A 174 LARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ------KFTTKSDVWSFGVLLWELMTRG---------APPYPDVNT 238 (298)
T ss_dssp GGCCCSCGGGCBC-----CCBCGGGSCHHHHHHC------CCCHHHHHHHHHHHHHHHHTTS---------CCSSTTSCT
T ss_pred ccccccccchhccccccCCCCCccccChHHhcCC------CCChHHHHHHHHHHHHHHHhCC---------CCCCccCCH
Confidence 9987654433222233445688899999999776 6778999999999999999962 445544321
Q ss_pred CCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhhccc
Q psy14889 367 MDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLACADM 433 (443)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~~~~ 433 (443)
......+. .......+ ..++..+.+++.+||+.||++|||+.++++.|+++.....
T Consensus 239 -----~~~~~~~~-~~~~~~~~-----~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~ 294 (298)
T 3f66_A 239 -----FDITVYLL-QGRRLLQP-----EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 294 (298)
T ss_dssp -----TTHHHHHH-TTCCCCCC-----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred -----HHHHHHHh-cCCCCCCC-----ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 11112111 12222222 2356789999999999999999999999999999987643
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=343.82 Aligned_cols=244 Identities=23% Similarity=0.302 Sum_probs=186.4
Q ss_pred hhhhccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccch---HHHHHHHHHHh-ccCCCceeeeeeccccCCc
Q psy14889 132 RTLAKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEASW---SRETEIYSTVL-LRHENILGYIGSDMTSRNS 205 (443)
Q Consensus 132 ~~~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~---~~e~ei~~~~~-l~H~nIv~l~g~~~~~~~~ 205 (443)
..+.++|++.+.||+|+||+||+|.+ +|+.||||++........ ....|+..+.. .+||||+++++++.+.
T Consensus 53 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~--- 129 (311)
T 3p1a_A 53 SFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEG--- 129 (311)
T ss_dssp CHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET---
T ss_pred chhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeC---
Confidence 44557899999999999999999998 589999998755332221 22233333333 4899999999998765
Q ss_pred ccEEEeeecccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEE
Q psy14889 206 CTQLWLVTHYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIA 283 (443)
Q Consensus 206 ~~~~~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~ 283 (443)
..+++||||+ +|+|.+++.. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+
T Consensus 130 -~~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--------~ivH~Dikp~NIll~~~~~~kl~ 199 (311)
T 3p1a_A 130 -GILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ--------GLVHLDVKPANIFLGPRGRCKLG 199 (311)
T ss_dssp -TEEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT--------TEECCCCSGGGEEECGGGCEEEC
T ss_pred -CEEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--------CEecCCCCHHHEEECCCCCEEEc
Confidence 4689999999 5699998864 4699999999999999999999998 99999999999999999999999
Q ss_pred ecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCC
Q psy14889 284 DFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHD 363 (443)
Q Consensus 284 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~ 363 (443)
|||++........ .....||+.|+|||++.+ .++.++|||||||++|||++| ..|+..
T Consensus 200 DFG~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~-------~~~~~~DiwslG~il~el~~g----------~~~~~~ 257 (311)
T 3p1a_A 200 DFGLLVELGTAGA-----GEVQEGDPRYMAPELLQG-------SYGTAADVFSLGLTILEVACN----------MELPHG 257 (311)
T ss_dssp CCTTCEECC-----------CCCCCGGGCCGGGGGT-------CCSTHHHHHHHHHHHHHHHHT----------CCCCSS
T ss_pred cceeeeecccCCC-----CcccCCCccccCHhHhcC-------CCCchhhHHHHHHHHHHHHhC----------CCCCCC
Confidence 9999976654322 233469999999998875 456899999999999999999 333322
Q ss_pred CCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 364 LVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
. ....... .....+.. ....+.++.+++.+||+.||++|||+.|+++
T Consensus 258 ~-------~~~~~~~-~~~~~~~~-----~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 258 G-------EGWQQLR-QGYLPPEF-----TAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp H-------HHHHHHT-TTCCCHHH-----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred c-------cHHHHHh-ccCCCccc-----ccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 1 1111111 11111111 1235678999999999999999999999985
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=345.70 Aligned_cols=267 Identities=21% Similarity=0.305 Sum_probs=197.7
Q ss_pred hhccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccc----hHHHHHHHHHHhccCCCceeeeeeccccCCccc
Q psy14889 134 LAKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEAS----WSRETEIYSTVLLRHENILGYIGSDMTSRNSCT 207 (443)
Q Consensus 134 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~----~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~ 207 (443)
+.++|++.+.||+|+||.||+|++ +++.||||++....... .....|+..+..++||||+++++++........
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 457899999999999999999997 68899999986543222 122456666666899999999999877655445
Q ss_pred EEEeeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecC
Q psy14889 208 QLWLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFG 286 (443)
Q Consensus 208 ~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfG 286 (443)
..++||||+++|+|.++++. ..+++.++..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~--------~ivH~dlkp~Nil~~~~~~~kl~Dfg 161 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN--------GIIHRDVKPANIMISATNAVKVMDFG 161 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT--------TCCCCCCCGGGEEEETTSCEEECCCS
T ss_pred ccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CCCcCCCCHHHEEEcCCCCEEEeecc
Confidence 67999999999999999964 6799999999999999999999999 99999999999999999999999999
Q ss_pred CcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCC
Q psy14889 287 LAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVP 366 (443)
Q Consensus 287 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~ 366 (443)
+++.+....... .......||+.|+|||++.+. .++.++||||||+++|||++| ..||...
T Consensus 162 ~a~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~------~~~~~~Di~slG~~l~~ll~g----------~~pf~~~-- 222 (311)
T 3ork_A 162 IARAIADSGNSV-TQTAAVIGTAQYLSPEQARGD------SVDARSDVYSLGCVLYEVLTG----------EPPFTGD-- 222 (311)
T ss_dssp CC-------------------CCTTCCHHHHHTC------CCCHHHHHHHHHHHHHHHHHS----------SCSCCCS--
T ss_pred Cccccccccccc-ccccccCcCcccCCHHHhcCC------CCCchHhHHHHHHHHHHHHhC----------CCCCCCC--
Confidence 997765432221 112345789999999999876 677899999999999999999 7777653
Q ss_pred CCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCc-HHHHHHHHHHHhhccc
Q psy14889 367 MDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLS-ALRVKKTLIKLACADM 433 (443)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-~~evl~~L~~l~~~~~ 433 (443)
...............+ .......++.++.+++.+||+.||++||+ ++++...+.++....+
T Consensus 223 ---~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~~ 284 (311)
T 3ork_A 223 ---SPVSVAYQHVREDPIP---PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEP 284 (311)
T ss_dssp ---SHHHHHHHHHHCCCCC---HHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTTCC
T ss_pred ---ChHHHHHHHhcCCCCC---cccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcCCC
Confidence 1222222111111111 10111235678999999999999999995 5556677777665443
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-44 Score=345.82 Aligned_cols=255 Identities=23% Similarity=0.433 Sum_probs=195.7
Q ss_pred ccccccceeeeecCeEEEEEEE--CCcee----EEEEeeccCc--cchHHHHHHHHHHhccCCCceeeeeeccccCCccc
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENV----AVKIFFSRDE--ASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCT 207 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~v----AvK~~~~~~~--~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~ 207 (443)
++|++.+.||+|+||.||+|.+ +++.| |+|.+..... .......|+..+..++||||+++++++....
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~---- 90 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST---- 90 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS----
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC----
Confidence 6899999999999999999998 45554 6666543322 2233345666777799999999999987653
Q ss_pred EEEeeecccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEec
Q psy14889 208 QLWLVTHYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADF 285 (443)
Q Consensus 208 ~~~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~Df 285 (443)
.++|+||+.+|+|.+++.. ..+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+||
T Consensus 91 -~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~--------~ivH~Dikp~NIl~~~~~~~kL~Df 161 (327)
T 3lzb_A 91 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR--------RLVHRDLAARNVLVKTPQHVKITDF 161 (327)
T ss_dssp -EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT--------TCCCSCCCGGGEEEEETTEEEECCT
T ss_pred -ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC--------CCcCCCCCHHHEEEcCCCCEEEccC
Confidence 5899999999999999964 5699999999999999999999999 9999999999999999999999999
Q ss_pred CCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh-cccCCCcccccCCCCCCC
Q psy14889 286 GLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR-RTKANGIFEEYKAPYHDL 364 (443)
Q Consensus 286 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt-g~~~~~~~~~~~~P~~~~ 364 (443)
|+++......... ......||+.|+|||.+.+. .++.++||||||+++|||++ | ..||...
T Consensus 162 G~a~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~------~~~~~~Di~slG~il~ell~~g----------~~p~~~~ 223 (327)
T 3lzb_A 162 GLAKLLGAEEKEY--HAEGGKVPIKWMALESILHR------IYTHQSDVWSYGVTVWELMTFG----------SKPYDGI 223 (327)
T ss_dssp TC------------------CCCGGGSCHHHHHHC------CCCHHHHHHHHHHHHHHHHTTS----------CCTTTTC
T ss_pred cceeEccCccccc--cccCCCccccccCHHHHcCC------CCChHHHHHHHHHHHHHHHHCC----------CCCCCCC
Confidence 9998765433221 12334578899999999876 67789999999999999999 8 6777654
Q ss_pred CCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhhcc
Q psy14889 365 VPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLACAD 432 (443)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~~~ 432 (443)
....+...+... .....+ ..++.++.+++.+||+.||.+|||+.|+++.|+++....
T Consensus 224 -----~~~~~~~~~~~~-~~~~~~-----~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 280 (327)
T 3lzb_A 224 -----PASEISSILEKG-ERLPQP-----PICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDP 280 (327)
T ss_dssp -----CGGGHHHHHHTT-CCCCCC-----TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSH
T ss_pred -----CHHHHHHHHHcC-CCCCCC-----ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCc
Confidence 223333333322 222222 336678999999999999999999999999999998654
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=345.73 Aligned_cols=244 Identities=23% Similarity=0.306 Sum_probs=190.5
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccc----hHHHHHHHHHHhc-cCCCceeeeeeccccCCcccE
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEAS----WSRETEIYSTVLL-RHENILGYIGSDMTSRNSCTQ 208 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~----~~~e~ei~~~~~l-~H~nIv~l~g~~~~~~~~~~~ 208 (443)
++|++.+.||+|+||.||+|+. +++.||+|++....... .....|+..+..+ +||||+++++++.+. ..
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~----~~ 84 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE----SR 84 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS----SE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeC----CE
Confidence 6899999999999999999998 58899999987543211 1122344444445 899999999998776 46
Q ss_pred EEeeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCC
Q psy14889 209 LWLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGL 287 (443)
Q Consensus 209 ~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGl 287 (443)
+++||||+++|+|.+++.+ ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 85 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~--------~ivHrDlkp~NIll~~~g~~kL~DFG~ 156 (345)
T 3a8x_A 85 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER--------GIIYRDLKLDNVLLDSEGHIKLTDYGM 156 (345)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT--------TCBCCCCCGGGEEECTTSCEEECCGGG
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC--------CceecCCCHHHEEECCCCCEEEEeccc
Confidence 8999999999999999965 6799999999999999999999999 999999999999999999999999999
Q ss_pred cccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCC
Q psy14889 288 AVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPM 367 (443)
Q Consensus 288 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~ 367 (443)
++....... ......||+.|+|||++.+. .++.++|||||||++|||++| ..||......
T Consensus 157 a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~ell~g----------~~pf~~~~~~ 216 (345)
T 3a8x_A 157 CKEGLRPGD----TTSTFCGTPNYIAPEILRGE------DYGFSVDWWALGVLMFEMMAG----------RSPFDIVGSS 216 (345)
T ss_dssp CBCSCCTTC----CBCCCCSCGGGCCHHHHTTC------CBCTHHHHHHHHHHHHHHHHS----------SCTTTTTTC-
T ss_pred cccccCCCC----cccccCCCccccCccccCCC------CCChHHhHHHHHHHHHHHHhC----------CCCcCCcccc
Confidence 975432211 12445899999999999876 677899999999999999999 5566432111
Q ss_pred ----CCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcH
Q psy14889 368 ----DPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSA 418 (443)
Q Consensus 368 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~ 418 (443)
......+...+.. ....+| ...+.++.+|+.+||+.||++||++
T Consensus 217 ~~~~~~~~~~~~~~i~~--~~~~~p-----~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 217 DNPDQNTEDYLFQVILE--KQIRIP-----RSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp ------CHHHHHHHHHH--CCCCCC-----TTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred cccccccHHHHHHHHHc--CCCCCC-----CCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 1122233333322 223333 2356789999999999999999995
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=360.08 Aligned_cols=255 Identities=22% Similarity=0.274 Sum_probs=197.7
Q ss_pred hhccccccceeeeecCeEEEEEEE--CCceeEEEEeeccC------ccchHHHHHHHHHHhccCCCceeeeeeccccCCc
Q psy14889 134 LAKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRD------EASWSRETEIYSTVLLRHENILGYIGSDMTSRNS 205 (443)
Q Consensus 134 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~------~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~ 205 (443)
..++|++.+.||+|+||+||+|++ +++.||||++.... ......|.+++ ..++||||+++++++.+.
T Consensus 72 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il--~~~~hp~Iv~l~~~~~~~--- 146 (437)
T 4aw2_A 72 HREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVL--VNGDSKWITTLHYAFQDD--- 146 (437)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHH--HHSCTTTBCCEEEEEECS---
T ss_pred ChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHH--HhCCCCCEEEEEEEEeeC---
Confidence 347899999999999999999998 47899999986421 12234455444 458999999999999876
Q ss_pred ccEEEeeecccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEE
Q psy14889 206 CTQLWLVTHYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIA 283 (443)
Q Consensus 206 ~~~~~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~ 283 (443)
..+++||||+++|+|.+++.+ ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+
T Consensus 147 -~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~--------giiHrDLKp~NILl~~~g~vkL~ 217 (437)
T 4aw2_A 147 -NNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQL--------HYVHRDIKPDNILMDMNGHIRLA 217 (437)
T ss_dssp -SEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT--------TEECCCCSGGGEEECTTSCEEEC
T ss_pred -CEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhC--------CeEecccCHHHeeEcCCCCEEEc
Confidence 458999999999999999975 6799999999999999999999998 99999999999999999999999
Q ss_pred ecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCC
Q psy14889 284 DFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHD 363 (443)
Q Consensus 284 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~ 363 (443)
|||+|+......... ....+||+.|+|||++...... ...++.++|||||||++|||++| ..||..
T Consensus 218 DFGla~~~~~~~~~~---~~~~~GT~~Y~APE~l~~~~~~-~~~~~~~~DvwSlGvil~elltG----------~~Pf~~ 283 (437)
T 4aw2_A 218 DFGSCLKLMEDGTVQ---SSVAVGTPDYISPEILQAMEGG-KGRYGPECDWWSLGVCMYEMLYG----------ETPFYA 283 (437)
T ss_dssp CCTTCEECCTTSCEE---CCSCCSCGGGCCHHHHHHHHTS-CCEECTHHHHHHHHHHHHHHHHS----------SCTTCC
T ss_pred chhhhhhcccCCCcc---cccccCCcCeeChHHHhhcccC-CCCCCCcCeeHHHHHHHHHHHhC----------CCCCCC
Confidence 999997665432221 2345799999999998731100 01567899999999999999999 778765
Q ss_pred CCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCC--CCcHHHHHH
Q psy14889 364 LVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANV--RLSALRVKK 423 (443)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--Rps~~evl~ 423 (443)
. ...+....+........+|..+ ...+.++.+||++||..+|++ ||+++|+++
T Consensus 284 ~-----~~~~~~~~i~~~~~~~~~p~~~--~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 284 E-----SLVETYGKIMNHKERFQFPTQV--TDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp S-----SHHHHHHHHHTHHHHCCCCSSC--CCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred C-----ChhHHHHhhhhccccccCCccc--ccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 3 2223322222111122333221 235678999999999998888 999999876
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=343.36 Aligned_cols=245 Identities=25% Similarity=0.339 Sum_probs=189.2
Q ss_pred hccccccceeeeecCeEEEEEEE-----CCceeEEEEeeccCc-----cchHHHHHHHHHHhccCCCceeeeeeccccCC
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVW-----HGENVAVKIFFSRDE-----ASWSRETEIYSTVLLRHENILGYIGSDMTSRN 204 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~-----~~~~vAvK~~~~~~~-----~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~ 204 (443)
.++|++.+.||+|+||.||+++. +|+.||+|++..... .......|+..+..++||||+++++++...
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-- 93 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTG-- 93 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECS--
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcC--
Confidence 47899999999999999999987 578999999865321 112223455556669999999999998776
Q ss_pred cccEEEeeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEE
Q psy14889 205 SCTQLWLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIA 283 (443)
Q Consensus 205 ~~~~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~ 283 (443)
..+++||||+++|+|.+++.+ ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+
T Consensus 94 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~--------~ivH~Dlkp~Nill~~~~~~kl~ 163 (327)
T 3a62_A 94 --GKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQK--------GIIYRDLKPENIMLNHQGHVKLT 163 (327)
T ss_dssp --SCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT--------TCCCCCCCTTTEEECTTSCEEEC
T ss_pred --CEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC--------CEEcccCCHHHeEECCCCcEEEE
Confidence 357999999999999999964 5789999999999999999999999 99999999999999999999999
Q ss_pred ecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCC
Q psy14889 284 DFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHD 363 (443)
Q Consensus 284 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~ 363 (443)
|||+++........ .....||+.|+|||++.+. .++.++||||||+++|||++| ..||..
T Consensus 164 Dfg~~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~el~~g----------~~pf~~ 223 (327)
T 3a62_A 164 DFGLCKESIHDGTV----THTFCGTIEYMAPEILMRS------GHNRAVDWWSLGALMYDMLTG----------APPFTG 223 (327)
T ss_dssp CCSCC--------------CTTSSCCTTSCHHHHTTS------CCCTHHHHHHHHHHHHHHHHS----------SCSCCC
T ss_pred eCCcccccccCCcc----ccccCCCcCccCHhhCcCC------CCCCcccchhHHHHHHHHHHC----------CCCCCC
Confidence 99998754332211 2345799999999999776 667899999999999999999 777765
Q ss_pred CCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCC-----cHHHHHH
Q psy14889 364 LVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRL-----SALRVKK 423 (443)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~ 423 (443)
. ........+.. ....++ ...+.++.+++.+||+.||++|| ++.|+++
T Consensus 224 ~-----~~~~~~~~i~~--~~~~~p-----~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 224 E-----NRKKTIDKILK--CKLNLP-----PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp S-----SHHHHHHHHHH--TCCCCC-----TTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred C-----CHHHHHHHHHh--CCCCCC-----CCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 3 22222222221 122233 23567899999999999999999 7778765
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=348.71 Aligned_cols=249 Identities=22% Similarity=0.307 Sum_probs=197.0
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccC----ccchHHHHHHHHHHhccCCCceeeeeeccccCCcccEE
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRD----EASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQL 209 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~----~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~ 209 (443)
++|++.+.||+|+||.||++.. +++.||+|++.... ........|+..+..++||||+++++++.+. ..+
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~----~~~ 90 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDE----EDM 90 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS----SEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC----CEE
Confidence 6899999999999999999998 57899999986432 1112233566666669999999999999876 458
Q ss_pred EeeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCc
Q psy14889 210 WLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA 288 (443)
Q Consensus 210 ~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla 288 (443)
++||||+.+|+|.+++.+ ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~--------givHrDlkp~NIll~~~g~vkL~DFG~a 162 (384)
T 4fr4_A 91 FMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQ--------RIIHRDMKPDNILLDEHGHVHITDFNIA 162 (384)
T ss_dssp EEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT--------TEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CceeccCcHHHeEECCCCCEEEecccee
Confidence 999999999999999975 4799999999999999999999999 9999999999999999999999999999
Q ss_pred ccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCC
Q psy14889 289 VSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMD 368 (443)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~ 368 (443)
+.+..... .....||+.|+|||++...... .++.++|||||||++|||++| ..||.....
T Consensus 163 ~~~~~~~~-----~~~~~gt~~Y~aPE~~~~~~~~---~~~~~~DiwSlG~il~elltG----------~~Pf~~~~~-- 222 (384)
T 4fr4_A 163 AMLPRETQ-----ITTMAGTKPYMAPEMFSSRKGA---GYSFAVDWWSLGVTAYELLRG----------RRPYHIRSS-- 222 (384)
T ss_dssp EECCTTCC-----BCCCCSCGGGCCGGGTCCCSSC---CBCTTHHHHHHHHHHHHHHHS----------SCSSCCCTT--
T ss_pred eeccCCCc-----eeccCCCccccCCeeeccCCCC---CCCccceeechHHHHHHHHhC----------CCCCCCCCC--
Confidence 87653321 2446899999999999753211 567899999999999999999 677764321
Q ss_pred CChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCc-HHHHHH
Q psy14889 369 PSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLS-ALRVKK 423 (443)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-~~evl~ 423 (443)
.....+...+.. .....| ...+..+.+||.+||+.||.+||+ +.++++
T Consensus 223 ~~~~~~~~~~~~--~~~~~p-----~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 223 TSSKEIVHTFET--TVVTYP-----SAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp SCHHHHHHHHHH--CCCCCC-----TTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred ccHHHHHHHHhh--cccCCC-----CcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 122333333222 222233 235678999999999999999998 666654
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=347.15 Aligned_cols=241 Identities=20% Similarity=0.281 Sum_probs=197.4
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCc----cchHHHHHHHHHHhccCCCceeeeeeccccCCcccEE
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDE----ASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQL 209 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~----~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~ 209 (443)
++|++.+.||+|+||.||+|+. +|+.||||++..... .......|+..+..++||||+++++++.+. ..+
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~----~~~ 116 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN----SNL 116 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS----SEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC----CEE
Confidence 6899999999999999999998 589999999865321 112233456666669999999999998876 458
Q ss_pred EeeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCc
Q psy14889 210 WLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA 288 (443)
Q Consensus 210 ~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla 288 (443)
++||||+++|+|.+++.+ ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 117 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~--------~ivHrDlkp~NIll~~~g~~kL~DFg~a 188 (350)
T 1rdq_E 117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL--------DLIYRDLKPENLLIDQQGYIQVTDFGFA 188 (350)
T ss_dssp EEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT--------TEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC--------CcccccCccceEEECCCCCEEEcccccc
Confidence 999999999999999975 6799999999999999999999999 9999999999999999999999999999
Q ss_pred ccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCC
Q psy14889 289 VSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMD 368 (443)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~ 368 (443)
+..... .....||+.|+|||++.+. .++.++|||||||++|||++| ..||...
T Consensus 189 ~~~~~~-------~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~ell~g----------~~Pf~~~---- 241 (350)
T 1rdq_E 189 KRVKGR-------TWTLCGTPEALAPEIILSK------GYNKAVDWWALGVLIYEMAAG----------YPPFFAD---- 241 (350)
T ss_dssp EECSSC-------BCCCEECGGGCCHHHHTTC------CBCTHHHHHHHHHHHHHHHHS----------SCSSCCS----
T ss_pred eeccCC-------cccccCCccccCHHHhcCC------CCCCcCCEecccHhHhHHhhC----------CCCCCCC----
Confidence 866432 1345799999999999876 677899999999999999999 7777653
Q ss_pred CChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCc-----HHHHHH
Q psy14889 369 PSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLS-----ALRVKK 423 (443)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~ 423 (443)
....+...+... ...+| ...+.++.+++.+||+.||++||+ +.+|++
T Consensus 242 -~~~~~~~~i~~~--~~~~p-----~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 242 -QPIQIYEKIVSG--KVRFP-----SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp -SHHHHHHHHHHC--CCCCC-----TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred -CHHHHHHHHHcC--CCCCC-----CCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 223333333222 22333 235678999999999999999998 788765
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=354.81 Aligned_cols=261 Identities=23% Similarity=0.381 Sum_probs=191.4
Q ss_pred ccccccceeeeecCeEEEEEEEC---C--ceeEEEEeeccCcc--chHHHHHHHHHHhccCCCceeeeeeccccCCcccE
Q psy14889 136 KQISLSECIGKGRYGEVWRGVWH---G--ENVAVKIFFSRDEA--SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQ 208 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~~---~--~~vAvK~~~~~~~~--~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~ 208 (443)
..|.+.+.||+|+||.||+|.+. + ..||||.+...... ......|+..+..++||||+++++++..... .
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~---~ 165 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG---S 165 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSS---C
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCC---C
Confidence 35788899999999999999872 2 36899987643322 2233456666667999999999998765432 4
Q ss_pred EEeeecccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecC
Q psy14889 209 LWLVTHYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFG 286 (443)
Q Consensus 209 ~~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfG 286 (443)
.++||||+++|+|.+++.. ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||
T Consensus 166 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~--------~ivHrDlkp~NIll~~~~~~kL~DFG 237 (373)
T 3c1x_A 166 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK--------KFVHRDLAARNCMLDEKFTVKVADFG 237 (373)
T ss_dssp CEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT--------TCCCSCCCGGGEEECTTCCEEECCC-
T ss_pred eEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC--------CEecCccchheEEECCCCCEEEeecc
Confidence 6899999999999999965 4589999999999999999999999 99999999999999999999999999
Q ss_pred CcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCC
Q psy14889 287 LAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVP 366 (443)
Q Consensus 287 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~ 366 (443)
+++.................+|+.|+|||.+.+. .++.++||||||+++|||+||. ..||.....
T Consensus 238 ~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~------~~~~~~DvwSlG~il~ellt~~---------~~p~~~~~~ 302 (373)
T 3c1x_A 238 LARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ------KFTTKSDVWSFGVLLWELMTRG---------APPYPDVNT 302 (373)
T ss_dssp --------------------CCGGGSCHHHHHHC------CCCHHHHHHHHHHHHHHHHTTS---------CCSCTTSCS
T ss_pred ccccccccccccccccCCCCCcccccChHHhcCC------CCCcHHHHHHHHHHHHHHHhCc---------CCCCCCCCH
Confidence 9986644322211122344678899999999876 6778999999999999999952 456655321
Q ss_pred CCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhhccc
Q psy14889 367 MDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLACADM 433 (443)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~~~~ 433 (443)
. +....+. ...++..+ ..++..+.+++.+||+.||++|||+.++++.|+++.....
T Consensus 303 ~-----~~~~~~~-~~~~~~~p-----~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~ 358 (373)
T 3c1x_A 303 F-----DITVYLL-QGRRLLQP-----EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 358 (373)
T ss_dssp S-----CHHHHHH-TTCCCCCC-----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred H-----HHHHHHH-cCCCCCCC-----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 1 1112221 12222222 3366789999999999999999999999999999987654
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-44 Score=337.87 Aligned_cols=249 Identities=20% Similarity=0.318 Sum_probs=193.6
Q ss_pred hhhhccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc--chHHHHHHHHHHhccCCCceeeeeeccccCCccc
Q psy14889 132 RTLAKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA--SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCT 207 (443)
Q Consensus 132 ~~~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~--~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~ 207 (443)
..+.++|.+.+.||+|+||.||++.. ++..||+|++...... ....+.|+..+..++||||+++++++.+. .
T Consensus 18 g~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~----~ 93 (285)
T 3is5_A 18 GTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDY----H 93 (285)
T ss_dssp SCHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS----S
T ss_pred CChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecC----C
Confidence 44567899999999999999999998 5889999998654322 23345677777779999999999998765 4
Q ss_pred EEEeeecccCcccHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEE---cCCCc
Q psy14889 208 QLWLVTHYHSFGSLYDHLNR-----TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILV---KTNGT 279 (443)
Q Consensus 208 ~~~lv~e~~~~gsL~~~l~~-----~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl---~~~~~ 279 (443)
..++||||+++|+|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+|||+ +.++.
T Consensus 94 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~--------~ivH~dikp~NIl~~~~~~~~~ 165 (285)
T 3is5_A 94 NMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ--------HVVHKDLKPENILFQDTSPHSP 165 (285)
T ss_dssp EEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT--------TCCCCCCSGGGEEESSSSTTCC
T ss_pred eEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC--------CEEECCCCHHHEEEecCCCCCC
Confidence 58999999999999998843 5699999999999999999999999 99999999999999 45578
Q ss_pred EEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCC
Q psy14889 280 CVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKA 359 (443)
Q Consensus 280 ~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~ 359 (443)
+||+|||++........ .....||+.|+|||++.+ .++.++||||||+++|||++| ..
T Consensus 166 ~kl~Dfg~a~~~~~~~~-----~~~~~~t~~y~aPE~~~~-------~~~~~~Di~slG~il~~ll~g----------~~ 223 (285)
T 3is5_A 166 IKIIDFGLAELFKSDEH-----STNAAGTALYMAPEVFKR-------DVTFKCDIWSAGVVMYFLLTG----------CL 223 (285)
T ss_dssp EEECCCCCCCC---------------CTTGGGCCHHHHTT-------CCCHHHHHHHHHHHHHHHHHS----------SC
T ss_pred EEEEeeecceecCCccc-----CcCcccccCcCChHHhcc-------CCCcccCeehHHHHHHHHHhC----------CC
Confidence 99999999976554221 234578999999999864 456899999999999999999 67
Q ss_pred CCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 360 PYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 360 P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
||.+. ................... ....++++.+|+.+||+.||++|||+.|+++
T Consensus 224 pf~~~-----~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 224 PFTGT-----SLEEVQQKATYKEPNYAVE----CRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp SSCCS-----SHHHHHHHHHHCCCCCCC------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred CCCCC-----CHHHHHhhhccCCcccccc----cCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 77653 2333333332222211111 1224578999999999999999999999985
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=346.96 Aligned_cols=244 Identities=23% Similarity=0.314 Sum_probs=194.3
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccC----ccchHHHHHHHHHHhc-cCCCceeeeeeccccCCcccE
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRD----EASWSRETEIYSTVLL-RHENILGYIGSDMTSRNSCTQ 208 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~----~~~~~~e~ei~~~~~l-~H~nIv~l~g~~~~~~~~~~~ 208 (443)
++|++.+.||+|+||.||+|+. +|+.||||++.... ........|...+..+ +||||+++++++.+. ..
T Consensus 20 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~----~~ 95 (353)
T 2i0e_A 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM----DR 95 (353)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECS----SE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcC----CE
Confidence 6899999999999999999998 47889999986532 1112223344444434 899999999998776 46
Q ss_pred EEeeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCC
Q psy14889 209 LWLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGL 287 (443)
Q Consensus 209 ~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGl 287 (443)
+++||||+++|+|.+++.+ ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 96 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~--------givHrDlkp~NIll~~~g~vkL~DFG~ 167 (353)
T 2i0e_A 96 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK--------GIIYRDLKLDNVMLDSEGHIKIADFGM 167 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT--------TCBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CEEeccCCHHHEEEcCCCcEEEEeCCc
Confidence 8999999999999999975 6799999999999999999999999 999999999999999999999999999
Q ss_pred cccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCC
Q psy14889 288 AVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPM 367 (443)
Q Consensus 288 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~ 367 (443)
++....... .....+||+.|+|||++.+. .++.++|||||||++|||++| ..||...
T Consensus 168 a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~ell~G----------~~Pf~~~--- 224 (353)
T 2i0e_A 168 CKENIWDGV----TTKTFCGTPDYIAPEIIAYQ------PYGKSVDWWAFGVLLYEMLAG----------QAPFEGE--- 224 (353)
T ss_dssp CBCCCCTTC----CBCCCCSCGGGCCHHHHTTC------CBSTHHHHHHHHHHHHHHHHS----------SCSSCCS---
T ss_pred ccccccCCc----ccccccCCccccChhhhcCC------CcCCcccccchHHHHHHHHcC----------CCCCCCC---
Confidence 975432211 12456899999999999876 677899999999999999999 7777653
Q ss_pred CCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCc-----HHHHHH
Q psy14889 368 DPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLS-----ALRVKK 423 (443)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~ 423 (443)
....+...+... ...+| ...+.++.+|+.+||+.||++||+ +.++++
T Consensus 225 --~~~~~~~~i~~~--~~~~p-----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 225 --DEDELFQSIMEH--NVAYP-----KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp --SHHHHHHHHHHC--CCCCC-----TTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred --CHHHHHHHHHhC--CCCCC-----CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 233333333222 22333 235678999999999999999995 567664
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=337.72 Aligned_cols=266 Identities=19% Similarity=0.254 Sum_probs=199.8
Q ss_pred hhccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCc-cchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEE
Q psy14889 134 LAKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDE-ASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLW 210 (443)
Q Consensus 134 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~ 210 (443)
+.++|++.+.||+|+||.||+|.. +++.||||++..... .....|.++ +..++|+|++..++.+.... ...+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~--l~~l~~~~~i~~~~~~~~~~---~~~~ 81 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKI--YKMMQGGVGIPTIRWCGAEG---DYNV 81 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHH--HHHHTTSTTCCCEEEEEEET---TEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHH--HHHhcCCCCCCeeeeecCCC---CceE
Confidence 447899999999999999999996 688999998654432 334444444 44488998888877765443 4579
Q ss_pred eeecccCcccHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEE---cCCCcEEEEec
Q psy14889 211 LVTHYHSFGSLYDHLN--RTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILV---KTNGTCVIADF 285 (443)
Q Consensus 211 lv~e~~~~gsL~~~l~--~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl---~~~~~~kl~Df 285 (443)
+||||+ +|+|.+++. ...+++..+..++.||+.||.|||+. +|+||||||+|||+ +.++.+||+||
T Consensus 82 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~--------~ivH~Dlkp~NIl~~~~~~~~~~kL~Df 152 (296)
T 4hgt_A 82 MVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK--------NFIHRDVKPDNFLMGLGKKGNLVYIIDF 152 (296)
T ss_dssp EEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT--------TEECSCCSGGGEEECCGGGTTCEEECCC
T ss_pred EEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CeecCCCCHHHeeeeccCCCCeEEEecC
Confidence 999999 899999997 46799999999999999999999999 99999999999999 78899999999
Q ss_pred CCcccccccCCcCC---CCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCC
Q psy14889 286 GLAVSYSQLSNKMD---IPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYH 362 (443)
Q Consensus 286 Gla~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~ 362 (443)
|+++.......... .......||+.|+|||.+.+. .++.++|||||||++|||++| ..||.
T Consensus 153 g~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~Di~slG~il~~l~~g----------~~pf~ 216 (296)
T 4hgt_A 153 GLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGI------EQSRRDDLESLGYVLMYFNLG----------SLPWQ 216 (296)
T ss_dssp TTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTC------CCCHHHHHHHHHHHHHHHHHS----------SCTTS
T ss_pred ccceeccCcccCccCCCCcccccCCCccccchHHhcCC------CCCchhHHHHHHHHHHHHhcC----------CCCCc
Confidence 99987665432211 122345799999999999876 677899999999999999999 66776
Q ss_pred CCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhhccc
Q psy14889 363 DLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLACADM 433 (443)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~~~~ 433 (443)
........ ..+..........+ .+ .....++.++.+++.+||+.||++|||+.++++.|+++.+...
T Consensus 217 ~~~~~~~~-~~~~~~~~~~~~~~-~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~ 283 (296)
T 4hgt_A 217 GLKAATKR-QKYERISEKKMSTP-IE--VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp SCCCSSSS-SHHHHHHHHHHHSC-HH--HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred ccchhhhh-hhhhhhhcccccch-hh--hhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhC
Confidence 54322211 11111111100000 00 0012245789999999999999999999999999999987654
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=335.93 Aligned_cols=260 Identities=21% Similarity=0.350 Sum_probs=202.6
Q ss_pred cccccceeeeecCeEEEEEEE--CCc---eeEEEEeeccCccc--hHHHHHHHHHHhccCCCceeeeeeccccCCcccEE
Q psy14889 137 QISLSECIGKGRYGEVWRGVW--HGE---NVAVKIFFSRDEAS--WSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQL 209 (443)
Q Consensus 137 ~~~~~~~lG~G~fg~Vy~~~~--~~~---~vAvK~~~~~~~~~--~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~ 209 (443)
.|...+.||+|+||.||+|.+ ++. .||+|++....... .....|+..+..++||||+++++++.+... ..
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---~~ 98 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEG---LP 98 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSS---CC
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCC---Cc
Confidence 567779999999999999987 332 69999886533322 223456666777999999999999876643 24
Q ss_pred EeeecccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCC
Q psy14889 210 WLVTHYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGL 287 (443)
Q Consensus 210 ~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGl 287 (443)
++||||+.+|+|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 99 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~--------~i~H~dikp~Nili~~~~~~kl~Dfg~ 170 (298)
T 3pls_A 99 HVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQ--------KFVHRDLAARNCMLDESFTVKVADFGL 170 (298)
T ss_dssp EEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT--------TCCCSCCSGGGEEECTTCCEEECCTTS
T ss_pred EEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC--------CcccCCCCcceEEEcCCCcEEeCcCCC
Confidence 899999999999999975 5689999999999999999999999 999999999999999999999999999
Q ss_pred cccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCC
Q psy14889 288 AVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPM 367 (443)
Q Consensus 288 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~ 367 (443)
++.................+|+.|+|||.+.+. .++.++||||||+++|||++|. ..||...
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~il~~l~~g~---------~~~~~~~--- 232 (298)
T 3pls_A 171 ARDILDREYYSVQQHRHARLPVKWTALESLQTY------RFTTKSDVWSFGVLLWELLTRG---------APPYRHI--- 232 (298)
T ss_dssp SCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTC------CCCHHHHHHHHHHHHHHHHHTS---------CCTTTTS---
T ss_pred cccccCCcccccccCcCCCCCccccChhhhccC------CCChhhchhhHHHHHHHHhhCC---------CCCCccC---
Confidence 986654332222233445788999999999876 6778999999999999999972 2333332
Q ss_pred CCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhhccc
Q psy14889 368 DPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLACADM 433 (443)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~~~~ 433 (443)
........+... .....+ ..++..+.+++.+||+.||.+|||+.++++.|+++.....
T Consensus 233 --~~~~~~~~~~~~-~~~~~~-----~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~ 290 (298)
T 3pls_A 233 --DPFDLTHFLAQG-RRLPQP-----EYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL 290 (298)
T ss_dssp --CGGGHHHHHHTT-CCCCCC-----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred --CHHHHHHHhhcC-CCCCCC-----ccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence 222333333222 222222 3356789999999999999999999999999999987654
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=352.37 Aligned_cols=272 Identities=17% Similarity=0.181 Sum_probs=199.3
Q ss_pred hccccccceeeeecCeEEEEEEE-----CCceeEEEEeeccCccc------------hHHHHHHHHHHhccCCCceeeee
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVW-----HGENVAVKIFFSRDEAS------------WSRETEIYSTVLLRHENILGYIG 197 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~-----~~~~vAvK~~~~~~~~~------------~~~e~ei~~~~~l~H~nIv~l~g 197 (443)
.++|.+.+.||+|+||.||+|.+ ++..||||+........ .....|+..+..++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 46899999999999999999998 45789999886543211 11124455566689999999999
Q ss_pred eccccCCcccEEEeeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcC
Q psy14889 198 SDMTSRNSCTQLWLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKT 276 (443)
Q Consensus 198 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~ 276 (443)
++..........++||||+ +++|.+++.. ..+++.+++.++.||+.||+|||+. +|+||||||+|||++.
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~--------~ivH~Dlkp~NIll~~ 186 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHEN--------EYVHGDIKAANLLLGY 186 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHT--------TEECSCCSGGGEEEES
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CeeCCCcCHHHEEEcc
Confidence 9887433336789999999 8999999975 4799999999999999999999999 9999999999999998
Q ss_pred CC--cEEEEecCCcccccccCCcCC---CCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCC
Q psy14889 277 NG--TCVIADFGLAVSYSQLSNKMD---IPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKAN 351 (443)
Q Consensus 277 ~~--~~kl~DfGla~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~ 351 (443)
++ .+||+|||+++.+........ .......||+.|+|||++.+. .++.++|||||||++|||++|
T Consensus 187 ~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~Di~slG~il~ell~g---- 256 (345)
T 2v62_A 187 KNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGV------ALSRRSDVEILGYCMLRWLCG---- 256 (345)
T ss_dssp SSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTC------CCCHHHHHHHHHHHHHHHHHS----
T ss_pred CCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCC------CCCchhhHHHHHHHHHHHHhC----
Confidence 87 999999999987654322211 111345799999999999876 677899999999999999999
Q ss_pred CcccccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCC----CCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHH
Q psy14889 352 GIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNR----WVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIK 427 (443)
Q Consensus 352 ~~~~~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 427 (443)
..||..... ........... ....++.. .....++.++.+++.+||+.||++|||+.+|++.|++
T Consensus 257 ------~~pf~~~~~---~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~ 325 (345)
T 2v62_A 257 ------KLPWEQNLK---DPVAVQTAKTN--LLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNP 325 (345)
T ss_dssp ------SCTTGGGTT---CHHHHHHHHHH--HHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCT
T ss_pred ------CCCcccccc---ccHHHHHHHHh--hcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 677754321 11111111100 00111100 0011356789999999999999999999999999998
Q ss_pred Hhhcccccc
Q psy14889 428 LACADMYIH 436 (443)
Q Consensus 428 l~~~~~~~~ 436 (443)
+.......+
T Consensus 326 ~~~~~~~~d 334 (345)
T 2v62_A 326 HGIPLGPLD 334 (345)
T ss_dssp TCCCCCCCC
T ss_pred cCCcccCCC
Confidence 776544444
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-44 Score=352.89 Aligned_cols=262 Identities=21% Similarity=0.342 Sum_probs=193.2
Q ss_pred ccccccceeeee--cCeEEEEEEE--CCceeEEEEeeccCccc---hHHHHHHHHHHhccCCCceeeeeeccccCCcccE
Q psy14889 136 KQISLSECIGKG--RYGEVWRGVW--HGENVAVKIFFSRDEAS---WSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQ 208 (443)
Q Consensus 136 ~~~~~~~~lG~G--~fg~Vy~~~~--~~~~vAvK~~~~~~~~~---~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~ 208 (443)
++|++.+.||+| +||.||+|++ +|+.||||++....... .....|+..+..++||||+++++++.+. ..
T Consensus 25 ~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~----~~ 100 (389)
T 3gni_B 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD----NE 100 (389)
T ss_dssp GGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET----TE
T ss_pred CcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEEC----CE
Confidence 689999999999 9999999998 58999999987543222 2224566667779999999999999876 46
Q ss_pred EEeeecccCcccHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEec
Q psy14889 209 LWLVTHYHSFGSLYDHLNR---TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADF 285 (443)
Q Consensus 209 ~~lv~e~~~~gsL~~~l~~---~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~Df 285 (443)
+++||||+++|+|.+++.. ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~--------~ivHrDlkp~NIll~~~~~~kl~df 172 (389)
T 3gni_B 101 LWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM--------GYVHRSVKASHILISVDGKVYLSGL 172 (389)
T ss_dssp EEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT--------TEECCCCSGGGEEECTTCCEEECCG
T ss_pred EEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhC--------CeecCCCCHHHEEEcCCCCEEEccc
Confidence 8999999999999999964 5699999999999999999999999 9999999999999999999999999
Q ss_pred CCcccccccCCc---CCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCC
Q psy14889 286 GLAVSYSQLSNK---MDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYH 362 (443)
Q Consensus 286 Gla~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~ 362 (443)
|++......... .........||+.|+|||++.+... .++.++|||||||++|||++| ..||.
T Consensus 173 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~----~~~~~~DiwslG~il~el~~g----------~~pf~ 238 (389)
T 3gni_B 173 RSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQ----GYDAKSDIYSVGITACELANG----------HVPFK 238 (389)
T ss_dssp GGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSS----CBCTHHHHHHHHHHHHHHHHS----------SCTTT
T ss_pred ccceeeccccccccccccccccccccccccCHHHHhccCC----CCCcHhHHHHHHHHHHHHHHC----------CCCCC
Confidence 998655332211 1112233478999999999986311 567899999999999999999 55554
Q ss_pred CCCCCCCChHHHHhhhh-------------------------------hcCCC---CCCCCCCCCchhHHHHHHHHHHHh
Q psy14889 363 DLVPMDPSFDDMRKVIC-------------------------------IDQQR---PVLPNRWVSDSTLNAMTKVMKECW 408 (443)
Q Consensus 363 ~~~~~~~~~~~~~~~~~-------------------------------~~~~~---~~~~~~~~~~~~~~~l~~li~~cl 408 (443)
+................ ..... ...+........+..+.+|+.+||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L 318 (389)
T 3gni_B 239 DMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCL 318 (389)
T ss_dssp TCCSTTHHHHC--------------------------------------------------------CCHHHHHHHHHHT
T ss_pred CCCHHHHHHHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHh
Confidence 42211100000000000 00000 000000012335677999999999
Q ss_pred cCCcCCCCcHHHHHH
Q psy14889 409 HQNANVRLSALRVKK 423 (443)
Q Consensus 409 ~~dP~~Rps~~evl~ 423 (443)
+.||++|||+.|+++
T Consensus 319 ~~dP~~Rpta~ell~ 333 (389)
T 3gni_B 319 QRNPDARPSASTLLN 333 (389)
T ss_dssp CSCTTTSCCHHHHTT
T ss_pred hcCcccCCCHHHHhc
Confidence 999999999999985
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=348.87 Aligned_cols=251 Identities=21% Similarity=0.306 Sum_probs=173.9
Q ss_pred cccccc---ceeeeecCeEEEEEEE--CCceeEEEEeeccCccchHHHHHHHHHHhcc-CCCceeeeeeccccCCcccEE
Q psy14889 136 KQISLS---ECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEASWSRETEIYSTVLLR-HENILGYIGSDMTSRNSCTQL 209 (443)
Q Consensus 136 ~~~~~~---~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~-H~nIv~l~g~~~~~~~~~~~~ 209 (443)
++|++. +.||+|+||.||+|.+ +++.||||++.......... |+..+..+. ||||+++++++.+. ...
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~--e~~~l~~l~~h~niv~~~~~~~~~----~~~ 81 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK--EITALKLCEGHPNIVKLHEVFHDQ----LHT 81 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGGHHHHHH--HHHHHHHTTTCTTBCCEEEEEECS----SEE
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhhhhhHHH--HHHHHHHhcCCCCeeEEEEEEEcC----CEE
Confidence 345543 7899999999999998 58899999987654444444 444444466 99999999998766 457
Q ss_pred EeeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCC---cEEEEec
Q psy14889 210 WLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNG---TCVIADF 285 (443)
Q Consensus 210 ~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~---~~kl~Df 285 (443)
++||||+++|+|.+++.. ..+++.++..++.||+.||+|||+. +|+||||||+|||++.++ .+||+||
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~--------~ivH~Dlkp~NIll~~~~~~~~~kl~Df 153 (325)
T 3kn6_A 82 FLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDV--------GVVHRDLKPENLLFTDENDNLEIKIIDF 153 (325)
T ss_dssp EEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT--------TEECCCCCGGGEEEEC----CEEEECCC
T ss_pred EEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CCeecCCCHHHEEEecCCCcccEEEecc
Confidence 999999999999999965 5699999999999999999999999 999999999999998766 8999999
Q ss_pred CCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCC
Q psy14889 286 GLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLV 365 (443)
Q Consensus 286 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~ 365 (443)
|+++........ .....||+.|+|||++.+. .++.++|||||||++|||++| ..||....
T Consensus 154 g~a~~~~~~~~~----~~~~~~t~~y~aPE~~~~~------~~~~~~DiwslG~il~~ll~g----------~~pf~~~~ 213 (325)
T 3kn6_A 154 GFARLKPPDNQP----LKTPCFTLHYAAPELLNQN------GYDESCDLWSLGVILYTMLSG----------QVPFQSHD 213 (325)
T ss_dssp TTCEECCC--------------------------C------CCCHHHHHHHHHHHHHHHHHS----------SCTTC---
T ss_pred ccceecCCCCCc----ccccCCCcCccCHHHhcCC------CCCCccchHHHHHHHHHHHhC----------CCCCCCCc
Confidence 999765443221 2345789999999999776 677899999999999999999 66665432
Q ss_pred CCC--CChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 366 PMD--PSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 366 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
... ....++...+.. .....+.. ....+++++.+|+.+||+.||++|||+.|+++
T Consensus 214 ~~~~~~~~~~~~~~i~~--~~~~~~~~-~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 214 RSLTCTSAVEIMKKIKK--GDFSFEGE-AWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp ----CCCHHHHHHHHTT--TCCCCCSH-HHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred cccccccHHHHHHHHHc--CCCCCCcc-cccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 211 112222222221 11212110 00125678999999999999999999999874
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=346.81 Aligned_cols=260 Identities=23% Similarity=0.400 Sum_probs=204.3
Q ss_pred hhccccccceeeeecCeEEEEEEEC--C-----ceeEEEEeeccCcc--chHHHHHHHHHHhc-cCCCceeeeeeccccC
Q psy14889 134 LAKQISLSECIGKGRYGEVWRGVWH--G-----ENVAVKIFFSRDEA--SWSRETEIYSTVLL-RHENILGYIGSDMTSR 203 (443)
Q Consensus 134 ~~~~~~~~~~lG~G~fg~Vy~~~~~--~-----~~vAvK~~~~~~~~--~~~~e~ei~~~~~l-~H~nIv~l~g~~~~~~ 203 (443)
..++|.+.+.||+|+||.||+|.+. + ..||+|.+...... ......|+..+..+ +||||+++++++....
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 123 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGG 123 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence 3478999999999999999999983 2 37999998654322 22234566666668 8999999999987764
Q ss_pred CcccEEEeeecccCcccHHHHhcc---------------cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCC
Q psy14889 204 NSCTQLWLVTHYHSFGSLYDHLNR---------------TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIK 268 (443)
Q Consensus 204 ~~~~~~~lv~e~~~~gsL~~~l~~---------------~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk 268 (443)
.+++||||+++|+|.+++.. ..+++..++.++.||+.||.|||+. +|+|||||
T Consensus 124 ----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--------~ivH~Dlk 191 (333)
T 2i1m_A 124 ----PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK--------NCIHRDVA 191 (333)
T ss_dssp ----SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT--------TEECSCCS
T ss_pred ----ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC--------CcccCCcc
Confidence 46999999999999999853 2479999999999999999999999 99999999
Q ss_pred CCCEEEcCCCcEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh-c
Q psy14889 269 SKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR-R 347 (443)
Q Consensus 269 ~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt-g 347 (443)
|+|||++.++.+||+|||+++......... ......||+.|+|||.+.+. .++.++||||||+++|||+| |
T Consensus 192 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~il~el~t~g 263 (333)
T 2i1m_A 192 ARNVLLTNGHVAKIGDFGLARDIMNDSNYI--VKGNARLPVKWMAPESIFDC------VYTVQSDVWSYGILLWEIFSLG 263 (333)
T ss_dssp GGGCEEEGGGEEEBCCCGGGCCGGGCTTSE--ECSSCEECGGGSCHHHHHHC------CCCHHHHHHHHHHHHHHHTTTS
T ss_pred cceEEECCCCeEEECcccccccccccccee--ecCCCCCCccccCHHHhccC------CCChHHHHHHHHHHHHHHHcCC
Confidence 999999999999999999998665432211 12334678899999999876 67789999999999999998 6
Q ss_pred ccCCCcccccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHH
Q psy14889 348 TKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIK 427 (443)
Q Consensus 348 ~~~~~~~~~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 427 (443)
..||.+... .......... ...+..+ ..++..+.+++.+||+.||.+|||+.++++.|++
T Consensus 264 ----------~~p~~~~~~----~~~~~~~~~~-~~~~~~~-----~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~ 323 (333)
T 2i1m_A 264 ----------LNPYPGILV----NSKFYKLVKD-GYQMAQP-----AFAPKNIYSIMQACWALEPTHRPTFQQICSFLQE 323 (333)
T ss_dssp ----------CCSSTTCCS----SHHHHHHHHH-TCCCCCC-----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ----------CCCCcccch----hHHHHHHHhc-CCCCCCC-----CCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHH
Confidence 667765421 1233333322 2222222 2345789999999999999999999999999999
Q ss_pred Hhhccc
Q psy14889 428 LACADM 433 (443)
Q Consensus 428 l~~~~~ 433 (443)
+.....
T Consensus 324 ~~~~~~ 329 (333)
T 2i1m_A 324 QAQEDR 329 (333)
T ss_dssp HHHHHH
T ss_pred HHHhhh
Confidence 887653
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=336.16 Aligned_cols=258 Identities=19% Similarity=0.310 Sum_probs=203.8
Q ss_pred ccccccc-eeeeecCeEEEEEEE----CCceeEEEEeeccCcc--chHHHHHHHHHHhccCCCceeeeeeccccCCcccE
Q psy14889 136 KQISLSE-CIGKGRYGEVWRGVW----HGENVAVKIFFSRDEA--SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQ 208 (443)
Q Consensus 136 ~~~~~~~-~lG~G~fg~Vy~~~~----~~~~vAvK~~~~~~~~--~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~ 208 (443)
++|.+.+ .||+|+||.||+|.+ ++..||||++...... ......|+..+..++||||+++++++... .
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~ 83 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-----A 83 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-----S
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEecCC-----C
Confidence 5677776 999999999999986 4678999998764322 22234566666679999999999998432 3
Q ss_pred EEeeecccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecC
Q psy14889 209 LWLVTHYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFG 286 (443)
Q Consensus 209 ~~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfG 286 (443)
.++||||+++|+|.+++.. ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--------~i~H~dlkp~Nili~~~~~~kl~Dfg 155 (287)
T 1u59_A 84 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK--------NFVHRDLAARNVLLVNRHYAKISDFG 155 (287)
T ss_dssp EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT--------TEECCCCSGGGEEEEETTEEEECCCT
T ss_pred cEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHC--------CEeeCCCchheEEEcCCCCEEECccc
Confidence 7999999999999999953 5699999999999999999999999 99999999999999999999999999
Q ss_pred CcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh-cccCCCcccccCCCCCCCC
Q psy14889 287 LAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR-RTKANGIFEEYKAPYHDLV 365 (443)
Q Consensus 287 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt-g~~~~~~~~~~~~P~~~~~ 365 (443)
++.......... .......||+.|+|||++.+. .++.++||||||+++|||++ | ..||....
T Consensus 156 ~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~il~ellt~g----------~~p~~~~~ 218 (287)
T 1u59_A 156 LSKALGADDSYY-TARSAGKWPLKWYAPECINFR------KFSSRSDVWSYGVTMWEALSYG----------QKPYKKMK 218 (287)
T ss_dssp TCEECTTCSCEE-CCCCSSCCCGGGCCHHHHHHC------EECHHHHHHHHHHHHHHHHTTS----------CCTTTTCC
T ss_pred ceeeeccCccee-eccccccccccccCHHHhccC------CCCchhhHHHHHHHHHHHHcCC----------CCCcccCC
Confidence 998765432221 112334578899999999765 56689999999999999998 8 67776532
Q ss_pred CCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhhcccc
Q psy14889 366 PMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLACADMY 434 (443)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~~~~~ 434 (443)
.......+.. ..++..+ ..++.++.+++.+||+.||++|||+.++++.|+++..+...
T Consensus 219 -----~~~~~~~i~~-~~~~~~~-----~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 276 (287)
T 1u59_A 219 -----GPEVMAFIEQ-GKRMECP-----PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 276 (287)
T ss_dssp -----THHHHHHHHT-TCCCCCC-----TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHT
T ss_pred -----HHHHHHHHhc-CCcCCCC-----CCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCC
Confidence 2233333322 2233333 34667899999999999999999999999999999876543
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=335.91 Aligned_cols=268 Identities=18% Similarity=0.231 Sum_probs=203.2
Q ss_pred hhccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEe
Q psy14889 134 LAKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWL 211 (443)
Q Consensus 134 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~l 211 (443)
+.++|++.+.||+|+||.||+|+. +|+.||||++....... ....|+..+..++|+|++..++.+.... ...++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~e~~~l~~l~~~~~i~~~~~~~~~~---~~~~l 82 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP-QLHIESKIYKMMQGGVGIPTIRWCGAEG---DYNVM 82 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCC-HHHHHHHHHHHHTTSTTCCCEEEEEEET---TEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchh-HHHHHHHHHHHhhcCCCCCccccccCCC---CceEE
Confidence 347899999999999999999996 68999999886543322 2334444555589998887777665443 45799
Q ss_pred eecccCcccHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEE---cCCCcEEEEecC
Q psy14889 212 VTHYHSFGSLYDHLN--RTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILV---KTNGTCVIADFG 286 (443)
Q Consensus 212 v~e~~~~gsL~~~l~--~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl---~~~~~~kl~DfG 286 (443)
||||+ +|+|.+++. ...+++..+..++.|++.||.|||++ +|+||||||+|||+ +.++.+||+|||
T Consensus 83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--------~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg 153 (296)
T 3uzp_A 83 VMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK--------NFIHRDVKPDNFLMGLGKKGNLVYIIDFG 153 (296)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT--------TEECSCCCGGGEEECCGGGTTCEEECCCT
T ss_pred EEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC--------CeeeCCCCHHHeEEecCCCCCeEEEeeCC
Confidence 99999 899999996 46799999999999999999999999 99999999999999 588899999999
Q ss_pred CcccccccCCcCC---CCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCC
Q psy14889 287 LAVSYSQLSNKMD---IPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHD 363 (443)
Q Consensus 287 la~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~ 363 (443)
+++.......... .......||+.|+|||.+.+. .++.++|||||||++|||++| ..||..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~Di~slG~il~~l~~g----------~~pf~~ 217 (296)
T 3uzp_A 154 LAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGI------EQSRRDDLESLGYVLMYFNLG----------SLPWQG 217 (296)
T ss_dssp TCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTC------CCCHHHHHHHHHHHHHHHHHS----------SCTTSS
T ss_pred CcccccccccccccccccccccccccccCChhhhcCC------CCCcchhhHHHHHHHHHHHhC----------CCCCCC
Confidence 9987665432211 112445799999999999876 677899999999999999999 667765
Q ss_pred CCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhhcccc
Q psy14889 364 LVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLACADMY 434 (443)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~~~~~ 434 (443)
....... ..+........ ....+ .....++.++.+++.+||+.||++|||+.++++.|+++.+....
T Consensus 218 ~~~~~~~-~~~~~~~~~~~-~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~ 284 (296)
T 3uzp_A 218 LKAATKR-QKYERISEKKM-STPIE--VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp CCCSSSS-SHHHHHHHHHH-HSCHH--HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred cCchhhh-hhhhhhccccc-CCchH--HHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCC
Confidence 4322111 11111111100 00000 00123557899999999999999999999999999999876544
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=346.65 Aligned_cols=250 Identities=22% Similarity=0.277 Sum_probs=185.4
Q ss_pred hhhccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEE
Q psy14889 133 TLAKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLW 210 (443)
Q Consensus 133 ~~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~ 210 (443)
.+.++|++.+.||+|+||.||+|.+ +++.||||++..... ......|+..+..++||||+++++++.+. ...+
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~----~~~~ 124 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVD-KKIVRTEIGVLLRLSHPNIIKLKEIFETP----TEIS 124 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------CHHHHHCCCTTBCCEEEEEECS----SEEE
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchh-HHHHHHHHHHHHhCCCCCCcceeeeEecC----CeEE
Confidence 4457899999999999999999998 478899999865432 22233455556669999999999999776 4589
Q ss_pred eeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcC---CCcEEEEecC
Q psy14889 211 LVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKT---NGTCVIADFG 286 (443)
Q Consensus 211 lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~---~~~~kl~DfG 286 (443)
+||||+++|+|.+++.. ..+++.++..++.||+.||.|||+. +|+||||||+|||++. ++.+||+|||
T Consensus 125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~--------~ivH~Dikp~NIll~~~~~~~~~kl~Dfg 196 (349)
T 2w4o_A 125 LVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHEN--------GIVHRDLKPENLLYATPAPDAPLKIADFG 196 (349)
T ss_dssp EEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHT--------TCCCCCCCGGGEEESSSSTTCCEEECCCC
T ss_pred EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CeEecCCCcccEEEecCCCCCCEEEccCc
Confidence 99999999999999865 5689999999999999999999999 9999999999999976 8899999999
Q ss_pred CcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCC
Q psy14889 287 LAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVP 366 (443)
Q Consensus 287 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~ 366 (443)
+++....... .....||+.|+|||++.+. .++.++|||||||++|||++| ..||.+..
T Consensus 197 ~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~ell~g----------~~pf~~~~- 254 (349)
T 2w4o_A 197 LSKIVEHQVL-----MKTVCGTPGYCAPEILRGC------AYGPEVDMWSVGIITYILLCG----------FEPFYDER- 254 (349)
T ss_dssp ---------------------CGGGSCHHHHTTC------CCCTHHHHHHHHHHHHHHHHS----------SCTTCCTT-
T ss_pred cccccCcccc-----cccccCCCCccCHHHhcCC------CCCcccchHHHHHHHHHHHhC----------CCCCCCCc-
Confidence 9976543211 2345799999999999876 677899999999999999999 67776532
Q ss_pred CCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 367 MDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
........+.... ...+..+ ....+.++.+|+.+||+.||++|||+.|+++
T Consensus 255 ---~~~~~~~~i~~~~--~~~~~~~-~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 255 ---GDQFMFRRILNCE--YYFISPW-WDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp ---CHHHHHHHHHTTC--CCCCTTT-TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ---ccHHHHHHHHhCC--CccCCch-hhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 2222222222111 1111111 1346678999999999999999999999886
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-44 Score=344.98 Aligned_cols=252 Identities=21% Similarity=0.334 Sum_probs=190.6
Q ss_pred hccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc--chHHHHHHHHHHhccCCCceeeeeeccccCC------
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA--SWSRETEIYSTVLLRHENILGYIGSDMTSRN------ 204 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~--~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~------ 204 (443)
.++|++.+.||+|+||.||+|++ +|+.||||++...... ......|+..+..++||||+++++++.+...
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 36899999999999999999998 5899999998654322 2334567777777999999999998865432
Q ss_pred -----------------------------------------------cccEEEeeecccCcccHHHHhcc----cCCCHH
Q psy14889 205 -----------------------------------------------SCTQLWLVTHYHSFGSLYDHLNR----TTLNHH 233 (443)
Q Consensus 205 -----------------------------------------------~~~~~~lv~e~~~~gsL~~~l~~----~~l~~~ 233 (443)
....+++||||+++|+|.+++.+ ...++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 11247999999999999999965 335667
Q ss_pred HHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcccccccCCcCC--------CCCCCc
Q psy14889 234 QMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMD--------IPPNPR 305 (443)
Q Consensus 234 ~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~--------~~~~~~ 305 (443)
.++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.......... ......
T Consensus 165 ~~~~i~~qi~~aL~~LH~~--------~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSK--------GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQ 236 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHT--------TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSC
T ss_pred HHHHHHHHHHHHHHHHHhC--------CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhcccccccccccccccc
Confidence 7899999999999999999 999999999999999999999999999987765422111 112345
Q ss_pred ccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCChHHHHhhhhhcCCCC
Q psy14889 306 VGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRP 385 (443)
Q Consensus 306 ~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (443)
.||+.|+|||++.+. .++.++||||||+++|||++| ..|+... ........ ..
T Consensus 237 ~gt~~y~aPE~~~~~------~~~~~~Di~slG~il~el~~~----------~~~~~~~-------~~~~~~~~-~~--- 289 (332)
T 3qd2_B 237 VGTKLYMSPEQIHGN------NYSHKVDIFSLGLILFELLYS----------FSTQMER-------VRIITDVR-NL--- 289 (332)
T ss_dssp C-CGGGSCHHHHHCC------CCCTHHHHHHHHHHHHHHHSC----------CCCHHHH-------HHHHHHHH-TT---
T ss_pred CCCcCccChHHhcCC------CCcchhhHHHHHHHHHHHHHc----------CCChhHH-------HHHHHHhh-cc---
Confidence 799999999999876 677899999999999999998 3332210 11111111 11
Q ss_pred CCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 386 VLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 386 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
..+. .....+..+.+++.+||+.||++|||+.|+++
T Consensus 290 ~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 290 KFPL--LFTQKYPQEHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp CCCH--HHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred CCCc--ccccCChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence 1111 01234467899999999999999999999986
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-43 Score=331.37 Aligned_cols=250 Identities=24% Similarity=0.324 Sum_probs=198.8
Q ss_pred hhccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc---chHHHHHHHHHHhccCCCceeeeeeccccCCcccE
Q psy14889 134 LAKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA---SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQ 208 (443)
Q Consensus 134 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~---~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~ 208 (443)
+.++|++.+.||+|+||.||+|.. +|+.||+|++...... ....+.|+..+..++||||+++++++... ..
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----~~ 79 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE----SF 79 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS----SE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcC----CE
Confidence 457899999999999999999998 5889999998654322 12234566666679999999999998766 45
Q ss_pred EEeeecccCcccHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCc---EEEEe
Q psy14889 209 LWLVTHYHSFGSLYDHLN-RTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGT---CVIAD 284 (443)
Q Consensus 209 ~~lv~e~~~~gsL~~~l~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~---~kl~D 284 (443)
.++||||+++|+|.+++. +..+++..+..++.|++.||.|||+. +|+||||||+||+++.++. +||+|
T Consensus 80 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~--------~i~H~dikp~Nil~~~~~~~~~~kl~D 151 (284)
T 3kk8_A 80 HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN--------GIVHRNLKPENLLLASKAKGAAVKLAD 151 (284)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT--------TEECSCCCGGGEEESSSSTTCCEEECC
T ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CcCcCCCCHHHEEEecCCCCCcEEEee
Confidence 799999999999988875 46799999999999999999999999 9999999999999987665 99999
Q ss_pred cCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCC
Q psy14889 285 FGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDL 364 (443)
Q Consensus 285 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~ 364 (443)
||++........ .....||+.|+|||.+.+. .++.++||||||+++|||++| ..||.+.
T Consensus 152 fg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~~l~~l~~g----------~~pf~~~ 210 (284)
T 3kk8_A 152 FGLAIEVNDSEA-----WHGFAGTPGYLSPEVLKKD------PYSKPVDIWACGVILYILLVG----------YPPFWDE 210 (284)
T ss_dssp CTTCEECCSSCB-----CCCSCSCGGGCCHHHHTTC------CBCTHHHHHHHHHHHHHHHHS----------SCSSCCS
T ss_pred ceeeEEcccCcc-----ccCCCCCcCCcCchhhcCC------CCCcccchHHHHHHHHHHHHC----------CCCCCCC
Confidence 999976654322 1345799999999999876 677899999999999999999 6777653
Q ss_pred CCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHH
Q psy14889 365 VPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKT 424 (443)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 424 (443)
........+.........+. ....+.++.+++.+||+.||++|||+.|+++.
T Consensus 211 -----~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 211 -----DQHRLYAQIKAGAYDYPSPE---WDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp -----SHHHHHHHHHHTCCCCCTTT---TTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred -----chhHHHHHHHhccccCCchh---hcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 22333333322222222211 13356789999999999999999999999873
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-44 Score=350.53 Aligned_cols=242 Identities=24% Similarity=0.337 Sum_probs=190.5
Q ss_pred hccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccchHH----HHHHHH-HHhccCCCceeeeeeccccCCccc
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEASWSR----ETEIYS-TVLLRHENILGYIGSDMTSRNSCT 207 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~----e~ei~~-~~~l~H~nIv~l~g~~~~~~~~~~ 207 (443)
.++|++.+.||+|+||.||+|+. +++.||||++.......... ..|... +..++||||+++++++.+. .
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~----~ 112 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTA----D 112 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECS----S
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeC----C
Confidence 37899999999999999999998 57899999987643221111 122222 2347999999999998876 4
Q ss_pred EEEeeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecC
Q psy14889 208 QLWLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFG 286 (443)
Q Consensus 208 ~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfG 286 (443)
.+|+||||+++|+|.+++.+ ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 113 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~--------givHrDlkp~NIll~~~g~ikL~DFG 184 (373)
T 2r5t_A 113 KLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSL--------NIVYRDLKPENILLDSQGHIVLTDFG 184 (373)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT--------TCCCCCCCGGGEEECTTSCEEECCCC
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CceecCCCHHHEEECCCCCEEEeeCc
Confidence 68999999999999999975 6799999999999999999999999 99999999999999999999999999
Q ss_pred CcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCC
Q psy14889 287 LAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVP 366 (443)
Q Consensus 287 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~ 366 (443)
+++....... .....+||+.|+|||++.+. .++.++|||||||++|||++| ..||...
T Consensus 185 ~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~ell~G----------~~Pf~~~-- 242 (373)
T 2r5t_A 185 LCKENIEHNS----TTSTFCGTPEYLAPEVLHKQ------PYDRTVDWWCLGAVLYEMLYG----------LPPFYSR-- 242 (373)
T ss_dssp BCGGGBCCCC----CCCSBSCCCCCCCHHHHTTC------CCCTHHHHHHHHHHHHHHHHS----------SCTTCCS--
T ss_pred cccccccCCC----ccccccCCccccCHHHhCCC------CCCchhhhHHHHHHHHHHHcC----------CCCCCCC--
Confidence 9976432221 23456899999999999876 677899999999999999999 7777653
Q ss_pred CCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHH
Q psy14889 367 MDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALR 420 (443)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e 420 (443)
...++...+... ...++ ...+..+.+|+.+||+.||.+||++.+
T Consensus 243 ---~~~~~~~~i~~~--~~~~~-----~~~~~~~~~li~~lL~~dp~~R~~~~~ 286 (373)
T 2r5t_A 243 ---NTAEMYDNILNK--PLQLK-----PNITNSARHLLEGLLQKDRTKRLGAKD 286 (373)
T ss_dssp ---BHHHHHHHHHHS--CCCCC-----SSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred ---CHHHHHHHHHhc--ccCCC-----CCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence 223333333222 12222 235678999999999999999999853
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=338.27 Aligned_cols=257 Identities=28% Similarity=0.356 Sum_probs=190.4
Q ss_pred hhhccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCc--------cchHHHHHHHH-HHhccCCCceeeeeeccc
Q psy14889 133 TLAKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDE--------ASWSRETEIYS-TVLLRHENILGYIGSDMT 201 (443)
Q Consensus 133 ~~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~--------~~~~~e~ei~~-~~~l~H~nIv~l~g~~~~ 201 (443)
...++|++.+.||+|+||.||+|+. +++.||||++..... ....+|.++.. +..++||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 3457999999999999999999996 689999998864321 12333433332 223469999999999876
Q ss_pred cCC-cccEEEeeecccCcccHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCC
Q psy14889 202 SRN-SCTQLWLVTHYHSFGSLYDHLNRT---TLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTN 277 (443)
Q Consensus 202 ~~~-~~~~~~lv~e~~~~gsL~~~l~~~---~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~ 277 (443)
... ....+++||||+. |+|.+++... .+++..+..++.||+.||+|||+. +|+||||||+|||++.+
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~--------~ivH~Dlkp~Nil~~~~ 156 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN--------CIVHRDLKPENILVTSG 156 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHT--------TCCCSCCCTTTEEECTT
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC--------CcccCCCCHHHEEEcCC
Confidence 542 2235799999998 5999999753 399999999999999999999999 99999999999999999
Q ss_pred CcEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCccccc
Q psy14889 278 GTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEY 357 (443)
Q Consensus 278 ~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~ 357 (443)
+.+||+|||+++....... .....||+.|+|||++.+. .++.++|||||||++|||++|
T Consensus 157 ~~~kl~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~~l~~g---------- 215 (308)
T 3g33_A 157 GTVKLADFGLARIYSYQMA-----LTPVVVTLWYRAPEVLLQS------TYATPVDMWSVGCIFAEMFRR---------- 215 (308)
T ss_dssp SCEEECSCSCTTTSTTCCC-----SGGGGCCCSSCCHHHHHTS------CCCSTHHHHHHHHHHHHTTTS----------
T ss_pred CCEEEeeCccccccCCCcc-----cCCccccccccCchHHcCC------CCCchHHHHHHHHHHHHHHhC----------
Confidence 9999999999976543221 2345789999999999876 677899999999999999999
Q ss_pred CCCCCCCCCCCCChHHHHhhhhhcCCCCC--CCCC-----------------CCCchhHHHHHHHHHHHhcCCcCCCCcH
Q psy14889 358 KAPYHDLVPMDPSFDDMRKVICIDQQRPV--LPNR-----------------WVSDSTLNAMTKVMKECWHQNANVRLSA 418 (443)
Q Consensus 358 ~~P~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~-----------------~~~~~~~~~l~~li~~cl~~dP~~Rps~ 418 (443)
..||.... ..+.+..........+. .+.. ......+..+.+|+.+||+.||++|||+
T Consensus 216 ~~pf~~~~----~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~ 291 (308)
T 3g33_A 216 KPLFCGNS----EADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISA 291 (308)
T ss_dssp SCSCCCSS----HHHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCH
T ss_pred CCCCCCCC----HHHHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCH
Confidence 55665421 11222222211110000 0000 0012356789999999999999999999
Q ss_pred HHHHH
Q psy14889 419 LRVKK 423 (443)
Q Consensus 419 ~evl~ 423 (443)
.|+++
T Consensus 292 ~e~l~ 296 (308)
T 3g33_A 292 FRALQ 296 (308)
T ss_dssp HHHHT
T ss_pred HHHhc
Confidence 99885
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-44 Score=342.78 Aligned_cols=261 Identities=22% Similarity=0.380 Sum_probs=204.3
Q ss_pred hhhccccccceeeeecCeEEEEEEE-------CCceeEEEEeeccCccc--hHHHHHHHHHHhc-cCCCceeeeeecccc
Q psy14889 133 TLAKQISLSECIGKGRYGEVWRGVW-------HGENVAVKIFFSRDEAS--WSRETEIYSTVLL-RHENILGYIGSDMTS 202 (443)
Q Consensus 133 ~~~~~~~~~~~lG~G~fg~Vy~~~~-------~~~~vAvK~~~~~~~~~--~~~e~ei~~~~~l-~H~nIv~l~g~~~~~ 202 (443)
...++|++.+.||+|+||.||+|.+ +++.||||++....... .....|+..+..+ +||||+++++++...
T Consensus 24 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 103 (316)
T 2xir_A 24 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 103 (316)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred cchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC
Confidence 3457899999999999999999985 35789999986543322 2234555555557 799999999998765
Q ss_pred CCcccEEEeeecccCcccHHHHhcccC-----------------CCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEe
Q psy14889 203 RNSCTQLWLVTHYHSFGSLYDHLNRTT-----------------LNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHR 265 (443)
Q Consensus 203 ~~~~~~~~lv~e~~~~gsL~~~l~~~~-----------------l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHr 265 (443)
. ..+++||||+++|+|.+++.... +++..+..++.|++.||.|||+. +|+||
T Consensus 104 ~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~--------~i~H~ 172 (316)
T 2xir_A 104 G---GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR--------KCIHR 172 (316)
T ss_dssp T---SCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT--------TCCCS
T ss_pred C---CceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC--------Ccccc
Confidence 3 24699999999999999996532 78999999999999999999999 99999
Q ss_pred CCCCCCEEEcCCCcEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHH
Q psy14889 266 DIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVC 345 (443)
Q Consensus 266 Dlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ell 345 (443)
||||+|||++.++.+||+|||+++......... ......||+.|+|||++.+. .++.++||||||+++|||+
T Consensus 173 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~------~~~~~~Di~slG~il~~l~ 244 (316)
T 2xir_A 173 DLAARNILLSEKNVVKICDFGLARDIYKDPDYV--RKGDARLPLKWMAPETIFDR------VYTIQSDVWSFGVLLWEIF 244 (316)
T ss_dssp CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSE--EETTEEECGGGCCHHHHHHC------CCCHHHHHHHHHHHHHHHH
T ss_pred cCccceEEECCCCCEEECCCccccccccCccce--eccCCCcceeecCchhhccc------cccchhHHHHHHHHHHHHH
Confidence 999999999999999999999997664322211 12344678899999999776 6778999999999999999
Q ss_pred h-cccCCCcccccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHH
Q psy14889 346 R-RTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKT 424 (443)
Q Consensus 346 t-g~~~~~~~~~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 424 (443)
| | ..||.... ....+...+.. ......+ ...+..+.+++.+||+.||.+|||+.++++.
T Consensus 245 t~g----------~~p~~~~~----~~~~~~~~~~~-~~~~~~~-----~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 245 SLG----------ASPYPGVK----IDEEFCRRLKE-GTRMRAP-----DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp TTS----------CCSSTTCC----CSHHHHHHHHH-TCCCCCC-----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hCC----------CCCCcccc----hhHHHHHHhcc-CccCCCC-----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 8 7 66776532 11233332222 2222222 2355789999999999999999999999999
Q ss_pred HHHHhhcc
Q psy14889 425 LIKLACAD 432 (443)
Q Consensus 425 L~~l~~~~ 432 (443)
|+++.+..
T Consensus 305 L~~~~~~~ 312 (316)
T 2xir_A 305 LGNLLQAN 312 (316)
T ss_dssp HHHHHHHH
T ss_pred HHHHHhhh
Confidence 99998764
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=349.83 Aligned_cols=249 Identities=20% Similarity=0.280 Sum_probs=197.5
Q ss_pred hhccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCc-cchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEE
Q psy14889 134 LAKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDE-ASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLW 210 (443)
Q Consensus 134 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~ 210 (443)
+.++|++.+.||+|+||.||+|.. +|+.||+|++..... .......|+..+..++||||+++++++.+. ..++
T Consensus 49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~----~~~~ 124 (387)
T 1kob_A 49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDK----YEMV 124 (387)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECS----SEEE
T ss_pred cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeC----CEEE
Confidence 347899999999999999999998 588999999865432 222345667777779999999999998776 4589
Q ss_pred eeecccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcC--CCcEEEEecC
Q psy14889 211 LVTHYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKT--NGTCVIADFG 286 (443)
Q Consensus 211 lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~--~~~~kl~DfG 286 (443)
+||||+++|+|.+++.. ..+++..+..++.||+.||.|||+. +|+||||||+|||++. ++.+||+|||
T Consensus 125 lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--------givHrDlkp~NIll~~~~~~~vkL~DFG 196 (387)
T 1kob_A 125 LILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH--------SIVHLDIKPENIMCETKKASSVKIIDFG 196 (387)
T ss_dssp EEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHT--------TEECCCCCGGGEEESSTTCCCEEECCCT
T ss_pred EEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CeeecccchHHeEEecCCCCceEEEecc
Confidence 99999999999999965 3689999999999999999999999 9999999999999974 4689999999
Q ss_pred CcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCC
Q psy14889 287 LAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVP 366 (443)
Q Consensus 287 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~ 366 (443)
+++....... .....||+.|+|||++.+. .++.++|||||||++|||++| ..||.+.
T Consensus 197 ~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~------~~~~~~DiwSlG~il~elltg----------~~Pf~~~-- 253 (387)
T 1kob_A 197 LATKLNPDEI-----VKVTTATAEFAAPEIVDRE------PVGFYTDMWAIGVLGYVLLSG----------LSPFAGE-- 253 (387)
T ss_dssp TCEECCTTSC-----EEEECSSGGGCCHHHHTTC------CBCHHHHHHHHHHHHHHHHHS----------CCSSCCS--
T ss_pred cceecCCCcc-----eeeeccCCCccCchhccCC------CCCCcccEeeHhHHHHHHHhC----------CCCCCCC--
Confidence 9987654221 1234689999999999876 667899999999999999999 6777653
Q ss_pred CCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 367 MDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
........+..... ..+.. ....++.++.+|+.+||+.||++|||+.|+++
T Consensus 254 ---~~~~~~~~i~~~~~--~~~~~-~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 254 ---DDLETLQNVKRCDW--EFDED-AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp ---SHHHHHHHHHHCCC--CCCSS-TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ---CHHHHHHHHHhCCC--CCCcc-ccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 12222222222111 11111 11235678999999999999999999999986
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-44 Score=359.15 Aligned_cols=246 Identities=22% Similarity=0.325 Sum_probs=193.6
Q ss_pred hhccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCc----cchHHHHHHHHHHhccCCCceeeeeeccccCCccc
Q psy14889 134 LAKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDE----ASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCT 207 (443)
Q Consensus 134 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~----~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~ 207 (443)
..++|++.+.||+|+||.||+|.. +|+.||||++..... .......|+..+..++||||+++++++.+. .
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~----~ 221 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTH----D 221 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEET----T
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeC----C
Confidence 347899999999999999999998 588999999865321 111223455555568999999999999876 4
Q ss_pred EEEeeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHH-chhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEec
Q psy14889 208 QLWLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHT-EIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADF 285 (443)
Q Consensus 208 ~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~-~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~Df 285 (443)
.+++||||+++|+|.+++.+ ..+++..+..++.||+.||+|||+ . +|+||||||+|||++.++.+||+||
T Consensus 222 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--------giiHrDlkp~NIll~~~~~~kl~DF 293 (446)
T 4ejn_A 222 RLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK--------NVVYRDLKLENLMLDKDGHIKITDF 293 (446)
T ss_dssp EEEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHT--------CCCCCCCCGGGEEECSSSCEEECCC
T ss_pred EEEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcC--------CEEECCCCHHHEEECCCCCEEEccC
Confidence 58999999999999999864 679999999999999999999998 6 9999999999999999999999999
Q ss_pred CCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCC
Q psy14889 286 GLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLV 365 (443)
Q Consensus 286 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~ 365 (443)
|+++........ .....||+.|+|||++.+. .++.++|||||||++|||++| ..||...
T Consensus 294 G~a~~~~~~~~~----~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~ell~g----------~~Pf~~~- 352 (446)
T 4ejn_A 294 GLCKEGIKDGAT----MKTFCGTPEYLAPEVLEDN------DYGRAVDWWGLGVVMYEMMCG----------RLPFYNQ- 352 (446)
T ss_dssp CCCCTTCC---------CCSSSCGGGCCHHHHHTS------CCCTHHHHHHHHHHHHHHHHS----------SCSSCCS-
T ss_pred CCceeccCCCcc----cccccCCccccCHhhcCCC------CCCCccchhhhHHHHHHHhhC----------CCCCCCC-
Confidence 999754332221 2446899999999999776 677899999999999999999 7777653
Q ss_pred CCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCC-----cHHHHHH
Q psy14889 366 PMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRL-----SALRVKK 423 (443)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~ 423 (443)
....+...+.... ..+| ...+.++.+|+.+||+.||.+|| |+.|+++
T Consensus 353 ----~~~~~~~~i~~~~--~~~p-----~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 353 ----DHEKLFELILMEE--IRFP-----RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp ----SHHHHHHHHHHCC--CCCC-----TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ----CHHHHHHHHHhCC--CCCC-----ccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 2333333333222 2233 23567899999999999999999 9999986
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=344.21 Aligned_cols=251 Identities=22% Similarity=0.311 Sum_probs=196.1
Q ss_pred hhccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEe
Q psy14889 134 LAKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWL 211 (443)
Q Consensus 134 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~l 211 (443)
+.++|++.+.||+|+||.||+|.. +|+.||||++..... ....|.+++... .+||||+++++++.+. ..+++
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~E~~~l~~~-~~hp~iv~~~~~~~~~----~~~~l 93 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-DPTEEIEILLRY-GQHPNIITLKDVYDDG----KYVYV 93 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-CCHHHHHHHHHH-TTSTTBCCEEEEEECS----SEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-ChHHHHHHHHHh-cCCCCcCeEEEEEEcC----CEEEE
Confidence 457899999999999999999998 588999999866543 334455554331 3899999999998766 46899
Q ss_pred eecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCC----CcEEEEecC
Q psy14889 212 VTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTN----GTCVIADFG 286 (443)
Q Consensus 212 v~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~----~~~kl~DfG 286 (443)
||||+++|+|.+++.+ ..+++..+..++.||+.||.|||+. +|+||||||+|||+.++ +.+||+|||
T Consensus 94 v~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~--------givHrDlkp~NIl~~~~~~~~~~~kl~Dfg 165 (342)
T 2qr7_A 94 VTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQ--------GVVHRDLKPSNILYVDESGNPESIRICDFG 165 (342)
T ss_dssp EECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHT--------TEECSCCCGGGEEESSSSCSGGGEEECCCT
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC--------CcEeccCCHHHEEEecCCCCcCeEEEEECC
Confidence 9999999999998864 5699999999999999999999999 99999999999998543 359999999
Q ss_pred CcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCC
Q psy14889 287 LAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVP 366 (443)
Q Consensus 287 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~ 366 (443)
+++........ .....||+.|+|||++.+. .++.++|||||||++|||++| ..||....
T Consensus 166 ~a~~~~~~~~~----~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~ell~g----------~~Pf~~~~- 224 (342)
T 2qr7_A 166 FAKQLRAENGL----LMTPCYTANFVAPEVLERQ------GYDAACDIWSLGVLLYTMLTG----------YTPFANGP- 224 (342)
T ss_dssp TCEECBCTTCC----BCCSSCCSSCCCHHHHHHH------HHHHHHHHHHHHHHHHHHHHS----------SCSSCSST-
T ss_pred CcccCcCCCCc----eeccCCCccccCHHHhcCC------CCCCccCeeeHhHHHHHHhcC----------CCCCCCCC-
Confidence 99876543221 2345789999999999865 456799999999999999999 66776431
Q ss_pred CCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 367 MDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
.....++...+..... .++.. .....+.++.+|+.+||+.||++|||+.++++
T Consensus 225 -~~~~~~~~~~i~~~~~--~~~~~-~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 225 -DDTPEEILARIGSGKF--SLSGG-YWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp -TSCHHHHHHHHHHCCC--CCCST-TTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred -cCCHHHHHHHHccCCc--ccCcc-ccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 1233444444333222 11111 11346678999999999999999999999886
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-44 Score=350.57 Aligned_cols=191 Identities=23% Similarity=0.328 Sum_probs=160.3
Q ss_pred hhhhccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccchHHHHHHHHHHhcc-----CCCceeeeeeccccCC
Q psy14889 132 RTLAKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEASWSRETEIYSTVLLR-----HENILGYIGSDMTSRN 204 (443)
Q Consensus 132 ~~~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~-----H~nIv~l~g~~~~~~~ 204 (443)
..+.++|.+.+.||+|+||.||+|++ +++.||||++..........+.|+..+..+. ||||+++++++...
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~-- 108 (360)
T 3llt_A 31 MLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYY-- 108 (360)
T ss_dssp CEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEET--
T ss_pred eEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeEC--
Confidence 44568999999999999999999998 6889999998653333333334444444465 99999999998876
Q ss_pred cccEEEeeecccCcccHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcC-----
Q psy14889 205 SCTQLWLVTHYHSFGSLYDHLNRT---TLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKT----- 276 (443)
Q Consensus 205 ~~~~~~lv~e~~~~gsL~~~l~~~---~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~----- 276 (443)
..+++||||+ +++|.+++... .+++..+..++.||+.||+|||+. +|+||||||+|||++.
T Consensus 109 --~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~--------~ivHrDlkp~NIll~~~~~~~ 177 (360)
T 3llt_A 109 --DHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKM--------SLTHTDLKPENILLDDPYFEK 177 (360)
T ss_dssp --TEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT--------TEECSCCSGGGEEESCTTCCE
T ss_pred --CeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC--------CeeeCCCCcccEEEccccccc
Confidence 4589999999 88999999754 499999999999999999999999 9999999999999975
Q ss_pred --------------------CCcEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHH
Q psy14889 277 --------------------NGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYA 336 (443)
Q Consensus 277 --------------------~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS 336 (443)
++.+||+|||+++..... .....||+.|+|||++.+. .++.++||||
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-------~~~~~gt~~y~aPE~~~~~------~~~~~~Diws 244 (360)
T 3llt_A 178 SLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-------HGSIINTRQYRAPEVILNL------GWDVSSDMWS 244 (360)
T ss_dssp EEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-------CCSCCSCGGGCCHHHHTTC------CCCTTHHHHH
T ss_pred cccchhcccccccccccccCCCCEEEEeccCceecCCC-------CcCccCcccccCcHHHcCC------CCCCccchHH
Confidence 789999999999764432 1345789999999999876 6778999999
Q ss_pred HHHHHHHHHhcc
Q psy14889 337 LGLVLWEVCRRT 348 (443)
Q Consensus 337 ~Gvvl~elltg~ 348 (443)
|||++|||++|+
T Consensus 245 lG~il~ell~g~ 256 (360)
T 3llt_A 245 FGCVLAELYTGS 256 (360)
T ss_dssp HHHHHHHHHHSS
T ss_pred HHHHHHHHHHCC
Confidence 999999999993
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=337.75 Aligned_cols=260 Identities=21% Similarity=0.338 Sum_probs=202.7
Q ss_pred ccccccc-eeeeecCeEEEEEEE----CCceeEEEEeeccCcc---chHHHHHHHHHHhccCCCceeeeeeccccCCccc
Q psy14889 136 KQISLSE-CIGKGRYGEVWRGVW----HGENVAVKIFFSRDEA---SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCT 207 (443)
Q Consensus 136 ~~~~~~~-~lG~G~fg~Vy~~~~----~~~~vAvK~~~~~~~~---~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~ 207 (443)
++|.+.+ .||+|+||.||+|.+ .++.||||++...... ......|+..+..++||||+++++++.. .
T Consensus 16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~ 90 (291)
T 1xbb_A 16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-----E 90 (291)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-----S
T ss_pred hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEECC-----C
Confidence 6788888 999999999999965 3678999998654322 2233466777777999999999999832 2
Q ss_pred EEEeeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecC
Q psy14889 208 QLWLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFG 286 (443)
Q Consensus 208 ~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfG 286 (443)
..++||||+++|+|.+++.. ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||
T Consensus 91 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~--------~i~H~dikp~Nil~~~~~~~kl~Dfg 162 (291)
T 1xbb_A 91 SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES--------NFVHRDLAARNVLLVTQHYAKISDFG 162 (291)
T ss_dssp SEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT--------TEECSCCSGGGEEEEETTEEEECCCT
T ss_pred CcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhC--------CeEcCCCCcceEEEeCCCcEEEccCC
Confidence 36899999999999999975 4599999999999999999999999 99999999999999999999999999
Q ss_pred CcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh-cccCCCcccccCCCCCCCC
Q psy14889 287 LAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR-RTKANGIFEEYKAPYHDLV 365 (443)
Q Consensus 287 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt-g~~~~~~~~~~~~P~~~~~ 365 (443)
++........... ......+|+.|+|||.+.+. .++.++||||||+++|||++ | ..||...
T Consensus 163 ~~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~il~~l~~~g----------~~p~~~~- 224 (291)
T 1xbb_A 163 LSKALRADENYYK-AQTHGKWPVKWYAPECINYY------KFSSKSDVWSFGVLMWEAFSYG----------QKPYRGM- 224 (291)
T ss_dssp TCEECCTTCSEEE-C----CCCGGGCCHHHHHHC------EEEHHHHHHHHHHHHHHHHTTT----------CCSSTTC-
T ss_pred cceeeccCCCccc-ccccCCCCceeeChHHhccC------CCChhhhHHHHHHHHHHHHhcC----------CCCCCCC-
Confidence 9977654332211 11223567899999999765 55679999999999999999 8 6777653
Q ss_pred CCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhhcccccc
Q psy14889 366 PMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLACADMYIH 436 (443)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~~~~~~~ 436 (443)
....+...+.. ...+..+ ..++..+.+++.+||+.||++|||+.++++.|+++........
T Consensus 225 ----~~~~~~~~~~~-~~~~~~~-----~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~ 285 (291)
T 1xbb_A 225 ----KGSEVTAMLEK-GERMGCP-----AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEG 285 (291)
T ss_dssp ----CHHHHHHHHHT-TCCCCCC-----TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHHHH
T ss_pred ----CHHHHHHHHHc-CCCCCCC-----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhhcc
Confidence 22333333322 2233333 3466789999999999999999999999999999987655443
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-44 Score=343.73 Aligned_cols=259 Identities=21% Similarity=0.365 Sum_probs=204.7
Q ss_pred hhhhccccccceeeeecCeEEEEEEEC-------CceeEEEEeeccCccc--hHHHHHHHHHHhccCCCceeeeeecccc
Q psy14889 132 RTLAKQISLSECIGKGRYGEVWRGVWH-------GENVAVKIFFSRDEAS--WSRETEIYSTVLLRHENILGYIGSDMTS 202 (443)
Q Consensus 132 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~~~--~~~e~ei~~~~~l~H~nIv~l~g~~~~~ 202 (443)
+...++|++.+.||+|+||.||+|.+. ++.||||++....... .....|+..+..++||||+++++++.+.
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 100 (322)
T 1p4o_A 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 100 (322)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccC
Confidence 344578999999999999999999864 5789999986543222 2234567777779999999999998776
Q ss_pred CCcccEEEeeecccCcccHHHHhcc-----------cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCC
Q psy14889 203 RNSCTQLWLVTHYHSFGSLYDHLNR-----------TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKN 271 (443)
Q Consensus 203 ~~~~~~~~lv~e~~~~gsL~~~l~~-----------~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~N 271 (443)
. ..++||||+++|+|.+++.. ..+++..++.++.||+.||.|||+. +|+||||||+|
T Consensus 101 ~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--------~i~H~dikp~N 168 (322)
T 1p4o_A 101 Q----PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN--------KFVHRDLAARN 168 (322)
T ss_dssp S----SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT--------TCBCSCCSGGG
T ss_pred C----ccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC--------CCccCCCccce
Confidence 3 46899999999999999964 3579999999999999999999999 99999999999
Q ss_pred EEEcCCCcEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh-cccC
Q psy14889 272 ILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR-RTKA 350 (443)
Q Consensus 272 iLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt-g~~~ 350 (443)
||++.++.+||+|||+++......... ......||+.|+|||.+.+. .++.++||||||+++|||++ |
T Consensus 169 Ili~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~il~el~~~g--- 237 (322)
T 1p4o_A 169 CMVAEDFTVKIGDFGMTRDIYETDYYR--KGGKGLLPVRWMSPESLKDG------VFTTYSDVWSFGVVLWEIATLA--- 237 (322)
T ss_dssp EEECTTCCEEECCTTCCCGGGGGGCEE--GGGSSEECGGGCCHHHHHHC------CCCHHHHHHHHHHHHHHHHHTS---
T ss_pred EEEcCCCeEEECcCccccccccccccc--cccCCCCCCCccChhhhccC------CCCchhhHHHHHHHHHHHHhcC---
Confidence 999999999999999997654432111 11234578899999999876 67789999999999999999 6
Q ss_pred CCcccccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhh
Q psy14889 351 NGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLAC 430 (443)
Q Consensus 351 ~~~~~~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~ 430 (443)
..||... ........+... ..+..+ ..++..+.+++.+||+.||++|||+.|+++.|+++..
T Consensus 238 -------~~p~~~~-----~~~~~~~~~~~~-~~~~~~-----~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 238 -------EQPYQGL-----SNEQVLRFVMEG-GLLDKP-----DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp -------CCTTTTS-----CHHHHHHHHHTT-CCCCCC-----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred -------CCccccC-----CHHHHHHHHHcC-CcCCCC-----CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 6677653 233333333222 222222 3466789999999999999999999999999998765
Q ss_pred c
Q psy14889 431 A 431 (443)
Q Consensus 431 ~ 431 (443)
.
T Consensus 300 ~ 300 (322)
T 1p4o_A 300 P 300 (322)
T ss_dssp T
T ss_pred c
Confidence 3
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=341.15 Aligned_cols=257 Identities=24% Similarity=0.397 Sum_probs=200.9
Q ss_pred ccccccceeeeecCeEEEEEEE--CCce--eEEEEeeccCc--cchHHHHHHHHHHhc-cCCCceeeeeeccccCCcccE
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGEN--VAVKIFFSRDE--ASWSRETEIYSTVLL-RHENILGYIGSDMTSRNSCTQ 208 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~--vAvK~~~~~~~--~~~~~e~ei~~~~~l-~H~nIv~l~g~~~~~~~~~~~ 208 (443)
++|++.+.||+|+||.||+|++ ++.. ||||.+..... .......|+..+..+ +||||+++++++.+. ..
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~----~~ 100 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR----GY 100 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEET----TE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeC----Cc
Confidence 6899999999999999999987 4554 49998764321 222334566666668 899999999998766 45
Q ss_pred EEeeecccCcccHHHHhccc-----------------CCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCC
Q psy14889 209 LWLVTHYHSFGSLYDHLNRT-----------------TLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKN 271 (443)
Q Consensus 209 ~~lv~e~~~~gsL~~~l~~~-----------------~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~N 271 (443)
+++||||+++|+|.+++... .+++..++.++.||+.||.|||+. +|+||||||+|
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~--------~ivH~dlkp~N 172 (327)
T 1fvr_A 101 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK--------QFIHRDLAARN 172 (327)
T ss_dssp EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT--------TEECSCCSGGG
T ss_pred eEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC--------CccCCCCccce
Confidence 89999999999999999653 589999999999999999999999 99999999999
Q ss_pred EEEcCCCcEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh-cccC
Q psy14889 272 ILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR-RTKA 350 (443)
Q Consensus 272 iLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt-g~~~ 350 (443)
||++.++.+||+|||+++....... .....+|+.|+|||.+.+. .++.++||||||+++|||++ |
T Consensus 173 Il~~~~~~~kL~Dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~il~ellt~g--- 238 (327)
T 1fvr_A 173 ILVGENYVAKIADFGLSRGQEVYVK-----KTMGRLPVRWMAIESLNYS------VYTTNSDVWSYGVLLWEIVSLG--- 238 (327)
T ss_dssp EEECGGGCEEECCTTCEESSCEECC-----C----CCTTTCCHHHHHHC------EECHHHHHHHHHHHHHHHHTTS---
T ss_pred EEEcCCCeEEEcccCcCcccccccc-----ccCCCCCccccChhhhccc------cCCchhcchHHHHHHHHHHcCC---
Confidence 9999999999999999874332211 1233578899999999765 56689999999999999998 8
Q ss_pred CCcccccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhh
Q psy14889 351 NGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLAC 430 (443)
Q Consensus 351 ~~~~~~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~ 430 (443)
..||... ........+.. ......+ ..++..+.+|+.+||+.||++|||+.++++.|+++.+
T Consensus 239 -------~~pf~~~-----~~~~~~~~~~~-~~~~~~~-----~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 300 (327)
T 1fvr_A 239 -------GTPYCGM-----TCAELYEKLPQ-GYRLEKP-----LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 300 (327)
T ss_dssp -------CCTTTTC-----CHHHHHHHGGG-TCCCCCC-----TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -------CCCCCCC-----cHHHHHHHhhc-CCCCCCC-----CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 6777653 22333333322 1222222 3366789999999999999999999999999999988
Q ss_pred cccccc
Q psy14889 431 ADMYIH 436 (443)
Q Consensus 431 ~~~~~~ 436 (443)
......
T Consensus 301 ~~~~~~ 306 (327)
T 1fvr_A 301 ERKTYV 306 (327)
T ss_dssp SSSCSB
T ss_pred hhcCcc
Confidence 765443
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=349.23 Aligned_cols=263 Identities=25% Similarity=0.357 Sum_probs=187.4
Q ss_pred hhhhccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCc---cchHHHHHHHHHHhcc-CCCceeeeeeccccCCc
Q psy14889 132 RTLAKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDE---ASWSRETEIYSTVLLR-HENILGYIGSDMTSRNS 205 (443)
Q Consensus 132 ~~~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~---~~~~~e~ei~~~~~l~-H~nIv~l~g~~~~~~~~ 205 (443)
..+.++|++.+.||+|+||.||+|.+ +|+.||||++..... .......|+..+..+. ||||+++++++.....
T Consensus 5 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~- 83 (388)
T 3oz6_A 5 RHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADND- 83 (388)
T ss_dssp HHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTS-
T ss_pred CcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCC-
Confidence 34557899999999999999999987 589999998854322 1222235666666676 9999999999876543
Q ss_pred ccEEEeeecccCcccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEec
Q psy14889 206 CTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADF 285 (443)
Q Consensus 206 ~~~~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~Df 285 (443)
..+++||||++ |+|.+++....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+||
T Consensus 84 -~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~--------~ivHrDlkp~NIll~~~~~~kl~DF 153 (388)
T 3oz6_A 84 -RDVYLVFDYME-TDLHAVIRANILEPVHKQYVVYQLIKVIKYLHSG--------GLLHRDMKPSNILLNAECHVKVADF 153 (388)
T ss_dssp -SCEEEEEECCS-EEHHHHHHHTCCCHHHHHHHHHHHHHHHHHHHHT--------TEECCCCCGGGEEECTTCCEEECCC
T ss_pred -CEEEEEecccC-cCHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC--------CEEeCCCCHHHeEEcCCCCEEecCC
Confidence 35899999998 6999999888999999999999999999999999 9999999999999999999999999
Q ss_pred CCcccccccCCc-----------------CCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcc
Q psy14889 286 GLAVSYSQLSNK-----------------MDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRT 348 (443)
Q Consensus 286 Gla~~~~~~~~~-----------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~ 348 (443)
|+|+.+...... ........+||+.|+|||++.+.. .++.++|||||||++|||++|
T Consensus 154 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~~DiwSlG~il~ell~g- 227 (388)
T 3oz6_A 154 GLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGST-----KYTKGIDMWSLGCILGEILCG- 227 (388)
T ss_dssp TTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCC-----CCCTHHHHHHHHHHHHHHHHS-
T ss_pred cccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCC-----CCCChhhHHHHHHHHHHHHhC-
Confidence 999866431110 011123457999999999997631 567899999999999999999
Q ss_pred cCCCcccccCCCCCCCCCCCCChHHHHhhhhhcCC----------------------------CCCCCCCC---------
Q psy14889 349 KANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQ----------------------------RPVLPNRW--------- 391 (443)
Q Consensus 349 ~~~~~~~~~~~P~~~~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~--------- 391 (443)
..||.+.. ..+.+..++..... .......+
T Consensus 228 ---------~~pf~~~~----~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (388)
T 3oz6_A 228 ---------KPIFPGSS----TMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLK 294 (388)
T ss_dssp ---------SCSCCCSS----HHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHH
T ss_pred ---------CCCCCCCC----HHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhccc
Confidence 55554421 11111111110000 00000000
Q ss_pred --CCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHH
Q psy14889 392 --VSDSTLNAMTKVMKECWHQNANVRLSALRVKKT 424 (443)
Q Consensus 392 --~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 424 (443)
....++.++.+|+.+||+.||++|||+.|+++.
T Consensus 295 ~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 295 INPKADCNEEALDLLDKLLQFNPNKRISANDALKH 329 (388)
T ss_dssp HCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred ccccccCCHHHHHHHHHhhccCcccCCCHHHHhCC
Confidence 001345689999999999999999999999875
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-44 Score=354.58 Aligned_cols=254 Identities=23% Similarity=0.269 Sum_probs=194.7
Q ss_pred hhccccccceeeeecCeEEEEEEE--CCceeEEEEeeccC------ccchHHHHHHHHHHhccCCCceeeeeeccccCCc
Q psy14889 134 LAKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRD------EASWSRETEIYSTVLLRHENILGYIGSDMTSRNS 205 (443)
Q Consensus 134 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~------~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~ 205 (443)
..++|++.+.||+|+||.||+++. +|+.||||++.... ......|.+++ ..++||||+++++++.+.
T Consensus 59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il--~~~~hp~Iv~l~~~~~~~--- 133 (412)
T 2vd5_A 59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVL--VNGDRRWITQLHFAFQDE--- 133 (412)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHH--HHSCTTTBCCEEEEEECS---
T ss_pred ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHH--HhcCCCCeeeEEEEEeeC---
Confidence 347899999999999999999998 58999999986422 12233444444 458999999999999876
Q ss_pred ccEEEeeecccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEE
Q psy14889 206 CTQLWLVTHYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIA 283 (443)
Q Consensus 206 ~~~~~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~ 283 (443)
..+++||||+++|+|.+++.+ ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+
T Consensus 134 -~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~--------giiHrDLKp~NILld~~g~vkL~ 204 (412)
T 2vd5_A 134 -NYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRL--------GYVHRDIKPDNILLDRCGHIRLA 204 (412)
T ss_dssp -SEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHT--------TEECCCCSGGGEEECTTSCEEEC
T ss_pred -CEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--------CeeecccCHHHeeecCCCCEEEe
Confidence 468999999999999999975 4799999999999999999999998 99999999999999999999999
Q ss_pred ecCCcccccccCCcCCCCCCCcccccCcccccccccccc-cCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCC
Q psy14889 284 DFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESIN-MDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYH 362 (443)
Q Consensus 284 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~ 362 (443)
|||+++......... ....+||+.|+|||++..... .....++.++|||||||++|||++| ..||.
T Consensus 205 DFGla~~~~~~~~~~---~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG----------~~Pf~ 271 (412)
T 2vd5_A 205 DFGSCLKLRADGTVR---SLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYG----------QTPFY 271 (412)
T ss_dssp CCTTCEECCTTSCEE---CSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHS----------SCTTC
T ss_pred echhheeccCCCccc---cceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhC----------CCCCC
Confidence 999998765432211 234579999999999974210 0001567899999999999999999 77776
Q ss_pred CCCCCCCChHHH-HhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCC---CcHHHHHH
Q psy14889 363 DLVPMDPSFDDM-RKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVR---LSALRVKK 423 (443)
Q Consensus 363 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---ps~~evl~ 423 (443)
.. ...+. .++... .....+|. ....++.++.+||++||. +|.+| |+++|+++
T Consensus 272 ~~-----~~~~~~~~i~~~-~~~~~~p~--~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 272 AD-----STAETYGKIVHY-KEHLSLPL--VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp CS-----SHHHHHHHHHTH-HHHCCCC------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred CC-----CHHHHHHHHHhc-ccCcCCCc--cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 53 22222 232211 11112221 112356789999999999 99998 58888865
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=337.36 Aligned_cols=259 Identities=25% Similarity=0.387 Sum_probs=194.1
Q ss_pred hccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCc----cchHHHHHHHHHHhccCCCceeeeeeccccCCcccE
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDE----ASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQ 208 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~----~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~ 208 (443)
.++|++.+.||+|+||.||+|.. +|+.||||++..... .......|+..+..++||||+++++++... ..
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~----~~ 106 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIED----NE 106 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET----TE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC----Cc
Confidence 46899999999999999999997 689999999865321 122234567777779999999999998876 45
Q ss_pred EEeeecccCcccHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEE
Q psy14889 209 LWLVTHYHSFGSLYDHLNR-----TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIA 283 (443)
Q Consensus 209 ~~lv~e~~~~gsL~~~l~~-----~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~ 283 (443)
.++||||+++|+|.+++.. ..+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+
T Consensus 107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~--------~i~H~dl~p~NIl~~~~~~~kl~ 178 (310)
T 2wqm_A 107 LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR--------RVMHRDIKPANVFITATGVVKLG 178 (310)
T ss_dssp EEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT--------TCCCCCCCGGGEEECTTSCEEEC
T ss_pred EEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC--------CeeCCCCcHHHEEEcCCCCEEEE
Confidence 8999999999999999853 5689999999999999999999999 99999999999999999999999
Q ss_pred ecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCC
Q psy14889 284 DFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHD 363 (443)
Q Consensus 284 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~ 363 (443)
|||++......... .....||+.|+|||.+.+. .++.++||||||+++|||++| ..||.+
T Consensus 179 Dfg~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~------~~~~~~Dv~slG~il~~l~~g----------~~p~~~ 238 (310)
T 2wqm_A 179 DLGLGRFFSSKTTA----AHSLVGTPYYMSPERIHEN------GYNFKSDIWSLGCLLYEMAAL----------QSPFYG 238 (310)
T ss_dssp CC----------------------CCSSCCHHHHTTC------CCCHHHHHHHHHHHHHHHHHS----------SCTTC-
T ss_pred eccceeeecCCCcc----ccccCCCeeEeChHHhCCC------CCCchhhHHHHHHHHHHHHhC----------CCCCcc
Confidence 99998765532221 1334689999999999876 667899999999999999999 667654
Q ss_pred CCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhhccc
Q psy14889 364 LVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLACADM 433 (443)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~~~~ 433 (443)
.. .........+.. ...+..+ ...++.++.+++.+||+.||++|||+.++++.|+++.....
T Consensus 239 ~~---~~~~~~~~~~~~-~~~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~ 300 (310)
T 2wqm_A 239 DK---MNLYSLCKKIEQ-CDYPPLP----SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTA 300 (310)
T ss_dssp -----CCHHHHHHHHHT-TCSCCCC----TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred cc---hhHHHHHHHhhc-ccCCCCc----ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhh
Confidence 31 122233333222 1222222 13356789999999999999999999999999999986543
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=335.67 Aligned_cols=252 Identities=23% Similarity=0.298 Sum_probs=190.0
Q ss_pred ccccccceeeeecCeEEEEEEE-CCceeEEEEeeccCcc---chHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEe
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW-HGENVAVKIFFSRDEA---SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWL 211 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~---~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~l 211 (443)
++|++.+.||+|+||.||+|+. +|+.||+|++...... ......|+..+..++||||+++++++.+. ..+++
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----~~~~l 77 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTK----KRLVL 77 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECS----SCEEE
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccC----CeEEE
Confidence 5799999999999999999998 5899999998654322 23334667777779999999999998776 35799
Q ss_pred eecccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcc
Q psy14889 212 VTHYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAV 289 (443)
Q Consensus 212 v~e~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~ 289 (443)
||||+++ +|.+++.. ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 78 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--------~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 148 (288)
T 1ob3_A 78 VFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR--------RVLHRDLKPQNLLINREGELKIADFGLAR 148 (288)
T ss_dssp EEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHT--------TCCCSCCCGGGEEECTTSCEEECCTTHHH
T ss_pred EEEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC--------CeecCCCCHHHEEEcCCCCEEEeECcccc
Confidence 9999985 99998864 6799999999999999999999999 99999999999999999999999999997
Q ss_pred cccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCC
Q psy14889 290 SYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDP 369 (443)
Q Consensus 290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~ 369 (443)
........ .....||+.|+|||++.+.. .++.++|||||||++|||++| ..||....
T Consensus 149 ~~~~~~~~----~~~~~~t~~y~aPE~~~~~~-----~~~~~~DiwslG~il~~l~~g----------~~pf~~~~---- 205 (288)
T 1ob3_A 149 AFGIPVRK----YTHEIVTLWYRAPDVLMGSK-----KYSTTIDIWSVGCIFAEMVNG----------TPLFPGVS---- 205 (288)
T ss_dssp HHCC-------------CCCTTCCHHHHTTCC-----SCCTHHHHHHHHHHHHHHHHS----------SCSCCCSS----
T ss_pred ccCccccc----cccccccccccCchheeCCC-----CCCcHHHHHHHHHHHHHHHhC----------CCCCCCCC----
Confidence 65432211 13347899999999987541 466899999999999999999 55655421
Q ss_pred ChHHHHhhhhhcC---------------CCCCCC----C--CCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 370 SFDDMRKVICIDQ---------------QRPVLP----N--RWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 370 ~~~~~~~~~~~~~---------------~~~~~~----~--~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
..+.......... ..+..+ . .......+.++.+|+.+||+.||++|||+.|+++
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 206 EADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp HHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHHHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 1111111111000 000000 0 0011235678999999999999999999999875
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=340.72 Aligned_cols=252 Identities=25% Similarity=0.333 Sum_probs=179.4
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc--chHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEe
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA--SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWL 211 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~--~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~l 211 (443)
++|++.+.||+|+||.||+|.. +|+.||||++...... ......|+..+..++||||+++++++.+. ..+++
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~----~~~~l 80 (317)
T 2pmi_A 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTE----NKLTL 80 (317)
T ss_dssp --------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCT----TEEEE
T ss_pred cceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEEC----CeEEE
Confidence 6899999999999999999987 5899999998654322 23334567777779999999999998776 45899
Q ss_pred eecccCcccHHHHhcc-------cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEe
Q psy14889 212 VTHYHSFGSLYDHLNR-------TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIAD 284 (443)
Q Consensus 212 v~e~~~~gsL~~~l~~-------~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~D 284 (443)
||||++ |+|.+++.. ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|
T Consensus 81 v~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~--------~ivH~Dlkp~NIl~~~~~~~kl~D 151 (317)
T 2pmi_A 81 VFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN--------KILHRDLKPQNLLINKRGQLKLGD 151 (317)
T ss_dssp EEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT--------TEECCCCCGGGEEECTTCCEEECC
T ss_pred EEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC--------CeeeCCCChHHeEEcCCCCEEECc
Confidence 999998 699999853 3589999999999999999999998 999999999999999999999999
Q ss_pred cCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCC
Q psy14889 285 FGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDL 364 (443)
Q Consensus 285 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~ 364 (443)
||+++........ .....||+.|+|||++.+.. .++.++|||||||++|||++| ..||...
T Consensus 152 fg~~~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~-----~~~~~~DiwslG~il~el~~g----------~~pf~~~ 212 (317)
T 2pmi_A 152 FGLARAFGIPVNT----FSSEVVTLWYRAPDVLMGSR-----TYSTSIDIWSCGCILAEMITG----------KPLFPGT 212 (317)
T ss_dssp CSSCEETTSCCCC----CCCCCSCCTTCCHHHHTTCC-----CCCTHHHHHHHHHHHHHHHHS----------SCSCCCS
T ss_pred CccceecCCCccc----CCCCcccccccCchHhhCCC-----CCCcHHHHHHHHHHHHHHHhC----------CCCCCCC
Confidence 9999776532221 23457899999999987541 466899999999999999999 5555442
Q ss_pred CCCCCChHHHHhhhhhcC---------------CCCCCCCC-----------CCCchhHHHHHHHHHHHhcCCcCCCCcH
Q psy14889 365 VPMDPSFDDMRKVICIDQ---------------QRPVLPNR-----------WVSDSTLNAMTKVMKECWHQNANVRLSA 418 (443)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~---------------~~~~~~~~-----------~~~~~~~~~l~~li~~cl~~dP~~Rps~ 418 (443)
. ..+.......... ..+..+.. ......+.++.+|+.+||+.||++|||+
T Consensus 213 ~----~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~ 288 (317)
T 2pmi_A 213 N----DEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSA 288 (317)
T ss_dssp S----HHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCH
T ss_pred C----hHHHHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCH
Confidence 1 1111111111000 00000000 0012345689999999999999999999
Q ss_pred HHHHH
Q psy14889 419 LRVKK 423 (443)
Q Consensus 419 ~evl~ 423 (443)
.|+++
T Consensus 289 ~e~l~ 293 (317)
T 2pmi_A 289 KQALH 293 (317)
T ss_dssp HHHTT
T ss_pred HHHhC
Confidence 99876
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=338.82 Aligned_cols=260 Identities=23% Similarity=0.262 Sum_probs=195.4
Q ss_pred hccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccc----hHHHHHHHHHHhccCCCceeeeeeccccCCcccE
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEAS----WSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQ 208 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~----~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~ 208 (443)
.++|++.+.||+|+||.||+|.. +++.||||++....... ...+.|+..+..++||||+++++++... ..
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~----~~ 108 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEID----GQ 108 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET----TE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeC----Ce
Confidence 37899999999999999999997 58899999986543221 2334677777779999999999998775 45
Q ss_pred EEeeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCC
Q psy14889 209 LWLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGL 287 (443)
Q Consensus 209 ~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGl 287 (443)
+++||||+++++|.+++.. ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~--------~i~H~dlkp~NIl~~~~~~~kl~Dfg~ 180 (309)
T 2h34_A 109 LYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAA--------GATHRDVKPENILVSADDFAYLVDFGI 180 (309)
T ss_dssp EEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT--------TCCCSCCCGGGEEECTTSCEEECSCCC
T ss_pred EEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------cCCcCCCChHHEEEcCCCCEEEecCcc
Confidence 8999999999999999975 5799999999999999999999999 999999999999999999999999999
Q ss_pred cccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCC
Q psy14889 288 AVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPM 367 (443)
Q Consensus 288 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~ 367 (443)
+......... ......||+.|+|||.+.+. .++.++||||||+++|||++| ..||...
T Consensus 181 ~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~il~~l~~g----------~~pf~~~--- 238 (309)
T 2h34_A 181 ASATTDEKLT---QLGNTVGTLYYMAPERFSES------HATYRADIYALTCVLYECLTG----------SPPYQGD--- 238 (309)
T ss_dssp -------------------CCGGGCCGGGTCC----------CCCHHHHHHHHHHHHHHS----------SCSSCSC---
T ss_pred Cccccccccc---cccccCCCcCccCHHHHcCC------CCCchHhHHHHHHHHHHHHHC----------CCCCCCc---
Confidence 8765432211 12345789999999999876 667899999999999999999 6777653
Q ss_pred CCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCC-cHHHHHHHHHHHhhcccc
Q psy14889 368 DPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRL-SALRVKKTLIKLACADMY 434 (443)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-s~~evl~~L~~l~~~~~~ 434 (443)
....+...+......+. .....++.++.+++.+||+.||++|| |++++++.|+++......
T Consensus 239 --~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~ 300 (309)
T 2h34_A 239 --QLSVMGAHINQAIPRPS----TVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQ 300 (309)
T ss_dssp --HHHHHHHHHHSCCCCGG----GTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC----
T ss_pred --hHHHHHHHhccCCCCcc----ccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhcc
Confidence 12223333222111110 11233566899999999999999999 999999999998766543
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=347.18 Aligned_cols=265 Identities=14% Similarity=0.182 Sum_probs=200.8
Q ss_pred hccccccceeeeecCeEEEEEEEC----------CceeEEEEeeccCccchHHHHHHHHHHhccCCCceee---------
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVWH----------GENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGY--------- 195 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~~----------~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~H~nIv~l--------- 195 (443)
.++|++.+.||+|+||.||+|... ++.||||++... .....|.++ +..++||||+++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--~~~~~E~~~--l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--GRLFNEQNF--FQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--STHHHHHHH--HHHHCCHHHHHHHHHHTTCTT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--chHHHHHHH--HHHhcccchhhhhhhhccCCc
Confidence 368999999999999999999883 689999998654 334445444 444899999984
Q ss_pred ------eeeccccCCcccEEEeeecccCcccHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeC
Q psy14889 196 ------IGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNR---TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRD 266 (443)
Q Consensus 196 ------~g~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~---~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrD 266 (443)
++++.... ...++||||+ +|+|.+++.. ..+++..++.++.||+.||.|||+. +|+|||
T Consensus 117 ~~i~~~~~~~~~~~---~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~--------~ivH~D 184 (352)
T 2jii_A 117 LAIPTCMGFGVHQD---KYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHEN--------EYVHGN 184 (352)
T ss_dssp CSCCCCCEEEEETT---TEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT--------TCBCSC
T ss_pred cCccchhhccccCC---cEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhC--------CccCCC
Confidence 44444322 4689999999 8999999975 5799999999999999999999999 999999
Q ss_pred CCCCCEEEcCCC--cEEEEecCCcccccccCCcCC---CCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHH
Q psy14889 267 IKSKNILVKTNG--TCVIADFGLAVSYSQLSNKMD---IPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVL 341 (443)
Q Consensus 267 lk~~NiLl~~~~--~~kl~DfGla~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl 341 (443)
|||+|||++.++ .+||+|||+++.+........ .......||+.|+|||++.+. .++.++||||||+++
T Consensus 185 ikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~Di~slG~il 258 (352)
T 2jii_A 185 VTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGC------GPSRRSDLQSLGYCM 258 (352)
T ss_dssp CCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTC------CCCHHHHHHHHHHHH
T ss_pred CCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccC------CCCchhhHHHHHHHH
Confidence 999999999998 999999999987654332211 112345799999999999876 677899999999999
Q ss_pred HHHHhcccCCCcccccCCCCCCCCCCCCChHHHHhhhh-hcCCCCCCCCC-CCCchhHHHHHHHHHHHhcCCcCCCCcHH
Q psy14889 342 WEVCRRTKANGIFEEYKAPYHDLVPMDPSFDDMRKVIC-IDQQRPVLPNR-WVSDSTLNAMTKVMKECWHQNANVRLSAL 419 (443)
Q Consensus 342 ~elltg~~~~~~~~~~~~P~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rps~~ 419 (443)
|||++| ..||..... ....+..... .......+... ......+.++.+++.+||+.||++|||+.
T Consensus 259 ~el~~g----------~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ 325 (352)
T 2jii_A 259 LKWLYG----------FLPWTNCLP---NTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYA 325 (352)
T ss_dssp HHHHHS----------CCTTGGGTT---CHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHH
T ss_pred HHHHhC----------CCCcccCCc---CHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHH
Confidence 999999 677766432 2222222211 11111111111 11123467899999999999999999999
Q ss_pred HHHHHHHHHhhcccc
Q psy14889 420 RVKKTLIKLACADMY 434 (443)
Q Consensus 420 evl~~L~~l~~~~~~ 434 (443)
++++.|+++.+....
T Consensus 326 ~l~~~L~~~~~~~~~ 340 (352)
T 2jii_A 326 MLRNNLEALLQDLRV 340 (352)
T ss_dssp HHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHhcCC
Confidence 999999999876543
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-43 Score=333.47 Aligned_cols=248 Identities=30% Similarity=0.441 Sum_probs=201.2
Q ss_pred hhccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc--chHHHHHHHHHHhccCCCceeeeeeccccCCcccEE
Q psy14889 134 LAKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA--SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQL 209 (443)
Q Consensus 134 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~--~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~ 209 (443)
..+.|++.+.||+|+||.||+|.. +++.||||++...... ....+.|+..+..++||||+++++++... ..+
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----~~~ 95 (303)
T 3a7i_A 20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD----TKL 95 (303)
T ss_dssp GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEET----TEE
T ss_pred hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC----CeE
Confidence 346799999999999999999987 5889999998654322 22334566666679999999999998775 458
Q ss_pred EeeecccCcccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcc
Q psy14889 210 WLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAV 289 (443)
Q Consensus 210 ~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~ 289 (443)
++||||+++++|.+++....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++.
T Consensus 96 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--------~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~ 167 (303)
T 3a7i_A 96 WIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSE--------KKIHRDIKAANVLLSEHGEVKLADFGVAG 167 (303)
T ss_dssp EEEEECCTTEEHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT--------TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CCccCCCChheEEECCCCCEEEeecccce
Confidence 9999999999999999988999999999999999999999999 99999999999999999999999999997
Q ss_pred cccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCC
Q psy14889 290 SYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDP 369 (443)
Q Consensus 290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~ 369 (443)
........ .....||+.|+|||.+.+. .++.++||||||+++|||++| ..||...
T Consensus 168 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~il~~l~~g----------~~p~~~~----- 222 (303)
T 3a7i_A 168 QLTDTQIK----RNTFVGTPFWMAPEVIKQS------AYDSKADIWSLGITAIELARG----------EPPHSEL----- 222 (303)
T ss_dssp ECBTTBCC----BCCCCSCGGGCCHHHHTTC------CBCTHHHHHHHHHHHHHHHHS----------SCTTTTS-----
T ss_pred ecCccccc----cCccCCCcCccCHHHHhcC------CCCchhhhHHHHHHHHHHccC----------CCCCCCc-----
Confidence 76543211 2345789999999999876 667899999999999999999 6677553
Q ss_pred ChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHH
Q psy14889 370 SFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKT 424 (443)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 424 (443)
........+.. ...+.++ ..++..+.+++.+||+.||++|||+.++++.
T Consensus 223 ~~~~~~~~~~~-~~~~~~~-----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 223 HPMKVLFLIPK-NNPPTLE-----GNYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp CHHHHHHHHHH-SCCCCCC-----SSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred CHHHHHHHhhc-CCCCCCc-----cccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 12222222221 2222222 3356789999999999999999999999874
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=331.76 Aligned_cols=255 Identities=21% Similarity=0.313 Sum_probs=200.0
Q ss_pred hhhhccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccchHHHHHHHHHHhccCCCceeeeeeccccC------
Q psy14889 132 RTLAKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIGSDMTSR------ 203 (443)
Q Consensus 132 ~~~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~------ 203 (443)
..+.++|++.+.||+|+||.||+|.+ +++.||+|++.... .... .|+..+..++||||+++++++....
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~--~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-EKAE--REVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-GGGH--HHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred chhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-HHHH--HHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 34557899999999999999999998 58999999986543 2333 4455555599999999999875411
Q ss_pred ------CcccEEEeeecccCcccHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEE
Q psy14889 204 ------NSCTQLWLVTHYHSFGSLYDHLNR---TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILV 274 (443)
Q Consensus 204 ------~~~~~~~lv~e~~~~gsL~~~l~~---~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl 274 (443)
.....+++||||+++|+|.+++.. ..+++..+..++.|++.||.|||+. +|+||||||+|||+
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--------~i~H~dlkp~Nil~ 155 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK--------KLINRDLKPSNIFL 155 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHT--------TEECSCCSGGGEEE
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC--------CeeeccCCHHHEEE
Confidence 112458999999999999999953 4699999999999999999999999 99999999999999
Q ss_pred cCCCcEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcc
Q psy14889 275 KTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIF 354 (443)
Q Consensus 275 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~ 354 (443)
+.++.+||+|||++........ .....||+.|+|||.+.+. .++.++||||||+++|||++|
T Consensus 156 ~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~il~~l~~~------- 217 (284)
T 2a19_B 156 VDTKQVKIGDFGLVTSLKNDGK-----RTRSKGTLRYMSPEQISSQ------DYGKEVDLYALGLILAELLHV------- 217 (284)
T ss_dssp EETTEEEECCCTTCEESSCCSC-----CCCCCSCCTTSCHHHHHCS------CCCTHHHHHHHHHHHHHHHSC-------
T ss_pred cCCCCEEECcchhheecccccc-----ccccCCcccccChhhhccC------CCcchhhhHHHHHHHHHHHhc-------
Confidence 9999999999999977654322 2334689999999999875 667899999999999999999
Q ss_pred cccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhhcccc
Q psy14889 355 EEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLACADMY 434 (443)
Q Consensus 355 ~~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~~~~~ 434 (443)
..|+... ......... ..++ ...+..+.+++.+||+.||++|||+.|+++.|..+......
T Consensus 218 ---~~~~~~~-------~~~~~~~~~----~~~~-----~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~ 278 (284)
T 2a19_B 218 ---CDTAFET-------SKFFTDLRD----GIIS-----DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEK 278 (284)
T ss_dssp ---CSSHHHH-------HHHHHHHHT----TCCC-----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC----
T ss_pred ---CCcchhH-------HHHHHHhhc----cccc-----ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCc
Confidence 4444321 111111111 1112 22456799999999999999999999999999998876544
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=368.39 Aligned_cols=256 Identities=19% Similarity=0.314 Sum_probs=197.9
Q ss_pred ccccccc-eeeeecCeEEEEEEE----CCceeEEEEeeccCc--cchHHHHHHHHHHhccCCCceeeeeeccccCCcccE
Q psy14889 136 KQISLSE-CIGKGRYGEVWRGVW----HGENVAVKIFFSRDE--ASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQ 208 (443)
Q Consensus 136 ~~~~~~~-~lG~G~fg~Vy~~~~----~~~~vAvK~~~~~~~--~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~ 208 (443)
+++.+.+ .||+|+||.||+|.+ ++..||||+++.... .......|+..+..++|||||++++++... .
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-----~ 409 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-----A 409 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEESS-----S
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEeccC-----C
Confidence 3445555 799999999999987 245799999865432 223334666667779999999999998653 2
Q ss_pred EEeeecccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecC
Q psy14889 209 LWLVTHYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFG 286 (443)
Q Consensus 209 ~~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfG 286 (443)
+++||||+++|+|.+++.. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 410 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~--------~iiHrDlkp~NILl~~~~~vkL~DFG 481 (613)
T 2ozo_A 410 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK--------NFVHRNLAARNVLLVNRHYAKISDFG 481 (613)
T ss_dssp EEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT--------TCCCSCCSGGGEEEEETTEEEECCCS
T ss_pred eEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC--------CEEcCcCCHHHEEEcCCCcEEEeecc
Confidence 7999999999999999953 5699999999999999999999999 99999999999999999999999999
Q ss_pred CcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh-cccCCCcccccCCCCCCCC
Q psy14889 287 LAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR-RTKANGIFEEYKAPYHDLV 365 (443)
Q Consensus 287 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt-g~~~~~~~~~~~~P~~~~~ 365 (443)
+++.+........ ......+|+.|+|||++.+. .++.++|||||||++|||++ | ..||.+..
T Consensus 482 la~~~~~~~~~~~-~~~~~~~~~~y~APE~~~~~------~~~~~sDvwSlGv~l~ellt~G----------~~Pf~~~~ 544 (613)
T 2ozo_A 482 LSKALGADDSYYT-ARSAGKWPLKWYAPECINFR------KFSSRSDVWSYGVTMWEALSYG----------QKPYKKMK 544 (613)
T ss_dssp TTTTCC---------------CCTTSCHHHHHHC------CCCHHHHHHHHHHHHHHHHTTS----------CCTTTTCC
T ss_pred CcccccCCCceee-eccCCCCccceeCHhhhcCC------CCCcHHHHHHHHHHHHHHHHCC----------CCCCCCCC
Confidence 9987654322111 11223467899999999876 67789999999999999998 8 77887642
Q ss_pred CCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhhcc
Q psy14889 366 PMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLACAD 432 (443)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~~~ 432 (443)
..++...+.. ..+...+ ..++.++.+||.+||+.||++|||+.+|++.|+.+....
T Consensus 545 -----~~~~~~~i~~-~~~~~~p-----~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~ 600 (613)
T 2ozo_A 545 -----GPEVMAFIEQ-GKRMECP-----PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 600 (613)
T ss_dssp -----SHHHHHHHHT-TCCCCCC-----TTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred -----HHHHHHHHHc-CCCCCCC-----CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 2333333322 2333333 346788999999999999999999999999999986543
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-44 Score=343.51 Aligned_cols=270 Identities=21% Similarity=0.290 Sum_probs=201.7
Q ss_pred hccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc-chHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEe
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA-SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWL 211 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~-~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~l 211 (443)
.++|++.+.||+|+||.||++.. +|+.||||++...... ......|+..+..++||||+++++++..........++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 36899999999999999999997 6899999988654332 22334566666679999999999998754433457899
Q ss_pred eecccCcccHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecC
Q psy14889 212 VTHYHSFGSLYDHLNR-----TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFG 286 (443)
Q Consensus 212 v~e~~~~gsL~~~l~~-----~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfG 286 (443)
||||+++|+|.+++.. ..+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~--------~ivH~dlkp~NIl~~~~~~~kl~dfg 179 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK--------GYAHRDLKPTNILLGDEGQPVLMDLG 179 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT--------TEECCCCCGGGEEECTTSCEEECCCS
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC--------CcccCCCCHHHEEEcCCCCEEEEecC
Confidence 9999999999999864 5699999999999999999999999 99999999999999999999999999
Q ss_pred CcccccccCCcCC-----CCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCC
Q psy14889 287 LAVSYSQLSNKMD-----IPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPY 361 (443)
Q Consensus 287 la~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~ 361 (443)
++........... .......||+.|+|||++.+.... .++.++||||||+++|||++| ..||
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~~~~Di~slG~il~el~~g----------~~p~ 246 (317)
T 2buj_A 180 SMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHC---VIDERTDVWSLGCVLYAMMFG----------EGPY 246 (317)
T ss_dssp SCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEE---EECTHHHHHHHHHHHHHHHHS----------SCTT
T ss_pred cchhcccccccccccccccccccccCCcccCCHhHhccCCCc---CCCchhhHHHHHHHHHHHHhC----------CCCh
Confidence 9865432111000 000123578999999998754211 356899999999999999999 5666
Q ss_pred CCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhhcccc
Q psy14889 362 HDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLACADMY 434 (443)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~~~~~ 434 (443)
......... ....... ... .+. ....+..+.+++.+||+.||.+|||+.++++.|+.+....+.
T Consensus 247 ~~~~~~~~~---~~~~~~~-~~~--~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~ 310 (317)
T 2buj_A 247 DMVFQKGDS---VALAVQN-QLS--IPQ---SPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPG 310 (317)
T ss_dssp HHHHHTTSC---HHHHHHC-C----CCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC
T ss_pred hhhhcccch---hhHHhhc-cCC--CCc---cccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCC
Confidence 432111111 1111111 111 111 123567899999999999999999999999999998766544
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=338.97 Aligned_cols=262 Identities=20% Similarity=0.327 Sum_probs=193.6
Q ss_pred hccccccceeeeecCeEEEEEEEC-----CceeEEEEeeccCccc---hHHHHHHHHHHhccCCCceeeeeeccccCCc-
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVWH-----GENVAVKIFFSRDEAS---WSRETEIYSTVLLRHENILGYIGSDMTSRNS- 205 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~~-----~~~vAvK~~~~~~~~~---~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~- 205 (443)
.++|.+.+.||+|+||.||+|.+. +..||||++....... .....|+..+..++||||+++++++......
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 112 (313)
T 3brb_A 33 RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQG 112 (313)
T ss_dssp GGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-----
T ss_pred HHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccC
Confidence 368999999999999999999872 3479999986543221 2234566677779999999999998765432
Q ss_pred ccEEEeeecccCcccHHHHhc-------ccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCC
Q psy14889 206 CTQLWLVTHYHSFGSLYDHLN-------RTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNG 278 (443)
Q Consensus 206 ~~~~~lv~e~~~~gsL~~~l~-------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~ 278 (443)
....++||||+++|+|.+++. ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++
T Consensus 113 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~--------~ivH~dikp~NIli~~~~ 184 (313)
T 3brb_A 113 IPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR--------NFLHRDLAARNCMLRDDM 184 (313)
T ss_dssp --CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT--------TCCCCCCSGGGEEECTTS
T ss_pred CcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC--------CcccCCCCcceEEEcCCC
Confidence 124699999999999999983 24699999999999999999999998 999999999999999999
Q ss_pred cEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh-cccCCCccccc
Q psy14889 279 TCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR-RTKANGIFEEY 357 (443)
Q Consensus 279 ~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt-g~~~~~~~~~~ 357 (443)
.+||+|||+++........ .......+++.|+|||.+.+. .++.++||||||+++|||++ |
T Consensus 185 ~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~il~el~~~g---------- 246 (313)
T 3brb_A 185 TVCVADFGLSKKIYSGDYY--RQGRIAKMPVKWIAIESLADR------VYTSKSDVWAFGVTMWEIATRG---------- 246 (313)
T ss_dssp CEEECSCSCC------------------CCGGGSCHHHHHSS------CCCHHHHHHHHHHHHHHHHTTS----------
T ss_pred cEEEeecCcceeccccccc--CcccccCCCccccCchhhcCC------CccchhhhHHHHHHHHHHHhcC----------
Confidence 9999999999766543211 112334578899999999776 67789999999999999999 6
Q ss_pred CCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhhccc
Q psy14889 358 KAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLACADM 433 (443)
Q Consensus 358 ~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~~~~ 433 (443)
..||.... ...+...+.. ...+..+ ..++..+.+++.+||+.||++|||+.++++.|+++.+..+
T Consensus 247 ~~p~~~~~-----~~~~~~~~~~-~~~~~~~-----~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp 311 (313)
T 3brb_A 247 MTPYPGVQ-----NHEMYDYLLH-GHRLKQP-----EDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311 (313)
T ss_dssp CCSSTTCC-----GGGHHHHHHT-TCCCCCB-----TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred CCCCccCC-----HHHHHHHHHc-CCCCCCC-----ccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 56665531 2222222221 2222222 3466789999999999999999999999999999987654
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=342.43 Aligned_cols=247 Identities=26% Similarity=0.385 Sum_probs=194.1
Q ss_pred hhccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccc----hHHHHHHHHHHhccCCCceeeeeeccccCCccc
Q psy14889 134 LAKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEAS----WSRETEIYSTVLLRHENILGYIGSDMTSRNSCT 207 (443)
Q Consensus 134 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~----~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~ 207 (443)
..+.|+..+.||+|+||.||+|.. +|+.||||++....... .....|+..+..++||||+++++++... .
T Consensus 52 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~----~ 127 (348)
T 1u5q_A 52 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE----H 127 (348)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET----T
T ss_pred hhhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC----C
Confidence 346799999999999999999997 68999999986543211 1224566666679999999999998776 4
Q ss_pred EEEeeecccCcccHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEec
Q psy14889 208 QLWLVTHYHSFGSLYDHLN--RTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADF 285 (443)
Q Consensus 208 ~~~lv~e~~~~gsL~~~l~--~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~Df 285 (443)
..++||||+. |+|.+++. +..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+||
T Consensus 128 ~~~lv~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--------~ivH~Dlkp~NIll~~~~~~kL~Df 198 (348)
T 1u5q_A 128 TAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH--------NMIHRDVKAGNILLSEPGLVKLGDF 198 (348)
T ss_dssp EEEEEEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT--------TCBCCCCSGGGEEEETTTEEEECCC
T ss_pred eEEEEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CeeeCCCCHHHEEECCCCCEEEeec
Confidence 5899999998 68888874 46799999999999999999999999 9999999999999999999999999
Q ss_pred CCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCC
Q psy14889 286 GLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLV 365 (443)
Q Consensus 286 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~ 365 (443)
|+++..... ....||+.|+|||++.+... ..++.++|||||||++|||++| ..||....
T Consensus 199 G~a~~~~~~--------~~~~gt~~y~aPE~~~~~~~---~~~~~~~DiwslG~il~ell~g----------~~p~~~~~ 257 (348)
T 1u5q_A 199 GSASIMAPA--------NSFVGTPYWMAPEVILAMDE---GQYDGKVDVWSLGITCIELAER----------KPPLFNMN 257 (348)
T ss_dssp TTCBSSSSB--------CCCCSCGGGCCHHHHHTTSS---CCBCTHHHHHHHHHHHHHHHHS----------SCTTTTSC
T ss_pred cCceecCCC--------CcccCCcceeCHhhhccccC---CCCCcHHHHHHHHHHHHHHHhC----------CCCCCCCC
Confidence 999765432 23479999999999853211 1567899999999999999999 66775531
Q ss_pred CCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHH
Q psy14889 366 PMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKT 424 (443)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 424 (443)
....+.... .. ..+... ....+..+.+|+.+||+.||++|||+.++++.
T Consensus 258 ----~~~~~~~~~-~~-~~~~~~----~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 258 ----AMSALYHIA-QN-ESPALQ----SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp ----HHHHHHHHH-HS-CCCCCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred ----hHHHHHHHH-hc-CCCCCC----CCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 122222222 21 222222 13356789999999999999999999998763
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-43 Score=350.85 Aligned_cols=277 Identities=19% Similarity=0.212 Sum_probs=197.5
Q ss_pred hhhccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc---chHHHHHHHHHHhccCCCceeeeeeccccCC-cc
Q psy14889 133 TLAKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA---SWSRETEIYSTVLLRHENILGYIGSDMTSRN-SC 206 (443)
Q Consensus 133 ~~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~---~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~-~~ 206 (443)
.+.++|.+.+.||+|+||.||+|.+ +++.||||++...... ......|+..+..++||||+++++++..... ..
T Consensus 23 ~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 102 (432)
T 3n9x_A 23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKF 102 (432)
T ss_dssp CCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred eecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcC
Confidence 3457999999999999999999998 5789999998653222 1223456666677999999999999876531 12
Q ss_pred cEEEeeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEec
Q psy14889 207 TQLWLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADF 285 (443)
Q Consensus 207 ~~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~Df 285 (443)
..+++||||+. |+|.++++. ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+||
T Consensus 103 ~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~--------givHrDlkp~NILl~~~~~~kL~DF 173 (432)
T 3n9x_A 103 DELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHES--------GIIHRDLKPANCLLNQDCSVKVCDF 173 (432)
T ss_dssp CCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHT--------TEECCCCCGGGEEECTTCCEEECCC
T ss_pred CeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC--------CCCCCCCCHHHeEECCCCCEEEccC
Confidence 35899999987 599999975 4599999999999999999999999 9999999999999999999999999
Q ss_pred CCcccccccCCcC------------------CCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhc
Q psy14889 286 GLAVSYSQLSNKM------------------DIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRR 347 (443)
Q Consensus 286 Gla~~~~~~~~~~------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg 347 (443)
|+|+......... .......+||+.|+|||++.... .++.++|||||||++|||++|
T Consensus 174 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~-----~~~~~~DiwSlG~il~ell~g 248 (432)
T 3n9x_A 174 GLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQE-----NYTKSIDIWSTGCIFAELLNM 248 (432)
T ss_dssp TTCEEC-------------------------------CCCCCTTCCHHHHTTCS-----CCCTHHHHHHHHHHHHHHHTT
T ss_pred CCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCC-----CCCcccccchHHHHHHHHHhc
Confidence 9998765432110 01124568999999999875431 577899999999999999998
Q ss_pred ccCCCcccccCCCCCCCCCCC-----------------------------CC--------hHHHHhhhhhcCCCCCCCCC
Q psy14889 348 TKANGIFEEYKAPYHDLVPMD-----------------------------PS--------FDDMRKVICIDQQRPVLPNR 390 (443)
Q Consensus 348 ~~~~~~~~~~~~P~~~~~~~~-----------------------------~~--------~~~~~~~~~~~~~~~~~~~~ 390 (443)
..|+.....+..|+....... +. .......+.........+..
T Consensus 249 ~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (432)
T 3n9x_A 249 LQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLK 328 (432)
T ss_dssp CTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHH
T ss_pred ccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHH
Confidence 777655544444443211100 00 00011111111111100000
Q ss_pred CCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 391 WVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 391 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
......+.++.+|+.+||+.||++|||+.|+++
T Consensus 329 ~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 361 (432)
T 3n9x_A 329 QKYPSISDDGINLLESMLKFNPNKRITIDQALD 361 (432)
T ss_dssp HHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000235678999999999999999999999987
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=358.28 Aligned_cols=255 Identities=24% Similarity=0.388 Sum_probs=200.2
Q ss_pred hHHHhhhhccccccceeeeecCeEEEEEEE--CCceeEEEEeeccC---ccchHHHHHHHHHHhccCCCceeeeeecccc
Q psy14889 128 LLIQRTLAKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRD---EASWSRETEIYSTVLLRHENILGYIGSDMTS 202 (443)
Q Consensus 128 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~---~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~ 202 (443)
...+..+.++|++.+.||+|+||.||+|.. +++.||||++.... ........|+..+..++||||+++++++.+.
T Consensus 14 ~~~~g~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 93 (486)
T 3mwu_A 14 LYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDS 93 (486)
T ss_dssp CTTCCHHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred ccccCChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcC
Confidence 334455668999999999999999999998 58999999985432 2222334566666669999999999998776
Q ss_pred CCcccEEEeeecccCcccHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEc---CCC
Q psy14889 203 RNSCTQLWLVTHYHSFGSLYDHLN-RTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVK---TNG 278 (443)
Q Consensus 203 ~~~~~~~~lv~e~~~~gsL~~~l~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~---~~~ 278 (443)
..+++||||+.+|+|.+++. ...+++..+..++.||+.||.|||+. +|+||||||+|||++ .++
T Consensus 94 ----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~--------~ivH~Dlkp~Nil~~~~~~~~ 161 (486)
T 3mwu_A 94 ----SSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH--------NIVHRDLKPENILLESKEKDC 161 (486)
T ss_dssp ----SEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT--------TCCCSCCSGGGEEESSSSTTC
T ss_pred ----CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CeEeccCchHHEEEecCCCCC
Confidence 45899999999999998885 46799999999999999999999999 999999999999995 456
Q ss_pred cEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccC
Q psy14889 279 TCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYK 358 (443)
Q Consensus 279 ~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~ 358 (443)
.+||+|||+++....... .....||+.|+|||++.+ .++.++|||||||++|||++| .
T Consensus 162 ~~kl~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~-------~~~~~~DiwslG~il~~ll~g----------~ 219 (486)
T 3mwu_A 162 DIKIIDFGLSTCFQQNTK-----MKDRIGTAYYIAPEVLRG-------TYDEKCDVWSAGVILYILLSG----------T 219 (486)
T ss_dssp CEEECSCSCTTTBCCC---------CCTTGGGGCCGGGGGS-------CCCHHHHHHHHHHHHHHHHHS----------S
T ss_pred CEEEEECCcCeECCCCCc-----cCCCcCCCCCCCHHHhCC-------CCCchhhHHHHHHHHHHHHhC----------C
Confidence 799999999976654321 234579999999999875 466899999999999999999 7
Q ss_pred CCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHH
Q psy14889 359 APYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKT 424 (443)
Q Consensus 359 ~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 424 (443)
.||.+. ....+...+.........+. ...++.++.+|+.+||+.||++|||+.++++.
T Consensus 220 ~pf~~~-----~~~~~~~~i~~~~~~~~~~~---~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 220 PPFYGK-----NEYDILKRVETGKYAFDLPQ---WRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp CSSCCS-----SHHHHHHHHHHTCCCSCSGG---GGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred CCCCCC-----CHHHHHHHHHhCCCCCCCcc---cCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 777653 22333333333222222221 13456789999999999999999999999874
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=346.17 Aligned_cols=251 Identities=12% Similarity=0.178 Sum_probs=197.5
Q ss_pred hhccccccceeeeecCeEEEEEE-----E--CCceeEEEEeeccCccchHHHHHHHHHHhcc---CCCceeeeeeccccC
Q psy14889 134 LAKQISLSECIGKGRYGEVWRGV-----W--HGENVAVKIFFSRDEASWSRETEIYSTVLLR---HENILGYIGSDMTSR 203 (443)
Q Consensus 134 ~~~~~~~~~~lG~G~fg~Vy~~~-----~--~~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~---H~nIv~l~g~~~~~~ 203 (443)
..++|.+.+.||+|+||.||+|. . +++.||||++.......+..|.++... ++ |+||+++++++....
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~--l~~~~~~~iv~~~~~~~~~~ 140 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMER--LKPSMQHMFMKFYSAHLFQN 140 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHHH--SCGGGGGGBCCEEEEEECSS
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHHH--hhhhhhhhhhhhheeeecCC
Confidence 34789999999999999999994 2 588999999876655555555544443 55 999999999988764
Q ss_pred CcccEEEeeecccCcccHHHHhc------ccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcC-
Q psy14889 204 NSCTQLWLVTHYHSFGSLYDHLN------RTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKT- 276 (443)
Q Consensus 204 ~~~~~~~lv~e~~~~gsL~~~l~------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~- 276 (443)
..++||||+++|+|.+++. ...+++..++.++.||+.||+|||+. +|+||||||+|||++.
T Consensus 141 ----~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~--------~ivHrDiKp~NIll~~~ 208 (365)
T 3e7e_A 141 ----GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC--------EIIHGDIKPDNFILGNG 208 (365)
T ss_dssp ----CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT--------TEECCCCSGGGEEECGG
T ss_pred ----CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC--------CeecCCCCHHHEEeccc
Confidence 4699999999999999995 35699999999999999999999998 9999999999999998
Q ss_pred ----------CCcEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh
Q psy14889 277 ----------NGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR 346 (443)
Q Consensus 277 ----------~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt 346 (443)
++.+||+|||+|+.+....... ......||+.|+|||++.+. .++.++|||||||++|||+|
T Consensus 209 ~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~ellt 280 (365)
T 3e7e_A 209 FLEQDDEDDLSAGLALIDLGQSIDMKLFPKGT--IFTAKCETSGFQCVEMLSNK------PWNYQIDYFGVAATVYCMLF 280 (365)
T ss_dssp GTCC------CTTEEECCCTTCEEGGGSCTTE--EECCSSCTTSCCCHHHHTTC------CBSTHHHHHHHHHHHHHHHH
T ss_pred ccCccccccccCCEEEeeCchhhhhhccCCCc--eeeeecCCCCCCChHHhcCC------CCCccccHHHHHHHHHHHHh
Confidence 8999999999997654221111 12345799999999999876 67789999999999999999
Q ss_pred cccCCCcccccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCC-CcHHHHHHHH
Q psy14889 347 RTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVR-LSALRVKKTL 425 (443)
Q Consensus 347 g~~~~~~~~~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R-ps~~evl~~L 425 (443)
| ..||....... .. ....++. ...++.+.+++..|++.+|.+| |++.++.+.|
T Consensus 281 g----------~~pf~~~~~~~---------~~---~~~~~~~----~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l 334 (365)
T 3e7e_A 281 G----------TYMKVKNEGGE---------CK---PEGLFRR----LPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKL 334 (365)
T ss_dssp S----------SCCCEEEETTE---------EE---ECSCCTT----CSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHH
T ss_pred C----------CCccccCCCCc---------ee---echhccc----cCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHH
Confidence 9 55554321100 00 0011111 1135678999999999999999 4789999999
Q ss_pred HHHhhcc
Q psy14889 426 IKLACAD 432 (443)
Q Consensus 426 ~~l~~~~ 432 (443)
+++.+..
T Consensus 335 ~~~l~~~ 341 (365)
T 3e7e_A 335 KKVFQQH 341 (365)
T ss_dssp HHHHHHH
T ss_pred HHHHHHh
Confidence 9887654
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=355.35 Aligned_cols=244 Identities=24% Similarity=0.383 Sum_probs=197.4
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCc----cchHHHHHHHHHHhccCCCceeeeeeccccCCcccEE
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDE----ASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQL 209 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~----~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~ 209 (443)
++|.+.+.||+|+||.||+|.+ +|+.||||++..... .......|+..+..++||||+++++++.+. ..+
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~----~~~ 91 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTP----SDI 91 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECS----SEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC----CEE
Confidence 6899999999999999999998 589999999865321 112334667777779999999999998776 458
Q ss_pred EeeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCc
Q psy14889 210 WLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA 288 (443)
Q Consensus 210 ~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla 288 (443)
++||||+++|+|.+++.+ ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 92 ~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~--------givHrDLkp~NIll~~~~~vkL~DFG~a 163 (476)
T 2y94_A 92 FMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRH--------MVVHRDLKPENVLLDAHMNAKIADFGLS 163 (476)
T ss_dssp EEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTT--------TEECSCCSGGGEEECTTCCEEECCCSSC
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CCCcccccHHHEEEecCCCeEEEeccch
Confidence 999999999999999964 5799999999999999999999998 9999999999999999999999999999
Q ss_pred ccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCC
Q psy14889 289 VSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMD 368 (443)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~ 368 (443)
+....... .....||+.|+|||++.+.. ..+.++|||||||++|||++| ..||.+.
T Consensus 164 ~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~-----~~~~~~DiwSlGvil~elltG----------~~Pf~~~---- 219 (476)
T 2y94_A 164 NMMSDGEF-----LRTSCGSPNYAAPEVISGRL-----YAGPEVDIWSSGVILYALLCG----------TLPFDDD---- 219 (476)
T ss_dssp EECCTTCC-----BCCCCSCSTTCCHHHHTTCC-----BCSHHHHHHHHHHHHHHHHHS----------SCSSCCS----
T ss_pred hhcccccc-----ccccCCCcCeEChhhccCCC-----CCCCcceehhhHHHHHHHhhC----------CCCCCCC----
Confidence 87654221 23457999999999998752 124789999999999999999 6777653
Q ss_pred CChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 369 PSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
....+...+... ....| ...+.++.+|+.+||+.||++|||+.|+++
T Consensus 220 -~~~~~~~~i~~~--~~~~p-----~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 220 -HVPTLFKKICDG--IFYTP-----QYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp -SSHHHHHHHHTT--CCCCC-----TTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -CHHHHHHHHhcC--CcCCC-----ccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 122233322221 12222 234567999999999999999999999987
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=339.41 Aligned_cols=250 Identities=20% Similarity=0.271 Sum_probs=198.2
Q ss_pred hhhccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc-------chHHHHHHHHHHhccCCCceeeeeeccccC
Q psy14889 133 TLAKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA-------SWSRETEIYSTVLLRHENILGYIGSDMTSR 203 (443)
Q Consensus 133 ~~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~-------~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~ 203 (443)
.+.++|++.+.||+|+||.||+|.. +|+.||||++...... ....+.|+..+..++||||+++++++.+.
T Consensus 9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~- 87 (321)
T 2a2a_A 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENR- 87 (321)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-
T ss_pred hhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecC-
Confidence 4457899999999999999999998 5889999998654321 22334566666679999999999998766
Q ss_pred CcccEEEeeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCC----
Q psy14889 204 NSCTQLWLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNG---- 278 (443)
Q Consensus 204 ~~~~~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~---- 278 (443)
..+++||||+++|+|.+++.. ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++
T Consensus 88 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~--------~ivH~dikp~NIl~~~~~~~~~ 156 (321)
T 2a2a_A 88 ---TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTK--------KIAHFDLKPENIMLLDKNIPIP 156 (321)
T ss_dssp ---SEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHT--------TEECCCCSGGGEEESCTTSSSC
T ss_pred ---CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CeecCCCChHHEEEecCCCCcC
Confidence 458999999999999999964 5689999999999999999999999 999999999999999888
Q ss_pred cEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccC
Q psy14889 279 TCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYK 358 (443)
Q Consensus 279 ~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~ 358 (443)
.+||+|||++........ .....||+.|+|||++.+. .++.++||||||+++|||++| .
T Consensus 157 ~~kl~Dfg~~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~------~~~~~~Di~slG~il~~l~~g----------~ 215 (321)
T 2a2a_A 157 HIKLIDFGLAHEIEDGVE-----FKNIFGTPEFVAPEIVNYE------PLGLEADMWSIGVITYILLSG----------A 215 (321)
T ss_dssp CEEECCCTTCEECCTTCC-----CCCCCSCGGGCCHHHHTTC------CCCTHHHHHHHHHHHHHHHHS----------C
T ss_pred CEEEccCccceecCcccc-----ccccCCCCCccCcccccCC------CCCCccccHHHHHHHHHHHHC----------C
Confidence 799999999977654321 2345799999999999766 667899999999999999999 6
Q ss_pred CCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 359 APYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 359 ~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
.||... ........+.. .....+.. .....+..+.+++.+||+.||++|||+.|+++
T Consensus 216 ~pf~~~-----~~~~~~~~i~~--~~~~~~~~-~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 216 SPFLGD-----TKQETLANITS--VSYDFDEE-FFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp CSSCCS-----SHHHHHHHHHT--TCCCCCHH-HHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred CCCCCC-----CHHHHHHHHHh--cccccChh-hhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 777553 22222222221 11111110 01234567999999999999999999999986
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=340.09 Aligned_cols=264 Identities=27% Similarity=0.403 Sum_probs=201.6
Q ss_pred hccccccceeeeecCeEEEEEEE------CCceeEEEEeeccCcc-chHHHHHHHHHHhccCCCceeeeeeccccCCccc
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVW------HGENVAVKIFFSRDEA-SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCT 207 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~------~~~~vAvK~~~~~~~~-~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~ 207 (443)
.++|++.+.||+|+||.||+|.+ +++.||||++...... ....+.|+..+..++||||+++++++..... .
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~--~ 117 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR--R 117 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC------
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCC--C
Confidence 46799999999999999999985 4789999998654332 2234567777777999999999999876532 3
Q ss_pred EEEeeecccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEec
Q psy14889 208 QLWLVTHYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADF 285 (443)
Q Consensus 208 ~~~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~Df 285 (443)
.+++||||+++|+|.+++.. ..+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+||
T Consensus 118 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~--------~ivH~dikp~NIli~~~~~~kL~Df 189 (326)
T 2w1i_A 118 NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK--------RYIHRDLATRNILVENENRVKIGDF 189 (326)
T ss_dssp CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHT--------TEECSCCCGGGEEEEETTEEEECCC
T ss_pred ceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC--------CEeccCCCcceEEEcCCCcEEEecC
Confidence 47899999999999999975 4599999999999999999999998 9999999999999999999999999
Q ss_pred CCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCC-
Q psy14889 286 GLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDL- 364 (443)
Q Consensus 286 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~- 364 (443)
|++........... ......++..|+|||.+.+. .++.++||||||+++|||+||.. ||...
T Consensus 190 g~~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~il~el~tg~~----------~~~~~~ 252 (326)
T 2w1i_A 190 GLTKVLPQDKEYYK-VKEPGESPIFWYAPESLTES------KFSVASDVWSFGVVLYELFTYIE----------KSKSPP 252 (326)
T ss_dssp TTCEECCSSCSEEE-CSSCCSCCGGGCCHHHHHHC------EEEHHHHHHHHHHHHHHHHHTTC----------GGGSHH
T ss_pred cchhhccccccccc-cccCCCCceeEECchhhcCC------CCCchhhHHHHHHHHHHHHhcCC----------CCCCCH
Confidence 99987654332111 11234577889999999775 55689999999999999999944 33221
Q ss_pred ------CCCCCC-h---HHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhhc
Q psy14889 365 ------VPMDPS-F---DDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLACA 431 (443)
Q Consensus 365 ------~~~~~~-~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~~ 431 (443)
...... . ..+...+. ...++..+ ..++.++.+++.+||+.||++|||+.++++.|+++.+.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 253 AEFMRMIGNDKQGQMIVFHLIELLK-NNGRLPRP-----DGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp HHHHHHHCTTCCTHHHHHHHHHHHH-TTCCCCCC-----TTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHhhccccchhhhHHHHHHHhh-cCCCCCCC-----CcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 000001 0 11112221 12222222 34677899999999999999999999999999998764
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-43 Score=329.16 Aligned_cols=256 Identities=20% Similarity=0.270 Sum_probs=199.7
Q ss_pred hhhccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc-chHHHHHHHHHHhccCCCceeeeeeccccCCcccEE
Q psy14889 133 TLAKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA-SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQL 209 (443)
Q Consensus 133 ~~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~-~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~ 209 (443)
.+.++|++.+.||+|+||.||+|.. ++..||+|++...... ......|+..+..++||||+++++++.+. ...
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~----~~~ 81 (277)
T 3f3z_A 6 DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDN----TDI 81 (277)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS----SEE
T ss_pred hhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecC----CeE
Confidence 3457899999999999999999998 4678999988654322 22334566666779999999999998766 458
Q ss_pred EeeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEE---cCCCcEEEEec
Q psy14889 210 WLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILV---KTNGTCVIADF 285 (443)
Q Consensus 210 ~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl---~~~~~~kl~Df 285 (443)
++||||+++++|.+++.. ..+++..+..++.|++.||.|||+. +|+||||||+|||+ +.++.+||+||
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--------~i~H~dlkp~Nil~~~~~~~~~~~l~Df 153 (277)
T 3f3z_A 82 YLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKL--------NVAHRDLKPENFLFLTDSPDSPLKLIDF 153 (277)
T ss_dssp EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT--------TEECCCCSGGGEEESSSSTTCCEEECCC
T ss_pred EEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC--------CccCCCCCHHHEEEecCCCCCcEEEEec
Confidence 999999999999998854 6689999999999999999999999 99999999999999 78889999999
Q ss_pred CCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCC
Q psy14889 286 GLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLV 365 (443)
Q Consensus 286 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~ 365 (443)
|++........ .....||+.|+|||.+.+ .++.++||||||+++|||++| ..||...
T Consensus 154 g~~~~~~~~~~-----~~~~~~t~~y~aPE~~~~-------~~~~~~Di~slG~~l~~l~~g----------~~p~~~~- 210 (277)
T 3f3z_A 154 GLAARFKPGKM-----MRTKVGTPYYVSPQVLEG-------LYGPECDEWSAGVMMYVLLCG----------YPPFSAP- 210 (277)
T ss_dssp TTCEECCTTSC-----BCCCCSCTTTCCHHHHTT-------CBCTTHHHHHHHHHHHHHHHS----------SCSSCCS-
T ss_pred ccceeccCccc-----hhccCCCCCccChHHhcc-------cCCchhhehhHHHHHHHHHHC----------CCCCCCC-
Confidence 99976654322 134479999999999864 456899999999999999999 6777653
Q ss_pred CCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH--HHHHHhh
Q psy14889 366 PMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK--TLIKLAC 430 (443)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~--~L~~l~~ 430 (443)
........+.... ...+.. ....++..+.+++.+||+.||++|||+.++++ .+++...
T Consensus 211 ----~~~~~~~~~~~~~--~~~~~~-~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~ 270 (277)
T 3f3z_A 211 ----TDSEVMLKIREGT--FTFPEK-DWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQLS 270 (277)
T ss_dssp ----SHHHHHHHHHHCC--CCCCHH-HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHHC
T ss_pred ----CHHHHHHHHHhCC--CCCCch-hhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcccc
Confidence 2233333222221 111110 00135678999999999999999999999986 4444443
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=343.27 Aligned_cols=241 Identities=21% Similarity=0.284 Sum_probs=193.2
Q ss_pred hhhccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc---------chHHHHHHHHHHhccCCCceeeeeeccc
Q psy14889 133 TLAKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA---------SWSRETEIYSTVLLRHENILGYIGSDMT 201 (443)
Q Consensus 133 ~~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~---------~~~~e~ei~~~~~l~H~nIv~l~g~~~~ 201 (443)
...++|++.+.||+|+||.||+|.. +++.||||++...... ......|+..+..++||||+++++++.+
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 100 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN 100 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence 4557899999999999999999987 6889999998654211 1112345555666999999999999876
Q ss_pred cCCcccEEEeeecccCcc-cHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCc
Q psy14889 202 SRNSCTQLWLVTHYHSFG-SLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGT 279 (443)
Q Consensus 202 ~~~~~~~~~lv~e~~~~g-sL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~ 279 (443)
. ..+++||||+..| +|.+++.. ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.
T Consensus 101 ~----~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~--------~ivH~Dlkp~NIll~~~~~ 168 (335)
T 3dls_A 101 Q----GFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLK--------DIIHRDIKDENIVIAEDFT 168 (335)
T ss_dssp S----SEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHT--------TEECSCCSGGGEEECTTSC
T ss_pred C----CEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CeEEeccCHHHEEEcCCCc
Confidence 6 4589999999777 99999975 4799999999999999999999999 9999999999999999999
Q ss_pred EEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCC-CCccchHHHHHHHHHHHhcccCCCcccccC
Q psy14889 280 CVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFES-FKKADIYALGLVLWEVCRRTKANGIFEEYK 358 (443)
Q Consensus 280 ~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~-~~~sDvwS~Gvvl~elltg~~~~~~~~~~~ 358 (443)
+||+|||+++....... .....||+.|+|||++.+. .+ +.++|||||||++|||++| .
T Consensus 169 ~kL~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~------~~~~~~~DiwslG~il~el~~g----------~ 227 (335)
T 3dls_A 169 IKLIDFGSAAYLERGKL-----FYTFCGTIEYCAPEVLMGN------PYRGPELEMWSLGVTLYTLVFE----------E 227 (335)
T ss_dssp EEECCCTTCEECCTTCC-----BCEECSCGGGCCHHHHTTC------CBCSHHHHHHHHHHHHHHHHHS----------S
T ss_pred EEEeecccceECCCCCc-----eeccCCCccccChhhhcCC------CCCCCcccchhHHHHHHHHHhC----------C
Confidence 99999999977654322 1335799999999999875 33 5789999999999999999 6
Q ss_pred CCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHH
Q psy14889 359 APYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKT 424 (443)
Q Consensus 359 ~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 424 (443)
.||.... ... ......+ ..++.++.+|+.+||+.||++|||+.++++.
T Consensus 228 ~pf~~~~----------~~~---~~~~~~~-----~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 228 NPFCELE----------ETV---EAAIHPP-----YLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp CSCSSGG----------GGT---TTCCCCS-----SCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred CchhhHH----------HHH---hhccCCC-----cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 6765421 011 0111111 2255689999999999999999999999874
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=334.23 Aligned_cols=251 Identities=22% Similarity=0.335 Sum_probs=196.8
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc---chHHHHHHHHHHhccCCCceeeeeeccccCCcccEEE
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA---SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLW 210 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~---~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~ 210 (443)
++|++.+.||+|+||.||+|.. +++.||+|++...... ......|+..+..++||||+++++++..... ..++
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--~~~~ 83 (279)
T 2w5a_A 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTN--TTLY 83 (279)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGG--TEEE
T ss_pred hheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCC--ceEE
Confidence 6899999999999999999998 5899999998654322 2223456666667999999999998765432 4689
Q ss_pred eeecccCcccHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCC-----eEEeCCCCCCEEEcCCCcE
Q psy14889 211 LVTHYHSFGSLYDHLNR-----TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPA-----IAHRDIKSKNILVKTNGTC 280 (443)
Q Consensus 211 lv~e~~~~gsL~~~l~~-----~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~-----iiHrDlk~~NiLl~~~~~~ 280 (443)
+||||+++|+|.+++.. ..+++..++.++.|++.||.|||+. + |+||||||+|||++.++.+
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--------~~~~~~ivH~dl~p~NIl~~~~~~~ 155 (279)
T 2w5a_A 84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR--------SDGGHTVLHRDLKPANVFLDGKQNV 155 (279)
T ss_dssp EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH--------C------CCCCCSGGGEEECSSSCE
T ss_pred EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc--------cCCCCeeEEeccchhhEEEcCCCCE
Confidence 99999999999999964 2499999999999999999999998 6 9999999999999999999
Q ss_pred EEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCC
Q psy14889 281 VIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAP 360 (443)
Q Consensus 281 kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P 360 (443)
||+|||+++......... ....||+.|+|||.+.+. .++.++||||||+++|||++| ..|
T Consensus 156 kl~dfg~~~~~~~~~~~~----~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~il~~l~~g----------~~p 215 (279)
T 2w5a_A 156 KLGDFGLARILNHDTSFA----KTFVGTPYYMSPEQMNRM------SYNEKSDIWSLGCLLYELCAL----------MPP 215 (279)
T ss_dssp EECCCCHHHHC---CHHH----HHHHSCCTTCCHHHHHCC-------CCHHHHHHHHHHHHHHHHHS----------SCS
T ss_pred EEecCchheeeccccccc----cccCCCccccChHHhccC------CCCchhhHHHHHHHHHHHHHC----------CCC
Confidence 999999997654322110 123688999999999875 667899999999999999999 667
Q ss_pred CCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHH
Q psy14889 361 YHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIK 427 (443)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 427 (443)
|... ....+...+.. ...+.++ ..++.++.+++.+||+.||++|||+.|+++.+..
T Consensus 216 ~~~~-----~~~~~~~~i~~-~~~~~~~-----~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 216 FTAF-----SQKELAGKIRE-GKFRRIP-----YRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp SCCS-----SHHHHHHHHHH-TCCCCCC-----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred Cccc-----CHHHHHHHHhh-cccccCC-----cccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 7653 22333333322 2222333 2356789999999999999999999999986543
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=342.34 Aligned_cols=259 Identities=25% Similarity=0.359 Sum_probs=200.1
Q ss_pred HHhhhhccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc---------chHHHHHHHHHHhc-cCCCceeeee
Q psy14889 130 IQRTLAKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA---------SWSRETEIYSTVLL-RHENILGYIG 197 (443)
Q Consensus 130 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~---------~~~~e~ei~~~~~l-~H~nIv~l~g 197 (443)
....+.++|.+.+.||+|+||.||+|.+ +|+.||||++...... ......|+..+..+ +||||+++++
T Consensus 88 ~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 167 (365)
T 2y7j_A 88 AAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLID 167 (365)
T ss_dssp HHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred hhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEE
Confidence 3455667899999999999999999998 5899999998654311 11123445555556 8999999999
Q ss_pred eccccCCcccEEEeeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcC
Q psy14889 198 SDMTSRNSCTQLWLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKT 276 (443)
Q Consensus 198 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~ 276 (443)
++... ...++||||+++|+|.+++.. ..+++..+..++.||+.||.|||+. +|+||||||+|||++.
T Consensus 168 ~~~~~----~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~--------gi~H~Dlkp~NIl~~~ 235 (365)
T 2y7j_A 168 SYESS----SFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHAN--------NIVHRDLKPENILLDD 235 (365)
T ss_dssp EEEBS----SEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT--------TEECSCCSGGGEEECT
T ss_pred EEeeC----CEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CeecCCCCHHHEEECC
Confidence 98765 468999999999999999965 5799999999999999999999998 9999999999999999
Q ss_pred CCcEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccc
Q psy14889 277 NGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEE 356 (443)
Q Consensus 277 ~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~ 356 (443)
++.+||+|||++..+..... .....||+.|+|||++.+........++.++|||||||++|||++|
T Consensus 236 ~~~ikl~DfG~~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g--------- 301 (365)
T 2y7j_A 236 NMQIRLSDFGFSCHLEPGEK-----LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG--------- 301 (365)
T ss_dssp TCCEEECCCTTCEECCTTCC-----BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHS---------
T ss_pred CCCEEEEecCcccccCCCcc-----cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHC---------
Confidence 99999999999977654322 2345799999999998754322222577899999999999999999
Q ss_pred cCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 357 YKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 357 ~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
..||... ........+.........+. | ...+..+.+++.+||+.||++|||+.++++
T Consensus 302 -~~pf~~~-----~~~~~~~~i~~~~~~~~~~~-~--~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 302 -SPPFWHR-----RQILMLRMIMEGQYQFSSPE-W--DDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp -SCSSCCS-----SHHHHHHHHHHTCCCCCHHH-H--SSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred -CCCCCCC-----CHHHHHHHHHhCCCCCCCcc-c--ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 6777553 22223232222222111110 0 224567999999999999999999999986
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-43 Score=353.54 Aligned_cols=276 Identities=18% Similarity=0.224 Sum_probs=184.1
Q ss_pred hhccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc---chHHHHHHHHHHhccCCCceeeeeeccccC-Cccc
Q psy14889 134 LAKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA---SWSRETEIYSTVLLRHENILGYIGSDMTSR-NSCT 207 (443)
Q Consensus 134 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~---~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~-~~~~ 207 (443)
+.++|++.+.||+|+||.||+|.+ +++.||||++...... ......|+..+..++||||+++++++.... ....
T Consensus 51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 130 (458)
T 3rp9_A 51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD 130 (458)
T ss_dssp SCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred cCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence 457899999999999999999987 5899999988653222 122235666666699999999999986543 2224
Q ss_pred EEEeeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecC
Q psy14889 208 QLWLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFG 286 (443)
Q Consensus 208 ~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfG 286 (443)
.+|+||||+. |+|.+++.. ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||
T Consensus 131 ~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~--------~iiHrDlKp~NILl~~~~~~kl~DFG 201 (458)
T 3rp9_A 131 ELYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSA--------GILHRDLKPANCLVNQDCSVKVCDFG 201 (458)
T ss_dssp CEEEEECCCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHT--------TCBCCCCCGGGEEECTTCCEEECCCT
T ss_pred eEEEEEeccc-cchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhC--------CcCCCCCChhhEEECCCCCEeecccc
Confidence 6899999985 699999875 4699999999999999999999999 99999999999999999999999999
Q ss_pred CcccccccCCcCC-----------------------CCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHH
Q psy14889 287 LAVSYSQLSNKMD-----------------------IPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWE 343 (443)
Q Consensus 287 la~~~~~~~~~~~-----------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~e 343 (443)
+|+.......... ......+||+.|+|||++.... .++.++|||||||++||
T Consensus 202 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-----~~~~~~DiwSlG~il~e 276 (458)
T 3rp9_A 202 LARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQE-----NYTEAIDVWSIGCIFAE 276 (458)
T ss_dssp TCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCC-----CCCTHHHHHHHHHHHHH
T ss_pred cchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCC-----CCCcHhHHHHHHHHHHH
Confidence 9987653221100 1123457899999999875431 57789999999999999
Q ss_pred HHhcccCCCcccc-cCCCCCCCCCCCC----------------ChHHHHhhhhhc-----------------------CC
Q psy14889 344 VCRRTKANGIFEE-YKAPYHDLVPMDP----------------SFDDMRKVICID-----------------------QQ 383 (443)
Q Consensus 344 lltg~~~~~~~~~-~~~P~~~~~~~~~----------------~~~~~~~~~~~~-----------------------~~ 383 (443)
|++|..++..+.. +..+|.+...... ..+.+..+.... ..
T Consensus 277 lltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~ 356 (458)
T 3rp9_A 277 LLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPK 356 (458)
T ss_dssp HHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCC
T ss_pred HHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCC
Confidence 9997554332222 2333433210000 001111110000 00
Q ss_pred CCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 384 RPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 384 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
....+-.......+.++.+|+.+||..||++|||++|+++
T Consensus 357 ~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~ 396 (458)
T 3rp9_A 357 REGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLA 396 (458)
T ss_dssp CCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 0000000001224678999999999999999999999987
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=346.17 Aligned_cols=243 Identities=22% Similarity=0.335 Sum_probs=187.4
Q ss_pred ccceeeeecCeEEEEEEE--CCceeEEEEeeccCc-cchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEeeeccc
Q psy14889 140 LSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDE-ASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVTHYH 216 (443)
Q Consensus 140 ~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e~~ 216 (443)
..+.||+|+||.||+|.. +|+.||+|++..... .......|+..+..++||||+++++++.+. ..+++||||+
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~----~~~~lv~E~~ 168 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESK----NDIVLVMEYV 168 (373)
T ss_dssp EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECS----SEEEEEEECC
T ss_pred cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEEC----CEEEEEEeCC
Confidence 367899999999999998 589999999876442 222335667777779999999999998776 4589999999
Q ss_pred CcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEE--cCCCcEEEEecCCccccc
Q psy14889 217 SFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILV--KTNGTCVIADFGLAVSYS 292 (443)
Q Consensus 217 ~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl--~~~~~~kl~DfGla~~~~ 292 (443)
++|+|.+++.. ..+++..+..++.||+.||.|||+. +|+||||||+|||+ +.++.+||+|||+++.+.
T Consensus 169 ~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--------~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~ 240 (373)
T 2x4f_A 169 DGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQM--------YILHLDLKPENILCVNRDAKQIKIIDFGLARRYK 240 (373)
T ss_dssp TTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHT--------TEECCCCCGGGEEEEETTTTEEEECCCSSCEECC
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--------CcccccCCHHHEEEecCCCCcEEEEeCCCceecC
Confidence 99999998854 4699999999999999999999999 99999999999999 566799999999998765
Q ss_pred ccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCChH
Q psy14889 293 QLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFD 372 (443)
Q Consensus 293 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~~~ 372 (443)
.... .....||+.|+|||++.+. .++.++|||||||++|||++| ..||.... ..+
T Consensus 241 ~~~~-----~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~elltg----------~~pf~~~~----~~~ 295 (373)
T 2x4f_A 241 PREK-----LKVNFGTPEFLAPEVVNYD------FVSFPTDMWSVGVIAYMLLSG----------LSPFLGDN----DAE 295 (373)
T ss_dssp TTCB-----CCCCCSSCTTCCHHHHTTC------BCCHHHHHHHHHHHHHHHHHS----------SCTTCCSS----HHH
T ss_pred Cccc-----cccccCCCcEeChhhccCC------CCCcHHhHHHHHHHHHHHHhC----------CCCCCCCC----HHH
Confidence 4322 1334799999999999765 567899999999999999999 67776531 122
Q ss_pred HHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 373 DMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
.+..+... .. .++.. .....+.++.+|+.+||+.||.+|||+.|+++
T Consensus 296 ~~~~i~~~-~~--~~~~~-~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 296 TLNNILAC-RW--DLEDE-EFQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp HHHHHHHT-CC--CSCSG-GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHHhc-cC--CCChh-hhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 22333322 11 11110 01235678999999999999999999999987
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=328.92 Aligned_cols=243 Identities=24% Similarity=0.419 Sum_probs=193.6
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCc----cchHHHHHHHHHHhccCCCceeeeeeccccCCcccEE
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDE----ASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQL 209 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~----~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~ 209 (443)
++|++.+.||+|+||.||+|.+ ++..||||++..... .......|+..+..++||||+++++++.+. ...
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----~~~ 84 (279)
T 3fdn_A 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA----TRV 84 (279)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS----SEE
T ss_pred ccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecC----CEE
Confidence 6899999999999999999998 477899999854321 122234566666669999999999998766 457
Q ss_pred EeeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCc
Q psy14889 210 WLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA 288 (443)
Q Consensus 210 ~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla 288 (443)
++||||+++|+|.+++.+ ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 85 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~--------~i~H~dlkp~Nili~~~~~~~l~Dfg~~ 156 (279)
T 3fdn_A 85 YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK--------RVIHRDIKPENLLLGSAGELKIADFGWS 156 (279)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTT--------TCEECCCCGGGEEECTTSCEEECSCCEE
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CEecccCChHhEEEcCCCCEEEEecccc
Confidence 999999999999999865 6799999999999999999999988 9999999999999999999999999998
Q ss_pred ccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCC
Q psy14889 289 VSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMD 368 (443)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~ 368 (443)
....... .....||+.|+|||.+.+. .++.++||||||+++|||++| ..||...
T Consensus 157 ~~~~~~~------~~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~il~~l~~g----------~~p~~~~---- 210 (279)
T 3fdn_A 157 VHAPSSR------RTDLCGTLDYLPPEMIEGR------MHDEKVDLWSLGVLCYEFLVG----------KPPFEAN---- 210 (279)
T ss_dssp SCC--------------CCCCTTCCHHHHTTC------CCCTTHHHHHHHHHHHHHHHS----------SCTTCCS----
T ss_pred ccCCccc------ccccCCCCCccCHhHhccC------CCCccchhHhHHHHHHHHHHC----------CCCCCCC----
Confidence 5543321 1334789999999999876 566899999999999999999 6777643
Q ss_pred CChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHH
Q psy14889 369 PSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKT 424 (443)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 424 (443)
........+.. .....+ ...+..+.+|+.+||+.||++|||+.|+++.
T Consensus 211 -~~~~~~~~~~~--~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 211 -TYQETYKRISR--VEFTFP-----DFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp -SHHHHHHHHHH--TCCCCC-----TTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred -cHHHHHHHHHh--CCCCCC-----CcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 22333332222 122222 2355779999999999999999999999974
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=330.71 Aligned_cols=248 Identities=24% Similarity=0.382 Sum_probs=194.9
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc---chHHHHHHHHHHhccCCCceeeeeeccccCCcccEEE
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA---SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLW 210 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~---~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~ 210 (443)
+.|.+.+.||+|+||.||+|.+ ++..||+|++...... ......|+..+..++||||+++++++.........++
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 4688999999999999999998 5788999988654322 2223456777777999999999999876544446789
Q ss_pred eeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCC--eEEeCCCCCCEEEc-CCCcEEEEecC
Q psy14889 211 LVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPA--IAHRDIKSKNILVK-TNGTCVIADFG 286 (443)
Q Consensus 211 lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~--iiHrDlk~~NiLl~-~~~~~kl~DfG 286 (443)
+||||+++|+|.+++.. ..+++..+..++.|++.||.|||+. + |+||||||+|||++ .++.+||+|||
T Consensus 106 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~--------~~~i~H~dikp~Nil~~~~~~~~kl~Dfg 177 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR--------TPPIIHRDLKCDNIFITGPTGSVKIGDLG 177 (290)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS--------SSCCCCSCCCGGGEEESSTTSCEEECCTT
T ss_pred EEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcC--------CCCEEECCCCHHHEEEECCCCCEEEeeCC
Confidence 99999999999999976 6799999999999999999999998 6 99999999999998 78899999999
Q ss_pred CcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCC
Q psy14889 287 LAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVP 366 (443)
Q Consensus 287 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~ 366 (443)
++........ ....||+.|+|||++.+ .++.++||||||+++|||++| ..||....
T Consensus 178 ~~~~~~~~~~------~~~~~t~~y~aPE~~~~-------~~~~~~Di~slG~~l~~l~~g----------~~pf~~~~- 233 (290)
T 1t4h_A 178 LATLKRASFA------KAVIGTPEFMAPEMYEE-------KYDESVDVYAFGMCMLEMATS----------EYPYSECQ- 233 (290)
T ss_dssp GGGGCCTTSB------EESCSSCCCCCGGGGGT-------CCCTHHHHHHHHHHHHHHHHS----------SCTTTTCS-
T ss_pred Cccccccccc------ccccCCcCcCCHHHHhc-------cCCCcchHHHHHHHHHHHHhC----------CCCCCCcC-
Confidence 9965443221 23468999999998864 466899999999999999999 67776531
Q ss_pred CCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 367 MDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
........+......... +...+.++.+++.+||+.||++|||+.|+++
T Consensus 234 ---~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 234 ---NAAQIYRRVTSGVKPASF-----DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp ---SHHHHHHHHTTTCCCGGG-----GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ---cHHHHHHHHhccCCcccc-----CCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 223333322221111111 1234467999999999999999999999885
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=341.52 Aligned_cols=261 Identities=23% Similarity=0.331 Sum_probs=200.5
Q ss_pred hhhccccccceeeeecCeEEEEEEE-------CCceeEEEEeeccCc--cchHHHHHHHHHHhccCCCceeeeeeccccC
Q psy14889 133 TLAKQISLSECIGKGRYGEVWRGVW-------HGENVAVKIFFSRDE--ASWSRETEIYSTVLLRHENILGYIGSDMTSR 203 (443)
Q Consensus 133 ~~~~~~~~~~~lG~G~fg~Vy~~~~-------~~~~vAvK~~~~~~~--~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~ 203 (443)
...++|++.+.||+|+||.||+|.+ ++..||||++..... .......|+..+..++||||+++++++....
T Consensus 27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (327)
T 2yfx_A 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 106 (327)
T ss_dssp CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC
Confidence 3457899999999999999999984 366899999854322 2223345666666799999999999988764
Q ss_pred CcccEEEeeecccCcccHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEc
Q psy14889 204 NSCTQLWLVTHYHSFGSLYDHLNRT--------TLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVK 275 (443)
Q Consensus 204 ~~~~~~~lv~e~~~~gsL~~~l~~~--------~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~ 275 (443)
..++||||+++|+|.+++... .+++..++.++.|++.||.|||+. +|+||||||+|||++
T Consensus 107 ----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~--------~i~H~dlkp~NIli~ 174 (327)
T 2yfx_A 107 ----PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN--------HFIHRDIAARNCLLT 174 (327)
T ss_dssp ----SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT--------TCCCSCCCGGGEEES
T ss_pred ----CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC--------CeecCcCCHhHEEEe
Confidence 368999999999999999643 489999999999999999999999 999999999999998
Q ss_pred C---CCcEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh-cccCC
Q psy14889 276 T---NGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR-RTKAN 351 (443)
Q Consensus 276 ~---~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt-g~~~~ 351 (443)
. +..+||+|||++.......... ......||+.|+|||.+.+. .++.++||||||+++|||+| |
T Consensus 175 ~~~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~il~ellt~g---- 242 (327)
T 2yfx_A 175 CPGPGRVAKIGDFGMARDIYRASYYR--KGGCAMLPVKWMPPEAFMEG------IFTSKTDTWSFGVLLWEIFSLG---- 242 (327)
T ss_dssp CSSTTCCEEECCCHHHHHHHC--------CCGGGSCGGGCCHHHHHHC------CCCHHHHHHHHHHHHHHHHTTS----
T ss_pred cCCCcceEEECccccccccccccccc--cCCCcCCCcceeCHhHhcCC------CCCchhhHHHHHHHHHHHHcCC----
Confidence 4 4469999999997654322111 12334678999999999776 67789999999999999998 7
Q ss_pred CcccccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhhc
Q psy14889 352 GIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLACA 431 (443)
Q Consensus 352 ~~~~~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~~ 431 (443)
..||... ........+... ..+..+ ..++..+.+++.+||+.||.+|||+.++++.|+.+...
T Consensus 243 ------~~p~~~~-----~~~~~~~~~~~~-~~~~~~-----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 305 (327)
T 2yfx_A 243 ------YMPYPSK-----SNQEVLEFVTSG-GRMDPP-----KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305 (327)
T ss_dssp ------CCSSTTC-----CHHHHHHHHHTT-CCCCCC-----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ------CCCCCCc-----CHHHHHHHHhcC-CCCCCC-----CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence 6677653 223333333222 222222 33567899999999999999999999999999998775
Q ss_pred ccc
Q psy14889 432 DMY 434 (443)
Q Consensus 432 ~~~ 434 (443)
...
T Consensus 306 ~~~ 308 (327)
T 2yfx_A 306 PDV 308 (327)
T ss_dssp HHH
T ss_pred HHH
Confidence 543
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-43 Score=358.55 Aligned_cols=248 Identities=23% Similarity=0.289 Sum_probs=197.9
Q ss_pred hccccccceeeeecCeEEEEEEE--CCceeEEEEeeccC----ccchHHHHHHHHHHhccCCCceeeeeeccccCCcccE
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRD----EASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQ 208 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~----~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~ 208 (443)
.++|.+.+.||+|+||.||+|+. +|+.||||++.... ........|+..+..++||||+++++++.+. ..
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~----~~ 258 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETK----DA 258 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECS----SE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeC----CE
Confidence 46799999999999999999998 58999999986532 1122223455555569999999999998776 45
Q ss_pred EEeeecccCcccHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEec
Q psy14889 209 LWLVTHYHSFGSLYDHLNR---TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADF 285 (443)
Q Consensus 209 ~~lv~e~~~~gsL~~~l~~---~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~Df 285 (443)
+++||||+++|+|.+++.. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+||
T Consensus 259 l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~--------gIvHrDLKPeNILld~~g~vKL~DF 330 (576)
T 2acx_A 259 LCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE--------RIVYRDLKPENILLDDHGHIRISDL 330 (576)
T ss_dssp EEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHT--------TEECCCCCGGGEEECTTSCEEECCC
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC--------CEeccCCchheEEEeCCCCeEEEec
Confidence 8999999999999999865 3499999999999999999999999 9999999999999999999999999
Q ss_pred CCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCC
Q psy14889 286 GLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLV 365 (443)
Q Consensus 286 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~ 365 (443)
|+++....... .....||+.|+|||++.+. .++.++|||||||++|||++| ..||....
T Consensus 331 Gla~~~~~~~~-----~~~~~GT~~Y~APEvl~~~------~~~~~~DiwSLGvilyeLltG----------~~PF~~~~ 389 (576)
T 2acx_A 331 GLAVHVPEGQT-----IKGRVGTVGYMAPEVVKNE------RYTFSPDWWALGCLLYEMIAG----------QSPFQQRK 389 (576)
T ss_dssp TTCEECCTTCC-----EECCCSCGGGCCHHHHTTC------EESSHHHHHHHHHHHHHHHHS----------SCSSSCSS
T ss_pred ccceecccCcc-----ccccCCCccccCHHHHcCC------CCCccchHHHHHHHHHHHHhC----------CCCCcccc
Confidence 99987654321 1234799999999999876 567899999999999999999 67776542
Q ss_pred CCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCC-----cHHHHHH
Q psy14889 366 PMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRL-----SALRVKK 423 (443)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~ 423 (443)
.. .....+...+... ...++ ...+.++.+|+.+||+.||++|| ++.||++
T Consensus 390 ~~-~~~~~i~~~i~~~--~~~~p-----~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 390 KK-IKREEVERLVKEV--PEEYS-----ERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp SC-CCHHHHHHHHHHC--CCCCC-----TTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred cc-hhHHHHHHHhhcc--cccCC-----ccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 21 1233344333221 22222 33567899999999999999999 7888875
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=368.11 Aligned_cols=249 Identities=21% Similarity=0.344 Sum_probs=195.1
Q ss_pred ceeeeecCeEEEEEEE----CCceeEEEEeeccCccc---hHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEeeec
Q psy14889 142 ECIGKGRYGEVWRGVW----HGENVAVKIFFSRDEAS---WSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVTH 214 (443)
Q Consensus 142 ~~lG~G~fg~Vy~~~~----~~~~vAvK~~~~~~~~~---~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e 214 (443)
+.||+|+||.||+|.+ .++.||||+++...... .....|+..+..++|||||++++++... .+++|||
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-----~~~lv~E 449 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-----SWMLVME 449 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESS-----SEEEEEE
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-----CEEEEEE
Confidence 4799999999999976 35789999986543221 2334566666669999999999998543 3689999
Q ss_pred ccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcccccc
Q psy14889 215 YHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQ 293 (443)
Q Consensus 215 ~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~~~ 293 (443)
|+++|+|.+++.. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 450 ~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~--------~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 521 (635)
T 4fl3_A 450 MAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES--------NFVHRDLAARNVLLVTQHYAKISDFGLSKALRA 521 (635)
T ss_dssp CCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT--------TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC
T ss_pred ccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHC--------CEeCCCCChHhEEEeCCCCEEEEEcCCcccccc
Confidence 9999999999965 5699999999999999999999999 999999999999999999999999999987654
Q ss_pred cCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh-cccCCCcccccCCCCCCCCCCCCChH
Q psy14889 294 LSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR-RTKANGIFEEYKAPYHDLVPMDPSFD 372 (443)
Q Consensus 294 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt-g~~~~~~~~~~~~P~~~~~~~~~~~~ 372 (443)
..... .......||+.|+|||++.+. .++.++|||||||++|||++ | ..||.+. ...
T Consensus 522 ~~~~~-~~~~~~~~t~~y~APE~~~~~------~~~~~sDvwSlGv~l~ellt~G----------~~Pf~~~-----~~~ 579 (635)
T 4fl3_A 522 DENYY-KAQTHGKWPVKWYAPECINYY------KFSSKSDVWSFGVLMWEAFSYG----------QKPYRGM-----KGS 579 (635)
T ss_dssp --------------CGGGSCHHHHHHC------CCCHHHHHHHHHHHHHHHHTTT----------CCSSTTC-----CHH
T ss_pred Ccccc-ccccCCCCceeeeChhhhcCC------CCCcHHHHHHHHHHHHHHHhCC----------CCCCCCC-----CHH
Confidence 33221 112334577899999999776 67789999999999999998 8 7788664 333
Q ss_pred HHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhhc
Q psy14889 373 DMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLACA 431 (443)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~~ 431 (443)
++...+.. ..++..+ ..++.++.+||.+||+.||++|||+.+|++.|+++...
T Consensus 580 ~~~~~i~~-~~~~~~p-----~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 632 (635)
T 4fl3_A 580 EVTAMLEK-GERMGCP-----AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 632 (635)
T ss_dssp HHHHHHHT-TCCCCCC-----TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHc-CCCCCCC-----CCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 44444432 2333333 34678899999999999999999999999999987653
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-43 Score=354.90 Aligned_cols=254 Identities=24% Similarity=0.296 Sum_probs=187.4
Q ss_pred hccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc---chHHHHHHHHHHhccCCCceeeeeeccccC--Cccc
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA---SWSRETEIYSTVLLRHENILGYIGSDMTSR--NSCT 207 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~---~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~--~~~~ 207 (443)
.++|++.+.||+|+||.||+|.. +|+.||||++...... ......|+..+..++||||+++++++.... ....
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 47899999999999999999987 5889999998654221 222345666666799999999999987553 2235
Q ss_pred EEEeeecccCcccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCC
Q psy14889 208 QLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGL 287 (443)
Q Consensus 208 ~~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGl 287 (443)
.+++||||+.+ +|.+.+.. .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~-~l~~~~~~~~~~qil~aL~~lH~~--------~iiHrDlkp~NIll~~~~~~kl~DFG~ 210 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQM-ELDHERMSYLLYQMLCGIKHLHSA--------GIIHRDLKPSNIVVKSDCTLKILDFGL 210 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTS-CCCHHHHHHHHHHHHHHHHHHHHT--------TCCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred eEEEEEeCCCC-CHHHHHhh-cCCHHHHHHHHHHHHHHHHHHHHC--------CcccCCCChHhEEEeCCCCEEEEEEEe
Confidence 68999999986 57666643 499999999999999999999999 999999999999999999999999999
Q ss_pred cccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCC
Q psy14889 288 AVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPM 367 (443)
Q Consensus 288 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~ 367 (443)
|+...... ......||+.|+|||++.+. .++.++|||||||++|||++| ..||.+..
T Consensus 211 a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwSlG~il~ell~g----------~~pF~g~~-- 267 (464)
T 3ttj_A 211 ARTAGTSF-----MMTPYVVTRYYRAPEVILGM------GYKENVDIWSVGCIMGEMVRH----------KILFPGRD-- 267 (464)
T ss_dssp C-----CC-----CC----CCCTTCCHHHHTTC------CCCTTHHHHHHHHHHHHHHHS----------SCSSCCSS--
T ss_pred eeecCCCc-----ccCCCcccccccCHHHHcCC------CCCHHHHHHHHHHHHHHHHhC----------CCCCCCCC--
Confidence 97665321 12446899999999999876 677899999999999999999 55665421
Q ss_pred CCChHHHHhhhhhc-------------------CCCCCCCCCC----CC-----------chhHHHHHHHHHHHhcCCcC
Q psy14889 368 DPSFDDMRKVICID-------------------QQRPVLPNRW----VS-----------DSTLNAMTKVMKECWHQNAN 413 (443)
Q Consensus 368 ~~~~~~~~~~~~~~-------------------~~~~~~~~~~----~~-----------~~~~~~l~~li~~cl~~dP~ 413 (443)
..+.+..++... ...+...... .+ ...+.++.+|+.+||+.||+
T Consensus 268 --~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~ 345 (464)
T 3ttj_A 268 --YIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPA 345 (464)
T ss_dssp --HHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTT
T ss_pred --HHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChh
Confidence 111111111100 0111111000 00 01256799999999999999
Q ss_pred CCCcHHHHHH
Q psy14889 414 VRLSALRVKK 423 (443)
Q Consensus 414 ~Rps~~evl~ 423 (443)
+|||+.|+++
T Consensus 346 ~R~ta~e~L~ 355 (464)
T 3ttj_A 346 KRISVDDALQ 355 (464)
T ss_dssp TSCCHHHHHT
T ss_pred hCCCHHHHhc
Confidence 9999999987
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-43 Score=336.99 Aligned_cols=257 Identities=27% Similarity=0.428 Sum_probs=192.3
Q ss_pred hhccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccchHHHHHHHHHHhc-cCCCceeeeeeccccCCc--ccE
Q psy14889 134 LAKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEASWSRETEIYSTVLL-RHENILGYIGSDMTSRNS--CTQ 208 (443)
Q Consensus 134 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~e~ei~~~~~l-~H~nIv~l~g~~~~~~~~--~~~ 208 (443)
..++|++.+.||+|+||.||+|.+ +|+.||||++............|+..+..+ +||||+++++++...... ...
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~ 101 (326)
T 2x7f_A 22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ 101 (326)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccce
Confidence 457899999999999999999998 689999999876544444445556555556 899999999998764311 246
Q ss_pred EEeeecccCcccHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEec
Q psy14889 209 LWLVTHYHSFGSLYDHLNR---TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADF 285 (443)
Q Consensus 209 ~~lv~e~~~~gsL~~~l~~---~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~Df 285 (443)
+++||||+++|+|.+++.. ..+++..+..++.||+.||.|||+. +|+|+||||+|||++.++.+||+||
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--------~ivH~dlkp~NIl~~~~~~~kl~Df 173 (326)
T 2x7f_A 102 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH--------KVIHRDIKGQNVLLTENAEVKLVDF 173 (326)
T ss_dssp EEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT--------TCCCCCCSGGGEEECTTCCEEECCC
T ss_pred EEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC--------CccccCCcHHHEEEcCCCCEEEeeC
Confidence 8999999999999999964 5699999999999999999999999 9999999999999999999999999
Q ss_pred CCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCC
Q psy14889 286 GLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLV 365 (443)
Q Consensus 286 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~ 365 (443)
|++......... .....||+.|+|||++...... ...++.++||||||+++|||++| ..||.+..
T Consensus 174 g~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~-~~~~~~~~Di~slG~il~~l~~g----------~~p~~~~~ 238 (326)
T 2x7f_A 174 GVSAQLDRTVGR----RNTFIGTPYWMAPEVIACDENP-DATYDFKSDLWSLGITAIEMAEG----------APPLCDMH 238 (326)
T ss_dssp TTTC-----------------CCGGGCCHHHHC---------CCTTHHHHHHHHHHHHHHHS----------SCTTTTSC
T ss_pred cCceecCcCccc----cccccCCccccChhhhcccccc-CcCCCccchHHHHHHHHHHHHhC----------CCCCCCCc
Confidence 998765432211 1334789999999998732111 01567899999999999999999 66775531
Q ss_pred CCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 366 PMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
.......+... ..+... ....+..+.+++.+||+.||++|||+.++++
T Consensus 239 -----~~~~~~~~~~~-~~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 239 -----PMRALFLIPRN-PAPRLK----SKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp -----HHHHHHHHHHS-CCCCCS----CSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred -----HHHHHHHhhcC-ccccCC----ccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 12222222211 112211 2335678999999999999999999999987
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-43 Score=330.76 Aligned_cols=244 Identities=24% Similarity=0.361 Sum_probs=175.1
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCc----cchHHHHHHHHHHhccCCCceeeeeeccccCCcccEE
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDE----ASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQL 209 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~----~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~ 209 (443)
++|++.+.||+|+||.||+|.. +|+.||||++..... .......|+..+..++||||+++++++.+. ...
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----~~~ 86 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDS----NYV 86 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECS----SEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccC----CeE
Confidence 6799999999999999999997 689999999864321 112334566666779999999999998775 458
Q ss_pred EeeecccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCC
Q psy14889 210 WLVTHYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGL 287 (443)
Q Consensus 210 ~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGl 287 (443)
++||||+++++|.+++.. ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--------~i~H~dl~p~Nili~~~~~~kl~dfg~ 158 (278)
T 3cok_A 87 YLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSH--------GILHRDLTLSNLLLTRNMNIKIADFGL 158 (278)
T ss_dssp EEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHT--------TEECSSCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC--------CeecCCCCHHHEEEcCCCCEEEEeecc
Confidence 999999999999999975 5699999999999999999999999 999999999999999999999999999
Q ss_pred cccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCC
Q psy14889 288 AVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPM 367 (443)
Q Consensus 288 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~ 367 (443)
+......... .....||+.|+|||.+.+. .++.++||||||+++|||++| ..||......
T Consensus 159 ~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~il~~l~~g----------~~p~~~~~~~ 218 (278)
T 3cok_A 159 ATQLKMPHEK----HYTLCGTPNYISPEIATRS------AHGLESDVWSLGCMFYTLLIG----------RPPFDTDTVK 218 (278)
T ss_dssp CEECC--------------------------------------CTHHHHHHHHHHHHHHS----------SCSSCCCSCC
T ss_pred eeeccCCCCc----ceeccCCCCcCCcchhcCC------CCCchhhHHHHHHHHHHHHhC----------CCCCCChhHH
Confidence 9766532221 1234689999999998865 566899999999999999999 5566543211
Q ss_pred CCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 368 DPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
........ .....+ ...+.++.+++.+||+.||++|||+.++++
T Consensus 219 ----~~~~~~~~---~~~~~~-----~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 219 ----NTLNKVVL---ADYEMP-----SFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp ---------CCS---SCCCCC-----TTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ----HHHHHHhh---cccCCc-----cccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 11111110 111122 235578999999999999999999999886
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=333.19 Aligned_cols=260 Identities=25% Similarity=0.425 Sum_probs=193.2
Q ss_pred hccccccceeeeecCeEEEEEEEC---Cc--eeEEEEeeccC----ccchHHHHHHHHHHhccCCCceeeeeeccccCCc
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVWH---GE--NVAVKIFFSRD----EASWSRETEIYSTVLLRHENILGYIGSDMTSRNS 205 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~--~vAvK~~~~~~----~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~ 205 (443)
.++|++.+.||+|+||.||+|.+. ++ .||||++.... ........|+..+..++||||+++++++....
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 94 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-- 94 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC--
Confidence 368999999999999999999862 23 58999876432 11223345666667799999999999987653
Q ss_pred ccEEEeeecccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEE
Q psy14889 206 CTQLWLVTHYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIA 283 (443)
Q Consensus 206 ~~~~~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~ 283 (443)
.++||||+++|+|.+++.. ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+
T Consensus 95 ---~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~--------~i~H~dikp~Nili~~~~~~kl~ 163 (291)
T 1u46_A 95 ---MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK--------RFIHRDLAARNLLLATRDLVKIG 163 (291)
T ss_dssp ---CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHT--------TEECSCCCGGGEEEEETTEEEEC
T ss_pred ---ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhC--------CcccCCCchheEEEcCCCCEEEc
Confidence 5899999999999999964 5699999999999999999999999 99999999999999999999999
Q ss_pred ecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh-cccCCCcccccCCCCC
Q psy14889 284 DFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR-RTKANGIFEEYKAPYH 362 (443)
Q Consensus 284 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt-g~~~~~~~~~~~~P~~ 362 (443)
|||++.......... .......+|..|+|||.+.+. .++.++||||||+++|||++ | ..||.
T Consensus 164 Dfg~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~il~~l~~~g----------~~p~~ 226 (291)
T 1u46_A 164 DFGLMRALPQNDDHY-VMQEHRKVPFAWCAPESLKTR------TFSHASDTWMFGVTLWEMFTYG----------QEPWI 226 (291)
T ss_dssp CCTTCEECCC-CCEE-EC-----CCGGGCCHHHHHHC------EEEHHHHHHHHHHHHHHHHTTS----------CCTTT
T ss_pred cccccccccccccch-hhhccCCCCceeeCchhhcCC------CCCchhhHHHHHHHHHHHHhCC----------CCCcc
Confidence 999998765432211 112234678899999999765 45679999999999999999 8 67776
Q ss_pred CCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhhcccc
Q psy14889 363 DLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLACADMY 434 (443)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~~~~~ 434 (443)
.. ........+.........+ ..++..+.+++.+||+.||++|||+.++++.|+++......
T Consensus 227 ~~-----~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 288 (291)
T 1u46_A 227 GL-----NGSQILHKIDKEGERLPRP-----EDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTDMR 288 (291)
T ss_dssp TC-----CHHHHHHHHHTSCCCCCCC-----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-----
T ss_pred cC-----CHHHHHHHHHccCCCCCCC-----cCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccchh
Confidence 53 2233333332222222222 34667899999999999999999999999999998766543
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=328.85 Aligned_cols=241 Identities=23% Similarity=0.363 Sum_probs=189.8
Q ss_pred hhccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCc---cchHHHHHHHHHHhc-cCCCceeeeeeccccCCccc
Q psy14889 134 LAKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDE---ASWSRETEIYSTVLL-RHENILGYIGSDMTSRNSCT 207 (443)
Q Consensus 134 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~---~~~~~e~ei~~~~~l-~H~nIv~l~g~~~~~~~~~~ 207 (443)
..++|++.+.||+|+||.||+|.. +++.||||++..... .......|+..+..+ +||||+++++++.+. .
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~----~ 84 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAED----D 84 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEET----T
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecC----C
Confidence 447899999999999999999998 589999999875422 222334566666556 999999999998766 4
Q ss_pred EEEeeecccCcccHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCC-----
Q psy14889 208 QLWLVTHYHSFGSLYDHLNR-----TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTN----- 277 (443)
Q Consensus 208 ~~~lv~e~~~~gsL~~~l~~-----~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~----- 277 (443)
..++||||+++|+|.+++.. ..+++..+..++.||+.||.|||+. +|+||||||+|||++.+
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~--------~ivH~Dikp~NIl~~~~~~~~~ 156 (289)
T 1x8b_A 85 HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM--------SLVHMDIKPSNIFISRTSIPNA 156 (289)
T ss_dssp EEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT--------TEECSCCSGGGEEEC-------
T ss_pred eEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC--------CEeecCCCHHHEEEcCCCCCcc
Confidence 68999999999999999964 5689999999999999999999999 99999999999999844
Q ss_pred --------------CcEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHH
Q psy14889 278 --------------GTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWE 343 (443)
Q Consensus 278 --------------~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~e 343 (443)
..+||+|||++...... ....||+.|+|||.+.+.. .++.++||||||+++||
T Consensus 157 ~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--------~~~~gt~~y~aPE~~~~~~-----~~~~~~Di~slG~il~~ 223 (289)
T 1x8b_A 157 ASEEGDEDDWASNKVMFKIGDLGHVTRISSP--------QVEEGDSRFLANEVLQENY-----THLPKADIFALALTVVC 223 (289)
T ss_dssp -------------CCCEEECCCTTCEETTCS--------CCCCCCGGGCCHHHHTTCC-----TTHHHHHHHHHHHHHHH
T ss_pred cccccccccccCCceEEEEcccccccccCCc--------cccCCCccccChhHhcCCC-----CCCchhhHHHHHHHHHH
Confidence 47999999999766532 2235899999999997642 34479999999999999
Q ss_pred HHhcccCCCcccccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 344 VCRRTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 344 lltg~~~~~~~~~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
|++| ..|+... ....... ....+.++ ..++..+.+++.+||+.||++|||+.|+++
T Consensus 224 l~~~----------~~~~~~~-------~~~~~~~--~~~~~~~~-----~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 224 AAGA----------EPLPRNG-------DQWHEIR--QGRLPRIP-----QVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp HTTC----------CCCCSSS-------HHHHHHH--TTCCCCCS-----SCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HhcC----------CCCCcch-------hHHHHHH--cCCCCCCC-----cccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 9998 3333221 1222221 12223333 335678999999999999999999999875
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=343.47 Aligned_cols=250 Identities=24% Similarity=0.373 Sum_probs=194.5
Q ss_pred ccccccceeeeecCeEEEEEEE-----CCceeEEEEeeccC-------ccchHHHHHHHHHHhc-cCCCceeeeeecccc
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW-----HGENVAVKIFFSRD-------EASWSRETEIYSTVLL-RHENILGYIGSDMTS 202 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~-----~~~~vAvK~~~~~~-------~~~~~~e~ei~~~~~l-~H~nIv~l~g~~~~~ 202 (443)
++|++.+.||+|+||.||+|+. +++.||||++.... ......|.+++.. + +||||+++++++...
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~--l~~h~~iv~~~~~~~~~ 131 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH--IRQSPFLVTLHYAFQTE 131 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHH--HHTCTTBCCEEEEEEET
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHH--ccCCCceeEEEEEEeeC
Confidence 6899999999999999999987 58899999885422 1223345555444 6 699999999998766
Q ss_pred CCcccEEEeeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEE
Q psy14889 203 RNSCTQLWLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCV 281 (443)
Q Consensus 203 ~~~~~~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~k 281 (443)
..+++||||+++|+|.+++.. ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+|
T Consensus 132 ----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~--------~ivH~Dlkp~NIll~~~~~~k 199 (355)
T 1vzo_A 132 ----TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKL--------GIIYRDIKLENILLDSNGHVV 199 (355)
T ss_dssp ----TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT--------TCCCCCCCGGGEEECTTSCEE
T ss_pred ----ceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC--------CcccCCCCHHHEEECCCCcEE
Confidence 458999999999999999964 6799999999999999999999998 999999999999999999999
Q ss_pred EEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCC
Q psy14889 282 IADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPY 361 (443)
Q Consensus 282 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~ 361 (443)
|+|||+++.+....... .....||+.|+|||++.+... .++.++|||||||++|||++| ..||
T Consensus 200 l~DfG~a~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~----~~~~~~DvwslG~il~ell~g----------~~pf 262 (355)
T 1vzo_A 200 LTDFGLSKEFVADETER---AYDFCGTIEYMAPDIVRGGDS----GHDKAVDWWSLGVLMYELLTG----------ASPF 262 (355)
T ss_dssp ESCSSEEEECCGGGGGG---GCGGGSCCTTCCHHHHTTCC-------CTHHHHHHHHHHHHHHHHS----------SCTT
T ss_pred EeeCCCCeecccCCCCc---ccCcccCcCccChhhhcCCCC----CCCchhhHHHHHHHHHHHHHC----------CCCC
Confidence 99999997654322211 234579999999999985321 456899999999999999999 6677
Q ss_pred CCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCC-----cHHHHHHH
Q psy14889 362 HDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRL-----SALRVKKT 424 (443)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~ 424 (443)
...... .....+...+.. ..+..+ ..++..+.+|+.+||+.||++|| |+.|+++.
T Consensus 263 ~~~~~~-~~~~~~~~~~~~--~~~~~~-----~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 263 TVDGEK-NSQAEISRRILK--SEPPYP-----QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp SCTTSC-CCHHHHHHHHHH--CCCCCC-----TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred ccCCcc-chHHHHHHHHhc--cCCCCC-----cccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 543221 122333332221 122233 33567899999999999999999 99999874
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=355.86 Aligned_cols=248 Identities=23% Similarity=0.297 Sum_probs=196.6
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCc----cchHHHHHHHHHHhccCCCceeeeeeccccCCcccEE
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDE----ASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQL 209 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~----~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~ 209 (443)
++|.+.+.||+|+||.||+|+. +|+.||+|++..... .......|+..+..++||||+++++++.+. ..+
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~----~~l 260 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETK----TDL 260 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECS----SEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeC----CEE
Confidence 6799999999999999999998 589999999865321 112223455555569999999999998776 458
Q ss_pred EeeecccCcccHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEe
Q psy14889 210 WLVTHYHSFGSLYDHLNR-----TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIAD 284 (443)
Q Consensus 210 ~lv~e~~~~gsL~~~l~~-----~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~D 284 (443)
++||||+++|+|.+++.. ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|
T Consensus 261 ~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~--------gIvHrDLKP~NILl~~~g~vkL~D 332 (543)
T 3c4z_A 261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR--------NIIYRDLKPENVLLDDDGNVRISD 332 (543)
T ss_dssp EEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT--------TEECCCCCGGGEEECTTSCEEECC
T ss_pred EEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc--------CCcccCCChHHEEEeCCCCEEEee
Confidence 999999999999999864 3599999999999999999999999 999999999999999999999999
Q ss_pred cCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCC
Q psy14889 285 FGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDL 364 (443)
Q Consensus 285 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~ 364 (443)
||+++.+...... .....||+.|+|||++.+. .++.++|||||||++|||++| ..||...
T Consensus 333 FGla~~~~~~~~~----~~~~~GT~~Y~APE~l~~~------~~~~~~DiwSlGvilyelltG----------~~PF~~~ 392 (543)
T 3c4z_A 333 LGLAVELKAGQTK----TKGYAGTPGFMAPELLLGE------EYDFSVDYFALGVTLYEMIAA----------RGPFRAR 392 (543)
T ss_dssp CTTCEECCTTCCC----BCCCCSCTTTSCHHHHTTC------CBCTHHHHHHHHHHHHHHHHS----------SCSSCCT
T ss_pred cceeeeccCCCcc----cccccCCccccChhhhcCC------CCChHHhcCcchHHHHHHHhC----------CCCCCCC
Confidence 9999876543221 2345899999999999876 677899999999999999999 6777654
Q ss_pred CCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcH-----HHHHH
Q psy14889 365 VPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSA-----LRVKK 423 (443)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~-----~evl~ 423 (443)
... .....+...+... ....| ...+..+.+|+.+||+.||++||++ .+|++
T Consensus 393 ~~~-~~~~~~~~~i~~~--~~~~p-----~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 393 GEK-VENKELKQRVLEQ--AVTYP-----DKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp TCC-CCHHHHHHHHHHC--CCCCC-----TTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred ccc-hhHHHHHHHHhhc--ccCCC-----cccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 221 1233343333221 22233 3356789999999999999999964 66654
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=338.94 Aligned_cols=255 Identities=20% Similarity=0.342 Sum_probs=188.3
Q ss_pred hccccccceeeeecCeEEEEEEE-CCceeEEEEeeccCccc---hHHHHHHHHHHhccC--CCceeeeeeccccCCcccE
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVW-HGENVAVKIFFSRDEAS---WSRETEIYSTVLLRH--ENILGYIGSDMTSRNSCTQ 208 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~---~~~e~ei~~~~~l~H--~nIv~l~g~~~~~~~~~~~ 208 (443)
.++|++.+.||+|+||.||++.. +++.||||++....... .....|+..+..++| |||+++++++.+. ..
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~----~~ 83 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD----QY 83 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS----SE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeC----CE
Confidence 36799999999999999999988 67889999986543221 122345555555766 9999999998876 46
Q ss_pred EEeeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCC
Q psy14889 209 LWLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGL 287 (443)
Q Consensus 209 ~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGl 287 (443)
+++||| +.+|+|.+++.. ..+++.++..++.||+.||.|||+. +|+||||||+|||++ ++.+||+|||+
T Consensus 84 ~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~--------~iiHrDikp~NIll~-~~~~kl~DFG~ 153 (343)
T 3dbq_A 84 IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH--------GIVHSDLKPANFLIV-DGMLKLIDFGI 153 (343)
T ss_dssp EEEEEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHT--------TCCCCCCCGGGEEEE-TTEEEECCCSS
T ss_pred EEEEEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CeecCCCCcceEEEE-CCcEEEeeccc
Confidence 899999 467899999965 5799999999999999999999999 999999999999997 67899999999
Q ss_pred cccccccCCcCCCCCCCcccccCccccccccccccc-----CcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCC
Q psy14889 288 AVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINM-----DCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYH 362 (443)
Q Consensus 288 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-----~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~ 362 (443)
++......... ......||+.|+|||++.+.... ....++.++|||||||++|||++| ..||.
T Consensus 154 a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g----------~~pf~ 221 (343)
T 3dbq_A 154 ANQMQPDTTSV--VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYG----------KTPFQ 221 (343)
T ss_dssp SCCC--------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHS----------SCTTT
T ss_pred ccccCcccccc--cCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhC----------CCcch
Confidence 98765432211 12345799999999998652110 001567899999999999999999 67776
Q ss_pred CCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHH
Q psy14889 363 DLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKT 424 (443)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 424 (443)
.... ....+...+ ........+ ...+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 222 ~~~~---~~~~~~~~~-~~~~~~~~~-----~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 222 QIIN---QISKLHAII-DPNHEIEFP-----DIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp TCCS---HHHHHHHHH-CTTSCCCCC-----CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhhh---HHHHHHHHh-cCCcccCCc-----ccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 5321 112222222 112222222 2245679999999999999999999999864
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=327.63 Aligned_cols=257 Identities=19% Similarity=0.275 Sum_probs=198.9
Q ss_pred hccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCc-------cchHHHHHHHHHHhccCCCceeeeeeccccCCc
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDE-------ASWSRETEIYSTVLLRHENILGYIGSDMTSRNS 205 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~-------~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~ 205 (443)
.++|++.+.||+|+||.||+|.. +|+.||+|++..... .....+.|+..+..++||||+++++++.+.
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--- 80 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENK--- 80 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS---
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCC---
Confidence 46799999999999999999998 588999998865421 122334566666679999999999998775
Q ss_pred ccEEEeeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCC----cE
Q psy14889 206 CTQLWLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNG----TC 280 (443)
Q Consensus 206 ~~~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~----~~ 280 (443)
...++||||+++++|.+++.+ ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++ .+
T Consensus 81 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~--------~i~H~dl~p~Nil~~~~~~~~~~~ 151 (283)
T 3bhy_A 81 -TDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSK--------RIAHFDLKPENIMLLDKNVPNPRI 151 (283)
T ss_dssp -SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT--------TEECSCCSGGGEEESCSSSSSCCE
T ss_pred -CeEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CccCCCCChHHEEEecCCCCCCce
Confidence 457999999999999999964 6799999999999999999999998 999999999999998877 89
Q ss_pred EEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCC
Q psy14889 281 VIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAP 360 (443)
Q Consensus 281 kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P 360 (443)
||+|||++........ .....||+.|+|||++.+. .++.++||||||+++|||++| ..|
T Consensus 152 kl~dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~il~~l~~g----------~~p 210 (283)
T 3bhy_A 152 KLIDFGIAHKIEAGNE-----FKNIFGTPEFVAPEIVNYE------PLGLEADMWSIGVITYILLSG----------ASP 210 (283)
T ss_dssp EECCCTTCEECC-------------CCCGGGCCHHHHTTC------CCCTHHHHHHHHHHHHHHHHS----------SCT
T ss_pred EEEecccceeccCCCc-----ccccCCCcCccCcceecCC------CCCcchhhhhHHHHHHHHHHC----------CCC
Confidence 9999999976643221 1334689999999999765 667899999999999999999 667
Q ss_pred CCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH--HHHHHhhcc
Q psy14889 361 YHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK--TLIKLACAD 432 (443)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~--~L~~l~~~~ 432 (443)
|... ........+... ....+.. .....+..+.+++.+||+.||++|||+.++++ .++.+....
T Consensus 211 ~~~~-----~~~~~~~~~~~~--~~~~~~~-~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~ 276 (283)
T 3bhy_A 211 FLGE-----TKQETLTNISAV--NYDFDEE-YFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRN 276 (283)
T ss_dssp TCCS-----SHHHHHHHHHTT--CCCCCHH-HHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHCC
T ss_pred CCCc-----chHHHHHHhHhc--ccCCcch-hcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHHh
Confidence 7653 222222222111 1111110 01234567999999999999999999999997 566665544
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=347.90 Aligned_cols=254 Identities=13% Similarity=0.091 Sum_probs=174.4
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccc------hHHHHH-HHHHHhccCCCceeeeeec-------
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEAS------WSRETE-IYSTVLLRHENILGYIGSD------- 199 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~------~~~e~e-i~~~~~l~H~nIv~l~g~~------- 199 (443)
.+|.+.+.||+|+||.||+|.+ +|+.||||++....... ...|.+ +..+.. +||||++++..+
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehhe
Confidence 5699999999999999999997 58899999987654311 122322 223333 699988855332
Q ss_pred cccCC-------------cccEEEeeecccCcccHHHHhcc--cCCCHHHH------HHHHHHHHHHHHHHHHchhcCCC
Q psy14889 200 MTSRN-------------SCTQLWLVTHYHSFGSLYDHLNR--TTLNHHQM------MKICLSIVNGLVHLHTEIFGTQG 258 (443)
Q Consensus 200 ~~~~~-------------~~~~~~lv~e~~~~gsL~~~l~~--~~l~~~~~------~~i~~qia~gL~yLH~~~~~~~~ 258 (443)
..... ....+++||||++ |+|.+++.. ..+.+..+ ..++.||+.||+|||++
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~------ 213 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK------ 213 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT------
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHC------
Confidence 21111 0134799999999 899999974 35666666 78889999999999999
Q ss_pred CCCeEEeCCCCCCEEEcCCCcEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHH
Q psy14889 259 KPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALG 338 (443)
Q Consensus 259 ~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~G 338 (443)
+|+||||||+|||++.++.+||+|||+++....... ...+|+.|+|||++.+... .++.++||||||
T Consensus 214 --~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~~-------~~~~t~~y~aPE~~~~~~~----~~~~~~DiwSlG 280 (371)
T 3q60_A 214 --GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGP-------ASSVPVTYAPREFLNASTA----TFTHALNAWQLG 280 (371)
T ss_dssp --TEEETTCSGGGEEECTTSCEEECCGGGEEETTCEEE-------GGGSCGGGCCHHHHTCSEE----ECCHHHHHHHHH
T ss_pred --CCccCcCCHHHEEECCCCCEEEEecceeeecCCCcc-------CccCCcCCcChhhccCCCC----CcCccccHHHHH
Confidence 999999999999999999999999999986643221 2357799999999976211 567899999999
Q ss_pred HHHHHHHhcccCCCcccccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcH
Q psy14889 339 LVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSA 418 (443)
Q Consensus 339 vvl~elltg~~~~~~~~~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~ 418 (443)
|++|||++| ..||....+.....................+. ...++..+.+|+.+||+.||++|||+
T Consensus 281 ~il~elltg----------~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~L~~dP~~Rpt~ 347 (371)
T 3q60_A 281 LSIYRVWCL----------FLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGS---CTPLPDFVKTLIGRFLNFDRRRRLLP 347 (371)
T ss_dssp HHHHHHHHS----------SCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTT---SSCCCHHHHHHHHHHTCSSTTTCCCH
T ss_pred HHHHHHHhC----------CCCCCCcCcccccchhhhhhhhccccccchhh---ccCCCHHHHHHHHHHcCCChhhCCCH
Confidence 999999999 56665542211100000000000011111111 13467889999999999999999999
Q ss_pred HHHHH
Q psy14889 419 LRVKK 423 (443)
Q Consensus 419 ~evl~ 423 (443)
.++++
T Consensus 348 ~e~l~ 352 (371)
T 3q60_A 348 LEAME 352 (371)
T ss_dssp HHHTT
T ss_pred HHHhc
Confidence 99975
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=330.84 Aligned_cols=253 Identities=22% Similarity=0.291 Sum_probs=189.1
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccc---hHHHHHHHHHHhccCCCceeeeeeccccCCcccEEE
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEAS---WSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLW 210 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~---~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~ 210 (443)
++|++.+.||+|+||.||+|.+ +|+.||||++....... .....|+..+..++||||+++++++... ...+
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~----~~~~ 78 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRK----RRLH 78 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET----TEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecC----CeEE
Confidence 6899999999999999999998 48999999886543322 2224566667779999999999998766 4579
Q ss_pred eeecccCcccHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcc
Q psy14889 211 LVTHYHSFGSLYDHLN-RTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAV 289 (443)
Q Consensus 211 lv~e~~~~gsL~~~l~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~ 289 (443)
+||||+++++|.+++. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++.
T Consensus 79 lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~--------~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 150 (311)
T 4agu_A 79 LVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH--------NCIHRDVKPENILITKHSVIKLCDFGFAR 150 (311)
T ss_dssp EEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHT--------TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHC--------CCcCCCCChhhEEEcCCCCEEEeeCCCch
Confidence 9999999999999886 45699999999999999999999999 99999999999999999999999999997
Q ss_pred cccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCC
Q psy14889 290 SYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDP 369 (443)
Q Consensus 290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~ 369 (443)
........ .....||..|+|||++.+.. .++.++||||||+++|||++| ..||.....
T Consensus 151 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~-----~~~~~~Di~slG~il~~l~~g----------~~p~~~~~~--- 208 (311)
T 4agu_A 151 LLTGPSDY----YDDEVATRWYRSPELLVGDT-----QYGPPVDVWAIGCVFAELLSG----------VPLWPGKSD--- 208 (311)
T ss_dssp ECC----------------GGGCCHHHHHTCS-----CCCTHHHHHHHHHHHHHHHHS----------SCSCCCSSH---
T ss_pred hccCcccc----cCCCcCCccccChHHHhcCC-----CCCcchhhHHHHHHHHHHHhC----------CCCCCCCCH---
Confidence 76533222 13447899999999987631 567899999999999999999 666654311
Q ss_pred ChHHHHhhhhh------------------cCCCCCCCCCCC-----CchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 370 SFDDMRKVICI------------------DQQRPVLPNRWV-----SDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 370 ~~~~~~~~~~~------------------~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
.+........ .......+.... ....+..+.+|+.+||+.||++|||+.|+++
T Consensus 209 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 209 -VDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp -HHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred -HHHHHHHHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 1111111000 000000010000 0235567999999999999999999999985
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=327.41 Aligned_cols=251 Identities=25% Similarity=0.373 Sum_probs=196.5
Q ss_pred hccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc--chHHHHHHHHHHhccCCCceeeeeeccccCCcccEEE
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA--SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLW 210 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~--~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~ 210 (443)
.++|++.+.||+|+||.||+|.. +++.||||++...... ......|+..+..++||||+++++++.+. ...+
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----~~~~ 81 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG----NIQY 81 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEET----TEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcC----CEEE
Confidence 46899999999999999999998 5889999998654322 22334566666679999999999998765 4579
Q ss_pred eeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcc
Q psy14889 211 LVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAV 289 (443)
Q Consensus 211 lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~ 289 (443)
+||||+++|+|.+++.. ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++.
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~--------~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 153 (276)
T 2yex_A 82 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI--------GITHRDIKPENLLLDERDNLKISDFGLAT 153 (276)
T ss_dssp EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHT--------TEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC--------CeeccCCChHHEEEccCCCEEEeeCCCcc
Confidence 99999999999999975 4799999999999999999999998 99999999999999999999999999997
Q ss_pred cccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCC
Q psy14889 290 SYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDP 369 (443)
Q Consensus 290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~ 369 (443)
......... ......||+.|+|||.+.+.. ..+.++||||||+++|||++| ..||.....
T Consensus 154 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~-----~~~~~~Di~slG~il~~l~~g----------~~p~~~~~~--- 213 (276)
T 2yex_A 154 VFRYNNRER--LLNKMCGTLPYVAPELLKRRE-----FHAEPVDVWSCGIVLTAMLAG----------ELPWDQPSD--- 213 (276)
T ss_dssp ECEETTEEC--CBCCCCSCGGGCCGGGGTCSS-----BCHHHHHHHHHHHHHHHHHHS----------SCCCSCSCT---
T ss_pred ccCCCcchh--cccCCccccCccChHHHhcCC-----CCCCcchHHHHHHHHHHHHhC----------CCCCCCCch---
Confidence 654322111 123457899999999997652 124689999999999999999 667765322
Q ss_pred ChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 370 SFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
........... ....+. ....+..+.+++.+||+.||++|||+.|+++
T Consensus 214 ~~~~~~~~~~~---~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 214 SCQEYSDWKEK---KTYLNP---WKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp TSHHHHHHHTT---CTTSTT---GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHHHhhhc---ccccCc---hhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 11222222211 111111 1345678999999999999999999999876
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=353.60 Aligned_cols=249 Identities=23% Similarity=0.372 Sum_probs=194.5
Q ss_pred hhhccccccceeeeecCeEEEEEEE--CCceeEEEEeeccC---ccchHHHHHHHHHHhccCCCceeeeeeccccCCccc
Q psy14889 133 TLAKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRD---EASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCT 207 (443)
Q Consensus 133 ~~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~---~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~ 207 (443)
.+.++|++.+.||+|+||.||+|.. ++..||||++.... ........|+..+..++||||+++++++.+. .
T Consensus 34 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~----~ 109 (494)
T 3lij_A 34 HLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDK----R 109 (494)
T ss_dssp CHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECS----S
T ss_pred chhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC----C
Confidence 3456899999999999999999998 58899999986532 1223334566677779999999999999776 4
Q ss_pred EEEeeecccCcccHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCC---CcEEEE
Q psy14889 208 QLWLVTHYHSFGSLYDHLN-RTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTN---GTCVIA 283 (443)
Q Consensus 208 ~~~lv~e~~~~gsL~~~l~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~---~~~kl~ 283 (443)
.+++||||+++|+|.+++. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.+ +.+||+
T Consensus 110 ~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--------~ivH~Dlkp~Nil~~~~~~~~~~kl~ 181 (494)
T 3lij_A 110 NYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKH--------NIVHRDLKPENLLLESKEKDALIKIV 181 (494)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT--------TEECSCCSGGGEEESCSSTTCCEEEC
T ss_pred EEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC--------CceeccCChhhEEEeCCCCCCcEEEE
Confidence 5899999999999998875 46799999999999999999999999 99999999999999764 459999
Q ss_pred ecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCC
Q psy14889 284 DFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHD 363 (443)
Q Consensus 284 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~ 363 (443)
|||+++....... .....||+.|+|||++.+ .++.++|||||||++|||++| ..||..
T Consensus 182 DfG~a~~~~~~~~-----~~~~~gt~~y~aPE~l~~-------~~~~~~DiwslG~il~~ll~g----------~~pf~~ 239 (494)
T 3lij_A 182 DFGLSAVFENQKK-----MKERLGTAYYIAPEVLRK-------KYDEKCDVWSIGVILFILLAG----------YPPFGG 239 (494)
T ss_dssp CCTTCEECBTTBC-----BCCCCSCTTTCCHHHHTT-------CBCTHHHHHHHHHHHHHHHHS----------SCSSCC
T ss_pred ECCCCeECCCCcc-----ccccCCCcCeeCHHHHcc-------cCCCchhHHHHHHHHHHHHhC----------CCCCCC
Confidence 9999987654322 234579999999999863 566899999999999999999 777765
Q ss_pred CCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 364 LVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
. ....+...+.........+ .| ..++..+.+|+.+||+.||.+|||+.|+++
T Consensus 240 ~-----~~~~~~~~i~~~~~~~~~~-~~--~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 240 Q-----TDQEILRKVEKGKYTFDSP-EW--KNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp S-----SHHHHHHHHHHTCCCCCSG-GG--TTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred C-----CHHHHHHHHHhCCCCCCch-hc--ccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 3 2333433333322222111 11 235678999999999999999999999986
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=335.63 Aligned_cols=247 Identities=19% Similarity=0.264 Sum_probs=198.6
Q ss_pred hhccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCc----cchHHHHHHHHHHhccCCCceeeeeeccccCCccc
Q psy14889 134 LAKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDE----ASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCT 207 (443)
Q Consensus 134 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~----~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~ 207 (443)
..++|.+.+.||+|+||.||++.+ +++.||+|++..... .......|+..+..++||||+++++++.+. .
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----~ 114 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDN----D 114 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS----S
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC----C
Confidence 347899999999999999999998 478999999865421 122234566677779999999999998776 4
Q ss_pred EEEeeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecC
Q psy14889 208 QLWLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFG 286 (443)
Q Consensus 208 ~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfG 286 (443)
.+++||||+.+++|.+++.. ..+++.++..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||
T Consensus 115 ~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--------~ivH~dlkp~NIl~~~~~~~kl~Dfg 186 (335)
T 2owb_A 115 FVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN--------RVIHRDLKLGNLFLNEDLEVKIGDFG 186 (335)
T ss_dssp EEEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT--------TEECSCCCGGGEEECTTCCEEECCCT
T ss_pred eEEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC--------CCEecCCCchhEEEcCCCCEEEeecc
Confidence 58999999999999999865 6799999999999999999999999 99999999999999999999999999
Q ss_pred CcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCC
Q psy14889 287 LAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVP 366 (443)
Q Consensus 287 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~ 366 (443)
++......... .....||..|+|||++.+. .++.++||||||+++|||++| ..||...
T Consensus 187 ~~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~------~~~~~~Di~slG~il~~l~~g----------~~pf~~~-- 244 (335)
T 2owb_A 187 LATKVEYDGER----KKVLCGTPNYIAPEVLSKK------GHSFEVDVWSIGCIMYTLLVG----------KPPFETS-- 244 (335)
T ss_dssp TCEECCSTTCC----BCCCCSCCSSCCHHHHHTS------CBCTHHHHHHHHHHHHHHHHS----------SCTTCCS--
T ss_pred CceecccCccc----ccccCCCccccCHHHhccC------CCCchhhHHHHHHHHHHHHHC----------cCCCCCC--
Confidence 99776532221 2345789999999999775 567899999999999999999 6677543
Q ss_pred CCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHH
Q psy14889 367 MDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKT 424 (443)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 424 (443)
........+.. ....++ ..++..+.+|+.+||+.||++|||+.|+++.
T Consensus 245 ---~~~~~~~~~~~--~~~~~~-----~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 245 ---CLKETYLRIKK--NEYSIP-----KHINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp ---SHHHHHHHHHH--TCCCCC-----TTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ---CHHHHHHHHhc--CCCCCC-----ccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 22222222221 122222 2355679999999999999999999999873
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=341.50 Aligned_cols=255 Identities=21% Similarity=0.323 Sum_probs=190.1
Q ss_pred hhccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccc---hHHHHHHHHHHhccCCCceeeeeeccccCC--cc
Q psy14889 134 LAKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEAS---WSRETEIYSTVLLRHENILGYIGSDMTSRN--SC 206 (443)
Q Consensus 134 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~---~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~--~~ 206 (443)
+.++|++.+.||+|+||.||+|.. +|+.||||++....... .....|+..+..++||||+++++++..... ..
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 357899999999999999999998 58999999985432221 222456666677999999999999876532 12
Q ss_pred cEEEeeecccCcccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecC
Q psy14889 207 TQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFG 286 (443)
Q Consensus 207 ~~~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfG 286 (443)
..+++||||+ +++|.++++...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~--------~ivH~Dlkp~NIll~~~~~~kl~Dfg 173 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAA--------GIIHRDLKPGNLAVNEDCELKILDFG 173 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT--------TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred ceEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CccccCcCHHHEEEcCCCCEEEEeee
Confidence 3469999999 78999999888899999999999999999999999 99999999999999999999999999
Q ss_pred CcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCC
Q psy14889 287 LAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVP 366 (443)
Q Consensus 287 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~ 366 (443)
+++..... .....||+.|+|||++.+.. .++.++|||||||++|||++| ..||.+..
T Consensus 174 ~a~~~~~~-------~~~~~~t~~y~aPE~~~~~~-----~~~~~~DiwslG~il~ell~g----------~~pf~~~~- 230 (367)
T 1cm8_A 174 LARQADSE-------MTGYVVTRWYRAPEVILNWM-----RYTQTVDIWSVGCIMAEMITG----------KTLFKGSD- 230 (367)
T ss_dssp TCEECCSS-------CCSSCSCGGGCCTHHHHTTT-----CCCTTHHHHHHHHHHHHHHHS----------SCSSCCSS-
T ss_pred cccccccc-------cCcCcCCCCcCCHHHHhCCC-----CCChhhhHHHHHHHHHHHHhC----------CCCCCCCC-
Confidence 99765432 23457899999999987631 567899999999999999999 55665421
Q ss_pred CCCChHHHHhhhhhcCC--------------------CCCCCC-CC--CCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 367 MDPSFDDMRKVICIDQQ--------------------RPVLPN-RW--VSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 367 ~~~~~~~~~~~~~~~~~--------------------~~~~~~-~~--~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
..+.+..+...... .+..+. .+ .....+..+.+|+.+||+.||++|||+.|+++
T Consensus 231 ---~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 231 ---HLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp ---HHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ---HHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 11111111111000 000000 00 11235678999999999999999999999987
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-43 Score=338.46 Aligned_cols=255 Identities=20% Similarity=0.269 Sum_probs=186.0
Q ss_pred hhhccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccc---hHHHHHHHHHHhccCCCceeeeeeccccCCccc
Q psy14889 133 TLAKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEAS---WSRETEIYSTVLLRHENILGYIGSDMTSRNSCT 207 (443)
Q Consensus 133 ~~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~---~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~ 207 (443)
...++|++.+.||+|+||.||+|.. +++.||||++....... .....|+..+..++||||+++++++.+. .
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----~ 106 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHN----H 106 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEET----T
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecC----C
Confidence 3347899999999999999999987 68899999986543222 1223566667779999999999998776 4
Q ss_pred EEEeeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEc-----CCCcEE
Q psy14889 208 QLWLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVK-----TNGTCV 281 (443)
Q Consensus 208 ~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~-----~~~~~k 281 (443)
.+++||||++ |+|.+++.. ..+++..+..++.||+.||.|||+. +|+||||||+|||++ .++.+|
T Consensus 107 ~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~--------~ivH~Dlkp~NIll~~~~~~~~~~~k 177 (329)
T 3gbz_A 107 RLHLIFEYAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSR--------RCLHRDLKPQNLLLSVSDASETPVLK 177 (329)
T ss_dssp EEEEEEECCS-EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT--------TCCCSCCCGGGEEEEC-----CCEEE
T ss_pred EEEEEEecCC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CEECCCCCHHHEEEecCCCCccceEE
Confidence 5899999998 599999865 5799999999999999999999999 999999999999994 455699
Q ss_pred EEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCC
Q psy14889 282 IADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPY 361 (443)
Q Consensus 282 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~ 361 (443)
|+|||+++........ .....||+.|+|||++.+.. .++.++|||||||++|||++| ..||
T Consensus 178 l~Dfg~a~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~-----~~~~~~DiwslG~il~ell~g----------~~pf 238 (329)
T 3gbz_A 178 IGDFGLARAFGIPIRQ----FTHEIITLWYRPPEILLGSR-----HYSTSVDIWSIACIWAEMLMK----------TPLF 238 (329)
T ss_dssp ECCTTHHHHHC---------------CCTTCCHHHHTTCC-----CCCTHHHHHHHHHHHHHHHHS----------SCSS
T ss_pred ECcCCCccccCCcccc----cCCCcCCccccCHHHhcCCC-----CCCcHHHHHHHHHHHHHHHHC----------CCCc
Confidence 9999999766532221 23447899999999997642 467899999999999999999 5566
Q ss_pred CCCCCCCCChHHHHhhhhhcCCC---------------CCCCCCC-------CCchhHHHHHHHHHHHhcCCcCCCCcHH
Q psy14889 362 HDLVPMDPSFDDMRKVICIDQQR---------------PVLPNRW-------VSDSTLNAMTKVMKECWHQNANVRLSAL 419 (443)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~-------~~~~~~~~l~~li~~cl~~dP~~Rps~~ 419 (443)
.... ..+.+.......... ...+... .....+.++.+|+.+||+.||++|||+.
T Consensus 239 ~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ 314 (329)
T 3gbz_A 239 PGDS----EIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAK 314 (329)
T ss_dssp CCSS----HHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred CCCC----HHHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHH
Confidence 5421 112222222111000 0000000 0011457889999999999999999999
Q ss_pred HHHH
Q psy14889 420 RVKK 423 (443)
Q Consensus 420 evl~ 423 (443)
|+++
T Consensus 315 e~l~ 318 (329)
T 3gbz_A 315 NALE 318 (329)
T ss_dssp HHHT
T ss_pred HHhC
Confidence 9875
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=336.63 Aligned_cols=263 Identities=25% Similarity=0.391 Sum_probs=182.4
Q ss_pred hccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccc-hHHHHHHHHHHhcc-CCCceeeeeecccc----CCcc
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEAS-WSRETEIYSTVLLR-HENILGYIGSDMTS----RNSC 206 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~-~~~e~ei~~~~~l~-H~nIv~l~g~~~~~----~~~~ 206 (443)
..+|++.+.||+|+||.||+|++ +++.||||++....... .....|+..+..+. ||||+++++++... ....
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 36899999999999999999998 68999999886544322 22345555565575 99999999998422 1222
Q ss_pred cEEEeeecccCcccHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCC--eEEeCCCCCCEEEcCCCcE
Q psy14889 207 TQLWLVTHYHSFGSLYDHLNR----TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPA--IAHRDIKSKNILVKTNGTC 280 (443)
Q Consensus 207 ~~~~lv~e~~~~gsL~~~l~~----~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~--iiHrDlk~~NiLl~~~~~~ 280 (443)
..+++||||+. |+|.+++.. ..+++..++.++.||+.||.|||+. + |+||||||+|||++.++.+
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~--------~~~ivH~Dikp~NIl~~~~~~~ 177 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ--------KPPIIHRDLKVENLLLSNQGTI 177 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS--------SSCCBCCCCCGGGCEECTTSCE
T ss_pred ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC--------CCCEEEccCCcccEEECCCCCE
Confidence 56899999996 799998853 5699999999999999999999998 7 9999999999999999999
Q ss_pred EEEecCCcccccccCCcCC--------CCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCC
Q psy14889 281 VIADFGLAVSYSQLSNKMD--------IPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANG 352 (443)
Q Consensus 281 kl~DfGla~~~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~ 352 (443)
||+|||+++.......... .......||+.|+|||++..... ..++.++||||||+++|||++|
T Consensus 178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~---~~~~~~~Dv~slG~il~el~~g----- 249 (337)
T 3ll6_A 178 KLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSN---FPIGEKQDIWALGCILYLLCFR----- 249 (337)
T ss_dssp EBCCCTTCBCCSSCC-------------------------------CCTT---SCSSHHHHHHHHHHHHHHHHHS-----
T ss_pred EEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhcccc---CCCChHHhHHHHHHHHHHHHhC-----
Confidence 9999999987654322110 01123468999999999842211 1667899999999999999999
Q ss_pred cccccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhhcc
Q psy14889 353 IFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLACAD 432 (443)
Q Consensus 353 ~~~~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~~~ 432 (443)
..||...... .... .......+ ...+..+.+|+.+||+.||++|||+.|+++.|+++....
T Consensus 250 -----~~p~~~~~~~--------~~~~-~~~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~ 310 (337)
T 3ll6_A 250 -----QHPFEDGAKL--------RIVN-GKYSIPPH-----DTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR 310 (337)
T ss_dssp -----SCCC---------------------CCCCTT-----CCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred -----CCCCcchhHH--------Hhhc-CcccCCcc-----cccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 6666543111 1110 01111111 223446889999999999999999999999999998754
Q ss_pred c
Q psy14889 433 M 433 (443)
Q Consensus 433 ~ 433 (443)
.
T Consensus 311 ~ 311 (337)
T 3ll6_A 311 N 311 (337)
T ss_dssp T
T ss_pred C
Confidence 3
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=337.72 Aligned_cols=260 Identities=23% Similarity=0.311 Sum_probs=192.7
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc---chHHHHHHHHHHhccCCCceeeeeeccccCCc----c
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA---SWSRETEIYSTVLLRHENILGYIGSDMTSRNS----C 206 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~---~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~----~ 206 (443)
++|++.+.||+|+||.||+|.. +|+.||||++...... ......|+..+..++||||+++++++...... .
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 6899999999999999999998 5889999988544322 22334566666669999999999998764321 2
Q ss_pred cEEEeeecccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEe
Q psy14889 207 TQLWLVTHYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIAD 284 (443)
Q Consensus 207 ~~~~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~D 284 (443)
..+++||||+++ +|.+.+.. ..+++.++..++.||+.||.|||+. +|+||||||+|||++.++.+||+|
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~--------~ivH~Dlkp~NIl~~~~~~~kl~D 167 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN--------KILHRDMKAANVLITRDGVLKLAD 167 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHT--------TEECCCCSGGGEEECTTSCEEECC
T ss_pred ceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC--------CeeCCCCCHHHEEEcCCCCEEEcc
Confidence 468999999985 78777754 5799999999999999999999999 999999999999999999999999
Q ss_pred cCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCC
Q psy14889 285 FGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDL 364 (443)
Q Consensus 285 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~ 364 (443)
||+++.+...............||+.|+|||++.+.. .++.++|||||||++|||++| ..||...
T Consensus 168 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~~DiwslG~il~ell~g----------~~pf~~~ 232 (351)
T 3mi9_A 168 FGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGER-----DYGPPIDLWGAGCIMAEMWTR----------SPIMQGN 232 (351)
T ss_dssp CTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCC-----SCCTHHHHHHHHHHHHHHHHS----------SCSCCCS
T ss_pred chhcccccccccccccccCCcccccCccCchhhcCCC-----CCCcHhHHHHHHHHHHHHHhC----------CCCCCCC
Confidence 9999876643333333334567899999999987642 456899999999999999999 5555542
Q ss_pred CCCCCChHHHHhhhhhcCCC-CCCCCCC------------------CCc-----hhHHHHHHHHHHHhcCCcCCCCcHHH
Q psy14889 365 VPMDPSFDDMRKVICIDQQR-PVLPNRW------------------VSD-----STLNAMTKVMKECWHQNANVRLSALR 420 (443)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~------------------~~~-----~~~~~l~~li~~cl~~dP~~Rps~~e 420 (443)
. ............... +...... ... ..+..+.+|+.+||+.||++|||+.|
T Consensus 233 ~----~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e 308 (351)
T 3mi9_A 233 T----EQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDD 308 (351)
T ss_dssp S----HHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred C----hHHHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHH
Confidence 1 111111111110000 0000000 000 01356889999999999999999999
Q ss_pred HHH
Q psy14889 421 VKK 423 (443)
Q Consensus 421 vl~ 423 (443)
+++
T Consensus 309 ~l~ 311 (351)
T 3mi9_A 309 ALN 311 (351)
T ss_dssp HHT
T ss_pred HhC
Confidence 987
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=330.25 Aligned_cols=248 Identities=22% Similarity=0.314 Sum_probs=196.0
Q ss_pred hhccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCc-cchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEE
Q psy14889 134 LAKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDE-ASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLW 210 (443)
Q Consensus 134 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~ 210 (443)
+.++|.+.+.||+|+||.||+++. +|+.||+|++..... .....+.|+..+..++||||+++++++.+. ...+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----~~~~ 82 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYEST----THYY 82 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECS----SEEE
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccC----CEEE
Confidence 457899999999999999999998 589999999875432 222334566666679999999999998765 4589
Q ss_pred eeecccCcccHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEE---cCCCcEEEEecC
Q psy14889 211 LVTHYHSFGSLYDHLN-RTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILV---KTNGTCVIADFG 286 (443)
Q Consensus 211 lv~e~~~~gsL~~~l~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl---~~~~~~kl~DfG 286 (443)
+||||+++|+|.+++. ...+++..+..++.|++.||.|||+. +|+||||||+||++ +.++.+||+|||
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~--------~i~H~dikp~NIl~~~~~~~~~~kl~Dfg 154 (304)
T 2jam_A 83 LVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHEN--------GIVHRDLKPENLLYLTPEENSKIMITDFG 154 (304)
T ss_dssp EEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT--------TCCCCSCCGGGCEESSSSTTCCEEBCSCS
T ss_pred EEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC--------CccccCCCHHHEEEecCCCCCCEEEccCC
Confidence 9999999999999885 46789999999999999999999999 99999999999999 778899999999
Q ss_pred CcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCC
Q psy14889 287 LAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVP 366 (443)
Q Consensus 287 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~ 366 (443)
++....... .....||+.|+|||.+.+. .++.++||||||+++|||++| ..||...
T Consensus 155 ~~~~~~~~~------~~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~il~~l~~g----------~~pf~~~-- 210 (304)
T 2jam_A 155 LSKMEQNGI------MSTACGTPGYVAPEVLAQK------PYSKAVDCWSIGVITYILLCG----------YPPFYEE-- 210 (304)
T ss_dssp TTCCCCCBT------THHHHSCCCBCCTTTBSSC------SCCHHHHHHHHHHHHHHHHHS----------SCTTTTS--
T ss_pred cceecCCCc------cccccCCCCccChHHhccC------CCCchhhHHHHHHHHHHHHHC----------CCCCCCC--
Confidence 986543211 1234689999999999875 667899999999999999999 6777653
Q ss_pred CCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 367 MDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
........+...... .+.. .....+..+.+++.+||+.||++|||+.|+++
T Consensus 211 ---~~~~~~~~i~~~~~~--~~~~-~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 211 ---TESKLFEKIKEGYYE--FESP-FWDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp ---CHHHHHHHHHHCCCC--CCTT-TTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred ---CHHHHHHHHHcCCCC--CCcc-ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 223333333222211 1111 11346678999999999999999999999986
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=327.79 Aligned_cols=247 Identities=19% Similarity=0.267 Sum_probs=198.3
Q ss_pred hhccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc----chHHHHHHHHHHhccCCCceeeeeeccccCCccc
Q psy14889 134 LAKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA----SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCT 207 (443)
Q Consensus 134 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~----~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~ 207 (443)
..++|.+.+.||+|+||.||++.. +++.||+|++...... ......|+..+..++||||+++++++.+. .
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----~ 88 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDN----D 88 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS----S
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccC----C
Confidence 347899999999999999999998 4789999988654321 22234566677779999999999998765 4
Q ss_pred EEEeeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecC
Q psy14889 208 QLWLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFG 286 (443)
Q Consensus 208 ~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfG 286 (443)
..++||||+++++|.+++.. ..+++.++..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||
T Consensus 89 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--------~i~H~dl~p~Nil~~~~~~~kl~dfg 160 (294)
T 2rku_A 89 FVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN--------RVIHRDLKLGNLFLNEDLEVKIGDFG 160 (294)
T ss_dssp EEEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT--------TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CccccCCChHhEEEcCCCCEEEEecc
Confidence 58999999999999999865 6799999999999999999999999 99999999999999999999999999
Q ss_pred CcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCC
Q psy14889 287 LAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVP 366 (443)
Q Consensus 287 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~ 366 (443)
++......... .....||+.|+|||.+.+. .++.++||||||+++|||++| ..||...
T Consensus 161 ~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~~l~~l~~g----------~~p~~~~-- 218 (294)
T 2rku_A 161 LATKVEYDGER----KKVLCGTPNYIAPEVLSKK------GHSFEVDVWSIGCIMYTLLVG----------KPPFETS-- 218 (294)
T ss_dssp TCEECCSTTCC----BCCCCSCCSSCCHHHHTTS------CBCTHHHHHHHHHHHHHHHHS----------SCTTCCS--
T ss_pred CceecccCccc----cccccCCCCcCCcchhccC------CCCchhhHHHHHHHHHHHHhC----------CCCCCCC--
Confidence 99766432221 2335789999999999765 567899999999999999999 6677553
Q ss_pred CCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHH
Q psy14889 367 MDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKT 424 (443)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 424 (443)
...+....+. .....++ ...+..+.+++.+||+.||++|||+.|+++.
T Consensus 219 ---~~~~~~~~~~--~~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 219 ---CLKETYLRIK--KNEYSIP-----KHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp ---SHHHHHHHHH--TTCCCCC-----TTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ---CHHHHHHHHh--hccCCCc-----cccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 2222222221 1222233 2355679999999999999999999999874
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-43 Score=335.65 Aligned_cols=263 Identities=21% Similarity=0.268 Sum_probs=188.3
Q ss_pred hcccccc-ceeeeecCeEEEEEEE--CCceeEEEEeeccCcc-chHHHHHHHHHHh-ccCCCceeeeeeccccCCcccEE
Q psy14889 135 AKQISLS-ECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA-SWSRETEIYSTVL-LRHENILGYIGSDMTSRNSCTQL 209 (443)
Q Consensus 135 ~~~~~~~-~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~-~~~~e~ei~~~~~-l~H~nIv~l~g~~~~~~~~~~~~ 209 (443)
.+.|.+. +.||+|+||.||+|.. +++.||||++...... ......|+..+.. ++||||+++++++.+. ..+
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~----~~~ 86 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEE----DRF 86 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEET----TEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC----CEE
Confidence 4678885 7899999999999987 6899999998654332 2233445555554 5799999999998776 468
Q ss_pred EeeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCc---EEEEec
Q psy14889 210 WLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGT---CVIADF 285 (443)
Q Consensus 210 ~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~---~kl~Df 285 (443)
++||||+++|+|.+++.. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++. +||+||
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~--------~ivH~dlkp~Nil~~~~~~~~~~kl~Df 158 (316)
T 2ac3_A 87 YLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNK--------GIAHRDLKPENILCEHPNQVSPVKICDF 158 (316)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT--------TCCCCCCCGGGEEESCSSSSCSEEECCT
T ss_pred EEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC--------CceeCCCCHHHEEEccCCCcCceEEEEc
Confidence 999999999999999964 6799999999999999999999999 9999999999999998775 999999
Q ss_pred CCcccccccCCcC---CCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCC
Q psy14889 286 GLAVSYSQLSNKM---DIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYH 362 (443)
Q Consensus 286 Gla~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~ 362 (443)
|++.......... ........||+.|+|||++.+..... ..++.++|||||||++|||++| ..||.
T Consensus 159 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~~~~~~DiwslG~il~~l~~g----------~~pf~ 227 (316)
T 2ac3_A 159 DLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEA-SIYDKRCDLWSLGVILYILLSG----------YPPFV 227 (316)
T ss_dssp TCCC-------------------CCSGGGCCHHHHHHTSHHH-HHHTTTHHHHHHHHHHHHHHHS----------SCSCC
T ss_pred cCccccccCCccccccccccccccCCcCccChHHhhcccccc-cCCCcccccHhHHHHHHHHHHC----------CCCCc
Confidence 9987654321111 11112346999999999987521000 0456799999999999999999 55554
Q ss_pred CCCCCCCC----------hHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 363 DLVPMDPS----------FDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 363 ~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
.....+.. ...+...+... ...++.. .....+..+.+|+.+||+.||++|||+.|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~--~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 228 GRCGSDCGWDRGEACPACQNMLFESIQEG--KYEFPDK-DWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp CCCCSCSCC----CCHHHHHHHHHHHHHC--CCCCCHH-HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ccccccccccccccchhHHHHHHHHHhcc--CcccCch-hcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 43221100 11122222211 1122210 00124568999999999999999999999987
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=354.08 Aligned_cols=249 Identities=23% Similarity=0.318 Sum_probs=195.5
Q ss_pred hhhccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc--------------chHHHHHHHHHHhccCCCceeee
Q psy14889 133 TLAKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA--------------SWSRETEIYSTVLLRHENILGYI 196 (443)
Q Consensus 133 ~~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~--------------~~~~e~ei~~~~~l~H~nIv~l~ 196 (443)
.+.++|.+.+.||+|+||.||+|.. +++.||||++...... ......|+..+..++||||++++
T Consensus 33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~ 112 (504)
T 3q5i_A 33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF 112 (504)
T ss_dssp CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 3557899999999999999999998 5789999998653211 12234677777779999999999
Q ss_pred eeccccCCcccEEEeeecccCcccHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEc
Q psy14889 197 GSDMTSRNSCTQLWLVTHYHSFGSLYDHLN-RTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVK 275 (443)
Q Consensus 197 g~~~~~~~~~~~~~lv~e~~~~gsL~~~l~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~ 275 (443)
+++.+. ..+++||||+++|+|.+++. ...+++..+..++.||+.||.|||+. +|+||||||+|||++
T Consensus 113 ~~~~~~----~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~--------~ivH~Dlkp~Nil~~ 180 (504)
T 3q5i_A 113 DVFEDK----KYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKH--------NIVHRDIKPENILLE 180 (504)
T ss_dssp EEEECS----SEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT--------TEECSCCSGGGEEES
T ss_pred EEEEcC----CEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC--------CeEeCCCcHHHEEEe
Confidence 999776 46899999999999999885 46799999999999999999999999 999999999999998
Q ss_pred CCC---cEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCC
Q psy14889 276 TNG---TCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANG 352 (443)
Q Consensus 276 ~~~---~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~ 352 (443)
.++ .+||+|||++........ .....||+.|+|||++.+ .++.++|||||||++|||++|
T Consensus 181 ~~~~~~~~kl~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~-------~~~~~~DiwslG~il~~ll~g----- 243 (504)
T 3q5i_A 181 NKNSLLNIKIVDFGLSSFFSKDYK-----LRDRLGTAYYIAPEVLKK-------KYNEKCDVWSCGVIMYILLCG----- 243 (504)
T ss_dssp STTCCSSEEECCCTTCEECCTTSC-----BCCCCSCTTTCCHHHHTT-------CBCTHHHHHHHHHHHHHHHHS-----
T ss_pred cCCCCccEEEEECCCCEEcCCCCc-----cccccCCcCCCCHHHhcc-------CCCchHHHHHHHHHHHHHHhC-----
Confidence 876 699999999987654322 234579999999999864 566899999999999999999
Q ss_pred cccccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 353 IFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 353 ~~~~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
..||.+. ....+...+.........+ . ...++.++.+|+.+||+.||.+|||+.|+++
T Consensus 244 -----~~pf~~~-----~~~~~~~~i~~~~~~~~~~-~--~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 244 -----YPPFGGQ-----NDQDIIKKVEKGKYYFDFN-D--WKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp -----SCSSCCS-----SHHHHHHHHHHCCCCCCHH-H--HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -----CCCCCCC-----CHHHHHHHHHcCCCCCCcc-c--cCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 7777653 2333333333222211111 0 0235678999999999999999999999986
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=364.69 Aligned_cols=245 Identities=23% Similarity=0.313 Sum_probs=195.7
Q ss_pred hccccccceeeeecCeEEEEEEE--CCceeEEEEeeccC----ccchHHHHHHHHHHhc-cCCCceeeeeeccccCCccc
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRD----EASWSRETEIYSTVLL-RHENILGYIGSDMTSRNSCT 207 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~----~~~~~~e~ei~~~~~l-~H~nIv~l~g~~~~~~~~~~ 207 (443)
.++|++.+.||+|+||.||+|++ +++.||||++.... ........|...+..+ +||||+++++++.+. .
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~----~ 415 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM----D 415 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCS----S
T ss_pred ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeC----C
Confidence 36799999999999999999998 57889999986431 1112222334344333 799999999998776 4
Q ss_pred EEEeeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecC
Q psy14889 208 QLWLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFG 286 (443)
Q Consensus 208 ~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfG 286 (443)
.+||||||+++|+|.+++.+ ..+++..+..++.||+.||+|||+. +|+||||||+||||+.++.+||+|||
T Consensus 416 ~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~--------gIiHrDLKp~NILl~~~g~ikL~DFG 487 (674)
T 3pfq_A 416 RLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK--------GIIYRDLKLDNVMLDSEGHIKIADFG 487 (674)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT--------SEECCCCCSTTEEECSSSCEEECCCT
T ss_pred EEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CeEeccCChhhEEEcCCCcEEEeecc
Confidence 58999999999999999975 6799999999999999999999999 99999999999999999999999999
Q ss_pred CcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCC
Q psy14889 287 LAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVP 366 (443)
Q Consensus 287 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~ 366 (443)
+|+....... ......||+.|+|||++.+. .++.++|||||||++|||++| ..||.+.
T Consensus 488 la~~~~~~~~----~~~~~~GT~~Y~APE~l~~~------~~~~~~DvwSlGvilyelltG----------~~Pf~~~-- 545 (674)
T 3pfq_A 488 MCKENIWDGV----TTKTFCGTPDYIAPEIIAYQ------PYGKSVDWWAFGVLLYEMLAG----------QAPFEGE-- 545 (674)
T ss_dssp TCEECCCTTC----CBCCCCSCSSSCCHHHHTCC------CBSTHHHHHHHHHHHHHHHHS----------SCSSCCS--
T ss_pred eeeccccCCc----ccccccCCCcccCHhhhcCC------CCCccceEechHHHHHHHHcC----------CCCCCCC--
Confidence 9975432221 12456899999999999876 677899999999999999999 7788653
Q ss_pred CCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcH-----HHHHH
Q psy14889 367 MDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSA-----LRVKK 423 (443)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~-----~evl~ 423 (443)
...++...+.. ....+| ...+.++.+||.+||+.||++||++ +||++
T Consensus 546 ---~~~~~~~~i~~--~~~~~p-----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 546 ---DEDELFQSIME--HNVAYP-----KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp ---SHHHHHHHHHS--SCCCCC-----TTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred ---CHHHHHHHHHh--CCCCCC-----ccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 23344333322 223333 3356789999999999999999997 66654
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=334.10 Aligned_cols=254 Identities=18% Similarity=0.284 Sum_probs=194.2
Q ss_pred HHHhhhhcccccc-ceeeeecCeEEEEEEE--CCceeEEEEeeccCcc---chHHHHHHHHHHhc-cCCCceeeeeeccc
Q psy14889 129 LIQRTLAKQISLS-ECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA---SWSRETEIYSTVLL-RHENILGYIGSDMT 201 (443)
Q Consensus 129 ~~~~~~~~~~~~~-~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~---~~~~e~ei~~~~~l-~H~nIv~l~g~~~~ 201 (443)
...+.+.+.|.+. +.||+|+||.||+|.. +++.||||++...... ......|+..+..+ +||||+++++++..
T Consensus 21 ~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~ 100 (327)
T 3lm5_A 21 QSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYEN 100 (327)
T ss_dssp BCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred HHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEe
Confidence 3445666788887 8999999999999998 5899999988653221 22233455444445 56999999999876
Q ss_pred cCCcccEEEeeecccCcccHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcC--
Q psy14889 202 SRNSCTQLWLVTHYHSFGSLYDHLNR---TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKT-- 276 (443)
Q Consensus 202 ~~~~~~~~~lv~e~~~~gsL~~~l~~---~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~-- 276 (443)
. ..+++||||+++|+|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.
T Consensus 101 ~----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~--------givH~Dikp~NIl~~~~~ 168 (327)
T 3lm5_A 101 T----SEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN--------NIVHLDLKPQNILLSSIY 168 (327)
T ss_dssp S----SEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHT--------TEECSCCCGGGEEESCBT
T ss_pred C----CeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC--------CeecCcCChHHEEEecCC
Confidence 6 458999999999999999854 5699999999999999999999999 9999999999999998
Q ss_pred -CCcEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCccc
Q psy14889 277 -NGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFE 355 (443)
Q Consensus 277 -~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~ 355 (443)
++.+||+|||+++....... .....||+.|+|||++.+. .++.++||||||+++|||++|
T Consensus 169 ~~~~~kL~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~~ll~g-------- 229 (327)
T 3lm5_A 169 PLGDIKIVDFGMSRKIGHACE-----LREIMGTPEYLAPEILNYD------PITTATDMWNIGIIAYMLLTH-------- 229 (327)
T ss_dssp TBCCEEECCGGGCEEC--------------CCCGGGCCHHHHTTC------CCCTHHHHHHHHHHHHHHHHS--------
T ss_pred CCCcEEEeeCccccccCCccc-----cccccCCcCccCCeeecCC------CCCchhhHHHHHHHHHHHHhC--------
Confidence 78999999999987654322 1335799999999999766 677899999999999999999
Q ss_pred ccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 356 EYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 356 ~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
..||... ........+....... +.. ....++..+.+++.+||+.||++|||+.++++
T Consensus 230 --~~pf~~~-----~~~~~~~~i~~~~~~~--~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 230 --TSPFVGE-----DNQETYLNISQVNVDY--SEE-TFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp --SCSSCCS-----SHHHHHHHHHHTCCCC--CTT-TTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred --CCCCCCC-----CchHHHHHHHhccccc--Cch-hhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 6777553 2222222222111111 111 11336678999999999999999999999976
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=340.67 Aligned_cols=259 Identities=22% Similarity=0.297 Sum_probs=196.4
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccc--hHHHHHHHHHHhccCCCceeeeeeccccC-CcccEEE
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEAS--WSRETEIYSTVLLRHENILGYIGSDMTSR-NSCTQLW 210 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~--~~~e~ei~~~~~l~H~nIv~l~g~~~~~~-~~~~~~~ 210 (443)
++|++.+.||+|+||.||+|.. +++.||||++....... .....|+..+..++||||+++++++.... ......+
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 106 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 106 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEE
Confidence 6899999999999999999987 58899999986433222 22345666666799999999999987553 2224579
Q ss_pred eeecccCcccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCccc
Q psy14889 211 LVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVS 290 (443)
Q Consensus 211 lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~ 290 (443)
+||||+. |+|.++++...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 107 iv~e~~~-~~L~~~l~~~~~~~~~~~~i~~qi~~aL~~LH~~--------~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 177 (364)
T 3qyz_A 107 IVQDLME-TDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA--------NVLHRDLKPSNLLLNTTCDLKICDFGLARV 177 (364)
T ss_dssp EEEECCS-EEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT--------TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEcccC-cCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHC--------CeecCCCChHhEEECCCCCEEEEeCcceEe
Confidence 9999998 5999999988999999999999999999999999 999999999999999999999999999987
Q ss_pred ccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCC
Q psy14889 291 YSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPS 370 (443)
Q Consensus 291 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~ 370 (443)
........ .......||+.|+|||++.+.. .++.++|||||||++|||++| ..||.....
T Consensus 178 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~-----~~~~~~DiwslG~il~ell~g----------~~pf~~~~~---- 237 (364)
T 3qyz_A 178 ADPDHDHT-GFLTEYVATRWYRAPEIMLNSK-----GYTKSIDIWSVGCILAEMLSN----------RPIFPGKHY---- 237 (364)
T ss_dssp CCGGGCBC-CTTCCCCSCGGGCCHHHHHTBC-----SCSTHHHHHHHHHHHHHHHHS----------SCSSCCSSG----
T ss_pred cCCCCCcc-ccccccccccCCCCCHHhcCCC-----CCCcchhHHHHHHHHHHHHHC----------CCCCCCCCh----
Confidence 65433221 1124457999999999876542 466899999999999999999 566654321
Q ss_pred hHHHHhhhhhc-----------------------CCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 371 FDDMRKVICID-----------------------QQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 371 ~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
.+.+....... ......+........+.++.+|+.+||+.||++|||+.|+++
T Consensus 238 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 238 LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp GGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 11111111000 000000000001234567999999999999999999999986
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=355.13 Aligned_cols=249 Identities=22% Similarity=0.357 Sum_probs=199.1
Q ss_pred hhhccccccceeeeecCeEEEEEEE--CCceeEEEEeeccC----ccchHHHHHHHHHHhccCCCceeeeeeccccCCcc
Q psy14889 133 TLAKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRD----EASWSRETEIYSTVLLRHENILGYIGSDMTSRNSC 206 (443)
Q Consensus 133 ~~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~----~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~ 206 (443)
.+.++|++.+.||+|+||.||+|.. +|+.||||++.... ........|+..+..++||||+++++++.+.
T Consensus 23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~---- 98 (484)
T 3nyv_A 23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDK---- 98 (484)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECS----
T ss_pred cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC----
Confidence 3457899999999999999999998 58999999986532 1222334666677779999999999998776
Q ss_pred cEEEeeecccCcccHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEE---cCCCcEEE
Q psy14889 207 TQLWLVTHYHSFGSLYDHLN-RTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILV---KTNGTCVI 282 (443)
Q Consensus 207 ~~~~lv~e~~~~gsL~~~l~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl---~~~~~~kl 282 (443)
..+++||||+.+|+|.+++. ...+++..+..++.||+.||.|||+. +|+||||||+|||+ +.++.+||
T Consensus 99 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--------~ivH~Dlkp~Nil~~~~~~~~~~kl 170 (484)
T 3nyv_A 99 GYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN--------KIVHRDLKPENLLLESKSKDANIRI 170 (484)
T ss_dssp SEEEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHT--------TCCCSCCCGGGEEESSSSTTCCEEE
T ss_pred CEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CeeeCCCCHHHEEEecCCCCCcEEE
Confidence 46899999999999999885 46799999999999999999999999 99999999999999 56789999
Q ss_pred EecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCC
Q psy14889 283 ADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYH 362 (443)
Q Consensus 283 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~ 362 (443)
+|||+++.+..... .....||+.|+|||++.+ .++.++|||||||++|||++| ..||.
T Consensus 171 ~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~-------~~~~~~DiwslG~il~~ll~g----------~~pf~ 228 (484)
T 3nyv_A 171 IDFGLSTHFEASKK-----MKDKIGTAYYIAPEVLHG-------TYDEKCDVWSTGVILYILLSG----------CPPFN 228 (484)
T ss_dssp CCTTHHHHBCCCCS-----HHHHTTGGGTCCHHHHHT-------CCCTHHHHHHHHHHHHHHHHS----------SCSSC
T ss_pred EeeeeeEEcccccc-----cccCCCCccccCceeecC-------CCCCcceeHHHHHHHHHHHHC----------CCCCC
Confidence 99999976654321 123469999999999865 456899999999999999999 77776
Q ss_pred CCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 363 DLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
.. ....+...+.........+. ...++..+.+|+.+||+.||++|||+.|+++
T Consensus 229 ~~-----~~~~~~~~i~~~~~~~~~~~---~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 229 GA-----NEYDILKKVEKGKYTFELPQ---WKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp CS-----SHHHHHHHHHHCCCCCCSGG---GGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CC-----CHHHHHHHHHcCCCCCCCcc---cccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 53 22333333333322222221 1346678999999999999999999999986
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=342.43 Aligned_cols=254 Identities=19% Similarity=0.335 Sum_probs=188.0
Q ss_pred ccccccceeeeecCeEEEEEEE-CCceeEEEEeeccCccc---hHHHHHHHHHHhcc--CCCceeeeeeccccCCcccEE
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW-HGENVAVKIFFSRDEAS---WSRETEIYSTVLLR--HENILGYIGSDMTSRNSCTQL 209 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~---~~~e~ei~~~~~l~--H~nIv~l~g~~~~~~~~~~~~ 209 (443)
++|++.+.||+|+||.||+|.. +++.||||++....... .....|+..+..++ ||||+++++++... ..+
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~----~~~ 131 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD----QYI 131 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS----SEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecC----CEE
Confidence 5699999999999999999988 58899999986543221 22234555555565 59999999998776 458
Q ss_pred EeeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCc
Q psy14889 210 WLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA 288 (443)
Q Consensus 210 ~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla 288 (443)
++||| +.+|+|.+++.+ ..+++..+..++.||+.||.|||+. +|+||||||+|||++ ++.+||+|||++
T Consensus 132 ~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~--------~ivHrDlkp~NIll~-~~~~kl~DFG~a 201 (390)
T 2zmd_A 132 YMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH--------GIVHSDLKPANFLIV-DGMLKLIDFGIA 201 (390)
T ss_dssp EEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTT--------TCCCCCCCGGGEEES-SSCEEECCCSSS
T ss_pred EEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CeeecCCCHHHEEEE-CCeEEEEecCcc
Confidence 99999 567899999964 5789999999999999999999998 999999999999995 589999999999
Q ss_pred ccccccCCcCCCCCCCcccccCccccccccccccc-----CcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCC
Q psy14889 289 VSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINM-----DCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHD 363 (443)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-----~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~ 363 (443)
+.+....... ......||+.|+|||++.+.... ....++.++|||||||++|||++| ..||..
T Consensus 202 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G----------~~Pf~~ 269 (390)
T 2zmd_A 202 NQMQPDTTSV--VKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYG----------KTPFQQ 269 (390)
T ss_dssp CCC-----------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHS----------SCTTTT
T ss_pred ccccCCCccc--cCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHC----------CCcchh
Confidence 8765432211 12345799999999998752110 001567899999999999999999 677765
Q ss_pred CCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHH
Q psy14889 364 LVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKT 424 (443)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 424 (443)
... ....+...+ ........+. ..+.++.+|+.+||+.||++|||+.|+++.
T Consensus 270 ~~~---~~~~~~~~~-~~~~~~~~~~-----~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 270 IIN---QISKLHAII-DPNHEIEFPD-----IPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp CCC---HHHHHHHHH-CTTSCCCCCC-----CSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhH---HHHHHHHHh-CccccCCCCc-----cchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 321 112222222 1122222222 235679999999999999999999999864
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-43 Score=349.53 Aligned_cols=254 Identities=20% Similarity=0.283 Sum_probs=187.4
Q ss_pred hhhhccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCc---------cchHHHHHHHHHHhccCCCceeeeeecc
Q psy14889 132 RTLAKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDE---------ASWSRETEIYSTVLLRHENILGYIGSDM 200 (443)
Q Consensus 132 ~~~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~---------~~~~~e~ei~~~~~l~H~nIv~l~g~~~ 200 (443)
..+.++|.+.+.||+|+||.||+|.. +++.||||++..... .....+.|+..+..++||||+++++++.
T Consensus 131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~ 210 (419)
T 3i6u_A 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 210 (419)
T ss_dssp HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 45568999999999999999999998 578999999865321 1112345666666699999999999975
Q ss_pred ccCCcccEEEeeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCC-
Q psy14889 201 TSRNSCTQLWLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNG- 278 (443)
Q Consensus 201 ~~~~~~~~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~- 278 (443)
.. .+++||||+++|+|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++
T Consensus 211 ~~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~--------~ivHrDlkp~NIll~~~~~ 277 (419)
T 3i6u_A 211 AE-----DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN--------GIIHRDLKPENVLLSSQEE 277 (419)
T ss_dssp SS-----EEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHT--------TCCCSCCCGGGEEESSSSS
T ss_pred cC-----ceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC--------CccccCCChHhEEEecCCC
Confidence 43 36899999999999998864 6799999999999999999999998 999999999999997544
Q ss_pred --cEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccc
Q psy14889 279 --TCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEE 356 (443)
Q Consensus 279 --~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~ 356 (443)
.+||+|||+++....... .....||+.|+|||++.+... ..++.++|||||||++|||++|
T Consensus 278 ~~~~kl~DFG~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~---~~~~~~~DiwslG~il~~lltg--------- 340 (419)
T 3i6u_A 278 DCLIKITDFGHSKILGETSL-----MRTLCGTPTYLAPEVLVSVGT---AGYNRAVDCWSLGVILFICLSG--------- 340 (419)
T ss_dssp SCCEEECCSSTTTSCC----------------CTTCCTTTTC-------CTTHHHHHHHHHHHHHHHHHHS---------
T ss_pred cceEEEeecccceecCCCcc-----ccccCCCCCccCceeeecCCC---CCCCchhhhHhHHHHHHHHHHC---------
Confidence 599999999987653221 234579999999999864211 1566899999999999999999
Q ss_pred cCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 357 YKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 357 ~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
..||....... .+...+... .....+.. ....+..+.+|+.+||+.||++|||+.|+++
T Consensus 341 -~~pf~~~~~~~----~~~~~i~~~-~~~~~~~~--~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 341 -YPPFSEHRTQV----SLKDQITSG-KYNFIPEV--WAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp -SCSSCCCSSSC----CHHHHHHTT-CCCCCHHH--HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred -CCCCCCCcchH----HHHHHHhcC-CCCCCchh--hcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 66775532211 122222111 11111110 0224678999999999999999999999886
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-42 Score=324.41 Aligned_cols=242 Identities=22% Similarity=0.375 Sum_probs=195.6
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccC----ccchHHHHHHHHHHhccCCCceeeeeeccccCCcccEE
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRD----EASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQL 209 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~----~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~ 209 (443)
++|++.+.||+|+||.||+|.. ++..||||++.... ........|+..+..++||||+++++++.+. ...
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----~~~ 89 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDR----KRI 89 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS----SEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcC----CEE
Confidence 6899999999999999999998 47789999986432 1122334566666679999999999998765 458
Q ss_pred EeeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCc
Q psy14889 210 WLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA 288 (443)
Q Consensus 210 ~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla 288 (443)
++||||+++|+|.+++.. ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~--------~i~H~dl~p~Nil~~~~~~~kl~Dfg~~ 161 (284)
T 2vgo_A 90 YLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHER--------KVIHRDIKPENLLMGYKGELKIADFGWS 161 (284)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTT--------TEECCCCSGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CceecCCCHHHEEEcCCCCEEEeccccc
Confidence 999999999999999864 5799999999999999999999998 9999999999999999999999999998
Q ss_pred ccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCC
Q psy14889 289 VSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMD 368 (443)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~ 368 (443)
....... .....||+.|+|||.+.+. .++.++||||||+++|||++| ..||...
T Consensus 162 ~~~~~~~------~~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~il~~l~~g----------~~pf~~~---- 215 (284)
T 2vgo_A 162 VHAPSLR------RRTMCGTLDYLPPEMIEGK------THDEKVDLWCAGVLCYEFLVG----------MPPFDSP---- 215 (284)
T ss_dssp EECSSSC------BCCCCSCGGGCCHHHHTTC------CBCTTHHHHHHHHHHHHHHHS----------SCTTCCS----
T ss_pred ccCcccc------cccccCCCCcCCHHHhccC------CCCcccchhhHHHHHHHHHHC----------CCCCCCC----
Confidence 6554321 1334789999999999876 667899999999999999999 6677543
Q ss_pred CChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 369 PSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
........+.. ....++ ...+..+.+++.+||+.||.+|||+.++++
T Consensus 216 -~~~~~~~~~~~--~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 216 -SHTETHRRIVN--VDLKFP-----PFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp -SHHHHHHHHHT--TCCCCC-----TTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -CHhHHHHHHhc--cccCCC-----CcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 22222222211 222233 235578999999999999999999999987
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-42 Score=326.49 Aligned_cols=255 Identities=22% Similarity=0.292 Sum_probs=198.0
Q ss_pred hhccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc----------chHHHHHHHHHHhcc-CCCceeeeeecc
Q psy14889 134 LAKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA----------SWSRETEIYSTVLLR-HENILGYIGSDM 200 (443)
Q Consensus 134 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~----------~~~~e~ei~~~~~l~-H~nIv~l~g~~~ 200 (443)
+.++|++.+.||+|+||.||+|.. +|+.||||++...... ......|+..+..+. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 347899999999999999999998 5789999998654311 111234555555574 999999999987
Q ss_pred ccCCcccEEEeeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCc
Q psy14889 201 TSRNSCTQLWLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGT 279 (443)
Q Consensus 201 ~~~~~~~~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~ 279 (443)
.. ...++||||+++|+|.+++.. ..+++..+..++.||+.||.|||+. +|+||||||+||+++.++.
T Consensus 95 ~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~--------~i~H~dl~p~Nil~~~~~~ 162 (298)
T 1phk_A 95 TN----TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL--------NIVHRDLKPENILLDDDMN 162 (298)
T ss_dssp CS----SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT--------TEECSCCSGGGEEECTTCC
T ss_pred cC----CeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC--------CcccCCCCcceEEEcCCCc
Confidence 65 468999999999999999975 5799999999999999999999999 9999999999999999999
Q ss_pred EEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCC
Q psy14889 280 CVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKA 359 (443)
Q Consensus 280 ~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~ 359 (443)
+||+|||++........ .....||+.|+|||++.+........++.++||||||+++|||++| ..
T Consensus 163 ~kl~dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g----------~~ 227 (298)
T 1phk_A 163 IKLTDFGFSCQLDPGEK-----LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG----------SP 227 (298)
T ss_dssp EEECCCTTCEECCTTCC-----BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHS----------SC
T ss_pred EEEecccchhhcCCCcc-----cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHC----------CC
Confidence 99999999976654221 1334789999999998643221112567899999999999999999 66
Q ss_pred CCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 360 PYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 360 P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
||... ........+.........+. ....+..+.+++.+||+.||++|||+.|+++
T Consensus 228 p~~~~-----~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 228 PFWHR-----KQMLMLRMIMSGNYQFGSPE---WDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp SSCCS-----SHHHHHHHHHHTCCCCCTTT---GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred CCcCc-----cHHHHHHHHhcCCcccCccc---ccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 77543 22333333322222211111 1346678999999999999999999999875
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-42 Score=328.40 Aligned_cols=249 Identities=29% Similarity=0.428 Sum_probs=192.5
Q ss_pred hhhccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEE
Q psy14889 133 TLAKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLW 210 (443)
Q Consensus 133 ~~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~ 210 (443)
...++|++.+.||+|+||.||+|.+ +|+.||||++..... ......|+..+..++||||+++++++... ..++
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----~~~~ 100 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD-LQEIIKEISIMQQCDSPHVVKYYGSYFKN----TDLW 100 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC-CHHHHHHHHHHHTCCCTTBCCEEEEEEET----TEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH-HHHHHHHHHHHHhCCCCCCccEEEEEEeC----CEEE
Confidence 3457899999999999999999998 489999999865432 22334566666669999999999998765 4579
Q ss_pred eeecccCcccHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCc
Q psy14889 211 LVTHYHSFGSLYDHLN--RTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA 288 (443)
Q Consensus 211 lv~e~~~~gsL~~~l~--~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla 288 (443)
+||||+++|+|.+++. ...+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.+||+|||++
T Consensus 101 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--------~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 172 (314)
T 3com_A 101 IVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM--------RKIHRDIKAGNILLNTEGHAKLADFGVA 172 (314)
T ss_dssp EEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT--------TEECCCCSGGGEEECTTCCEEECCCTTC
T ss_pred EEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC--------CCcCCCcCHHHEEECCCCCEEEeecccc
Confidence 9999999999999986 46799999999999999999999998 9999999999999999999999999999
Q ss_pred ccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCC
Q psy14889 289 VSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMD 368 (443)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~ 368 (443)
......... .....||+.|+|||.+.+. .++.++||||||+++|||++| ..||....
T Consensus 173 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~il~~l~~g----------~~p~~~~~--- 229 (314)
T 3com_A 173 GQLTDTMAK----RNTVIGTPFWMAPEVIQEI------GYNCVADIWSLGITAIEMAEG----------KPPYADIH--- 229 (314)
T ss_dssp EECBTTBSC----BCCCCSCGGGCCHHHHSSS------CBCTTHHHHHHHHHHHHHHHS----------SCTTTTSC---
T ss_pred hhhhhhccc----cCccCCCCCccChhhcCCC------CCCccccHHHHHHHHHHHHhC----------CCCCCCCC---
Confidence 766543221 2345789999999999876 667899999999999999999 66776531
Q ss_pred CChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 369 PSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
.......... ...+... .+...+..+.+++.+||+.||.+|||+.++++
T Consensus 230 --~~~~~~~~~~-~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 230 --PMRAIFMIPT-NPPPTFR---KPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp --HHHHHHHHHH-SCCCCCS---SGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred --hHHHHHHHhc-CCCcccC---CcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 1111111111 1111111 12335678999999999999999999999986
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-43 Score=337.84 Aligned_cols=252 Identities=22% Similarity=0.295 Sum_probs=183.6
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccch--HHHHHHHHHHhccCCCceeeeeeccccCCcccEEEe
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEASW--SRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWL 211 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~--~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~l 211 (443)
++|.+.+.||+|+||.||+|.. +++.||||++........ ....|+..+..++||||+++++++.+. ..+++
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----~~~~l 77 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTE----KSLTL 77 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECS----SCEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeC----CEEEE
Confidence 5799999999999999999998 588999998864332211 112355556669999999999998776 34799
Q ss_pred eecccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcc
Q psy14889 212 VTHYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAV 289 (443)
Q Consensus 212 v~e~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~ 289 (443)
||||++ |+|.+++.. ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 78 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~--------~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 148 (324)
T 3mtl_A 78 VFEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQ--------KVLHRDLKPQNLLINERGELKLADFGLAR 148 (324)
T ss_dssp EEECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT--------TEEESSCCGGGEEECTTCCEEECSSSEEE
T ss_pred Eecccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--------CccCCCcCHHHEEECCCCCEEEccCcccc
Confidence 999998 599998864 4589999999999999999999999 99999999999999999999999999997
Q ss_pred cccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCC
Q psy14889 290 SYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDP 369 (443)
Q Consensus 290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~ 369 (443)
........ .....||+.|+|||++.+.. .++.++|||||||++|||++| ..||.+..
T Consensus 149 ~~~~~~~~----~~~~~~t~~y~aPE~~~~~~-----~~~~~~DiwslG~il~~l~~g----------~~pf~~~~---- 205 (324)
T 3mtl_A 149 AKSIPTKT----YDNEVVTLWYRPPDILLGST-----DYSTQIDMWGVGCIFYEMATG----------RPLFPGST---- 205 (324)
T ss_dssp CC----------------CGGGCCHHHHTTCC-----CCCTHHHHHHHHHHHHHHHHS----------SCSCCCSS----
T ss_pred cccCCccc----cccccCcccccChhhhcCCC-----CCCcHHHHHHHHHHHHHHHhC----------CCCCCCCC----
Confidence 65432221 23447899999999987641 567899999999999999999 55665421
Q ss_pred ChHHHHhhhhhcCCC--CCCC--------------CCC------CCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 370 SFDDMRKVICIDQQR--PVLP--------------NRW------VSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 370 ~~~~~~~~~~~~~~~--~~~~--------------~~~------~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
..+............ ...+ ... .....+.++.+|+.+||+.||++|||+.|+++
T Consensus 206 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 206 VEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp HHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 111111111110000 0000 000 00124567899999999999999999999987
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=339.35 Aligned_cols=254 Identities=20% Similarity=0.325 Sum_probs=190.2
Q ss_pred hhccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccchHHHHHHHHHHhccCCCceeeeeeccccCC-------
Q psy14889 134 LAKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIGSDMTSRN------- 204 (443)
Q Consensus 134 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~------- 204 (443)
..++|++.+.||+|+||.||+|.. +|+.||||++..... ... .|+..+..++||||+++++++.....
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-~~~--~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~ 81 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-YKN--RELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQ 81 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-SCC--HHHHHHTTCCCTTBCCEEEEEEEC---------
T ss_pred ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-hHH--HHHHHHHHcCCCCccchhheeeecCcccccccc
Confidence 347899999999999999999988 689999998865432 223 35555566999999999999865321
Q ss_pred ---------------------------cccEEEeeecccCcccHHHHhc-----ccCCCHHHHHHHHHHHHHHHHHHHHc
Q psy14889 205 ---------------------------SCTQLWLVTHYHSFGSLYDHLN-----RTTLNHHQMMKICLSIVNGLVHLHTE 252 (443)
Q Consensus 205 ---------------------------~~~~~~lv~e~~~~gsL~~~l~-----~~~l~~~~~~~i~~qia~gL~yLH~~ 252 (443)
....+++||||++ |+|.+.+. ...+++..+..++.||+.||.|||+.
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 160 (383)
T 3eb0_A 82 PPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL 160 (383)
T ss_dssp ----------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT
T ss_pred cccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 1245889999998 58887774 36799999999999999999999998
Q ss_pred hhcCCCCCCeEEeCCCCCCEEEc-CCCcEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCc
Q psy14889 253 IFGTQGKPAIAHRDIKSKNILVK-TNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKK 331 (443)
Q Consensus 253 ~~~~~~~~~iiHrDlk~~NiLl~-~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~ 331 (443)
+|+||||||+|||++ .++.+||+|||+++.+..... .....||+.|+|||++.+.. .++.+
T Consensus 161 --------gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~-----~~~~~ 222 (383)
T 3eb0_A 161 --------GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP-----SVAYICSRFYRAPELMLGAT-----EYTPS 222 (383)
T ss_dssp --------TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC-----CCCCCCCSSCCCHHHHTTCS-----SCCTH
T ss_pred --------cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC-----CcCcccCCCccCHHHhcCCC-----CCCcc
Confidence 999999999999998 688999999999987654322 23457899999999987642 46789
Q ss_pred cchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCChHHHHhhhhhcC--------------CCCCCCC----CC--
Q psy14889 332 ADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQ--------------QRPVLPN----RW-- 391 (443)
Q Consensus 332 sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~----~~-- 391 (443)
+|||||||++|||++| ..||.+.. ..+.+...+.... ....++. .|
T Consensus 223 ~DiwslG~il~ell~g----------~~pf~~~~----~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (383)
T 3eb0_A 223 IDLWSIGCVFGELILG----------KPLFSGET----SIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRK 288 (383)
T ss_dssp HHHHHHHHHHHHHHHS----------SCSSCCSS----HHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHH
T ss_pred hhhhhHHHHHHHHHhC----------CCCCCCCC----hHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHh
Confidence 9999999999999999 66666531 1122222221100 0001111 00
Q ss_pred -CCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 392 -VSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 392 -~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
.+...+.++.+|+.+||+.||++|||+.|+++
T Consensus 289 ~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 289 ILPEGTPSLAIDLLEQILRYEPDLRINPYEAMA 321 (383)
T ss_dssp HSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred hCCCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 12335678999999999999999999999985
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=334.28 Aligned_cols=251 Identities=21% Similarity=0.266 Sum_probs=191.4
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccchHHHHHHHHHHhcc-CCCceeeeeeccccCCcccEEEee
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEASWSRETEIYSTVLLR-HENILGYIGSDMTSRNSCTQLWLV 212 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~-H~nIv~l~g~~~~~~~~~~~~~lv 212 (443)
++|++.+.||+|+||.||+|.. +++.||||++.........+|.+++ ..++ ||||+++++++.+... ...++|
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l--~~l~~~~~i~~~~~~~~~~~~--~~~~lv 111 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKIL--ENLRGGPNIITLADIVKDPVS--RTPALV 111 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCHHHHHHHHHHH--HHHTTSTTBCCEEEEEECTTT--CCEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccchHHHHHHHHHH--HHcCCCCCEEEeeeeeccCCC--CceEEE
Confidence 6899999999999999999987 6899999998765554444555444 4476 9999999999876433 457999
Q ss_pred ecccCcccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCC-cEEEEecCCcccc
Q psy14889 213 THYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNG-TCVIADFGLAVSY 291 (443)
Q Consensus 213 ~e~~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~-~~kl~DfGla~~~ 291 (443)
|||+.+++|.++++. +++..+..++.||+.||+|||+. +|+||||||+|||++.++ .+||+|||+++..
T Consensus 112 ~e~~~~~~l~~~~~~--~~~~~~~~~~~qi~~~l~~lH~~--------~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~ 181 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQT--LTDYDIRFYMYEILKALDYCHSM--------GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 181 (330)
T ss_dssp EECCCCCCHHHHGGG--CCHHHHHHHHHHHHHHHHHHHHT--------TEECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EeccCchhHHHHHHh--CCHHHHHHHHHHHHHHHHHHHhC--------CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEc
Confidence 999999999999854 89999999999999999999999 999999999999999777 8999999999766
Q ss_pred cccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCCh
Q psy14889 292 SQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSF 371 (443)
Q Consensus 292 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~~ 371 (443)
..... .....||..|+|||.+.+.. .++.++|||||||++|||++| ..||..... ..
T Consensus 182 ~~~~~-----~~~~~~~~~y~aPE~~~~~~-----~~~~~~DiwslG~il~~ll~g----------~~p~~~~~~---~~ 238 (330)
T 3nsz_A 182 HPGQE-----YNVRVASRYFKGPELLVDYQ-----MYDYSLDMWSLGCMLASMIFR----------KEPFFHGHD---NY 238 (330)
T ss_dssp CTTCC-----CCSCCSCGGGCCHHHHTTCC-----CCCTHHHHHHHHHHHHHHHHT----------CSSSSCCSS---HH
T ss_pred CCCCc-----cccccccccccChhhhcCCC-----cCCchhhHHHHHHHHHHHHhC----------CCCcccCCc---hH
Confidence 54322 23457899999999987631 567899999999999999999 556543211 11
Q ss_pred HHHHhhh------------hhcCC--------------CC---CCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHH
Q psy14889 372 DDMRKVI------------CIDQQ--------------RP---VLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVK 422 (443)
Q Consensus 372 ~~~~~~~------------~~~~~--------------~~---~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl 422 (443)
+.+.... ..... .. ...........+.++.+|+.+||+.||++|||+.|++
T Consensus 239 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l 318 (330)
T 3nsz_A 239 DQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM 318 (330)
T ss_dssp HHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred HHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHh
Confidence 1111100 00000 00 0000001122567899999999999999999999998
Q ss_pred H
Q psy14889 423 K 423 (443)
Q Consensus 423 ~ 423 (443)
+
T Consensus 319 ~ 319 (330)
T 3nsz_A 319 E 319 (330)
T ss_dssp T
T ss_pred c
Confidence 6
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=346.22 Aligned_cols=192 Identities=23% Similarity=0.305 Sum_probs=159.0
Q ss_pred hhhhccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccchHHHHHHHHHHhc------cCCCceeeeeeccccC
Q psy14889 132 RTLAKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEASWSRETEIYSTVLL------RHENILGYIGSDMTSR 203 (443)
Q Consensus 132 ~~~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~e~ei~~~~~l------~H~nIv~l~g~~~~~~ 203 (443)
..+..+|++.+.||+|+||.||+|.. +++.||||++............|+..+..+ +|+||+++++++...
T Consensus 93 ~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~- 171 (429)
T 3kvw_A 93 DHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR- 171 (429)
T ss_dssp CEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET-
T ss_pred CcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC-
Confidence 44567899999999999999999988 478999999865433222333344444334 678999999998776
Q ss_pred CcccEEEeeecccCcccHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCc-
Q psy14889 204 NSCTQLWLVTHYHSFGSLYDHLNR---TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGT- 279 (443)
Q Consensus 204 ~~~~~~~lv~e~~~~gsL~~~l~~---~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~- 279 (443)
..+++||||+. |+|.+++.. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.
T Consensus 172 ---~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~--------~ivHrDlKp~NILl~~~~~~ 239 (429)
T 3kvw_A 172 ---NHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN--------RIIHCDLKPENILLKQQGRS 239 (429)
T ss_dssp ---TEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHH--------TEECSCCSGGGEEESSTTSC
T ss_pred ---CeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC--------CeecCCCCHHHeEEccCCCc
Confidence 46899999997 699999865 3499999999999999999999999 9999999999999999987
Q ss_pred -EEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhccc
Q psy14889 280 -CVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTK 349 (443)
Q Consensus 280 -~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~ 349 (443)
+||+|||++...... .....||+.|+|||++.+. .++.++|||||||++|||++|++
T Consensus 240 ~vkL~DFG~a~~~~~~-------~~~~~gt~~y~aPE~~~~~------~~~~~~DiwSlG~il~elltG~~ 297 (429)
T 3kvw_A 240 GIKVIDFGSSCYEHQR-------VYTYIQSRFYRAPEVILGA------RYGMPIDMWSLGCILAELLTGYP 297 (429)
T ss_dssp CEEECCCTTCEETTCC-------CCSSCSCGGGCCHHHHHTB------CCCTHHHHHHHHHHHHHHHHSSC
T ss_pred ceEEeecccceecCCc-------ccccCCCCCccChHHHhCC------CCCchHHHHhHHHHHHHHHhCCC
Confidence 999999999654432 2345789999999999876 67789999999999999999933
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=338.48 Aligned_cols=255 Identities=19% Similarity=0.300 Sum_probs=172.4
Q ss_pred hhhhccccccc-eeeeecCeEEEEEEE--CCceeEEEEeeccCccchHHHHHHHHHHhccCCCceeeeeeccccCCcccE
Q psy14889 132 RTLAKQISLSE-CIGKGRYGEVWRGVW--HGENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQ 208 (443)
Q Consensus 132 ~~~~~~~~~~~-~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~ 208 (443)
..+.++|.+.+ .||+|+||.||+|.+ +|+.||||++..... ...+... ....+.||||+++++++.........
T Consensus 24 ~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~e~~~-~~~~~~h~~i~~~~~~~~~~~~~~~~ 100 (336)
T 3fhr_A 24 YAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK--ARQEVDH-HWQASGGPHIVCILDVYENMHHGKRC 100 (336)
T ss_dssp SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH--HHHHHHH-HHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH--HHHHHHH-HHHhcCCCChHHHHHHHhhccCCCce
Confidence 34567899854 699999999999998 489999999865322 2222222 23347999999999998764443356
Q ss_pred EEeeecccCcccHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCC---CcEEE
Q psy14889 209 LWLVTHYHSFGSLYDHLNRT---TLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTN---GTCVI 282 (443)
Q Consensus 209 ~~lv~e~~~~gsL~~~l~~~---~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~---~~~kl 282 (443)
+++||||+++|+|.+++.+. .+++.++..++.||+.||.|||+. +|+||||||+|||++.+ +.+||
T Consensus 101 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~--------~ivH~dlkp~NIll~~~~~~~~~kl 172 (336)
T 3fhr_A 101 LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH--------NIAHRDVKPENLLYTSKEKDAVLKL 172 (336)
T ss_dssp EEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHT--------TEECSCCSGGGEEESCSSTTCCEEE
T ss_pred EEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CeecCCCCHHHEEEEecCCCceEEE
Confidence 89999999999999999653 599999999999999999999999 99999999999999864 55999
Q ss_pred EecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCC
Q psy14889 283 ADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYH 362 (443)
Q Consensus 283 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~ 362 (443)
+|||+++...... .....||+.|+|||++.+. .++.++||||||+++|||++| ..||.
T Consensus 173 ~Dfg~~~~~~~~~------~~~~~~t~~y~aPE~~~~~------~~~~~~Di~slG~il~~l~~g----------~~pf~ 230 (336)
T 3fhr_A 173 TDFGFAKETTQNA------LQTPCYTPYYVAPEVLGPE------KYDKSCDMWSLGVIMYILLCG----------FPPFY 230 (336)
T ss_dssp CCCTTCEEC----------------------------C------HHHHHHHHHHHHHHHHHHHHS----------SCCC-
T ss_pred eccccceeccccc------cccCCCCcCccChhhhCCC------CCCchhhHHHHHHHHHHHHHC----------CCCCC
Confidence 9999997654322 1234689999999998765 556799999999999999999 66665
Q ss_pred CCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 363 DLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
......... .....+.... ...+.. ....++.++.+|+.+||+.||++|||+.|+++
T Consensus 231 ~~~~~~~~~-~~~~~~~~~~--~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 231 SNTGQAISP-GMKRRIRLGQ--YGFPNP-EWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp -----------------------CCCTT-TSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred Cccchhhhh-hHHHhhhccc--cccCch-hhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 432211111 1111111111 111111 11236678999999999999999999999997
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=328.19 Aligned_cols=251 Identities=24% Similarity=0.387 Sum_probs=182.5
Q ss_pred hccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccchH--HH-HHHHHHHhccCCCceeeeeeccccCCcccEE
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEASWS--RE-TEIYSTVLLRHENILGYIGSDMTSRNSCTQL 209 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~--~e-~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~ 209 (443)
.++|++.+.||+|+||.||+|.. +|+.||||++......... .. .+...+..++||||+++++++.+.. ..
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~----~~ 81 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREG----DV 81 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS----SE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccC----CE
Confidence 47899999999999999999998 6899999998654322211 11 2222345589999999999998763 47
Q ss_pred EeeecccCcccHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEe
Q psy14889 210 WLVTHYHSFGSLYDHLNR-----TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIAD 284 (443)
Q Consensus 210 ~lv~e~~~~gsL~~~l~~-----~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~D 284 (443)
++||||++ |+|.+++.. ..+++..+..++.|++.||.|||++. +|+||||||+|||++.++.+||+|
T Consensus 82 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-------~i~H~dlkp~Nil~~~~~~~kl~D 153 (290)
T 3fme_A 82 WICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL-------SVIHRDVKPSNVLINALGQVKMCD 153 (290)
T ss_dssp EEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS-------CCCCCCCSGGGCEECTTCCEEBCC
T ss_pred EEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC-------CeecCCCCHHHEEECCCCCEEEee
Confidence 99999998 588887743 57999999999999999999999852 899999999999999999999999
Q ss_pred cCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCC
Q psy14889 285 FGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDL 364 (443)
Q Consensus 285 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~ 364 (443)
||+++........ ....||+.|+|||.+...... ..++.++||||||+++|||++| ..||...
T Consensus 154 fg~~~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~--~~~~~~~Di~slG~il~~l~~g----------~~p~~~~ 216 (290)
T 3fme_A 154 FGISGYLVDDVAK-----DIDAGCKPYMAPERINPELNQ--KGYSVKSDIWSLGITMIELAIL----------RFPYDSW 216 (290)
T ss_dssp C--------------------CCCCCCSCHHHHSCCTTC----CCHHHHHHHHHHHHHHHHHT----------SCSSCCC
T ss_pred cCCcccccccccc-----cccCCCccccChhhcChhhcC--cCCCcHHHHHHHHHHHHHHHHC----------CCCcccc
Confidence 9999766543221 234689999999997422111 1567899999999999999999 6677543
Q ss_pred CCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 365 VPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
. .....+..... ...+..+. ...+.++.+++.+||+.||++|||+.|+++
T Consensus 217 ~---~~~~~~~~~~~--~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 217 G---TPFQQLKQVVE--EPSPQLPA----DKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp S---CHHHHHHHHHH--SCCCCCCT----TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred C---chHHHHHHHhc--cCCCCccc----ccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 1 12233333332 22222222 335678999999999999999999999987
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=334.85 Aligned_cols=267 Identities=19% Similarity=0.250 Sum_probs=193.4
Q ss_pred hhhccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccc--hHHHHHHHHHHhccCCCceeeeeeccccC-Cccc
Q psy14889 133 TLAKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEAS--WSRETEIYSTVLLRHENILGYIGSDMTSR-NSCT 207 (443)
Q Consensus 133 ~~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~--~~~e~ei~~~~~l~H~nIv~l~g~~~~~~-~~~~ 207 (443)
.+.++|++.+.||+|+||.||+|.+ +|+.||||++....... .....|+..+..++||||+++++++.... ....
T Consensus 8 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 87 (353)
T 2b9h_A 8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN 87 (353)
T ss_dssp CSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCC
T ss_pred ccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccc
Confidence 3457899999999999999999998 48899999986433221 22235666666799999999999876532 1224
Q ss_pred EEEeeecccCcccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCC
Q psy14889 208 QLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGL 287 (443)
Q Consensus 208 ~~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGl 287 (443)
..++||||+. |+|.+++....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 88 ~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~--------~ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 158 (353)
T 2b9h_A 88 EVYIIQELMQ-TDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGS--------NVIHRDLKPSNLLINSNCDLKVCDFGL 158 (353)
T ss_dssp CEEEEECCCS-EEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT--------TEECSCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEeccC-ccHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHC--------CeecCCCCHHHeEEcCCCcEEEEeccc
Confidence 5799999998 6999999888999999999999999999999999 999999999999999999999999999
Q ss_pred cccccccCCcCC------CCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCC
Q psy14889 288 AVSYSQLSNKMD------IPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPY 361 (443)
Q Consensus 288 a~~~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~ 361 (443)
++.......... .......||+.|+|||++.... .++.++|||||||++|||++| ..||
T Consensus 159 a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~~Di~slG~il~~l~~g----------~~pf 223 (353)
T 2b9h_A 159 ARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSA-----KYSRAMDVWSCGCILAELFLR----------RPIF 223 (353)
T ss_dssp CEECC----------------CCCCCCGGGCCHHHHHSCC-----CCCHHHHHHHHHHHHHHHHHS----------SCSC
T ss_pred ccccccccccccCccccccchhhccccccccCCeeeccCC-----CccchhhHHHHHHHHHHHHhC----------CCCC
Confidence 987654321111 0123357899999999876531 566899999999999999999 4455
Q ss_pred CCCCC--------------------CCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHH
Q psy14889 362 HDLVP--------------------MDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRV 421 (443)
Q Consensus 362 ~~~~~--------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ev 421 (443)
.+... ..................+..+.......++.++.+|+.+||+.||++|||+.|+
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el 303 (353)
T 2b9h_A 224 PGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEA 303 (353)
T ss_dssp CCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred CCCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHH
Confidence 43210 0000000111110000000000000012356789999999999999999999999
Q ss_pred HH
Q psy14889 422 KK 423 (443)
Q Consensus 422 l~ 423 (443)
++
T Consensus 304 l~ 305 (353)
T 2b9h_A 304 LE 305 (353)
T ss_dssp HT
T ss_pred hc
Confidence 87
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-42 Score=325.39 Aligned_cols=248 Identities=29% Similarity=0.396 Sum_probs=190.8
Q ss_pred cccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc-chHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEeee
Q psy14889 137 QISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA-SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVT 213 (443)
Q Consensus 137 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~-~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv~ 213 (443)
+|.....||+|+||.||+|.+ +++.||||.+...... ......|+..+..++||||+++++++... ...++||
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----~~~~lv~ 98 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSEN----GFIKIFM 98 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEET----TEEEEEE
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeC----CcEEEEE
Confidence 344455999999999999998 5789999988654332 22334566667779999999999998765 4579999
Q ss_pred cccCcccHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcC-CCcEEEEecCCc
Q psy14889 214 HYHSFGSLYDHLNRT----TLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKT-NGTCVIADFGLA 288 (443)
Q Consensus 214 e~~~~gsL~~~l~~~----~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~-~~~~kl~DfGla 288 (443)
||+++|+|.+++... .+++..+..++.|++.||.|||+. +|+|+||||+||+++. ++.+||+|||++
T Consensus 99 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--------~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~ 170 (295)
T 2clq_A 99 EQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN--------QIVHRDIKGDNVLINTYSGVLKISDFGTS 170 (295)
T ss_dssp ECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT--------TEECCCCSGGGEEEETTTCCEEECCTTTC
T ss_pred EeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC--------CEEccCCChhhEEEECCCCCEEEeecccc
Confidence 999999999999653 467889999999999999999998 9999999999999988 899999999999
Q ss_pred ccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCC
Q psy14889 289 VSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMD 368 (443)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~ 368 (443)
......... .....||+.|+|||++.+... .++.++||||||+++|||++| ..||.....
T Consensus 171 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~----~~~~~~Di~slG~il~~l~~g----------~~pf~~~~~-- 230 (295)
T 2clq_A 171 KRLAGINPC----TETFTGTLQYMAPEIIDKGPR----GYGKAADIWSLGCTIIEMATG----------KPPFYELGE-- 230 (295)
T ss_dssp EESCC---------CCCCCCGGGCCHHHHHHGGG----GCSHHHHHHHHHHHHHHHHHT----------SCTTGGGSS--
T ss_pred cccCCCCCc----ccccCCCccccChhhhcCCCC----CCCcHHHHHHHHHHHHHHHHC----------CCCccCCCc--
Confidence 766432211 234578999999999976421 356799999999999999999 667754311
Q ss_pred CChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 369 PSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
........ ......+.++ ..++.++.+++.+||+.||++|||+.++++
T Consensus 231 -~~~~~~~~-~~~~~~~~~~-----~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 231 -PQAAMFKV-GMFKVHPEIP-----ESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp -HHHHHHHH-HHHCCCCCCC-----TTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred -hhHHHHhh-cccccccccc-----ccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11111111 1122333333 335678999999999999999999999875
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=334.82 Aligned_cols=254 Identities=23% Similarity=0.299 Sum_probs=187.7
Q ss_pred hccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc------chHHHHHHHHHHhccCCCceeeeeeccccCCcc
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA------SWSRETEIYSTVLLRHENILGYIGSDMTSRNSC 206 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~------~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~ 206 (443)
.++|++.+.||+|+||.||+|.+ +|+.||||++...... ......|+..+..++||||+++++++.+..
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--- 85 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS--- 85 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT---
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC---
Confidence 47899999999999999999998 4889999988643211 122345666666699999999999987663
Q ss_pred cEEEeeecccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEe
Q psy14889 207 TQLWLVTHYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIAD 284 (443)
Q Consensus 207 ~~~~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~D 284 (443)
..++||||+++ +|.+++.. ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|
T Consensus 86 -~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--------~ivH~Dlkp~Nil~~~~~~~kl~D 155 (346)
T 1ua2_A 86 -NISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH--------WILHRDLKPNNLLLDENGVLKLAD 155 (346)
T ss_dssp -CCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHT--------TCCCCCCCGGGEEECTTCCEEECC
T ss_pred -ceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHC--------CEECCCCCHHHEEEcCCCCEEEEe
Confidence 46999999985 89988865 3589999999999999999999999 999999999999999999999999
Q ss_pred cCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCC
Q psy14889 285 FGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDL 364 (443)
Q Consensus 285 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~ 364 (443)
||+++.+...... .....||+.|+|||++.+.. .++.++|||||||++|||++| ..||...
T Consensus 156 fg~a~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~-----~~~~~~DiwslG~il~ell~g----------~~~~~~~ 216 (346)
T 1ua2_A 156 FGLAKSFGSPNRA----YTHQVVTRWYRAPELLFGAR-----MYGVGVDMWAVGCILAELLLR----------VPFLPGD 216 (346)
T ss_dssp CGGGSTTTSCCCC----CCCSCCCCTTCCHHHHTTCS-----CCCHHHHHHHHHHHHHHHHHS----------SCSSCCS
T ss_pred cccceeccCCccc----CCcccccccccCchHhhCCC-----CCCchhhhHhHHHHHHHHHHC----------CCCCCCC
Confidence 9999776432221 23457899999999987541 456899999999999999999 4555442
Q ss_pred CCCCCChHHHHhhhhhcCCCC--C------CCCC------------CCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHH
Q psy14889 365 VPMDPSFDDMRKVICIDQQRP--V------LPNR------------WVSDSTLNAMTKVMKECWHQNANVRLSALRVKKT 424 (443)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~--~------~~~~------------~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 424 (443)
. ..+.+........... . .+.. ......+.++.+|+.+||+.||++|||+.|+++.
T Consensus 217 ~----~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 217 S----DLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp S----HHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred C----HHHHHHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 1 1122222221110000 0 0000 0012345789999999999999999999999873
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=337.48 Aligned_cols=251 Identities=23% Similarity=0.309 Sum_probs=193.9
Q ss_pred hccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccc--hHHHHHHHHHHhccCCCceeeeeeccccCCcccEEE
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEAS--WSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLW 210 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~--~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~ 210 (443)
.++|++.+.||+|+||.||+|.+ +++.||+|++....... .....|+..+..++||||+++++++... ..++
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----~~~~ 107 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD----GEIS 107 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEET----TEEE
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEEC----CEEE
Confidence 47899999999999999999998 48899999987543222 2234566666679999999999998876 4589
Q ss_pred eeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcc
Q psy14889 211 LVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAV 289 (443)
Q Consensus 211 lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~ 289 (443)
+||||+++|+|.+++.. ..+++..+..++.|++.||.|||+.. +|+||||||+|||++.++.+||+|||++.
T Consensus 108 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~-------~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 180 (360)
T 3eqc_A 108 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH-------KIMHRDVKPSNILVNSRGEIKLCDFGVSG 180 (360)
T ss_dssp EEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHH-------CCCCSCCSGGGEEECTTCCEEECCCCCCH
T ss_pred EEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhC-------CEEcCCccHHHEEECCCCCEEEEECCCCc
Confidence 99999999999999975 57999999999999999999999842 89999999999999999999999999997
Q ss_pred cccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCC---
Q psy14889 290 SYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVP--- 366 (443)
Q Consensus 290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~--- 366 (443)
...... .....||+.|+|||++.+. .++.++||||||+++|||++|+. ||.....
T Consensus 181 ~~~~~~------~~~~~gt~~y~aPE~~~~~------~~~~~~Di~slG~il~~l~~g~~----------pf~~~~~~~~ 238 (360)
T 3eqc_A 181 QLIDSM------ANSFVGTRSYMSPERLQGT------HYSVQSDIWSMGLSLVEMAVGRY----------PIPPPDAKEL 238 (360)
T ss_dssp HHHHHC----------CCCCTTCCHHHHTTC------CCSHHHHHHHHHHHHHHHHHTSC----------CSSCCCHHHH
T ss_pred cccccc------ccCCCCCCCeECHHHHcCC------CCCchhhHHHHHHHHHHHHhCCC----------CCCCCCHHHH
Confidence 654321 1234789999999999876 67789999999999999999954 4432100
Q ss_pred ----------------------------------CCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCc
Q psy14889 367 ----------------------------------MDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNA 412 (443)
Q Consensus 367 ----------------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP 412 (443)
...........+.. ...+..+ ....+.++.+|+.+||+.||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~----~~~~~~~~~~li~~~L~~dP 313 (360)
T 3eqc_A 239 ELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVN-EPPPKLP----SGVFSLEFQDFVNKCLIKNP 313 (360)
T ss_dssp HHHHC------------------------------CCCHHHHHHHHHH-SCCCCCC----TTTSCHHHHHHHHHHHCSST
T ss_pred HHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhc-cCCCCCC----cccccHHHHHHHHHHhhcCh
Confidence 00000111111111 1122222 23356789999999999999
Q ss_pred CCCCcHHHHHH
Q psy14889 413 NVRLSALRVKK 423 (443)
Q Consensus 413 ~~Rps~~evl~ 423 (443)
++|||+.|+++
T Consensus 314 ~~Rpt~~ell~ 324 (360)
T 3eqc_A 314 AERADLKQLMV 324 (360)
T ss_dssp TTSCCHHHHHT
T ss_pred hhCCCHHHHhh
Confidence 99999999987
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=330.05 Aligned_cols=254 Identities=24% Similarity=0.372 Sum_probs=191.6
Q ss_pred hhccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccc-hHHHHHHHHHHhccCCCceeeeeeccccCCcccEEE
Q psy14889 134 LAKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEAS-WSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLW 210 (443)
Q Consensus 134 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~-~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~ 210 (443)
..++|++.+.||+|+||.||+|.+ +++.||+|++....... .....|+..+..++||||+++++++... ...+
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----~~~~ 92 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHD----GKLW 92 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-----CEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeC----CeEE
Confidence 347899999999999999999998 48899999886543322 2334556666669999999999998876 3579
Q ss_pred eeecccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCc
Q psy14889 211 LVTHYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA 288 (443)
Q Consensus 211 lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla 288 (443)
+||||+++|+|.+++.. ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 93 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~--------~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 164 (302)
T 2j7t_A 93 IMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK--------RIIHRDLKAGNVLMTLEGDIRLADFGVS 164 (302)
T ss_dssp EEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT--------TCCCCCCSGGGEEECTTSCEEECCCHHH
T ss_pred EEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcC--------CcccCCCCHHHEEECCCCCEEEEECCCC
Confidence 99999999999999864 6799999999999999999999999 9999999999999999999999999997
Q ss_pred ccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCC
Q psy14889 289 VSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMD 368 (443)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~ 368 (443)
......... .....||+.|+|||++....... ..++.++||||||+++|||++| ..||....
T Consensus 165 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~-~~~~~~~Di~slG~il~~l~~g----------~~p~~~~~--- 226 (302)
T 2j7t_A 165 AKNLKTLQK----RDSFIGTPYWMAPEVVMCETMKD-TPYDYKADIWSLGITLIEMAQI----------EPPHHELN--- 226 (302)
T ss_dssp HHHHHHHHC---------CCGGGCCHHHHHHHHTTS-TTTTTHHHHHHHHHHHHHHHHS----------SCTTTTSC---
T ss_pred ccccccccc----cccccCChhhcCCeeeccccCCC-CCCchhhhHHHHHHHHHHHhcC----------CCCCccCC---
Confidence 543321111 12346899999999985221100 1567899999999999999999 66776531
Q ss_pred CChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 369 PSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
.......... . ..+.. ..+..++..+.+++.+||+.||++|||+.++++
T Consensus 227 -~~~~~~~~~~-~-~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 227 -PMRVLLKIAK-S-DPPTL---LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp -HHHHHHHHHH-S-CCCCC---SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred -HHHHHHHHhc-c-CCccc---CCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 1122222221 1 11111 122446678999999999999999999999875
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-43 Score=336.09 Aligned_cols=269 Identities=26% Similarity=0.418 Sum_probs=195.9
Q ss_pred hhhhccccccceeeeecCeEEEEEEECCceeEEEEeeccCc---cchHHHHHHHHHHhccCCCceeeeeeccccCCcccE
Q psy14889 132 RTLAKQISLSECIGKGRYGEVWRGVWHGENVAVKIFFSRDE---ASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQ 208 (443)
Q Consensus 132 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~---~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~ 208 (443)
+...++|++.+.||+|+||.||+|.+.+ .||+|++..... .....+.|+..+..++||||+++++++.+.. .
T Consensus 29 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~-~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~ 103 (319)
T 2y4i_B 29 DIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP----H 103 (319)
T ss_dssp SSCCSCEECCCBCCCSSSSEEEEEEESS-SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS----C
T ss_pred cCCHHHeEEeeEeccCCceEEEEEEEcC-eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC----c
Confidence 3345789999999999999999999865 599998864321 1112234555555689999999999988763 4
Q ss_pred EEeeecccCcccHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecC
Q psy14889 209 LWLVTHYHSFGSLYDHLNRT--TLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFG 286 (443)
Q Consensus 209 ~~lv~e~~~~gsL~~~l~~~--~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfG 286 (443)
+++||||+++++|.+++... .+++..+..++.||+.||.|||+. +|+||||||+|||++ ++.+||+|||
T Consensus 104 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~--------~i~H~dlkp~NIl~~-~~~~~l~Dfg 174 (319)
T 2y4i_B 104 LAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK--------GILHKDLKSKNVFYD-NGKVVITDFG 174 (319)
T ss_dssp EEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHT--------TCCCCCCCSTTEEEC---CCEECCCS
T ss_pred eEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC--------CccccCCChhhEEEe-CCCEEEeecC
Confidence 79999999999999999764 599999999999999999999999 999999999999998 6799999999
Q ss_pred CcccccccCCc-CCCCCCCcccccCccccccccccccc---CcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCC
Q psy14889 287 LAVSYSQLSNK-MDIPPNPRVGTKRYMSPEILDESINM---DCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYH 362 (443)
Q Consensus 287 la~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~ 362 (443)
+++........ .........||+.|+|||++.+.... ....++.++||||||+++|||++| ..||.
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g----------~~p~~ 244 (319)
T 2y4i_B 175 LFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAR----------EWPFK 244 (319)
T ss_dssp CCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHS----------SCSSS
T ss_pred CccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhC----------CCCCC
Confidence 98765322111 11112334689999999998753210 012467899999999999999999 67776
Q ss_pred CCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhhcccc
Q psy14889 363 DLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLACADMY 434 (443)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~~~~~ 434 (443)
.. ........+.. ...+.... ..++.++.+++.+||+.||++|||+.++++.|+++......
T Consensus 245 ~~-----~~~~~~~~~~~-~~~~~~~~----~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~ 306 (319)
T 2y4i_B 245 TQ-----PAEAIIWQMGT-GMKPNLSQ----IGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRR 306 (319)
T ss_dssp SC-----CHHHHHHHHHT-TCCCCCCC----SSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC------
T ss_pred CC-----CHHHHHHHhcc-CCCCCCCc----CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 53 22333322222 22222221 23455799999999999999999999999999998876544
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=321.61 Aligned_cols=246 Identities=22% Similarity=0.353 Sum_probs=189.6
Q ss_pred hccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCc----cchHHHHHHHHHHhccCCCceeeeeeccccCCcccE
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDE----ASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQ 208 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~----~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~ 208 (443)
.++|.+.+.||+|+||.||+|.+ +|+.||||++..... .......|+..+..++||||+++++++... ..
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----~~ 85 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTP----TD 85 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS----SE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecC----Ce
Confidence 37899999999999999999998 589999999865321 122334566667779999999999998765 45
Q ss_pred EEeeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCC
Q psy14889 209 LWLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGL 287 (443)
Q Consensus 209 ~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGl 287 (443)
.++||||+++++|.+++.. ..+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.+||+|||+
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~--------~i~H~dl~p~Nil~~~~~~~~l~dfg~ 157 (276)
T 2h6d_A 86 FFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRH--------MVVHRDLKPENVLLDAHMNAKIADFGL 157 (276)
T ss_dssp EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHH--------CSSCCCCCGGGEEECTTSCEEECCCCG
T ss_pred EEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC--------CCccCCCChhhEEECCCCCEEEeeccc
Confidence 8999999999999999964 5799999999999999999999999 999999999999999999999999999
Q ss_pred cccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCC
Q psy14889 288 AVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPM 367 (443)
Q Consensus 288 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~ 367 (443)
+........ .....||+.|+|||.+.+.. ..+.++||||||+++|||++| ..||...
T Consensus 158 ~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~-----~~~~~~Di~slG~~l~~l~~g----------~~p~~~~--- 214 (276)
T 2h6d_A 158 SNMMSDGEF-----LRTSCGSPNYAAPEVISGRL-----YAGPEVDIWSCGVILYALLCG----------TLPFDDE--- 214 (276)
T ss_dssp GGCCCC------------------CCTGGGTTSC-----CCHHHHHHHHHHHHHHHHHHS----------SCSSCCS---
T ss_pred ccccCCCcc-----eecccCCccccCHHHHcCCC-----CCCccchHHHHHHHHHHHHhC----------CCCCCCC---
Confidence 976653221 12346899999999987652 124789999999999999999 6677543
Q ss_pred CCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHH
Q psy14889 368 DPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKT 424 (443)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 424 (443)
........+... ....+ ...+..+.+++.+||+.||++|||+.++++.
T Consensus 215 --~~~~~~~~~~~~--~~~~~-----~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 215 --HVPTLFKKIRGG--VFYIP-----EYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp --SHHHHHHHHHHC--CCCCC-----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred --cHHHHHHHhhcC--cccCc-----hhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 223333333221 12222 2355779999999999999999999999873
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=344.04 Aligned_cols=265 Identities=21% Similarity=0.212 Sum_probs=193.8
Q ss_pred hHHHhhhhccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccchHHHHHHHHHHhcc--------CCCceeeee
Q psy14889 128 LLIQRTLAKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEASWSRETEIYSTVLLR--------HENILGYIG 197 (443)
Q Consensus 128 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~--------H~nIv~l~g 197 (443)
......+.++|++.+.||+|+||.||+|+. +++.||||++............|+..+..++ |+||+++++
T Consensus 29 ~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~ 108 (397)
T 1wak_A 29 VKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLD 108 (397)
T ss_dssp SCTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEE
T ss_pred EehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeec
Confidence 334455568999999999999999999987 5889999998654332223334555554454 888999999
Q ss_pred eccccCCcccEEEeeecccCcccHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEE
Q psy14889 198 SDMTSRNSCTQLWLVTHYHSFGSLYDHLNR---TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILV 274 (443)
Q Consensus 198 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~---~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl 274 (443)
++.........+++||||+. |+|.+++.. ..+++..+..++.||+.||.|||+++ +|+||||||+|||+
T Consensus 109 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~-------givHrDikp~NIll 180 (397)
T 1wak_A 109 DFKISGVNGTHICMVFEVLG-HHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKC-------RIIHTDIKPENILL 180 (397)
T ss_dssp EEEEEETTEEEEEEEECCCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT-------CEECCCCSGGGEEE
T ss_pred ceeecCCCCceEEEEEeccC-ccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhC-------CEecCCCCHHHeeE
Confidence 98754333367899999995 566666643 46999999999999999999999852 89999999999999
Q ss_pred cCCC-------------------------------------------------cEEEEecCCcccccccCCcCCCCCCCc
Q psy14889 275 KTNG-------------------------------------------------TCVIADFGLAVSYSQLSNKMDIPPNPR 305 (443)
Q Consensus 275 ~~~~-------------------------------------------------~~kl~DfGla~~~~~~~~~~~~~~~~~ 305 (443)
+.++ .+||+|||++...... ....
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-------~~~~ 253 (397)
T 1wak_A 181 SVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-------FTED 253 (397)
T ss_dssp CCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-------SCSC
T ss_pred eccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-------CccC
Confidence 8775 7999999999766532 1334
Q ss_pred ccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCCh--HHHHhhhhhcCC
Q psy14889 306 VGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSF--DDMRKVICIDQQ 383 (443)
Q Consensus 306 ~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~~--~~~~~~~~~~~~ 383 (443)
.||+.|+|||++.+. .++.++|||||||++|||+|| ..||.......... ..+.........
T Consensus 254 ~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~elltg----------~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 317 (397)
T 1wak_A 254 IQTRQYRSLEVLIGS------GYNTPADIWSTACMAFELATG----------DYLFEPHSGEEYTRDEDHIALIIELLGK 317 (397)
T ss_dssp CSCGGGCCHHHHHTS------CCCTHHHHHHHHHHHHHHHHS----------SCSCCCCCCSSSCHHHHHHHHHHHHHCS
T ss_pred CCCCcccCChhhcCC------CCCcHHHHHHHHHHHHHHhhC----------CCCCCCCcccccCchHHHHHHHHHhcCC
Confidence 789999999999876 677899999999999999999 55665432221111 111111110000
Q ss_pred CC---------------------CCCC-------------CCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 384 RP---------------------VLPN-------------RWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 384 ~~---------------------~~~~-------------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
.+ .+.. .-.+...+..+.+|+.+||+.||++|||+.|+++
T Consensus 318 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 318 VPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred CChHHhhcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 00 0000 0012456778999999999999999999999985
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=323.29 Aligned_cols=253 Identities=23% Similarity=0.385 Sum_probs=199.6
Q ss_pred HHHhhhhccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCc---cchHHHHHHHHHHhccCCCceeeeeeccccC
Q psy14889 129 LIQRTLAKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDE---ASWSRETEIYSTVLLRHENILGYIGSDMTSR 203 (443)
Q Consensus 129 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~---~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~ 203 (443)
..+..+.++|++.+.||+|+||.||+|.. +++.||||++..... .......|+..+..++||||+++++++...
T Consensus 15 ~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~- 93 (287)
T 2wei_A 15 YFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDS- 93 (287)
T ss_dssp HHTHHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-
T ss_pred hHHHHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCC-
Confidence 34566678999999999999999999998 588999999865322 222334566667779999999999998765
Q ss_pred CcccEEEeeecccCcccHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCC---Cc
Q psy14889 204 NSCTQLWLVTHYHSFGSLYDHLN-RTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTN---GT 279 (443)
Q Consensus 204 ~~~~~~~lv~e~~~~gsL~~~l~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~---~~ 279 (443)
...++||||+++++|.+++. ...+++..+..++.||+.||.|||+. +|+||||||+||+++.+ +.
T Consensus 94 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~--------~i~H~dl~p~NIlv~~~~~~~~ 162 (287)
T 2wei_A 94 ---SSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH--------NIVHRDLKPENILLESKEKDCD 162 (287)
T ss_dssp ---SEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT--------TCCCSCCCGGGEEESCSSTTCC
T ss_pred ---CeEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CeeccCCChhhEEEecCCCccc
Confidence 45899999999999998885 46799999999999999999999999 99999999999999764 47
Q ss_pred EEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCC
Q psy14889 280 CVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKA 359 (443)
Q Consensus 280 ~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~ 359 (443)
+||+|||++........ .....||+.|+|||.+.+ .++.++||||||+++|||++| ..
T Consensus 163 ~kL~Dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~-------~~~~~~Di~slG~~l~~l~~g----------~~ 220 (287)
T 2wei_A 163 IKIIDFGLSTCFQQNTK-----MKDRIGTAYYIAPEVLRG-------TYDEKCDVWSAGVILYILLSG----------TP 220 (287)
T ss_dssp EEECSTTGGGTBCCCSS-----CSCHHHHHTTCCHHHHTT-------CCCTHHHHHHHHHHHHHHHHS----------SC
T ss_pred EEEeccCcceeecCCCc-----cccccCcccccChHHhcC-------CCCCchhhHhHHHHHHHHHhC----------CC
Confidence 99999999976543221 233468999999999865 356799999999999999999 66
Q ss_pred CCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 360 PYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 360 P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
||... ....+...+.........+. ...++.++.+++.+||+.||++|||+.|+++
T Consensus 221 p~~~~-----~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 221 PFYGK-----NEYDILKRVETGKYAFDLPQ---WRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp SSCCS-----SHHHHHHHHHHCCCCCCSGG---GTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCC-----CHHHHHHHHHcCCCCCCchh---hhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 77653 22333333332222222221 1235678999999999999999999999987
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=347.49 Aligned_cols=264 Identities=22% Similarity=0.275 Sum_probs=199.3
Q ss_pred hhccccccceeeeecCeEEEEEEE--CCceeEEEEeeccC-ccchHHHHHHHHHHhccCCCcee-eeeeccccCCcccEE
Q psy14889 134 LAKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRD-EASWSRETEIYSTVLLRHENILG-YIGSDMTSRNSCTQL 209 (443)
Q Consensus 134 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~-~~~~~~e~ei~~~~~l~H~nIv~-l~g~~~~~~~~~~~~ 209 (443)
+.++|.+.+.||+|+||.||+|.+ +++.||||++.... ......|.+++.. ++|++++. +..++... ...
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~--L~~~~~i~~i~~~~~~~----~~~ 78 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRI--LQGGTGIPNVRWFGVEG----DYN 78 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHH--TTTSTTCCCEEEEEEET----TEE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHH--hcCCCCCCeEEEEEeeC----CEE
Confidence 347899999999999999999997 58999999876543 2344555555544 77755444 44443333 457
Q ss_pred EeeecccCcccHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEE---cCCCcEEEEe
Q psy14889 210 WLVTHYHSFGSLYDHLN--RTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILV---KTNGTCVIAD 284 (443)
Q Consensus 210 ~lv~e~~~~gsL~~~l~--~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl---~~~~~~kl~D 284 (443)
+|||||+ +++|.+++. ...+++..++.++.||+.||.|||+. +|+||||||+|||| +.++.+||+|
T Consensus 79 ~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~--------gIvHrDIKP~NILl~~~~~~~~vkL~D 149 (483)
T 3sv0_A 79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK--------SFLHRDIKPDNFLMGLGRRANQVYIID 149 (483)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT--------TEECCCCCGGGEEECCGGGTTCEEECC
T ss_pred EEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CEeecccCcceEEEecCCCCCeEEEEe
Confidence 9999999 899999997 56799999999999999999999999 99999999999999 6889999999
Q ss_pred cCCcccccccCCcCC---CCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCC
Q psy14889 285 FGLAVSYSQLSNKMD---IPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPY 361 (443)
Q Consensus 285 fGla~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~ 361 (443)
||+++.+........ .......||..|+|||++.+. .++.++|||||||+||||++| ..||
T Consensus 150 FGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~------~~s~~sDvwSlGvil~elltG----------~~Pf 213 (483)
T 3sv0_A 150 FGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGI------EQSRRDDLESLGYVLMYFLRG----------SLPW 213 (483)
T ss_dssp CTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC------CCCHHHHHHHHHHHHHHHHHS----------SCTT
T ss_pred CCcceeccCCccccccccccccccCCCccccCHHHhcCC------CCChHHHHHHHHHHHHHHHhC----------CCCC
Confidence 999987765433221 112356799999999999876 677899999999999999999 7777
Q ss_pred CCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhhcc
Q psy14889 362 HDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLACAD 432 (443)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~~~ 432 (443)
.+..... ....+....... ...... .....++.++.+|+..||+.||++||++.+|++.|+++....
T Consensus 214 ~~~~~~~-~~~~~~~i~~~~-~~~~~~--~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~ 280 (483)
T 3sv0_A 214 QGLKAGT-KKQKYEKISEKK-VATSIE--ALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE 280 (483)
T ss_dssp SSCCCSS-HHHHHHHHHHHH-HHSCHH--HHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred ccccchh-HHHHHHHHhhcc-ccccHH--HHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence 7643211 111222211110 000000 000224578999999999999999999999999999987643
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-42 Score=359.58 Aligned_cols=257 Identities=21% Similarity=0.404 Sum_probs=200.4
Q ss_pred hhhhccccccceeeeecCeEEEEEEEC-----CceeEEEEeeccCccc--hHHHHHHHHHHhccCCCceeeeeeccccCC
Q psy14889 132 RTLAKQISLSECIGKGRYGEVWRGVWH-----GENVAVKIFFSRDEAS--WSRETEIYSTVLLRHENILGYIGSDMTSRN 204 (443)
Q Consensus 132 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-----~~~vAvK~~~~~~~~~--~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~ 204 (443)
+...++|++.+.||+|+||.||+|.+. +..||||.+....... .....|+..+..++||||+++++++.+.
T Consensus 386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-- 463 (656)
T 2j0j_A 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN-- 463 (656)
T ss_dssp BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS--
T ss_pred ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC--
Confidence 334578999999999999999999983 3469999876433221 2234566666679999999999998543
Q ss_pred cccEEEeeecccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEE
Q psy14889 205 SCTQLWLVTHYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVI 282 (443)
Q Consensus 205 ~~~~~~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl 282 (443)
..++||||+++|+|.+++.. ..+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||
T Consensus 464 ---~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--------givHrDikp~NILl~~~~~vkL 532 (656)
T 2j0j_A 464 ---PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK--------RFVHRDIAARNVLVSSNDCVKL 532 (656)
T ss_dssp ---SCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHT--------TCCCSCCSGGGEEEEETTEEEE
T ss_pred ---ceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC--------CccccccchHhEEEeCCCCEEE
Confidence 36899999999999999974 3689999999999999999999999 9999999999999999999999
Q ss_pred EecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh-cccCCCcccccCCCC
Q psy14889 283 ADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR-RTKANGIFEEYKAPY 361 (443)
Q Consensus 283 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt-g~~~~~~~~~~~~P~ 361 (443)
+|||+++........ ......+|+.|+|||++.+. .++.++||||||+++|||++ | ..||
T Consensus 533 ~DFG~a~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~------~~~~~~DiwSlG~il~ellt~g----------~~Pf 593 (656)
T 2j0j_A 533 GDFGLSRYMEDSTYY---KASKGKLPIKWMAPESINFR------RFTSASDVWMFGVCMWEILMHG----------VKPF 593 (656)
T ss_dssp CCCCCCCSCCC-------------CCGGGCCHHHHHHC------CCCHHHHHHHHHHHHHHHHTTS----------CCTT
T ss_pred EecCCCeecCCCcce---eccCCCCCcceeCHHHhcCC------CCCchhhHHHHHHHHHHHHHcC----------CCCC
Confidence 999999876543211 12234577899999999766 67789999999999999997 7 6677
Q ss_pred CCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhhc
Q psy14889 362 HDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLACA 431 (443)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~~ 431 (443)
.+. ...+....+.. ..++..+ ..++..+.+++.+||+.||++|||+.++++.|+++.+.
T Consensus 594 ~~~-----~~~~~~~~i~~-~~~~~~~-----~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 594 QGV-----KNNDVIGRIEN-GERLPMP-----PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp TTC-----CHHHHHHHHHH-TCCCCCC-----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCC-----CHHHHHHHHHc-CCCCCCC-----ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 653 22333333322 2233333 34667899999999999999999999999999998764
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=334.86 Aligned_cols=254 Identities=23% Similarity=0.303 Sum_probs=184.1
Q ss_pred hccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc---chHHHHHHHHHHhccCCCceeeeeeccccCC--ccc
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA---SWSRETEIYSTVLLRHENILGYIGSDMTSRN--SCT 207 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~---~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~--~~~ 207 (443)
.++|++.+.||+|+||.||+|.. +++.||||++...... ......|+..+..++||||+++++++..... ...
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 37899999999999999999987 5889999998653221 1222356666667999999999999876531 223
Q ss_pred EEEeeecccCcccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCC
Q psy14889 208 QLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGL 287 (443)
Q Consensus 208 ~~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGl 287 (443)
.+++||||+. |+|.+++. ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 104 ~~~lv~e~~~-~~l~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~--------~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 173 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQ-MELDHERMSYLLYQMLCGIKHLHSA--------GIIHRDLKPSNIVVKSDCTLKILDFGL 173 (371)
T ss_dssp EEEEEEECCS-EEHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHT--------TCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred ceEEEEEcCC-CCHHHHHh-hccCHHHHHHHHHHHHHHHHHHHHC--------CeecccCCHHHEEEcCCCCEEEEEeec
Confidence 6899999998 48888885 4699999999999999999999999 999999999999999999999999999
Q ss_pred cccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCC
Q psy14889 288 AVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPM 367 (443)
Q Consensus 288 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~ 367 (443)
++...... ......||+.|+|||++.+. .++.++|||||||++|||++| ..||.+..
T Consensus 174 a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~el~~g----------~~pf~~~~-- 230 (371)
T 2xrw_A 174 ARTAGTSF-----MMTPYVVTRYYRAPEVILGM------GYKENVDIWSVGCIMGEMIKG----------GVLFPGTD-- 230 (371)
T ss_dssp ---------------------CTTCCHHHHTTC------CCCTTHHHHHHHHHHHHHHHS----------SCSSCCSS--
T ss_pred cccccccc-----ccCCceecCCccCHHHhcCC------CCCchHhHHHHHHHHHHHHhC----------CCCCCCCC--
Confidence 97654321 12345799999999999876 677899999999999999999 55665421
Q ss_pred CCChHHHHhhhhhcC-------------------CCCCCCCC---------C------CCchhHHHHHHHHHHHhcCCcC
Q psy14889 368 DPSFDDMRKVICIDQ-------------------QRPVLPNR---------W------VSDSTLNAMTKVMKECWHQNAN 413 (443)
Q Consensus 368 ~~~~~~~~~~~~~~~-------------------~~~~~~~~---------~------~~~~~~~~l~~li~~cl~~dP~ 413 (443)
..+.+...+.... ..+..... . .....+..+.+|+.+||+.||+
T Consensus 231 --~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~ 308 (371)
T 2xrw_A 231 --HIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDAS 308 (371)
T ss_dssp --HHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGG
T ss_pred --HHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChh
Confidence 1111111110000 01111000 0 0012367899999999999999
Q ss_pred CCCcHHHHHH
Q psy14889 414 VRLSALRVKK 423 (443)
Q Consensus 414 ~Rps~~evl~ 423 (443)
+|||+.|+++
T Consensus 309 ~R~t~~e~l~ 318 (371)
T 2xrw_A 309 KRISVDEALQ 318 (371)
T ss_dssp GSCCHHHHHH
T ss_pred hCCCHHHHhC
Confidence 9999999987
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=340.55 Aligned_cols=255 Identities=21% Similarity=0.307 Sum_probs=176.3
Q ss_pred hhccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc---chHHHHHHHHHHhccCCCceeeeeeccccCC--cc
Q psy14889 134 LAKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA---SWSRETEIYSTVLLRHENILGYIGSDMTSRN--SC 206 (443)
Q Consensus 134 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~---~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~--~~ 206 (443)
+.++|++.+.||+|+||.||+|.. +|+.||||++...... ......|+..+..++||||+++++++..... ..
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 447899999999999999999987 6889999998653221 1222356666667999999999999865421 12
Q ss_pred cEEEeeecccCcccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecC
Q psy14889 207 TQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFG 286 (443)
Q Consensus 207 ~~~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfG 286 (443)
..+++|+||+ +++|.+++....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--------givH~Dlkp~NIll~~~~~~kL~DFG 177 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA--------DIIHRDLKPSNLAVNEDCELKILDFG 177 (367)
T ss_dssp CCCEEEEECC-CEECC-----CCCCHHHHHHHHHHHHHHHHHHHHT--------TCCCCCCCGGGEEECTTCCEEECC--
T ss_pred CeEEEEeccc-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CeeeCCCCHhhEEECCCCCEEEeecc
Confidence 3479999999 58999999888899999999999999999999999 99999999999999999999999999
Q ss_pred CcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCC
Q psy14889 287 LAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVP 366 (443)
Q Consensus 287 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~ 366 (443)
+++..... .....||+.|+|||++.+.. .++.++|||||||++|||++| ..||.+..
T Consensus 178 ~a~~~~~~-------~~~~~~t~~y~aPE~~~~~~-----~~~~~~DiwslG~il~ell~g----------~~pf~~~~- 234 (367)
T 2fst_X 178 LARHTADE-------MTGYVATRWYRAPEIMLNWM-----HYNQTVDIWSVGCIMAELLTG----------RTLFPGTD- 234 (367)
T ss_dssp --------------------CCCTTCCHHHHTTCC-----SCCTTHHHHHHHHHHHHHHHS----------SCSCCCSS-
T ss_pred cccccccc-------CCCcCcCcCccChHHHcCCc-----CCCchhhHHHHHHHHHHHHhC----------CCCCCCCC-
Confidence 99765432 23457899999999987631 567899999999999999999 55665431
Q ss_pred CCCChHHHHhhhhhcC--------------------CCCCCCCCC---CCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 367 MDPSFDDMRKVICIDQ--------------------QRPVLPNRW---VSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 367 ~~~~~~~~~~~~~~~~--------------------~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
..+.+..+..... ..+..+... .....+..+.+|+.+||+.||++|||+.|+++
T Consensus 235 ---~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 235 ---HIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp ---HHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ---HHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 1111111111000 001111100 00124567999999999999999999999986
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=324.04 Aligned_cols=251 Identities=21% Similarity=0.324 Sum_probs=193.6
Q ss_pred hccccccceeeeecCeEEEEEEE--CCceeEEEEeeccC-----ccchHHHHHHHHHHhccCCCceeeeeeccccCCccc
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRD-----EASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCT 207 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~-----~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~ 207 (443)
.++|.+.+.||+|+||.||++.. +++.||+|++.... ........|+..+..++||||+++++++..... .
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~--~ 81 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEK--Q 81 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC-----
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC--C
Confidence 47899999999999999999998 57899999986532 122333566777777999999999999854432 4
Q ss_pred EEEeeecccCcccHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEe
Q psy14889 208 QLWLVTHYHSFGSLYDHLN---RTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIAD 284 (443)
Q Consensus 208 ~~~lv~e~~~~gsL~~~l~---~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~D 284 (443)
..++||||+.+| |.+++. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|
T Consensus 82 ~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~--------~i~H~dlkp~NIl~~~~~~~kl~d 152 (305)
T 2wtk_C 82 KMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ--------GIVHKDIKPGNLLLTTGGTLKISA 152 (305)
T ss_dssp CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHT--------TEECSCCSGGGEEECTTCCEEECC
T ss_pred eEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHC--------CeeecCCCcccEEEcCCCcEEeec
Confidence 579999999976 666664 35799999999999999999999999 999999999999999999999999
Q ss_pred cCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCC
Q psy14889 285 FGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDL 364 (443)
Q Consensus 285 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~ 364 (443)
||++.......... ......||+.|+|||++.+... ..+.++||||||+++|||++| ..||...
T Consensus 153 fg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~----~~~~~~Di~slG~il~~l~~g----------~~p~~~~ 216 (305)
T 2wtk_C 153 LGVAEALHPFAADD--TCRTSQGSPAFQPPEIANGLDT----FSGFKVDIWSAGVTLYNITTG----------LYPFEGD 216 (305)
T ss_dssp CTTCEECCTTCSSC--EECCCCSCGGGCCHHHHTCCSC----EESHHHHHHHHHHHHHHHHHS----------SCSCCCS
T ss_pred cccccccCcccccc--ccccCCCCCCCcChhhccCccc----CCcchhhHHHHHHHHHHHHhC----------CCCCCCc
Confidence 99997665322111 1134468999999999875411 235689999999999999999 6677653
Q ss_pred CCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHH
Q psy14889 365 VPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKT 424 (443)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 424 (443)
........+... ...++ ..++..+.+++.+||+.||++|||+.|+++.
T Consensus 217 -----~~~~~~~~i~~~--~~~~~-----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 217 -----NIYKLFENIGKG--SYAIP-----GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp -----SHHHHHHHHHHC--CCCCC-----SSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred -----hHHHHHHHHhcC--CCCCC-----CccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 223333333221 22222 3356789999999999999999999999874
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=342.65 Aligned_cols=259 Identities=24% Similarity=0.325 Sum_probs=181.7
Q ss_pred hhccccccceeeeecCeEEEEE-EECCceeEEEEeeccCccchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEee
Q psy14889 134 LAKQISLSECIGKGRYGEVWRG-VWHGENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLV 212 (443)
Q Consensus 134 ~~~~~~~~~~lG~G~fg~Vy~~-~~~~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv 212 (443)
+.+.|...+.||+|+||+||.+ ..+|+.||||++..........|.+++... .+||||+++++++.+. ..+++|
T Consensus 13 l~~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~~~~~~~E~~~l~~l-~~HpnIv~~~~~~~~~----~~~~lv 87 (434)
T 2rio_A 13 LKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTES-DDHPNVIRYYCSETTD----RFLYIA 87 (434)
T ss_dssp CSSCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGGHHHHHHHHHHHHHH-TTSTTBCCEEEEEECS----SEEEEE
T ss_pred hhheeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHHHHHHHHHHHHHHhc-cCCCCcCeEEEEEecC----CeEEEE
Confidence 3456777889999999999654 458999999998765444444454444331 4899999999998765 468999
Q ss_pred ecccCcccHHHHhcccCC--------CHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCC-------
Q psy14889 213 THYHSFGSLYDHLNRTTL--------NHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTN------- 277 (443)
Q Consensus 213 ~e~~~~gsL~~~l~~~~l--------~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~------- 277 (443)
|||+. |+|.+++..... ++..++.++.||+.||+|||+. +|+||||||+|||++.+
T Consensus 88 ~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~--------~ivHrDLkp~NILl~~~~~~~~~~ 158 (434)
T 2rio_A 88 LELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL--------KIIHRDLKPQNILVSTSSRFTADQ 158 (434)
T ss_dssp ECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT--------TEECCCCSGGGEEEECCHHHHSCC
T ss_pred EecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC--------CccccCCChHhEEEecCccccccc
Confidence 99996 699999975432 2334578999999999999999 99999999999999754
Q ss_pred ------CcEEEEecCCcccccccCCcCCCCCCCcccccCccccccccccccc-CcCCCCCccchHHHHHHHHHHHh-ccc
Q psy14889 278 ------GTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINM-DCFESFKKADIYALGLVLWEVCR-RTK 349 (443)
Q Consensus 278 ------~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~~~~~~sDvwS~Gvvl~ellt-g~~ 349 (443)
+.+||+|||+++.................||+.|+|||++.+.... ....++.++|||||||++|||+| |
T Consensus 159 ~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g-- 236 (434)
T 2rio_A 159 QTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKG-- 236 (434)
T ss_dssp TTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTS--
T ss_pred ccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCC--
Confidence 4899999999987765332222122345799999999999763210 01267789999999999999999 7
Q ss_pred CCCcccccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 350 ANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 350 ~~~~~~~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
..||.+... .. ..........+.. .......++.++.+|+.+||+.||++|||+.++++
T Consensus 237 --------~~Pf~~~~~-----~~-~~i~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 237 --------KHPFGDKYS-----RE-SNIIRGIFSLDEM-KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp --------CCTTCSTTT-----HH-HHHHHTCCCCCCC-TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --------CCCCCCchh-----hH-HHHhcCCCCcccc-cccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 667754321 11 1121111111111 11223457789999999999999999999999985
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=329.88 Aligned_cols=251 Identities=20% Similarity=0.257 Sum_probs=189.6
Q ss_pred hhhccccccceeeeecCeEEEEEEE---CCceeEEEEeeccCccchHHHHHHHHHHhccCC------CceeeeeeccccC
Q psy14889 133 TLAKQISLSECIGKGRYGEVWRGVW---HGENVAVKIFFSRDEASWSRETEIYSTVLLRHE------NILGYIGSDMTSR 203 (443)
Q Consensus 133 ~~~~~~~~~~~lG~G~fg~Vy~~~~---~~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~H~------nIv~l~g~~~~~~ 203 (443)
.+.++|++.+.||+|+||.||+|.. +++.||||++............|+..+..++|+ +|+++++++...
T Consensus 11 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~- 89 (339)
T 1z57_A 11 VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH- 89 (339)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET-
T ss_pred CccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC-
Confidence 4457999999999999999999987 478999999865433323334455555546655 499999998766
Q ss_pred CcccEEEeeecccCcccHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcC----
Q psy14889 204 NSCTQLWLVTHYHSFGSLYDHLNRT---TLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKT---- 276 (443)
Q Consensus 204 ~~~~~~~lv~e~~~~gsL~~~l~~~---~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~---- 276 (443)
..+++||||+ +++|.+++... .+++..+..++.||+.||+|||+. +|+||||||+|||++.
T Consensus 90 ---~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--------~ivH~Dlkp~Nil~~~~~~~ 157 (339)
T 1z57_A 90 ---GHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN--------KLTHTDLKPENILFVQSDYT 157 (339)
T ss_dssp ---TEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT--------TEECCCCCGGGEEESCCCEE
T ss_pred ---CcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHC--------CCcCCCCCHHHEEEeccccc
Confidence 4689999999 78999999653 589999999999999999999999 9999999999999987
Q ss_pred ---------------CCcEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHH
Q psy14889 277 ---------------NGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVL 341 (443)
Q Consensus 277 ---------------~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl 341 (443)
++.+||+|||+++..... .....||+.|+|||++.+. .++.++|||||||++
T Consensus 158 ~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-------~~~~~gt~~y~aPE~~~~~------~~~~~~Di~slG~il 224 (339)
T 1z57_A 158 EAYNPKIKRDERTLINPDIKVVDFGSATYDDEH-------HSTLVSTRHYRAPEVILAL------GWSQPCDVWSIGCIL 224 (339)
T ss_dssp EEEC----CEEEEESCCCEEECCCSSCEETTSC-------CCSSCSCGGGCCHHHHTTS------CCCTHHHHHHHHHHH
T ss_pred cccCCccccccccccCCCceEeeCcccccCccc-------cccccCCccccChHHhhCC------CCCcchhhHHHHHHH
Confidence 668999999999764432 1345789999999999876 677899999999999
Q ss_pred HHHHhcccCCCcccccCCCCCCCCCCCCChHHHHhhhhhcC------------------------------------CCC
Q psy14889 342 WEVCRRTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQ------------------------------------QRP 385 (443)
Q Consensus 342 ~elltg~~~~~~~~~~~~P~~~~~~~~~~~~~~~~~~~~~~------------------------------------~~~ 385 (443)
|||++| ..||.... ..+.......... ..+
T Consensus 225 ~el~~g----------~~pf~~~~----~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (339)
T 1z57_A 225 IEYYLG----------FTVFPTHD----SKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKP 290 (339)
T ss_dssp HHHHHS----------SCSCCCSC----HHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCC
T ss_pred HHHHhC----------CCCCCCCC----hHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcc
Confidence 999999 55554321 0111111000000 000
Q ss_pred CCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 386 VLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 386 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
...........+..+.+|+.+||+.||++|||+.|+++
T Consensus 291 ~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 328 (339)
T 1z57_A 291 LKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALK 328 (339)
T ss_dssp GGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred hhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhc
Confidence 00001112456788999999999999999999999875
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=334.13 Aligned_cols=260 Identities=24% Similarity=0.338 Sum_probs=188.0
Q ss_pred HhhhhccccccceeeeecCeEEEEEEE-CCceeEEEEeeccCccc------------hHHHHHHHHHHhccCCCceeeee
Q psy14889 131 QRTLAKQISLSECIGKGRYGEVWRGVW-HGENVAVKIFFSRDEAS------------WSRETEIYSTVLLRHENILGYIG 197 (443)
Q Consensus 131 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~------------~~~e~ei~~~~~l~H~nIv~l~g 197 (443)
...+.++|++.+.||+|+||.||+|.. +|+.||||++....... .....|+..+..++||||+++++
T Consensus 17 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 96 (362)
T 3pg1_A 17 LHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRD 96 (362)
T ss_dssp HHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSE
T ss_pred HHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceee
Confidence 345568999999999999999999987 68999999885432110 23345666666799999999999
Q ss_pred eccccC-CcccEEEeeecccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEE
Q psy14889 198 SDMTSR-NSCTQLWLVTHYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILV 274 (443)
Q Consensus 198 ~~~~~~-~~~~~~~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl 274 (443)
++.... .....+++||||+. |+|.+++.. ..+++..+..++.||+.||.|||+. +|+||||||+|||+
T Consensus 97 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--------~ivH~Dlkp~NIl~ 167 (362)
T 3pg1_A 97 IFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEA--------GVVHRDLHPGNILL 167 (362)
T ss_dssp EEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHT--------TCCCCCCCGGGEEE
T ss_pred eEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC--------cCEecCCChHHEEE
Confidence 986533 22346899999998 688888864 3699999999999999999999999 99999999999999
Q ss_pred cCCCcEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcc
Q psy14889 275 KTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIF 354 (443)
Q Consensus 275 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~ 354 (443)
+.++.+||+|||+++....... .....||+.|+|||++.+.. .++.++|||||||++|||++|
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~-----~~~~~~DiwslG~il~~l~~g------- 230 (362)
T 3pg1_A 168 ADNNDITICDFNLAREDTADAN-----KTHYVTHRWYRAPELVMQFK-----GFTKLVDMWSAGCVMAEMFNR------- 230 (362)
T ss_dssp CTTCCEEECCTTC--------------------CGGGCCHHHHTTCT-----TCCTHHHHHHHHHHHHHHHHS-------
T ss_pred cCCCCEEEEecCcccccccccc-----cceecccceecCcHHhcCCC-----CCCcHhHHHhHHHHHHHHHhC-------
Confidence 9999999999999975443221 23457899999999987631 566899999999999999999
Q ss_pred cccCCCCCCCCCCCCChHHHHhhhhhc---------------------CCCCCCCCC-C--CCchhHHHHHHHHHHHhcC
Q psy14889 355 EEYKAPYHDLVPMDPSFDDMRKVICID---------------------QQRPVLPNR-W--VSDSTLNAMTKVMKECWHQ 410 (443)
Q Consensus 355 ~~~~~P~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~-~--~~~~~~~~l~~li~~cl~~ 410 (443)
..||.... ..+.+....... ......+.. + .....+..+.+|+.+||+.
T Consensus 231 ---~~pf~~~~----~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 303 (362)
T 3pg1_A 231 ---KALFRGST----FYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEF 303 (362)
T ss_dssp ---SCSCCCSS----HHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCS
T ss_pred ---CCCCCCCC----HHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcC
Confidence 56665421 111111111100 000011100 0 1123456799999999999
Q ss_pred CcCCCCcHHHHHH
Q psy14889 411 NANVRLSALRVKK 423 (443)
Q Consensus 411 dP~~Rps~~evl~ 423 (443)
||++|||+.|+++
T Consensus 304 dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 304 NPQRRISTEQALR 316 (362)
T ss_dssp SGGGSCCHHHHHT
T ss_pred ChhhCCCHHHHHc
Confidence 9999999999986
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=333.59 Aligned_cols=253 Identities=24% Similarity=0.348 Sum_probs=190.0
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccch---HHHHHHHHHHhccCCCceeeeeeccccCCcccEEE
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEASW---SRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLW 210 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~---~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~ 210 (443)
++|++.+.||+|+||.||+|.. +|+.||||++........ ....|+..+..++||||+++++++.+. ...+
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----~~~~ 100 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKK----KRWY 100 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET----TEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecC----CEEE
Confidence 6899999999999999999998 488999998865443321 223566667779999999999998766 4589
Q ss_pred eeecccCcccHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcc
Q psy14889 211 LVTHYHSFGSLYDHLN-RTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAV 289 (443)
Q Consensus 211 lv~e~~~~gsL~~~l~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~ 289 (443)
+||||+++++|.+++. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 101 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~--------~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 172 (331)
T 4aaa_A 101 LVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSH--------NIIHRDIKPENILVSQSGVVKLCDFGFAR 172 (331)
T ss_dssp EEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHT--------TCCCCCCCGGGEEECTTSCEEECCCTTC-
T ss_pred EEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHC--------CEEccCcChheEEEcCCCcEEEEeCCCce
Confidence 9999999999998865 46799999999999999999999999 99999999999999999999999999997
Q ss_pred cccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCC
Q psy14889 290 SYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDP 369 (443)
Q Consensus 290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~ 369 (443)
........ .....||+.|+|||++.+.. .++.++|||||||++|||++| ..||....
T Consensus 173 ~~~~~~~~----~~~~~~t~~y~aPE~~~~~~-----~~~~~~Di~slG~il~~l~~g----------~~pf~~~~---- 229 (331)
T 4aaa_A 173 TLAAPGEV----YDDEVATRWYRAPELLVGDV-----KYGKAVDVWAIGCLVTEMFMG----------EPLFPGDS---- 229 (331)
T ss_dssp ---------------CCCCCTTCCHHHHTTCT-----TCCTHHHHHHHHHHHHHHHHS----------SCSCCCSS----
T ss_pred eecCCccc----cCCCcCCccccCcccccCCC-----CcchHHHHHHHHHHHHHHHhC----------CCCCCCCC----
Confidence 66543221 13347899999999987642 456899999999999999999 56665431
Q ss_pred ChHHHHhhhhhc-------------------CCCCCCCCCC----CCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 370 SFDDMRKVICID-------------------QQRPVLPNRW----VSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 370 ~~~~~~~~~~~~-------------------~~~~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
..+......... ...+...... ....++..+.+|+.+||+.||++|||+.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 230 DIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp HHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred cHHHHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 111111111100 0001110000 01235678999999999999999999999886
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=337.63 Aligned_cols=252 Identities=21% Similarity=0.284 Sum_probs=189.1
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccchHHHHHHHHHHhccCCCceeeeeeccccCC--cccEEEe
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIGSDMTSRN--SCTQLWL 211 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~--~~~~~~l 211 (443)
.+|++.+.||+|+||.||+|++ +|+.||||++..... ...+ |+..+..++||||+++++++..... ....+++
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~--E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l 130 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-FKNR--ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 130 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-SCCH--HHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-hHHH--HHHHHHHcCCCCccceeeEEeccCCCCcceeEEe
Confidence 5799999999999999999998 589999998865332 2233 4555556999999999999865322 2245789
Q ss_pred eecccCcccHHHHhc-----ccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCC-CcEEEEec
Q psy14889 212 VTHYHSFGSLYDHLN-----RTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTN-GTCVIADF 285 (443)
Q Consensus 212 v~e~~~~gsL~~~l~-----~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~-~~~kl~Df 285 (443)
||||+++ +|.+.+. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.+ +.+||+||
T Consensus 131 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~--------~ivHrDlkp~NILl~~~~~~~kl~DF 201 (420)
T 1j1b_A 131 VLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF--------GICHRDIKPQNLLLDPDTAVLKLCDF 201 (420)
T ss_dssp EEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT--------TEECSCCSGGGEEEETTTTEEEECCC
T ss_pred ehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC--------CccccCCChhhEEEeCCCCeEEeccc
Confidence 9999985 6766653 36799999999999999999999998 99999999999999965 57899999
Q ss_pred CCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCC
Q psy14889 286 GLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLV 365 (443)
Q Consensus 286 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~ 365 (443)
|+++.+..... .....||+.|+|||++.+.. .++.++|||||||++|||++| ..||.+..
T Consensus 202 G~a~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~-----~~~~~~DiwSlG~il~ell~G----------~~pf~~~~ 261 (420)
T 1j1b_A 202 GSAKQLVRGEP-----NVSYICSRYYRAPELIFGAT-----DYTSSIDVWSAGCVLAELLLG----------QPIFPGDS 261 (420)
T ss_dssp TTCEECCTTCC-----CCSCCSCTTSCCHHHHTTCS-----SCCTHHHHHHHHHHHHHHHHS----------SCSSCCSS
T ss_pred hhhhhcccCCC-----ceeeeeCCCcCCHHHHcCCC-----CCCchhhhHHHHHHHHHHHhC----------CCCCCCCC
Confidence 99987643221 23457899999999987541 466899999999999999999 66776531
Q ss_pred CCCCChHHHHhhhhh--------------cCCCCCCCCC----C---CCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 366 PMDPSFDDMRKVICI--------------DQQRPVLPNR----W---VSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 366 ~~~~~~~~~~~~~~~--------------~~~~~~~~~~----~---~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
..+.+.+++.. ......++.. | .....+.++.+|+.+||+.||++|||+.|+++
T Consensus 262 ----~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 262 ----GVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp ----HHHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ----HHHHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 11222222211 0011111110 0 11235678999999999999999999999985
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=332.03 Aligned_cols=259 Identities=19% Similarity=0.219 Sum_probs=182.2
Q ss_pred hhhhccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccchHHHHHHHHHHhccCCCceeeeeeccccCC---cc
Q psy14889 132 RTLAKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIGSDMTSRN---SC 206 (443)
Q Consensus 132 ~~~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~---~~ 206 (443)
....++|++.+.||+|+||.||+|.+ +|+.||||++............++..+..++||||+++++++..... ..
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 98 (360)
T 3e3p_A 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRD 98 (360)
T ss_dssp HHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTC
T ss_pred hhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccc
Confidence 34447899999999999999999998 58899999886654443344455555566899999999999865332 12
Q ss_pred cEEEeeecccCcccHHHHhc-----ccCCCHHHHHHHHHHHHHHHHHHH--HchhcCCCCCCeEEeCCCCCCEEEcC-CC
Q psy14889 207 TQLWLVTHYHSFGSLYDHLN-----RTTLNHHQMMKICLSIVNGLVHLH--TEIFGTQGKPAIAHRDIKSKNILVKT-NG 278 (443)
Q Consensus 207 ~~~~lv~e~~~~gsL~~~l~-----~~~l~~~~~~~i~~qia~gL~yLH--~~~~~~~~~~~iiHrDlk~~NiLl~~-~~ 278 (443)
..+++||||+++ +|.+.+. ...+++..+..++.|++.||.||| +. +|+||||||+|||++. ++
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~--------~ivH~Dlkp~NIll~~~~~ 169 (360)
T 3e3p_A 99 IYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV--------NVCHRDIKPHNVLVNEADG 169 (360)
T ss_dssp EEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT--------CCBCSCCCGGGEEEETTTT
T ss_pred eeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC--------CeecCcCCHHHEEEeCCCC
Confidence 347899999986 5544432 356899999999999999999999 66 9999999999999997 89
Q ss_pred cEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccC
Q psy14889 279 TCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYK 358 (443)
Q Consensus 279 ~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~ 358 (443)
.+||+|||+++....... .....||+.|+|||++.+.. .++.++|||||||++|||++| .
T Consensus 170 ~~kl~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~-----~~~~~~Di~slG~il~ell~g----------~ 229 (360)
T 3e3p_A 170 TLKLCDFGSAKKLSPSEP-----NVAYICSRYYRAPELIFGNQ-----HYTTAVDIWSVGCIFAEMMLG----------E 229 (360)
T ss_dssp EEEECCCTTCBCCCTTSC-----CCSTTSCGGGCCHHHHTTCS-----SCCTHHHHHHHHHHHHHHHHS----------S
T ss_pred cEEEeeCCCceecCCCCC-----cccccCCcceeCHHHHcCCC-----CCCcHHHHHHHHHHHHHHHhC----------C
Confidence 999999999987654322 23457899999999986541 467899999999999999999 6
Q ss_pred CCCCCCCCCCCChHHHHhhhhhcCCCC--------------------CCC--C--CCCCchhHHHHHHHHHHHhcCCcCC
Q psy14889 359 APYHDLVPMDPSFDDMRKVICIDQQRP--------------------VLP--N--RWVSDSTLNAMTKVMKECWHQNANV 414 (443)
Q Consensus 359 ~P~~~~~~~~~~~~~~~~~~~~~~~~~--------------------~~~--~--~~~~~~~~~~l~~li~~cl~~dP~~ 414 (443)
.||.... ....+..........+ ..+ . .......+.++.+|+.+||+.||.+
T Consensus 230 ~pf~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 305 (360)
T 3e3p_A 230 PIFRGDN----SAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEE 305 (360)
T ss_dssp CSSCCSS----HHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGG
T ss_pred CCcCCCC----hHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccc
Confidence 6665531 1112222211000000 000 0 0011225678999999999999999
Q ss_pred CCcHHHHHH
Q psy14889 415 RLSALRVKK 423 (443)
Q Consensus 415 Rps~~evl~ 423 (443)
|||+.|+++
T Consensus 306 Rpt~~e~l~ 314 (360)
T 3e3p_A 306 RMKPYEALC 314 (360)
T ss_dssp SCCHHHHTT
T ss_pred cCCHHHHhc
Confidence 999999986
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=322.73 Aligned_cols=256 Identities=21% Similarity=0.358 Sum_probs=189.4
Q ss_pred hccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccchHHHHHHHHHHhccCCCceeeeeeccccCC--------
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIGSDMTSRN-------- 204 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~-------- 204 (443)
.++|++.+.||+|+||.||+|.. +++.||||++............|+..+..++||||+++++++.+...
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV 84 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence 46899999999999999999997 68999999986543333334567777777999999999998765321
Q ss_pred -cccEEEeeecccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEE
Q psy14889 205 -SCTQLWLVTHYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCV 281 (443)
Q Consensus 205 -~~~~~~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~k 281 (443)
....+++||||+++|+|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+|
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~--------~i~H~dlkp~Nil~~~~~~~k 156 (303)
T 1zy4_A 85 KKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQ--------GIIHRDLKPMNIFIDESRNVK 156 (303)
T ss_dssp -CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHT--------TCCCSCCCGGGEEECTTSCEE
T ss_pred ccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhC--------CeecccCCHHhEEEcCCCCEE
Confidence 12568999999999999999964 4578899999999999999999999 999999999999999999999
Q ss_pred EEecCCcccccccCCcC----------CCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCC
Q psy14889 282 IADFGLAVSYSQLSNKM----------DIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKAN 351 (443)
Q Consensus 282 l~DfGla~~~~~~~~~~----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~ 351 (443)
|+|||++.......... ........||+.|+|||++.+.. .++.++||||||+++|||+++
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-----~~~~~~Di~slG~il~~l~~p---- 227 (303)
T 1zy4_A 157 IGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTG-----HYNEKIDMYSLGIIFFEMIYP---- 227 (303)
T ss_dssp ECCCCCCSCTTC-------------------------CTTSCHHHHTSCS-----CCCTHHHHHHHHHHHHHHHSC----
T ss_pred EeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCC-----CCcchhhHHHHHHHHHHHHhc----
Confidence 99999997664321100 01123456899999999987531 466899999999999999973
Q ss_pred CcccccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 352 GIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 352 ~~~~~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
|.... ........+. .....++.. .....+..+.+++.+||+.||++|||+.++++
T Consensus 228 ---------~~~~~----~~~~~~~~~~--~~~~~~~~~-~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 228 ---------FSTGM----ERVNILKKLR--SVSIEFPPD-FDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp ---------CSSHH----HHHHHHHHHH--STTCCCCTT-CCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------cCCch----hHHHHHHhcc--ccccccCcc-ccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 21100 0111112111 122223322 22446678999999999999999999999986
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=343.85 Aligned_cols=251 Identities=13% Similarity=0.141 Sum_probs=181.3
Q ss_pred hccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCc----cchHHHHHH---HHHHhccCCCceeeeeec------
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDE----ASWSRETEI---YSTVLLRHENILGYIGSD------ 199 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~----~~~~~e~ei---~~~~~l~H~nIv~l~g~~------ 199 (443)
.++|.+.+.||+|+||.||+|.+ +|+.||||++..... .......|+ ..+..++|||||++++.+
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 36899999999999999999996 589999999864321 112223455 334446899999998443
Q ss_pred -cccCC----------cc---cEEEeeecccCcccHHHHhcc-cCCC-------HHHHHHHHHHHHHHHHHHHHchhcCC
Q psy14889 200 -MTSRN----------SC---TQLWLVTHYHSFGSLYDHLNR-TTLN-------HHQMMKICLSIVNGLVHLHTEIFGTQ 257 (443)
Q Consensus 200 -~~~~~----------~~---~~~~lv~e~~~~gsL~~~l~~-~~l~-------~~~~~~i~~qia~gL~yLH~~~~~~~ 257 (443)
.+... .. ...++||||+ +|+|.+++.. ..++ +..++.++.||+.||+|||+.
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~----- 225 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY----- 225 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT-----
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC-----
Confidence 32211 00 0268999999 5899999964 3344 488889999999999999999
Q ss_pred CCCCeEEeCCCCCCEEEcCCCcEEEEecCCcccccccCCcCCCCCCCcccccCccccccccccc-----ccCcCCCCCcc
Q psy14889 258 GKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESI-----NMDCFESFKKA 332 (443)
Q Consensus 258 ~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~~~~~~s 332 (443)
+|+||||||+|||++.++.+||+|||+++...... ....| +.|+|||++.+.. ......++.++
T Consensus 226 ---~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~-------~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~ 294 (377)
T 3byv_A 226 ---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGARV-------VSSVS-RGFEPPELEARRATISYHRDRRTLMTFSF 294 (377)
T ss_dssp ---TEECSCCCGGGEEECTTCCEEECCGGGCEETTCEE-------ECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHH
T ss_pred ---CeecCCCCHHHEEEcCCCCEEEEechhheecCCcc-------cCCCC-cCccChhhhcccccccccccccccCChhh
Confidence 99999999999999999999999999997543311 23467 8999999997640 00001456899
Q ss_pred chHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCc
Q psy14889 333 DIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNA 412 (443)
Q Consensus 333 DvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP 412 (443)
|||||||++|||++| ..||........ ..... ... ..++.++.+|+.+||+.||
T Consensus 295 DvwSlG~il~elltg----------~~Pf~~~~~~~~----~~~~~---~~~---------~~~~~~~~~li~~~L~~dp 348 (377)
T 3byv_A 295 DAWALGLVIYWIWCA----------DLPITKDAALGG----SEWIF---RSC---------KNIPQPVRALLEGFLRYPK 348 (377)
T ss_dssp HHHHHHHHHHHHHHS----------SCCC------CC----SGGGG---SSC---------CCCCHHHHHHHHHHTCSSG
T ss_pred hHHHHHHHHHHHHHC----------CCCCcccccccc----hhhhh---hhc---------cCCCHHHHHHHHHHcCCCc
Confidence 999999999999999 667655321111 01110 000 2255789999999999999
Q ss_pred CCCCcHHHHHH--HHHHH
Q psy14889 413 NVRLSALRVKK--TLIKL 428 (443)
Q Consensus 413 ~~Rps~~evl~--~L~~l 428 (443)
++|||+.|+++ .++++
T Consensus 349 ~~Rpt~~e~l~hp~f~~~ 366 (377)
T 3byv_A 349 EDRLLPLQAMETPEYEQL 366 (377)
T ss_dssp GGCCCHHHHHTSHHHHHH
T ss_pred hhCCCHHHHhhChHHHHH
Confidence 99999999986 44443
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=336.80 Aligned_cols=255 Identities=18% Similarity=0.266 Sum_probs=189.1
Q ss_pred hhccccccceeeeecCeEEEEEEE-CCceeEEEEeeccCccchHHHHHHHHHHhccCCCceeeeeeccccCC--cccEEE
Q psy14889 134 LAKQISLSECIGKGRYGEVWRGVW-HGENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIGSDMTSRN--SCTQLW 210 (443)
Q Consensus 134 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~--~~~~~~ 210 (443)
...+|++.+.||+|+||.||+|++ .+..||+|++..... ...+ |+..+..++||||+++++++..... ....++
T Consensus 38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~-~~~~--E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 38 REIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR-FKNR--ELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT-SCCH--HHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred ccceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc-hHHH--HHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 346799999999999999999998 556699998754332 2223 4455555999999999999865432 224478
Q ss_pred eeecccCcccHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEc-CCCcEEEEec
Q psy14889 211 LVTHYHSFGSLYDHLN----RTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVK-TNGTCVIADF 285 (443)
Q Consensus 211 lv~e~~~~gsL~~~l~----~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~-~~~~~kl~Df 285 (443)
+||||++++.+..... ...+++..+..++.||+.||+|||+. +|+||||||+|||++ .++.+||+||
T Consensus 115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~--------~ivHrDlkp~Nill~~~~~~~kL~DF 186 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI--------GICHRDIKPQNLLLDPPSGVLKLIDF 186 (394)
T ss_dssp EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT--------TEECSCCSGGGEEEETTTTEEEECCC
T ss_pred EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CccCCCCCHHHEEEcCCCCcEEEeeC
Confidence 9999998754433322 46799999999999999999999999 999999999999999 7899999999
Q ss_pred CCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCC
Q psy14889 286 GLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLV 365 (443)
Q Consensus 286 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~ 365 (443)
|+++....... .....||+.|+|||++.+.. .++.++|||||||++|||++| ..||.+..
T Consensus 187 G~a~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~-----~~~~~~DiwSlG~il~ell~g----------~~pf~~~~ 246 (394)
T 4e7w_A 187 GSAKILIAGEP-----NVSYICSRYYRAPELIFGAT-----NYTTNIDIWSTGCVMAELMQG----------QPLFPGES 246 (394)
T ss_dssp TTCEECCTTCC-----CCSSCSCGGGCCHHHHTTCS-----SCCTHHHHHHHHHHHHHHHHS----------SCSSCCSS
T ss_pred CCcccccCCCC-----CcccccCcCccCHHHHcCCC-----CCCcHHHHHHHHHHHHHHHhC----------CCCCCCCC
Confidence 99987644322 23457899999999987642 467899999999999999999 66776531
Q ss_pred CCCCChHHHHhhhhh--------------cCCCCCCCCC-------CCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 366 PMDPSFDDMRKVICI--------------DQQRPVLPNR-------WVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 366 ~~~~~~~~~~~~~~~--------------~~~~~~~~~~-------~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
..+.+..++.. ......++.. ......+.++.+|+.+||+.||++|||+.|+++
T Consensus 247 ----~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 247 ----GIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp ----HHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ----HHHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 11122221110 0001111110 011235678999999999999999999999986
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=328.00 Aligned_cols=261 Identities=21% Similarity=0.233 Sum_probs=188.9
Q ss_pred hhccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccc-hHHHHHHHHHHhccCCCceeeeeeccccC-------
Q psy14889 134 LAKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEAS-WSRETEIYSTVLLRHENILGYIGSDMTSR------- 203 (443)
Q Consensus 134 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~-~~~e~ei~~~~~l~H~nIv~l~g~~~~~~------- 203 (443)
+.++|.+.+.||+|+||.||+|.. +++.||||++....... .....|+..+..++||||+++++++....
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 88 (320)
T 2i6l_A 9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV 88 (320)
T ss_dssp ETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC--
T ss_pred cCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccc
Confidence 457899999999999999999998 48899999886554322 23346677777799999999999875432
Q ss_pred ---CcccEEEeeecccCcccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEc-CCCc
Q psy14889 204 ---NSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVK-TNGT 279 (443)
Q Consensus 204 ---~~~~~~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~-~~~~ 279 (443)
......++||||+. |+|.+++.+..+++..+..++.|++.||+|||+. +|+||||||+|||++ +++.
T Consensus 89 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--------~i~H~dlkp~Nil~~~~~~~ 159 (320)
T 2i6l_A 89 GSLTELNSVYIVQEYME-TDLANVLEQGPLLEEHARLFMYQLLRGLKYIHSA--------NVLHRDLKPANLFINTEDLV 159 (320)
T ss_dssp --CCSCSEEEEEEECCS-EEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT--------TCBCCCCSGGGEEEETTTTE
T ss_pred ccccccCceeEEeeccC-CCHHHHhhcCCccHHHHHHHHHHHHHHHHHHHhC--------CEecCCCCHHHEEEcCCCCe
Confidence 11246899999998 6999999988999999999999999999999999 999999999999997 5679
Q ss_pred EEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCC
Q psy14889 280 CVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKA 359 (443)
Q Consensus 280 ~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~ 359 (443)
+||+|||+++......... .......+|..|+|||.+.+.. .++.++||||||+++|||++| ..
T Consensus 160 ~kl~Dfg~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~-----~~~~~~Di~slG~il~el~~g----------~~ 223 (320)
T 2i6l_A 160 LKIGDFGLARIMDPHYSHK-GHLSEGLVTKWYRSPRLLLSPN-----NYTKAIDMWAAGCIFAEMLTG----------KT 223 (320)
T ss_dssp EEECCCTTCBCC---------CCCGGGSCCTTCCHHHHHCTT-----CCCHHHHHHHHHHHHHHHHHS----------SC
T ss_pred EEEccCccccccCCCcccc-cccccccccccccCcHHhcCcc-----cCCchhhhHhHHHHHHHHHhC----------CC
Confidence 9999999998765322111 1123346789999999886531 566899999999999999999 66
Q ss_pred CCCCCCCCCCChHHHHhhhhhc----------------------CCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCc
Q psy14889 360 PYHDLVPMDPSFDDMRKVICID----------------------QQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLS 417 (443)
Q Consensus 360 P~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps 417 (443)
||.... ..+.+....... ...+..+.......++.++.+++.+||+.||++|||
T Consensus 224 pf~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 299 (320)
T 2i6l_A 224 LFAGAH----ELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLT 299 (320)
T ss_dssp SSCCSS----HHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCC
T ss_pred CCCCCC----HHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCC
Confidence 665431 111111111100 000110000001235678999999999999999999
Q ss_pred HHHHHH
Q psy14889 418 ALRVKK 423 (443)
Q Consensus 418 ~~evl~ 423 (443)
+.|+++
T Consensus 300 ~~ell~ 305 (320)
T 2i6l_A 300 AEEALS 305 (320)
T ss_dssp HHHHHT
T ss_pred HHHHhC
Confidence 999986
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=331.55 Aligned_cols=253 Identities=21% Similarity=0.282 Sum_probs=190.5
Q ss_pred hhhccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCc---------cchHHHHHHHHHHhccCCCceeeeeeccc
Q psy14889 133 TLAKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDE---------ASWSRETEIYSTVLLRHENILGYIGSDMT 201 (443)
Q Consensus 133 ~~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~---------~~~~~e~ei~~~~~l~H~nIv~l~g~~~~ 201 (443)
.+.++|.+.+.||+|+||.||+|.. +++.||||++..... .....+.|+..+..++||||+++++++..
T Consensus 7 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 86 (322)
T 2ycf_A 7 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 86 (322)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred hhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC
Confidence 3457899999999999999999998 578999998854321 11123456666666999999999999865
Q ss_pred cCCcccEEEeeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCc-
Q psy14889 202 SRNSCTQLWLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGT- 279 (443)
Q Consensus 202 ~~~~~~~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~- 279 (443)
.. .++||||+++|+|.+++.. ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.
T Consensus 87 ~~-----~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--------~ivH~dlkp~NIl~~~~~~~ 153 (322)
T 2ycf_A 87 ED-----YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN--------GIIHRDLKPENVLLSSQEED 153 (322)
T ss_dssp SS-----EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHT--------TEECCCCSGGGEEESSSSSS
T ss_pred Cc-----eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC--------CeeccCCCHHHEEEecCCCC
Confidence 42 6999999999999998864 5799999999999999999999999 9999999999999987664
Q ss_pred --EEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCccccc
Q psy14889 280 --CVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEY 357 (443)
Q Consensus 280 --~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~ 357 (443)
+||+|||+++........ ....||+.|+|||++..... ..++.++|||||||++|||++|
T Consensus 154 ~~~kl~Dfg~~~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~---~~~~~~~Di~slG~il~~l~~g---------- 215 (322)
T 2ycf_A 154 CLIKITDFGHSKILGETSLM-----RTLCGTPTYLAPEVLVSVGT---AGYNRAVDCWSLGVILFICLSG---------- 215 (322)
T ss_dssp CCEEECCCTTCEECCCCHHH-----HHHHSCCTTCCHHHHHHTTT---TTCTTHHHHHHHHHHHHHHHHS----------
T ss_pred CeEEEccCccceeccccccc-----ccccCCcCccCchhhccCCC---CCCCchhhHHHHHHHHHHHHhC----------
Confidence 999999999766432111 12368999999999753111 1567899999999999999999
Q ss_pred CCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 358 KAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 358 ~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
..||....... .+...+... .....+.. ....+..+.+++.+||+.||++|||+.++++
T Consensus 216 ~~pf~~~~~~~----~~~~~~~~~-~~~~~~~~--~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 216 YPPFSEHRTQV----SLKDQITSG-KYNFIPEV--WAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp SCSSCSTTCSS----CHHHHHHHT-CCCCCHHH--HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCCcccchHH----HHHHHHHhC-ccccCchh--hhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 66776532211 112222111 11111110 1224578999999999999999999999984
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=329.87 Aligned_cols=257 Identities=26% Similarity=0.373 Sum_probs=181.7
Q ss_pred hhccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc--chHHHHHHHHHHhccCCCceeeeeeccccCCcccEE
Q psy14889 134 LAKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA--SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQL 209 (443)
Q Consensus 134 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~--~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~ 209 (443)
..++|.+.+.||+|+||.||+|.. +++.||||++...... ......|+..+..++||||+++++++.... ..
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~ 88 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKD----EL 88 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSS----CE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecC----Cc
Confidence 347899999999999999999987 6899999987543221 122235566666689999999999988764 47
Q ss_pred EeeecccCcccHHHHhcc---------cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcE
Q psy14889 210 WLVTHYHSFGSLYDHLNR---------TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTC 280 (443)
Q Consensus 210 ~lv~e~~~~gsL~~~l~~---------~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~ 280 (443)
++||||+++|+|.+++.. ..+++..+..++.||+.||.|||+. +|+||||||+||+++.++.+
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--------~i~H~dl~p~Nil~~~~~~~ 160 (303)
T 2vwi_A 89 WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN--------GQIHRDVKAGNILLGEDGSV 160 (303)
T ss_dssp EEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT--------TCCCCCCSGGGEEECTTCCE
T ss_pred EEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC--------CCCCCCCChhhEEEcCCCCE
Confidence 999999999999999852 4589999999999999999999999 99999999999999999999
Q ss_pred EEEecCCcccccccCCcC-CCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCC
Q psy14889 281 VIADFGLAVSYSQLSNKM-DIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKA 359 (443)
Q Consensus 281 kl~DfGla~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~ 359 (443)
||+|||++.......... ........||+.|+|||++.+.. .++.++||||||+++|||++| ..
T Consensus 161 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-----~~~~~~Di~slG~il~~l~~g----------~~ 225 (303)
T 2vwi_A 161 QIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVR-----GYDFKADIWSFGITAIELATG----------AA 225 (303)
T ss_dssp EECCCHHHHHCC---------------CCCTTCCHHHHHHHH-----CCCTHHHHHHHHHHHHHHHHS----------SC
T ss_pred EEEeccchheeccCCCccchhhhcccCCCccccCHHHhcccc-----CCCchhhHHHHHHHHHHHHhC----------CC
Confidence 999999987654322111 11123457899999999987531 456899999999999999999 66
Q ss_pred CCCCCCCCCCChHHHHhhhhhcCCCCCCCC----CCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 360 PYHDLVPMDPSFDDMRKVICIDQQRPVLPN----RWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 360 P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
||..... ......... ...+..+. .......+.++.+++.+||+.||.+|||+.++++
T Consensus 226 pf~~~~~----~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 226 PYHKYPP----MKVLMLTLQ--NDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp TTTTSCG----GGHHHHHHT--SSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CCccCch----hhHHHHHhc--cCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 6655321 111111111 11111111 0111335678999999999999999999999986
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=333.69 Aligned_cols=256 Identities=20% Similarity=0.331 Sum_probs=190.2
Q ss_pred hhhccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccc---hHHHHHHHHHHhccCCCceeeeeeccccCCc--
Q psy14889 133 TLAKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEAS---WSRETEIYSTVLLRHENILGYIGSDMTSRNS-- 205 (443)
Q Consensus 133 ~~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~---~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~-- 205 (443)
.+.++|.+.+.||+|+||.||+|.. +|+.||||++....... .....|+..+..++||||+++++++......
T Consensus 39 ~l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 118 (371)
T 4exu_A 39 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRN 118 (371)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTT
T ss_pred cccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccc
Confidence 3557899999999999999999987 58999999986543221 2234566666679999999999998765432
Q ss_pred ccEEEeeecccCcccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEec
Q psy14889 206 CTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADF 285 (443)
Q Consensus 206 ~~~~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~Df 285 (443)
...+++||||+. |+|.+++.. .+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+||
T Consensus 119 ~~~~~lv~e~~~-~~l~~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~--------~ivH~Dikp~NIll~~~~~~kL~Df 188 (371)
T 4exu_A 119 FYDFYLVMPFMQ-TDLQKIMGM-EFSEEKIQYLVYQMLKGLKYIHSA--------GVVHRDLKPGNLAVNEDCELKILDF 188 (371)
T ss_dssp CCCCEEEEECCC-EEHHHHTTS-CCCHHHHHHHHHHHHHHHHHHHHT--------TCCCSCCCGGGEEECTTCCEEECST
T ss_pred ceeEEEEEcccc-ccHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHC--------CCcCCCcCHHHeEECCCCCEEEEec
Confidence 123489999998 699988854 499999999999999999999999 9999999999999999999999999
Q ss_pred CCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCC
Q psy14889 286 GLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLV 365 (443)
Q Consensus 286 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~ 365 (443)
|+++..... .....||+.|+|||++.+.. .++.++|||||||++|||++| ..||....
T Consensus 189 g~a~~~~~~-------~~~~~~t~~y~aPE~~~~~~-----~~~~~~DiwslG~il~el~~g----------~~pf~~~~ 246 (371)
T 4exu_A 189 GLARHADAE-------MTGYVVTRWYRAPEVILSWM-----HYNQTVDIWSVGCIMAEMLTG----------KTLFKGKD 246 (371)
T ss_dssp TCC---------------CTTCCCTTSCHHHHSCCS-----CCCTTHHHHHHHHHHHHHHHS----------SCSCCCSS
T ss_pred CcccccccC-------cCCcccCccccCHHHhcCCC-----CCCcHHhHHHHHHHHHHHHhC----------CCCCCCCC
Confidence 999765432 23457899999999987631 567899999999999999999 56665421
Q ss_pred CCCCChHHHHhhhhhcCC--------------------CCCCCCC-C--CCchhHHHHHHHHHHHhcCCcCCCCcHHHHH
Q psy14889 366 PMDPSFDDMRKVICIDQQ--------------------RPVLPNR-W--VSDSTLNAMTKVMKECWHQNANVRLSALRVK 422 (443)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~--------------------~~~~~~~-~--~~~~~~~~l~~li~~cl~~dP~~Rps~~evl 422 (443)
..+.+......... .+..+.. + .....+..+.+|+.+||+.||++|||+.|++
T Consensus 247 ----~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 322 (371)
T 4exu_A 247 ----YLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQAL 322 (371)
T ss_dssp ----HHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHH
T ss_pred ----hHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHh
Confidence 11111111110000 0000000 0 0123467899999999999999999999998
Q ss_pred HH
Q psy14889 423 KT 424 (443)
Q Consensus 423 ~~ 424 (443)
+.
T Consensus 323 ~h 324 (371)
T 4exu_A 323 TH 324 (371)
T ss_dssp TS
T ss_pred cC
Confidence 63
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=332.24 Aligned_cols=196 Identities=26% Similarity=0.310 Sum_probs=157.0
Q ss_pred HhhhhccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccchHHHHHHHHHHhcc-CC-----Cceeeeeecccc
Q psy14889 131 QRTLAKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEASWSRETEIYSTVLLR-HE-----NILGYIGSDMTS 202 (443)
Q Consensus 131 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~-H~-----nIv~l~g~~~~~ 202 (443)
.+.+.++|++.+.||+|+||.||+|.. +++.||||++..........+.|+..+..++ |+ +|+++++++...
T Consensus 49 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 128 (382)
T 2vx3_A 49 GEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR 128 (382)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred CCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence 344568999999999999999999988 5789999998654332222233444433343 54 489999988776
Q ss_pred CCcccEEEeeecccCcccHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEc--CC
Q psy14889 203 RNSCTQLWLVTHYHSFGSLYDHLNR---TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVK--TN 277 (443)
Q Consensus 203 ~~~~~~~~lv~e~~~~gsL~~~l~~---~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~--~~ 277 (443)
..+++||||+. |+|.+++.. ..+++..+..++.|++.||.|||++ ..+|+||||||+|||++ .+
T Consensus 129 ----~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~------~~~ivHrDlkp~NIll~~~~~ 197 (382)
T 2vx3_A 129 ----NHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP------ELSIIHCDLKPENILLCNPKR 197 (382)
T ss_dssp ----TEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST------TTCEECCCCSGGGEEESSTTS
T ss_pred ----CceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC------CCCEEcCCCCcccEEEecCCC
Confidence 46899999997 599999965 3589999999999999999999964 23999999999999995 47
Q ss_pred CcEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccC
Q psy14889 278 GTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKA 350 (443)
Q Consensus 278 ~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~ 350 (443)
+.+||+|||+++..... .....||+.|+|||++.+. .++.++|||||||++|||+||+.|
T Consensus 198 ~~~kL~DFG~a~~~~~~-------~~~~~~t~~y~aPE~~~~~------~~~~~~DiwSlG~il~elltg~~p 257 (382)
T 2vx3_A 198 SAIKIVDFGSSCQLGQR-------IYQYIQSRFYRSPEVLLGM------PYDLAIDMWSLGCILVEMHTGEPL 257 (382)
T ss_dssp CCEEECCCTTCEETTCC-------CCSSCSCGGGCCHHHHTTC------CCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred CcEEEEeccCceecccc-------cccccCCccccChHHHcCC------CCCcHHHHHHHHHHHHHHHhCCCC
Confidence 78999999999776432 1345789999999999876 677899999999999999999443
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=334.17 Aligned_cols=257 Identities=19% Similarity=0.208 Sum_probs=190.1
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccchHHHHHHHHHHhcc-----------CCCceeeeeecccc
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEASWSRETEIYSTVLLR-----------HENILGYIGSDMTS 202 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~-----------H~nIv~l~g~~~~~ 202 (443)
++|.+.+.||+|+||.||+|.. +++.||||++..........+.|+..+..++ ||||+++++++...
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~ 98 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 98 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhcc
Confidence 6899999999999999999997 6889999998654333333334444444444 89999999998876
Q ss_pred CCcccEEEeeecccCcccHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcC---
Q psy14889 203 RNSCTQLWLVTHYHSFGSLYDHLNR---TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKT--- 276 (443)
Q Consensus 203 ~~~~~~~~lv~e~~~~gsL~~~l~~---~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~--- 276 (443)
......+++||||+ +++|.+++.. ..+++..+..++.||+.||.|||+++ +|+||||||+|||++.
T Consensus 99 ~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~-------~ivH~Dikp~NIll~~~~~ 170 (373)
T 1q8y_A 99 GPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC-------GIIHTDIKPENVLMEIVDS 170 (373)
T ss_dssp ETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT-------CEECSCCSGGGEEEEEEET
T ss_pred CCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcC-------CEEecCCChHHeEEeccCC
Confidence 54445789999999 7899999864 45999999999999999999999852 8999999999999953
Q ss_pred ---CCcEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCc
Q psy14889 277 ---NGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGI 353 (443)
Q Consensus 277 ---~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~ 353 (443)
.+.+||+|||++....... ....||+.|+|||++.+. .++.++|||||||++|||++|
T Consensus 171 ~~~~~~~kl~Dfg~a~~~~~~~-------~~~~~t~~y~aPE~~~~~------~~~~~~Di~slG~il~el~~g------ 231 (373)
T 1q8y_A 171 PENLIQIKIADLGNACWYDEHY-------TNSIQTREYRSPEVLLGA------PWGCGADIWSTACLIFELITG------ 231 (373)
T ss_dssp TTTEEEEEECCCTTCEETTBCC-------CSCCSCGGGCCHHHHHTC------CCCTHHHHHHHHHHHHHHHHS------
T ss_pred CcCcceEEEcccccccccCCCC-------CCCCCCccccCcHHHhCC------CCCchHhHHHHHHHHHHHHhC------
Confidence 3489999999997665321 234789999999999876 677899999999999999999
Q ss_pred ccccCCCCCCCCCCCC--ChHHHHhhhhhcCCCC---------------------CCC-------------CCCCCchhH
Q psy14889 354 FEEYKAPYHDLVPMDP--SFDDMRKVICIDQQRP---------------------VLP-------------NRWVSDSTL 397 (443)
Q Consensus 354 ~~~~~~P~~~~~~~~~--~~~~~~~~~~~~~~~~---------------------~~~-------------~~~~~~~~~ 397 (443)
..||........ ....+...+......+ ... ....+...+
T Consensus 232 ----~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (373)
T 1q8y_A 232 ----DFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEA 307 (373)
T ss_dssp ----SCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHH
T ss_pred ----CCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchH
Confidence 556654321110 1111111111100000 000 000124567
Q ss_pred HHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 398 NAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 398 ~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
.++.+||.+||+.||++|||+.|+++
T Consensus 308 ~~~~~li~~~L~~dP~~Rpt~~ell~ 333 (373)
T 1q8y_A 308 KEISDFLSPMLQLDPRKRADAGGLVN 333 (373)
T ss_dssp HHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred HHHHHHHHHHhccCccccCCHHHHhh
Confidence 88999999999999999999999987
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=330.16 Aligned_cols=250 Identities=18% Similarity=0.253 Sum_probs=195.8
Q ss_pred hccccccceeeeecCeEEEEEEECCceeEEEEeeccCccc------------------hHHHHHHHHHHhccCCCceeee
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVWHGENVAVKIFFSRDEAS------------------WSRETEIYSTVLLRHENILGYI 196 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~------------------~~~e~ei~~~~~l~H~nIv~l~ 196 (443)
.++|.+.+.||+|+||.||+|.++|+.||||++....... .....|+..+..++||||++++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 109 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCE 109 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCS
T ss_pred cCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEE
Confidence 4789999999999999999999999999999986432111 3445667777779999999999
Q ss_pred eeccccCCcccEEEeeecccCcccHHHH------hc---ccCCCHHHHHHHHHHHHHHHHHHHH-chhcCCCCCCeEEeC
Q psy14889 197 GSDMTSRNSCTQLWLVTHYHSFGSLYDH------LN---RTTLNHHQMMKICLSIVNGLVHLHT-EIFGTQGKPAIAHRD 266 (443)
Q Consensus 197 g~~~~~~~~~~~~~lv~e~~~~gsL~~~------l~---~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~~~~~~iiHrD 266 (443)
+++.+. ...++||||+++|+|.++ +. ...+++..+..++.|++.||.|||+ . +|+|||
T Consensus 110 ~~~~~~----~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--------~i~H~d 177 (348)
T 2pml_X 110 GIITNY----DEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK--------NICHRD 177 (348)
T ss_dssp EEEESS----SEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS--------CEECCC
T ss_pred EEEeeC----CeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC--------CEeecC
Confidence 998776 458999999999999998 64 3579999999999999999999998 7 999999
Q ss_pred CCCCCEEEcCCCcEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCC-ccchHHHHHHHHHHH
Q psy14889 267 IKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFK-KADIYALGLVLWEVC 345 (443)
Q Consensus 267 lk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~-~sDvwS~Gvvl~ell 345 (443)
|||+|||++.++.+||+|||++....... .....||..|+|||.+.+.. .++. ++||||||+++|||+
T Consensus 178 l~p~Nil~~~~~~~kl~dfg~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~-----~~~~~~~Di~slG~il~~l~ 246 (348)
T 2pml_X 178 VKPSNILMDKNGRVKLSDFGESEYMVDKK------IKGSRGTYEFMPPEFFSNES-----SYNGAKVDIWSLGICLYVMF 246 (348)
T ss_dssp CCGGGEEECTTSCEEECCCTTCEECBTTE------ECSSCSCGGGCCGGGGSSCC-----CEEHHHHHHHHHHHHHHHHH
T ss_pred CChHhEEEcCCCcEEEecccccccccccc------ccCCCCCcCccCchhhcCCC-----CCCcchhhHHHHHHHHHHHH
Confidence 99999999999999999999997664321 13347899999999997652 2234 899999999999999
Q ss_pred hcccCCCcccccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCC--------------CCCchhHHHHHHHHHHHhcCC
Q psy14889 346 RRTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNR--------------WVSDSTLNAMTKVMKECWHQN 411 (443)
Q Consensus 346 tg~~~~~~~~~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~l~~li~~cl~~d 411 (443)
+| ..||..... . ......+.. .....+.. ......+..+.+|+.+||+.|
T Consensus 247 ~g----------~~pf~~~~~---~-~~~~~~i~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 310 (348)
T 2pml_X 247 YN----------VVPFSLKIS---L-VELFNNIRT--KNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKN 310 (348)
T ss_dssp HS----------SCSSCCSSC---S-HHHHHHHTS--CCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSS
T ss_pred hC----------CCCCCCCCc---H-HHHHHHHhc--cCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCC
Confidence 99 666654321 1 222222211 11112210 001345678999999999999
Q ss_pred cCCCCcHHHHHH
Q psy14889 412 ANVRLSALRVKK 423 (443)
Q Consensus 412 P~~Rps~~evl~ 423 (443)
|.+|||+.|+++
T Consensus 311 P~~Rps~~e~l~ 322 (348)
T 2pml_X 311 PAERITSEDALK 322 (348)
T ss_dssp GGGSCCHHHHHT
T ss_pred hhhCCCHHHHhc
Confidence 999999999986
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=325.48 Aligned_cols=253 Identities=24% Similarity=0.369 Sum_probs=172.3
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccc--hHHHHHHH-HHHhccCCCceeeeeeccccCCcccEEE
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEAS--WSRETEIY-STVLLRHENILGYIGSDMTSRNSCTQLW 210 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~--~~~e~ei~-~~~~l~H~nIv~l~g~~~~~~~~~~~~~ 210 (443)
++|++.+.||+|+||.||+|.. +|+.||||++....... .....|+. .+..++||||+++++++... ...+
T Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~----~~~~ 97 (327)
T 3aln_A 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFRE----GDCW 97 (327)
T ss_dssp CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECS----SEEE
T ss_pred HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeC----CceE
Confidence 6899999999999999999998 48999999987543222 12223333 34457999999999998876 4579
Q ss_pred eeecccCcccHHHHhc------ccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEe
Q psy14889 211 LVTHYHSFGSLYDHLN------RTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIAD 284 (443)
Q Consensus 211 lv~e~~~~gsL~~~l~------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~D 284 (443)
+||||+.+ +|.+++. ...+++..+..++.|++.||.|||+.. +|+||||||+|||++.++.+||+|
T Consensus 98 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~-------~ivH~dlkp~NIll~~~~~~kl~D 169 (327)
T 3aln_A 98 ICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL-------KIIHRDIKPSNILLDRSGNIKLCD 169 (327)
T ss_dssp EEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH-------SCCCSCCCGGGEEEETTTEEEECC
T ss_pred EEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC-------CEeECCCCHHHEEEcCCCCEEEcc
Confidence 99999985 8888775 467999999999999999999999863 899999999999999999999999
Q ss_pred cCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCC
Q psy14889 285 FGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDL 364 (443)
Q Consensus 285 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~ 364 (443)
||+++....... .....||+.|+|||++...... ..++.++||||||+++|||++| ..||...
T Consensus 170 fg~~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~--~~~~~~~Di~slG~il~~l~~g----------~~pf~~~ 232 (327)
T 3aln_A 170 FGISGQLVDSIA-----KTRDAGCRPYMAPERIDPSASR--QGYDVRSDVWSLGITLYELATG----------RFPYPKW 232 (327)
T ss_dssp CSSSCC-------------------------------------CCSHHHHHHHHHHHHHHHHS----------CCCSSCC
T ss_pred CCCceecccccc-----cccCCCCccccCceeeccccCc--CCCCchhhHHHHHHHHHHHHHC----------CCCCCCc
Confidence 999976653221 1234689999999998432111 1567899999999999999999 6666543
Q ss_pred CCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 365 VPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
.. ..+.+.... ....+.++.. ....++..+.+|+.+||+.||++|||+.++++
T Consensus 233 ~~---~~~~~~~~~--~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 233 NS---VFDQLTQVV--KGDPPQLSNS-EEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp ----------CCCC--CSCCCCCCCC-SSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ch---HHHHHHHHh--cCCCCCCCCc-ccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 11 111111111 1112222211 11346678999999999999999999999976
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=337.01 Aligned_cols=200 Identities=25% Similarity=0.365 Sum_probs=146.5
Q ss_pred hhccccc-cceeeeecCeEEEEEEEC----CceeEEEEeeccCccchHHHHHHHHHHhccCCCceeeeeeccccCCcccE
Q psy14889 134 LAKQISL-SECIGKGRYGEVWRGVWH----GENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQ 208 (443)
Q Consensus 134 ~~~~~~~-~~~lG~G~fg~Vy~~~~~----~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~ 208 (443)
+.+.|.+ .++||+|+||.||+|++. ++.||||++..... ......|+..+..++||||+++++++..... ..
T Consensus 18 ~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~--~~ 94 (405)
T 3rgf_A 18 VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-SMSACREIALLRELKHPNVISLQKVFLSHAD--RK 94 (405)
T ss_dssp HHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-CHHHHHHHHHHHHCCCTTBCCCCEEEEETTT--TE
T ss_pred hhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-CHHHHHHHHHHHhcCCCCeeeEeeEEecCCC--Ce
Confidence 3456776 458999999999999963 67899999865432 2233455666666999999999999865433 46
Q ss_pred EEeeecccCcccHHHHhcc----------cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEE----
Q psy14889 209 LWLVTHYHSFGSLYDHLNR----------TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILV---- 274 (443)
Q Consensus 209 ~~lv~e~~~~gsL~~~l~~----------~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl---- 274 (443)
+++||||+. |+|.+++.. ..+++..+..++.||+.||.|||+. +|+||||||+|||+
T Consensus 95 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~--------~ivH~Dlkp~NIll~~~~ 165 (405)
T 3rgf_A 95 VWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN--------WVLHRDLKPANILVMGEG 165 (405)
T ss_dssp EEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT--------TCCCCCCCGGGEEECCSS
T ss_pred EEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC--------CEeCCCcCHHHeEEecCC
Confidence 899999997 588888742 1499999999999999999999999 99999999999999
Q ss_pred cCCCcEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCC
Q psy14889 275 KTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKAN 351 (443)
Q Consensus 275 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~ 351 (443)
+.++.+||+|||+++.+...... ........||+.|+|||++.+.. .++.++|||||||++|||++|+.|+
T Consensus 166 ~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~~DiwSlG~il~ell~g~~pf 236 (405)
T 3rgf_A 166 PERGRVKIADMGFARLFNSPLKP-LADLDPVVVTFWYRAPELLLGAR-----HYTKAIDIWAIGCIFAELLTSEPIF 236 (405)
T ss_dssp TTTTCEEECCTTCCC-----------------CCCTTCCHHHHTTCC-----SCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred CCCCcEEEEECCCceecCCCCcc-cccCCCceecCcccCchhhcCCC-----cccchhhhHHHHHHHHHHHhCCCCC
Confidence 67789999999999876542211 11123457999999999997642 4678999999999999999995443
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=328.13 Aligned_cols=253 Identities=17% Similarity=0.226 Sum_probs=188.2
Q ss_pred HhhhhccccccceeeeecCeEEEEEEE--CC-ceeEEEEeeccCccchHHHHHHHHHHhccCCC------ceeeeeeccc
Q psy14889 131 QRTLAKQISLSECIGKGRYGEVWRGVW--HG-ENVAVKIFFSRDEASWSRETEIYSTVLLRHEN------ILGYIGSDMT 201 (443)
Q Consensus 131 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~--~~-~~vAvK~~~~~~~~~~~~e~ei~~~~~l~H~n------Iv~l~g~~~~ 201 (443)
...+.++|++.+.||+|+||.||+|.. ++ +.||||++............|+..+..++|+| ++.+++++..
T Consensus 14 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~ 93 (355)
T 2eu9_A 14 GDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF 93 (355)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE
T ss_pred CceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee
Confidence 344568999999999999999999997 34 68999998654333333344555555566665 8888888776
Q ss_pred cCCcccEEEeeecccCcccHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEE----
Q psy14889 202 SRNSCTQLWLVTHYHSFGSLYDHLNR---TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILV---- 274 (443)
Q Consensus 202 ~~~~~~~~~lv~e~~~~gsL~~~l~~---~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl---- 274 (443)
. ..+++||||+ +|+|.+++.. ..+++.++..++.||+.||.|||+. +|+||||||+|||+
T Consensus 94 ~----~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~--------~ivH~Dlkp~NIll~~~~ 160 (355)
T 2eu9_A 94 H----GHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHEN--------QLTHTDLKPENILFVNSE 160 (355)
T ss_dssp T----TEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTT--------TEECCCCCGGGEEESCCC
T ss_pred C----CeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC--------CcccCCCCHHHEEEeccc
Confidence 5 4689999999 5677777754 3599999999999999999999998 99999999999999
Q ss_pred ---------------cCCCcEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHH
Q psy14889 275 ---------------KTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGL 339 (443)
Q Consensus 275 ---------------~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gv 339 (443)
+.++.+||+|||+++..... .....||+.|+|||++.+. .++.++|||||||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-------~~~~~gt~~y~aPE~~~~~------~~~~~~Di~slG~ 227 (355)
T 2eu9_A 161 FETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH-------HTTIVATRHYRPPEVILEL------GWAQPCDVWSIGC 227 (355)
T ss_dssp EEEEECCC-CCCEEEESCCCEEECCCTTCEETTSC-------CCSSCSCGGGCCHHHHTTC------CCCTHHHHHHHHH
T ss_pred ccccccccccccccccCCCcEEEeecCcccccccc-------ccCCcCCCcccCCeeeecC------CCCCccchHHHHH
Confidence 66789999999999764332 1345799999999999876 6778999999999
Q ss_pred HHHHHHhcccCCCcccccCCCCCCCCCCCCChHHHHhhhhhcCC------------------------------------
Q psy14889 340 VLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQ------------------------------------ 383 (443)
Q Consensus 340 vl~elltg~~~~~~~~~~~~P~~~~~~~~~~~~~~~~~~~~~~~------------------------------------ 383 (443)
++|||++| ..||.... ..+...........
T Consensus 228 il~el~~g----------~~pf~~~~----~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (355)
T 2eu9_A 228 ILFEYYRG----------FTLFQTHE----NREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENC 293 (355)
T ss_dssp HHHHHHHS----------SCSCCCSS----HHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHC
T ss_pred HHHHHHhC----------CCCCCCCC----HHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccC
Confidence 99999999 55554421 01111111000000
Q ss_pred CCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 384 RPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 384 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
.+...........+.++.+|+.+||+.||++|||+.|+++
T Consensus 294 ~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 333 (355)
T 2eu9_A 294 KPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALL 333 (355)
T ss_dssp CCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0000001112345678999999999999999999999975
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=321.50 Aligned_cols=255 Identities=26% Similarity=0.354 Sum_probs=190.7
Q ss_pred hccccccceeeeecCeEEEEEEE---CCceeEEEEeeccCc-----cchHHHHHHHHH-HhccCCCceeeeeeccccC-C
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVW---HGENVAVKIFFSRDE-----ASWSRETEIYST-VLLRHENILGYIGSDMTSR-N 204 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~---~~~~vAvK~~~~~~~-----~~~~~e~ei~~~-~~l~H~nIv~l~g~~~~~~-~ 204 (443)
.++|++.+.||+|+||.||+|.+ +|+.||||++..... ....+|.++... ..++||||+++++++.... .
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~ 89 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 89 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence 37899999999999999999997 378899998864321 233344443332 2358999999999986321 1
Q ss_pred cccEEEeeecccCcccHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEE
Q psy14889 205 SCTQLWLVTHYHSFGSLYDHLNR---TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCV 281 (443)
Q Consensus 205 ~~~~~~lv~e~~~~gsL~~~l~~---~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~k 281 (443)
....+++||||+. |+|.+++.. ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+|
T Consensus 90 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--------gi~H~dlkp~Nili~~~~~~k 160 (326)
T 1blx_A 90 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH--------RVVHRDLKPQNILVTSSGQIK 160 (326)
T ss_dssp SEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT--------TCCCCCCCGGGEEECTTCCEE
T ss_pred CCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC--------CceeccCCHHHeEEcCCCCEE
Confidence 2256899999998 699999864 3499999999999999999999999 999999999999999999999
Q ss_pred EEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCC
Q psy14889 282 IADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPY 361 (443)
Q Consensus 282 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~ 361 (443)
|+|||+++....... .....||..|+|||++.+. .++.++||||||+++|||++| ..||
T Consensus 161 l~Dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~il~~l~~g----------~~pf 219 (326)
T 1blx_A 161 LADFGLARIYSFQMA-----LTSVVVTLWYRAPEVLLQS------SYATPVDLWSVGCIFAEMFRR----------KPLF 219 (326)
T ss_dssp ECSCCSCCCCCGGGG-----GCCCCCCCTTCCHHHHTTC------CCCTHHHHHHHHHHHHHHHHS----------SCSC
T ss_pred EecCcccccccCCCC-----ccccccccceeCHHHHhcC------CCCcchhHHHHHHHHHHHHcC----------CCCC
Confidence 999999976653221 1335789999999999876 667899999999999999999 5566
Q ss_pred CCCCCCCCChHHHHhhhhhcCC-------------------CCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHH
Q psy14889 362 HDLVPMDPSFDDMRKVICIDQQ-------------------RPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVK 422 (443)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl 422 (443)
.... ....+......... ....+.......++..+.+|+.+||+.||++|||+.|++
T Consensus 220 ~~~~----~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l 295 (326)
T 1blx_A 220 RGSS----DVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 295 (326)
T ss_dssp CCSS----HHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred CCCC----HHHHHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 5421 11111111110000 000000011234667899999999999999999999998
Q ss_pred H
Q psy14889 423 K 423 (443)
Q Consensus 423 ~ 423 (443)
+
T Consensus 296 ~ 296 (326)
T 1blx_A 296 S 296 (326)
T ss_dssp T
T ss_pred c
Confidence 5
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=323.84 Aligned_cols=245 Identities=18% Similarity=0.287 Sum_probs=191.0
Q ss_pred hHHHhhhhccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCc---------cchHHHHHHHHHHhccCCCceeee
Q psy14889 128 LLIQRTLAKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDE---------ASWSRETEIYSTVLLRHENILGYI 196 (443)
Q Consensus 128 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~---------~~~~~e~ei~~~~~l~H~nIv~l~ 196 (443)
....+.+.++|++.+.||+|+||.||+|.. +++.||||++..... .....|.+++....-.|+||++++
T Consensus 35 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~ 114 (320)
T 3a99_A 35 GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLL 114 (320)
T ss_dssp -----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEE
T ss_pred ccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEE
Confidence 344456678999999999999999999987 688999999865422 233445555554222469999999
Q ss_pred eeccccCCcccEEEeeecccCc-ccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEE
Q psy14889 197 GSDMTSRNSCTQLWLVTHYHSF-GSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILV 274 (443)
Q Consensus 197 g~~~~~~~~~~~~~lv~e~~~~-gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl 274 (443)
+++... ...++|+||+.+ ++|.+++.. ..+++..+..++.||+.||+|||+. +|+||||||+|||+
T Consensus 115 ~~~~~~----~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~--------~ivH~Dlkp~NIll 182 (320)
T 3a99_A 115 DWFERP----DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC--------GVLHRDIKDENILI 182 (320)
T ss_dssp EEEECS----SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT--------TEECCCCSGGGEEE
T ss_pred EEEecC----CcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC--------CcEeCCCCHHHEEE
Confidence 998776 457999999976 899999864 6799999999999999999999998 99999999999999
Q ss_pred c-CCCcEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCc
Q psy14889 275 K-TNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGI 353 (443)
Q Consensus 275 ~-~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~ 353 (443)
+ +++.+||+|||+++...... .....||+.|+|||++.+.. ..+.++||||||+++|||++|
T Consensus 183 ~~~~~~~kL~Dfg~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~-----~~~~~~Di~slG~il~el~~g------ 245 (320)
T 3a99_A 183 DLNRGELKLIDFGSGALLKDTV------YTDFDGTRVYSPPEWIRYHR-----YHGRSAAVWSLGILLYDMVCG------ 245 (320)
T ss_dssp ETTTTEEEECCCTTCEECCSSC------BCCCCSCGGGSCHHHHHHSC-----BCHHHHHHHHHHHHHHHHHHS------
T ss_pred eCCCCCEEEeeCcccccccccc------ccCCCCCccCCChHHhccCC-----CCCccchHHhHHHHHHHHHHC------
Confidence 9 78899999999997765322 12346899999999987652 124688999999999999999
Q ss_pred ccccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 354 FEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 354 ~~~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
..||... ... .. . .... ...++.++.+|+.+||+.||++|||+.|+++
T Consensus 246 ----~~pf~~~-------~~~---~~-~--~~~~-----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 246 ----DIPFEHD-------EEI---IR-G--QVFF-----RQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp ----SCSCCSH-------HHH---HH-C--CCCC-----SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----CCCCCCh-------hhh---hc-c--cccc-----cccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 6676542 111 11 0 1111 1335678999999999999999999999986
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=336.27 Aligned_cols=250 Identities=21% Similarity=0.320 Sum_probs=182.9
Q ss_pred ccccccceeeeecCeE-EEEEEECCceeEEEEeeccCccchHHHHHHHHHHhc-cCCCceeeeeeccccCCcccEEEeee
Q psy14889 136 KQISLSECIGKGRYGE-VWRGVWHGENVAVKIFFSRDEASWSRETEIYSTVLL-RHENILGYIGSDMTSRNSCTQLWLVT 213 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~-Vy~~~~~~~~vAvK~~~~~~~~~~~~e~ei~~~~~l-~H~nIv~l~g~~~~~~~~~~~~~lv~ 213 (443)
.+|.+.+.||+|+||+ ||++..+|+.||||++.........+|.+++.. + +|||||++++++.+. ...++||
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~~~~~E~~~l~~--l~~HpnIv~l~~~~~~~----~~~~lv~ 97 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRE--SDEHPNVIRYFCTEKDR----QFQYIAI 97 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEEECHHHHHHHHH--SCCCTTBCCEEEEEEET----TEEEEEE
T ss_pred EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHHHHHHHHHHHHh--ccCCCCcCeEEEEEecC----CEEEEEE
Confidence 5699999999999998 556666899999999876555555555555444 6 899999999998765 4579999
Q ss_pred cccCcccHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcC-----CCcEEEEecC
Q psy14889 214 HYHSFGSLYDHLNRT--TLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKT-----NGTCVIADFG 286 (443)
Q Consensus 214 e~~~~gsL~~~l~~~--~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~-----~~~~kl~DfG 286 (443)
||+. |+|.+++... .+.+..+..++.||+.||.|||+. +|+||||||+|||++. ...+||+|||
T Consensus 98 E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~--------~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG 168 (432)
T 3p23_A 98 ELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSL--------NIVHRDLKPHNILISMPNAHGKIKAMISDFG 168 (432)
T ss_dssp ECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHT--------TCCCCCCSTTSEEECCCBTTTBCCEEECCTT
T ss_pred ECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHC--------cCEeCCCCHHHEEEecCCCCCceeEEEeccc
Confidence 9997 6999999754 355667789999999999999999 9999999999999953 2368899999
Q ss_pred CcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh-cccCCCcccccCCCCCCCC
Q psy14889 287 LAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR-RTKANGIFEEYKAPYHDLV 365 (443)
Q Consensus 287 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt-g~~~~~~~~~~~~P~~~~~ 365 (443)
+++......... .......||+.|+|||++.+.... .++.++|||||||++|||++ | ..||....
T Consensus 169 ~a~~~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~---~~t~~~DiwSlG~il~ellt~g----------~~pf~~~~ 234 (432)
T 3p23_A 169 LCKKLAVGRHSF-SRRSGVPGTEGWIAPEMLSEDCKE---NPTYTVDIFSAGCVFYYVISEG----------SHPFGKSL 234 (432)
T ss_dssp EEECC-------------CCSCTTSCCGGGTSCC------CCCTHHHHHHHHHHHHHHHTTS----------CBTTBSTT
T ss_pred ceeeccCCCcce-eeccccCCCcCccChhhhhccccc---CCCcHHHHHHHHHHHHHHHcCC----------CCCcchhh
Confidence 998765432111 112345799999999999753211 56679999999999999999 6 56665421
Q ss_pred CCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 366 PMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
........ .... .+........+..+.+|+.+||+.||++|||+.++++
T Consensus 235 -----~~~~~~~~-~~~~---~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 235 -----QRQANILL-GACS---LDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp -----THHHHHHT-TCCC---CTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -----HHHHHHHh-ccCC---ccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 11211111 1111 1111112345677899999999999999999999984
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=325.79 Aligned_cols=252 Identities=20% Similarity=0.321 Sum_probs=189.7
Q ss_pred hhccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccc---hHHHHHHHHHHhccCCCceeeeeeccccCCc--c
Q psy14889 134 LAKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEAS---WSRETEIYSTVLLRHENILGYIGSDMTSRNS--C 206 (443)
Q Consensus 134 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~---~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~--~ 206 (443)
+.++|.+.+.||+|+||.||+|.. +|+.||||++....... .....|+..+..++||||+++++++...... .
T Consensus 22 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 101 (353)
T 3coi_A 22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 101 (353)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred cCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence 347899999999999999999998 58999999986543221 2224566666679999999999998765431 1
Q ss_pred cEEEeeecccCcccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecC
Q psy14889 207 TQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFG 286 (443)
Q Consensus 207 ~~~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfG 286 (443)
..+++||||+. |+|.+++.. .+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~~-~~~~~~~~~i~~qi~~al~~LH~~--------~ivH~dlkp~NIl~~~~~~~kl~Dfg 171 (353)
T 3coi_A 102 YDFYLVMPFMQ-TDLQKIMGL-KFSEEKIQYLVYQMLKGLKYIHSA--------GVVHRDLKPGNLAVNEDCELKILDFG 171 (353)
T ss_dssp CCCEEEEECCS-EEGGGTTTS-CCCHHHHHHHHHHHHHHHHHHHHT--------TCCCSSCCGGGEEECTTCCEEECSTT
T ss_pred eeEEEEecccc-CCHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC--------CcccCCCCHHHEeECCCCcEEEeecc
Confidence 23589999998 699988754 599999999999999999999999 99999999999999999999999999
Q ss_pred CcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCC
Q psy14889 287 LAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVP 366 (443)
Q Consensus 287 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~ 366 (443)
+++..... .....||+.|+|||++.+.. .++.++||||||+++|||++| ..||....
T Consensus 172 ~~~~~~~~-------~~~~~~t~~y~aPE~~~~~~-----~~~~~~Di~slG~il~el~~g----------~~pf~~~~- 228 (353)
T 3coi_A 172 LARHADAE-------MTGYVVTRWYRAPEVILSWM-----HYNQTVDIWSVGCIMAEMLTG----------KTLFKGKD- 228 (353)
T ss_dssp CTTC---------------CCSBCCSCHHHHSCCS-----CCCTTHHHHHHHHHHHHHHHS----------SCSSBSSC-
T ss_pred cccCCCCC-------ccccccCcCcCCHHHHhCcC-----CCCchhhHHHHHHHHHHHHhC----------CCCCCCCC-
Confidence 99765432 13347899999999987631 566899999999999999999 56665431
Q ss_pred CCCChHHHHhhhhh-----------------------cCC--CCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHH
Q psy14889 367 MDPSFDDMRKVICI-----------------------DQQ--RPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRV 421 (443)
Q Consensus 367 ~~~~~~~~~~~~~~-----------------------~~~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ev 421 (443)
..+.+...... ... +..+.. .....+..+.+|+.+||+.||++|||+.++
T Consensus 229 ---~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~ 303 (353)
T 3coi_A 229 ---YLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQ--LFPRASPQAADLLEKMLELDVDKRLTAAQA 303 (353)
T ss_dssp ---HHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTT--TCTTSCHHHHHHHHHHSCSCTTTSCCHHHH
T ss_pred ---HHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHH--hcCCcCHHHHHHHHHHcCCCcccCCCHHHH
Confidence 11111111110 000 111111 113456789999999999999999999999
Q ss_pred HH
Q psy14889 422 KK 423 (443)
Q Consensus 422 l~ 423 (443)
++
T Consensus 304 l~ 305 (353)
T 3coi_A 304 LT 305 (353)
T ss_dssp HT
T ss_pred hc
Confidence 86
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=318.45 Aligned_cols=256 Identities=20% Similarity=0.332 Sum_probs=186.9
Q ss_pred hhccccccceeeeecCeEEEEEEE-CCceeEEEEeeccCcc---chHHHHHHHHHHhcc--CCCceeeeeeccccCCccc
Q psy14889 134 LAKQISLSECIGKGRYGEVWRGVW-HGENVAVKIFFSRDEA---SWSRETEIYSTVLLR--HENILGYIGSDMTSRNSCT 207 (443)
Q Consensus 134 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~---~~~~e~ei~~~~~l~--H~nIv~l~g~~~~~~~~~~ 207 (443)
..++|++.+.||+|+||.||++.. +++.||||++...... ......|+..+..++ ||||+++++++... .
T Consensus 26 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~----~ 101 (313)
T 3cek_A 26 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD----Q 101 (313)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECS----S
T ss_pred ccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecC----C
Confidence 346899999999999999999988 5889999998654322 122234555555565 69999999998776 4
Q ss_pred EEEeeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecC
Q psy14889 208 QLWLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFG 286 (443)
Q Consensus 208 ~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfG 286 (443)
.+++||| +.+++|.+++.. ..+++..+..++.|++.||.|||+. +|+||||||+|||++ ++.+||+|||
T Consensus 102 ~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~--------~ivH~dlkp~NIl~~-~~~~kL~Dfg 171 (313)
T 3cek_A 102 YIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH--------GIVHSDLKPANFLIV-DGMLKLIDFG 171 (313)
T ss_dssp EEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHT--------TCCCCCCCGGGEEEE-TTEEEECCCS
T ss_pred EEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CceecCCCcccEEEE-CCeEEEeecc
Confidence 5899999 567899999964 6799999999999999999999999 999999999999996 4899999999
Q ss_pred CcccccccCCcCCCCCCCcccccCccccccccccccc-----CcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCC
Q psy14889 287 LAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINM-----DCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPY 361 (443)
Q Consensus 287 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-----~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~ 361 (443)
+++......... ......||+.|+|||.+.+.... ....++.++||||||+++|||++| ..||
T Consensus 172 ~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g----------~~pf 239 (313)
T 3cek_A 172 IANQMQPDTTSV--VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYG----------KTPF 239 (313)
T ss_dssp SSCC----------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHS----------SCTT
T ss_pred ccccccCccccc--cccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhC----------CCch
Confidence 997665432211 12345789999999998752110 001566899999999999999999 6677
Q ss_pred CCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHH
Q psy14889 362 HDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKT 424 (443)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 424 (443)
..... ....+.... ........+ ...+.++.+++.+||+.||++|||+.|+++.
T Consensus 240 ~~~~~---~~~~~~~~~-~~~~~~~~~-----~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 240 QQIIN---QISKLHAII-DPNHEIEFP-----DIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp TTCCS---HHHHHHHHH-CTTSCCCCC-----CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhHHH---HHHHHHHHH-hcccccCCc-----ccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 65321 112222222 112222222 2245679999999999999999999999874
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=319.70 Aligned_cols=241 Identities=20% Similarity=0.317 Sum_probs=184.1
Q ss_pred HhhhhccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc-------chHHHHHHHHHHhc----cCCCceeeee
Q psy14889 131 QRTLAKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA-------SWSRETEIYSTVLL----RHENILGYIG 197 (443)
Q Consensus 131 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~-------~~~~e~ei~~~~~l----~H~nIv~l~g 197 (443)
.+.+.++|++.+.||+|+||.||+|.. +++.||||++...... ....+.|+..+..+ +||||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 345668899999999999999999987 6889999998654321 11112344444446 8999999999
Q ss_pred eccccCCcccEEEeeecc-cCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEc
Q psy14889 198 SDMTSRNSCTQLWLVTHY-HSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVK 275 (443)
Q Consensus 198 ~~~~~~~~~~~~~lv~e~-~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~ 275 (443)
++.... ..++|+|| +.+++|.+++.+ ..+++..+..++.||+.||.|||+. +|+||||||+||+++
T Consensus 106 ~~~~~~----~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~--------~i~H~dlkp~Nil~~ 173 (312)
T 2iwi_A 106 WFETQE----GFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSR--------GVVHRDIKDENILID 173 (312)
T ss_dssp EC---------CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHH--------TEECCCCSGGGEEEE
T ss_pred EEecCC----eEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CeeecCCChhhEEEe
Confidence 987763 46899999 789999999964 5699999999999999999999999 999999999999999
Q ss_pred -CCCcEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCC-CCccchHHHHHHHHHHHhcccCCCc
Q psy14889 276 -TNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFES-FKKADIYALGLVLWEVCRRTKANGI 353 (443)
Q Consensus 276 -~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~-~~~sDvwS~Gvvl~elltg~~~~~~ 353 (443)
.++.+||+|||++....... .....||..|+|||++.+. .+ +.++||||||+++|||++|
T Consensus 174 ~~~~~~kl~dfg~~~~~~~~~------~~~~~~~~~y~aPE~~~~~------~~~~~~~Di~slG~il~~l~~g------ 235 (312)
T 2iwi_A 174 LRRGCAKLIDFGSGALLHDEP------YTDFDGTRVYSPPEWISRH------QYHALPATVWSLGILLYDMVCG------ 235 (312)
T ss_dssp TTTTEEEECCCSSCEECCSSC------BCCCCSCTTTSCHHHHHHS------CBCHHHHHHHHHHHHHHHHHHS------
T ss_pred CCCCeEEEEEcchhhhcccCc------ccccCCcccccCceeeecC------CCCCccchHHHHHHHHHHHHHC------
Confidence 88999999999997765422 1334689999999998765 33 2489999999999999999
Q ss_pred ccccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 354 FEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 354 ~~~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
..||... ... .. ....++ ..++..+.+++.+||+.||++|||+.|+++
T Consensus 236 ----~~pf~~~-------~~~---~~---~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 236 ----DIPFERD-------QEI---LE---AELHFP-----AHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp ----SCSCCSH-------HHH---HH---TCCCCC-----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ----CCCCCCh-------HHH---hh---hccCCc-----ccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 6676542 111 11 111222 235678999999999999999999999987
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=317.80 Aligned_cols=252 Identities=21% Similarity=0.329 Sum_probs=175.7
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccchH--HHHH-HHHHHhccCCCceeeeeeccccCCcccEEE
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEASWS--RETE-IYSTVLLRHENILGYIGSDMTSRNSCTQLW 210 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~--~e~e-i~~~~~l~H~nIv~l~g~~~~~~~~~~~~~ 210 (443)
++|++.+.||+|+||.||+|.+ +|+.||||++......... ...+ ...+..++||||+++++++... ..++
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~----~~~~ 100 (318)
T 2dyl_A 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITN----TDVF 100 (318)
T ss_dssp GGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS----SEEE
T ss_pred ccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecC----CcEE
Confidence 6899999999999999999998 5899999998754332211 1122 2234457999999999998876 4589
Q ss_pred eeecccCcccHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCc
Q psy14889 211 LVTHYHSFGSLYDHLN--RTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA 288 (443)
Q Consensus 211 lv~e~~~~gsL~~~l~--~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla 288 (443)
+||||+ ++.+..+.. ...+++..+..++.|++.||.|||+.. +|+||||||+|||++.++.+||+|||++
T Consensus 101 lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~-------~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 172 (318)
T 2dyl_A 101 IAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKH-------GVIHRDVKPSNILLDERGQIKLCDFGIS 172 (318)
T ss_dssp EEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHH-------CCCCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhC-------CEEeCCCCHHHEEECCCCCEEEEECCCc
Confidence 999999 456666554 367999999999999999999999832 8999999999999999999999999999
Q ss_pred ccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCC
Q psy14889 289 VSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMD 368 (443)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~ 368 (443)
........ .....||+.|+|||++...... ...++.++||||||+++|||++| ..||....
T Consensus 173 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~-~~~~~~~~Di~slG~il~~l~~g----------~~pf~~~~--- 233 (318)
T 2dyl_A 173 GRLVDDKA-----KDRSAGCAAYMAPERIDPPDPT-KPDYDIRADVWSLGISLVELATG----------QFPYKNCK--- 233 (318)
T ss_dssp -------------------CCTTCCHHHHC---------CCTHHHHHHHHHHHHHHHHS----------SCTTTTCC---
T ss_pred hhccCCcc-----ccccCCCccccChhhccccccc-ccCCccccchhhHHHHHHHHHhC----------CCCCCCCC---
Confidence 76543221 1234689999999998632111 01567899999999999999999 66776531
Q ss_pred CChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 369 PSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
...+.+..... ...+..+. ...++.++.+++.+||+.||.+|||+.++++
T Consensus 234 ~~~~~~~~~~~--~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 234 TDFEVLTKVLQ--EEPPLLPG---HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp SHHHHHHHHHH--SCCCCCCS---SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ccHHHHHHHhc--cCCCCCCc---cCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 12222223222 22233332 1235678999999999999999999999986
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=309.95 Aligned_cols=235 Identities=12% Similarity=0.097 Sum_probs=178.1
Q ss_pred hhhccccccceeeeecCeEEEEEEEC--CceeEEEEeeccCccc----hHHHHHHHHHHhccCCCceeeeeeccccCCcc
Q psy14889 133 TLAKQISLSECIGKGRYGEVWRGVWH--GENVAVKIFFSRDEAS----WSRETEIYSTVLLRHENILGYIGSDMTSRNSC 206 (443)
Q Consensus 133 ~~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~----~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~ 206 (443)
.+.++|++.+.||+|+||.||+|.+. |+.||||++....... .....|+..+..++||||+++++++.+.
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~---- 103 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTR---- 103 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET----
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEEC----
Confidence 34578999999999999999999984 8999999987543322 2334566666779999999999998776
Q ss_pred cEEEeeecccCcccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecC
Q psy14889 207 TQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFG 286 (443)
Q Consensus 207 ~~~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfG 286 (443)
...++||||+++++|.++++++ ....++..++.|++.||+|||+. +|+||||||+|||++.++.+||+++|
T Consensus 104 ~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~i~~ql~~aL~~lH~~--------givH~Dikp~NIll~~~g~~kl~~~~ 174 (286)
T 3uqc_A 104 AGGLVVAEWIRGGSLQEVADTS-PSPVGAIRAMQSLAAAADAAHRA--------GVALSIDHPSRVRVSIDGDVVLAYPA 174 (286)
T ss_dssp TEEEEEEECCCEEEHHHHHTTC-CCHHHHHHHHHHHHHHHHHHHHT--------TCCCCCCSGGGEEEETTSCEEECSCC
T ss_pred CcEEEEEEecCCCCHHHHHhcC-CChHHHHHHHHHHHHHHHHHHHC--------CCccCCCCcccEEEcCCCCEEEEecc
Confidence 4589999999999999999765 46667899999999999999999 99999999999999999999998543
Q ss_pred CcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCC
Q psy14889 287 LAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVP 366 (443)
Q Consensus 287 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~ 366 (443)
|++ .++.++|||||||++|||+|| ..||.+...
T Consensus 175 ------------------------~~~-------------~~~~~~Di~slG~il~elltg----------~~Pf~~~~~ 207 (286)
T 3uqc_A 175 ------------------------TMP-------------DANPQDDIRGIGASLYALLVN----------RWPLPEAGV 207 (286)
T ss_dssp ------------------------CCT-------------TCCHHHHHHHHHHHHHHHHHS----------EECSCCCSB
T ss_pred ------------------------ccC-------------CCCchhHHHHHHHHHHHHHHC----------CCCCCcCCc
Confidence 333 234689999999999999999 556655321
Q ss_pred CCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhhccc
Q psy14889 367 MDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLACADM 433 (443)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~~~~ 433 (443)
..... ...+.. ...+..+ ......++.++.+++.+||+.||++| |+.|+++.|+++.....
T Consensus 208 ~~~~~-~~~~~~---~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~ 268 (286)
T 3uqc_A 208 RSGLA-PAERDT---AGQPIEP-ADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVAD 268 (286)
T ss_dssp CCCSE-ECCBCT---TSCBCCH-HHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred chhhH-HHHHHh---ccCCCCh-hhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence 11000 000000 0000000 00112356789999999999999999 99999999999886543
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=343.76 Aligned_cols=245 Identities=18% Similarity=0.229 Sum_probs=188.4
Q ss_pred hhhhccccccceeeeecCeEEEEEEE---CCceeEEEEeeccCcc--chHHHHHHHHHHhccCCCceeeeeeccccCCcc
Q psy14889 132 RTLAKQISLSECIGKGRYGEVWRGVW---HGENVAVKIFFSRDEA--SWSRETEIYSTVLLRHENILGYIGSDMTSRNSC 206 (443)
Q Consensus 132 ~~~~~~~~~~~~lG~G~fg~Vy~~~~---~~~~vAvK~~~~~~~~--~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~ 206 (443)
+.+.++|++.+.||+|+||.||+|.+ +|+.||||++...... ......|+..+..++||||+++++++.......
T Consensus 76 ~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 155 (681)
T 2pzi_A 76 DIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHG 155 (681)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTS
T ss_pred CEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCC
Confidence 34558999999999999999999997 4789999988643322 122345666667799999999999988654321
Q ss_pred -cEEEeeecccCcccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEec
Q psy14889 207 -TQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADF 285 (443)
Q Consensus 207 -~~~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~Df 285 (443)
...|+||||+++++|.+++.. .+++.+++.++.||+.||.|||+. +|+||||||+|||++.+ .+||+||
T Consensus 156 ~~~~~lv~E~~~g~~L~~~~~~-~l~~~~~~~~~~qi~~aL~~lH~~--------giiHrDlkp~NIll~~~-~~kl~DF 225 (681)
T 2pzi_A 156 DPVGYIVMEYVGGQSLKRSKGQ-KLPVAEAIAYLLEILPALSYLHSI--------GLVYNDLKPENIMLTEE-QLKLIDL 225 (681)
T ss_dssp CEEEEEEEECCCCEECC----C-CCCHHHHHHHHHHHHHHHHHHHHT--------TEECCCCSGGGEEECSS-CEEECCC
T ss_pred CceeEEEEEeCCCCcHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHC--------CCeecccChHHeEEeCC-cEEEEec
Confidence 236999999999999998865 799999999999999999999999 99999999999999886 8999999
Q ss_pred CCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCC
Q psy14889 286 GLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLV 365 (443)
Q Consensus 286 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~ 365 (443)
|+++..... ....||+.|+|||++.+. .+.++|||||||++|||++| ..||....
T Consensus 226 G~a~~~~~~--------~~~~gt~~y~aPE~~~~~-------~~~~sDi~slG~~l~~l~~g----------~~~~~~~~ 280 (681)
T 2pzi_A 226 GAVSRINSF--------GYLYGTPGFQAPEIVRTG-------PTVATDIYTVGRTLAALTLD----------LPTRNGRY 280 (681)
T ss_dssp TTCEETTCC--------SCCCCCTTTSCTTHHHHC-------SCHHHHHHHHHHHHHHHHSC----------CCEETTEE
T ss_pred ccchhcccC--------CccCCCccccCHHHHcCC-------CCCceehhhhHHHHHHHHhC----------CCCCcccc
Confidence 999766432 234799999999998764 35799999999999999999 34443311
Q ss_pred CCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCC-cHHHHHHHHHHHh
Q psy14889 366 PMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRL-SALRVKKTLIKLA 429 (443)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-s~~evl~~L~~l~ 429 (443)
... ++........+..+.+++.+||+.||++|| +++++...|..+.
T Consensus 281 ~~~------------------~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 281 VDG------------------LPEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp CSS------------------CCTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ccc------------------ccccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 000 000000112345789999999999999999 5777777777654
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=337.18 Aligned_cols=275 Identities=20% Similarity=0.212 Sum_probs=191.6
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc--chHHHHHHHHHHhccCCCceeeeeeccccC--CcccEE
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA--SWSRETEIYSTVLLRHENILGYIGSDMTSR--NSCTQL 209 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~--~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~--~~~~~~ 209 (443)
++|++.+.||+|+||.||+|.+ +|+.||||++...... ......|+..+..++||||+++++++.... ......
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 7899999999999999999987 5899999987653221 122345666666699999999999976521 112457
Q ss_pred EeeecccCcccHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCc---EEE
Q psy14889 210 WLVTHYHSFGSLYDHLNRT----TLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGT---CVI 282 (443)
Q Consensus 210 ~lv~e~~~~gsL~~~l~~~----~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~---~kl 282 (443)
++||||+++|+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++. +||
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~--------gIVHrDLKP~NILl~~~g~~~~vKL 165 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN--------RIIHRDLKPENIVLQPGPQRLIHKI 165 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT--------TBCCCCCCSTTEEEECCSSSCEEEE
T ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC--------CCccCCCCHHHeEeecCCCceeEEE
Confidence 9999999999999999752 599999999999999999999998 9999999999999997764 999
Q ss_pred EecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCC
Q psy14889 283 ADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYH 362 (443)
Q Consensus 283 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~ 362 (443)
+|||++........ .....||+.|+|||.+.+. .++.++||||||+++|||++|..|+...... ..|.
T Consensus 166 ~DFG~a~~~~~~~~-----~~~~~gt~~Y~APE~l~~~------~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~-~~~~ 233 (676)
T 3qa8_A 166 IDLGYAKELDQGEL-----CTEFVGTLQYLAPELLEQK------KYTVTVDYWSFGTLAFECITGFRPFLPNWQP-VQWH 233 (676)
T ss_dssp CSCCCCCBTTSCCC-----CCCCCSCCTTCSSCSSCCS------CCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH-HHSS
T ss_pred cccccccccccccc-----cccccCCcccCChHHhccC------CCCchhHHHHHHHHHHHHHHCCCCCCcccch-hhhh
Confidence 99999987654321 2345799999999999876 6778999999999999999995443210000 0000
Q ss_pred CCCCCCCChH-----HHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHH-----HHHHHHHHhhcc
Q psy14889 363 DLVPMDPSFD-----DMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALR-----VKKTLIKLACAD 432 (443)
Q Consensus 363 ~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e-----vl~~L~~l~~~~ 432 (443)
.......... ........ ......+ .......+..+.+++.+||+.||++|||+.+ ..+.++.+.+..
T Consensus 234 ~~i~~~~~~~~~~~~~l~g~~~~-~~~lp~p-~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~k 311 (676)
T 3qa8_A 234 GKVREKSNEHIVVYDDLTGAVKF-SSVLPTP-NHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLK 311 (676)
T ss_dssp TTCC------CCSCCCCSSSCCC-CSSSCCS-CCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCCC
T ss_pred hhhhcccchhhhhhhhhcccccc-ccccCCc-hhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhcc
Confidence 0000000000 00000000 0001111 1223457889999999999999999999988 556777766543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=302.21 Aligned_cols=233 Identities=19% Similarity=0.271 Sum_probs=172.9
Q ss_pred hhcccccc-ceeeeecCeEEEEEEE--CCceeEEEEeeccCccchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEE
Q psy14889 134 LAKQISLS-ECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLW 210 (443)
Q Consensus 134 ~~~~~~~~-~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~ 210 (443)
+.++|.+. +.||+|+||.||+|.. +++.||||++... .....|.++.. ..++||||+++++++.........++
T Consensus 15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~e~~~~~-~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--PKARREVELHW-RASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--HHHHHHHHHHH-HHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--HHHHHHHHHHH-HhccCCCchhHHhhhhhhcCCCceEE
Confidence 34677776 7899999999999998 6889999998542 23344554442 23799999999999876333235689
Q ss_pred eeecccCcccHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcC---CCcEEEEe
Q psy14889 211 LVTHYHSFGSLYDHLNRT---TLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKT---NGTCVIAD 284 (443)
Q Consensus 211 lv~e~~~~gsL~~~l~~~---~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~---~~~~kl~D 284 (443)
+||||+++|+|.+++... .+++..+..++.|++.||.|||+. +|+||||||+|||++. ++.+||+|
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--------~i~H~dlkp~Nil~~~~~~~~~~kl~D 163 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI--------NIAHRDVKPENLLYTSKRPNAILKLTD 163 (299)
T ss_dssp EEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT--------TEECCCCSGGGEEESSSSTTCCEEECC
T ss_pred EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC--------CcccCCCCHHHEEEecCCCCCcEEEec
Confidence 999999999999999753 599999999999999999999999 9999999999999998 78999999
Q ss_pred cCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCC
Q psy14889 285 FGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDL 364 (443)
Q Consensus 285 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~ 364 (443)
||++..... . .++.++|||||||++|||++| ..||...
T Consensus 164 fg~a~~~~~--------------------------~------~~~~~~DiwslG~il~el~tg----------~~pf~~~ 201 (299)
T 3m2w_A 164 FGFAKETTG--------------------------E------KYDKSCDMWSLGVIMYILLCG----------YPPFYSN 201 (299)
T ss_dssp CTTCEECTT--------------------------C------GGGGHHHHHHHHHHHHHHHHS----------SCSCCC-
T ss_pred ccccccccc--------------------------c------cCCchhhHHHHHHHHHHHHHC----------CCCCCCC
Confidence 999854321 1 344689999999999999999 5666543
Q ss_pred CCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 365 VPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
...... ......+ .......+.. ....++.++.+++.+||+.||++|||+.|+++
T Consensus 202 ~~~~~~-~~~~~~~--~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 202 HGLAIS-PGMKTRI--RMGQYEFPNP-EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp -------CCSCCSS--CTTCCSSCHH-HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cchhhh-HHHHHHH--hhccccCCch-hcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 111000 0000000 0001111100 00235678999999999999999999999987
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=316.89 Aligned_cols=245 Identities=17% Similarity=0.157 Sum_probs=175.9
Q ss_pred hccccccceeeeecCeEEEEEEECCceeEEEEeeccCcc---------chHHHHHHHHHHhcc---------CCCceeee
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVWHGENVAVKIFFSRDEA---------SWSRETEIYSTVLLR---------HENILGYI 196 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~---------~~~~e~ei~~~~~l~---------H~nIv~l~ 196 (443)
.++|++.+.||+|+||+||+|+++|+.||||++...... ......|+..+..++ ||||+++.
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~ 98 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLN 98 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEE
T ss_pred cccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhc
Confidence 478999999999999999999999999999998654321 022233444443354 55555555
Q ss_pred ee-----------------ccccCC---------cccEEEeeecccCcccHHHHhcccCCCHHHHHHHHHHHHHHHHHHH
Q psy14889 197 GS-----------------DMTSRN---------SCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLH 250 (443)
Q Consensus 197 g~-----------------~~~~~~---------~~~~~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH 250 (443)
++ +.+..+ ....+++||||+++|++.+.+.+..+++..+..++.||+.||+|||
T Consensus 99 ~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~~~~~~~~~~i~~qi~~aL~~lH 178 (336)
T 2vuw_A 99 SVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAE 178 (336)
T ss_dssp EEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTTCCCHHHHHHHHHHHHHHHHHHH
T ss_pred ceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhcCCCHHHHHHHHHHHHHHHHHHH
Confidence 44 433100 0246899999999998877777778999999999999999999999
Q ss_pred -HchhcCCCCCCeEEeCCCCCCEEEcCCC--------------------cEEEEecCCcccccccCCcCCCCCCCccccc
Q psy14889 251 -TEIFGTQGKPAIAHRDIKSKNILVKTNG--------------------TCVIADFGLAVSYSQLSNKMDIPPNPRVGTK 309 (443)
Q Consensus 251 -~~~~~~~~~~~iiHrDlk~~NiLl~~~~--------------------~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~ 309 (443)
+. +|+||||||+|||++.++ .+||+|||+|+..... ...||+
T Consensus 179 ~~~--------~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~---------~~~gt~ 241 (336)
T 2vuw_A 179 ASL--------RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG---------IVVFCD 241 (336)
T ss_dssp HHH--------CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT---------EEECCC
T ss_pred HhC--------CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC---------cEEEee
Confidence 88 999999999999999887 8999999999876532 247999
Q ss_pred CcccccccccccccCcCCCCCccchHHHHHH-HHHHHhcccCCCcccccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCC
Q psy14889 310 RYMSPEILDESINMDCFESFKKADIYALGLV-LWEVCRRTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLP 388 (443)
Q Consensus 310 ~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvv-l~elltg~~~~~~~~~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (443)
.|+|||++.+. . +.++||||||++ .+++++| ..||.... ........+.........+
T Consensus 242 ~y~aPE~~~g~------~-~~~~Diwsl~~~~~~~~~~g----------~~p~~~~~----~~~~~~~~~~~~~~~~~~~ 300 (336)
T 2vuw_A 242 VSMDEDLFTGD------G-DYQFDIYRLMKKENNNRWGE----------YHPYSNVL----WLHYLTDKMLKQMTFKTKC 300 (336)
T ss_dssp CTTCSGGGCCC------S-SHHHHHHHHHHHHHTTCTTS----------CCTHHHHH----HHHHHHHHHHHTCCCSSCC
T ss_pred cccChhhhcCC------C-ccceehhhhhCCCCcccccc----------cCCCcchh----hhhHHHHhhhhhhccCccc
Confidence 99999999865 2 579999998777 7777777 55664310 0011111111111111111
Q ss_pred CCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHH
Q psy14889 389 NRWVSDSTLNAMTKVMKECWHQNANVRLSALRVK 422 (443)
Q Consensus 389 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl 422 (443)
.......+++++.+|+++||+.| |+.|++
T Consensus 301 ~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 301 NTPAMKQIKRKIQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp CSHHHHHHHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred chhhhhhcCHHHHHHHHHHhccC-----CHHHHH
Confidence 11112357889999999999977 888887
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-39 Score=319.13 Aligned_cols=245 Identities=15% Similarity=0.191 Sum_probs=171.2
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc----chHHHHHHHHHHhccC-CCceeeeee----------
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA----SWSRETEIYSTVLLRH-ENILGYIGS---------- 198 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~----~~~~e~ei~~~~~l~H-~nIv~l~g~---------- 198 (443)
..|...+.||+|+||.||+|.+ +|+.||||++...... ....+.|+..+..++| +|+.....+
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 4688889999999999999998 4999999988633221 2233455555555766 322111111
Q ss_pred -----------ccccC-CcccEEEeeecccCcccHHHHhc--------ccCCCHHHHHHHHHHHHHHHHHHHHchhcCCC
Q psy14889 199 -----------DMTSR-NSCTQLWLVTHYHSFGSLYDHLN--------RTTLNHHQMMKICLSIVNGLVHLHTEIFGTQG 258 (443)
Q Consensus 199 -----------~~~~~-~~~~~~~lv~e~~~~gsL~~~l~--------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~ 258 (443)
..... .....++++|+++ +++|.++++ +..+++..++.++.||+.||+|||+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~------ 230 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY------ 230 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT------
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC------
Confidence 11110 0012356777765 479999884 34578889999999999999999999
Q ss_pred CCCeEEeCCCCCCEEEcCCCcEEEEecCCcccccccCCcCCCCCCCcccccCccccccccccccc----CcCCCCCccch
Q psy14889 259 KPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINM----DCFESFKKADI 334 (443)
Q Consensus 259 ~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~----~~~~~~~~sDv 334 (443)
+|+||||||+|||++.++.+||+|||+++..... .....| +.|+|||++...... ....++.++||
T Consensus 231 --~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~Dv 300 (413)
T 3dzo_A 231 --GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDT 300 (413)
T ss_dssp --TEECSCCCGGGEEECTTCCEEECCGGGCEETTEE-------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHH
T ss_pred --CcccCCcccceEEEecCCeEEEEeccceeecCCc-------cccCCC-CceeCchhhhccccccccccCcCCCchhhH
Confidence 9999999999999999999999999998765543 133467 999999999422100 01156789999
Q ss_pred HHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCC
Q psy14889 335 YALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANV 414 (443)
Q Consensus 335 wS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~ 414 (443)
|||||++|||++| ..||....... ...... ... ..+++.+.+||.+||+.||++
T Consensus 301 wSlGvil~elltg----------~~Pf~~~~~~~----~~~~~~---~~~---------~~~~~~~~~li~~~l~~dP~~ 354 (413)
T 3dzo_A 301 WTLGLAIYWIWCA----------DLPNTDDAALG----GSEWIF---RSC---------KNIPQPVRALLEGFLRYPKED 354 (413)
T ss_dssp HHHHHHHHHHHHS----------SCCCCTTGGGS----CSGGGG---SSC---------CCCCHHHHHHHHHHTCSSGGG
T ss_pred HHHHHHHHHHHHC----------CCCCCCcchhh----hHHHHH---hhc---------ccCCHHHHHHHHHHccCChhh
Confidence 9999999999999 66665432111 001111 001 124568999999999999999
Q ss_pred CCcHHHHHH
Q psy14889 415 RLSALRVKK 423 (443)
Q Consensus 415 Rps~~evl~ 423 (443)
|||+.++++
T Consensus 355 Rpt~~~~l~ 363 (413)
T 3dzo_A 355 RLLPLQAME 363 (413)
T ss_dssp SCCHHHHTT
T ss_pred CcCHHHHHh
Confidence 999877643
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-31 Score=274.88 Aligned_cols=178 Identities=18% Similarity=0.165 Sum_probs=120.1
Q ss_pred eeeecCeEEEEEE--ECCceeEEEEeeccCc-----------cchHHHHHHHHHHhc-cCCCceeeeeeccccCCcccEE
Q psy14889 144 IGKGRYGEVWRGV--WHGENVAVKIFFSRDE-----------ASWSRETEIYSTVLL-RHENILGYIGSDMTSRNSCTQL 209 (443)
Q Consensus 144 lG~G~fg~Vy~~~--~~~~~vAvK~~~~~~~-----------~~~~~e~ei~~~~~l-~H~nIv~l~g~~~~~~~~~~~~ 209 (443)
.+.|++|.+..++ +.|+.+|+|++..... .......|+..+.++ .|+||+++++++.+. ..+
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~----~~~ 317 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENA----QSG 317 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECS----SEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEEC----CEE
Confidence 4556666655443 3689999999865321 111223466666666 799999999999877 568
Q ss_pred EeeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCc
Q psy14889 210 WLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA 288 (443)
Q Consensus 210 ~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla 288 (443)
||||||++||+|.+++.+ +.++.. .|+.||+.||+|||++ |||||||||+|||++.++.+||+|||+|
T Consensus 318 yLVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~--------GIIHRDIKPeNILL~~dg~vKL~DFGlA 386 (569)
T 4azs_A 318 WLVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQ--------GFWHDDVRPWNVMVDARQHARLIDFGSI 386 (569)
T ss_dssp EEEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHT--------TCEESCCCGGGEEECTTSCEEECCCTTE
T ss_pred EEEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHC--------CceeccCchHhEEECCCCCEEEeecccC
Confidence 999999999999999975 456654 5789999999999999 9999999999999999999999999999
Q ss_pred ccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhc
Q psy14889 289 VSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRR 347 (443)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg 347 (443)
+........ ..+.+||+.|||||++.+. +..++|+||+|++++++.++
T Consensus 387 r~~~~~~~~----~~t~vGTp~YmAPE~l~g~-------~~~~~d~~s~g~~~~~l~~~ 434 (569)
T 4azs_A 387 VTTPQDCSW----PTNLVQSFFVFVNELFAEN-------KSWNGFWRSAPVHPFNLPQP 434 (569)
T ss_dssp ESCC---CC----SHHHHHHHHHHHHHHC------------------------CCCCTT
T ss_pred eeCCCCCcc----ccCceechhhccHHHhCCC-------CCCcccccccccchhhhccc
Confidence 876543222 2346899999999999864 33679999999999888766
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.8e-28 Score=252.19 Aligned_cols=184 Identities=18% Similarity=0.151 Sum_probs=135.4
Q ss_pred cccceeeeecCeEEEEEEECCceeEEEEeeccCcc---------chHHHHHHHHHHhccCCCceeeeeeccccCCcccEE
Q psy14889 139 SLSECIGKGRYGEVWRGVWHGENVAVKIFFSRDEA---------SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQL 209 (443)
Q Consensus 139 ~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~---------~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~ 209 (443)
...+.||+|+||.||+|.+.+..+|+|+....... ......|+..+..++||||+++..++.... ..
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~----~~ 414 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLD----NK 414 (540)
T ss_dssp ---------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETT----TT
T ss_pred CCCCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCC----cc
Confidence 34678999999999999889999999986443211 111245666666799999995555444432 24
Q ss_pred EeeecccCcccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcc
Q psy14889 210 WLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAV 289 (443)
Q Consensus 210 ~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~ 289 (443)
++||||+++|+|.+++.+ +..++.|+++||.|||++ +|+||||||+|||++. .+||+|||+++
T Consensus 415 ~lVmE~~~ggsL~~~l~~-------~~~i~~qi~~aL~~LH~~--------gIiHrDiKp~NILl~~--~~kL~DFGla~ 477 (540)
T 3en9_A 415 RIMMSYINGKLAKDVIED-------NLDIAYKIGEIVGKLHKN--------DVIHNDLTTSNFIFDK--DLYIIDFGLGK 477 (540)
T ss_dssp EEEEECCCSEEHHHHSTT-------CTHHHHHHHHHHHHHHHT--------TEECTTCCTTSEEESS--SEEECCCTTCE
T ss_pred EEEEECCCCCCHHHHHHH-------HHHHHHHHHHHHHHHHHC--------cCccCCCCHHHEEECC--eEEEEECccCE
Confidence 899999999999999976 668999999999999999 9999999999999998 99999999998
Q ss_pred cccccCCcCC---CCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhc
Q psy14889 290 SYSQLSNKMD---IPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRR 347 (443)
Q Consensus 290 ~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg 347 (443)
.......... .......||+.|||||++..... .|+..+|+||..+-..+-+.+
T Consensus 478 ~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~----~Y~~~~d~ws~vl~~l~~v~~ 534 (540)
T 3en9_A 478 ISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLE----GYKSVYDRWEIILELMKDVER 534 (540)
T ss_dssp ECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHH----HHHHHCTTHHHHHHHHHHHHT
T ss_pred ECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHH----HHHHHHhHHHHHHHHHHHHHh
Confidence 7754321100 00123579999999999986321 455678999999988888776
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=2.5e-24 Score=203.39 Aligned_cols=144 Identities=19% Similarity=0.153 Sum_probs=109.9
Q ss_pred ccccccceeeeecCeEEEEEEE-CCceeEEEEeeccCc-------------------cchHHHHHHHHHHhccCCCceee
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW-HGENVAVKIFFSRDE-------------------ASWSRETEIYSTVLLRHENILGY 195 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~-------------------~~~~~e~ei~~~~~l~H~nIv~l 195 (443)
..|.+.+.||+|+||.||+|.+ +|+.||||++..... .......|+..+..++ | +++
T Consensus 90 ~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v 166 (282)
T 1zar_A 90 KVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAV 166 (282)
T ss_dssp SCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSS
T ss_pred eEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCc
Confidence 3466779999999999999998 688999998853221 1112234555555576 4 555
Q ss_pred eeeccccCCcccEEEeeecccCcccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEc
Q psy14889 196 IGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVK 275 (443)
Q Consensus 196 ~g~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~ 275 (443)
.+++... ..++||||+++|+|.+ +.. .....++.|++.||.|||+. +|+||||||+|||++
T Consensus 167 ~~~~~~~-----~~~lvmE~~~g~~L~~-l~~-----~~~~~i~~qi~~~l~~lH~~--------giiHrDlkp~NILl~ 227 (282)
T 1zar_A 167 PKVYAWE-----GNAVLMELIDAKELYR-VRV-----ENPDEVLDMILEEVAKFYHR--------GIVHGDLSQYNVLVS 227 (282)
T ss_dssp CCEEEEE-----TTEEEEECCCCEEGGG-CCC-----SCHHHHHHHHHHHHHHHHHT--------TEECSCCSTTSEEEE
T ss_pred CeEEecc-----ceEEEEEecCCCcHHH-cch-----hhHHHHHHHHHHHHHHHHHC--------CCEeCCCCHHHEEEE
Confidence 5544332 3589999999999998 532 34557999999999999998 999999999999999
Q ss_pred CCCcEEEEecCCcccccccCCcCCCCCCCcccccCccccccccc
Q psy14889 276 TNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDE 319 (443)
Q Consensus 276 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 319 (443)
++.+||+|||+|+. +..++|||++..
T Consensus 228 -~~~vkl~DFG~a~~-----------------~~~~~a~e~l~r 253 (282)
T 1zar_A 228 -EEGIWIIDFPQSVE-----------------VGEEGWREILER 253 (282)
T ss_dssp -TTEEEECCCTTCEE-----------------TTSTTHHHHHHH
T ss_pred -CCcEEEEECCCCeE-----------------CCCCCHHHHHHH
Confidence 99999999999852 345789998864
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=1.2e-20 Score=175.96 Aligned_cols=134 Identities=18% Similarity=0.200 Sum_probs=101.1
Q ss_pred ccccceeeeecCeEEEEEEE--CCce--eEEEEeeccCcc-------------------------chHHHHHHHHHHhcc
Q psy14889 138 ISLSECIGKGRYGEVWRGVW--HGEN--VAVKIFFSRDEA-------------------------SWSRETEIYSTVLLR 188 (443)
Q Consensus 138 ~~~~~~lG~G~fg~Vy~~~~--~~~~--vAvK~~~~~~~~-------------------------~~~~e~ei~~~~~l~ 188 (443)
|++.+.||+|+||.||+|.+ +|+. ||||++...... ....+.|+..+..++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 67889999999999999998 7888 999986432110 012345666666678
Q ss_pred CCCc--eeeeeeccccCCcccEEEeeecccCc-c----cHHHHhcccCCCHHHHHHHHHHHHHHHHHHH-HchhcCCCCC
Q psy14889 189 HENI--LGYIGSDMTSRNSCTQLWLVTHYHSF-G----SLYDHLNRTTLNHHQMMKICLSIVNGLVHLH-TEIFGTQGKP 260 (443)
Q Consensus 189 H~nI--v~l~g~~~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~l~~~~~~~i~~qia~gL~yLH-~~~~~~~~~~ 260 (443)
|+++ ...++. ...+|||||+.+ | +|.++... .++..+..++.|++.||.||| +.
T Consensus 129 ~~~i~~p~~~~~--------~~~~lVmE~~g~~g~~~~~L~~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~-------- 190 (258)
T 1zth_A 129 EAGVSVPQPYTY--------MKNVLLMEFIGEDELPAPTLVELGRE--LKELDVEGIFNDVVENVKRLYQEA-------- 190 (258)
T ss_dssp HTTCCCCCEEEE--------ETTEEEEECCEETTEECCBHHHHGGG--GGGSCHHHHHHHHHHHHHHHHHTS--------
T ss_pred hCCCCCCeEEEc--------CCCEEEEEecCCCCCccccHHHHhhc--cChHHHHHHHHHHHHHHHHHHHHC--------
Confidence 8764 333332 124899999942 4 67766532 345678899999999999999 77
Q ss_pred CeEEeCCCCCCEEEcCCCcEEEEecCCcccc
Q psy14889 261 AIAHRDIKSKNILVKTNGTCVIADFGLAVSY 291 (443)
Q Consensus 261 ~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~ 291 (443)
+|+||||||+|||++. .++|+|||+|...
T Consensus 191 givHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 191 ELVHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp CEECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred CEEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 9999999999999998 9999999999643
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.70 E-value=3.3e-17 Score=159.31 Aligned_cols=138 Identities=15% Similarity=0.180 Sum_probs=95.2
Q ss_pred ccccceeeeecCeEEEEEEE-CCceeEEEEeeccCc--------c---------chHHHHHHHHHHhccCCCceeeeeec
Q psy14889 138 ISLSECIGKGRYGEVWRGVW-HGENVAVKIFFSRDE--------A---------SWSRETEIYSTVLLRHENILGYIGSD 199 (443)
Q Consensus 138 ~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~--------~---------~~~~e~ei~~~~~l~H~nIv~l~g~~ 199 (443)
|++...||+|+||.||+|.. +|+.||||+++.... . .+..+..+ .....|+|+++++...
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl--~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRL--AAIKEFAFMKALYEEG 174 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHH--HHHHHHHHHHHHHHTT
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHH--HHHHHHHHHHHHHhcC
Confidence 88999999999999999987 799999998743210 0 01111111 1112355555544332
Q ss_pred cccCCc--ccEEEeeecccCcccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCC
Q psy14889 200 MTSRNS--CTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTN 277 (443)
Q Consensus 200 ~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~ 277 (443)
...... ....+|||||+++++|.++.. ......++.|++.+|.|||.. |||||||||.|||++++
T Consensus 175 v~vp~p~~~~~~~LVME~i~G~~L~~l~~-----~~~~~~l~~qll~~l~~lH~~--------gIVHrDLKp~NILl~~d 241 (397)
T 4gyi_A 175 FPVPEPIAQSRHTIVMSLVDALPMRQVSS-----VPDPASLYADLIALILRLAKH--------GLIHGDFNEFNILIREE 241 (397)
T ss_dssp CSCCCEEEEETTEEEEECCSCEEGGGCCC-----CSCHHHHHHHHHHHHHHHHHT--------TEECSCCSTTSEEEEEE
T ss_pred CCCCeeeeccCceEEEEecCCccHhhhcc-----cHHHHHHHHHHHHHHHHHHHC--------CCcCCCCCHHHEEEeCC
Confidence 211000 011269999999998876542 233467889999999999998 99999999999999887
Q ss_pred C----------cEEEEecCCccc
Q psy14889 278 G----------TCVIADFGLAVS 290 (443)
Q Consensus 278 ~----------~~kl~DfGla~~ 290 (443)
+ .+.|+||+-+..
T Consensus 242 gd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 242 KDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp ECSSCTTSEEEEEEECCCTTCEE
T ss_pred CCcccccccccceEEEEeCCccc
Confidence 6 389999997643
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.33 E-value=9.5e-12 Score=115.54 Aligned_cols=144 Identities=14% Similarity=0.061 Sum_probs=106.4
Q ss_pred ccccccceeeeecCeEEEEEEECCceeEEEEeec---cCccchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEee
Q psy14889 136 KQISLSECIGKGRYGEVWRGVWHGENVAVKIFFS---RDEASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLV 212 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~---~~~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv 212 (443)
..|++...++.|+.+.||+....+..+++|+... ........|.+++.... .|.++.++++++... ...|+|
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~-~~~~vP~v~~~~~~~----~~~~lv 88 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLE-GKLPVPKVLHFERHD----GWSNLL 88 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHT-TTSCCCCEEEEEEET----TEEEEE
T ss_pred ccceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCCCHHHHHHHHHHHHHHh-cCCCCCeEEEEEecC----CceEEE
Confidence 4688888899899999999988889999998864 23334555665555421 366777888877654 457999
Q ss_pred ecccCcccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhcC------------------------------------
Q psy14889 213 THYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGT------------------------------------ 256 (443)
Q Consensus 213 ~e~~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~------------------------------------ 256 (443)
|||++|.+|.+.+. +......++.+++.+|..||+.....
T Consensus 89 ~e~i~G~~l~~~~~----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (263)
T 3tm0_A 89 MSEADGVLCSEEYE----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPF 164 (263)
T ss_dssp EECCSSEEHHHHCC----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSS
T ss_pred EEecCCeehhhccC----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccC
Confidence 99999999987642 22334578899999999999821000
Q ss_pred ---------------CCCCCeEEeCCCCCCEEEcCCCcEEEEecCCc
Q psy14889 257 ---------------QGKPAIAHRDIKSKNILVKTNGTCVIADFGLA 288 (443)
Q Consensus 257 ---------------~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla 288 (443)
...+.++|+|+++.|||++++..+.|+||+.+
T Consensus 165 ~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a 211 (263)
T 3tm0_A 165 KDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRS 211 (263)
T ss_dssp SSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTC
T ss_pred CCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhc
Confidence 01256999999999999987666789999876
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.14 E-value=1.3e-10 Score=107.34 Aligned_cols=139 Identities=16% Similarity=0.047 Sum_probs=93.7
Q ss_pred cccccceeeeecCeEEEEEEE-CCceeEEEEeeccCccchHHHHHHHHHHhccCCC--ceeeeeeccccCCcccEEEeee
Q psy14889 137 QISLSECIGKGRYGEVWRGVW-HGENVAVKIFFSRDEASWSRETEIYSTVLLRHEN--ILGYIGSDMTSRNSCTQLWLVT 213 (443)
Q Consensus 137 ~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~H~n--Iv~l~g~~~~~~~~~~~~~lv~ 213 (443)
.+.+....+.|..+.||+... +|..+++|+...........|.+++.. +.+.+ +.+++++.... ...++||
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~~~~~~~E~~~l~~--l~~~~~~vP~~~~~~~~~----~~~~~v~ 94 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGALNELQDEAARLSW--LATTGVPCAAVLDVVTEA----GRDWLLL 94 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCTTSCHHHHHHHHHH--HHTTTCCBCCEEEEEECS----SCEEEEE
T ss_pred CCceEecccCCCCceEEEEecCCCCeEEEEeCCcccchhhhHHHHHHHH--HHhCCCCCCeEEEeccCC----CCCEEEE
Confidence 455444434566699999976 467899998755433444556555554 54434 45577776544 2368999
Q ss_pred cccCcccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhc--------------------------------------
Q psy14889 214 HYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFG-------------------------------------- 255 (443)
Q Consensus 214 e~~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~-------------------------------------- 255 (443)
||+++.+|. ... .+ ...++.+++..|..||+....
T Consensus 95 e~i~G~~l~--~~~--~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (264)
T 1nd4_A 95 GEVPGQDLL--SSH--LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAP 167 (264)
T ss_dssp ECCSSEETT--TSC--CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCH
T ss_pred EecCCcccC--cCc--CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccH
Confidence 999998884 221 12 236778888889999875210
Q ss_pred ------------CCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCc
Q psy14889 256 ------------TQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA 288 (443)
Q Consensus 256 ------------~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla 288 (443)
....+.++|+|++|.|||++++..++|+|||.+
T Consensus 168 ~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a 212 (264)
T 1nd4_A 168 AELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRL 212 (264)
T ss_dssp HHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTC
T ss_pred HHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhc
Confidence 011234999999999999987766789999986
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.06 E-value=5.1e-10 Score=108.83 Aligned_cols=146 Identities=13% Similarity=0.152 Sum_probs=103.0
Q ss_pred cceeeeecCeEEEEEEECCceeEEEEee--ccC----ccchHHHHHHHHHHhcc--CCCceeeeeeccccCCcccEEEee
Q psy14889 141 SECIGKGRYGEVWRGVWHGENVAVKIFF--SRD----EASWSRETEIYSTVLLR--HENILGYIGSDMTSRNSCTQLWLV 212 (443)
Q Consensus 141 ~~~lG~G~fg~Vy~~~~~~~~vAvK~~~--~~~----~~~~~~e~ei~~~~~l~--H~nIv~l~g~~~~~~~~~~~~~lv 212 (443)
.+.|+.|.++.||+....+..+++|+.. ... ......|.+++.. +. +.++.++++++.+... .+..++|
T Consensus 43 ~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~--L~~~~vpvP~~~~~~~~~~~-~g~~~~v 119 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDA--LAGTDVPVAKMYALCEDESV-IGRAFYI 119 (359)
T ss_dssp EEECCC-CCSCEEEEECSSCEEEEECCCC----------CHHHHHHHHHH--HTTSSSCCCCEEEEECCTTT-TSSCEEE
T ss_pred EEEcCCcccceEEEEEECCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHH--hhcCCCCCCcEEEECCCCCc-cCCeEEE
Confidence 5678999999999998878889999765 221 2234445555544 54 4567788887765421 1346899
Q ss_pred ecccCcccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhcCC-----------------------------------
Q psy14889 213 THYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQ----------------------------------- 257 (443)
Q Consensus 213 ~e~~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~----------------------------------- 257 (443)
|||+++..+.+.. -..++..+...++.++++.|..||+......
T Consensus 120 me~v~G~~l~~~~-~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (359)
T 3dxp_A 120 MEFVSGRVLWDQS-LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMD 198 (359)
T ss_dssp EECCCCBCCCCTT-CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHH
T ss_pred EEecCCeecCCCc-cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHH
Confidence 9999988775422 1347788889999999999999998421100
Q ss_pred ---------------CCCCeEEeCCCCCCEEEcCCCc--EEEEecCCccc
Q psy14889 258 ---------------GKPAIAHRDIKSKNILVKTNGT--CVIADFGLAVS 290 (443)
Q Consensus 258 ---------------~~~~iiHrDlk~~NiLl~~~~~--~kl~DfGla~~ 290 (443)
..+.++|+|+++.|||++.++. +.|+||+.+..
T Consensus 199 ~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 199 SLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 1358999999999999997753 68999998853
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.78 E-value=7.6e-09 Score=98.08 Aligned_cols=144 Identities=20% Similarity=0.127 Sum_probs=95.0
Q ss_pred cceeeeecCeEEEEEEECCceeEEEEeeccCccchHHHHHHHHHHhc-cCCC--ceeeeeeccccCCcccEEEeeecccC
Q psy14889 141 SECIGKGRYGEVWRGVWHGENVAVKIFFSRDEASWSRETEIYSTVLL-RHEN--ILGYIGSDMTSRNSCTQLWLVTHYHS 217 (443)
Q Consensus 141 ~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~e~ei~~~~~l-~H~n--Iv~l~g~~~~~~~~~~~~~lv~e~~~ 217 (443)
.+.++.|.+..||+.. ..+++|+.... ......+.|...+..+ .+.. +.+.+....... .....|+|||+++
T Consensus 25 i~~~~~G~~n~v~~v~---~~~vlR~~~~~-~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~-~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN---RDFIFKFPKHS-RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSE-TYQMSFAGFTKIK 99 (304)
T ss_dssp CCEEEECSSEEEEEST---TSEEEEEESSH-HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCS-SCSCSCEEEECCC
T ss_pred eEecCCCCcceEEEEC---CEEEEEecCCc-chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCC-CCCcceEEEcccC
Confidence 4568999999999863 67889975432 1122233344443334 3322 334444432221 1123478999999
Q ss_pred cccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchh-------------------------------------------
Q psy14889 218 FGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIF------------------------------------------- 254 (443)
Q Consensus 218 ~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~------------------------------------------- 254 (443)
+.+|.+... ..++..+...++.+++..|..||+...
T Consensus 100 G~~l~~~~~-~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 178 (304)
T 3sg8_A 100 GVPLTPLLL-NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYR 178 (304)
T ss_dssp CEECCHHHH-HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHH
T ss_pred CeECCcccc-ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHH
Confidence 988865332 457888889999999999999997210
Q ss_pred ---c----CCCCCCeEEeCCCCCCEEEcC--CCcEEEEecCCccc
Q psy14889 255 ---G----TQGKPAIAHRDIKSKNILVKT--NGTCVIADFGLAVS 290 (443)
Q Consensus 255 ---~----~~~~~~iiHrDlk~~NiLl~~--~~~~kl~DfGla~~ 290 (443)
. ....+.++|+|+++.||++++ ...+.|+||+.+..
T Consensus 179 ~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~ 223 (304)
T 3sg8_A 179 DILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAI 223 (304)
T ss_dssp HHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEE
T ss_pred HHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCcc
Confidence 0 122367899999999999998 45678999998854
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.33 E-value=4.8e-06 Score=77.00 Aligned_cols=138 Identities=14% Similarity=0.055 Sum_probs=91.7
Q ss_pred eeeeecCe-EEEEEEE--CCceeEEEEeeccCccchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEeeecccCcc
Q psy14889 143 CIGKGRYG-EVWRGVW--HGENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVTHYHSFG 219 (443)
Q Consensus 143 ~lG~G~fg-~Vy~~~~--~~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e~~~~g 219 (443)
.+..|..| .||+... .+..+.+|+-..........|.+++.... .+--+.++++++.+. ...++|||++++.
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~~~~~~~E~~~l~~l~-~~vPVP~v~~~~~~~----~~~~lvme~l~G~ 105 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGSVANDVTDEMVRLNWLT-AFMPLPTIKHFIRTP----DDAWLLTTAIPGK 105 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETHHHHHHHHHHHHHHHHT-TTSCCCCEEEEEEET----TEEEEEEECCCSE
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCCCHhHHHHHHHHHHHhc-cCCCcCeEEEEEEEC----CeEEEEEEeeCCc
Confidence 34556555 6898765 35689999875544444455655554422 222355667776554 3469999999998
Q ss_pred cHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhc--------------------------------------------
Q psy14889 220 SLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFG-------------------------------------------- 255 (443)
Q Consensus 220 sL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~-------------------------------------------- 255 (443)
++.+.... .......+..+++..|.-||+....
T Consensus 106 ~~~~~~~~---~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (272)
T 4gkh_A 106 TAFQVLEE---YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKE 182 (272)
T ss_dssp EHHHHHHH---CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHH
T ss_pred cccccccC---CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHH
Confidence 88776532 2233456777888888888864210
Q ss_pred ------CCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCc
Q psy14889 256 ------TQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA 288 (443)
Q Consensus 256 ------~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla 288 (443)
....+.++|+|+.+.|||++.++.+-|+||+.+
T Consensus 183 l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a 221 (272)
T 4gkh_A 183 MHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRV 221 (272)
T ss_dssp HHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTC
T ss_pred HHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccc
Confidence 012335899999999999998777789999876
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.26 E-value=5.6e-06 Score=78.30 Aligned_cols=141 Identities=18% Similarity=0.116 Sum_probs=92.0
Q ss_pred cceeeeecCeEEEEEEECCceeEEEEeeccCccchHHHHHHHHHHhccCC---CceeeeeeccccCCcccEEEeeecccC
Q psy14889 141 SECIGKGRYGEVWRGVWHGENVAVKIFFSRDEASWSRETEIYSTVLLRHE---NILGYIGSDMTSRNSCTQLWLVTHYHS 217 (443)
Q Consensus 141 ~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~H~---nIv~l~g~~~~~~~~~~~~~lv~e~~~ 217 (443)
.+.++.|....||+. |..+++|+-.. .......+.|...+..+.+. .+.+.+.+..... ...++||||++
T Consensus 24 v~~l~~G~~n~v~~v---g~~~VlR~~~~-~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~---g~~~~v~e~i~ 96 (306)
T 3tdw_A 24 VESLGEGFRNYAILV---NGDWVFRFPKS-QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSD---GNPFVGYRKVQ 96 (306)
T ss_dssp EEEEEECSSEEEEEE---TTTEEEEEESS-HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTT---SCEEEEEECCC
T ss_pred eeecCCCcceeEEEE---CCEEEEEecCC-chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCC---CceEEEEeccC
Confidence 456888988899987 77889997432 11122233444444435542 2445555543221 33579999999
Q ss_pred cccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhc------------------------------------------
Q psy14889 218 FGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFG------------------------------------------ 255 (443)
Q Consensus 218 ~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~------------------------------------------ 255 (443)
+..|.+.. -..++..+...++.+++..|..||+....
T Consensus 97 G~~l~~~~-~~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~ 175 (306)
T 3tdw_A 97 GQILGEDG-MAVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLR 175 (306)
T ss_dssp SEECHHHH-HTTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHH
T ss_pred CeECchhh-hhhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHH
Confidence 98887632 13456677777788888888888864220
Q ss_pred ----------CCCCCCeEEeCCCCCCEEEcC---CCc-EEEEecCCcc
Q psy14889 256 ----------TQGKPAIAHRDIKSKNILVKT---NGT-CVIADFGLAV 289 (443)
Q Consensus 256 ----------~~~~~~iiHrDlk~~NiLl~~---~~~-~kl~DfGla~ 289 (443)
....+.++|+|+.+.|||++. ++. +.|+||+.+.
T Consensus 176 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~ 223 (306)
T 3tdw_A 176 FQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAA 223 (306)
T ss_dssp HHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCE
T ss_pred HHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcC
Confidence 013457899999999999987 355 5899999874
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.18 E-value=2.5e-06 Score=82.48 Aligned_cols=149 Identities=11% Similarity=0.062 Sum_probs=89.2
Q ss_pred cccee-eeecCeEEEEEEEC--------CceeEEEEeeccC------ccchHHHHHHHHHHhcc-CCCceeeeeeccccC
Q psy14889 140 LSECI-GKGRYGEVWRGVWH--------GENVAVKIFFSRD------EASWSRETEIYSTVLLR-HENILGYIGSDMTSR 203 (443)
Q Consensus 140 ~~~~l-G~G~fg~Vy~~~~~--------~~~vAvK~~~~~~------~~~~~~e~ei~~~~~l~-H~nIv~l~g~~~~~~ 203 (443)
..+.| +.|....+|+.... +..+++|+..... ......|.+++....-. .-.+.++++++.+..
T Consensus 24 ~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~ 103 (357)
T 3ats_A 24 VESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGD 103 (357)
T ss_dssp EEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSST
T ss_pred EEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCC
Confidence 34667 88888999988765 6788999764332 13445555555442211 234566776654432
Q ss_pred CcccEEEeeecccCcccHHHHhcc-------cCCCHHHHHHHHHHHHHHHHHHHHchh----------------------
Q psy14889 204 NSCTQLWLVTHYHSFGSLYDHLNR-------TTLNHHQMMKICLSIVNGLVHLHTEIF---------------------- 254 (443)
Q Consensus 204 ~~~~~~~lv~e~~~~gsL~~~l~~-------~~l~~~~~~~i~~qia~gL~yLH~~~~---------------------- 254 (443)
. ....++||||+++..+.+.+.. ..++..+...++.++++.|.-||+...
T Consensus 104 ~-~g~~~~v~e~l~G~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~La~LH~~~~~~~~l~~~~~~~~~~~~~~~~~ 182 (357)
T 3ats_A 104 V-LGTPFFLMDYVEGVVPPDVMPYTFGDNWFADAPAERQRQLQDATVAALATLHSIPNAQNTFSFLTQGRTSDTTLHRHF 182 (357)
T ss_dssp T-TSSCEEEEECCCCBCCCBTTBGGGSCSTTTTSCHHHHHHHHHHHHHHHHHHTTCSSHHHHTGGGC-----CCHHHHHH
T ss_pred c-cCCceEEEEecCCCChhhcCcccccccccCCCCHHHHHHHHHHHHHHHHHHhCCCCccCChhhccCCCCCCchHHHHH
Confidence 1 1234799999998766542210 023344444455555555555553110
Q ss_pred -------------------------------cCC---CCCCeEEeCCCCCCEEEcCCCcEEEEecCCcc
Q psy14889 255 -------------------------------GTQ---GKPAIAHRDIKSKNILVKTNGTCVIADFGLAV 289 (443)
Q Consensus 255 -------------------------------~~~---~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~ 289 (443)
... ..+.++|+|+.+.|||++++..+.|+||+.+.
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~ 251 (357)
T 3ats_A 183 NWVRSWYDFAVEGIGRSPLLERTFEWLQSHWPDDAAAREPVLLWGDARVGNVLYRDFQPVAVLDWEMVA 251 (357)
T ss_dssp HHHHHHHHHHHHHHCCCHHHHHHHHHHHHTCCHHHHHSCCEEECSSCSGGGEEEETTEEEEECCGGGCE
T ss_pred HHHHHHHHhhccCCCCChHHHHHHHHHHHhCCCcccCCCceEEeCCCCCCeEEEeCCcEEEEEcccccc
Confidence 000 14689999999999999965557899998873
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.92 E-value=8.1e-05 Score=71.02 Aligned_cols=30 Identities=23% Similarity=0.407 Sum_probs=27.2
Q ss_pred CCCeEEeCCCCCCEEEcCCCcEEEEecCCc
Q psy14889 259 KPAIAHRDIKSKNILVKTNGTCVIADFGLA 288 (443)
Q Consensus 259 ~~~iiHrDlk~~NiLl~~~~~~kl~DfGla 288 (443)
.+.++|+|+.+.|||++.++.+.|+||+.+
T Consensus 221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a 250 (346)
T 2q83_A 221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTV 250 (346)
T ss_dssp SCCEECSSCSTTSEEECGGGCEEECCCTTC
T ss_pred cCceecCCCCcccEEEeCCCcEEEEehhhc
Confidence 458999999999999988889999999976
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.86 E-value=8.3e-05 Score=72.82 Aligned_cols=30 Identities=17% Similarity=0.313 Sum_probs=25.6
Q ss_pred CCCeEEeCCCCCCEEEcCCCcEEEEecCCcc
Q psy14889 259 KPAIAHRDIKSKNILVKTNGTCVIADFGLAV 289 (443)
Q Consensus 259 ~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~ 289 (443)
.+.++|+|+.+.|||++.+ .++|+||..+.
T Consensus 226 ~~~L~HGDl~~~Nil~~~~-~~~lID~e~a~ 255 (397)
T 2olc_A 226 AETLIHGDLHTGSIFASEH-ETKVIDPEFAF 255 (397)
T ss_dssp CCEEECSCCSGGGEEECSS-CEEECCCTTCE
T ss_pred CCceeeCCCCcCcEEEeCC-CeEEEeCcccc
Confidence 3589999999999999876 48999998764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.80 E-value=0.00012 Score=69.19 Aligned_cols=142 Identities=13% Similarity=0.104 Sum_probs=84.3
Q ss_pred ccceeeeecCeEEEEEEECCceeEEEEeeccCccchHHHHHHHHHHhcc-CCCceeeeeeccccCCcccEEEeeecccCc
Q psy14889 140 LSECIGKGRYGEVWRGVWHGENVAVKIFFSRDEASWSRETEIYSTVLLR-HENILGYIGSDMTSRNSCTQLWLVTHYHSF 218 (443)
Q Consensus 140 ~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~-H~nIv~l~g~~~~~~~~~~~~~lv~e~~~~ 218 (443)
-.+.|+.|....+|+...++..+++|+........+..|.+.+....-. ...+.+.+++.... ...++||||+++
T Consensus 40 ~~~~l~gG~~n~~y~v~~~~~~~vlK~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~----g~~~lvme~l~G 115 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLINDEVQTVFVKINERSYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQ----GHSFLLLEALNK 115 (312)
T ss_dssp EEEEECCSSSSEEEEEESSSCEEEEEEEEGGGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECS----SEEEEEEECCCC
T ss_pred eeEEeCCccceeeeEEEECCCeEEEEeCCcccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecC----CceEEEEEeccC
Confidence 3567899999999999888889999987654333444555554442111 24566777765443 346999999998
Q ss_pred ccHH--------HHh---cc--c--C-------------------CCHHHHH---HHHHHH-------------HHHHHH
Q psy14889 219 GSLY--------DHL---NR--T--T-------------------LNHHQMM---KICLSI-------------VNGLVH 248 (443)
Q Consensus 219 gsL~--------~~l---~~--~--~-------------------l~~~~~~---~i~~qi-------------a~gL~y 248 (443)
..+. ..| +. . . -+|.... ++..++ ..-++.
T Consensus 116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~ 195 (312)
T 3jr1_A 116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI 195 (312)
T ss_dssp CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence 6541 111 11 1 0 1233221 111111 111222
Q ss_pred HHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecC
Q psy14889 249 LHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFG 286 (443)
Q Consensus 249 LH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfG 286 (443)
+-...-+....|.++|+|+.+.|++++.++ +.|.||.
T Consensus 196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 221111123467999999999999999887 8899974
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.77 E-value=0.00016 Score=71.43 Aligned_cols=72 Identities=13% Similarity=0.049 Sum_probs=45.2
Q ss_pred cceeeeecCeEEEEEEECCceeEEEEeecc-----C--c---cchHHHHHHHHHHh-ccCCCceeeeeeccccCCcccEE
Q psy14889 141 SECIGKGRYGEVWRGVWHGENVAVKIFFSR-----D--E---ASWSRETEIYSTVL-LRHENILGYIGSDMTSRNSCTQL 209 (443)
Q Consensus 141 ~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~-----~--~---~~~~~e~ei~~~~~-l~H~nIv~l~g~~~~~~~~~~~~ 209 (443)
.+.||.|..+.||+...++..++||..... . . .....|.|+..... .....+.+++.+.. . ..
T Consensus 39 i~~l~~G~~n~vyrv~~~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~~-~-----~~ 112 (420)
T 2pyw_A 39 IKEVGDGNLNFVFIVVGSSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFDR-T-----MA 112 (420)
T ss_dssp EEECCCSSSCEEEEEECSSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEET-T-----TT
T ss_pred EEEccCCCcEEEEEEEcCCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEECC-C-----cc
Confidence 467899999999999777788999943211 1 1 22344666655432 12234556666541 1 23
Q ss_pred Eeeeccc-Cc
Q psy14889 210 WLVTHYH-SF 218 (443)
Q Consensus 210 ~lv~e~~-~~ 218 (443)
++||||+ ++
T Consensus 113 ~lv~e~l~~g 122 (420)
T 2pyw_A 113 LIGMRYLEPP 122 (420)
T ss_dssp EEEECCCCTT
T ss_pred EEEEeecCCc
Confidence 8999999 76
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.62 E-value=0.0003 Score=66.03 Aligned_cols=132 Identities=16% Similarity=0.051 Sum_probs=72.3
Q ss_pred cceeeeecCeEEEEEEECCceeEEEEeeccCccchHHHHHHHHHHhccCCCc-eeeeeeccccCCcccEEEeeeccc-Cc
Q psy14889 141 SECIGKGRYGEVWRGVWHGENVAVKIFFSRDEASWSRETEIYSTVLLRHENI-LGYIGSDMTSRNSCTQLWLVTHYH-SF 218 (443)
Q Consensus 141 ~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~H~nI-v~l~g~~~~~~~~~~~~~lv~e~~-~~ 218 (443)
.+.|+.|....+|+. ..+++|+..........++.|...+..+...++ .+++++..+. -++++||+ ++
T Consensus 23 i~~l~gG~tN~~~~~----~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~~~~------~~~v~e~i~~g 92 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA----GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVDPAT------GVMVTRYIAGA 92 (301)
T ss_dssp CEEEESCSSEEEEEE----TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEECTTT------CCEEEECCTTC
T ss_pred eeEcCCcccccccee----eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEECCC------CEEEEeecCCC
Confidence 677889999999998 678889775432222223333333332322222 3555543222 16899999 55
Q ss_pred ccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchh--------------------------------------------
Q psy14889 219 GSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIF-------------------------------------------- 254 (443)
Q Consensus 219 gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~-------------------------------------------- 254 (443)
.+|....-. ....++.++++.|+-||+...
T Consensus 93 ~~l~~~~~~------~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l 166 (301)
T 3dxq_A 93 QTMSPEKFK------TRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSAL 166 (301)
T ss_dssp EECCHHHHH------HSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHH
T ss_pred ccCCHhhHh------hhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHH
Confidence 444210000 000123333333344443210
Q ss_pred -cCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcc
Q psy14889 255 -GTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAV 289 (443)
Q Consensus 255 -~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~ 289 (443)
.....+.++|+|+.+.||+ ..++.+.|+||..+.
T Consensus 167 ~~~~~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~ 201 (301)
T 3dxq_A 167 AAHPLPLAACHCDPLCENFL-DTGERMWIVDWEYSG 201 (301)
T ss_dssp HSSCCCCEEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred HhcCCCceeeccCCCcCCEE-ECCCCEEEEeccccc
Confidence 0123456899999999999 566778999998874
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.50 E-value=0.00096 Score=62.09 Aligned_cols=75 Identities=13% Similarity=0.079 Sum_probs=47.3
Q ss_pred ccccccceeeeecCeEEEEEEE-CCceeEEEEeeccCc---cchHHHHHHHHHHhccCC---CceeeeeeccccCCcccE
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW-HGENVAVKIFFSRDE---ASWSRETEIYSTVLLRHE---NILGYIGSDMTSRNSCTQ 208 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~---~~~~~e~ei~~~~~l~H~---nIv~l~g~~~~~~~~~~~ 208 (443)
..+.-.+.+|.|..+.||+... +|+.|.||+...... ..+..|.+.+.. +.-. -+.+.+++. .
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~--L~~~~~vpvP~v~~~~---~----- 84 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDW--LGRSFGSPVPQVAGWD---D----- 84 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHH--HTCSTTCCSCCEEEEE---T-----
T ss_pred CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHH--HHhhCCCCcceEEecc---C-----
Confidence 3455678899999999999998 789999997644322 123344444443 4321 234444432 1
Q ss_pred EEeeecccCccc
Q psy14889 209 LWLVTHYHSFGS 220 (443)
Q Consensus 209 ~~lv~e~~~~gs 220 (443)
-++||||..++.
T Consensus 85 ~~lv~e~l~~~~ 96 (288)
T 3f7w_A 85 RTLAMEWVDERP 96 (288)
T ss_dssp TEEEEECCCCCC
T ss_pred ceEEEEeecccC
Confidence 168999987654
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.47 E-value=0.00073 Score=64.27 Aligned_cols=31 Identities=26% Similarity=0.351 Sum_probs=27.1
Q ss_pred CCCeEEeCCCCCCEEEcCC----CcEEEEecCCcc
Q psy14889 259 KPAIAHRDIKSKNILVKTN----GTCVIADFGLAV 289 (443)
Q Consensus 259 ~~~iiHrDlk~~NiLl~~~----~~~kl~DfGla~ 289 (443)
.+.++|+|+.+.|||++.+ ..+.|+||+.+.
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~ 216 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAK 216 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcC
Confidence 4589999999999999875 689999999874
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.23 E-value=0.0013 Score=62.10 Aligned_cols=147 Identities=8% Similarity=0.005 Sum_probs=76.0
Q ss_pred cceeeeecCeEEEEEEECCceeEEEEeecc-CccchHHHHHHHHHHhccCCCceeeeeeccccC--CcccEEEeeecccC
Q psy14889 141 SECIGKGRYGEVWRGVWHGENVAVKIFFSR-DEASWSRETEIYSTVLLRHENILGYIGSDMTSR--NSCTQLWLVTHYHS 217 (443)
Q Consensus 141 ~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~-~~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~--~~~~~~~lv~e~~~ 217 (443)
.+.|+.|....+|+...++..+++|+.... .......|.++.....-+.-.+.+++....... ......+++++|++
T Consensus 27 ~~~i~~G~~n~~~~v~~~~g~~vlk~~~~~~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l~ 106 (322)
T 2ppq_A 27 YKGIAEGVENSNFLLHTTKDPLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFLE 106 (322)
T ss_dssp EEEECC---EEEEEEEESSCCEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECCC
T ss_pred eeccCCCcccceEEEEeCCccEEEEEeCCCCCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEeCC
Confidence 456777888999999886668899987652 233444455554442211111233332110000 00134588999998
Q ss_pred cccHHH-----------H---hcc--cCC--------C---HHHHHH------------HHHHHHHHHHHHHHchhcCCC
Q psy14889 218 FGSLYD-----------H---LNR--TTL--------N---HHQMMK------------ICLSIVNGLVHLHTEIFGTQG 258 (443)
Q Consensus 218 ~gsL~~-----------~---l~~--~~l--------~---~~~~~~------------i~~qia~gL~yLH~~~~~~~~ 258 (443)
+..+.. . ++. ..+ . |..... +...+...++++.... ....
T Consensus 107 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~-~~~~ 185 (322)
T 2ppq_A 107 GMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHW-PKDL 185 (322)
T ss_dssp CBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHC-CCSS
T ss_pred CcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhC-cccC
Confidence 754311 0 111 010 1 111100 0112444556665431 1122
Q ss_pred CCCeEEeCCCCCCEEEcCCCcEEEEecCCc
Q psy14889 259 KPAIAHRDIKSKNILVKTNGTCVIADFGLA 288 (443)
Q Consensus 259 ~~~iiHrDlk~~NiLl~~~~~~kl~DfGla 288 (443)
.++++|+|+.+.|||++.+..+.|+||+.+
T Consensus 186 ~~~liHgDl~~~Nil~~~~~~~~lIDf~~a 215 (322)
T 2ppq_A 186 PAGVIHADLFQDNVFFLGDELSGLIDFYFA 215 (322)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTC
T ss_pred CcccCCCCCCccCEEEeCCceEEEecchhc
Confidence 458999999999999998766689999876
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.16 E-value=0.0044 Score=61.70 Aligned_cols=73 Identities=14% Similarity=0.051 Sum_probs=43.5
Q ss_pred cceeeeecCeEEEEEEECC--ceeEEEEeeccCccchHHHHHHHHHHhccCCCc-eeeeeeccccCCcccEEEeeecccC
Q psy14889 141 SECIGKGRYGEVWRGVWHG--ENVAVKIFFSRDEASWSRETEIYSTVLLRHENI-LGYIGSDMTSRNSCTQLWLVTHYHS 217 (443)
Q Consensus 141 ~~~lG~G~fg~Vy~~~~~~--~~vAvK~~~~~~~~~~~~e~ei~~~~~l~H~nI-v~l~g~~~~~~~~~~~~~lv~e~~~ 217 (443)
.+.|+.|-...+|+....+ ..+++|+..........++.|...+..+...++ .++++.+. + .+|+||++
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~---~-----G~v~e~I~ 184 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFT---N-----GRIEEFMD 184 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEET---T-----EEEEECCC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeC---C-----eEEEEeeC
Confidence 4568888889999998865 788999764332222333444444444554444 45666652 1 25999998
Q ss_pred cccH
Q psy14889 218 FGSL 221 (443)
Q Consensus 218 ~gsL 221 (443)
+.+|
T Consensus 185 G~~l 188 (458)
T 2qg7_A 185 GYAL 188 (458)
T ss_dssp SEEC
T ss_pred CccC
Confidence 7444
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.06 E-value=0.0013 Score=63.57 Aligned_cols=30 Identities=20% Similarity=0.339 Sum_probs=24.6
Q ss_pred CCCeEEeCCCCCCEEEcCCCcEEEEecCCcc
Q psy14889 259 KPAIAHRDIKSKNILVKTNGTCVIADFGLAV 289 (443)
Q Consensus 259 ~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~ 289 (443)
.+.++|+|+.+.|||++++. +.|+||..+.
T Consensus 211 ~~~l~HgDl~~~Nil~~~~~-~~lID~e~a~ 240 (369)
T 3c5i_A 211 TIVFCHNDLQENNIINTNKC-LRLIDFEYSG 240 (369)
T ss_dssp CEEEECSCCCGGGEEECC-C-EEECCCTTCE
T ss_pred CeEEEeCCCCcccEEecCCc-EEEEEecCCC
Confidence 34789999999999997655 8999998763
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.05 E-value=0.0023 Score=63.28 Aligned_cols=71 Identities=14% Similarity=0.181 Sum_probs=42.9
Q ss_pred cceeeeecCeEEEEEEEC---------CceeEEEEeeccCc-cchHHHHHHHHHHhccCCCc-eeeeeeccccCCcccEE
Q psy14889 141 SECIGKGRYGEVWRGVWH---------GENVAVKIFFSRDE-ASWSRETEIYSTVLLRHENI-LGYIGSDMTSRNSCTQL 209 (443)
Q Consensus 141 ~~~lG~G~fg~Vy~~~~~---------~~~vAvK~~~~~~~-~~~~~e~ei~~~~~l~H~nI-v~l~g~~~~~~~~~~~~ 209 (443)
.+.|+.|-...||+.... +..+++|+...... .....|..++.. +...++ .++++.+..
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~~~~li~E~~~l~~--L~~~g~~P~l~~~~~~-------- 147 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTL--LSERHLGPKLYGIFSG-------- 147 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHH--HHHTTSSSCEEEEETT--------
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCcHHHHHHHHHHHHH--HHhCCCCCcEEEEeCC--------
Confidence 456888888999999874 46889998743222 333345544443 332233 456665421
Q ss_pred EeeecccCcccH
Q psy14889 210 WLVTHYHSFGSL 221 (443)
Q Consensus 210 ~lv~e~~~~gsL 221 (443)
.+|+||+++.+|
T Consensus 148 g~v~e~l~G~~l 159 (429)
T 1nw1_A 148 GRLEEYIPSRPL 159 (429)
T ss_dssp EEEECCCCEEEC
T ss_pred CEEEEEeCCccc
Confidence 388999876443
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.97 E-value=0.00071 Score=42.80 Aligned_cols=33 Identities=18% Similarity=0.439 Sum_probs=23.0
Q ss_pred hhhhhHHhHHHHHHHHHHHHHHHHHHHHhhhhh
Q psy14889 47 ILKLSMAILGPVIVLGMLAAVIVLFMRRNHRKK 79 (443)
Q Consensus 47 ~~~i~~~i~~~~~~l~~~~~~~~~~~~~~~~~~ 79 (443)
...|+.++++++++++++++++++++||+++++
T Consensus 9 ~~aIA~gVVgGv~~v~ii~~~~~~~~RRRr~~~ 41 (44)
T 2l2t_A 9 TPLIAAGVIGGLFILVIVGLTFAVYVRRKSIKK 41 (44)
T ss_dssp SHHHHHHHHHHHHHHHHHHHHHHHHHHTTCSSC
T ss_pred cceEEEeehHHHHHHHHHHHHHHHHhhhhhhhh
Confidence 345888888888887777777666666665543
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.96 E-value=0.006 Score=53.70 Aligned_cols=98 Identities=17% Similarity=0.236 Sum_probs=62.6
Q ss_pred ccHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcccccccCC
Q psy14889 219 GSLYDHLN--RTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSN 296 (443)
Q Consensus 219 gsL~~~l~--~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~~~~~~ 296 (443)
-||.+.|+ +.++++++++.++.|.+.+|.-+-... . + ..+=+-|..|++..+|.+.+.+ ..+.
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~-----~-~-~~~i~~~~~i~l~~dG~V~f~~-~~s~------- 97 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRR-----Q-P-RHRVRSAAQIRVWRDGAVTLAP-AADD------- 97 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT-----C-C-CCCCCSGGGEEEETTSCEEECC-C----------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcc-----c-C-CceecCCcceEEecCCceeccc-cccc-------
Confidence 47899885 588999999999999999887652110 0 1 1223346888999999888764 2110
Q ss_pred cCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhc
Q psy14889 297 KMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRR 347 (443)
Q Consensus 297 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg 347 (443)
.....+.|||.... ..+.+.=|||+|+++|.-+--
T Consensus 98 ---------~~~~~~~~pe~~~~-------~~te~~~IysLG~tLY~ALDy 132 (229)
T 2yle_A 98 ---------AGEPPPVAGKLGYS-------QCMETEVIESLGIIIYKALDY 132 (229)
T ss_dssp ------------------CCSSS-------SSCHHHHHHHHHHHHHHHHTT
T ss_pred ---------ccccCCCChhhccc-------cchHHHHHHHHHHHHHHHhhc
Confidence 01124678887642 344678899999999998753
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.95 E-value=0.00052 Score=43.57 Aligned_cols=31 Identities=32% Similarity=0.514 Sum_probs=22.2
Q ss_pred hhhhHHhHHHHHHHHHHHHHHHHHHHHhhhh
Q psy14889 48 LKLSMAILGPVIVLGMLAAVIVLFMRRNHRK 78 (443)
Q Consensus 48 ~~i~~~i~~~~~~l~~~~~~~~~~~~~~~~~ 78 (443)
..|+.++++++++++++++++++++||++++
T Consensus 11 ~~IA~gVVgGv~~~~ii~~~~~~~~RRr~~~ 41 (44)
T 2ks1_B 11 PSIATGMVGALLLLLVVALGIGLFMRRRHIV 41 (44)
T ss_dssp SSSTHHHHHHHHHHHHHHHHHHHHHHTTTCC
T ss_pred ceEEeehhHHHHHHHHHHHHHHHHhhhhHhh
Confidence 3578888888888877777766666665544
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.52 E-value=0.019 Score=54.15 Aligned_cols=29 Identities=24% Similarity=0.214 Sum_probs=25.0
Q ss_pred CCCeEEeCCCCCCEEEcCCCcEEEEecCCcc
Q psy14889 259 KPAIAHRDIKSKNILVKTNGTCVIADFGLAV 289 (443)
Q Consensus 259 ~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~ 289 (443)
.+.++|+|+++.|||++ + .+.|+||+.+.
T Consensus 194 ~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~ 222 (328)
T 1zyl_A 194 TVLRLHGDCHAGNILWR-D-GPMFVDLDDAR 222 (328)
T ss_dssp CCEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred CeeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence 45789999999999998 4 89999998763
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.45 E-value=0.0074 Score=59.35 Aligned_cols=140 Identities=12% Similarity=0.112 Sum_probs=79.3
Q ss_pred cceeeeecCeEEEEEEEC---------CceeEEEEeeccCccchHHHHHHHHHHhccCCC-ceeeeeeccccCCcccEEE
Q psy14889 141 SECIGKGRYGEVWRGVWH---------GENVAVKIFFSRDEASWSRETEIYSTVLLRHEN-ILGYIGSDMTSRNSCTQLW 210 (443)
Q Consensus 141 ~~~lG~G~fg~Vy~~~~~---------~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~H~n-Iv~l~g~~~~~~~~~~~~~ 210 (443)
.+.|..|-...+|+.... +..+++|+..........++.|...+..+.-.+ ..++++.+. + +
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~~---~-----~ 146 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADFP---E-----G 146 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEET---T-----E
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEcC---C-----C
Confidence 456777888899999875 678999986443322233334444333343222 344554321 1 6
Q ss_pred eeecccCcccHHH--------------Hh---cc--c---CC---------CHHHHHHHHHHH-----------------
Q psy14889 211 LVTHYHSFGSLYD--------------HL---NR--T---TL---------NHHQMMKICLSI----------------- 242 (443)
Q Consensus 211 lv~e~~~~gsL~~--------------~l---~~--~---~l---------~~~~~~~i~~qi----------------- 242 (443)
+|+||+++..|.. .| +. . .+ -+.++.++..++
T Consensus 147 ~I~efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~ 226 (424)
T 3mes_A 147 RIEEFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYS 226 (424)
T ss_dssp EEEECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHH
T ss_pred EEEEEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHH
Confidence 8999998865321 01 10 0 11 133443333322
Q ss_pred --HHHHHHHHHchh----------------cCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcc
Q psy14889 243 --VNGLVHLHTEIF----------------GTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAV 289 (443)
Q Consensus 243 --a~gL~yLH~~~~----------------~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~ 289 (443)
...+.+|....- .......++|+|+.+.||+ +.++.+.|+||..|.
T Consensus 227 ~l~~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~ 290 (424)
T 3mes_A 227 KILEEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSA 290 (424)
T ss_dssp HHHHHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCC
Confidence 233445543321 1122457899999999999 788899999998873
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.37 E-value=0.011 Score=57.18 Aligned_cols=138 Identities=14% Similarity=0.133 Sum_probs=74.5
Q ss_pred ceeeeecCeEEEEEEEC---------CceeEEEEeeccC--ccchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEE
Q psy14889 142 ECIGKGRYGEVWRGVWH---------GENVAVKIFFSRD--EASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLW 210 (443)
Q Consensus 142 ~~lG~G~fg~Vy~~~~~---------~~~vAvK~~~~~~--~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~ 210 (443)
+.|..|-...+|+.... ++.+++|+.-... .....+|.+++.... .+.-..++++.+.+ .
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~-~~gv~P~ll~~~~~--------g 126 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILA-ERSLGPQLYGVFPE--------G 126 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHH-HTTSSCCEEEEETT--------E
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHH-hcCCCCeEEEEcCC--------c
Confidence 45766888899998763 3678999753211 122334544444321 12222456665432 2
Q ss_pred eeecccCcccHHH--------------Hh---ccc------CC--CHHHHHHHHHHHHH-------------------HH
Q psy14889 211 LVTHYHSFGSLYD--------------HL---NRT------TL--NHHQMMKICLSIVN-------------------GL 246 (443)
Q Consensus 211 lv~e~~~~gsL~~--------------~l---~~~------~l--~~~~~~~i~~qia~-------------------gL 246 (443)
+||||+++..|.. .| +.. .. -+.++.++..++.. .+
T Consensus 127 ~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~ 206 (379)
T 3feg_A 127 RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEM 206 (379)
T ss_dssp EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHH
T ss_pred cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHH
Confidence 8899998755431 01 111 11 13445555544322 23
Q ss_pred HHHHHchhcCCCCCCeEEeCCCCCCEEEcCC----CcEEEEecCCc
Q psy14889 247 VHLHTEIFGTQGKPAIAHRDIKSKNILVKTN----GTCVIADFGLA 288 (443)
Q Consensus 247 ~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~----~~~kl~DfGla 288 (443)
..|....-.......++|+|+.+.|||++.+ +.+.|+||..+
T Consensus 207 ~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a 252 (379)
T 3feg_A 207 GNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYS 252 (379)
T ss_dssp HHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTC
T ss_pred HHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccC
Confidence 4444332112234578999999999999877 68999999876
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=96.13 E-value=0.0052 Score=38.74 Aligned_cols=29 Identities=21% Similarity=0.552 Sum_probs=14.0
Q ss_pred hhhHHhHHHHHHHHHHHHHHHHHHHHhhhh
Q psy14889 49 KLSMAILGPVIVLGMLAAVIVLFMRRNHRK 78 (443)
Q Consensus 49 ~i~~~i~~~~~~l~~~~~~~~~~~~~~~~~ 78 (443)
.++.++++ ++++++++++++++.|||+.+
T Consensus 13 ~Ia~~vVG-vll~vi~~l~~~~~~RRR~~~ 41 (44)
T 2jwa_A 13 SIISAVVG-ILLVVVLGVVFGILIKRRQQK 41 (44)
T ss_dssp HHHHHHHH-HHHHHHHHHHHHHHHHHHCSC
T ss_pred chHHHHHH-HHHHHHHHHHHHhheehhhhh
Confidence 45555555 444444444444555544433
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.61 E-value=0.093 Score=49.79 Aligned_cols=32 Identities=28% Similarity=0.421 Sum_probs=28.0
Q ss_pred CCCeEEeCCCCCCEEEcCCCcEEEEecCCccc
Q psy14889 259 KPAIAHRDIKSKNILVKTNGTCVIADFGLAVS 290 (443)
Q Consensus 259 ~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~ 290 (443)
.+.++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 45899999999999999888899999987743
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=92.78 E-value=0.19 Score=48.86 Aligned_cols=29 Identities=24% Similarity=0.446 Sum_probs=24.3
Q ss_pred CeEEeCCCCCCEEE------cCCCcEEEEecCCcc
Q psy14889 261 AIAHRDIKSKNILV------KTNGTCVIADFGLAV 289 (443)
Q Consensus 261 ~iiHrDlk~~NiLl------~~~~~~kl~DfGla~ 289 (443)
.++|+|+.+.|||+ +++..+.++||.+|.
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 46799999999999 445679999998873
|
| >4fao_E Activin receptor type-2B; TGF-beta, CTK, cystine knot, extracellular domain, signaling protein-signaling protein complex; HET: NAG; 3.36A {Homo sapiens} | Back alignment and structure |
|---|
Probab=92.33 E-value=0.032 Score=43.97 Aligned_cols=24 Identities=29% Similarity=0.684 Sum_probs=18.7
Q ss_pred CCeeEecCCCCCCCCCCCCCCCCC
Q psy14889 10 GQFTIQCCDGDFCNNGSFPILPPS 33 (443)
Q Consensus 10 ~~~~~~~~~~~~c~~~~~~~~~~~ 33 (443)
.+.+||||.|++||.+++..+++.
T Consensus 81 ~~~~fCCC~gdlCN~nfs~~p~~~ 104 (124)
T 4fao_E 81 PQVYFCCCEGNFCNERFTHLPEAG 104 (124)
T ss_dssp CSEEEEEECSTTTTSSEEECC---
T ss_pred CCcEEEecCCCccCCceeecCCCC
Confidence 579999999999999987766544
|
| >1iij_A ERBB-2 receptor protein-tyrosine kinase; alpha-helix-PI-bulge-alpha-helix, signaling protein; NMR {Synthetic} SCOP: j.35.1.1 | Back alignment and structure |
|---|
Probab=92.27 E-value=0.045 Score=32.55 Aligned_cols=29 Identities=17% Similarity=0.441 Sum_probs=13.9
Q ss_pred hhhhhhHHhHHHHHHHHHHHHHHHHHHHHh
Q psy14889 46 YILKLSMAILGPVIVLGMLAAVIVLFMRRN 75 (443)
Q Consensus 46 ~~~~i~~~i~~~~~~l~~~~~~~~~~~~~~ 75 (443)
....++.++++ +++++++.+.+.++.|||
T Consensus 6 ~~~sIaagVvg-lll~vii~l~~~~~iRRr 34 (35)
T 1iij_A 6 PVTFIIATVVG-VLLFLILVVVVGILIKRR 34 (35)
T ss_dssp HHHHHHHHHHH-HHHHHHHTTTTTHHHHHC
T ss_pred CCcEeHHHHHH-HHHHHHHHHHhheEEeec
Confidence 34446666666 444444444444444443
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=90.32 E-value=0.39 Score=29.29 Aligned_cols=11 Identities=18% Similarity=0.410 Sum_probs=4.2
Q ss_pred HHHHHHHHHHH
Q psy14889 61 LGMLAAVIVLF 71 (443)
Q Consensus 61 l~~~~~~~~~~ 71 (443)
+++++++++++
T Consensus 24 v~li~~l~~~~ 34 (38)
T 2k1k_A 24 AALLLGILVFR 34 (38)
T ss_dssp HHHHHHHHHHH
T ss_pred HHHHHHHHHHH
Confidence 33333333333
|
| >2k9y_A Ephrin type-A receptor 2; receptor tyrosine kinase, membrane protein, dimeric transmembrane domain, ephrin receptor, ATP-binding, glycoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=89.72 E-value=0.16 Score=31.71 Aligned_cols=16 Identities=19% Similarity=0.059 Sum_probs=8.7
Q ss_pred hhhhhHHhHHHHHHHH
Q psy14889 47 ILKLSMAILGPVIVLG 62 (443)
Q Consensus 47 ~~~i~~~i~~~~~~l~ 62 (443)
...|+.++++++++++
T Consensus 12 ~~~I~~~vv~Gv~ll~ 27 (41)
T 2k9y_A 12 NLAVIGGVAVGVVLLL 27 (41)
T ss_dssp STHHHHHHHHHHHHHH
T ss_pred eEEEEeehhHHHHHHH
Confidence 3445666666555543
|
| >1bte_A Protein (activin receptor type II); serine kinase, ligand binding domain, three-finger transferase; HET: NAG; 1.50A {Mus musculus} SCOP: g.7.1.3 PDB: 2goo_C* 1lx5_B* | Back alignment and structure |
|---|
Probab=89.30 E-value=0.071 Score=40.26 Aligned_cols=22 Identities=23% Similarity=0.570 Sum_probs=18.8
Q ss_pred CCeeEecCCCCCCCCCCCCCCC
Q psy14889 10 GQFTIQCCDGDFCNNGSFPILP 31 (443)
Q Consensus 10 ~~~~~~~~~~~~c~~~~~~~~~ 31 (443)
+++.||||.|++||..+...|+
T Consensus 74 ~~~~fCCC~gd~CN~nft~~p~ 95 (97)
T 1bte_A 74 PEVYFCCCEGNMCNEKFSYFPE 95 (97)
T ss_dssp CSSEEEEECSTTGGGSEEECCC
T ss_pred CCEEEEECCCCccccCcccCCC
Confidence 6899999999999998776543
|
| >2l8s_A Integrin alpha-1; transmembrane region, detergent micelle, CE adhesion; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=86.48 E-value=0.79 Score=30.14 Aligned_cols=26 Identities=8% Similarity=0.167 Sum_probs=16.5
Q ss_pred hhhhhhHHhHHHHHHHHHHHHHHHHH
Q psy14889 46 YILKLSMAILGPVIVLGMLAAVIVLF 71 (443)
Q Consensus 46 ~~~~i~~~i~~~~~~l~~~~~~~~~~ 71 (443)
..|.|+++++++++++++++++++-+
T Consensus 8 p~WiIi~svl~GLLLL~Lii~~LwK~ 33 (54)
T 2l8s_A 8 PLWVILLSAFAGLLLLMLLILALWKI 33 (54)
T ss_dssp CTHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred chHHHHHHHHHHHHHHHHHHHHHHHc
Confidence 35667777777777666666555533
|
| >2klu_A T-cell surface glycoprotein CD4; cell membrane, disulfide bond, HOST- virus interaction, immune response, immunoglobulin domain, lipoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=85.94 E-value=0.52 Score=32.13 Aligned_cols=25 Identities=32% Similarity=0.466 Sum_probs=10.8
Q ss_pred hHHHHHHHHHH-HHHHHHHHHHhhhh
Q psy14889 54 ILGPVIVLGML-AAVIVLFMRRNHRK 78 (443)
Q Consensus 54 i~~~~~~l~~~-~~~~~~~~~~~~~~ 78 (443)
++|+++.++++ .+.++++.++++|+
T Consensus 13 vlGg~~~lll~~glcI~ccvkcrhRr 38 (70)
T 2klu_A 13 VLGGVAGLLLFIGLGIFFSVRSRHRR 38 (70)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHSSCCS
T ss_pred HHhHHHHHHHHHHHHHHHhhHHHHHH
Confidence 44444444433 34444444444444
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=85.65 E-value=0.43 Score=41.77 Aligned_cols=85 Identities=12% Similarity=0.076 Sum_probs=60.7
Q ss_pred ccCCCceeeeeeccccCCcccEEEeeecccCcccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeC
Q psy14889 187 LRHENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRD 266 (443)
Q Consensus 187 l~H~nIv~l~g~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrD 266 (443)
..||+.+.. .+-.+.+ . ++..|-...+...+-.-..++...+++++.+|+.-..++++. +|--
T Consensus 42 ~~~~~Fl~~-~I~e~eD----~--v~~~y~~~~~~~~f~~ik~~~~~eKlr~l~ni~~l~~~~~~r----------~tf~ 104 (215)
T 4ann_A 42 QHSPYFIDA-ELTELRD----S--FQIHYDINDNHTPFDNIKSFTKNEKLRYLLNIKNLEEVNRTR----------YTFV 104 (215)
T ss_dssp SCCTTBCCE-EEEECSS----E--EEEEECCCTTSEEGGGGGGSCHHHHHHHHHHGGGGGGGGGSS----------EECC
T ss_pred ccCCcccce-EEEEccc----E--EEEEEEcCcccCCHHHHHhcCHHHHHHHHHHHHHHHHHhcCc----------eEEE
Confidence 578888855 2322332 2 333443334444444446688999999999999887777655 8999
Q ss_pred CCCCCEEEcCCCcEEEEecCCc
Q psy14889 267 IKSKNILVKTNGTCVIADFGLA 288 (443)
Q Consensus 267 lk~~NiLl~~~~~~kl~DfGla 288 (443)
|.|+|++++.++.+++.-.|+-
T Consensus 105 L~P~NL~f~~~~~p~i~~RGik 126 (215)
T 4ann_A 105 LAPDELFFTRDGLPIAKTRGLQ 126 (215)
T ss_dssp CSGGGEEECTTSCEEESCCEET
T ss_pred EecceEEEcCCCCEEEEEccCc
Confidence 9999999999999999988864
|
| >2knc_A Integrin alpha-IIB; transmembrane signaling, protein structure, cell A cleavage on PAIR of basic residues, disease mutation, disul bond, glycoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=85.17 E-value=1.1 Score=29.62 Aligned_cols=26 Identities=19% Similarity=0.300 Sum_probs=16.0
Q ss_pred hhhhhhHHhHHHHHHHHHHHHHHHHH
Q psy14889 46 YILKLSMAILGPVIVLGMLAAVIVLF 71 (443)
Q Consensus 46 ~~~~i~~~i~~~~~~l~~~~~~~~~~ 71 (443)
..|.|+++++++++++++++++++-+
T Consensus 11 p~wiIi~svl~GLllL~li~~~LwK~ 36 (54)
T 2knc_A 11 PIWWVLVGVLGGLLLLTILVLAMWKV 36 (54)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred chHHHHHHHHHHHHHHHHHHHHHHHc
Confidence 35566677777776666665555533
|
| >4fao_C Serine/threonine-protein kinase receptor R3; TGF-beta, CTK, cystine knot, extracellular domain, signaling protein-signaling protein complex; HET: NAG; 3.36A {Homo sapiens} PDB: 2lcr_A | Back alignment and structure |
|---|
Probab=80.45 E-value=1.2 Score=34.14 Aligned_cols=29 Identities=24% Similarity=0.560 Sum_probs=21.3
Q ss_pred ccccCCCCCeeEecCCCCCCCCCCCCCCC
Q psy14889 3 SCHSVNVGQFTIQCCDGDFCNNGSFPILP 31 (443)
Q Consensus 3 ~~~~~~~~~~~~~~~~~~~c~~~~~~~~~ 31 (443)
.|++...+.+..-||.+|+||.+..+.+|
T Consensus 57 ~C~~s~~~~~~i~CC~tDfCN~~l~p~Lp 85 (106)
T 4fao_C 57 LCRGRPTEFVNHYCCDSHLCNHNVSLVLE 85 (106)
T ss_dssp GGGCCCCSSEEEEEECSTTTTSSCCCCCC
T ss_pred ccCCCCCCceEEEecCccccCCCCCcCcc
Confidence 47766666788888899999976555543
|
| >2knc_B Integrin beta-3; transmembrane signaling, protein structure, cell A cleavage on PAIR of basic residues, disease mutation, disul bond, glycoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=80.18 E-value=3 Score=30.01 Aligned_cols=24 Identities=25% Similarity=0.607 Sum_probs=13.8
Q ss_pred hhhhhHHhHHHHHHHHHHHHHHHH
Q psy14889 47 ILKLSMAILGPVIVLGMLAAVIVL 70 (443)
Q Consensus 47 ~~~i~~~i~~~~~~l~~~~~~~~~ 70 (443)
.+.|+++++++++++.+++++++-
T Consensus 10 ~~~Iv~gvi~gilliGllllliwk 33 (79)
T 2knc_B 10 ILVVLLSVMGAILLIGLAALLIWK 33 (79)
T ss_dssp SHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred chhhHHHHHHHHHHHHHHHHHHHH
Confidence 445666666666665555544443
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 443 | ||||
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-88 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 5e-45 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-41 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-39 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-38 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 8e-37 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-36 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 6e-36 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-35 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-35 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 6e-35 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 8e-35 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-34 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-33 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-33 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-33 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-32 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-32 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-32 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-32 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 5e-32 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 5e-32 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 6e-32 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 9e-32 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-31 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-31 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 8e-31 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-30 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-30 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-30 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-30 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-30 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 6e-30 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-29 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-29 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 7e-29 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 8e-29 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-28 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 7e-28 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-27 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 7e-27 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-26 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 5e-26 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-25 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-24 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-24 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-24 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 7e-24 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-23 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-23 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-23 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-23 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-23 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-23 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 4e-23 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 5e-23 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 4e-22 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 7e-22 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 6e-21 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 9e-21 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-18 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 8e-16 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-13 | |
| d2h62c1 | 84 | g.7.1.3 (C:34-117) BMP receptor Ia ectodomain {Hum | 6e-04 |
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 269 bits (689), Expect = 1e-88
Identities = 184/296 (62%), Positives = 225/296 (76%)
Query: 134 LAKQISLSECIGKGRYGEVWRGVWHGENVAVKIFFSRDEASWSRETEIYSTVLLRHENIL 193
+A+ I L E IGKGR+GEVWRG W GE VAVKIF SR+E SW RE EIY TV+LRHENIL
Sbjct: 1 IARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENIL 60
Query: 194 GYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEI 253
G+I +D + TQLWLV+ YH GSL+D+LNR T+ M+K+ LS +GL HLH EI
Sbjct: 61 GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEI 120
Query: 254 FGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMS 313
GTQGKPAIAHRD+KSKNILVK NGTC IAD GLAV + ++ +DI PN RVGTKRYM+
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 180
Query: 314 PEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFDD 373
PE+LD+SINM FESFK+ADIYA+GLV WE+ RR GI E+Y+ PY+DLVP DPS ++
Sbjct: 181 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 240
Query: 374 MRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLA 429
MRKV+C + RP +PNRW S L M K+M+ECW+ N RL+ALR+KKTL +L+
Sbjct: 241 MRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (394), Expect = 5e-45
Identities = 78/298 (26%), Positives = 129/298 (43%), Gaps = 40/298 (13%)
Query: 137 QISLSECIGKGRYGEVWRGVWHGENVAVKIFFSRDEASWSRE---TEIYSTVLLRHENIL 193
QI++ + IG G +G V++G WHG+ VAVK+ + E+ RH NIL
Sbjct: 9 QITVGQRIGSGSFGTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 194 GYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHL--NRTTLNHHQMMKICLSIVNGLVHLHT 251
++G + QL +VT + SLY HL T +++ I G+ +LH
Sbjct: 68 LFMGYS-----TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH- 121
Query: 252 EIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRY 311
+I HRD+KS NI + + T I DFGLA S+ S G+ +
Sbjct: 122 -------AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF--EQLSGSILW 172
Query: 312 MSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSF 371
M+PE++ D ++D+YA G+VL+E+ + PY ++
Sbjct: 173 MAPEVIR---MQDKNPYSFQSDVYAFGIVLYELMTG----------QLPYSNINNR---- 215
Query: 372 DDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLA 429
D + ++ P L + AM ++M EC + + R ++ ++ LA
Sbjct: 216 DQIIFMVGRGYLSPDLSKVR--SNCPKAMKRLMAECLKKKRDERPLFPQILASIELLA 271
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 3e-41
Identities = 73/293 (24%), Positives = 130/293 (44%), Gaps = 48/293 (16%)
Query: 136 KQISLSECIGKGRYGEVWRGVWHGENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGY 195
K++ L + IGKG +G+V G + G VAVK D + + E LRH N++
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKC-IKNDATAQAFLAEASVMTQLRHSNLVQL 65
Query: 196 IGSDMTSRNSCTQLWLVTHYHSFGSLYDHL---NRTTLNHHQMMKICLSIVNGLVHLHTE 252
+G + + L++VT Y + GSL D+L R+ L ++K L + + +L
Sbjct: 66 LGVIVEEKG---GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE-- 120
Query: 253 IFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYM 312
HRD+ ++N+LV + ++DFGL S + +P ++
Sbjct: 121 ------GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV-------KWT 167
Query: 313 SPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFD 372
+PE L E + K+D+++ G++LWE I+ + PY +
Sbjct: 168 APEALREK------KFSTKSDVWSFGILLWE---------IYSFGRVPYPRI-----PLK 207
Query: 373 DMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTL 425
D+ + + P+ + +VMK CWH +A +R S L++++ L
Sbjct: 208 DVVPRVE-KGYKMDAPDGCPPA-----VYEVMKNCWHLDAAMRPSFLQLREQL 254
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 2e-39
Identities = 63/287 (21%), Positives = 124/287 (43%), Gaps = 41/287 (14%)
Query: 142 ECIGKGRYGEVWRGVWH--GENVAVKIFFSRDEASWSR-ETEIYSTVLLRHENILGYIGS 198
+G G +G+V++ A K+ ++ E EI H NI+ + +
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 199 DMTSRNSCTQLWLVTHYHSFGSLYDHLNRT--TLNHHQMMKICLSIVNGLVHLHTEIFGT 256
N LW++ + + G++ + L Q+ +C ++ L +LH
Sbjct: 78 FYYENN----LWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH------ 127
Query: 257 QGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEI 316
I HRD+K+ NIL +G +ADFG++ ++ + + +GT +M+PE+
Sbjct: 128 --DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR----DSFIGTPYWMAPEV 181
Query: 317 LDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFDDMRK 376
+ + D + KAD+++LG+ L E+ E + P+H+L PM + K
Sbjct: 182 VMCETSKDRPYDY-KADVWSLGITLIEMA----------EIEPPHHELNPM----RVLLK 226
Query: 377 VICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423
+ + P+RW S+ +K+C +N + R + ++ +
Sbjct: 227 IAKSEPPTLAQPSRWSSN-----FKDFLKKCLEKNVDARWTTSQLLQ 268
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (347), Expect = 2e-38
Identities = 63/291 (21%), Positives = 108/291 (37%), Gaps = 45/291 (15%)
Query: 140 LSECIGKGRYGEVWRGVWH--GENVAVKIFFSRDEASWSRE---TEIYSTVLLRHENILG 194
IG+G + V++G+ VA R R+ E L+H NI+
Sbjct: 13 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 72
Query: 195 YIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEI 253
+ S ++ + LVT + G+L +L R + + C I+ GL LHT
Sbjct: 73 FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR- 131
Query: 254 FGTQGKPAIAHRDIKSKNILV-KTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYM 312
P I HRD+K NI + G+ I D GLA K +GT +M
Sbjct: 132 -----TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA------VIGTPEFM 180
Query: 313 SPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFD 372
+PE+ +E + + D+YA G+ + E+ + PY + +
Sbjct: 181 APEMYEEKYD-------ESVDVYAFGMCMLEMATS----------EYPYSECQNAAQIYR 223
Query: 373 DMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423
+P ++ + ++++ C QN + R S +
Sbjct: 224 -----RVTSGVKPASFDKVAIPE----VKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 8e-37
Identities = 58/295 (19%), Positives = 119/295 (40%), Gaps = 48/295 (16%)
Query: 136 KQISLSECIGKGRYGEVWRGVWHGEN-VAVKIFFSRDEASWSRETEIYSTVLLRHENILG 194
+ + L E +G G++GEVW G ++G VAVK + + E L+H+ ++
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVR 72
Query: 195 YIGSDMTSRNSCTQLWLVTHYHSFGSLYDHL---NRTTLNHHQMMKICLSIVNGLVHLHT 251
+ ++++T Y GSL D L + L ++++ + I G+ +
Sbjct: 73 LYAVV-----TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE- 126
Query: 252 EIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRY 311
+ HRD+++ NILV +C IADFGLA + + ++
Sbjct: 127 -------ERNYIHRDLRAANILVSDTLSCKIADFGLA---RLIEDNEYTAREGAKFPIKW 176
Query: 312 MSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSF 371
+PE ++ K+D+++ G++L E+ + P
Sbjct: 177 TAPEAINYGTFT------IKSDVWSFGILLTEIVTHGR----------------IPYPGM 214
Query: 372 DDMRKVICIDQ-QRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTL 425
+ + +++ R V P+ + + ++M+ CW + R + ++ L
Sbjct: 215 TNPEVIQNLERGYRMVRPDNCPEE-----LYQLMRLCWKERPEDRPTFDYLRSVL 264
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 3e-36
Identities = 56/297 (18%), Positives = 111/297 (37%), Gaps = 44/297 (14%)
Query: 136 KQISLSECIGKGRYGEVWRGVW-HGENVAVKIFFSRDEASWSRETEIYSTVLLRHENILG 194
+++ + IG G++G V G W + + VA+K + E + L H ++
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQ 64
Query: 195 YIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNH--HQMMKICLSIVNGLVHLHTE 252
G + + LV + G L D+L ++ +CL + G+ +L
Sbjct: 65 LYGVCLEQAP----ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE-- 118
Query: 253 IFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYM 312
+ + HRD+ ++N LV N ++DFG+ + + ++
Sbjct: 119 ------EACVIHRDLAARNCLVGENQVIKVSDFGM---TRFVLDDQYTSSTGTKFPVKWA 169
Query: 313 SPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFD 372
SPE+ S K+D+++ G+++WEV K +
Sbjct: 170 SPEVFSFSRYS------SKSDVWSFGVLMWEVFSEGK----------------IPYENRS 207
Query: 373 DMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLA 429
+ V I + R S + ++M CW + R + R+ + L ++A
Sbjct: 208 NSEVVEDISTGFRLYKPRLASTH----VYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 132 bits (333), Expect = 6e-36
Identities = 65/295 (22%), Positives = 108/295 (36%), Gaps = 50/295 (16%)
Query: 136 KQISLSECIGKGRYGEVWRGVWH--GENVAVKIF---FSRDEASWSR-ETEIYSTVLLRH 189
K S IG G +G V+ E VA+K + W E+ LRH
Sbjct: 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74
Query: 190 ENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHL-NRTTLNHHQMMKICLSIVNGLVH 248
N + Y G + WLV Y + ++ L ++ + + GL +
Sbjct: 75 PNTIQYRGCYLREHT----AWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAY 130
Query: 249 LHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGT 308
LH + HRD+K+ NIL+ G + DFG A + P N VGT
Sbjct: 131 LH--------SHNMIHRDVKAGNILLSEPGLVKLGDFGSA--------SIMAPANSFVGT 174
Query: 309 KRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMD 368
+M+PE++ MD + K D+++LG+ E+ R K P ++ M
Sbjct: 175 PYWMAPEVIL---AMDEGQYDGKVDVWSLGITCIELAER----------KPPLFNMNAM- 220
Query: 369 PSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423
+ + + P L + S+ + C + R ++ + K
Sbjct: 221 ---SALYHI--AQNESPALQSGHWSE----YFRNFVDSCLQKIPQDRPTSEVLLK 266
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (329), Expect = 1e-35
Identities = 64/285 (22%), Positives = 114/285 (40%), Gaps = 44/285 (15%)
Query: 142 ECIGKGRYGEVWRGVWH--GENVAVKIFFSRDEASWSR-ETEIYSTVLLRHENILGYIGS 198
E IG+G G V+ + G+ VA++ + + EI ++ NI+ Y+ S
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 199 DMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQG 258
+ LW+V Y + GSL D + T ++ Q+ +C + L LH+
Sbjct: 86 YLVGDE----LWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN------ 135
Query: 259 KPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILD 318
+ HRDIKS NIL+ +G+ + DFG + +K + VGT +M+PE++
Sbjct: 136 --QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR----STMVGTPYWMAPEVVT 189
Query: 319 ESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFDDMRKVI 378
K DI++LG++ E+ + PY + P+ + +
Sbjct: 190 RK------AYGPKVDIWSLGIMAIEMIEG----------EPPYLNENPL----RALYLIA 229
Query: 379 CIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423
P +S + + C + R SA + +
Sbjct: 230 TNGTPELQNP-EKLSAIFRD----FLNRCLDMDVEKRGSAKELLQ 269
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 3e-35
Identities = 63/298 (21%), Positives = 119/298 (39%), Gaps = 48/298 (16%)
Query: 136 KQISLSECIGKGRYGEVWRGVWH-GENVAVKIFF--SRDEASWSRETEIYSTVLLRHENI 192
K ++ + +G G++G V G W +VA+K+ S E + E ++ L HE +
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMN--LSHEKL 61
Query: 193 LGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHL--NRTTLNHHQMMKICLSIVNGLVHLH 250
+ G R ++++T Y + G L ++L R Q++++C + + +L
Sbjct: 62 VQLYGVCTKQRP----IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE 117
Query: 251 TEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKR 310
HRD+ ++N LV G ++DFGL+ + + R
Sbjct: 118 --------SKQFLHRDLAARNCLVNDQGVVKVSDFGLS---RYVLDDEYTSSVGSKFPVR 166
Query: 311 YMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPS 370
+ PE+L S K+DI+A G+++WE+ K PY
Sbjct: 167 WSPPEVLMYSKFS------SKSDIWAFGVLMWEIYSL---------GKMPYER------- 204
Query: 371 FDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKL 428
F + I Q + S+ + +M CWH+ A+ R + + ++ +
Sbjct: 205 FTNSETAEHIAQGLRLYRPHLASEK----VYTIMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 6e-35
Identities = 57/312 (18%), Positives = 106/312 (33%), Gaps = 50/312 (16%)
Query: 139 SLSECIGKGRYGEVWRGVWH--GENVAVKIFFSRDEASWSRE--TEIYSTVLLRHENILG 194
+G G G V++ G +A K+ + + + E+ I+G
Sbjct: 9 EKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVG 68
Query: 195 YIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRT-TLNHHQMMKICLSIVNGLVHLHTEI 253
+ G+ + + + + GSL L + + + K+ ++++ GL +L
Sbjct: 69 FYGAFYSDGE----ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE-- 122
Query: 254 FGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMS 313
K I HRD+K NILV + G + DFG++ D N VGT+ YMS
Sbjct: 123 -----KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI------DSMANSFVGTRSYMS 171
Query: 314 PEILDESINMDCFESFKKADIYALGLVLWEVC---------------------RRTKANG 352
PE L + ++DI+++GL L E+ A
Sbjct: 172 PERLQGT------HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAE 225
Query: 353 IFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTK-VMKECWHQN 411
+ P L + + P + + + + +C +N
Sbjct: 226 TPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKN 285
Query: 412 ANVRLSALRVKK 423
R ++
Sbjct: 286 PAERADLKQLMV 297
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 8e-35
Identities = 57/292 (19%), Positives = 108/292 (36%), Gaps = 46/292 (15%)
Query: 142 ECIGKGRYGEVWRGVWH--GENVAVKIFFSRDEASWSRET---EIYSTVLLRHENILGYI 196
IG G YG + G+ + K ++ E+ L+H NI+ Y
Sbjct: 10 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 69
Query: 197 GSDMTSRNSCTQLWLVTHYHSFGSLYDHL-----NRTTLNHHQMMKICLSIVNGLVHLHT 251
+ N+ L++V Y G L + R L+ ++++ + L H
Sbjct: 70 DRIIDRTNTT--LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR 127
Query: 252 EIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRY 311
G + HRD+K N+ + + DFGLA + ++ VGT Y
Sbjct: 128 RSDGGHT---VLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA----KAFVGTPYY 180
Query: 312 MSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSF 371
MSPE ++ +K+DI++LG +L+E+C P+ S
Sbjct: 181 MSPEQMNRM------SYNEKSDIWSLGCLLYELCAL----------MPPFTAF-----SQ 219
Query: 372 DDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423
++ I + + +P R+ + + +++ + R S + +
Sbjct: 220 KELAGKIR-EGKFRRIPYRYSDE-----LNEIITRMLNLKDYHRPSVEEILE 265
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 1e-34
Identities = 65/289 (22%), Positives = 111/289 (38%), Gaps = 43/289 (14%)
Query: 140 LSECIGKGRYGEVWRGVWH--GENVAVKIFFSRDEASWSR--ETEIYSTVLLRHENILGY 195
L + +G+G YGEV V E VAVKI + + EI +L HEN++ +
Sbjct: 9 LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 68
Query: 196 IGSDMTSRNSCTQLWLVTHYHSFGSLYDHL-NRTTLNHHQMMKICLSIVNGLVHLHTEIF 254
G +L Y S G L+D + + + ++ G+V+LH
Sbjct: 69 YGHRREG----NIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---- 120
Query: 255 GTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSP 314
I HRDIK +N+L+ I+DFGLA + N + N GT Y++P
Sbjct: 121 ----GIGITHRDIKPENLLLDERDNLKISDFGLATVFR--YNNRERLLNKMCGTLPYVAP 174
Query: 315 EILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFDDM 374
E+L + D+++ G+VL + D
Sbjct: 175 ELLKRREFHA-----EPVDVWSCGIVLTAMLAGE-----------------LPWDQPSDS 212
Query: 375 RKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423
+ +++ N W +A ++ + +N + R++ +KK
Sbjct: 213 CQEYSDWKEKKTYLNPWKKID--SAPLALLHKILVENPSARITIPDIKK 259
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 1e-33
Identities = 65/294 (22%), Positives = 119/294 (40%), Gaps = 46/294 (15%)
Query: 136 KQISLSECIGKGRYGEVWRGVWHGEN-VAVKIFFSRDEASWSRETEIYSTVLLRHENILG 194
+ + L +G+G +GEVW G W+G VA+K + + E LRHE ++
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQ 76
Query: 195 YIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHH---QMMKICLSIVNGLVHLHT 251
S +++VT Y S GSL D L T + Q++ + I +G+ ++
Sbjct: 77 LYAVV-----SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE- 130
Query: 252 EIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRY 311
+ HRD+++ NILV N C +ADFGLA + + ++
Sbjct: 131 -------RMNYVHRDLRAANILVGENLVCKVADFGLA---RLIEDNEYTARQGAKFPIKW 180
Query: 312 MSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSF 371
+PE K+D+++ G++L E + + + PY +V
Sbjct: 181 TAPEAALYG------RFTIKSDVWSFGILLTE---------LTTKGRVPYPGMVNR---- 221
Query: 372 DDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTL 425
++ + + P P +S + +M +CW + R + ++ L
Sbjct: 222 -EVLDQVERGYRMPCPPE--CPES----LHDLMCQCWRKEPEERPTFEYLQAFL 268
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (316), Expect = 2e-33
Identities = 63/311 (20%), Positives = 110/311 (35%), Gaps = 49/311 (15%)
Query: 138 ISLSECIGKGRYGEVWRGVWHGEN-----VAVKIFFSRDEASWSRE--TEIYSTVLLRHE 190
+ +E IG+G +G V+ G + AVK + + TE H
Sbjct: 29 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHP 88
Query: 191 NILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHL--NRTTLNHHQMMKICLSIVNGLVH 248
N+L +G + S S +V Y G L + + ++ L + G+
Sbjct: 89 NVLSLLGICLRSEGS---PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKF 145
Query: 249 LHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGT 308
L HRD+ ++N ++ T +ADFGLA
Sbjct: 146 LA--------SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLP 197
Query: 309 KRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMD 368
++M+ E L K+D+++ G++LWE + PY D+ D
Sbjct: 198 VKWMALESLQTQKFT------TKSDVWSFGVLLWE---------LMTRGAPPYPDVNTFD 242
Query: 369 PSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTL--- 425
+ + Q R +L + D + +VM +CWH A +R S + +
Sbjct: 243 -------ITVYLLQGRRLLQPEYCPDP----LYEVMLKCWHPKAEMRPSFSELVSRISAI 291
Query: 426 IKLACADMYIH 436
+ Y+H
Sbjct: 292 FSTFIGEHYVH 302
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 4e-33
Identities = 54/299 (18%), Positives = 108/299 (36%), Gaps = 49/299 (16%)
Query: 136 KQISLSE-CIGKGRYGEVWRGVWH----GENVAVKIFFSRDEASWSRE---TEIYSTVLL 187
K ++L + +G G +G V +G + + VAVKI + ++ E L
Sbjct: 6 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL 65
Query: 188 RHENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRT-TLNHHQMMKICLSIVNGL 246
+ I+ IG LV G L +L + + ++++ + G+
Sbjct: 66 DNPYIVRMIGICE-----AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGM 120
Query: 247 VHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRV 306
+L HRD+ ++N+L+ T I+DFGL+ +
Sbjct: 121 KYLEES--------NFVHRDLAARNVLLVTQHYAKISDFGLSKALRA-DENYYKAQTHGK 171
Query: 307 GTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVP 366
++ +PE ++ K+D+++ G+++WE F + PY +
Sbjct: 172 WPVKWYAPECINYYKFS------SKSDVWSFGVLMWE---------AFSYGQKPYRGMKG 216
Query: 367 MDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTL 425
++ ++ +R P + M +M CW + R V+ L
Sbjct: 217 S-----EVTAMLE-KGERMGCPAGCPRE-----MYDLMNLCWTYDVENRPGFAAVELRL 264
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (306), Expect = 2e-32
Identities = 56/291 (19%), Positives = 106/291 (36%), Gaps = 53/291 (18%)
Query: 140 LSECIGKGRYGEVWRGVWH--GENVAVKIF----FSRDEASWSRETEIYSTVLLRHENIL 193
+ +GKG++G V+ +A+K+ + E+ LRH NIL
Sbjct: 10 IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNIL 69
Query: 194 GYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTT-LNHHQMMKICLSIVNGLVHLHTE 252
G + T+++L+ Y G++Y L + + + + + N L + H
Sbjct: 70 RLYGYFHDA----TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH-- 123
Query: 253 IFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYM 312
+ HRDIK +N+L+ + G IADFG +V GT Y+
Sbjct: 124 ------SKRVIHRDIKPENLLLGSAGELKIADFGWSVH------APSSRRTTLCGTLDYL 171
Query: 313 SPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFD 372
PE+++ +K D+++LG++ +E K P+ ++
Sbjct: 172 PPEMIEGR------MHDEKVDLWSLGVLCYEFLVG----------KPPFE-----ANTYQ 210
Query: 373 DMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423
+ K I + P+ ++ N + R V +
Sbjct: 211 ETYKRIS--RVEFTFPDFVTEG-----ARDLISRLLKHNPSQRPMLREVLE 254
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 2e-32
Identities = 65/324 (20%), Positives = 119/324 (36%), Gaps = 75/324 (23%)
Query: 137 QISLSECIGKGRYGEVWRGVWHGEN-------VAVKIFFSR----DEASWSRETEIYSTV 185
+ + +G G +G+V +G + VAVK+ + + + E ++ +
Sbjct: 38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ- 96
Query: 186 LLRHENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHL-------------------- 225
L HENI+ +G+ S ++L+ Y +G L ++L
Sbjct: 97 LGSHENIVNLLGACTLSGP----IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRL 152
Query: 226 ----NRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCV 281
+ L ++ + G+ L + HRD+ ++N+LV
Sbjct: 153 EEEEDLNVLTFEDLLCFAYQVAKGMEFLE--------FKSCVHRDLAARNVLVTHGKVVK 204
Query: 282 IADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVL 341
I DFGLA SN + ++M+PE L E I K+D+++ G++L
Sbjct: 205 ICDFGLARDIMSDSNYV--VRGNARLPVKWMAPESLFEGI------YTIKSDVWSYGILL 256
Query: 342 WEVCRRTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMT 401
WE IF PY P + K+I + + P + +
Sbjct: 257 WE---------IFSLGVNPYPG----IPVDANFYKLIQ-NGFKMDQPFYATEE-----IY 297
Query: 402 KVMKECWHQNANVRLSALRVKKTL 425
+M+ CW ++ R S + L
Sbjct: 298 IIMQSCWAFDSRKRPSFPNLTSFL 321
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 123 bits (309), Expect = 4e-32
Identities = 44/291 (15%), Positives = 103/291 (35%), Gaps = 48/291 (16%)
Query: 140 LSECIGKGRYGEVWRGVWH--GENVAVKIFFSRDEASWSR-ETEIYSTVLLRHENILGYI 196
+ E +G G +G V R G N A K + E+ EI + +LRH ++
Sbjct: 30 IHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLH 89
Query: 197 GSDMTSRNSCTQLWLVTHYHSFGSLYDHL--NRTTLNHHQMMKICLSIVNGLVHLHTEIF 254
+ + ++ + S G L++ + ++ + ++ + GL H+H
Sbjct: 90 DAFEDDNE----MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---- 141
Query: 255 GTQGKPAIAHRDIKSKNILV--KTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYM 312
+ H D+K +NI+ K + + DFGL + +
Sbjct: 142 ----ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTA-----EFA 192
Query: 313 SPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFD 372
+PE+ + D++++G++ + + +P+ + +
Sbjct: 193 APEVAEGK------PVGYYTDMWSVGVLSYILLSG----------LSPFGG----ENDDE 232
Query: 373 DMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423
+R V D +S+ + +++ + N R++ + +
Sbjct: 233 TLRNVKSCDWNMDDSAFSGISEDGKD----FIRKLLLADPNTRMTIHQALE 279
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (308), Expect = 4e-32
Identities = 50/292 (17%), Positives = 102/292 (34%), Gaps = 44/292 (15%)
Query: 140 LSECIGKGRYGEVWRGVWH--GENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIG 197
S+ +G G G+V + E A+K+ +D RE E++ + +I+ +
Sbjct: 16 TSQVLGLGINGKVLQIFNKRTQEKFALKML--QDCPKARREVELHWR-ASQCPHIVRIVD 72
Query: 198 SDMTSRNSCTQLWLVTHYHSFGSLYDHLNR---TTLNHHQMMKICLSIVNGLVHLHTEIF 254
L +V G L+ + + +I SI + +LH
Sbjct: 73 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---- 128
Query: 255 GTQGKPAIAHRDIKSKNILV---KTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRY 311
IAHRD+K +N+L + N + DFG A + ++ T Y
Sbjct: 129 ----SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY-----TPYY 179
Query: 312 MSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSF 371
++PE+L + K D+++LG++++ + P++ + S
Sbjct: 180 VAPEVLGPE------KYDKSCDMWSLGVIMYILLCG----------YPPFYSNHGLAISP 223
Query: 372 DDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423
++ + P VS+ +++ R++
Sbjct: 224 GMKTRIRMGQYEFPNPEWSEVSEEVKM----LIRNLLKTEPTQRMTITEFMN 271
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 5e-32
Identities = 64/318 (20%), Positives = 117/318 (36%), Gaps = 69/318 (21%)
Query: 136 KQISLSECIGKGRYGEVWRGVWHGEN----VAVKIF----FSRDEASWSRETEIYSTVLL 187
I + IG+G +G+V + + A+K D ++ E E+ L
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCK-LG 68
Query: 188 RHENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNR-----------------TTL 230
H NI+ +G+ L+L Y G+L D L + +TL
Sbjct: 69 HHPNIINLLGACEHRGY----LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 124
Query: 231 NHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVS 290
+ Q++ + G+ +L + HRD+ ++NILV N IADFGL+
Sbjct: 125 SSQQLLHFAADVARGMDYLS--------QKQFIHRDLAARNILVGENYVAKIADFGLSRG 176
Query: 291 YSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKA 350
K R+M+ E L+ S+ +D+++ G++LWE+
Sbjct: 177 QEVYVKKTMG-----RLPVRWMAIESLNYSVYT------TNSDVWSYGVLLWEIVSL--- 222
Query: 351 NGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQ 410
PY + + K+ R P + + +M++CW +
Sbjct: 223 ------GGTPYCGMTCA----ELYEKL--PQGYRLEKPLNCDDE-----VYDLMRQCWRE 265
Query: 411 NANVRLSALRVKKTLIKL 428
R S ++ +L ++
Sbjct: 266 KPYERPSFAQILVSLNRM 283
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 5e-32
Identities = 55/309 (17%), Positives = 114/309 (36%), Gaps = 56/309 (18%)
Query: 128 LLIQRTLAKQISLSEC-IGKGRYGEVWRGVWH----GENVAVKIF----FSRDEASWSRE 178
L ++R + +++ +G G +G V +GV+ +VA+K+ D RE
Sbjct: 3 LFLKR---DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMRE 59
Query: 179 TEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHL--NRTTLNHHQMM 236
+I L + I+ IG L LV G L+ L R + +
Sbjct: 60 AQIMHQ--LDNPYIVRLIGVC-----QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVA 112
Query: 237 KICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSN 296
++ + G+ +L + HRD+ ++N+L+ I+DFGL+ + +
Sbjct: 113 ELLHQVSMGMKYLE--------EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA-DD 163
Query: 297 KMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEE 356
+ ++ +PE ++ ++D+++ G+ +WE
Sbjct: 164 SYYTARSAGKWPLKWYAPECINFRKFS------SRSDVWSYGVTMWE---------ALSY 208
Query: 357 YKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRL 416
+ PY + + M + +R P + + +M +CW R
Sbjct: 209 GQKPYKKMKGP----EVMAFI--EQGKRMECPPECPPE-----LYALMSDCWIYKWEDRP 257
Query: 417 SALRVKKTL 425
L V++ +
Sbjct: 258 DFLTVEQRM 266
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 121 bits (304), Expect = 6e-32
Identities = 64/303 (21%), Positives = 116/303 (38%), Gaps = 48/303 (15%)
Query: 136 KQISLSECIGKGRYGEVWRGVWHGEN-----VAVKIFFSRDEASWSRE--TEIYSTVLLR 188
+ + + IG G +GEV G VA+K S R+ +E
Sbjct: 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD 85
Query: 189 HENILGYIGSDMTSRNSCTQLWLVTHYHSFGSL--YDHLNRTTLNHHQMMKICLSIVNGL 246
H N++ G S + ++T + GSL + N Q++ + I G+
Sbjct: 86 HPNVIHLEGVVTKSTP----VMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGM 141
Query: 247 VHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDI-PPNPR 305
+L HRD+ ++NILV +N C ++DFGL+ ++
Sbjct: 142 KYLA--------DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGG 193
Query: 306 VGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLV 365
R+ +PE + + +D+++ G+V+WEV + PY D+
Sbjct: 194 KIPIRWTAPEAIQYR------KFTSASDVWSYGIVMWEVMSYG---------ERPYWDMT 238
Query: 366 PMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTL 425
D + I+Q + P A+ ++M +CW ++ N R ++ TL
Sbjct: 239 NQD-------VINAIEQDYRLPPPMDCPS----ALHQLMLDCWQKDRNHRPKFGQIVNTL 287
Query: 426 IKL 428
K+
Sbjct: 288 DKM 290
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 9e-32
Identities = 66/304 (21%), Positives = 114/304 (37%), Gaps = 50/304 (16%)
Query: 136 KQISLSECIGKGRYGEVWRGVWHGEN-----VAVKIF----FSRDEASWSRETEIYSTVL 186
K + L E +G G +G V RG W + VAVK S+ EA E+ +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 187 LRHENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHL--NRTTLNHHQMMKICLSIVN 244
L H N++ G +T + +VT GSL D L ++ + + + +
Sbjct: 68 LDHRNLIRLYGVVLTP-----PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAE 122
Query: 245 GLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNP 304
G+ +L HRD+ ++N+L+ T I DFGL + Q ++ +
Sbjct: 123 GMGYLE--------SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ-NDDHYVMQEH 173
Query: 305 RVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDL 364
R + +PE L +D + G+ LWE +F + P+ L
Sbjct: 174 RKVPFAWCAPESLKTRTF------SHASDTWMFGVTLWE---------MFTYGQEPWIGL 218
Query: 365 VPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKT 424
+ I + +R P D + VM +CW R + + ++
Sbjct: 219 NGS-----QILHKIDKEGERLPRPEDCPQD-----IYNVMVQCWAHKPEDRPTFVALRDF 268
Query: 425 LIKL 428
L++
Sbjct: 269 LLEA 272
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 3e-31
Identities = 61/302 (20%), Positives = 120/302 (39%), Gaps = 33/302 (10%)
Query: 142 ECIGKGRYGEVWRGVWH--GENVAVKIFFSRDEASWSRET---EIYSTVLLRHENILGYI 196
IG+G +GEV++ G+ VA+K +E T EI LL+HEN++ I
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75
Query: 197 GSDMTSRNSCTQ----LWLVTHYHSFGSLYDHLNRTT-LNHHQMMKICLSIVNGLVHLHT 251
T + + ++LV + N ++ ++ ++NGL ++H
Sbjct: 76 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH- 134
Query: 252 EIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRY 311
+ I HRD+K+ N+L+ +G +ADFGLA ++S N RV T Y
Sbjct: 135 -------RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWY 187
Query: 312 MSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTK----------ANGIFEEYKAPY 361
PE+L + D++ G ++ E+ R+ I + +
Sbjct: 188 RPPELLLGERDYG-----PPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 242
Query: 362 HDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRV 421
++ P +++ K+ + Q+ + +R + ++ + + R+ +
Sbjct: 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
Query: 422 KK 423
Sbjct: 303 LN 304
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (298), Expect = 3e-31
Identities = 63/304 (20%), Positives = 114/304 (37%), Gaps = 53/304 (17%)
Query: 137 QISLSECIGKGRYGEVWRGVWHGEN------VAVKI----FFSRDEASWSRETEIYSTVL 186
++ + IG G +GEV++G+ + VA+K + + + E I
Sbjct: 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQ-- 65
Query: 187 LRHENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHL--NRTTLNHHQMMKICLSIVN 244
H NI+ G + + ++T Y G+L L + Q++ + I
Sbjct: 66 FSHHNIIRLEGVISKYKP----MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAA 121
Query: 245 GLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNP 304
G+ +L HRD+ ++NILV +N C ++DFGL+ + +
Sbjct: 122 GMKYLA--------NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED-DPEATYTTSG 172
Query: 305 RVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDL 364
R+ +PE + +D+++ G+V+WEV Y +
Sbjct: 173 GKIPIRWTAPEAISYRKFT------SASDVWSFGIVMWEVM--------------TYGER 212
Query: 365 VPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKT 424
+ S ++ K I D R P S + ++M +CW Q R +
Sbjct: 213 PYWELSNHEVMKAIN-DGFRLPTPMDCPSA-----IYQLMMQCWQQERARRPKFADIVSI 266
Query: 425 LIKL 428
L KL
Sbjct: 267 LDKL 270
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 119 bits (299), Expect = 8e-31
Identities = 54/291 (18%), Positives = 102/291 (35%), Gaps = 52/291 (17%)
Query: 142 ECIGKGRYGEVWRGVWH--GENVAVKIF---FSRDEASWSRETEIYSTVLLRHENILGYI 196
E +G G +G V R V G K + D+ + E I + L H ++
Sbjct: 35 EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQ--LHHPKLINLH 92
Query: 197 GSDMTSRNSCTQLWLVTHYHSFGSLYDHL--NRTTLNHHQMMKICLSIVNGLVHLHTEIF 254
+ + L+ + S G L+D + ++ +++ GL H+H
Sbjct: 93 DAFEDKYE----MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---- 144
Query: 255 GTQGKPAIAHRDIKSKNILV--KTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYM 312
+ +I H DIK +NI+ K + I DFGLA + D T +
Sbjct: 145 ----EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP-----DEIVKVTTATAEFA 195
Query: 313 SPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFD 372
+PEI+D D++A+G++ + + +P+ + +
Sbjct: 196 APEIVDRE------PVGFYTDMWAIGVLGYVLLSG----------LSPFAGEDDL----E 235
Query: 373 DMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423
++ V D + VS + +K + RL+ +
Sbjct: 236 TLQNVKRCDWEFDEDAFSSVSPEAKD----FIKNLLQKEPRKRLTVHDALE 282
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 117 bits (294), Expect = 1e-30
Identities = 58/294 (19%), Positives = 109/294 (37%), Gaps = 41/294 (13%)
Query: 140 LSECIGKGRYGEVWRGVWH--GENVAVKIFFSRDEASWS-RETEIYSTVLLRHENILGYI 196
E +G+G V R + + AVKI S+S E + L+ +IL +
Sbjct: 7 PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKV 66
Query: 197 GSDMTSRN------SCTQLWLVTHYHSFGSLYDHL-NRTTLNHHQMMKICLSIVNGLVHL 249
+ T +LV G L+D+L + TL+ + KI +++ + L
Sbjct: 67 SGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICAL 126
Query: 250 HTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTK 309
H K I HRD+K +NIL+ + + DFG + GT
Sbjct: 127 H--------KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP-----GEKLREVCGTP 173
Query: 310 RYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDP 369
Y++PEI++ S+N + K+ D+++ G++++ + P+
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG----------SPPFWH----RK 219
Query: 370 SFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423
+R ++ + Q SD+ + ++ R +A
Sbjct: 220 QMLMLRMIMSGNYQFGSPEWDDYSDTVKD----LVSRFLVVQPQKRYTAEEALA 269
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 3e-30
Identities = 54/286 (18%), Positives = 100/286 (34%), Gaps = 49/286 (17%)
Query: 140 LSECIGKGRYGEVWRGVWH--GENVAVKIFFSRDEASWSRETEIYSTV----LLRHENIL 193
+ +G+G + V A+KI R ++ + L H +
Sbjct: 12 FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 71
Query: 194 GYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRT-TLNHHQMMKICLSIVNGLVHLHTE 252
+ L+ Y G L ++ + + + IV+ L +LH
Sbjct: 72 KLYFTFQDDEK----LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH-- 125
Query: 253 IFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYM 312
I HRD+K +NIL+ + I DFG A S S + N VGT +Y+
Sbjct: 126 ------GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA--RANSFVGTAQYV 177
Query: 313 SPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFD 372
SPE+L E + K +D++ALG +++++ P+ +
Sbjct: 178 SPELLTEK------SACKSSDLWALGCIIYQLVAG----------LPPFRA-------GN 214
Query: 373 DMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSA 418
+ I + P ++ ++++ +A RL
Sbjct: 215 EYLIFQKIIKLEYDFPEKFFPK-----ARDLVEKLLVLDATKRLGC 255
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 116 bits (291), Expect = 3e-30
Identities = 58/300 (19%), Positives = 121/300 (40%), Gaps = 50/300 (16%)
Query: 136 KQISLSECIGKGRYGEVWRGVWH--GENVAVKIFF--SRDEASWSRETEIYSTVLLRHEN 191
I++ +G G+YGEV+ GVW VAVK + + + +E + ++H N
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKE--IKHPN 74
Query: 192 ILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHL---NRTTLNHHQMMKICLSIVNGLVH 248
++ +G +++T + ++G+L D+L NR ++ ++ + I + + +
Sbjct: 75 LVQLLGVCTREPP----FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 130
Query: 249 LHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGT 308
L K HRD+ ++N LV N +ADFGL+ ++
Sbjct: 131 LE--------KKNFIHRDLAARNCLVGENHLVKVADFGLS---RLMTGDTYTAHAGAKFP 179
Query: 309 KRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMD 368
++ +PE L + + K+D++A G++LWE+
Sbjct: 180 IKWTAPESLAYN------KFSIKSDVWAFGVLLWEIATYGM----------------SPY 217
Query: 369 PSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKL 428
P D + +++ + + + ++M+ CW N + R S + + +
Sbjct: 218 PGIDLSQVYELLEKDYRMERPEGCPE----KVYELMRACWQWNPSDRPSFAEIHQAFETM 273
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 3e-30
Identities = 55/319 (17%), Positives = 109/319 (34%), Gaps = 70/319 (21%)
Query: 137 QISLSECIGKGRYGEVWRGVWH-------GENVAVKIF----FSRDEASWSRETEIYSTV 185
++S + +G G +G+V + VAVK+ + + E ++ S
Sbjct: 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY- 82
Query: 186 LLRHENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNR------------------ 227
L H NI+ +G+ ++T Y +G L + L R
Sbjct: 83 LGNHMNIVNLLGACTIGGP----TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 138
Query: 228 -TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFG 286
L+ ++ + G+ L HRD+ ++NIL+ I DFG
Sbjct: 139 ELALDLEDLLSFSYQVAKGMAFLA--------SKNCIHRDLAARNILLTHGRITKICDFG 190
Query: 287 LAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR 346
LA SN + ++M+PE + + ++D+++ G+ LWE+
Sbjct: 191 LARDIKNDSNYV--VKGNARLPVKWMAPESIFNCVYT------FESDVWSYGIFLWELFS 242
Query: 347 RTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKE 406
P K + ++ + + + M +MK
Sbjct: 243 LGS----------------SPYPGMPVDSKFYKMIKEGFRMLS---PEHAPAEMYDIMKT 283
Query: 407 CWHQNANVRLSALRVKKTL 425
CW + R + ++ + +
Sbjct: 284 CWDADPLKRPTFKQIVQLI 302
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 4e-30
Identities = 58/287 (20%), Positives = 105/287 (36%), Gaps = 52/287 (18%)
Query: 140 LSECIGKGRYGEVWRGVWH--GENVAVKIF-----FSRDEASWSRETEIYSTVLLRHENI 192
L + +GKG +G+V+ + + A+K D+ + + ++ H +
Sbjct: 6 LHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFL 65
Query: 193 LGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHL-NRTTLNHHQMMKICLSIVNGLVHLHT 251
+ T N L+ V Y + G L H+ + + + I+ GL LH
Sbjct: 66 THMFCTFQTKEN----LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH- 120
Query: 252 EIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRY 311
I +RD+K NIL+ +G IADFG+ D N GT Y
Sbjct: 121 -------SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML----GDAKTNTFCGTPDY 169
Query: 312 MSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSF 371
++PEIL + D ++ G++L+E+ ++P+
Sbjct: 170 IAPEILLGQ------KYNHSVDWWSFGVLLYEMLIG----------QSPF-------HGQ 206
Query: 372 DDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSA 418
D+ I P P RW+ + ++ + + + RL
Sbjct: 207 DEEELFHSIRMDNPFYP-RWLEKEAKD----LLVKLFVREPEKRLGV 248
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 6e-30
Identities = 60/296 (20%), Positives = 111/296 (37%), Gaps = 29/296 (9%)
Query: 142 ECIGKGRYGEVWRGVWH--GENVAVKIFFSRDEASWSRET--EIYSTVLLRHENILGYIG 197
IG+G YG V + VA+K + ++ + T EI + RHENI+G
Sbjct: 14 SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 73
Query: 198 SDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQ 257
+ + + LY L L++ + I+ GL ++H
Sbjct: 74 IIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH------- 126
Query: 258 GKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEIL 317
+ HRD+K N+L+ T I DFGLA + V T+ Y +PEI+
Sbjct: 127 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF-LTEYVATRWYRAPEIM 184
Query: 318 DESINMDCFESFKKADIYALGLVLWEVC----------RRTKANGIFEEYKAPYHDLVPM 367
++ K DI+++G +L E+ + N I +P + +
Sbjct: 185 -----LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 239
Query: 368 DPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423
+ ++ + + V NR ++ A+ ++ + N + R+ +
Sbjct: 240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKAL-DLLDKMLTFNPHKRIEVEQALA 294
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 113 bits (284), Expect = 3e-29
Identities = 63/328 (19%), Positives = 115/328 (35%), Gaps = 78/328 (23%)
Query: 137 QISLSECIGKGRYGEVWRGVWH-------GENVAVKIF----FSRDEASWSRETEIYSTV 185
I IG+G +G V++ VAVK+ + +A + RE + +
Sbjct: 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE- 72
Query: 186 LLRHENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTT---------------- 229
+ NI+ +G + + L+ Y ++G L + L +
Sbjct: 73 -FDNPNIVKLLGVCAVGKP----MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRA 127
Query: 230 ---------LNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTC 280
L+ + + I + G+ +L + HRD+ ++N LV N
Sbjct: 128 RVSSPGPPPLSCAEQLCIARQVAAGMAYLS--------ERKFVHRDLATRNCLVGENMVV 179
Query: 281 VIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLV 340
IADFGL+ + S R+M PE + ++D++A G+V
Sbjct: 180 KIADFGLSRNIY--SADYYKADGNDAIPIRWMPPESIFY------NRYTTESDVWAYGVV 231
Query: 341 LWEVCRRTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAM 400
LWE IF PY+ + + + V D P + +
Sbjct: 232 LWE---------IFSYGLQPYYGMAHE----EVIYYV--RDGNILACPENCPLE-----L 271
Query: 401 TKVMKECWHQNANVRLSALRVKKTLIKL 428
+M+ CW + R S + + L ++
Sbjct: 272 YNLMRLCWSKLPADRPSFCSIHRILQRM 299
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (285), Expect = 4e-29
Identities = 46/290 (15%), Positives = 98/290 (33%), Gaps = 47/290 (16%)
Query: 140 LSECIGKGRYGEVWRGVWH--GENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIG 197
++E +G+G +G V R V + K + + EI + RH NIL
Sbjct: 9 IAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHE 68
Query: 198 SDMTSRNSCTQLWLVTHYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFG 255
S + L ++ + S +++ +N LN +++ + L LH
Sbjct: 69 SFESMEE----LVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH----- 119
Query: 256 TQGKPAIAHRDIKSKNILVKTNGTCV--IADFGLAVSYSQLSNKMDIPPNPRVGTKRYMS 313
I H DI+ +NI+ +T + I +FG A K Y +
Sbjct: 120 ---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL-----KPGDNFRLLFTAPEYYA 171
Query: 314 PEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFDD 373
PE+ D+++LG +++ + P+ + +
Sbjct: 172 PEVHQHD------VVSTATDMWSLGTLVYVLLSG----------INPFLA----ETNQQI 211
Query: 374 MRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423
+ ++ + + +S ++ + + R++A +
Sbjct: 212 IENIMNAEYTFDEEAFKEISIEAMD----FVDRLLVKERKSRMTASEALQ 257
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (283), Expect = 7e-29
Identities = 61/311 (19%), Positives = 121/311 (38%), Gaps = 51/311 (16%)
Query: 129 LIQRTLAKQISLSECIGKGRYGEVWRGVWHGEN------VAVKIFFSRDEASWSRE--TE 180
L++ + + +G G +G V++G+W E VA+K ++E E
Sbjct: 2 LLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 61
Query: 181 IYSTVLLRHENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNH--HQMMKI 238
Y + + ++ +G +TS + L+T FG L D++ N ++
Sbjct: 62 AYVMASVDNPHVCRLLGICLTS-----TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW 116
Query: 239 CLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKM 298
C+ I G+ +L + HRD+ ++N+LVKT I DFGLA + +
Sbjct: 117 CVQIAKGMNYLE--------DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG--AEEK 166
Query: 299 DIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYK 358
+ ++M+ E + I ++D+++ G+ +WE +
Sbjct: 167 EYHAEGGKVPIKWMALESILHRIYT------HQSDVWSYGVTVWE---------LMTFGS 211
Query: 359 APYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSA 418
PY + ++ ++ +R P D + +M +CW +A+ R
Sbjct: 212 KPYDGI-----PASEISSILE-KGERLPQPPICTID-----VYMIMVKCWMIDADSRPKF 260
Query: 419 LRVKKTLIKLA 429
+ K+A
Sbjct: 261 RELIIEFSKMA 271
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 112 bits (280), Expect = 8e-29
Identities = 60/304 (19%), Positives = 115/304 (37%), Gaps = 41/304 (13%)
Query: 133 TLAKQISLSECIGKGRYGEVWRGVWH--GENVAVKIF---FSRDEASWSR-ETEIYSTVL 186
L+ + L E +G G EV +VAVK+ +RD + + R E +
Sbjct: 4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAA 63
Query: 187 LRHENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRT-TLNHHQMMKICLSIVNG 245
L H I+ + + ++V Y +L D ++ + + +++
Sbjct: 64 LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQA 123
Query: 246 LVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPR 305
L H + I HRD+K NI++ + DFG+A + + S
Sbjct: 124 LNFSH--------QNGIIHRDVKPANIMISATNAVKVMDFGIARAIAD-SGNSVTQTAAV 174
Query: 306 VGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLV 365
+GT +Y+SPE ++D+Y+LG VL+EV + P+
Sbjct: 175 IGTAQYLSPEQARGD------SVDARSDVYSLGCVLYEVLTG----------EPPFTGDS 218
Query: 366 PMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRL-SALRVKKT 424
P+ + + D P + +S + V+ + +N R +A ++
Sbjct: 219 PV----SVAYQHVREDPIPPSARHEGLSAD----LDAVVLKALAKNPENRYQTAAEMRAD 270
Query: 425 LIKL 428
L+++
Sbjct: 271 LVRV 274
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (279), Expect = 1e-28
Identities = 54/301 (17%), Positives = 114/301 (37%), Gaps = 51/301 (16%)
Query: 137 QISLSECIGKGRYGEVWRGVWHGEN-----VAVKIFFSRDEASWSRE--TEIYSTVLLRH 189
+I L CIG+G++G+V +G++ VA+K + S + E + H
Sbjct: 8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 67
Query: 190 ENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRT--TLNHHQMMKICLSIVNGLV 247
+I+ IG + +W++ + G L L +L+ ++ + L
Sbjct: 68 PHIVKLIGVI-----TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALA 122
Query: 248 HLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVG 307
+L HRDI ++N+LV +N + DFGL+ + + +
Sbjct: 123 YLE--------SKRFVHRDIAARNVLVSSNDCVKLGDFGLSR---YMEDSTYYKASKGKL 171
Query: 308 TKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPM 367
++M+PE ++ +D++ G+ +WE+ P+ +
Sbjct: 172 PIKWMAPESINFR------RFTSASDVWMFGVCMWEILMH---------GVKPFQGVKNN 216
Query: 368 DPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIK 427
D + ++ + +R +P + +M +CW + + R +K L
Sbjct: 217 DV----IGRI--ENGERLPMPPNCPPT-----LYSLMTKCWAYDPSRRPRFTELKAQLST 265
Query: 428 L 428
+
Sbjct: 266 I 266
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 110 bits (275), Expect = 7e-28
Identities = 49/294 (16%), Positives = 107/294 (36%), Gaps = 53/294 (18%)
Query: 140 LSECIGKGRYGEVWRGVWH--GENVAVKIF----FSRDEASWSRETEIYSTVLLRHENIL 193
+ +G G + EV + VA+K E S E + ++H NI+
Sbjct: 13 FRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHK--IKHPNIV 70
Query: 194 GYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHL-NRTTLNHHQMMKICLSIVNGLVHLHTE 252
+ + L+L+ S G L+D + + ++ +++ + +LH
Sbjct: 71 ALDDIYESGGH----LYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLH-- 124
Query: 253 IFGTQGKPAIAHRDIKSKNILVKT---NGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTK 309
I HRD+K +N+L + + +I+DFGL+ S GT
Sbjct: 125 ------DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTA-----CGTP 173
Query: 310 RYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDP 369
Y++PE+L + K D +++G++ + + P++D
Sbjct: 174 GYVAPEVLAQK------PYSKAVDCWSIGVIAYILLCG----------YPPFYDENDAKL 217
Query: 370 SFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423
+++ + + +SDS + ++ ++ R + + +
Sbjct: 218 ----FEQILKAEYEFDSPYWDDISDSAKD----FIRHLMEKDPEKRFTCEQALQ 263
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 109 bits (274), Expect = 3e-27
Identities = 65/299 (21%), Positives = 113/299 (37%), Gaps = 52/299 (17%)
Query: 139 SLSECIGKGRYGEVWRGVWH--GENVAVKIF------FSRDEASWSRETEIYSTV-LLRH 189
S+ IG+G +GEV+ G+ A+K + E E + S V
Sbjct: 7 SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDC 66
Query: 190 ENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNH-HQMMKICLSIVNGLVH 248
I+ + T L + + G L+ HL++ + M I+ GL H
Sbjct: 67 PFIVCMSYAFHTPDK----LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEH 122
Query: 249 LHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGT 308
+H + +RD+K NIL+ +G I+D GLA +S P+ VGT
Sbjct: 123 MH--------NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS------KKKPHASVGT 168
Query: 309 KRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMD 368
YM+PE+L + + D AD ++LG +L+++ R +P+
Sbjct: 169 HGYMAPEVLQKGVAYD-----SSADWFSLGCMLFKLLRG----------HSPFR-----Q 208
Query: 369 PSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIK 427
D ++ + V S + +++ ++ N RL L +K
Sbjct: 209 HKTKDKHEIDRMTLTMAVELPDSFSPE----LRSLLEGLLQRDVNRRLGCLGRGAQEVK 263
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (267), Expect = 7e-27
Identities = 62/297 (20%), Positives = 120/297 (40%), Gaps = 36/297 (12%)
Query: 142 ECIGKGRYGEVWRGVWH--GENVAVKIF------FSRDEASWSRETEIYSTVLLRHENIL 193
+ +G+G++ V++ + VA+K ++D + + EI L H NI+
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 194 GYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHL-NRTTLNHHQMMKICLSIVNGLVHLHTE 252
G + + N + LV + N L + L + GL +LH
Sbjct: 64 GLLDAFGHKSN----ISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH-- 117
Query: 253 IFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYM 312
+ I HRD+K N+L+ NG +ADFGLA S+ + +V T+ Y
Sbjct: 118 ------QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY----THQVVTRWYR 167
Query: 313 SPEILDESINMDCFESFKKADIYALGLVLWEVCRRT---KANGIFEEYKAPYHDL-VPMD 368
+PE+L + D++A+G +L E+ R + ++ + L P +
Sbjct: 168 APELLFGARMYG-----VGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTE 222
Query: 369 PSFDDMRKVICID--QQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423
+ DM + + P +P + + + + +++ + N R++A + K
Sbjct: 223 EQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (263), Expect = 3e-26
Identities = 62/322 (19%), Positives = 130/322 (40%), Gaps = 71/322 (22%)
Query: 137 QISLSECIGKGRYGEVWRGVWHGEN---------VAVKIF----FSRDEASWSRETEIYS 183
++ L + +G+G +G+V G + VAVK+ +D + E E+
Sbjct: 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMK 73
Query: 184 TVLLRHENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHL-----------------N 226
+ +H+NI+ +G+ L+++ Y S G+L ++L
Sbjct: 74 M-IGKHKNIINLLGACTQDGP----LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 128
Query: 227 RTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFG 286
L+ ++ + G+ +L HRD+ ++N+LV + IADFG
Sbjct: 129 EEQLSSKDLVSCAYQVARGMEYLA--------SKKCIHRDLAARNVLVTEDNVMKIADFG 180
Query: 287 LAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR 346
LA ++M+PE L + I ++D+++ G++LWE
Sbjct: 181 LARDIH--HIDYYKKTTNGRLPVKWMAPEALFDRIYT------HQSDVWSFGVLLWE--- 229
Query: 347 RTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKE 406
IF +PY + +++ K++ + R P+ ++ + +M++
Sbjct: 230 ------IFTLGGSPYPGV-----PVEELFKLLK-EGHRMDKPSNCTNE-----LYMMMRD 272
Query: 407 CWHQNANVRLSALRVKKTLIKL 428
CWH + R + ++ + L ++
Sbjct: 273 CWHAVPSQRPTFKQLVEDLDRI 294
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (261), Expect = 5e-26
Identities = 57/312 (18%), Positives = 116/312 (37%), Gaps = 64/312 (20%)
Query: 136 KQISLSECIGKGRYGEVWRGVWH-------GENVAVKIF----FSRDEASWSRETEIYST 184
++I++S +G+G +G V+ GV VA+K R+ + E +
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 185 VLLRHENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHL-----------NRTTLNHH 233
+++ +G + ++ + G L +L +
Sbjct: 80 --FNCHHVVRLLGVVSQGQP----TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 133
Query: 234 QMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQ 293
+M+++ I +G+ +L+ HRD+ ++N +V + T I DFG+ +
Sbjct: 134 KMIQMAGEIADGMAYLN--------ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 185
Query: 294 LSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGI 353
+ R+MSPE L + + +D+++ G+VLWE I
Sbjct: 186 TDYYR--KGGKGLLPVRWMSPESLKDGVFT------TYSDVWSFGVVLWE---------I 228
Query: 354 FEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNAN 413
+ PY L +R V ++ P+ + ++M+ CW N
Sbjct: 229 ATLAEQPYQGLSNEQV----LRFV--MEGGLLDKPDNCPDM-----LFELMRMCWQYNPK 277
Query: 414 VRLSALRVKKTL 425
+R S L + ++
Sbjct: 278 MRPSFLEIISSI 289
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (253), Expect = 4e-25
Identities = 49/304 (16%), Positives = 93/304 (30%), Gaps = 65/304 (21%)
Query: 134 LAKQISLSECIGKGRYGEVWRGVWH--GENVAVKIF---------FSRDEASWSRETEIY 182
L Q + +G G +G V+ G+ VA+K + E +
Sbjct: 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 61
Query: 183 STVLLRHENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHL--NRTTLNHHQMMKICL 240
V ++ + + L+ R L
Sbjct: 62 KKVSSGFSGVIRLLDWFERPDS----FVLILERPEPVQDLFDFITERGALQEELARSFFW 117
Query: 241 SIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTN-GTCVIADFGLAVSYSQLSNKMD 299
++ + H H + HRDIK +NIL+ N G + DFG D
Sbjct: 118 QVLEAVRHCH--------NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK------D 163
Query: 300 IPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKA 359
GT+ Y PE + + A +++LG++L++
Sbjct: 164 TVYTDFDGTRVYSPPEWIRYHRYHG-----RSAAVWSLGILLYD---------------- 202
Query: 360 PYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSAL 419
+V D F+ ++I + V + VS + +++ C + R +
Sbjct: 203 ----MVCGDIPFEHDEEII----RGQVFFRQRVSSECQH----LIRWCLALRPSDRPTFE 250
Query: 420 RVKK 423
++
Sbjct: 251 EIQN 254
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 101 bits (253), Expect = 1e-24
Identities = 57/304 (18%), Positives = 104/304 (34%), Gaps = 44/304 (14%)
Query: 140 LSECIGKGRYGEVWRGVWH--GENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIG 197
L +G+G+Y EV+ + E V VKI + RE +I L NI+
Sbjct: 39 LVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILEN-LRGGPNIITLAD 97
Query: 198 SDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQ 257
+ LV + + L + + I+ L + H
Sbjct: 98 IVKDPVSRT--PALVFEHVNNTDFKQLYQT--LTDYDIRFYMYEILKALDYCH------- 146
Query: 258 GKPAIAHRDIKSKNILVKT-NGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEI 316
I HRD+K N+++ + + D+GLA Y N RV ++ + PE+
Sbjct: 147 -SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP-----GQEYNVRVASRYFKGPEL 200
Query: 317 LDESINMDCFESFKKADIYALGLVLWEVC-----------------RRTKANGIFEEYKA 359
L + D D+++LG +L + R K G + Y
Sbjct: 201 LVDYQMYD-----YSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY 255
Query: 360 PYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSAL 419
+ +DP F+D+ + + + + A+ + + + RL+A
Sbjct: 256 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEAL-DFLDKLLRYDHQSRLTAR 314
Query: 420 RVKK 423
+
Sbjct: 315 EAME 318
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (250), Expect = 1e-24
Identities = 50/307 (16%), Positives = 106/307 (34%), Gaps = 55/307 (17%)
Query: 131 QRTLAKQISLSECIGKGRYGEVWRGVWH--GENVAVKIFFSRDEASWSRET-------EI 181
Q + E +G G++ V + G A K R S R E+
Sbjct: 5 QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 64
Query: 182 YSTVLLRHENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYD-HLNRTTLNHHQMMKICL 240
++H N++ + + L+ + G L+D + +L + +
Sbjct: 65 SILKEIQHPNVITLHEVYENKTD----VILILELVAGGELFDFLAEKESLTEEEATEFLK 120
Query: 241 SIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGT----CVIADFGLAVSYSQLSN 296
I+NG+ +LH IAH D+K +NI++ I DFGLA +
Sbjct: 121 QILNGVYYLH--------SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN- 171
Query: 297 KMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEE 356
GT +++PEI++ +AD++++G++ + +
Sbjct: 172 ----EFKNIFGTPEFVAPEIVNYE------PLGLEADMWSIGVITYILLSG--------- 212
Query: 357 YKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRL 416
+P+ D + + V ++ + S + ++ ++ R+
Sbjct: 213 -ASPFLG----DTKQETLANVSAVNYEFEDEYFSNTSALAKD----FIRRLLVKDPKKRM 263
Query: 417 SALRVKK 423
+ +
Sbjct: 264 TIQDSLQ 270
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 100 bits (249), Expect = 2e-24
Identities = 52/303 (17%), Positives = 92/303 (30%), Gaps = 47/303 (15%)
Query: 140 LSECIGKGRYGEVWRGVWH--GENVAVKIFFSR-DEASWSRETEIYSTVL-LRHENILGY 195
+ IG+G +G ++ G + VA+K R D E Y + + Y
Sbjct: 9 VGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYY 68
Query: 196 IGSDMTSRNSCTQLWLVTHYHSFGSL-YDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIF 254
G + LV L + + ++ + +H
Sbjct: 69 FGQE------GLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---- 118
Query: 255 GTQGKPAIAHRDIKSKNILV-----KTNGTCVIADFGLAVSYSQLSNKMDIPPNPR---V 306
+ ++ +RDIK N L+ K + DFG+ Y K IP +
Sbjct: 119 ----EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLS 174
Query: 307 GTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVP 366
GT RYMS E ++ D+ ALG V R +
Sbjct: 175 GTARYMSINTHLGR------EQSRRDDLEALGHVFMYFLRGSLPW--------------Q 214
Query: 367 MDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLI 426
+ + +K I +++ P R + K M + + ++
Sbjct: 215 GLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFS 274
Query: 427 KLA 429
K+
Sbjct: 275 KVL 277
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.8 bits (245), Expect = 7e-24
Identities = 65/299 (21%), Positives = 104/299 (34%), Gaps = 35/299 (11%)
Query: 139 SLSECIGKGRYGEVWRGVWH--GENVAVKIFFSRDEASWSRET---EIYSTVLLRHENIL 193
E IG+G YG V++ GE VA+K E T EI L H NI+
Sbjct: 5 QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIV 64
Query: 194 GYIGSDMTSRNSCTQLWLVTHY--HSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHT 251
+ T +L+LV + D T + + ++ GL H
Sbjct: 65 KLLDVIHTE----NKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH- 119
Query: 252 EIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRY 311
+ HRD+K +N+L+ T G +ADFGLA ++ V T Y
Sbjct: 120 -------SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY----THEVVTLWY 168
Query: 312 MSPEILDESINMDCFESFKKADIYALGLVLWEVCRR-------TKANGIFEEYKAPYHDL 364
+PEIL DI++LG + E+ R ++ + +F ++
Sbjct: 169 RAPEILLGCKYYS-----TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD 223
Query: 365 VPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423
+ P M + V ++ + H + N R+SA
Sbjct: 224 EVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.5 bits (247), Expect = 1e-23
Identities = 61/321 (19%), Positives = 105/321 (32%), Gaps = 43/321 (13%)
Query: 119 TSGSGSGLPLLIQRTLAKQISLSECIGKGRYGEVWRGVWH--GENVAVKIFFSRDEASWS 176
T G G P + T K I G G +G V++ GE VA+K +D+ +
Sbjct: 9 TPGQGPDRPQEVSYTDTKVI------GNGSFGVVYQAKLCDSGELVAIKK-VLQDKRFKN 61
Query: 177 RETEIYSTVLLRHENILGYIGSDMTS--RNSCTQLWLVTHYHSFGSLYDHLN----RTTL 230
RE +I L H NI+ +S + L LV Y + + TL
Sbjct: 62 RELQIMRK--LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL 119
Query: 231 NHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNG-TCVIADFGLAV 289
+ + L ++H I HRDIK +N+L+ + + DFG A
Sbjct: 120 PVIYVKLYMYQLFRSLAYIH--------SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171
Query: 290 SYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVC---- 345
+ P + ++ Y +PE++ + + D+++ G VL E+
Sbjct: 172 QLVR-----GEPNVSYICSRYYRAPELIFGATDYT-----SSIDVWSAGCVLAELLLGQP 221
Query: 346 ---RRTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTK 402
+ + + E K + Q + + T
Sbjct: 222 IFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIA 281
Query: 403 VMKECWHQNANVRLSALRVKK 423
+ RL+ L
Sbjct: 282 LCSRLLEYTPTARLTPLEACA 302
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.4 bits (244), Expect = 1e-23
Identities = 65/304 (21%), Positives = 111/304 (36%), Gaps = 46/304 (15%)
Query: 142 ECIGKGRYGEVWRGVWH---GENVAVKIF-----FSRDEASWSRETEIYSTV-LLRHENI 192
IG+G YG+V++ G VA+K S RE + + H N+
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72
Query: 193 LGYIGSDMTSR-NSCTQLWLVTHYHSFG--SLYDHLNRTTLNHHQMMKICLSIVNGLVHL 249
+ SR + T+L LV + + D + + + + ++ GL L
Sbjct: 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 132
Query: 250 HTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTK 309
H+ + HRD+K +NILV ++G +ADFGLA YS + V T
Sbjct: 133 HSH--------RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV-----VVTL 179
Query: 310 RYMSPEILDESINMDCFESFKKADIYALGLVLWE-VCRRTKANG---------IFEEYKA 359
Y +PE+L +S D++++G + E R+ G I +
Sbjct: 180 WYRAPEVLLQSSYA------TPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL 233
Query: 360 PYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSAL 419
P + P D + Q + + + ++ +C N R+SA
Sbjct: 234 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTD-IDELGKD----LLLKCLTFNPAKRISAY 288
Query: 420 RVKK 423
Sbjct: 289 SALS 292
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.6 bits (242), Expect = 2e-23
Identities = 57/319 (17%), Positives = 115/319 (36%), Gaps = 65/319 (20%)
Query: 137 QISLSECIGKGRYGEVWRGVWHGEN-------VAVKIFFSRDEASWSRETEIYSTVLLR- 188
++ L + +G+G +G+V G + VAVK+ S R +L+
Sbjct: 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 73
Query: 189 --HENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLN-----------------RTT 229
H N++ +G+ L ++ + FG+L +L +
Sbjct: 74 GHHLNVVNLLGACTKPGG---PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 130
Query: 230 LNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAV 289
L ++ + G+ L HRD+ ++NIL+ I DFGLA
Sbjct: 131 LTLEHLICYSFQVAKGMEFLA--------SRKCIHRDLAARNILLSEKNVVKICDFGLAR 182
Query: 290 SYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTK 349
+ + + ++M+PE + + + ++D+++ G++LWE+
Sbjct: 183 DIYKDPDYVRK--GDARLPLKWMAPETIFDRVYT------IQSDVWSFGVLLWEIFSL-- 232
Query: 350 ANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWH 409
+PY + D+ + R P+ + M + M +CWH
Sbjct: 233 -------GASPYPGV-----KIDEEFCRRLKEGTRMRAPDYTTPE-----MYQTMLDCWH 275
Query: 410 QNANVRLSALRVKKTLIKL 428
+ R + + + L L
Sbjct: 276 GEPSQRPTFSELVEHLGNL 294
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 97.3 bits (241), Expect = 2e-23
Identities = 60/294 (20%), Positives = 107/294 (36%), Gaps = 33/294 (11%)
Query: 142 ECIGKGRYGEVWRGVWH-GENVAVKIFFSRDEASWSRET---EIYSTVLLRHENILGYIG 197
E IG+G YG V++ + GE A+K E T EI L+H NI+
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 198 SDMTSRNSCTQLWLVTHYHSFGSLYDHL-NRTTLNHHQMMKICLSIVNGLVHLHTEIFGT 256
T + L LV + L L ++NG+ + H
Sbjct: 68 VIHTKKR----LVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH------ 117
Query: 257 QGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEI 316
+ HRD+K +N+L+ G IADFGLA ++ K + T Y +P++
Sbjct: 118 --DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY----THEIVTLWYRAPDV 171
Query: 317 LDESINMDCFESFKKADIYALGLVLWEVCR-------RTKANGIFEEYKAPYHDLVPMDP 369
L S DI+++G + E+ ++A+ + ++ P
Sbjct: 172 LMGSKKYS-----TTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWP 226
Query: 370 SFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423
+ ++ K LP + ++ + + N R++A + +
Sbjct: 227 NVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.3 bits (244), Expect = 2e-23
Identities = 56/286 (19%), Positives = 104/286 (36%), Gaps = 51/286 (17%)
Query: 142 ECIGKGRYGEVWRGVWH--GENVAVKIFFSRDEASWSR----ETEIYSTVLLRHENILGY 195
+ +GKG +G+V G A+KI + TE RH +
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 196 IGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIF 254
+ T L V Y + G L+ HL+R + IV+ L +LH
Sbjct: 71 KYAFQTHDR----LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH---- 122
Query: 255 GTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSP 314
+ +RDIK +N+++ +G I DFGL M GT Y++P
Sbjct: 123 ----SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM----KTFCGTPEYLAP 174
Query: 315 EILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFDDM 374
E+L+++ + + D + LG+V++E+ + P+++ D
Sbjct: 175 EVLEDN------DYGRAVDWWGLGVVMYEMMCG----------RLPFYN--------QDH 210
Query: 375 RKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALR 420
++ + + R +S + ++ ++ RL
Sbjct: 211 ERLFELILMEEIRFPRTLSPEAKS----LLAGLLKKDPKQRLGGGP 252
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 97.2 bits (241), Expect = 2e-23
Identities = 48/296 (16%), Positives = 94/296 (31%), Gaps = 43/296 (14%)
Query: 140 LSECIGKGRYGEVWRGVWH--GENVAVKIFFSR-DEASWSRETEIYSTVLLRHENILGYI 196
L IG G +G+++ G GE VA+K+ + E++IY +++ + I
Sbjct: 11 LGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYK--MMQGGVGIPTI 68
Query: 197 GSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRT-TLNHHQMMKICLSIVNGLVHLHTEIFG 255
+ +V + + ++ + +++ + ++H
Sbjct: 69 RWCGAEGD---YNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH----- 120
Query: 256 TQGKPAIAHRDIKSKNILV---KTNGTCVIADFGLAVSYSQLSNKMDIPPNPR---VGTK 309
HRD+K N L+ K I DFGLA Y IP GT
Sbjct: 121 ---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 177
Query: 310 RYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDP 369
RY S E ++ D+ +LG VL +
Sbjct: 178 RYASINTHLGI------EQSRRDDLESLGYVLMYFNLGSLPW--------------QGLK 217
Query: 370 SFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTL 425
+ +K I +++ P + + + C + + +++
Sbjct: 218 AATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLF 273
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.6 bits (239), Expect = 4e-23
Identities = 53/295 (17%), Positives = 101/295 (34%), Gaps = 33/295 (11%)
Query: 142 ECIGKGRYGEVWRGVWH--GENVAVKIFFSRDEASWSRET---EIYSTVLLRHENILGYI 196
E IG+G YG V++ E VA+K D+ + EI L+H+NI+
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 197 GSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGT 256
+ + Y L+ + ++ GL H
Sbjct: 68 DVLHSDKKLTLVFEFCDQDLKK---YFDSCNGDLDPEIVKSFLFQLLKGLGFCH------ 118
Query: 257 QGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEI 316
+ HRD+K +N+L+ NG +A+FGLA ++ + V T Y P++
Sbjct: 119 --SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY----SAEVVTLWYRPPDV 172
Query: 317 LDESINMDCFESFKKADIYALGLVLWEVCRRTK----ANGIFEEYKAPYHDLVPMDPSFD 372
L + D+++ G + E+ + N + ++ K + L
Sbjct: 173 LFGAKLYS-----TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQW 227
Query: 373 DMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKE----CWHQNANVRLSALRVKK 423
+ + P+ P + + + ++ N R+SA +
Sbjct: 228 PSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 96.7 bits (240), Expect = 5e-23
Identities = 47/287 (16%), Positives = 98/287 (34%), Gaps = 52/287 (18%)
Query: 140 LSECIGKGRYGEVWRGVWH--GENVAVKIF----FSRDEASWSRETEIYSTVLLRHENIL 193
+ +G G +G V G A+K+ R + E ++ H I+
Sbjct: 8 ILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFII 67
Query: 194 GYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEI 253
G+ ++ + + F + + L +LH
Sbjct: 68 RMWGTFQDAQQIFMIMDYIEGGELF---SLLRKSQRFPNPVAKFYAAEVCLALEYLH--- 121
Query: 254 FGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMS 313
I +RD+K +NIL+ NG I DFG A ++ + GT Y++
Sbjct: 122 -----SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTL-------CGTPDYIA 169
Query: 314 PEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFDD 373
PE++ K D ++ G++++E+ P++D M
Sbjct: 170 PEVVSTK------PYNKSIDWWSFGILIYEMLAG----------YTPFYDSNTM----KT 209
Query: 374 MRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALR 420
K++ + + P + ++ + ++ ++ + RL L+
Sbjct: 210 YEKILNAELRFP----PFFNEDVKD----LLSRLITRDLSQRLGNLQ 248
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 94.9 bits (235), Expect = 4e-22
Identities = 48/286 (16%), Positives = 96/286 (33%), Gaps = 54/286 (18%)
Query: 142 ECIGKGRYGEVWRGVWH--GENVAVKIFFSRDEASWSR----ETEIYSTVLLRHENILGY 195
+ +G G +G V G + A+KI + + E + ++
Sbjct: 47 KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 196 IGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRT-TLNHHQMMKICLSIVNGLVHLHTEIF 254
S + L++V Y + G ++ HL R + IV +LH
Sbjct: 107 EFSFKD----NSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---- 158
Query: 255 GTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSP 314
+ +RD+K +N+L+ G + DFG A + + P ++P
Sbjct: 159 ----SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTP-------EALAP 207
Query: 315 EILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFDDM 374
EI+ K D +ALG++++E+ P+ +
Sbjct: 208 EIILSK------GYNKAVDWWALGVLIYEMAAG----------YPPFFAD-------QPI 244
Query: 375 RKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALR 420
+ I + P+ + SD + +++ + R L+
Sbjct: 245 QIYEKIVSGKVRFPSHFSSD-----LKDLLRNLLQVDLTKRFGNLK 285
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.2 bits (233), Expect = 7e-22
Identities = 55/293 (18%), Positives = 111/293 (37%), Gaps = 37/293 (12%)
Query: 142 ECIGKGRYGEVWRGVWH--GENVAVKIFFSRDEASWSRET---EIYSTVLLRHENILGYI 196
+G G YG V G VAVK ++ + E+ ++HEN++G +
Sbjct: 24 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 197 GSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRT-TLNHHQMMKICLSIVNGLVHLHTEIFG 255
+R+ + H G+ +++ + L + + I+ GL ++H
Sbjct: 84 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH----- 138
Query: 256 TQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPE 315
I HRD+K N+ V + I DFGLA D V T+ Y +PE
Sbjct: 139 ---SADIIHRDLKPSNLAVNEDCELKILDFGLA-------RHTDDEMTGYVATRWYRAPE 188
Query: 316 ILDESINMDCFESFKKADIYALGLVLWEVCRR----------TKANGIFEEYKAPYHDLV 365
I+ ++ + + DI+++G ++ E+ + I P +L+
Sbjct: 189 IMLNWMHYN-----QTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 243
Query: 366 PMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSA 418
S + + Q + + A+ ++++ +++ R++A
Sbjct: 244 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAV-DLLEKMLVLDSDKRITA 295
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.1 bits (225), Expect = 6e-21
Identities = 60/290 (20%), Positives = 113/290 (38%), Gaps = 47/290 (16%)
Query: 142 ECIGKGRYGEVWRGV-----WHGENVAVKIFFSRDEASWSRET-----EIYSTVLLRHEN 191
+ +G G YG+V+ G+ A+K+ ++ T E +R
Sbjct: 30 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89
Query: 192 ILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHL-NRTTLNHHQMMKICLSIVNGLVHLH 250
L + + +L L+ Y + G L+ HL R H++ IV L HLH
Sbjct: 90 FLVTLHYAFQTET---KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLH 146
Query: 251 TEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKR 310
K I +RDIK +NIL+ +NG V+ DFGL+ + + GT
Sbjct: 147 --------KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC---GTIE 195
Query: 311 YMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPS 370
YM+P+I+ + K D ++LG++++E+ +P+ +
Sbjct: 196 YMAPDIVRGGDSGHD----KAVDWWSLGVLMYELLTG----------ASPFTVDGEKNSQ 241
Query: 371 FDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALR 420
+ R+++ + P + +S + +++ ++ RL
Sbjct: 242 AEISRRILKSEPPYP----QEMSALAKD----LIQRLLMKDPKKRLGCGP 283
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.7 bits (224), Expect = 9e-21
Identities = 52/293 (17%), Positives = 106/293 (36%), Gaps = 37/293 (12%)
Query: 142 ECIGKGRYGEVWRGVWH--GENVAVKIFFSRDEASWSRET---EIYSTVLLRHENILGYI 196
+ +G G YG V V G VA+K + ++ + E+ +RHEN++G +
Sbjct: 24 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLL 83
Query: 197 GSDMTSRNSCTQLWLVTHYHSFGSLYDHL-NRTTLNHHQMMKICLSIVNGLVHLHTEIFG 255
G+ L L ++ + ++ GL ++H
Sbjct: 84 DVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIH----- 138
Query: 256 TQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPE 315
I HRD+K N+ V + I DFGLA V T+ Y +PE
Sbjct: 139 ---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGY-------VVTRWYRAPE 188
Query: 316 ILDESINMDCFESFKKADIYALGLVLWEVCRRTK----------ANGIFEEYKAPYHDLV 365
++ + + DI+++G ++ E+ I + P + V
Sbjct: 189 VILNWMRYT-----QTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 243
Query: 366 PMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSA 418
S + + + + +++++ A+ ++++ +A R++A
Sbjct: 244 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAV-NLLEKMLVLDAEQRVTA 295
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.2 bits (207), Expect = 2e-18
Identities = 51/223 (22%), Positives = 84/223 (37%), Gaps = 28/223 (12%)
Query: 133 TLAKQISLSECIGKGRYGEVWRGVWH--GENVAVKIF---FSRDEASWSRETEIYSTVLL 187
T+ K+ + IG G G V NVA+K F + E+ +
Sbjct: 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV 73
Query: 188 RHENILGYIGS--DMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNG 245
H+NI+ + + ++LV H +M + ++ G
Sbjct: 74 NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD--HERMSYLLYQMLCG 131
Query: 246 LVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPR 305
+ HLH I HRD+K NI+VK++ T I DFGLA + P
Sbjct: 132 IKHLH--------SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-----SFMMTPY 178
Query: 306 VGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRT 348
V T+ Y +PE + + DI+++G ++ E+ R
Sbjct: 179 VVTRYYRAPE------VILGMGYKENVDIWSVGCIMGEMVRHK 215
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 76.2 bits (186), Expect = 8e-16
Identities = 36/219 (16%), Positives = 74/219 (33%), Gaps = 29/219 (13%)
Query: 140 LSECIGKGRYGEVWRGVWH--GENVAVKIFFSRDEASWSRETEIYSTVLLRHENI----- 192
L +G G + VW +VA+KI + + E EI + +
Sbjct: 17 LVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDS 76
Query: 193 --------LGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVN 244
L + + + +L + + +I ++
Sbjct: 77 MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLL 136
Query: 245 GLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNP 304
GL ++H + I H DIK +N+L++ + + ++ + D
Sbjct: 137 GLDYMHR-------RCGIIHTDIKPENVLMEIVDSPEN-LIQIKIADLGNACWYDEHYTN 188
Query: 305 RVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWE 343
+ T+ Y SPE+L + ADI++ +++E
Sbjct: 189 SIQTREYRSPEVLLGA------PWGCGADIWSTACLIFE 221
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 66.0 bits (160), Expect = 3e-13
Identities = 21/166 (12%), Positives = 43/166 (25%), Gaps = 27/166 (16%)
Query: 139 SLSECIGKGRYGEVWRGVWH-GENVAVKIF-----------FSRDEASWSRETEIYSTVL 186
++ + +G+G+ V+ VK RD +
Sbjct: 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSAR 62
Query: 187 LRHENILGYIGSDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGL 246
+ G + + ++ LY ++ I+ +
Sbjct: 63 NEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRV------RVENPDEVLDMILEEV 116
Query: 247 VHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYS 292
+ I H D+ N+LV + I DF +V
Sbjct: 117 AKFY--------HRGIVHGDLSQYNVLV-SEEGIWIIDFPQSVEVG 153
|
| >d2h62c1 g.7.1.3 (C:34-117) BMP receptor Ia ectodomain {Human (Homo sapiens) [TaxId: 9606]} Length = 84 | Back information, alignment and structure |
|---|
class: Small proteins fold: Snake toxin-like superfamily: Snake toxin-like family: Extracellular domain of cell surface receptors domain: BMP receptor Ia ectodomain species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.5 bits (84), Expect = 6e-04
Identities = 11/31 (35%), Positives = 14/31 (45%), Gaps = 2/31 (6%)
Query: 4 CHSVNV--GQFTIQCCDGDFCNNGSFPILPP 32
C + TI+CC + CN P LPP
Sbjct: 54 CKDSPKAQLRRTIECCRTNLCNQYLQPTLPP 84
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 443 | |||
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.91 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.25 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.05 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.25 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.35 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.29 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.79 | |
| d2h62c1 | 84 | BMP receptor Ia ectodomain {Human (Homo sapiens) [ | 86.5 | |
| d1btea_ | 96 | Type II activin receptor {Mouse (Mus musculus) [Ta | 84.92 |
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-60 Score=448.96 Aligned_cols=298 Identities=62% Similarity=1.061 Sum_probs=254.4
Q ss_pred hccccccceeeeecCeEEEEEEECCceeEEEEeeccCccchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEeeec
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVWHGENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVTH 214 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e 214 (443)
.++|.+.+.||+|+||.||+|+++|+.||||++..+......+|.|+..+..++|||||+++|++.+.......+++|||
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~E 81 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEe
Confidence 36788999999999999999999999999999977766667778888887779999999999999887665567899999
Q ss_pred ccCcccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCccccccc
Q psy14889 215 YHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQL 294 (443)
Q Consensus 215 ~~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~~~~ 294 (443)
|+++|+|.+++++..+++.+++.++.|+|.||+|||+...+..+.++|+||||||+||||+.++.+||+|||+++.....
T Consensus 82 y~~~g~L~~~l~~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~ 161 (303)
T d1vjya_ 82 YHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSA 161 (303)
T ss_dssp CCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETT
T ss_pred cccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccCC
Confidence 99999999999998999999999999999999999986544445679999999999999999999999999999877654
Q ss_pred CCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCChHHH
Q psy14889 295 SNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFDDM 374 (443)
Q Consensus 295 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~~~~~ 374 (443)
............||+.|+|||++.+........++.++|||||||+||||+||..+++..+....|+.............
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (303)
T d1vjya_ 162 TDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241 (303)
T ss_dssp TTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHH
T ss_pred CcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHH
Confidence 44333334556899999999998765332222356799999999999999999988887777788888887777788888
Q ss_pred HhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhhcc
Q psy14889 375 RKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLACAD 432 (443)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~~~ 432 (443)
.........+|.++..+...+.+..+.+|+.+||+.||++|||+.||++.|+++.++.
T Consensus 242 ~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 299 (303)
T d1vjya_ 242 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp HHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhc
Confidence 8888777788888877777778888999999999999999999999999999998654
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-56 Score=419.97 Aligned_cols=264 Identities=30% Similarity=0.450 Sum_probs=206.3
Q ss_pred hccccccceeeeecCeEEEEEEECCceeEEEEeeccCc---cchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEe
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVWHGENVAVKIFFSRDE---ASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWL 211 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~---~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~l 211 (443)
.++|++.+.||+|+||+||+|++++ .||||++..... .......|+..+..++|||||+++|++..+ .+++
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~-----~~~l 80 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAP-----QLAI 80 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECSS-----SCEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEECC-EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEecc-----EEEE
Confidence 4789999999999999999998765 599999864322 122334677777779999999999987543 3689
Q ss_pred eecccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcc
Q psy14889 212 VTHYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAV 289 (443)
Q Consensus 212 v~e~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~ 289 (443)
||||+++|+|.+++.. ..+++.+++.++.|||+||+|||++ +||||||||+|||++.++.+||+|||+|+
T Consensus 81 v~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~--------~ivHrDlKp~NiLl~~~~~~Kl~DFGla~ 152 (276)
T d1uwha_ 81 VTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK--------SIIHRDLKSNNIFLHEDLTVKIGDFGLAT 152 (276)
T ss_dssp EEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHT--------TCCCSCCCGGGEEEETTSSEEECCCCCSC
T ss_pred EEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcC--------CEeccccCHHHEEEcCCCCEEEcccccee
Confidence 9999999999999953 5699999999999999999999998 99999999999999999999999999998
Q ss_pred cccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCC
Q psy14889 290 SYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDP 369 (443)
Q Consensus 290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~ 369 (443)
......... ......||+.|||||++.+.... .++.++|||||||++|||+|| +.||.+..
T Consensus 153 ~~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~---~~~~~sDiwS~Gv~l~el~tg----------~~Pf~~~~---- 213 (276)
T d1uwha_ 153 VKSRWSGSH--QFEQLSGSILWMAPEVIRMQDKN---PYSFQSDVYAFGIVLYELMTG----------QLPYSNIN---- 213 (276)
T ss_dssp C--------------CCCCGGGCCHHHHTTCSSC---CCCHHHHHHHHHHHHHHHHHS----------SCTTTTCC----
T ss_pred eccccCCcc--cccccccCcccCCHHHHhcccCC---CCCchhhhhhhHHHHHHHHHC----------CCCCCCCC----
Confidence 765432221 22445799999999999754221 567899999999999999999 77887642
Q ss_pred ChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhhccc
Q psy14889 370 SFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLACADM 433 (443)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~~~~ 433 (443)
....+...+......+..+. ....+++++.+||.+||+.||++|||+.||++.|+.+.++.+
T Consensus 214 ~~~~~~~~~~~~~~~p~~~~--~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~P 275 (276)
T d1uwha_ 214 NRDQIIFMVGRGYLSPDLSK--VRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275 (276)
T ss_dssp CHHHHHHHHHHTSCCCCGGG--SCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred hHHHHHHHHhcCCCCCcchh--ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcCC
Confidence 23344444443333333221 124577889999999999999999999999999999987654
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-56 Score=413.80 Aligned_cols=255 Identities=23% Similarity=0.410 Sum_probs=199.5
Q ss_pred ccccccceeeeecCeEEEEEEE-CCceeEEEEeeccCccchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEeeec
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW-HGENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVTH 214 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e 214 (443)
++|++.+.||+|+||+||+|.+ +++.||||++............|+..+..++|||||+++|++.... .+++|||
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~----~~~lv~E 80 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA----PICLVFE 80 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS----SCEEEEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCC----ceEEEEE
Confidence 6799999999999999999998 5778999998765544445566777777799999999999998764 3699999
Q ss_pred ccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCccccc
Q psy14889 215 YHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYS 292 (443)
Q Consensus 215 ~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~~ 292 (443)
|+++|+|.+++.. ..+++..++.++.|||.||+|||+. +|+||||||+|||+++++.+||+|||+|+...
T Consensus 81 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~--------~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 152 (263)
T d1sm2a_ 81 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA--------CVIHRDLAARNCLVGENQVIKVSDFGMTRFVL 152 (263)
T ss_dssp CCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT--------TCCCTTCSGGGEEECGGGCEEECSCC------
T ss_pred ecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhcc--------ceeecccchhheeecCCCCeEecccchheecc
Confidence 9999999999854 5689999999999999999999998 99999999999999999999999999998765
Q ss_pred ccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCChH
Q psy14889 293 QLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFD 372 (443)
Q Consensus 293 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~~~ 372 (443)
...... .....||+.|+|||++.+. .++.++|||||||++|||+|++ ..||... ...
T Consensus 153 ~~~~~~---~~~~~gt~~y~aPE~l~~~------~~~~k~DVwS~Gvil~el~t~~---------~~~~~~~-----~~~ 209 (263)
T d1sm2a_ 153 DDQYTS---STGTKFPVKWASPEVFSFS------RYSSKSDVWSFGVLMWEVFSEG---------KIPYENR-----SNS 209 (263)
T ss_dssp ---------------CTTSCCHHHHTTC------CCCHHHHHHHHHHHHHHHHTTS---------CCTTCSC-----CHH
T ss_pred CCCcee---ecceecCcccCChHHhcCC------CCCchhhhcchHHHHHHHHHCC---------CCCCCCC-----CHH
Confidence 432221 2335789999999999876 7789999999999999999962 3334332 333
Q ss_pred HHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhhc
Q psy14889 373 DMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLACA 431 (443)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~~ 431 (443)
++...+.. ..++..| ..+++++.+|+.+||+.||++|||++||++.|+++.++
T Consensus 210 ~~~~~i~~-~~~~~~p-----~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 210 EVVEDIST-GFRLYKP-----RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp HHHHHHHH-TCCCCCC-----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHh-cCCCCCc-----cccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 44444332 2333333 34667899999999999999999999999999999764
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-55 Score=408.60 Aligned_cols=255 Identities=23% Similarity=0.369 Sum_probs=205.8
Q ss_pred hccccccceeeeecCeEEEEEEEC-CceeEEEEeeccCccchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEeee
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVWH-GENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVT 213 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv~ 213 (443)
.++|++.+.||+|+||.||+|.++ ++.||||++............|+..+..++|||||+++|++.+. .+++||
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-----~~~iv~ 86 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE-----PIYIIT 86 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SCEEEE
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeeccC-----CeEEEE
Confidence 478999999999999999999995 67899999876554444455666667779999999999987553 258999
Q ss_pred cccCcccHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCccc
Q psy14889 214 HYHSFGSLYDHLNR---TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVS 290 (443)
Q Consensus 214 e~~~~gsL~~~l~~---~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~ 290 (443)
||+++|+|.+++.. ..+++..++.++.||++||.|||++ +|+||||||+||||++++.+||+|||+|+.
T Consensus 87 Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~--------~ivHrDiKp~NIll~~~~~~Kl~DFGla~~ 158 (272)
T d1qpca_ 87 EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER--------NYIHRDLRAANILVSDTLSCKIADFGLARL 158 (272)
T ss_dssp ECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT--------TEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CcccCccchhheeeecccceeeccccceEE
Confidence 99999999998854 3699999999999999999999998 999999999999999999999999999987
Q ss_pred ccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCC
Q psy14889 291 YSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPS 370 (443)
Q Consensus 291 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~ 370 (443)
+....... .....||+.|||||++.++ .++.++|||||||++|||+|| ..|+... ..
T Consensus 159 ~~~~~~~~---~~~~~gt~~y~APE~~~~~------~~~~~sDvwS~Gvvl~ellt~----------~~~~~~~----~~ 215 (272)
T d1qpca_ 159 IEDNEYTA---REGAKFPIKWTAPEAINYG------TFTIKSDVWSFGILLTEIVTH----------GRIPYPG----MT 215 (272)
T ss_dssp CSSSCEEC---CTTCCCCTTTSCHHHHHHC------EECHHHHHHHHHHHHHHHHTT----------TCCSSTT----CC
T ss_pred ccCCcccc---ccccCCcccccChHHHhCC------CCCchhhhhhhHHHHHHHHhC----------CCCCCCC----CC
Confidence 75432221 2345789999999999876 667899999999999999997 3333322 12
Q ss_pred hHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhhc
Q psy14889 371 FDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLACA 431 (443)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~~ 431 (443)
..++...+. ...++..| ..+++++.+|+.+||+.||++|||+++|++.|+++-.+
T Consensus 216 ~~~~~~~i~-~~~~~~~p-----~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 216 NPEVIQNLE-RGYRMVRP-----DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp HHHHHHHHH-TTCCCCCC-----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHH-hcCCCCCc-----ccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 333333332 23344444 34677899999999999999999999999999987543
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.3e-55 Score=415.18 Aligned_cols=262 Identities=24% Similarity=0.378 Sum_probs=199.0
Q ss_pred ccccccceeeeecCeEEEEEEEC--Cc---eeEEEEeeccCcc--chHHHHHHHHHHhccCCCceeeeeeccccCCcccE
Q psy14889 136 KQISLSECIGKGRYGEVWRGVWH--GE---NVAVKIFFSRDEA--SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQ 208 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~~--~~---~vAvK~~~~~~~~--~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~ 208 (443)
++|++.+.||+|+||+||+|.+. ++ .||||.+...... ......|+..+..++|||||+++|++.+.. .
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~----~ 101 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKST----P 101 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS----S
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC----E
Confidence 67899999999999999999983 32 5888887553322 223456777777799999999999997764 4
Q ss_pred EEeeecccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecC
Q psy14889 209 LWLVTHYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFG 286 (443)
Q Consensus 209 ~~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfG 286 (443)
+++|||||++|+|.+++.. ..+++.+++.++.|||+||.|||++ +|+||||||+||||+.++++||+|||
T Consensus 102 ~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~--------~iiHrDlKp~NILl~~~~~~Kl~DFG 173 (299)
T d1jpaa_ 102 VMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADM--------NYVHRDLAARNILVNSNLVCKVSDFG 173 (299)
T ss_dssp CEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT--------TCCCSCCCGGGEEECTTCCEEECCC-
T ss_pred EEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhC--------CCccCccccceEEECCCCcEEECCcc
Confidence 7999999999999998865 4699999999999999999999998 99999999999999999999999999
Q ss_pred CcccccccCCcCC-CCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh-cccCCCcccccCCCCCCC
Q psy14889 287 LAVSYSQLSNKMD-IPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR-RTKANGIFEEYKAPYHDL 364 (443)
Q Consensus 287 la~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt-g~~~~~~~~~~~~P~~~~ 364 (443)
+|+.+........ .......||+.|||||.+.+. .++.++|||||||++|||+| | ..||.+.
T Consensus 174 la~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~------~~~~~sDvwS~Gvvl~el~t~g----------~~Pf~~~ 237 (299)
T d1jpaa_ 174 LSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYR------KFTSASDVWSYGIVMWEVMSYG----------ERPYWDM 237 (299)
T ss_dssp ----------------------CGGGSCHHHHHSC------CCCHHHHHHHHHHHHHHHHTTS----------CCTTTTC
T ss_pred cceEccCCCCcceeeecccccCCccccCHHHHhcC------CCCcccccccchHHHHHHHhCC----------CCCCCCC
Confidence 9987765433221 112234688999999999876 77789999999999999998 6 6787764
Q ss_pred CCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhhcccccc
Q psy14889 365 VPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLACADMYIH 436 (443)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~~~~~~~ 436 (443)
...++...+.. ..++..+ ..+++++.+|+.+||+.||++|||+.||++.|+++.+....++
T Consensus 238 -----~~~~~~~~i~~-~~~~~~~-----~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~p~slk 298 (299)
T d1jpaa_ 238 -----TNQDVINAIEQ-DYRLPPP-----MDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNPNSLK 298 (299)
T ss_dssp -----CHHHHHHHHHT-TCCCCCC-----TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGGGT
T ss_pred -----CHHHHHHHHHc-CCCCCCC-----ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcChhhCC
Confidence 33444444432 2333333 3467889999999999999999999999999999988765543
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-54 Score=410.89 Aligned_cols=247 Identities=26% Similarity=0.430 Sum_probs=203.4
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc-chHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEee
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA-SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLV 212 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~-~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv 212 (443)
++|++.+.||+|+||+||+|.. +|+.||||++...... ......|+..+..++|||||++++++.+. ..+|+|
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~----~~~~iv 95 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG----DELWVV 95 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEET----TEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEEC----CEEEEE
Confidence 5799999999999999999997 5999999998654332 22334566666679999999999999876 458999
Q ss_pred ecccCcccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCccccc
Q psy14889 213 THYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYS 292 (443)
Q Consensus 213 ~e~~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~~ 292 (443)
|||+++|+|.+++.+..+++.++..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+|+.+.
T Consensus 96 mEy~~gg~L~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~--------~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~ 167 (293)
T d1yhwa1 96 MEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN--------QVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 167 (293)
T ss_dssp EECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT--------TEECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEecCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHC--------CCcccCCcHHHeEECCCCcEeeccchhheeec
Confidence 9999999999999888999999999999999999999999 99999999999999999999999999998765
Q ss_pred ccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCChH
Q psy14889 293 QLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFD 372 (443)
Q Consensus 293 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~~~ 372 (443)
..... .....||+.|+|||++.+. .++.++|||||||++|||+|| ..||.+.. ..+
T Consensus 168 ~~~~~----~~~~~gt~~Y~aPE~~~~~------~~~~~~DiwSlGvilyemltG----------~~Pf~~~~----~~~ 223 (293)
T d1yhwa1 168 PEQSK----RSTMVGTPYWMAPEVVTRK------AYGPKVDIWSLGIMAIEMIEG----------EPPYLNEN----PLR 223 (293)
T ss_dssp STTCC----BCCCCSCGGGCCHHHHSSS------CBCTHHHHHHHHHHHHHHHHS----------SCTTTTSC----HHH
T ss_pred ccccc----ccccccCCCccChhhhcCC------CCCchhceehHhHHHHHHhhC----------CCCCCCCC----HHH
Confidence 43222 2445799999999999876 677899999999999999999 77886531 223
Q ss_pred HHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 373 DMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
.+........ +.++ .+..+++++.+||.+||+.||++|||+.|+++
T Consensus 224 ~~~~~~~~~~--~~~~---~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 224 ALYLIATNGT--PELQ---NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp HHHHHHHHCS--CCCS---SGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred HHHHHHhCCC--CCCC---CcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 3333332222 2221 12456788999999999999999999999875
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.8e-55 Score=413.78 Aligned_cols=258 Identities=21% Similarity=0.359 Sum_probs=210.9
Q ss_pred hhhccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEE
Q psy14889 133 TLAKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLW 210 (443)
Q Consensus 133 ~~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~ 210 (443)
...++|++.+.||+|+||+||+|.+ +|+.||||++............|+..+..++|||||+++|++.+.. .++
T Consensus 14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~----~~~ 89 (287)
T d1opja_ 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP----PFY 89 (287)
T ss_dssp CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS----SCE
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCC----eeE
Confidence 3447899999999999999999998 5889999998765544444556677777799999999999998764 369
Q ss_pred eeecccCcccHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCC
Q psy14889 211 LVTHYHSFGSLYDHLNR---TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGL 287 (443)
Q Consensus 211 lv~e~~~~gsL~~~l~~---~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGl 287 (443)
+||||+++|+|.+++.+ ..+++..++.++.|||+||+|||++ +|+||||||+|||+++++.+||+|||+
T Consensus 90 iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~--------~iiHrDlKp~NILl~~~~~~Kl~DFG~ 161 (287)
T d1opja_ 90 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK--------NFIHRDLAARNCLVGENHLVKVADFGL 161 (287)
T ss_dssp EEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT--------TCCCSCCSGGGEEECGGGCEEECCCCC
T ss_pred EEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHC--------CcccCccccCeEEECCCCcEEEccccc
Confidence 99999999999999854 5789999999999999999999998 999999999999999999999999999
Q ss_pred cccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCC
Q psy14889 288 AVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPM 367 (443)
Q Consensus 288 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~ 367 (443)
|+......... .....||+.|+|||++.+. .++.++|||||||++|||++| ..||...
T Consensus 162 a~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~------~~~~k~DiwS~Gv~l~ell~~----------~~p~~~~--- 219 (287)
T d1opja_ 162 SRLMTGDTYTA---HAGAKFPIKWTAPESLAYN------KFSIKSDVWAFGVLLWEIATY----------GMSPYPG--- 219 (287)
T ss_dssp TTTCCSSSSEE---ETTEEECGGGCCHHHHHHC------CCSHHHHHHHHHHHHHHHHTT----------SCCSSTT---
T ss_pred eeecCCCCcee---eccccccccccChHHHcCC------CCCchhhhhhHHHHHHHHHhC----------CCCCCCc---
Confidence 98765433221 2334688999999999876 778899999999999999998 4454332
Q ss_pred CCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhhc
Q psy14889 368 DPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLACA 431 (443)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~~ 431 (443)
.....+.+.+.. ..++..+ ..+++++.+|+.+||+.||++|||+.||++.|+.+.+.
T Consensus 220 -~~~~~~~~~i~~-~~~~~~~-----~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 220 -IDLSQVYELLEK-DYRMERP-----EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp -CCHHHHHHHHHT-TCCCCCC-----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred -chHHHHHHHHhc-CCCCCCC-----ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 133444444432 3334444 34677899999999999999999999999999988654
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-54 Score=406.55 Aligned_cols=252 Identities=22% Similarity=0.343 Sum_probs=190.1
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccc---hHHHHHHHHHHhccCCCceeeeeeccccCCcccEEE
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEAS---WSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLW 210 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~---~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~ 210 (443)
++|++.+.||+|+||+||+|+. +|+.||||++....... ...+.|+..+..++|||||++++++.+... ..+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~--~~~~ 81 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTN--TTLY 81 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC------CEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCC--CEEE
Confidence 6899999999999999999998 58999999986543222 223467777777999999999999876433 3579
Q ss_pred eeecccCcccHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEec
Q psy14889 211 LVTHYHSFGSLYDHLNR-----TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADF 285 (443)
Q Consensus 211 lv~e~~~~gsL~~~l~~-----~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~Df 285 (443)
+||||+++|+|.+++.+ ..+++..++.++.||+.||.|||+.. ....+|+||||||+|||++.++.+||+||
T Consensus 82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~---~~~~~IiHrDiKp~NIll~~~~~vkl~DF 158 (269)
T d2java1 82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS---DGGHTVLHRDLKPANVFLDGKQNVKLGDF 158 (269)
T ss_dssp EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHC---C---------CCGGGEEECTTSCEEECCH
T ss_pred EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhc---CCCCCEEeCcCchhhcCcCCCCcEEEeec
Confidence 99999999999999853 56999999999999999999999871 00124999999999999999999999999
Q ss_pred CCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCC
Q psy14889 286 GLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLV 365 (443)
Q Consensus 286 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~ 365 (443)
|+|+.+...... .....||+.|||||++.+. .++.++|||||||++|||+|| ..||...
T Consensus 159 G~a~~~~~~~~~----~~~~~gt~~Y~APE~l~~~------~~~~~~DIwSlGvilyel~tg----------~~Pf~~~- 217 (269)
T d2java1 159 GLARILNHDTSF----AKAFVGTPYYMSPEQMNRM------SYNEKSDIWSLGCLLYELCAL----------MPPFTAF- 217 (269)
T ss_dssp HHHHHC---------------CCCSCCCHHHHTTC------CCCHHHHHHHHHHHHHHHHHS----------SCSCCCS-
T ss_pred cceeecccCCCc----cccCCCCcccCCHHHHcCC------CCChHHHHHhhCHHHHHHhhC----------CCCCCCC-
Confidence 999877543222 2346899999999999876 678899999999999999999 7777653
Q ss_pred CCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 366 PMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
...++...+... ..+.++ ..+++++.+|+.+||+.||++|||+.|+++
T Consensus 218 ----~~~~~~~~i~~~-~~~~~~-----~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 218 ----SQKELAGKIREG-KFRRIP-----YRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp ----SHHHHHHHHHHT-CCCCCC-----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----CHHHHHHHHHcC-CCCCCC-----cccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 333444433322 223333 336678999999999999999999999875
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-54 Score=399.93 Aligned_cols=250 Identities=24% Similarity=0.439 Sum_probs=208.8
Q ss_pred ccccccceeeeecCeEEEEEEE-CCceeEEEEeeccCccchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEeeec
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW-HGENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVTH 214 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e 214 (443)
++|++.+.||+|+||+||+|++ +++.||||+++..........+|+..+..++||||++++|++.+.. .+++|||
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~----~~~iv~E 79 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQR----PIFIITE 79 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSS----SEEEEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCC----ceEEEEE
Confidence 6899999999999999999999 4668999999776555455566777777799999999999998763 4799999
Q ss_pred ccCcccHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCccccc
Q psy14889 215 YHSFGSLYDHLN--RTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYS 292 (443)
Q Consensus 215 ~~~~gsL~~~l~--~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~~ 292 (443)
|+++|+|.+++. ...+++..+.+++.|+++||+|||+. +|+||||||+|||+++++.+||+|||+++.+.
T Consensus 80 y~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~--------~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~ 151 (258)
T d1k2pa_ 80 YMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK--------QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL 151 (258)
T ss_dssp CCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT--------TBCCSCCSGGGEEECTTCCEEECCCSSCCBCS
T ss_pred ccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhc--------CcccccccceeEEEcCCCcEEECcchhheecc
Confidence 999999999974 46799999999999999999999998 99999999999999999999999999998765
Q ss_pred ccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh-cccCCCcccccCCCCCCCCCCCCCh
Q psy14889 293 QLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR-RTKANGIFEEYKAPYHDLVPMDPSF 371 (443)
Q Consensus 293 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt-g~~~~~~~~~~~~P~~~~~~~~~~~ 371 (443)
..... ......||+.|+|||.+.+. .++.++|||||||++|||+| | ..||.+. ..
T Consensus 152 ~~~~~---~~~~~~~t~~y~aPE~~~~~------~~~~ksDiwS~G~~l~el~t~g----------~~Pf~~~-----~~ 207 (258)
T d1k2pa_ 152 DDEYT---SSVGSKFPVRWSPPEVLMYS------KFSSKSDIWAFGVLMWEIYSLG----------KMPYERF-----TN 207 (258)
T ss_dssp SSSCC---CCCCSCCCGGGCCHHHHHHC------CCCHHHHHHHHHHHHHHHHTTS----------CCTTTTS-----CH
T ss_pred CCCce---eecccCCCCCcCCcHHhcCC------CCCcceeecccchhhHhHHhcC----------CCCCCCC-----CH
Confidence 43322 22345799999999999876 77889999999999999998 6 6788764 33
Q ss_pred HHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHH
Q psy14889 372 DDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIK 427 (443)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 427 (443)
.++...+.. ..++..| ..++.++.+||.+||+.||++|||+++|++.|.+
T Consensus 208 ~~~~~~i~~-~~~~~~p-----~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 208 SETAEHIAQ-GLRLYRP-----HLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp HHHHHHHHT-TCCCCCC-----TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred HHHHHHHHh-CCCCCCc-----ccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 445444432 3344444 3466789999999999999999999999999864
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-54 Score=404.99 Aligned_cols=249 Identities=26% Similarity=0.390 Sum_probs=196.8
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc--chHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEe
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA--SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWL 211 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~--~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~l 211 (443)
++|++.+.||+|+||+||+|++ +|+.||||++...... ....+.|+..+..++|||||++++++.+. ..+|+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~----~~~~i 80 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG----NIQYL 80 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEET----TEEEE
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccC----ceeEE
Confidence 6899999999999999999998 5899999998654321 22234566667779999999999999876 46899
Q ss_pred eecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCccc
Q psy14889 212 VTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVS 290 (443)
Q Consensus 212 v~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~ 290 (443)
||||+++|+|.+++.+ ..+++.++..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+.
T Consensus 81 vmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~--------~IiHrDiKp~NILl~~~~~~KL~DFG~a~~ 152 (271)
T d1nvra_ 81 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI--------GITHRDIKPENLLLDERDNLKISDFGLATV 152 (271)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHT--------TEECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc--------CCccCcccHHHEEECCCCCEEEccchhhee
Confidence 9999999999999965 5799999999999999999999999 999999999999999999999999999987
Q ss_pred ccccCCcCCCCCCCcccccCcccccccccccccCcCCC-CCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCC
Q psy14889 291 YSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFES-FKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDP 369 (443)
Q Consensus 291 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~-~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~ 369 (443)
+....... .....+||+.|||||++.+. .+ +.++|||||||++|||+|| ..||.....
T Consensus 153 ~~~~~~~~--~~~~~~GT~~Y~APE~~~~~------~~~~~~~DiwSlGvilyeml~G----------~~pf~~~~~--- 211 (271)
T d1nvra_ 153 FRYNNRER--LLNKMCGTLPYVAPELLKRR------EFHAEPVDVWSCGIVLTAMLAG----------ELPWDQPSD--- 211 (271)
T ss_dssp CEETTEEC--CBCCCCSCGGGSCTHHHHCS------SBCHHHHHHHHHHHHHHHHHHS----------SCSCSSSST---
T ss_pred eccCCccc--cccceeeCcCccCHhHhcCC------CCCCCceeeeHhHHHHHHHHhC----------CCCCCCCCh---
Confidence 65432211 12456899999999999876 33 4689999999999999999 677765321
Q ss_pred ChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 370 SFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
.......... . ....+ . ...+++++.+|+.+||+.||++|||++|+++
T Consensus 212 ~~~~~~~~~~-~--~~~~~-~--~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 212 SCQEYSDWKE-K--KTYLN-P--WKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp TSHHHHHHHT-T--CTTST-T--GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHHHHhc-C--CCCCC-c--cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1112222211 1 11111 1 1345678999999999999999999999865
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-54 Score=404.40 Aligned_cols=255 Identities=20% Similarity=0.329 Sum_probs=204.8
Q ss_pred ccccccce-eeeecCeEEEEEEEC----CceeEEEEeeccCcc--chHHHHHHHHHHhccCCCceeeeeeccccCCcccE
Q psy14889 136 KQISLSEC-IGKGRYGEVWRGVWH----GENVAVKIFFSRDEA--SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQ 208 (443)
Q Consensus 136 ~~~~~~~~-lG~G~fg~Vy~~~~~----~~~vAvK~~~~~~~~--~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~ 208 (443)
++|.+.+. ||+|+||+||+|.+. +..||||++...... .....+|+..+.+++|||||+++|++.+. .
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-----~ 82 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-----A 82 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-----S
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-----e
Confidence 56778885 999999999999873 447999998654322 22334566666779999999999998643 2
Q ss_pred EEeeecccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecC
Q psy14889 209 LWLVTHYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFG 286 (443)
Q Consensus 209 ~~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfG 286 (443)
+++||||+++|+|.+++.. ..+++.+++.++.|||.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 83 ~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~--------~iiHrDlKp~Nill~~~~~~Kl~DFG 154 (285)
T d1u59a_ 83 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK--------NFVHRDLAARNVLLVNRHYAKISDFG 154 (285)
T ss_dssp EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT--------TEECCCCSGGGEEEEETTEEEECCCT
T ss_pred EEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhC--------CeecCcCchhheeeccCCceeeccch
Confidence 6899999999999999853 5799999999999999999999998 99999999999999999999999999
Q ss_pred CcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh-cccCCCcccccCCCCCCCC
Q psy14889 287 LAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR-RTKANGIFEEYKAPYHDLV 365 (443)
Q Consensus 287 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt-g~~~~~~~~~~~~P~~~~~ 365 (443)
+|+.+....... .......||+.|+|||++.++ .++.++|||||||++|||+| | ..||.+..
T Consensus 155 la~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~------~~~~ksDVwS~Gv~l~E~lt~G----------~~Pf~~~~ 217 (285)
T d1u59a_ 155 LSKALGADDSYY-TARSAGKWPLKWYAPECINFR------KFSSRSDVWSYGVTMWEALSYG----------QKPYKKMK 217 (285)
T ss_dssp TCEECTTCSCEE-CCCCSSCCCGGGCCHHHHHHC------EECHHHHHHHHHHHHHHHHTTS----------CCTTTTCC
T ss_pred hhhccccccccc-ccccccccCccccChHHHhCC------CCCccchhhcchHHHHHHHhCC----------CCCCCCCC
Confidence 998776533222 222345789999999999876 66789999999999999998 7 77887642
Q ss_pred CCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhhc
Q psy14889 366 PMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLACA 431 (443)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~~ 431 (443)
..++...+. ...++..| ..+++++.+||.+||+.||++|||+.+|++.|+.+..+
T Consensus 218 -----~~~~~~~i~-~~~~~~~p-----~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 218 -----GPEVMAFIE-QGKRMECP-----PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp -----THHHHHHHH-TTCCCCCC-----TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----HHHHHHHHH-cCCCCCCC-----CcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 233434333 33444444 34678899999999999999999999999999876643
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-54 Score=399.05 Aligned_cols=242 Identities=24% Similarity=0.430 Sum_probs=200.7
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccC----ccchHHHHHHHHHHhccCCCceeeeeeccccCCcccEE
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRD----EASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQL 209 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~----~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~ 209 (443)
++|++.+.||+|+||+||+|++ +|+.||+|++.... ........|+..+..++|||||++++++.+. ..+
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~----~~~ 81 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA----TRV 81 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS----SEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEEC----CEE
Confidence 5799999999999999999998 58899999986432 2223334567777779999999999999876 458
Q ss_pred EeeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCc
Q psy14889 210 WLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA 288 (443)
Q Consensus 210 ~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla 288 (443)
++||||+++|+|.+++.+ ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|
T Consensus 82 ~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~--------~ivHrDiKp~Nill~~~~~~kl~DFG~a 153 (263)
T d2j4za1 82 YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK--------RVIHRDIKPENLLLGSAGELKIADFGWS 153 (263)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT--------TCCCCCCCGGGEEECTTSCEEECCCCSC
T ss_pred EEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CeeeeeeccccceecCCCCEeeccccee
Confidence 999999999999999965 6799999999999999999999999 9999999999999999999999999999
Q ss_pred ccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCC
Q psy14889 289 VSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMD 368 (443)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~ 368 (443)
+...... .....||+.|||||++.+. .++.++|||||||++|||++| +.||.+.
T Consensus 154 ~~~~~~~------~~~~~Gt~~Y~APE~~~~~------~~~~~~DiwSlGvilyell~G----------~~Pf~~~---- 207 (263)
T d2j4za1 154 VHAPSSR------RTTLCGTLDYLPPEMIEGR------MHDEKVDLWSLGVLCYEFLVG----------KPPFEAN---- 207 (263)
T ss_dssp SCCCCCC------CEETTEEGGGCCHHHHTTC------CCCTTHHHHHHHHHHHHHHHS----------SCTTCCS----
T ss_pred eecCCCc------ccccCCCCcccCHHHHcCC------CCCchhhhhhHhHHHHHHhcC----------CCCCCCC----
Confidence 7655322 1335799999999999876 677899999999999999999 7788653
Q ss_pred CChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 369 PSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
...++...+. ...+.+| ..+++++.+|+.+||+.||++|||++|+++
T Consensus 208 -~~~~~~~~i~--~~~~~~p-----~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 208 -TYQETYKRIS--RVEFTFP-----DFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp -SHHHHHHHHH--TTCCCCC-----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -CHHHHHHHHH--cCCCCCC-----ccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 3333333332 2233333 336678999999999999999999999986
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-53 Score=402.83 Aligned_cols=263 Identities=24% Similarity=0.329 Sum_probs=202.2
Q ss_pred hccccccceeeeecCeEEEEEEECC------ceeEEEEeeccCccc--hHHHHHHHHHHhccCCCceeeeeeccccCCcc
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVWHG------ENVAVKIFFSRDEAS--WSRETEIYSTVLLRHENILGYIGSDMTSRNSC 206 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~~~------~~vAvK~~~~~~~~~--~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~ 206 (443)
.+.|++.++||+|+||+||+|.+.+ ..||||++....... .....|+..+..++|||||+++|++.+..
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~--- 82 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK--- 82 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS---
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCC---
Confidence 3578999999999999999998832 369999986543222 22345667777799999999999998764
Q ss_pred cEEEeeecccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEe
Q psy14889 207 TQLWLVTHYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIAD 284 (443)
Q Consensus 207 ~~~~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~D 284 (443)
.+++||||+.+|+|.+++.. ..+++.+++.++.||+.||+|||+. +|+||||||+||||+.++.+||+|
T Consensus 83 -~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~--------~iiHrDlKp~NILl~~~~~~Kl~D 153 (283)
T d1mqba_ 83 -PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM--------NYVHRDLAARNILVNSNLVCKVSD 153 (283)
T ss_dssp -SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT--------TCCCSCCCGGGEEECTTCCEEECC
T ss_pred -ceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcccc--------ccccCccccceEEECCCCeEEEcc
Confidence 47999999999999998854 5799999999999999999999998 999999999999999999999999
Q ss_pred cCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCC
Q psy14889 285 FGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDL 364 (443)
Q Consensus 285 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~ 364 (443)
||+|+.+....... .......||+.|||||++.+. .++.++|||||||++|||++| ..|+...
T Consensus 154 FGla~~~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~------~~~~~sDI~S~Gvil~el~t~----------~~~~~~~ 216 (283)
T d1mqba_ 154 FGLSRVLEDDPEAT-YTTSGGKIPIRWTAPEAISYR------KFTSASDVWSFGIVMWEVMTY----------GERPYWE 216 (283)
T ss_dssp CCC------------------CCCGGGSCHHHHHSC------CCCHHHHHHHHHHHHHHHHTT----------SCCTTTT
T ss_pred cchhhcccCCCccc-eEeccCCCCccccCHHHHccC------CCCCcccccccHHHHHHHHhC----------CCCcccc
Confidence 99998765432221 122345689999999999876 777899999999999999997 3444332
Q ss_pred CCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhhcccccc
Q psy14889 365 VPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLACADMYIH 436 (443)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~~~~~~~ 436 (443)
....++...+. ...++..+ ..++.++.+|+.+||+.||++|||+.||++.|+++.+..+..+
T Consensus 217 ----~~~~~~~~~i~-~~~~~~~~-----~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p~~l~ 278 (283)
T d1mqba_ 217 ----LSNHEVMKAIN-DGFRLPTP-----MDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLK 278 (283)
T ss_dssp ----CCHHHHHHHHH-TTCCCCCC-----TTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGGGG
T ss_pred ----CCHHHHHHHHh-ccCCCCCc-----hhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCccccc
Confidence 13344444443 23344444 3467889999999999999999999999999999988766554
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-53 Score=403.69 Aligned_cols=252 Identities=23% Similarity=0.381 Sum_probs=199.8
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccc-hHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEee
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEAS-WSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLV 212 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~-~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv 212 (443)
+.|++.+.||+|+||+||+|++ +|+.||||++....... .....|+..+..++|||||++++++.+. ..+++|
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~----~~~~lv 87 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYE----NNLWIL 87 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEET----TEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC----CeEEEE
Confidence 5689999999999999999998 58899999986543322 2334555566669999999999999876 458999
Q ss_pred ecccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCccc
Q psy14889 213 THYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVS 290 (443)
Q Consensus 213 ~e~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~ 290 (443)
|||+++|+|.+++.+ ..+++.++..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+|+.
T Consensus 88 mEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~--------~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~ 159 (288)
T d2jfla1 88 IEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN--------KIIHRDLKAGNILFTLDGDIKLADFGVSAK 159 (288)
T ss_dssp EECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT--------TEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--------CEEEeecChhheeECCCCCEEEEechhhhc
Confidence 999999999999753 5699999999999999999999999 999999999999999999999999999976
Q ss_pred ccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCC
Q psy14889 291 YSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPS 370 (443)
Q Consensus 291 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~ 370 (443)
........ ....||+.|+|||++....... ..++.++|||||||++|||+|| ..||.+.. .
T Consensus 160 ~~~~~~~~----~~~~Gt~~y~APE~l~~~~~~~-~~y~~k~DiwSlGvilyemltg----------~~Pf~~~~----~ 220 (288)
T d2jfla1 160 NTRTIQRR----DSFIGTPYWMAPEVVMCETSKD-RPYDYKADVWSLGITLIEMAEI----------EPPHHELN----P 220 (288)
T ss_dssp CHHHHHHH----TCCCSCCTTCCHHHHTTCSTTT-SSTTTHHHHHHHHHHHHHHHHS----------SCTTTTSC----G
T ss_pred cCCCcccc----cccccccccCCHHHHhhcccCC-CCCChhhhHHHHHHHHHHHhhC----------CCCCCCCC----H
Confidence 55432221 3457999999999986432211 1677899999999999999999 77886642 2
Q ss_pred hHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 371 FDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
.+.+.+.... ..+.++ .+..+++++.+||.+||+.||++|||+.|+++
T Consensus 221 ~~~~~~i~~~--~~~~~~---~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 221 MRVLLKIAKS--EPPTLA---QPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp GGHHHHHHHS--CCCCCS---SGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHHHHcC--CCCCCC---ccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 2233333322 122222 12456788999999999999999999999876
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-53 Score=410.49 Aligned_cols=252 Identities=24% Similarity=0.397 Sum_probs=199.8
Q ss_pred hccccccceeeeecCeEEEEEEEC--C-----ceeEEEEeeccCc--cchHHHHHHHHHHhc-cCCCceeeeeeccccCC
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVWH--G-----ENVAVKIFFSRDE--ASWSRETEIYSTVLL-RHENILGYIGSDMTSRN 204 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~~--~-----~~vAvK~~~~~~~--~~~~~e~ei~~~~~l-~H~nIv~l~g~~~~~~~ 204 (443)
.++|++.+.||+|+||+||+|++. + ..||||.+..... .......|+..+..+ +|||||+++|++.+..
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~- 114 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG- 114 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC-
Confidence 478999999999999999999873 2 2689998854322 222334455555556 8999999999998774
Q ss_pred cccEEEeeecccCcccHHHHhccc------------------------CCCHHHHHHHHHHHHHHHHHHHHchhcCCCCC
Q psy14889 205 SCTQLWLVTHYHSFGSLYDHLNRT------------------------TLNHHQMMKICLSIVNGLVHLHTEIFGTQGKP 260 (443)
Q Consensus 205 ~~~~~~lv~e~~~~gsL~~~l~~~------------------------~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~ 260 (443)
.+++|||||++|+|.++++.. .+++..++.++.||++||+|||++
T Consensus 115 ---~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~-------- 183 (325)
T d1rjba_ 115 ---PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK-------- 183 (325)
T ss_dssp ---SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT--------
T ss_pred ---eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC--------
Confidence 479999999999999999542 389999999999999999999999
Q ss_pred CeEEeCCCCCCEEEcCCCcEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHH
Q psy14889 261 AIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLV 340 (443)
Q Consensus 261 ~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvv 340 (443)
+||||||||+|||++.++.+||+|||+|+......... ......||+.|||||++.++ .++.++|||||||+
T Consensus 184 ~IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~l~~~------~~~~~~DiwS~Gvi 255 (325)
T d1rjba_ 184 SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYV--VRGNARLPVKWMAPESLFEG------IYTIKSDVWSYGIL 255 (325)
T ss_dssp TEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSE--EETTEEECGGGCCHHHHHHC------CCCHHHHHHHHHHH
T ss_pred CeeeccCchhccccccCCeEEEeeccccccccCCCcee--eeccccCCCccCChHHHcCC------CCCcceeccchhHH
Confidence 99999999999999999999999999998765433221 12345689999999999876 77899999999999
Q ss_pred HHHHHh-cccCCCcccccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHH
Q psy14889 341 LWEVCR-RTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSAL 419 (443)
Q Consensus 341 l~ellt-g~~~~~~~~~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ 419 (443)
+|||+| | ..||.+.. ....+.+.+. ...++..| ..+++++.+||.+||+.||++|||++
T Consensus 256 l~emlt~g----------~~Pf~~~~----~~~~~~~~~~-~~~~~~~p-----~~~~~~l~~li~~cl~~dP~~RPt~~ 315 (325)
T d1rjba_ 256 LWEIFSLG----------VNPYPGIP----VDANFYKLIQ-NGFKMDQP-----FYATEEIYIIMQSCWAFDSRKRPSFP 315 (325)
T ss_dssp HHHHTTTS----------CCSSTTCC----CSHHHHHHHH-TTCCCCCC-----TTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred HHHHHhCC----------CCCCCCCC----HHHHHHHHHh-cCCCCCCC-----CcCCHHHHHHHHHHcCCChhHCcCHH
Confidence 999998 7 67776542 2233444433 33344444 34677899999999999999999999
Q ss_pred HHHHHHH
Q psy14889 420 RVKKTLI 426 (443)
Q Consensus 420 evl~~L~ 426 (443)
||++.|.
T Consensus 316 ei~~~L~ 322 (325)
T d1rjba_ 316 NLTSFLG 322 (325)
T ss_dssp HHHHHHH
T ss_pred HHHHHHh
Confidence 9999985
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-53 Score=396.36 Aligned_cols=248 Identities=24% Similarity=0.393 Sum_probs=195.8
Q ss_pred ccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc---chHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEee
Q psy14889 138 ISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA---SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLV 212 (443)
Q Consensus 138 ~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~---~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv 212 (443)
|++.+.||+|+||+||+|.+ ++..||+|.+...... ....+.|+..+..++|||||++++++.+.......+++|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 47788999999999999998 5789999988654322 222356777777799999999999987654434678999
Q ss_pred ecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEc-CCCcEEEEecCCccc
Q psy14889 213 THYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVK-TNGTCVIADFGLAVS 290 (443)
Q Consensus 213 ~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~-~~~~~kl~DfGla~~ 290 (443)
|||+++|+|.+++.+ ..+++..+..++.||++||+|||++ .++|+||||||+|||++ +++.+||+|||+|+.
T Consensus 91 mE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~------~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~ 164 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR------TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 164 (270)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS------SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHC------CCCEEeCCcChhhceeeCCCCCEEEeecCccee
Confidence 999999999999965 6799999999999999999999998 22499999999999996 478999999999975
Q ss_pred ccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCC
Q psy14889 291 YSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPS 370 (443)
Q Consensus 291 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~ 370 (443)
..... .....||+.|||||++.+ .++.++|||||||++|||++| +.||.+.. .
T Consensus 165 ~~~~~------~~~~~GT~~Y~aPE~~~~-------~~~~~~DIwSlGvilyel~~g----------~~Pf~~~~----~ 217 (270)
T d1t4ha_ 165 KRASF------AKAVIGTPEFMAPEMYEE-------KYDESVDVYAFGMCMLEMATS----------EYPYSECQ----N 217 (270)
T ss_dssp CCTTS------BEESCSSCCCCCGGGGGT-------CCCTHHHHHHHHHHHHHHHHS----------SCTTTTCS----S
T ss_pred ccCCc------cCCcccCccccCHHHhCC-------CCCCcCchhhHHHHHHHHHHC----------CCCCCCcc----c
Confidence 44321 124579999999999864 567899999999999999999 77886531 2
Q ss_pred hHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 371 FDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
...+.+.+......+.+ +...++++.+|+.+||+.||++|||+.|+++
T Consensus 218 ~~~~~~~i~~~~~~~~~-----~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 218 AAQIYRRVTSGVKPASF-----DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp HHHHHHHHTTTCCCGGG-----GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHcCCCCccc-----CccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 33444433322211111 2335567999999999999999999999975
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-53 Score=399.58 Aligned_cols=247 Identities=21% Similarity=0.358 Sum_probs=195.7
Q ss_pred ceeeeecCeEEEEEEEC----CceeEEEEeeccCcc---chHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEeeec
Q psy14889 142 ECIGKGRYGEVWRGVWH----GENVAVKIFFSRDEA---SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVTH 214 (443)
Q Consensus 142 ~~lG~G~fg~Vy~~~~~----~~~vAvK~~~~~~~~---~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e 214 (443)
++||+|+||+||+|.+. ++.||||++...... ......|+..+.+++|||||+++|++.+. ..+||||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-----~~~lvmE 87 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-----SWMLVME 87 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-----SEEEEEE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-----CEEEEEE
Confidence 46999999999999873 457999998643322 12234566667779999999999998543 2589999
Q ss_pred ccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcccccc
Q psy14889 215 YHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQ 293 (443)
Q Consensus 215 ~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~~~ 293 (443)
|+++|+|.+++++ ..+++.+++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.+..
T Consensus 88 ~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~--------~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~ 159 (277)
T d1xbba_ 88 MAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES--------NFVHRDLAARNVLLVTQHYAKISDFGLSKALRA 159 (277)
T ss_dssp CCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT--------TEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred cCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhC--------CcccCCCcchhhcccccCcccccchhhhhhccc
Confidence 9999999999975 6699999999999999999999998 999999999999999999999999999987654
Q ss_pred cCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh-cccCCCcccccCCCCCCCCCCCCChH
Q psy14889 294 LSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR-RTKANGIFEEYKAPYHDLVPMDPSFD 372 (443)
Q Consensus 294 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt-g~~~~~~~~~~~~P~~~~~~~~~~~~ 372 (443)
...... ......||+.|||||.+.+. .++.++|||||||++|||+| | +.||.+. ...
T Consensus 160 ~~~~~~-~~~~~~gt~~y~APE~l~~~------~~~~~sDiwS~Gv~l~ellt~g----------~~Pf~~~-----~~~ 217 (277)
T d1xbba_ 160 DENYYK-AQTHGKWPVKWYAPECINYY------KFSSKSDVWSFGVLMWEAFSYG----------QKPYRGM-----KGS 217 (277)
T ss_dssp TCSEEE-C----CCCGGGCCHHHHHHC------EEEHHHHHHHHHHHHHHHHTTT----------CCSSTTC-----CHH
T ss_pred cccccc-cccccCCCceecCchhhcCC------CCCchhhhccchhhhhHHhhCC----------CCCCCCC-----CHH
Confidence 332211 12345789999999999876 66789999999999999998 7 7788764 234
Q ss_pred HHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHh
Q psy14889 373 DMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLA 429 (443)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~ 429 (443)
++...+. ...++..| ..+++++.+||.+||+.||++|||+.+|++.|+..-
T Consensus 218 ~~~~~i~-~~~~~~~p-----~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 268 (277)
T d1xbba_ 218 EVTAMLE-KGERMGCP-----AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268 (277)
T ss_dssp HHHHHHH-TTCCCCCC-----TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred HHHHHHH-cCCCCCCC-----cccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence 4444443 23444444 346788999999999999999999999999888754
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-53 Score=398.73 Aligned_cols=258 Identities=23% Similarity=0.326 Sum_probs=202.8
Q ss_pred hccccccceeeeecCeEEEEEEE-CCceeEEEEeeccCccchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEeee
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVW-HGENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVT 213 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv~ 213 (443)
.++|++.+.||+|+||+||+|.+ +++.||||++............|+..+.+++|||||+++|++.+. .+++||
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~-----~~~lv~ 90 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE-----PIYIVT 90 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SCEEEE
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEecC-----CeEEEE
Confidence 46899999999999999999998 456899999876555444455666667779999999999998543 258999
Q ss_pred cccCcccHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCccc
Q psy14889 214 HYHSFGSLYDHLNR---TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVS 290 (443)
Q Consensus 214 e~~~~gsL~~~l~~---~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~ 290 (443)
||+++|+|..++.. ..+++.+++.++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+|+.
T Consensus 91 Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~--------~ivH~DlKp~NIll~~~~~~kl~DfGla~~ 162 (285)
T d1fmka3 91 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM--------NYVHRDLRAANILVGENLVCKVADFGLARL 162 (285)
T ss_dssp CCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT--------TCCCSCCSGGGEEECGGGCEEECCCCTTC-
T ss_pred EecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhh--------heecccccceEEEECCCCcEEEcccchhhh
Confidence 99999999999864 4699999999999999999999998 999999999999999999999999999987
Q ss_pred ccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCC
Q psy14889 291 YSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPS 370 (443)
Q Consensus 291 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~ 370 (443)
....... ......||+.|+|||++..+ .++.++|||||||++|||+|| ..||... ..
T Consensus 163 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~ksDI~S~Giil~el~t~----------~~p~~~~----~~ 219 (285)
T d1fmka3 163 IEDNEYT---ARQGAKFPIKWTAPEAALYG------RFTIKSDVWSFGILLTELTTK----------GRVPYPG----MV 219 (285)
T ss_dssp ----------------CCGGGSCHHHHHHC------CCCHHHHHHHHHHHHHHHHTT----------TCCSSTT----CC
T ss_pred ccCCCce---eeccccccccccChHHHhCC------CCCcHHhhhcchHHHHHHHhC----------CCCCCCC----CC
Confidence 6543221 12335789999999999877 777899999999999999998 3444332 13
Q ss_pred hHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhhcccc
Q psy14889 371 FDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLACADMY 434 (443)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~~~~~ 434 (443)
..++...+.. ..++..+ ..+++++.+|+.+||+.||++|||+++|++.|++......+
T Consensus 220 ~~~~~~~i~~-~~~~~~~-----~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p 277 (285)
T d1fmka3 220 NREVLDQVER-GYRMPCP-----PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 277 (285)
T ss_dssp HHHHHHHHHT-TCCCCCC-----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred HHHHHHHHHh-cCCCCCC-----cccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCC
Confidence 3444444432 2333333 34678899999999999999999999999999987765544
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-53 Score=394.59 Aligned_cols=251 Identities=28% Similarity=0.504 Sum_probs=198.9
Q ss_pred ccccccceeeeecCeEEEEEEECCceeEEEEeeccCccchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEeeecc
Q psy14889 136 KQISLSECIGKGRYGEVWRGVWHGENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVTHY 215 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e~ 215 (443)
++|++.+.||+|+||.||+|.++|+.||||+++.... .....+|+..+.+++||||++++|++.+... .+++||||
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~~-~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~---~~~lv~ey 82 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDAT-AQAFLAEASVMTQLRHSNLVQLLGVIVEEKG---GLYIVTEY 82 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC-----CCEEEECC
T ss_pred HHeEEeEEEecCCCeEEEEEEECCeEEEEEEECcHHH-HHHHHHHHHHHHhCCCCCEeeEEEEEEecCC---cEEEEEec
Confidence 6799999999999999999999999999999865432 2334456666777999999999999865432 36999999
Q ss_pred cCcccHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCccccc
Q psy14889 216 HSFGSLYDHLNR---TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYS 292 (443)
Q Consensus 216 ~~~gsL~~~l~~---~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~~ 292 (443)
+++|+|.+++.. ..+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 83 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~--------~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~ 154 (262)
T d1byga_ 83 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN--------NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 154 (262)
T ss_dssp CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT--------TCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccC--------ceeccccchHhheecCCCCEeecccccceecC
Confidence 999999999964 3499999999999999999999998 99999999999999999999999999997654
Q ss_pred ccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCChH
Q psy14889 293 QLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFD 372 (443)
Q Consensus 293 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~~~ 372 (443)
... ....+|..|+|||++.++ .+++++|||||||++|||+|+. ..||... ...
T Consensus 155 ~~~-------~~~~~~~~y~aPE~l~~~------~~t~~sDIwSfG~il~el~t~~---------~~p~~~~-----~~~ 207 (262)
T d1byga_ 155 STQ-------DTGKLPVKWTAPEALREK------KFSTKSDVWSFGILLWEIYSFG---------RVPYPRI-----PLK 207 (262)
T ss_dssp --------------CCTTTSCHHHHHHC------CCCHHHHHHHHHHHHHHHHTTS---------CCSCTTS-----CGG
T ss_pred CCC-------ccccccccCCChHHHhCC------CCChHHHHHhHHHHHHHHHHCC---------CCCCCCC-----CHH
Confidence 322 233678899999999876 7789999999999999999841 4555543 223
Q ss_pred HHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhhc
Q psy14889 373 DMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLACA 431 (443)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~~ 431 (443)
++...+. ...++.++. .+++++.+|+.+||+.||++|||+.+|++.|+++...
T Consensus 208 ~~~~~i~-~~~~~~~~~-----~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~ 260 (262)
T d1byga_ 208 DVVPRVE-KGYKMDAPD-----GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260 (262)
T ss_dssp GHHHHHT-TTCCCCCCT-----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHH-cCCCCCCCc-----cCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence 3333332 234555553 3567899999999999999999999999999998654
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.1e-53 Score=402.77 Aligned_cols=246 Identities=25% Similarity=0.347 Sum_probs=198.4
Q ss_pred hccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccc----hHHHHHHHHHHhccCCCceeeeeeccccCCcccE
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEAS----WSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQ 208 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~----~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~ 208 (443)
.+.|+..+.||+|+||+||+|++ +|+.||||++....... ...+.|+..+..++|||||++++++.+. ..
T Consensus 14 ~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~----~~ 89 (309)
T d1u5ra_ 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE----HT 89 (309)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET----TE
T ss_pred HHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEEC----CE
Confidence 35699999999999999999997 58899999986543221 2234677777789999999999999876 45
Q ss_pred EEeeecccCcccHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCC
Q psy14889 209 LWLVTHYHSFGSLYDHLN-RTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGL 287 (443)
Q Consensus 209 ~~lv~e~~~~gsL~~~l~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGl 287 (443)
+|+|||||.+|+|..++. +..+++.++..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 90 ~~iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~--------~iiHrDiKp~NILl~~~~~~Kl~DFG~ 161 (309)
T d1u5ra_ 90 AWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH--------NMIHRDVKAGNILLSEPGLVKLGDFGS 161 (309)
T ss_dssp EEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT--------TCBCCCCSGGGEEEETTTEEEECCCTT
T ss_pred EEEEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC--------CEeccCCCcceEEECCCCCEEEeeccc
Confidence 899999999999987664 46799999999999999999999999 999999999999999999999999999
Q ss_pred cccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCC
Q psy14889 288 AVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPM 367 (443)
Q Consensus 288 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~ 367 (443)
|+..... ....||+.|||||++.+.... .|+.++|||||||++|||++| ..||.+..
T Consensus 162 a~~~~~~--------~~~~GT~~Y~APE~~~~~~~~---~y~~~~DiwSlGvilyel~~g----------~~Pf~~~~-- 218 (309)
T d1u5ra_ 162 ASIMAPA--------NSFVGTPYWMAPEVILAMDEG---QYDGKVDVWSLGITCIELAER----------KPPLFNMN-- 218 (309)
T ss_dssp CBSSSSB--------CCCCSCGGGCCHHHHTTTTSC---CBCTHHHHHHHHHHHHHHHHS----------SCTTTTSC--
T ss_pred ccccCCC--------CccccCccccCHHHHhccCCC---CcCchhhhhhHHHHHHHHHHC----------CCCCCCCC--
Confidence 9765432 234799999999998653211 577899999999999999999 77876531
Q ss_pred CCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 368 DPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
..+.+..... . ..+.++ +..+++++.+||.+||+.||++|||+.|+++
T Consensus 219 --~~~~~~~i~~-~-~~~~~~----~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 219 --AMSALYHIAQ-N-ESPALQ----SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp --HHHHHHHHHH-S-CCCCCS----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred --HHHHHHHHHh-C-CCCCCC----CCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 2223333332 2 222222 2345678999999999999999999999975
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.7e-53 Score=401.36 Aligned_cols=250 Identities=20% Similarity=0.298 Sum_probs=188.1
Q ss_pred hhhccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc--chHHHHHHHHHHhccCCCceeeeeeccccCCcccE
Q psy14889 133 TLAKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA--SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQ 208 (443)
Q Consensus 133 ~~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~--~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~ 208 (443)
.+.+.|++.+.||+|+||+||+|++ +|+.||||++...... ....+.|+..+..++|||||++++++.+. ..
T Consensus 6 di~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~----~~ 81 (307)
T d1a06a_ 6 DIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESG----GH 81 (307)
T ss_dssp CGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECS----SE
T ss_pred CCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC----CE
Confidence 3457799999999999999999998 5889999998654322 22234566666779999999999999876 46
Q ss_pred EEeeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEc---CCCcEEEEe
Q psy14889 209 LWLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVK---TNGTCVIAD 284 (443)
Q Consensus 209 ~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~---~~~~~kl~D 284 (443)
+|+|||||++|+|.+++.+ ..+++.++..++.||+.||+|||+. +|+||||||+|||+. +++.+||+|
T Consensus 82 ~~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~--------~iiHrDiKp~Nil~~~~~~~~~vkl~D 153 (307)
T d1a06a_ 82 LYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDL--------GIVHRDLKPENLLYYSLDEDSKIMISD 153 (307)
T ss_dssp EEEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHT--------TCCCSCCCGGGEEESSSSTTCCEEECC
T ss_pred EEEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhc--------eeeeEEecccceeecccCCCceEEEec
Confidence 8999999999999999964 6799999999999999999999999 999999999999995 478999999
Q ss_pred cCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCC
Q psy14889 285 FGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDL 364 (443)
Q Consensus 285 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~ 364 (443)
||+|+....... ....+||+.|||||++.+. .++.++|||||||++|||++| ..||.+.
T Consensus 154 FG~a~~~~~~~~-----~~~~~GT~~y~APE~~~~~------~~~~~~DiwSlGvilyell~g----------~~Pf~~~ 212 (307)
T d1a06a_ 154 FGLSKMEDPGSV-----LSTACGTPGYVAPEVLAQK------PYSKAVDCWSIGVIAYILLCG----------YPPFYDE 212 (307)
T ss_dssp C-----------------------CTTSCHHHHTTC------CCCTHHHHHHHHHHHHHHHHS----------SCSCCCS
T ss_pred cceeEEccCCCe-----eeeeeeCccccCcHHHcCC------CCCcHHHhhhhhHHHHHHHhC----------CCCCCCC
Confidence 999986653321 2345799999999999876 677899999999999999999 7787653
Q ss_pred CCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 365 VPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
....+...+.........+ ....+++++.+|+.+||+.||++|||+.|+++
T Consensus 213 -----~~~~~~~~i~~~~~~~~~~---~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 213 -----NDAKLFEQILKAEYEFDSP---YWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp -----SHHHHHHHHHTTCCCCCTT---TTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -----CHHHHHHHHhccCCCCCCc---cccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 2233333333222222111 12346778999999999999999999999987
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-53 Score=398.13 Aligned_cols=247 Identities=22% Similarity=0.293 Sum_probs=197.9
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccC----ccchHHHHHHHHHHhccCCCceeeeeeccccCCcccEE
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRD----EASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQL 209 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~----~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~ 209 (443)
++|++.+.||+|+||+||+|++ +|+.||||++.... ........|+..+..++|||||++++++.+. ..+
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~----~~~ 83 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD----EKL 83 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECS----SEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEEC----CEE
Confidence 6799999999999999999998 58999999986432 1222334566666669999999999998876 458
Q ss_pred EeeecccCcccHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCc
Q psy14889 210 WLVTHYHSFGSLYDHLN-RTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA 288 (443)
Q Consensus 210 ~lv~e~~~~gsL~~~l~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla 288 (443)
|+||||+++|+|.+++. .+.+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+|
T Consensus 84 ~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~--------~iiHrDiKp~NIll~~~~~vkl~DFG~a 155 (288)
T d1uu3a_ 84 YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK--------GIIHRDLKPENILLNEDMHIQITDFGTA 155 (288)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT--------TEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccc--------cEEcCcCCccccccCCCceEEecccccc
Confidence 99999999999999886 46899999999999999999999999 9999999999999999999999999999
Q ss_pred ccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCC
Q psy14889 289 VSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMD 368 (443)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~ 368 (443)
+.+....... ......||+.|+|||++.+. .++.++|||||||++|||+|| ..||...
T Consensus 156 ~~~~~~~~~~--~~~~~~GT~~Y~APE~~~~~------~~~~~~DiwSlGvilyell~g----------~~Pf~~~---- 213 (288)
T d1uu3a_ 156 KVLSPESKQA--RANSFVGTAQYVSPELLTEK------SACKSSDLWALGCIIYQLVAG----------LPPFRAG---- 213 (288)
T ss_dssp EECC------------CCCCGGGCCHHHHHTC------CCCHHHHHHHHHHHHHHHHHS----------SCSSCCS----
T ss_pred eecccCCccc--ccccccCCccccCceeeccC------CCCcccceehhhHHHHHHhhC----------CCCCCCc----
Confidence 8775432221 12345799999999999876 677899999999999999999 7788653
Q ss_pred CChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHH
Q psy14889 369 PSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKT 424 (443)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 424 (443)
....+...+. ...+.+| ..+++++.+||.+||+.||++|||++|+++.
T Consensus 214 -~~~~~~~~i~--~~~~~~p-----~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 214 -NEYLIFQKII--KLEYDFP-----EKFFPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp -SHHHHHHHHH--TTCCCCC-----TTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred -CHHHHHHHHH--cCCCCCC-----ccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 2233333332 2233344 2356789999999999999999999997553
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-52 Score=399.66 Aligned_cols=259 Identities=22% Similarity=0.352 Sum_probs=206.6
Q ss_pred hhhhccccccceeeeecCeEEEEEEEC-------CceeEEEEeeccCccc--hHHHHHHHHHHhccCCCceeeeeecccc
Q psy14889 132 RTLAKQISLSECIGKGRYGEVWRGVWH-------GENVAVKIFFSRDEAS--WSRETEIYSTVLLRHENILGYIGSDMTS 202 (443)
Q Consensus 132 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~~~--~~~e~ei~~~~~l~H~nIv~l~g~~~~~ 202 (443)
+...++|++.+.||+|+||+||+|++. ++.||||++....... .....|+..+..++||||+++++++...
T Consensus 9 e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~ 88 (301)
T d1lufa_ 9 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG 88 (301)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred cCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccC
Confidence 334578999999999999999999874 3689999986543322 2234566677779999999999999876
Q ss_pred CCcccEEEeeecccCcccHHHHhcc-------------------------cCCCHHHHHHHHHHHHHHHHHHHHchhcCC
Q psy14889 203 RNSCTQLWLVTHYHSFGSLYDHLNR-------------------------TTLNHHQMMKICLSIVNGLVHLHTEIFGTQ 257 (443)
Q Consensus 203 ~~~~~~~~lv~e~~~~gsL~~~l~~-------------------------~~l~~~~~~~i~~qia~gL~yLH~~~~~~~ 257 (443)
. ..++||||+++|+|.+++.. ..+++..++.++.|++.||+|||+.
T Consensus 89 ~----~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~----- 159 (301)
T d1lufa_ 89 K----PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER----- 159 (301)
T ss_dssp S----SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT-----
T ss_pred C----ceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC-----
Confidence 4 36899999999999999853 2388999999999999999999998
Q ss_pred CCCCeEEeCCCCCCEEEcCCCcEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHH
Q psy14889 258 GKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYAL 337 (443)
Q Consensus 258 ~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~ 337 (443)
+||||||||+|||++.++.+||+|||+|+......... ......||+.|+|||.+.+. .++.++|||||
T Consensus 160 ---~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~------~~t~ksDVwS~ 228 (301)
T d1lufa_ 160 ---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK--ADGNDAIPIRWMPPESIFYN------RYTTESDVWAY 228 (301)
T ss_dssp ---TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC------CCBCGGGCCHHHHHHC------CCCHHHHHHHH
T ss_pred ---CeEeeEEcccceEECCCCcEEEccchhheeccCCcccc--ccCCCCcCcCcCCHHHHccC------CCChhhhhccc
Confidence 99999999999999999999999999998665433222 22445788999999999876 78899999999
Q ss_pred HHHHHHHHhcccCCCcccccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCc
Q psy14889 338 GLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLS 417 (443)
Q Consensus 338 Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps 417 (443)
||++|||++|. ..||.+. ...++...+. ...++..| ..+++++.+|+.+||+.||++|||
T Consensus 229 Gvvl~ell~~~---------~~p~~~~-----~~~e~~~~v~-~~~~~~~p-----~~~~~~~~~li~~cl~~~P~~RPt 288 (301)
T d1lufa_ 229 GVVLWEIFSYG---------LQPYYGM-----AHEEVIYYVR-DGNILACP-----ENCPLELYNLMRLCWSKLPADRPS 288 (301)
T ss_dssp HHHHHHHHTTT---------CCTTTTS-----CHHHHHHHHH-TTCCCCCC-----TTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred hhhHHHHHccC---------CCCCCCC-----CHHHHHHHHH-cCCCCCCC-----ccchHHHHHHHHHHcCCChhHCcC
Confidence 99999999982 2456553 3334444433 23344444 346778999999999999999999
Q ss_pred HHHHHHHHHHHhh
Q psy14889 418 ALRVKKTLIKLAC 430 (443)
Q Consensus 418 ~~evl~~L~~l~~ 430 (443)
|.||++.|+++.+
T Consensus 289 ~~ev~~~L~~i~~ 301 (301)
T d1lufa_ 289 FCSIHRILQRMCE 301 (301)
T ss_dssp HHHHHHHHHHTTC
T ss_pred HHHHHHHHHHhcC
Confidence 9999999999853
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-53 Score=406.47 Aligned_cols=257 Identities=22% Similarity=0.314 Sum_probs=198.9
Q ss_pred hhccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccc--hHHHHHHHHHHhccCCCceeeeeeccccCCcccEE
Q psy14889 134 LAKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEAS--WSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQL 209 (443)
Q Consensus 134 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~--~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~ 209 (443)
..++|++.+.||+|+||+||+|++ +|+.||+|++....... .....|+..+..++|||||++++++.+. ..+
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~----~~~ 79 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD----GEI 79 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECS----SEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC----CEE
Confidence 357899999999999999999998 58999999986543222 2334677777779999999999999876 458
Q ss_pred EeeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCc
Q psy14889 210 WLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA 288 (443)
Q Consensus 210 ~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla 288 (443)
++||||+++|+|.+++.+ ..+++..+..++.|++.||.|||+.+ +|+||||||+|||++.++.+||+|||+|
T Consensus 80 ~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~-------~IiHRDiKP~NILl~~~~~vkl~DFGla 152 (322)
T d1s9ja_ 80 SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH-------KIMHRDVKPSNILVNSRGEIKLCDFGVS 152 (322)
T ss_dssp EEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHH-------CCCCSCCSGGGEEECTTCCEEECCCCCC
T ss_pred EEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhC-------CEEccccCHHHeeECCCCCEEEeeCCCc
Confidence 999999999999999964 67999999999999999999999732 8999999999999999999999999999
Q ss_pred ccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCC
Q psy14889 289 VSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMD 368 (443)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~ 368 (443)
+.+.... ....+||+.|+|||++.+. .++.++|||||||++|||++|+ .||.......
T Consensus 153 ~~~~~~~------~~~~~GT~~Y~APEvl~~~------~y~~~~DiWSlGvil~ell~G~----------~Pf~~~~~~~ 210 (322)
T d1s9ja_ 153 GQLIDSM------ANSFVGTRSYMSPERLQGT------HYSVQSDIWSMGLSLVEMAVGR----------YPIPPPDAKE 210 (322)
T ss_dssp HHHHHHT------C---CCSSCCCCHHHHHCS------CCCTTHHHHHHHHHHHHHHHSS----------CCSSCCCTTH
T ss_pred cccCCCc------cccccCCccccCchHHcCC------CCCcHHHHHHHHHHHHHHHHCC----------CCCCCCCHHH
Confidence 8765322 2345899999999999886 7789999999999999999994 4443311000
Q ss_pred -------------------------------------CChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCC
Q psy14889 369 -------------------------------------PSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQN 411 (443)
Q Consensus 369 -------------------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 411 (443)
.......... .....+..+ ....+.++.+|+.+||+.|
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~----~~~~s~~~~dli~~~L~~d 285 (322)
T d1s9ja_ 211 LELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYI-VNEPPPKLP----SGVFSLEFQDFVNKCLIKN 285 (322)
T ss_dssp HHHHC------------------------------CCCCHHHHHHHH-HTSCCCCCC----BTTBCHHHHHHHHHHTCSS
T ss_pred HHHHHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhh-hccCCccCc----cccCCHHHHHHHHHHcCCC
Confidence 0000000111 011112222 2234578999999999999
Q ss_pred cCCCCcHHHHHH--HHHHH
Q psy14889 412 ANVRLSALRVKK--TLIKL 428 (443)
Q Consensus 412 P~~Rps~~evl~--~L~~l 428 (443)
|++|||++|+++ .+++.
T Consensus 286 P~~R~ta~e~L~Hpf~~~~ 304 (322)
T d1s9ja_ 286 PAERADLKQLMVHAFIKRS 304 (322)
T ss_dssp TTTSCCHHHHHTSHHHHHH
T ss_pred hhHCcCHHHHhhCHhhCcC
Confidence 999999999987 35543
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-52 Score=398.68 Aligned_cols=261 Identities=22% Similarity=0.377 Sum_probs=196.0
Q ss_pred hhccccccceeeeecCeEEEEEEEC-------CceeEEEEeeccCccc--hHHHHHHHHHHh-ccCCCceeeeeeccccC
Q psy14889 134 LAKQISLSECIGKGRYGEVWRGVWH-------GENVAVKIFFSRDEAS--WSRETEIYSTVL-LRHENILGYIGSDMTSR 203 (443)
Q Consensus 134 ~~~~~~~~~~lG~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~~~--~~~e~ei~~~~~-l~H~nIv~l~g~~~~~~ 203 (443)
..++|++.+.||+|+||.||+|.+. ++.||||++....... .....|...+.. .+|+||+.+++++....
T Consensus 11 ~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~ 90 (299)
T d1ywna1 11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 90 (299)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred cHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCC
Confidence 3478999999999999999999872 3579999986433221 111223333322 47999999999987654
Q ss_pred CcccEEEeeecccCcccHHHHhcc-----------------cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeC
Q psy14889 204 NSCTQLWLVTHYHSFGSLYDHLNR-----------------TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRD 266 (443)
Q Consensus 204 ~~~~~~~lv~e~~~~gsL~~~l~~-----------------~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrD 266 (443)
. .+++|||||++|+|.++++. ..+++.+++.++.||++||.|||++ +|+|||
T Consensus 91 ~---~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~--------~ivHrD 159 (299)
T d1ywna1 91 G---PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR--------KCIHRD 159 (299)
T ss_dssp S---CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT--------TCCCSC
T ss_pred C---eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC--------CCcCCc
Confidence 3 47999999999999999853 2488999999999999999999999 999999
Q ss_pred CCCCCEEEcCCCcEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh
Q psy14889 267 IKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR 346 (443)
Q Consensus 267 lk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt 346 (443)
|||+||||++++.+||+|||+|+......... ......||+.|+|||++.+. .++.++|||||||++|||+|
T Consensus 160 lKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~--~~~~~~gt~~y~APE~l~~~------~~~~~sDiwS~Gvil~ellt 231 (299)
T d1ywna1 160 LAARNILLSEKNVVKICDFGLARDIYKDPDYV--RKGDARLPLKWMAPETIFDR------VYTIQSDVWSFGVLLWEIFS 231 (299)
T ss_dssp CCGGGEEECGGGCEEECC------CCSCTTSC--CTTSCCCGGGGCCHHHHHHC------CCCHHHHHHHHHHHHHHHHT
T ss_pred CCccceeECCCCcEEEccCcchhhcccccccc--ccCceeeCccccchhHhhcC------CCCcccceeehHHHHHHHHh
Confidence 99999999999999999999998765433221 22455799999999999876 77899999999999999999
Q ss_pred cccCCCcccccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHH
Q psy14889 347 RTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLI 426 (443)
Q Consensus 347 g~~~~~~~~~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 426 (443)
|. ..||.... ..+.+...+. ...++..| +.+++++.+||.+||+.||++|||+.||++.|+
T Consensus 232 ~~---------~~p~~~~~----~~~~~~~~~~-~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~ 292 (299)
T d1ywna1 232 LG---------ASPYPGVK----IDEEFCRRLK-EGTRMRAP-----DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 292 (299)
T ss_dssp TS---------CCSSTTCC----CSHHHHHHHH-HTCCCCCC-----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CC---------CCCCCCCC----HHHHHHHHHh-cCCCCCCC-----ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 72 34665432 2233333333 23444444 336678999999999999999999999999999
Q ss_pred HHhhcc
Q psy14889 427 KLACAD 432 (443)
Q Consensus 427 ~l~~~~ 432 (443)
++.+++
T Consensus 293 ~ilq~n 298 (299)
T d1ywna1 293 NLLQAN 298 (299)
T ss_dssp HHHHHH
T ss_pred HHHhCC
Confidence 998754
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-52 Score=392.09 Aligned_cols=254 Identities=22% Similarity=0.414 Sum_probs=193.7
Q ss_pred hccccccceeeeecCeEEEEEEEC-----CceeEEEEeeccCccc--hHHHHHHHHHHhccCCCceeeeeeccccCCccc
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVWH-----GENVAVKIFFSRDEAS--WSRETEIYSTVLLRHENILGYIGSDMTSRNSCT 207 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~~-----~~~vAvK~~~~~~~~~--~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~ 207 (443)
.++|++.+.||+|+||.||+|.+. +..||||.+....... .....|+..+..++|||||+++|++.+.
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~----- 80 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN----- 80 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS-----
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-----
Confidence 468999999999999999999873 2458888875433222 2334677777779999999999998643
Q ss_pred EEEeeecccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEec
Q psy14889 208 QLWLVTHYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADF 285 (443)
Q Consensus 208 ~~~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~Df 285 (443)
.+++||||+++|+|.+++.. ..+++.+++.++.||++||.|||+. +|+||||||+||++++++.+||+||
T Consensus 81 ~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~--------~iiHrDlKp~NIll~~~~~~Kl~Df 152 (273)
T d1mp8a_ 81 PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK--------RFVHRDIAARNVLVSSNDCVKLGDF 152 (273)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT--------TCCCSCCSGGGEEEEETTEEEECC-
T ss_pred eEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhccc--------CeeccccchhheeecCCCcEEEccc
Confidence 36999999999999998753 5689999999999999999999999 9999999999999999999999999
Q ss_pred CCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh-cccCCCcccccCCCCCCC
Q psy14889 286 GLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR-RTKANGIFEEYKAPYHDL 364 (443)
Q Consensus 286 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt-g~~~~~~~~~~~~P~~~~ 364 (443)
|+|+.+...... ......||+.|+|||++.+. .++.++|||||||++|||+| | ..||.+.
T Consensus 153 G~a~~~~~~~~~---~~~~~~gt~~y~apE~l~~~------~~~~~~DiwSlGvil~e~lt~g----------~~P~~~~ 213 (273)
T d1mp8a_ 153 GLSRYMEDSTYY---KASKGKLPIKWMAPESINFR------RFTSASDVWMFGVCMWEILMHG----------VKPFQGV 213 (273)
T ss_dssp ---------------------CCGGGCCHHHHHHC------CCSHHHHHHHHHHHHHHHHTTS----------CCTTTTC
T ss_pred hhheeccCCcce---eccceecCcccchhhHhccC------CCCCccccccchHHHHHHHhcC----------CCCCCCC
Confidence 999876543222 12345689999999999876 77789999999999999998 6 6677654
Q ss_pred CCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhhc
Q psy14889 365 VPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLACA 431 (443)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~~ 431 (443)
. ..++...+. ...++..+ ..+++++.+||.+||+.||++|||+.||++.|+++.+.
T Consensus 214 ~-----~~~~~~~i~-~~~~~~~~-----~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 214 K-----NNDVIGRIE-NGERLPMP-----PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp C-----GGGHHHHHH-TTCCCCCC-----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred C-----HHHHHHHHH-cCCCCCCC-----CCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 2 233333332 23334443 34678899999999999999999999999999998765
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-52 Score=398.28 Aligned_cols=255 Identities=22% Similarity=0.418 Sum_probs=199.1
Q ss_pred ccccccceeeeecCeEEEEEEE--CCc----eeEEEEeeccCcc--chHHHHHHHHHHhccCCCceeeeeeccccCCccc
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGE----NVAVKIFFSRDEA--SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCT 207 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~----~vAvK~~~~~~~~--~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~ 207 (443)
.+|++.+.||+|+||+||+|.+ +|+ .||||.+...... ......|+..+..++|||||+++|++.+..
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~---- 84 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST---- 84 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSS----
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC----
Confidence 4699999999999999999998 343 5888887543222 223345666666699999999999997653
Q ss_pred EEEeeecccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEec
Q psy14889 208 QLWLVTHYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADF 285 (443)
Q Consensus 208 ~~~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~Df 285 (443)
.++++||+.+|+|.+++.. ..+++..++.++.|||.||+|||++ +|+||||||+|||++.++.+||+||
T Consensus 85 -~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~--------~iiHrDlKp~NIll~~~~~~kl~DF 155 (317)
T d1xkka_ 85 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR--------RLVHRDLAARNVLVKTPQHVKITDF 155 (317)
T ss_dssp -EEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHT--------TCCCSCCCGGGEEEEETTEEEECCC
T ss_pred -eeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHc--------CcccCcchhhcceeCCCCCeEeecc
Confidence 4788999999999998864 5799999999999999999999998 9999999999999999999999999
Q ss_pred CCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCC
Q psy14889 286 GLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLV 365 (443)
Q Consensus 286 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~ 365 (443)
|+|+......... ......||+.|+|||++.++ .++.++|||||||++|||+|+. ..||.+.
T Consensus 156 Gla~~~~~~~~~~--~~~~~~gt~~y~APE~l~~~------~~~~~sDvwS~Gvil~el~t~g---------~~p~~~~- 217 (317)
T d1xkka_ 156 GLAKLLGAEEKEY--HAEGGKVPIKWMALESILHR------IYTHQSDVWSYGVTVWELMTFG---------SKPYDGI- 217 (317)
T ss_dssp SHHHHTTTTCC----------CCTTTSCHHHHHHC------CCCHHHHHHHHHHHHHHHHTTS---------CCTTTTS-
T ss_pred ccceecccccccc--cccccccCccccChHHHhcC------CCChhhhhhhHHHHHHHHHHCC---------CCCCCCC-
Confidence 9998765433222 12334689999999999877 7789999999999999999941 6677654
Q ss_pred CCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhhc
Q psy14889 366 PMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLACA 431 (443)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~~ 431 (443)
...++...+.. ..++..| ..++.++.+|+.+||+.||++|||+.||++.|+++...
T Consensus 218 ----~~~~~~~~i~~-~~~~~~p-----~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~ 273 (317)
T d1xkka_ 218 ----PASEISSILEK-GERLPQP-----PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273 (317)
T ss_dssp ----CGGGHHHHHHH-TCCCCCC-----TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred ----CHHHHHHHHHc-CCCCCCC-----cccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence 22344444432 3344444 34678899999999999999999999999999998754
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.6e-51 Score=387.42 Aligned_cols=264 Identities=21% Similarity=0.309 Sum_probs=203.7
Q ss_pred hhccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc----chHHHHHHHHHHhccCCCceeeeeeccccCCccc
Q psy14889 134 LAKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA----SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCT 207 (443)
Q Consensus 134 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~----~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~ 207 (443)
+.++|++.+.||+|+||+||+|++ +|+.||||++...... ....+.|+..+..++|||||++++++........
T Consensus 5 l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~ 84 (277)
T d1o6ya_ 5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 84 (277)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSE
T ss_pred ccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCc
Confidence 357899999999999999999997 5899999998654322 1223567777777999999999999987765556
Q ss_pred EEEeeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecC
Q psy14889 208 QLWLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFG 286 (443)
Q Consensus 208 ~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfG 286 (443)
.+|+||||+++|+|.+++.. +.+++.++..++.||+.||+|||++ +|+||||||+|||++.++..+|+|||
T Consensus 85 ~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~--------~iiHrDiKP~NIll~~~~~~~l~d~~ 156 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN--------GIIHRDVKPANIMISATNAVKVMDFG 156 (277)
T ss_dssp EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT--------TEECCCCSGGGEEEETTSCEEECCCT
T ss_pred eEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhC--------CccCccccCcccccCccccceeehhh
Confidence 78999999999999998854 6799999999999999999999998 99999999999999999999999999
Q ss_pred CcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCC
Q psy14889 287 LAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVP 366 (443)
Q Consensus 287 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~ 366 (443)
.+......... ........||+.|+|||++.+. .++.++|||||||++|||+|| ..||.+..
T Consensus 157 ~~~~~~~~~~~-~~~~~~~~Gt~~Y~aPE~~~~~------~~~~~~DiwSlGvilyelltG----------~~Pf~~~~- 218 (277)
T d1o6ya_ 157 IARAIADSGNS-VTQTAAVIGTAQYLSPEQARGD------SVDARSDVYSLGCVLYEVLTG----------EPPFTGDS- 218 (277)
T ss_dssp TCEECC-----------------TTCCHHHHTTC------CCCHHHHHHHHHHHHHHHHHS----------SCSCCCSS-
T ss_pred hhhhhcccccc-ccccccccCcccccCHHHHcCC------CCCcceecccchHHHHHHHhC----------CCCCCCcC-
Confidence 98765443222 1123456799999999999876 677899999999999999999 77876531
Q ss_pred CCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCC-cHHHHHHHHHHHhh
Q psy14889 367 MDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRL-SALRVKKTLIKLAC 430 (443)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-s~~evl~~L~~l~~ 430 (443)
..+...+.+.. ...+ + ......+++++.+++.+||+.||++|| |++++++.|.++.+
T Consensus 219 ---~~~~~~~~~~~-~~~~--~-~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~n 276 (277)
T d1o6ya_ 219 ---PVSVAYQHVRE-DPIP--P-SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276 (277)
T ss_dssp ---HHHHHHHHHHC-CCCC--G-GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHC
T ss_pred ---HHHHHHHHHhc-CCCC--C-chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHhC
Confidence 12223333322 1111 1 112244678899999999999999999 89999999998763
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-52 Score=389.62 Aligned_cols=253 Identities=25% Similarity=0.419 Sum_probs=194.9
Q ss_pred ccccccceeeeecCeEEEEEEEC---C--ceeEEEEeeccCc----cchHHHHHHHHHHhccCCCceeeeeeccccCCcc
Q psy14889 136 KQISLSECIGKGRYGEVWRGVWH---G--ENVAVKIFFSRDE----ASWSRETEIYSTVLLRHENILGYIGSDMTSRNSC 206 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~~---~--~~vAvK~~~~~~~----~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~ 206 (443)
++|++.+.||+|+||.||+|+++ + ..||||++..... .......|+..+..++|||||+++|++.+.
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~---- 83 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP---- 83 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS----
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec----
Confidence 67999999999999999999873 2 3689998754321 112234666667779999999999999754
Q ss_pred cEEEeeecccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEe
Q psy14889 207 TQLWLVTHYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIAD 284 (443)
Q Consensus 207 ~~~~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~D 284 (443)
.+++||||+++|+|.+++.. ..+++..++.++.|||.||.|||++ +|+||||||+|||++.++.+||+|
T Consensus 84 -~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~--------~iiHrDikp~NIll~~~~~vkl~D 154 (273)
T d1u46a_ 84 -PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK--------RFIHRDLAARNLLLATRDLVKIGD 154 (273)
T ss_dssp -SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHT--------TEECSCCCGGGEEEEETTEEEECC
T ss_pred -chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhC--------CEeeeeecHHHhccccccceeecc
Confidence 25899999999999988753 5699999999999999999999998 999999999999999999999999
Q ss_pred cCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHh-cccCCCcccccCCCCCC
Q psy14889 285 FGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCR-RTKANGIFEEYKAPYHD 363 (443)
Q Consensus 285 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ellt-g~~~~~~~~~~~~P~~~ 363 (443)
||+++.+....... .......||..|+|||.+.+. .++.++|||||||++|||+| | ..||.+
T Consensus 155 fGl~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~------~~~~~~Di~S~Gvil~emlt~G----------~~Pf~~ 217 (273)
T d1u46a_ 155 FGLMRALPQNDDHY-VMQEHRKVPFAWCAPESLKTR------TFSHASDTWMFGVTLWEMFTYG----------QEPWIG 217 (273)
T ss_dssp CTTCEECCC-CCEE-EC-----CCGGGCCHHHHHHC------EEEHHHHHHHHHHHHHHHHTTS----------CCTTTT
T ss_pred chhhhhcccCCCcc-eecCccccCcccCCHHHHhCC------CCCcchhhhhhHHHHHHHHhCC----------CCCCCC
Confidence 99998775543322 122344678899999999876 66689999999999999998 7 678865
Q ss_pred CCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHH
Q psy14889 364 LVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKL 428 (443)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l 428 (443)
. ...+....+.....++..+ ..+++.+.+|+.+||+.||++|||+.||++.|.++
T Consensus 218 ~-----~~~~~~~~i~~~~~~~~~~-----~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 218 L-----NGSQILHKIDKEGERLPRP-----EDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp C-----CHHHHHHHHHTSCCCCCCC-----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred c-----CHHHHHHHHHhCCCCCCCc-----ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 4 3344444444444444443 34667899999999999999999999999999875
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.3e-51 Score=399.44 Aligned_cols=248 Identities=17% Similarity=0.323 Sum_probs=199.6
Q ss_pred hccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccc-hHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEe
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEAS-WSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWL 211 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~-~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~l 211 (443)
-++|++.+.||+|+||.||+|++ +|+.||||++....... ...+.|+..+..++|||||++++++.+. ..+++
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~----~~~~i 100 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD----NEMVM 100 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEET----TEEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEEC----CEEEE
Confidence 36899999999999999999998 58999999986544322 2234567777779999999999998876 46899
Q ss_pred eecccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcC--CCcEEEEecCC
Q psy14889 212 VTHYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKT--NGTCVIADFGL 287 (443)
Q Consensus 212 v~e~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~--~~~~kl~DfGl 287 (443)
|||||++|+|.+++.+ ..+++..+..++.||+.||.|||++ +|+||||||+|||++. ++.+||+|||+
T Consensus 101 vmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~--------~iiHrDiKp~NIll~~~~~~~vkL~DFG~ 172 (350)
T d1koaa2 101 IYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN--------NYVHLDLKPENIMFTTKRSNELKLIDFGL 172 (350)
T ss_dssp EECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHT--------TEECCCCCGGGEEESSTTSCCEEECCCTT
T ss_pred EEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhc--------CCeeeeechhHeeeccCCCCeEEEeecch
Confidence 9999999999999843 5699999999999999999999999 9999999999999964 57899999999
Q ss_pred cccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCC
Q psy14889 288 AVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPM 367 (443)
Q Consensus 288 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~ 367 (443)
|+.+...... ....||+.|||||++.+. .++.++|||||||++|||++| ..||.+.
T Consensus 173 a~~~~~~~~~-----~~~~gT~~Y~aPEv~~~~------~~~~~~DiwSlGvilyell~G----------~~Pf~~~--- 228 (350)
T d1koaa2 173 TAHLDPKQSV-----KVTTGTAEFAAPEVAEGK------PVGYYTDMWSVGVLSYILLSG----------LSPFGGE--- 228 (350)
T ss_dssp CEECCTTSCE-----EEECSCTTTCCHHHHHTC------CBCHHHHHHHHHHHHHHHHHS----------SCSSCCS---
T ss_pred heeccccccc-----ceecCcccccCHHHHcCC------CCChhHhhhhhhHHHHHHHhC----------CCCCCCC---
Confidence 9876543222 335799999999999876 677899999999999999999 7787653
Q ss_pred CCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 368 DPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
...+....+...... .+.. ....+++++.+||.+||+.||++|||+.|+++
T Consensus 229 --~~~~~~~~i~~~~~~--~~~~-~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 229 --NDDETLRNVKSCDWN--MDDS-AFSGISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp --SHHHHHHHHHHTCCC--SCCG-GGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred --CHHHHHHHHHhCCCC--CCcc-cccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 223333332222211 1111 11345678999999999999999999999987
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-51 Score=390.44 Aligned_cols=250 Identities=19% Similarity=0.263 Sum_probs=199.9
Q ss_pred hhhccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCc-------cchHHHHHHHHHHhccCCCceeeeeeccccC
Q psy14889 133 TLAKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDE-------ASWSRETEIYSTVLLRHENILGYIGSDMTSR 203 (443)
Q Consensus 133 ~~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~-------~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~ 203 (443)
.+.++|++.+.||+|+||+||+|++ +|+.||||++..... .....+.|+..+..++|||||++++++.+.
T Consensus 7 ~i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~- 85 (293)
T d1jksa_ 7 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK- 85 (293)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-
T ss_pred CcccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-
Confidence 3557899999999999999999998 589999999864321 122335666667779999999999999876
Q ss_pred CcccEEEeeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCC----
Q psy14889 204 NSCTQLWLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNG---- 278 (443)
Q Consensus 204 ~~~~~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~---- 278 (443)
..+++|||||++|+|.+++.+ ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++
T Consensus 86 ---~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~--------~ivHrDiKp~Nill~~~~~~~~ 154 (293)
T d1jksa_ 86 ---TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL--------QIAHFDLKPENIMLLDRNVPKP 154 (293)
T ss_dssp ---SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT--------TEECCCCSGGGEEESCSSSSSC
T ss_pred ---CEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhc--------ceeecccccceEEEecCCCccc
Confidence 468999999999999999964 6799999999999999999999999 999999999999998876
Q ss_pred cEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccC
Q psy14889 279 TCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYK 358 (443)
Q Consensus 279 ~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~ 358 (443)
.+||+|||+|+....... .....||+.|+|||++.+. .++.++|||||||++|||++| .
T Consensus 155 ~vkl~DfG~a~~~~~~~~-----~~~~~~t~~y~APE~~~~~------~~~~~~DiwSlGvilyell~g----------~ 213 (293)
T d1jksa_ 155 RIKIIDFGLAHKIDFGNE-----FKNIFGTPEFVAPEIVNYE------PLGLEADMWSIGVITYILLSG----------A 213 (293)
T ss_dssp CEEECCCTTCEECTTSCB-----CSCCCCCGGGCCHHHHTTC------CBCTHHHHHHHHHHHHHHHHS----------S
T ss_pred ceEecchhhhhhcCCCcc-----ccccCCCCcccCHHHHcCC------CCCCcccchhhhHHHHHHHcC----------C
Confidence 599999999987654322 2345789999999999876 677899999999999999999 7
Q ss_pred CCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 359 APYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 359 ~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
.||.+. ...+....+... ....+.. ....++.++.+||++||+.||++|||++|+++
T Consensus 214 ~Pf~~~-----~~~~~~~~i~~~--~~~~~~~-~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 214 SPFLGD-----TKQETLANVSAV--NYEFEDE-YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp CSSCCS-----SHHHHHHHHHTT--CCCCCHH-HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCCCCC-----CHHHHHHHHHhc--CCCCCch-hcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 787653 222332222211 1111110 01235678999999999999999999999986
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-51 Score=389.11 Aligned_cols=258 Identities=23% Similarity=0.353 Sum_probs=202.7
Q ss_pred cccceeeeecCeEEEEEEEC---C--ceeEEEEeeccCcc--chHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEe
Q psy14889 139 SLSECIGKGRYGEVWRGVWH---G--ENVAVKIFFSRDEA--SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWL 211 (443)
Q Consensus 139 ~~~~~lG~G~fg~Vy~~~~~---~--~~vAvK~~~~~~~~--~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~l 211 (443)
.+.++||+|+||+||+|.+. + ..||||++...... ......|+..+.+++|||||+++|++...+ ..+++
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~---~~~~l 106 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE---GSPLV 106 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETT---TEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecC---CceEE
Confidence 44688999999999999982 2 25899988643222 223356667777799999999999987654 35799
Q ss_pred eecccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcc
Q psy14889 212 VTHYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAV 289 (443)
Q Consensus 212 v~e~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~ 289 (443)
|||||++|+|.+++.. ..+++..++.++.|+|.||.|||+. +|+||||||+|||+++++.+||+|||+++
T Consensus 107 v~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~--------~iiHrDLK~~NILl~~~~~~kL~DFG~~~ 178 (311)
T d1r0pa_ 107 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK--------KFVHRDLAARNCMLDEKFTVKVADFGLAR 178 (311)
T ss_dssp EEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT--------TCCCSCCSGGGEEECTTCCEEECSSGGGC
T ss_pred EEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhccc--------CcccCCccHHhEeECCCCCEEEecccchh
Confidence 9999999999999865 3577889999999999999999998 99999999999999999999999999998
Q ss_pred cccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCC
Q psy14889 290 SYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDP 369 (443)
Q Consensus 290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~ 369 (443)
.................||+.|+|||.+... .++.++||||||+++|||+|| ..||.....
T Consensus 179 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~ksDI~SfGivl~El~t~----------~~p~~~~~~--- 239 (311)
T d1r0pa_ 179 DMYDKEFDSVHNKTGAKLPVKWMALESLQTQ------KFTTKSDVWSFGVLLWELMTR----------GAPPYPDVN--- 239 (311)
T ss_dssp CTTTTTCCCTTCTTCSSCCGGGSCHHHHHHC------CCCHHHHHHHHHHHHHHHHTT----------SCCSCC------
T ss_pred hccccccccceecccccccccccChHHHhcC------CCCChhHhhhhHHHHHHHHHC----------CCCCCCCCC---
Confidence 7765444333334456799999999999876 778999999999999999998 455544321
Q ss_pred ChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhhccc
Q psy14889 370 SFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLACADM 433 (443)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~~~~ 433 (443)
..++...+. ...++..| ..+++++.+||.+||+.||++|||+.||++.|+++.+...
T Consensus 240 -~~~~~~~i~-~g~~~~~p-----~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~ 296 (311)
T d1r0pa_ 240 -TFDITVYLL-QGRRLLQP-----EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 296 (311)
T ss_dssp ----CHHHHH-TTCCCCCC-----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred -HHHHHHHHH-cCCCCCCc-----ccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhh
Confidence 112222222 23444444 3366789999999999999999999999999999987643
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=7.2e-51 Score=382.03 Aligned_cols=253 Identities=23% Similarity=0.300 Sum_probs=203.6
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccc----------hHHHHHHHHHHhcc-CCCceeeeeecccc
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEAS----------WSRETEIYSTVLLR-HENILGYIGSDMTS 202 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~----------~~~e~ei~~~~~l~-H~nIv~l~g~~~~~ 202 (443)
++|++.+.||+|+||+||+|+. +|+.||||++....... .....|+..+..++ ||||+++++++.+.
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 6899999999999999999998 68999999986543211 11235666676786 99999999999876
Q ss_pred CCcccEEEeeecccCcccHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEE
Q psy14889 203 RNSCTQLWLVTHYHSFGSLYDHLN-RTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCV 281 (443)
Q Consensus 203 ~~~~~~~~lv~e~~~~gsL~~~l~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~k 281 (443)
..+||||||+++|||.++++ +..+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+|
T Consensus 83 ----~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~--------~ivHrDlkp~Nill~~~~~~k 150 (277)
T d1phka_ 83 ----TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL--------NIVHRDLKPENILLDDDMNIK 150 (277)
T ss_dssp ----SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT--------TEECSCCSGGGEEECTTCCEE
T ss_pred ----cceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc--------CCcccccccceEEEcCCCCeE
Confidence 46899999999999999995 46899999999999999999999998 999999999999999999999
Q ss_pred EEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCC
Q psy14889 282 IADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPY 361 (443)
Q Consensus 282 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~ 361 (443)
|+|||+++.+..... .....||+.|+|||.+.+........++.++||||+||++|||++| +.||
T Consensus 151 l~DFG~a~~~~~~~~-----~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g----------~~Pf 215 (277)
T d1phka_ 151 LTDFGFSCQLDPGEK-----LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG----------SPPF 215 (277)
T ss_dssp ECCCTTCEECCTTCC-----BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHS----------SCSS
T ss_pred EccchheeEccCCCc-----eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccC----------CCCC
Confidence 999999987764322 2345799999999999865433333577899999999999999999 7788
Q ss_pred CCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 362 HDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
.+. ........+.........+. ...+++++++|+.+||+.||++|||++||++
T Consensus 216 ~~~-----~~~~~~~~i~~~~~~~~~~~---~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 216 WHR-----KQMLMLRMIMSGNYQFGSPE---WDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp CCS-----SHHHHHHHHHHTCCCCCTTT---GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred CCC-----CHHHHHHHHHhCCCCCCCcc---cccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 763 22333333333222222221 2357788999999999999999999999865
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-50 Score=390.37 Aligned_cols=244 Identities=23% Similarity=0.338 Sum_probs=201.6
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccC----ccchHHHHHHHHHHhccCCCceeeeeeccccCCcccEE
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRD----EASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQL 209 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~----~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~ 209 (443)
++|++.+.||+|+||.||+|+. +|+.||||++.... ........|+..+..++||||+++++++.+. ..+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~----~~~ 80 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH----DRL 80 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECS----SEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccc----ccc
Confidence 6899999999999999999997 68999999986432 1222234566666779999999999999887 458
Q ss_pred EeeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCc
Q psy14889 210 WLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA 288 (443)
Q Consensus 210 ~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla 288 (443)
|+||||+++|+|.+++.+ ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|
T Consensus 81 ~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~--------~iiHRDlKP~NILl~~~g~vkl~DFG~a 152 (337)
T d1o6la_ 81 CFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR--------DVVYRDIKLENLMLDKDGHIKITDFGLC 152 (337)
T ss_dssp EEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT--------TCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred ccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhc--------CccccccCHHHeEecCCCCEEEeecccc
Confidence 999999999999999975 6799999999999999999999999 9999999999999999999999999999
Q ss_pred ccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCC
Q psy14889 289 VSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMD 368 (443)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~ 368 (443)
+........ ....+||+.|+|||++.+. .++.++|||||||++|||++| ..||.+.
T Consensus 153 ~~~~~~~~~----~~~~~GT~~Y~aPE~~~~~------~y~~~~DiwSlGvilyeml~G----------~~pf~~~---- 208 (337)
T d1o6la_ 153 KEGISDGAT----MKTFCGTPEYLAPEVLEDN------DYGRAVDWWGLGVVMYEMMCG----------RLPFYNQ---- 208 (337)
T ss_dssp BCSCCTTCC----BCCCEECGGGCCGGGGSSS------CBCTTHHHHHHHHHHHHHHHS----------SCSSCCS----
T ss_pred cccccCCcc----cccceeCHHHhhhhhccCC------CCChhhcccchhhHHHHHHHC----------CCCCCCc----
Confidence 866543222 2456899999999999887 778999999999999999999 7777663
Q ss_pred CChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCc-----HHHHHH
Q psy14889 369 PSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLS-----ALRVKK 423 (443)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~ 423 (443)
+...+.+.+... .+.+| ..+++++.+||.+||+.||++||+ +.|+++
T Consensus 209 -~~~~~~~~i~~~--~~~~p-----~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 209 -DHERLFELILME--EIRFP-----RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp -SHHHHHHHHHHC--CCCCC-----TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -CHHHHHHHHhcC--CCCCC-----ccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 334444444332 23344 336678999999999999999995 888876
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-51 Score=389.82 Aligned_cols=255 Identities=24% Similarity=0.411 Sum_probs=202.7
Q ss_pred ccccccceeeeecCeEEEEEEE--CCc--eeEEEEeeccCc--cchHHHHHHHHHHhc-cCCCceeeeeeccccCCcccE
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGE--NVAVKIFFSRDE--ASWSRETEIYSTVLL-RHENILGYIGSDMTSRNSCTQ 208 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~--~vAvK~~~~~~~--~~~~~e~ei~~~~~l-~H~nIv~l~g~~~~~~~~~~~ 208 (443)
++|++.+.||+|+||+||+|.+ +|. .||||++..... .......|+..+..+ +|||||+++|++.+. ..
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~----~~ 85 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR----GY 85 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEET----TE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecC----Ce
Confidence 6899999999999999999998 344 477887754322 222334566666667 799999999999876 46
Q ss_pred EEeeecccCcccHHHHhcc-----------------cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCC
Q psy14889 209 LWLVTHYHSFGSLYDHLNR-----------------TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKN 271 (443)
Q Consensus 209 ~~lv~e~~~~gsL~~~l~~-----------------~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~N 271 (443)
+++||||+++|+|.++++. ..+++..++.++.|||.||.|||+. +|+||||||+|
T Consensus 86 ~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~--------~iiHrDlkp~N 157 (309)
T d1fvra_ 86 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK--------QFIHRDLAARN 157 (309)
T ss_dssp EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT--------TEECSCCSGGG
T ss_pred eEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC--------Cccccccccce
Confidence 8999999999999999853 4689999999999999999999999 99999999999
Q ss_pred EEEcCCCcEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCC
Q psy14889 272 ILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKAN 351 (443)
Q Consensus 272 iLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~ 351 (443)
||++.++.+||+|||+|+........ ....||..|+|||.+.++ .++.++|||||||++|||++|.
T Consensus 158 IL~~~~~~~kl~DfG~a~~~~~~~~~-----~~~~gt~~y~aPE~l~~~------~~~~~sDvwSfGvil~ell~~~--- 223 (309)
T d1fvra_ 158 ILVGENYVAKIADFGLSRGQEVYVKK-----TMGRLPVRWMAIESLNYS------VYTTNSDVWSYGVLLWEIVSLG--- 223 (309)
T ss_dssp EEECGGGCEEECCTTCEESSCEECCC---------CCTTTCCHHHHHHC------EECHHHHHHHHHHHHHHHHTTS---
T ss_pred EEEcCCCceEEccccccccccccccc-----cceecCCcccchHHhccC------CCCccceeehhHHHHHHHHhcC---
Confidence 99999999999999999765543222 234689999999999876 6778999999999999999972
Q ss_pred CcccccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhhc
Q psy14889 352 GIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLACA 431 (443)
Q Consensus 352 ~~~~~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~~ 431 (443)
..||.+. ...++...+.. ..++..+ ..+++++.+||.+||+.||++|||+.||++.|+++.+.
T Consensus 224 ------~~p~~~~-----~~~~~~~~i~~-~~~~~~~-----~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 286 (309)
T d1fvra_ 224 ------GTPYCGM-----TCAELYEKLPQ-GYRLEKP-----LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286 (309)
T ss_dssp ------CCTTTTC-----CHHHHHHHGGG-TCCCCCC-----TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred ------CCCCCCC-----CHHHHHHHHHh-cCCCCCC-----ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 3456543 33444444432 3444444 34678899999999999999999999999999999876
Q ss_pred cc
Q psy14889 432 DM 433 (443)
Q Consensus 432 ~~ 433 (443)
..
T Consensus 287 ~~ 288 (309)
T d1fvra_ 287 RK 288 (309)
T ss_dssp SS
T ss_pred Cc
Confidence 54
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=6.2e-51 Score=395.06 Aligned_cols=248 Identities=19% Similarity=0.271 Sum_probs=200.3
Q ss_pred hccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc-chHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEe
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA-SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWL 211 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~-~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~l 211 (443)
.++|++.+.||+|+||.||+|+. +|+.||||++...... ....+.|+..+..++|||||++++++.+. ..+|+
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~----~~~~i 103 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDK----YEMVL 103 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECS----SEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC----CEEEE
Confidence 36799999999999999999998 5899999998664432 23335677777779999999999999876 46899
Q ss_pred eecccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEc--CCCcEEEEecCC
Q psy14889 212 VTHYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVK--TNGTCVIADFGL 287 (443)
Q Consensus 212 v~e~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~--~~~~~kl~DfGl 287 (443)
|||||++|+|.+++.. ..+++.++..++.||+.||.|||+. +|+||||||+|||++ .++.+||+|||+
T Consensus 104 vmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~--------~iiHRDiKp~NILl~~~~~~~vkL~DFGl 175 (352)
T d1koba_ 104 ILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH--------SIVHLDIKPENIMCETKKASSVKIIDFGL 175 (352)
T ss_dssp EEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHT--------TEECCCCCGGGEEESSTTCCCEEECCCTT
T ss_pred EEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--------CeeecccccccccccccCCCeEEEeeccc
Confidence 9999999999998754 3699999999999999999999998 999999999999998 568999999999
Q ss_pred cccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCC
Q psy14889 288 AVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPM 367 (443)
Q Consensus 288 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~ 367 (443)
|+.+...... ....||+.|+|||++.+. .++.++|||||||++|||+|| ..||.+.
T Consensus 176 a~~~~~~~~~-----~~~~gt~~y~aPE~~~~~------~~~~~~DiwSlGvilyelltG----------~~Pf~~~--- 231 (352)
T d1koba_ 176 ATKLNPDEIV-----KVTTATAEFAAPEIVDRE------PVGFYTDMWAIGVLGYVLLSG----------LSPFAGE--- 231 (352)
T ss_dssp CEECCTTSCE-----EEECSSGGGCCHHHHTTC------CBCHHHHHHHHHHHHHHHHHS----------CCSSCCS---
T ss_pred ceecCCCCce-----eeccCcccccCHHHHcCC------CCCCccchHHHHHHHHHHHhC----------CCCCCCC---
Confidence 9877543221 234789999999999876 677899999999999999999 7788653
Q ss_pred CCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 368 DPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
........+.... ..++.. ....++.++.+||.+||+.||.+|||+.|+++
T Consensus 232 --~~~~~~~~i~~~~--~~~~~~-~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 232 --DDLETLQNVKRCD--WEFDED-AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp --SHHHHHHHHHHCC--CCCCSS-TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred --CHHHHHHHHHhCC--CCCCcc-cccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 2223322222211 112211 11346678999999999999999999999976
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-51 Score=387.59 Aligned_cols=256 Identities=23% Similarity=0.430 Sum_probs=200.4
Q ss_pred hccccccceeeeecCeEEEEEEEC---------CceeEEEEeeccCccc--hHHHHHHHHHHhc-cCCCceeeeeecccc
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVWH---------GENVAVKIFFSRDEAS--WSRETEIYSTVLL-RHENILGYIGSDMTS 202 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~~---------~~~vAvK~~~~~~~~~--~~~e~ei~~~~~l-~H~nIv~l~g~~~~~ 202 (443)
.++|.+.+.||+|+||.||+|++. +..||||++....... .....|...+..+ +|||||++++++.+.
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 478999999999999999999863 2369999986543322 2222344444445 899999999999876
Q ss_pred CCcccEEEeeecccCcccHHHHhcc-----------------cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEe
Q psy14889 203 RNSCTQLWLVTHYHSFGSLYDHLNR-----------------TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHR 265 (443)
Q Consensus 203 ~~~~~~~~lv~e~~~~gsL~~~l~~-----------------~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHr 265 (443)
. .+++||||+++|+|.+++.. ..+++.+++.++.||+.||+|||+. +||||
T Consensus 92 ~----~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~--------~ivHr 159 (299)
T d1fgka_ 92 G----PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK--------KCIHR 159 (299)
T ss_dssp S----SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT--------TCCCS
T ss_pred C----eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC--------CEEee
Confidence 3 47999999999999999953 2489999999999999999999999 99999
Q ss_pred CCCCCCEEEcCCCcEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHH
Q psy14889 266 DIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVC 345 (443)
Q Consensus 266 Dlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~ell 345 (443)
||||+|||++.++.+||+|||+++......... ......||+.|+|||.+.++ .++.++|||||||++|||+
T Consensus 160 DiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~------~y~~k~DiwS~Gvvl~ell 231 (299)
T d1fgka_ 160 DLAARNVLVTEDNVMKIADFGLARDIHHIDYYK--KTTNGRLPVKWMAPEALFDR------IYTHQSDVWSFGVLLWEIF 231 (299)
T ss_dssp CCSGGGEEECTTCCEEECSTTCCCCGGGCCTTC--CCTTSCCGGGGSCHHHHHHC------CCCHHHHHHHHHHHHHHHH
T ss_pred eecccceeecCCCCeEeccchhhcccccccccc--ccccCCCChhhhhhhHhcCC------CCCchhhhHHhHHHHHHhc
Confidence 999999999999999999999998776543322 22445789999999999876 7789999999999999999
Q ss_pred hcccCCCcccccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHH
Q psy14889 346 RRTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTL 425 (443)
Q Consensus 346 tg~~~~~~~~~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 425 (443)
+++ ..||.+. ....+...+. ...++..|. .+++++.+||.+||+.||++|||+.||++.|
T Consensus 232 ~~g---------~~p~~~~-----~~~~~~~~i~-~~~~~~~p~-----~~~~~l~~li~~cl~~dP~~Rps~~eil~~L 291 (299)
T d1fgka_ 232 TLG---------GSPYPGV-----PVEELFKLLK-EGHRMDKPS-----NCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 291 (299)
T ss_dssp TTS---------CCSSTTC-----CHHHHHHHHH-TTCCCCCCS-----SCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred cCC---------CCCCCCC-----CHHHHHHHHH-cCCCCCCCc-----cchHHHHHHHHHHccCCHhHCcCHHHHHHHH
Confidence 841 5666553 3344444443 344454443 3667899999999999999999999999999
Q ss_pred HHHhh
Q psy14889 426 IKLAC 430 (443)
Q Consensus 426 ~~l~~ 430 (443)
+++.+
T Consensus 292 ~~i~a 296 (299)
T d1fgka_ 292 DRIVA 296 (299)
T ss_dssp HHHHH
T ss_pred HHHhh
Confidence 99865
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.1e-50 Score=384.86 Aligned_cols=241 Identities=21% Similarity=0.324 Sum_probs=197.7
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccC----ccchHHHHHHHHHHhccCCCceeeeeeccccCCcccEE
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRD----EASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQL 209 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~----~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~ 209 (443)
++|++.+.||+|+||+||+|++ +|+.||||++.... ........|+..+..++|||||++++++.+. ..+
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~----~~~ 79 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA----QQI 79 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECS----SEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeC----Cee
Confidence 5799999999999999999998 58999999986432 1222334566666679999999999999876 468
Q ss_pred EeeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCc
Q psy14889 210 WLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA 288 (443)
Q Consensus 210 ~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla 288 (443)
|+||||+++|+|..++.. ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|
T Consensus 80 ~ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~--------~iiHrDiKp~NILl~~~g~vkL~DFG~a 151 (316)
T d1fota_ 80 FMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK--------DIIYRDLKPENILLDKNGHIKITDFGFA 151 (316)
T ss_dssp EEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTT--------TEECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred eeEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccC--------cEEccccCchheeEcCCCCEEEecCccc
Confidence 999999999999998864 5689999999999999999999998 9999999999999999999999999999
Q ss_pred ccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCC
Q psy14889 289 VSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMD 368 (443)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~ 368 (443)
+...... ....||+.|||||++.+. .++.++|||||||++|||+|| ..||.+.
T Consensus 152 ~~~~~~~-------~~~~Gt~~Y~APE~l~~~------~y~~~~DiwSlGvilyemltG----------~~Pf~~~---- 204 (316)
T d1fota_ 152 KYVPDVT-------YTLCGTPDYIAPEVVSTK------PYNKSIDWWSFGILIYEMLAG----------YTPFYDS---- 204 (316)
T ss_dssp EECSSCB-------CCCCSCTTTCCHHHHTTC------CBCTTHHHHHHHHHHHHHHHS----------SCTTCCS----
T ss_pred eEecccc-------ccccCcccccCHHHHcCC------CCCchhhccccchhHHHHHhC----------CCCCCCc----
Confidence 8765422 345899999999999876 677899999999999999999 7788653
Q ss_pred CChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCC-----cHHHHHH
Q psy14889 369 PSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRL-----SALRVKK 423 (443)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~ 423 (443)
...++...+... ...+| ...++++.+++.+||+.||.+|+ |++++++
T Consensus 205 -~~~~~~~~i~~~--~~~~p-----~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 205 -NTMKTYEKILNA--ELRFP-----PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp -SHHHHHHHHHHC--CCCCC-----TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred -CHHHHHHHHHcC--CCCCC-----CCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 223333333222 22233 23557899999999999999996 8999876
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-50 Score=386.63 Aligned_cols=260 Identities=23% Similarity=0.403 Sum_probs=205.6
Q ss_pred hhhccccccceeeeecCeEEEEEEEC-------CceeEEEEeeccCccch--HHHHHHHHHHhc-cCCCceeeeeecccc
Q psy14889 133 TLAKQISLSECIGKGRYGEVWRGVWH-------GENVAVKIFFSRDEASW--SRETEIYSTVLL-RHENILGYIGSDMTS 202 (443)
Q Consensus 133 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~~~~--~~e~ei~~~~~l-~H~nIv~l~g~~~~~ 202 (443)
...++|++.++||+|+||.||+|++. ++.||||++........ ....|+..+..+ +|||||+++|++.+.
T Consensus 20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~ 99 (311)
T d1t46a_ 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (311)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence 34589999999999999999999862 45899999865433221 223455555556 799999999999877
Q ss_pred CCcccEEEeeecccCcccHHHHhccc-------------------CCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeE
Q psy14889 203 RNSCTQLWLVTHYHSFGSLYDHLNRT-------------------TLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIA 263 (443)
Q Consensus 203 ~~~~~~~~lv~e~~~~gsL~~~l~~~-------------------~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~ii 263 (443)
. .+++|||||++|+|.++++.. .+++..++.++.||+.||+|||++ +|+
T Consensus 100 ~----~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~--------~iv 167 (311)
T d1t46a_ 100 G----PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK--------NCI 167 (311)
T ss_dssp S----SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT--------TCC
T ss_pred C----EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC--------Cee
Confidence 4 369999999999999998542 489999999999999999999999 999
Q ss_pred EeCCCCCCEEEcCCCcEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHH
Q psy14889 264 HRDIKSKNILVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWE 343 (443)
Q Consensus 264 HrDlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~e 343 (443)
||||||+|||++.++.+||+|||+++......... ......||+.|+|||.+.+. .++.++|||||||++||
T Consensus 168 HrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DIwS~G~~l~e 239 (311)
T d1t46a_ 168 HRDLAARNILLTHGRITKICDFGLARDIKNDSNYV--VKGNARLPVKWMAPESIFNC------VYTFESDVWSYGIFLWE 239 (311)
T ss_dssp CSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSE--ECSSSEECGGGCCHHHHHHC------CCCHHHHHHHHHHHHHH
T ss_pred ecccccccccccccCcccccccchheeccCCCcce--EeeecccChHHcCHHHhcCC------CCCCcccccchHHHHHH
Confidence 99999999999999999999999998766433222 22446899999999999876 67789999999999999
Q ss_pred HHhcccCCCcccccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 344 VCRRTKANGIFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 344 lltg~~~~~~~~~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
|+|++ ..||... ...+.+.+.+. ...++..+ ..+++.+.+||.+||+.||++|||+.||++
T Consensus 240 llt~g---------~p~~~~~----~~~~~~~~~i~-~~~~~~~~-----~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 240 LFSLG---------SSPYPGM----PVDSKFYKMIK-EGFRMLSP-----EHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp HHTTT---------CCSSTTC----CSSHHHHHHHH-HTCCCCCC-----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHhCC---------CCCCCCC----CHHHHHHHHHh-cCCCCCCc-----ccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 99962 3334332 12234444443 23444444 235678999999999999999999999999
Q ss_pred HHHHHhhc
Q psy14889 424 TLIKLACA 431 (443)
Q Consensus 424 ~L~~l~~~ 431 (443)
.|+++..+
T Consensus 301 ~L~~~i~~ 308 (311)
T d1t46a_ 301 LIEKQISE 308 (311)
T ss_dssp HHHHHHHH
T ss_pred HHHHhhcc
Confidence 99987654
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-50 Score=390.69 Aligned_cols=253 Identities=19% Similarity=0.268 Sum_probs=193.2
Q ss_pred hccccccc-eeeeecCeEEEEEEE--CCceeEEEEeeccCccchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEe
Q psy14889 135 AKQISLSE-CIGKGRYGEVWRGVW--HGENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWL 211 (443)
Q Consensus 135 ~~~~~~~~-~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~l 211 (443)
.++|.+.+ .||+|+||+||+|++ +++.||||++... ....+|.++... ..+|||||++++++.+.......+|+
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--~~~~~E~~~~~~-~~~hpnIv~l~~~~~~~~~~~~~~~i 86 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--PKARREVELHWR-ASQCPHIVRIVDVYENLYAGRKCLLI 86 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--HHHHHHHHHHHH-HTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--HHHHHHHHHHHH-hcCCCCCCeEEEEEeecccCCCEEEE
Confidence 36898765 699999999999997 5899999998542 233445444332 25899999999998764433367899
Q ss_pred eecccCcccHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcC---CCcEEEEec
Q psy14889 212 VTHYHSFGSLYDHLNR---TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKT---NGTCVIADF 285 (443)
Q Consensus 212 v~e~~~~gsL~~~l~~---~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~---~~~~kl~Df 285 (443)
|||||++|+|.+++.+ ..+++.++..++.||+.||+|||+. +|+||||||+|||++. ++.+||+||
T Consensus 87 vmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~--------~iiHRDiKp~NIll~~~~~~~~~Kl~DF 158 (335)
T d2ozaa1 87 VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI--------NIAHRDVKPENLLYTSKRPNAILKLTDF 158 (335)
T ss_dssp EEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHT--------TEECCCCSGGGEEESCSSTTCCEEECCC
T ss_pred EEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHc--------CCcccccccccccccccccccccccccc
Confidence 9999999999999965 3699999999999999999999999 9999999999999986 457999999
Q ss_pred CCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCC
Q psy14889 286 GLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLV 365 (443)
Q Consensus 286 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~ 365 (443)
|+|+....... .....||+.|||||++.+. .++.++|||||||++|||+|| ..||.+..
T Consensus 159 G~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~------~y~~~~DiwSlGvily~lltg----------~~Pf~~~~ 217 (335)
T d2ozaa1 159 GFAKETTSHNS-----LTTPCYTPYYVAPEVLGPE------KYDKSCDMWSLGVIMYILLCG----------YPPFYSNH 217 (335)
T ss_dssp TTCEECCCCCC-----CCCCSCCCSSCCCCCCCGG------GGSHHHHHHHHHHHHHHHTTS----------SCSCEETT
T ss_pred ceeeeccCCCc-----cccccCCcccCCcHHHcCC------CCCHHHHHHhhchhHHHHhhC----------CCCCCCCC
Confidence 99987654322 2345799999999999876 677899999999999999999 66776532
Q ss_pred CCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 366 PMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
.... ...+...+. .....+|.. ....+++++.+||.+||+.||++|||+.|+++
T Consensus 218 ~~~~-~~~~~~~i~--~~~~~~~~~-~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 218 GLAI-SPGMKTRIR--MGQYEFPNP-EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp CC---------CCC--SCSSSCCTT-HHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHH-HHHHHHHHh--cCCCCCCCc-ccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 2111 111111111 111122211 11235678999999999999999999999987
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-50 Score=387.62 Aligned_cols=249 Identities=19% Similarity=0.264 Sum_probs=200.7
Q ss_pred hhccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEe
Q psy14889 134 LAKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWL 211 (443)
Q Consensus 134 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~l 211 (443)
+-++|++.+.||+|+||+||+|.+ +|+.||||++..........+.|+..+..++|||||++++++.+. ..+||
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~----~~~~l 78 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESM----EELVM 78 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEET----TEEEE
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEEC----CEEEE
Confidence 347899999999999999999998 588999999977655544555677777779999999999999876 46899
Q ss_pred eecccCcccHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCC--CcEEEEecCC
Q psy14889 212 VTHYHSFGSLYDHLNRT--TLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTN--GTCVIADFGL 287 (443)
Q Consensus 212 v~e~~~~gsL~~~l~~~--~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~--~~~kl~DfGl 287 (443)
|||||++|+|.+++... .+++.++..++.||+.||+|||+. +|+||||||+|||++.+ ..+||+|||+
T Consensus 79 vmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~--------~iiHrDlKp~NIll~~~~~~~ikl~DFG~ 150 (321)
T d1tkia_ 79 IFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH--------NIGHFDIRPENIIYQTRRSSTIKIIEFGQ 150 (321)
T ss_dssp EECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHT--------TEECCCCCGGGEEESSSSCCCEEECCCTT
T ss_pred EEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc--------CCCcccccccceeecCCCceEEEEcccch
Confidence 99999999999999653 689999999999999999999998 99999999999999854 4899999999
Q ss_pred cccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCC
Q psy14889 288 AVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPM 367 (443)
Q Consensus 288 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~ 367 (443)
++........ ....||+.|+|||.+.+. .++.++|||||||++|||++| ..||...
T Consensus 151 ~~~~~~~~~~-----~~~~~t~~y~ape~~~~~------~~~~~~DiWSlGvily~ll~G----------~~Pf~~~--- 206 (321)
T d1tkia_ 151 ARQLKPGDNF-----RLLFTAPEYYAPEVHQHD------VVSTATDMWSLGTLVYVLLSG----------INPFLAE--- 206 (321)
T ss_dssp CEECCTTCEE-----EEEESCGGGSCHHHHTTC------EECHHHHHHHHHHHHHHHHHS----------SCTTCCS---
T ss_pred hhccccCCcc-----cccccccccccchhccCC------CCCchhhcccHHHHHHHHHhC----------CCCCCCC---
Confidence 9776432211 234789999999998876 667899999999999999999 7787653
Q ss_pred CCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 368 DPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
....+...+.... ..++... ...+++++.+|+.+||..||++|||+.|+++
T Consensus 207 --~~~~~~~~i~~~~--~~~~~~~-~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 207 --TNQQIIENIMNAE--YTFDEEA-FKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp --SHHHHHHHHHHTC--CCCCHHH-HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred --CHHHHHHHHHhCC--CCCChhh-ccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 2233333322221 1122100 0135678999999999999999999999987
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-50 Score=384.15 Aligned_cols=243 Identities=23% Similarity=0.386 Sum_probs=197.2
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccC----cc--chHHHHHHHHHHhccCCCceeeeeeccccCCccc
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRD----EA--SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCT 207 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~----~~--~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~ 207 (443)
++|.+.+.||+|+||+||+|++ +|+.||||++.... .. ....|..+.. ..++|||||++++++.+. .
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~-~~~~hp~Iv~~~~~~~~~----~ 76 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLS-LAWEHPFLTHMFCTFQTK----E 76 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHH-HHTTCTTBCCEEEEEECS----S
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHH-HhCCCCcEEEEEEEEccC----C
Confidence 5799999999999999999998 68999999986431 11 2222333322 248999999999999887 4
Q ss_pred EEEeeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecC
Q psy14889 208 QLWLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFG 286 (443)
Q Consensus 208 ~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfG 286 (443)
.+|+||||+++|+|.+++.. ..+++.++..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||
T Consensus 77 ~~yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~--------~iiHrDikp~NiL~~~~~~~kl~DFG 148 (320)
T d1xjda_ 77 NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK--------GIVYRDLKLDNILLDKDGHIKIADFG 148 (320)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT--------TCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred ceeEEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC--------CeeeccCcccceeecCCCceeccccc
Confidence 58999999999999999964 6799999999999999999999999 99999999999999999999999999
Q ss_pred CcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCC
Q psy14889 287 LAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVP 366 (443)
Q Consensus 287 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~ 366 (443)
+++........ .....||+.|+|||++.+. .++.++|||||||++|||+|| ..||.+.
T Consensus 149 ~a~~~~~~~~~----~~~~~gt~~y~aPE~~~~~------~~~~~~DiwSlGvilyemltG----------~~PF~~~-- 206 (320)
T d1xjda_ 149 MCKENMLGDAK----TNTFCGTPDYIAPEILLGQ------KYNHSVDWWSFGVLLYEMLIG----------QSPFHGQ-- 206 (320)
T ss_dssp TCBCCCCTTCC----BCCCCSCGGGCCHHHHTTC------CBCTHHHHHHHHHHHHHHHHS----------SCSSCCS--
T ss_pred hhhhccccccc----ccccCCCCCcCCHHHHcCC------CCCchhhhhhhhHHHHHHHhC----------CCCCCCC--
Confidence 99865543222 2345799999999999887 777899999999999999999 7788653
Q ss_pred CCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHH-HHHH
Q psy14889 367 MDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSAL-RVKK 423 (443)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~-evl~ 423 (443)
....+...+.. ..+.+| ..+++++.+|+.+||+.||++|||+. ++++
T Consensus 207 ---~~~~~~~~i~~--~~~~~p-----~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 207 ---DEEELFHSIRM--DNPFYP-----RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp ---SHHHHHHHHHH--CCCCCC-----TTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ---CHHHHHHHHHc--CCCCCC-----ccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 33444443332 234444 23567899999999999999999985 6753
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-50 Score=385.52 Aligned_cols=260 Identities=21% Similarity=0.367 Sum_probs=208.6
Q ss_pred hhhccccccceeeeecCeEEEEEEEC-------CceeEEEEeeccCccc--hHHHHHHHHHHhccCCCceeeeeeccccC
Q psy14889 133 TLAKQISLSECIGKGRYGEVWRGVWH-------GENVAVKIFFSRDEAS--WSRETEIYSTVLLRHENILGYIGSDMTSR 203 (443)
Q Consensus 133 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~~~--~~~e~ei~~~~~l~H~nIv~l~g~~~~~~ 203 (443)
...++|++.+.||+|+||+||+|.+. ++.||||++....... .....|+..+..++|||||+++|++....
T Consensus 17 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~ 96 (308)
T d1p4oa_ 17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 96 (308)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCC
Confidence 33478999999999999999999874 4689999986543222 22346777777799999999999997764
Q ss_pred CcccEEEeeecccCcccHHHHhcc-----------cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCE
Q psy14889 204 NSCTQLWLVTHYHSFGSLYDHLNR-----------TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNI 272 (443)
Q Consensus 204 ~~~~~~~lv~e~~~~gsL~~~l~~-----------~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~Ni 272 (443)
..++||||+++|+|.+++.. ..+++..+..++.|+|+||.|||++ +|+||||||+||
T Consensus 97 ----~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~--------~ivHrDlk~~Ni 164 (308)
T d1p4oa_ 97 ----PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN--------KFVHRDLAARNC 164 (308)
T ss_dssp ----SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT--------TCBCSCCSGGGE
T ss_pred ----ceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC--------CeeeceEcCCce
Confidence 36999999999999999853 2478999999999999999999998 999999999999
Q ss_pred EEcCCCcEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCC
Q psy14889 273 LVKTNGTCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANG 352 (443)
Q Consensus 273 Ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~ 352 (443)
|++.++++||+|||+|+.+....... ......||+.|+|||.+.+. .++.++||||||+++|||+||+
T Consensus 165 Lld~~~~~Kl~DFGla~~~~~~~~~~--~~~~~~~t~~y~aPe~l~~~------~~~~~~Dv~S~G~il~El~t~~---- 232 (308)
T d1p4oa_ 165 MVAEDFTVKIGDFGMTRDIYETDYYR--KGGKGLLPVRWMSPESLKDG------VFTTYSDVWSFGVVLWEIATLA---- 232 (308)
T ss_dssp EECTTCCEEECCTTCCCGGGGGGCEE--GGGSSEECGGGCCHHHHHHC------CCCHHHHHHHHHHHHHHHHHTS----
T ss_pred eecCCceEEEeecccceeccCCccee--eccceecccccCCHHHHccC------CCCcccccccHHHHHHHHHhCC----
Confidence 99999999999999998765543221 12334789999999999877 6778999999999999999983
Q ss_pred cccccCCCCCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhhcc
Q psy14889 353 IFEEYKAPYHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLACAD 432 (443)
Q Consensus 353 ~~~~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~~~ 432 (443)
..||.+. ...+....+. ...++..| ..++..+.+||.+||+.||++|||+.+|++.|++..+..
T Consensus 233 -----~~p~~~~-----~~~~~~~~i~-~~~~~~~p-----~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~ 296 (308)
T d1p4oa_ 233 -----EQPYQGL-----SNEQVLRFVM-EGGLLDKP-----DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG 296 (308)
T ss_dssp -----CCTTTTS-----CHHHHHHHHH-TTCCCCCC-----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTT
T ss_pred -----CCCCCCC-----CHHHHHHHHH-hCCCCCCc-----ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence 3566553 3344444333 23344443 346678999999999999999999999999999876654
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=9.2e-50 Score=388.74 Aligned_cols=246 Identities=26% Similarity=0.384 Sum_probs=194.9
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccC------ccchHHH-HHHHHHHhccCCCceeeeeeccccCCcc
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRD------EASWSRE-TEIYSTVLLRHENILGYIGSDMTSRNSC 206 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~------~~~~~~e-~ei~~~~~l~H~nIv~l~g~~~~~~~~~ 206 (443)
++|++.+.||+|+||.||+|++ +|+.||||++.... ......| .++..+..++|||||++++++.+.
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~---- 79 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP---- 79 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS----
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEEC----
Confidence 5799999999999999999998 58999999985422 1122223 234444557899999999999876
Q ss_pred cEEEeeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEec
Q psy14889 207 TQLWLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADF 285 (443)
Q Consensus 207 ~~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~Df 285 (443)
..+|+||||+++|+|.+++.+ ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+||
T Consensus 80 ~~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~--------~iiHrDlKP~NILl~~~g~iKl~DF 151 (364)
T d1omwa3 80 DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR--------FVVYRDLKPANILLDEHGHVRISDL 151 (364)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT--------TEECCCCSGGGEEECSSSCEEECCC
T ss_pred CEEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHC--------CccceeeccceeEEcCCCcEEEeee
Confidence 458999999999999999964 6789999999999999999999999 9999999999999999999999999
Q ss_pred CCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCC
Q psy14889 286 GLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLV 365 (443)
Q Consensus 286 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~ 365 (443)
|+|+.+.... .....||+.|+|||++..+. .++.++|||||||++|||+|| ..||....
T Consensus 152 Gla~~~~~~~------~~~~~GT~~y~APE~~~~~~-----~~~~~~DiwSlGvilyemltG----------~~Pf~~~~ 210 (364)
T d1omwa3 152 GLACDFSKKK------PHASVGTHGYMAPEVLQKGV-----AYDSSADWFSLGCMLFKLLRG----------HSPFRQHK 210 (364)
T ss_dssp TTCEECSSSC------CCSCCSCGGGCCHHHHSTTC-----CCCTHHHHHHHHHHHHHHHHS----------SCSSCSSC
T ss_pred ceeeecCCCc------ccccccccccchhHHhhcCC-----CCCcccchhHHHHHHHHHHhC----------CCCCCCCC
Confidence 9998765422 23457999999999997542 567899999999999999999 77776542
Q ss_pred CCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCc-----HHHHHH
Q psy14889 366 PMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLS-----ALRVKK 423 (443)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~ 423 (443)
.. ....+.... ....+..+ ..+++++.+||.+||+.||++||| ++|+++
T Consensus 211 ~~--~~~~~~~~~--~~~~~~~~-----~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 211 TK--DKHEIDRMT--LTMAVELP-----DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp SS--CHHHHHHHS--SSCCCCCC-----SSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred HH--HHHHHHHhc--ccCCCCCC-----CCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 11 122222211 12222222 346678999999999999999999 688875
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.2e-49 Score=385.99 Aligned_cols=241 Identities=20% Similarity=0.287 Sum_probs=198.7
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccC----ccchHHHHHHHHHHhccCCCceeeeeeccccCCcccEE
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRD----EASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQL 209 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~----~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~ 209 (443)
++|++.+.||+|+||.||+|++ +|+.||||++.... ........|+..+..++|||||++++++.+. ..+
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~----~~~ 116 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN----SNL 116 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS----SEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccc----ccc
Confidence 6899999999999999999998 58999999986432 1122234566667779999999999998876 458
Q ss_pred EeeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCc
Q psy14889 210 WLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA 288 (443)
Q Consensus 210 ~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla 288 (443)
++||||+.+|+|.+++.+ ..+++..+..++.||+.||.|||++ +||||||||+|||++.++.+||+|||+|
T Consensus 117 ~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~--------~iiHRDIKP~NILl~~~g~ikL~DFG~a 188 (350)
T d1rdqe_ 117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL--------DLIYRDLKPENLLIDQQGYIQVTDFGFA 188 (350)
T ss_dssp EEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT--------TEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred ccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CEecCcCCHHHcccCCCCCEEeeeceee
Confidence 999999999999999864 6799999999999999999999999 9999999999999999999999999999
Q ss_pred ccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCC
Q psy14889 289 VSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMD 368 (443)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~ 368 (443)
+.+.... ....||+.|||||++.+. .++.++|||||||++|||+|| ..||.+.
T Consensus 189 ~~~~~~~-------~~~~Gt~~Y~APE~~~~~------~~~~~~DiwSlGvilyemltG----------~~Pf~~~---- 241 (350)
T d1rdqe_ 189 KRVKGRT-------WTLCGTPEALAPEIILSK------GYNKAVDWWALGVLIYEMAAG----------YPPFFAD---- 241 (350)
T ss_dssp EECSSCB-------CCCEECGGGCCHHHHTTC------CBCTHHHHHHHHHHHHHHHHS----------SCSSCCS----
T ss_pred eeccccc-------ccccCccccCCHHHHcCC------CCCccccccchhHHHHHHHhC----------CCCCCCc----
Confidence 8765322 345899999999999876 677899999999999999999 7788653
Q ss_pred CChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCC-----cHHHHHH
Q psy14889 369 PSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRL-----SALRVKK 423 (443)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~ 423 (443)
....+...+... .+..+ ..+++++.+|+++||+.||.+|+ |++++++
T Consensus 242 -~~~~~~~~i~~~--~~~~p-----~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 242 -QPIQIYEKIVSG--KVRFP-----SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp -SHHHHHHHHHHC--CCCCC-----TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred -CHHHHHHHHhcC--CCCCC-----ccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 223333333222 22333 23567899999999999999994 8999986
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-49 Score=373.34 Aligned_cols=248 Identities=22% Similarity=0.276 Sum_probs=186.6
Q ss_pred cceeeeecCeEEEEEEE--CCceeEEEEeeccCcc------chHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEee
Q psy14889 141 SECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA------SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLV 212 (443)
Q Consensus 141 ~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~------~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv 212 (443)
+++||+|+||+||+|++ +|+.||||++...... ......|+..+..++|||||++++++.+.. .+++|
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~----~~~iv 78 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS----NISLV 78 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT----CCEEE
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCC----ceeeh
Confidence 57899999999999997 5899999988543221 122345666666799999999999998774 47999
Q ss_pred ecccCcccHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcccc
Q psy14889 213 THYHSFGSLYDHLN-RTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVSY 291 (443)
Q Consensus 213 ~e~~~~gsL~~~l~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~~ 291 (443)
|||+.++++..+.. +..+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+..
T Consensus 79 mE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~--------~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~ 150 (299)
T d1ua2a_ 79 FDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH--------WILHRDLKPNNLLLDENGVLKLADFGLAKSF 150 (299)
T ss_dssp EECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHT--------TCCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred hhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcc--------ceecccCCcceEEecCCCccccccCcccccc
Confidence 99999988877775 45799999999999999999999999 9999999999999999999999999999766
Q ss_pred cccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCCh
Q psy14889 292 SQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSF 371 (443)
Q Consensus 292 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~~ 371 (443)
...... ....+||+.|+|||++.... .++.++|||||||++|||+|| ..||.... ..
T Consensus 151 ~~~~~~----~~~~~gt~~y~aPE~~~~~~-----~~~~~~DiwSlGvil~el~~g----------~~pf~~~~----~~ 207 (299)
T d1ua2a_ 151 GSPNRA----YTHQVVTRWYRAPELLFGAR-----MYGVGVDMWAVGCILAELLLR----------VPFLPGDS----DL 207 (299)
T ss_dssp TSCCCC----CCCSCCCCTTCCHHHHTTCS-----CCCHHHHHHHHHHHHHHHHHS----------SCSSCCSS----HH
T ss_pred CCCccc----ccceecChhhccHHHHccCC-----CCChhhhhhhcchHHHHHHhC----------cCCCCCCC----HH
Confidence 543222 23457999999999987542 456899999999999999999 55654421 11
Q ss_pred HHHHhhhhhcCC-----------------CCCCCCC---CCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 372 DDMRKVICIDQQ-----------------RPVLPNR---WVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 372 ~~~~~~~~~~~~-----------------~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
+.+..+...... ....+.. ......++++.+|+.+||+.||++|||++|+++
T Consensus 208 ~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 208 DQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp HHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 222221111000 0000000 001134578999999999999999999999986
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-49 Score=367.88 Aligned_cols=238 Identities=18% Similarity=0.304 Sum_probs=188.9
Q ss_pred hccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCc---------cchHHHHHHHHHHhccCCCceeeeeeccccC
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDE---------ASWSRETEIYSTVLLRHENILGYIGSDMTSR 203 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~---------~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~ 203 (443)
.++|++.+.||+|+||+||+|++ +|+.||||++..... ....+|.+++....-.|||||++++++.+.
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~- 81 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP- 81 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS-
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC-
Confidence 46899999999999999999998 589999999864321 223445555554323499999999999876
Q ss_pred CcccEEEeeecccCc-ccHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCC-CcE
Q psy14889 204 NSCTQLWLVTHYHSF-GSLYDHLN-RTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTN-GTC 280 (443)
Q Consensus 204 ~~~~~~~lv~e~~~~-gsL~~~l~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~-~~~ 280 (443)
..+++||||+.+ +++.+++. +..+++.++..++.||+.||+|||+. +|+||||||+|||++.+ +.+
T Consensus 82 ---~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~--------~iiHrDiKp~NIll~~~~~~v 150 (273)
T d1xwsa_ 82 ---DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC--------GVLHRDIKDENILIDLNRGEL 150 (273)
T ss_dssp ---SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT--------TEECSCCSGGGEEEETTTTEE
T ss_pred ---CeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC--------CCccccCcccceEEecCCCeE
Confidence 457999999975 68888875 46899999999999999999999999 99999999999999854 799
Q ss_pred EEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCC
Q psy14889 281 VIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAP 360 (443)
Q Consensus 281 kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P 360 (443)
||+|||+|+...... .+...||+.|+|||++.+.. .++.++|||||||++|||+|| ..|
T Consensus 151 kl~DFG~a~~~~~~~------~~~~~GT~~y~aPE~~~~~~-----~~~~~~DiwSlGvilyell~g----------~~P 209 (273)
T d1xwsa_ 151 KLIDFGSGALLKDTV------YTDFDGTRVYSPPEWIRYHR-----YHGRSAAVWSLGILLYDMVCG----------DIP 209 (273)
T ss_dssp EECCCTTCEECCSSC------BCCCCSCGGGSCHHHHHHSC-----BCHHHHHHHHHHHHHHHHHHS----------SCS
T ss_pred EECccccceeccccc------ccccccCCCcCCHHHHcCCC-----CCCcccccccceeeehhHhhC----------CCC
Confidence 999999997654321 23457999999999998652 124678999999999999999 677
Q ss_pred CCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 361 YHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
|... ..+.. ....++ ..+++++.+|+.+||+.||++|||++|+++
T Consensus 210 f~~~-------~~i~~------~~~~~~-----~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 210 FEHD-------EEIIR------GQVFFR-----QRVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp CCSH-------HHHHH------CCCCCS-----SCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCc-------hHHhh------cccCCC-----CCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 7542 11111 111222 235678999999999999999999999976
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-47 Score=364.36 Aligned_cols=256 Identities=25% Similarity=0.325 Sum_probs=190.7
Q ss_pred hccccccceeeeecCeEEEEEEE--C-CceeEEEEeeccC-----ccchHHHHHHHH-HHhccCCCceeeeeeccccC-C
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVW--H-GENVAVKIFFSRD-----EASWSRETEIYS-TVLLRHENILGYIGSDMTSR-N 204 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~--~-~~~vAvK~~~~~~-----~~~~~~e~ei~~-~~~l~H~nIv~l~g~~~~~~-~ 204 (443)
.++|++.+.||+|+||+||+|++ + ++.||||++.... .....+|.+++. +...+||||+++++++.... .
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 36899999999999999999997 2 5679999885432 122334444433 33358999999999986432 2
Q ss_pred cccEEEeeecccCcccHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEE
Q psy14889 205 SCTQLWLVTHYHSFGSLYDHL--NRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVI 282 (443)
Q Consensus 205 ~~~~~~lv~e~~~~gsL~~~l--~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl 282 (443)
....++++|||+.+|++.... ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~--------~ivHrDiKp~NILi~~~~~~kl 157 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH--------RVVHRDLKPQNILVTSSGQIKL 157 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT--------TCCCCCCCGGGEEECTTCCEEE
T ss_pred cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhC--------CEEecCCCccEEEEcCCCCeee
Confidence 235689999999988775544 346799999999999999999999999 9999999999999999999999
Q ss_pred EecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCC
Q psy14889 283 ADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYH 362 (443)
Q Consensus 283 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~ 362 (443)
+|||+++....... .....||+.|+|||++.+. .++.++||||+||++|||+|| ..||.
T Consensus 158 ~dfg~~~~~~~~~~-----~~~~~gT~~Y~APE~~~~~------~y~~~~DiwSlG~il~ell~g----------~~pf~ 216 (305)
T d1blxa_ 158 ADFGLARIYSFQMA-----LTSVVVTLWYRAPEVLLQS------SYATPVDLWSVGCIFAEMFRR----------KPLFR 216 (305)
T ss_dssp CSCCSCCCCCGGGG-----GCCCCCCCTTCCHHHHTTC------CCCTHHHHHHHHHHHHHHHHS----------SCSCC
T ss_pred cchhhhhhhccccc-----CCCcccChhhcCcchhcCC------CCChhehhhchHHHHHHHHHC----------CCCCC
Confidence 99999876543322 2345899999999999876 778999999999999999999 56665
Q ss_pred CCCCCCCChHHHHhhhhhcC-------------------CCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 363 DLVPMDPSFDDMRKVICIDQ-------------------QRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
+.. ..+.+........ .....+........++.+.+|+.+||+.||++|||+.|+++
T Consensus 217 ~~~----~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 217 GSS----DVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp CSS----HHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCC----HHHHHHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 421 1111111111000 00000000112335678999999999999999999999876
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-47 Score=365.20 Aligned_cols=254 Identities=25% Similarity=0.311 Sum_probs=190.3
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCc---cchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEE
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDE---ASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLW 210 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~---~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~ 210 (443)
++|++.+.||+|+||+||+|++ +|+.||||++..... .......|+..+..++|||||++++++.+. ..++
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~----~~~~ 77 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTE----NKLY 77 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEET----TEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccc----ccee
Confidence 5899999999999999999998 589999999854322 123345677777779999999999999876 4689
Q ss_pred eeecccCcccHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCc
Q psy14889 211 LVTHYHSFGSLYDHLN--RTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA 288 (443)
Q Consensus 211 lv~e~~~~gsL~~~l~--~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla 288 (443)
+||||+.++.+..... ...+++..+..++.||+.||+|||++ +||||||||+|||++.++.+||+|||+|
T Consensus 78 iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~--------~IiHrDiKpeNIl~~~~~~~kl~DFG~a 149 (298)
T d1gz8a_ 78 LVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH--------RVLHRDLKPQNLLINTEGAIKLADFGLA 149 (298)
T ss_dssp EEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT--------TCCCSCCCGGGEEECTTSCEEECSTTHH
T ss_pred EEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcC--------CEEccccCchheeecccCcceeccCCcc
Confidence 9999998654443322 35699999999999999999999999 9999999999999999999999999999
Q ss_pred ccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCC
Q psy14889 289 VSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMD 368 (443)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~ 368 (443)
+........ .....||+.|+|||.+.... .++.++|||||||++|||++| ..||....
T Consensus 150 ~~~~~~~~~----~~~~~gt~~y~apE~~~~~~-----~~~~~~DiwSlGvily~m~~G----------~~Pf~~~~--- 207 (298)
T d1gz8a_ 150 RAFGVPVRT----YTHEVVTLWYRAPEILLGCK-----YYSTAVDIWSLGCIFAEMVTR----------RALFPGDS--- 207 (298)
T ss_dssp HHHCCCSBC----TTCCBCCCTTCCHHHHTTCS-----SCCTHHHHHHHHHHHHHHHHS----------SCSCCCSS---
T ss_pred eeccCCccc----ceeecccceeeehhhhcccc-----CCCccccccccchhhhHHhhC----------CCCCCCCC---
Confidence 776543222 24458999999999887652 345899999999999999999 55664321
Q ss_pred CChHHHHhhhhh---------------cCCCCCCCCCCC------CchhHHHHHHHHHHHhcCCcCCCCcHHHHHHH
Q psy14889 369 PSFDDMRKVICI---------------DQQRPVLPNRWV------SDSTLNAMTKVMKECWHQNANVRLSALRVKKT 424 (443)
Q Consensus 369 ~~~~~~~~~~~~---------------~~~~~~~~~~~~------~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 424 (443)
..+.+.+.... .......+.... ....+.++.+|+.+||+.||++|||++|+++.
T Consensus 208 -~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 208 -EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp -HHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -HHHHHHHHHHhcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 11111111100 001111111000 11345678999999999999999999999874
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1e-47 Score=363.14 Aligned_cols=253 Identities=23% Similarity=0.271 Sum_probs=191.1
Q ss_pred ccccccceeeeecCeEEEEEEE-CCceeEEEEeeccCcc---chHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEe
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW-HGENVAVKIFFSRDEA---SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWL 211 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~---~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~l 211 (443)
++|++.+.||+|+||+||+|++ +|+.||||++...... ......|+..+..++|||||++++++.... ..++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~----~~~i 77 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKK----RLVL 77 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSS----CEEE
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCC----ceeE
Confidence 5899999999999999999998 6899999998654322 233456777777799999999999998774 4799
Q ss_pred eecccCcccHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCccc
Q psy14889 212 VTHYHSFGSLYDHLN-RTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVS 290 (443)
Q Consensus 212 v~e~~~~gsL~~~l~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~ 290 (443)
++||+.++++..+.. ...+++.++..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+|..
T Consensus 78 ~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~--------~IvHrDiKp~NIll~~~~~~kl~DfG~a~~ 149 (286)
T d1ob3a_ 78 VFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR--------RVLHRDLKPQNLLINREGELKIADFGLARA 149 (286)
T ss_dssp EEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHT--------TCCCSCCCGGGEEECTTSCEEECCTTHHHH
T ss_pred EEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccC--------cEEecCCCCceeeEcCCCCEEeccccccee
Confidence 999999888777765 46799999999999999999999998 999999999999999999999999999977
Q ss_pred ccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCC
Q psy14889 291 YSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPS 370 (443)
Q Consensus 291 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~ 370 (443)
....... .....|++.|+|||.+.+.. .++.++|||||||++|||++| ..||.+.. .
T Consensus 150 ~~~~~~~----~~~~~~~~~y~~pE~~~~~~-----~~~~~~DiwslGv~l~el~~G----------~~pf~~~~----~ 206 (286)
T d1ob3a_ 150 FGIPVRK----YTHEIVTLWYRAPDVLMGSK-----KYSTTIDIWSVGCIFAEMVNG----------TPLFPGVS----E 206 (286)
T ss_dssp HCC-------------CCCTTCCHHHHTTCC-----SCCTHHHHHHHHHHHHHHHHS----------SCSCCCSS----H
T ss_pred cccCccc----cceecccchhhhHHHHhCCC-----CCCcceeehhcCcHHHHHHHC----------CCCCCCCC----H
Confidence 6543221 23446899999999987642 456899999999999999999 55554321 1
Q ss_pred hHHHHhhhhhc---------------------CCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 371 FDDMRKVICID---------------------QQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 371 ~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
.+.+.+..... ......+........++.+.+|+.+||+.||++|||+.|+++
T Consensus 207 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 207 ADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp HHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11111111000 000001101112335678999999999999999999999974
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-47 Score=367.77 Aligned_cols=262 Identities=21% Similarity=0.248 Sum_probs=191.1
Q ss_pred hccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccc--hHHHHHHHHHHhccCCCceeeeeeccccCCcccEEE
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEAS--WSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLW 210 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~--~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~ 210 (443)
..+|++.+.||+|+||+||+|.. +|+.||||++....... .....|+..+..++||||+++++++..........+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 46799999999999999999987 59999999986543221 122346666666999999999999876533222234
Q ss_pred eeecccCcccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCccc
Q psy14889 211 LVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAVS 290 (443)
Q Consensus 211 lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~~ 290 (443)
++++|+.+|+|.+++....+++..+..++.||+.||+|||++ +||||||||+|||++.++.+||+|||+|+.
T Consensus 87 ~l~~~~~~g~L~~~l~~~~l~~~~i~~i~~qil~al~yLH~~--------~iiHRDIKp~NILl~~~~~~kl~DfG~a~~ 158 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA--------NVLHRDLKPSNLLLNTTCDLKICDFGLARV 158 (345)
T ss_dssp EEEEECCCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT--------TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeecCCchhhhhhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CCcCCCCCcceEEECCCCCEEEcccCceee
Confidence 455667789999999888999999999999999999999999 999999999999999999999999999987
Q ss_pred ccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCC
Q psy14889 291 YSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPS 370 (443)
Q Consensus 291 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~ 370 (443)
........ .......||+.|+|||++.... .++.++||||+||++|||++| ..||.....
T Consensus 159 ~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~-----~~~~~~DiwSlG~il~eml~g----------~~pf~~~~~---- 218 (345)
T d1pmea_ 159 ADPDHDHT-GFLTEYVATRWYRAPEIMLNSK-----GYTKSIDIWSVGCILAEMLSN----------RPIFPGKHY---- 218 (345)
T ss_dssp CCGGGCBC-CTTCCCCSCGGGCCGGGTTTBC-----SCSTHHHHHHHHHHHHHHHHS----------SCSCCCSSH----
T ss_pred ccCCCccc-eeeccccccceechHHHhhcCC-----CCCchhhhhccCceehHHhhC----------CCCCCCCCH----
Confidence 65433222 1234567999999999986552 456899999999999999999 556644210
Q ss_pred hHHHHhhh-----------------------hhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHH
Q psy14889 371 FDDMRKVI-----------------------CIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKT 424 (443)
Q Consensus 371 ~~~~~~~~-----------------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 424 (443)
.+...... .........+........+.++.+|+.+||+.||++|||+.|+++.
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 219 LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00110000 0000000000000011244679999999999999999999999874
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.7e-47 Score=359.37 Aligned_cols=261 Identities=19% Similarity=0.255 Sum_probs=192.9
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCc-cchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEee
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDE-ASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLV 212 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv 212 (443)
++|++.+.||+|+||+||+|++ +|+.||||++..... .....|.+++ ..++|+|++..++.+.... ...++|
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~--~~l~~~~~i~~~~~~~~~~---~~~~iv 81 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIY--KMMQGGVGIPTIRWCGAEG---DYNVMV 81 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHH--HHSTTSTTCCCEEEEEEET---TEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHH--HHccCCCcccEEEEEEecC---CEEEEE
Confidence 5799999999999999999998 588999998765432 3444455544 4488887776666554433 357899
Q ss_pred ecccCcccHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcC---CCcEEEEecCC
Q psy14889 213 THYHSFGSLYDHLN--RTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKT---NGTCVIADFGL 287 (443)
Q Consensus 213 ~e~~~~gsL~~~l~--~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~---~~~~kl~DfGl 287 (443)
|||+. |+|.+.+. ...+++..+..++.|++.||+|||++ +|+||||||+|||++. +..+||+|||+
T Consensus 82 me~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--------~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~ 152 (299)
T d1ckia_ 82 MELLG-PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK--------NFIHRDVKPDNFLMGLGKKGNLVYIIDFGL 152 (299)
T ss_dssp EECCC-CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT--------TEECSCCCGGGEEECCGGGTTCEEECCCSS
T ss_pred EEEcC-CchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHC--------CeeeccCCHhhccccccCCCceeeeeccCc
Confidence 99996 56666654 46799999999999999999999999 9999999999999854 45799999999
Q ss_pred cccccccCCcCC---CCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCC
Q psy14889 288 AVSYSQLSNKMD---IPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDL 364 (443)
Q Consensus 288 a~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~ 364 (443)
|+.+........ .......||+.|||||.+.+. .++.++|||||||++|||+|| ..||...
T Consensus 153 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwSlG~~l~el~tg----------~~P~~~~ 216 (299)
T d1ckia_ 153 AKKYRDARTHQHIPYRENKNLTGTARYASINTHLGI------EQSRRDDLESLGYVLMYFNLG----------SLPWQGL 216 (299)
T ss_dssp CEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTB------CCCHHHHHHHHHHHHHHHHHS----------SCTTCCC
T ss_pred ceeccccccccceeccccCCcCCCccccCHHHHhCC------CCCChhhEEecCHHHHHHHhC----------CCccccc
Confidence 987765332211 122456799999999999876 677999999999999999999 7777664
Q ss_pred CCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhh
Q psy14889 365 VPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLAC 430 (443)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~ 430 (443)
........ ........ .....+ .....+++++.+++.+||+.||++||++.++.+.|+.+..
T Consensus 217 ~~~~~~~~-~~~~~~~~-~~~~~~--~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 217 KAATKRQK-YERISEKK-MSTPIE--VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp C--------HHHHHHHH-HHSCHH--HHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred chHHHHHH-HHHhhccc-CCCChh--HhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 33221111 11111000 001000 0112366789999999999999999999999999988754
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-47 Score=366.01 Aligned_cols=261 Identities=21% Similarity=0.309 Sum_probs=192.8
Q ss_pred hhccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccc---hHHHHHHHHHHhccCCCceeeeeeccccCC--cc
Q psy14889 134 LAKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEAS---WSRETEIYSTVLLRHENILGYIGSDMTSRN--SC 206 (443)
Q Consensus 134 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~---~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~--~~ 206 (443)
+.++|++.+.||+|+||+||+|.+ +|+.||||++....... .....|+..+..++|||||++++++..... ..
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 558999999999999999999998 58999999986533221 122456666777999999999999876542 22
Q ss_pred cEEEeeecccCcccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecC
Q psy14889 207 TQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFG 286 (443)
Q Consensus 207 ~~~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfG 286 (443)
..+++||||+ +++|..+.+...+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~--------~IiHrDiKp~NIL~~~~~~~kl~Dfg 166 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAA--------GIIHRDLKPGNLAVNEDCELKILDFG 166 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT--------TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred ceEEEEEecc-cccHHHHHHhccccHHHHHHHHHHHHHHHHHHHhC--------CCcccccCcchhhccccccccccccc
Confidence 3579999999 46899888888999999999999999999999999 99999999999999999999999999
Q ss_pred CcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCC
Q psy14889 287 LAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVP 366 (443)
Q Consensus 287 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~ 366 (443)
+|+..... .+...||+.|+|||.+.+.. .++.++||||+||++|||++| ..||.+..
T Consensus 167 ~a~~~~~~-------~~~~~~t~~y~aPE~~~~~~-----~~~~~~DiwSlGvil~ell~g----------~~pf~~~~- 223 (346)
T d1cm8a_ 167 LARQADSE-------MTGYVVTRWYRAPEVILNWM-----RYTQTVDIWSVGCIMAEMITG----------KTLFKGSD- 223 (346)
T ss_dssp TCEECCSS-------CCSSCSCGGGCCTHHHHTTT-----CCCTTHHHHHHHHHHHHHHHS----------SCSSCCSS-
T ss_pred ceeccCCc-------cccccccccccCHHHHcCCC-----CCCccchhhcchHHHHHHHHC----------cCCCCCCC-
Confidence 99766432 23457999999999987642 456899999999999999999 55664421
Q ss_pred CCCChHHHHhhhhhcCC--------------------CCCCCC---CCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 367 MDPSFDDMRKVICIDQQ--------------------RPVLPN---RWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 367 ~~~~~~~~~~~~~~~~~--------------------~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
....+......... .+.... .......++.+.+|+.+||..||++|||+.|+++
T Consensus 224 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~ 300 (346)
T d1cm8a_ 224 ---HLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300 (346)
T ss_dssp ---HHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ---hHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 11111111100000 000000 0011234567899999999999999999999987
Q ss_pred H--HHHHh
Q psy14889 424 T--LIKLA 429 (443)
Q Consensus 424 ~--L~~l~ 429 (443)
. ++.+.
T Consensus 301 Hp~f~~~~ 308 (346)
T d1cm8a_ 301 HPYFESLH 308 (346)
T ss_dssp SGGGTTTC
T ss_pred ChhhCcCC
Confidence 4 55544
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-46 Score=357.34 Aligned_cols=261 Identities=22% Similarity=0.274 Sum_probs=187.7
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCc---cchHHHHHHHHHHhccCCCceeeeeeccccCCc----c
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDE---ASWSRETEIYSTVLLRHENILGYIGSDMTSRNS----C 206 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~---~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~----~ 206 (443)
++|++.+.||+|+||+||+|++ +|+.||||++..... .......|+..+..++||||+++++++...... .
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 7899999999999999999998 589999998754322 122234566666669999999999998654211 1
Q ss_pred cEEEeeecccCcccHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEec
Q psy14889 207 TQLWLVTHYHSFGSLYDHLN-RTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADF 285 (443)
Q Consensus 207 ~~~~lv~e~~~~gsL~~~l~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~Df 285 (443)
..+++||||+.++++..+.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+||
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~--------~ivHrDlKp~NILl~~~~~~kl~df 161 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN--------KILHRDMKAANVLITRDGVLKLADF 161 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHT--------TEECCCCCGGGEEECTTSCEEECCC
T ss_pred ceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccC--------CEEecCcCchheeecCCCcEEeeec
Confidence 35799999999877776654 36799999999999999999999999 9999999999999999999999999
Q ss_pred CCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCC
Q psy14889 286 GLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLV 365 (443)
Q Consensus 286 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~ 365 (443)
|+++.+...............||+.|+|||++.+.. .++.++|||||||++|||++| +.||.+..
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~-----~~~~k~DiwSlGvil~el~~g----------~~pf~~~~ 226 (318)
T d3blha1 162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGER-----DYGPPIDLWGAGCIMAEMWTR----------SPIMQGNT 226 (318)
T ss_dssp TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCS-----SCCTHHHHHHHHHHHHHHHHS----------SCSCCCSS
T ss_pred ceeeecccccccccccccceecCHHHhhHHHHcCCC-----CCCcHHHcccCCceeeeHhhC----------CCCCCCCC
Confidence 999876654433333344568999999999987642 466899999999999999999 55554321
Q ss_pred CCCCChHHHHhhhhhcCCC-CCCCCCC------------------C-----CchhHHHHHHHHHHHhcCCcCCCCcHHHH
Q psy14889 366 PMDPSFDDMRKVICIDQQR-PVLPNRW------------------V-----SDSTLNAMTKVMKECWHQNANVRLSALRV 421 (443)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~-~~~~~~~------------------~-----~~~~~~~l~~li~~cl~~dP~~Rps~~ev 421 (443)
............... +...... . .......+.+||.+||+.||++|||++|+
T Consensus 227 ----~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~el 302 (318)
T d3blha1 227 ----EQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302 (318)
T ss_dssp ----HHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred ----HHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHH
Confidence 111111111100000 0000000 0 00113467899999999999999999999
Q ss_pred HH
Q psy14889 422 KK 423 (443)
Q Consensus 422 l~ 423 (443)
++
T Consensus 303 L~ 304 (318)
T d3blha1 303 LN 304 (318)
T ss_dssp HH
T ss_pred Hc
Confidence 85
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-46 Score=362.19 Aligned_cols=260 Identities=20% Similarity=0.222 Sum_probs=191.3
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccchHHHHHHHHHHhccCCCceeeeeeccccCC--cccEEEe
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIGSDMTSRN--SCTQLWL 211 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~--~~~~~~l 211 (443)
.+|+..++||+|+||+||+|++ +|+.||||++..... ...+|. ..+..++||||+++++++..... ...+++|
T Consensus 20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~Ei--~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-FKNREL--QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-SCCHHH--HHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-HHHHHH--HHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 3689999999999999999998 589999999865432 233444 44555999999999999865422 2246899
Q ss_pred eecccCcccHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCC-cEEEEecC
Q psy14889 212 VTHYHSFGSLYDHLN----RTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNG-TCVIADFG 286 (443)
Q Consensus 212 v~e~~~~gsL~~~l~----~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~-~~kl~DfG 286 (443)
||||+++|.+..+.. ...+++.++..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~--------~IiHrDiKp~NILl~~~~~~~kl~DFG 168 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF--------GICHRDIKPQNLLLDPDTAVLKLCDFG 168 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT--------TEECCCCCGGGEEECTTTCCEEECCCT
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc--------CCcccCCCcceEEEecCCCceeEeccc
Confidence 999998764443332 35799999999999999999999998 999999999999999775 89999999
Q ss_pred CcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCC
Q psy14889 287 LAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVP 366 (443)
Q Consensus 287 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~ 366 (443)
+++.+..... .....||..|+|||.+.+.. .++.++|||||||++|||++| ..||....
T Consensus 169 ~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~-----~~~~~~DIwSlG~il~el~~g----------~~pf~~~~- 227 (350)
T d1q5ka_ 169 SAKQLVRGEP-----NVSYICSRYYRAPELIFGAT-----DYTSSIDVWSAGCVLAELLLG----------QPIFPGDS- 227 (350)
T ss_dssp TCEECCTTSC-----CCSCCSCTTSCCHHHHTTCS-----SCCTHHHHHHHHHHHHHHHHT----------SCSSCCSS-
T ss_pred chhhccCCcc-----cccccccccccChHHhhccc-----CCCcceeecccceEEEehhhC----------CCCCCCCC-
Confidence 9987654322 23457999999999887542 567899999999999999999 56665421
Q ss_pred CCCChHHHHhhhhh--------------cCCCCCCCCC-------CCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH--
Q psy14889 367 MDPSFDDMRKVICI--------------DQQRPVLPNR-------WVSDSTLNAMTKVMKECWHQNANVRLSALRVKK-- 423 (443)
Q Consensus 367 ~~~~~~~~~~~~~~--------------~~~~~~~~~~-------~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~-- 423 (443)
..+.+..++.. ......++.. ......++++.+|+.+||+.||++|||+.|+++
T Consensus 228 ---~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp 304 (350)
T d1q5ka_ 228 ---GVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS 304 (350)
T ss_dssp ---HHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred ---HHHHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCH
Confidence 11111111110 0001111100 112235678999999999999999999999986
Q ss_pred HHHHHhh
Q psy14889 424 TLIKLAC 430 (443)
Q Consensus 424 ~L~~l~~ 430 (443)
.++++.+
T Consensus 305 ~f~~~~~ 311 (350)
T d1q5ka_ 305 FFDELRD 311 (350)
T ss_dssp GGGGGGC
T ss_pred hhccccC
Confidence 3555544
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.6e-46 Score=355.77 Aligned_cols=263 Identities=20% Similarity=0.211 Sum_probs=200.6
Q ss_pred hccccccceeeeecCeEEEEEEE--CCceeEEEEeeccC-ccchHHHHHHHHHHhccC-CCceeeeeeccccCCcccEEE
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRD-EASWSRETEIYSTVLLRH-ENILGYIGSDMTSRNSCTQLW 210 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~-~~~~~~e~ei~~~~~l~H-~nIv~l~g~~~~~~~~~~~~~ 210 (443)
.++|++.+.||+|+||+||+|++ +|+.||||++.... ......|.++.. .+.| +|++.+++++... ...+
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~--~l~~~~~i~~~~~~~~~~----~~~~ 77 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYK--LLAGCTGIPNVYYFGQEG----LHNV 77 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHH--HTTTCTTCCCEEEEEEET----TEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHH--HhcCCCCCCEEEEEeecC----CccE
Confidence 46899999999999999999997 58999999875543 233444544444 3655 8999999988765 4579
Q ss_pred eeecccCcccHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcC-----CCcEEEE
Q psy14889 211 LVTHYHSFGSLYDHLNR--TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKT-----NGTCVIA 283 (443)
Q Consensus 211 lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~-----~~~~kl~ 283 (443)
+||||+ +|+|.+++.. ..+++.++..++.|++.||+|||+. +|+||||||+|||++. ++.+||+
T Consensus 78 ~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~--------giiHrDiKp~Nili~~~~~~~~~~vkl~ 148 (293)
T d1csna_ 78 LVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK--------SLVYRDIKPDNFLIGRPNSKNANMIYVV 148 (293)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTT--------TEECCCCCGGGEEECCSSSTTTTCEEEC
T ss_pred EEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHC--------CceeccCCccceeecCcccccCCceEEc
Confidence 999998 5799998864 5699999999999999999999998 9999999999999975 5689999
Q ss_pred ecCCcccccccCCcCC---CCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCC
Q psy14889 284 DFGLAVSYSQLSNKMD---IPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAP 360 (443)
Q Consensus 284 DfGla~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P 360 (443)
|||+|+.+........ .......||+.|||||++.+. .++.++|||||||++|||+|| ..|
T Consensus 149 DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~------~~~~~~DiwSlG~~l~elltg----------~~P 212 (293)
T d1csna_ 149 DFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGR------EQSRRDDLEALGHVFMYFLRG----------SLP 212 (293)
T ss_dssp CCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC------CCCHHHHHHHHHHHHHHHHHS----------SCT
T ss_pred ccceeEEcccCccccceeecccCceEEchhhcCHHHhcCC------CCChHHHHHHhhHHHHHHHhC----------CCc
Confidence 9999987764332221 123456899999999999876 678899999999999999999 778
Q ss_pred CCCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHHHHHHHhhcc
Q psy14889 361 YHDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKKTLIKLACAD 432 (443)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~l~~~~ 432 (443)
|....... ............ .....+ .....+++++.+++..||..+|++||+++.+.+.|+++.+..
T Consensus 213 f~~~~~~~-~~~~~~~i~~~~-~~~~~~--~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~ 280 (293)
T d1csna_ 213 WQGLKAAT-NKQKYERIGEKK-QSTPLR--ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 280 (293)
T ss_dssp TSSCCSCC-HHHHHHHHHHHH-HHSCHH--HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred CCCccchh-HHHHHHHHHhcc-CCCChH--HhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence 86543221 111111111111 111100 011235678999999999999999999999999999887644
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.7e-46 Score=360.31 Aligned_cols=251 Identities=21% Similarity=0.259 Sum_probs=190.0
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccchHHHHHHHHHHhc-cCCCceeeeeeccccCCcccEEEee
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEASWSRETEIYSTVLL-RHENILGYIGSDMTSRNSCTQLWLV 212 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~e~ei~~~~~l-~H~nIv~l~g~~~~~~~~~~~~~lv 212 (443)
++|++.+.||+|+||+||+|+. +|+.||||++.........+|.++ +..+ .||||+++++++..... ..+++|
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~i--l~~l~~hpnIv~~~~~~~~~~~--~~~~~v 110 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKI--LENLRGGPNIITLADIVKDPVS--RTPALV 110 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHH--HHHHTTSTTBCCEEEEEECTTT--CSEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHH--HHhccCCCCCcEEEEEEEecCC--CceeEE
Confidence 6799999999999999999998 589999999876555444455544 4446 49999999999875543 357999
Q ss_pred ecccCcccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCC-cEEEEecCCcccc
Q psy14889 213 THYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNG-TCVIADFGLAVSY 291 (443)
Q Consensus 213 ~e~~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~-~~kl~DfGla~~~ 291 (443)
|||+.+|+|..+. +.+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+|+..
T Consensus 111 ~e~~~~~~L~~~~--~~l~e~~i~~i~~qil~aL~~LH~~--------gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~ 180 (328)
T d3bqca1 111 FEHVNNTDFKQLY--QTLTDYDIRFYMYEILKALDYCHSM--------GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 180 (328)
T ss_dssp EECCCSCBGGGTT--TSCCHHHHHHHHHHHHHHHHHHHHT--------TEECCCCSGGGEEEETTTTEEEECCGGGCEEC
T ss_pred EeecCCCcHHHHh--cCCCHHHHHHHHHHHHHHHHHHhhc--------ccccccccccceEEcCCCCeeeecccccceec
Confidence 9999999998775 4699999999999999999999999 999999999999998765 6899999999876
Q ss_pred cccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCCCh
Q psy14889 292 SQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDPSF 371 (443)
Q Consensus 292 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~~~ 371 (443)
..... .....||+.|+|||.+.+.. .++.++||||+||++|||++| ..||..... ..
T Consensus 181 ~~~~~-----~~~~~~t~~y~aPE~~~~~~-----~~~~~~DiwslG~~l~e~~~g----------~~pf~~~~~---~~ 237 (328)
T d3bqca1 181 HPGQE-----YNVRVASRYFKGPELLVDYQ-----MYDYSLDMWSLGCMLASMIFR----------KEPFFHGHD---NY 237 (328)
T ss_dssp CTTCC-----CCSCCSCGGGCCHHHHTTCC-----CCCTHHHHHHHHHHHHHHHHT----------CSSSSCCSS---HH
T ss_pred cCCCc-----ccccccCccccCcccccCCC-----CCCcccchhhhhhhhHHhccC----------CCCCCCCch---hH
Confidence 54322 24457899999999987652 456899999999999999999 555543211 11
Q ss_pred HHHHhhhh------------h------------cC--CCC---CCCCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHH
Q psy14889 372 DDMRKVIC------------I------------DQ--QRP---VLPNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVK 422 (443)
Q Consensus 372 ~~~~~~~~------------~------------~~--~~~---~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl 422 (443)
........ . .. ... ..........+++++.+||++||+.||++|||++|++
T Consensus 238 ~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L 317 (328)
T d3bqca1 238 DQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM 317 (328)
T ss_dssp HHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 10000000 0 00 000 0001111233567899999999999999999999997
Q ss_pred H
Q psy14889 423 K 423 (443)
Q Consensus 423 ~ 423 (443)
+
T Consensus 318 ~ 318 (328)
T d3bqca1 318 E 318 (328)
T ss_dssp T
T ss_pred c
Confidence 5
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-46 Score=355.16 Aligned_cols=249 Identities=25% Similarity=0.383 Sum_probs=193.8
Q ss_pred ccccccceeeeecCeEEEEEEE-----CCceeEEEEeeccC-------ccchHHHHHHHHHHhccC-CCceeeeeecccc
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW-----HGENVAVKIFFSRD-------EASWSRETEIYSTVLLRH-ENILGYIGSDMTS 202 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~-----~~~~vAvK~~~~~~-------~~~~~~e~ei~~~~~l~H-~nIv~l~g~~~~~ 202 (443)
++|++.+.||+|+||+||+|+. +|+.||||++.... .....+|.++ +.+++| |||+++++++.+.
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~i--l~~l~h~pnIv~~~~~~~~~ 101 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQV--LEHIRQSPFLVTLHYAFQTE 101 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHH--HHHHHTCTTBCCEEEEEEET
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHH--HHhccCCCeEEEeeeeeccC
Confidence 6799999999999999999986 37899999875321 1223345444 444767 8999999998877
Q ss_pred CCcccEEEeeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEE
Q psy14889 203 RNSCTQLWLVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCV 281 (443)
Q Consensus 203 ~~~~~~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~k 281 (443)
..++++|||+.+|+|.+++.. ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+|
T Consensus 102 ----~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~--------~ivHrDiKp~Nill~~~~~vk 169 (322)
T d1vzoa_ 102 ----TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKL--------GIIYRDIKLENILLDSNGHVV 169 (322)
T ss_dssp ----TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT--------TCCCCCCCGGGEEECTTSCEE
T ss_pred ----CceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcC--------CEEeccCCccceeecCCCCEE
Confidence 458999999999999999864 5788999999999999999999999 999999999999999999999
Q ss_pred EEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCC
Q psy14889 282 IADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPY 361 (443)
Q Consensus 282 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~ 361 (443)
|+|||+|+.+....... .....||+.|+|||.+.+... .++.++|||||||+||||+|| ..||
T Consensus 170 L~DFG~a~~~~~~~~~~---~~~~~g~~~~~~pe~~~~~~~----~~~~ksDIWSlG~iLyelltG----------~~PF 232 (322)
T d1vzoa_ 170 LTDFGLSKEFVADETER---AYDFCGTIEYMAPDIVRGGDS----GHDKAVDWWSLGVLMYELLTG----------ASPF 232 (322)
T ss_dssp ESCSSEEEECCGGGGGG---GCGGGSCCTTCCHHHHTTCC-------CTHHHHHHHHHHHHHHHHS----------SCTT
T ss_pred Eeeccchhhhccccccc---ccccccccccchhHHhhcCCc----CCCchhhhHHHHHHHHHHHhC----------CCCC
Confidence 99999998765433221 234579999999999976522 456799999999999999999 7788
Q ss_pred CCCCCCCCChHHHHhhhhhcCCCCCCCCCCCCchhHHHHHHHHHHHhcCCcCCCCc-----HHHHHH
Q psy14889 362 HDLVPMDPSFDDMRKVICIDQQRPVLPNRWVSDSTLNAMTKVMKECWHQNANVRLS-----ALRVKK 423 (443)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~ 423 (443)
....... ....+.+... ...+.++ ..+++++.+|+.+||+.||++||| ++|+++
T Consensus 233 ~~~~~~~-~~~~i~~~~~--~~~~~~~-----~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 233 TVDGEKN-SQAEISRRIL--KSEPPYP-----QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp SCTTSCC-CHHHHHHHHH--HCCCCCC-----TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred CCCCHHH-HHHHHHHhcc--cCCCCCc-----ccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 6654332 2223322221 1223333 236678999999999999999994 788876
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-45 Score=344.99 Aligned_cols=254 Identities=22% Similarity=0.249 Sum_probs=193.8
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc---chHHHHHHHHHHhccCCCceeeeeeccccCCcccEEE
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA---SWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLW 210 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~---~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~ 210 (443)
++|++.+.||+|+||+||+|++ +|+.||||+++..... ......|+..+..++||||+++++++.+. ...+
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~----~~~~ 77 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD----KKLT 77 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECS----SEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccc----ccee
Confidence 5799999999999999999998 5889999998654322 22334677777779999999999999887 4579
Q ss_pred eeecccCcccHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCcc
Q psy14889 211 LVTHYHSFGSLYDHLNR-TTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLAV 289 (443)
Q Consensus 211 lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~ 289 (443)
+|+|++.+++|..++.. ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||.|+
T Consensus 78 iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~--------~IvHrDiKP~NIli~~~~~~kl~DFG~a~ 149 (292)
T d1unla_ 78 LVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR--------NVLHRDLKPQNLLINRNGELKLANFGLAR 149 (292)
T ss_dssp EEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT--------TEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcC--------CEeeecccCcccccccCCceeeeecchhh
Confidence 99999999999888754 5789999999999999999999998 99999999999999999999999999998
Q ss_pred cccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCCC
Q psy14889 290 SYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMDP 369 (443)
Q Consensus 290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~~ 369 (443)
........ .....++..|+|||.+.... .++.++|||||||++|||++| ..||.... .
T Consensus 150 ~~~~~~~~----~~~~~~~~~~~~pe~~~~~~-----~~~~~~DiwSlG~il~ell~g----------~~p~~~~~---~ 207 (292)
T d1unla_ 150 AFGIPVRC----YSAEVVTLWYRPPDVLFGAK-----LYSTSIDMWSAGCIFAELANA----------GRPLFPGN---D 207 (292)
T ss_dssp ECCSCCSC----CCSCCSCGGGCCHHHHTTCS-----CCCTHHHHHHHHHHHHHHTTT----------SCCSCCCS---S
T ss_pred cccCCCcc----ceeeccccchhhhhHhccCC-----CCCchhhccccchHHHHHhhC----------CCCCCCCC---C
Confidence 76543322 23346778999999987652 356899999999999999999 44543211 1
Q ss_pred ChHHHHhhhhhcCC-----------------CCCC----CCCCCCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 370 SFDDMRKVICIDQQ-----------------RPVL----PNRWVSDSTLNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 370 ~~~~~~~~~~~~~~-----------------~~~~----~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
..+.+......... .+.. .........++.+.+|+.+||+.||++|||++|+++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 208 VDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp HHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11111111110000 0000 000112234578999999999999999999999875
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-45 Score=355.83 Aligned_cols=260 Identities=20% Similarity=0.255 Sum_probs=191.1
Q ss_pred hccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccc---hHHHHHHHHHHhccCCCceeeeeeccccCC-cccE
Q psy14889 135 AKQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEAS---WSRETEIYSTVLLRHENILGYIGSDMTSRN-SCTQ 208 (443)
Q Consensus 135 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~---~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~-~~~~ 208 (443)
.++|++.+.||+|+||+||+|+. +|+.||||++....... .....|+..+..++|||||++++++..... ....
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 47899999999999999999997 58999999986543221 122456666777999999999999864421 1122
Q ss_pred EEeeecccCcccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCc
Q psy14889 209 LWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA 288 (443)
Q Consensus 209 ~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla 288 (443)
.+++++|+.+|+|.+++..+.+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+|++|||++
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~~l~e~~~~~i~~qil~aL~~LH~~--------giiHrDiKp~NILi~~~~~~kl~dfg~a 168 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA--------DIIHRDLKPSNLAVNEDCELKILDFGLA 168 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT--------TCCCCCCCGGGEEECTTCCEEECCC---
T ss_pred eEEEEEeecCCchhhhcccccccHHHHHHHHHHHHHHHHHHHhC--------CCcccccCCccccccccccccccccchh
Confidence 45667788899999999888999999999999999999999999 9999999999999999999999999998
Q ss_pred ccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCC
Q psy14889 289 VSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMD 368 (443)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~ 368 (443)
....... ....||+.|+|||.+.+.. .++.++|||||||++|||++| ..||.+..
T Consensus 169 ~~~~~~~-------~~~~g~~~y~apE~~~~~~-----~~~~~~DiwSlGv~l~~ll~g----------~~pF~~~~--- 223 (348)
T d2gfsa1 169 RHTDDEM-------TGYVATRWYRAPEIMLNWM-----HYNQTVDIWSVGCIMAELLTG----------RTLFPGTD--- 223 (348)
T ss_dssp -CCTGGG-------SSSCHHHHTSCHHHHTTCS-----CCCTTHHHHHHHHHHHHHHHS----------SCSCCCSS---
T ss_pred cccCccc-------ccccccccccCchhhcCCc-----cCCcccchhhhhHHHHHHHhC----------CCCCCCCC---
Confidence 6554322 3457999999999877652 346899999999999999999 55664321
Q ss_pred CChHHHHhhhhhc--------------------CCCCCCCCCC---CCchhHHHHHHHHHHHhcCCcCCCCcHHHHHH--
Q psy14889 369 PSFDDMRKVICID--------------------QQRPVLPNRW---VSDSTLNAMTKVMKECWHQNANVRLSALRVKK-- 423 (443)
Q Consensus 369 ~~~~~~~~~~~~~--------------------~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~-- 423 (443)
.......+.... ...+..+... .....+.++.+||.+||+.||++|||+.|+++
T Consensus 224 -~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp 302 (348)
T d2gfsa1 224 -HIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 302 (348)
T ss_dssp -HHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred -HHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCH
Confidence 011111111000 0001111100 01234567899999999999999999999987
Q ss_pred HHHHH
Q psy14889 424 TLIKL 428 (443)
Q Consensus 424 ~L~~l 428 (443)
.++++
T Consensus 303 ~f~~~ 307 (348)
T d2gfsa1 303 YFAQY 307 (348)
T ss_dssp GGTTT
T ss_pred hhCCC
Confidence 35444
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-44 Score=349.99 Aligned_cols=258 Identities=22% Similarity=0.270 Sum_probs=181.2
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCcc---chHHHHHHHHHHhccCCCceeeeeeccccCC--cccE
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEA---SWSRETEIYSTVLLRHENILGYIGSDMTSRN--SCTQ 208 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~---~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~--~~~~ 208 (443)
++|++.++||+|+||+||+|++ +|+.||||++...... ......|+..+..++|||||++++++..... ....
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 6899999999999999999998 5899999998654322 1223456666667999999999999875432 2357
Q ss_pred EEeeecccCcccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCc
Q psy14889 209 LWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA 288 (443)
Q Consensus 209 ~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla 288 (443)
+|+||||+.++.+ +.+. ..+++..+..++.||+.||.|||+. ||+||||||+|||++.++.+|++|||++
T Consensus 97 ~~iv~Ey~~~~l~-~~~~-~~~~~~~i~~~~~qil~gl~~LH~~--------giiHrDlKP~Nil~~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 97 VYLVMELMDANLC-QVIQ-MELDHERMSYLLYQMLCGIKHLHSA--------GIIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_dssp EEEEEECCSEEHH-HHHT-SCCCHHHHHHHHHHHHHHHHHHHHT--------TCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred eEEEEeccchHHH-Hhhh-cCCCHHHHHHHHHHHHHHHHHhhhc--------ccccccCCccccccccccceeeechhhh
Confidence 8999999986544 4443 4689999999999999999999999 9999999999999999999999999998
Q ss_pred ccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCCcccccCCCCCCCCCCC
Q psy14889 289 VSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANGIFEEYKAPYHDLVPMD 368 (443)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~~~~~~~~P~~~~~~~~ 368 (443)
+....... .....||+.|+|||++.+. .+++++||||+||++|||++| ..||.+.....
T Consensus 167 ~~~~~~~~-----~~~~~~t~~y~aPE~l~~~------~~~~~~DiwSlG~~l~ell~g----------~~pF~~~~~~~ 225 (355)
T d2b1pa1 167 RTAGTSFM-----MTPYVVTRYYRAPEVILGM------GYKENVDIWSVGCIMGEMVRH----------KILFPGRDYID 225 (355)
T ss_dssp -------------------CCTTCCHHHHTTC------CCCTTHHHHHHHHHHHHHHHS----------SCSSCCSSHHH
T ss_pred hccccccc-----cccccccccccChhhhcCC------CCCCCcccccccchHHHHhhC----------CCCCCCCCHHH
Confidence 76554322 2345799999999999876 677899999999999999999 55554321000
Q ss_pred ------------------CChHHHHhhhhhcCCCCCC-----------CC-CCCCchhHHHHHHHHHHHhcCCcCCCCcH
Q psy14889 369 ------------------PSFDDMRKVICIDQQRPVL-----------PN-RWVSDSTLNAMTKVMKECWHQNANVRLSA 418 (443)
Q Consensus 369 ------------------~~~~~~~~~~~~~~~~~~~-----------~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~ 418 (443)
................... +. .......++++.+|+.+||+.||++|||+
T Consensus 226 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta 305 (355)
T d2b1pa1 226 QWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 305 (355)
T ss_dssp HHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCH
T ss_pred HHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCH
Confidence 0000000011000000000 00 00012346789999999999999999999
Q ss_pred HHHHHH
Q psy14889 419 LRVKKT 424 (443)
Q Consensus 419 ~evl~~ 424 (443)
+|+++.
T Consensus 306 ~elL~H 311 (355)
T d2b1pa1 306 DDALQH 311 (355)
T ss_dssp HHHHTS
T ss_pred HHHhcC
Confidence 999853
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.7e-40 Score=322.41 Aligned_cols=256 Identities=19% Similarity=0.221 Sum_probs=177.1
Q ss_pred ccccccceeeeecCeEEEEEEE--CCceeEEEEeeccCccchHHHHHHHHHHhc-----------cCCCceeeeeecccc
Q psy14889 136 KQISLSECIGKGRYGEVWRGVW--HGENVAVKIFFSRDEASWSRETEIYSTVLL-----------RHENILGYIGSDMTS 202 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~e~ei~~~~~l-----------~H~nIv~l~g~~~~~ 202 (443)
++|++.++||+|+||+||+|+. +|+.||||+++.........+.|+..+..+ .|+||+++++++...
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 4699999999999999999997 689999999875533222333444433333 468899999988765
Q ss_pred CCcccEEEeeecccCccc-HHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCCC
Q psy14889 203 RNSCTQLWLVTHYHSFGS-LYDHL---NRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTNG 278 (443)
Q Consensus 203 ~~~~~~~~lv~e~~~~gs-L~~~l---~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~~ 278 (443)
.. ...+++++++..+. ..... ....+++..+..++.||+.||+|||+.. +|+||||||+|||++.++
T Consensus 93 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~-------~IvHrDlKp~NIll~~~~ 163 (362)
T d1q8ya_ 93 GP--NGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC-------GIIHTDIKPENVLMEIVD 163 (362)
T ss_dssp ET--TEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT-------CEECSCCSGGGEEEEEEE
T ss_pred cc--cceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc-------CcccccCChhHeeeeccC
Confidence 44 23455555544333 22222 2357899999999999999999999831 899999999999998765
Q ss_pred ------cEEEEecCCcccccccCCcCCCCCCCcccccCcccccccccccccCcCCCCCccchHHHHHHHHHHHhcccCCC
Q psy14889 279 ------TCVIADFGLAVSYSQLSNKMDIPPNPRVGTKRYMSPEILDESINMDCFESFKKADIYALGLVLWEVCRRTKANG 352 (443)
Q Consensus 279 ------~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~sDvwS~Gvvl~elltg~~~~~ 352 (443)
.+|++|||.|...... .....||+.|+|||++... .++.++||||+||+++||++|+
T Consensus 164 ~~~~~~~~kl~dfg~s~~~~~~-------~~~~~gt~~y~aPE~~~~~------~~~~~~DiwSlG~il~el~~g~---- 226 (362)
T d1q8ya_ 164 SPENLIQIKIADLGNACWYDEH-------YTNSIQTREYRSPEVLLGA------PWGCGADIWSTACLIFELITGD---- 226 (362)
T ss_dssp TTTTEEEEEECCCTTCEETTBC-------CCSCCSCGGGCCHHHHHTC------CCCTHHHHHHHHHHHHHHHHSS----
T ss_pred cccccceeeEeecccccccccc-------cccccccccccChhhcccc------CCCccccccchHHHHHHHHHCC----
Confidence 3899999998755432 2345799999999999876 6778999999999999999994
Q ss_pred cccccCCCCCCCCCCCC--ChHHHHhhhhhcC---------------------CCCCCC-------------CCCCCchh
Q psy14889 353 IFEEYKAPYHDLVPMDP--SFDDMRKVICIDQ---------------------QRPVLP-------------NRWVSDST 396 (443)
Q Consensus 353 ~~~~~~~P~~~~~~~~~--~~~~~~~~~~~~~---------------------~~~~~~-------------~~~~~~~~ 396 (443)
.||........ ..+.+...+..-+ ...... ........
T Consensus 227 ------~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (362)
T d1q8ya_ 227 ------FLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDE 300 (362)
T ss_dssp ------CCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHH
T ss_pred ------CCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCccc
Confidence 44443211100 0001111000000 000000 00112346
Q ss_pred HHHHHHHHHHHhcCCcCCCCcHHHHHH
Q psy14889 397 LNAMTKVMKECWHQNANVRLSALRVKK 423 (443)
Q Consensus 397 ~~~l~~li~~cl~~dP~~Rps~~evl~ 423 (443)
++++.+|+.+||..||.+|||++|+++
T Consensus 301 ~~~~~dll~~mL~~dP~~Rpta~e~L~ 327 (362)
T d1q8ya_ 301 AKEISDFLSPMLQLDPRKRADAGGLVN 327 (362)
T ss_dssp HHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred CHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 788999999999999999999999986
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.91 E-value=8.9e-25 Score=192.39 Aligned_cols=132 Identities=16% Similarity=0.145 Sum_probs=101.8
Q ss_pred ccccceeeeecCeEEEEEEE-CCceeEEEEeeccCc-------------cc------hHHHHHHHHHHhccCCCceeeee
Q psy14889 138 ISLSECIGKGRYGEVWRGVW-HGENVAVKIFFSRDE-------------AS------WSRETEIYSTVLLRHENILGYIG 197 (443)
Q Consensus 138 ~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~-------------~~------~~~e~ei~~~~~l~H~nIv~l~g 197 (443)
+.+.++||+|+||+||+|.. +|+.||||+++.... .. ...+.|...+..+.|.+++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 35678999999999999987 789999998643110 01 11134555666689999998876
Q ss_pred eccccCCcccEEEeeecccCcccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhcCCCCCCeEEeCCCCCCEEEcCC
Q psy14889 198 SDMTSRNSCTQLWLVTHYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGTQGKPAIAHRDIKSKNILVKTN 277 (443)
Q Consensus 198 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~~~~~~iiHrDlk~~NiLl~~~ 277 (443)
+.. .+++|||++++.+.+ ++......++.|++.||.|||+. +|+||||||+|||++++
T Consensus 82 ~~~--------~~lvme~~~~~~~~~------l~~~~~~~i~~ql~~~l~~lH~~--------giiHrDiKP~NILv~~~ 139 (191)
T d1zara2 82 WEG--------NAVLMELIDAKELYR------VRVENPDEVLDMILEEVAKFYHR--------GIVHGDLSQYNVLVSEE 139 (191)
T ss_dssp EET--------TEEEEECCCCEEGGG------CCCSCHHHHHHHHHHHHHHHHHT--------TEECSCCSTTSEEEETT
T ss_pred ecC--------CEEEEEeeccccccc------hhhHHHHHHHHHHHHHHHHHhhC--------CEEEccCChhheeeeCC
Confidence 521 269999999865543 45566778999999999999998 99999999999999865
Q ss_pred CcEEEEecCCccccc
Q psy14889 278 GTCVIADFGLAVSYS 292 (443)
Q Consensus 278 ~~~kl~DfGla~~~~ 292 (443)
.++|+|||+|+...
T Consensus 140 -~~~liDFG~a~~~~ 153 (191)
T d1zara2 140 -GIWIIDFPQSVEVG 153 (191)
T ss_dssp -EEEECCCTTCEETT
T ss_pred -CEEEEECCCcccCC
Confidence 58999999986554
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.25 E-value=3.5e-06 Score=75.35 Aligned_cols=144 Identities=15% Similarity=0.065 Sum_probs=91.4
Q ss_pred ccccccceeeeecCeEEEEEEECCceeEEEEeeccCc---cchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEee
Q psy14889 136 KQISLSECIGKGRYGEVWRGVWHGENVAVKIFFSRDE---ASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLV 212 (443)
Q Consensus 136 ~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~---~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv 212 (443)
+.|+..+..+-++.+.||+...++..+.||+...... .....|.++..... .+--+.+++.+.... ...++|
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~-~~vpvP~vl~~~~~~----~~~~lv 88 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLE-GKLPVPKVLHFERHD----GWSNLL 88 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHT-TTSCCCCEEEEEEET----TEEEEE
T ss_pred hceEEEEcCCCCCCCcEEEEEeCCCeEEEEEcCCCcccchhhHHHHHHHHHHHh-ccCCCCcEEEEEecC----CceEEE
Confidence 4566555544445578999887888899998754332 22334444433321 222245556554433 346899
Q ss_pred ecccCcccHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchhcC------------------------------------
Q psy14889 213 THYHSFGSLYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIFGT------------------------------------ 256 (443)
Q Consensus 213 ~e~~~~gsL~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~------------------------------------ 256 (443)
|++.++.++.+.... ......++.+++..+..||+.....
T Consensus 89 ~~~l~G~~~~~~~~~----~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (263)
T d1j7la_ 89 MSEADGVLCSEEYED----EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPF 164 (263)
T ss_dssp EECCSSEEHHHHTTT----CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSC
T ss_pred EEecccccccccccc----cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccc
Confidence 999999888765432 2223445677777788888642110
Q ss_pred ---------------CCCCCeEEeCCCCCCEEEcCCCcEEEEecCCc
Q psy14889 257 ---------------QGKPAIAHRDIKSKNILVKTNGTCVIADFGLA 288 (443)
Q Consensus 257 ---------------~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla 288 (443)
...+.++|+|+.|.|||+++++.+-|+||+.+
T Consensus 165 ~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a 211 (263)
T d1j7la_ 165 KDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRS 211 (263)
T ss_dssp SSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTC
T ss_pred hHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhc
Confidence 01235899999999999998777789999876
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.05 E-value=7.8e-06 Score=72.56 Aligned_cols=135 Identities=16% Similarity=0.049 Sum_probs=81.8
Q ss_pred eeeeecC-eEEEEEEEC-CceeEEEEeeccCccchHHHHHHHHHHhccCCCceeeeeeccccCCcccEEEeeecccCccc
Q psy14889 143 CIGKGRY-GEVWRGVWH-GENVAVKIFFSRDEASWSRETEIYSTVLLRHENILGYIGSDMTSRNSCTQLWLVTHYHSFGS 220 (443)
Q Consensus 143 ~lG~G~f-g~Vy~~~~~-~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e~~~~gs 220 (443)
.+..|.. +.||+...+ +..+.+|............|.+.+....-..-.+.+++++..+. ...++||+|+++-+
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~----~~~~~v~~~i~G~~ 92 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEA----GRDWLLLGEVPGQD 92 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECS----SCEEEEEECCSSEE
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCHhHHHHHHHHHHHHHhcCCCCCceeeecccc----cceEEEEEeeeccc
Confidence 3444543 678998874 55688897766555556667666655332333355666665544 34689999998866
Q ss_pred HHHHhcccCCCHHHHHHHHHHHHHHHHHHHHchh----------------------------------------------
Q psy14889 221 LYDHLNRTTLNHHQMMKICLSIVNGLVHLHTEIF---------------------------------------------- 254 (443)
Q Consensus 221 L~~~l~~~~l~~~~~~~i~~qia~gL~yLH~~~~---------------------------------------------- 254 (443)
+.+.. ... ...+.+++..|.-||+...
T Consensus 93 ~~~~~----~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 165 (255)
T d1nd4a_ 93 LLSSH----LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARL 165 (255)
T ss_dssp TTTSC----CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHH
T ss_pred ccccc----ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHH
Confidence 53311 111 1122334444444443110
Q ss_pred ----cCCCCCCeEEeCCCCCCEEEcCCCcEEEEecCCc
Q psy14889 255 ----GTQGKPAIAHRDIKSKNILVKTNGTCVIADFGLA 288 (443)
Q Consensus 255 ----~~~~~~~iiHrDlk~~NiLl~~~~~~kl~DfGla 288 (443)
.....+.++|+|+.|.|||++++..+-|+||+.+
T Consensus 166 ~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~ 203 (255)
T d1nd4a_ 166 KARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRL 203 (255)
T ss_dssp HHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTC
T ss_pred HHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhc
Confidence 0112345899999999999998777789999876
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.25 E-value=0.00098 Score=62.76 Aligned_cols=29 Identities=17% Similarity=0.320 Sum_probs=25.0
Q ss_pred CCeEEeCCCCCCEEEcCCCcEEEEecCCcc
Q psy14889 260 PAIAHRDIKSKNILVKTNGTCVIADFGLAV 289 (443)
Q Consensus 260 ~~iiHrDlk~~NiLl~~~~~~kl~DfGla~ 289 (443)
+.++|+|+.+.|||++++. ++|+||..|.
T Consensus 223 ~~LiHGDl~~gNIlv~~~~-~~vID~E~a~ 251 (392)
T d2pula1 223 ETLIHGDLHTGSIFASEHE-TKVIDPEFAF 251 (392)
T ss_dssp CEEECSCCCGGGEEECSSC-EEECCCTTCE
T ss_pred cceeccCCcCCceeEcCCc-eEEechhhcc
Confidence 3689999999999998765 8999998873
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.35 E-value=0.0066 Score=56.84 Aligned_cols=75 Identities=15% Similarity=0.138 Sum_probs=43.5
Q ss_pred cccccceeeeecCeEEEEEEEC---------CceeEEEEeeccCccchHHHHHHHHHHhccCCCc-eeeeeeccccCCcc
Q psy14889 137 QISLSECIGKGRYGEVWRGVWH---------GENVAVKIFFSRDEASWSRETEIYSTVLLRHENI-LGYIGSDMTSRNSC 206 (443)
Q Consensus 137 ~~~~~~~lG~G~fg~Vy~~~~~---------~~~vAvK~~~~~~~~~~~~e~ei~~~~~l~H~nI-v~l~g~~~~~~~~~ 206 (443)
++++ +.|+-|-.-.+|+.... ++.|.+++.- .......++.|...+..+.-.++ .++++++..
T Consensus 44 ~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----- 116 (395)
T d1nw1a_ 44 HLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NPETESHLVAESVIFTLLSERHLGPKLYGIFSG----- 116 (395)
T ss_dssp GEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT-----
T ss_pred ceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-CcchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC-----
Confidence 4444 56777888899998863 2456666553 32233334444444443432344 467776532
Q ss_pred cEEEeeecccCcccH
Q psy14889 207 TQLWLVTHYHSFGSL 221 (443)
Q Consensus 207 ~~~~lv~e~~~~gsL 221 (443)
.+|+||+++..|
T Consensus 117 ---g~I~efi~g~~l 128 (395)
T d1nw1a_ 117 ---GRLEEYIPSRPL 128 (395)
T ss_dssp ---EEEECCCCEEEC
T ss_pred ---ceEEEEeccccC
Confidence 588999987544
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.29 E-value=0.012 Score=53.49 Aligned_cols=29 Identities=24% Similarity=0.206 Sum_probs=23.7
Q ss_pred CCCeEEeCCCCCCEEEcCCCcEEEEecCCcc
Q psy14889 259 KPAIAHRDIKSKNILVKTNGTCVIADFGLAV 289 (443)
Q Consensus 259 ~~~iiHrDlk~~NiLl~~~~~~kl~DfGla~ 289 (443)
..++||+|+.+.|||++++ ..++||+-+.
T Consensus 191 p~~liHgDlh~~NvL~~~~--~~~IDFdd~~ 219 (325)
T d1zyla1 191 TVLRLHGDCHAGNILWRDG--PMFVDLDDAR 219 (325)
T ss_dssp CCEECCSSCSGGGEEESSS--EEECCCTTCC
T ss_pred CceeecCCCCcccEEEeCC--ceEEechhcc
Confidence 4589999999999999743 4589998763
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.79 E-value=0.049 Score=48.68 Aligned_cols=30 Identities=20% Similarity=0.330 Sum_probs=27.0
Q ss_pred CCCeEEeCCCCCCEEEcCCCcEEEEecCCc
Q psy14889 259 KPAIAHRDIKSKNILVKTNGTCVIADFGLA 288 (443)
Q Consensus 259 ~~~iiHrDlk~~NiLl~~~~~~kl~DfGla 288 (443)
..++||+|+.+.||+++.+...-|.||+.+
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~ 211 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFA 211 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTC
T ss_pred ccccccCCcchhhhhcccccceeEeccccc
Confidence 448999999999999998887889999976
|
| >d2h62c1 g.7.1.3 (C:34-117) BMP receptor Ia ectodomain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Snake toxin-like superfamily: Snake toxin-like family: Extracellular domain of cell surface receptors domain: BMP receptor Ia ectodomain species: Human (Homo sapiens) [TaxId: 9606]
Probab=86.50 E-value=0.12 Score=36.22 Aligned_cols=30 Identities=37% Similarity=0.784 Sum_probs=22.3
Q ss_pred ccccCCC--CCeeEecCCCCCCCCCCCCCCCC
Q psy14889 3 SCHSVNV--GQFTIQCCDGDFCNNGSFPILPP 32 (443)
Q Consensus 3 ~~~~~~~--~~~~~~~~~~~~c~~~~~~~~~~ 32 (443)
.|++... +.+..+||++|+||.+..+.+||
T Consensus 53 ~C~~~~~~~~~~~~~CC~~D~CN~~l~P~lpP 84 (84)
T d2h62c1 53 QCKDSPKAQLRRTIECCRTNLCNQYLQPTLPP 84 (84)
T ss_dssp HHHCCTTCSSCEEEEEECSTTGGGGCCCCCCC
T ss_pred EeCCCCCCCCceEEEeCCCCccCcCCcCCCCc
Confidence 3554433 46788999999999998877665
|
| >d1btea_ g.7.1.3 (A:) Type II activin receptor {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Snake toxin-like superfamily: Snake toxin-like family: Extracellular domain of cell surface receptors domain: Type II activin receptor species: Mouse (Mus musculus) [TaxId: 10090]
Probab=84.92 E-value=0.063 Score=38.45 Aligned_cols=20 Identities=25% Similarity=0.674 Sum_probs=17.3
Q ss_pred CCeeEecCCCCCCCCCCCCC
Q psy14889 10 GQFTIQCCDGDFCNNGSFPI 29 (443)
Q Consensus 10 ~~~~~~~~~~~~c~~~~~~~ 29 (443)
.+..||||.||+||..++..
T Consensus 73 ~~~~FCCC~gd~CN~nfs~~ 92 (96)
T d1btea_ 73 PEVYFCCCEGNMCNEKFSYF 92 (96)
T ss_dssp CSSEEEEECSTTGGGSEEEC
T ss_pred CceEEEeCCCCccccccccC
Confidence 47899999999999987754
|